Citrus Sinensis ID: 003772
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 796 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.953 | 0.912 | 0.365 | 1e-134 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.924 | 0.844 | 0.350 | 1e-114 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.900 | 0.864 | 0.346 | 1e-103 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.905 | 0.882 | 0.323 | 6e-90 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.876 | 0.842 | 0.320 | 2e-86 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.840 | 0.839 | 0.325 | 4e-86 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.856 | 0.782 | 0.294 | 2e-83 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.363 | 0.352 | 0.48 | 1e-75 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.937 | 0.875 | 0.296 | 3e-72 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.876 | 0.822 | 0.301 | 2e-69 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 480 bits (1236), Expect = e-134, Method: Compositional matrix adjust.
Identities = 310/847 (36%), Positives = 465/847 (54%), Gaps = 88/847 (10%)
Query: 1 MASSVYAVLILLLTISGITNVAQQQHPQPKSIGLGSSLSPTKQ---PGSWNSSLGAFQFG 57
M S +++ L+L + T Q+ + S+ +G SL+ ++ SW S G F FG
Sbjct: 1 MGSLSCSIIHLVLILQLQTFFVFSQNIRNGSVPVGESLTASESQQISSSWRSPSGDFAFG 60
Query: 58 FYK--QDAGFKVGIWLLTFPDITIVWTAYRDDPP---VSSNAALTLTKDGKLILRTEEGH 112
F K + GF + IW D TIVW A + V + + +TLT DG L++ G
Sbjct: 61 FRKIQPNDGFTLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIADPRGQ 120
Query: 113 D--KVVAAGKSEPASSASMLDSGNFVLYNNRSD----IIWSSFKIPTDTILGNQSLLAGN 166
+ + ++ G S D GNFVL+ + S+ ++WSSF+ PTDT+L NQ++ G
Sbjct: 121 ELWRALSGGS---VSRGRFTDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGR 177
Query: 167 ELFSRISETSSSTGRFRLNMQRDGNLVLYPIN----TIDDYTEAYWASDSQRERQ--LHL 220
L SR +ETS GRF L ++ DGNL L+ +N + D Y+ S++ + L
Sbjct: 178 NLSSRRTETSFKKGRFSLRLEDDGNLQLHSLNAETASESDIYSQYYESNTNDPNNPGIQL 237
Query: 221 YLSNTGNLVLL--DDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSHYPVPKGAYNT 278
+ +G + +L ++S ++KD P + SI I +L +PK A
Sbjct: 238 VFNQSGEIYVLQRNNSRFVVKD--RDP--DFSIAAPFYISTGFLLSTI----IPKEARRI 289
Query: 279 ---------SVDWNVPDDLCEVKTFCGLNSYCTLYDDQ-PMCRCLPGTDFLDPNQTSSGC 328
+ PDD CG N+ C+L +++ P C C DP+ C
Sbjct: 290 VGGCLLGLCRDNMCSPDDALG-NMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDC 348
Query: 329 ERKFVDERCKGINISAE-----YNMTSMEKMTW--DDYYYFKASITKEECKESCLEDCEC 381
F + C+ N +A Y ++EK W DY + A+ +E CK SCL DC C
Sbjct: 349 LPDFEMQTCRPENQTANSDVNLYEFITLEKTNWPFGDYESY-ANYDEERCKASCLSDCLC 407
Query: 382 DVALYEESVDDKPSYCTKQKLPLKSAKRDLKNSSSSIAYFKTGIRNITTSSNNTNSAMPQ 441
++ + D K C K+K PL +R + S + + K R+I + +P
Sbjct: 408 AAVIFGTNRDLK---CWKKKFPLSHGERSPRGDSDT--FIKVRNRSI--------ADVPV 454
Query: 442 DRNRSKKAIILILVITIGLVTCSCAFLTFSGVFIFKYQVLKYEWLLENGSLGL------- 494
NR+KK LI+ ++ L T AF+ F ++ + K + +++N + +
Sbjct: 455 TGNRAKKLDWLIIACSVLLGTS--AFVIFDTSCSYR-KTKKSKNMMKNQARDIGRTTATT 511
Query: 495 -AYESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMVTE 550
A E NLR F+Y EL +AT F EELG+G+FG VYKG L E VAVKKL+++ +
Sbjct: 512 TANELNLRVFTYGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLD 571
Query: 551 GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWD 610
E+EF+ E+ VIG+ HHKNLVRLIG+C E +++VYE++ G+LA+ LFR P S W+
Sbjct: 572 NEKEFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFRRPRPS--WE 629
Query: 611 ERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670
+R IA +A+GILYLH+EC IIHCDIKPQNIL+DE++T +ISDFGLAKLL+ +QT T
Sbjct: 630 DRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYT 689
Query: 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA 730
T +RGT+GY+APEW++N+PI+ K DV+SYGV+LLEIVCC++ ++++ + ++LINWA
Sbjct: 690 LTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKKAVDLE----DNVILINWA 745
Query: 731 YKCFIDRELNKLVRGQEV---DRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787
Y CF L L D T+E +KI +WC+Q+E +RP+M++V MLEG+ +
Sbjct: 746 YDCFRQGRLEDLTEDDSEAMNDMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQV 805
Query: 788 SIPPCPT 794
PP P+
Sbjct: 806 FDPPNPS 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 412 bits (1058), Expect = e-114, Method: Compositional matrix adjust.
Identities = 286/815 (35%), Positives = 427/815 (52%), Gaps = 79/815 (9%)
Query: 32 IGLGSSLSPTKQPGSWNSSLGAFQFGF--YKQDAGFKVGIWLLTFP-DITIVWTAYRDDP 88
IGLGS L ++ +W S+ G F GF +K F + IW P D TIVW+ R+ P
Sbjct: 30 IGLGSKLKASEPNRAWVSANGTFAIGFTRFKPTDRFLLSIWFAQLPGDPTIVWSPNRNSP 89
Query: 89 PVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLYNNR---SDII 145
V+ A L L G L+L +++ + + SA M +SGNF+L I
Sbjct: 90 -VTKEAVLELEATGNLVL-SDQNTVVWTSNTSNHGVESAVMSESGNFLLLGTEVTAGPTI 147
Query: 146 WSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNM-QRDGNLVL---YPINTID 201
W SF P+DT+L NQ L EL S S S G + L M Q+ +L L Y IN
Sbjct: 148 WQSFSQPSDTLLPNQPLTVSLELTSNPSP--SRHGHYSLKMLQQHTSLSLGLTYNINLDP 205
Query: 202 DYTEAYWASD--SQRERQLHLYLSNTGN--LVLLDDSMGIIKDLYESPS------NNSS- 250
+YW+ S + L +TG+ +V + S+G + +Y++P NNSS
Sbjct: 206 HANYSYWSGPDISNVTGDVTAVLDDTGSFKIVYGESSIGAVY-VYKNPVDDNRNYNNSSN 264
Query: 251 -------IIRRLTIGHNGILRLFSHYPVPKGAYNTSVDWNVPDDLCEVKTFCGLNSYCTL 303
++RRL + +NG LRL+ G+ +W + C++ CG N C L
Sbjct: 265 LGLTKNPVLRRLVLENNGNLRLYRWDNDMNGSSQWVPEWAAVSNPCDIAGICG-NGVCNL 323
Query: 304 --YDDQPMCRCLPGTDFLDPNQTSSGC--ERKFVDERCKGINISAEYNMTSMEKMTWDDY 359
C CLPG+ L + + C V E IN + + ++++++ +Y
Sbjct: 324 DRTKKNADCLCLPGSVKLPDQENAKLCSDNSSLVQECESNINRNGSFKISTVQET---NY 380
Query: 360 YYFKASITK--------EECKESCLEDCECDVALYEESVDDKPSYCTKQKLPLKSAKRDL 411
Y+ + S+ + +C E CL DC+C ++Y +DD+ YC LKS
Sbjct: 381 YFSERSVIENISDISNVRKCGEMCLSDCKCVASVY--GLDDEKPYC----WILKSLNFGG 434
Query: 412 KNSSSSIAYFKTGIRNITTSSNNTNSAMPQDRNRSKKAIILILVITIGLVTCSCAFLTFS 471
S + KT S++N N + + ++ + +L++ I +G++ +
Sbjct: 435 FRDPGSTLFVKTRANESYPSNSNNNDSKSR-KSHGLRQKVLVIPIVVGML----VLVALL 489
Query: 472 GVFIFKYQVLKYEWLLENGSLGLAYESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGT 531
G+ ++ Y + + L L + SF+Y +L+ TN F + LG G FG VYKGT
Sbjct: 490 GMLLY-YNLDRKRTLKRAAKNSLILCDSPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGT 548
Query: 532 LYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591
+ GE LVAVK+L++ ++ GEREF E++ IG HH NLVRL GYC+EDS RLLVYEYM
Sbjct: 549 V-AGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMI 607
Query: 592 NGSLADILFRGPERS--LGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF 649
NGSL +F + + L W R IA A+GI Y H++C IIHCDIKP+NIL+D+
Sbjct: 608 NGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDN 667
Query: 650 WTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC 709
+ K+SDFGLAK++ + + T++RGTRGY+APEW N PI+VKADV+SYG++LLEIV
Sbjct: 668 FCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVG 727
Query: 710 CRRNMEIDPSKPEEIVLINWAYKCF--------IDRELNKLVRGQEVDRNTLENMIKIGL 761
RRN+++ E+ WAYK +D+ L + +EV + +K+
Sbjct: 728 GRRNLDMS-YDAEDFFYPGWAYKELTNGTSLKAVDKRLQGVAEEEEVVK-----ALKVAF 781
Query: 762 WCVQDEPALRPSMKSVVLMLEGITD-ISIPPCPTS 795
WC+QDE ++RPSM VV +LEG +D I++PP P +
Sbjct: 782 WCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMPQT 816
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 376 bits (965), Expect = e-103, Method: Compositional matrix adjust.
Identities = 273/789 (34%), Positives = 384/789 (48%), Gaps = 72/789 (9%)
Query: 31 SIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPV 90
+I LGS + + +W S F F + + ++F +W+A V
Sbjct: 26 TIPLGSVIYASGSNQNWPSPNSTFSVSFVPSPSPNSF-LAAVSFAGSVPIWSA----GTV 80
Query: 91 SSNAALTLTKDGKLILRTEEGHDKVVAAGKSE--PASSASMLDSGNFVLYNNRSDIIWSS 148
S +L L G L R G V K++ +S S+ D+G F+L NNRS +WSS
Sbjct: 81 DSRGSLRLHTSGSL--RLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSS 138
Query: 149 FKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYW 208
F PTDTI+ +Q+ AG L S G + ++R GNL L + +
Sbjct: 139 FDNPTDTIVQSQNFTAGKILRS---------GLYSFQLERSGNLTLRWNTSAIYWNHGLN 189
Query: 209 ASDSQRERQLHLYLSNTGNLVLLDDSM-GIIKDLYESPSNNSSIIRRLTIGHNGILRLFS 267
+S S L L G + + + ++ G + +Y +S+ R L + +G LR++S
Sbjct: 190 SSFSSNLSSPRLSLQTNGVVSIFESNLLGGAEIVYSGDYGDSNTFRFLKLDDDGNLRIYS 249
Query: 268 HYPVPKGAYNTSVDWNVPDDLCEVKTFCGLNSYCTLYDDQPMCRCLP-GTDFLDPNQTSS 326
G N W+ D C V +CG C+ D P+C C DF+D N
Sbjct: 250 SASRNSGPVN--AHWSAVDQ-CLVYGYCGNFGICSYNDTNPICSCPSRNFDFVDVNDRRK 306
Query: 327 GCERKFVDERCKGINISAEYNMTSMEKMTWDD----YYYFKASITKEECKESCLEDCECD 382
GC+RK C G + T + T++D +F S C+ +CL C
Sbjct: 307 GCKRKVELSDCSGNTTMLDLVHTRL--FTYEDDPNSESFFAGS---SPCRANCLSSVLC- 360
Query: 383 VALYEESVDDKPSYCTKQKLPLKSAKRDLKNSSSSIAYFKTGIRNITTSSNNTNSAMPQD 442
L S+ D C QK P S S +Y K + +N A D
Sbjct: 361 --LASVSMSDGSGNCW-QKHPGSFFTGYQWPSVPSTSYVKVCGPVV---ANTLERATKGD 414
Query: 443 RNRSKKAIILILV-----------ITIGLVTCSCAFLTFSGVFIFKYQVLKYEWLLENGS 491
N SK + ++ V + IGL C C G Y +L+Y +
Sbjct: 415 DNNSKVHLWIVAVAVIAGLLGLVAVEIGLWWCCCRKNPRFGTLSSHYTLLEY-------A 467
Query: 492 LGLAYESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG 551
G + F+Y EL++ T FKE+LG G FG VY+G L +VAVK+LE + +G
Sbjct: 468 SGAPVQ-----FTYKELQRCTKSFKEKLGAGGFGTVYRGVL-TNRTVVAVKQLEG-IEQG 520
Query: 552 EREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFR-GPERSLGWD 610
E++FR E+ I THH NLVRLIG+C++ RLLVYE+M NGSL + LF + L W+
Sbjct: 521 EKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWE 580
Query: 611 ERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR- 669
R IA AKGI YLH+EC I+HCDIKP+NIL+D+ + AK+SDFGLAKLL P R
Sbjct: 581 YRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRY 640
Query: 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW 729
+ VRGTRGY+APEW N PI+ K+DV+SYG+VLLE+V +RN ++ + I W
Sbjct: 641 NMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSI-W 699
Query: 730 AYKCFIDREL-----NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
AY+ F +L Q VD + M+K WC+Q++P RP+M VV MLEGI
Sbjct: 700 AYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGI 759
Query: 785 TDISIPPCP 793
T+I P CP
Sbjct: 760 TEIKNPLCP 768
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 332 bits (852), Expect = 6e-90, Method: Compositional matrix adjust.
Identities = 264/816 (32%), Positives = 385/816 (47%), Gaps = 95/816 (11%)
Query: 34 LGSSLS-PTKQPGSWNSSLGAFQFGFYK-QDAGFKVGIWL-----LTFPDITIVWTAYRD 86
LGSSL + + + SS G F GFY+ F +W + TIVW+A D
Sbjct: 34 LGSSLVVESYESSTLQSSDGTFSSGFYEVYTHAFTFSVWYSKTEAAAANNKTIVWSANPD 93
Query: 87 DPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKS-EPASSASMLDSGNFVLYNNRSDII 145
P + +ALTL KDG ++L +G A G + A +LD+GN V+ ++ + +
Sbjct: 94 RPVHARRSALTLQKDGNMVLTDYDGAAVWRADGNNFTGVQRARLLDTGNLVIEDSGGNTV 153
Query: 146 WSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTE 205
W SF PTDT L Q + A L S FR + VL I + ++
Sbjct: 154 WQSFDSPTDTFLPTQLITAATRLVPTTQSRSPGNYIFRFSDLS----VLSLIYHVPQVSD 209
Query: 206 AYWASDSQRERQLHLYLSNTGNLVLLDDSMGII--KDLYESPSNNSS-----IIRRLTIG 258
YW Q Q N+ L +L DS G++ D + + +S + RRLT+
Sbjct: 210 IYWPDPDQNLYQDGRNQYNSTRLGMLTDS-GVLASSDFADGQALVASDVGPGVKRRLTLD 268
Query: 259 HNGILRLFSHYPVPKGAYNTS-VDWNVPDDLCEVKTFCGLNSYCTLYDDQPMCRCLPGTD 317
+G LRL+S G+++ S V P C + CG N C Y P C C PG
Sbjct: 269 PDGNLRLYSMND-SDGSWSVSMVAMTQP---CNIHGLCGPNGICH-YSPTPTCSCPPGYA 323
Query: 318 FLDPNQTSSGCERKFVDERCKGINISAEYNMTSMEKMT------WDDYYYFKASITKEEC 371
+P + GC V+ C Y+ SM + W S++ C
Sbjct: 324 TRNPGNWTEGC-MAIVNTTCD------RYDKRSMRFVRLPNTDFWGSDQQHLLSVSLRTC 376
Query: 372 KESCLEDCECDVALYEESVDDKPSYCTKQKLPLKSAKRDLKNSSSSIAYFK--TGIR--N 427
++ C+ DC C Y+E C + + R S Y K TG+ N
Sbjct: 377 RDICISDCTCKGFQYQEGTGS----CYPKAYLF--SGRTYPTSDVRTIYLKLPTGVSVSN 430
Query: 428 ITTSSNNTNSAMPQ--DRNRSKKAI-----------------ILILVITIGLVTCSCAFL 468
++ ++P+ D +R K+I +F+
Sbjct: 431 ALIPRSDVFDSVPRRLDCDRMNKSIREPFPDVHKTGGGESKWFYFYGFIAAFFVVEVSFI 490
Query: 469 TFSGVFIFKYQVLKYE-WLLENGSLGLAYESNLRSFSYNELKKATNRFKEELGKGSFGAV 527
+F+ F+ K ++ E W E G + SN R +SY EL KAT +FK ELG+G G V
Sbjct: 491 SFAWFFVLKRELRPSELWASEKGYKAMT--SNFRRYSYRELVKATRKFKVELGRGESGTV 548
Query: 528 YKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587
YKG L + ++ VAVKKLE V +G+ F+AE+ VIGR +H NLVR+ G+C+E S RLLV
Sbjct: 549 YKGVL-EDDRHVAVKKLEN-VRQGKEVFQAELSVIGRINHMNLVRIWGFCSEGSHRLLVS 606
Query: 588 EYMSNGSLADILF-RGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM 646
EY+ NGSLA+ILF G L W+ R IA VAKG+ YLH EC +IHCD+KP+NIL+
Sbjct: 607 EYVENGSLANILFSEGGNILLDWEGRFNIALGVAKGLAYLHHECLEWVIHCDVKPENILL 666
Query: 647 DEFWTAKISDFGLAKLL-MPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLL 705
D+ + KI+DFGL KLL T+ + VRGT GY+APEW + PI+ K DV+SYGVVLL
Sbjct: 667 DQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTLGYIAPEWVSSLPITAKVDVYSYGVVLL 726
Query: 706 EIVCCRRNMEIDPSKPEEIVLINWAYKC---------------FIDRELNKLVRGQEVDR 750
E++ R E+ E ++ + ++D +LN+ V+
Sbjct: 727 ELLTGTRVSELVGGTDEVHSMLRKLVRMLSAKLEGEEQSWIDGYLDSKLNR-----PVNY 781
Query: 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786
+IK+ + C++++ + RP+M+ V L D
Sbjct: 782 VQARTLIKLAVSCLEEDRSKRPTMEHAVQTLLSADD 817
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (820), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 253/790 (32%), Positives = 382/790 (48%), Gaps = 92/790 (11%)
Query: 49 SSLGAFQFGFYK--QDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLIL 106
SS G ++ GF+K + F +G+W TI+W A RD N+++ +G LIL
Sbjct: 40 SSDGTYEMGFFKPGSSSNFYIGMWYKQLSQ-TILWVANRDKAVSDKNSSVFKISNGNLIL 98
Query: 107 RTEEGHDKVVAAG----KSEPASSASMLDSGNFVLYNNRS----DIIWSSFKIPTDTILG 158
V + G S A A + D GN VL S +++W SF P DT L
Sbjct: 99 LDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWLP 158
Query: 159 ------NQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWAS-- 210
++ L S S S G F L + Y I + + + YW+S
Sbjct: 159 GVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDES---TAYKI--LWNGSNEYWSSGP 213
Query: 211 --------DSQRERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGI 262
DS E +L+ Y+ N DS +Y N + R + +G
Sbjct: 214 WNPQSRIFDSVPEMRLN-YIYNFSFFSNTTDSY-FTYSIY-----NQLNVSRFVMDVSGQ 266
Query: 263 LRLFSHYPVPKGAYNTSVDWNVPDDLCEVKTFCGLNSYCTLYDDQPMCRCLPGTDFL--- 319
++ F+ K A+N + W+ P C+V +CG C+ +P CRC G +
Sbjct: 267 IKQFTWLEGNK-AWN--LFWSQPRQQCQVYRYCGSFGICS-DKSEPFCRCPQGFRPMSQK 322
Query: 320 --DPNQTSSGCERKFVDERCKGINISAEYNMTSMEKMTWDDYYYFKASITKEECKESCLE 377
D S+GC RK + +C +I+ + + +M K+ + + S++ C +C
Sbjct: 323 DWDLKDYSAGCVRK-TELQCSRGDINQFFRLPNM-KLADNSEVLTRTSLSI--CASACQG 378
Query: 378 DCECDVALYEESVDDKPSYCTKQKLPLKSAKRDLKNSSSSIAYFK---TGIRNITTSSNN 434
DC C Y+E K +K L L+ + + NS +I Y + + + N+ S +
Sbjct: 379 DCSCKAYAYDEG-SSKCLVWSKDVLNLQQLEDE--NSEGNIFYLRLAASDVPNVGASGKS 435
Query: 435 TNSAMPQDRNRSKKAIILILVITIGLVTCSCAFLTFSGVFIFKYQVLKYEWLLENGSLGL 494
N + I ++ ++G++ + + + + G
Sbjct: 436 NNKGL----------IFGAVLGSLGVIVLVLLVVILILRYRRRKR-----------MRGE 474
Query: 495 AYESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE 554
+ L +FSY EL+ AT F ++LG G FG+V+KG L +AVK+LE +++GE++
Sbjct: 475 KGDGTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSD-IAVKRLEG-ISQGEKQ 532
Query: 555 FRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERS---LGWDE 611
FR E+ IG H NLVRL G+C+E SK+LLVY+YM NGSL LF LGW
Sbjct: 533 FRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKL 592
Query: 612 RVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671
R +IA A+G+ YLHDEC IIHCDIKP+NIL+D + K++DFGLAKL+ D +R
Sbjct: 593 RFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVL 652
Query: 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLI-NWA 730
T +RGTRGY+APEW I+ KADV+SYG++L E+V RRN E S+ E++ +WA
Sbjct: 653 TTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTE--QSENEKVRFFPSWA 710
Query: 731 YKCFI-DRELNKLV----RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785
D ++ LV G VD + K+ WC+QDE + RP+M VV +LEG+
Sbjct: 711 ATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVL 770
Query: 786 DISIPPCPTS 795
+++ PP P S
Sbjct: 771 EVNPPPFPRS 780
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (819), Expect = 4e-86, Method: Compositional matrix adjust.
Identities = 248/762 (32%), Positives = 363/762 (47%), Gaps = 93/762 (12%)
Query: 54 FQFGFYKQDAG---FKVGIWLLTFPDITIVWTAYRDDPPVSSNAA-LTLTKDGKLILRTE 109
F+ GF+ G + +GI + P T VW A R P +++ L LT G LI+
Sbjct: 40 FRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPDSSTLELTSTGYLIVSNL 99
Query: 110 EGHDKVV-AAGKSEPASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNEL 168
D VV +P + ++GN +L N+ +W SF PTDT L ++ +
Sbjct: 100 --RDGVVWQTDNKQPGTDFRFSETGNLILINDDGSPVWQSFDNPTDTWLPGMNVTGLTAM 157
Query: 169 FSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQRERQL---------H 219
S S S G + L + N + T YW++ + +
Sbjct: 158 TSWRSLFDPSPGFYSLRLSPSFN----EFQLVYKGTTPYWSTGNWTGEAFVGVPEMTIPY 213
Query: 220 LYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSHYPVPKGAYNTS 279
+Y + N S I +S S + R +G NG L+ ++ P + ++N
Sbjct: 214 IYRFHFVNPYTPTASFWYIVPPLDSVSEPR--LTRFMVGANGQLKQYTWDPQTQ-SWN-- 268
Query: 280 VDWNVPDDLCEVKTFCGLNSYCTLYDDQPMCRCLPGTDFLDPNQT-------SSGCERKF 332
+ W P+D C V CG +C+ +P C C+ G F N S GC R+
Sbjct: 269 MFWLQPEDPCRVYNLCGQLGFCSSELLKP-CACIRG--FRPRNDAAWRSDDYSDGCRREN 325
Query: 333 VDERCKGINISAEYNMTSMEKMTWD-DYYYFKASITKEECKESCLEDCECDVALYEESVD 391
D K A + + +D D + ++K C ++CL + C V Y +
Sbjct: 326 GDSGEKSDTFEA------VGDLRYDGDVKMSRLQVSKSSCAKTCLGNSSC-VGFYHK--- 375
Query: 392 DKPSYCTKQKLPLKSAKRDLKNSSSSIAYFKTGIRNITTSSNNTNSAMPQDRNRSKKAII 451
+K + C K+ L+S +LKNS +I SK II
Sbjct: 376 EKSNLC---KILLESPN-NLKNSKGNI---------------------------SKSIII 404
Query: 452 LILVITIGLVTCSCAFLTFSGVFIFKYQVLKYEWLLENGSLGLAYESNLRSFSYNELKKA 511
L V+ + S T I + K + + G A NL+ FS+ EL+ A
Sbjct: 405 LCSVVG----SISVLGFTLLVPLILLKRSRKRKKTRKQDEDGFAVL-NLKVFSFKELQSA 459
Query: 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLV 571
TN F +++G G FGAV+KGTL VAVK+LE+ GE EFRAE+ IG H NLV
Sbjct: 460 TNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLER-PGSGESEFRAEVCTIGNIQHVNLV 518
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
RL G+C+E+ RLLVY+YM GSL+ L R + L W+ R RIA AKGI YLH+ C
Sbjct: 519 RLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWETRFRIALGTAKGIAYLHEGCR 578
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
IIHCDIKP+NIL+D + AK+SDFGLAKLL D +R +RGT GY+APEW PI
Sbjct: 579 DCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGLPI 638
Query: 692 SVKADVFSYGVVLLEIVCCRRNMEIDP-------SKPEEIVLINWAYKCFIDRELNKLVR 744
+ KADV+S+G+ LLE++ RRN+ ++ ++PE+ WA + I ++ +V
Sbjct: 639 TTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAREIIQGNVDSVVD 698
Query: 745 GQ---EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783
+ E + + M + +WC+QD +RP+M +VV MLEG
Sbjct: 699 SRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 310 bits (795), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 240/814 (29%), Positives = 369/814 (45%), Gaps = 132/814 (16%)
Query: 44 PGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGK 103
PG +SS G F F D+G + +W++ RD P VSS+ + LT G
Sbjct: 64 PGGDDSSTG-FYFSVVHVDSG-------------STIWSSNRDSP-VSSSGTMNLTPQGI 108
Query: 104 LILRTEEGHDKVVAAGK---SEPASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQ 160
++ E+G ++ + P S + D+GN +L ++ + +W SF PTD+I+ Q
Sbjct: 109 SVI--EDGKSQIPVWSTPVLASPVKSLRLTDAGNLLLLDHLNVSLWESFDFPTDSIVLGQ 166
Query: 161 SLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQRERQL-- 218
L G L +S + STG ++ + L+ + + YW +
Sbjct: 167 RLKLGMFLSGSVSRSDFSTGDYKFLVGESDGLMQW-------RGQNYWKLRMHIRANVDS 219
Query: 219 -----HLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSHYPVPK 273
+L ++ +G ++ + ++ + PS++ + + + G + R
Sbjct: 220 NFPVEYLTVTTSGLALMARNGTVVVVRVALPPSSDFRVAKMDSSGKFIVSRF-------- 271
Query: 274 GAYNTSVDWNVPDDLCEVKTFCGLNSYCTLYDDQPMCRCLPGTDFLDPNQTSSGCERKFV 333
N +++ P D C++ CG C L D NQ+ S C +
Sbjct: 272 SGKNLVTEFSGPMDSCQIPFVCGKLGLCNL-------------DNASENQSCS-CPDEMR 317
Query: 334 DERCKGINISAEYNMT---SMEKMTWD------DYYYFKASITKE--------ECKESCL 376
+ KG+ + +++ S E YF T C + C
Sbjct: 318 MDAGKGVCVPVSQSLSLPVSCEARNISYLELGLGVSYFSTHFTDPVEHGLPLLACHDICS 377
Query: 377 EDCECDVALYEESVDDKPSYCTKQKLPLKSAKRDLKNSSSSIAYFKTGIRNITTSSNNTN 436
++C C YE + + Y K S ++ + I Y K IR TN
Sbjct: 378 KNCSCLGVFYENT--SRSCYLVKDSFGSLSLVKNSPENHDLIGYVKLSIRK-------TN 428
Query: 437 SAMPQDRNRSKKAIILILVITIGLVTCSCAFLTFSGVFIF--KYQVLKYEWL-------- 486
+ P + NR + +I ++ L+ CS FL + ++ + V++Y +
Sbjct: 429 AQPPGNNNRGGSSFPVIALV---LLPCSGFFLLIALGLLWWRRCAVMRYSSIREKQVTRP 485
Query: 487 --LENGSLGLAYESNL-RSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKK 543
E+G LG + L + F + EL++AT FK ++G G FG+VYKGTL E L+AVKK
Sbjct: 486 GSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTL-PDETLIAVKK 544
Query: 544 LEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGP 603
+ G +EF E+ +IG H NLV+L G+CA + LLVYEYM++GSL LF G
Sbjct: 545 ITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGN 604
Query: 604 ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663
L W ER IA A+G+ YLH C+ IIHCD+KP+NIL+ + + KISDFGL+KLL
Sbjct: 605 GPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLL 664
Query: 664 MPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEE 723
+++ FT +RGTRGY+APEW N IS KADV+SYG+VLLE+V R+N S+
Sbjct: 665 NQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFR-SRSNS 723
Query: 724 IVLIN---------------------------WAYKCFIDRELNKLVRGQEVDRNTLENM 756
+ N Y D L V QE E +
Sbjct: 724 VTEDNNQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEA-----EKL 778
Query: 757 IKIGLWCVQDEPALRPSMKSVVLMLEGITDISIP 790
++I L CV +EPALRP+M +VV M EG + P
Sbjct: 779 VRIALCCVHEEPALRPTMAAVVGMFEGSIPLGNP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (728), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 144/300 (48%), Positives = 206/300 (68%), Gaps = 11/300 (3%)
Query: 503 FSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVI 562
F+Y +L+ ATN F +LG+G FG+VY+GTL G +L AVKKLE + +G++EFRAE+ +I
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRL-AVKKLEG-IGQGKKEFRAEVSII 540
Query: 563 GRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERS--LGWDERVRIASDVA 620
G HH +LVRL G+CAE + RLL YE++S GSL +FR + L WD R IA A
Sbjct: 541 GSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTA 600
Query: 621 KGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGY 680
KG+ YLH++C+A I+HCDIKP+NIL+D+ + AK+SDFGLAKL+ +Q+ FT +RGTRGY
Sbjct: 601 KGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGY 660
Query: 681 MAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSK-PEEIVLINWAYKCFIDREL 739
+APEW N IS K+DV+SYG+VLLE++ R+N DPS+ E+ ++A+K + +L
Sbjct: 661 LAPEWITNYAISEKSDVYSYGMVLLELIGGRKNY--DPSETSEKCHFPSFAFKKMEEGKL 718
Query: 740 NKLVRGQ----EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPPCPTS 795
+V G+ +V ++ +K LWC+Q++ RPSM VV MLEG+ + PP ++
Sbjct: 719 MDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSST 778
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 273 bits (699), Expect = 3e-72, Method: Compositional matrix adjust.
Identities = 255/861 (29%), Positives = 399/861 (46%), Gaps = 115/861 (13%)
Query: 1 MASSVYAVLILLLTISGITNVAQQQHPQPKSIGLGSSLSPTKQPGSWNSSLGAFQFGFY- 59
M SV+ + LL VA Q K++ GS+L + S+ F+ GF+
Sbjct: 1 MILSVFFYMFLLHIRRLDCFVAVQD---SKTLFKGSTLINDSHGETLVSAGQRFELGFFT 57
Query: 60 ---KQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGH---D 113
D +GIW +T+VW A R+ P + + T++KDG L + +G D
Sbjct: 58 PNGSSDERRYLGIWFYNLHPLTVVWVANRESPVLDRSCIFTISKDGNLEVIDSKGRVYWD 117
Query: 114 KVVAAGKSEPASSASMLDSGNFVLYN--NRSDIIWSSFKIPTDTILGNQSLLAGNELFSR 171
V ++D+GN VL + N ++++W SF+ PTDT L + L S
Sbjct: 118 TGVKPSSVSAERMVKLMDNGNLVLISDGNEANVVWQSFQNPTDTFLPGMRMDENMTLSSW 177
Query: 172 ISETSSSTGRFRLNM--QRDGNLVLYPINTIDDYTEAYWAS--------DSQRERQLHLY 221
S S G F M + D +++ + YW S + + +
Sbjct: 178 RSFNDPSHGNFTFQMDQEEDKQFIIW------KRSMRYWKSGISGKFIGSDEMPYAISYF 231
Query: 222 LSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSHYPVPKGAYNTSVD 281
LSN V + ++ + L+ S N+ R T+ +G + F G +
Sbjct: 232 LSNFTETVTVHNAS--VPPLFTSLYTNT----RFTMSSSGQAQYFRL----DGERFWAQI 281
Query: 282 WNVPDDLCEVKTFCGLNSYCTLYDDQPMCRCLPG--TDFLDP---NQTSSGCERKFVDER 336
W P D C V CG C +++ MC+CLPG +FL+ S GC R+
Sbjct: 282 WAEPRDECSVYNACGNFGSCNSKNEE-MCKCLPGFRPNFLEKWVKGDFSGGCSRESRICG 340
Query: 337 CKGINISAEY-NMTSMEKMTWDDYYYFKASITKEECKESCLEDCECDVALYEESVDDKPS 395
G+ + + N++ +E + D + + ++EC+ CL +C+C YEE VD S
Sbjct: 341 KDGVVVGDMFLNLSVVEVGSPDSQF---DAHNEKECRAECLNNCQCQAYSYEE-VDILQS 396
Query: 396 YCTKQKLPLKSAKRDLKNSSSSIAYFKTGIRN--ITTSSNNTNSAMPQDRNR---SKKAI 450
TK + L+ DL N G RN I + + S + + R R +K +
Sbjct: 397 N-TKCWIWLE----DLNNLKEGY----LGSRNVFIRVAVPDIGSHVERGRGRYGEAKTPV 447
Query: 451 ILILVITIGLVTCSCAFL-----TFSGVFIFKYQVLK-----------------YEWLLE 488
+LI+V+T S A L T S VF+ + +V K + L+E
Sbjct: 448 VLIIVVTF----TSAAILVVLSSTASYVFLQRRKVNKELGSIPRGVHLCDSERHIKELIE 503
Query: 489 NGSLGL--AYESNLRSFSYNELKKATNRFKE--ELGKGSFGAVYKGTLYKGEKLVAVKKL 544
+G + ++ SF + AT+ F +LG+G FG VYKG ++ G++ +AVK+L
Sbjct: 504 SGRFKQDDSQGIDVPSFELETILYATSNFSNANKLGQGGFGPVYKG-MFPGDQEIAVKRL 562
Query: 545 EKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILF-RGP 603
+ +G EF+ E+ +I + H+NLVRL+GYC ++LL+YEYM + SL +F R
Sbjct: 563 SRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDRKL 622
Query: 604 ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663
+ L W R I +A+G+LYLH + IIH D+K NIL+DE KISDFGLA++
Sbjct: 623 CQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIF 682
Query: 664 MPDQTRTFT-LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEI-DPSKP 721
+T T V GT GYM+PE+ S K+DVFS+GVV++E + +RN +P K
Sbjct: 683 GGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEKS 742
Query: 722 EEIVLINWAYKCFIDRELNKLVRGQEVDRNTLE---------NMIKIGLWCVQDEPALRP 772
++ W +L K RG E+ L+ + +GL CVQ++P RP
Sbjct: 743 LSLLGHAW--------DLWKAERGIELLDQALQESCETEGFLKCLNVGLLCVQEDPNDRP 794
Query: 773 SMKSVVLMLEGITDISIPPCP 793
+M +VV ML G ++ + P P
Sbjct: 795 TMSNVVFML-GSSEAATLPTP 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 265 bits (676), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 243/806 (30%), Positives = 367/806 (45%), Gaps = 108/806 (13%)
Query: 54 FQFGFYKQDAGFK--VGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEG 111
F+ GF+ + +GIW D +VW A R P + L ++ DG L+L +G
Sbjct: 51 FELGFFSPGSSTHRFLGIWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLL--DG 108
Query: 112 HDKVVAAGKSEPASS------ASMLDSGNFVLYNNRSD-IIWSSFKIPTDTILGNQSL-- 162
+ V + E +++ S+ D+GNFVL +D IW SF PTDT L +
Sbjct: 109 KNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSETDTDRPIWESFNHPTDTFLPQMRVRV 168
Query: 163 ---LAGNELF-SRISETSSSTGRFRLNMQRDG--NLVLYPINTIDDYTEAYWASDSQRER 216
N F S SET S G + L + G +VL+ N + W S
Sbjct: 169 NPQTGDNHAFVSWRSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNS------ 222
Query: 217 QLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSHYPVPKGAY 276
+ N+ LL + + K L P S+ +L F K Y
Sbjct: 223 ---AIFTGIPNMSLLTNYLYGFK-LSSPPDETGSVYFTYVPSDPSVLLRF------KVLY 272
Query: 277 NTS---VDWNV-----------PDDLCEVKTFCGLNSYCTLYDDQPMCRCLPGTDFLDPN 322
N + + WN PD C+ CG C + +C C+ G + +
Sbjct: 273 NGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSNGICSCIHGYEQVSVG 332
Query: 323 QTSSGCERKFVDERCKGINIS-AEYNMTSMEKMTWDDYYYFKASITK-EECKESCLEDCE 380
S GC R+ +C+ NIS E +++ + D+ + ++ E+C+E CL +C
Sbjct: 333 NWSRGCRRR-TPLKCER-NISVGEDEFLTLKSVKLPDFEIPEHNLVDPEDCRERCLRNCS 390
Query: 381 CDVALYEESVDDKPSYCTKQKLPLKSAKRDLKNSSSSIAYFKTGIRNITTSSNNTNSAMP 440
C+ +Y + +DL + + F+ G ++ +S +
Sbjct: 391 CN------------AYSLVGGIGCMIWNQDLVD----LQQFEAGGSSLHIRL--ADSEVG 432
Query: 441 QDRNRSKKAII---LILVITIGLVT--------------CSCAFLTFSGVFIFKYQVLKY 483
++R ++K A+I L+ VI IG+ C T + V + K
Sbjct: 433 ENR-KTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKE 491
Query: 484 EWLLENGSLGLAYE------SNLRSFSYNELKKATNRF--KEELGKGSFGAVYKGTLYKG 535
+GS+ + E S L FS N + ATN F + ELG+G FG VYKG L G
Sbjct: 492 TTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDG 551
Query: 536 EKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595
+ +AVK+L +G EF+ E+ +I + H+NLVRL+G C E +++LVYEYM N SL
Sbjct: 552 RE-IAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSL 610
Query: 596 ADILFRGPERSL-GWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKI 654
LF +++L W R I +A+G+LYLH + IIH D+K N+L+D KI
Sbjct: 611 DFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKI 670
Query: 655 SDFGLAKLLMPDQTRTFTL-VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRN 713
SDFG+A++ +Q T+ V GT GYM+PE+ SVK+DV+S+GV+LLEIV +RN
Sbjct: 671 SDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRN 730
Query: 714 MEIDPSKPEEIVLINWAYKCFIDRELNKLV----RGQEVDRNTLENMIKIGLWCVQDEPA 769
+ S E LI +A+ + +LV R R L I + + CVQD A
Sbjct: 731 TSLRSS--EHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALR-CIHVAMLCVQDSAA 787
Query: 770 LRPSMKSVVLMLEGIT-DISIPPCPT 794
RP+M SV+LMLE T ++ P PT
Sbjct: 788 ERPNMASVLLMLESDTATLAAPRQPT 813
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 796 | ||||||
| 359477046 | 798 | PREDICTED: G-type lectin S-receptor-like | 0.978 | 0.976 | 0.573 | 0.0 | |
| 225431565 | 791 | PREDICTED: G-type lectin S-receptor-like | 0.973 | 0.979 | 0.563 | 0.0 | |
| 359477052 | 767 | PREDICTED: G-type lectin S-receptor-like | 0.940 | 0.976 | 0.564 | 0.0 | |
| 224093336 | 755 | predicted protein [Populus trichocarpa] | 0.929 | 0.980 | 0.575 | 0.0 | |
| 147867430 | 930 | hypothetical protein VITISV_038238 [Viti | 0.934 | 0.8 | 0.560 | 0.0 | |
| 356546166 | 810 | PREDICTED: G-type lectin S-receptor-like | 0.977 | 0.960 | 0.529 | 0.0 | |
| 357478041 | 854 | Receptor like kinase [Medicago truncatul | 0.927 | 0.864 | 0.537 | 0.0 | |
| 357478045 | 928 | Kinase-like protein [Medicago truncatula | 0.928 | 0.796 | 0.525 | 0.0 | |
| 359477048 | 792 | PREDICTED: G-type lectin S-receptor-like | 0.977 | 0.982 | 0.483 | 0.0 | |
| 359477040 | 774 | PREDICTED: G-type lectin S-receptor-like | 0.943 | 0.970 | 0.508 | 0.0 |
| >gi|359477046|ref|XP_002275786.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 892 bits (2304), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/805 (57%), Positives = 582/805 (72%), Gaps = 26/805 (3%)
Query: 3 SSVYAVLILLLTISGITNVAQQQHPQPKS-IGLGSSLSPTKQPGSWNSSLGAFQFGFYKQ 61
+SV V +LL S A+ P+P + I LGSSLSP +P SW S G F FGFY+Q
Sbjct: 7 ASVSVVYFILLVFSA----AEGAQPKPSNQISLGSSLSPESEPTSWPSRSGQFAFGFYQQ 62
Query: 62 DAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKS 121
F VGIWL+ P+ T+VWTA RDDPPV+SNA L LTKDGKL+LRT++G +K++A +
Sbjct: 63 GLNFAVGIWLVGNPNNTVVWTANRDDPPVNSNATLDLTKDGKLLLRTDQGEEKLIANATT 122
Query: 122 EPASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFS--RISETSSST 179
A+ ASMLDSGNFVLYN SD IW SF PTDTILG QSL G EL S +SE+ S+
Sbjct: 123 A-AAFASMLDSGNFVLYNEDSDPIWESFSFPTDTILGGQSLRTGGELVSISSLSESDHSS 181
Query: 180 GRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQRERQLHLYLSNT-GNLVLL-DDSMGI 237
GRF LNMQ DGNLVLYP +T +AYW++ + HLYL+++ G+L+L +D +G
Sbjct: 182 GRFDLNMQLDGNLVLYPADTAHTPGDAYWSTGTFTSGS-HLYLNDSRGDLLLRRNDDLGS 240
Query: 238 IKDLYESP----SNNSSIIRRLTIGHNGILRLFSHYPVPKGAYNTSVDWNVPDDLCEVKT 293
+ + S + + +I R T+ +G+ RL+SH +++ +V + C+VK+
Sbjct: 241 LTSVLTSSSSINKDANKVIYRATLDVDGVFRLYSHANYNNSEPKITMEESVLNSACDVKS 300
Query: 294 FCGLNSYCTLYDDQPMCRCLPGTDFLDPNQTSSGCERKFVDERCK-GINISAEYNMTSME 352
FCG NS+CT DD+P C CLPG+DF+DPN+ S GC R F +E C+ G + Y + +ME
Sbjct: 301 FCGFNSFCTFADDKPYCDCLPGSDFIDPNRRSLGCGRNFSEEGCRDGEEKAPFYGIKTME 360
Query: 353 KMTWDDYYYFKASITKEECKESCLEDCECDVALYEESVDDKPSYCTKQKLPLKSAKRDLK 412
+ W D+ YF A ++K++C SCLEDC+C ALY + C KQ PL+ RD K
Sbjct: 361 NLNWGDHAYFDAPMSKDDCSNSCLEDCDCGAALYLNGL------CKKQNFPLRYVVRDRK 414
Query: 413 NSSSSIAYFKTGIRNITTSSNNTNSAM-PQDRNRSKKAIILILVITIGLVTCSCAFLTFS 471
SS+ A+ K G+R+I T + S P SKKA++LI+V+++ VTCS L+FS
Sbjct: 415 VSST--AFLKVGMRSIETKNGTFPSPKKPPVIVTSKKAVVLIIVLSLSFVTCSFVALSFS 472
Query: 472 GVFIFKYQVLKYEWLLENGSLGLAYESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGT 531
G FIFKY+VL+Y LLE G+LG A E L+ FSY EL +AT+ FKEELGKGSFGAVYKG
Sbjct: 473 GFFIFKYRVLRYRRLLETGNLGPAKELTLQLFSYKELIRATSGFKEELGKGSFGAVYKGF 532
Query: 532 LYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591
LYK +KLVAVK+LEK+V EGEREF+AEM IGRTHH+NLVRL+GYCAE+S+RLLVYEYMS
Sbjct: 533 LYKSKKLVAVKRLEKIVEEGEREFQAEMRAIGRTHHRNLVRLMGYCAENSRRLLVYEYMS 592
Query: 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT 651
NGSLA++LF R W+ERVRIA DVA+GILYLH+ECE PIIHCDIKPQNILMDEF
Sbjct: 593 NGSLANLLFNAGTRP-HWNERVRIALDVARGILYLHEECETPIIHCDIKPQNILMDEFLN 651
Query: 652 AKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCR 711
AKISDFGLAKLLMPDQTRTFT VRGTRGY+APEW +NTPISVKAD++SYG+VLLEIVCCR
Sbjct: 652 AKISDFGLAKLLMPDQTRTFTGVRGTRGYLAPEWQRNTPISVKADIYSYGIVLLEIVCCR 711
Query: 712 RNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALR 771
+NME+ PEEI+L NW Y+C + REL+KLV + D+ TLE M+K+GLWC+QDEPALR
Sbjct: 712 KNMEVQVKNPEEIILSNWVYQCMVSRELDKLVADEVADKKTLERMVKVGLWCIQDEPALR 771
Query: 772 PSMKSVVLMLEGITDISIPPCPTSS 796
PSMKSVVL+LEGITDI +PPCPT++
Sbjct: 772 PSMKSVVLILEGITDIVVPPCPTTT 796
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431565|ref|XP_002276127.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2284), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/807 (56%), Positives = 572/807 (70%), Gaps = 32/807 (3%)
Query: 3 SSVYAVLILLLTISGITNVAQQQHPQPKSIGLGSS-LSPTKQPGSWNSSLGAFQFGFYKQ 61
+ VY V +L V Q+ P I L S+ LSPT QP SW S G F FGFY Q
Sbjct: 2 ACVYVVFLLFFV--SFEAVGAQEEPPAGFITLESATLSPTIQPTSWTSPSGIFAFGFYPQ 59
Query: 62 DAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKS 121
+ F +GIWL+ + T+VWTA+RDDPPV +A L LT +GKL+LRT + +KV+
Sbjct: 60 GSDFLLGIWLMD-EEKTLVWTAHRDDPPVPLDAKL-LTINGKLLLRTGQSEEKVIV---- 113
Query: 122 EPASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGR 181
E AS A M DSGNF++YN +IW SFK PTDTILG Q+L G++LFS +SET+ STGR
Sbjct: 114 ESASFAFMRDSGNFMVYNQSFHVIWESFKFPTDTILGGQNLTTGDQLFSSLSETNHSTGR 173
Query: 182 FRLNMQRDGNLVLYPINTIDDYTEAYWASDSQRERQL---HLYLSN-TGNLVLLDDSMGI 237
FRL MQ DGNLV Y ++ + +AYWAS + R+ + +YL++ TG LV+ + + +
Sbjct: 174 FRLQMQTDGNLVSYFVDALPMVLDAYWASGT-RDGDVSMNQMYLNDATGQLVIRNSTNLV 232
Query: 238 IKD-LYESPSNNSSIIRRLTIGHNGILRLFSHYPVPKGAYNTSVDWNV--PDDLCEVKTF 294
+ LY S + + I + ++G+ R++SH + SV W+ D+ C+VK F
Sbjct: 233 TRAVLYTSSRSAKNTIYSARLSYDGMFRMYSHSFDSNSNGDKSVLWSAVAEDEKCQVKGF 292
Query: 295 CGLNSYCTLYDDQPMCRCLPGTDFLDPNQTSSGCERKFVDERCKGINISAEYNMTSMEK- 353
CGLNSYCT + +P C CLPGTDF+D NQ GC + F + C I+ SA Y++ E+
Sbjct: 293 CGLNSYCTRNNSEPYCVCLPGTDFVDSNQKLLGCLKNFTEYSCNNISYSASYHIVRAEQN 352
Query: 354 MTWDDYYYFKASITKEECKESCLEDCECDVALYEESVDDKPSYCTKQKLPLKSAKRDLKN 413
+ WDD YFK +++ EEC CLEDC C+VALY DK YC+K+ LPLK A+ D
Sbjct: 353 LQWDDLPYFKGTMSMEECINGCLEDCNCEVALY-----DKDGYCSKRALPLKYARSD--E 405
Query: 414 SSSSIAYFKTGIRNITTSSNNTNSAMPQDRNRSK----KAIILILVITIGLVTCSCAFLT 469
+ S A+FK ++I N S +P K ++LILVIT+G +TCS L
Sbjct: 406 NVLSAAFFKVSKKSIEI--KNDTSFIPDHTTEVTTTSTKDLVLILVITVGFITCSFVSLA 463
Query: 470 FSGVFIFKYQVLKYEWLLENGSLGLAYESNLRSFSYNELKKATNRFKEELGKGSFGAVYK 529
SG FIFK++V KY LLE+G GL E ++SFSY EL+KA+ FKEELGKG+FG VY
Sbjct: 464 ISGFFIFKFRVAKYRRLLEDGKRGLMEELKMQSFSYKELQKASRNFKEELGKGAFGTVYL 523
Query: 530 GTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589
G L+KG+KLVA+K+LEKMV EGEREFRAEM IGRTHHKNLVRL+GYC E SKRLLVYEY
Sbjct: 524 GVLHKGKKLVAIKRLEKMVEEGEREFRAEMRAIGRTHHKNLVRLLGYCTEGSKRLLVYEY 583
Query: 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF 649
MSN SLADILF+ R WDERVRIA DVA+GILYLH+ECEAPIIHCDIKPQNILMD+F
Sbjct: 584 MSNRSLADILFKSKTRP-PWDERVRIALDVARGILYLHEECEAPIIHCDIKPQNILMDDF 642
Query: 650 WTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC 709
WTAKISDFGLAKLLMPDQTRTFT VRGTRGY+APEW +N PISVKADV+SYG+VLLE+VC
Sbjct: 643 WTAKISDFGLAKLLMPDQTRTFTGVRGTRGYLAPEWQQNIPISVKADVYSYGIVLLELVC 702
Query: 710 CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPA 769
CRRN+E++ SKPEEIVL NWAYKCF+ EL KL+ G+EV+R +LE M+K+GLWC+QDEPA
Sbjct: 703 CRRNLEVNVSKPEEIVLSNWAYKCFVAGELYKLLGGEEVERKSLEEMVKLGLWCIQDEPA 762
Query: 770 LRPSMKSVVLMLEGITDISIPPCPTSS 796
LRPS+KS+VLMLEGIT+I++PPCPT++
Sbjct: 763 LRPSIKSIVLMLEGITEIAVPPCPTTT 789
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477052|ref|XP_002276297.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 881 bits (2276), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/799 (56%), Positives = 565/799 (70%), Gaps = 50/799 (6%)
Query: 9 LILLLTISGITNVAQQQHPQPKSIGLGSS-LSPTKQPGSWNSSLGAFQFGFYKQDAGFKV 67
++ LL +V Q+ P + I L S+ LSPT QP SW S G F FGFY Q + F +
Sbjct: 6 VVFLLFFVSFEDVGAQEEPPAEFITLESATLSPTIQPTSWLSPSGLFAFGFYPQGSDFLL 65
Query: 68 GIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSA 127
GIWL+ + T+ WTA+RDDPPV +A L LT +GKL+LRT + +KV+ E AS A
Sbjct: 66 GIWLMD-KERTLSWTAHRDDPPVPLDAKL-LTINGKLLLRTRQSEEKVIV----ESASFA 119
Query: 128 SMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQ 187
M DSGNFV+YN +IW SFK PTDTILG Q+L G LFS +SET+ STGRFRL+MQ
Sbjct: 120 LMRDSGNFVVYNKSYHVIWESFKFPTDTILGGQNLTTGVPLFSSLSETNHSTGRFRLDMQ 179
Query: 188 RDGNLVLYPINTIDDYTEAYWASDSQR---ERQLHLYLSNT-GNLVLLD----DSMGIIK 239
DGNLVLY +++ +AYWAS++ + LYL++T G LV+ + ++ GII
Sbjct: 180 ADGNLVLYFADSMLSSVDAYWASNTWKAGNSMDHQLYLNDTTGGLVVRNSTNLETRGII- 238
Query: 240 DLYESPSNNSSIIRRLTIGHNGILRLFSHYPVPKGAYNTSVDWNVPDDL--CEVKTFCGL 297
Y+ S+ S I + +NG+ +++SH G N ++ W+ + C+VK FCGL
Sbjct: 239 --YKGSSSASKTIYSARLSYNGMFQVYSHSFDSNGNDNKTLAWSAVATVNQCQVKGFCGL 296
Query: 298 NSYCTLYDDQPMCRCLPGTDFLDPNQTSSGCERKFVDERCKGINISAEYNMTSMEKMTWD 357
NSYCT D +P C CLPGTDF+D Q GC + F + C I+ SA Y+M + + WD
Sbjct: 297 NSYCTQNDIEPYCYCLPGTDFVDSKQMLLGCLKNFTESSCNNISYSASYHMVREDNLVWD 356
Query: 358 DYYYFKASITKEECKESCLEDCECDVALYEESVDDKPSYCTKQKLPLKSAKRDLKNSSSS 417
D YFK ++T +EC CLEDC CDVALY D+ +C+K+ LPLK AKR SS
Sbjct: 357 DLPYFKETMTIDECSNGCLEDCNCDVALY-----DQDGHCSKRALPLKYAKRSRDVQSS- 410
Query: 418 IAYFKTGIRNITTSSNNTNSAMPQDRNRSKKAIILILVITIGLVTCSCAFLTFSGVFIFK 477
A+FK ++ +LILVITIG +TCS L SG FIFK
Sbjct: 411 -AFFKVRTTDL----------------------VLILVITIGFITCSFVSLAISGFFIFK 447
Query: 478 YQVLKYEWLLENGSLGLAYESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEK 537
++V+KY LLE+G LGL E ++SFSY EL+KA+ FKEELGKG+FG VY G L +G+K
Sbjct: 448 FRVVKYRRLLEDGKLGLTEELKMQSFSYKELQKASRNFKEELGKGAFGTVYLGVLQQGKK 507
Query: 538 LVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLAD 597
LVA+K+LEKMV EGEREFRAEM IGRTHHKNLVRL+GYC E S+RLLVYEYMSN SLAD
Sbjct: 508 LVAIKRLEKMVEEGEREFRAEMRAIGRTHHKNLVRLLGYCTEGSRRLLVYEYMSNRSLAD 567
Query: 598 ILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDF 657
ILF+ R WDERVRIA DVA+GILYLH+ECEAPIIHCDIKPQNILMD+FWTAKISDF
Sbjct: 568 ILFKSKTRP-PWDERVRIALDVARGILYLHEECEAPIIHCDIKPQNILMDDFWTAKISDF 626
Query: 658 GLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEID 717
GLAKLLMPDQTRTFT VRGTRGY+APEW +N PISVKADV+SYG+VLLE+VCCRRN+E++
Sbjct: 627 GLAKLLMPDQTRTFTGVRGTRGYLAPEWQQNIPISVKADVYSYGIVLLELVCCRRNLEVN 686
Query: 718 PSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777
S+PEEIVL NWAYKCF+ EL+KL+ G+EV+R +LE M+K+GLWC+QDEPALRPS+KS+
Sbjct: 687 VSEPEEIVLSNWAYKCFVAGELHKLLGGEEVERKSLEQMVKLGLWCIQDEPALRPSIKSI 746
Query: 778 VLMLEGITDISIPPCPTSS 796
VLMLEGIT+I++PPCPT++
Sbjct: 747 VLMLEGITEIAVPPCPTTT 765
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224093336|ref|XP_002309887.1| predicted protein [Populus trichocarpa] gi|222852790|gb|EEE90337.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 855 bits (2210), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/771 (57%), Positives = 548/771 (71%), Gaps = 31/771 (4%)
Query: 34 LGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSN 93
LGSSLS P SW S F FGFY+Q +GF VGIWL + PD T WT RD P VSSN
Sbjct: 6 LGSSLSTNIPPTSWRSPSRHFAFGFYRQGSGFIVGIWLASKPDATFTWTINRDVPHVSSN 65
Query: 94 AALTLTKDGKLILRTEEGH---DKVVAAGKSEPASSASMLDSGNFVLYNNRSDIIWSSFK 150
A L LTK GKL+LR + +++ A AS A MLDSGNFVLYN S+ IW SF
Sbjct: 66 ATLELTKKGKLLLRRHRNNATDEEIFIANFKGSASYAQMLDSGNFVLYNEHSEAIWESFS 125
Query: 151 IPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWAS 210
PTDTILG Q+L G ELFSR S STGRF L MQ DGNLVLYP++T+D +AYW+S
Sbjct: 126 FPTDTILGGQNLYKGGELFSRASAIDLSTGRFHLKMQDDGNLVLYPVDTLDLPLDAYWSS 185
Query: 211 DSQRERQLHLYLSNTGNLVLLDDSMGIIKDL--YESPSNNSSIIRRLTIGHNGILRLFSH 268
D+ +HL L+ TG+L+L++ ++ IK + S SN++SII R T+ ++GI RL+SH
Sbjct: 186 DTYGNPGIHLILTGTGDLLLVNQTLHKIKTVTSSGSESNSTSIIYRATLDYDGIFRLYSH 245
Query: 269 YPVPKGAYNTSVDWNVPDDLCEVKTFCGLNSYCTLYDD-QPMCRCLPGTDFLDPNQTSSG 327
Y S+ W VP CEV+ FCG NSYCT+ DD QP C CLPGT ++DPNQ G
Sbjct: 246 NFDGVAKYIISLMWYVPWIQCEVRGFCGFNSYCTMNDDDQPDCLCLPGTAYVDPNQRFRG 305
Query: 328 CERKFVDERCKGIN-ISAEYNMTSMEKMTWDDYYYFKASITKEECKESCLEDCECDVALY 386
CER + + CK N +S+ YN+T M+++ WDD YF+AS+++E C++SCLEDC C ALY
Sbjct: 306 CERDYNEGSCKHTNEMSSLYNITVMDQIAWDDNAYFQASMSEEGCRKSCLEDCNCAGALY 365
Query: 387 EESVDDKPSYCTKQKLPLKSAKRDLKNSSSSIAYFKTGIRNITTSSNNTNSAMPQDRNRS 446
E C KQK P+K A + S S +FK + I + S
Sbjct: 366 ESG------NCKKQKYPVKYAWKTEDQLSKS--FFKVALEII--------------QRTS 403
Query: 447 KKAIILILVITIGLVTCSCAFLTFSGVFIFKYQVLKYEWLLENGSLGLAYESNLRSFSYN 506
KKA++LILV+++ +T L SG+FIFK +V+K E+G+ GLA E LR+FSY
Sbjct: 404 KKAVVLILVMSLAFITWCLVALAISGLFIFKSRVIKGRMQTESGNFGLARELTLRAFSYR 463
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
ELKKAT FKEELGKGS GAVYKGTLYKG+K +AVK+LEK+V+E EREF AEM IG+TH
Sbjct: 464 ELKKATKGFKEELGKGSSGAVYKGTLYKGKKAIAVKRLEKVVSESEREFLAEMRSIGKTH 523
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
HKNLVRL+GYC E S RLLVYEYMSNGSLA++LFR ER W +RV+IA D+AKGILYL
Sbjct: 524 HKNLVRLLGYCTEGSHRLLVYEYMSNGSLANLLFRN-ERIPDWSDRVKIALDIAKGILYL 582
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
H+ECEAPI+HCDIKPQNILMD+FWTAKISDFGLAKLL+PDQTRT T+ RGT GYMAPEW
Sbjct: 583 HEECEAPIMHCDIKPQNILMDDFWTAKISDFGLAKLLVPDQTRTLTIARGTPGYMAPEWT 642
Query: 687 K-NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745
K +TP SVK DV+SYGVVLLEIV CRRNM+I+ SKPEE++L WAY+ + REL++L G
Sbjct: 643 KISTPTSVKVDVYSYGVVLLEIVFCRRNMKINVSKPEEVLLSKWAYELLVARELDRLDLG 702
Query: 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPPCPTSS 796
++VDR LE M+ IG+WC+QDEP LRPSMK+VV+MLEGITD+S+PP PTS+
Sbjct: 703 EDVDRQKLEKMVMIGIWCIQDEPGLRPSMKTVVMMLEGITDVSVPPHPTSA 753
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147867430|emb|CAN78998.1| hypothetical protein VITISV_038238 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 848 bits (2191), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/789 (56%), Positives = 554/789 (70%), Gaps = 45/789 (5%)
Query: 21 VAQQQHPQPKSIGLGSS-LSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITI 79
V Q+ P I L S+ LSPT QP SW S G F FGFY Q + F +GIWL+ + T+
Sbjct: 172 VGAQEEPPAGFITLESATLSPTIQPTSWTSPSGIFAFGFYPQGSDFLLGIWLMD-EEKTL 230
Query: 80 VWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLYN 139
VWTA+RDDPPV +A L LT +GKL+LRT + +KV+ E AS A M DSGNF++YN
Sbjct: 231 VWTAHRDDPPVPLDAKL-LTINGKLLLRTGQSEEKVIV----ESASFAFMRDSGNFMVYN 285
Query: 140 NRSDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINT 199
+IW SFK PTDTILG Q+L G++LFS +SET+ STGRFRL MQ DGNLV Y ++
Sbjct: 286 QSFHVIWESFKFPTDTILGGQNLTTGDQLFSSLSETNHSTGRFRLQMQTDGNLVSYFVDA 345
Query: 200 IDDYTEAYWASDSQRERQL---HLYLSN-TGNLVLLDDSMGIIKD-LYESPSNNSSIIRR 254
+ +AYWAS + R+ + +YL++ TG LV+ + + + + LY S + + I
Sbjct: 346 LPMVLDAYWASGT-RDGDVSMNQMYLNDATGQLVIRNSTNLVTRAVLYTSSRSAKNTIYS 404
Query: 255 LTIGHNGILRLFSHYPVPKGAYNTSVDWNV--PDDLCEVKTFCGLNSYCTLYDDQPMCRC 312
+ ++G+ R++SH + SV W+ D+ C+VK FCGLNSYCT + +P C C
Sbjct: 405 ARLSYDGMFRMYSHSFDSNSNGDKSVLWSAVAEDEKCQVKGFCGLNSYCTRNNSEPYCVC 464
Query: 313 LPGTDFLDPNQTSSGCERKFVDERCKGINISAEYNMTSMEK-MTWDDYYYFKASITKEEC 371
LPGTDF+D NQ GC + F + C I+ SA Y++ E+ + WDD YFK +++ EEC
Sbjct: 465 LPGTDFVDSNQKLLGCLKNFTEYSCNNISYSASYHIVRAEQNLQWDDLPYFKGTMSMEEC 524
Query: 372 KESCLEDCECDVALYEESVDDKPSYCTKQKLPLKSAKRDLKNSSSSIAYFKTGIRNITTS 431
CLEDC C+VALY DK YC+K+ LPLK A+ D + S A+FK ++I
Sbjct: 525 INGCLEDCNCEVALY-----DKDGYCSKRALPLKYARSD--ENVLSAAFFKVSKKSIEI- 576
Query: 432 SNNTNSAMPQDRNRSK----KAIILILVITIGLVTCSCAFLTFSGVFIFKYQVLKYEWLL 487
N S +P K ++LILVIT+G +TCS L SG FIFK++V KY LL
Sbjct: 577 -KNDTSFIPDHTTEVTTTSTKDLVLILVITVGFITCSFVSLAISGFFIFKFRVAKYRRLL 635
Query: 488 ENGSLGLAYESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM 547
E+G GL E ++SFSY EL+KA+ FKEELGK KLVA+K+LEKM
Sbjct: 636 EDGKRGLMEELKMQSFSYKELQKASRNFKEELGK---------------KLVAIKRLEKM 680
Query: 548 VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSL 607
V EGEREFRAEM IGRTHHKNLVRL+GYC E SKRLLVYEYMSN SLADILF+ R
Sbjct: 681 VEEGEREFRAEMRAIGRTHHKNLVRLLGYCTEGSKRLLVYEYMSNRSLADILFKSKTRP- 739
Query: 608 GWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667
WDERVRIA DVA+GILYLH+ECEAPIIHCDIKPQNILMD+FWTAKISDFGLAKLLMPDQ
Sbjct: 740 PWDERVRIALDVARGILYLHEECEAPIIHCDIKPQNILMDDFWTAKISDFGLAKLLMPDQ 799
Query: 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLI 727
TRTFT VRGTRGY+APEW +N PISVKADV+SYG+VLLE+VCCRRN+E++ SKPEEIVL
Sbjct: 800 TRTFTGVRGTRGYLAPEWQQNIPISVKADVYSYGIVLLELVCCRRNLEVNVSKPEEIVLS 859
Query: 728 NWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787
NWAYKCF+ EL KL+ G+EV+R +LE M+K+GLWC+QDEPALRPS+KS+VLMLEGIT+I
Sbjct: 860 NWAYKCFVAGELYKLLGGEEVERKSLEEMVKLGLWCIQDEPALRPSIKSIVLMLEGITEI 919
Query: 788 SIPPCPTSS 796
++PPCPT++
Sbjct: 920 AVPPCPTTT 928
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546166|ref|XP_003541502.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 826 bits (2133), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/821 (52%), Positives = 554/821 (67%), Gaps = 43/821 (5%)
Query: 4 SVYAVLILLLTISGITNVAQQQHPQPKSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDA 63
++ + LLL +S T V +Q I G+SL P W S G F FGFY Q+
Sbjct: 3 AIAITVTLLLLVSTGTRVEMKQ------IQPGASLVPNTTLAWWPSPSGQFAFGFYPQEQ 56
Query: 64 G--FKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKS 121
G F + IWL++ + +VWTA RDDPPV+SNA L LTKDGK +L E G +K +A +
Sbjct: 57 GDAFVIAIWLVSGENKIVVWTARRDDPPVTSNAKLQLTKDGKFLLIDEHGEEKSIADIIA 116
Query: 122 EPASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGR 181
+ ASSASMLDSGNFVLYNN S IIW SF PTDT+LG QSL G++L S S S STGR
Sbjct: 117 K-ASSASMLDSGNFVLYNNNSSIIWQSFDYPTDTLLGGQSLPNGHQLVSASSNNSHSTGR 175
Query: 182 FRLNMQRDGNLVLYPINTIDDYTEAYWASDSQRER-QLHLYLSNTGNLVLLDDSMG-IIK 239
+R MQ DGNLV+YP++T D +AYWAS + + +LYL+ TG L +L+DS G I+K
Sbjct: 176 YRFKMQDDGNLVMYPVSTTDTALDAYWASSTTNSGFKTNLYLNQTGLLQILNDSDGSIMK 235
Query: 240 DLYES---PSNNSSIIRRLTIGHNGILRLFSHYPVPKGAYNTSVDWNVPDD-LCEVKTFC 295
LY P++ + II R T+ +G RL+ H+ G++ + W PD+ C VK FC
Sbjct: 236 TLYHHSSFPNDGNRIIYRSTLDFDGFFRLYKHFD--NGSFQKAHHW--PDENACAVKGFC 291
Query: 296 GLNSYCTLYDDQPMCRCLPGTDFLDPNQTSSGCERKFVDERCKGINISAE-YNMTSME-K 353
G NSYCT D QP+C CLP + + P ++ GC+R F +E C G SA Y+M ME
Sbjct: 292 GFNSYCTFNDTQPLCTCLPDFELIYPTDSTRGCKRSFQNEDCNGQKDSATFYDMKPMEDT 351
Query: 354 MTWDDYYYFKASITKEECKESCLEDCECDVALYEESVDDKPSYCTKQKLPLKSAKR---D 410
D YFKA + KE+C +CL DC C+ Y DD C KQ+LPL+ +R D
Sbjct: 352 FVGTDNPYFKAKMPKEDCSSACLADCSCEAVFY----DDTEESCMKQRLPLRYLRRPGQD 407
Query: 411 LKNSSSSIAYFKTGIRNITTSSNNTNSAMPQD-----RNRSKKAIILILVITIGLVTCSC 465
+ ++ + K G R++ + N N Q + KA + I+VIT C
Sbjct: 408 EFGVNQALLFLKVGNRSLNNGTGNDNPVPEQPSPTPIKTTRNKATVQIVVITSVFSLLLC 467
Query: 466 AFLTFSGVFIFKYQVLKYEWLLENGSLGLAYESNLRS-------FSYNELKKATNRFKEE 518
+ + S +++K ++L YE L+E G+ GL+ E L+S FSY+ELK+ATN FK++
Sbjct: 468 STIVISSHYMYKIRILSYERLMEMGNWGLSEELTLKSEELTLKRFSYSELKRATNNFKQK 527
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCA 578
LG+GSFGAVYKG L KG +L+AVK+LEK+V EGEREF+AEM IG+THH+NLVRL+G+CA
Sbjct: 528 LGRGSFGAVYKGGLNKGRRLIAVKRLEKLVEEGEREFQAEMRAIGKTHHRNLVRLLGFCA 587
Query: 579 EDSKRLLVYEYMSNGSLADILFRG-PERSLGWDERVRIASDVAKGILYLHDECEAPIIHC 637
E SKRLLVYEYM NGSL +++F +R GWDERVRIA ++AKGILYLH+ECEAPIIHC
Sbjct: 588 EGSKRLLVYEYMPNGSLENLIFGAQSQRRPGWDERVRIALEIAKGILYLHEECEAPIIHC 647
Query: 638 DIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYK-NTPISVKAD 696
DIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT T RGTRGY+APEW K N PISVK D
Sbjct: 648 DIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTITGARGTRGYVAPEWDKLNIPISVKVD 707
Query: 697 VFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT-LEN 755
V+SYG+VLLEI+CCRRN+E+ S+PE +L NWAYKCF+ +LNKL + VD T +EN
Sbjct: 708 VYSYGIVLLEILCCRRNIEVHVSEPEAALLSNWAYKCFVSGQLNKLFLWESVDNKTSVEN 767
Query: 756 MIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPPCPTSS 796
++K+ LWC+QDEP LRP+MKSVVLMLEGITDI+IPPCP SS
Sbjct: 768 IVKVALWCIQDEPFLRPTMKSVVLMLEGITDIAIPPCPNSS 808
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357478041|ref|XP_003609306.1| Receptor like kinase [Medicago truncatula] gi|357478087|ref|XP_003609329.1| Receptor like kinase [Medicago truncatula] gi|355510361|gb|AES91503.1| Receptor like kinase [Medicago truncatula] gi|355510384|gb|AES91526.1| Receptor like kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 778 bits (2008), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/770 (53%), Positives = 530/770 (68%), Gaps = 32/770 (4%)
Query: 47 WNSSLGAFQFGFYKQ-DAGFKVGIWLLTFPDI--TIVWTAYRDDPPVSSNAALTLTKDGK 103
W S G F FGFY Q + GF +GIWL+ + TIVWTA RDDPPV+S L T G
Sbjct: 51 WLSPSGQFAFGFYSQGNNGFAIGIWLVGKNKMNSTIVWTANRDDPPVTSTVKLQFTMKGT 110
Query: 104 LILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLY--NNRSDIIWSSFKIPTDTILGNQS 161
+IL ++G K++ + ASSASMLDSGNFVLY NN S IIW SF PTDT+L +QS
Sbjct: 111 IILTDQQGQQKLIVNANTR-ASSASMLDSGNFVLYDNNNISSIIWQSFDHPTDTLLESQS 169
Query: 162 LLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQRER-QLHL 220
L G +L S +SET+ STGRF+LNMQ DGNLVLYP + +AYWASD+ + HL
Sbjct: 170 LPCGGKLSSSLSETNHSTGRFQLNMQVDGNLVLYPAYIAETSWDAYWASDTVSANVKHHL 229
Query: 221 YLSNTGNLVLLDDS-----MGIIKDLYE--SPSNNSSIIRRLTIGHNGILRLFSHYPVPK 273
YL +TG L +LDDS + I+ D E + + I R T+ +G+ RL + + V
Sbjct: 230 YLKSTGLLQILDDSSDSSLIKILNDADEDQQETGGNQTIYRATLDFDGVFRLHARH-VNN 288
Query: 274 GAYN--TSVDWNVPDDLCEVKTFCGLNSYCTLYDDQPMCRCLPGTDFLDPNQTSSGCERK 331
G+ S N P CEVK FC LNSYCT DD+P+C CL G F+D N+ + GCER
Sbjct: 289 GSDKIIASFPGNNP---CEVKGFCSLNSYCTFKDDKPLCNCLTGYKFIDANEKTLGCERN 345
Query: 332 FVDERCKGINIS-AEYNMTSMEKMTWDDYYYFKAS--ITKEECKESCLEDCECDVALYEE 388
+ C+ A Y+M M + W D+ YF+ ++++EC +CL DC C ALYEE
Sbjct: 346 YSKAECRAEKDGLAFYDMVPMNNIVWKDHPYFETEDILSEKECSFACLVDCNCWAALYEE 405
Query: 389 SVDDKPSYCTKQKLPLKSAKRDLK-NSSSSIAYFKTGIRNITTSSNNTNSAMPQD-RNRS 446
C KQ LPL+ R + + S + AY K G +I N PQ S
Sbjct: 406 E------RCKKQGLPLRYVTRTHEADDSPAAAYIKVGNGSIENWKGNDTLFYPQPPLITS 459
Query: 447 KKAIILILVITIGLVTCSCAFLTFSGVFIFKYQVLKYEWLLENGSLGLAYESNLRSFSYN 506
KA++ I+++T C+ + S +++K +VL+Y+ L + G+LGL E LR FSYN
Sbjct: 460 TKAVVHIIIVTSIFTALLCSAILISIHYVYKIRVLRYKRLTDTGNLGLNEEVTLRRFSYN 519
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
ELK+ATN FKEELGKG+FG+VYKG L KG++L+AVK+LEK+V EGE+EF+AE+ IG+TH
Sbjct: 520 ELKRATNHFKEELGKGAFGSVYKGALNKGKRLIAVKRLEKVVEEGEKEFQAEVRSIGKTH 579
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H+NLVRL+G+C E SKRLLVYEYMSNGSL +LF G +R W+ERVRIA D+A+GILYL
Sbjct: 580 HRNLVRLLGFCVEGSKRLLVYEYMSNGSLGKLLF-GDQRRPDWNERVRIALDIARGILYL 638
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
H+EC+APIIHCD+KPQNILMD+FWTAKISDFGLAKLLMPDQTRTFT+VRGTRGYMAPEW
Sbjct: 639 HEECDAPIIHCDLKPQNILMDKFWTAKISDFGLAKLLMPDQTRTFTMVRGTRGYMAPEWN 698
Query: 687 KNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746
KN ISVK DV+SYG+VLLEI+CCRRN++++ +PEEI+L W YKCFI ++NKLV +
Sbjct: 699 KNVAISVKTDVYSYGIVLLEILCCRRNLDVNVLEPEEILLAGWTYKCFIAGDVNKLVPSE 758
Query: 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPPCPTSS 796
+D+N +ENM+K+ LWC+QD+P LRP+MK VVLMLEGITDI+IPPCP S+
Sbjct: 759 AIDKNVMENMVKVALWCIQDDPFLRPTMKGVVLMLEGITDIAIPPCPNSN 808
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357478045|ref|XP_003609308.1| Kinase-like protein [Medicago truncatula] gi|357478091|ref|XP_003609331.1| Kinase-like protein [Medicago truncatula] gi|355510363|gb|AES91505.1| Kinase-like protein [Medicago truncatula] gi|355510386|gb|AES91528.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 777 bits (2007), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/765 (52%), Positives = 521/765 (68%), Gaps = 26/765 (3%)
Query: 47 WNSSLGAFQFGFYKQ-DAGFKVGIWLLTFPDI--TIVWTAYRDDPPVSSNAALTLTKDGK 103
W S G F FGFY Q + GF +GIWL+ + TIVWTA RDDPPV+S L T G
Sbjct: 53 WFSPSGQFAFGFYSQGNNGFAIGIWLVGKNKMNNTIVWTANRDDPPVTSTVKLQFTMKGT 112
Query: 104 LILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLYNNR--SDIIWSSFKIPTDTILGNQS 161
+IL ++G K++ + ASSASMLDSGNFVLY+N S IIW SF PTDT+L +QS
Sbjct: 113 IILTDQQGQQKLIVNANTR-ASSASMLDSGNFVLYDNHNISSIIWQSFDHPTDTLLESQS 171
Query: 162 LLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQRER-QLHL 220
L G +L S +SET+ STGRF+LNMQ DGNLVLYP T ++YW SD+ + HL
Sbjct: 172 LPCGGQLSSSLSETNHSTGRFQLNMQVDGNLVLYPAYTTKTGWDSYWTSDTVSANVKHHL 231
Query: 221 YLSNTGNLVLLDDS-----MGIIKDLYESPSNN-SSIIRRLTIGHNGILRLFSHYPVPKG 274
YL++TG L + +DS + +++ E N + I R T+ +G+ RL++ Y V G
Sbjct: 232 YLNSTGLLQIWNDSSDSSRITTLRNTEEDQQNTGNQTIYRATLDFDGVFRLYA-YHVNNG 290
Query: 275 AYNTSVDWNVPDDLCEVKTFCGLNSYCTLYDDQPMCRCLPGTDFLDPNQTSSGCERKFVD 334
+ W + C VK FCG NS+CT DD+P+C CLPG +D N+ + GCER +
Sbjct: 291 SNIIMGSWPGKNP-CYVKGFCGYNSFCTFDDDKPVCNCLPGYKLIDANEDTLGCERNYST 349
Query: 335 ERCKGINIS-AEYNMTSMEKMTWDDYYYFKAS--ITKEECKESCLEDCECDVALYEESVD 391
C+G A YNM M + W+D+ YFK ++EEC +CL DC C A+YEE
Sbjct: 350 SECRGDKYGVAFYNMVPMTNLVWNDHPYFKDDDMSSEEECLFACLIDCNCWAAIYEEG-- 407
Query: 392 DKPSYCTKQKLPLKSAKRDLKNSSSSIAYFKTGIRNITTSSNNTNSAMPQDRNRSKKAII 451
C KQ LPL+ KR + + A+ K G +I +S + S KAI+
Sbjct: 408 ----RCKKQGLPLRYVKRTHEADDFTTAFLKVGNNSIQSSKGYERPFAYPIKTTSNKAIV 463
Query: 452 LILVITIGLVTCSCAFLTFSGVFIFKYQVLKYEWLLENGSLG-LAYESNLRSFSYNELKK 510
I+V+T SC+ + S +++K +VLKY+ L E + G + LR F+YNEL++
Sbjct: 464 HIIVVTSLFSIMSCSTIVISIHYMYKIRVLKYKRLTETVNFGGQNADLALRRFTYNELRR 523
Query: 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNL 570
ATN FKEELGKG+FG VYKG L KG++L+AVK+LEK+V +GEREF+AE+ IG+THH+NL
Sbjct: 524 ATNNFKEELGKGAFGKVYKGALNKGKRLIAVKRLEKVVEDGEREFQAEVRSIGKTHHRNL 583
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
VRL+G+C E SKRLLVYEYMSNGSL +LF G +R WDERVR+A D+A+GI YLH+EC
Sbjct: 584 VRLLGFCHEGSKRLLVYEYMSNGSLEKLLF-GDQRRPDWDERVRMALDIARGISYLHEEC 642
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT+VRGTRGYMAPEW N P
Sbjct: 643 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTVVRGTRGYMAPEWNMNVP 702
Query: 691 ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750
IS+KADV+SYG++L EI+CCRRN++++ +PEEI+L WAYKC + ++N LV + +D
Sbjct: 703 ISLKADVYSYGIMLFEILCCRRNLDVNVLEPEEILLSGWAYKCLVAGQVNNLVPWEVIDN 762
Query: 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPPCPTS 795
N +ENM+K+ LWC+QD+P LRP+MK VVLMLEG+TDI+IPPCP S
Sbjct: 763 NVMENMVKVALWCIQDDPFLRPTMKGVVLMLEGVTDIAIPPCPDS 807
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477048|ref|XP_002275811.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 750 bits (1937), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/803 (48%), Positives = 533/803 (66%), Gaps = 25/803 (3%)
Query: 3 SSVYAVLILLLTISGITNVAQQQHPQPKSIGLGSSLSPT-KQPGSWNSSLGAFQFGFYKQ 61
+SV+ V L L G+ + Q + K I L SSLSP P W S G F FGFY Q
Sbjct: 2 ASVWFVFFLPLLCVGV----RAQPEKAKLISLNSSLSPKYGSPMGWASPSGLFAFGFYPQ 57
Query: 62 DAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKS 121
+GF VGIWL+ + T+VWTA RDDPP S+NA L T+DGKL+L+TEEG + + G S
Sbjct: 58 GSGFSVGIWLVGTDENTVVWTANRDDPPASANAKLYFTEDGKLLLQTEEGSEISITDG-S 116
Query: 122 EPASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGR 181
PA +ASMLDSG+FVLY+ +IW+SF PTDT+LG Q+L + ++ S S ++ S+G
Sbjct: 117 GPAVAASMLDSGSFVLYDQNLSVIWNSFSYPTDTLLGGQNLDSNKKMVSSESRSNHSSGW 176
Query: 182 FRLNMQRDGNLVLYPINTIDDYTEAYWASDSQRERQLHLYLS----NTGNLVLLDDSMG- 236
F L MQ DGNLV YP+N+ + ++YW+S + +L+ Y + NT + L M
Sbjct: 177 FFLAMQGDGNLVSYPVNSSGESDDSYWSSGTSSASRLNFYSTQLSLNTEGALYLSSGMSS 236
Query: 237 -IIKDLYES--PSNNSSIIRRLTIGHNGILRLFSHYPVPKGAYNTSVDWNVPDDLCEVKT 293
II+ S PS N + I R T +GI RL+SH G+ N S+ W+ D C+VK
Sbjct: 237 LIIQTFRNSSNPSKNKTTIYRATFDPDGIFRLYSHRFENNGSSNESIVWSSLSDQCDVKG 296
Query: 294 FCGLNSYCTLYDDQPMCRCLPGTDFLDPNQTSSGCERKFVDERCKGINIS-AEYNMTSME 352
FCG NSYC+ + C CLPG F +P++ GC R F + C +N YN+T++E
Sbjct: 297 FCGFNSYCSNPGAKAECHCLPGFAFNNPSEKIRGCSRIFNGDDCSKMNNQLISYNITTLE 356
Query: 353 KMTWDDYYYFKASITKEECKESCLEDCECDVALYEESVDDKPSYCTKQKLPLKSAKRDLK 412
W DY Y+K S+ EEC + CL+DC C ALY + C K KLP++ + +
Sbjct: 357 NTGWGDYPYYKKSMKMEECSKFCLDDCNCGAALY------RNGSCYKYKLPVRYGR--IN 408
Query: 413 NSSSSIAYFKTGIRNITTSSNNTNSAMPQD-RNRSKKAIILILVITIGLVTCSCAFLTFS 471
+ ++ A K ++ + ++ + M + + KK +IL+L +++G + C + S
Sbjct: 409 RNETATALLKGHLQRVKSAYRPPPAPMNTEVKIDGKKTLILVLSLSLGSIAFLCLVIAIS 468
Query: 472 GVFIFKYQVLKYEWLLENGSLGLAYESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGT 531
+++++QV Y L E +LG E L+SFSY+EL+KAT+ F+EELG+G +GAVYKGT
Sbjct: 469 SFWVYRHQVWSYRQLSEEVNLGSTEEFTLQSFSYDELEKATDGFREELGRGCYGAVYKGT 528
Query: 532 LYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591
+ + K+VAVK+LEK+V +GE+EF+AEM IG+THH+NLVRL+G+C E SK+LLVYE+M
Sbjct: 529 IERDNKVVAVKRLEKVVEQGEKEFQAEMTAIGQTHHRNLVRLLGFCIEGSKKLLVYEFMR 588
Query: 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT 651
NGSLAD+LF +RS+ W RVRIA ++A+GILYLH+ECE+ I+HCDIKPQNILMD+ WT
Sbjct: 589 NGSLADLLFNAEKRSI-WKVRVRIALELARGILYLHEECESQIVHCDIKPQNILMDDAWT 647
Query: 652 AKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCR 711
AKISDFG +KLLMP+Q T +RGT GY APEW+KNT ISVKAD++S+GVVLLEIVCCR
Sbjct: 648 AKISDFGFSKLLMPNQEGIVTGIRGTAGYSAPEWHKNTLISVKADIYSFGVVLLEIVCCR 707
Query: 712 RNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALR 771
R++E+ S +EI+L +W Y C + REL+KLV ++V+ +LE M+K+GLWCVQD+PALR
Sbjct: 708 RSIEVKVSTADEIILSSWVYGCLVARELDKLVGDEQVEFKSLERMVKVGLWCVQDDPALR 767
Query: 772 PSMKSVVLMLEGITDISIPPCPT 794
PSMK+V+LMLEG DI PP PT
Sbjct: 768 PSMKNVILMLEGTVDIPFPPSPT 790
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477040|ref|XP_002275651.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1896), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/778 (50%), Positives = 517/778 (66%), Gaps = 27/778 (3%)
Query: 21 VAQQQHPQPKSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIV 80
VA + +I GSSL+PT W S + FGFYKQ G+ +GI+L P T+V
Sbjct: 16 VAAAAQQRGSNISRGSSLTPTSN-SFWLSPNRLYAFGFYKQGDGYYLGIFLNGIPQKTVV 74
Query: 81 WTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLYNN 140
WTA RDDPPV S AAL T +G+L L+T+ G K +A S AS ASMLDSGNFVLY++
Sbjct: 75 WTANRDDPPVPSTAALHFTSEGRLRLQTQ-GQQKEIA--NSTSASFASMLDSGNFVLYSS 131
Query: 141 RSDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTI 200
D++W SF +PTDT+L Q LLAG ELFS +SET+ STG FRL MQ DGNLV YP+ T
Sbjct: 132 DGDMVWQSFDLPTDTLLLGQRLLAGKELFSSVSETNPSTGMFRLKMQNDGNLVQYPVKTP 191
Query: 201 DDYTEAYWASDSQR-ERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGH 259
D T AY+AS++ + L+L G+L LL+ + IK++ + +N ++ L I
Sbjct: 192 DAPTYAYYASETGGVGDNVTLHLDGGGHLYLLNTNGSNIKNITDGGYDNENLYL-LRIDP 250
Query: 260 NGILRLFSHYPVPKGAYNTSVDWNVPDDLCEVKTFCGLNSYCTLYDDQPMCRCLPGTDFL 319
+GI +L+SH G++ S+ W +D C K CG+N +C L DD+P CRCLPG DF+
Sbjct: 251 DGIFKLYSHDSGQNGSW--SILWRSLNDKCAPKGLCGVNGFCVLLDDRPDCRCLPGFDFV 308
Query: 320 DPNQTSSGCERKFVDERCKGINISAEYNMTSMEKMTWDDYYYFKASI-TKEECKESCLED 378
+ SSGC R F E CK + S +Y M+++E W+D Y SI T+E+C+++CLED
Sbjct: 309 VASNWSSGCIRNFQQEICKSKDGSTKYTMSTLENTWWEDASYSTLSIPTQEDCEQACLED 368
Query: 379 CECDVALYEESVDDKPSYCTKQKLPLKSAKRDLKNSSSSIAYFKTGIRNITTSSNNTNSA 438
C C+ AL+ K C KQ+ PL+ +R L +S+ I + K G T S N
Sbjct: 369 CNCEAALF------KDGSCKKQRFPLRFGRRSLGDSN--ILFVKMGSSTATPSLQN---- 416
Query: 439 MPQDRNRSKKAIILILVITIGLVTCSCAFLTFSGVFIFKYQVLKYEWLLENGSLGLAYES 498
PQD+ +S A ILVI++ L + + L SGV I + + Y+ + E ++ L +
Sbjct: 417 -PQDKRKSPGAKD-ILVISVSLASFALIILAISGVLIRRNNLWAYKKISETVNVELTEDV 474
Query: 499 NLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAE 558
LRSF+Y EL+K TN F EE+GKG+ G VYKG G+++VAVKKLEK++ EGE EF+ E
Sbjct: 475 ALRSFTYMELEKVTNGFMEEIGKGASGTVYKGATSNGQRIVAVKKLEKVLAEGEIEFQNE 534
Query: 559 MHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASD 618
+ VIGRTHH+NLVRL+GYC + RLLVYEYMSNGSLAD LF P + W ER+ IA +
Sbjct: 535 LKVIGRTHHRNLVRLLGYCLDGPNRLLVYEYMSNGSLADWLFT-PGKQPRWSERMGIALN 593
Query: 619 VAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR 678
VA+GILYLH+ECE IIHCDIKPQNILMDE+ AKISDFGLAKLLM DQT T T +RGTR
Sbjct: 594 VARGILYLHEECETCIIHCDIKPQNILMDEYRCAKISDFGLAKLLMHDQTNTSTGIRGTR 653
Query: 679 GYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKP-EEIVLINWAYKCFIDR 737
GY+APEW++ P+SVKADV+SYG+VLLE +CCRRN +D S P EE++L W Y+CF
Sbjct: 654 GYVAPEWHRKQPVSVKADVYSYGIVLLETICCRRN--VDWSLPDEEVILEEWVYQCFEAG 711
Query: 738 ELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPPCPTS 795
EL KLV +EVDR L+ M+K+GLWC+ D+P+LRPSMK V+LMLEG DI +PP P S
Sbjct: 712 ELGKLVGDEEVDRRQLDMMVKVGLWCILDDPSLRPSMKKVLLMLEGTVDIPVPPSPVS 769
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 796 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.373 | 0.358 | 0.490 | 4.7e-99 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.358 | 0.347 | 0.486 | 6.2e-93 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.370 | 0.356 | 0.464 | 3.9e-89 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.762 | 0.696 | 0.304 | 4.1e-79 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.341 | 0.347 | 0.418 | 1.8e-69 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.968 | 0.908 | 0.294 | 9.2e-68 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.355 | 0.334 | 0.393 | 2.5e-67 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.396 | 0.392 | 0.359 | 1.7e-66 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.355 | 0.332 | 0.391 | 2.6e-66 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.368 | 0.362 | 0.388 | 5.9e-66 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 726 (260.6 bits), Expect = 4.7e-99, Sum P(2) = 4.7e-99
Identities = 151/308 (49%), Positives = 197/308 (63%)
Query: 494 LAYESNLR-SFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE 552
L Y S F+Y EL++ T FKE+LG G FG VY+G L +VAVK+LE + +GE
Sbjct: 464 LEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVL-TNRTVVAVKQLEG-IEQGE 521
Query: 553 REFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPE-RSLGWDE 611
++FR E+ I THH NLVRLIG+C++ RLLVYE+M NGSL + LF + L W+
Sbjct: 522 KQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEY 581
Query: 612 RVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR-T 670
R IA AKGI YLH+EC I+HCDIKP+NIL+D+ + AK+SDFGLAKLL P R
Sbjct: 582 RFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYN 641
Query: 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA 730
+ VRGTRGY+APEW N PI+ K+DV+SYG+VLLE+V +RN ++ + I WA
Sbjct: 642 MSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSI-WA 700
Query: 731 YKCFIDRELN-----KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785
Y+ F +L Q VD + M+K WC+Q++P RP+M VV MLEGIT
Sbjct: 701 YEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGIT 760
Query: 786 DISIPPCP 793
+I P CP
Sbjct: 761 EIKNPLCP 768
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 713 (256.0 bits), Expect = 6.2e-93, Sum P(2) = 6.2e-93
Identities = 144/296 (48%), Positives = 204/296 (68%)
Query: 503 FSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVI 562
F+Y +L+ ATN F +LG+G FG+VY+GTL G +L AVKKLE + +G++EFRAE+ +I
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRL-AVKKLEG-IGQGKKEFRAEVSII 540
Query: 563 GRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERS--LGWDERVRIASDVA 620
G HH +LVRL G+CAE + RLL YE++S GSL +FR + L WD R IA A
Sbjct: 541 GSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTA 600
Query: 621 KGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGY 680
KG+ YLH++C+A I+HCDIKP+NIL+D+ + AK+SDFGLAKL+ +Q+ FT +RGTRGY
Sbjct: 601 KGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGY 660
Query: 681 MAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKP-EEIVLINWAYKCFIDREL 739
+APEW N IS K+DV+SYG+VLLE++ R+N DPS+ E+ ++A+K + +L
Sbjct: 661 LAPEWITNYAISEKSDVYSYGMVLLELIGGRKNY--DPSETSEKCHFPSFAFKKMEEGKL 718
Query: 740 NKLVRGQ----EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPP 791
+V G+ +V ++ +K LWC+Q++ RPSM VV MLEG+ + PP
Sbjct: 719 MDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPP 774
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 687 (246.9 bits), Expect = 3.9e-89, Sum P(2) = 3.9e-89
Identities = 143/308 (46%), Positives = 195/308 (63%)
Query: 497 ESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFR 556
+ L +FSY EL+ AT F ++LG G FG+V+KG L +AVK+LE +++GE++FR
Sbjct: 477 DGTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSD-IAVKRLEG-ISQGEKQFR 534
Query: 557 AEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERS---LGWDERV 613
E+ IG H NLVRL G+C+E SK+LLVY+YM NGSL LF LGW R
Sbjct: 535 TEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRF 594
Query: 614 RIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL 673
+IA A+G+ YLHDEC IIHCDIKP+NIL+D + K++DFGLAKL+ D +R T
Sbjct: 595 QIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTT 654
Query: 674 VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLI-NWAYK 732
+RGTRGY+APEW I+ KADV+SYG++L E+V RRN E S+ E++ +WA
Sbjct: 655 MRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTE--QSENEKVRFFPSWAAT 712
Query: 733 CFI-DRELNKLV----RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787
D ++ LV G VD + K+ WC+QDE + RP+M VV +LEG+ ++
Sbjct: 713 ILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEV 772
Query: 788 SIPPCPTS 795
+ PP P S
Sbjct: 773 NPPPFPRS 780
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 720 (258.5 bits), Expect = 4.1e-79, Sum P(2) = 4.1e-79
Identities = 200/656 (30%), Positives = 316/656 (48%)
Query: 80 VWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGK---SEPASSASMLDSGNFV 136
+W++ RD P VSS+ + LT G ++ E+G ++ + P S + D+GN +
Sbjct: 86 IWSSNRDSP-VSSSGTMNLTPQGISVI--EDGKSQIPVWSTPVLASPVKSLRLTDAGNLL 142
Query: 137 LYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYP 196
L ++ + +W SF PTD+I+ Q L G L +S + STG ++ + L+ +
Sbjct: 143 LLDHLNVSLWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGESDGLMQWR 202
Query: 197 INTIDDYTEAYWASDSQRERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLT 256
A+ +L ++ +G ++ + ++ + PS++ + + +
Sbjct: 203 GQNYWKLRMHIRANVDSNFPVEYLTVTTSGLALMARNGTVVVVRVALPPSSDFRVAKMDS 262
Query: 257 IGHNGILRLFSHYPVPKGAYNTSVDWNVPDDLCEVKTFCGLNSYCTLYD--DQPMCRCLP 314
G I+ FS G N +++ P D C++ CG C L + + C C P
Sbjct: 263 SG-KFIVSRFS------GK-NLVTEFSGPMDSCQIPFVCGKLGLCNLDNASENQSCSC-P 313
Query: 315 GTDFLDPNQ--TSSGCERKFVDERCKGINISAEYNMTSMEKMTWDDYYY--FKASITKEE 370
+D + + + C+ NIS Y + + ++ + +
Sbjct: 314 DEMRMDAGKGVCVPVSQSLSLPVSCEARNIS--YLELGLGVSYFSTHFTDPVEHGLPLLA 371
Query: 371 CKESCLEDCECDVALYEESVDDKPSYCTKQKLPLKSAKRDLKNSSSSIAYFKTGIRNIXX 430
C + C ++C C YE + + Y K S ++ + I Y K IR
Sbjct: 372 CHDICSKNCSCLGVFYENT--SRSCYLVKDSFGSLSLVKNSPENHDLIGYVKLSIRK--- 426
Query: 431 XXXXXXXAMPQDRNRSKKAXXXXXXXXXXXXXCSCAFLTFS-GVF------IFKYQVLKY 483
A P N + CS FL + G+ + +Y ++
Sbjct: 427 -----TNAQPPGNNN--RGGSSFPVIALVLLPCSGFFLLIALGLLWWRRCAVMRYSSIRE 479
Query: 484 EWL-----LENGSLGLAYESNL-RSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEK 537
+ + E+G LG + L + F + EL++AT FK ++G G FG+VYKGTL E
Sbjct: 480 KQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTL-PDET 538
Query: 538 LVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLAD 597
L+AVKK+ G +EF E+ +IG H NLV+L G+CA + LLVYEYM++GSL
Sbjct: 539 LIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEK 598
Query: 598 ILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDF 657
LF G L W ER IA A+G+ YLH C+ IIHCD+KP+NIL+ + + KISDF
Sbjct: 599 TLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDF 658
Query: 658 GLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRN 713
GL+KLL +++ FT +RGTRGY+APEW N IS KADV+SYG+VLLE+V R+N
Sbjct: 659 GLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKN 714
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 541 (195.5 bits), Expect = 1.8e-69, Sum P(3) = 1.8e-69
Identities = 118/282 (41%), Positives = 180/282 (63%)
Query: 508 LKKATNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT 565
+ +AT+ F +LG+G FG VYKGTL G++ VAVK+L + +G EF+ E+ +I +
Sbjct: 458 VSEATSGFSAGNKLGQGGFGPVYKGTLACGQE-VAVKRLSRTSRQGVEEFKNEIKLIAKL 516
Query: 566 HHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILF-RGPERSLGWDERVRIASDVAKGIL 624
H+NLV+++GYC ++ +R+L+YEY N SL +F + R L W +RV I +A+G+L
Sbjct: 517 QHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGML 576
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL-VRGTRGYMAP 683
YLH++ IIH D+K N+L+D AKISDFGLA+ L D+T T V GT GYM+P
Sbjct: 577 YLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSP 636
Query: 684 EWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE----L 739
E+ + S+K+DVFS+GV++LEIV RRN ++ ++ L+ A++ F++ + +
Sbjct: 637 EYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFR-NEEHKLNLLGHAWRQFLEDKAYEII 695
Query: 740 NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLML 781
++ V D + + +I IGL CVQ +P RP+M VVLML
Sbjct: 696 DEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLML 737
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 688 (247.2 bits), Expect = 9.2e-68, P = 9.2e-68
Identities = 244/828 (29%), Positives = 373/828 (45%)
Query: 3 SSVYAVLILLLTISGITNVAQQQHPQPKSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQD 62
+S+Y L L + +++A + +S+ G + P P LG F G
Sbjct: 7 TSLYLSLFLYFFLYE-SSMAANTIRRGESLRDGINHKPLVSPQK-TFELGFFSPG--SST 62
Query: 63 AGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEG----HDKVVAA 118
F +GIW D +VW A R P + L ++ DG L+L + + ++
Sbjct: 63 HRF-LGIWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESS 121
Query: 119 GKSEPASSASMLDSGNFVLYNNRSDI-IWSSFKIPTDTILGNQSLLAG-----NELF-SR 171
+ S+ D+GNFVL +D IW SF PTDT L + N F S
Sbjct: 122 TTNNNNRVVSIHDTGNFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSW 181
Query: 172 ISETSSSTGRFRLNMQRDG--NLVLYPINTIDDYTEAYWASDSQRERQLHLYLSNT--G- 226
SET S G + L + G +VL+ N + W S L+N G
Sbjct: 182 RSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGF 241
Query: 227 NLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSHYPVPKGAYNTSVDWNVPD 286
L D G + Y PS+ S++ R + +NG K + PD
Sbjct: 242 KLSSPPDETGSVYFTYV-PSD-PSVLLRFKVLYNGTEEELRWNETLKKWTKFQSE---PD 296
Query: 287 DLCEVKTFCGLNSYCTLYDDQPMCRCLPGTDFLDPNQTSSGCERKFVDERCKGINISA-E 345
C+ CG C + +C C+ G + + S GC R+ +C+ NIS E
Sbjct: 297 SECDQYNRCGKFGICDMKGSNGICSCIHGYEQVSVGNWSRGCRRR-TPLKCER-NISVGE 354
Query: 346 YNMTSMEKMTWDDYYYFKASITK-EECKESCLEDCECDV---------ALYEESVDDKPS 395
+++ + D+ + ++ E+C+E CL +C C+ ++ + + D
Sbjct: 355 DEFLTLKSVKLPDFEIPEHNLVDPEDCRERCLRNCSCNAYSLVGGIGCMIWNQDLVDLQQ 414
Query: 396 Y-CTKQKLPLKSAKRDL-KNSSSSIAYFKTGIRNIXXXXXXXXXAMPQDRNRSKKAXXXX 453
+ L ++ A ++ +N + IA + + A+ R + KK
Sbjct: 415 FEAGGSSLHIRLADSEVGENRKTKIAVI---VAVLVGVILIGIFALLLWRFKRKKDVSGA 471
Query: 454 XXXXXXXXXCSCAFLTFSGVFIFKYQVLKYEWLLENGSLGLAYESNLRSFSYNELKKATN 513
A LT S + + ++E ++ S L FS N + ATN
Sbjct: 472 YCGKNTDTSVVVADLTKSKETTSAFSG-SVDIMIEGKAVNT---SELPVFSLNAIAIATN 527
Query: 514 RF-KE-ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLV 571
F KE ELG+G FG VYKG L G + +AVK+L +G EF+ E+ +I + H+NLV
Sbjct: 528 DFCKENELGRGGFGPVYKGVLEDGRE-IAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLV 586
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSL-GWDERVRIASDVAKGILYLHDEC 630
RL+G C E +++LVYEYM N SL LF +++L W R I +A+G+LYLH +
Sbjct: 587 RLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDS 646
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL-VRGTRGYMAPEWYKNT 689
IIH D+K N+L+D KISDFG+A++ +Q T+ V GT GYM+PE+
Sbjct: 647 RLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEG 706
Query: 690 PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW-AYKCFIDREL-NKLVRGQE 747
SVK+DV+S+GV+LLEIV +RN + S+ ++ W Y EL + +R
Sbjct: 707 LFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTC 766
Query: 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT-DISIPPCPT 794
R L I + + CVQD A RP+M SV+LMLE T ++ P PT
Sbjct: 767 SKREALR-CIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPT 813
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 499 (180.7 bits), Expect = 2.5e-67, Sum P(2) = 2.5e-67
Identities = 117/297 (39%), Positives = 178/297 (59%)
Query: 505 YNELKKATNRFKEE--LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVI 562
+ L ATN F + LG+G FG VYKG L G++ +AVK+L KM ++G EF E+ +I
Sbjct: 513 WKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKE-IAVKRLSKMSSQGTDEFMNEVRLI 571
Query: 563 GRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERS-LGWDERVRIASDVAK 621
+ H NLVRL+G C + +++L+YEY+ N SL LF S L W +R I + +A+
Sbjct: 572 AKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIAR 631
Query: 622 GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL-VRGTRGY 680
G+LYLH + IIH D+K N+L+D+ T KISDFG+A++ ++T T V GT GY
Sbjct: 632 GLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGY 691
Query: 681 MAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740
M+PE+ + S+K+DVFS+GV+LLEI+ +RN S ++ L+ + ++ + + +
Sbjct: 692 MSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSN-RDLNLLGFVWRHWKEGKEL 750
Query: 741 KLVRGQEVDRNTLE-------NMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIP 790
++V +D + E I+IGL CVQ+ RP M SV++ML G +IP
Sbjct: 751 EIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVML-GSETTAIP 806
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 501 (181.4 bits), Expect = 1.7e-66, Sum P(4) = 1.7e-66
Identities = 122/339 (35%), Positives = 189/339 (55%)
Query: 468 LTFSGVFIFKYQVLKYE-WLLENGSLGLAYESNLRSFSYNELKKATNRFK--EELGKGSF 524
L F+ + +++Y+ + + W +NG S + F + ++ ATN F +LG+G F
Sbjct: 443 LVFAAIMLWRYRAKQNDAW--KNG-FERQDVSGVNFFEMHTIRTATNNFSPSNKLGQGGF 499
Query: 525 GAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584
G VYKG L G++ + VK+L +G EF E+ +I + H+NLVRL+GYC + ++L
Sbjct: 500 GPVYKGKLVDGKE-IGVKRLASSSGQGTEEFMNEITLISKLQHRNLVRLLGYCIDGEEKL 558
Query: 585 LVYEYMSNGSLADILFRGP--ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQ 642
L+YE+M N SL DI P + L W +R I +A+G+LYLH + +IH D+K
Sbjct: 559 LIYEFMVNKSL-DIFIFDPCLKFELDWPKRFNIIQGIARGLLYLHRDSRLRVIHRDLKVS 617
Query: 643 NILMDEFWTAKISDFGLAKLLMPDQTRTFTL-VRGTRGYMAPEWYKNTPISVKADVFSYG 701
NIL+D+ KISDFGLA++ Q + T V GT GYM+PE+ S K+D++S+G
Sbjct: 618 NILLDDRMNPKISDFGLARMFQGTQYQDNTRRVVGTLGYMSPEYAWAGLFSEKSDIYSFG 677
Query: 702 VVLLEIVCCRR-NMEIDPSKPEEIVLINWAYKC------FIDRELNKLVRGQEVDRNTLE 754
V++LEI+ +R + I + + ++ W C +DR+L + EV R
Sbjct: 678 VLMLEIISGKRISRFIYGDESKGLLAYTWDSWCETGGSNLLDRDLTDTCQAFEVAR---- 733
Query: 755 NMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPPCP 793
++IGL CVQ E RP+ V+ ML TD+ +P P
Sbjct: 734 -CVQIGLLCVQHEAVDRPNTLQVLSMLTSATDLPVPKQP 771
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 496 (179.7 bits), Expect = 2.6e-66, Sum P(2) = 2.6e-66
Identities = 116/296 (39%), Positives = 176/296 (59%)
Query: 505 YNELKKATNRFKE--ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVI 562
+ E+ ATN F +LG+G FG VYKG L G+++ AVK+L K +G EF+ E+ +I
Sbjct: 516 FEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEM-AVKRLSKTSVQGTDEFKNEVKLI 574
Query: 563 GRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERS-LGWDERVRIASDVAK 621
R H NLVRL+ C + +++L+YEY+ N SL LF S L W R I + +A+
Sbjct: 575 ARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIAR 634
Query: 622 GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL-VRGTRGY 680
G+LYLH + IIH D+K NIL+D++ T KISDFG+A++ D+T T V GT GY
Sbjct: 635 GLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGY 694
Query: 681 MAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740
M+PE+ + S+K+DVFS+GV+LLEI+ +RN S ++ L+ ++ + + +
Sbjct: 695 MSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSD-RDLNLLGCVWRNWKEGKGL 753
Query: 741 KLVRGQEVDRNT------LENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIP 790
+++ D ++ + I+IGL CVQ+ RP+M V+LML G +IP
Sbjct: 754 EIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILML-GSESTTIP 808
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 5.9e-66, Sum P(2) = 5.9e-66
Identities = 119/306 (38%), Positives = 176/306 (57%)
Query: 498 SNLRSFSYNELKKATNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREF 555
S L+ F N ++ AT+ F +LG+G FG+VYKG L G++ +AVK+L +G+ EF
Sbjct: 479 SGLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKE-IAVKRLSSSSGQGKEEF 537
Query: 556 RAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPER-SLGWDERVR 614
E+ +I + HKNLVR++G C E +RLLVYE++ N SL LF +R + W +R
Sbjct: 538 MNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRKRLEIDWPKRFN 597
Query: 615 IASDVAKGILYLH-DECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL 673
I +A+G+ YLH D C +IH D+K NIL+DE KISDFGLA++ + + T
Sbjct: 598 IIEGIARGLHYLHRDSC-LRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTR 656
Query: 674 -VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLI----N 728
V GT GYMAPE+ S K+D++S+GV+LLEI+ + + + +L +
Sbjct: 657 RVAGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEKISRFSYGRQGKTLLAYAWES 716
Query: 729 WAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDIS 788
W ID L+K V +E ++IGL CVQ +PA RP+ ++ ML +D++
Sbjct: 717 WCESGGIDL-LDKDV-ADSCHPLEVERCVQIGLLCVQHQPADRPNTMELLSMLTTTSDLT 774
Query: 789 IPPCPT 794
P PT
Sbjct: 775 SPKQPT 780
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3659 | 0.9535 | 0.9122 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00034873001 | SubName- Full=Chromosome chr4 scaffold_73, whole genome shotgun sequence; (796 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 796 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-53 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-50 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-48 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-38 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-28 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-27 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-25 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-24 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-21 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-20 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-20 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 7e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-19 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-19 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-13 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 1e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-11 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-07 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 4e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-05 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 3e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-04 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 0.004 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 4e-55
Identities = 86/277 (31%), Positives = 126/277 (45%), Gaps = 35/277 (12%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHKNLV 571
+LG GSFG VYK K+VAVK L+K ++ ++ R E+ ++ R H N+V
Sbjct: 2 ELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
RLI + LV EY G L D L R L DE +IA + +G+ YLH
Sbjct: 62 RLIDAFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGLEYLHSN-- 117
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYK-NTP 690
IIH D+KP+NIL+DE KI+DFGLAK L+ + T V GT YMAPE
Sbjct: 118 -GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNG 175
Query: 691 ISVKADVFSYGVVLLEIVC---------CRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741
K DV+S GV+L E++ +++ + + E
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVV 778
L++ C+ +P+ RP+ + ++
Sbjct: 236 LIK-----------------KCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 6e-53
Identities = 77/217 (35%), Positives = 115/217 (52%), Gaps = 15/217 (6%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTHHKNLVRLIGYC 577
LG+G FG VY K K VA+K ++K + E E+ ++ + +H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 578 AEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHC 637
+++ LV EY GSL D+L + L DE +RI + +G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 638 DIKPQNILMDE-FWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE-WYKNTPISVKA 695
D+KP+NIL+D K++DFGL+KLL + GT YMAPE S K+
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLL-TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 696 DVFSYGVVLLEIVCC----RRNMEIDPSK---PEEIV 725
D++S GV+L E+ R+ ++ DP K +EI+
Sbjct: 176 DIWSLGVILYELPELKDLIRKMLQKDPEKRPSAKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 73/199 (36%), Positives = 106/199 (53%), Gaps = 8/199 (4%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTHHKNLVR 572
E+LG+GSFG VY K KLVA+K ++K + +RE E+ ++ + H N+VR
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
L ++ K LV EY G L D+L + S DE + + YLH +
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE--DEARFYLRQILSALEYLHSKG-- 117
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
I+H D+KP+NIL+DE K++DFGLA+ L P + T T V GT YMAPE
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT-TFV-GTPEYMAPEVLLGKGYG 174
Query: 693 VKADVFSYGVVLLEIVCCR 711
D++S GV+L E++ +
Sbjct: 175 KAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 5e-48
Identities = 86/279 (30%), Positives = 132/279 (47%), Gaps = 34/279 (12%)
Query: 514 RFKEELGKGSFGAVYKGTLY----KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHK 568
++LG+G+FG VYKG L K + VAVK L++ +E + EF E ++ + H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
N+V+L+G C E+ +V EYM G L L R L + + A +A+G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG---YMAPEW 685
+ IH D+ +N L+ E KISDFGL++ L D RG + +MAPE
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YRKRGGKLPIRWMAPES 174
Query: 686 YKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-LNKLVR 744
K + K+DV+S+GV+L EI +P Y + E L L
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEI------FT-LGEQP---------YPGMSNEEVLEYLKN 218
Query: 745 GQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLML 781
G + + N + + L C ++P RP+ +V +L
Sbjct: 219 GYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 5e-47
Identities = 86/281 (30%), Positives = 137/281 (48%), Gaps = 37/281 (13%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEK----LVAVKKLEKMVTEGER-EFRAEMHVIGRTHHK 568
++LG+G+FG VYKGTL VAVK L++ +E + EF E ++ + H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
N+V+L+G C E+ ++V EYM G L D L + + L + + A +A+G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG---YMAPEW 685
+ IH D+ +N L+ E KISDFGL++ L D V+G + +MAPE
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YKVKGGKLPIRWMAPES 175
Query: 686 YKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPS---KPEEIVLINWAYKCFIDRELNKL 742
K + K+DV+S+GV+L EI + +P E+ L L
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIF----TLGEEPYPGMSNAEV--------------LEYL 217
Query: 743 VRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLML 781
+G + + N + K+ L C ++P RP+ +V +L
Sbjct: 218 KKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 9e-47
Identities = 74/204 (36%), Positives = 110/204 (53%), Gaps = 14/204 (6%)
Query: 514 RFKEELGKGSFGAVYKGTLY----KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHK 568
++LG+G+FG VYKGTL E VAVK L++ +E ER EF E ++ + H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
N+VRL+G C + +V EYM G L D L R L + +++A +AKG+ YL
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG---YMAPEW 685
+ +H D+ +N L+ E KISDFGL++ + D G + +MAPE
Sbjct: 121 K---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPES 175
Query: 686 YKNTPISVKADVFSYGVVLLEIVC 709
K+ + K+DV+S+GV+L EI
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 8e-42
Identities = 87/288 (30%), Positives = 133/288 (46%), Gaps = 48/288 (16%)
Query: 517 EELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHKNLVR 572
++LG+G+FG VYKG L VAVK L++ +E ER +F E V+ + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADIL-------FRGPERSLGWDERVRIASDVAKGILY 625
L+G C E+ LV EYM G L D L + +L + + A +AKG+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 626 LHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL-----VRGTRGY 680
L +H D+ +N L+ E KISDFGL++ + D +R +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 681 MAPEWYKNTPISVKADVFSYGVVLLEIVCCRR----NMEIDPSKPEEIVLINWAYKCFID 736
MAPE K+ + K+DV+S+GV+L EI + EE+
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-----SNEEV------------ 216
Query: 737 RELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
L L +G + + + + ++ L C Q +P RP+ +V LE
Sbjct: 217 --LEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 7e-38
Identities = 66/200 (33%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKK--LEKMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
E LG+GSFG+VY +L+AVK L E E+ ++ H N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 575 G-YCAEDSKRLLVY-EYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGILYLHDEC 630
G E+ L ++ EY+S GSL+ +L ++ E V + + +G+ YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL----KKFGKLPEPVIRKYTRQILEGLAYLHSNG 121
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL----MPDQTRTFTLVRGTRGYMAPEWY 686
I+H DIK NIL+D K++DFG AK L + T + VRGT +MAPE
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS---VRGTPYWMAPEVI 175
Query: 687 KNTPISVKADVFSYGVVLLE 706
+ AD++S G ++E
Sbjct: 176 RGEEYGRAADIWSLGCTVIE 195
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 70/194 (36%), Positives = 106/194 (54%), Gaps = 12/194 (6%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
+GKG FG V G Y+G+K VAVK L+ T + F AE V+ H NLV+L+
Sbjct: 10 LGATIGKGEFGDVMLGD-YRGQK-VAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLL 66
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERS-LGWDERVRIASDVAKGILYLHDECEAP 633
G + + +V EYM+ GSL D L R R+ + +++ A DV +G+ YL E
Sbjct: 67 GVVLQGNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLE---EKN 122
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV 693
+H D+ +N+L+ E AK+SDFGLAK + ++ + + APE + S
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFST 178
Query: 694 KADVFSYGVVLLEI 707
K+DV+S+G++L EI
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 9e-33
Identities = 64/196 (32%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKK--LEKMVTEGEREFRAEMHVIGRTHHKNLVR 572
+ +G+G+FG VYKG + VA+K+ LEK+ E + E+ ++ H N+V+
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 573 LIGYCAEDSKRL-LVYEYMSNGSLADILFR-GPERSLGWDERVRIASDVAKGILYLHDEC 630
IG E S L ++ EY NGSL I+ + GP V +G+ YLH++
Sbjct: 64 YIG-SIETSDSLYIILEYAENGSLRQIIKKFGP---FPESLVAVYVYQVLQGLAYLHEQ- 118
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
+IH DIK NIL + K++DFG+A + D ++ V GT +MAPE + +
Sbjct: 119 --GVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMSG 175
Query: 691 ISVKADVFSYGVVLLE 706
S +D++S G ++E
Sbjct: 176 ASTASDIWSLGCTVIE 191
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 67/192 (34%), Positives = 100/192 (52%), Gaps = 10/192 (5%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKL-EKMVTEGEREFRAEMHVIGRTHHKNLVRLIGY 576
LG+GS G VYK K+ A+KK+ E ++ E+ + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 577 CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGILYLHDECEAPI 634
++ + +V EYM GSLAD+L ++ E V IA + KG+ YLH + I
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDYLHTK--RHI 121
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVK 694
IH DIKP N+L++ KI+DFG++K+L + T V GT YM+PE + S
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYA 180
Query: 695 ADVFSYGVVLLE 706
AD++S G+ LLE
Sbjct: 181 ADIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 6/193 (3%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
E++GKG FG VYK + K VA+K ++ E + + E+ ++ + H N+V+
Sbjct: 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY 62
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
G + + +V E+ S GSL D+L + ++L + + ++ KG+ YLH
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYLH---SNG 118
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV 693
IIH DIK NIL+ K+ DFGL+ L + R T+V GT +MAPE P
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR-NTMV-GTPYWMAPEVINGKPYDY 176
Query: 694 KADVFSYGVVLLE 706
KAD++S G+ +E
Sbjct: 177 KADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-30
Identities = 79/280 (28%), Positives = 121/280 (43%), Gaps = 22/280 (7%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE---FRAEMHVIGR-THHKN 569
R +LG+GSFG VY KLVA+K L K + +E F E+ ++ H N
Sbjct: 3 RILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADIL-FRGPERSLGWDERVRIASDVAKGILYLHD 628
+V+L + ++ LV EY+ GSL D+L G + L E + I + + + YLH
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH- 118
Query: 629 ECEAPIIHCDIKPQNILMDEF-WTAKISDFGLAKLLMPDQTRT-----FTLVRGTRGYMA 682
IIH DIKP+NIL+D K+ DFGLAKLL + + + GT GYMA
Sbjct: 119 --SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 683 PEWYK---NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739
PE S +D++S G+ L E++ E + + + +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 740 NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779
+ L + + + +P R S S +
Sbjct: 237 SPLS--PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 5/202 (2%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+ + + + +LG G FG V++G L+ VAVK L K T ++F AE ++ +
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEG-LWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLR 59
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H L++L C + +V E M GSL + L G R+L + + +A+ VA G+ YL
Sbjct: 60 HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
IH D+ +N+L+ E K++DFGLA+++ D + + APE
Sbjct: 120 E---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAA 176
Query: 687 KNTPISVKADVFSYGVVLLEIV 708
S+K+DV+S+G++L EIV
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 3e-30
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 10/202 (4%)
Query: 516 KEELGKGSFGAVYKGTLYKGEKLVAVKK--LEKMVTEGEREF-RAEMHVIGRTHHKNLVR 572
+++GKGSFG VY KL +K+ L M +E ERE E+ ++ + +H N+++
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIK 63
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADIL--FRGPERSLGWDERVRIASDVAKGILYLHDEC 630
E K +V EY G L+ + + + ++ + + + YLH
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR- 122
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
I+H DIKPQNI + K+ DFG++K+L T+V GT Y++PE +N P
Sbjct: 123 --KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKP 179
Query: 691 ISVKADVFSYGVVLLEIVCCRR 712
+ K+D++S G VL E+ +
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 73/205 (35%), Positives = 112/205 (54%), Gaps = 11/205 (5%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+ + + + + +LG G FG V+ GT + G VAVK L K T F E ++ +
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGT-WNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLR 59
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H LV+L C+E+ +V EYMS GSL D L G + L + V +A+ +A+G+ YL
Sbjct: 60 HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAP 683
IH D+ +NIL+ E KI+DFGLA+L+ D+ +T G + + AP
Sbjct: 120 E---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPIKWTAP 173
Query: 684 EWYKNTPISVKADVFSYGVVLLEIV 708
E ++K+DV+S+G++L EIV
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 72/200 (36%), Positives = 104/200 (52%), Gaps = 21/200 (10%)
Query: 519 LGKGSFGAVY----KGTLYKGEKLVAVKKLEK--MVTEGEREF-RAEMHVIGRTHHKNLV 571
LGKGSFG V K T KL A+K L+K ++ E E E +++ R +H +V
Sbjct: 1 LGKGSFGKVLLVRKKDT----GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIV 56
Query: 572 RLIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVR-IASDVAKGILYLHDE 629
+L Y + ++L LV EY G L L + E +ER R A+++ + YLH
Sbjct: 57 KLH-YAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFS-EERARFYAAEIVLALEYLH-- 110
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT 689
II+ D+KP+NIL+D K++DFGLAK L + +RT T GT Y+APE
Sbjct: 111 -SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGK 168
Query: 690 PISVKADVFSYGVVLLEIVC 709
D +S GV+L E++
Sbjct: 169 GYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 85/288 (29%), Positives = 140/288 (48%), Gaps = 32/288 (11%)
Query: 514 RFKEELGKGSFGAVYKGTL-----YKGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHH 567
+F ++LG+G FG V GE VAVK L E R +F E+ ++ H
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGE-QVAVKSLNHSGEEQHRSDFEREIEILRTLDH 65
Query: 568 KNLVRLIGYCAEDSKR--LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILY 625
+N+V+ G C + R L+ EY+ +GSL D L R ++ + + +S + KG+ Y
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDY 124
Query: 626 LHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG----YM 681
L + IH D+ +NIL++ KISDFGLAK+L D + + V+ +
Sbjct: 125 LGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPED--KDYYYVKEPGESPIFWY 179
Query: 682 APEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFI-DREL 739
APE + + S +DV+S+GV L E+ + P E + +I A I R L
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS--PP-AEFLRMIGIAQGQMIVTRLL 236
Query: 740 NKLVRGQEVDR-----NTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
L G+ + R + + +++K+ C + EP RPS ++L+++
Sbjct: 237 ELLKEGERLPRPPSCPDEVYDLMKL---CWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 65/206 (31%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E + + +LG G FG V++G L+K VA+K L+ +++F+ E+ + R
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLR 60
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPE-RSLGWDERVRIASDVAKGILY 625
HK+L+ L C+ ++ E M GSL L R PE + L + +A VA+G+ Y
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 626 LHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD---QTRTFTLVRGTRGYMA 682
L ++ IH D+ +NIL+ E K++DFGLA+L+ D + + T A
Sbjct: 120 LEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----A 172
Query: 683 PEWYKNTPISVKADVFSYGVVLLEIV 708
PE + S K+DV+S+G++L E+
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMF 198
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 61/194 (31%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
E+LG+GS+G+VYK + ++VA+K + V E +E E+ ++ + +V+
Sbjct: 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
G +++ +V EY GS++DI+ + ++L +E I KG+ YLH
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIM-KITNKTLTEEEIAAILYQTLKGLEYLHSN---K 119
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV 693
IH DIK NIL++E AK++DFG++ L + T++ GT +MAPE + +
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNN 178
Query: 694 KADVFSYGVVLLEI 707
KAD++S G+ +E+
Sbjct: 179 KADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 79/269 (29%), Positives = 117/269 (43%), Gaps = 37/269 (13%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIG 575
LG+G+ G+V K L + A+K + + +++ E+ + +V+ G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 576 YCAEDSKRLL--VYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGILYLHDECE 631
++S + EY GSL I + +R E+V +IA V KG+ YLH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-- 124
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
IIH DIKP NIL+ K+ DFG++ L+ TFT GT YMAPE + P
Sbjct: 125 -KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGKPY 180
Query: 692 SVKADVFSYGVVLLEIVCCR--------------------RNMEIDPSKPEEIVLINW-- 729
S+ +DV+S G+ LLE+ R NM K E I W
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240
Query: 730 AYKCFIDRELNKLVRGQEVDRNTLENMIK 758
+K FI + L K R T +M++
Sbjct: 241 EFKDFIKQCLEK----DPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 70/205 (34%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 519 LGKGSFGAVYKG-TLYKGEKLVAVK--KLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIG 575
+G G+FG VY L GE L+AVK +++ + +E EM V+ H NLV+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGE-LMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 576 YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGILYLHDECEAP 633
K + EY S G+L ++L G R L DE V + +G+ YLH
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHG--RIL--DEHVIRVYTLQLLEGLAYLH---SHG 119
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG---YMAPEWYKNTP 690
I+H DIKP NI +D K+ DFG A L + T V+ G YMAPE
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 691 ISVK---ADVFSYGVVLLEIVCCRR 712
AD++S G V+LE+ +R
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 67/196 (34%), Positives = 102/196 (52%), Gaps = 15/196 (7%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHKNLVRLIGY 576
ELG G+ G V K K++AVK + + E + + E+ ++ + + +V G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 577 CAEDSKRLLVYEYMSNGSLADILFRG----PERSLGWDERVRIASDVAKGILYLHDECEA 632
+ + EYM GSL IL PER LG +IA V KG+ YLH++ +
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKHK- 121
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
IIH D+KP NIL++ K+ DFG++ L+ +TF GT YMAPE + S
Sbjct: 122 -IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGNDYS 177
Query: 693 VKADVFSYGVVLLEIV 708
VK+D++S G+ L+E+
Sbjct: 178 VKSDIWSLGLSLIELA 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 74/229 (32%), Positives = 115/229 (50%), Gaps = 38/229 (16%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKL-EKMVTEGEREFRAEMH 560
E+ + RF EELG+G+FG VYKG L VA+K L E + ++EFR E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 561 VIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFR--------------GPERS 606
++ H N+V L+G C ++ +++EY+++G L + L R + S
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 607 LGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666
L + + IA +A G+ YL +H D+ +N L+ E T KISDFGL++ +
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 667 -----QTRTFTLVRGTRGYMAPE---WYKNTPISVKADVFSYGVVLLEI 707
Q+++ VR +M PE + K T S D++S+GVVL EI
Sbjct: 178 DYYRVQSKSLLPVR----WMPPEAILYGKFTTES---DIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 10/204 (4%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+++ K +LG G +G VY+G K VAVK L++ E E EF E V+
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 60
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H NLV+L+G C + ++ E+M+ G+L D L + + + +A+ ++ + YL
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAP 683
+ IH D+ +N L+ E K++DFGL++L+ D T+T G + + AP
Sbjct: 121 EKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAP 174
Query: 684 EWYKNTPISVKADVFSYGVVLLEI 707
E S+K+DV+++GV+L EI
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 80/295 (27%), Positives = 129/295 (43%), Gaps = 61/295 (20%)
Query: 518 ELGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHKNLV 571
ELG+GSFG VY+G E VA+K + + + ER EF E V+ + ++V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADIL--------FRGPERSLGWDERVRIASDVAKGI 623
RL+G + L+V E M+ G L L + +++A+++A G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 624 LYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA-------------KLLMPDQTRT 670
YL +H D+ +N ++ E T KI DFG+ K L+P
Sbjct: 133 AYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP----- 184
Query: 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA 730
VR +MAPE K+ + K+DV+S+GVVL E+ L
Sbjct: 185 ---VR----WMAPESLKDGVFTTKSDVWSFGVVLWEMA----------------TLAEQP 221
Query: 731 YKCFIDRELNKLV-RGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
Y+ + E+ K V G +D N + ++++ C Q P +RP+ +V L+
Sbjct: 222 YQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 70/202 (34%), Positives = 110/202 (54%), Gaps = 18/202 (8%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG---EREFRAEMHVIGRTHHKNLV 571
F +ELG G FG V+ G ++G+ VA+K M+ EG E +F E V+ + H NLV
Sbjct: 8 FLKELGSGQFGVVHLG-KWRGKIDVAIK----MIREGAMSEDDFIEEAKVMMKLSHPNLV 62
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
+L G C + +V EYM+NG L + L + LG + + + SDV + + YL
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLESNG- 120
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAPEWYKN 688
IH D+ +N L+ E K+SDFGLA+ ++ DQ +T +GT+ + PE +
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDY 175
Query: 689 TPISVKADVFSYGVVLLEIVCC 710
+ S K+DV+S+GV++ E+
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 74/263 (28%), Positives = 126/263 (47%), Gaps = 25/263 (9%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG---EREFRAEMHVIGRTHHKNL 570
+E+G G FG V+ G + K VA+K + EG E +F E V+ + H L
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRK-VAIK----TIREGAMSEEDFIEEAQVMMKLSHPKL 61
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
V+L G C E S LV+E+M +G L+D L R + + + DV +G+ YL
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
+IH D+ +N L+ E K+SDFG+ + ++ DQ + T + + +PE + +
Sbjct: 121 ---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 691 ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750
S K+DV+S+GV++ E+ + + S E + IN ++ + R ++ V
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSV------- 230
Query: 751 NTLENMIKIGLWCVQDEPALRPS 773
++ C ++ P RPS
Sbjct: 231 ------YELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 44/229 (19%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEG-------EREFRAEMHVIGR 564
+F + +G+GSF V + K A+K L+K ++ E E+E V+ R
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKE------VLTR 57
Query: 565 -THHKNLVRLIGYCAEDSKRL-LVYEYMSNGSLAD-ILFRGPERSLGWDERVRIASDVAK 621
H +++L Y +D + L V EY NG L I G SL A+++
Sbjct: 58 LNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILL 113
Query: 622 GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ-------------- 667
+ YLH IIH D+KP+NIL+D+ KI+DFG AK+L P+
Sbjct: 114 ALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 668 -----TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCR 711
R F GT Y++PE P +D+++ G ++ +++ +
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 64/196 (32%), Positives = 105/196 (53%), Gaps = 13/196 (6%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKL-EKMVTEGEREFRAEMHVIGRTHHKNLVRLIG 575
E++GKG+FG VYKG L KG VAVK + + +R+F E ++ + H N+V+LIG
Sbjct: 1 EKIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 576 YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPII 635
C + +V E + GSL L R + L + ++++ D A G+ YL + I
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 636 HCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR----GYMAPEWYKNTPI 691
H D+ +N L+ E KISDFG+++ ++ +T+ G + + APE
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 692 SVKADVFSYGVVLLEI 707
+ ++DV+SYG++L E
Sbjct: 173 TSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 14/195 (7%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKK--LEKMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
E +GKGSFG VYK + ++VA+K LE+ E E + + E+ + + + +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSPYITKYY 65
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGILYLHDECEA 632
G + SK ++ EY GS D+L G DE I +V G+ YLH+E +
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGK-----LDETYIAFILREVLLGLEYLHEEGK- 119
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
IH DIK NIL+ E K++DFG++ L ++ T V GT +MAPE K +
Sbjct: 120 --IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYD 176
Query: 693 VKADVFSYGVVLLEI 707
KAD++S G+ +E+
Sbjct: 177 EKADIWSLGITAIEL 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 27/205 (13%)
Query: 517 EELGKGSFGAVYKGTL---YKGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHKNLVR 572
+ +G G FG V +G L K E VA+K L+ ++ +R +F E ++G+ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
L G + +++ EYM NGSL D R + + V + +A G+ YL +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN-- 126
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLL-MPDQTRTFTLVRGTRG------YMAPE- 684
+H D+ +NIL++ K+SDFGL++ L + T T T+G + APE
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------TKGGKIPIRWTAPEA 179
Query: 685 --WYKNTPISVKADVFSYGVVLLEI 707
+ K T S DV+S+G+V+ E+
Sbjct: 180 IAYRKFTSAS---DVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 28/223 (12%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEK-----LVAVKKLEKM-VTEGEREFRAEMH 560
+++ T K ELG+G+FG V+ G Y E LVAVK L++ + ++F E
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60
Query: 561 VIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL------------FRGPERSLG 608
++ H+N+V+ G C E ++V+EYM +G L L P L
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 609 WDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668
+ ++IA +A G++YL + +H D+ +N L+ KI DFG+++ + T
Sbjct: 121 LSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY---T 174
Query: 669 RTFTLVRGTR----GYMAPEWYKNTPISVKADVFSYGVVLLEI 707
+ V G +M PE + ++DV+S+GVVL EI
Sbjct: 175 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 72/191 (37%), Positives = 109/191 (57%), Gaps = 12/191 (6%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGY 576
E +G+G FGAV +G Y G+K VAVK ++ VT + F E V+ + HHKNLVRL+G
Sbjct: 12 EIIGEGEFGAVLQGE-YTGQK-VAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGV 67
Query: 577 CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIH 636
+ + V E MS G+L + L + + ++ + DVA+G+ YL + ++H
Sbjct: 68 ILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 637 CDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKAD 696
D+ +NIL+ E AK+SDFGLA++ + V+ T APE K+ S K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179
Query: 697 VFSYGVVLLEI 707
V+SYGV+L E+
Sbjct: 180 VWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRA--EMHVIGRTHHKNLV 571
+ E++G+G+ G VYK T K VA+KK M + + E+ ++ H N+V
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKK---MRLRKQNKELIINEILIMKDCKHPNIV 78
Query: 572 RLIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
L +V EYM GSL DI+ + + + +V +G+ YLH
Sbjct: 79 DYYD-SYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNEPQIAYVCREVLQGLEYLH--- 133
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
+IH DIK NIL+ + + K++DFG A L ++++ ++V GT +MAPE K
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKD 192
Query: 691 ISVKADVFSYGVVLLEIV 708
K D++S G++ +E+
Sbjct: 193 YGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 81/279 (29%), Positives = 139/279 (49%), Gaps = 25/279 (8%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+ + T + ++LG G FG V+ G Y G VA+K L++ E F AE +++ +
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQ 59
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H LVRL ++ ++ EYM NGSL D L L ++ + +A+ +A+G+ ++
Sbjct: 60 HPRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAP 683
IH D++ NIL+ E KI+DFGLA+L+ ++ +T G + + AP
Sbjct: 119 E---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAP 172
Query: 684 EWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743
E ++K+DV+S+G++L EIV R + PE I + L +
Sbjct: 173 EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI------------QNLERGY 220
Query: 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
R D N E + ++ C +++P RP+ + + +LE
Sbjct: 221 RMPRPD-NCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 74/196 (37%), Positives = 106/196 (54%), Gaps = 14/196 (7%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
+ + +GKG FG V G Y+G K VAVK ++ T + F AE V+ + H NLV+L
Sbjct: 9 KLLQTIGKGEFGDVMLGD-YRGNK-VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQL 64
Query: 574 IGYCAEDSKRL-LVYEYMSNGSLADILFRGPERS-LGWDERVRIASDVAKGILYLHDECE 631
+G E+ L +V EYM+ GSL D L R RS LG D ++ + DV + + YL
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN-- 121
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
+H D+ +N+L+ E AK+SDFGL K Q V+ T APE +
Sbjct: 122 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKF 176
Query: 692 SVKADVFSYGVVLLEI 707
S K+DV+S+G++L EI
Sbjct: 177 STKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-24
Identities = 91/366 (24%), Positives = 169/366 (46%), Gaps = 30/366 (8%)
Query: 427 NITTSSNNTNSAMPQDRNRSKKAIILILVITIGLVTCSCAFLTFSGVFIFKYQVLKYEWL 486
NI +T S +P + K + A + F VFI L+ + +
Sbjct: 604 NIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRV 663
Query: 487 -LENGSLGLAYESN--LRSFSYNELKKATNRFKEE--LGKGSFGAVYKGTLYKGEKLVAV 541
E+G+ L + + +S + N++ + KEE + +G GA YKG K V
Sbjct: 664 ENEDGTWELQFFDSKVSKSITINDILSSL---KEENVISRGKKGASYKGKSIKNGMQFVV 720
Query: 542 KKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFR 601
K++ + + E A+M G+ H N+V+LIG C + L++EY+ +L+++L
Sbjct: 721 KEINDVNSIPSSEI-ADM---GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-- 774
Query: 602 GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661
R+L W+ R +IA +AK + +LH C ++ ++ P+ I++D + L
Sbjct: 775 ---RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830
Query: 662 LLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKP 721
LL D + Y+APE + I+ K+D++ +G++L+E++ + + +
Sbjct: 831 LLCTDTKCFI-----SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH 885
Query: 722 EEIVLINWAYKCF----IDRELNKLVRGQ-EVDRNTLENMIKIGLWCVQDEPALRPSMKS 776
IV WA C+ +D ++ +RG V++N + ++ + L C +P RP
Sbjct: 886 GSIV--EWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAND 943
Query: 777 VVLMLE 782
V+ LE
Sbjct: 944 VLKTLE 949
|
Length = 968 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 68/192 (35%), Positives = 107/192 (55%), Gaps = 8/192 (4%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTHHKNLVRLIG 575
E++GKGSFG V+KG + +K+VA+K ++ E E E + E+ V+ + + + G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 576 YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPII 635
+D+K ++ EY+ GS D+L GP L + I ++ KG+ YLH E + I
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKK---I 123
Query: 636 HCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKA 695
H DIK N+L+ E K++DFG+A L Q + T V GT +MAPE K + KA
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKA 182
Query: 696 DVFSYGVVLLEI 707
D++S G+ +E+
Sbjct: 183 DIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 89/289 (30%), Positives = 130/289 (44%), Gaps = 59/289 (20%)
Query: 519 LGKGSFGAVYKGTLYKG------EKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLV 571
LG G+FG VY+G LY+G E VAVK L + +E E +F E ++ + +H+N+V
Sbjct: 14 LGHGAFGEVYEG-LYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRG---PER--SLGWDERVRIASDVAKGILYL 626
RLIG E R ++ E M+ G L L PER SL + + A DVAKG YL
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 627 HDECEAPIIHCDIKPQNILMDEFW---TAKISDFGLAKLLMPDQTRTFTLVRGTRG---- 679
E IH DI +N L+ AKI+DFG+A+ D R +G R
Sbjct: 133 E---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLPI 185
Query: 680 -YMAPEWYKNTPISVKADVFSYGVVLLEIVC-------CRRNMEIDPSKPEEIVLINWAY 731
+M PE + + + K DV+S+GV+L EI R N E+
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV--------------- 230
Query: 732 KCFIDRELNKLVRGQEVD--RNTLENMIKIGLWCVQDEPALRPSMKSVV 778
+ + G +D + + +I C Q P RP+ +++
Sbjct: 231 -------MEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 83/299 (27%), Positives = 139/299 (46%), Gaps = 57/299 (19%)
Query: 519 LGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMVTEGE-REFRAEMHVIGRTHHKNLVR 572
LG+G FG V K T ++ G VAVK L++ + E R+ +E +++ + +H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 573 LIGYCAEDSKRLLVYEYMSNGSL----------------------ADILFRGPERSLGWD 610
L G C++D LL+ EY GSL + L ER+L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 611 ERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670
+ + A +++G+ YL E ++H D+ +N+L+ E KISDFGL++ + +
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED--- 181
Query: 671 FTLVRGTRG-----YMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIV 725
+ V+ ++G +MA E + + ++DV+S+GV+L EIV N P E
Sbjct: 182 -SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY--PGIAPE-- 236
Query: 726 LINWAYKCFIDRELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
R N L G ++R N E M + L C + EP RP+ + LE
Sbjct: 237 -----------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 65/197 (32%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 516 KEELGKGSFGAVYKGTLYKGEKLVAVKK--LEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
++GKGSFG V+K +++ A+K+ L KM E E V+ + ++R
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
+ K +V EY NG L +L R L D+ R + G+ +LH +
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---K 121
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV 693
I+H DIK N+ +D + KI D G+AKLL + T+V GT Y++PE ++ P +
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKPYNE 180
Query: 694 KADVFSYGVVLLEIVCC 710
K+DV++ GVVL E CC
Sbjct: 181 KSDVWALGVVLYE--CC 195
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 69/195 (35%), Positives = 106/195 (54%), Gaps = 14/195 (7%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTHHKNLVRLIG 575
E +GKGSFG VYKG + +++VA+K ++ E E E + E+ V+ + + R G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 576 YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIAS---DVAKGILYLHDECEA 632
+ +K ++ EY+ GS D+L GP E IA+ ++ KG+ YLH E +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPL------EETYIATILREILKGLDYLHSERK- 122
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
IH DIK N+L+ E K++DFG+A L Q + T V GT +MAPE K +
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYD 179
Query: 693 VKADVFSYGVVLLEI 707
KAD++S G+ +E+
Sbjct: 180 FKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 84/299 (28%), Positives = 140/299 (46%), Gaps = 51/299 (17%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLY----KGEKLVAVKKLEKMVTEGE-REFRAEMHV 561
EL + RF EELG+ +FG +YKG LY +LVA+K L+ + + EF+ E +
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 562 IGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL-FRGPERSLGW--DER------ 612
+ HH N+V L+G ++ +++EY++ G L + L R P +G DE
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 613 ------VRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666
+ IA +A G+ YL +H D+ +NIL+ E KISD GL++ +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 667 -----QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKP 721
Q ++ +R +M PE S +D++S+GVVL EI + + P
Sbjct: 178 DYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIF----SFGLQP--- 226
Query: 722 EEIVLINWAYKCFIDRELNKLVRGQEV---DRNTLENMIKIGLWCVQDEPALRPSMKSV 777
Y F ++E+ ++VR +++ + M + C Q+ P+ RP K +
Sbjct: 227 ---------YYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 66/199 (33%), Positives = 108/199 (54%), Gaps = 18/199 (9%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG---EREFRAEMHVIGRTHHKNLV 571
F +ELG G FG V G ++G+ VA+K M+ EG E EF E V+ + H+ LV
Sbjct: 8 FLKELGTGQFGVVKYGK-WRGQYDVAIK----MIKEGSMSEDEFIEEAKVMMKLSHEKLV 62
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
+L G C + +V EYMSNG L + L R + + + + DV +G+ YL +
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYLESK-- 119
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAPEWYKN 688
IH D+ +N L+D+ K+SDFGL++ ++ D+ +T G++ + PE
Sbjct: 120 -QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLY 175
Query: 689 TPISVKADVFSYGVVLLEI 707
+ S K+DV+++GV++ E+
Sbjct: 176 SKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 67/220 (30%), Positives = 113/220 (51%), Gaps = 10/220 (4%)
Query: 519 LGKGSFGAVYKGTLY---KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHKNLVRLI 574
+G G FG V++G L + E VA+K L+ TE +R +F +E ++G+ H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
G + +++ EYM NG+L D R + + V + +A G+ YL D
Sbjct: 73 GVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNY 128
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG--YMAPEWYKNTPIS 692
+H D+ +NIL++ K+SDFGL+++L D T+T G + APE +
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188
Query: 693 VKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYK 732
+DV+S+G+V+ E++ D S E + IN ++
Sbjct: 189 SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 73/204 (35%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 514 RFKEELGKGSFGAV----YKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKN 569
+F ++LGKG+FG+V Y ++VAVKKL+ E R+F E+ ++ H N
Sbjct: 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDN 66
Query: 570 LVRLIGYCAEDSKR--LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLH 627
+V+ G C +R LV EY+ GSL D L + ER L + + AS + KG+ YL
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER-LDHRKLLLYASQICKGMEYLG 125
Query: 628 DECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR--GTRG--YMAP 683
+H D+ +NIL++ KI DFGL K+L Q + + VR G + AP
Sbjct: 126 ---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL--PQDKEYYKVREPGESPIFWYAP 180
Query: 684 EWYKNTPISVKADVFSYGVVLLEI 707
E + SV +DV+S+GVVL E+
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKL--EKMVTEGERE-FRAEMHVIGRTHHKNLVRL 573
E +GKGSFG V K K++ K++ M TE E++ +E++++ H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 574 IGYCAEDSKRLL--VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILY-----L 626
+ S + L V EY G LA ++ + + ER I + IL L
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKK------ERKYIEEEFIWRILTQLLLAL 118
Query: 627 HDECEAP------IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGY 680
+ EC ++H D+KP NI +D K+ DFGLAK+L D + T V GT Y
Sbjct: 119 Y-ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYY 176
Query: 681 MAPEWYKNTPISVKADVFSYGVVLLEI 707
M+PE + K+D++S G ++ E+
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 6e-23
Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 14/195 (7%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTHHKNLVRLIG 575
E +GKGSFG V+KG + +++VA+K ++ E E E + E+ V+ + + + G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 576 YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIAS---DVAKGILYLHDECEA 632
+ +K ++ EY+ GS D+L GP +DE +IA+ ++ KG+ YLH E +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGP-----FDE-FQIATMLKEILKGLDYLHSEKK- 122
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
IH DIK N+L+ E K++DFG+A L Q + T V GT +MAPE + +
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYD 179
Query: 693 VKADVFSYGVVLLEI 707
KAD++S G+ +E+
Sbjct: 180 SKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 7e-23
Identities = 70/203 (34%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKK--LEKMVTEGEREFRAEMHVIGRTHHKNLVR 572
E +G G+ VY + VA+K+ LEK T + E R E+ + + +H N+V+
Sbjct: 5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVK 63
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIAS---DVAKGILYLHDE 629
+ LV Y+S GSL DI+ R G DE + IA+ +V KG+ YLH
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRG-GLDEAI-IATVLKEVLKGLEYLHSN 121
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT----FTLVRGTRGYMAPEW 685
+ IH DIK NIL+ E + KI+DFG++ L RT T V GT +MAPE
Sbjct: 122 GQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAPEV 177
Query: 686 YKN-TPISVKADVFSYGVVLLEI 707
+ KAD++S+G+ +E+
Sbjct: 178 MEQVHGYDFKADIWSFGITAIEL 200
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 8e-23
Identities = 70/205 (34%), Positives = 111/205 (54%), Gaps = 12/205 (5%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+ + + + ++LG G FG V+ GT + G VAVK L K T F E ++ +
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLR 59
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H LV+L +E+ +V EYMS GSL D L G R+L V +A+ VA G+ Y+
Sbjct: 60 HDKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAP 683
IH D++ NIL+ + KI+DFGLA+L+ ++ +T +G + + AP
Sbjct: 119 E---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAP 172
Query: 684 EWYKNTPISVKADVFSYGVVLLEIV 708
E ++K+DV+S+G++L E+V
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 69/211 (32%), Positives = 109/211 (51%), Gaps = 19/211 (9%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGT-LYKGEKL---VAVKKL-EKMVTEGEREFRAEMHV 561
LK+ + LG G+FG VYKG + +GEK+ VA+K L E+ + +E E +V
Sbjct: 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV 62
Query: 562 IGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAK 621
+ H ++VRL+G C S+ L+ + M G L D + R + ++G + +AK
Sbjct: 63 MASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYV-RNHKDNIGSQYLLNWCVQIAK 120
Query: 622 GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG-- 679
G+ YL E ++H D+ +N+L+ KI+DFGLAKLL D+ G
Sbjct: 121 GMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE----YHAEGGKV 173
Query: 680 ---YMAPEWYKNTPISVKADVFSYGVVLLEI 707
+MA E + + K+DV+SYGV + E+
Sbjct: 174 PIKWMALESILHRIYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 72/214 (33%), Positives = 104/214 (48%), Gaps = 33/214 (15%)
Query: 519 LGKGSFGAVYKGTLY------KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHKNLV 571
LG G+FG VY+GT G VAVK L K T+ E+ EF E H++ +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADIL-------FRGPERSLGWDERVRIASDVAKGIL 624
+L+G C + + ++ E M G L L F P +L E + I DVAKG +
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL--KELLDICLDVAKGCV 120
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFW-----TAKISDFGLAK-LLMPDQTRTFTLVRGTR 678
YL IH D+ +N L+ E KI DFGLA+ + D R G
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR----KEGEG 173
Query: 679 ----GYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+MAPE + + ++DV+S+GV++ EI+
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 73/274 (26%), Positives = 128/274 (46%), Gaps = 46/274 (16%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLE-KMVTEGEREFRA-EMHVIGRTHHKNLVRLIGY 576
LGKGS+G+VYK + A+K+++ +++ ERE E+ ++ +H N+ I Y
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI---ISY 64
Query: 577 CAE--DSKRL-LVYEYMSNGSLADILFRGPE--RSLGWDERVRIASDVAKGILYLHDECE 631
D +L +V EY G L+ + + + + + E RI + +G+ LH++
Sbjct: 65 KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-- 122
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
I+H D+K NIL+ KI D G++K+L + +T GT YMAPE +K P
Sbjct: 123 -KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWKGRPY 178
Query: 692 SVKADVFSYGVVLLEIVCCR-----RNMEIDPSKPEEIVLINWAYKCFIDRELN-KLVRG 745
S K+D++S G +L E+ R+M+ +L K+ RG
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQ----------------------DLRYKVQRG 216
Query: 746 Q--EVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777
+ + +++ +Q +P LRP+ +
Sbjct: 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 75/276 (27%), Positives = 132/276 (47%), Gaps = 42/276 (15%)
Query: 519 LGKGSFGAVYKGTLYK---GEKLVAVKK--LEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
LGKG+FG + TLY+ + LV K+ L ++ + R+ E+ ++ H N++
Sbjct: 8 LGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRG-----PERSLGWDERVRIASDVAKGILYLHD 628
+ +D+ L+ EY + G+L D + R E + W +I S V+ Y+H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-YLFQIVSAVS----YIH- 118
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN 688
+A I+H DIK NI + + K+ DFG++K+L + + T+V GT YM+PE +
Sbjct: 119 --KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQG 175
Query: 689 TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ-- 746
+ K+D+++ G VL E++ +R D + P +V K+V+G
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTF--DATNPLNLV--------------VKIVQGNYT 219
Query: 747 -EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLML 781
V + E +I + +Q +P RP+ V+
Sbjct: 220 PVVSVYSSE-LISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 80/282 (28%), Positives = 138/282 (48%), Gaps = 31/282 (10%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+ + + R +LG+G FG V+ GT + G VA+K L K T F E ++ +
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGT-WNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLR 59
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H LV L +E+ +V E+M GSL D L G + L + V +A+ +A G+ Y+
Sbjct: 60 HDKLVPLYAVVSEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI 118
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAP 683
IH D++ NIL+ + KI+DFGLA+L+ ++ +T +G + + AP
Sbjct: 119 E---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAP 172
Query: 684 EWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-LNKL 742
E ++K+DV+S+G++L E+V R Y ++RE L ++
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGR----------------VPYPGMVNREVLEQV 216
Query: 743 VRGQEV--DRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
RG + + E++ ++ C + +P RP+ + + LE
Sbjct: 217 ERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 85/293 (29%), Positives = 139/293 (47%), Gaps = 48/293 (16%)
Query: 519 LGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGE-REFRAEMHV---IGRTHHKN 569
LG+G+FG V K VAVK L+ TE + + +EM + IG+ HKN
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKN 77
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADIL--------------FRGPERSLGWDERVRI 615
++ L+G C ++ +V EY ++G+L D L R PE +L + V
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 616 ASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK-LLMPDQTRTFTLV 674
A VA+G+ +L + IH D+ +N+L+ E KI+DFGLA+ + D R T
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 675 RGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF 734
R +MAPE + + ++DV+S+GV+L EI + S I +
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI------FTLGGSPYPGIPV-------- 240
Query: 735 IDRELNKLVR-GQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
EL KL++ G +++ N + + + C + P+ RP+ K +V L+ +
Sbjct: 241 --EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 54/172 (31%), Positives = 86/172 (50%), Gaps = 15/172 (8%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLE-KMVTEG-----EREFRAEMHVIGRTHHKNLVR 572
+G+G+ G V+K + + VA+KK+ + + G RE +A H +V+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC----QHPYVVK 63
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
L+ S +LV EYM L+++L R ER L + + KG+ Y+H
Sbjct: 64 LLDVFPHGSGFVLVMEYMP-SDLSEVL-RDEERPLPEAQVKSYMRMLLKGVAYMH---AN 118
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
I+H D+KP N+L+ KI+DFGLA+L ++ R ++ TR Y APE
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 16/198 (8%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTHHKNLVRLIGY 576
ELG G+FG VYK +K L A K+ ++ +E E E F E+ ++ H N+V L
Sbjct: 12 ELGDGAFGKVYK-AQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 577 CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIH 636
++K ++ E+ G+L I+ ER L + + + + + +LH +IH
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 637 CDIKPQNILMDEFWTAKISDFGL-AKLLMPDQTR-TFTLVRGTRGYMAP-----EWYKNT 689
D+K NIL+ K++DFG+ AK Q R TF GT +MAP E +K+
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVVACETFKDN 183
Query: 690 PISVKADVFSYGVVLLEI 707
P KAD++S G+ L+E+
Sbjct: 184 PYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 6e-22
Identities = 71/207 (34%), Positives = 108/207 (52%), Gaps = 23/207 (11%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEK-----LVAVKKLEKMVTEGERE-FRAEMHVIGRTH-- 566
F + LG G+FG V + T Y K VAVK L+ ERE +E+ ++ +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIM--SHLG 96
Query: 567 -HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILY 625
H+N+V L+G C L++ EY G L + L R E L ++ + + VAKG+ +
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 626 LHDE-CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRG-TR---GY 680
L + C IH D+ +N+L+ KI DFGLA+ +M D +V+G R +
Sbjct: 157 LASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN---YVVKGNARLPVKW 209
Query: 681 MAPEWYKNTPISVKADVFSYGVVLLEI 707
MAPE N + ++DV+SYG++L EI
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 81/282 (28%), Positives = 139/282 (49%), Gaps = 31/282 (10%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+ + + R + +LG+G FG V+ GT + G VA+K L K T F E V+ +
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 59
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H+ LV+L +E+ +V EYMS GSL D L + L + V +A+ +A G+ Y+
Sbjct: 60 HEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAP 683
+H D++ NIL+ E K++DFGLA+L+ ++ +T +G + + AP
Sbjct: 119 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAP 172
Query: 684 EWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-LNKL 742
E ++K+DV+S+G++L E+ R Y ++RE L+++
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELTTKGR----------------VPYPGMVNREVLDQV 216
Query: 743 VRGQEV--DRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
RG + E++ + C + EP RP+ + + LE
Sbjct: 217 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 70/204 (34%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 517 EELGKGSFGAVYKGTLYK----GEKLVAVKKL--EKMVTEGEREFRAEMHVIGRTHHKNL 570
+ELG G+FG+V KG +Y E VAVK L E + G++EF E V+ + H +
Sbjct: 1 KELGHGNFGSVVKG-VYLMKSGKEVEVAVKTLKQEHIAA-GKKEFLREASVMAQLDHPCI 58
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
VRLIG C + +LV E G L L + E + + +A VA G+ YL
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVS--DLKELAHQVAMGMAYLE--- 112
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAP-EWYKNT 689
+H D+ +N+L+ AKISDFG+++ L R T P +WY
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS----DYYRATTAGRWPLKWYAPE 168
Query: 690 PI-----SVKADVFSYGVVLLEIV 708
I S K+DV+SYGV L E
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 79/302 (26%), Positives = 133/302 (44%), Gaps = 41/302 (13%)
Query: 508 LKKATNRFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGEREFRAEMHVI 562
+K+ K ELG+G+FG V+ Y + + LVAVK L+ ++F E ++
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 563 GRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL----------ADILFRG-PERSLGWDE 611
H+++V+ G C E ++V+EYM +G L A ++ G L +
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 612 RVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK-LLMPDQTR- 669
+ IA +A G++YL + +H D+ +N L+ E KI DFG+++ + D R
Sbjct: 122 MLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178
Query: 670 ---TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVL 726
T +R +M PE + ++DV+S GVVL EI + S E I
Sbjct: 179 GGHTMLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234
Query: 727 INWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786
I R + R + + + L C Q EP +R ++K + +L+ +
Sbjct: 235 ITQG-------------RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
Query: 787 IS 788
S
Sbjct: 282 AS 283
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLE-----KMVTEGE-REFRAEMHVIGRTHHKNL 570
E LGKG++G VY G +G+ L+AVK++E + E E + + E+ ++ H N+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQ-LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFR-GPERSLGWDERV--RIASDVAKGILYLH 627
V+ +G C +D+ + E++ GS++ IL R GP E V + + G+ YLH
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP-----LPEPVFCKYTKQILDGVAYLH 119
Query: 628 DECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM-----PDQTRTFTLVRGTRGYMA 682
+ C ++H DIK N+++ K+ DFG A+ L + + GT +MA
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 683 PEWYKNTPISVKADVFSYGVVLLEI 707
PE + K+D++S G + E+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 58/195 (29%), Positives = 102/195 (52%), Gaps = 13/195 (6%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVR 572
+++E LG G+ G VYK +++AVK + +T E +++ +E+ ++ + ++
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIG 63
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
G +++ + E+M GSL D+ + PE LG RIA V KG+ YL
Sbjct: 64 FYGAFFVENRISICTEFMDGGSL-DVYRKIPEHVLG-----RIAVAVVKGLTYLWS---L 114
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
I+H D+KP N+L++ K+ DFG++ L+ +T+ GT YMAPE
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPERISGEQYG 171
Query: 693 VKADVFSYGVVLLEI 707
+ +DV+S G+ +E+
Sbjct: 172 IHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 63/203 (31%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 514 RFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHKN 569
+ +E +G G FG V +G L K E VA+K L+ TE +R +F +E ++G+ H N
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
++ L G + +++ E+M NG+L D R + + V + +A G+ YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR-TFTLVRGTR---GYMAPEW 685
E +H D+ +NIL++ K+SDFGL++ L D + T+T G + + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 686 YKNTPISVKADVFSYGVVLLEIV 708
+ +DV+SYG+V+ E++
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 5e-21
Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 514 RFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHKN 569
+ ++ +G G FG V G L K E VA+K L+ TE +R +F +E ++G+ H N
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
++ L G + ++V EYM NGSL D R + + V + +A G+ YL D
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD- 124
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG------YMAP 683
+H D+ +NIL++ K+SDFGL+++L D +T TRG + AP
Sbjct: 125 --MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT----TRGGKIPIRWTAP 178
Query: 684 EWYKNTPISVKADVFSYGVVLLEIV 708
E + +DV+SYG+V+ E++
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 14/209 (6%)
Query: 520 GKGSFGAVYKGTLYKGEKLVAVKKL--EKMVTEGE-REFRAEMHVIGRTHHKNLVRLIGY 576
GKG+FG V +K+ A+K + +K V +G R E ++ +H LV L Y
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW-Y 67
Query: 577 CAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEAPI 634
+D + + LV + + G L L + + S +E+V+ ++ + YLH I
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLSQKVKFS---EEQVKFWICEIVLALEYLH---SKGI 121
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVK 694
IH DIKP NIL+DE I+DF +A + T T + GT GYMAPE SV
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKV-TPDTLTTSTS-GTPGYMAPEVLCRQGYSVA 179
Query: 695 ADVFSYGVVLLEIVCCRRNMEIDPSKPEE 723
D +S GV E + +R +
Sbjct: 180 VDWWSLGVTAYECLRGKRPYRGHSRTIRD 208
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 70/267 (26%), Positives = 121/267 (45%), Gaps = 52/267 (19%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE----------FRAEMHVIGRTH 566
E +GKG++G VY +++AVK++E T R R+E+ +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGIL 624
H N+V+ +G+ + + EY+ GS+ L R R ++E++ V +G+
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGR---FEEQLVRFFTEQVLEGLA 122
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK----LLMPDQTRTFTLVRGTRGY 680
YLH + I+H D+K N+L+D KISDFG++K + DQ + ++G+ +
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS---MQGSVFW 176
Query: 681 MAPEWYKNTP--ISVKADVFSYGVVLLEIVCCRR---NMEI------------DPSKPEE 723
MAPE + S K D++S G V+LE+ RR + E P P +
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236
Query: 724 IVL------INWAYKCFIDRELNKLVR 744
+ + +++ CF +N R
Sbjct: 237 VSMNLSPVALDFLNACF---TINPDNR 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 82/294 (27%), Positives = 131/294 (44%), Gaps = 44/294 (14%)
Query: 515 FKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKN 569
K ELG+G+FG V+ Y K + LVAVK L+ ++F+ E ++ H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSL----------ADILFRGPERS----LGWDERVRI 615
+V+ G C + ++V+EYM +G L A IL G R LG + + I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 616 ASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK-LLMPDQTR----T 670
AS +A G++YL + +H D+ +N L+ KI DFG+++ + D R T
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA 730
+R +M PE + ++DV+S+GV+L EI + S E I I
Sbjct: 186 MLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241
Query: 731 YKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
R E R + + I L C Q EP R ++K + +L +
Sbjct: 242 -------------RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG---EREFRAEMHVIGRTHHKNLV 571
F +ELG G FG V+ G ++ + VA+K + EG E +F E V+ + H LV
Sbjct: 8 FMKELGSGQFGVVHLGK-WRAQIKVAIKA----INEGAMSEEDFIEEAKVMMKLSHPKLV 62
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
+L G C + +V E+M NG L + L R + L D + + DV +G+ YL
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLE---R 118
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
IH D+ +N L+ K+SDFG+ + ++ D+ + + + + PE + +
Sbjct: 119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 692 SVKADVFSYGVVLLEI 707
S K+DV+S+GV++ E+
Sbjct: 179 SSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 84/292 (28%), Positives = 139/292 (47%), Gaps = 55/292 (18%)
Query: 518 ELGKGSFGAVYKGT---LYKGE--KLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHKNLV 571
ELG+GSFG VY+G + KGE VAVK + + + ER EF E V+ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWD-------------ERVRIASD 618
RL+G ++ L+V E M++G L L RSL + E +++A++
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYL-----RSLRPEAENNPGRPPPTLQEMIQMAAE 127
Query: 619 VAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR 678
+A G+ YL+ + +H D+ +N ++ +T KI DFG+ + D T +G +
Sbjct: 128 IADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGK 180
Query: 679 G-----YMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKC 733
G +MAPE K+ + +D++S+GVVL EI L Y+
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LAEQPYQG 224
Query: 734 FIDRELNKLVR-GQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
+ ++ K V G +D+ N E + + C Q P +RP+ +V +L+
Sbjct: 225 LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 82/286 (28%), Positives = 126/286 (44%), Gaps = 43/286 (15%)
Query: 515 FKEELGKGSFGAVY----KGTLYKGEK-LVAVKKLEKMVTEGEREFRAEMHVIGRTHHKN 569
K ELG+G+FG V+ L + +K LVAVK L++ ++F+ E ++ H++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSL----------ADILFRG---PERSLGWDERVRIA 616
+VR G C E L+V+EYM +G L A IL G L + + IA
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 617 SDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ-----TRTF 671
S +A G++YL +H D+ +N L+ + KI DFG+++ + RT
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAY 731
+R +M PE + ++D++S+GVVL EI + S E I I
Sbjct: 186 LPIR----WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG- 240
Query: 732 KCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777
REL E R + I C Q EP R +K +
Sbjct: 241 -----REL-------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 63/200 (31%), Positives = 107/200 (53%), Gaps = 8/200 (4%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKL--EKMVTEGEREFRAEMHVIGRTHHKNLVRLIGY 576
+G+G+FG V+ +KLV +K++ E+M + + E V+ H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 577 CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIH 636
ED ++V EY G+LA+ + + SL DE I + +L LH I+H
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYI-QKRCNSL-LDEDT-ILHFFVQILLALHHVHTKLILH 124
Query: 637 CDIKPQNILMDEFWTA-KISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKA 695
D+K QNIL+D+ KI DFG++K+L +++ +T+V GT Y++PE + P + K+
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVV-GTPCYISPELCEGKPYNQKS 182
Query: 696 DVFSYGVVLLEIVCCRRNME 715
D+++ G VL E+ +R E
Sbjct: 183 DIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+ + + + ++LG G FG V+ G Y VAVK L K T + F E +++
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMG-YYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQ 59
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H LVRL ++ ++ EYM+ GSL D L + + + ++ +A+G+ Y+
Sbjct: 60 HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAP 683
+ IH D++ N+L+ E KI+DFGLA+++ ++ +T G + + AP
Sbjct: 120 ERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAP 173
Query: 684 EWYKNTPISVKADVFSYGVVLLEIV 708
E ++K+DV+S+G++L EIV
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVK--KLEKMVTEGEREFRAEMHVIGRTHHKNLVR 572
+ +G G++G VYK +LVA+K KLE + + E+ ++ H N+V
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVA 64
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
G K +V EY GSL DI L + + + KG+ YLH E
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLH---ET 120
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF----TLVRGTRGYMAPEWY-- 686
IH DIK NIL+ E K++DFG++ L T T + + GT +MAPE
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFI-GTPYWMAPEVAAV 175
Query: 687 -KNTPISVKADVFSYGVVLLE 706
+ K D+++ G+ +E
Sbjct: 176 ERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 66/213 (30%), Positives = 114/213 (53%), Gaps = 23/213 (10%)
Query: 514 RFKEELGKGSFGAVYKGTLYK-GEKL-VAVKKLEKMVTEGE-REFRAEMHVIGRT-HHKN 569
+F++ +G+G+FG V + + K G K+ A+K L++ +E + R+F E+ V+ + HH N
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADILFR--------------GPERSLGWDERVRI 615
++ L+G C + EY G+L D L + G +L + ++
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 616 ASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR 675
ASDVA G+ YL ++ IH D+ +N+L+ E +KI+DFGL++ + T+ R
Sbjct: 125 ASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGR 179
Query: 676 GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+MA E + + K+DV+S+GV+L EIV
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 5e-20
Identities = 78/282 (27%), Positives = 136/282 (48%), Gaps = 28/282 (9%)
Query: 517 EELGKGSFGAVYKGTLYK--------GEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTHH 567
LG+G FG V +LY GE +VAVK L++ + ++ E++++ +H
Sbjct: 10 RVLGEGHFGKV---SLYCYDPANDGTGE-MVAVKTLKRECGQQNTSGWKKEINILKTLYH 65
Query: 568 KNLVRLIGYCAEDSKR--LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILY 625
+N+V+ G C+E + L+ EY+ GSL D L P+ L + + A + +G+ Y
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAY 122
Query: 626 LHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG---YMA 682
LH + IH D+ +N+L+D KI DFGLAK + P+ + + + A
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYA 178
Query: 683 PEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742
E K S +DV+S+GV L E++ + + P K EE++ + R + L
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV-RLIELL 237
Query: 743 VRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
RG + N + + + C + E RP+ +S++ +L+
Sbjct: 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 6e-20
Identities = 58/193 (30%), Positives = 94/193 (48%), Gaps = 24/193 (12%)
Query: 539 VAVKKLEKMVTEGERE---FRAEMHVIGRTHHKNLVRLI--GYCAEDSKRLLVYEYMSNG 593
VA+K L E E + FR E + R +H N+V L+ G V+EY+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGR 64
Query: 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM---DEFW 650
+L ++L + +L E R+ V + H+ I+H D+KPQNI++
Sbjct: 65 TLREVL--AADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRP 119
Query: 651 TAKISDFGLAKLLMPDQ--------TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGV 702
AK+ DFG+ LL P TRT T V GT Y APE + P++ +D++++G+
Sbjct: 120 HAKVLDFGIGTLL-PGVRDADVATLTRT-TEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 703 VLLEIVCCRRNME 715
+ LE + +R ++
Sbjct: 178 IFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 7e-20
Identities = 33/89 (37%), Positives = 46/89 (51%), Gaps = 3/89 (3%)
Query: 76 DITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASS--ASMLDSG 133
+ T+VW A R +P S+ L L DG L+L + V ++ S S A + D G
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVL-YDGNGRVVWSSNTSGKGSGCVAVLQDDG 59
Query: 134 NFVLYNNRSDIIWSSFKIPTDTILGNQSL 162
N VLY+N ++W SF PTDT+L Q
Sbjct: 60 NLVLYDNSGKVLWQSFDHPTDTLLPGQKD 88
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 7e-20
Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 38/225 (16%)
Query: 514 RFKEELGKGSFGAVYKGTL-----YKGEKLVAVKKL-EKMVTEGEREFRAEMHVIGRTHH 567
+ ++G+G+FG V++ Y+ +VAVK L E+ + + +F+ E ++ H
Sbjct: 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH 67
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFR--------------------GPERSL 607
N+V+L+G CA L++EYM+ G L + L L
Sbjct: 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 608 GWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA-KLLMPD 666
E++ IA VA G+ YL E +H D+ +N L+ E KI+DFGL+ + D
Sbjct: 128 SCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 667 QTRT----FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEI 707
+ +R +M PE + ++DV++YGVVL EI
Sbjct: 185 YYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-19
Identities = 66/218 (30%), Positives = 114/218 (52%), Gaps = 33/218 (15%)
Query: 514 RFKEELGKGSFGAVYKGTLYK-GEKL-VAVKKLEKMVTEGE-REFRAEMHVIGRT-HHKN 569
+F++ +G+G+FG V K + K G ++ A+K++++ ++ + R+F E+ V+ + HH N
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRG--------------PERSLGWDERVRI 615
++ L+G C L EY +G+L D L + +L + +
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 616 ASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR 675
A+DVA+G+ YL + IH D+ +NIL+ E + AKI+DFGL++ V+
Sbjct: 130 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVK 179
Query: 676 GTRG-----YMAPEWYKNTPISVKADVFSYGVVLLEIV 708
T G +MA E + + +DV+SYGV+L EIV
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 25/208 (12%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKM-VTEGERE-----FRAEMHVIGRTHHKNL 570
++LG G+F + Y+ K L+AVK++ + T E+E R E+ ++ R +H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFR-GPERSLGWDERVRIA--SDVAKGILYLH 627
+R++G EDS L E+M+ GS++ +L + G + E V I + +G+ YLH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA-----FKEAVIINYTEQLLRGLSYLH 120
Query: 628 DECEAPIIHCDIKPQNILMDEFWTA---KISDFGLAKLLMPDQTRTFTL---VRGTRGYM 681
+ IIH D+K N+L+D T +I+DFG A L T + GT +M
Sbjct: 121 EN---QIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 682 APEWYKNTPISVKADVFSYGVVLLEIVC 709
APE + DV+S G V++E+
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMAT 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 70/211 (33%), Positives = 111/211 (52%), Gaps = 35/211 (16%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLE-------------KMVTEGEREFRAEMHVIGRT 565
+G GSFG+VY G +L+AVK++E M+ RE + ++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE----IALLKEL 63
Query: 566 HHKNLVRLIGYCAEDSKRLLVY-EYMSNGSLADIL--FRGPERSLGWDERVR-IASDVAK 621
H+N+V+ +G + D+ L ++ EY+ GS+A +L + E +L VR + K
Sbjct: 64 QHENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL-----VRNFVRQILK 117
Query: 622 GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT-----LVRG 676
G+ YLH+ IIH DIK NIL+D KISDFG++K L + T T ++G
Sbjct: 118 GLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174
Query: 677 TRGYMAPEWYKNTPISVKADVFSYGVVLLEI 707
+ +MAPE K T + KAD++S G +++E+
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 21/202 (10%)
Query: 517 EELGKGSFGAVYKG-TLYKGEKLVAVKKL-----EKMVTEGEREFRAEMHVIGRTHHKNL 570
E LG GSFG+VY+G L G+ AVK++ + E ++ E+ ++ + H N+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGD-FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFR-GPERSLGWDERVRIAS-DVAKGILYLHD 628
V+ +G E+ + E + GSLA +L + G + +R+ + + G+ YLHD
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFP----EPVIRLYTRQILLGLEYLHD 120
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP-DQTRTFTLVRGTRGYMAPEWYK 687
+H DIK NIL+D K++DFG+AK ++ ++F +G+ +MAPE
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF---KGSPYWMAPEVIA 174
Query: 688 NT-PISVKADVFSYGVVLLEIV 708
+ AD++S G +LE+
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMA 196
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNLVRLIG 575
LGKG FG V + K+ A KKL+K +GE+ E ++ + + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDE-RVRI-ASDVAKGILYLHDECEA 632
Y E L LV M+ G L ++ E G+ E R A+ + G+ +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEP--GFPEARAIFYAAQIICGLEHLHQR--- 114
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
I++ D+KP+N+L+D+ +ISD GLA + + + GT GYMAPE +
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGRA-GTPGYMAPEVLQGEVYD 172
Query: 693 VKADVFSYGVVLLEIVCCR 711
D F+ G L E++ R
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 79/284 (27%), Positives = 135/284 (47%), Gaps = 42/284 (14%)
Query: 519 LGKGSFGAVYKGTLYK-GEKL-VAVKKLEKMVTEGE-REFRAEMHVIGRT-HHKNLVRLI 574
+G+G+FG V K + K G ++ A+K++++ ++ + R+F E+ V+ + HH N++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFR--------------GPERSLGWDERVRIASDVA 620
G C L EY +G+L D L + +L + + A+DVA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 621 KGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGY 680
+G+ YL + IH D+ +NIL+ E + AKI+DFGL++ + T+ R +
Sbjct: 123 RGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRW 177
Query: 681 MAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL- 739
MA E + + +DV+SYGV+L EIV L Y EL
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVS----------------LGGTPYCGMTCAELY 221
Query: 740 NKLVRG--QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLML 781
KL +G E N + + + C +++P RPS +++ L
Sbjct: 222 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 30/221 (13%)
Query: 501 RSFSYNELKKATNRFKEELGKGSFGAVYKGT-LYKGEKL---VAVKKLEKMVTEGEREFR 556
R EL+K + LG G FG V+KG + +G+ + VA+K ++ G + F+
Sbjct: 2 RILKETELRKL-----KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD--RSGRQTFQ 54
Query: 557 A---EMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFR-----GPERSLG 608
M +G H +VRL+G C S +L V + GSL D + + P+R L
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLN 113
Query: 609 WDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668
W +AKG+ YL + ++H ++ +NIL+ +I+DFG+A LL PD
Sbjct: 114 W------CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164
Query: 669 RTF-TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+ F + + +MA E + ++DV+SYGV + E++
Sbjct: 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 66/203 (32%), Positives = 94/203 (46%), Gaps = 30/203 (14%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLE---KMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
E+G GSFGAVY + ++VA+KK+ K E ++ E+ + + H N +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 575 GYCAEDSKRLLVYEYMSNGSLADIL--FRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
G + LV EY GS +DIL + P + E I +G+ YLH
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDILEVHKKPLQE---VEIAAICHGALQGLAYLHSHER- 136
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE-------- 684
IH DIK NIL+ E T K++DFG A L+ P +F GT +MAPE
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN--SFV---GTPYWMAPEVILAMDEG 189
Query: 685 WYKNTPISVKADVFSYGVVLLEI 707
Y K DV+S G+ +E+
Sbjct: 190 QYDG-----KVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 30/208 (14%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE--------REFRAEMHVIGRTHHK 568
E+G+G++G VYK + VA+KK+ V E RE A + + H
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVR--VPLSEEGIPLSTLREI-ALLKQLESFEHP 61
Query: 569 NLVRLIGYCA-EDSKR----LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGI 623
N+VRL+ C + R LV+E++ LA L + P+ L + + + +G+
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 624 LYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAP 683
+LH I+H D+KPQNIL+ KI+DFGLA++ T V T Y AP
Sbjct: 121 DFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYRAP 175
Query: 684 E----WYKNTPISVKADVFSYGVVLLEI 707
E TP+ D++S G + E+
Sbjct: 176 EVLLQSSYATPV----DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 66/197 (33%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE---GEREFRAEMHVIGRTHHKNLVRLIG 575
LGKG FG V + K+ A KKL+K + GE+ E ++ + + +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
Y E L LV M+ G L ++ ER L + + ++ + GIL+LH I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDI 116
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVK 694
++ D+KP+N+L+D+ ++SD GLA + + D +T T GT GYMAPE K P S
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLA-VELKD-GKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 695 ADVFSYGVVLLEIVCCR 711
D F+ G + E+V R
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 79/289 (27%), Positives = 135/289 (46%), Gaps = 57/289 (19%)
Query: 518 ELGKGSFGAVYKGTLYKG------EKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHKNL 570
ELG+GSFG VY+G + KG E VA+K + + + ER EF E V+ + ++
Sbjct: 13 ELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDER-------------VRIAS 617
VRL+G ++ L++ E M+ G L L RSL + +++A
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYL-----RSLRPEMENNPVQAPPSLKKMIQMAG 126
Query: 618 DVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGT 677
++A G+ YL+ +H D+ +N ++ E +T KI DFG+ + D T +G
Sbjct: 127 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGG 179
Query: 678 RG-----YMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYK 732
+G +M+PE K+ + +DV+S+GVVL EI L Y+
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA----------------TLAEQPYQ 223
Query: 733 CFIDRELNKLV-RGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVV 778
+ ++ + V G +D+ N + + ++ C Q P +RPS ++
Sbjct: 224 GMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLY---KGE--KLVAVKKLEKMVTEGER-EFRAEMH 560
E+ +T RF EELG+ FG VYKG L+ GE + VA+K L+ R EF+ E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 561 VIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL-FRGPERSLGW--DER----- 612
+ R H N+V L+G ++ +++ Y S+ L + L R P +G D++
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 613 ------VRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK-LLMP 665
V I + +A G+ +L ++H D+ +N+L+ + KISD GL + +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 666 DQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEI 707
D + +M+PE S+ +D++SYGVVL E+
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 66/192 (34%), Positives = 100/192 (52%), Gaps = 8/192 (4%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKL-EKMVTEGEREFRAEMHVIGRTHHKNLVRLIG 575
E LGKG+FG V+KGTL K + VAVK E + E + +F +E ++ + H N+V+LIG
Sbjct: 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 576 YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE-CEAPI 634
C + +V E + G L R + L + V+ A D A G+ YL + C
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLESKNC---- 114
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVK 694
IH D+ +N L+ E KISDFG+++ + L + + APE S +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 695 ADVFSYGVVLLE 706
+DV+SYG++L E
Sbjct: 175 SDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 75/279 (26%), Positives = 135/279 (48%), Gaps = 25/279 (8%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+ + + + +++LG G FG V+ T K K VAVK + K + F AE +V+
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTM-KPGSMSVEAFLAEANVMKTLQ 59
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H LV+L ++ ++ E+M+ GSL D L + + ++ +A+G+ ++
Sbjct: 60 HDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAP 683
+ IH D++ NIL+ KI+DFGLA+++ ++ +T G + + AP
Sbjct: 119 E---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAP 172
Query: 684 EWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743
E ++K+DV+S+G++L+EIV R S PE I R L +
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI------------RALERGY 220
Query: 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
R + N E + I + C ++ P RP+ + + +L+
Sbjct: 221 RMPRPE-NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 69/241 (28%), Positives = 110/241 (45%), Gaps = 28/241 (11%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK-MVTEG--EREFRAEMHVIGRTHHKNLVRLIG 575
LG G FG V + + A+K ++K + E + +E ++ +H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 576 YCA-EDSKRL-LVYEYMSNGSLADILFRGPERSLG----WDERVRIASDVAKGILYLHDE 629
Y +D K + ++ EY G L IL R G + R IA V YLH+
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTIL-----RDRGLFDEYTARFYIAC-VVLAFEYLHNR 112
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT 689
II+ D+KP+N+L+D K+ DFG AK L Q +T+T GT Y+APE N
Sbjct: 113 ---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC-GTPEYVAPEIILNK 167
Query: 690 PISVKADVFSYGVVLLEIVCCR---RNMEIDPSKPEEIVLI---NWAYKCFIDRELNKLV 743
D +S G++L E++ R + DP + +L + +ID+ L+
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLI 227
Query: 744 R 744
+
Sbjct: 228 K 228
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 8e-19
Identities = 72/237 (30%), Positives = 120/237 (50%), Gaps = 21/237 (8%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG--EREFRAEMHVIGR 564
ELK ELG G+ G V+K +K L+ +KL + + + E+ V+
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFK-VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE 59
Query: 565 THHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRG---PERSLGWDERVRIASDVAK 621
+ +V G D + + E+M GSL +L + PE+ LG +V IA V K
Sbjct: 60 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSIA--VIK 114
Query: 622 GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYM 681
G+ YL ++ + I+H D+KP NIL++ K+ DFG++ L+ +F GTR YM
Sbjct: 115 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYM 169
Query: 682 APEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE 738
+PE + T SV++D++S G+ L+E+ R I P +E+ L+ + C ++ +
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGR--YPIPPPDAKELELM---FGCPVEGD 221
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 61/196 (31%), Positives = 100/196 (51%), Gaps = 14/196 (7%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCA 578
LGKG++G VY + +A+K++ + + + E+ + H+N+V+ +G +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 579 EDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRI--ASDVAKGILYLHDECEAPIIH 636
E+ + E + GSL+ +L R L +E+ I + +G+ YLHD I+H
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVH 131
Query: 637 CDIKPQNILMDEF-WTAKISDFGLAKLL--MPDQTRTFTLVRGTRGYMAPEWYKNTP--I 691
DIK N+L++ + KISDFG +K L + T TFT GT YMAPE P
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEVIDKGPRGY 188
Query: 692 SVKADVFSYGVVLLEI 707
AD++S G ++E+
Sbjct: 189 GAPADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 56/192 (29%), Positives = 95/192 (49%), Gaps = 9/192 (4%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGY 576
++G+GS G V T + VAVKK++ + + RE VI R H N+V +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMD-LRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 577 CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIH 636
+ +V E++ G+L DI+ + ++ + V K + +LH + +IH
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQ---GVIH 138
Query: 637 CDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKAD 696
DIK +IL+ K+SDFG + + R +LV GT +MAPE P + D
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVD 197
Query: 697 VFSYGVVLLEIV 708
++S G++++E+V
Sbjct: 198 IWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 12/195 (6%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKL-EKMVTEGEREFRAEMHVIGRTHHKNLVRLIG 575
E +G+G+FG V+ G L VAVK E + + + +F E ++ + H N+VRLIG
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 576 YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPII 635
C + +V E + G L R L E +++ + A G+ YL + I
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 636 HCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR----GYMAPEWYKNTPI 691
H D+ +N L+ E KISDFG+++ ++ + G + + APE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 692 SVKADVFSYGVVLLE 706
S ++DV+S+G++L E
Sbjct: 174 SSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 21/215 (9%)
Query: 508 LKKATNRF--KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGR- 564
L T F E +G+G++G VYK K +LVA+K ++ ++ + E E + E +++ +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKY 59
Query: 565 THHKNLVRLIG------YCAEDSKRLLVYEYMSNGSLADIL--FRGPERSLGWDERVRIA 616
++H N+ G D + LV E GS+ D++ R + L + I
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 617 SDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRG 676
+ +G+ YLH+ +IH DIK QNIL+ + K+ DFG++ L R T + G
Sbjct: 120 RETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-G 175
Query: 677 TRGYMAPE-----WYKNTPISVKADVFSYGVVLLE 706
T +MAPE + ++DV+S G+ +E
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 37/210 (17%)
Query: 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-------REFRA--EMHVIGRTH 566
E+LG+G++G VYK K ++VA+KK+ ++ E E RE E+
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELK------ 56
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGIL 624
H N+V+L+ + K LV+EY L L + R + I + +G+
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDK---RPGPLSPNLIKSIMYQLLRGLA 112
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
Y H I+H D+KPQNIL++ K++DFGLA+ RT+T T Y APE
Sbjct: 113 YCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVVTLWYRAPE 168
Query: 685 ------WYKNTPISVKADVFSYGVVLLEIV 708
Y +T + D++S G + E++
Sbjct: 169 ILLGSKHY-STAV----DIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 519 LGKGSFGAVYKGTLYKGEKL---VAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLI 574
+GKG FG VY GTL + AVK L ++ E +F E ++ H N++ L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 575 GYC-AEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
G C + L+V YM +G L + + R + + + VAKG+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYL---ASKK 118
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG------YMAPEWYK 687
+H D+ +N ++DE +T K++DFGLA+ + + + V G +MA E +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIY---DKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 688 NTPISVKADVFSYGVVLLEIV 708
+ K+DV+S+GV+L E++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEM---HVIGRTHHKNLVRLIG 575
LGKG FG V + KL A KKL K + + + M ++ + H + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDE--RVRIASDVAKGILYLHDECEA 632
Y + L LV M+ G L ++ E + G+ E + + G+ +LH +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QR 116
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
II+ D+KP+N+L+D +ISD GLA L Q++T GT G+MAPE +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYD 175
Query: 693 VKADVFSYGVVLLEIVCCR 711
D F+ GV L E++ R
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGERE-FRAEMHVIGRTHHKNLV 571
F + LG GSFG V K A+K L K +V + E E ++ H LV
Sbjct: 5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLV 64
Query: 572 RLIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDE 629
L G +D L LV EY+ G L L + R A+ V + YLH
Sbjct: 65 NLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV---ARFYAAQVVLALEYLHSL 120
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT 689
I++ D+KP+N+L+D KI+DFG AK + + RT+TL GT Y+APE +
Sbjct: 121 ---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYTLC-GTPEYLAPEIILSK 173
Query: 690 PISVKADVFSYGVVLLEIVC 709
D ++ G+++ E++
Sbjct: 174 GYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 39/213 (18%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-----REFRAEMHVIGRTHHKNLV 571
++LG G+FG+VY + +LVA+KK++K E RE ++ + H N+V
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKL---NEHPNIV 61
Query: 572 RLIGYCAE---DSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVR-IASDVAKGILYL 626
+L E ++ L V+EYM G+L L + + + +R I + +G+ ++
Sbjct: 62 KLK----EVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL--MPDQTRTFTLVRGTRGYMAPE 684
H H D+KP+N+L+ KI+DFGLA+ + P +T TR Y APE
Sbjct: 116 HK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPE 168
Query: 685 ------WYKNTPISVKADVFSYGVVLLEIVCCR 711
Y ++P+ D+++ G ++ E+ R
Sbjct: 169 ILLRSTSY-SSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 76/268 (28%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-REFRAEMHVIGRTHHKNLVRL 573
+ELGKG++G+VYK +A+K++ + E + + E+ ++ + +V
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGILYLHDECE 631
G + + EYM GSL D L+ G + G E V RI V KG+ +L +E
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYK---- 687
IIH D+KP N+L++ K+ DFG++ L+ +T G + YMAPE K
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPERIKSGGP 178
Query: 688 --NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745
N +V++DV+S G+ +LE+ R P PE I +D + L G
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRY-----PYPPETYANIFAQLSAIVDGDPPTLPSG 233
Query: 746 QEVDRNTLENMIKIGLWCVQDEPALRPS 773
D C+ P RP+
Sbjct: 234 YSDDAQDFVAK------CLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 4e-18
Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 18/215 (8%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG--EREFRAEMHVIGRTHHKNLVRLIG 575
ELG G+ G V K +K L+ +KL + + + E+ V+ + +V G
Sbjct: 12 ELGAGNGGVVTK-VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 576 YCAEDSKRLLVYEYMSNGSLADIL---FRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
D + + E+M GSL +L R PE LG +V IA V +G+ YL ++ +
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---KVSIA--VLRGLAYLREKHQ- 124
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
I+H D+KP NIL++ K+ DFG++ L+ +F GTR YM+PE + T S
Sbjct: 125 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYS 180
Query: 693 VKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLI 727
V++D++S G+ L+E+ R I P +E+ I
Sbjct: 181 VQSDIWSMGLSLVELAIGR--YPIPPPDAKELEAI 213
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 5e-18
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 28/205 (13%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-F-----RAEMHVIGRTHHKNL 570
++G+G++G VYK K +LVA+KK+ E E+E F R E+ ++ + H N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIR-EIKLLQKLRHPNI 60
Query: 571 VRLIGYCAEDSKR--LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
VRL K +V+EYM + L +L PE + + +G+ YLH
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEW--- 685
I+H DIK NIL++ K++DFGLA+ + +T T Y PE
Sbjct: 119 ---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175
Query: 686 ---YKNTPISVKADVFSYGVVLLEI 707
Y + D++S G +L E+
Sbjct: 176 ATRY-GPEV----DMWSVGCILAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 45/231 (19%)
Query: 502 SFSYNELKKATNRFKEELGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMVTEG-EREF 555
+F + L++ T LG+G FG V+ GE LV VK L+K E + EF
Sbjct: 1 AFPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEF 55
Query: 556 RAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERS-------LG 608
R E+ + + HKN+VRL+G C E ++ EY G L L + L
Sbjct: 56 RRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 609 WDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK------- 661
++V + + +A G+ +L + A +H D+ +N L+ K+S L+K
Sbjct: 116 TKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172
Query: 662 -----LLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEI 707
L+P +R ++APE + S K+DV+S+GV++ E+
Sbjct: 173 YKLRNALIP--------LR----WLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 51/198 (25%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKL---EKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
++G+G++G VYK ++VA+KK+ + + R E+ ++ +H N+++L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKL 63
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADI--LFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
+ LV+E+M D+ L + +R L + +G+ + H
Sbjct: 64 LDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---S 116
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE-WYKNTP 690
I+H D+KP+N+L++ K++DFGLA+ R +T TR Y APE +
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKG 175
Query: 691 ISVKADVFSYGVVLLEIV 708
S D++S G + E++
Sbjct: 176 YSTPVDIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 67/231 (29%), Positives = 107/231 (46%), Gaps = 37/231 (16%)
Query: 507 ELKKATNRFKEELGKGSFGAVY----KGTL-YKGEK---------LVAVKKLEKMVTEGE 552
E + R KE+LG+G FG V+ +G + GE LVAVK L VT+
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 553 R-EFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERS----- 606
R +F E+ ++ R + N++RL+G C D ++ EYM NG L L + S
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 607 -----LGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661
+ + +A +A G+ YL +H D+ +N L+ +T KI+DFG+++
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 662 LLMPD-----QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEI 707
L Q R +R +MA E + +DV+++GV L E+
Sbjct: 178 NLYSGDYYRIQGRAVLPIR----WMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 513 NRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-------REFRAEMHVIG 563
N+++ +G+G++G V K ++VA+KK K + E RE + V+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVK----VLR 55
Query: 564 RTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGI 623
+ H+N+V L + LV+EY+ +L ++L P L D + + I
Sbjct: 56 QLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASP-GGLPPDAVRSYIWQLLQAI 113
Query: 624 LYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAP 683
Y H IIH DIKP+NIL+ E K+ DFG A+ L T TR Y AP
Sbjct: 114 AYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 684 E-WYKNTPISVKADVFSYGVVLLEI 707
E +T DV++ G ++ E+
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 33/210 (15%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKN-LVRLIG-- 575
+ KG++G V+ + A+K ++K + + V ++ L +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKK------ADMIRKNQVDQVLTERDILSQAQSPY 54
Query: 576 -----YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLG-WDERV--RIASDVAKGILYL 626
Y + K L LV EY+ G LA +L ++G DE V +++ + YL
Sbjct: 55 VVKLYYSFQGKKNLYLVMEYLPGGDLASLL-----ENVGSLDEDVARIYIAEIVLALEYL 109
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK-------LLMPDQTRTFTLVRGTRG 679
H IIH D+KP NIL+D K++DFGL+K + + D + + GT
Sbjct: 110 H---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 680 YMAPEWYKNTPISVKADVFSYGVVLLEIVC 709
Y+APE S D +S G +L E +
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 65/218 (29%), Positives = 110/218 (50%), Gaps = 22/218 (10%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRA----EMHVIGRTHHKNLVRL 573
ELG G+ G V K L++ L+ +KL + E + R E+ V+ + +V
Sbjct: 8 ELGAGNGGVVTK-VLHRPSGLIMARKLIHL--EIKPAIRNQIIRELKVLHECNSPYIVGF 64
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRG---PERSLGWDERVRIASDVAKGILYLHDEC 630
G D + + E+M GSL +L + PE LG +I+ V +G+ YL ++
Sbjct: 65 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLREKH 119
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
+ I+H D+KP NIL++ K+ DFG++ L+ +F GTR YM+PE + T
Sbjct: 120 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTH 174
Query: 691 ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLIN 728
+V++D++S G+ L+E+ R I P +E+ +
Sbjct: 175 YTVQSDIWSLGLSLVEMAIGR--YPIPPPDAKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGR-THHKNLVRLI 574
E +G G++G VYKG K +L A+K ++ VTE E E + E++++ + +HH+N+
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDEEEEIKLEINMLKKYSHHRNIATYY 79
Query: 575 GY------CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
G D + LV E+ GS+ D++ +L D I ++ +G+ +LH
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA 139
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYK- 687
+IH DIK QN+L+ E K+ DFG++ L R T + GT +MAPE
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIAC 195
Query: 688 ----NTPISVKADVFSYGVVLLEI 707
+ ++D++S G+ +E+
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 27/226 (11%)
Query: 494 LAYESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM-VTEGE 552
L + N+L+ E+G G+ G VYK K ++AVK++ + E
Sbjct: 3 LTIDGQKYPADLNDLE-----NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN 57
Query: 553 REFRAEMHVIGRTHH-KNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRG-----PERS 606
+ ++ V+ ++H +V+ GY DS + E MS + D L + PE
Sbjct: 58 KRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDI 115
Query: 607 LGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666
LG ++ + K + YL ++ +IH D+KP NIL+D K+ DFG++ L+
Sbjct: 116 LG-----KMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168
Query: 667 QTRTFTLVRGTRGYMAPEWYK-NTPIS---VKADVFSYGVVLLEIV 708
+ +T + G YMAPE P ++ADV+S G+ L+E+
Sbjct: 169 KAKTRS--AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA 212
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 5e-17
Identities = 85/310 (27%), Positives = 140/310 (45%), Gaps = 60/310 (19%)
Query: 519 LGKGSFGAVYKGTLYKGEK-------LVAVKKLEKMVTEGE-REFRAEMH---VIGRTHH 567
LG+G FG V + Y +K VAVK L+ T+ + + +EM +IG+ H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--H 77
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL--------------FRGPERSLGWDERV 613
KN++ L+G C ++ ++ EY + G+L + L + PE L + + V
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 614 RIASDVAKGILYLHDE-CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP-DQTRTF 671
A VA+G+ YL C IH D+ +N+L+ E KI+DFGLA+ + D +
Sbjct: 138 SCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAY 731
+ R +MAPE + + ++DV+S+G+++ EI L Y
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI----------------FTLGGSPY 237
Query: 732 KCFIDRELNKLVR-GQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT--- 785
EL KL+R G +D+ N + + C P RP+ K +V L+ +
Sbjct: 238 PGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297
Query: 786 -----DISIP 790
D+S+P
Sbjct: 298 SEEYLDLSMP 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 39/231 (16%)
Query: 514 RFKEELGKGSFGAVY-------KGTLYK---------GEKLVAVKKLEKMVTEGER-EFR 556
F E+LG+G FG V+ + K LVAVK L ++ R +F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 557 AEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVR-- 614
E+ ++ R N+ RL+G C D ++ EYM NG L L + + G +
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 615 -------IASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667
+A+ +A G+ YL +H D+ +N L+ + +T KI+DFG+++ L
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY--- 181
Query: 668 TRTFTLVRGT-----RGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRR 712
+ + V+G R +MA E + K+DV+++GV L EI+ CR
Sbjct: 182 SSDYYRVQGRAPLPIR-WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 20/197 (10%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRA----EMHVIGRTHHKNLVRL 573
+LG G+ G+V + K V + + + R E+ ++ +V
Sbjct: 12 DLGAGNGGSV---SKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSF 68
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRG---PERSLGWDERVRIASDVAKGILYLHDEC 630
G ++ + E+M GSL I +G P LG +IA V +G+ YL++
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYNVH 123
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
I+H DIKP NIL++ K+ DFG++ L+ TF GT YM+PE +
Sbjct: 124 R--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV---GTSTYMSPERIQGGK 178
Query: 691 ISVKADVFSYGVVLLEI 707
+VK+DV+S G+ ++E+
Sbjct: 179 YTVKSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 73/287 (25%), Positives = 127/287 (44%), Gaps = 40/287 (13%)
Query: 519 LGKGSFGAVYKGTLYKGEKL---VAVK--KLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
LG+G FG+V +G L + + VAVK KL+ EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 574 IGYCAEDSKR------LLVYEYMSNGSLADILFR-----GPERSLGWDERVRIASDVAKG 622
IG C E S +++ +M +G L L PE+ L ++ D+A G
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK-LPLQTLLKFMVDIALG 125
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA-KLLMPDQTRTFTLVRGTRGYM 681
+ YL + IH D+ +N ++ E T ++DFGL+ K+ D R + + ++
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 682 APEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPS-KPEEIVLINWAYKCFIDRELN 740
A E + + K+DV+++GV + EI R P + EI +
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEI--------------YD 226
Query: 741 KLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785
L G + + + L+ + + C + +P RP+ + +LE I
Sbjct: 227 YLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 18/200 (9%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKL-----EKMVTEGEREFRAEMHVIGRTHHKNLV 571
E +G+G++GAVY+G ++VA+K + + V++ +RE A + + ++ N+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREV-ALLSQLRQSQPPNIT 65
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGP--ERSLGWDERVRIASDVAKGILYLHDE 629
+ G + + ++ EY GS+ ++ GP E+ + I +V + Y+H
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----IIREVLVALKYIH-- 118
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN- 688
+ +IH DIK NIL+ K+ DFG+A LL + ++ T V GT +MAPE
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEG 176
Query: 689 TPISVKADVFSYGVVLLEIV 708
KAD++S G+ + E+
Sbjct: 177 KYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYC 577
ELG G+FG VYK + L A K +E E ++ E+ ++ +H +V+L+G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 578 AEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHC 637
D K ++ E+ G++ I+ +R L + I + + + YLH IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHR 134
Query: 638 DIKPQNILMDEFWTAKISDFGL-AKLLMPDQTRTFTLVRGTRGYMAP-----EWYKNTPI 691
D+K N+L+ K++DFG+ AK + Q R + GT +MAP E K+TP
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMCETMKDTPY 192
Query: 692 SVKADVFSYGVVLLEIVCCRRNMEIDPSKPE 722
KAD++S G+ L+E+ +I+P E
Sbjct: 193 DYKADIWSLGITLIEMA------QIEPPHHE 217
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKK--LEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGY 576
+G+GSFG +Y + +K+ L KM + + + E+ ++ + H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 577 CAEDSKRLLVYEYMSNGSLAD-------ILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
E+ + +V EY G L +LF ++ L W ++ G+ ++HD
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFS-EDQILSW------FVQISLGLKHIHDR 120
Query: 630 CEAPIIHCDIKPQNILMDEF-WTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN 688
I+H DIK QNI + + AK+ DFG+A+ L +T V GT Y++PE +N
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQN 176
Query: 689 TPISVKADVFSYGVVLLEIVCCRRNME 715
P + K D++S G VL E+ + E
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 90/322 (27%), Positives = 144/322 (44%), Gaps = 59/322 (18%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEK-------LVAVKKLEKMVTEGE-REFRAE 558
EL + + LG+G FG V +K VAVK L+ T+ + + +E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 559 MHV---IGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL--------------FR 601
M + IG+ HKN++ L+G C +D ++ EY S G+L + L +
Sbjct: 68 MEMMKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125
Query: 602 GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661
PE L + + V A VA+G+ YL + IH D+ +N+L+ E KI+DFGLA+
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 662 LLMP-DQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSK 720
+ D + T R +MAPE + + ++DV+S+GV+L EI + S
Sbjct: 183 DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI------FTLGGS- 235
Query: 721 PEEIVLINWAYKCFIDRELNKLVR-GQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSV 777
Y EL KL++ G +D+ N + I C P+ RP+ K +
Sbjct: 236 ---------PYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL 286
Query: 778 VLMLEGI---------TDISIP 790
V L+ + D+S+P
Sbjct: 287 VEDLDRVLTVTSTDEYLDLSVP 308
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 70/208 (33%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEM---HVIGRT-HHKNLVRLI 574
LGKGSFG V L ++L AVK L+K V + + M V+ H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 575 GYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI--ASDVAKGILYLHDECE 631
C + RL V EY++ G D++F +RS +DE A+++ G+ +LH E
Sbjct: 63 S-CFQTKDRLFFVMEYVNGG---DLMFH-IQRSGRFDEPRARFYAAEIVLGLQFLH---E 114
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAK--LLMPDQTRTFTLVRGTRGYMAPEWYKNT 689
II+ D+K N+L+D KI+DFG+ K +L T TF GT Y+APE
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC---GTPDYIAPEILSYQ 171
Query: 690 PISVKADVFSYGVVLLEIVCCRRNMEID 717
P D ++ GV+L E++ + E D
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 2e-16
Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGR-THHKNLVRLIG 575
E +G G++G VYKG K +L A+K ++ + + E E + E++++ + +HH+N+ G
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 576 YCAE------DSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
+ D + LV E+ GS+ D++ +L + I ++ +G+ +LH
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH-- 128
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYK-- 687
+ +IH DIK QN+L+ E K+ DFG++ L R T + GT +MAPE
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 186
Query: 688 ---NTPISVKADVFSYGVVLLEI 707
+ K+D++S G+ +E+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 56/204 (27%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKL---EKMVTEGEREFRAEMHVIGRTHHKNL 570
+ ++++G+G F VY+ T K VA+KK+ E M + ++ E+ ++ + +H N+
Sbjct: 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNV 64
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADIL--FRG-----PERSLGWDERVRIASDVAKGI 623
++ + ED++ +V E G L+ ++ F+ PER++ W V++ S V
Sbjct: 65 IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-WKYFVQLCSAVE--- 120
Query: 624 LYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAP 683
++H ++H DIKP N+ + K+ D GL + T +LV GT YM+P
Sbjct: 121 -HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 684 EWYKNTPISVKADVFSYGVVLLEI 707
E + K+D++S G +L E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 4e-16
Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 34/205 (16%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-------FRA--EMHVIGRTHHKN 569
LG+G++ VYK + ++VA+KK++ GER+ F A E+ ++ H N
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKL----GERKEAKDGINFTALREIKLLQELKHPN 63
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVA-------KG 622
++ L+ S LV+E+M L + + + L +D+ +G
Sbjct: 64 IIGLLDVFGHKSNINLVFEFME-TDL-EKVIKDKSIVL-------TPADIKSYMLMTLRG 114
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMA 682
+ YLH I+H D+KP N+L+ K++DFGLA+ R T TR Y A
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNRKMTHQVVTRWYRA 170
Query: 683 PE-WYKNTPISVKADVFSYGVVLLE 706
PE + V D++S G + E
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 89/302 (29%), Positives = 140/302 (46%), Gaps = 56/302 (18%)
Query: 519 LGKGSFGAVYKGTLYKGEK-------LVAVKKLEKMVTEGE-REFRAEMH---VIGRTHH 567
LG+G FG V +K VAVK L+ TE + + +EM +IG+ H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--H 83
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL--------------FRGPERSLGWDERV 613
KN++ L+G C +D ++ EY S G+L + L + PE L + + V
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 614 RIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK-LLMPDQTRTFT 672
A VA+G+ YL + IH D+ +N+L+ E KI+DFGLA+ + D + T
Sbjct: 144 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYK 732
R +MAPE + + ++DV+S+GV+L EI + P P E
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVE--------- 249
Query: 733 CFIDRELNKLVR-GQEVDR-----NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786
EL KL++ G +D+ N L M++ C P+ RP+ K +V L+ I
Sbjct: 250 -----ELFKLLKEGHRMDKPSNCTNELYMMMRD---CWHAVPSQRPTFKQLVEDLDRILA 301
Query: 787 IS 788
++
Sbjct: 302 LT 303
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 517 EELGKGSFGAVYKGTLYK--GEKLVAVKKLE-------KMVTEGEREFR---AEMHVIGR 564
E LG G+FG VYK K G+ L+A+K++ K E ++ +E+ +I
Sbjct: 6 EHLGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 565 T-HHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGI 623
H N+VR E+ + +V + + L + E+ + E RI + + +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE-RIWNIFVQMV 123
Query: 624 L---YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGY 680
L YLH E I+H D+ P NI++ E I+DFGLAK P+ T V GT Y
Sbjct: 124 LALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILY 179
Query: 681 MAPEWYKNTPISVKADVFSYGVVLLEIV 708
PE KN P KADV+++G +L ++
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMC 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 6e-16
Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFR---AEMHVIGRTHHKNLVRLIG 575
LGKG+FG V K A+K L+K V + E E V+ T H L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-K 61
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEAP 633
Y + RL V EY + G L L R ER ++R R +++ + YLH C+
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSR--ERVFS-EDRARFYGAEIVSALGYLH-SCD-- 115
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAK--LLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
+++ D+K +N+++D+ KI+DFGL K + +TF GT Y+APE ++
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAPEVLEDNDY 172
Query: 692 SVKADVFSYGVVLLEIVCCR 711
D + GVV+ E++C R
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 7e-16
Identities = 71/221 (32%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 500 LRSFSYNELKKATNRFKEELGKGSFGAVYKGT-LYKGEKL---VAVKKL-EKMVTEGERE 554
LR ELK+ + LG G+FG VYKG + +GE + VA+K L E + E
Sbjct: 1 LRILKETELKRV-----KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE 55
Query: 555 FRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFR-----GPERSLGW 609
F E ++ H +LVRL+G C + +L V + M +G L D + G + L W
Sbjct: 56 FMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW 114
Query: 610 DERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669
+AKG++YL E ++H D+ +N+L+ KI+DFGLA+LL D+ +
Sbjct: 115 ------CVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE-K 164
Query: 670 TFTLVRGTR--GYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+ G +MA E + ++DV+SYGV + E++
Sbjct: 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 64/194 (32%), Positives = 95/194 (48%), Gaps = 10/194 (5%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE---GEREFRAEMHVIGRTHHKNLVRLIG 575
LGKG FG V + K+ A KKLEK + GE E ++ + + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
Y E L LV M+ G L ++ E V A+++ G+ LH E I
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RI 123
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVK 694
++ D+KP+NIL+D+ +ISD GLA + QT + GT GYMAPE KN +
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTFS 181
Query: 695 ADVFSYGVVLLEIV 708
D ++ G +L E++
Sbjct: 182 PDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMVTEGERE-FRAEMHVI 562
EL + + + LG G FG + +G L K E VA+ L ++ +R F AE +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 563 GRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKG 622
G+ H N+VRL G + ++V EYMSNG+L D R E L + + + +A G
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASG 119
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT-FTLVRGTRG-- 679
+ YL E +H + +L++ KIS F L D++ +T + G
Sbjct: 120 MKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVL 173
Query: 680 YMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+ APE + S +DV+S+G+V+ E++
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 60/202 (29%), Positives = 106/202 (52%), Gaps = 25/202 (12%)
Query: 519 LGKGSFGAVY---------KGTLY--KGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHH 567
LG+GSFG V+ G LY K K +K +++ T+ ER+ AE++ H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN------H 57
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYL 626
+V+L + K L+ +++ G D+ R + + +E V+ +++A + +L
Sbjct: 58 PFIVKLHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELALALDHL 114
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
H II+ D+KP+NIL+DE K++DFGL+K + + + ++ GT YMAPE
Sbjct: 115 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVV 170
Query: 687 KNTPISVKADVFSYGVVLLEIV 708
+ AD +S+GV++ E++
Sbjct: 171 NRRGHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 9/210 (4%)
Query: 500 LRSF-SYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAE 558
LRS S + KK RF E++G+G+ G VY + VA+K++ + E
Sbjct: 8 LRSIVSVGDPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINE 66
Query: 559 MHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASD 618
+ V+ + N+V + + +V EY++ GSL D++ E + + + +
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRE 123
Query: 619 VAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR 678
+ + +LH +IH DIK NIL+ + K++DFG + P+Q++ T+V GT
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 179
Query: 679 GYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+MAPE K D++S G++ +E+V
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 20/201 (9%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLE--KMVTEGEREFRA---EMHVIGRTHHKNLVRL 573
LG+G+FG VY + +AVK++ E ++E A E+ ++ H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 574 IGYCAEDSKRLLVY-EYMSNGSLADILFRGPERSLG-WDERV--RIASDVAKGILYLHDE 629
G C D + L ++ EYM GS+ D L ++ G E V + + +G+ YLH
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQL-----KAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL--MPDQTRTFTLVRGTRGYMAPEWYK 687
I+H DIK NIL D K+ DFG +K L + V GT +M+PE
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 688 NTPISVKADVFSYGVVLLEIV 708
KADV+S G ++E++
Sbjct: 181 GEGYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLE--KMVTEGERE-FRAEMHVIGRTHHKNLVRLIG 575
+GKG F VYK ++VA+KK++ +M+ R+ E+ ++ + H N+++ +
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 576 YCAEDSKRLLVYEYMSNGSLADIL--FRG-----PERSLGWDERVRIASDVAKGILYLHD 628
E+++ +V E G L+ ++ F+ PER++ W V++ S + ++H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-WKYFVQLCS----ALEHMH- 123
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN 688
I+H DIKP N+ + K+ D GL + T +LV GT YM+PE
Sbjct: 124 --SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHE 180
Query: 689 TPISVKADVFSYGVVLLEIVCCR 711
+ K+D++S G +L E+ +
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 9/210 (4%)
Query: 500 LRSF-SYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAE 558
LR+ S + KK RF E++G+G+ G VY + VA+K++ + E
Sbjct: 8 LRTIVSVGDPKKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINE 66
Query: 559 MHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASD 618
+ V+ H N+V + + +V EY++ GSL D++ E + + + +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRE 123
Query: 619 VAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR 678
+ + +LH +IH DIK NIL+ + K++DFG + P+Q++ T+V GT
Sbjct: 124 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 179
Query: 679 GYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+MAPE K D++S G++ +E+V
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 65/198 (32%), Positives = 97/198 (48%), Gaps = 18/198 (9%)
Query: 518 ELGKGSFGAVYKGTLYKGEKL---VAVKKL----EKMVTEGEREFRAEMHVIGRTHHKNL 570
ELG G+FG V KG +YK K VA+K L EK V + E E ++ + + +
Sbjct: 2 ELGSGNFGCVKKG-VYKMRKKQIDVAIKVLKNENEKSVRD---EMMREAEIMHQLDNPYI 57
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
VR+IG C E +LV E S G L L G + + V + V+ G+ YL
Sbjct: 58 VRMIGVC-EAEALMLVMEMASGGPLNKFL-SGKKDEITVSNVVELMHQVSMGMKYLE--- 112
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT--RTFTLVRGTRGYMAPEWYKN 688
+H D+ +N+L+ AKISDFGL+K L D + + + + + APE
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 689 TPISVKADVFSYGVVLLE 706
S ++DV+SYG+ + E
Sbjct: 173 RKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGY 576
++G+GS G V T+ KLVAVKK++ + + RE VI R H+N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMD-LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 577 CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIH 636
+ +V E++ G+L DI+ + ++ + V K + LH + +IH
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLHAQ---GVIH 139
Query: 637 CDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKAD 696
DIK +IL+ K+SDFG + + R +LV GT +MAPE P + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVD 198
Query: 697 VFSYGVVLLEIV 708
++S G++++E+V
Sbjct: 199 IWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 38/279 (13%)
Query: 517 EELGKGSFGAVYKGTLYK--GEKL-VAVKKL--EKMVTEGEREFRAEMHVIGRTHHKNLV 571
++LG GSFG V +G G+ + VAVK L +K+ ++ +F E ++ H+NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-SDIMDDFLKEAAIMHSLDHENLI 59
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
RL G ++V E GSL D L + A +A G+ YL +
Sbjct: 60 RLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK-- 116
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAPEWYKN 688
IH D+ +NIL+ KI DFGL + L P + + + + APE +
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRAL-PQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 689 TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKP------EEIVLINWAYKCFIDRELNKL 742
S +DV+ +GV L E M +P +I+ K ID+E +L
Sbjct: 175 RTFSHASDVWMFGVTLWE-------MFTYGEEPWAGLSGSQIL-----KK--IDKEGERL 220
Query: 743 VRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLML 781
R + ++ M++ C PA RP+ ++ L
Sbjct: 221 ERPEACPQDIYNVMLQ----CWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 23/203 (11%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE------FRAEMHVIGRTHHKNL 570
E++G+G++G VYKG K ++VA+KK+ E E E R E+ ++ H N+
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIR-EISLLKELQHPNI 61
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIAS---DVAKGILYLH 627
V L ++S+ L++E++S L L P + + + S + +GIL+ H
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCH 118
Query: 628 DECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL-MPDQTRTFTLVRGTRGYMAPEWY 686
++H D+KPQN+L+D K++DFGLA+ +P + T +V T Y APE
Sbjct: 119 SR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVL 173
Query: 687 KNTP-ISVKADVFSYGVVLLEIV 708
+P S D++S G + E+
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 85/302 (28%), Positives = 137/302 (45%), Gaps = 56/302 (18%)
Query: 519 LGKGSFGAVYKGTLYKGEK-------LVAVKKLEKMVTEGE-REFRAEMHV---IGRTHH 567
LG+G FG V +K VAVK L+ TE + + +EM + IG+ H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 80
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL--------------FRGPERSLGWDERV 613
KN++ L+G C +D ++ EY S G+L + L R P+ + + + V
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 614 RIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP-DQTRTFT 672
VA+G+ YL + IH D+ +N+L+ E KI+DFGLA+ + D + T
Sbjct: 141 SCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYK 732
R +MAPE + + ++DV+S+GV++ EI L Y
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI----------------FTLGGSPYP 241
Query: 733 CFIDRELNKLVR-GQEVDR-----NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786
EL KL++ G +D+ N L M++ C P+ RP+ K +V L+ I
Sbjct: 242 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRD---CWHAIPSHRPTFKQLVEDLDRILT 298
Query: 787 IS 788
++
Sbjct: 299 LT 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 14/197 (7%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEM---HVIGRTHHKNLVRLIG 575
LGKGSFG V L + +L AVK L+K V + + M ++ + + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDE-RVRI-ASDVAKGILYLHDECEA 632
C + RL V E+++ G D++F ++S +DE R R A+++ +++LHD+
Sbjct: 63 CCFQTPDRLFFVMEFVNGG---DLMFH-IQKSRRFDEARARFYAAEITSALMFLHDK--- 115
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
II+ D+K N+L+D K++DFG+ K + + T T GT Y+APE +
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYG 174
Query: 693 VKADVFSYGVVLLEIVC 709
D ++ GV+L E++C
Sbjct: 175 PSVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 30/219 (13%)
Query: 503 FSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-REFRAEMHV 561
F+ +LK E+G+G+FG V K ++AVK++ V E E + ++ V
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV 55
Query: 562 IGRTHH-KNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRG---------PERSLGWDE 611
+ R+ +V+ G + + E M SL D ++ PE LG
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWICMELMDI-SL-DKFYKYVYEVLKSVIPEEILG--- 110
Query: 612 RVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671
+IA K + YL +E + IIH D+KP NIL+D K+ DFG++ L+ +T
Sbjct: 111 --KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTR 166
Query: 672 TLVRGTRGYMAPEW---YKNTPISVKADVFSYGVVLLEI 707
G R YMAPE V++DV+S G+ L E+
Sbjct: 167 DA--GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 64/245 (26%), Positives = 106/245 (43%), Gaps = 47/245 (19%)
Query: 507 ELKKATNRFKEELGKGSFGAV---------------YKGTLYKGEKL-VAVKKLEKMVTE 550
+ + FKE+LG+G FG V + + KG L VAVK L +
Sbjct: 1 KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK 60
Query: 551 GER-EFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFR-------- 601
R +F E+ ++ R N++RL+G C ++ ++ EYM NG L L
Sbjct: 61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE 120
Query: 602 ---------GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTA 652
++ + + +A +A G+ YL +H D+ +N L+ E T
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTI 177
Query: 653 KISDFGLAKLLMPD-----QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEI 707
KI+DFG+++ L Q R +R +MA E + +DV+++GV L EI
Sbjct: 178 KIADFGMSRNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFTTASDVWAFGVTLWEI 233
Query: 708 V-CCR 711
+ C+
Sbjct: 234 LMLCK 238
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 64/195 (32%), Positives = 96/195 (49%), Gaps = 12/195 (6%)
Query: 518 ELGKGSFGAVYKGTL--YKGEKLVAVKKLEKMVTEG--EREFRAEMHVIGRTHHKNLVRL 573
ELG G+FG V KG K EK VAVK L+ + + E E +V+ + + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
IG C E +LV E G L L + + + + V+ G+ YL E
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLE---ETN 115
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT--RTFTLVRGTRGYMAPEWYKNTPI 691
+H D+ +N+L+ AKISDFGL+K L D+ + T + + APE
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 692 SVKADVFSYGVVLLE 706
S K+DV+S+GV++ E
Sbjct: 176 SSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 21/199 (10%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKL-----EKMVTE-GEREFRAEMHVIGRTHHKNLVR 572
+G+GS+G V K + ++VA+KK +KMV + RE R ++ + H+NLV
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR----MLKQLRHENLVN 64
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDE-RVR-IASDVAKGILYLHDEC 630
LI + LV+E++ + L D L + P G DE RVR + +GI + H
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPN---GLDESRVRKYLFQILRGIEFCHSH- 119
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY-KNT 689
IIH DIKP+NIL+ + K+ DFG A+ L +T TR Y APE +T
Sbjct: 120 --NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDT 176
Query: 690 PISVKADVFSYGVVLLEIV 708
D+++ G ++ E++
Sbjct: 177 KYGRAVDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 4e-15
Identities = 53/205 (25%), Positives = 101/205 (49%), Gaps = 8/205 (3%)
Query: 504 SYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIG 563
S + KK R+ E++G+G+ G V+ + VA+K++ + E+ V+
Sbjct: 13 SIGDPKKKYTRY-EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMK 71
Query: 564 RTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGI 623
+ N+V + + +V EY++ GSL D++ E + + + + + +
Sbjct: 72 ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQAL 128
Query: 624 LYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAP 683
+LH +IH DIK N+L+ + K++DFG + P+Q++ T+V GT +MAP
Sbjct: 129 EFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAP 184
Query: 684 EWYKNTPISVKADVFSYGVVLLEIV 708
E K D++S G++ +E+V
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-15
Identities = 67/217 (30%), Positives = 110/217 (50%), Gaps = 20/217 (9%)
Query: 500 LRSFSYNELKKATNRFKEELGKGSFGAVYKGT-LYKGEKL---VAVKKL-EKMVTEGERE 554
LR E KK + LG G+FG VYKG + +GEK+ VA+K+L E + +E
Sbjct: 1 LRILKETEFKKI-----KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 55
Query: 555 FRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVR 614
E +V+ + ++ RL+G C + +L + + M G L D + + +G +
Sbjct: 56 ILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN-IGSQYLLN 113
Query: 615 IASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLV 674
+AKG+ YL E ++H D+ +N+L+ KI+DFGLAKLL D+
Sbjct: 114 WCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA-- 168
Query: 675 RGTR---GYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
G + +MA E + + ++DV+SYGV + E++
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 32/207 (15%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-------RE--FRAEMHVIGRTHH 567
E++G+G++G VYK ++VA+KK+ ++ TE E RE E++ H
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELN------H 57
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLH 627
N+VRL+ ++K LV+E++ + L + P L + +GI Y H
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 628 DECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL-MPDQTRTFTLVRGTRGYMAPEW- 685
++H D+KPQN+L+D K++DFGLA+ +P +T T +V T Y APE
Sbjct: 117 SH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 171
Query: 686 ----YKNTPISVKADVFSYGVVLLEIV 708
+TP+ D++S G + E+V
Sbjct: 172 LGSRQYSTPV----DIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 69/204 (33%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE---GEREFRAEMHVIGRTHHK 568
T R LGKG FG V + K+ A KKLEK + GE E ++ + + +
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 569 NLVRLIGYCAEDSKRL-LVYEYMSNGSLA-DILFRGPERSLGWDER--VRIASDVAKGIL 624
+V L Y E L LV M+ G L I G G+DE V A+++ G+
Sbjct: 61 FVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNP---GFDEERAVFYAAEITCGLE 116
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
LH E I++ D+KP+NIL+D++ +ISD GLA + +P+ V GT GYMAPE
Sbjct: 117 DLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRV-GTVGYMAPE 171
Query: 685 WYKNTPISVKADVFSYGVVLLEIV 708
KN + D + G ++ E++
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 6e-15
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 38/224 (16%)
Query: 515 FKEELGKGSFGAVY----KGTLYKGEK------------LVAVKKLEKMVTEGER-EFRA 557
FKE+LG+G FG V+ +G +K LVAVK L + + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 558 EMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVR--- 614
E+ ++ R N++RL+ C ++ EYM NG L L R + V
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 615 ------IASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD-- 666
+A+ +A G+ YL +H D+ +N L+ + +T KI+DFG+++ L
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 667 ---QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEI 707
Q R +R +M+ E + +DV+++GV L EI
Sbjct: 186 YRIQGRAVLPIR----WMSWESILLGKFTTASDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-15
Identities = 64/196 (32%), Positives = 92/196 (46%), Gaps = 16/196 (8%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLE---KMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
E+G GSFGAVY T ++VAVKK+ K E ++ E+ + + H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
G ++ LV EY GS +D+L ++ L E I +G+ YLH +
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLL-EVHKKPLQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE---WYKNTPI 691
IH DIK NIL+ E K++DFG A P +F GT +MAPE
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSP--ANSFV---GTPYWMAPEVILAMDEGQY 197
Query: 692 SVKADVFSYGVVLLEI 707
K DV+S G+ +E+
Sbjct: 198 DGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYC 577
ELG G+FG VYK + L A K ++ E ++ E+ ++ H N+V+L+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 578 AEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHC 637
++ ++ E+ + G++ ++ ER L + + + + YLH E IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLH---ENKIIHR 127
Query: 638 DIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR-----GTRGYMAPEWY-----K 687
D+K NIL K++DFG++ T T+ R GT +MAPE K
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSA------KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 688 NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPE 722
+ P KADV+S G+ L+E+ +I+P E
Sbjct: 182 DRPYDYKADVWSLGITLIEMA------QIEPPHHE 210
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 62/216 (28%), Positives = 111/216 (51%), Gaps = 28/216 (12%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE----REFRAEMHVIGRTHHKNLVR 572
E++G+G++G VYK ++VA+KK+ ++ TE E R E+ ++ +H N+V+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIR-EISLLKELNHPNIVK 63
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
L+ ++K LV+E++ + L + P + + +G+ + H
Sbjct: 64 LLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH--- 119
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLL-MPDQTRTFTLVRGTRGYMAPEW-----Y 686
++H D+KPQN+L++ K++DFGLA+ +P +T T +V T Y APE Y
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 177
Query: 687 KNTPISVKADVFSYGVVLLEIVCCRRNM-----EID 717
+T + D++S G + E+V RR + EID
Sbjct: 178 YSTAV----DIWSLGCIFAEMV-TRRALFPGDSEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 56/192 (29%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGY 576
++G+GS G V T K VAVKK++ + + RE VI R HH+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMD-LRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 577 CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIH 636
+ +V E++ G+L DI+ + ++ + V + + YLH++ +IH
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQ---GVIH 141
Query: 637 CDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKAD 696
DIK +IL+ K+SDFG + + + +LV GT +MAPE P + D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVD 200
Query: 697 VFSYGVVLLEIV 708
++S G++++E++
Sbjct: 201 IWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 9/210 (4%)
Query: 500 LRSF-SYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAE 558
LRS S + KK RF E++G+G+ G VY + VA++++ + E
Sbjct: 9 LRSIVSVGDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 559 MHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASD 618
+ V+ + N+V + + +V EY++ GSL D++ E + + + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRE 124
Query: 619 VAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR 678
+ + +LH +IH DIK NIL+ + K++DFG + P+Q++ T+V GT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 180
Query: 679 GYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+MAPE K D++S G++ +E++
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 32/208 (15%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNLVRLIG 575
+G G++G V + + VA+KK+ + + + +R R E+ ++ H+N++ L+
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLD 66
Query: 576 -YCAEDSKRL----LVYEYMSNGSLADI--LFRGPERSLGWDERVR-IASDVAKGILYLH 627
+ +V E M D+ + + P + L D+ ++ + +G+ YLH
Sbjct: 67 ILRPPSPEDFNDVYIVTELME----TDLHKVIKSP-QPLT-DDHIQYFLYQILRGLKYLH 120
Query: 628 DECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRG--TRGYMAPE- 684
A +IH D+KP NIL++ KI DFGLA+ + PD+ L TR Y APE
Sbjct: 121 ---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPEL 177
Query: 685 ---WYK-NTPISVKADVFSYGVVLLEIV 708
+ I D++S G + E++
Sbjct: 178 LLSSSRYTKAI----DIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 65/198 (32%), Positives = 101/198 (51%), Gaps = 18/198 (9%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEM---HVIG-RTHHKNLVRLI 574
LGKGSFG V L + A+K L+K V + + M V+ H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61
Query: 575 GYCAEDSKRLL--VYEYMSNGSLADILFRGPERSLGWDE-RVRI-ASDVAKGILYLHDEC 630
+C +K L V EY++ G D++F + S +DE R R A+++ G+ +LH +
Sbjct: 62 -FCTFQTKEHLFFVMEYLNGG---DLMFH-IQSSGRFDEARARFYAAEIICGLQFLHKK- 115
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
II+ D+K N+L+D+ KI+DFG+ K M + + T GT Y+APE K
Sbjct: 116 --GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQK 172
Query: 691 ISVKADVFSYGVVLLEIV 708
+ D +S+GV+L E++
Sbjct: 173 YNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 24/201 (11%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEM---HVIGRTHHKNLVRLIG 575
LGKGSFG V ++L A+K L+K V + + M V+ + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 576 YCAEDSKRL-LVYEYMSNGSLADIL-----FRGPERSLGWDERVRIASDVAKGILYLHDE 629
C + RL V EY++ G L + F+ P V A+++A G+ +LH +
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHA-------VFYAAEIAIGLFFLHSK 120
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAK--LLMPDQTRTFTLVRGTRGYMAPEWYK 687
II+ D+K N+++D KI+DFG+ K + TRTF GT Y+APE
Sbjct: 121 ---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---GTPDYIAPEIIA 174
Query: 688 NTPISVKADVFSYGVVLLEIV 708
P D +++GV+L E++
Sbjct: 175 YQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 68/198 (34%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFR---AEMHV-IGRTHHKNLVRLI 574
+GKGSFG V K AVK L+K ++E + AE +V + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 575 GYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEA 632
Y + + +L V +Y++ G L L R ERS + R R A+++A + YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQR--ERSFP-EPRARFYAAEIASALGYLH---SL 115
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAK--LLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
II+ D+KP+NIL+D ++DFGL K + T TF GT Y+APE + P
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC---GTPEYLAPEVLRKQP 172
Query: 691 ISVKADVFSYGVVLLEIV 708
D + G VL E++
Sbjct: 173 YDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 49/213 (23%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE------FRAEMHVIGRTHHKNLVR 572
+G+G++G VY+ ++VA+KK+ +M + ER+ R E+ ++ H N+V
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKV-RM--DNERDGIPISSLR-EITLLLNLRHPNIVE 70
Query: 573 L---------------IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVR-IA 616
L + YC +D LL + M F + V+ +
Sbjct: 71 LKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPTP------FSESQ--------VKCLM 114
Query: 617 SDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL-MPDQTRTFTLVR 675
+ +G+ YLH+ IIH D+K N+L+ + KI+DFGLA+ +P + T +V
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV- 170
Query: 676 GTRGYMAPEWYKNTPISVKA-DVFSYGVVLLEI 707
T Y APE A D+++ G +L E+
Sbjct: 171 -TLWYRAPELLLGCTTYTTAIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 67/196 (34%), Positives = 97/196 (49%), Gaps = 14/196 (7%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE---FRAEMHVIGRT-HHKNLVRLI 574
+GKGSFG V AVK L+K ++E AE +V+ + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 575 GYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEA 632
Y + +++L V +Y++ G L L R ER + R R A++VA I YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQR--ERCFL-EPRARFYAAEVASAIGYLHSL--- 115
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
II+ D+KP+NIL+D ++DFGL K + + T T GT Y+APE + P
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEPYD 174
Query: 693 VKADVFSYGVVLLEIV 708
D + G VL E++
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 519 LGKGSFGAVYKGTLYKGEKL--VAVKKLE-KMVTEGERE-FRAEMHVIGRTHHKNLVRLI 574
LG+G FG+V +G L + + + VAVK ++ + T E E F +E + H N++RLI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 575 GYCAEDSKR------LLVYEYMSNGSLADILFRG---------PERSLGWDERVRIASDV 619
G C + + +++ +M +G L L P + L V+ +D+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQML-----VKFMTDI 121
Query: 620 AKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA-KLLMPDQTRTFTLVRGTR 678
A G+ YL + IH D+ +N +++E ++DFGL+ K+ D R + +
Sbjct: 122 ASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 679 GYMAPEWYKNTPISVKADVFSYGVVLLEI 707
++A E + + K+DV+S+GV + EI
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 518 ELGKGSFGAV----YKGTLYKGEKLVAVKKLEKMVTEGER--EFRAEMHVIGRTHHKNLV 571
+LG+G FG V Y + VAVK L K + G + + E+ ++ +H+N+V
Sbjct: 11 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 572 RLIGYCAEDSKR--LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
+ G C ED L+ E++ +GSL + L R + + ++++ A + KG+ YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYLGSR 128
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG----YMAPEW 685
+H D+ +N+L++ KI DFGL K + D + + V+ + APE
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD--KEYYTVKDDLDSPVFWYAPEC 183
Query: 686 YKNTPISVKADVFSYGVVLLEIV 708
+ + +DV+S+GV L E++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 39/290 (13%)
Query: 500 LRSFSYNELKKATNRFKEELGKGSFGAVYKGT-LYKGEKL---VAVKKL-EKMVTEGERE 554
+R ELKK + LG G+FG VYKG + GE + VA+K L E + +E
Sbjct: 1 MRILKETELKKV-----KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE 55
Query: 555 FRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVR 614
E +V+ + RL+G C + +L V + M G L D + +R +G + +
Sbjct: 56 ILDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDR-IGSQDLLN 113
Query: 615 IASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLV 674
+AKG+ YL E ++H D+ +N+L+ KI+DFGLA+LL D+T
Sbjct: 114 WCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA-- 168
Query: 675 RGTR---GYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAY 731
G + +MA E + + ++DV+SYGV + E++ +KP Y
Sbjct: 169 DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTF-------GAKP---------Y 212
Query: 732 KCFIDRELNKLV-RGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVV 778
RE+ L+ +G+ + + ++ I + C + RP + +V
Sbjct: 213 DGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 24/201 (11%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEM---HVIGRTHHKNLVRLIG 575
LGKGSFG V ++L A+K L+K V + + M V+ + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 576 YCAEDSKRL-LVYEYMSNGSLADIL-----FRGPERSLGWDERVRIASDVAKGILYLHDE 629
C + RL V EY++ G L + F+ P+ V A++++ G+ +LH
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQA-------VFYAAEISVGLFFLH-- 118
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD--QTRTFTLVRGTRGYMAPEWYK 687
II+ D+K N+++D KI+DFG+ K M D TRTF GT Y+APE
Sbjct: 119 -RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC---GTPDYIAPEIIA 174
Query: 688 NTPISVKADVFSYGVVLLEIV 708
P D ++YGV+L E++
Sbjct: 175 YQPYGKSVDWWAYGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 4e-14
Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 25/213 (11%)
Query: 506 NELKKATNRFKEELGKGSFGAVYKGTLYKGEKL--VAVKKLEKMVTEGEREFR---AEMH 560
N++K F LG GSFG V T YK E VA+K+ EK +++ +E
Sbjct: 25 NKMKYEDFNFIRTLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERK 83
Query: 561 VIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDV- 619
++ +H V L G ++S LV E++ G L R R +DV
Sbjct: 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK----------RFPNDVG 133
Query: 620 ---AKGILYLHDECEA-PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR 675
A I+ + + ++ I++ D+KP+N+L+D+ K++DFG AK++ TRT+TL
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYTLC- 189
Query: 676 GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
GT Y+APE N AD ++ G+ + EI+
Sbjct: 190 GTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 517 EELGKGSFGAVYKGTLYKGEKL--VAVKKLEKMVTEGER-EFRAEMHVIGRTHHKNLVRL 573
+E+G G FG V G ++G V VK+L T E+ F E+ +H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILF--RGPERSLGWDERV--RIASDVAKGILYLHDE 629
+G C E LLV E+ G L + L RG + + V R+A +VA G+L+LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA-QKDVLQRMACEVASGLLWLH-- 117
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP------DQTRTFTLVRGTRGYMAP 683
+A IH D+ +N + + KI D+GLA P L ++AP
Sbjct: 118 -QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPL-----RWLAP 171
Query: 684 EWY-------KNTPISVKADVFSYGVVLLEI 707
E + K++++S GV + E+
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 5e-14
Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 47/221 (21%)
Query: 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLE---KMVTEGEREFRAEMHVIGRTHHKNLVR 572
++LGKG++G V+K + +++VA+KK+ + T+ +R FR M + H N+V+
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVK 71
Query: 573 LIG-YCAEDSKRL-LVYEYM----SNGSLADILFRGPERSLGWDERVR---IASDVAKGI 623
L+ AE+ K + LV+EYM A+IL E V I + K +
Sbjct: 72 LLNVIKAENDKDIYLVFEYMETDLHAVIRANIL-----------EDVHKRYIMYQLLKAL 120
Query: 624 LYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG---- 679
Y+H +IH D+KP NIL++ K++DFGLA R+ + +
Sbjct: 121 KYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLA--------RSLSELEENPENPVL 169
Query: 680 --YMAPEWYKNTPISVKA-------DVFSYGVVLLEIVCCR 711
Y+A WY+ I + + D++S G +L E++ +
Sbjct: 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLE---KMVTEGEREFRAEMHVIGRTHH 567
A R ++++G+G F VY+ T VA+KK++ M + + E+ ++ + +H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL--FRG-----PERSLGWDERVRIASDVA 620
N+++ ED++ +V E G L+ ++ F+ PE+++ W V++ S
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-WKYFVQLCS--- 117
Query: 621 KGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGY 680
+ ++H ++H DIKP N+ + K+ D GL + T +LV GT Y
Sbjct: 118 -ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172
Query: 681 MAPEWYKNTPISVKADVFSYGVVLLEI 707
M+PE + K+D++S G +L E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 6e-14
Identities = 63/196 (32%), Positives = 92/196 (46%), Gaps = 16/196 (8%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLE---KMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
E+G GSFGAVY + ++VA+KK+ K E ++ E+ + R H N +
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
G + LV EY GS +D+L ++ L E I +G+ YLH +
Sbjct: 92 GCYLREHTAWLVMEYCL-GSASDLL-EVHKKPLQEVEIAAITHGALQGLAYLHSH---NM 146
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE---WYKNTPI 691
IH DIK NIL+ E K++DFG A + P +F GT +MAPE
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASP--ANSFV---GTPYWMAPEVILAMDEGQY 201
Query: 692 SVKADVFSYGVVLLEI 707
K DV+S G+ +E+
Sbjct: 202 DGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-REFRAEMHVIGRTHH-KNLVRLI 574
EELG+G++G V K ++AVK++ V E + ++ + R+ V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRG--------PERSLGWDERVRIASDVAKGILYL 626
G + + E M SL D ++ PE LG +IA + K + YL
Sbjct: 67 GALFREGDVWICMEVMDT-SL-DKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYL 119
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
H + +IH D+KP N+L++ K+ DFG++ L+ +T G + YMAPE
Sbjct: 120 HSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA--GCKPYMAPERI 175
Query: 687 ----KNTPISVKADVFSYGVVLLEI 707
VK+DV+S G+ ++E+
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE--------REFRAEMHVIGRTHHKN 569
E+G G++G VYK VA+K + V E RE A + + H N
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVR--VQTNEDGLPLSTVREV-ALLKRLEAFDHPN 63
Query: 570 LVRLIGYCA-----EDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGIL 624
+VRL+ CA ++K LV+E++ L L + P L + + +G+
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
+LH C I+H D+KP+NIL+ K++DFGLA++ T +V T Y APE
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPE 177
Query: 685 WYKNTPISVKADVFSYGVVLLEI 707
+ + D++S G + E+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 12/195 (6%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE---GEREFRAEMHVIGRTHHKNLVRLIG 575
LGKG FG V + K+ A K+LEK + GE E ++ + + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
Y E L LV M+ G L ++ + + A+++ G+ LH E
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NT 123
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLA-KLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV 693
++ D+KP+NIL+D++ +ISD GLA K+ + R GT GYMAPE N ++
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAPEVLNNQRYTL 180
Query: 694 KADVFSYGVVLLEIV 708
D + G ++ E++
Sbjct: 181 SPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 66/197 (33%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFR---AEMHVIGRT-HHKNLVRLI 574
+GKGSFG V K AVK L+K + +E + AE +V+ + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEAP 633
K V ++++ G L L R ERS + R R A+++A + YLH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQR--ERSFP-EPRARFYAAEIASALGYLH---SIN 116
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAK--LLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
I++ D+KP+NIL+D ++DFGL K + D T TF GT Y+APE + P
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC---GTPEYLAPEVIRKQPY 173
Query: 692 SVKADVFSYGVVLLEIV 708
D + G VL E++
Sbjct: 174 DNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 36/216 (16%)
Query: 517 EELGKGSFGAVYKGTLYK----GEKLVAVKKL--EKMVTEGEREFRAEMHVIGRTHHKNL 570
+++G+GSFG K L K G++ V +K++ KM + E R E+ V+ H N+
Sbjct: 6 KKIGEGSFG---KAILVKSKEDGKQYV-IKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSL-------ADILFRGPERS-LGWDERVRIASDVAKG 622
V+ E+ +V +Y G L +LF PE L W ++ +A
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLF--PEDQILDWFVQICLA------ 113
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR---GTRG 679
+ ++HD I+H DIK QNI + + T K+ DFG+A++L T L R GT
Sbjct: 114 LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVELARTCIGTPY 166
Query: 680 YMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNME 715
Y++PE +N P + K+D+++ G VL E+ + E
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 516 KEELGKGSFGAVYKGT--LYKGEKL-VAVKKLEKMVTEGERE-FRAEMHVIGRTHHKNLV 571
+G+G FG VY+G + EK+ VAVK + + RE F E +++ + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
+LIG ++ +V E G L L SL + + ++ + YL +
Sbjct: 71 KLIGVI-TENPVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESK-- 126
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
+H DI +N+L+ K+ DFGL++ L + + + +MAPE
Sbjct: 127 -RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 692 SVKADVFSYGVVLLEI 707
+ +DV+ +GV + EI
Sbjct: 186 TSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-13
Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 8/108 (7%)
Query: 46 SWNSSLGAFQFGFYK-QDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKL 104
+ S F+ GF+ I + T+VW A RD+P VS + LTL DG L
Sbjct: 9 TLVSGNSLFELGFFTLIMQNDYNLILYKSSSR-TVVWVANRDNP-VSDSCTLTLQSDGNL 66
Query: 105 ILRTEEGHDKVVAAGKSEPASS---ASMLDSGNFVLYNNRSDIIWSSF 149
+L +G +VV + + A+ +LD GN V+Y++ + +W SF
Sbjct: 67 VL--YDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSF 112
|
Length = 114 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 9/201 (4%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRA---EMHVIGRTHHKNLV 571
F +GKGS+G V K +KKL + RE +A E ++ + H N+V
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKL-NLRNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 572 RLI-GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
+ ED +V + G L L + L ++ V +A + YLH
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH--- 119
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
E I+H D+K QN+ + K+ D G+A++L TL+ GT YM+PE + N P
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKP 178
Query: 691 ISVKADVFSYGVVLLEIVCCR 711
+ K+DV++ G + E+ +
Sbjct: 179 YNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 70/245 (28%), Positives = 101/245 (41%), Gaps = 66/245 (26%)
Query: 498 SNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE--- 554
S LR Y L K LG+G+FG VYK K ++VA+KK+ + E++
Sbjct: 5 SKLRD--YEILGK--------LGEGTFGEVYKARQIKTGRVVALKKI---LMHNEKDGFP 51
Query: 555 ---FRAEMHVIGRTHHKNLVRLIGYCAEDSKRL--------LVYEYMSNGSLADILFRGP 603
R E+ ++ + H N+V LI E + +V YM + L+ +L
Sbjct: 52 ITALR-EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLE--- 106
Query: 604 ERSLGWDERVRIASDVAK--------GILYLHDECEAPIIHCDIKPQNILMDEFWTAKIS 655
+ V++ K GI YLH E I+H DIK NIL+D KI+
Sbjct: 107 ------NPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIA 157
Query: 656 DFGLAKLL----------MPDQTRTFTLVRGTRGYMAPE----WYKNTPISVKADVFSYG 701
DFGLA+ TR +T + TR Y PE + T D++ G
Sbjct: 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTT---AVDIWGIG 214
Query: 702 VVLLE 706
V E
Sbjct: 215 CVFAE 219
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 60/196 (30%), Positives = 92/196 (46%), Gaps = 16/196 (8%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLE---KMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
E+G GSFGAVY + ++VA+KK+ K E ++ E+ + + H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
G + LV EY GS +D+L ++ L E + +G+ YLH +
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDLL-EVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 136
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE---WYKNTPI 691
IH D+K NIL+ E K+ DFG A ++ P F GT +MAPE
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANXFV---GTPYWMAPEVILAMDEGQY 191
Query: 692 SVKADVFSYGVVLLEI 707
K DV+S G+ +E+
Sbjct: 192 DGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 24/201 (11%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGE----REFRAEMHVIGRTHHKNL 570
+ + KG+FG+VY A+K L+K M+ + + + RA M + G + +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGES--PYV 59
Query: 571 VRLIGYCAEDSKR--LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
+L Y + SK LV EY++ G A ++ W ++ ++V G+ LH
Sbjct: 60 AKL--YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQ 115
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL-LMPDQTRTFTLVRGTRGYMAPEWYK 687
IIH DIKP+N+L+D+ K++DFGL++ L + F GT Y+APE
Sbjct: 116 R---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---KKFV---GTPDYLAPETIL 166
Query: 688 NTPISVKADVFSYGVVLLEIV 708
+D +S G V+ E +
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 10/196 (5%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG--EREFRAEMHVIGRTHHKNLVRLI 574
E+LG+G++ VYKG ++VA+K++ EG R E+ ++ H+N+VRL
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLH 64
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
++K +LV+EYM + G +L + + KGI + H E +
Sbjct: 65 DVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRV 121
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLL-MPDQTRTFTLVRGTRGYMAPEWYKNTPI-S 692
+H D+KPQN+L+++ K++DFGLA+ +P T + +V T Y AP+ + S
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYS 179
Query: 693 VKADVFSYGVVLLEIV 708
D++S G ++ E++
Sbjct: 180 TSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 37/217 (17%)
Query: 504 SYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKL----EKMVTEGEREFRAEM 559
S +EL++ NR +G G+ G VYK +L A+K + E V R+ E+
Sbjct: 72 SLSELER-VNR----IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV---RRQICREI 123
Query: 560 HVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDV 619
++ +H N+V+ + + ++ E+M GSL E + DE+ +DV
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL--------EGTHIADEQF--LADV 173
Query: 620 AK----GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR 675
A+ GI YLH I+H DIKP N+L++ KI+DFG++++L + V
Sbjct: 174 ARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV- 229
Query: 676 GTRGYMAPEWYKNTPISVKA------DVFSYGVVLLE 706
GT YM+PE NT ++ A D++S GV +LE
Sbjct: 230 GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 518 ELGKGSFGAVYKG-TLYKGEKLVAVKKL------EKMVTEGEREFRAEMHVIGRTHHKNL 570
E+G+G++G V+K L G + VA+K++ E M RE A + + H N+
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPNV 66
Query: 571 VRLIGYCA-----EDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILY 625
VRL C ++K LV+E++ L L + PE + + + + +G+ +
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 626 LHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEW 685
LH ++H D+KPQNIL+ K++DFGLA++ T +V T Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEV 180
Query: 686 YKNTPISVKADVFSYGVVLLEI 707
+ + D++S G + E+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-------FRAEMHVIGRTHHKN 569
++G+GS+G V+K + ++VA+KK E E + R E+ ++ + H N
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKF----VESEDDPVIKKIALR-EIRMLKQLKHPN 61
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
LV LI K LV+EY + ++ + L + P R + +I + + + H
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 630 -CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEW--- 685
C IH D+KP+NIL+ + K+ DFG A++L +T TR Y APE
Sbjct: 120 NC----IHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDYVATRWYRAPELLVG 174
Query: 686 ---YKNTPISVKADVFSYGVVLLEIVC 709
Y P+ DV++ G V E++
Sbjct: 175 DTQY-GPPV----DVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE---GEREFRAEMHVIGRTHHK 568
T R LGKG FG V + K+ A KKLEK + GE E ++ + + +
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 569 NLVRLIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI--ASDVAKGILY 625
+V L Y E L LV M+ G L ++ + G+DE+ I A+++ G+
Sbjct: 61 FVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLED 117
Query: 626 LHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEW 685
L E I++ D+KP+NIL+D+ +ISD GLA + +P+ V GT GYMAPE
Sbjct: 118 LQRE---RIVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETVRGRV-GTVGYMAPEV 172
Query: 686 YKNTPISVKADVFSYGVVLLEIV 708
N + D + G ++ E++
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 55/192 (28%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-HKNLVRLIGY 576
++G+GS G V + VAVK ++ + + RE VI R + H+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMD-LRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 577 CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIH 636
+ ++ E++ G+L DI+ + L ++ + V + + YLH + +IH
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLHSQ---GVIH 140
Query: 637 CDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKAD 696
DIK +IL+ K+SDFG + D + +LV GT +MAPE TP + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVD 199
Query: 697 VFSYGVVLLEIV 708
++S G++++E+V
Sbjct: 200 IWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE---FRAEMHVIGRTHHKNLVRLIG 575
+G+G FG V + A+K ++K V + F E ++ ++ + +L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ- 67
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
Y +D L LV EY G L +L R ++ +DE + +A+ +L +H +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ---FDEDM-AQFYLAELVLAIHSVHQMGY 123
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEW------YKN 688
+H DIKP+N+L+D K++DFG A L ++ L GT Y+APE
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 689 TPISVKADVFSYGVVLLEIVCCRRNMEIDPS 719
V+ D +S GV+ E++ R S
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 28/204 (13%)
Query: 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEK---MVTEGEREFRAEMHVIGRTHHKNLVR 572
E LG GSFG V + A+K L+K + + + E ++ H +V
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAK--------GIL 624
++ ++++ + E++ G L L R G R +DVAK
Sbjct: 83 MMCSFQDENRVYFLLEFVVGGELFTHL-----RKAG-----RFPNDVAKFYHAELVLAFE 132
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
YLH II+ D+KP+N+L+D K++DFG AK + PD RTFTL GT Y+APE
Sbjct: 133 YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PD--RTFTLC-GTPEYLAPE 185
Query: 685 WYKNTPISVKADVFSYGVVLLEIV 708
++ D ++ GV+L E +
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 6e-13
Identities = 63/197 (31%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFR---AEMHVIGRTHHKNLVRLIG 575
LGKG+FG V K A+K L+K V + E E V+ T H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-K 61
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
Y + RL V EY++ G L L R ER D +++ + YLH I
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLH---SGKI 116
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVK 694
++ D+K +N+++D+ KI+DFGL K + D T GT Y+APE ++
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYGRA 175
Query: 695 ADVFSYGVVLLEIVCCR 711
D + GVV+ E++C R
Sbjct: 176 VDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 33/208 (15%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE------FRAEMHVIGRTHHKNL 570
E++G+G++G VYK + +A+KK+ E E E R E+ ++ H N+
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIR---LEQEDEGVPSTAIR-EISLLKEMQHGNI 63
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIAS---DVAKGILYLH 627
VRL + + LV+EY+ + L + P+ + R+ I + + +GI Y H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPD--FAKNPRL-IKTYLYQILRGIAYCH 119
Query: 628 DECEAPIIHCDIKPQNILMDEFWTA-KISDFGLAKLL-MPDQTRTFTLVRGTRGYMAPEW 685
++H D+KPQN+L+D A K++DFGLA+ +P RTFT T Y APE
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--VRTFTHEVVTLWYRAPEI 174
Query: 686 -----YKNTPISVKADVFSYGVVLLEIV 708
+ +TP+ D++S G + E+V
Sbjct: 175 LLGSRHYSTPV----DIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 72/268 (26%), Positives = 110/268 (41%), Gaps = 83/268 (30%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEK-----LVAVKKLEKMVTEGER--EFRAEMH----VI 562
+ + LG+G+FG V + + + EK VAVK M+ EG E++A M +I
Sbjct: 10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVK----MLKEGATASEYKALMTELKILI 65
Query: 563 GRTHHKNLVRLIGYCAEDSKRLLV-YEYMSNGSLADIL--------------FRGPERSL 607
HH N+V L+G C + L+V EY G+L++ L R E
Sbjct: 66 HIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQ 125
Query: 608 GWDERVRIASD---------------------------------------------VAKG 622
++ R+ S VA+G
Sbjct: 126 KEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARG 185
Query: 623 ILYLHD-ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM--PDQTRTFTLVRGTRG 679
+ +L +C IH D+ +NIL+ E KI DFGLA+ + PD R R
Sbjct: 186 MEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD-ARLPLK 240
Query: 680 YMAPEWYKNTPISVKADVFSYGVVLLEI 707
+MAPE + + ++DV+S+GV+L EI
Sbjct: 241 WMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREF---RAEMHVIGRTHHKNLVRLIG 575
+G+GS+ V L K +++ A+K ++K + + + + E HV + + +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEAP 633
C + + RL LV EY++ G D++F + +E R A+++ + +LH E
Sbjct: 63 SCFQTTSRLFLVIEYVNGG---DLMFHMQRQRKLPEEHARFYAAEICIALNFLH---ERG 116
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAK--LLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
II+ D+K N+L+D K++D+G+ K L D T TF GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC---GTPNYIAPEILRGEEY 173
Query: 692 SVKADVFSYGVVLLEIVCCRRNMEIDPSKPE 722
D ++ GV++ E++ R +I P+
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 64/195 (32%), Positives = 93/195 (47%), Gaps = 12/195 (6%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK---MVTEGEREFRAEMHVIGRT-HHKNLVRLI 574
+GKGSFG V EK AVK L+K + + E+ +E +V+ + H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEAP 633
K V +Y++ G L L R ER + R R A+++A + YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQR--ERCF-LEPRARFYAAEIASALGYLH---SLN 116
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV 693
I++ D+KP+NIL+D ++DFGL K + T T GT Y+APE P
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPYDR 175
Query: 694 KADVFSYGVVLLEIV 708
D + G VL E++
Sbjct: 176 TVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHV-----IGRTHHK 568
+ L +G+FG ++ G L + + K V + E + + + + H+
Sbjct: 9 TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQ 68
Query: 569 NLVRLIGYCAEDS-KRLLVYEYMSNGSLADILFRGPE------RSLGWDERVRIASDVAK 621
N++ ++ C ED ++Y YM+ G+L L + ++L + V +A +A
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 622 GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD--------QTRTFTL 673
G+ YLH +IH DI +N ++DE KI+D L++ L P + R
Sbjct: 129 GMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK- 184
Query: 674 VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRN--MEIDP 718
+MA E N S +DV+S+GV+L E++ + +EIDP
Sbjct: 185 ------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLE--KMVTEGER------EFRAEMHVIGRTHH 567
++ LGKGSFG VY L K +K VA ++L+ K + GE + E ++ + H
Sbjct: 5 QQRLGKGSFGTVY---LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL--FRGPERSLGWDERVRIASDVAKGILY 625
+V+ E ++ EY L L + ++L ++ + G+ Y
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 626 LHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP--DQTRTFTLVRGTRGYMAP 683
+H + I+H D+K +NI + KI DFG+++LLM D TFT GT YM+P
Sbjct: 122 MH---QRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFT---GTPYYMSP 174
Query: 684 EWYKNTPISVKADVFSYGVVLLEIVC 709
E K+ K+D++S G +L E+ C
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFR---AEMHVIGRTHHKNLVRLIG 575
LGKG+FG V + A+K L K V + E E V+ T H L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-K 61
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
Y + RL V EY + G L L R ER + +++ + YLH +
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DV 116
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT--RTFTLVRGTRGYMAPEWYKNTPIS 692
++ DIK +N+++D+ KI+DFGL K + D +TF GT Y+APE ++
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAPEVLEDNDYG 173
Query: 693 VKADVFSYGVVLLEIVCCR 711
D + GVV+ E++C R
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 67/223 (30%), Positives = 95/223 (42%), Gaps = 44/223 (19%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK---MVTEGEREFRAEMHVIGRTHHKNLVRLIG 575
+G+G+FG V+ ++ A+K L K + RAE ++ +V+L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRG---PERSLGWDERVRIASDVAKGILYLHDECE 631
Y +D + L LV EYM G L ++L R PE + R IA V + +H
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA----RFYIAELVL-ALDSVHK--- 119
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAK-------------LLMPDQTRTFTLVR--- 675
IH DIKP NIL+D K++DFGL K R LVR
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 676 ------------GTRGYMAPEWYKNTPISVKADVFSYGVVLLE 706
GT Y+APE + TP ++ D +S GV+L E
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEM---HVIGRTHHKNLV 571
F LGKGSFG V ++L A+K L+K V + + M V+ + +
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFL 63
Query: 572 RLIGYCAEDSKRL-LVYEYMSNGSLADIL-----FRGPERSLGWDERVRIASDVAKGILY 625
+ C + RL V EY++ G L + F+ P V A+++A G+ +
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHA-------VFYAAEIAIGLFF 116
Query: 626 LHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD--QTRTFTLVRGTRGYMAP 683
LH + II+ D+K N+++D KI+DFG+ K M D T+TF GT Y+AP
Sbjct: 117 LHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC---GTPDYIAP 170
Query: 684 EWYKNTPISVKADVFSYGVVLLEIV 708
E P D +++GV+L E++
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 512 TNRFKE--ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE---GEREFRAEMHVIGRTH 566
TNR+ + +G G+FG V + VA+KK+ K + +R +R E+ ++
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLR 67
Query: 567 HKNLVRLIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVR-IASDVAKGIL 624
H+N++ L + + V E + L +L P + ++ + +G+
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLE----KQFIQYFLYQILRGLK 122
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
Y+H A ++H D+KP NIL++E KI DFGLA++ P T + TR Y APE
Sbjct: 123 YVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS----TRYYRAPE 175
Query: 685 ----WYKNTPISVKADVFSYGVVLLEIV 708
W K V+ D++S G + E++
Sbjct: 176 IMLTWQK---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 79/290 (27%), Positives = 124/290 (42%), Gaps = 50/290 (17%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-----HHKNLVRL 573
LGKGSFG V+ L + A+K L+K V + + M V R H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTM-VEKRVLSLAWEHPFLTHL 61
Query: 574 IGYCAEDSKRLL--VYEYMSNGSLADILFRGPE-RSLGWDERVRIASDVAKGILYLHDEC 630
YC +K L V EY++ G D++F A+++ G+ +LH +
Sbjct: 62 --YCTFQTKENLFFVMEYLNGG---DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK- 115
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
I++ D+K NIL+D KI+DFG+ K M +T T GT Y+APE
Sbjct: 116 --GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQK 172
Query: 691 ISVKADVFSYGVVLLEIVCCRRNME-IDPSKP-EEIVLINWAYKCFIDRELNKL------ 742
+ D +S+GV+L E++ + D + + I + N Y ++ RE +
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFV 232
Query: 743 --------VRG--------QEVDRNTLENMIKIGLWCVQDEPALRPSMKS 776
V+G +E+D + LE + EP +P +KS
Sbjct: 233 REPERRLGVKGDIRQHPFFREIDWSALEER--------EIEPPFKPKVKS 274
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 58/195 (29%), Positives = 98/195 (50%), Gaps = 16/195 (8%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKL---EKMVTEGEREFRAEMHVIGRTHHKNLVRLIG 575
+G G+FG V+ E A+K + E + + E+ E V+ H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 576 YCAEDSKRLL--VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
+ E +R L + EY+ G L L R R AS++ + YLH +
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLF-YASEIVCALEYLHSK---E 121
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV 693
I++ D+KP+NIL+D+ K++DFG AK L + RT+TL GT Y+APE ++ +
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKL---RDRTWTLC-GTPEYLAPEVIQSKGHNK 177
Query: 694 KADVFSYGVVLLEIV 708
D ++ G+++ E++
Sbjct: 178 AVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLE--KMVTEGEREFRA---EMHVIGRTHHK 568
R + LG+G+FG VY + +AVK+++ E +E A E+ ++ H+
Sbjct: 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 569 NLVRLIGYCAEDSKRLL--VYEYMSNGSLADILFRGPERSLG-WDERV--RIASDVAKGI 623
+V+ G + +R L E+M GS+ D L +S G E V + + +G+
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-----KSYGALTENVTRKYTRQILEGV 119
Query: 624 LYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT-----LVRGTR 678
YLH I+H DIK NIL D K+ DFG +K L QT + V GT
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL---QTICLSGTGMKSVTGTP 173
Query: 679 GYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+M+PE KAD++S G ++E++
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 519 LGKGSFGAVY---KGTLYKGEKLVAVKKLEKM-------VTEGEREFRAEMHVIGRTHHK 568
LG G++G V+ K + KL A+K L+K E R R + + R
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF- 66
Query: 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
LV L D+K L+ +Y++ G L L+ +R + VR+ +A+ +L L
Sbjct: 67 -LVTLHYAFQTDTKLHLILDYVNGGELFTHLY---QREHFTESEVRVY--IAEIVLALDH 120
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYK 687
+ II+ DIK +NIL+D ++DFGL+K + ++ R ++ GT YMAPE +
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAPEVIR 179
Query: 688 NTPI--SVKADVFSYGVVLLEIV 708
D +S GV+ E++
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREF---RAEMHVIGR-THHKNLVRLI 574
+G+GS+ V L K E++ A+K ++K + + + + E HV + ++H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEAP 633
+S+ V EY++ G D++F + +E R +++++ + YLH E
Sbjct: 63 SCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNYLH---ERG 116
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAK--LLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
II+ D+K N+L+D K++D+G+ K L D T TF GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEILRGEDY 173
Query: 692 SVKADVFSYGVVLLEIVCCRRNMEI 716
D ++ GV++ E++ R +I
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGERE-FRAEMHV---IGRTHH 567
R LG+G FG V K +L A+K L+K ++ E E E + H
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERH 61
Query: 568 KNLVRLIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
LV L C + + V EY + G D++ V A+ V G+ YL
Sbjct: 62 PFLVNLFA-CFQTEDHVCFVMEYAAGG---DLMMHIHTDVFSEPRAVFYAACVVLGLQYL 117
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM--PDQTRTFTLVRGTRGYMAPE 684
H+ I++ D+K N+L+D KI+DFGL K M D+T TF GT ++APE
Sbjct: 118 HEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC---GTPEFLAPE 171
Query: 685 WYKNTPISVKADVFSYGVVLLEIVCC 710
T + D + GV++ E++
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEM---HVIGRTHHKNLVRLIG 575
LGKGSFG V L +++ A+K L+K V + + M ++ + +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 576 YCAEDSKRLL-VYEYMSNGSLADILFRGPERSLGWDE-RVRI-ASDVAKGILYLHDECEA 632
C + RL V EY++ G D++F+ +RS +DE R R A++V +++LH
Sbjct: 63 CCFQTKDRLFFVMEYVNGG---DLMFQ-IQRSRKFDEPRSRFYAAEVTLALMFLH---RH 115
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
+I+ D+K NIL+D K++DFG+ K + + T T GT Y+APE +
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEILQELEYG 174
Query: 693 VKADVFSYGVVLLEIVCCRRNMEID 717
D ++ GV++ E++ + E D
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEAD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 62/198 (31%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFR---AEMHVIGRTHHKNLVRLIG 575
LGKG+FG V + A+K L+K V + E E V+ + H L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-K 61
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEAP 633
Y + RL V EY + G L L R ER ++R R +++ + YLH E
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSR--ERVFS-EDRARFYGAEIVSALDYLHSEKN-- 116
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV 693
+++ D+K +N+++D+ KI+DFGL K + D T GT Y+APE ++
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGR 175
Query: 694 KADVFSYGVVLLEIVCCR 711
D + GVV+ E++C R
Sbjct: 176 AVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 58/173 (33%), Positives = 88/173 (50%), Gaps = 13/173 (7%)
Query: 519 LGKGSFGAVY---KGTLYKGEKLVAVKKLEK-MVTEGEREF---RAEMHVIGRTHHKNLV 571
LGKG +G V+ K T K+ A+K L+K + +++ +AE +++ H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
LI K L+ EY+S G L L R E D S+++ + +LH +
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQ-- 119
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
II+ D+KP+NIL+D K++DFGL K + + T T T GT YMAPE
Sbjct: 120 -GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 13/194 (6%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRA----EMHVIGRTHHKNLVRLI 574
+G+G++G V K + +++VA+KK + +E E + E+ ++ +N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKD--SEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVR-IASDVAKGILYLHDECEAP 633
K LV+EY+ L ++L P E+VR + K I + H +
Sbjct: 67 EAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVP--PEKVRSYIYQLIKAIHWCH---KND 120
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV 693
I+H DIKP+N+L+ K+ DFG A+ L +T TR Y +PE P
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 694 KADVFSYGVVLLEI 707
D++S G +L E+
Sbjct: 181 AVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 1e-11
Identities = 34/108 (31%), Positives = 51/108 (47%), Gaps = 13/108 (12%)
Query: 49 SSLGAFQFGFYKQ--DAGFKVGIWLLTFPDI--TIVWTAYRDDPPVSSNAALTLTKDGKL 104
SS F+ GF+K + I + T+VW A RD+P S+ LTL DG L
Sbjct: 12 SSGSLFELGFFKLIMQSRDYNLIL---YKGSSRTVVWVANRDNP-SGSSCTLTLQSDGNL 67
Query: 105 ILRTEEGHDKVVAA---GKSEPASSASMLDSGNFVLYNNRSDIIWSSF 149
++ +G VV + + +LD GN VLY++ + +W SF
Sbjct: 68 VI--YDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSF 113
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 60/196 (30%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRA--EMHVIGRTHHKNLVRLI 574
E+LG+GS+ VYKG +LVA+K + M TE F A E ++ H N+V L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANIVLLH 69
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
V+EYM LA + + P ++ R+ + +G+ Y+H + I
Sbjct: 70 DIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQ---HI 124
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKL-LMPDQTRTFTLVRGTRGYMAPE-WYKNTPIS 692
+H D+KPQN+L+ K++DFGLA+ +P QT + +V T Y P+ T S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYS 182
Query: 693 VKADVFSYGVVLLEIV 708
D++ G + +E++
Sbjct: 183 SALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 34/209 (16%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK---MVTEGEREFRAEMHVIGRTHHKNLVRLIG 575
+G G++G V K + VA+KKL + +R +R E+ ++ H+N++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81
Query: 576 YCAEDSKR------LLVYEYMSNGSLADILFRGPERSLGWDERVR-IASDVAKGILYLHD 628
S LV M L +I+ + L D+ ++ + + +G+ Y+H
Sbjct: 82 VFTPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLS-DDHIQFLVYQILRGLKYIH- 135
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE---- 684
A IIH D+KP NI ++E KI DFGLA+ + T V TR Y APE
Sbjct: 136 --SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT---GYV-ATRWYRAPEIMLN 189
Query: 685 W--YKNTPISVKADVFSYGVVLLEIVCCR 711
W Y T D++S G ++ E++ +
Sbjct: 190 WMHYNQT-----VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVI-GRTHHKNLVRLIG 575
E +GKG++G VYK T K L AVK L+ +++ + E AE +++ +H N+V+ G
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDP-ISDVDEEIEAEYNILQSLPNHPNVVKFYG 86
Query: 576 --YCAED---SKRLLVYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGILYLHD 628
Y A+ + LV E + GS+ +++ DE + I G+ +LH+
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYK- 687
IIH D+K NIL+ K+ DFG++ L + R T V GT +MAPE
Sbjct: 147 N---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIAC 202
Query: 688 ----NTPISVKADVFSYGVVLLEI 707
+ + DV+S G+ +E+
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFR---AEMHVIGRTHHKNLVRLIG 575
+GKG+FG VY+ ++ A+K L K ++E E +++ RT ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 576 Y---CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
DS LV +YMS G L F ++ + E R +A+ +L L +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFSED-RAKFYIAELVLALEHLHKY 115
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAK--LLMPDQTRTFTLVRGTRGYMAPE-WYKNT 689
I++ D+KP+NIL+D + DFGL+K L T TF GT Y+APE
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPEVLLDEK 172
Query: 690 PISVKADVFSYGVVLLEIVC 709
+ D +S GV++ E+ C
Sbjct: 173 GYTKHVDFWSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGY 576
+ +G G++G VYK +L AVK ++ + + E+ ++ H N+V G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 577 CAEDSKRLLVYEYMSNGSLADIL-FRGPERSLGWDERVRIASDVAKGILYLHDECEAPII 635
K + EY GSL DI GP L + + + +G+ YLH + + +
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGLAYLHSKGK---M 128
Query: 636 HCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY---KNTPIS 692
H DIK NIL+ + K++DFG+A + + + + GT +MAPE KN +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187
Query: 693 VKADVFSYGVVLLEI 707
D+++ G+ +E+
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 31/204 (15%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-----REFRAEMHVIGRTHHKNLVRL 573
+G+G+F V K K K A+K ++K E RE +A + + + H N++RL
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQA-LRRL--SPHPNILRL 63
Query: 574 IGYCAED-SKRL-LVYEYMSNGSLADILFRGPERSLGWDERVR-IASDVAKGILYLHDEC 630
I + + RL LV+E M + +L + L +G +R L ++RV+ + K + ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-DMNLYE-LIKGRKRPLP-EKRVKSYMYQLLKSLDHMH--- 117
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE------ 684
I H DIKP+NIL+ K++DFG + + +T TR Y APE
Sbjct: 118 RNGIFHRDIKPENILIK-DDILKLADFGSCRGI--YSKPPYTEYISTRWYRAPECLLTDG 174
Query: 685 WYKNTPISVKADVFSYGVVLLEIV 708
+Y K D+++ G V EI+
Sbjct: 175 YY-----GPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 24/160 (15%)
Query: 520 GKGSFGAVYKGTL--YKGEKLVAVKKLEKMVTEGE-------REFRAEMHVIGRTHHKNL 570
G+G++G VYK K K A+KK + + RE + ++ H+N+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLRELKHENV 64
Query: 571 VRLIGYCAEDSKRL--LVYEYMSNGSLADILF-RGPERSLGWDERVR-IASDVAKGILYL 626
V L+ E + + L+++Y + I F R +R V+ + + G+ YL
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 627 HDECEAPIIHCDIKPQNILM----DEFWTAKISDFGLAKL 662
H ++H D+KP NIL+ E KI D GLA+L
Sbjct: 125 HSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKL--EKMVTEGEREFRA---EMHVIGRTHHK 568
R + LG+G+FG VY + +AVK++ + E +E A E+ ++ H
Sbjct: 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 569 NLVRLIGYCAED--SKRLLVY-EYMSNGSLADILFRGPERSLG-WDERV--RIASDVAKG 622
+V+ G C D K+L ++ EYM GS+ D L ++ G E V R + +G
Sbjct: 65 RIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-----KAYGALTENVTRRYTRQILQG 118
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT-----LVRGT 677
+ YLH I+H DIK NIL D K+ DFG +K + QT + V GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI---QTICMSGTGIKSVTGT 172
Query: 678 RGYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+M+PE KADV+S ++E++
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-11
Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 25/164 (15%)
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL----LMPDQTRTFTLVRGTR 678
+L +H +IH DIK NIL+ K+ DFG +K+ + D RTF GT
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC---GTP 209
Query: 679 GYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE 738
Y+APE ++ P S KAD+FS GV+L E++ +R D EE+
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR--PFDGENMEEV-------------- 253
Query: 739 LNKLVRGQ--EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780
++K + G+ + + M +I + +P RPS ++ M
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVI-GRTHHKNLVRLIG 575
E +GKG++G V+K K AVK L+ + + + E AE +++ + H N+V+ G
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 576 -YCAEDSKR----LLVYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGILYLHD 628
Y +D K LV E + GS+ D++ +R +E + I + G+ +LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH- 141
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYK- 687
IH D+K NIL+ K+ DFG++ L + R T V GT +MAPE
Sbjct: 142 --VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIAC 198
Query: 688 ----NTPISVKADVFSYGVVLLEI 707
++ + DV+S G+ +E+
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFR---AEMHVIGRTHHKNLVRL 573
++G+G +G V+ ++VA+K+++K + E R E ++ T + LV+L
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 574 IGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
+ Y +D + L L EY+ G +L L D +++ + + LH E
Sbjct: 67 L-YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDALH---EL 120
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
IH D+KP+N L+D K++DFGL+K ++ T ++V G+ YMAPE +
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANSVV-GSPDYMAPEVLRGKGYD 176
Query: 693 VKADVFSYGVVLLEIVC 709
D +S G +L E +C
Sbjct: 177 FTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 55/181 (30%), Positives = 86/181 (47%), Gaps = 22/181 (12%)
Query: 539 VAVKKLEK---MVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL-------LVYE 588
VA+KKL + VT +R +R E+ ++ +HKN++ L+ K L LV E
Sbjct: 44 VAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLN-VFTPQKSLEEFQDVYLVME 101
Query: 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE 648
M + +L ++ + L + + + GI +LH A IIH D+KP NI++
Sbjct: 102 LM-DANLCQVI----QMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKS 153
Query: 649 FWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
T KI DFGLA+ T +V TR Y APE D++S G ++ E++
Sbjct: 154 DCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211
Query: 709 C 709
Sbjct: 212 R 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 8e-11
Identities = 74/290 (25%), Positives = 126/290 (43%), Gaps = 48/290 (16%)
Query: 519 LGKGSFGAVYKGTLY----KGEKLVAVK--KLEKMVTEGEREFRAEMHVIGRTHHKNLVR 572
LGKG FG+V + L +K VAVK K + + EF E + H N+++
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQK-VAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 573 LIGYCAEDSKR------LLVYEYMSNGSLADIL---------FRGPERSLGWDERVRIAS 617
LIG + +++ +M +G L L F P ++L VR
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL-----VRFMI 120
Query: 618 DVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA-KLLMPDQTRTFTLVRG 676
D+A G+ YL + IH D+ +N +++E T ++DFGL+ K+ D R +
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 677 TRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFID 736
++A E + + +DV+++GV + EI+ R + EI
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIM-TRGQTPYAGVENSEI------------ 224
Query: 737 RELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
N L++G + + + LE++ ++ C EP RPS + + LE I
Sbjct: 225 --YNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 50/194 (25%), Positives = 90/194 (46%), Gaps = 5/194 (2%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTHHKNLVRLIGYC 577
+G+GSFG ++ A+K++ + E R E ++ + H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 578 AEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHC 637
D +V EY G L + + D ++ + G+ ++H++ ++H
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHR 124
Query: 638 DIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADV 697
DIK +NI + + K+ DFG A+LL T V GT Y+ PE ++N P + K+D+
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNKSDI 183
Query: 698 FSYGVVLLEIVCCR 711
+S G +L E+ +
Sbjct: 184 WSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE------FRAEMHVIGRTHHKNLV 571
++G+G++G VYK +LVA+KK+ + E+E R E+ ++ + +H+N+V
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIR-EIKILRQLNHRNIV 69
Query: 572 RLIGYCAEDSKRL----------LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAK 621
L + L LV+EYM + L +L G D + +
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLE 127
Query: 622 GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYM 681
G+ Y H + +H DIK NIL++ K++DFGLA+L +++R +T T Y
Sbjct: 128 GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 682 APEWY----KNTPISVKADVFSYGVVLLEI 707
PE + P DV+S G +L E+
Sbjct: 185 PPELLLGEERYGP---AIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKK-LEKMVTEGE-----REFRAEMHVIGRTHHKNL 570
E++G+G++G VYK KLVA+KK +M EG RE + + +
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQML---SESIYI 63
Query: 571 VRLIGYCAEDSKR-----LLVYEYMSNG--SLADILFRGPERSLGWDERVRIASDVAKGI 623
VRL+ + K LV+EY+ + D RGP R L + KG+
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 624 LYLHDECEAPIIHCDIKPQNILMD-EFWTAKISDFGLAK-LLMPDQTRTFTLVRGTRGYM 681
+ H ++H D+KPQN+L+D + KI+D GL + +P ++ T +V T Y
Sbjct: 124 AHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYR 178
Query: 682 APE-WYKNTPISVKADVFSYGVVLLEIV 708
APE +T S D++S G + E+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 18/214 (8%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK-MVTEGER--EFRAEMHVIGR-THHKNLVRLI 574
+G+GS+ V L K ++ A+K ++K +V + E + E HV ++H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEAP 633
+S+ V E++S G D++F + +E R +++++ + +LH E
Sbjct: 63 SCFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALNFLH---ERG 116
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAK--LLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
II+ D+K N+L+D K++D+G+ K + D T TF GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC---GTPNYIAPEILRGEDY 173
Query: 692 SVKADVFSYGVVLLEIVCCRRNMEI--DPSKPEE 723
D ++ GV++ E++ R +I P++
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRA--EMHVIGRTHHKNLVRLI 574
E+LG+GS+ VYKG KLVA+K + EG F A E ++ H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIVLLH 69
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
LV+EY+ L + + P L + + +G+ Y+H + I
Sbjct: 70 DIIHTKETLTLVFEYVHT-DLCQYMDKHPG-GLHPENVKLFLFQLLRGLSYIH---QRYI 124
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKL-LMPDQTRTFTLVRGTRGYMAPE-WYKNTPIS 692
+H D+KPQN+L+ + K++DFGLA+ +P T + +V T Y P+ +T S
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTEYS 182
Query: 693 VKADVFSYGVVLLEIV 708
D++ G + +E++
Sbjct: 183 TCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 8/169 (4%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGY 576
+ +G G++G VYK +L A+K ++ E + E+ ++ H N+V G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 577 CAEDSKRLLVYEYMSNGSLADIL-FRGPERSLGWDERVRIASDVAKGILYLHDECEAPII 635
K + E+ GSL DI GP L + ++ + +G+ YLH + + +
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLHSKGK---M 128
Query: 636 HCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
H DIK NIL+ + K++DFG++ + + + + GT +MAPE
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 58/194 (29%), Positives = 95/194 (48%), Gaps = 11/194 (5%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFR-AEMHVIGRTHHKNLVRLIG 575
+GKGSFG V + +++ A+K + K +V+ E AE V+ + + +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 576 YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDE-RVRIASDVAKGILYLHDECEAPI 634
K LV +++ G L F +R +D R R + A+ + L + + +
Sbjct: 61 SFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYT--AELLCALENLHKFNV 114
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVK 694
I+ D+KP+NIL+D + DFGL KL M D +T T GT Y+APE +
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYTKA 173
Query: 695 ADVFSYGVVLLEIV 708
D ++ GV+L E++
Sbjct: 174 VDWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 48/153 (31%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 517 EELGKGSFGAVYKGTLYKG--EKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRL 573
+E+G G FG V G + G V VK+L + + + +F E H NL++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADIL--FRGPERSLGWDERV--RIASDVAKGILYLHDE 629
+G C E + LLV E+ G L L R E + D R+A ++A G+L+LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAE-LMTPDPTTLQRMACEIALGLLHLH-- 117
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662
+ IH D+ +N L+ T KI D+GL+
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 519 LGKGSFGAVYKG-TLYKGEKLVAVK-KLEKMVTEGEREFRA---EMHVIGRTHHKNLVRL 573
LG+G+FG VY + G +L A + + + E +E A E+ ++ H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 574 IGYCAEDSKRLLV--YEYMSNGSLADILFRGPERSLG-WDERV--RIASDVAKGILYLHD 628
G + +++ L EYM GS+ D L ++ G E V + + +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQL-----KAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT-----LVRGTRGYMAP 683
I+H DIK NIL D K+ DFG +K L QT + V GT +M+P
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICMSGTGIRSVTGTPYWMSP 178
Query: 684 EWYKNTPISVKADVFSYGVVLLEIV 708
E KADV+S G ++E++
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 64/234 (27%), Positives = 111/234 (47%), Gaps = 35/234 (14%)
Query: 519 LGKGSFGAVY---KGTLYKGEKLVAVKKLEKMV----TEGEREFRAEMHVIGRTHHKNLV 571
LG G++G V+ K T + KL A+K L+K + R E +V+ +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 572 RLIGYCAE-DSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIAS-DVAKGILYLHDE 629
+ Y + ++K L+ +Y+S G + L+ +R ++ VR S ++ + +LH
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLH-- 122
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAK-LLMPDQTRTFTLVRGTRGYMAPEWYKN 688
+ I++ DIK +NIL+D ++DFGL+K L ++ RT++ GT YMAPE +
Sbjct: 123 -KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-GTIEYMAPEIIRG 180
Query: 689 TPISVKA-DVFSYGVVLLEIV-----------------CCRRNMEIDPSKPEEI 724
KA D +S G+++ E++ RR ++ DP P I
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFI 234
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNLVR--- 572
+G G+FG V+ T + K VA+KK+ + + +R FR E+ ++ H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66
Query: 573 -----LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYL 626
I E + V + L I+ S + V++ + +G+ YL
Sbjct: 67 ILQPPHIDPFEE----IYVVTELMQSDLHKIIVSPQPLS---SDHVKVFLYQILRGLKYL 119
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
H A I+H DIKP N+L++ KI DFGLA++ PD+++ T T+ Y APE
Sbjct: 120 H---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 687 KNTP-ISVKADVFSYGVVLLEIV 708
+ + D++S G + E++
Sbjct: 177 MGSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEK---MVTEGEREFRAEMHVIGRTHHKNLVRL 573
E +G G++G V + K VA+KK+ + T +R R E+ ++ H N++ +
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAI 69
Query: 574 ---IGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVR-IASDVAKGILYLHD 628
+ D K + +V + M + L I+ + +E +R + +G+ Y+H
Sbjct: 70 RDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLT---EEHIRYFLYQLLRGLKYIH- 124
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP---DQTRTFTLVRGTRGYMAPEW 685
A +IH D+KP N+L++E +I DFG+A+ L + T TR Y APE
Sbjct: 125 --SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 686 YKNTP-ISVKADVFSYGVVLLEIV 708
+ P + D++S G + E++
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 30/188 (15%)
Query: 603 PERSLGWDERVRIASDVAKGILYLHDE-CEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661
L D+ +R +S VA+G+ +L + C IH D+ +N+L+ + AKI DFGLA+
Sbjct: 205 DSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 662 LLMPDQTRTFTLVRGTR----GYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEID 717
+M D +V+G +MAPE + +V++DV+SYG++L EI ++
Sbjct: 261 DIMNDSN---YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS---- 313
Query: 718 PSKPEEIVLINWAYKCFIDRELNKLV-RGQEVDRN--TLENMIKIGLWCVQDEPALRPSM 774
P +L+N + K+V RG ++ R + I C EP RP+
Sbjct: 314 ---PYPGILVN--------SKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTF 362
Query: 775 KSVVLMLE 782
+ +++
Sbjct: 363 SQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 21/154 (13%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE------FRAEMHVIGRTHHKNL 570
E++G+G++G V+K + ++VA+K++ + + E R E+ ++ HKN+
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALR-EICLLKELKHKNI 61
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIAS---DVAKGILYLH 627
VRL D K LV+EY L + + G + + S + KG+ + H
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 628 DECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661
++H D+KPQN+L+++ K++DFGLA+
Sbjct: 117 SH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 7/169 (4%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGERE-FRAEMHVIGRTHHKNLVRLIG 575
+G+G+FG V L +K+ A+K L K M+ E FR E V+ ++ + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 576 YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPII 635
+++ LV +Y G L +L + +R L D +++ I +H + +
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVH---QLHYV 124
Query: 636 HCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
H DIKP NILMD +++DFG LM D T ++ GT Y++PE
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE--REFRAEMHVIGRTHHKNLVRLI 574
E+LG+G++ V+KG E LVA+K++ EG R E+ ++ H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEAP 633
D LV+EY+ + G S+ V+I + +G+ Y H
Sbjct: 71 DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM---HNVKIFLYQILRGLAYCH---RRK 124
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKL-LMPDQTRTFTLVRGTRGYMAPE-WYKNTPI 691
++H D+KPQN+L++E K++DFGLA+ +P +T + +V T Y P+ ++
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEY 182
Query: 692 SVKADVFSYGVVLLEIVCCR 711
S + D++ G + E+ R
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE--REFRAEMHVIGRTHHKNLVRLI 574
++LG+G++ V+KG E LVA+K++ EG R E+ ++ H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEAP 633
+ LV+EY+ + + G S+ V+I + +G+ Y H +
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSM---HNVKIFMFQLLRGLSYCH---KRK 123
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKL-LMPDQTRTFTLVRGTRGYMAPE-WYKNTPI 691
I+H D+KPQN+L++E K++DFGLA+ +P +T + +V T Y P+ +T
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEY 181
Query: 692 SVKADVFSYGVVLLEIVCCR 711
S D++ G +L E+ R
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 18/198 (9%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEM---HVIGRTHHKNLVRLIG 575
LGKGSFG V L + AVK L+K V + + M V+ + +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL- 61
Query: 576 YCAEDSKRLL--VYEYMSNGSLADILFRGPERSLGWDERVRI---ASDVAKGILYLHDEC 630
YC +K L V E+++ G D++F ++ G + R A+++ G+ +LH +
Sbjct: 62 YCTFQTKEHLFFVMEFLNGG---DLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK- 115
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
II+ D+K N+++D KI+DFG+ K + R T GT Y+APE +
Sbjct: 116 --GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLK 172
Query: 691 ISVKADVFSYGVVLLEIV 708
+ D +S+GV+L E++
Sbjct: 173 YTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 15/197 (7%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAE--MHVIGRTHHKNLVRL 573
+G+G FG VY K+ A+K L+K + +GE E M + T +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEA 632
+ Y +L + NG D+ + + + ++ +R A+++ G+ ++H+
Sbjct: 62 MTYAFHTPDKLCFILDLMNG--GDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF-- 117
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE-WYKNTPI 691
+++ D+KP NIL+DE +ISD GLA + GT GYMAPE K T
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAY 173
Query: 692 SVKADVFSYGVVLLEIV 708
AD FS G +L +++
Sbjct: 174 DSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-------REFRAEMHVIGRT 565
NR +E G++G VY+ K ++VA+KKL KM E E RE + +
Sbjct: 11 NRIEE----GTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLREINILL----KL 61
Query: 566 HHKNLVRL--IGYCAEDSKRLLVYEYMSNGSLADILFRGPER-SLGWDERVRIASDVAKG 622
H N+V + + + K +V EY+ + L ++ + E + + G
Sbjct: 62 QHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS--EVKCLMLQLLSG 118
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMA 682
+ +LHD I+H D+K N+L++ KI DFGLA+ + +T + T Y A
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVVTLWYRA 174
Query: 683 PEWYKNTPI-SVKADVFSYGVVLLEI 707
PE S D++S G + E+
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAEL 200
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 35/213 (16%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKL----EKMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
LG GS G V+ +K VAVKK+ + V RE + +I R H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIK----IIRRLDHDNIVKVY 68
Query: 575 GYCAEDSKRL--------------LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDV 619
L +V EYM LA++L +GP E R+ +
Sbjct: 69 EVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSE----EHARLFMYQL 123
Query: 620 AKGILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISDFGLAKLLMPDQTRTFTLVRG-- 676
+G+ Y+H A ++H D+KP N+ ++ E KI DFGLA+++ P + L G
Sbjct: 124 LRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 677 TRGYMAPEWYKNTPISVKA-DVFSYGVVLLEIV 708
T+ Y +P + KA D+++ G + E++
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 6/94 (6%)
Query: 621 KGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP--DQTRTFTLVRGTR 678
+G+ Y+H A ++H D+KP N+L++ KI DFGLA++ P D T T TR
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 679 GYMAPEWYKNTPISVKA-DVFSYGVVLLEIVCCR 711
Y APE N+ KA D++S G +L E++ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAE--MHVIGRTHHKNLVRL 573
+G+G FG VY K+ A+K L+K + +GE E M + T +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 574 IGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECE 631
+ Y +L + + M+ G D+ + + + + +R A+++ G+ ++H+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF- 117
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE-WYKNTP 690
+++ D+KP NIL+DE +ISD GLA + GT GYMAPE K
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVA 172
Query: 691 ISVKADVFSYGVVLLEIV 708
AD FS G +L +++
Sbjct: 173 YDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 52/239 (21%), Positives = 98/239 (41%), Gaps = 52/239 (21%)
Query: 506 NELKKATNRFKE---ELGKGSFGAVYKGTLYKGEKLVAVKKLE----KMVTEGERE---- 554
N + R+ + LG+G++G V K K+VA+KK++ +R+
Sbjct: 1 NMSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGM 60
Query: 555 ----FRA--EMHVIGRTHHKNLVRLIG-YCAEDSKRLLVYEYMSNGSLADILFRGPERSL 607
F E+ ++ H+N++ L+ Y D L V + M+ L ++
Sbjct: 61 CGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINL-VMDIMA-SDLKKVV-------- 110
Query: 608 GWDERVR--------IASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGL 659
D ++R I + G+ LH + +H D+ P NI ++ KI+DFGL
Sbjct: 111 --DRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGL 165
Query: 660 AK-----LLMPDQTRTFTLVRGTRGYMAPE----WYKNTPISVKADVFSYGVVLLEIVC 709
A+ ++ T+ R R M + WY+ + + A+ + + V + + C
Sbjct: 166 ARRYGYPPYSDTLSKDETMQR--REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGC 222
|
Length = 335 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 32/208 (15%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK---MVTEGEREFRAEMHVIGRTHHKNLVRLI- 574
+G G++G+V K VAVKKL + + +R +R E+ ++ H+N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 575 ----GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
E+ + + ++ L +I+ + L D + + +G+ Y+H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIH--- 137
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
A IIH D+KP N+ ++E KI DFGLA+ + T GY+A WY+
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRWYRAPE 187
Query: 691 I-------SVKADVFSYGVVLLEIVCCR 711
I + D++S G ++ E++ R
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 61/230 (26%), Positives = 95/230 (41%), Gaps = 40/230 (17%)
Query: 514 RFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGE-REFRAEMHVIGRTHHK 568
FK + LGKG G V+ L KL A+K L+K M+ + + E ++ H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLH 627
L L ++ LV +Y G L +L R P + L +E R A++V + YLH
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLS-EEVARFYAAEVLLALEYLH 120
Query: 628 DECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL------------------------ 663
I++ D+KP+NIL+ E +SDF L+K
Sbjct: 121 --LLG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 664 -----MPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
R+ + V GT Y+APE D ++ G++L E++
Sbjct: 178 SETFSEEPSFRSNSFV-GTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 61/229 (26%), Positives = 106/229 (46%), Gaps = 31/229 (13%)
Query: 497 ESNLRSF-----SYNELKKATNRFKEELGKGSFG---AVYKGTLYKGEKLVAVKKLEKMV 548
++N S ++ LK+ N + +G G+ G A Y L E+ VA+KKL +
Sbjct: 7 DNNFYSVEIGDSTFTVLKRYQNL--KPIGSGAQGIVCAAYDAIL---ERNVAIKKLSRPF 61
Query: 549 ---TEGEREFRAEMHVIGRTHHKNLVRLIGY-----CAEDSKRLLVYEYMSNGSLADILF 600
T +R +R E+ ++ +HKN++ L+ E+ + + + + + +L ++
Sbjct: 62 QNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI- 119
Query: 601 RGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA 660
+ L + + + GI +LH A IIH D+KP NI++ T KI DFGLA
Sbjct: 120 ---QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173
Query: 661 KLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC 709
+ T +V TR Y APE D++S G ++ E++
Sbjct: 174 RTAGTSFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 35/206 (16%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE---GEREFRAEMHVIGRTHHKNLVRLIG 575
+G G++G+V + + VA+KKL + +R +R E+ ++ H+N++ L+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 576 -YCAEDSKR-----LLVYEYMSNGSLADILFRGPERSLGWDERVR-IASDVAKGILYLHD 628
+ + S LV YM L I G S +++V+ + + G+ Y+H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQT-DLQKI--MGHPLS---EDKVQYLVYQMLCGLKYIH- 134
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE---- 684
A IIH D+KP N+ ++E KI DFGLA+ D T +V TR Y APE
Sbjct: 135 --SAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV--TRWYRAPEVILN 188
Query: 685 W--YKNTPISVKADVFSYGVVLLEIV 708
W Y T D++S G ++ E++
Sbjct: 189 WMHYNQT-----VDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 514 RFKE--ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE---GEREFRAEMHVIGRTHHK 568
R+++ ++G G++G V + VA+KKL + +R +R E+ ++ H+
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHE 74
Query: 569 NLVRLIGYCAEDSKR------LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKG 622
N++ L+ D LV +M L ++ L D + + KG
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLM---KHEKLSEDRIQFLVYQMLKG 130
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMA 682
+ Y+H A IIH D+KP N+ ++E KI DFGLA+ D T +V TR Y A
Sbjct: 131 LKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVV--TRWYRA 183
Query: 683 PE----WYKNTPISVKADVFSYGVVLLEIV 708
PE W T D++S G ++ E++
Sbjct: 184 PEVILNWMHYTQ---TVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 55/179 (30%), Positives = 84/179 (46%), Gaps = 20/179 (11%)
Query: 539 VAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGY------CAEDSKRLLVYEY 589
VAVKKL + T +R +R E+ ++ +HKN++ L+ E LV E
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107
Query: 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF 649
M + +L ++ L + + + GI +LH A IIH D+KP NI++
Sbjct: 108 M-DANLCQVI----HMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSD 159
Query: 650 WTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
T KI DFGLA+ + T +V TR Y APE D++S G ++ E+V
Sbjct: 160 CTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 65/227 (28%), Positives = 109/227 (48%), Gaps = 27/227 (11%)
Query: 496 YESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGER 553
YE +R ++K + +G+G+FG V +K+ A+K L K M+ +
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87
Query: 554 EF-RAEMHVIGRTHHKNLVRLIGYCA-EDSKRL-LVYEYMSNGSLADIL--FRGPERSLG 608
F E ++ + +V+L +CA +D K L +V EYM G L +++ + PE+
Sbjct: 88 AFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--- 142
Query: 609 WDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668
W + A+ +L L +IH D+KP N+L+D+ K++DFG + D+T
Sbjct: 143 WAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DET 195
Query: 669 ---RTFTLVRGTRGYMAPEWYKNTP----ISVKADVFSYGVVLLEIV 708
R T V GT Y++PE K+ + D +S GV L E++
Sbjct: 196 GMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 50/224 (22%), Positives = 87/224 (38%), Gaps = 42/224 (18%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGER---EFRAEMHVIGRTHHKNLVRLIG 575
+GKG G VY + VA+KK+ + ++E F E + H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 576 YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERV--------------RIASDVAK 621
C++ Y+ +L +L +S+ E + I +
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLL-----KSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 622 GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL-------- 673
I Y+H + ++H D+KP NIL+ F I D+G A ++ +
Sbjct: 125 TIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 674 ---------VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+ GT YMAPE P S D+++ GV+L +++
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGERE-FRAEMHVIGRTHHKNLVRLIG 575
+G+G+FG V + ++ A+K L K M+ E FR E V+ + + L
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL-H 67
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAK-----GILYLHDE 629
Y +D L LV +Y G L +L + +R + D+A+ +L +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDR---------LPEDMARFYLAEMVLAIDSV 118
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
+ +H DIKP N+L+D+ +++DFG L+ D T + GT Y++PE
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE--REFRAEMHVIGRTHHKNLVRLI 574
++LG+G++ VYKG + LVA+K++ EG R E+ ++ H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
+ LV+EY+ + L L S+ + +G+ Y H +
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKL-LMPDQTRTFTLVRGTRGYMAPE-WYKNTPIS 692
+H D+KPQN+L++E K++DFGLA+ +P +T + +V T Y P+ +T S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYS 183
Query: 693 VKADVFSYGVVLLEIVCCR 711
+ D++ G + E+ R
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 2e-08
Identities = 26/73 (35%), Positives = 33/73 (45%), Gaps = 12/73 (16%)
Query: 247 NNSSIIRRLTIGHNGILRLFSHYPVPKGAYNTSVDWN----VPDDLCEVKTFCGLNSYCT 302
N+SI RLT+ G L F+ P S DWN P D C+V CG YC
Sbjct: 41 TNNSIYSRLTLSSEGSLERFTWIP-------NSQDWNLFWSAPKDQCDVYGRCGPYGYCD 93
Query: 303 LYDDQPMCRCLPG 315
+ + P C C+ G
Sbjct: 94 V-NTSPKCNCIKG 105
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 51/233 (21%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGERE-FRAEMHVIGRTHHKNLVRLIG 575
+G+G+FG V + A+KKL K M+ + + RAE ++ + +V+L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL-- 66
Query: 576 YCA-EDSKRL-LVYEYMSNGSLADILFRGPERSLGWDE-RVRIASDVAKGILYLHDECEA 632
Y + +D L L+ EY+ G + +L + + + +E R IA + IL + +
Sbjct: 67 YYSFQDENYLYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIA----ETILAIDSIHKL 120
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF--------------------- 671
IH DIKP N+L+D K+SDFGL L F
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 672 ------TLVR----------GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
T R GT Y+APE + T + + D +S GV++ E++
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 60/234 (25%), Positives = 106/234 (45%), Gaps = 34/234 (14%)
Query: 519 LGKGSFGAVY---KGTLYKGEKLVAVKKLEKMV----TEGEREFRAEMHVIGRTHHKNLV 571
LG G++G V+ K + + KL A+K L+K + R E V+ +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 572 RLIGYCAE-DSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIAS-DVAKGILYLHDE 629
+ Y + D+K L+ +Y++ G L L +R ++ V+I S ++ + +LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLALEHLH-- 122
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYK-- 687
+ II+ DIK +NIL+D ++DFGL+K D+ GT YMAP+ +
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 688 NTPISVKADVFSYGVVLLEIVC-----------------CRRNMEIDPSKPEEI 724
+ D +S GV++ E++ RR ++ +P P+E+
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 235
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 44/141 (31%), Positives = 67/141 (47%), Gaps = 16/141 (11%)
Query: 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNIL 645
+Y Y++ S R L D+ + I + +G+ YLH + IIH D+K +NI
Sbjct: 143 LYTYLTKRS----------RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIF 189
Query: 646 MDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLL 705
+++ I D G A+ P F + GT APE + KAD++S G+VL
Sbjct: 190 INDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLF 247
Query: 706 EIVCCRRNMEIDP-SKPEEIV 725
E++ + DP S PEE V
Sbjct: 248 EMLAYPSTIFEDPPSTPEEYV 268
|
Length = 357 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 31/226 (13%)
Query: 517 EELGKGSFGAVYKG------TLYKGEKLVAVKKLEKMVTEGER---EFRAEMHVIGRTHH 567
E LG+G+F +YKG L V + K++ R F ++ + H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPER-SLGWDERVRIASDVAKGILYL 626
K+LV+L G C D + ++V EY+ G L L R SL W ++ +A +A + YL
Sbjct: 61 KHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 627 HDECEAPIIHCDIKPQNILM-----DEFWT--AKISDFGLAKLLMPDQTRTFTLVRGTRG 679
D+ ++H ++ +NIL+ +E + K+SD G+ + +R + R
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP---ITVLSREERVERIP-- 169
Query: 680 YMAPEWYKNTP--ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEE 723
++APE +N +++ AD +S+G LLEI C + E
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEI-CSNGEEPLSTLSSSE 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 49/170 (28%), Positives = 84/170 (49%), Gaps = 9/170 (5%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGERE-FRAEMHVIGRTHHKNLVRLIG 575
+G+G+FG V + E++ A+K L K M+ E FR E +V+ + + L
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL-H 67
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
Y +D L LV +Y G L +L + +R ++ R +A+ +L +H +
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLP--EDMARFY--IAEMVLAIHSIHQLHY 123
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
+H DIKP N+L+D +++DFG + D T ++ GT Y++PE
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 34/206 (16%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK---MVTEGEREFRAEMHVIGRTHHKNLVRLI- 574
+G G++G+V + + VAVKKL + + R +R E+ ++ H+N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLD 81
Query: 575 ----GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVR-IASDVAKGILYLHDE 629
E+ + + + L +I+ + L DE V+ + + +G+ Y+H
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGADLNNIV---KCQKLS-DEHVQFLIYQLLRGLKYIH-- 135
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT 689
A IIH D+KP N+ ++E +I DFGLA+ + T GY+A WY+
Sbjct: 136 -SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT----------GYVATRWYRAP 184
Query: 690 PISVK-------ADVFSYGVVLLEIV 708
I + D++S G ++ E++
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 59/210 (28%), Positives = 89/210 (42%), Gaps = 33/210 (15%)
Query: 518 ELGKGSFGAV----YKGTLYKGEKLVAVKKL-----EKMVTE-GEREFRAEMHVIGRTHH 567
ELG+G++G V T E+ VA+KK+ +K++ + RE + H G H
Sbjct: 7 ELGQGAYGIVCSARNAET--SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG---H 61
Query: 568 KNLVRLIGYCAEDS---KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIAS---DVAK 621
KN+ L L +YE + L I+ RS S +
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEADLHQII-----RSGQPLTDAHFQSFIYQILC 116
Query: 622 GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT---FTLVRGTR 678
G+ Y+H A ++H D+KP N+L++ KI DFGLA+ + T TR
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 679 GYMAPE-WYKNTPISVKADVFSYGVVLLEI 707
Y APE + DV+S G +L E+
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 8e-08
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 28/225 (12%)
Query: 496 YESNLRSFSYNELKKATNRFKEELGKGSFG---AVYKGTLYKGEKLVAVKKLEKMV---T 549
Y + ++ LK+ N + +G G+ G A Y L ++ VA+KKL + T
Sbjct: 4 YSVEVGDSTFTVLKRYQNL--KPIGSGAQGIVCAAYDAVL---DRNVAIKKLSRPFQNQT 58
Query: 550 EGEREFRAEMHVIGRTHHKNLVRLIGY------CAEDSKRLLVYEYMSNGSLADILFRGP 603
+R +R E+ ++ +HKN++ L+ E LV E M + +L ++
Sbjct: 59 HAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVI---- 112
Query: 604 ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663
+ L + + + GI +LH A IIH D+KP NI++ T KI DFGLA+
Sbjct: 113 QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169
Query: 664 MPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
T +V TR Y APE D++S G ++ E+V
Sbjct: 170 GTSFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-08
Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 9/171 (5%)
Query: 556 RAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRI 615
R+E+H + H +V+ D K LL+ EY S G L + + + L + E +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEY-EV 171
Query: 616 ASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL----LMPDQTRTF 671
+ +L L + ++H D+K NI + K+ DFG +K + D +F
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231
Query: 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPE 722
GT Y+APE ++ S KAD++S GV+L E++ R + PS+ E
Sbjct: 232 C---GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK-GPSQRE 278
|
Length = 478 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 25/158 (15%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-------REFRAEMHVIGRTHHKNLV 571
+G+G+FG V+K K +++VA+KK+ M E E RE + ++ H+N+V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPITALREIK----ILQLLKHENVV 74
Query: 572 RLIGYC-----AEDSKR---LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGI 623
LI C + + LV+E+ + LA +L E ++ + G+
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-SNKNVKFTLSEIKKVMKMLLNGL 132
Query: 624 LYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661
Y+H I+H D+K NIL+ + K++DFGLA+
Sbjct: 133 YYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 45/189 (23%), Positives = 86/189 (45%), Gaps = 22/189 (11%)
Query: 532 LYKGE---KLVAVKKLEKMVTEGE---REFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL- 584
+YKG K V ++ +K + E+ + R N++++ G+ + L
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 585 ---LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKP 641
L+ EY + G L ++L + E+ L + ++ +A D KG+ L+ P + ++
Sbjct: 96 RLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151
Query: 642 QNILMDEFWTAKISDFGLAKLL-MPDQTRTFTLVRGTRGYMAPEWYKN--TPISVKADVF 698
+ L+ E + KI GL K+L P +V Y + + + + ++K D++
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIY 206
Query: 699 SYGVVLLEI 707
S GVVL EI
Sbjct: 207 SLGVVLWEI 215
|
Length = 283 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 52/213 (24%), Positives = 98/213 (46%), Gaps = 33/213 (15%)
Query: 517 EELGKGSFGAVYKGTL----------YKGEKLVAVKKLEKMVTEGERE----FRAEMHVI 562
E LG+G+ +Y G L Y EK +K + K++ R+ F ++
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEK--EIKVILKVLDPSHRDISLAFFETASMM 58
Query: 563 GRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKG 622
+ HK++V L G C D + ++V E++ G L D+ L + ++A +A
Sbjct: 59 RQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQLASA 117
Query: 623 ILYLHDECEAPIIHCDIKPQNILM-------DEFWTAKISDFGLAKLLMPDQTRTFTLVR 675
+ YL D+ ++H ++ +NIL+ + K+SD G+ ++ Q +
Sbjct: 118 LSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI-- 172
Query: 676 GTRGYMAPEWYKNTP-ISVKADVFSYGVVLLEI 707
++APE +++ +S+ AD +S+G L EI
Sbjct: 173 ---PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 83/346 (23%), Positives = 137/346 (39%), Gaps = 88/346 (25%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEK-----LVAVKKLEKMVTEGE-REFRAEMH 560
E + R + LG G+FG V + + + +K VAVK L++ T E + +E+
Sbjct: 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELK 62
Query: 561 V-IGRTHHKNLVRLIGY---------------------------------CAEDSKRLLV 586
+ I +H N+V L+G E S +
Sbjct: 63 ILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRG 122
Query: 587 Y----------EYMSNGSLADILFR----------GPERS--------LGWDERVRIASD 618
+ A +LF P + L ++ + +
Sbjct: 123 RFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQ 182
Query: 619 VAKGILYLHD-ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM--PDQTRTFTLVR 675
VA+G+ +L +C IH D+ +NIL+ E KI DFGLA+ + PD R + R
Sbjct: 183 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS-AR 237
Query: 676 GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI 735
+MAPE + + ++DV+S+GV+L EI + P V IN + C
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL-------GASPYPGVQINEEF-C-- 287
Query: 736 DRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLML 781
+ L R + + T E + +I L C Q +P RP+ ++V +L
Sbjct: 288 -QRLKDGTRMRAPENATPE-IYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 63/261 (24%), Positives = 99/261 (37%), Gaps = 60/261 (22%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK---MVTEGEREFRAEMHVIGRTHHKNLVRLIG 575
+G G+FG V L A+K L K ++ +AE ++ ++ +V+L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRG---PERSLGWDERVRIASDVAKGILYLHDECE 631
Y +D L V +Y+ G + +L R E R IA ++ I +H +
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL----ARFYIA-ELTCAIESVH---K 119
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLA------------------------------- 660
IH DIKP NIL+D K++DFGL
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 661 ----------KLLMPDQTR--TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+ R +LV GT Y+APE T + D +S GV+L E++
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLV-GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 709 CCRRNMEIDPSKPEEIVLINW 729
+ D ++ +INW
Sbjct: 239 VGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 67/283 (23%), Positives = 122/283 (43%), Gaps = 50/283 (17%)
Query: 517 EELGKGSFGAVYKGT---------LYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHH 567
E LG+G+F ++KG L+K E V +K L+K F ++ + H
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTE--VLLKVLDKSHRNYSESFFEAASMMSQLSH 58
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLH 627
K+LV G C + ++V EY+ GSL D + + + ++ +A +A + +L
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAWALHFLE 117
Query: 628 DECEAPIIHCDIKPQNILMDEFWTA--------KISDFGLAKLLMPDQTRTFTLVRGTRG 679
D+ + H ++ +N+L+ K+SD G++ ++P + L R
Sbjct: 118 DK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP---KEILLERIP-- 169
Query: 680 YMAPEWYKNTP-ISVKADVFSYGVVLLEIVCCRRNMEI---DPSKPEEIVLINWAYKCFI 735
++ PE +N +S+ AD +S+G L EI + + D K + +
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEI-FSGGDKPLSALDSQKKLQF---------YE 219
Query: 736 DRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVV 778
DR + E L N+I C+ EP RPS ++++
Sbjct: 220 DRHQLPAPKWTE-----LANLIN---QCMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 521 KGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEG-EREFRAEMHVIGRTHHKNLVRLIGYC 577
+G+FG VY G KL AVK ++K M+ + + +AE + + +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 578 AEDSKRLLVYEYMSNGSLADILFRGPERSLGW-DER--VRIASDVAKGILYLHDECEAPI 634
+ LV EY+ G + +L G+ DE V+ S+VA + YLH I
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLL-----HIYGYFDEEMAVKYISEVALALDYLH---RHGI 125
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLLM 664
IH D+KP N+L+ K++DFGL+K+ +
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 496 YESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGER 553
YE + +K + +G+G+FG V +++ A+K L K M+ +
Sbjct: 28 YEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDS 87
Query: 554 EFR-AEMHVIGRTHHKNLVRLIGYCAEDSKRL-LVYEYMSNGSLADIL--FRGPERSLGW 609
F E ++ + + +V+L Y +D K L +V EYM G L +++ + PE+ W
Sbjct: 88 AFFWEERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK---W 143
Query: 610 DERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA-KLLMPDQT 668
R A +V + +H IH D+KP N+L+D+ K++DFG K+
Sbjct: 144 -ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198
Query: 669 RTFTLVRGTRGYMAPEWYKNTPISV----KADVFSYGVVLLEIV 708
R T V GT Y++PE K+ + D +S GV L E++
Sbjct: 199 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNLVRLIG 575
+G+G++G V + + VA+KK+ + +R R E+ ++ H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 576 YCAEDSKR-----LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
+ +VYE M L I+ R + +L D + +G+ Y+H
Sbjct: 72 IMPPPHREAFNDVYIVYELMDT-DLHQII-RSSQ-TLSDDHCQYFLYQLLRGLKYIH--- 125
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF-TLVRGTRGYMAPEWYKNT 689
A ++H D+KP N+L++ KI DFGLA+ + F T TR Y APE N
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLNC 183
Query: 690 PISVKA-DVFSYGVVLLEI 707
A DV+S G + E+
Sbjct: 184 SEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-07
Identities = 21/62 (33%), Positives = 31/62 (50%), Gaps = 6/62 (9%)
Query: 178 STGRFRLNMQRDGNLVLYPINTIDDYTEAYWASD-SQRERQLHLYLSNTGNLVLLDDSMG 236
+ + L +Q DGNLVLY D W+S+ S + L + GNLVL D+S
Sbjct: 15 TDSSYTLILQSDGNLVLY-----DGNGRVVWSSNTSGKGSGCVAVLQDDGNLVLYDNSGK 69
Query: 237 II 238
++
Sbjct: 70 VL 71
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRA--EMHVIGRTHHKNLVRLI 574
++LG+GS+ VYKG +LVA+K++ EG F A E ++ H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLH 69
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDER-VRI-ASDVAKGILYLHDECEA 632
LV+EY+ L + G VR+ + +G+ Y H
Sbjct: 70 DIIHTKKTLTLVFEYLDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR--- 122
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAK 661
++H D+KPQN+L+ E K++DFGLA+
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 514 RFKEELGKGSFGAVYKGT-LYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKN 569
+ +E +GKGS+G V + GEK VA+KK+ + V++ R R E+ ++ H +
Sbjct: 3 KIQEVIGKGSYGVVCSAIDTHTGEK-VAIKKINDVFEHVSDATRILR-EIKLLRLLRHPD 60
Query: 570 LVRLIGYCAEDSKR-----LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGIL 624
+V + S+R +V+E M + L ++ L + + + +
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVI--KANDDLTPEHHQFFLYQLLRALK 117
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ-TRTF-TLVRGTRGYMA 682
Y+H A + H D+KP+NIL + KI DFGLA++ D T F T TR Y A
Sbjct: 118 YIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 683 PE-----WYKNTPISVKADVFSYGVVLLEIV 708
PE + K TP D++S G + E++
Sbjct: 175 PELCGSFFSKYTP---AIDIWSIGCIFAEVL 202
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 54/163 (33%), Positives = 80/163 (49%), Gaps = 20/163 (12%)
Query: 619 VAKGILYLHD-ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM--PDQTRTFTLVR 675
VAKG+ +L +C IH D+ +NIL+ E KI DFGLA+ + PD R R
Sbjct: 188 VAKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD-AR 242
Query: 676 GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI 735
+MAPE + ++++DV+S+GV+L EI + P V I+ + C
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-------GASPYPGVKIDEEF-C-- 292
Query: 736 DRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVV 778
R L + R + D T E M + L C EP+ RP+ +V
Sbjct: 293 -RRLKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 69/295 (23%), Positives = 120/295 (40%), Gaps = 62/295 (21%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVA-VKKLEKMVTEGE-----REFRAEMHVIGRTH------ 566
LG+G+ +Y G L ++E E RE R + V+ +H
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 567 ------------HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVR 614
H +L + G C S+ ++V E++ +G L D+ R + + ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAWKIT 121
Query: 615 IASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP-----DQTR 669
+A +A + YL D+ ++H ++ +NIL+ + GLA+ P D
Sbjct: 122 VAQQLASALSYLEDK---NLVHGNVCAKNILL--------ARLGLAEGTSPFIKLSDPGV 170
Query: 670 TFT-LVRGTR----GYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEE 723
+FT L R R ++APE +S AD +S+G LLEI C + + P E
Sbjct: 171 SFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI-CFDGEVPLKERTPSE 229
Query: 724 IVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVV 778
+ F +++ R E L +I C+ EP RPS ++++
Sbjct: 230 -------KERFYEKKH----RLPEPSCKELATLIS---QCLTYEPTQRPSFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 58/230 (25%), Positives = 104/230 (45%), Gaps = 49/230 (21%)
Query: 506 NELKKATNR---FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVI 562
N++ ++ N+ +G GSFG VY+ + VA+KK V + + E+ ++
Sbjct: 58 NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKK----VLQDPQYKNRELLIM 113
Query: 563 GRTHHKNLVRLIGYCAEDSKR----------------LLVYEYM-----SNGSLADILFR 601
+H N++ L Y + + V++YM +N +L L
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL-- 171
Query: 602 GPERSLGWDERVRIAS-DVAKGILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISDFGL 659
V++ S + + + Y+H + I H D+KPQN+L+D T K+ DFG
Sbjct: 172 -----------VKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGS 217
Query: 660 AKLLMPDQTRTFTLVRGTRGYMAPE-WYKNTPISVKADVFSYGVVLLEIV 708
AK L+ Q R+ + + +R Y APE T + D++S G ++ E++
Sbjct: 218 AKNLLAGQ-RSVSYI-CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 41/151 (27%), Positives = 70/151 (46%), Gaps = 14/151 (9%)
Query: 517 EELGKGSFGAVYKGTLYKGEKL--VAVKKLEKMVTEGER-EFRAEMHVIGRTHHKNLVRL 573
+E+G G FG V +Y + V VK+L+ + E+ EF + H N+++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADIL-----FRGPERSLGWDERVRIASDVAKGILYLHD 628
+G C E LLV+EY G L L R + L R+A ++A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEIAAGVTHMH- 116
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGL 659
+ +H D+ +N + T K+ D+G+
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 44/177 (24%), Positives = 76/177 (42%), Gaps = 23/177 (12%)
Query: 547 MVTEGEREFRA-EMHVIGRTHHKNLVRLIGYCAEDSKRLLV--------YEYMSNGSLAD 597
++ G+R A E H++ +H ++++L G + L+ Y Y++
Sbjct: 121 VIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAA----- 175
Query: 598 ILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDF 657
+R++ + + I V + I YLH E IIH DIK +NI ++ + DF
Sbjct: 176 ------KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDF 226
Query: 658 GLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNM 714
G A + + GT APE P D++S G+VL E+ C ++
Sbjct: 227 GAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 14/107 (13%)
Query: 607 LGWDERVRIASDVAKGILYLHDE-CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665
L + + V + VA G+ +L + C +H D+ +N+L+ E KI DFGLA+ +M
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMR 291
Query: 666 DQT-----RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEI 707
D TF ++ +MAPE N + +DV+S+G++L EI
Sbjct: 292 DSNYISKGSTFLPLK----WMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHKNLVRLIGY 576
+G+G+FG V K+ A+K L K M+ + F E I + V + Y
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 577 CAEDSKRL-LVYEYMSNGSLADIL--FRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
+D + L +V EYM G L +++ + PE+ W R + A+ +L L
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---W---ARFYT--AEVVLALDAIHSMG 162
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP--- 690
IH D+KP N+L+D+ K++DFG + + GT Y++PE K+
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 691 -ISVKADVFSYGVVLLEIV 708
+ D +S GV L E++
Sbjct: 223 YYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 522 GSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGERE--FRAEMHVIGRTHHKNLVRLIGYC 577
G++GAVY + + A+KK+ K ++ + + F E ++ + +V + +C
Sbjct: 12 GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSM--FC 68
Query: 578 AEDSKRLL--VYEYMSNGSLADILFR-GPERSLGWD-ERVRIASDVAKGILYLHDECEAP 633
+ ++KR L V EY+ G A +L G L D R+ A V + YLH+
Sbjct: 69 SFETKRHLCMVMEYVEGGDCATLLKNIGA---LPVDMARMYFAETVL-ALEYLHN---YG 121
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKL-LM-----------PDQTRTFT--LVRGTRG 679
I+H D+KP N+L+ K++DFGL+K+ LM TR F V GT
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181
Query: 680 YMAPEWYKNTPISVKADVFSYGVVLLEIV 708
Y+APE D ++ G++L E +
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 37/109 (33%), Positives = 59/109 (54%), Gaps = 12/109 (11%)
Query: 604 ERSLGWDERVRIASDVAKGILYLHDE-CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662
E +L ++ + + VAKG+ +L + C IH D+ +NIL+ KI DFGLA+
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARD 263
Query: 663 LMPDQTRTFTLVRGTR----GYMAPEWYKNTPISVKADVFSYGVVLLEI 707
+ D +V+G +MAPE N + ++DV+SYG++L EI
Sbjct: 264 IRNDSN---YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 40/132 (30%), Positives = 61/132 (46%), Gaps = 16/132 (12%)
Query: 495 AYESNLRSF------SYN---ELKKATNRFKEELGKGSFGAVYKGTLYK-GEK----LVA 540
A E N +F YN E + +F + LG G+FG V + T + G++ VA
Sbjct: 13 AAEGNNYTFIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVA 72
Query: 541 VKKLEKMVTEGERE-FRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADI 598
VK L+ ERE +E+ ++ HKN+V L+G C L++ EY G L +
Sbjct: 73 VKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNF 132
Query: 599 LFRGPERSLGWD 610
L + E L +
Sbjct: 133 LRKKAETFLNFV 144
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 36/127 (28%), Positives = 64/127 (50%), Gaps = 14/127 (11%)
Query: 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE-CEAPIIHCDIKPQNIL 645
Y+ ++ + ++L L + + VA+G+ +L + C +H D+ +N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVL 269
Query: 646 MDEFWTAKISDFGLAKLLMPDQT-----RTFTLVRGTRGYMAPEWYKNTPISVKADVFSY 700
+ + KI DFGLA+ +M D TF V+ +MAPE + + +DV+SY
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK----WMAPESIFDNLYTTLSDVWSY 325
Query: 701 GVVLLEI 707
G++L EI
Sbjct: 326 GILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 50/231 (21%)
Query: 519 LGKGSFGAVY------KGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVR 572
+G+G+FG V G +Y + L LEK E RAE ++ +V+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK---EQVAHIRAERDILVEADGAWVVK 65
Query: 573 LIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
+ Y +D + L L+ E++ G + +L + + +L + ++ I +H +
Sbjct: 66 MF-YSFQDKRNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIH---Q 119
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLL------------------------MPDQ 667
IH DIKP N+L+D K+SDFGL L M +
Sbjct: 120 LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179
Query: 668 TRTFTLVR----------GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+ T + GT Y+APE + T + D +S GV++ E++
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 18/86 (20%)
Query: 153 TDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDS 212
++T+ Q+L++GN LF G F L MQ D NL+LY + W ++
Sbjct: 1 SNTLSSGQTLVSGNSLFE--------LGFFTLIMQNDYNLILY--KSS--SRTVVWVAN- 47
Query: 213 QRERQLH----LYLSNTGNLVLLDDS 234
R+ + L L + GNLVL D
Sbjct: 48 -RDNPVSDSCTLTLQSDGNLVLYDGD 72
|
Length = 114 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 20/151 (13%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGE-REFRAEMHVIGRTHHKNLVRLIG 575
+GKG+FG V K+ A+K L K M + + +AE V+ + +V L
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY- 67
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDV-----AKGILYLHDE 629
Y +D++ L L+ E++ G L +L + +D + DV A+ +L +
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTMLIK-------YDT---FSEDVTRFYMAECVLAIEAV 117
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLA 660
+ IH DIKP NIL+D K+SDFGL+
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 33/95 (34%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEK-----LVAVKKLEKMVTEGERE-FRAEMHVIGRT-H 566
F + LG G+FG V + T Y K VAVK L+ ERE +E+ V+ +
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 97
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFR 601
H N+V L+G C L++ EY G L + L R
Sbjct: 98 HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRR 132
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 3e-05
Identities = 56/259 (21%), Positives = 103/259 (39%), Gaps = 36/259 (13%)
Query: 459 GLVTCSCAFLTFSGVFIFKYQVLKYEWLLENGSLGLAYESNLRSFSYNELKKATNRFKEE 518
G V + A L F+ ++V+ L G+ G + LR EE
Sbjct: 131 GPVPLAQAKLKHDDEFLAHFRVID---DLPAGAFGKIFICALR------------ASTEE 175
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYC- 577
K E+L+A K K + + E+ +GR +H+N++++
Sbjct: 176 AEARRGVNSTNQGKPKCERLIA--KRVKAGSRAAIQLENEILALGRLNHENILKIEEILR 233
Query: 578 AEDSKRLL-------VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
+E + ++ +Y +M + + F +R L R I + + Y+HD+
Sbjct: 234 SEANTYMITQKYDFDLYSFMYDEA-----FDWKDRPLLKQTR-AIMKQLLCAVEYIHDK- 286
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL-MPDQTRTFTLVRGTRGYMAPEWYKNT 689
+IH DIK +NI ++ + DFG A + + V GT +PE
Sbjct: 287 --KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV-GTVATNSPEILAGD 343
Query: 690 PISVKADVFSYGVVLLEIV 708
D++S G++LL+++
Sbjct: 344 GYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 3e-05
Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 41/232 (17%)
Query: 506 NELKKATNRFKEELGKGSFGAVY----KGT----LYKGEKLVAVKKLEKMVTEGEREFRA 557
LK K +L G FG V K T + K K +E MV
Sbjct: 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMV--------- 61
Query: 558 EMHVIGRTHHKNLVRLIGYCAEDSKR--LLVYEYMSNGSLADILFRGPERSLGWDERVRI 615
H + + + N ++L Y + + + +L+ +Y+ +G L D+L + E L E +I
Sbjct: 62 --HQLMK-DNPNFIKL--YYSVTTLKGHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKI 114
Query: 616 ASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF-WTAKISDFGLAKLLMPDQTRTFTLV 674
+ + + LH + IIH DIK +N+L D + D+GL K+ T +
Sbjct: 115 IRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-----IGTPSCY 166
Query: 675 RGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCR------RNMEIDPSK 720
GT Y +PE K V D ++ GV+ E++ + + E+D
Sbjct: 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES 218
|
Length = 267 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 49/175 (28%), Positives = 70/175 (40%), Gaps = 44/175 (25%)
Query: 519 LGKGSFGAVYKGTL-----YKGEKLVAVKKLEKMVTE---GEREFRAEMHVIGRTHHKNL 570
LG+G+FG VYK +L K K V K E E ER RA + + L
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFL 199
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADI--------------------LFRGPERSLGWD 610
+ ++ + LV+ Y +LAD+ L +G ER
Sbjct: 200 EPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLER----- 252
Query: 611 ERVRIASDVAKGILY----LHDECEAPIIHCDIKPQNILMDEF-WTAKISDFGLA 660
+I + + IL+ LH I+H D+KPQNI+ E + KI D G A
Sbjct: 253 -ENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 50/231 (21%)
Query: 519 LGKGSFGAVY------KGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVR 572
+G+G+FG V G +Y + L LEK E RAE ++ +V+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK---EQVGHIRAERDILVEADSLWVVK 65
Query: 573 LIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
+ Y +D L L+ E++ G + +L + + +E + +A+ +L + +
Sbjct: 66 MF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT---EEETQFY--IAETVLAIDSIHQ 119
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLL------------------------MPDQ 667
IH DIKP N+L+D K+SDFGL L M +
Sbjct: 120 LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 668 TRTFTLVR----------GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+ T R GT Y+APE + T + D +S GV++ E++
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 32/91 (35%), Positives = 42/91 (46%), Gaps = 4/91 (4%)
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA-KLLMPDQTRTFTLVRGTRGYMAP 683
YLH IIH D+K +NI +DE A + DFG A KL T GT +P
Sbjct: 200 YLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSP 256
Query: 684 EWYKNTPISVKADVFSYGVVLLEIVCCRRNM 714
E P K D++S G+VL E+ +
Sbjct: 257 ELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 45/148 (30%), Positives = 67/148 (45%), Gaps = 16/148 (10%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREF---RAEMHVIGRTHHKNLVRLIG 575
LG G+FG V L A+K L K + +AE ++ ++ +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY- 67
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRG---PERSLGWDERVRIASDVAKGILYLHDECE 631
Y +D L V +Y+ G + +L R PE R IA ++ I +H +
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL----ARFYIA-ELTLAIESVH---K 119
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGL 659
IH DIKP NIL+D K++DFGL
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 41/145 (28%), Positives = 65/145 (44%), Gaps = 10/145 (6%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK---MVTEGEREFRAEMHVIGRTHHKNLVRLIG 575
LG G+FG V + L A+K L K ++ +AE ++ ++ +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLY- 67
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
Y +D L V +Y+ G + +L R +G +A+ + +
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 635 IHCDIKPQNILMDEFWTAKISDFGL 659
IH DIKP NIL+D K++DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 3e-04
Identities = 12/45 (26%), Positives = 21/45 (46%), Gaps = 2/45 (4%)
Query: 337 CKGINISAEYNMTSMEKMTWDDYYYFKASITKEECKESCLEDCEC 381
C G + + + + D +I+ EEC+E+CL +C C
Sbjct: 5 CGGDGSTDGFLK--LPDVKLPDNASAITAISLEECREACLSNCSC 47
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 9e-04
Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 29/227 (12%)
Query: 518 ELGKGSFGAVYKGTLYKG--EKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL-- 573
++G+G++G VYK G EK A+K++E T E+ ++ H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEG--TGISMSACREIALLRELKHPNVIALQK 65
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERS------LGWDERVRIASDVAKGILYLH 627
+ D K L+++Y + I F ++ L + + GI YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 628 DECEAPIIHCDIKPQNILM----DEFWTAKISDFGLAKLLMPDQTRTFTL--VRGTRGYM 681
++H D+KP NIL+ E KI+D G A+L L V T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 682 APEWYKNTPISVKA-DVFSYGVVLLEIVC------CRRNMEIDPSKP 721
APE KA D+++ G + E++ CR+ +I S P
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-DIKTSNP 228
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.002
Identities = 20/57 (35%), Positives = 27/57 (47%), Gaps = 6/57 (10%)
Query: 183 RLNMQRDGNLVLYPINTIDDYTEAYWASDSQRERQ-LHLYLSNTGNLVLLDDSMGII 238
L +Q DGNLV+Y D W+S++ R L L + GNLVL D +
Sbjct: 58 TLTLQSDGNLVIY-----DGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFL 109
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKL-----VAVKKLEKMVTEGE-REFRAEMHV-IGRTH 566
+ + LG+G+FG V + + +K VAVK L++ T E R +E+ + I H
Sbjct: 10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 69
Query: 567 HKNLVRLIGYCAEDSKRLLV-YEYMSNGSLADIL 599
H N+V L+G C + L+V E+ G+L++ L
Sbjct: 70 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 27/226 (11%)
Query: 518 ELGKGSFGAVYKGTLYKG--EKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL-- 573
++G+G++G VYK G ++ A+K++E T E+ ++ H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEG--TGISMSACREIALLRELKHPNVISLQK 65
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILY-----LHD 628
+ D K L+++Y + I F ++ + V++ + K +LY +H
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN--KKPVQLPRGMVKSLLYQILDGIHY 123
Query: 629 ECEAPIIHCDIKPQNILM----DEFWTAKISDFGLAKLLMPDQTRTFTL--VRGTRGYMA 682
++H D+KP NIL+ E KI+D G A+L L V T Y A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 683 PEWYKNTPISVKA-DVFSYGVVLLEIVC------CRRNMEIDPSKP 721
PE KA D+++ G + E++ CR+ +I S P
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-DIKTSNP 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 0.004
Identities = 25/88 (28%), Positives = 38/88 (43%), Gaps = 21/88 (23%)
Query: 153 TDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQ-RDGNLVLYPINTIDDYTEAY-WAS 210
++ + Q+L++ LF G F+L MQ RD NL+LY + W
Sbjct: 1 SNPLSSGQTLVSSGSLF--------ELGFFKLIMQSRDYNLILY-----KGSSRTVVWV- 46
Query: 211 DSQRERQLH----LYLSNTGNLVLLDDS 234
+ R+ L L + GNLV+ D S
Sbjct: 47 -ANRDNPSGSSCTLTLQSDGNLVIYDGS 73
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 47/228 (20%)
Query: 511 ATNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHK 568
+T RFK LG+G+FG V + K ++ AVK + + V + R+ + E+ + +
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVK-IVRNVPKYTRDAKIEIQFMEKVRQA 185
Query: 569 N------LVRLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRGP--ERSLGWDERVRIASDV 619
+ L+++ Y ++ + + L D I+ GP R L +I
Sbjct: 186 DPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLA-----QIIFQT 240
Query: 620 AKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR---------- 669
+ Y H E ++H D+KP+NILM+ T D + L PD R
Sbjct: 241 GVALDYFHTELH--LMHTDLKPENILMETSDTV--VDPVTNRALPPDPCRVRICDLGGCC 296
Query: 670 ----TFTLVRGTRGYMAPE------WYKNTPISVKADVFSYGVVLLEI 707
+ T + TR Y +PE W +T D++S G ++ E+
Sbjct: 297 DERHSRTAIVSTRHYRSPEVVLGLGWMYST------DMWSMGCIIYEL 338
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 796 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.21 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.06 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.05 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 98.96 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.96 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.9 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.88 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.75 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.71 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.66 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.65 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.63 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.46 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.44 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.44 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.44 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.29 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.2 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.97 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.93 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.93 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.8 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.74 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.72 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.71 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.69 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.56 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.41 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.38 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.3 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.24 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.19 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.11 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.98 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.92 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.81 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.74 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.67 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.58 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.27 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.06 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.05 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.01 | |
| PLN02236 | 344 | choline kinase | 95.9 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.52 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.32 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.23 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.23 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.05 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.89 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.88 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.84 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-53 Score=453.67 Aligned_cols=287 Identities=45% Similarity=0.782 Sum_probs=248.0
Q ss_pred CCcccCHHHHHHHHHhhh--cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhh
Q 003772 499 NLRSFSYNELKKATNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGY 576 (796)
Q Consensus 499 ~~~~~~~~~l~~~~~~~~--~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~ 576 (796)
..+.|+|.++..||++|. +.||+|+||.||+|.+.++ ..||||++.....+..++|.+|+.++.+++|||||+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 578899999999999998 5899999999999999876 7899998876443325669999999999999999999999
Q ss_pred hccCC-ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEe
Q 003772 577 CAEDS-KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKIS 655 (796)
Q Consensus 577 ~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 655 (796)
|.+.+ +++||||||++|+|.++|+......++|..|++||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99999 59999999999999999987543389999999999999999999999998999999999999999999999999
Q ss_pred ccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh
Q 003772 656 DFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI 735 (796)
Q Consensus 656 DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
|||+++..........+...||.+|+|||++..+.+|.|+|||||||+|+||+||+++.+... ......+..|+...+.
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHHH
Confidence 999997654311111111169999999999999999999999999999999999999887654 2223347788888888
Q ss_pred hhhhhhhhcCCCC----CH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 736 DRELNKLVRGQEV----DR-NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 736 ~~~~~~~~~~~~~----~~-~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
++.+.+++++... .. ++..++.+++.+|++.+|.+||+|.+|+++|+.+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 8888888887632 32 6889999999999999999999999999999776654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=391.14 Aligned_cols=255 Identities=35% Similarity=0.530 Sum_probs=211.7
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchh--HHHHHHHHHHHhccCcCchhhhhhhhccCC-ceeEEEeec
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG--EREFRAEMHVIGRTHHKNLVRLIGYCAEDS-KRLLVYEYM 590 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~--~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~e~~ 590 (796)
.+.+.||+|+||+||+|.+... ..||||++....... .+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 3445699999999999999643 349999997633222 568999999999999999999999999988 799999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCC-eeeeccCccceEecCCC-ceEEeccCCccccCCCCc
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP-IIHCDIKPQNILMDEFW-TAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DFgl~~~~~~~~~ 668 (796)
++|+|.++|+......+++..+++++.|||+||.|||++ . ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999875568899999999999999999999998 6 99999999999999997 99999999998765432
Q ss_pred ceeeeeccCCCCCchhhhc--cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 669 RTFTLVRGTRGYMAPEWYK--NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~--~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
..++...||+.|||||++. ...++.|+|||||||+||||+||+.||..... . ... ...... -...
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~---~~~---~~v~~~------~~Rp 265 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V---QVA---SAVVVG------GLRP 265 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H---HHH---HHHHhc------CCCC
Confidence 2333366999999999999 56999999999999999999999999986542 1 111 110000 0112
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
..+..++..+..++.+||+.||..||++.+++.+|+.+..
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 2334477889999999999999999999999999997755
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=385.37 Aligned_cols=261 Identities=29% Similarity=0.437 Sum_probs=220.4
Q ss_pred HHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 507 ~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
++.....++.++||+|-||.||+|.+... ..||||.++.. ....+.|.+|+++|.+|+|+|||+++|+|..+...+||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 34455566789999999999999999654 57999999764 34457789999999999999999999999998899999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
||||+.|+|.++|....+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+||||++....+
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 9999999999999987788999999999999999999999999 9999999999999999999999999999966555
Q ss_pred CcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhc-ccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCC-RRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
.........-+..|.|||.+....++.|||||||||+||||+|. +.|+..... .++.+.++.
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----------------~ev~~~le~ 419 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----------------EEVLELLER 419 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----------------HHHHHHHhc
Confidence 55444444457789999999999999999999999999999994 445443321 111222221
Q ss_pred C---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCC
Q 003772 746 Q---EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISI 789 (796)
Q Consensus 746 ~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 789 (796)
. ..+..+++.+++++..||+.+|++|||++.+...|+.+.....
T Consensus 420 GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 420 GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 1 3467789999999999999999999999999999988765543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=375.45 Aligned_cols=248 Identities=26% Similarity=0.379 Sum_probs=212.3
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
.+|...+.||+|||+.||+++..+.++.||+|++.+.. ....+.+.+|+++.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 34566789999999999999998888999999997632 233456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
|+|++++|..++++ .+.+++..++.+..||+.||.|||+. +|+|||||..|+||+++.++||+|||||..+..+.
T Consensus 98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999985 68999999999999999999999999 99999999999999999999999999999987665
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
...+ ..+|||.|+|||++.....+..+||||+||+||-|+.|++||+...-. ..+..+... .-.
T Consensus 173 Erk~-TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk--------ety~~Ik~~-------~Y~ 236 (592)
T KOG0575|consen 173 ERKK-TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK--------ETYNKIKLN-------EYS 236 (592)
T ss_pred cccc-eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH--------HHHHHHHhc-------Ccc
Confidence 5444 467999999999999999999999999999999999999999865311 111111110 112
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.+........+|+..+|+.||.+|||+++|+.
T Consensus 237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 23355567889999999999999999999984
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=354.60 Aligned_cols=245 Identities=29% Similarity=0.412 Sum_probs=207.0
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCC-ceeEEEeecCCC
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS-KRLLVYEYMSNG 593 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~e~~~~g 593 (796)
.+.||+|..|+|||+.++.+++.+|+|.+..... ...+++.+|++++++.+||+||+++|.|.... ...++||||++|
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 3689999999999999999999999999954333 34578999999999999999999999999888 499999999999
Q ss_pred ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeee
Q 003772 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL 673 (796)
Q Consensus 594 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~ 673 (796)
||++++.. .+++++...-.++.++++||.|||+. ..||||||||+|||++..|.+||+|||.++.+... ....
T Consensus 164 SLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~t 236 (364)
T KOG0581|consen 164 SLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANT 236 (364)
T ss_pred CHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hccc
Confidence 99999976 47899999999999999999999973 49999999999999999999999999999987654 2234
Q ss_pred eccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCc-hhHHHHHHHHHhhhhhhhhhhhcC--CCCCH
Q 003772 674 VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKP-EEIVLINWAYKCFIDRELNKLVRG--QEVDR 750 (796)
Q Consensus 674 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 750 (796)
..||..|||||.+.+..++.++||||||+.++|+++|+-|+....... .-..+ +..++.. ...+.
T Consensus 237 fvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L------------l~~Iv~~ppP~lP~ 304 (364)
T KOG0581|consen 237 FVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL------------LCAIVDEPPPRLPE 304 (364)
T ss_pred ccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH------------HHHHhcCCCCCCCc
Confidence 569999999999999999999999999999999999999987642111 11111 1122221 11222
Q ss_pred -HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 751 -NTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 751 -~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...+++.+++..||++||.+|||..++++
T Consensus 305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 46788999999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=356.46 Aligned_cols=198 Identities=32% Similarity=0.498 Sum_probs=179.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.++||+|.||+||+|++++.+.+||||.+.+. ..+..+.+..|+.+|+.++|+|||++++++..++..+||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 44567799999999999999999999999999775 4455667889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC------CceEEeccCCccccC
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF------WTAKISDFGLAKLLM 664 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DFgl~~~~~ 664 (796)
.+|+|.++|++ .+.+++.....++.|||.||++||++ +||||||||+||||+.. -.+||+|||+|+.+.
T Consensus 92 ~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 92 NGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999987 46899999999999999999999999 99999999999999864 568999999999887
Q ss_pred CCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCC
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEID 717 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~ 717 (796)
... .....+|++-|||||++...+|+.|+|+||+|++|||+++|+.||...
T Consensus 167 ~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 167 PGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred chh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 433 233467999999999999999999999999999999999999999744
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=359.89 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=207.6
Q ss_pred HHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch-------hHHHHHHHHHHHhccCcCchhhhhhhhccCC
Q 003772 509 KKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE-------GEREFRAEMHVIGRTHHKNLVRLIGYCAEDS 581 (796)
Q Consensus 509 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 581 (796)
....+-+.+.||+|+||.|-+|..+..++.||||++++.... ......+|+++|++++|||||++++++.+.+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 445566789999999999999999999999999999763221 1233579999999999999999999999999
Q ss_pred ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC---CceEEeccC
Q 003772 582 KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF---WTAKISDFG 658 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFg 658 (796)
..|+|+||+++|.|.+.+.. .+.+.+..-..++.|++.|+.|||++ +|+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999977 56788888899999999999999999 99999999999999765 789999999
Q ss_pred CccccCCCCcceeeeeccCCCCCchhhhccCC--C-CccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh
Q 003772 659 LAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP--I-SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI 735 (796)
Q Consensus 659 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~-t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
+|+... ....+...+||+.|.|||++.+.. + ..|.|+||+||+||-+++|-.||......+.-... +.
T Consensus 325 lAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ-------I~ 395 (475)
T KOG0615|consen 325 LAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ-------IL 395 (475)
T ss_pred hhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH-------Hh
Confidence 999865 445566778999999999998763 3 34789999999999999999999865433311110 00
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 736 DRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.+. ..-....-.+..++..+++.+||..||++|||..|+++
T Consensus 396 ~G~---y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGR---YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCc---ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 000 00111223456678999999999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=390.20 Aligned_cols=268 Identities=30% Similarity=0.477 Sum_probs=220.1
Q ss_pred HHHHHHHHhhhcccCcccceEEEEEEEcCC-----cEEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhcc
Q 003772 506 NELKKATNRFKEELGKGSFGAVYKGTLYKG-----EKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAE 579 (796)
Q Consensus 506 ~~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~-----~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~ 579 (796)
.++....-.+.++||+|+||.||+|+.... ...||||.++..... ..++|++|++++..++|+|||+++|.|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 344455556778999999999999986432 357999999886666 67899999999999999999999999999
Q ss_pred CCceeEEEeecCCCChhhhhhcC--------CCC----CCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec
Q 003772 580 DSKRLLVYEYMSNGSLADILFRG--------PER----SLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD 647 (796)
Q Consensus 580 ~~~~~lV~e~~~~gsL~~~l~~~--------~~~----~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 647 (796)
++.+++|+|||.+|+|.+||... ... .|+..+.+.||.|||.||.||.++ .+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 99999999999999999999642 112 388899999999999999999998 999999999999999
Q ss_pred CCCceEEeccCCccccCCCCccee-eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHH
Q 003772 648 EFWTAKISDFGLAKLLMPDQTRTF-TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIV 725 (796)
Q Consensus 648 ~~~~~kl~DFgl~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~ 725 (796)
++..+||+||||++..-..+.... ....-..+|||||.+..++||++||||||||+|||++| |+.|+.....+ +
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-E--- 713 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-E--- 713 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-H---
Confidence 999999999999997654433222 23335689999999999999999999999999999998 66666533211 1
Q ss_pred HHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCCC
Q 003772 726 LINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIP 790 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p 790 (796)
+...+..+.+. ..+.+++..+++|+..||+.+|.+||+++||-..|+.....+.+
T Consensus 714 ----VIe~i~~g~lL------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 714 ----VIECIRAGQLL------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred ----HHHHHHcCCcc------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 11222222221 34678899999999999999999999999999999987665543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=336.12 Aligned_cols=260 Identities=24% Similarity=0.385 Sum_probs=210.4
Q ss_pred HHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeec--ccchhHHHHHHHHHHHhccCcCchhhhhh-hhccCCc-ee
Q 003772 509 KKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHKNLVRLIG-YCAEDSK-RL 584 (796)
Q Consensus 509 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~g-~~~~~~~-~~ 584 (796)
..+.+.+.++||+|.||.||++....+++.||.|.++- ...+..+....|+.+|++++|||||++++ -+.++.+ .+
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 34667788999999999999999998999999999863 23344566889999999999999999999 4555555 89
Q ss_pred EEEeecCCCChhhhhhc--CCCCCCchhHHHHHHHHHHHHHHHhhccCC-CCeeeeccCccceEecCCCceEEeccCCcc
Q 003772 585 LVYEYMSNGSLADILFR--GPERSLGWDERVRIASDVAKGILYLHDECE-APIIHCDIKPQNILMDEFWTAKISDFGLAK 661 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~ 661 (796)
|||||+..|+|.+.+++ ...+.+++..+++++.|++.||.++|.+-. .-|+||||||.||+|+.+|.+||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999999974 345789999999999999999999999422 138999999999999999999999999999
Q ss_pred ccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 662 LLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 662 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
.+....... ...+|||.||+||.+....++.||||||+||++|||+..+.||..+. -..+. . .+.+
T Consensus 177 ~l~s~~tfA-~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n----~~~L~----~-----KI~q 242 (375)
T KOG0591|consen 177 FLSSKTTFA-HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN----LLSLC----K-----KIEQ 242 (375)
T ss_pred HhcchhHHH-HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc----HHHHH----H-----HHHc
Confidence 886554433 34569999999999999999999999999999999999999997652 01110 0 1111
Q ss_pred hhcCCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 742 LVRGQEV-DRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 742 ~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
- +-... .......+.+++..|+..||+.||+...+++-+..
T Consensus 243 g-d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 243 G-DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred C-CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1 11112 25677889999999999999999996666655543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=377.92 Aligned_cols=269 Identities=27% Similarity=0.448 Sum_probs=225.3
Q ss_pred CCCcccCHHHHHHHHHhh-----------hcccCcccceEEEEEEEcCCc---EEEEEEEeecccchh-HHHHHHHHHHH
Q 003772 498 SNLRSFSYNELKKATNRF-----------KEELGKGSFGAVYKGTLYKGE---KLVAVKKLEKMVTEG-EREFRAEMHVI 562 (796)
Q Consensus 498 ~~~~~~~~~~l~~~~~~~-----------~~~LG~G~fg~Vy~g~~~~~~---~~vAvK~l~~~~~~~-~~~f~~E~~~l 562 (796)
.-...++|++.-.|-..| .++||.|.||.|++|.++..+ ..||||.++....+. .++|..|+.+|
T Consensus 605 ~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIM 684 (996)
T KOG0196|consen 605 TYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIM 684 (996)
T ss_pred eecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhc
Confidence 345667888776666554 457999999999999997554 479999999866554 46799999999
Q ss_pred hccCcCchhhhhhhhccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCcc
Q 003772 563 GRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQ 642 (796)
Q Consensus 563 ~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~ 642 (796)
.+++||||+++.|+.......+||+|||+||+|+.||..+ .+.+.+.++.-++.+||.||.||.+. ++|||||.++
T Consensus 685 GQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~-DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAAR 760 (996)
T KOG0196|consen 685 GQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN-DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAAR 760 (996)
T ss_pred ccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc-CCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhh
Confidence 9999999999999999999999999999999999999876 46699999999999999999999998 9999999999
Q ss_pred ceEecCCCceEEeccCCccccCCCCcceeeeecc--CCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCC
Q 003772 643 NILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRG--TRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPS 719 (796)
Q Consensus 643 NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~ 719 (796)
|||++.+..+|++|||+++.+..+.....+...| +.+|.|||.+...++|.+||||||||+|||.++ |.+|+=...
T Consensus 761 NILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS- 839 (996)
T KOG0196|consen 761 NILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS- 839 (996)
T ss_pred heeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-
Confidence 9999999999999999999886655444333323 468999999999999999999999999999998 666653222
Q ss_pred CchhHHHHHHHHHhhhhhhhhhhhcC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 720 KPEEIVLINWAYKCFIDRELNKLVRG---QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
..+. .+.++. -..+++++..|.+|++.|||+|..+||.+.+|+.+|++++.-
T Consensus 840 NQdV----------------IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 840 NQDV----------------IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred hHHH----------------HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 1111 111111 135789999999999999999999999999999999997653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=334.12 Aligned_cols=242 Identities=27% Similarity=0.354 Sum_probs=203.1
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
....+.+.||+|+||.||+++.++.++.+|+|++++.. ....+..++|..+|.+++||+||+++-.+.+.++.|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 34456789999999999999999999999999997732 234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+.||.|..+|.+ ++.+++..+..++.+|+.||.|||++ +||||||||+|||||++|.++|+|||+++......
T Consensus 105 d~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 105 DYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred eccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 99999999999987 67899999999999999999999999 99999999999999999999999999999654433
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
. .....+||+.|||||++....++..+|.||+|+++|||++|.+||....... .++.+..+. ...
T Consensus 180 ~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~--------~~~~I~~~k------~~~ 244 (357)
T KOG0598|consen 180 D-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK--------MYDKILKGK------LPL 244 (357)
T ss_pred C-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH--------HHHHHhcCc------CCC
Confidence 2 2233679999999999999999999999999999999999999997543111 111111111 011
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCC
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRP 772 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RP 772 (796)
.+........+++...|+.||+.|-
T Consensus 245 ~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCccCCHHHHHHHHHHhccCHHHhc
Confidence 2223456788999999999999995
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=352.24 Aligned_cols=261 Identities=27% Similarity=0.440 Sum_probs=209.5
Q ss_pred HHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 508 LKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 508 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
+......+.+.||+|.||+||+|.+.+ .||||+++-. ..+..+.|++|+..+++-+|.||+-+.|+|..... .|
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 333444567899999999999999964 4999999653 34456789999999999999999999999998777 99
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
|+.+|++.+|..+|+.. +..++....+.||.|||+||.|||.+ +|||||||..||||.+++.+||+|||++..-..
T Consensus 465 iTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred eehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 99999999999999864 46799999999999999999999999 999999999999999999999999999975432
Q ss_pred C-CcceeeeeccCCCCCchhhhccC---CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 666 D-QTRTFTLVRGTRGYMAPEWYKNT---PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 666 ~-~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
- .........|...|||||++... +|++++||||||+++|||++|..|+.... . +.+.+.. .+.+..
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-~-dqIifmV--GrG~l~----- 611 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-R-DQIIFMV--GRGYLM----- 611 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-h-hheEEEe--cccccC-----
Confidence 2 11222233477899999999654 89999999999999999999999998322 1 1111100 000000
Q ss_pred hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 742 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.+......+++..|.+|+..||..++++||++.+|+.+|+.+..
T Consensus 612 -pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 -PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11112344677889999999999999999999999999988776
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=332.24 Aligned_cols=268 Identities=28% Similarity=0.415 Sum_probs=203.6
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhc--cCcCchhhhhhhhccCC----ceeEEE
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGR--THHKNLVRLIGYCAEDS----KRLLVY 587 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~lV~ 587 (796)
.+.+.||+|+||.||||.+.+ +.||||++. .+..+.|++|-.+... ++|+||+++++.-..+. +.+||+
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~--~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDN--RLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhHHHhhcCccceeehhhccC--ceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 355789999999999999954 789999985 4556678888776664 58999999999887655 789999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccC------CCCeeeeccCccceEecCCCceEEeccCCcc
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC------EAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~ 661 (796)
||.++|+|.++|.. ..++|....+++..+++||+|||+.. +++|+|||||++||||.+|+++.|+|||+|.
T Consensus 288 ~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999999975 68999999999999999999999764 5789999999999999999999999999999
Q ss_pred ccCCCCcceee-eeccCCCCCchhhhccC-CCC-----ccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh
Q 003772 662 LLMPDQTRTFT-LVRGTRGYMAPEWYKNT-PIS-----VKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF 734 (796)
Q Consensus 662 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~~-~~t-----~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 734 (796)
++.++...... ..+||.+|||||++++. .+. .+.||||+|.+||||++.-.-+......+-..-+........
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 98766543322 36799999999999875 232 468999999999999997655432111111000000000011
Q ss_pred hhhhhhhhhcCC---------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCC
Q 003772 735 IDRELNKLVRGQ---------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISI 789 (796)
Q Consensus 735 ~~~~~~~~~~~~---------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 789 (796)
.-++++.++..+ ......+..+.+.+..||..||+-|-|+.=|.+.+.++..+..
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 111112111111 1122556788999999999999999999999988888766653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.91 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=205.1
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCC--ceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS--KRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~e~~ 590 (796)
....+.||+|.||.||++...+.++..|||..........+.+.+|+.+|.+++|||||+++|...... ..++.|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 345688999999999999998878899999987653333667899999999999999999999855444 689999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-CCceEEeccCCccccCC--CC
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE-FWTAKISDFGLAKLLMP--DQ 667 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgl~~~~~~--~~ 667 (796)
++|+|.+++.+... .+++..+..+..||++||.|||++ +|+||||||+|||++. ++.+||+|||+++.... ..
T Consensus 99 ~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred CCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999999987544 899999999999999999999998 9999999999999999 79999999999987763 22
Q ss_pred cceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
........||+.|||||++.++ ....++|||||||++.||+||++|+... ..... +........ ...
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~-----~~~~ig~~~------~~P 242 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAE-----ALLLIGRED------SLP 242 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHH-----HHHHHhccC------CCC
Confidence 2334456799999999999964 3446999999999999999999998753 11111 111111111 011
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLML 781 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 781 (796)
..+.....+..+++..|++.+|+.|||++++++..
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 34455667899999999999999999999999765
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=370.22 Aligned_cols=263 Identities=29% Similarity=0.448 Sum_probs=212.5
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCc-----EEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCcee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGE-----KLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~-----~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 584 (796)
..-.+.+.||+|+||.||.|...+.. ..||||.+.+... +...+|.+|..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 33345678999999999999876443 3599999987544 45678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCC-----CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCC
Q 003772 585 LVYEYMSNGSLADILFRGP-----ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGL 659 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl 659 (796)
|++|||++|+|..+|.+.+ ...+.....+.++.|||+|+.||+++ ++|||||..+|+||+....+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999998642 35688999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccee-eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcc-cCCCCCCCCchhHHHHHHHHHhhhhh
Q 003772 660 AKLLMPDQTRTF-TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCR-RNMEIDPSKPEEIVLINWAYKCFIDR 737 (796)
Q Consensus 660 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
|+.+...+.... ....-...|||||.+....+|.|+|||||||+|||++|.. .|+.... .. ++. ..+..+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~-n~-~v~------~~~~~g 920 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS-NF-EVL------LDVLEG 920 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc-hH-HHH------HHHHhC
Confidence 995544332222 2223457899999999999999999999999999999955 4543222 11 111 101111
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCCC
Q 003772 738 ELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIP 790 (796)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p 790 (796)
- .-..+..+++.+++|+..||+.+|++||++..|++.++.+.....+
T Consensus 921 g------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 921 G------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred C------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 1 1134678899999999999999999999999999999887665433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=335.53 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=208.6
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhH-HHHHHHHHHHhccC-cCchhhhhhhhccCC-ceeEEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-REFRAEMHVIGRTH-HKNLVRLIGYCAEDS-KRLLVY 587 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~-~~f~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~lV~ 587 (796)
.+|...++||.|.||.||+|+-...++.||||++++.....+ ..-.+|++.|.+++ ||||+++.+++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 457778999999999999999998889999999977544433 33578999999998 999999999999988 899999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
|||+. +|.++++++ +..+++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||....
T Consensus 90 E~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S-- 162 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS-- 162 (538)
T ss_pred Hhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc--
Confidence 99985 899999876 78999999999999999999999998 999999999999999999999999999997754
Q ss_pred cceeeeeccCCCCCchhhhc-cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHH-----hhhh-hhhh
Q 003772 668 TRTFTLVRGTRGYMAPEWYK-NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYK-----CFID-RELN 740 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~~~-~~~~ 740 (796)
....+..+.|..|+|||++. .+-|+.+.|+||+|||++|+.+.++.|....+.+ .+..+-.... .+.+ ..+.
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-qi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-QIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH-HHHHHHHHhCCCccccchhHHHHH
Confidence 33455667899999999875 5578999999999999999999998887543221 1111100000 0000 0011
Q ss_pred hhhcCC----------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 741 KLVRGQ----------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 741 ~~~~~~----------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
..+.-+ ..-+....+..+++..|++.||.+|||+++.+++
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111000 0112367889999999999999999999999865
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=340.17 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=210.5
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 586 (796)
..+.|++.||+|.|++|++++..+.++++|||++++.. ....+.+..|-..|.+| .||.|++++-.|.++..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 34568899999999999999999999999999997732 22344577899999999 899999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
+||+++|+|.++|.+ .+.+++...+.++.+|+.||+|||+. +||||||||+|||||.|+++||+|||.++.+.+.
T Consensus 153 Le~A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEecCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999999987 58899999999999999999999998 9999999999999999999999999999998643
Q ss_pred Ccc----------ee--eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh
Q 003772 667 QTR----------TF--TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF 734 (796)
Q Consensus 667 ~~~----------~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 734 (796)
... .. ...+||..|++||++.....++.+|+|+|||+||+|+.|++||....+ .. ..
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne----yl----iF--- 296 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE----YL----IF--- 296 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----HH----HH---
Confidence 221 11 346799999999999999999999999999999999999999975431 11 11
Q ss_pred hhhhhhhhhcC-CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 735 IDRELNKLVRG-QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 735 ~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
++++.- -.+++..++.+.+|+...|..||.+|+|..+|.+.
T Consensus 297 -----qkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 297 -----QKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -----HHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 111111 13344555778899999999999999999988753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=311.33 Aligned_cols=257 Identities=24% Similarity=0.309 Sum_probs=202.3
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
..++|+|+||+|||.+.++.++.||||++..... ...+--++|+++|++++|+|+|.++.+|......+||+||++.-
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT 86 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT 86 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH
Confidence 4579999999999999999999999999965322 22344688999999999999999999999999999999999984
Q ss_pred ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeee
Q 003772 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL 673 (796)
Q Consensus 594 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~ 673 (796)
+.+.|.+. -..++.+.+.+++.|+++|+.|+|++ ++|||||||+||||+.++.+||+|||+|+.+.. .....+.
T Consensus 87 -vL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTD 160 (396)
T KOG0593|consen 87 -VLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTD 160 (396)
T ss_pred -HHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhhh
Confidence 44445443 35688899999999999999999999 999999999999999999999999999998864 3345566
Q ss_pred eccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc--------
Q 003772 674 VRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR-------- 744 (796)
Q Consensus 674 ~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 744 (796)
.+.|..|+|||.+.+ .+|....||||+||++.||++|.+.|....+-+. ...+......+.+....-.-.
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ-Ly~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ-LYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH-HHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 778999999999988 5899999999999999999999988865443222 222222222222111110000
Q ss_pred -CCC--------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 745 -GQE--------VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 745 -~~~--------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
+.. .-+.....+++++..|++.||++|++-++++.
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 000 12234457899999999999999999999873
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.30 Aligned_cols=245 Identities=24% Similarity=0.360 Sum_probs=209.0
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
-++||+|+.|.||.+.....++.||||++........+.+.+|+.+|+..+|+|||+++..+..+++.++|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 36899999999999999888899999999886666677889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeec
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR 675 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~ 675 (796)
.|.+.+ ..+++.++..|+.++++||+|||.+ +|+|||||.+|||++.++.+||+|||++..+........ ...
T Consensus 358 TDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~-TmV 430 (550)
T KOG0578|consen 358 TDVVTK---TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS-TMV 430 (550)
T ss_pred hhhhhc---ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc-ccc
Confidence 999965 4599999999999999999999999 999999999999999999999999999998876665433 356
Q ss_pred cCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 003772 676 GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLEN 755 (796)
Q Consensus 676 gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (796)
||+.|||||++....|.+|.||||||++++||+-|.+|+-..........+ ..... .++ .........
T Consensus 431 GTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI-----a~ng~---P~l----k~~~klS~~ 498 (550)
T KOG0578|consen 431 GTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-----ATNGT---PKL----KNPEKLSPE 498 (550)
T ss_pred CCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH-----hhcCC---CCc----CCccccCHH
Confidence 999999999999999999999999999999999999999764321111100 00000 000 123345577
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHH
Q 003772 756 MIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 756 l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
+.+++.+||+.|+..||+++|+++
T Consensus 499 ~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 499 LKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHHHHHhhcchhcCCCHHHHhc
Confidence 999999999999999999999986
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.90 Aligned_cols=269 Identities=27% Similarity=0.397 Sum_probs=215.6
Q ss_pred HHHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhH-HHHHHHHHHHhccCcCchhhhhhhhccCCcee
Q 003772 506 NELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-REFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 506 ~~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~-~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 584 (796)
.|..+..-.|.++||+|-||.|.+.+... ...||||+++....... ++|..|+++|.+++||||++++|+|..++..+
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 44555556688999999999999999864 58999999987655544 78999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+|+|||++|+|.++|.+..-..+......+|+.|||.||+||.+. ++|||||.++|+|+|.++++||+|||+++-+-
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999999876444456677788999999999999998 99999999999999999999999999999765
Q ss_pred CCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhc--ccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 665 PDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCC--RRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 665 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
.+.. +......-+.+|||||.+..+++|+++|||+||+++||+++. .+|+.....+ ...+.+...+..+....
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e----~vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE----QVVENAGEFFRDQGRQV 764 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH----HHHHhhhhhcCCCCcce
Confidence 5443 333334467899999999999999999999999999999863 4565432211 11111111111111111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 742 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
.+ ..++-++..+++++.+||+.+-.+|||+++|...|+...
T Consensus 765 ~l---~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 765 VL---SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ec---cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 11 235677888999999999999999999999999987643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=347.26 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=204.1
Q ss_pred HHHHhhhcccCcccceEEEEEEEc-----CCcEEEEEEEeecccc-hhHHHHHHHHHHHhcc-CcCchhhhhhhhccCC-
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDS- 581 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~- 581 (796)
...+++.++||+|+||.||+|.+. ..++.||||++..... ...+.+.+|+.++.++ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 345677889999999999999752 2335799999975432 3346789999999999 8999999999887644
Q ss_pred ceeEEEeecCCCChhhhhhcCC----------------------------------------------------------
Q 003772 582 KRLLVYEYMSNGSLADILFRGP---------------------------------------------------------- 603 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 603 (796)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999999986421
Q ss_pred --CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc-eeeeeccCCCC
Q 003772 604 --ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR-TFTLVRGTRGY 680 (796)
Q Consensus 604 --~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y 680 (796)
...+++..+..++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++........ ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 13477888999999999999999998 9999999999999999999999999999865433221 11223456789
Q ss_pred CchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHH
Q 003772 681 MAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKI 759 (796)
Q Consensus 681 ~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 759 (796)
+|||++.+..++.++|||||||+||||++ |+.||........ . ......+.. ...+....+.+.++
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~------~~~~~~~~~------~~~~~~~~~~l~~l 309 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-F------CQRLKDGTR------MRAPENATPEIYRI 309 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-H------HHHHhcCCC------CCCCCCCCHHHHHH
Confidence 99999999999999999999999999997 8888865432211 0 011111100 11123445678999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 760 GLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 760 ~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
+.+||+.||.+|||+.||+++|+.+.+
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.13 Aligned_cols=244 Identities=27% Similarity=0.426 Sum_probs=211.3
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
|.+.+.||+|.||.||||+.+...+.||+|.+.+.. .++.+.+++|++++++++||||+.+++.++...+.++|.||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 456688999999999999999999999999997633 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
.+ +|..+|.. .+.++++.+..++.+++.||.|||+. +|+|||+||+|||++..+.+|++|||+++-+.. ....
T Consensus 84 ~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~v 156 (808)
T KOG0597|consen 84 VG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSV 156 (808)
T ss_pred hh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Ccee
Confidence 87 99999977 68899999999999999999999999 999999999999999999999999999997654 4456
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh-cCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV-RGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 749 (796)
.+.+.|||-|||||.+.+.+++..+|.||+||++||+.+|++||.... +. ..+..+. ++...+
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----i~-----------~Lv~~I~~d~v~~p 220 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----IT-----------QLVKSILKDPVKPP 220 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----HH-----------HHHHHHhcCCCCCc
Confidence 667889999999999999999999999999999999999999996431 00 0111111 122234
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.+....+..++...|++||..|.|..+++.
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 566778999999999999999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=326.91 Aligned_cols=261 Identities=25% Similarity=0.346 Sum_probs=208.9
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
..|.+.++||.|..++||+|.....++.||||++.-... ...+.++.|+..+..++||||++++..|..+...++||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 346778999999999999999988889999999964332 2358899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
|.+||+.++++..-...+++..+..|..++++||.|||++ +.||||||+.||||+++|.+||+|||.+-.+.....+
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 9999999999876666799999999999999999999999 9999999999999999999999999988766554433
Q ss_pred ee---eeeccCCCCCchhhhccC--CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 670 TF---TLVRGTRGYMAPEWYKNT--PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 670 ~~---~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
.. ....||+.|||||++... .|+.|+||||||++..||.+|..||...+.. .+.+... +.-.+ .+.....
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvLl~tL--qn~pp-~~~t~~~ 257 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KVLLLTL--QNDPP-TLLTSGL 257 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HHHHHHh--cCCCC-CcccccC
Confidence 22 335799999999996443 6899999999999999999999999755421 1111110 00000 0000001
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...........+.+++..||+.||++|||+++++.
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11112333457889999999999999999999974
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=348.97 Aligned_cols=259 Identities=30% Similarity=0.402 Sum_probs=209.4
Q ss_pred hhhcccCcccceEEEEEEEcCCcE---E-EEEEEeec---ccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEK---L-VAVKKLEK---MVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~---~-vAvK~l~~---~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
.+.++||+|+||.||+|++...+. . ||||..+. ......++|.+|++++++++|+|||+++|++..+..+++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 345899999999999999875422 3 89999874 3456678999999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
||+|.||+|.++|.+. .+.++..+++.++.+.|.||+|||++ +++||||..+|+|++.++.+||+|||+++....-
T Consensus 240 mEl~~gGsL~~~L~k~-~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKN-KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred EEecCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 9999999999999875 33799999999999999999999999 9999999999999999999999999998764311
Q ss_pred CcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
.. ......-+..|+|||.+....+++++|||||||++||+.+ |..|+..... .....+.. ..- -+
T Consensus 316 ~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~----~~v~~kI~--------~~~-~r 381 (474)
T KOG0194|consen 316 VM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN----YEVKAKIV--------KNG-YR 381 (474)
T ss_pred ee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH----HHHHHHHH--------hcC-cc
Confidence 11 1111235679999999999999999999999999999998 6777754321 11111110 000 01
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCCC
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIP 790 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p 790 (796)
...+...+..+..++..||..+|++||||.++.+.|+.+.....+
T Consensus 382 ~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 382 MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 123345667788888899999999999999999999988776554
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.24 Aligned_cols=263 Identities=23% Similarity=0.313 Sum_probs=207.2
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccC--CceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAED--SKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 587 (796)
.+...++||+|.||.||+++....++.||+|++.... .+......+||.+|++|+||||+++.+...+. ...|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 3444578999999999999999999999999987544 23345567899999999999999999998876 6899999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
|||++ +|..++.. ..-.++..++..++.|++.||.|+|+. +|+|||||.+|||||++|.+||+|||||+++....
T Consensus 198 eYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred ecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 99998 78887754 356899999999999999999999999 99999999999999999999999999999988888
Q ss_pred cceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHH----------HHHHHHhhhh
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVL----------INWAYKCFID 736 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~----------~~~~~~~~~~ 736 (796)
...++..+-|.-|+|||.+.+. .|++.+|+||.||||.||+.|+..+....+-+ .... ..|....+..
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHhCCCChhccccccCCc
Confidence 7778888889999999999876 79999999999999999999998876432211 1110 0111001100
Q ss_pred hhhhhhhcC-C----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 737 RELNKLVRG-Q----EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 737 ~~~~~~~~~-~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
-........ . +.-.......++|+..+|..||.+|.|+.++++.
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 000000000 0 0011234567888889999999999999998853
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.52 Aligned_cols=259 Identities=26% Similarity=0.386 Sum_probs=219.6
Q ss_pred HHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 508 LKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 508 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
+++....++++||-|-||.||.|.++...-.||||.++.. ....++|..|+.+++.++|||+|+++|+|..+...|||+
T Consensus 264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence 3333344678999999999999999999899999999874 345788999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
|||..|+|.++|.+-++..++.-..+.++.||+.||.||..+ ++|||||..+|+|+.++..+||+|||+++++..+.
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 999999999999988788888899999999999999999998 99999999999999999999999999999987665
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcc-cCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC-
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCR-RNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG- 745 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 745 (796)
........-...|.|||-+....++.|+|||+|||+||||.|.. .|+..- .+. .+..+++.
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-------dlS----------qVY~LLEkg 482 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-------DLS----------QVYGLLEKG 482 (1157)
T ss_pred eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-------cHH----------HHHHHHhcc
Confidence 54444444567899999999999999999999999999999854 444321 111 11122221
Q ss_pred --CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 746 --QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 746 --~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
..-+..|++.+++|++.||+.+|.+||++.|+-+.+|.+...
T Consensus 483 yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 483 YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 123567889999999999999999999999999999886543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=299.83 Aligned_cols=261 Identities=22% Similarity=0.265 Sum_probs=204.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
|.-.++||+|.||.||+|.+...++.||||+++.... .......+|++.|+.++|+||+.+++++...+..-||+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 3445789999999999999999999999999975322 22455788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
+. +|+..++. +...+....+..++.++++||+|||.+ .|+||||||.|+|+++++.+||+|||+++.+.+.....
T Consensus 84 ~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 84 PT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred cc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 85 78888865 367899999999999999999999999 99999999999999999999999999999987655444
Q ss_pred eeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc---C-
Q 003772 671 FTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR---G- 745 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~- 745 (796)
... +-|.-|+|||.+.+. .|+...|+||.|||+.||+-+.+-|.. ..+.+.....-.+.....++.+.++.. .
T Consensus 159 ~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG-~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 159 THQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG-DSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC-CchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 333 568999999999876 789999999999999999976654433 222222222211211111111111110 0
Q ss_pred ------C----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 746 ------Q----EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 746 ------~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
. ..-..+.....+++..++..||.+|.|.+|.+++
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 0122344567999999999999999999999876
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.80 Aligned_cols=262 Identities=20% Similarity=0.321 Sum_probs=206.1
Q ss_pred CCcccCHHHHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchh---HHHHHHHHHHHhccCcCchhhhhh
Q 003772 499 NLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG---EREFRAEMHVIGRTHHKNLVRLIG 575 (796)
Q Consensus 499 ~~~~~~~~~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~---~~~f~~E~~~l~~l~h~niv~l~g 575 (796)
+++.++.+++...+ ...||+|+++.||+|.. +++.||||++++..... .+.|.+|+.++.+++||||++++|
T Consensus 11 ~~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 11 DIKCIESDDIDKYT---SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred cceecCHHHcCCCC---CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 34555666662221 14699999999999998 46799999997643332 467889999999999999999999
Q ss_pred hhcc----CCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc
Q 003772 576 YCAE----DSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT 651 (796)
Q Consensus 576 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 651 (796)
++.+ ....++||||+++|+|.+++.. .+.+++...+.++.|++.||.|||+. .+++||||||+||++++++.
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYK 161 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCc
Confidence 9876 3467899999999999999976 45789999999999999999999974 27889999999999999999
Q ss_pred eEEeccCCccccCCCCcceeeeeccCCCCCchhhhcc--CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH
Q 003772 652 AKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN--TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW 729 (796)
Q Consensus 652 ~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 729 (796)
+||+|||+++.+.... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ....
T Consensus 162 ~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--~~~~---- 231 (283)
T PHA02988 162 LKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--KEIY---- 231 (283)
T ss_pred EEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--HHHH----
Confidence 9999999998654322 12347889999999976 6899999999999999999999999974421 1110
Q ss_pred HHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 730 AYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
....... .....+...+..+.+++..||+.||++|||+.||++.|+.+..
T Consensus 232 --~~i~~~~-----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 232 --DLIINKN-----NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred --HHHHhcC-----CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0000000 0011223456789999999999999999999999999987643
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=328.14 Aligned_cols=257 Identities=26% Similarity=0.365 Sum_probs=206.0
Q ss_pred HHHHhhhcccCcccceEEEEEEEc---CCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
...+.+.+.||+|+||.||+|.+. ..+..||+|+++.... ...+.|.+|+..+.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 445677889999999999999875 3456899999876433 334678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 84 VTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999999763 35789999999999999999999998 999999999999999999999999998765432
Q ss_pred CCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
..........++..|+|||.+.+..++.++|||||||++||+++ |+.||...... . . .+..... .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~--~----~~~~~~~-----~- 225 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--D--V----IKAVEDG-----F- 225 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--H--H----HHHHHCC-----C-
Confidence 22111112235678999999999999999999999999999775 89888643211 1 0 0000000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
....+..++..+.+++..||+.+|.+||++.+|++.|+++
T Consensus 226 ~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0122344567899999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=301.99 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=214.5
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCC-----ceeE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS-----KRLL 585 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l 585 (796)
.++++.+.||+|||+.||+++....++.+|+|++.....++.+..++|++..++++|||++++++++..+. ..||
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 45778899999999999999988888899999998877788888999999999999999999999987544 4899
Q ss_pred EEeecCCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 586 VYEYMSNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
+++|...|||.+.+... .+..+++.+++.|+.+|++||++||+. .++++||||||.|||+.+.+.++|.|||.+...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 99999999999998753 345799999999999999999999997 456999999999999999999999999999865
Q ss_pred CCCC--------cceeeeeccCCCCCchhhhc---cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHH
Q 003772 664 MPDQ--------TRTFTLVRGTRGYMAPEWYK---NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYK 732 (796)
Q Consensus 664 ~~~~--------~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 732 (796)
.-.- .........|..|+|||.+. +..+++++|||||||+||+|+.|..||+.......+..++...
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n-- 257 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN-- 257 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec--
Confidence 3211 11222344788999999985 4578999999999999999999999998654433333221100
Q ss_pred hhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 733 CFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
. +...+ ......+.+.+++.+|+|.||..||+..+++..++.+.
T Consensus 258 ----~---q~s~P--~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 258 ----A---QISIP--NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----c---ccccC--CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0 00000 11125678999999999999999999999999998764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=329.30 Aligned_cols=250 Identities=25% Similarity=0.314 Sum_probs=203.4
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+..+.||+|+||.||++....+++.||+|++.+.. ......+.+|+.++.+++|+||+++++++.+++..++|+||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 45678999999999999998888999999986532 223456789999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|+|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++....... .
T Consensus 83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05631 83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--T 157 (285)
T ss_pred CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--e
Confidence 999999988765455789999999999999999999998 99999999999999999999999999998754322 2
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
.....||..|+|||++.+..++.++|||||||++|||++|+.||............ ... +.. .....+.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~----~~~-----~~~--~~~~~~~ 226 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV----DRR-----VKE--DQEEYSE 226 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH----HHH-----hhc--ccccCCc
Confidence 23345899999999999999999999999999999999999999754332111000 000 000 0011223
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPS-----MKSVVL 779 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 779 (796)
.....+.+++..||+.||.+||+ ++++++
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 34567889999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.17 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=208.9
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
...+.+.||+|+||.||+|...+.++.||+|++... ....+++.+|+.++.+++|+||+++++++..++..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 345678899999999999999888889999998753 3345678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+++|.+++.......+++..++.++.|+++||.|||+. +++|+||||+||++++++.+||+|||++...........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 99999999765556789999999999999999999998 999999999999999999999999999987654332222
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
....++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ... .... .... ....+.
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~------~~~~-----~~~~-~~~~~~ 228 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQV------YELL-----EKGY-RMERPE 228 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHH------HHHH-----HCCC-CCCCCC
Confidence 22234668999999999999999999999999999998 8888754321 110 0100 0000 112233
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
..+..+.+++.+||+.+|++|||+.+++++|+.+
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 4457799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.48 Aligned_cols=250 Identities=31% Similarity=0.518 Sum_probs=196.7
Q ss_pred hhcccCcccceEEEEEEEc----CCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 515 FKEELGKGSFGAVYKGTLY----KGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~----~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.||.|.||.||+|.+. ..+..|+||+++.... +..+.|.+|++.+.+++||||++++|++.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999997 3457899999965333 3468899999999999999999999999988889999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc-
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT- 668 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~- 668 (796)
+++|+|.++|.......+++..++.++.||++||.|||+. +++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999886567899999999999999999999998 999999999999999999999999999987733222
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
...........|+|||.+....++.++||||||+++|||++ |+.|+.... .... .....+... ..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--~~~~------~~~~~~~~~------~~ 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--NEEI------IEKLKQGQR------LP 225 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--HHHH------HHHHHTTEE------TT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc--cccc------ccccccccc------ce
Confidence 22222346778999999999999999999999999999999 667764331 1110 011111100 11
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLML 781 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 781 (796)
.+...+..+.+++..||+.+|.+||||.+|++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2334567799999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=334.47 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=209.1
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc----cc-hhHHHHHHHHHHHhccC-cCchhhhhhhhccCCce
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM----VT-EGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~----~~-~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 583 (796)
...+.+.+.||+|.||.|+.|.....++.||||++++. .. ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 34566788999999999999999888899999977653 11 34556778999999999 99999999999999999
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC-CceEEeccCCccc
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF-WTAKISDFGLAKL 662 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFgl~~~ 662 (796)
++||||+.+|+|.+++.+ .+++.+.....++.|++.|++|+|+. +|+||||||+|||++.+ +++||+|||++..
T Consensus 96 ~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 999999999999999987 67888999999999999999999998 99999999999999999 9999999999998
Q ss_pred cCCCCcceeeeeccCCCCCchhhhccCC-CC-ccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh
Q 003772 663 LMPDQTRTFTLVRGTRGYMAPEWYKNTP-IS-VKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740 (796)
Q Consensus 663 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
.. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..... . .+..
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~-----l~~k------- 234 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---N-----LYRK------- 234 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---H-----HHHH-------
Confidence 74 2223344567999999999999987 75 7899999999999999999999862210 0 0111
Q ss_pred hhhcCC-CCCHHH-HHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 741 KLVRGQ-EVDRNT-LENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 741 ~~~~~~-~~~~~~-~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
+.... .++... ...+..++.+|++.||..|+|+.+|+ .-.-+.
T Consensus 235 -i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 235 -IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred -HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 11111 112222 67789999999999999999999999 444444
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=330.19 Aligned_cols=264 Identities=26% Similarity=0.378 Sum_probs=202.0
Q ss_pred HHHHhhhcccCcccceEEEEEEEcC----------------CcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhh
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYK----------------GEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVR 572 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~----------------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~ 572 (796)
...+.+.++||+|+||.||++.+.. .+..||+|.+.... .....+|.+|+.++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3455677899999999999998643 23479999987643 334567999999999999999999
Q ss_pred hhhhhccCCceeEEEeecCCCChhhhhhcCC-----------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCee
Q 003772 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGP-----------------ERSLGWDERVRIASDVAKGILYLHDECEAPII 635 (796)
Q Consensus 573 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iv 635 (796)
+++++.+.+..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 9999999999999999999999999985421 13478889999999999999999998 999
Q ss_pred eeccCccceEecCCCceEEeccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcc--c
Q 003772 636 HCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCR--R 712 (796)
Q Consensus 636 H~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~--~ 712 (796)
||||||+|||+++++.+||+|||+++.+...... ......++..|+|||++....++.++||||||+++|||+++. .
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999866443321 122234578899999999889999999999999999999754 4
Q ss_pred CCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 713 NMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 713 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
|+.... .... .......... ...... ...++.++..+.+++.+||+.+|.+|||+.+|++.|+.
T Consensus 241 p~~~~~--~~~~--~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELT--DEQV--IENAGEFFRD-QGRQVY--LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCC--HHHH--HHHHHHHhhh-cccccc--ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 554321 1111 1111111100 000000 01123456779999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=376.76 Aligned_cols=267 Identities=25% Similarity=0.514 Sum_probs=209.6
Q ss_pred cCHHHHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCc
Q 003772 503 FSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSK 582 (796)
Q Consensus 503 ~~~~~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 582 (796)
+++.++... ....+.||+|+||.||+|+....+..||||+++..... ...|++.+++++||||++++|+|.+++.
T Consensus 683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 683 ITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 445555433 23446799999999999999878889999998653321 2346888999999999999999999999
Q ss_pred eeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 583 RLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
.++||||+++|+|.++++ .++|..+.+++.|+|+||+|||+.+..+|+||||||+||+++.++.+++. |+....
T Consensus 758 ~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 999999999999999995 38999999999999999999997767799999999999999999888876 665543
Q ss_pred cCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 663 LMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 663 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
.... ....+++.|||||++.+..++.|+|||||||++|||++|+.|++...... .....|+............
T Consensus 832 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 904 (968)
T PLN00113 832 LCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH--GSIVEWARYCYSDCHLDMW 904 (968)
T ss_pred cccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC--CcHHHHHHHhcCccchhhe
Confidence 3221 12247899999999999999999999999999999999999986433222 2233343333222222222
Q ss_pred hcC-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 743 VRG-----QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 743 ~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
+++ ...+.++..++.+++.+||+.+|++||||+||+++|+++...
T Consensus 905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 221 123456778899999999999999999999999999988663
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=340.54 Aligned_cols=259 Identities=29% Similarity=0.410 Sum_probs=203.4
Q ss_pred HHHHhhhcccCcccceEEEEEEE-----cCCcEEEEEEEeeccc-chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCc
Q 003772 510 KATNRFKEELGKGSFGAVYKGTL-----YKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSK 582 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~-----~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~ 582 (796)
...+.+.+.||+|+||.||+++. .+....||||+++... ....+.+.+|+.++..+ +||||++++++|.+++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34567789999999999999974 2345689999996532 33456788999999999 89999999999999999
Q ss_pred eeEEEeecCCCChhhhhhcCC-----------------------------------------------------------
Q 003772 583 RLLVYEYMSNGSLADILFRGP----------------------------------------------------------- 603 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 603 (796)
.++||||+++|+|.+++.+..
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986421
Q ss_pred --------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 604 --------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 604 --------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
...+++..++.++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 12478889999999999999999998 9999999999999999999999999999876443221
Q ss_pred e-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 670 T-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 670 ~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
. .....++..|+|||.+.+..++.++|||||||++|||++ |..|+........ .. +....+ . ...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~---~~----~~~~~~-~-----~~~ 337 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK---FY----KMIKEG-Y-----RML 337 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH---HH----HHHHhC-c-----cCC
Confidence 1 112235678999999999999999999999999999998 7777754322111 10 000000 0 001
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
.+...+.++.+++.+||+.||++|||+.||+++|++.
T Consensus 338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1122346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=330.89 Aligned_cols=238 Identities=31% Similarity=0.467 Sum_probs=199.1
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCChh
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLA 596 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 596 (796)
+-||.|+.|.||+|++. ++.||||+++... ..+++-|++|+|+||+.+.|+|....-.|||||||..|-|.
T Consensus 130 eWlGSGaQGAVF~Grl~--netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH--NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhccCcccceeeeecc--CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 56999999999999995 4689999975421 34788999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeecc
Q 003772 597 DILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRG 676 (796)
Q Consensus 597 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~g 676 (796)
.+|+. +..+.......+..+||.||.|||.+ .|||||||.-||||..+..+||+|||-++....- ...-...|
T Consensus 201 ~VLka--~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaG 273 (904)
T KOG4721|consen 201 EVLKA--GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAG 273 (904)
T ss_pred HHHhc--cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhh
Confidence 99987 56788888999999999999999998 9999999999999999999999999999866433 22334569
Q ss_pred CCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHH
Q 003772 677 TRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENM 756 (796)
Q Consensus 677 t~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 756 (796)
|..|||||++.+.+.++|+|||||||+||||+||..|+....... + -| . +-.....+ ..+.++++-+
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----I-Iw--G--VGsNsL~L----pvPstcP~Gf 340 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----I-IW--G--VGSNSLHL----PVPSTCPDGF 340 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----e-EE--e--ccCCcccc----cCcccCchHH
Confidence 999999999999999999999999999999999999986433210 0 00 0 00011111 2345667778
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 757 IKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 757 ~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
.-|++.||+-.|..||++++++..|+-
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 889999999999999999999999864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=339.35 Aligned_cols=261 Identities=27% Similarity=0.406 Sum_probs=204.4
Q ss_pred HHHHHhhhcccCcccceEEEEEEEcC-----CcEEEEEEEeecccc-hhHHHHHHHHHHHhcc-CcCchhhhhhhhccCC
Q 003772 509 KKATNRFKEELGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMVT-EGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDS 581 (796)
Q Consensus 509 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~ 581 (796)
....+.+.+.||+|+||.||++.... ....||||++..... .....+.+|+.+++.+ +|+||++++++|.+..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 34456678999999999999998532 235799999975332 3345688999999999 8999999999999999
Q ss_pred ceeEEEeecCCCChhhhhhcCC----------------------------------------------------------
Q 003772 582 KRLLVYEYMSNGSLADILFRGP---------------------------------------------------------- 603 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 603 (796)
..++||||+++|+|.+++.+..
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999985421
Q ss_pred ----------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee-e
Q 003772 604 ----------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF-T 672 (796)
Q Consensus 604 ----------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~-~ 672 (796)
...+++..+++++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++.......... .
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 12478888999999999999999998 999999999999999999999999999986543322111 1
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
...++..|||||++.+..++.++|||||||++|||++ |+.||........... .... ... ...+..
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~-------~~~~-----~~~-~~~~~~ 339 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK-------MVKR-----GYQ-MSRPDF 339 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH-------HHHc-----ccC-ccCCCC
Confidence 2235678999999999899999999999999999997 9999865432111000 0000 000 011112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 752 TLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 752 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
.+..+.+++..||+.||.+|||+.+|+++|+++.
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 3467899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=293.83 Aligned_cols=247 Identities=26% Similarity=0.365 Sum_probs=209.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc---cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
.++.+.||+|.||.||+|+.+...-.||+|++.+. ..+.+.++++|+++-..|+||||+++++++.+....||++||
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 45678999999999999999999899999998662 223456799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
..+|+|...|.....+.+++.....++.|+|.||.|+|.. +|+||||||+|+|++.++.+||+|||-+..... .
T Consensus 104 a~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~---~ 177 (281)
T KOG0580|consen 104 APRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---N 177 (281)
T ss_pred cCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC---C
Confidence 9999999999977788899999999999999999999998 999999999999999999999999999976442 2
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....+||..|.+||...+...+...|+|++|++.||++.|.+||+..... + .++.+..-. -..+
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--e------tYkrI~k~~-------~~~p 242 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--E------TYKRIRKVD-------LKFP 242 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--H------HHHHHHHcc-------ccCC
Confidence 223456999999999999999999999999999999999999999865411 1 111111100 0123
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
........+++..|+..+|.+|.+..|++..
T Consensus 243 ~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 4455678899999999999999999999763
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=324.90 Aligned_cols=244 Identities=23% Similarity=0.255 Sum_probs=201.1
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||++.....++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 356688999999999999998888999999986532 22345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-- 155 (291)
T cd05612 83 VPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-- 155 (291)
T ss_pred CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence 999999999976 45789999999999999999999998 99999999999999999999999999998654321
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ... ....... ....+
T Consensus 156 --~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--~~~------~~~i~~~-------~~~~~ 218 (291)
T cd05612 156 --WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--FGI------YEKILAG-------KLEFP 218 (291)
T ss_pred --ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHH------HHHHHhC-------CcCCC
Confidence 224589999999999998999999999999999999999999864321 110 1111111 01122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPS-----MKSVVLM 780 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~ 780 (796)
......+.+++..||+.||.+||+ ++++++.
T Consensus 219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 233567889999999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=331.54 Aligned_cols=259 Identities=24% Similarity=0.314 Sum_probs=204.3
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
..+.+.+.||+|+||.||+++....+..+|+|++..... ...+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 345566889999999999999998889999999875432 3346799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+||++++++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 158 (331)
T cd06649 85 MDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (331)
T ss_pred CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence 999999999976 35689999999999999999999985 269999999999999999999999999997654322
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh--------------
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI-------------- 735 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 735 (796)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... . .........
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--L--EAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--H--HHHhcccccccccCCccccCccc
Confidence 223458999999999999999999999999999999999999996432110 0 000000000
Q ss_pred --------------------hhhhhhhhc---CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 736 --------------------DRELNKLVR---GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 736 --------------------~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
......+.. ...........+.+++.+||+.||++|||++||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 011122345679999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.33 Aligned_cols=261 Identities=20% Similarity=0.233 Sum_probs=202.3
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|+||.||+++...+++.||+|++.... ....+.+.+|+.++.+++|+||+++++++.+++..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 456788999999999999998888999999987532 233456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
+++.|..+... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 83 EKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 98877655433 35689999999999999999999998 99999999999999999999999999998765433333
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh---------h
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN---------K 741 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 741 (796)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||............ ............. .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI-QKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHhhCCCCHHHHHhhhccchhcc
Confidence 33456899999999999988999999999999999999999999754321111110 0000000000000 0
Q ss_pred hhcCCC---------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 742 LVRGQE---------VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 742 ~~~~~~---------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...+.. ........+.+++..||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000 01123457999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=330.17 Aligned_cols=242 Identities=26% Similarity=0.324 Sum_probs=199.0
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
+.||+|+||.||+++...+++.||||++.+.. ......+.+|+.++.+++|+||+++++++.+++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999998888999999997632 223456788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeee
Q 003772 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL 673 (796)
Q Consensus 594 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~ 673 (796)
+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~ 154 (323)
T cd05571 81 ELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccc
Confidence 99999876 46789999999999999999999998 99999999999999999999999999987532221 22233
Q ss_pred eccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 003772 674 VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTL 753 (796)
Q Consensus 674 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (796)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ..... .....+....
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~-----~~~~~-------~~~~~p~~~~ 219 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLF-----ELILM-------EEIRFPRTLS 219 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHH-----HHHHc-------CCCCCCCCCC
Confidence 4589999999999999999999999999999999999999964321 1100 00000 0111233445
Q ss_pred HHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003772 754 ENMIKIGLWCVQDEPALRP-----SMKSVVL 779 (796)
Q Consensus 754 ~~l~~l~~~cl~~dP~~RP-----t~~evl~ 779 (796)
..+.+++..||+.||++|| ++.++++
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 6788999999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.75 Aligned_cols=255 Identities=28% Similarity=0.411 Sum_probs=211.5
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+.+.++||.|+||.||+|.... ++.+|+|.+..........+..|+.+++.++|+||+++++++.+....++||||+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 456778999999999999999987 6789999998766556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|+|.+++.......+++..++.++.|++.||.|||+. +|+|+||||+||++++++.+||+|||.+..........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 999999999876667799999999999999999999998 99999999999999999999999999998764332222
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+. + ...... . ....+
T Consensus 162 -~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~-~-----~~~~~~-----~-~~~~~ 226 (261)
T cd05148 162 -SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEV-Y-----DQITAG-----Y-RMPCP 226 (261)
T ss_pred -cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHH-H-----HHHHhC-----C-cCCCC
Confidence 23335678999999998899999999999999999998 7888864321 111 0 000000 0 01123
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
..++..+.+++.+||+.+|.+|||++++++.|+.+
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 34557789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=319.60 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=206.6
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+.+.++||+|+||.||+|...+ +..||+|.+... ....+.+.+|+.++++++|+||+++++.+.+.+..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 445667899999999999999754 467999998653 234568899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|+|.+++.......+++..++.++.|+++||.|||+. +++|+||||+||++++++.++|+|||++..........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999999776567789999999999999999999998 99999999999999999999999999998765433222
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....++..|+|||++....++.++||||||+++|||++ |+.|+...... . .. ... .... .....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~-~~-~~~---------~~~~-~~~~~ 226 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--D-VM-SAL---------QRGY-RMPRM 226 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--H-HH-HHH---------HcCC-CCCCC
Confidence 222335678999999998889999999999999999998 88888543211 1 10 000 0000 01112
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
...+..+.+++.+|++.+|++||++++++++|+.+
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 23456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.68 Aligned_cols=256 Identities=30% Similarity=0.478 Sum_probs=206.6
Q ss_pred HHhhhcccCcccceEEEEEEEcCCc-----EEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGE-----KLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~-----~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
...+.+.||+|+||.||+|.....+ ..||+|.+..... .....|.+|+.++.+++|+||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 4456789999999999999876544 6799999865332 334678999999999999999999999999899999
Q ss_pred EEeecCCCChhhhhhcCCC--------------CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc
Q 003772 586 VYEYMSNGSLADILFRGPE--------------RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT 651 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 651 (796)
+|||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence 9999999999999975321 4588899999999999999999998 9999999999999999999
Q ss_pred eEEeccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHH
Q 003772 652 AKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINW 729 (796)
Q Consensus 652 ~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 729 (796)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .+.
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--~~~----- 235 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--QEV----- 235 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--HHH-----
Confidence 99999999986643322 12223346788999999998899999999999999999998 8888864321 111
Q ss_pred HHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 730 AYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
......+. ....+...+..+.+++.+||+.+|.+||+++||++.|+++
T Consensus 236 -~~~i~~~~------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 -IEMIRSRQ------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -HHHHHcCC------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 01111110 0112345668899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=327.03 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=213.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeec--ccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCc-eeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSK-RLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lV~e 588 (796)
.|...+.+|+|+||.++..+++.+++.+++|++.- ......+...+|+.++++++|||||.+.+.+.+++. .+|||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 35567899999999999999998889999998854 333344567899999999999999999999999888 999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|++||+|.+.+.+.++..++++.+..++.|++.|+.|||++ .|+|||||+.|||++.+..+||+|||+++.+.....
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999999999987778899999999999999999999988 999999999999999999999999999999877653
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
.. ....||+.||.||++.+.+|..|+|||||||++|||++-+++|....... +........ -...
T Consensus 162 ~a-~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------------Li~ki~~~~--~~Pl 226 (426)
T KOG0589|consen 162 LA-STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------------LILKINRGL--YSPL 226 (426)
T ss_pred hh-heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------------HHHHHhhcc--CCCC
Confidence 32 34569999999999999999999999999999999999999997553211 111111111 1234
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
+......+..++..|++.+|..||++.+++.+
T Consensus 227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 45566789999999999999999999999865
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.05 Aligned_cols=239 Identities=23% Similarity=0.303 Sum_probs=196.1
Q ss_pred cCcccceEEEEEEEcCCcEEEEEEEeecc---cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 519 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
||+|+||.||++.....++.||+|++.+. .......+.+|+.++.+++||||+++++.+.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999888889999999753 233446688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeec
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR 675 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~ 675 (796)
.+++.. ...+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++....... ......
T Consensus 81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~ 154 (312)
T cd05585 81 FHHLQR--EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFC 154 (312)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccccc
Confidence 999976 45789999999999999999999998 999999999999999999999999999986433222 223346
Q ss_pred cCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 003772 676 GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLEN 755 (796)
Q Consensus 676 gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (796)
||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ....... .....+......
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--~~------~~~~~~~-------~~~~~~~~~~~~ 219 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--NE------MYRKILQ-------EPLRFPDGFDRD 219 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--HH------HHHHHHc-------CCCCCCCcCCHH
Confidence 89999999999999999999999999999999999999964321 10 0111110 111223344567
Q ss_pred HHHHHHHhccCCCCCCCCH---HHHH
Q 003772 756 MIKIGLWCVQDEPALRPSM---KSVV 778 (796)
Q Consensus 756 l~~l~~~cl~~dP~~RPt~---~evl 778 (796)
+.+++..||+.||.+||+. .|++
T Consensus 220 ~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 220 AKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 8899999999999999864 5554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=333.64 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=203.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+|+....++.||||++.+.. ....+.+.+|+.++..++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 456688999999999999998888899999997642 22345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 83 VPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 999999999965 45788999999999999999999998 999999999999999999999999999986543
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..+ . ..+. ........
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~----~~~~-~~~~~~~~ 226 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW--K----ETLQ-RPVYDDPR 226 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc--c----cccc-CCCCCccc
Confidence 222345899999999999999999999999999999999999999754321110000000 0 0000 00000011
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
......+.+++..||+.+|.+||++.++++.
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 2345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.68 Aligned_cols=257 Identities=28% Similarity=0.423 Sum_probs=207.3
Q ss_pred HHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 509 KKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 509 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.....++.+.||+|++|.||+|.... ++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 34556778999999999999999754 4689999986533 345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++++|.+++.......+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999999765456789999999999999999999998 999999999999999999999999999987653322
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
........+..|+|||++.+..++.++||||||+++|||++ |+.|+..... .... .... ... ...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~-----~~~~-----~~~-~~~ 224 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVL-----QQVD-----QGY-RMP 224 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHH-----HHHH-----cCC-CCC
Confidence 22221223457999999999899999999999999999999 8888753321 1110 0000 000 011
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
.+......+.+++.+|++.+|.+||++.+|++.|+.+
T Consensus 225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 2234457799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=299.61 Aligned_cols=234 Identities=25% Similarity=0.312 Sum_probs=201.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
..+.+.||.|.||.|.+.+.+.++..+|+|++++..- ...+...+|..+|+.+.||+++++.+.+.+.+..++||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey 125 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY 125 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence 3456789999999999999999999999999986332 2345578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
.++|.|..+|++ .+++++..++.+|.||+.||+|||+. .|++|||||+|||||.+|.+||+|||+|+.....
T Consensus 126 v~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 126 VPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred cCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 999999999977 57899999999999999999999998 9999999999999999999999999999986432
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC-CC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ-EV 748 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 748 (796)
....+|||.|+|||++....+...+|.|||||++|||+.|..||..+... ..+++ ++.++ ..
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~--------~iY~K--------I~~~~v~f 260 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI--------QIYEK--------ILEGKVKF 260 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH--------HHHHH--------HHhCcccC
Confidence 44577999999999999999999999999999999999999999865421 01222 22222 23
Q ss_pred CHHHHHHHHHHHHHhccCCCCCC
Q 003772 749 DRNTLENMIKIGLWCVQDEPALR 771 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~R 771 (796)
+......+.+|+...|+.|-.+|
T Consensus 261 P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 261 PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcccCHHHHHHHHHHHhhhhHhh
Confidence 44455678888889999999988
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=310.60 Aligned_cols=253 Identities=24% Similarity=0.375 Sum_probs=214.5
Q ss_pred CHHHHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccC
Q 003772 504 SYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAED 580 (796)
Q Consensus 504 ~~~~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~ 580 (796)
.-..-.+.++.|.+.||+|.||.|-++.....++.||||.+.+..- ++.-.+++|++++..++||||+.++.+|...
T Consensus 46 hhkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk 125 (668)
T KOG0611|consen 46 HHKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK 125 (668)
T ss_pred CcccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC
Confidence 3334445678889999999999999999888889999999977443 3445688999999999999999999999999
Q ss_pred CceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCc
Q 003772 581 SKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA 660 (796)
Q Consensus 581 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~ 660 (796)
+...|||||..+|.|.+++.+ .+.|++.....++.||..|+.|+|.+ +++|||||.+|||||+++++||+|||++
T Consensus 126 dKIvivMEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLS 200 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLS 200 (668)
T ss_pred ceEEEEEEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchh
Confidence 999999999999999999977 57899999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcceeeeeccCCCCCchhhhccCCC-CccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh
Q 003772 661 KLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739 (796)
Q Consensus 661 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
.++.... .....+|++.|.+||++.+.+| .+..|-|||||+||-|+.|..||+..+. .. .+
T Consensus 201 Nly~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~-------------lv 262 (668)
T KOG0611|consen 201 NLYADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KR-------------LV 262 (668)
T ss_pred hhhcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HH-------------HH
Confidence 8875433 3345679999999999999988 6889999999999999999999975431 11 11
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 740 NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.++..+.-..++.+....-|++|||-.||++|.|+.+|..
T Consensus 263 rQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 263 RQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred HHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 2222222234455667888999999999999999999975
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=326.99 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=216.1
Q ss_pred HHHHHHhhhcccCcccceEEEEEEEcCC----cEEEEEEEeecc-cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCc
Q 003772 508 LKKATNRFKEELGKGSFGAVYKGTLYKG----EKLVAVKKLEKM-VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSK 582 (796)
Q Consensus 508 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~----~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 582 (796)
+.+..-.++++||.|-||.||+|...+. .-.||||..+.. .....+.|..|+.+++.++||||++++|+|.+ ..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 3344445678899999999999986433 347999999873 34456779999999999999999999999975 56
Q ss_pred eeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 583 RLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
.++|||.++-|.|+.+|..+ ...++......++.||+.||.|||+. .+|||||..+|||+.....+||+|||+++.
T Consensus 465 ~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence 78999999999999999874 57799999999999999999999999 999999999999999999999999999999
Q ss_pred cCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 663 LMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 663 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
+..+.....+...-+..|||||.+.-..+|.++|||-|||++|||++ |.+||..-...+ -+..
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~~ 604 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIGH 604 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEEE
Confidence 87766655555556788999999999999999999999999999997 778886543221 1111
Q ss_pred hhc--CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 742 LVR--GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 742 ~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
+-. +-..+++|++.++.++..||..+|.+||++.++...|+.+.+
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 111 124578999999999999999999999999999988876655
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.56 Aligned_cols=245 Identities=22% Similarity=0.267 Sum_probs=201.8
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
..+.+.+.||+|+||.||+++....++.||||++.+.. ....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 34567789999999999999998888999999997532 233456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 99999999999976 45788999999999999999999998 99999999999999999999999999998664322
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ......... ..
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~------~~~~i~~~~-------~~ 233 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--FR------IYEKILAGR-------LK 233 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--HH------HHHHHhcCC-------cC
Confidence 234589999999999999999999999999999999999999964321 10 011111111 01
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPS-----MKSVVL 779 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 779 (796)
.+......+.+++..||+.||.+||+ +.+++.
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 12223456889999999999999997 677763
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=311.13 Aligned_cols=261 Identities=28% Similarity=0.356 Sum_probs=200.6
Q ss_pred hhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhc--cCcCchhhhhhhhccCC----ceeEEEe
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGR--THHKNLVRLIGYCAEDS----KRLLVYE 588 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~lV~e 588 (796)
+.+.||+|.||.||+|.+.. +.||||++. ..+++.+.+|.++.+. |+|+||+.+++.=..+. .++||++
T Consensus 215 L~e~IGkGRyGEVwrG~wrG--e~VAVKiF~---srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRWRG--EDVAVKIFS---SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EEEEecCccccceeeccccC--CceEEEEec---ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 45789999999999999964 579999995 3456677777777765 59999999998755433 5799999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhcc-----CCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE-----CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
|.++|||.|+|.+ ..++.+..++++..+|.||+|||-+ .++.|.|||||+.|||+..++.+.|+|+|||...
T Consensus 290 YHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 290 YHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred cccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 9999999999975 6899999999999999999999965 4789999999999999999999999999999877
Q ss_pred CCCCc---ceeeeeccCCCCCchhhhccC------CCCccccchhhHHHHHHHhhc----------ccCCCCCCCCchhH
Q 003772 664 MPDQT---RTFTLVRGTRGYMAPEWYKNT------PISVKADVFSYGVVLLEIVCC----------RRNMEIDPSKPEEI 724 (796)
Q Consensus 664 ~~~~~---~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvil~elltg----------~~p~~~~~~~~~~~ 724 (796)
..... ......+||.+|||||++... ..-..+||||||.++||++-. +.||......++..
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ 446 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF 446 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH
Confidence 55432 233456799999999999764 122458999999999999852 34444322222221
Q ss_pred HHHHHHHHhh-hhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 725 VLINWAYKCF-IDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 725 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
.- +.+. =.+.+...+.....+.+.+..|.++++.||..+|.-|-|+=-+...|.++.+.
T Consensus 447 ee----MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 447 EE----MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred HH----HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 11 0111 11122222333345678899999999999999999999998888888777653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=328.58 Aligned_cols=253 Identities=28% Similarity=0.415 Sum_probs=212.3
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
++++.||+|+-|.|.+|++...++.+|||++.+.. ......+.+|+.+|+.+.|||++++++++.+..+.|+|.||+
T Consensus 15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 46688999999999999999999999999997642 223456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|-|.++|.+ ++.+++.+..+++.||+.|+.|+|.. +|+||||||+|+|||+.+++||+|||+|.+-.++.-
T Consensus 95 ~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl-- 167 (786)
T KOG0588|consen 95 PGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL-- 167 (786)
T ss_pred CCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCcc--
Confidence 99999999977 68899999999999999999999998 999999999999999999999999999987654432
Q ss_pred eeeeccCCCCCchhhhccCCC-CccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC-CC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ-EV 748 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 748 (796)
....+|++.|.|||++.+.+| ..++||||.|||||.|++|+.||+.+.. .. .+.++..+. +.
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~-------------LLlKV~~G~f~M 231 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RV-------------LLLKVQRGVFEM 231 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HH-------------HHHHHHcCcccC
Confidence 334579999999999999998 6889999999999999999999983321 00 111111111 22
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HhcCcCCCC
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVLM--LEGITDISI 789 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~~~~ 789 (796)
+.+...+..+|+..|+..||++|.|++||++. |.+...++.
T Consensus 232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPS 274 (786)
T ss_pred CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence 45666789999999999999999999999864 455444433
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=327.69 Aligned_cols=242 Identities=26% Similarity=0.327 Sum_probs=198.2
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
+.||+|+||.||++.....++.||+|++.+.. ......+.+|+.++++++||||+++++.+.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999998888999999997632 223456778999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeee
Q 003772 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL 673 (796)
Q Consensus 594 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~ 673 (796)
+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 154 (323)
T cd05595 81 ELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence 99998865 45789999999999999999999998 99999999999999999999999999987543222 12223
Q ss_pred eccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 003772 674 VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTL 753 (796)
Q Consensus 674 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (796)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. . ..... .....+....
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~-~-----~~~~~-------~~~~~p~~~~ 219 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RL-F-----ELILM-------EEIRFPRTLS 219 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--HH-H-----HHHhc-------CCCCCCCCCC
Confidence 45899999999999999999999999999999999999999643211 10 0 00000 0111223445
Q ss_pred HHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003772 754 ENMIKIGLWCVQDEPALRP-----SMKSVVL 779 (796)
Q Consensus 754 ~~l~~l~~~cl~~dP~~RP-----t~~evl~ 779 (796)
..+.+++..||+.||.+|| ++.++++
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 6788999999999999998 8888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=326.56 Aligned_cols=243 Identities=26% Similarity=0.332 Sum_probs=199.4
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
+.||+|+||.||++.....++.||||++.+.. ......+.+|+.+++.++||||+++++.+.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999998888999999997632 234467888999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeee
Q 003772 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL 673 (796)
Q Consensus 594 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~ 673 (796)
+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 81 ELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 99998865 45789999999999999999999998 99999999999999999999999999987543221 12233
Q ss_pred eccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 003772 674 VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTL 753 (796)
Q Consensus 674 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (796)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..... .....+....
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~~------~~~~~-------~~~~~p~~~~ 219 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLF------ELILM-------EDIKFPRTLS 219 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--HHH------HHhcc-------CCccCCCCCC
Confidence 46899999999999989999999999999999999999999643211 100 00000 0111233445
Q ss_pred HHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003772 754 ENMIKIGLWCVQDEPALRP-----SMKSVVLM 780 (796)
Q Consensus 754 ~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 780 (796)
..+.+++..||+.||.+|| ++.++++.
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 6788999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=313.68 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=200.9
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
...+.+.||+|+||.||++.+... ..+|+|.+... ....+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~-~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQ-IKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccC-ceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 345668899999999999988654 57999988643 2335678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+|+|.+++... ...+++..++.++.|++.||.|||+. +|+|+||||+||++++++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 99999998753 24689999999999999999999998 999999999999999999999999999986543332222
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .. ........ ....+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~------~~~i~~~~------~~~~~~ 224 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EV------VEMISRGF------RLYRPK 224 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HH------HHHHHCCC------CCCCCC
Confidence 22335668999999998889999999999999999999 88888543211 10 00011100 001112
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
.....+.+++.+||+.+|++||++.++++.|.
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 23457899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=315.50 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=206.1
Q ss_pred HHHhhhcccCcccceEEEEEEEcCC---cEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKG---EKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
..+.+.+.||+|+||.||+|.+... ...||||++..... ....+|.+|+.++.+++|+||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 3456678999999999999998643 45799999875433 3446789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+|+||||+||++++++.++|+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 9999999999999764 34789999999999999999999998 9999999999999999999999999999887522
Q ss_pred Cc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 667 QT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 667 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
.. .......++..|+|||.+.+..++.++||||||+++|||++ |..|+...... . .. ...... .
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~--~~----~~~~~~-----~- 225 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--D--VI----KAVEDG-----Y- 225 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--H--HH----HHHHcC-----C-
Confidence 21 11112335678999999999899999999999999999998 88887543211 0 00 000000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
....+...+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 01122344577899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=326.10 Aligned_cols=259 Identities=24% Similarity=0.368 Sum_probs=204.5
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcE----EEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCcee
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEK----LVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~----~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 584 (796)
...++..+.||+|+||.||+|++..+++ .||||+++... ....+++.+|+.+++.++|+||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 3455667889999999999998765443 48999987543 34457799999999999999999999998764 577
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 85 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999999764 34688999999999999999999998 99999999999999999999999999998775
Q ss_pred CCCccee-eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 665 PDQTRTF-TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 665 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
....... ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .. .. .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~--~~----~~~~~----- 227 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EI--SS----ILEKG----- 227 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HH--HH----HHhCC-----
Confidence 4333221 12224678999999999999999999999999999998 88888643211 10 00 00000
Q ss_pred hcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 743 VRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 743 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
.....+..+...+.+++..||+.+|++||++.+++..|..+..-
T Consensus 228 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 228 -ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 00011223456788999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=327.04 Aligned_cols=264 Identities=25% Similarity=0.336 Sum_probs=203.6
Q ss_pred HHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 509 KKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 509 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
....+.+.++||+|+||.||++.+...+..+|+|++..... .....+.+|++++++++|+||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 34566778899999999999999988888999998875432 33467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||+. .+|+|+||||+|||+++++.+||+|||++.......
T Consensus 83 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 83 EHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 99999999999976 45688999999999999999999974 269999999999999999999999999997653221
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHH-----H-------------
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLIN-----W------------- 729 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~-----~------------- 729 (796)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...........+.. .
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 1223588999999999998999999999999999999999999864322110000000 0
Q ss_pred -HHHhh---------hhhhhhhhhcC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 730 -AYKCF---------IDRELNKLVRG---QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 730 -~~~~~---------~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..... ........... .........++.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 00000 00000000000 0001123456899999999999999999999963
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=318.30 Aligned_cols=257 Identities=28% Similarity=0.467 Sum_probs=207.2
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCC-----cEEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhccCCce
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKG-----EKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~-----~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 583 (796)
..++.+.+.||+|+||.||+|...+. .+.||||.+...... ..+.+.+|++++.+++|+||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 45677889999999999999987533 468999999765444 457899999999999999999999999999999
Q ss_pred eEEEeecCCCChhhhhhcCC------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc
Q 003772 584 LLVYEYMSNGSLADILFRGP------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT 651 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 651 (796)
++||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999996531 24578899999999999999999998 9999999999999999999
Q ss_pred eEEeccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHH
Q 003772 652 AKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINW 729 (796)
Q Consensus 652 ~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 729 (796)
+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... . ..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~--~~-- 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--E--VI-- 234 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--H--HH--
Confidence 99999999976533221 11122335678999999999999999999999999999998 99988643211 1 00
Q ss_pred HHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 730 AYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
.....+. ....+...+..+.+++..||+.||++||++.||++.|++
T Consensus 235 --~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 --ECITQGR------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred --HHHHcCC------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 0000000 011223455778999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=316.89 Aligned_cols=251 Identities=26% Similarity=0.346 Sum_probs=203.1
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
++..+.||+|+||.||++.....++.||+|++..... .....+.+|+.++++++|+||+++++.+.+++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 4456789999999999999988888999999975322 2234578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.......+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence 9999999988765456799999999999999999999998 999999999999999999999999999986543222
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||............ .. .+.. .....+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~----~~-----~~~~--~~~~~~ 225 (285)
T cd05605 158 -IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV----ER-----RVKE--DQEEYS 225 (285)
T ss_pred -cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH----HH-----Hhhh--cccccC
Confidence 12335899999999999889999999999999999999999999753321100000 00 0110 011123
Q ss_pred HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRP-----SMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 779 (796)
......+.+++..||+.||.+|| +++++++
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 34567789999999999999999 8889854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=329.62 Aligned_cols=252 Identities=26% Similarity=0.401 Sum_probs=210.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcE----EEEEEEeecc-cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEK----LVAVKKLEKM-VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~----~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
.+-.++||.|+||+||+|.+...++ +||||++... ..+...++.+|+..|.+++|+||+|++|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3345789999999999998754443 7899988654 3445688999999999999999999999998766 88999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
+||+.|+|.++++.+ +..+-....+.|..|||+||.|||++ .++||||..+|||+..-..+||.|||+++++..+.
T Consensus 777 q~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999999874 56788899999999999999999998 99999999999999999999999999999987765
Q ss_pred cceeee-eccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 668 TRTFTL-VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 668 ~~~~~~-~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
..-... ..-.+.|||-|.+....+|.++|||||||++||++| |.+|.+..+.. ++.++++.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----------------eI~dlle~ 915 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----------------EIPDLLEK 915 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----------------HhhHHHhc
Confidence 543332 234568999999999999999999999999999998 66777544321 22222222
Q ss_pred ---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 746 ---QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 746 ---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
-..++.+..+++.++..||..|+..||+++++...+.+...
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 23467788899999999999999999999999988876543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=326.51 Aligned_cols=261 Identities=26% Similarity=0.400 Sum_probs=204.2
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCC-----cEEEEEEEeecccc-hhHHHHHHHHHHHhcc-CcCchhhhhhhhcc-CC
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKG-----EKLVAVKKLEKMVT-EGEREFRAEMHVIGRT-HHKNLVRLIGYCAE-DS 581 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~-----~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~-~~ 581 (796)
...+++.+.||+|+||.||+|...+. ++.||+|++..... ...+.+..|+.++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 34677889999999999999975432 36899999875332 3345678899999999 89999999998865 45
Q ss_pred ceeEEEeecCCCChhhhhhcCC----------------------------------------------------------
Q 003772 582 KRLLVYEYMSNGSLADILFRGP---------------------------------------------------------- 603 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 603 (796)
..++++||+++|+|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 6889999999999999986421
Q ss_pred -CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc-eeeeeccCCCCC
Q 003772 604 -ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYM 681 (796)
Q Consensus 604 -~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~ 681 (796)
...+++..+..++.||+.||.|||+. +|+||||||+||++++++.++|+|||+++.+...... ......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 12688999999999999999999998 9999999999999999999999999999876433221 122234567899
Q ss_pred chhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHH
Q 003772 682 APEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIG 760 (796)
Q Consensus 682 aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 760 (796)
|||++.+..++.++|||||||++|||++ |+.||......+. +. ....... ....+......+.+++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~~----~~~~~~~------~~~~~~~~~~~~~~l~ 309 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---FC----RRLKEGT------RMRAPEYATPEIYSIM 309 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---HH----HHHhccC------CCCCCccCCHHHHHHH
Confidence 9999999999999999999999999998 8888864321110 00 0000000 0111223456789999
Q ss_pred HHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 761 LWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 761 ~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.+||+.+|++||++.||+++|+.+.+
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=317.26 Aligned_cols=243 Identities=30% Similarity=0.407 Sum_probs=206.1
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+-.+.||+|.||.||+|.+...++.||||++.-... ...+++.+|+.+|..++++||.+++|.+..+...+++||||.+
T Consensus 16 ~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~g 95 (467)
T KOG0201|consen 16 TKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGG 95 (467)
T ss_pred ccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcC
Confidence 334789999999999999999999999999975433 3457789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|++.+.|.. ...+++..+.-+..+++.||.|||.+ +.+|||||+.|||+..++.+||+|||.+..+....... .
T Consensus 96 Gsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~ 169 (467)
T KOG0201|consen 96 GSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-K 169 (467)
T ss_pred cchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-c
Confidence 999999976 34558888888999999999999999 99999999999999999999999999998876665555 5
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC---CCCC
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG---QEVD 749 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 749 (796)
..+||+.|||||++....|+.|+||||||++.+||++|.+|+...... . ..-++.. ....
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--r---------------vlflIpk~~PP~L~ 232 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--R---------------VLFLIPKSAPPRLD 232 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc--e---------------EEEeccCCCCCccc
Confidence 567999999999999889999999999999999999999998643210 0 0011111 1112
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......+.+++..||++||+.|||+++++.
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 245567999999999999999999999874
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=318.72 Aligned_cols=262 Identities=27% Similarity=0.462 Sum_probs=209.3
Q ss_pred HHHHhhhcccCcccceEEEEEEEc-----CCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCcee
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 584 (796)
...+.+.+.||+|+||.||++... .....+|+|.+........+.+.+|++++.+++|+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 344567789999999999999852 234579999998766666778999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCC-----------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceE
Q 003772 585 LVYEYMSNGSLADILFRGP-----------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAK 653 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 653 (796)
+|+||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999986421 23589999999999999999999998 999999999999999999999
Q ss_pred EeccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHH
Q 003772 654 ISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAY 731 (796)
Q Consensus 654 l~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 731 (796)
|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... . . .
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~-~-----~ 232 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--E-V-----I 232 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--H-H-----H
Confidence 9999999865433221 1122335678999999999899999999999999999998 88887543211 1 0 0
Q ss_pred HhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCC
Q 003772 732 KCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDIS 788 (796)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 788 (796)
.....+... ..+......+.+++..||+.+|.+|||+.+|+..|+.+...+
T Consensus 233 ~~i~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 233 ECITQGRVL------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred HHHHcCCcC------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 111111100 112234467999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=313.35 Aligned_cols=258 Identities=20% Similarity=0.349 Sum_probs=208.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc---cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+|+....++.||||.+... .......+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 45678899999999999999888899999987642 223345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 590 MSNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 590 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
+++|+|.+++... ....++...+..++.|+++||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 9999999988532 235588999999999999999999998 99999999999999999999999999988764332
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........... . .+.....+..
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~------~-----~~~~~~~~~~ 228 (267)
T cd08228 161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC------Q-----KIEQCDYPPL 228 (267)
T ss_pred H-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH------H-----HHhcCCCCCC
Confidence 2 11223478899999999988899999999999999999999999865432211110 0 0111111111
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
........+.+++.+||+.+|++||++++|++.++++.
T Consensus 229 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 22345577999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.07 Aligned_cols=259 Identities=20% Similarity=0.341 Sum_probs=209.1
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+.+.+.||+|+||.||++....+++.+|||.+.... .....++.+|+.+++.++|+||+++++++.+++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 3566789999999999999988788899999886522 2234578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 589 YMSNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 589 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|+++++|.+++... ....+++..++.++.||++||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999988642 245689999999999999999999998 9999999999999999999999999998765433
Q ss_pred CcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
... .....++..|+|||++.+..++.++||||||+++|||++|..|+.......... .+ .+.....+.
T Consensus 160 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~-----~~~~~~~~~ 227 (267)
T cd08229 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL------CK-----KIEQCDYPP 227 (267)
T ss_pred Ccc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH------hh-----hhhcCCCCC
Confidence 221 123357889999999998889999999999999999999999986432211110 00 011111111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
.......+.+.+++.+||+.+|++||||.+|+++++++.
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 122345678999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=333.28 Aligned_cols=260 Identities=25% Similarity=0.359 Sum_probs=204.8
Q ss_pred HHHhhhcccCcccceEEEEEEEcCC-----cEEEEEEEeecccc-hhHHHHHHHHHHHhccC-cCchhhhhhhhccCCce
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKG-----EKLVAVKKLEKMVT-EGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~-----~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 583 (796)
..+.+.+.||+|+||.||+|+.... ...||||++..... ...+.+.+|++++.++. ||||+++++++.+.+..
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 3456778999999999999986422 24799999975433 33457899999999996 99999999999999999
Q ss_pred eEEEeecCCCChhhhhhcCC------------------------------------------------------------
Q 003772 584 LLVYEYMSNGSLADILFRGP------------------------------------------------------------ 603 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------ 603 (796)
++||||+++|+|.++|.+..
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 99999999999999886421
Q ss_pred ----------------------------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC
Q 003772 604 ----------------------------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF 649 (796)
Q Consensus 604 ----------------------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 649 (796)
...+++..+..++.|+++||.|||+. +|+|+||||+|||++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~ 273 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCC
Confidence 12477888899999999999999998 99999999999999999
Q ss_pred CceEEeccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHH
Q 003772 650 WTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLI 727 (796)
Q Consensus 650 ~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~ 727 (796)
+.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.|+........ .
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~-- 349 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--F-- 349 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--H--
Confidence 99999999999865433221 1122346778999999999899999999999999999997 8888764321110 0
Q ss_pred HHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 728 NWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
......+ . ....+...+..+.+++..||+.+|++|||+.+|+++|+.+.+
T Consensus 350 ---~~~~~~~-----~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 ---YNKIKSG-----Y-RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---HHHHhcC-----C-CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0000000 0 011223456779999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=318.31 Aligned_cols=259 Identities=27% Similarity=0.473 Sum_probs=208.8
Q ss_pred HHhhhcccCcccceEEEEEEEcC-----CcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
.+.+.+.||+|+||.||+++... ....+++|.+........+.+.+|+.++++++|+||+++++++.+....++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 34566889999999999998532 3457999998776666667899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCC--------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCce
Q 003772 587 YEYMSNGSLADILFRGP--------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTA 652 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 652 (796)
|||+++++|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+||++++++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999996531 24589999999999999999999998 99999999999999999999
Q ss_pred EEeccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHH
Q 003772 653 KISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWA 730 (796)
Q Consensus 653 kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 730 (796)
+|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... . .
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~--~---- 234 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--E--V---- 234 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--H--H----
Confidence 9999999976543322 11223346788999999999999999999999999999999 88887543211 1 0
Q ss_pred HHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 731 YKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
.+....+... ......+..+.+++.+||+.+|++|||+.+|+++|+.+...
T Consensus 235 ~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IECITQGRVL------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHhCCCCC------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 0111111111 11223456789999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=311.29 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=199.4
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
+.||+|+||.||+|.+..+++.+|+|.+.... .+....+.+|+.++++++|+||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999998888899999876533 33456799999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee-eee
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF-TLV 674 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~-~~~ 674 (796)
.+++... ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++........... ...
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 9998653 34689999999999999999999998 999999999999999999999999999976543211111 111
Q ss_pred ccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 003772 675 RGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTL 753 (796)
Q Consensus 675 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (796)
..+..|+|||.+.+..++.++||||||+++|||++ |..|+...... .. ... +... .....+...+
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~------~~~-----~~~~-~~~~~~~~~~ 222 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QT------REA-----IEQG-VRLPCPELCP 222 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HH------HHH-----HHcC-CCCCCcccCC
Confidence 23457999999999899999999999999999998 77777533211 00 000 0000 0112233445
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 754 ENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 754 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
..+.+++.+|++.+|++|||+.+|.++|+
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 67899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=326.50 Aligned_cols=246 Identities=24% Similarity=0.337 Sum_probs=194.7
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
.+.++||+|+||.||+++....++.||||++..... ...+.+.+|++++++++|+||+++++++.+++..++||||+++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 345789999999999999988888999999865433 3346789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+.. ...+..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.+..... ...
T Consensus 157 ~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 226 (353)
T PLN00034 157 GSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCN 226 (353)
T ss_pred Ccccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccc
Confidence 9986532 345677889999999999999998 999999999999999999999999999987643322 122
Q ss_pred eeccCCCCCchhhhccC-----CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 673 LVRGTRGYMAPEWYKNT-----PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
...||..|+|||.+... ..+.++|||||||++|||++|+.||............... .......
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-----------~~~~~~~ 295 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-----------CMSQPPE 295 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-----------hccCCCC
Confidence 34589999999987532 3456899999999999999999999743322111110000 0001112
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
........+.+++..||+.||++|||+.||++.
T Consensus 296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 233445678999999999999999999999975
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=313.03 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=204.7
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
...+.+.++||+|+||.||+|++.+. ..||+|++.... ...+.+.+|+.++++++|+||+++++++. ....++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 34567889999999999999988655 469999997532 23467899999999999999999999774 4567999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.+.....+++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+|||.++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999765556789999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
......++..|+|||+..+..++.++||||||+++|||++ |+.|+...... .. ....... .....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~~------~~~~~~~------~~~~~ 224 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EV------LDQVERG------YRMPC 224 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--HH------HHHHhcC------CCCCC
Confidence 2222346678999999998899999999999999999999 77777543211 11 0100000 00112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
..+.+..+.+++.+|++.+|++||++++++++|+..
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 334567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=330.56 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=203.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||++.....++.||||++.+.. ......+.+|+.++..++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 456688999999999999998888999999997532 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC--
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ-- 667 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~-- 667 (796)
+++|+|.+++.+. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 83 MPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 9999999999763 6789999999999999999999998 99999999999999999999999999998765433
Q ss_pred --------------------------cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCc
Q 003772 668 --------------------------TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKP 721 (796)
Q Consensus 668 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~ 721 (796)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 112223458999999999999999999999999999999999999997543111
Q ss_pred hhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 003772 722 EEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPS-MKSVVLM 780 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~ 780 (796)
. ....... ..... ........+.+.+++..|++ +|.+||+ ++++++.
T Consensus 238 --~------~~~i~~~--~~~~~-~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 238 --T------YNKIINW--KESLR-FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred --H------HHHHhcc--CCccc-CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 0 0101000 00000 00111245678899999998 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.20 Aligned_cols=246 Identities=26% Similarity=0.329 Sum_probs=198.8
Q ss_pred cCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 519 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
||+|+||+||++.....++.+|+|++.+... ...+.+..|+.++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 7999999999999988888999999865322 2335678899999999999999999999999999999999999999
Q ss_pred hhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeee
Q 003772 596 ADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL 673 (796)
Q Consensus 596 ~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~ 673 (796)
.+++... ....+++..+..++.||+.||.|||+. +|+||||||+||++++++.++|+|||++..+...... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 9888542 245689999999999999999999998 9999999999999999999999999999866443322 223
Q ss_pred eccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 003772 674 VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTL 753 (796)
Q Consensus 674 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (796)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||............ ..... . .....+....
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~----~~~~~----~---~~~~~~~~~~ 225 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL----KQRIL----N---DSVTYPDKFS 225 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH----HHhhc----c---cCCCCcccCC
Confidence 45899999999999999999999999999999999999999754322111110 00000 0 1112233456
Q ss_pred HHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003772 754 ENMIKIGLWCVQDEPALRP-----SMKSVVL 779 (796)
Q Consensus 754 ~~l~~l~~~cl~~dP~~RP-----t~~evl~ 779 (796)
..+.+++..||+.||++|| +++++++
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 7789999999999999999 7788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=318.46 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=201.7
Q ss_pred hhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.+.||+|+||.||+++-++.++.+|+|++++.. ....+.+++|-.+|...+++.||+++-.|.+.+.+||||||.+
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 4578999999999999999999999999998743 2345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC------
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP------ 665 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~------ 665 (796)
||++..+|.+ ...|++.....++.+++-|+.-+|+. ++|||||||+|+|||..|.+||+||||+.-+..
T Consensus 225 GGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~ 299 (550)
T KOG0605|consen 225 GGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES 299 (550)
T ss_pred CccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence 9999999987 68899999999999999999999998 999999999999999999999999999864311
Q ss_pred ----------------CC-c-----ce------------------eeeeccCCCCCchhhhccCCCCccccchhhHHHHH
Q 003772 666 ----------------DQ-T-----RT------------------FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLL 705 (796)
Q Consensus 666 ----------------~~-~-----~~------------------~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ 705 (796)
.. . .. ....+|||.|||||++.+..++..+|.||+|||+|
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Imy 379 (550)
T KOG0605|consen 300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMY 379 (550)
T ss_pred hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHH
Confidence 00 0 00 01135999999999999999999999999999999
Q ss_pred HHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHH
Q 003772 706 EIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPS---MKSVV 778 (796)
Q Consensus 706 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl 778 (796)
|||.|-+||..+.....-..+..|......+ ......++..+||.+|+. ||++|-- +.||.
T Consensus 380 EmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP-----------~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 380 EMLVGYPPFCSETPQETYRKIVNWRETLKFP-----------EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhhhccCC-----------CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 9999999998765433333333332211111 111223678899999998 9999976 44443
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=326.01 Aligned_cols=247 Identities=24% Similarity=0.291 Sum_probs=201.8
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCc-EEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGE-KLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~-~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
...+.+.+.||+|+||.||+|.....+ ..||+|++.+.. ....+.+.+|+.++..++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 345667789999999999999876544 689999986532 2334568899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 109 v~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999999976 45789999999999999999999998 999999999999999999999999999987543
Q ss_pred CCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .........
T Consensus 184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~-----~~~~i~~~~------- 244 (340)
T PTZ00426 184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---L-----IYQKILEGI------- 244 (340)
T ss_pred C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---H-----HHHHHhcCC-------
Confidence 2 12345899999999999988999999999999999999999999743211 0 111111111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRP-----SMKSVVLM 780 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 780 (796)
...+......+.+++..|++.+|.+|+ +++++++.
T Consensus 245 ~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 011223345678999999999999995 89988754
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=340.01 Aligned_cols=250 Identities=22% Similarity=0.265 Sum_probs=203.4
Q ss_pred HhhhcccCcccceEEEEEEEcCC-cEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKG-EKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~-~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.+.+.||+|+||.||++..... ++.||+|++..........+++|+.+++.++||||+++++++.+++..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 56778999999999999987766 67889998765545555678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc-
Q 003772 592 NGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT- 668 (796)
Q Consensus 592 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~- 668 (796)
+|+|.++|... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988642 235688899999999999999999998 999999999999999999999999999987644322
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ......+. ....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--~~~------~~~~~~~~------~~~~ 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--REI------MQQVLYGK------YDPF 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHH------HHHHHhCC------CCCC
Confidence 122335589999999999999999999999999999999999999864321 110 01111110 0112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
+......+.+++..||+.+|++||++++++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 2234467899999999999999999999864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=318.16 Aligned_cols=260 Identities=24% Similarity=0.326 Sum_probs=194.2
Q ss_pred HhhhcccCcccceEEEEEEEc-CCcEEEEEEEeecccc--hhHHHHHHHHHHHhcc---CcCchhhhhhhhc-----cCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLY-KGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRT---HHKNLVRLIGYCA-----EDS 581 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~-~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l---~h~niv~l~g~~~-----~~~ 581 (796)
+++.+.||+|+||.||+++.. .+++.||||++..... .....+.+|+.+++++ +||||+++++++. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 456788999999999999874 4567899999865322 2234566677776665 6999999999875 245
Q ss_pred ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcc
Q 003772 582 KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~ 661 (796)
..++|+||+. ++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 6899999997 6899999765556789999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 662 LLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 662 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...........+.... ....+.....
T Consensus 159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~-~~~~~~~~~~ 235 (290)
T cd07862 159 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI-GLPGEEDWPR 235 (290)
T ss_pred eccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh-CCCChhhchh
Confidence 65433 22233458999999999998899999999999999999999999987543211111110000 0000000000
Q ss_pred -------hhcCC------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 742 -------LVRGQ------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 742 -------~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..... ...+.....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 001223466789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.93 Aligned_cols=258 Identities=24% Similarity=0.344 Sum_probs=201.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcE----EEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEK----LVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~----~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
..++.+.||+|+||.||+|.+...++ .+++|.+..... ....++..|+..+.+++|+||+++++++. +...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEE
Confidence 34556889999999999999865554 477787754332 23457888899999999999999999875 4557889
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
+||+++|+|.+++... ...+++..++.++.||+.||.|||+. +++|+||||+||++++++.+||+|||+++.....
T Consensus 87 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 87 TQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 9999999999999753 35689999999999999999999998 9999999999999999999999999999876443
Q ss_pred Ccc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 667 QTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 667 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .. ..... ..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~--~~~~~----~~~~------ 228 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HE--VPDLL----EKGE------ 228 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HH--HHHHH----HCCC------
Confidence 321 2223446778999999998899999999999999999998 8888854321 11 00000 0000
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCC
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDIS 788 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 788 (796)
....+..+...+.+++.+||+.+|++|||+.|+++.|+.+.+-+
T Consensus 229 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 229 RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 00111223456788999999999999999999999998876644
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.70 Aligned_cols=255 Identities=20% Similarity=0.239 Sum_probs=197.5
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.+.||+|+||.||++.....++.||||+... ..+.+|+.++++++||||+++++++..+...++|+|++.
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 35667899999999999999988889999997532 346789999999999999999999999999999999985
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 167 -~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 167 -TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240 (391)
T ss_pred -CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence 688888865 35689999999999999999999998 999999999999999999999999999975433322333
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCc----hhHHHHHHHHHhh-------h---hh
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKP----EEIVLINWAYKCF-------I---DR 737 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~-------~---~~ 737 (796)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ....+.. ..... . ..
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~-i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL-IIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH-HHHHhcCChhhcCcchhH
Confidence 34569999999999999999999999999999999999998875322111 0000000 00000 0 00
Q ss_pred hhhh----hhc-----CCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 738 ELNK----LVR-----GQEV-----DRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 738 ~~~~----~~~-----~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.+.. ... .... ....+..+.+++.+||+.||.+|||++|+++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 000 0000 1133567889999999999999999999984
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=320.25 Aligned_cols=262 Identities=21% Similarity=0.247 Sum_probs=197.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+.+.+.||+|+||.||+|+....++.||||++..... .....+.+|+.+++.++|+||+++++++.++...++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 35667899999999999999988888999999875432 22346788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
. ++|.+++... ...++...+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 86 ~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 159 (303)
T cd07869 86 H-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HT 159 (303)
T ss_pred C-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-cc
Confidence 6 6788877653 45688899999999999999999998 99999999999999999999999999987543221 12
Q ss_pred eeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh------h-
Q 003772 671 FTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK------L- 742 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~- 742 (796)
.....+++.|+|||++.+. .++.++|||||||++|||++|+.||........................... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 2234578999999998754 5789999999999999999999999754321111111110000000000000 0
Q ss_pred ------hcCCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 743 ------VRGQE-----VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 743 ------~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..+.. ........+.+++..||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00012246789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.73 Aligned_cols=246 Identities=29% Similarity=0.383 Sum_probs=197.4
Q ss_pred cCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 519 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
||+|+||.||++.....++.+|+|++.... ....+.+..|++++.+++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999998888999999986422 12344566799999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeec
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR 675 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~ 675 (796)
.+++.......+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 9998765556789999999999999999999998 99999999999999999999999999998664322 222345
Q ss_pred cCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 003772 676 GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLEN 755 (796)
Q Consensus 676 gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (796)
|+..|+|||++.+..++.++|||||||++|||++|+.||............ .... +..... .........
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~----~~~~----~~~~~~--~~~~~~~~~ 225 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL----KRRT----LEDEVK--FEHQNFTEE 225 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH----HHHh----hccccc--cccccCCHH
Confidence 899999999999989999999999999999999999998643321111111 0000 110000 011234566
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHH
Q 003772 756 MIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 756 l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
+.+++..||+.||.+||+++|+++
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccchh
Confidence 899999999999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.06 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=206.5
Q ss_pred HHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 508 LKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 508 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
+...++++.++||+|+||.||++...+ ++.||+|.+.... .....+.+|+.++++++|+||+++++++. .+..++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 445677888999999999999999765 4679999987543 33567899999999999999999998864 46789999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999776567799999999999999999999998 99999999999999999999999999998765333
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
........++..|+|||++....++.++||||||+++|||++ |+.||..... .... ... .... ..
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~------~~~-----~~~~-~~ 222 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVI------QNL-----ERGY-RM 222 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHH------HHH-----HcCC-CC
Confidence 222223345678999999998889999999999999999999 8888864321 1110 000 0000 01
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
..+...+.++.+++.+|++.+|++|||+++++..|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1122345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=324.60 Aligned_cols=242 Identities=25% Similarity=0.328 Sum_probs=197.3
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
+.||+|+||.||++.....++.||+|++.+.. ......+..|++++..++|+||+++.+++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999998888999999997632 223456788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhc-cCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHD-ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 594 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
+|.+++.. ...+++..+..++.||+.||.|||+ . +|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (325)
T cd05594 81 ELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK 154 (325)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence 99998865 4578999999999999999999997 5 999999999999999999999999999875432221 222
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..... .....+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~------~~i~~-------~~~~~p~~~ 219 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLF------ELILM-------EEIRFPRTL 219 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHH------HHHhc-------CCCCCCCCC
Confidence 345899999999999999999999999999999999999999643211 100 00000 001122334
Q ss_pred HHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003772 753 LENMIKIGLWCVQDEPALRP-----SMKSVVL 779 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 779 (796)
...+.+++.+||+.||++|+ ++.++++
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 56788999999999999996 8999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=323.01 Aligned_cols=244 Identities=24% Similarity=0.369 Sum_probs=194.0
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|+||.||++.....++.+|+|++++.. ....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999998888999999997632 23345677888888776 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|..++.. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (329)
T cd05618 81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS 154 (329)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccc
Confidence 999988865 45789999999999999999999998 999999999999999999999999999875432211 222
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCch-hHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPE-EIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+........ ....+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-------~~~~p~~ 227 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------QIRIPRS 227 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC-------CCCCCCC
Confidence 34589999999999999999999999999999999999999964221110 000011111111110 1112334
Q ss_pred HHHHHHHHHHHhccCCCCCCCC
Q 003772 752 TLENMIKIGLWCVQDEPALRPS 773 (796)
Q Consensus 752 ~~~~l~~l~~~cl~~dP~~RPt 773 (796)
....+.+++..||+.||.+||+
T Consensus 228 ~~~~~~~ll~~~L~~dP~~R~~ 249 (329)
T cd05618 228 LSVKAASVLKSFLNKDPKERLG 249 (329)
T ss_pred CCHHHHHHHHHHhcCCHHHcCC
Confidence 4567889999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=321.80 Aligned_cols=268 Identities=21% Similarity=0.314 Sum_probs=199.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccC-----CceeE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAED-----SKRLL 585 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 585 (796)
+.+.+.||+|+||.||+|.....++.||||++.... ......+.+|+.++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 456789999999999999998888999999986432 23345688999999999999999999987543 24799
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
||||+. ++|.+++.. ...+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 v~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 82 VFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 999996 689988865 45689999999999999999999998 999999999999999999999999999986532
Q ss_pred CCc--ceeeeeccCCCCCchhhhcc--CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH-------HHHhh
Q 003772 666 DQT--RTFTLVRGTRGYMAPEWYKN--TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW-------AYKCF 734 (796)
Q Consensus 666 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~ 734 (796)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............... .....
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 221 11233458999999999876 57899999999999999999999998643211100000000 00000
Q ss_pred hhh---h-hhhhhcCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HhcCcC
Q 003772 735 IDR---E-LNKLVRGQEV-----DRNTLENMIKIGLWCVQDEPALRPSMKSVVLM--LEGITD 786 (796)
Q Consensus 735 ~~~---~-~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~ 786 (796)
... . +......... .+.....+.+++..||+.||++|||++|+++. ++++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000 0 0000000000 01234567899999999999999999999853 444443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=335.70 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=212.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-cCchhhhhhh-hcc------CCcee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-HKNLVRLIGY-CAE------DSKRL 584 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~-~~~------~~~~~ 584 (796)
.++.+.|.+|||+.||.+.+..++..+|+|++-....+..+.+++|+++|++|+ |+|||.+++. ... .-+.+
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 346688999999999999998887899999987667778889999999999997 9999999993 321 12578
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
|.||||.+|.|-|++..+....|++.++++|+.++++|+++||.. .++|||||||-+||||..++..||+|||.+.-..
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 999999999999999876667799999999999999999999986 7789999999999999999999999999997543
Q ss_pred CCCcc--ee------eeeccCCCCCchhhh---ccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHh
Q 003772 665 PDQTR--TF------TLVRGTRGYMAPEWY---KNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKC 733 (796)
Q Consensus 665 ~~~~~--~~------~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 733 (796)
..... .. -...-|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+.....
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------------- 264 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------------- 264 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------------
Confidence 22211 00 012368999999987 4668999999999999999999999999855211
Q ss_pred hhhhhhhhhhcCC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCCC
Q 003772 734 FIDRELNKLVRGQ---EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIP 790 (796)
Q Consensus 734 ~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p 790 (796)
.++... ...+.....|..||..||+.||.+||++-+|+..+-++...+.|
T Consensus 265 -------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 265 -------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred -------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 111111 12357788999999999999999999999999999887766544
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=311.20 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=201.5
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.+.||+|+||.||+|...+ ...+|||.+.... ....+|.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 34677899999999999998754 3469999887532 335679999999999999999999999999889999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+|+|.+++... ...+++..++.++.||+.||.|||+. +++|+||||+||++++++.+||+|||+++..........
T Consensus 83 ~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 83 NGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 99999999764 23689999999999999999999998 999999999999999999999999999986644332222
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .. ........ ....+.
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~------~~~~~~~~------~~~~~~ 224 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ET------VEKVSQGL------RLYRPH 224 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HH------HHHHhcCC------CCCCCC
Confidence 22335678999999998889999999999999999998 88887543211 10 00000000 001122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
.....+.+++.+||+.+|.+||++.+|+..|+
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 23577899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=321.11 Aligned_cols=241 Identities=24% Similarity=0.336 Sum_probs=192.9
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhc-cCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGR-THHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|+||.||+|+....++.||||++.+.. ....+.+..|..++.. .+|+||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999998888899999997632 2233445566666664 4899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 999999875 35789999999999999999999998 99999999999999999999999999997653322 2223
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ... . ..... .....+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--~~~-~-----~~i~~-------~~~~~~~~~ 219 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--DEL-F-----DSILN-------DRPHFPRWI 219 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--HHH-H-----HHHHc-------CCCCCCCCC
Confidence 34589999999999998999999999999999999999999964321 110 0 00000 011122334
Q ss_pred HHHHHHHHHHhccCCCCCCCCHH-HHH
Q 003772 753 LENMIKIGLWCVQDEPALRPSMK-SVV 778 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~-evl 778 (796)
...+.+++..||+.+|.+||++. +++
T Consensus 220 ~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 220 SKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 56688999999999999999986 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.55 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=204.1
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCC-----cEEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhccCCce
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKG-----EKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~-----~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 583 (796)
...+++.++||+|+||.||+|..... .+.||||++...... ..+.+.+|+.++.+++|+||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 34567789999999999999987542 468999999754433 245688999999999999999999999999999
Q ss_pred eEEEeecCCCChhhhhhcC--------------CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC
Q 003772 584 LLVYEYMSNGSLADILFRG--------------PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF 649 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 649 (796)
++++||+++++|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence 9999999999999998531 123588889999999999999999998 99999999999999999
Q ss_pred CceEEeccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHH
Q 003772 650 WTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLI 727 (796)
Q Consensus 650 ~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~ 727 (796)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..|+..... ...
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~~--- 235 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDV--- 235 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HHH---
Confidence 99999999998866433221 1222345779999999998889999999999999999998 6667653211 110
Q ss_pred HHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 728 NWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
........ ....+...+..+.+++..||+.+|.+||++.+|++.|+.
T Consensus 236 ---~~~i~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 ---IEMIRNRQ------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---HHHHHcCC------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111 011234566779999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.19 Aligned_cols=249 Identities=26% Similarity=0.377 Sum_probs=206.3
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.||+|++|.||++....+++.|++|.+... .....+.+.+|++++++++|+||+++++++.+++..++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 4568899999999999999888899999998642 23456678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++........ .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-~ 158 (256)
T cd08529 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-A 158 (256)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch-h
Confidence 99999999875567899999999999999999999998 9999999999999999999999999999876543222 2
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
....+++.|+|||++.+..++.++||||||+++|||++|+.|+..... .. . ........ ....+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~--~----~~~~~~~~------~~~~~~~ 224 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GA--L----ILKIIRGV------FPPVSQM 224 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HH--H----HHHHHcCC------CCCCccc
Confidence 233578899999999999999999999999999999999999864431 11 0 01111100 0112224
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 752 TLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 752 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
....+.+++.+||+.+|++||++.++++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 55779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.11 Aligned_cols=254 Identities=29% Similarity=0.441 Sum_probs=203.3
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
...+++.++||+|+||.||++....+ ..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCC-ceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 34567789999999999999987644 5699999875333 3467999999999999999999999875 4568999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||++++++.++|+|||++..+......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999999765556789999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... + .. ... ... .....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~-~~-----~~~-----~~~-~~~~~ 224 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--E-VL-----EQV-----ERG-YRMPC 224 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--H-HH-----HHH-----HcC-CCCCC
Confidence 2222235678999999998899999999999999999999 78887543211 1 00 000 000 01112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
+......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 23445679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.99 Aligned_cols=242 Identities=24% Similarity=0.338 Sum_probs=196.2
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|+||.||+|+....++.||||++.+.. ....+.+..|.+++..+ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999998888899999997632 23345577888888866 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|...+.. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (321)
T cd05591 81 GDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT 154 (321)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence 999998875 45689999999999999999999998 999999999999999999999999999875432222 223
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... . . ........ ...+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~-~-----~~~i~~~~-------~~~p~~~ 219 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--D-L-----FESILHDD-------VLYPVWL 219 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--H-H-----HHHHHcCC-------CCCCCCC
Confidence 345899999999999999999999999999999999999999754311 1 0 01111100 0112223
Q ss_pred HHHHHHHHHHhccCCCCCCC-------CHHHHHH
Q 003772 753 LENMIKIGLWCVQDEPALRP-------SMKSVVL 779 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RP-------t~~evl~ 779 (796)
...+.+++..||+.||++|| ++.++++
T Consensus 220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 46688999999999999999 7888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.65 Aligned_cols=237 Identities=25% Similarity=0.390 Sum_probs=193.0
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|+||.||+++...+++.||||++.+.. ....+.+..|..++..+ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999998888899999997532 23345677888888776 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (320)
T cd05590 81 GDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTS 154 (320)
T ss_pred chHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-ccc
Confidence 999998876 35789999999999999999999998 999999999999999999999999999875432221 223
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ........ ...+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--~~~------~~~i~~~~-------~~~~~~~ 219 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--DDL------FEAILNDE-------VVYPTWL 219 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHH------HHHHhcCC-------CCCCCCC
Confidence 34589999999999999999999999999999999999999964321 110 11111100 1112234
Q ss_pred HHHHHHHHHHhccCCCCCCCCH
Q 003772 753 LENMIKIGLWCVQDEPALRPSM 774 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~ 774 (796)
...+.+++..||+.||.+||+.
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 220 SQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CHHHHHHHHHHcccCHHHCCCC
Confidence 5678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.40 Aligned_cols=250 Identities=29% Similarity=0.433 Sum_probs=200.7
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
...+.+.||+|+||.||++.+.. +..+|+|++.+.. .....+.+|+.++++++|+||+++++++.+.+..++|+||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEecC-CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35677899999999999998864 5679999986532 234568889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++..........
T Consensus 83 ~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 83 NGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 99999999754 24789999999999999999999998 999999999999999999999999999986543322222
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... +.. .. +.... ....+.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~------~~-----~~~~~-~~~~~~ 224 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVV------ES-----VSAGY-RLYRPK 224 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHH------HH-----HHcCC-cCCCCC
Confidence 22224467999999999899999999999999999999 78887643211 110 00 00000 011223
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLML 781 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 781 (796)
..+..+.+++.+||+.+|++|||+.||++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 3567899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.53 Aligned_cols=251 Identities=22% Similarity=0.277 Sum_probs=199.1
Q ss_pred HhhhcccCcccceEEEEEEEc---CCcEEEEEEEeeccc----chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCcee
Q 003772 513 NRFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMV----TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 584 (796)
+.+.+.||+|+||.||+++.. ..++.||+|++.+.. ....+.+..|+.++.++ +|+||+++++++.+++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 346688999999999998763 356789999997532 22345678899999999 5999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 82 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 82 LILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999976 45689999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
...........||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.. .. ..
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~----~~-----~~-- 225 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR----RI-----LK-- 225 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH----HH-----hc--
Confidence 4433333345689999999999865 478999999999999999999999975432221111100 00 00
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRP-----SMKSVVL 779 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 779 (796)
.....+......+.+++..||+.||++|| +++++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 00112233456788999999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.46 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=204.8
Q ss_pred HHhhhcccCcccceEEEEEEEcCCc---EEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGE---KLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~---~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
.+...+.||+|+||.||+|.+...+ ..+|+|++.... ....+.+.+|+.++.+++|+|++++++++.+.+..++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 3455688999999999999986543 379999987543 334567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++++|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 86 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 86 EYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999653 35789999999999999999999998 99999999999999999999999999998664332
Q ss_pred cceeee--eccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 668 TRTFTL--VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 668 ~~~~~~--~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
...... ...+..|+|||++.+..++.++|||||||++|||++ |+.|+..... ... ....... .
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~------~~~i~~~------~ 227 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEV------MKAINDG------F 227 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHH------HHHHhcC------C
Confidence 222111 223457999999998889999999999999999997 9999854321 110 0111000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
........+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11122344577899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.77 Aligned_cols=260 Identities=23% Similarity=0.270 Sum_probs=198.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.+.++||+|+||.||+|.....++.||+|++..... .....+.+|+.++++++|+||+++++++.++...++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 5567889999999999999988889999999865332 234567899999999999999999999999889999999998
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+ +|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 87 ~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~ 160 (288)
T cd07871 87 S-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TY 160 (288)
T ss_pred c-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-cc
Confidence 4 899888653 34678999999999999999999998 999999999999999999999999999976533221 22
Q ss_pred eeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhh---------hhhh
Q 003772 672 TLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDR---------ELNK 741 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 741 (796)
....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||........ .............. ....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccchhhhc
Confidence 23457899999999875 4689999999999999999999999965432111 11000000000000 0000
Q ss_pred hhcCCC-------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 742 LVRGQE-------VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 742 ~~~~~~-------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...+.. ........+.+++.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 01122356789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=321.55 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=198.2
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|+||.||++.....++.||||++++.. ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999998888999999997632 22345678899999888 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++.+ .+.+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (329)
T cd05588 81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTS 154 (329)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC-ccc
Confidence 999998865 46799999999999999999999998 999999999999999999999999999875322211 222
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCc-hhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKP-EEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+..+...... ...+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~p~~ 227 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-------IRIPRS 227 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-------CCCCCC
Confidence 3468999999999999999999999999999999999999997432111 00000111111111110 112233
Q ss_pred HHHHHHHHHHHhccCCCCCCCC------HHHHHH
Q 003772 752 TLENMIKIGLWCVQDEPALRPS------MKSVVL 779 (796)
Q Consensus 752 ~~~~l~~l~~~cl~~dP~~RPt------~~evl~ 779 (796)
....+.+++..||+.||.+||+ +.++++
T Consensus 228 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 228 LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 4567889999999999999997 677763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.69 Aligned_cols=247 Identities=29% Similarity=0.398 Sum_probs=197.7
Q ss_pred ccCcccceEEEEEEE--cCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 518 ELGKGSFGAVYKGTL--YKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 518 ~LG~G~fg~Vy~g~~--~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
+||+|+||.||+|.+ ...++.+|+|+++.... ...+++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999965 34567899999865332 24567899999999999999999999875 45678999999999
Q ss_pred ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee--
Q 003772 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF-- 671 (796)
Q Consensus 594 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~-- 671 (796)
+|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 99999965 35689999999999999999999998 999999999999999999999999999987654432211
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
....++..|+|||.+....++.++||||||+++|||++ |+.||...... .. . .....+. ....+.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~--~----~~i~~~~------~~~~~~ 221 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EV--T----QMIESGE------RMECPQ 221 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HH--H----HHHHCCC------CCCCCC
Confidence 12234578999999988889999999999999999998 88888643211 11 0 0011100 011233
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
..+..+.+++.+||+.||++||++.+|++.|++.
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 4567789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.18 Aligned_cols=242 Identities=25% Similarity=0.320 Sum_probs=195.7
Q ss_pred cccCcccceEEEEEEEc---CCcEEEEEEEeeccc----chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 517 EELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMV----TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.||+|+||.||+++.. ..++.||||++++.. ......+.+|+.++++++||||+++++.+.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999864 356789999997532 12335678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.+ .+.+.+..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 999999999976 45688889999999999999999998 999999999999999999999999999875432222
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ........ ....+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--~------~~~~~~~~-------~~~~~ 220 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--K------TIDKILKG-------KLNLP 220 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--H------HHHHHHcC-------CCCCC
Confidence 122345899999999999988999999999999999999999999643211 0 01111110 01123
Q ss_pred HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRP-----SMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 779 (796)
......+.+++..||+.+|++|| ++.++++
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 33456788999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.00 Aligned_cols=256 Identities=30% Similarity=0.482 Sum_probs=202.4
Q ss_pred HHHhhhcccCcccceEEEEEEEc----CCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLY----KGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~----~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
...++.++||+|+||.||+|... ..+..||+|.+.... .+....+.+|+.++++++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 34567789999999999999852 344689999997533 3344678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCC---------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC
Q 003772 586 VYEYMSNGSLADILFRGP---------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW 650 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 650 (796)
||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +|+|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999985321 23578899999999999999999998 999999999999999999
Q ss_pred ceEEeccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHH
Q 003772 651 TAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLIN 728 (796)
Q Consensus 651 ~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~ 728 (796)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||..... ..+ .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~--~- 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEV--I- 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHH--H-
Confidence 999999999987643322 11222335678999999998889999999999999999998 8878753221 111 0
Q ss_pred HHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 729 WAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
+....... ...+......+.+++.+||+.+|.+||++.+|.++|.+
T Consensus 237 ---~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 ---EMVRKRQL------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHHcCCc------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 10000000 01223345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.95 Aligned_cols=256 Identities=26% Similarity=0.423 Sum_probs=200.9
Q ss_pred HHHhhhcccCcccceEEEEEEEcC-----CcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCcee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 584 (796)
..+.+.+.||+|+||.||+|.+.. .+..||||++.... .....++.+|+.+++.++|+||+++++++.++...+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 446677899999999999998642 34679999986432 234457899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCC--------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEec
Q 003772 585 LVYEYMSNGSLADILFRGP--------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISD 656 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 656 (796)
+|+||+++|+|.+++.... ...+++..++.++.|+++||.|||+. +++|+||||+||++++++.++|+|
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECC
Confidence 9999999999999986521 13467888999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCcce-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhh
Q 003772 657 FGLAKLLMPDQTRT-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCF 734 (796)
Q Consensus 657 Fgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 734 (796)
||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..|+..... .. .. ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~~-~~-----~~~ 234 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQ-VL-----RFV 234 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HH-HH-----HHH
Confidence 99987654332211 112235678999999999899999999999999999999 6777753321 11 00 000
Q ss_pred hhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 735 IDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
..... ...+...+..+.+++.+||+.+|++|||+.|++++|++
T Consensus 235 ~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGL------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCc------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 01100 11223445678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=324.88 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=202.1
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||++.....++.||+|++.+.. .+..+.+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 456688999999999999998888999999997632 23456688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.+. ...+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 83 ~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 83 QPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 9999999999763 35789999999999999999999998 9999999999999999999999999999876544433
Q ss_pred eeeeeccCCCCCchhhhc------cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 670 TFTLVRGTRGYMAPEWYK------NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
......||+.|+|||++. ...++.++|||||||++|||++|+.||....... . ....... ....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~-----~~~i~~~--~~~~ 228 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK---T-----YNNIMNF--QRFL 228 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH---H-----HHHHHcC--CCcc
Confidence 333446899999999987 4567899999999999999999999996443110 0 0111000 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
. -.........+.+++..|++ +|.+|||+.+++.
T Consensus 229 ~-~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 K-FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C-CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 00112345668889999998 9999999999984
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.23 Aligned_cols=258 Identities=29% Similarity=0.422 Sum_probs=205.5
Q ss_pred HHHhhhcccCcccceEEEEEEEcCC-----cEEEEEEEeeccc-chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCce
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKG-----EKLVAVKKLEKMV-TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~-----~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 583 (796)
..+.+.+.||+|+||.||++..... ...+|+|++.... .+...++.+|+.++.++ +|+||+++++++.+++..
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 3455668899999999999987533 3689999987532 33446688999999999 799999999999999999
Q ss_pred eEEEeecCCCChhhhhhcC--------------CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC
Q 003772 584 LLVYEYMSNGSLADILFRG--------------PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF 649 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 649 (796)
++||||+++|+|.+++... ....+++..++.++.|++.||.|||+. +|+|+||||+||+++++
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTED 168 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCC
Confidence 9999999999999999642 245789999999999999999999998 99999999999999999
Q ss_pred CceEEeccCCccccCCCCcce-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHH
Q 003772 650 WTAKISDFGLAKLLMPDQTRT-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLI 727 (796)
Q Consensus 650 ~~~kl~DFgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~ 727 (796)
+.+||+|||+++.+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..|+...... ..
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~--- 243 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--EL--- 243 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--HH---
Confidence 999999999998765433211 122235678999999999899999999999999999998 88877533211 10
Q ss_pred HHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 728 NWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
.+....+. ....+......+.+++.+|++.+|++|||+.|+++.|+.++
T Consensus 244 ---~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 ---FKLLKEGY------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---HHHHHcCC------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 01100000 01123344567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.33 Aligned_cols=254 Identities=28% Similarity=0.431 Sum_probs=203.3
Q ss_pred HhhhcccCcccceEEEEEEEc-----CCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
..+.++||+|+||.||++... ..+..+|+|.+..........+.+|++++.+++|+||+++++++.++...++++
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF 86 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence 445789999999999999753 234689999988766666778999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCC-------------CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEE
Q 003772 588 EYMSNGSLADILFRGPE-------------RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKI 654 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 654 (796)
||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEE
Confidence 99999999999875321 3588999999999999999999998 9999999999999999999999
Q ss_pred eccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHH
Q 003772 655 SDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYK 732 (796)
Q Consensus 655 ~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 732 (796)
+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... ... .
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~------~ 235 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EAI------E 235 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HHH------H
Confidence 999999765432221 1112235678999999999999999999999999999998 88887533211 100 0
Q ss_pred hhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 733 CFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
..... .....+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 236 ~~~~~------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CITQG------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHcC------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 00000 0011223445678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.28 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=195.3
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+.+.||+|+||.||+|+....++.||||++.+.. ....+.+++|+.++.+++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~ 83 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (381)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence 45678999999999999998888999999997532 234567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc-
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR- 669 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~- 669 (796)
++|+|.+++.+ ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 84 ~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 84 PGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 99999999976 35688999999999999999999998 9999999999999999999999999997643210000
Q ss_pred ---------------------------------------------eeeeeccCCCCCchhhhccCCCCccccchhhHHHH
Q 003772 670 ---------------------------------------------TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVL 704 (796)
Q Consensus 670 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil 704 (796)
......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 01124589999999999998999999999999999
Q ss_pred HHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHH--hccCCCCCCCCHHHHHHH
Q 003772 705 LEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLW--CVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 705 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPt~~evl~~ 780 (796)
|||++|+.||..............+ ... ... .........+.+++.. |+..+|..||++.+|+..
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~------~~~-~~~----~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINW------ENT-LHI----PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHcc------ccc-cCC----CCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999754321111100000 000 000 0011223455566655 566677779999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.33 Aligned_cols=260 Identities=25% Similarity=0.334 Sum_probs=198.2
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCC-----ceeEEEeec
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS-----KRLLVYEYM 590 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~e~~ 590 (796)
.+++|.|.||.||+|.+...++.||||+.-.... .--.|+++|++++|||||+++-++.... ...+|+|||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 3789999999999999998889999999854322 2245899999999999999998876422 245899999
Q ss_pred CCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC-CceEEeccCCccccCCCC
Q 003772 591 SNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF-WTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 591 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFgl~~~~~~~~ 667 (796)
+. +|.+.++.. .+..++...+.-+..||.+||.|||+. +|+||||||+|+|+|.+ +.+||+|||.|+.+..++
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 86 898888742 356788888999999999999999998 99999999999999965 999999999999998777
Q ss_pred cceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhh--------
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-------- 738 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 738 (796)
..... ..|.-|+|||.+.+. .|+.+.||||.||++.||+-|+..|..+.....-..+.. .......++
T Consensus 181 pniSY--icSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik-~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 181 PNISY--ICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIK-VLGTPTREDIKSMNPNY 257 (364)
T ss_pred CceeE--EEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHH-HhCCCCHHHHhhcCccc
Confidence 66443 358899999999876 799999999999999999999998876433221111111 000000011
Q ss_pred -------hhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhcCcC
Q 003772 739 -------LNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEGITD 786 (796)
Q Consensus 739 -------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~ 786 (796)
+....-.+........+.++++.++++.+|.+|.+..|++. ..+.+.+
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 11111001134456678999999999999999999999873 3444443
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=315.35 Aligned_cols=258 Identities=28% Similarity=0.433 Sum_probs=205.1
Q ss_pred HHHhhhcccCcccceEEEEEEEc-----CCcEEEEEEEeecccc-hhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCce
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 583 (796)
....+.+.||+|+||.||++... .....||||+++.... ...+.+.+|+.+++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 34566789999999999999752 3345899999876432 3346789999999999 799999999999999999
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
++|+||+++|+|.+++.......+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 9999999999999999765445589999999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 664 MPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 664 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
...... ......++..|+|||.+.+..++.++|||||||++|||++ |+.|+........ +.. . ....
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---~~~----~-~~~~--- 260 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---FYK----L-IKEG--- 260 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH---HHH----H-HHcC---
Confidence 443221 1112335678999999999999999999999999999998 8888764332110 000 0 0000
Q ss_pred hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 742 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
.. ...+.....++.+++.+|++.+|++|||+.||++.|+.+
T Consensus 261 -~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 -YR-MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -Cc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 011123346799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=327.00 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=204.6
Q ss_pred HHHHHHhhhcccCcccceEEEEEEEc-----CCcEEEEEEEeecccch-hHHHHHHHHHHHhccC-cCchhhhhhhhccC
Q 003772 508 LKKATNRFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTE-GEREFRAEMHVIGRTH-HKNLVRLIGYCAED 580 (796)
Q Consensus 508 l~~~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~ 580 (796)
+......+.++||+|+||.||+|++. ...+.||||+++..... ..+.+..|++++.++. |+||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 33444556789999999999999864 23468999999764332 3456889999999997 99999999999999
Q ss_pred CceeEEEeecCCCChhhhhhcCCC--------------------------------------------------------
Q 003772 581 SKRLLVYEYMSNGSLADILFRGPE-------------------------------------------------------- 604 (796)
Q Consensus 581 ~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 604 (796)
+..++|+||+++|+|.+++++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999999965311
Q ss_pred ----------------------------------------CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccce
Q 003772 605 ----------------------------------------RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNI 644 (796)
Q Consensus 605 ----------------------------------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NI 644 (796)
..+++..++.++.||+.||.|||+. +++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 2367778899999999999999998 999999999999
Q ss_pred EecCCCceEEeccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCch
Q 003772 645 LMDEFWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPE 722 (796)
Q Consensus 645 ll~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~ 722 (796)
|+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+........
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999986533221 11122346788999999998889999999999999999998 7888754332111
Q ss_pred hHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 723 EIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
. ......+ . ....+......+.+++..||+.+|.+||++++|++.|+.+.
T Consensus 351 ---~----~~~~~~~-----~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 ---F----YNAIKRG-----Y-RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---H----HHHHHcC-----C-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0 0000000 0 00112234567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=309.63 Aligned_cols=254 Identities=24% Similarity=0.414 Sum_probs=201.0
Q ss_pred hhhcccCcccceEEEEEEEcCCc---EEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCc------
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGE---KLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSK------ 582 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~---~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~------ 582 (796)
.+.+.||+|+||.||+|.+..+. ..||||+++... ......+.+|++.+..++|+||+++++++.+...
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 35688999999999999986533 689999987532 2345678999999999999999999998876554
Q ss_pred eeEEEeecCCCChhhhhhcC----CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccC
Q 003772 583 RLLVYEYMSNGSLADILFRG----PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFG 658 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 658 (796)
.++|+||+++|+|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence 79999999999999998542 234689999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCcce-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhh
Q 003772 659 LAKLLMPDQTRT-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFID 736 (796)
Q Consensus 659 l~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..|+..... .. ... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~--~~~----~~~~ 230 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HE--IYD----YLRH 230 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HH--HHH----HHHc
Confidence 998764433211 112234678999999998899999999999999999999 7777753321 11 100 0000
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 737 RELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
+. ....+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 231 ~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 1112334567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.50 Aligned_cols=253 Identities=21% Similarity=0.278 Sum_probs=201.6
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
...+.+.+.||+|+||.||+++....++.||+|++.+.. ....+.+.+|+.+++.++|+||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 345567789999999999999998888999999997532 22345578899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|||+++|+|.+++.. ..++...+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 122 ~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 122 MEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999864 3578888999999999999999998 9999999999999999999999999999876543
Q ss_pred CcceeeeeccCCCCCchhhhccC----CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNT----PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
.........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... . .+....... ...
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~------~~~~i~~~~-~~~ 266 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--G------TYSKIMDHK-NSL 266 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--H------HHHHHHcCC-CcC
Confidence 33222345689999999998754 4789999999999999999999999754311 0 011111100 000
Q ss_pred hcCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 003772 743 VRGQEVDRNTLENMIKIGLWCVQDEPAL--RPSMKSVVL 779 (796)
Q Consensus 743 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~ 779 (796)
.. .........+.+++..||+.+|.+ |||+.|+++
T Consensus 267 ~~--~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 267 TF--PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CC--CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 00 011234567889999999999988 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.14 Aligned_cols=264 Identities=27% Similarity=0.397 Sum_probs=202.5
Q ss_pred hhhcccCcccceEEEEEEE----cCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccC--CceeEE
Q 003772 514 RFKEELGKGSFGAVYKGTL----YKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAED--SKRLLV 586 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~----~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 586 (796)
.+.+.||+|+||+||++.. ...++.||+|.+..... .....+.+|++++++++|+||+++++++.+. ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5668899999999987653 34556899999875432 3456788999999999999999999987653 357899
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|||+++|+|.+++.. ..+++..++.++.|+++||.|||+. +|+|+||||+||++++++.++|+|||+++.....
T Consensus 87 ~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 999999999999965 3599999999999999999999998 9999999999999999999999999999876433
Q ss_pred Ccce--eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 667 QTRT--FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 667 ~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........... ...........+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI--GPKQGQMTVVRLIELLE 238 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh--cccccccchhhhhhhhh
Confidence 2211 1122356679999999988999999999999999999999999764332111100 00000000111111111
Q ss_pred C---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 745 G---QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 745 ~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
. ...+...+..+.+++..||+.+|++|||+++|+++|+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1 1123345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.46 Aligned_cols=267 Identities=30% Similarity=0.433 Sum_probs=202.1
Q ss_pred HhhhcccCcccceEEEEEEEc----CCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhcc--CCceeEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLY----KGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE--DSKRLLV 586 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~----~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV 586 (796)
.++.+.||+|+||.||++... ..++.||+|++........+.+.+|+.++.+++|+||+++++++.. ....++|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence 456688999999999999853 3467899999987666667789999999999999999999997654 3467899
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
+||+++|+|.+++.+. ...+++..++.++.|++.||.|||+. +|+|+||||+||++++++.+||+|||+++.....
T Consensus 86 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 86 MEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 9999999999999653 34689999999999999999999998 9999999999999999999999999999876443
Q ss_pred Ccceee--eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 667 QTRTFT--LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 667 ~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
...... ...++..|+|||.+.+..++.++||||||+++|||++|..++.............. .........+.+.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 240 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND-KQGQMIVYHLIELLK 240 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccc-cccccchHHHHHHHh
Confidence 321111 11234469999999988999999999999999999998776542211000000000 000000000111111
Q ss_pred CC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 745 GQ---EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 745 ~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
.. ......+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11 12234456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=307.11 Aligned_cols=249 Identities=29% Similarity=0.398 Sum_probs=200.5
Q ss_pred cccCcccceEEEEEEEcCCc---EEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGE---KLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~---~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
++||+|+||.||+|.....+ ..+|+|.+..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999875544 6899999876443 35567999999999999999999999875 5568999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 9999999763 4789999999999999999999998 9999999999999999999999999999876543322111
Q ss_pred --eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 673 --LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 673 --~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
...++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... . ........ . .....+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~--~~~~~~~~----~------~~~~~~ 220 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--A--EVIAMLES----G------ERLPRP 220 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--H--HHHHHHHc----C------CcCCCC
Confidence 1223567999999999999999999999999999998 8888864321 1 11111100 0 011223
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
...+..+.+++.+|++.+|++||++.+|++.|+++.
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 344567899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=307.75 Aligned_cols=253 Identities=28% Similarity=0.416 Sum_probs=202.2
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+.+.+.||+|++|.||++.+... ..+|+|++.... ...+.+.+|+.++++++|+|++++++++. .+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 3456778999999999999988665 469999886532 33467889999999999999999998875 45688999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|+|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999999765556689999999999999999999998 99999999999999999999999999998764333222
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....++..|+|||...+...+.++||||||+++|||++ |+.|+..... .. .. ..... .. ....+
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~-~~-~~~~~---------~~-~~~~~ 225 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--RE-VL-EQVER---------GY-RMPCP 225 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HH-HH-HHHHc---------CC-CCCCC
Confidence 222335678999999998899999999999999999999 8888764321 11 00 00000 00 01122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 3456779999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=318.29 Aligned_cols=242 Identities=26% Similarity=0.356 Sum_probs=197.0
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|+||.||++.....++.||||++.+.. ......+..|.+++..+ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999998888899999997642 23345677888888877 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++.+ ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (318)
T cd05570 81 GDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS 154 (318)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence 999998876 35799999999999999999999998 999999999999999999999999999875322221 122
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ... ....... ....+...
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~------~~~i~~~-------~~~~~~~~ 219 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DEL------FQSILED-------EVRYPRWL 219 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHH------HHHHHcC-------CCCCCCcC
Confidence 34589999999999999999999999999999999999999964321 110 0101000 01122334
Q ss_pred HHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 003772 753 LENMIKIGLWCVQDEPALRPSM-----KSVVL 779 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 779 (796)
...+.+++..||+.||.+|||+ .++++
T Consensus 220 ~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 220 SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 5678999999999999999999 88764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=311.04 Aligned_cols=257 Identities=28% Similarity=0.424 Sum_probs=204.6
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCc-----EEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCce
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGE-----KLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~-----~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 583 (796)
...+.+.+.||+|+||.||+|...... ..||+|.+.... ......+.+|+.++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 345566789999999999999886433 789999987543 23456788999999999999999999999999999
Q ss_pred eEEEeecCCCChhhhhhcCC--------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEe
Q 003772 584 LLVYEYMSNGSLADILFRGP--------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKIS 655 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 655 (796)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999999996532 23478899999999999999999998 99999999999999999999999
Q ss_pred ccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHh
Q 003772 656 DFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKC 733 (796)
Q Consensus 656 DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 733 (796)
|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.|+..... ... . ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~--~----~~ 233 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEV--L----KF 233 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHH--H----HH
Confidence 9999986543322 11222336788999999998889999999999999999998 8888753221 111 0 00
Q ss_pred hhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 734 FIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
..... ....+...+..+.+++..||+.+|++|||+.+|++.|+.
T Consensus 234 ~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 VIDGG------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HhcCC------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 00000 011233346789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=309.02 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=198.6
Q ss_pred hhcccCcccceEEEEEEEcCCcE--EEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccC------Ccee
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEK--LVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAED------SKRL 584 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~--~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 584 (796)
+.+.||+|+||.||+|.+...+. .+|+|.++.. .....+.+..|+.++.+++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 56889999999999999876654 6899988653 234456789999999999999999999987532 2468
Q ss_pred EEEeecCCCChhhhhhcC----CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCc
Q 003772 585 LVYEYMSNGSLADILFRG----PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA 660 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~ 660 (796)
+|+||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 999999999999987432 234589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcce-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhh
Q 003772 661 KLLMPDQTRT-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRE 738 (796)
Q Consensus 661 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
+.+....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .. . ......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~--~----~~~~~~~~ 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SE--I----YDYLRQGN 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HH--H----HHHHHcCC
Confidence 8765433211 112235678999999999999999999999999999999 7777753221 11 0 11111110
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 739 LNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
. ...+...+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 232 ~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 R------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 112234556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.64 Aligned_cols=244 Identities=26% Similarity=0.331 Sum_probs=194.7
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHH---hccCcCchhhhhhhhccCCceeEEE
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVI---GRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
++.+.||+|+||.||++.....++.||||++.+.. ....+.+..|+.++ .+++||||+++++++.+++..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45688999999999999998888999999997532 22334566666554 5678999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++|+|...+.. ..+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 82 E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 82 EYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred cCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 99999999988854 5699999999999999999999998 99999999999999999999999999987543222
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
. ......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... . .. ...... ...
T Consensus 156 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~-~~-----~~i~~~-------~~~ 219 (324)
T cd05589 156 D-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--E-VF-----DSIVND-------EVR 219 (324)
T ss_pred C-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--H-HH-----HHHHhC-------CCC
Confidence 1 222345899999999999999999999999999999999999999643211 1 00 001000 011
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRP-----SMKSVVL 779 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 779 (796)
.+......+.+++.+||+.||.+|| ++.++++
T Consensus 220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 2233456788999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.36 Aligned_cols=241 Identities=26% Similarity=0.333 Sum_probs=194.0
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhc-cCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGR-THHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|+||.||+|.....++.||||+++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999998888899999997642 2334456677777776 4899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (316)
T cd05619 81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTC 154 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-cee
Confidence 999999965 35688999999999999999999998 999999999999999999999999999875322221 223
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... .+.... .....+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~------~~~i~~-------~~~~~~~~~ 219 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EEL------FQSIRM-------DNPCYPRWL 219 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHH------HHHHHh-------CCCCCCccC
Confidence 34589999999999999999999999999999999999999964321 110 000000 001112234
Q ss_pred HHHHHHHHHHhccCCCCCCCCHH-HHH
Q 003772 753 LENMIKIGLWCVQDEPALRPSMK-SVV 778 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~-evl 778 (796)
...+.+++..||+.+|.+||++. ++.
T Consensus 220 ~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 220 TREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 45688999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=306.04 Aligned_cols=248 Identities=26% Similarity=0.355 Sum_probs=197.5
Q ss_pred ccCcccceEEEEEEEc--CCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCC
Q 003772 518 ELGKGSFGAVYKGTLY--KGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGS 594 (796)
Q Consensus 518 ~LG~G~fg~Vy~g~~~--~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 594 (796)
.||+|+||.||+|.+. +.+..||+|++..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 4456799999876433 33467999999999999999999999875 457899999999999
Q ss_pred hhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee--e
Q 003772 595 LADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF--T 672 (796)
Q Consensus 595 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~--~ 672 (796)
|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........... .
T Consensus 81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99998653 45789999999999999999999998 999999999999999999999999999986544332111 1
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
...++..|+|||.+....++.++||||||+++||+++ |..|+...... .. ....... .....+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~------~~~~~~~------~~~~~~~~ 222 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EV------MSFIEQG------KRLDCPAE 222 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HH------HHHHHCC------CCCCCCCC
Confidence 1223578999999998889999999999999999996 88888643211 10 0000000 01122344
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 752 TLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 752 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
+.+.+.+++..||+.+|++||++.+|.+.|+.+
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 567888999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=328.63 Aligned_cols=250 Identities=24% Similarity=0.301 Sum_probs=198.0
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+++....++.||||++.+.. ......+.+|+.++..++|+||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 345688999999999999998888999999997532 23345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 83 ~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 83 LPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 999999999976 45689999999999999999999998 9999999999999999999999999998765321110
Q ss_pred -------------------------------------eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhccc
Q 003772 670 -------------------------------------TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRR 712 (796)
Q Consensus 670 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~ 712 (796)
......||+.|+|||++....++.++|||||||++|||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0012358999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 003772 713 NMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPS---MKSVVL 779 (796)
Q Consensus 713 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~ 779 (796)
||...... .. ........ .....+ ......+.+.+++..|+. +|.+|++ +.++++
T Consensus 238 Pf~~~~~~--~~------~~~i~~~~-~~~~~~--~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 238 PFCSDNPQ--ET------YRKIINWK-ETLQFP--DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCHH--HH------HHHHHcCC-CccCCC--CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99744311 10 00000000 000000 011234567788888986 8999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=313.98 Aligned_cols=265 Identities=25% Similarity=0.367 Sum_probs=201.0
Q ss_pred HHHHHhhhcccCcccceEEEEEEEcCC--------------cEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhh
Q 003772 509 KKATNRFKEELGKGSFGAVYKGTLYKG--------------EKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRL 573 (796)
Q Consensus 509 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~--------------~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l 573 (796)
....+++.++||+|+||.||++..... ...||+|++..... .....|.+|++++.+++|+||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 344567789999999999999886432 23589999876432 334579999999999999999999
Q ss_pred hhhhccCCceeEEEeecCCCChhhhhhcCC----------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccc
Q 003772 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGP----------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQN 643 (796)
Q Consensus 574 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~N 643 (796)
++++...+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 999999999999999999999999986431 12478889999999999999999998 99999999999
Q ss_pred eEecCCCceEEeccCCccccCCCCcce-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcc--cCCCCCCCC
Q 003772 644 ILMDEFWTAKISDFGLAKLLMPDQTRT-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCR--RNMEIDPSK 720 (796)
Q Consensus 644 Ill~~~~~~kl~DFgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~--~p~~~~~~~ 720 (796)
|++++++.+||+|||++.......... .....++..|+|||++.+..++.++|||||||++|||+++. .|+....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~-- 237 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS-- 237 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC--
Confidence 999999999999999998654332211 12223567899999999889999999999999999999844 4544221
Q ss_pred chhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 721 PEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
...... ........ ...... ...+...+..+.+++.+||+.+|++||||.+|++.|+.
T Consensus 238 ~~~~~~--~~~~~~~~-~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 DEQVIE--NTGEFFRN-QGRQIY--LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred hHHHHH--HHHHhhhh-cccccc--CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111110 00000000 000000 01122345689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=322.28 Aligned_cols=199 Identities=25% Similarity=0.346 Sum_probs=173.9
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+.+.||+|+||.||++.....++.||||++.+.. ......+++|+.++.+++|+||+++++.+.++...++||||+
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL 83 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence 45688999999999999998888999999997532 223456888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc--
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT-- 668 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~-- 668 (796)
++|+|.+++.+ .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 84 ~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 84 PGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 99999999976 46799999999999999999999998 999999999999999999999999999876532110
Q ss_pred --------------------------------ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCC
Q 003772 669 --------------------------------RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEI 716 (796)
Q Consensus 669 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~ 716 (796)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001234689999999999999999999999999999999999999964
Q ss_pred C
Q 003772 717 D 717 (796)
Q Consensus 717 ~ 717 (796)
.
T Consensus 239 ~ 239 (363)
T cd05628 239 E 239 (363)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.33 Aligned_cols=242 Identities=23% Similarity=0.396 Sum_probs=192.4
Q ss_pred cccCcccceEEEEEEEcCCc-------EEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 517 EELGKGSFGAVYKGTLYKGE-------KLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~-------~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.||+|+||.||+|.....+ ..||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999875433 34888988765555667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc--------eEEeccCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT--------AKISDFGLAK 661 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DFgl~~ 661 (796)
+++|+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999999764 34689999999999999999999998 9999999999999987765 6999999987
Q ss_pred ccCCCCcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh
Q 003772 662 LLMPDQTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740 (796)
Q Consensus 662 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
...... ...++..|+|||++.+. .++.++||||||+++|||++|..++........... ...
T Consensus 157 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~--------~~~---- 219 (258)
T cd05078 157 TVLPKE-----ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ--------FYE---- 219 (258)
T ss_pred ccCCch-----hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH--------HHH----
Confidence 553321 23478899999999874 579999999999999999999644322211110000 000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 741 KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
.....+......+.+++..||+.+|++|||++++++.|+
T Consensus 220 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 ---DRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---ccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011122233466899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=305.45 Aligned_cols=258 Identities=21% Similarity=0.351 Sum_probs=208.3
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+|.....++.||+|.++... ....+.+.+|++++++++|+|++++++++.+.+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 456789999999999999998788899999886421 22356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 590 MSNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 590 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
+++|+|.+++... ....+++..++.++.|+++||.|||+. +|+|+||+|+||+++.++.++|+|||++..+....
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 9999999998642 245689999999999999999999998 99999999999999999999999999987654332
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.......... ........ ....
T Consensus 161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~~-----~~~~ 228 (267)
T cd08224 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL------CKKIEKCD-----YPPL 228 (267)
T ss_pred cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH------HhhhhcCC-----CCCC
Confidence 21 122347889999999998889999999999999999999999986443211110 00000000 0011
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
........+.+++..||+.+|++|||+.+|+++|+.+.
T Consensus 229 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11245567899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=310.09 Aligned_cols=256 Identities=26% Similarity=0.422 Sum_probs=204.2
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCc---EEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGE---KLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~---~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
..+++.+.||+|+||.||+|.+...+ ..||||++.... ....++|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34567789999999999999987554 369999987643 33456899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
+||+++|+|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 84 TEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999998754 35689999999999999999999998 9999999999999999999999999998765432
Q ss_pred Ccc-eeee-ec--cCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 667 QTR-TFTL-VR--GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 667 ~~~-~~~~-~~--gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
... .... .. .+..|+|||.+....++.++||||||+++|||++ |..|+..... .. ...... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~--~~~~i~---------~ 226 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QD--VINAIE---------Q 226 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HH--HHHHHH---------c
Confidence 221 1111 11 2357999999999999999999999999999886 8888853321 11 111100 0
Q ss_pred hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 742 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
. .....+.+.+..+.+++..||+.+|++||++.+|+.+|+++
T Consensus 227 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 D-YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C-CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01112234456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=304.26 Aligned_cols=247 Identities=28% Similarity=0.386 Sum_probs=198.9
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
+.||+|+||.||+|... ++..+|+|++...... ....+.+|+.++++++|+||+++++++.+.+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46899999999999875 4678999998764433 345688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeec
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR 675 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~ 675 (796)
.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+|||++...............
T Consensus 80 ~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 80 LSFLRKK-KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 9998653 34688999999999999999999998 9999999999999999999999999999765433222222223
Q ss_pred cCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHH
Q 003772 676 GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLE 754 (796)
Q Consensus 676 gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (796)
++..|+|||++....++.++||||||+++||+++ |..||...... ... ... .... ....+...+.
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~------~~~-----~~~~-~~~~~~~~~~ 221 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAR------EQV-----EKGY-RMSCPQKCPD 221 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHH------HHH-----HcCC-CCCCCCCCCH
Confidence 4678999999998899999999999999999998 88888543211 100 000 0000 1112234567
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 755 NMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 755 ~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
.+.+++..|++.+|++||++.|+++.|.
T Consensus 222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 222 DVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 8999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.77 Aligned_cols=240 Identities=25% Similarity=0.340 Sum_probs=202.6
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 587 (796)
..+|.++||+|.||+|+++..+..++.+|||.+++.. ....+..+.|..++... +||.|+.++.++...++.++||
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 3456789999999999999999999999999998743 33455677888888777 5999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+.||++..+.+ ...+++..+..++..|+.||.|||++ +||+||||.+|||||.+|.+||+|||+++......
T Consensus 449 ey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 449 EYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 9999999544443 47899999999999999999999999 99999999999999999999999999998754333
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh-cCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV-RGQ 746 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 746 (796)
......+||+.|||||++.+..|+..+|.|||||+||||+.|..||..+.+++ . ...++ +..
T Consensus 523 -~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee---~-------------FdsI~~d~~ 585 (694)
T KOG0694|consen 523 -DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE---V-------------FDSIVNDEV 585 (694)
T ss_pred -CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH---H-------------HHHHhcCCC
Confidence 34556789999999999999999999999999999999999999998654221 1 11111 122
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSM 774 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 774 (796)
..+.....+.+.++.+++..+|++|--+
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 3466677889999999999999999887
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=304.28 Aligned_cols=249 Identities=27% Similarity=0.359 Sum_probs=201.4
Q ss_pred cccCcccceEEEEEEEcC-Cc--EEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYK-GE--KLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~-~~--~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|++|.||+|.+.. ++ ..||||.+..... ...+.+..|+.++++++|+||+++++++.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999855 22 3699999987555 566789999999999999999999999888 889999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc--e
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR--T 670 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~--~ 670 (796)
|+|.+++.+.....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999765335789999999999999999999998 9999999999999999999999999999877543221 1
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+..... .... ... .........+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~--~~~---------~~~~~~~~~~ 223 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--SQIL--KKI---------DKEGERLERP 223 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHH--HHH---------HhcCCcCCCC
Confidence 112346789999999999899999999999999999999 9998853321 1110 000 0000011112
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
...+..+.+++.+|++.+|++|||+.+|++.|.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 234567999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=334.53 Aligned_cols=252 Identities=24% Similarity=0.307 Sum_probs=202.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccCC--------
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS-------- 581 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-------- 581 (796)
.+.+.+.||+|+||.||+++....++.||||++... .......+.+|+.++..++|+|++++...+...+
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 566788999999999999999888899999998653 2334567889999999999999999887765332
Q ss_pred ceeEEEeecCCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCC
Q 003772 582 KRLLVYEYMSNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGL 659 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl 659 (796)
..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 257999999999999998653 235688999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhh
Q 003772 660 AKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE 738 (796)
Q Consensus 660 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ........
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--~~~------~~~~~~~~ 261 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--EEV------MHKTLAGR 261 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHH------HHHHhcCC
Confidence 987643222 122335689999999999999999999999999999999999999964321 110 11111110
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 739 LNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
....+....+.+.+++..||+.+|.+||++.++++.
T Consensus 262 ------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 ------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 011234456779999999999999999999999763
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=317.26 Aligned_cols=241 Identities=24% Similarity=0.311 Sum_probs=194.0
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|+||.||+++....++.||+|++++.. ....+.+..|..++... +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999888899999997632 23345567788777754 899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 999999866 45788999999999999999999998 99999999999999999999999999987532221 2223
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .. ..... .....+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~-~~-----~~~~~-------~~~~~~~~~ 219 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DE-LF-----ESIRV-------DTPHYPRWI 219 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HH-HH-----HHHHh-------CCCCCCCCC
Confidence 45689999999999999999999999999999999999999964321 11 00 00000 011112234
Q ss_pred HHHHHHHHHHhccCCCCCCCCHH-HHH
Q 003772 753 LENMIKIGLWCVQDEPALRPSMK-SVV 778 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~-evl 778 (796)
...+.+++..||+.||++||++. ++.
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 45688999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.60 Aligned_cols=238 Identities=28% Similarity=0.362 Sum_probs=191.3
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHH-HHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMH-VIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|+||.||++....+++.||||++.+.. ....+++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999998888999999997532 122344555544 56789999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++.+ ...+++..+..++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (323)
T cd05575 81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS 154 (323)
T ss_pred CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence 999999876 45788999999999999999999998 99999999999999999999999999987543222 2223
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ....... ........
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~------~~~i~~~-------~~~~~~~~ 219 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--AEM------YDNILNK-------PLRLKPNI 219 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--HHH------HHHHHcC-------CCCCCCCC
Confidence 44589999999999999999999999999999999999999964321 110 0111110 01122234
Q ss_pred HHHHHHHHHHhccCCCCCCCCHH
Q 003772 753 LENMIKIGLWCVQDEPALRPSMK 775 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~ 775 (796)
...+.+++..||+.||.+||++.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CHHHHHHHHHHhhcCHHhCCCCC
Confidence 56789999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=314.37 Aligned_cols=261 Identities=28% Similarity=0.439 Sum_probs=204.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcE--EEEEEEeeccc-chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEe
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEK--LVAVKKLEKMV-TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~--~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 588 (796)
+.+.+.||+|+||.||+|.+.+++. .+++|.++... ....+.+.+|+.++.++ +||||+++++++.+.+..++|+|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 4567889999999999999876553 47888887532 33456789999999999 79999999999999999999999
Q ss_pred ecCCCChhhhhhcCC--------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEE
Q 003772 589 YMSNGSLADILFRGP--------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKI 654 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 654 (796)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 999999999996531 13588899999999999999999998 9999999999999999999999
Q ss_pred eccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHh
Q 003772 655 SDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKC 733 (796)
Q Consensus 655 ~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 733 (796)
+|||++....... .......+..|+|||++....++.++|||||||++|||++ |+.||...... .. ...
T Consensus 161 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--~~------~~~ 230 (297)
T cd05089 161 ADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--EL------YEK 230 (297)
T ss_pred CCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HH------HHH
Confidence 9999986432111 1111123567999999998889999999999999999998 88888643211 10 011
Q ss_pred hhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 003772 734 FIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPPC 792 (796)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~ 792 (796)
...+ . ....+......+.+++..||+.+|.+|||++++++.|+.+.....+..
T Consensus 231 ~~~~-----~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 283 (297)
T cd05089 231 LPQG-----Y-RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283 (297)
T ss_pred HhcC-----C-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence 1000 0 011223345678999999999999999999999999988876554443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.44 Aligned_cols=257 Identities=29% Similarity=0.464 Sum_probs=201.2
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcE--EEEEEEeeccc-chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEK--LVAVKKLEKMV-TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~--~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 586 (796)
..+.+.+.||+|+||.||+|.+...+. .+|+|.+.... ....+.+.+|++++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 345677899999999999999865543 56888776533 33456789999999999 899999999999999999999
Q ss_pred EeecCCCChhhhhhcCC--------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCce
Q 003772 587 YEYMSNGSLADILFRGP--------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTA 652 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 652 (796)
+||+++|+|.+++.+.. ...+++..++.++.|+++||.|||+. +++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999997532 23578999999999999999999998 99999999999999999999
Q ss_pred EEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHH
Q 003772 653 KISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAY 731 (796)
Q Consensus 653 kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 731 (796)
||+|||++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||...... +. .
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~------~ 233 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--EL------Y 233 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HH------H
Confidence 999999986432111 1111124568999999988889999999999999999998 88888533211 10 0
Q ss_pred HhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 732 KCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
...... . ....+......+.+++.+||+.+|++||++.+++++|+.+..
T Consensus 234 ~~~~~~-----~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 234 EKLPQG-----Y-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHHhcC-----C-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000000 0 001122344678999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=312.06 Aligned_cols=256 Identities=30% Similarity=0.466 Sum_probs=202.8
Q ss_pred hhhcccCcccceEEEEEEEcC-----CcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 514 RFKEELGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
++.+.||+|+||.||+|.... +...+++|.+..... .....+.+|+.++..++||||+++++.+.+++..++|+
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 456889999999999998642 235799998865433 33467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCC----------------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceE
Q 003772 588 EYMSNGSLADILFRGP----------------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNIL 645 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIl 645 (796)
||+.+|+|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence 9999999999986421 23588999999999999999999998 9999999999999
Q ss_pred ecCCCceEEeccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchh
Q 003772 646 MDEFWTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEE 723 (796)
Q Consensus 646 l~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~ 723 (796)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... +..
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~ 237 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--PER 237 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC--HHH
Confidence 999999999999999865433221 1122335678999999988889999999999999999998 888875322 111
Q ss_pred HHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 724 IVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
. .... ..... ...+......+.+++.+||+.+|++||++.++++.|+++..
T Consensus 238 ~--~~~~---------~~~~~-~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 L--FNLL---------KTGYR-MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H--HHHH---------hCCCC-CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 0100 00000 11123345678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=305.86 Aligned_cols=252 Identities=26% Similarity=0.363 Sum_probs=200.3
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch--------------hHHHHHHHHHHHhccCcCchhhhhhh
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE--------------GEREFRAEMHVIGRTHHKNLVRLIGY 576 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--------------~~~~f~~E~~~l~~l~h~niv~l~g~ 576 (796)
..+.+.+.||+|.||.|-+|.....++.||||++.+.... ..+..++|+.+|++++|+|||+++.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 3456778999999999999999999999999999652211 13468899999999999999999999
Q ss_pred hcc--CCceeEEEeecCCCChhhhhhcCCCCC-CchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceE
Q 003772 577 CAE--DSKRLLVYEYMSNGSLADILFRGPERS-LGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAK 653 (796)
Q Consensus 577 ~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 653 (796)
..+ .+..|||+|||..|.+.. ....+. +...++++++.++..||.|||.+ +||||||||+|+||++++.+|
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w---~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKW---CPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred ecCcccCceEEEEEeccCCcccc---CCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence 876 457899999999887643 223444 99999999999999999999999 999999999999999999999
Q ss_pred EeccCCccccCCCC----cceeeeeccCCCCCchhhhccC----CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHH
Q 003772 654 ISDFGLAKLLMPDQ----TRTFTLVRGTRGYMAPEWYKNT----PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIV 725 (796)
Q Consensus 654 l~DFgl~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~ 725 (796)
|+|||.+..+.... ........|||.|||||....+ -.+.+.||||+||+||-|+.|+.||..+... .
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~----~ 326 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL----E 326 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH----H
Confidence 99999998763321 1222336799999999998764 2467899999999999999999999754311 0
Q ss_pred HHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 003772 726 LINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLML 781 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 781 (796)
.++++.+..+. -...+++.+++.+|++.+|++||+.|.+..+|....
T Consensus 327 ----l~~KIvn~pL~-----fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 327 ----LFDKIVNDPLE-----FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ----HHHHHhcCccc-----CCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 12222221111 112335678899999999999999999999997654
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=305.47 Aligned_cols=250 Identities=31% Similarity=0.428 Sum_probs=205.2
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+.+.+.||.|+||.||++... ++.||||.+..... ..+.+.+|+.++.+++|+||+++++++.+++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 34566789999999999999875 56899999976544 5678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 999999999875555799999999999999999999998 999999999999999999999999999987632221
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
....+..|+|||.+....++.++||||||+++|||++ |+.|+..... .. +. ...... . ....+
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~--~~----~~~~~~-----~-~~~~~ 221 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KD--VV----PHVEKG-----Y-RMEAP 221 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HH--HH----HHHhcC-----C-CCCCc
Confidence 2234668999999998889999999999999999997 8888754321 11 00 000000 0 01112
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
...++.+.+++.+||+.+|++|||++||+.+|+.+
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 23457789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=306.54 Aligned_cols=241 Identities=23% Similarity=0.373 Sum_probs=190.3
Q ss_pred cccCcccceEEEEEEEcCC------------cEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCcee
Q 003772 517 EELGKGSFGAVYKGTLYKG------------EKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~------------~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 584 (796)
+.||+|+||.||+|+.... ...|++|.+..........|.+|+.++..++||||+++++++.+....+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999986422 2368999887655555667899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc-------eEEecc
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT-------AKISDF 657 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~DF 657 (796)
+||||+++|+|..++... ...+++..++.++.||++||.|||+. +|+||||||+|||++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999988653 35689999999999999999999998 9999999999999987654 899999
Q ss_pred CCccccCCCCcceeeeeccCCCCCchhhhc-cCCCCccccchhhHHHHHHHh-hcccCCCCCCCCchhHHHHHHHHHhhh
Q 003772 658 GLAKLLMPDQTRTFTLVRGTRGYMAPEWYK-NTPISVKADVFSYGVVLLEIV-CCRRNMEIDPSKPEEIVLINWAYKCFI 735 (796)
Q Consensus 658 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
|++....... ...++..|+|||.+. ...++.++|||||||++|||+ +|+.|+....... . ..+.
T Consensus 157 g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~-------~~~~ 222 (262)
T cd05077 157 GIPITVLSRQ-----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--K-------ERFY 222 (262)
T ss_pred CCCccccCcc-----cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--H-------HHHH
Confidence 9987653221 234678899999987 457899999999999999998 4776664322110 0 0000
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 736 DRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
.... .........+.+++..||+.||.+||++.+|++.|+
T Consensus 223 ~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQC-------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcCc-------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0000 011122456889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.31 Aligned_cols=254 Identities=22% Similarity=0.293 Sum_probs=202.9
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+.+.+.||+|+||.||+|+...+++.||+|++..........+.+|+.++.+++|+||+++++.+..++..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 34667789999999999999998888999999997655555667889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|.+++.. ...+++..+..++.|+++||.|||+. +|+|+||||+||++++++.++|+|||++........ .
T Consensus 89 ~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 89 GGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 99999999865 35689999999999999999999998 999999999999999999999999999987643221 1
Q ss_pred eeeeccCCCCCchhhhc---cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 671 FTLVRGTRGYMAPEWYK---NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
.....++..|+|||.+. ...++.++|||||||++|||++|+.|+.......... ........ ....
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--------~~~~~~~~---~~~~ 231 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--------LMSKSNFQ---PPKL 231 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--------eeecCCCC---CCCC
Confidence 12235788999999984 3457889999999999999999999985332111000 00000000 0000
Q ss_pred -CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 003772 748 -VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLML 781 (796)
Q Consensus 748 -~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 781 (796)
........+.+++.+||+.+|++|||+++|++.|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0112346788999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=323.38 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=199.4
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
..+++.+.||+|+||.||+++...+++.+|+|++.+.. ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 44567789999999999999999888999999987522 223456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 123 Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 123 EYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred cCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 99999999999964 3588899999999999999999998 99999999999999999999999999998765433
Q ss_pred cceeeeeccCCCCCchhhhccC----CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNT----PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
........||+.|+|||++... .++.++|||||||++|||++|+.||...... . . ......... . +
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--~-~-----~~~i~~~~~-~-~ 266 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--G-T-----YSKIMDHKN-S-L 266 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--H-H-----HHHHHhCCc-c-c
Confidence 3222345699999999999764 3789999999999999999999999744211 0 0 111110000 0 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPAL--RPSMKSVVLM 780 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 780 (796)
. -.........+.+++..|++.++.+ ||++.|+++.
T Consensus 267 ~-~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 N-FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred C-CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 0011233566778888899865544 8999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=308.13 Aligned_cols=250 Identities=23% Similarity=0.348 Sum_probs=199.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhccC------Ccee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAED------SKRL 584 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~------~~~~ 584 (796)
.+.+.+.||+|+||.||+|.....++.||+|++... ......+..|+.++.++ +|+||+++++++.+. ...+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 355678899999999999999888899999998754 34456788999999998 799999999998653 3578
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+||||+.+|+|.+++.......+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++....
T Consensus 86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999999875556789999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCcceeeeeccCCCCCchhhhc-----cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYK-----NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
.... ......|+..|+|||++. ...++.++|||||||++|||++|+.|+.......... ...
T Consensus 163 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~--------~~~---- 229 (272)
T cd06637 163 RTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF--------LIP---- 229 (272)
T ss_pred cccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH--------HHh----
Confidence 3222 222345889999999986 3367889999999999999999999986432111000 000
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 740 NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...............+.+++.+||+.+|.+|||+.+|+.
T Consensus 230 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 -RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -cCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000111112234467899999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=305.94 Aligned_cols=255 Identities=31% Similarity=0.470 Sum_probs=206.1
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
...+.+.+.||+|+||.||++...+ ...||||.+.... ...+++.+|+.++++++|+||+++++++.+....++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4455677899999999999999764 4779999987533 3456799999999999999999999999988899999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++..+......
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999999876556799999999999999999999998 9999999999999999999999999999876533222
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
.......+..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .... ... .... ....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~-----~~~-----~~~~-~~~~ 225 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVL-----EQV-----ERGY-RMPR 225 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH-----HHH-----HcCC-CCCC
Confidence 2222234568999999998899999999999999999999 8888853321 1111 000 0000 0111
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
+...+..+.+++.+|++.+|.+||+++++++.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 22335678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=323.30 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=198.9
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCC-----ceeEE
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS-----KRLLV 586 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV 586 (796)
.+.+.||+|+||.||++....+++.||||++.... ....+.+.+|++++..++|+||+++++++...+ ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 34578999999999999998888999999986532 234467889999999999999999999998766 78999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
+||+. ++|.+.+.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 83 ~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 83 TELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred eeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 99987 578887755 45789999999999999999999998 9999999999999999999999999999876544
Q ss_pred CcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH-------HHHhhhhhh
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW-------AYKCFIDRE 738 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~ 738 (796)
.........+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+... .........
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 33333344578999999999875 4799999999999999999999999654321100000000 000000000
Q ss_pred hhhhhcCC----------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 739 LNKLVRGQ----------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 739 ~~~~~~~~----------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
...+.... .......+.+.+++..||+.||.+|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 0112235678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=307.29 Aligned_cols=252 Identities=31% Similarity=0.500 Sum_probs=202.4
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHH--HHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGER--EFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~--~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
++.+.||+|+||+||++.....++.+|+|++......... ....|+.++.+++|+||+++++++.+....++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 4678999999999999999999999999999875443332 34569999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+++|.+++.. ...+++..++.++.|+++||.+||+. +|+|+||||+||++++++.++|+|||.+... .......
T Consensus 82 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~ 155 (260)
T PF00069_consen 82 GGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENF 155 (260)
T ss_dssp TEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEB
T ss_pred cccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-ccccccc
Confidence 9999999973 46789999999999999999999998 9999999999999999999999999999864 2222333
Q ss_pred eeeccCCCCCchhhhc-cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 672 TLVRGTRGYMAPEWYK-NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
....++..|+|||++. ....+.++||||+|+++|+|++|+.|+........... .............. ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~---~~~ 227 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI-----IEKILKRPLPSSSQ---QSR 227 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH-----HHHHHHTHHHHHTT---SHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh-----hhhccccccccccc---ccc
Confidence 4455889999999998 78899999999999999999999999875411111111 11111111111000 001
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.....+.+++..||+.||++|||+.++++
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11277999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=318.26 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=201.3
Q ss_pred HHHHhhhcccCcccceEEEEEEEc-----CCcEEEEEEEeeccc-chhHHHHHHHHHHHhcc-CcCchhhhhhhhccC-C
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAED-S 581 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~-~ 581 (796)
...+++.+.||+|+||.||+|... ..++.||||+++... ......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 456778899999999999999742 345789999997533 23446788999999999 689999999988654 4
Q ss_pred ceeEEEeecCCCChhhhhhcCC----------------------------------------------------------
Q 003772 582 KRLLVYEYMSNGSLADILFRGP---------------------------------------------------------- 603 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 603 (796)
..++|+||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999986421
Q ss_pred -------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc-eeeeec
Q 003772 604 -------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR-TFTLVR 675 (796)
Q Consensus 604 -------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~ 675 (796)
...+++..+..++.||++||.|||+. +|+||||||+||++++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12467888899999999999999998 9999999999999999999999999999865332221 111233
Q ss_pred cCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHH
Q 003772 676 GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLE 754 (796)
Q Consensus 676 gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (796)
++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ... .....+.. ...+....+
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~------~~~~~~~~------~~~~~~~~~ 309 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFC------RRLKEGTR------MRAPDYTTP 309 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHH------HHHhccCC------CCCCCCCCH
Confidence 5678999999998899999999999999999997 888875432111 100 00000000 011112335
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 755 NMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 755 ~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.+.+++..||+.+|++|||+.||++.|+.+.+
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 68999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=309.51 Aligned_cols=259 Identities=25% Similarity=0.351 Sum_probs=204.2
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcE----EEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEK----LVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~----~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
...++.+.||+|+||.||+|++...++ .||+|++.... ....+++.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 345566899999999999998755544 48999987533 3345678999999999999999999998875 45779
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
++||+++|+|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++.+..
T Consensus 86 ~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999999753 35689999999999999999999998 999999999999999999999999999987653
Q ss_pred CCcce-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 666 DQTRT-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 666 ~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
..... .....++..|+|||.+.+..++.++|||||||++|||++ |..|+...... ....... . .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~---------~-~ 227 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR----EIPDLLE---------K-G 227 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHH---------C-C
Confidence 32211 111234678999999999899999999999999999998 88887543211 1111000 0 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCC
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDIS 788 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 788 (796)
.....+......+.+++..||+.||++||++.++++.|+.+...+
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 228 ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 011112334567889999999999999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=319.98 Aligned_cols=239 Identities=24% Similarity=0.307 Sum_probs=193.5
Q ss_pred cccCcccceEEEEEEEc---CCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 517 EELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.||+|+||.||++... ..++.+|+|++.+... .....+..|++++.+++|+||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999998763 4567899999976332 233457789999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+|+|.+++.+ ...+++..+..++.||++||.|||+. +|+||||||+||++++++.+||+|||+++....... ..
T Consensus 82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~ 155 (318)
T cd05582 82 GGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KA 155 (318)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ce
Confidence 9999999965 45689999999999999999999998 999999999999999999999999999986543322 22
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
....|++.|+|||.+....++.++|||||||++|||++|+.||..... ... ....... ....+..
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--~~~------~~~i~~~-------~~~~p~~ 220 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--KET------MTMILKA-------KLGMPQF 220 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--HHH------HHHHHcC-------CCCCCCC
Confidence 335689999999999988899999999999999999999999964321 110 0000000 0112233
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHH
Q 003772 752 TLENMIKIGLWCVQDEPALRPSMKS 776 (796)
Q Consensus 752 ~~~~l~~l~~~cl~~dP~~RPt~~e 776 (796)
....+.+++..||+.||++||++.+
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 4567889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=313.13 Aligned_cols=263 Identities=27% Similarity=0.415 Sum_probs=203.8
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCc----------------EEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhh
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGE----------------KLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRL 573 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~----------------~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l 573 (796)
..+++.+.||+|+||.||++.....+ ..||+|++..... ...+.+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 44567799999999999999876432 5689999876433 345678999999999999999999
Q ss_pred hhhhccCCceeEEEeecCCCChhhhhhcCC---------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccce
Q 003772 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGP---------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNI 644 (796)
Q Consensus 574 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NI 644 (796)
++++..++..++|+||+++++|.+++.... ...+++..++.++.|++.||.|||+. +|+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 999999999999999999999999997532 13689999999999999999999998 999999999999
Q ss_pred EecCCCceEEeccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh--cccCCCCCCCCc
Q 003772 645 LMDEFWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC--CRRNMEIDPSKP 721 (796)
Q Consensus 645 ll~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt--g~~p~~~~~~~~ 721 (796)
++++++.++|+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ +..|+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-- 239 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence 999999999999999986543322 12223345778999999998889999999999999999998 5556543221
Q ss_pred hhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 722 EEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
... .......+........ ...+...+.++.+++.+||+.+|.+|||+.+|++.|+.
T Consensus 240 ~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 QQV--IENAGHFFRDDGRQIY---LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHH--HHHHHhcccccccccc---CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111 1111111111000000 01122344679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=314.46 Aligned_cols=265 Identities=27% Similarity=0.403 Sum_probs=208.9
Q ss_pred HHHHHHhhhcccCcccceEEEEEEEc-------CCcEEEEEEEeeccc-chhHHHHHHHHHHHhcc-CcCchhhhhhhhc
Q 003772 508 LKKATNRFKEELGKGSFGAVYKGTLY-------KGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRT-HHKNLVRLIGYCA 578 (796)
Q Consensus 508 l~~~~~~~~~~LG~G~fg~Vy~g~~~-------~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~ 578 (796)
+....+.+.+.||+|+||.||+++.. .....||+|.+.... ....+.+.+|+.++..+ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44556677899999999999999752 223579999987543 34456789999999999 8999999999999
Q ss_pred cCCceeEEEeecCCCChhhhhhcCC--------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccce
Q 003772 579 EDSKRLLVYEYMSNGSLADILFRGP--------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNI 644 (796)
Q Consensus 579 ~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NI 644 (796)
.....++||||+++|+|.+++.... ...+++..++.++.||++||.|||+. +|+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 9999999999999999999997531 24578889999999999999999998 999999999999
Q ss_pred EecCCCceEEeccCCccccCCCCcce-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCch
Q 003772 645 LMDEFWTAKISDFGLAKLLMPDQTRT-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPE 722 (796)
Q Consensus 645 ll~~~~~~kl~DFgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~ 722 (796)
++++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..|+.... ..
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~ 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VE 246 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--HH
Confidence 99999999999999998764432221 222335678999999998889999999999999999998 667764321 11
Q ss_pred hHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCC
Q 003772 723 EIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISI 789 (796)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 789 (796)
.. ........ ....+......+.+++..||+.+|.+|||+.||++.|+++..+..
T Consensus 247 ~~------~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 247 EL------FKLLKEGH------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred HH------HHHHHcCC------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 10 01111100 011223455779999999999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=309.48 Aligned_cols=255 Identities=29% Similarity=0.397 Sum_probs=201.2
Q ss_pred HHhhhcccCcccceEEEEEEEcC-----CcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
.+.+.+.||+|+||.||+|.+.. ....||+|.+..... .....|..|+.++++++|+||+++++++.+.+..++
T Consensus 7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (277)
T cd05036 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI 86 (277)
T ss_pred HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEE
Confidence 34556889999999999999876 567899998865433 334578999999999999999999999999889999
Q ss_pred EEeecCCCChhhhhhcCC-----CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC---ceEEecc
Q 003772 586 VYEYMSNGSLADILFRGP-----ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW---TAKISDF 657 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DF 657 (796)
||||+++++|.+++.... ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++ .+||+||
T Consensus 87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccC
Confidence 999999999999986532 13589999999999999999999998 999999999999998654 5999999
Q ss_pred CCccccCCCCcce-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhh
Q 003772 658 GLAKLLMPDQTRT-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFI 735 (796)
Q Consensus 658 gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
|+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||...... ... . ...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~--~----~~~ 235 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVM--E----FVT 235 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH--H----HHH
Confidence 9998763322111 111223568999999999999999999999999999997 88888643211 110 0 000
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 736 DRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
.. .....+...+..+.+++.+|++.+|++|||+.+|++.|+.
T Consensus 236 ~~------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 236 GG------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred cC------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 00 0111233445778999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=307.51 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=204.1
Q ss_pred HHHhhhcccCcccceEEEEEEEcCC---cEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKG---EKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
..+++.+.||+|+||.||+|.+... ...+|+|.++... ....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 3456678999999999999987533 3479999987533 23356789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|||+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999999999764 35689999999999999999999998 9999999999999999999999999999876543
Q ss_pred Ccceeee--eccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 667 QTRTFTL--VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 667 ~~~~~~~--~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
....... ..++..|+|||.+.+..++.++||||||+++||+++ |+.|+...... .. .. ..... .
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~--~~----~~~~~-----~ 226 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DV--IK----AIEEG-----Y 226 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HH--HH----HHhCC-----C
Confidence 3222211 223568999999999899999999999999999886 99888643211 10 00 00000 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
. .......+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 227 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 R-LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred c-CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=309.28 Aligned_cols=240 Identities=23% Similarity=0.375 Sum_probs=189.3
Q ss_pred ccCcccceEEEEEEEcCC------------------------cEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhh
Q 003772 518 ELGKGSFGAVYKGTLYKG------------------------EKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573 (796)
Q Consensus 518 ~LG~G~fg~Vy~g~~~~~------------------------~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l 573 (796)
.||+|+||.||+|.+... ...|++|++.........+|.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 589999999999985321 13589999876555556678999999999999999999
Q ss_pred hhhhccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC---
Q 003772 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW--- 650 (796)
Q Consensus 574 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 650 (796)
++++.++...++||||+++|+|..++.+. ...+++..++.++.||++||.|||+. +|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999988653 45789999999999999999999998 999999999999997643
Q ss_pred ----ceEEeccCCccccCCCCcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHh-hcccCCCCCCCCchhH
Q 003772 651 ----TAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIV-CCRRNMEIDPSKPEEI 724 (796)
Q Consensus 651 ----~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~ell-tg~~p~~~~~~~~~~~ 724 (796)
.+|++|||++....... ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+....... .
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~ 230 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--K 230 (274)
T ss_pred CccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--H
Confidence 38999999886443221 1236788999998876 56899999999999999995 6888875432111 0
Q ss_pred HHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 725 VLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
. .. .. . ....+......+.+++..||+.+|++|||+.+|++.|+
T Consensus 231 ~--~~-~~--------~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 E--RF-YE--------K---KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H--HH-HH--------h---ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 00 00 0 00111112346889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=307.98 Aligned_cols=259 Identities=22% Similarity=0.325 Sum_probs=205.9
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCC---cEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKG---EKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
.....+.+.||+|+||.||+|...+. ...||||...... ....+.+.+|+.++++++|+||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 34456778999999999999987543 3478999887654 3455679999999999999999999998875 55789
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999999763 34689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
..........++..|+|||.+....++.++||||||+++|||++ |..||...... +. .. ..... .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~-~~-----~~~~~------~ 225 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DV-IG-----RIENG------E 225 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HH-HH-----HHHcC------C
Confidence 43222222334568999999988889999999999999999996 99888644321 10 00 00000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
....+...+..+.+++.+|+..+|++|||+.+++..|+++...
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1112234457899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=306.85 Aligned_cols=250 Identities=29% Similarity=0.461 Sum_probs=197.6
Q ss_pred cccCcccceEEEEEEEcCCcE--EEEEEEeeccc-chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEK--LVAVKKLEKMV-TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~--~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|+||.||+|.+.+++. .+++|.+.... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999876654 57888887533 34456789999999999 799999999999999999999999999
Q ss_pred CChhhhhhcCC--------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccC
Q 003772 593 GSLADILFRGP--------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFG 658 (796)
Q Consensus 593 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 658 (796)
|+|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999996532 13578999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhh
Q 003772 659 LAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDR 737 (796)
Q Consensus 659 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
++....... .......+..|+|||++....++.++||||||+++|||++ |+.||...... .. .......
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~------~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--EL------YEKLPQG 227 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HH------HHHHhCC
Confidence 986322111 1111223567999999988889999999999999999997 88888543211 00 0111000
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 738 ELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
. ....+......+.+++..||+.+|.+|||+.+++..|+.+.
T Consensus 228 ~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 Y------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 00112234467899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=312.09 Aligned_cols=250 Identities=21% Similarity=0.317 Sum_probs=204.0
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
++.+.+.||+|+||.||+|.....++.||+|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 44556789999999999999887888999999976555566778999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+++|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++......... .
T Consensus 101 ~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~ 173 (296)
T cd06654 101 GGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 173 (296)
T ss_pred CCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc-c
Confidence 9999999854 4578999999999999999999998 9999999999999999999999999998765433221 1
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
....+++.|+|||.+.+...+.++|||||||++|||++|+.||....... . . ....... ......+..
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~-~----~~~~~~~-----~~~~~~~~~ 241 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--A-L----YLIATNG-----TPELQNPEK 241 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--h-H----HHHhcCC-----CCCCCCccc
Confidence 22357889999999998889999999999999999999999996443111 0 0 0000000 000011234
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 752 TLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 752 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
....+.+++.+||+.+|++|||+.+|++.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 45678899999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=317.88 Aligned_cols=241 Identities=25% Similarity=0.347 Sum_probs=194.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcC-chhhhhhhhccCCceeEEEe
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHK-NLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV~e 588 (796)
+.+.+.||+|+||.||+|+....++.||||++.+.. ....+.+..|..++..++|+ +|+++++++.+.+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 346688999999999999998888899999997632 23445678899999999765 58888888888899999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05587 82 YVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG- 155 (324)
T ss_pred CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence 9999999999865 35688999999999999999999998 99999999999999999999999999987532221
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ...... ....
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~------~~i~~~-------~~~~ 220 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELF------QSIMEH-------NVSY 220 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHH------HHHHcC-------CCCC
Confidence 122335689999999999999999999999999999999999999964321 1110 000000 0112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSM 774 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~ 774 (796)
+......+.+++..||+.||.+|++.
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 22345678899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=319.05 Aligned_cols=241 Identities=27% Similarity=0.328 Sum_probs=192.8
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHH-HHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMH-VIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|+||.||+++...+++.+|+|++.+.. ....+.+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999998888999999997532 223345555554 56779999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|..++.. ...+++..+..++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (325)
T cd05604 81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTT 154 (325)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcc
Confidence 999998865 46789999999999999999999998 99999999999999999999999999987542221 1223
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ........ ....+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~------~~~~~~~~-------~~~~~~~ 219 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--EM------YDNILHKP-------LVLRPGA 219 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--HH------HHHHHcCC-------ccCCCCC
Confidence 456899999999999999999999999999999999999999643211 10 11111110 0112234
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHH
Q 003772 753 LENMIKIGLWCVQDEPALRPSMKSVV 778 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~evl 778 (796)
...+.+++..|++.+|.+||++.+.+
T Consensus 220 ~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 220 SLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 56688999999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=316.56 Aligned_cols=240 Identities=26% Similarity=0.366 Sum_probs=193.8
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEee
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
.+.+.||+|+||.||+++....++.||||++.+.. ....+.+..|..++..+ +|++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 45688999999999999998888899999997632 22334567788888777 589999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+.+.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~- 156 (323)
T cd05616 83 VNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV- 156 (323)
T ss_pred CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-
Confidence 999999999865 35688999999999999999999998 999999999999999999999999999975432221
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. + .+..... ....+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~--~----~~~i~~~-------~~~~p 221 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DE--L----FQSIMEH-------NVAYP 221 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--HH--H----HHHHHhC-------CCCCC
Confidence 22234589999999999999999999999999999999999999964321 11 1 0111110 01122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSM 774 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~ 774 (796)
......+.+++.+|++.+|++|++.
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 3345678899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=304.92 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=204.5
Q ss_pred HHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 509 KKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 509 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
...++.+.++||+|+||.||++.+.. +..+|+|.+... ....+.+.+|+.++++++|+||+++++++.+ ...+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 34556778999999999999998754 457999988653 2345678999999999999999999999887 77899999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++|+|.+++.+.....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999775556789999999999999999999998 999999999999999999999999999986643332
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
.......++..|+|||++....++.++|+||||+++||+++ |+.|+...... .... ....+. ...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~----~~~~~~------~~~ 223 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIR----ALERGY------RMP 223 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH----HHHH----HHhCCC------CCC
Confidence 22222335678999999998889999999999999999999 88888643211 0000 000000 001
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
.....+..+.+++.+|++.+|++||++.+|.++|+.+
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 1233456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.06 Aligned_cols=249 Identities=33% Similarity=0.493 Sum_probs=205.1
Q ss_pred cccCcccceEEEEEEEcCC---cEEEEEEEeecccchh-HHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKG---EKLVAVKKLEKMVTEG-EREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~~~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|+||.||++..... +..|++|.+....... .+.+.+|++.+..++|+||+++++++.++...++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999865 7889999997654433 67899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCC-------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 593 GSLADILFRGP-------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 593 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
++|.+++.... ...+++..++.++.|+++||.|||+. +++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997642 36799999999999999999999998 999999999999999999999999999987754
Q ss_pred CCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 666 DQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 666 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
... .......++..|+|||.+....++.++||||+|+++|||++ |+.|+..... .. . .......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~--~----~~~~~~~------ 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EE--V----LEYLRKG------ 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HH--H----HHHHHcC------
Confidence 432 12223447889999999998899999999999999999999 5888865421 11 0 0111100
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
.....+.....++.+++..||+.+|.+|||+.+++..|+
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011223344678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=318.05 Aligned_cols=242 Identities=27% Similarity=0.350 Sum_probs=192.5
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHH-HHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEM-HVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~-~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|+||.||+++...+++.||+|++.+.. ......+..|. .+++.++|+||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999998888899999997532 12233444444 456788999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++.. ...+....+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~ 154 (325)
T cd05602 81 GELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTS 154 (325)
T ss_pred CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccc
Confidence 999999976 45678888899999999999999998 999999999999999999999999999975432221 223
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ....... .....+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~------~~~i~~~-------~~~~~~~~ 219 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EM------YDNILNK-------PLQLKPNI 219 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HH------HHHHHhC-------CcCCCCCC
Confidence 345899999999999999999999999999999999999999643211 10 0111110 11122344
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 753 LENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...+.+++..|++.+|.+||+..+.+.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 220 TNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 567889999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=304.45 Aligned_cols=248 Identities=30% Similarity=0.409 Sum_probs=199.7
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhc-cCCceeEEEeec
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCA-EDSKRLLVYEYM 590 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~e~~ 590 (796)
.+.+.+.||+|+||.||++... +..||+|.++.. ...+.+.+|+.++++++|+|++++++++. +++..++|+||+
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4566789999999999999875 467999998643 23567899999999999999999999764 456789999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|.+++.+.....+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-- 157 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCC--
Confidence 999999999875555689999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
....+..|+|||++.+..++.++|||||||++|||++ |+.|+..... .. ... .. ... ......
T Consensus 158 --~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~--~~~----~~-----~~~-~~~~~~ 221 (256)
T cd05082 158 --TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KD--VVP----RV-----EKG-YKMDAP 221 (256)
T ss_pred --CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HH--HHH----HH-----hcC-CCCCCC
Confidence 1224568999999999899999999999999999998 8888753321 11 000 00 000 011122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
...+..+.+++.+|++.+|++|||++++++.|+.+
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 34567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.11 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=201.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+++.+.||+|+||.||+|.....+..+++|.+........+.+.+|++++..++|+||+++++++.+++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 45678899999999999999888889999999766555667899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
++|..++.+. ...+++..+..++.|+++||.|||+. +++|+||||+||+++.++.+||+|||++........ ...
T Consensus 87 ~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~ 161 (282)
T cd06643 87 GAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD 161 (282)
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-ccc
Confidence 9999987652 45789999999999999999999998 999999999999999999999999999876533221 122
Q ss_pred eeccCCCCCchhhhc-----cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 673 LVRGTRGYMAPEWYK-----NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
...++..|+|||++. ...++.++|||||||++|||++|+.|+..... ..... .. .. ..... ..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~-~~-~~----~~~~~----~~ 229 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--MRVLL-KI-AK----SEPPT----LA 229 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--HHHHH-HH-hh----cCCCC----CC
Confidence 345889999999984 34578899999999999999999999864321 11100 00 00 00000 01
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.+......+.+++..||+.+|.+||++.++++.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122345678999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=304.78 Aligned_cols=249 Identities=27% Similarity=0.382 Sum_probs=202.7
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+...+.||+|+||.||+|.+...++.||+|.+.... ....+.+.+|+.++++++|+||+++++++..+...++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34556678999999999999998888899999987533 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++++|.+++.. ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 84 LGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred cCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 999999998854 4688999999999999999999998 999999999999999999999999999976643221
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
......++..|+|||++.+..++.++||||||+++|||++|+.|+....... .. ...... . .....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~------~~~~~~-----~-~~~~~ 222 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VL------FLIPKN-----S-PPTLE 222 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HH------hhhhcC-----C-CCCCC
Confidence 1122347889999999999899999999999999999999999986432111 00 000000 0 01122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
......+.+++.+||+.+|++||+|.+|++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2345678899999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=315.47 Aligned_cols=244 Identities=23% Similarity=0.354 Sum_probs=194.7
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|+||.||++....+++.||+|++.+... ...+.+..|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999998889999999976432 2345678899999888 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (327)
T cd05617 81 GDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS 154 (327)
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence 999998865 35799999999999999999999998 99999999999999999999999999987532221 1223
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......... ............ .....+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~-------~~~~~p~~~ 226 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-NTEDYLFQVILE-------KPIRIPRFL 226 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-ccHHHHHHHHHh-------CCCCCCCCC
Confidence 345899999999999999999999999999999999999999643222110 000111111111 011123334
Q ss_pred HHHHHHHHHHhccCCCCCCCCH
Q 003772 753 LENMIKIGLWCVQDEPALRPSM 774 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~ 774 (796)
...+.+++..||+.||.+||++
T Consensus 227 ~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 227 SVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CHHHHHHHHHHhccCHHHcCCC
Confidence 5668899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=306.23 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=198.6
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCChh
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLA 596 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 596 (796)
..||+|+||.||+|.+..++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 57999999999999998888899999988766666778999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCC--chhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-CCceEEeccCCccccCCCCcceeee
Q 003772 597 DILFRGPERSL--GWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE-FWTAKISDFGLAKLLMPDQTRTFTL 673 (796)
Q Consensus 597 ~~l~~~~~~~l--~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgl~~~~~~~~~~~~~~ 673 (796)
+++.... ..+ ++..+..++.||++||.|||+. +|+|+||||+||+++. ++.++|+|||++........ ....
T Consensus 94 ~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 168 (268)
T cd06624 94 ALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTET 168 (268)
T ss_pred HHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cccc
Confidence 9997532 234 7888899999999999999998 9999999999999986 67999999999976543222 1222
Q ss_pred eccCCCCCchhhhccC--CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 674 VRGTRGYMAPEWYKNT--PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 674 ~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
..+++.|+|||++... .++.++||||||+++|||++|+.|+.......... +... .. -.....+..
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----~~~~------~~--~~~~~~~~~ 236 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----FKVG------MF--KIHPEIPES 236 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH----hhhh------hh--ccCCCCCcc
Confidence 3478999999998764 37899999999999999999999986432211110 0000 00 001122334
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 752 TLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 752 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..+.+.+++.+||+.+|.+|||+.+|++
T Consensus 237 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 237 LSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 5577899999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=308.75 Aligned_cols=268 Identities=28% Similarity=0.424 Sum_probs=206.7
Q ss_pred HHhhhcccCcccceEEEEEEEcC----CcEEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhcc--CCcee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYK----GEKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAE--DSKRL 584 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~----~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~ 584 (796)
...+.+.||+|+||.||++.+.. .++.+|||++...... ..+.|.+|++++++++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 34566889999999999998753 3678999999765443 46789999999999999999999999877 55789
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+|+||+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 85 lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 999999999999999763 33699999999999999999999998 99999999999999999999999999998775
Q ss_pred CCCcce--eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 665 PDQTRT--FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 665 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+............. .........+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 238 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI--AQGQMIVTRLLEL 238 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc--ccccccHHHHHHH
Confidence 332211 111234567999999998899999999999999999999999876432211100000 0000000011111
Q ss_pred hcC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 743 VRG---QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 743 ~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
+.. ...+..++..+.+++.+||+.+|++|||+.||+++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 111 1122344577999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=326.10 Aligned_cols=251 Identities=23% Similarity=0.263 Sum_probs=195.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||++.....++.||||++.+.. ....+.+++|++++.+++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 345688999999999999998888999999986532 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 83 ~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 83 LPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999975 45788999999999999999999998 9999999999999999999999999999643211000
Q ss_pred ----------------------------------------------eeeeeccCCCCCchhhhccCCCCccccchhhHHH
Q 003772 670 ----------------------------------------------TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVV 703 (796)
Q Consensus 670 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvi 703 (796)
......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0001358999999999999999999999999999
Q ss_pred HHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCC---CCHHHHHHH
Q 003772 704 LLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALR---PSMKSVVLM 780 (796)
Q Consensus 704 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~evl~~ 780 (796)
+|||++|+.||...... .. ........ ..+..+ ........+.+++..|++ +|.+| +++.|+++.
T Consensus 238 l~elltG~~Pf~~~~~~--~~------~~~i~~~~-~~~~~p--~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 238 MFECLIGWPPFCSENSH--ET------YRKIINWR-ETLYFP--DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhcCCCCCCCCCHH--HH------HHHHHccC-CccCCC--CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999999643311 11 00000000 000000 011234567888888997 66665 699998864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.46 Aligned_cols=264 Identities=21% Similarity=0.301 Sum_probs=207.2
Q ss_pred HHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 509 KKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 509 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
....+++.+.||+|+||.||++.....++.||+|++.... ....+.+.+|++++..++|+||+++++++.+....++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3455677899999999999999998888899999886533 344578999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++++|.+++.+ .+.+++..+..++.+++.||.|||+. .+++|+||||+||++++++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 83 EFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred ecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999998865 35689999999999999999999973 289999999999999999999999999987543221
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
. ....|+..|+|||.+.+..++.++|||||||++|||++|+.||.............. ............ .....
T Consensus 159 ~---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~ 233 (284)
T cd06620 159 A---DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM-GILDLLQQIVQE-PPPRL 233 (284)
T ss_pred c---CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhh-HHHHHHHHHhhc-cCCCC
Confidence 1 234588999999999888999999999999999999999999975433211000000 000000000000 00111
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLML 781 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 781 (796)
...+.+..+.+++.+|++.||++|||+.||+++.
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1223556789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=304.91 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=201.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-----hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-----EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
+...+.||+|++|.||++.....++++|+|.+..... ...+.+.+|+.++.+++|+||+++++++.++...++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 3456889999999999999888888999999864321 22356889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||+++......
T Consensus 84 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 84 EYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999875 35688999999999999999999998 99999999999999999999999999998654322
Q ss_pred ccee--eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 668 TRTF--TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 668 ~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
.... ....++..|+|||++.+..++.++||||||+++|||++|+.||...... . .. .. .. .....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~-~~----~~-~~-----~~~~~ 225 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--A-AI----FK-IA-----TQPTN 225 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--H-HH----HH-Hh-----ccCCC
Confidence 2111 2344778999999999989999999999999999999999998643211 0 00 00 00 00011
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
...+......+.+++..||+.+|.+|||+.++++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 12233455678999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=309.21 Aligned_cols=250 Identities=27% Similarity=0.348 Sum_probs=202.0
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+..+.||+|+||.||++.....++.+|+|.+..... ...+.+.+|+.++.+++|+|++++++.+.+++..++||||+
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 445789999999999999998889999999875322 22356788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|.+++.......+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++........
T Consensus 83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 157 (285)
T cd05630 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 157 (285)
T ss_pred CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--
Confidence 999999999765456799999999999999999999998 999999999999999999999999999976543322
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||............ ..... ... .....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~-----~~~~~-~~~-----~~~~~ 226 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-----ERLVK-EVQ-----EEYSE 226 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH-----Hhhhh-hhh-----hhcCc
Confidence 12235899999999999999999999999999999999999999754322111110 00000 000 01122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPS-----MKSVVL 779 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 779 (796)
.....+.+++..||+.||.+||| +.|+++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 33456889999999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.49 Aligned_cols=252 Identities=27% Similarity=0.441 Sum_probs=194.1
Q ss_pred cccCcccceEEEEEEEcC---CcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhc-cCCceeEEEeecC
Q 003772 517 EELGKGSFGAVYKGTLYK---GEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCA-EDSKRLLVYEYMS 591 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~---~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~e~~~ 591 (796)
+.||+|+||.||+|.+.+ ....||||++.... ....+.+.+|+.+++.++|+||+++++++. .+...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998653 23579999986432 334567889999999999999999999775 4556899999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc--
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR-- 669 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~-- 669 (796)
+|+|.+++... ...+.+..++.++.|+++||.|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 99999999753 34567788899999999999999998 9999999999999999999999999999765432211
Q ss_pred -eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 670 -TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 670 -~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ........ .+ .....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~----~~------~~~~~ 223 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLL----QG------RRLLQ 223 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHh----cC------CCCCC
Confidence 111233567899999999889999999999999999999965543322111 11111000 00 00011
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
+...+..+.+++..||+.+|++||++.+|++.|+.+.
T Consensus 224 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 2223467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=308.72 Aligned_cols=250 Identities=24% Similarity=0.308 Sum_probs=200.4
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+..+.||+|+||.||++.....++.+|+|.+..... .....+.+|+.++++++|+|++++.+.+.+++..++||||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 345789999999999999988889999999865322 22345788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 157 (285)
T cd05632 83 NGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-- 157 (285)
T ss_pred cCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--
Confidence 999999998765456799999999999999999999998 999999999999999999999999999976533221
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
.....|+..|+|||.+.+..++.++|+||||+++|||++|+.||........... ... .+... ......
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~----~~~-----~~~~~--~~~~~~ 226 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE----VDR-----RVLET--EEVYSA 226 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHH-----hhhcc--ccccCc
Confidence 1234589999999999988999999999999999999999999974422111000 000 00000 001123
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPS-----MKSVVL 779 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 779 (796)
.....+.+++..|++.||.+||+ +.+++.
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 227 KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 34456789999999999999999 667765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=319.71 Aligned_cols=254 Identities=21% Similarity=0.268 Sum_probs=199.8
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
...+.+.+.||+|+||.||++.....++.+|+|++.+.. ....+.+.+|+.++..++||||+++++.+.+++..++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 345667789999999999999999888999999986522 22345678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|||+++|+|.+++.. ..++...+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 122 ~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 122 MEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 999999999999864 3578888999999999999999998 9999999999999999999999999999876543
Q ss_pred CcceeeeeccCCCCCchhhhccC----CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNT----PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
.........||+.|+|||++... .++.++|||||||++|||++|+.||...... .. ...+.... ..
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~-----~~~i~~~~-~~- 265 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GT-----YSKIMNHK-NS- 265 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---HH-----HHHHHcCC-Cc-
Confidence 33333345699999999999764 3789999999999999999999999743211 00 11111000 00
Q ss_pred hcCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 003772 743 VRGQEVDRNTLENMIKIGLWCVQDEPAL--RPSMKSVVLM 780 (796)
Q Consensus 743 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 780 (796)
.. -.........+.+++..|++.++.+ ||++.|+++.
T Consensus 266 ~~-~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 266 LT-FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cc-CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 00 0111234566888999999854443 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=303.96 Aligned_cols=250 Identities=20% Similarity=0.324 Sum_probs=204.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc-cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM-VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.+.+.||+|+||.||++.....++.+|+|.+... .....+.+..|+.++++++|+||+++++.+.+++..++|+||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 34668899999999999999888899999998643 23345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+|+|.+++.......++...++.++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++........ ..
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (255)
T cd08219 82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YA 157 (255)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-cc
Confidence 99999998765556789999999999999999999998 999999999999999999999999999976643222 11
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
....+++.|+|||++.+...+.++||||||+++|+|++|+.||..... .... ........ ...+..
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~~~~------~~~~~~~~------~~~~~~ 223 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--KNLI------LKVCQGSY------KPLPSH 223 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--HHHH------HHHhcCCC------CCCCcc
Confidence 234588899999999998999999999999999999999999864321 1100 00000000 112233
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 752 TLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 752 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
....+.+++.+||+.||++|||+.+|+..
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 45678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=319.24 Aligned_cols=254 Identities=21% Similarity=0.266 Sum_probs=197.7
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+++....++.||+|++.+.. ......+.+|..++..++|+||+++++++.+++..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456688999999999999998888999999987522 22344588899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.+. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 83 ~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 83 YVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999753 35688999999999999999999998 9999999999999999999999999999876544433
Q ss_pred eeeeeccCCCCCchhhhcc-----CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 670 TFTLVRGTRGYMAPEWYKN-----TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... . ......... .. ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~------~~~~i~~~~-~~-~~ 228 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--E------TYGKIMNHE-ER-FQ 228 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--H------HHHHHHcCC-Cc-cc
Confidence 3334568999999999875 46789999999999999999999999643211 0 011111000 00 00
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPAL--RPSMKSVVLM 780 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 780 (796)
-........+.+.+++.+|++..+.+ |+++.+++..
T Consensus 229 ~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00001123466888888888865544 5688888653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=309.28 Aligned_cols=269 Identities=23% Similarity=0.347 Sum_probs=203.2
Q ss_pred HHHhhhcccCcccceEEEEEEE----cCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccC--Cce
Q 003772 511 ATNRFKEELGKGSFGAVYKGTL----YKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAED--SKR 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~----~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 583 (796)
.++.+.+.||+|+||.||+++. ...++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3456678899999999999975 3456789999987543 33346799999999999999999999988775 567
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
++||||+++++|.+++.+. ...+++..++.++.|++.||.|||+. +++||||||+||++++++.++|+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 8999999999999998653 34689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcc--eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 664 MPDQTR--TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 664 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
...... ......++..|+|||.+.+..++.++||||||+++|||++++.|.............. ...+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGP-THGQMTVTRLVRV 238 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccc-ccccccHHHHHHH
Confidence 543321 1122346678999999998889999999999999999999876643211100000000 0000000000000
Q ss_pred hhc--CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 742 LVR--GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 742 ~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
... ....+......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000 0112234567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.38 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=191.9
Q ss_pred cccCcccceEEEEEEEcCC--cEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 517 EELGKGSFGAVYKGTLYKG--EKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~--~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
+.||+|+||.||+|...++ ...+|+|+++.... .....+.+|+.++++++|+||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 3689999999999986533 35799998865432 34457889999999999999999999999989999999999999
Q ss_pred ChhhhhhcCC---CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 594 SLADILFRGP---ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 594 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 23567778889999999999999998 99999999999999999999999999997543322211
Q ss_pred -eeeeccCCCCCchhhhccC-------CCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 671 -FTLVRGTRGYMAPEWYKNT-------PISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 671 -~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||...... ... ... .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~--~~~----~~~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--QVL--TYT----VREQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--HHH--HHH----hhcccCC
Confidence 1223467889999998643 35889999999999999996 99898643221 110 000 0000011
Q ss_pred hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 742 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
...+ .......+.+.+++..|+ .+|++|||++||+..|+
T Consensus 230 ~~~~-~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKP-RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCC-ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111 111123455778888998 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=307.99 Aligned_cols=260 Identities=25% Similarity=0.347 Sum_probs=206.3
Q ss_pred HHHHhhhcccCcccceEEEEEEEcC----CcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhcc-CCce
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYK----GEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAE-DSKR 583 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~----~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~ 583 (796)
...+.+.+.||+|+||.||+|.... .+..|++|++.... ....+.+.+|+.++++++|+||+++++++.+ +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4556677899999999999999875 25789999987543 3345678899999999999999999998776 4678
Q ss_pred eEEEeecCCCChhhhhhcCCC------CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEecc
Q 003772 584 LLVYEYMSNGSLADILFRGPE------RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDF 657 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 657 (796)
++++||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999865322 4689999999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCcce-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhh
Q 003772 658 GLAKLLMPDQTRT-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFI 735 (796)
Q Consensus 658 gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
|+++.+....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.|+..... .+ ...+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~--~~~~~~---- 233 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FE--MAAYLK---- 233 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HH--HHHHHH----
Confidence 9998764433221 122345678999999999899999999999999999999 8888864321 11 111100
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 736 DRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.. .. .......++.+.+++.+||+.+|++|||+.+|++.|+.+..
T Consensus 234 ~~-----~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DG-----YR-LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cC-----CC-CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 00 01122345678999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=315.09 Aligned_cols=245 Identities=26% Similarity=0.368 Sum_probs=206.4
Q ss_pred ccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCChhh
Q 003772 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLAD 597 (796)
Q Consensus 518 ~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 597 (796)
+||+|.||+||.|++.+....+|||.+.....+..+.+.+|+.+-++++|.|||+++|.+.+++..-+.||-.+||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999999999999999987777778889999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCC--chhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-CCceEEeccCCccccCCCCcceeeee
Q 003772 598 ILFRGPERSL--GWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE-FWTAKISDFGLAKLLMPDQTRTFTLV 674 (796)
Q Consensus 598 ~l~~~~~~~l--~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgl~~~~~~~~~~~~~~~ 674 (796)
+|... =+++ ++..+-.+..||++||.|||++ .|||||||-+|||++. .|.+||+|||-++++..- .......
T Consensus 662 LLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETF 736 (1226)
T KOG4279|consen 662 LLRSK-WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETF 736 (1226)
T ss_pred HHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccccccc
Confidence 99753 2344 6778888999999999999999 9999999999999974 689999999999887432 2233345
Q ss_pred ccCCCCCchhhhccC--CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 675 RGTRGYMAPEWYKNT--PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 675 ~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
-||..|||||++..+ .|..++|||||||++.||.|||+||..-.... ..++. +.-.......+.+.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-AAMFk-----------VGmyKvHP~iPeel 804 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-AAMFK-----------VGMYKVHPPIPEEL 804 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-Hhhhh-----------hcceecCCCCcHHH
Confidence 599999999999876 58899999999999999999999997443221 11110 11111223456777
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 753 LENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..+...++++|+.++|.+||+++++++
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 889999999999999999999999985
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.07 Aligned_cols=264 Identities=28% Similarity=0.425 Sum_probs=204.2
Q ss_pred HHHHhhhcccCcccceEEEEEEEcC-----CcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCce
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 583 (796)
..++.+.+.||+|+||.||+|...+ .+..||+|.+..... .....+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 3456677899999999999997642 245799998864332 2345688999999999999999999999999999
Q ss_pred eEEEeecCCCChhhhhhcCC--------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEe
Q 003772 584 LLVYEYMSNGSLADILFRGP--------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKIS 655 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 655 (796)
++||||+++|+|.+++.... ...+.+..+..++.|++.||.|||+. +|+||||||+||++++++.++|+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999996421 13356778889999999999999998 99999999999999999999999
Q ss_pred ccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHh
Q 003772 656 DFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKC 733 (796)
Q Consensus 656 DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 733 (796)
|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..|+..... ... ...
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--~~~------~~~ 233 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQV------LKF 233 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--HHH------HHH
Confidence 9999986543222 11122235678999999999899999999999999999998 6767753211 110 011
Q ss_pred hhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCCC
Q 003772 734 FIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIP 790 (796)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p 790 (796)
...+.. ...+......+.+++.+||+.+|++|||+.++++.|++....+..
T Consensus 234 ~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 234 VMDGGY------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred HHcCCC------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 111100 011223357899999999999999999999999999887655443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=315.26 Aligned_cols=238 Identities=27% Similarity=0.331 Sum_probs=190.9
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHH-HHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEM-HVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~-~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|+||.||+++...+++.||+|++.+... .....+..|. .+++.++|+||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999988889999999975321 2234455554 467889999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|...+.. ...+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 999988865 46788899999999999999999998 99999999999999999999999999987532222 1223
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .. . ...... .....+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~--~----~~~i~~-------~~~~~~~~~ 219 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--SQ--M----YDNILH-------KPLQLPGGK 219 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--HH--H----HHHHhc-------CCCCCCCCC
Confidence 34589999999999998999999999999999999999999964321 00 0 011110 011223344
Q ss_pred HHHHHHHHHHhccCCCCCCCCHH
Q 003772 753 LENMIKIGLWCVQDEPALRPSMK 775 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~ 775 (796)
...+.+++.+||+.+|.+||+..
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 220 TVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CHHHHHHHHHHccCCHhhcCCCC
Confidence 56788999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.84 Aligned_cols=256 Identities=27% Similarity=0.420 Sum_probs=201.9
Q ss_pred HHHhhhcccCcccceEEEEEEEcC-----CcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCcee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 584 (796)
..+++.+.||+|+||.||++.... ....||+|++.... ....+++.+|+.++.+++|+||+++++++.++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 345566889999999999998743 45789999987543 334567999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCC--------------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccce
Q 003772 585 LVYEYMSNGSLADILFRGP--------------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNI 644 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NI 644 (796)
+|+||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhhe
Confidence 9999999999999996421 13478889999999999999999998 999999999999
Q ss_pred EecCCCceEEeccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCch
Q 003772 645 LMDEFWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPE 722 (796)
Q Consensus 645 ll~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~ 722 (796)
++++++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..|+..... .
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~--~ 239 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--E 239 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--H
Confidence 999999999999999876543321 11112234667999999998899999999999999999998 7777753211 1
Q ss_pred hHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 723 EIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
+. .......... ..+...+..+.+++.+||+.+|.+|||+.||++.|++
T Consensus 240 ~~------~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EV------IYYVRDGNVL------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HH------HHHHhcCCCC------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 10 0111111110 1122345779999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=323.31 Aligned_cols=249 Identities=22% Similarity=0.292 Sum_probs=192.4
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+.++||+|+||.||+++....++.||+|++.+.. ....+.+.+|+.++++++|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 45678999999999999998888999999997532 233457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc--
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT-- 668 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~-- 668 (796)
++|+|.+++.+ ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 84 ~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 84 PGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 99999999976 35688999999999999999999998 999999999999999999999999999753321000
Q ss_pred --------------------------------------------ceeeeeccCCCCCchhhhccCCCCccccchhhHHHH
Q 003772 669 --------------------------------------------RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVL 704 (796)
Q Consensus 669 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil 704 (796)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 001123589999999999999999999999999999
Q ss_pred HHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 003772 705 LEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPS---MKSVVL 779 (796)
Q Consensus 705 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~ 779 (796)
|||++|+.||..............+ ...... .......+.+.+++..++ .+|.+|++ +.++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~-------~~~~~~----p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINW-------QTSLHI----PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcc-------CCCcCC----CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999999754211100000000 000000 011122344556665555 49999997 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.41 Aligned_cols=263 Identities=25% Similarity=0.372 Sum_probs=201.0
Q ss_pred HHHhhhcccCcccceEEEEEEEcC----------------CcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhh
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYK----------------GEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRL 573 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~----------------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l 573 (796)
..+.+.+.||+|+||.||++.... ....||+|++.... ......+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 345677899999999999985432 23579999997543 3345679999999999999999999
Q ss_pred hhhhccCCceeEEEeecCCCChhhhhhcCC---------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccce
Q 003772 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGP---------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNI 644 (796)
Q Consensus 574 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NI 644 (796)
++++.+++..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 999999999999999999999999987532 13477889999999999999999998 999999999999
Q ss_pred EecCCCceEEeccCCccccCCCCcce-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh--cccCCCCCCCCc
Q 003772 645 LMDEFWTAKISDFGLAKLLMPDQTRT-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC--CRRNMEIDPSKP 721 (796)
Q Consensus 645 ll~~~~~~kl~DFgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt--g~~p~~~~~~~~ 721 (796)
++++++.++|+|||+++.+....... .....++..|+|||......++.++|||||||++|||++ |..|+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence 99999999999999998664332211 112234678999999888889999999999999999998 5566643221
Q ss_pred hhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 722 EEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
.... ......+... ..... ...+..++..+.+++.+||+.||.+||++.+|++.|+.
T Consensus 240 ~~~~--~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQVI--ENTGEFFRDQ-GRQVY--LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHH--HHHHHHHhhc-ccccc--CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111 0000000000 00000 11123345789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=315.02 Aligned_cols=262 Identities=29% Similarity=0.395 Sum_probs=205.5
Q ss_pred HHHHHHhhhcccCcccceEEEEEEEcC-------CcEEEEEEEeeccc-chhHHHHHHHHHHHhcc-CcCchhhhhhhhc
Q 003772 508 LKKATNRFKEELGKGSFGAVYKGTLYK-------GEKLVAVKKLEKMV-TEGEREFRAEMHVIGRT-HHKNLVRLIGYCA 578 (796)
Q Consensus 508 l~~~~~~~~~~LG~G~fg~Vy~g~~~~-------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~ 578 (796)
+....+.+.+.||+|+||.||++.... ....+|+|.+.... .....++..|+.++.++ +|+||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 334567788999999999999998643 22469999997542 33456788999999999 7999999999999
Q ss_pred cCCceeEEEeecCCCChhhhhhcCC--------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccce
Q 003772 579 EDSKRLLVYEYMSNGSLADILFRGP--------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNI 644 (796)
Q Consensus 579 ~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NI 644 (796)
+.+..++|+||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence 9999999999999999999997532 23588999999999999999999998 999999999999
Q ss_pred EecCCCceEEeccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCch
Q 003772 645 LMDEFWTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPE 722 (796)
Q Consensus 645 ll~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~ 722 (796)
+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.|+..... .
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~ 249 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--E 249 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--H
Confidence 9999999999999999765432211 1111224568999999998889999999999999999998 7777753321 1
Q ss_pred hHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 723 EIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
... ...... .....+......+.+++..||+.+|++||||.+|++.|+.+.+
T Consensus 250 ~~~------~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 250 ELF------KLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHH------HHHHcC------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 100 000000 0011223445678899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=305.01 Aligned_cols=244 Identities=22% Similarity=0.341 Sum_probs=199.9
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCChh
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLA 596 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 596 (796)
..||+|+||.||++.....+..||||++........+.+.+|+..+.+++|+||+++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 56999999999999998888899999987655556677899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeecc
Q 003772 597 DILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRG 676 (796)
Q Consensus 597 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~g 676 (796)
+++.. ..+++..+..++.||+.||.|||+. +|+||||||+||++++++.++|+|||++........ ......+
T Consensus 108 ~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~ 180 (292)
T cd06658 108 DIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVG 180 (292)
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeec
Confidence 98854 4588999999999999999999998 999999999999999999999999999876543222 2223458
Q ss_pred CCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC-CCCHHHHHH
Q 003772 677 TRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ-EVDRNTLEN 755 (796)
Q Consensus 677 t~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 755 (796)
+..|+|||.+.+..++.++||||||+++|||++|+.|+...... .. . .. +....... .........
T Consensus 181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~-~-----~~-----~~~~~~~~~~~~~~~~~~ 247 (292)
T cd06658 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QA-M-----RR-----IRDNLPPRVKDSHKVSSV 247 (292)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH-H-----HH-----HHhcCCCccccccccCHH
Confidence 89999999999888999999999999999999999998643211 10 0 00 00001100 011123456
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 756 MIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 756 l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
+..++..|++.+|.+|||++++++.
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhC
Confidence 8889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=296.34 Aligned_cols=257 Identities=23% Similarity=0.302 Sum_probs=200.1
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeec--ccchhHHHHHHHHHHHhccCcCchhhhhhhhcc-----CCceeEEEe
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE-----DSKRLLVYE 588 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~lV~e 588 (796)
.+.||+|+||.|..+.....++.||||++.. ......++-.+|+++|+.++|+||+.+++++.. -...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 4779999999999999999999999999973 233456778899999999999999999998765 346899999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC-C
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD-Q 667 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~-~ 667 (796)
+|+ -+|...++. ++.++......+.+||++||.|+|+. +|+||||||+|++++.+..+||+|||+|+..... .
T Consensus 107 lMe-tDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 107 LME-TDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred HHh-hHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 994 588888876 45599999999999999999999998 9999999999999999999999999999987543 1
Q ss_pred cceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH--------HHHhhhhh-
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW--------AYKCFIDR- 737 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~- 737 (796)
...++....|.-|.|||++.+. .+|...||||.|||+.||++|+..|.....-.. ..+... ....+..+
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q-l~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ-LQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH-HHHHHHhcCCCCHHHHHHhccHH
Confidence 2334566789999999988654 799999999999999999999998874432111 110000 01111111
Q ss_pred ---hhhhhhcCCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 738 ---ELNKLVRGQE-----VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 738 ---~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
-+..+..... .-+...+..++|+.+||..||.+|+|++|.++
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111111111 12245577889999999999999999999975
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=326.12 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=195.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+++....++.||||++.+.. ......+.+|+.++.+++|+||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 456688999999999999998888999999986532 22345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC--
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ-- 667 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~-- 667 (796)
+++|+|.+++.+ ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 83 IPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999976 45688899999999999999999998 99999999999999999999999999975331100
Q ss_pred ----------------------------------------cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHH
Q 003772 668 ----------------------------------------TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEI 707 (796)
Q Consensus 668 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~el 707 (796)
........||+.|||||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001124589999999999999999999999999999999
Q ss_pred hhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCC---CHHHHHHH
Q 003772 708 VCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRP---SMKSVVLM 780 (796)
Q Consensus 708 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---t~~evl~~ 780 (796)
++|+.||..............| ...... .........+.+++..|+ .+|.+|+ |+.++++.
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~-------~~~~~~----~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINW-------ETTLHI----PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhcc-------CccccC----CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999754321110000000 000000 001123345666666765 4999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.63 Aligned_cols=249 Identities=27% Similarity=0.348 Sum_probs=203.8
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.+.||+|+||.||+|....+++.+++|.+..... .+++.+|++++++++|+||+++++++.++...++++||++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 35567889999999999999988788999999875432 6789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+++|.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........ ..
T Consensus 82 ~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (256)
T cd06612 82 AGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR 156 (256)
T ss_pred CCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence 99999998643 45789999999999999999999998 999999999999999999999999999987654322 12
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
....++..|+|||++.+..++.++||||||+++|||++|+.|+........... .. .........+..
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--------~~----~~~~~~~~~~~~ 224 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--------IP----NKPPPTLSDPEK 224 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--------hc----cCCCCCCCchhh
Confidence 223478899999999998999999999999999999999999874322110000 00 000000111223
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 752 TLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 752 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....+.+++.+||+.+|++|||++||++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 4467899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.43 Aligned_cols=260 Identities=23% Similarity=0.301 Sum_probs=201.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+++.+.||+|+||.||++.....+..+|+|.+..... .....+.+|++++.+++|+||+++++++.+++..++|+||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 3556889999999999999988888999999865422 334568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+++|.+++.. ...+++..+..++.|+++||.|||+. .+++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--- 155 (308)
T cd06615 83 GGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--- 155 (308)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccccc---
Confidence 9999999976 36789999999999999999999973 2899999999999999999999999999876533221
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh----------------
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI---------------- 735 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------------- 735 (796)
....++..|+|||.+.+..++.++||||||+++|||++|+.|+............. .......
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFG-RPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhc-CccccccccCCcccccCCCCCcc
Confidence 22357899999999988889999999999999999999999986432111000000 0000000
Q ss_pred -----hhhhhhhhc---CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 736 -----DRELNKLVR---GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 736 -----~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
......... +..........+.+++.+||+.+|++|||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 000111244568999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=315.84 Aligned_cols=262 Identities=18% Similarity=0.235 Sum_probs=196.9
Q ss_pred hhcccCcc--cceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 515 FKEELGKG--SFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 515 ~~~~LG~G--~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.++||+| +|++||++....+++.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999999899999999987532 233456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc-c
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT-R 669 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~-~ 669 (796)
++|+|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++++||+.......... .
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999765455689999999999999999999998 999999999999999999999999986543321111 0
Q ss_pred -----eeeeeccCCCCCchhhhcc--CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh------h
Q 003772 670 -----TFTLVRGTRGYMAPEWYKN--TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI------D 736 (796)
Q Consensus 670 -----~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~ 736 (796)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||..................... .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 0111235678999999976 46899999999999999999999999643211100000000000000 0
Q ss_pred hhhh-------------hh-----hcC-------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 737 RELN-------------KL-----VRG-------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 737 ~~~~-------------~~-----~~~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..+. .. ... ..........+.+++..||+.||++|||+.||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 00 000 0012233567899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=338.66 Aligned_cols=259 Identities=22% Similarity=0.302 Sum_probs=203.1
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.++||+|+||.||+|.....++.||||++..... ...++|.+|++++.+++||||+++++++.+++..++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 4566899999999999999988889999999865322 2346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC---------CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCc
Q 003772 590 MSNGSLADILFRG---------PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA 660 (796)
Q Consensus 590 ~~~gsL~~~l~~~---------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~ 660 (796)
+++|+|.+++... ....+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999998642 123456778899999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCc-----------------ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchh
Q 003772 661 KLLMPDQT-----------------RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEE 723 (796)
Q Consensus 661 ~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~ 723 (796)
+....... .......||+.|||||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~--k 238 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR--K 238 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh--h
Confidence 87621110 0011245899999999999999999999999999999999999999653211 1
Q ss_pred HHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHhcCcC
Q 003772 724 IVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRP-SMKSVVLMLEGITD 786 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~~~ 786 (796)
... .. .+..... .....+.+..+.+++.+|++.||++|| ++.++++.|+...+
T Consensus 239 i~~-----~~----~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISY-----RD----VILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhh-----hh----hccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 100 00 0000000 001123456788999999999999995 67777777776544
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.08 Aligned_cols=241 Identities=25% Similarity=0.364 Sum_probs=193.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccC-cCchhhhhhhhccCCceeEEEe
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e 588 (796)
+++.+.||+|+||.||++....+++.||+|++.+.. ....+.+..|..++..+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 356788999999999999998888999999997632 233456778888888885 5778889998888899999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 82 y~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 82 YVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 9999999999865 45799999999999999999999998 999999999999999999999999999875432221
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... .+...... ...
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~------~~~i~~~~-------~~~ 220 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DEL------FQSIMEHN-------VSY 220 (323)
T ss_pred -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHH------HHHHHhCC-------CCC
Confidence 12234589999999999999999999999999999999999999964321 110 01111100 112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSM 774 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~ 774 (796)
+......+.+++.+||+.+|.+|++.
T Consensus 221 p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 23344678899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.51 Aligned_cols=253 Identities=21% Similarity=0.300 Sum_probs=202.2
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+.+.+.||+|+||.||++.....++.||+|.++.........+.+|+.++..++|+||+++++.+.+.+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 35667789999999999999998888999999987655555567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|.+++.. .+.+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... ..
T Consensus 89 ~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 89 GGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 99999999865 45789999999999999999999998 99999999999999999999999999987654322 12
Q ss_pred eeeeccCCCCCchhhhc---cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 671 FTLVRGTRGYMAPEWYK---NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
.....|+..|+|||++. ...++.++|||||||++|||++|+.|+........ .. ............ .
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~--~~~~~~~~~~~~-------~ 232 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LF--LMTKSNFQPPKL-------K 232 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HH--hhhccCCCCCcc-------c
Confidence 22345889999999985 45688999999999999999999999854321110 00 000000000000 0
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
........+.+++..|++.+|++|||+++|++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 01123456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.54 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=197.8
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
.+.+.||+|+||.||++.....++.||+|++.... ....+.+.+|+.++.+++|+||+++++++...+..++|+||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 45688999999999999998888899999986542 33456799999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++....... ..
T Consensus 84 ~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~ 151 (279)
T cd06619 84 GSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AK 151 (279)
T ss_pred CChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---cc
Confidence 9996542 467888899999999999999998 99999999999999999999999999997654322 22
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...++..|+|||.+.+..++.++||||||+++|||++|+.||............... ....... ..........
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~ 225 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDE-----DPPVLPVGQF 225 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH-HHHHhcc-----CCCCCCCCcC
Confidence 245889999999999989999999999999999999999998643221111100000 0000000 0011112234
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 753 LENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
..++.+++..|++.+|++||+++|+++.
T Consensus 226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 226 SEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 4578899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=314.26 Aligned_cols=265 Identities=29% Similarity=0.423 Sum_probs=207.6
Q ss_pred HHHHHHHhhhcccCcccceEEEEEEEcC-------CcEEEEEEEeeccc-chhHHHHHHHHHHHhcc-CcCchhhhhhhh
Q 003772 507 ELKKATNRFKEELGKGSFGAVYKGTLYK-------GEKLVAVKKLEKMV-TEGEREFRAEMHVIGRT-HHKNLVRLIGYC 577 (796)
Q Consensus 507 ~l~~~~~~~~~~LG~G~fg~Vy~g~~~~-------~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~ 577 (796)
++...++.+.+.||+|+||.||++.... ....||+|.++... ....+++.+|+.++.++ +|+||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3445567788999999999999997532 22368999887533 33456899999999999 799999999999
Q ss_pred ccCCceeEEEeecCCCChhhhhhcC--------------CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccc
Q 003772 578 AEDSKRLLVYEYMSNGSLADILFRG--------------PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQN 643 (796)
Q Consensus 578 ~~~~~~~lV~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~N 643 (796)
.+++..++++||+++|+|.+++.+. ....+++..++.++.|+++||.|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 9999999999999999999999753 124588899999999999999999998 99999999999
Q ss_pred eEecCCCceEEeccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCc
Q 003772 644 ILMDEFWTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKP 721 (796)
Q Consensus 644 Ill~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~ 721 (796)
|++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 242 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 242 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999999865432211 1112234567999999999999999999999999999998 7777753321
Q ss_pred hhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCC
Q 003772 722 EEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDIS 788 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 788 (796)
... ........ ....+......+.+++..||+.+|++|||+.|+++.|+.+....
T Consensus 243 ~~~------~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 EEL------FKLLKEGH------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHH------HHHHHcCC------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 110 01111100 01122344567889999999999999999999999999887444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=316.78 Aligned_cols=254 Identities=22% Similarity=0.277 Sum_probs=196.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.++||+|+||.||+++....++.+|+|++.+.. ......+.+|+.++..++|+||+++++.+.+.+..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 345688999999999999999888999999996522 22334588899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.+. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 83 ~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 83 YVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred cCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999753 35689999999999999999999998 9999999999999999999999999999765443333
Q ss_pred eeeeeccCCCCCchhhhc-----cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 670 TFTLVRGTRGYMAPEWYK-----NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
......||+.|+|||++. ...++.++|||||||++|||++|+.||...... . .......... . ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~--~------~~~~i~~~~~-~-~~ 228 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--E------TYGKIMNHKE-R-FQ 228 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH--H------HHHHHhCCCc-c-cc
Confidence 333456899999999986 346889999999999999999999999643211 0 0111111000 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCC--CCCCHHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPA--LRPSMKSVVLM 780 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~--~RPt~~evl~~ 780 (796)
-..........+.+++..|+..++. .|+++.|+++.
T Consensus 229 ~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0001122345677788887755444 47899999765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=314.81 Aligned_cols=246 Identities=26% Similarity=0.355 Sum_probs=206.0
Q ss_pred hhhcccCcccceEEEEEEEcCCc---EEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGE---KLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~---~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
.+.|+||+|.||+|++|.+...+ -.||||.+...... ....|.+|+.+|.+|+|+|+++++|+..+ ...++|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 45689999999999999986432 47999999765544 56789999999999999999999999887 788999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc-
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT- 668 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~- 668 (796)
++.|||.+.|++.....+-......++.|||.||.||.++ +.|||||..+|+||-....+||+||||.+-+..+..
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 9999999999886677888999999999999999999999 999999999999999999999999999998865443
Q ss_pred ceeee-eccCCCCCchhhhccCCCCccccchhhHHHHHHHhhc-ccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 669 RTFTL-VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCC-RRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 669 ~~~~~-~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
..+.. ..-...|.|||.+....|+.++|||+|||+||||+|+ ..|+..... -.+.+.++..
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~qIL~~iD~~ 331 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------IQILKNIDAG 331 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------HHHHHhcccc
Confidence 22222 2345689999999999999999999999999999994 566653321 1122222222
Q ss_pred ---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 747 ---EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 747 ---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
..+..+.++++++++.||..+|++|||+..|++.
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 2367889999999999999999999999999743
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=322.44 Aligned_cols=257 Identities=21% Similarity=0.206 Sum_probs=195.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.+.+.||+|+||.||++.+...++.||||... ...+.+|+.++++++|+||+++++++..++..++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 456688999999999999999888899999642 2245789999999999999999999999999999999985
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc-ee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR-TF 671 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~-~~ 671 (796)
++|.+++... ...+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 244 ~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 244 SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 7888888653 34799999999999999999999998 9999999999999999999999999999876433221 12
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCc----hhHHHHHHHHHh------hh---hhh
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKP----EEIVLINWAYKC------FI---DRE 738 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~------~~---~~~ 738 (796)
....||..|+|||++.+..++.++|||||||+||||++|..++....... ....+....... +. ...
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 23458999999999999999999999999999999999887654332111 111111110000 00 000
Q ss_pred hhhhh--------cCC-CC-C----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 739 LNKLV--------RGQ-EV-D----RNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 739 ~~~~~--------~~~-~~-~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
+.... ... .. . ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 000 00 0 0122468889999999999999999999864
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.89 Aligned_cols=239 Identities=26% Similarity=0.431 Sum_probs=191.5
Q ss_pred cccCcccceEEEEEEEcCCc----------EEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 517 EELGKGSFGAVYKGTLYKGE----------KLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~----------~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
+.||+|+||.||+|.+...+ ..|++|.+...... ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999997665 35888887654333 6789999999999999999999999988 778999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC-------ceEEeccCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW-------TAKISDFGL 659 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~DFgl 659 (796)
+||+++|+|.+++.... ..+++..++.++.||+.||.|||+. +|+|+||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999997642 3789999999999999999999998 999999999999999887 799999999
Q ss_pred ccccCCCCcceeeeeccCCCCCchhhhccC--CCCccccchhhHHHHHHHhhc-ccCCCCCCCCchhHHHHHHHHHhhhh
Q 003772 660 AKLLMPDQTRTFTLVRGTRGYMAPEWYKNT--PISVKADVFSYGVVLLEIVCC-RRNMEIDPSKPEEIVLINWAYKCFID 736 (796)
Q Consensus 660 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
+...... ....++..|+|||++... .++.++||||||+++|||++| ..|+...... .... . +.
T Consensus 155 a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~~~--~--~~---- 220 (259)
T cd05037 155 PITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-EKER--F--YQ---- 220 (259)
T ss_pred ccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-hHHH--H--Hh----
Confidence 9865431 123367789999999877 789999999999999999995 5555433211 1000 0 00
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 737 RELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
.....+......+.+++..||+.+|++|||+.+|++.|+
T Consensus 221 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 -------DQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -------cCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 001111111267899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.28 Aligned_cols=250 Identities=28% Similarity=0.424 Sum_probs=198.7
Q ss_pred cccCcccceEEEEEEEcCCc------EEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 517 EELGKGSFGAVYKGTLYKGE------KLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~------~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.||+|+||.||+|+..+.. +.+|||.+.+.. ......+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999976433 679999886543 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC-----CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC-----ceEEeccCC
Q 003772 590 MSNGSLADILFRG-----PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW-----TAKISDFGL 659 (796)
Q Consensus 590 ~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DFgl 659 (796)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999753 224478899999999999999999998 999999999999999877 899999999
Q ss_pred ccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhh
Q 003772 660 AKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDR 737 (796)
Q Consensus 660 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.|+..... .. ... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~--~~~----~~~~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QE--VLQ----HVTAG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HH--HHH----HHhcC
Confidence 9765433221 1112235678999999999999999999999999999998 8888853321 11 000 00000
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 738 ELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
.....+...+..+.+++.+||+.+|.+||++.+|+++|++
T Consensus 230 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 ------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0011233456778999999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=310.71 Aligned_cols=259 Identities=27% Similarity=0.421 Sum_probs=203.4
Q ss_pred HHHHhhhcccCcccceEEEEEEEc-------CCcEEEEEEEeeccc-chhHHHHHHHHHHHhcc-CcCchhhhhhhhccC
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLY-------KGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAED 580 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~-------~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~ 580 (796)
...+.+.++||+|+||.||+++.. .....+|+|++.... ......+..|+.++.++ +|+||+++++++.++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 345567789999999999999753 234579999987533 33456788999999999 699999999999998
Q ss_pred CceeEEEeecCCCChhhhhhcCC--------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe
Q 003772 581 SKRLLVYEYMSNGSLADILFRGP--------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM 646 (796)
Q Consensus 581 ~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 646 (796)
+..++|+||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 99999999999999999996532 24588999999999999999999998 99999999999999
Q ss_pred cCCCceEEeccCCccccCCCCcce-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhH
Q 003772 647 DEFWTAKISDFGLAKLLMPDQTRT-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEI 724 (796)
Q Consensus 647 ~~~~~~kl~DFgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~ 724 (796)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~~ 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--EEL 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--HHH
Confidence 999999999999998664322211 111224567999999999899999999999999999999 7777753321 110
Q ss_pred HHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 725 VLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
........ ....+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 246 ------~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 246 ------FKLLREGH------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ------HHHHHcCC------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 00000000 01123344567889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.14 Aligned_cols=254 Identities=21% Similarity=0.257 Sum_probs=196.1
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc---cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+++....++.||+|++.+. .....+.+++|+.++..++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 45678899999999999999888899999999752 122345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.+. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 83 ~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 83 YVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred CCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999653 45688999999999999999999998 9999999999999999999999999999766543333
Q ss_pred eeeeeccCCCCCchhhhcc-----CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 670 TFTLVRGTRGYMAPEWYKN-----TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... +. ........ ....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~--~~------~~~i~~~~--~~~~ 228 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ET------YGKIMNHK--EHFQ 228 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--HH------HHHHHcCC--Cccc
Confidence 3333458999999999873 45788999999999999999999999643211 00 00010000 0000
Q ss_pred CCCCCHHHHHHHHHHHHHhccC--CCCCCCCHHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQD--EPALRPSMKSVVLM 780 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~--dP~~RPt~~evl~~ 780 (796)
-..........+.+++..|+.. ++..||++.++++.
T Consensus 229 ~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0011112345677777776654 34448899988865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=298.81 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=199.8
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
++||+|+||.||++.+.+ ++.||+|++...... ..+.+.+|+.++++++|+||+++++++.+....++|+||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999877 789999998764433 556899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee-eee
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF-TLV 674 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~-~~~ 674 (796)
.+++... ...+++..++.++.+++.||.|||++ +++||||||+||+++.++.++|+|||++........... ...
T Consensus 80 ~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 80 LTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9999653 34688999999999999999999998 999999999999999999999999999986543222111 112
Q ss_pred ccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 003772 675 RGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTL 753 (796)
Q Consensus 675 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (796)
..+..|+|||.+.+..++.++||||||+++|||++ |..|+....... ... . +... .....+...+
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~----~~~----~-----~~~~-~~~~~~~~~~ 221 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ----TRE----R-----IESG-YRMPAPQLCP 221 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH----HHH----H-----HhcC-CCCCCCccCC
Confidence 23567999999998899999999999999999999 777775432110 000 0 0000 0011223445
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 754 ENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 754 ~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
..+.+++..|++.+|.+|||+.||++.|+.
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.58 Aligned_cols=260 Identities=24% Similarity=0.296 Sum_probs=194.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch--hHHHHHHHHHHHhcc---CcCchhhhhhhhcc-----CCc
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE--GEREFRAEMHVIGRT---HHKNLVRLIGYCAE-----DSK 582 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l---~h~niv~l~g~~~~-----~~~ 582 (796)
+.+.+.||+|+||.||++.....++.||+|.+...... ....+.+|+.++.++ +|+||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 45668899999999999999988899999998653222 233456677776665 79999999998764 245
Q ss_pred eeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 583 RLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
.++|+||+. ++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 789999998 4898988765556689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 663 LMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 663 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
..... ......++..|+|||++.+..++.++|||||||++|||++|+.||................ ...........
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (288)
T cd07863 158 YSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI-GLPPEDDWPRD 234 (288)
T ss_pred ccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHh-CCCChhhCccc
Confidence 64322 1223457899999999999899999999999999999999999986443211110000000 00000000000
Q ss_pred h-------cCC------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 743 V-------RGQ------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 743 ~-------~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
. ... ...++..+.+.+++..||+.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000 011234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.04 Aligned_cols=258 Identities=21% Similarity=0.308 Sum_probs=207.3
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+.+.+.||+|+||.||++.....++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 34556788999999999999988788899999997655555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|.+++.+ ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~- 171 (297)
T cd06656 99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 171 (297)
T ss_pred CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-
Confidence 99999999854 4578899999999999999999998 9999999999999999999999999998765433221
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||........... ... .. ......+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~--------~~~---~~-~~~~~~~~ 239 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--------IAT---NG-TPELQNPE 239 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee--------ecc---CC-CCCCCCcc
Confidence 1223478899999999998899999999999999999999999964322110000 000 00 00001122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhcCcCC
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEGITDI 787 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~~ 787 (796)
.....+.+++..||+.+|++||++++|++ .++...+.
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence 34466889999999999999999999997 44444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=288.28 Aligned_cols=257 Identities=20% Similarity=0.265 Sum_probs=196.7
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccchh--HHHHHHHHHHHhccCcCchhhhhhhhc--cCCceeEEEeecC
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG--EREFRAEMHVIGRTHHKNLVRLIGYCA--EDSKRLLVYEYMS 591 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~--~~~f~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~e~~~ 591 (796)
.++|++|.||.||+|+++..++.||+|+++-..... .-.-.+|+.+|.+.+|||||.+-.+.. +-+..|+||||++
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 468999999999999999999999999996432111 123478999999999999999987765 3457999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+ +|..++... .+.+...++..+..|+++|++|||.. .|+|||||++|+|+.+.|.+||+|||+|+.+... ...+
T Consensus 161 h-DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~ 234 (419)
T KOG0663|consen 161 H-DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKPY 234 (419)
T ss_pred h-hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC-cccC
Confidence 7 788888765 46888999999999999999999998 9999999999999999999999999999987654 3455
Q ss_pred eeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH--------HHhhhhhhhh-h
Q 003772 672 TLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA--------YKCFIDRELN-K 741 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~-~ 741 (796)
+..+-|.-|+|||.+.+. .+++..|+||+|||+.||+++++.|.......+ ...+... ++.+..-... .
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-l~~If~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-LDKIFKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-HHHHHHHhCCCccccCCCccccchhhc
Confidence 666789999999999876 689999999999999999999988864432211 1110000 0000000000 0
Q ss_pred hh-cCC-------CCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 742 LV-RGQ-------EVDRN-TLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 742 ~~-~~~-------~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.- ... .+... ..+.-++++..++..||.+|-|++|-++
T Consensus 314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00 000 01111 3467788889999999999999999875
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=298.59 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=202.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhcc-CCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAE-DSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~ 589 (796)
+.+.+.||+|++|.||++....+++.+|+|++.... ....+.+.+|+.++++++|+|++++++.+.. +...++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 456789999999999999998888899999986532 2345678899999999999999999987764 4467899999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++++|.+++.......+++.+++.++.|++.||.+||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~- 157 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD- 157 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence 9999999999875556789999999999999999999998 999999999999999999999999999987643222
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
......+++.|+|||++.+..++.++||||||++++||++|+.|+..... .... .....+.+ ...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~------~~~~~~~~------~~~~ 223 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--NSLV------YRIIEGKL------PPMP 223 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--HHHH------HHHHhcCC------CCCc
Confidence 22234578999999999999999999999999999999999999864321 1110 00111111 1123
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
......+.+++.+|++.+|++|||+.++++.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 3455779999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=304.71 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=202.7
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+++.++||+|+||.||+|+....++.+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45677889999999999999998888999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|..++.+. ...+++..+..++.|+++||.|||+. +++|+||||+||+++.++.+||+|||++....... ..
T Consensus 92 ~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 92 PGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred CCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 999999887653 35689999999999999999999998 99999999999999999999999999987543221 11
Q ss_pred eeeeccCCCCCchhhhc-----cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 671 FTLVRGTRGYMAPEWYK-----NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
.....+++.|+|||++. ...++.++|||||||++|||++|+.|+..... ... . ......... .
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~-~-----~~~~~~~~~----~ 234 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRV-L-----LKIAKSEPP----T 234 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--HHH-H-----HHHhcCCCc----c
Confidence 22344788999999984 34578899999999999999999999864321 110 0 000000000 0
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...+......+.+++.+||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0112234456889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=301.66 Aligned_cols=246 Identities=27% Similarity=0.382 Sum_probs=202.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.+.+.||.|++|.||+|.....++.||+|++.... ......+.+|+.+++.++|+||+++++++.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 456688999999999999998888999999987543 3345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++.+..... ..
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (274)
T cd06609 83 GGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KR 155 (274)
T ss_pred CCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-cc
Confidence 99999998652 789999999999999999999998 999999999999999999999999999987754322 22
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
....++..|+|||++.+..++.++||||||+++|||++|+.|+...... ... ... ..... ......
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~~~------~~~-----~~~~~-~~~~~~ 221 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--RVL------FLI-----PKNNP-PSLEGN 221 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--HHH------HHh-----hhcCC-CCCccc
Confidence 2335788999999999988999999999999999999999998643211 100 000 00000 111111
Q ss_pred -HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 752 -TLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 752 -~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....+.+++..||+.+|++|||++++++
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 4567889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.78 Aligned_cols=260 Identities=22% Similarity=0.287 Sum_probs=198.0
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.+.++||+|+||.||+|.....++.||+|+++.... .....+.+|+.++++++|+||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 4566889999999999999988888999999875432 233467889999999999999999999999999999999998
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+ +|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++....... ..
T Consensus 88 ~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 161 (309)
T cd07872 88 K-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TY 161 (309)
T ss_pred C-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-cc
Confidence 5 888887653 35688999999999999999999998 999999999999999999999999999976433221 12
Q ss_pred eeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH--------HHhhhhh-hhhh
Q 003772 672 TLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA--------YKCFIDR-ELNK 741 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~-~~~~ 741 (796)
....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ....... ++..... ....
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 22347899999999865 4689999999999999999999999965432211 1110000 0000000 0000
Q ss_pred hhcCC-------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 742 LVRGQ-------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 742 ~~~~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.-.+. .........+.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 001123456789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=299.00 Aligned_cols=246 Identities=26% Similarity=0.399 Sum_probs=201.1
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-----chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-----TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
...+.||+|+||.||+|....+++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++.++...++|+|
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 45578999999999999998778899999986533 2345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++++|.+++.+ ...+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 83 LVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred ecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 9999999999975 34688999999999999999999998 99999999999999999999999999998764333
Q ss_pred ceeeeeccCCCCCchhhhccCC-CCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTP-ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
......++..|+|||.+.... ++.++|+||||+++|||++|+.||...... . .... . ........
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~-~~~~--~--------~~~~~~~~ 222 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--A-AVFK--I--------GRSKELPP 222 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--H-HHHH--H--------HhcccCCC
Confidence 223345788999999998776 899999999999999999999998654311 0 0000 0 00001112
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.+......+.+++.+||+.+|++||++++++.
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 23344577889999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.03 Aligned_cols=260 Identities=24% Similarity=0.326 Sum_probs=199.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.++||+|+||.||++.+...++.||+|++.+... ...+.+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 4456889999999999999988888999999865332 23467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|.++... ...+++..++.++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++........ .
T Consensus 83 ~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07846 83 DHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-V 156 (286)
T ss_pred CccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-c
Confidence 99999887754 34589999999999999999999998 999999999999999999999999999987644332 2
Q ss_pred eeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhh--------hhh-
Q 003772 671 FTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDR--------ELN- 740 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~- 740 (796)
.....++..|+|||++.+. .++.++||||||+++|||++|+.|+.............. ....+... .+.
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIK-CLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH-HhCCCchhhHHHhccchHhh
Confidence 2234478899999998754 578899999999999999999988864432111111100 00000000 000
Q ss_pred hhhcCC--------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 741 KLVRGQ--------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 741 ~~~~~~--------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...... ...+.....+.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000 001234577999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=299.11 Aligned_cols=251 Identities=27% Similarity=0.464 Sum_probs=199.9
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
...+.+.||+|+||.||++.+.. ++.+|+|++.... .....|.+|+.++++++|+|++++++++.+....++|+||++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 34567889999999999998864 4579999886532 234578999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 83 ~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99999998653 34688999999999999999999998 999999999999999999999999999986543322222
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
....++.+|+|||.+.+..++.++||||||+++|||++ |+.|+...... . .. +..... ... ..+.
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~--~~----~~~~~~--~~~----~~~~ 224 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--E--VV----ETINAG--FRL----YKPR 224 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--H--HH----HHHhCC--CCC----CCCC
Confidence 22234678999999998889999999999999999998 88887643211 0 00 000000 000 1112
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
.....+.+++.+||+.+|++|||+.+|+++|.
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 23467999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=301.45 Aligned_cols=247 Identities=27% Similarity=0.361 Sum_probs=200.4
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch---------hHHHHHHHHHHHhccCcCchhhhhhhhccCCcee
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE---------GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~---------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 584 (796)
.+.+.||+|++|.||+|.....++.+|+|.+...... ..+.+.+|+.++++++|+||+++++++.+.+..+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 3567899999999999998877889999988643221 2256889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++...
T Consensus 83 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 83 IFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999965 35688999999999999999999998 99999999999999999999999999998775
Q ss_pred CCCcc-----eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh
Q 003772 665 PDQTR-----TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739 (796)
Q Consensus 665 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..+ .. +
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~-------~~-----~ 224 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-QAI-------FK-----I 224 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-HHH-------HH-----H
Confidence 32111 111234788999999999988999999999999999999999999643211 000 00 0
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 740 NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
... .....+......+.+++.+||+.+|.+||++.+|++
T Consensus 225 ~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 225 GEN-ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred hcc-CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000 111223345677899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=301.48 Aligned_cols=253 Identities=27% Similarity=0.401 Sum_probs=189.5
Q ss_pred cccCcccceEEEEEEEcCC--cEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 517 EELGKGSFGAVYKGTLYKG--EKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~--~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
++||+|+||.||+|..... ...+++|.+.... ......+.+|+..++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 3699999999999976432 3478888876433 233467889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCC---CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc-
Q 003772 594 SLADILFRGPE---RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR- 669 (796)
Q Consensus 594 sL~~~l~~~~~---~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~- 669 (796)
+|.+++..... ...++.....++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976422 3356788899999999999999998 9999999999999999999999999998754332211
Q ss_pred eeeeeccCCCCCchhhhcc-------CCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 670 TFTLVRGTRGYMAPEWYKN-------TPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
......++..|+|||++.. ..++.++|||||||++|||++ |+.|+..... .. .+ ..........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~-~~-----~~~~~~~~~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQ-VL-----KQVVREQDIK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--HH-HH-----HHHhhccCcc
Confidence 1122235678999999753 356889999999999999999 6667653321 11 10 0000000001
Q ss_pred hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 742 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
... ..........+.+++..|+ .||++|||+++|+++|.
T Consensus 230 ~~~-~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPK-PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCC-CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111 1122344566777888898 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=298.69 Aligned_cols=251 Identities=23% Similarity=0.349 Sum_probs=206.3
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+++.+.||.|+||.||.++....++.+++|++... .....+.+.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 45668899999999999999888889999998653 2344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|+|.+++.......+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++........ .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 999999999765456789999999999999999999998 999999999999999999999999999987644332 2
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.|+...... +.. .....+.. .....
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~~~------~~~~~~~~------~~~~~ 223 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--NLV------VKIVQGNY------TPVVS 223 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--HHH------HHHHcCCC------CCCcc
Confidence 22345889999999999888999999999999999999999998643211 100 00011100 11123
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLML 781 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 781 (796)
.....+.+++..||+.+|.+||+++++++.+
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 4456788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=299.70 Aligned_cols=252 Identities=26% Similarity=0.404 Sum_probs=200.1
Q ss_pred hhhcccCcccceEEEEEEEcC-CcEEEEEEEeecc----------cchhHHHHHHHHHHHhc-cCcCchhhhhhhhccCC
Q 003772 514 RFKEELGKGSFGAVYKGTLYK-GEKLVAVKKLEKM----------VTEGEREFRAEMHVIGR-THHKNLVRLIGYCAEDS 581 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~-~~~~vAvK~l~~~----------~~~~~~~f~~E~~~l~~-l~h~niv~l~g~~~~~~ 581 (796)
.+.+.||+|+||.||+|.+.. .++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++.+++
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 456789999999999999877 5678999987531 12233557788888865 79999999999999999
Q ss_pred ceeEEEeecCCCChhhhhhc--CCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCC
Q 003772 582 KRLLVYEYMSNGSLADILFR--GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGL 659 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl 659 (796)
..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+. .+++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999998853 2345789999999999999999999963 2899999999999999999999999999
Q ss_pred ccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh
Q 003772 660 AKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739 (796)
Q Consensus 660 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... . .. ........
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--~--~~----~~~~~~~~ 230 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--S--LA----TKIVEAVY 230 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--H--HH----HHHhhccC
Confidence 98765433 233445889999999999888999999999999999999999998543211 0 00 00001100
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 740 NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
. ..........+.+++.+||+.||++||++.||..+++
T Consensus 231 ~-----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 E-----PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred C-----cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 0111133467889999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=307.07 Aligned_cols=248 Identities=20% Similarity=0.313 Sum_probs=202.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.+.+.||.|++|.||+|.....++.|++|.+........+.+.+|+.+++.++|+||+++++++.++...++|+||+++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 34557899999999999998888899999999765555567889999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......... ..
T Consensus 101 ~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~ 173 (296)
T cd06655 101 GSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RS 173 (296)
T ss_pred CcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CC
Confidence 999998854 4689999999999999999999998 9999999999999999999999999998865443221 12
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...++..|+|||.+.+..++.++|||||||++|||++|+.||...... .... ...... ......+...
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--~~~~------~~~~~~----~~~~~~~~~~ 241 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALY------LIATNG----TPELQNPEKL 241 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH------HHHhcC----CcccCCcccC
Confidence 235788999999999988999999999999999999999998654311 1000 000000 0000112234
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 753 LENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...+.+++.+||+.+|.+|||+.+|+.
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 467889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=304.16 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=199.7
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCChh
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLA 596 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 596 (796)
..||+|+||.||++.....++.||+|.+........+.+.+|+.++..++|+||+++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 47999999999999988778899999997655555667889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeecc
Q 003772 597 DILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRG 676 (796)
Q Consensus 597 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~g 676 (796)
+++.. ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........ ......+
T Consensus 107 ~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~ 179 (297)
T cd06659 107 DIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVG 179 (297)
T ss_pred HHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceec
Confidence 98754 4689999999999999999999998 999999999999999999999999999876543322 1223458
Q ss_pred CCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHH
Q 003772 677 TRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENM 756 (796)
Q Consensus 677 t~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 756 (796)
+..|+|||++.+..++.++||||||+++|||++|+.||...... .. . ....... .............+
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~-~-----~~~~~~~----~~~~~~~~~~~~~l 247 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QA-M-----KRLRDSP----PPKLKNAHKISPVL 247 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH-H-----HHHhccC----CCCccccCCCCHHH
Confidence 89999999999889999999999999999999999998643211 10 0 0000000 00001112234568
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHH
Q 003772 757 IKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 757 ~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.+++..||+.+|.+||++++|++.
T Consensus 248 ~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 248 RDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHhcCCcccCcCHHHHhhC
Confidence 899999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=283.55 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=203.6
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEee--cccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLE--KMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~--~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
...+.+.+.||+|.|+.||+......++.+|+|++. +.+..+.+++.+|+.+-+.++||||+++...+.+...+++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 455677899999999999999888888888988874 345557788999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC---CCceEEeccCCccccC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE---FWTAKISDFGLAKLLM 664 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFgl~~~~~ 664 (796)
|+|++++|..-+.+ +...++..+-.++.||++||.|+|.+ +|||||+||+|+++-. .--+||+|||++..+.
T Consensus 90 e~m~G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA--REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999999776654 25677888889999999999999999 9999999999999953 4458999999999887
Q ss_pred CCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
.........|||+|||||++...+++..+|||+.||+||-|+.|..||...... . .++.+..+. .+
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--r------lye~I~~g~----yd 230 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--R------LYEQIKAGA----YD 230 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--H------HHHHHhccc----cC
Confidence 333444567999999999999999999999999999999999999999753211 0 111111111 11
Q ss_pred CC-CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 003772 745 GQ-EVDRNTLENMIKIGLWCVQDEPALRPSMKSVV 778 (796)
Q Consensus 745 ~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 778 (796)
-. ..=+...+...+|+++||..||.+|.|+.|.+
T Consensus 231 ~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 231 YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 00 11123456788999999999999999998876
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=301.80 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=202.8
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.+.||.|+||.||++.....+..+|+|.+........+.+..|++++++++|+||+++++.+.++...++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 46777899999999999999987788999999976655566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+++|.+++.+. ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........ ..
T Consensus 86 ~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~ 160 (280)
T cd06611 86 GGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KR 160 (280)
T ss_pred CCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-cc
Confidence 99999998653 35689999999999999999999998 999999999999999999999999999876533222 12
Q ss_pred eeeccCCCCCchhhhc-----cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 672 TLVRGTRGYMAPEWYK-----NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
....+++.|+|||.+. ...++.++||||||+++|||++|+.|+...... . .... ....... .-
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~-~~~~-----~~~~~~~----~~ 228 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--R-VLLK-----ILKSEPP----TL 228 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--H-HHHH-----HhcCCCC----Cc
Confidence 2344889999999985 345788999999999999999999998643211 1 0000 0000000 00
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
..+......+.+++..||+.+|.+||++.+|++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1122334568899999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=301.98 Aligned_cols=255 Identities=28% Similarity=0.402 Sum_probs=201.8
Q ss_pred HhhhcccCcccceEEEEEEEcC-----CcEEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
+...+.||+|+||.||+|+.+. ..+.|++|.+.....+ ..+++.+|+.++++++|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (275)
T cd05046 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMI 86 (275)
T ss_pred ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEE
Confidence 3455789999999999999653 3467999998764443 456799999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCC-------CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCC
Q 003772 587 YEYMSNGSLADILFRGPE-------RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGL 659 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl 659 (796)
|||+++|+|.+++..... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||+
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccc
Confidence 999999999999976432 2689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhh
Q 003772 660 AKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRE 738 (796)
Q Consensus 660 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
+...............++..|+|||.+.+...+.++||||||+++|||++ |..||..... .. .. .....+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~-~~-----~~~~~~~ 235 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EE-VL-----NRLQAGK 235 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HH-HH-----HHHHcCC
Confidence 87543332222233346778999999988889999999999999999999 6667743211 11 00 0011111
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 739 LNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
+. .......+..+.+++.+||+.+|.+|||+.+++..|++
T Consensus 236 ~~-----~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 236 LE-----LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cC-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 10 01122345679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=313.42 Aligned_cols=192 Identities=26% Similarity=0.328 Sum_probs=165.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.+.||+|+||.||+|+....++.||+|+..+. ....|+.++++++|+||+++++++.++...++|+||+.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 356678999999999999999888889999985432 23569999999999999999999999999999999985
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 141 -~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 213 (357)
T PHA03209 141 -SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAF 213 (357)
T ss_pred -CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--ccc
Confidence 6888888653 45789999999999999999999998 9999999999999999999999999999753322 122
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCC
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEI 716 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~ 716 (796)
....||+.|+|||++.+..++.++|||||||++|||+++..++..
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 234589999999999999999999999999999999997666543
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.41 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=203.8
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+...+.||.|+||.||+|.....+..||||.+.... ......+.+|+.++++++|+||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3445678999999999999998888899999987533 344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|+|.+++.. ..+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 85 ~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06640 85 GGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence 99999999864 4688899999999999999999998 999999999999999999999999999976643322 1
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
.....++..|+|||++.+..++.++||||||+++|||++|+.|+...... ... .. ...........
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~------~~------~~~~~~~~~~~ 223 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--RVL------FL------IPKNNPPTLTG 223 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--hHh------hh------hhcCCCCCCch
Confidence 22234788999999999888999999999999999999999998643211 000 00 00001122344
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
..+..+.+++..||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 567789999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=313.03 Aligned_cols=259 Identities=22% Similarity=0.226 Sum_probs=195.6
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccC------Cc
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAED------SK 582 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~ 582 (796)
..+.+.+.||+|+||.||++.....++.||||++.... ....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 34566789999999999999998888899999997532 23446788999999999999999999987543 35
Q ss_pred eeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 583 RLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
.++||||+++ +|.+.+. ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred EEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 7999999975 6777764 3478889999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH-------HHHhhh
Q 003772 663 LMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW-------AYKCFI 735 (796)
Q Consensus 663 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~ 735 (796)
..... ......+|..|+|||++.+..++.++|||||||++|||++|+.||............... .... .
T Consensus 176 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 252 (364)
T cd07875 176 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK-L 252 (364)
T ss_pred cCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh-h
Confidence 54322 222345899999999999999999999999999999999999999644311100000000 0000 0
Q ss_pred hhhhhh---------------hhcC------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 736 DRELNK---------------LVRG------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 736 ~~~~~~---------------~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
...+.. .... ..........+.+++.+|++.||.+|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 0000 00111223578899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=303.12 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=205.1
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcE----EEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCcee
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEK----LVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~----~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 584 (796)
...+++.+.||+|+||.||+|.....++ .+|+|.+..... ....++.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3455677899999999999999765443 689998876543 345678999999999999999999999887 7889
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 999999999999999764 34589999999999999999999997 99999999999999999999999999998765
Q ss_pred CCCccee-eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 665 PDQTRTF-TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 665 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
....... ....++..|+|||.+....++.++||||||+++||+++ |+.|+..... .+.. ......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~------~~~~~~----- 227 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIP------DLLEKG----- 227 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHH------HHHhCC-----
Confidence 4332211 11223568999999988899999999999999999998 9998864321 1110 000000
Q ss_pred hcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 743 VRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 743 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.....+..+...+.+++..||..+|.+||++.++++.|+.+..
T Consensus 228 -~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 228 -ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0011122344568899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=302.89 Aligned_cols=260 Identities=24% Similarity=0.320 Sum_probs=197.5
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.||+|++|.||+|+....+..||||++.... ....+.+.+|+.++.+++|+||+++++++.+++..++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 45678999999999999998888899999986432 2234678899999999999999999999999999999999997
Q ss_pred CCChhhhhhcCC-CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 592 NGSLADILFRGP-ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 592 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|.+++.... ...+++..++.++.|+++||.|||+. +++|+||||+||++++++.+||+|||++....... ..
T Consensus 83 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (285)
T cd07861 83 -MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RV 157 (285)
T ss_pred -CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cc
Confidence 68988886533 36789999999999999999999998 99999999999999999999999999997654322 11
Q ss_pred eeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhh---------hhh
Q 003772 671 FTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDR---------ELN 740 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 740 (796)
.....+++.|+|||++.+. .++.++||||||+++|||++|+.|+.............. ......+. ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFR-ILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH-HhCCCChhhhhcchhhHHHH
Confidence 2223468899999998754 578999999999999999999999875432111100000 00000000 000
Q ss_pred hhhcC------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 741 KLVRG------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 741 ~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..... .........++.+++.+||+.||++|||+.+|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 0001123467789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=297.49 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=204.0
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|+||.||++....+++.+|+|++... .....+++.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 45668899999999999999888899999998653 2334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|.+++.......+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~- 157 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL- 157 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-
Confidence 999999999765445688999999999999999999998 9999999999999999999999999999865432221
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
.....+++.|+|||++.+...+.++|||||||+++||++|+.|+..... .+.. .....+. ....+.
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~~------~~~~~~~------~~~~~~ 223 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--KNLV------LKIIRGS------YPPVSS 223 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--HHHH------HHHhcCC------CCCCcc
Confidence 1223478899999999988999999999999999999999999864321 1110 0000000 011233
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.....+.+++.+||+.+|++||+|.+|++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 44567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=302.41 Aligned_cols=261 Identities=21% Similarity=0.258 Sum_probs=197.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|+||.||+++....++.+|+|++..... .....+.+|+.++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 3456789999999999999988888999999865322 22356788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
+ ++|.+++... ...+++..++.++.||++||.|||+. +|+|+||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (284)
T cd07839 82 D-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C 155 (284)
T ss_pred C-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence 7 5788877653 45689999999999999999999998 999999999999999999999999999986543221 1
Q ss_pred eeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhh---hhhhhhcCC
Q 003772 671 FTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDR---ELNKLVRGQ 746 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 746 (796)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.|+....................... .+.......
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 2223468899999998765 479999999999999999999998754332211111000000000000 000000000
Q ss_pred ------------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 747 ------------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 747 ------------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...+.....+.+++..||+.||.+|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 011234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.96 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=200.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+++.+.||+|+||.||++.....++.||+|.+.... ......+.+|+.++.+++|+||+++++.+...+..++|+||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 467789999999999999998788899999886532 2334678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCC-CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 592 NGSLADILFRGP-ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 592 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
+++|.+++.... ...+++..+..++.|++.||.|||++ .+|+|+||||+||+++.++.++|+|||++..+.....
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 158 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA-- 158 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc--
Confidence 999999886531 24789999999999999999999963 3899999999999999999999999999976533222
Q ss_pred eeeeccCCCCCchhhhccC------CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 671 FTLVRGTRGYMAPEWYKNT------PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.......... .+.....
T Consensus 159 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-------------~~~~~~~ 224 (286)
T cd06622 159 -KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA-------------QLSAIVD 224 (286)
T ss_pred -ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH-------------HHHHHhh
Confidence 123478899999998654 35889999999999999999999986432111000 0011111
Q ss_pred --CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 745 --GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 745 --~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....+......+.+++.+||+.+|++||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 225 GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11233446678899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=304.46 Aligned_cols=266 Identities=21% Similarity=0.262 Sum_probs=201.0
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch-----hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE-----GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-----~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
+.+.+.||+|+||.||+|.....++.||||++...... ....+..|++++.+++|+||+++++++.+++..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 34567899999999999999888889999999754322 3456778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+ +|+|.+++.... ..+++..++.++.||++||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 82 EFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred ccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 999 899999997632 4799999999999999999999998 99999999999999999999999999998765432
Q ss_pred cceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh------
Q 003772 668 TRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN------ 740 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 740 (796)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|..++...... ...................
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhccccc
Confidence 2 1122346788999999865 46789999999999999999997766533211 1110000000000000000
Q ss_pred hhhc---CC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HhcCc
Q 003772 741 KLVR---GQ-----EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM--LEGIT 785 (796)
Q Consensus 741 ~~~~---~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~ 785 (796)
.... .. .........+.+++..||+.+|++|||++||++. +++-.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 0000 00 0112335778999999999999999999999985 44433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=296.36 Aligned_cols=250 Identities=32% Similarity=0.494 Sum_probs=202.7
Q ss_pred hhcccCcccceEEEEEEEcCCc----EEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 515 FKEELGKGSFGAVYKGTLYKGE----KLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~----~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.||.|+||.||++.....+ ..||+|++...... ..+.+..|+.++.+++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 5678999999999999997655 78999999765443 567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999999764333389999999999999999999998 9999999999999999999999999999876544222
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
......+++.|+|||.+.+..++.++||||+|++++||++ |+.|+..... .. . .+...... ....
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~--~----~~~~~~~~------~~~~ 225 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EE--V----LEYLKKGY------RLPK 225 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HH--H----HHHHhcCC------CCCC
Confidence 2212336789999999988889999999999999999998 6666653211 00 0 00000000 0111
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVLML 781 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 781 (796)
....+.++.+++.+|++.+|++|||+.++++.|
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 223567799999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=306.30 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=199.5
Q ss_pred hhhcccCcccceEEEEEEEcCCcE----EEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEK----LVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~----~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
+..+.||+|+||.||+|.+...+. .||+|.+..... ....++.+|+.++.+++|+||+++++++... ..++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e 88 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ 88 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence 445789999999999998765554 578888865433 2344788999999999999999999988754 5679999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+|+||||+||++++++.+||+|||+++.......
T Consensus 89 ~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 89 LMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred hcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccc
Confidence 99999999998753 34688999999999999999999998 999999999999999999999999999987653322
Q ss_pred c-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 669 R-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 669 ~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
. ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... . ...+.. .+ ...
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~--~~~~~~----~~------~~~ 230 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--E--IPDLLE----KG------ERL 230 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--H--HHHHHH----CC------CCC
Confidence 1 1112335678999999999999999999999999999997 88888543211 0 101000 00 000
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
..+..+...+.+++..||..+|++||++++|++.|+.+..-
T Consensus 231 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11223446788999999999999999999999999886544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.22 Aligned_cols=246 Identities=25% Similarity=0.399 Sum_probs=198.8
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEe--ec--ccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCc--eeEEE
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKL--EK--MVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSK--RLLVY 587 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l--~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~--~~lV~ 587 (796)
+|.++||+|+|-+||+|.+...+.+||--.+ .+ ...+..+.|..|+.+|+.|+|+||++++..+.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4668899999999999999888877773322 22 123345789999999999999999999999987665 67899
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec-CCCceEEeccCCccccCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFgl~~~~~~~ 666 (796)
|.+..|+|+.++++ .+.++...+.+|+.||++||.|||++ .++|||||||-+||||+ ..|.+||+|+|||.++...
T Consensus 123 EL~TSGtLr~Y~kk--~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK--HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHH--hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999999987 46788899999999999999999998 78999999999999998 5689999999999987644
Q ss_pred CcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
... .+.|||-|||||.+. ..|.+.+||||||++++||+|+..|+.-.... ...+++...+.....+
T Consensus 200 ~ak---svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-------AQIYKKV~SGiKP~sl--- 265 (632)
T KOG0584|consen 200 HAK---SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-------AQIYKKVTSGIKPAAL--- 265 (632)
T ss_pred ccc---eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-------HHHHHHHHcCCCHHHh---
Confidence 332 356999999999998 67999999999999999999999998754322 1223333222111111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..-..+++.++|..||.. ..+|||+.|++.
T Consensus 266 --~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 266 --SKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --hccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 111235688999999998 999999999984
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=291.03 Aligned_cols=262 Identities=26% Similarity=0.337 Sum_probs=199.7
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch--hHHHHHHHHHHHhccCcCc-hhhhhhhhccCC------ce
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE--GEREFRAEMHVIGRTHHKN-LVRLIGYCAEDS------KR 583 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~h~n-iv~l~g~~~~~~------~~ 583 (796)
+...++||+|.||+||+|+.+..++.||+|++.-...+ ....-.+|+.++++++|+| |+++++++...+ ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 33446799999999999999999999999998654332 2344678999999999999 999999998877 78
Q ss_pred eEEEeecCCCChhhhhhcCCC--CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcc
Q 003772 584 LLVYEYMSNGSLADILFRGPE--RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~ 661 (796)
++|+||++. +|..++..... ..++...+..++.||++||+|||++ +|+||||||+||||++++.+||+|||+|+
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHH
Confidence 899999875 89998876433 4677789999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh
Q 003772 662 LLMPDQTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740 (796)
Q Consensus 662 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
...-. ....+...+|..|+|||++.+. .+++..||||+|||+.||++++..|..+.+... ...+-.......++.+.
T Consensus 169 a~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q-l~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 169 AFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ-LFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH-HHHHHHHcCCCCccCCC
Confidence 65422 2335556689999999999887 799999999999999999998888765543111 11000000000000000
Q ss_pred h---hhcCC----------CCC---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 741 K---LVRGQ----------EVD---RNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 741 ~---~~~~~----------~~~---~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
. +.+.+ ... +.......+++.+||+.+|.+|.|++..+++
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 00000 000 1111478899999999999999999999986
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.34 Aligned_cols=260 Identities=23% Similarity=0.260 Sum_probs=195.1
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccCC------c
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS------K 582 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~ 582 (796)
..+.+.+.||+|+||.||++.....++.||||++... .......+.+|+.+++.++|+||+++++++.... .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 3456678999999999999999888899999998653 2234567889999999999999999999886443 4
Q ss_pred eeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 583 RLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
.++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred eEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 6999999975 5666663 3478889999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHH-----------HH--
Q 003772 663 LMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLI-----------NW-- 729 (796)
Q Consensus 663 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~-----------~~-- 729 (796)
..... ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||............. ..
T Consensus 173 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 173 ACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 43221 2223458999999999999999999999999999999999999997442111000000 00
Q ss_pred -HHHhhhhh-------hhhhhhcC------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 730 -AYKCFIDR-------ELNKLVRG------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 730 -~~~~~~~~-------~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
....+... ...+.... ..........+.+++..||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 00000000 00111224568899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.68 Aligned_cols=251 Identities=23% Similarity=0.271 Sum_probs=201.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+++.+.||+|+||.||++.....++.+|+|.+..... ...+.+.+|++++.+++|+||+++++.+.++...++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 3456789999999999999988888999999976332 2456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+.+++|.+++.......+++..+..++.|+++||.|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred cCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 9999999999765567899999999999999999999998 9999999999999999999999999998755322110
Q ss_pred ----------------------------eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCc
Q 003772 670 ----------------------------TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKP 721 (796)
Q Consensus 670 ----------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~ 721 (796)
......|+..|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 0112347889999999999889999999999999999999999986433110
Q ss_pred hhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCC----HHHHHH
Q 003772 722 EEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPS----MKSVVL 779 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~evl~ 779 (796)
.+ ........ . ..........+.+++.+||+.+|++||| +.+++.
T Consensus 240 ---~~-----~~~~~~~~----~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 ---TF-----SNILKKEV----T-FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ---HH-----HHHhcCCc----c-CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 00 00000000 0 0111125678999999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=299.68 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=204.3
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.+.+.||+|+||.||++.....++.+++|.+........+.+.+|+.++++++|+||+++++++.++...+++|||+++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 45668899999999999999888889999999876555677899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
++|.+++... ...++...+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++........ ...
T Consensus 85 ~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 159 (262)
T cd06613 85 GSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRK 159 (262)
T ss_pred CcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-ccc
Confidence 9999988653 35789999999999999999999998 999999999999999999999999999986543221 122
Q ss_pred eeccCCCCCchhhhccC---CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 673 LVRGTRGYMAPEWYKNT---PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
...++..|+|||.+... .++.++||||||+++|||++|+.|+.......... ...... ... ......
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~---~~~~~~-----~~~--~~~~~~ 229 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF---LISKSN-----FPP--PKLKDK 229 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhcc-----CCC--ccccch
Confidence 34578899999999877 88999999999999999999999986432111000 000000 000 000112
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......+.+++.+||+.+|.+|||+++|+.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 334567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.25 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=202.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|+||.||++.....++.+|||.+... .....+.+.+|+.++++++|+||+++++.+..++..++|+||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 45568899999999999999888899999998653 2334567899999999999999999999999899999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC-CceEEeccCCccccCCCCcc
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF-WTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFgl~~~~~~~~~~ 669 (796)
++++|.+++.......+++..+..++.|+++||.|||+. +++|+||+|+||+++++ ..+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK- 157 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence 999999999775556689999999999999999999998 99999999999999854 4689999999987643322
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....++..|+|||.+.....+.++||||||+++|||++|+.|+...... ... . . ..... ....+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~--~---~-~~~~~------~~~~~ 222 (256)
T cd08220 158 -AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALV--L---K-IMSGT------FAPIS 222 (256)
T ss_pred -ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HHH--H---H-HHhcC------CCCCC
Confidence 12244788999999999888999999999999999999999998644211 110 0 0 00000 01112
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
......+.+++..||+.+|++|||++|+++.
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 2345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=296.36 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=188.2
Q ss_pred cccCcccceEEEEEEEcCCc--EEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 517 EELGKGSFGAVYKGTLYKGE--KLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~--~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
++||+|+||.||+|....+. ..+++|.+.... ....+.|.+|+.++..++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999764432 356677766533 234578999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCC--CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC-cce
Q 003772 594 SLADILFRGP--ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ-TRT 670 (796)
Q Consensus 594 sL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~-~~~ 670 (796)
+|.+++.+.. ....++..+..++.||++||.|||+. +++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997532 24567778889999999999999998 99999999999999999999999999986432211 111
Q ss_pred eeeeccCCCCCchhhhcc-------CCCCccccchhhHHHHHHHhhc-ccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 671 FTLVRGTRGYMAPEWYKN-------TPISVKADVFSYGVVLLEIVCC-RRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
.....++..|+|||++.. ...+.++||||||+++|||+++ ..|+.... ..+. ......+....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~------~~~~~~~~~~~~ 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--DREV------LNHVIKDQQVKL 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--HHHH------HHHHHhhccccc
Confidence 223447889999999853 2457899999999999999975 45654321 1111 111111111111
Q ss_pred hcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 743 VRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 743 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
..+ .......+++.+++..|| .+|++||++++|++.|.
T Consensus 230 ~~~-~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKP-QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCC-ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111 111224466788888999 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.33 Aligned_cols=249 Identities=27% Similarity=0.384 Sum_probs=202.0
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+...+.||+|+||.||+|.....++.|++|.+..... ...+.+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 3456889999999999999887888999999876444 35678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|.+++.. ...+++..+..++.|+++||.|||+. +|+|+||+|+||++++++.+||+|||++..........
T Consensus 82 ~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 82 SGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999976 34588999999999999999999998 99999999999999999999999999998765443322
Q ss_pred ee---eeccCCCCCchhhhccCC---CCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 671 FT---LVRGTRGYMAPEWYKNTP---ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 671 ~~---~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
.. ...++..|+|||++.... .+.++||||||+++|||++|+.||...... .... ... ... .
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~-----~~~-~~~------~ 223 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIM-----FHV-GAG------H 223 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHH-----HHH-hcC------C
Confidence 21 245788999999998766 899999999999999999999999643211 1100 000 000 0
Q ss_pred CCCCC--HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 745 GQEVD--RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 745 ~~~~~--~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....+ ......+.+++.+||+.+|.+|||+.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 01111 122566789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=323.08 Aligned_cols=256 Identities=22% Similarity=0.293 Sum_probs=189.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccC--------Cce
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAED--------SKR 583 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--------~~~ 583 (796)
.+.+.+.||+|+||.||+|.....++.||||++.... ....+|+.+++.++|+||+++++++... ...
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 3556789999999999999998888899999885432 2345799999999999999998875321 235
Q ss_pred eEEEeecCCCChhhhhhc--CCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC-ceEEeccCCc
Q 003772 584 LLVYEYMSNGSLADILFR--GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW-TAKISDFGLA 660 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgl~ 660 (796)
++||||+++ +|.+++.. .....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 689999985 67776643 2346789999999999999999999998 999999999999999654 7999999999
Q ss_pred cccCCCCcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh
Q 003772 661 KLLMPDQTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739 (796)
Q Consensus 661 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
+.+...... ....||+.|+|||++.+. .++.++|||||||++|||++|..||.............. .......+.+
T Consensus 219 ~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~-~~~~p~~~~~ 295 (440)
T PTZ00036 219 KNLLAGQRS--VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ-VLGTPTEDQL 295 (440)
T ss_pred hhccCCCCc--ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCCHHHH
Confidence 876433221 223579999999998764 689999999999999999999999864432111111000 0000000000
Q ss_pred h-------hhhcCC--------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 003772 740 N-------KLVRGQ--------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVV 778 (796)
Q Consensus 740 ~-------~~~~~~--------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 778 (796)
. ...-+. ..+...+.++.+++..||+.||.+|||+.|++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0 000000 01122346789999999999999999999998
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.38 Aligned_cols=241 Identities=25% Similarity=0.318 Sum_probs=188.2
Q ss_pred cCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhcc---CcCchhhhhhhhccCCceeEEEeecCC
Q 003772 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRT---HHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 519 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
||+|+||.||+++....++.||||++.+... .....+..|..++.+. +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999988889999999965322 1223345566666655 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++.+ ...+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~ 154 (330)
T cd05586 81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTN 154 (330)
T ss_pred ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Ccc
Confidence 999999875 46789999999999999999999998 999999999999999999999999999875432221 122
Q ss_pred eeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 673 LVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
...||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .. ......+.. ......
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--~~------~~~i~~~~~------~~~~~~ 220 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--QM------YRNIAFGKV------RFPKNV 220 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--HH------HHHHHcCCC------CCCCcc
Confidence 34589999999999765 4899999999999999999999998643211 00 111110000 011112
Q ss_pred HHHHHHHHHHHhccCCCCCCC----CHHHHHH
Q 003772 752 TLENMIKIGLWCVQDEPALRP----SMKSVVL 779 (796)
Q Consensus 752 ~~~~l~~l~~~cl~~dP~~RP----t~~evl~ 779 (796)
....+.+++..||+.||.+|| ++.++++
T Consensus 221 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 221 LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 346678999999999999998 4666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.87 Aligned_cols=250 Identities=22% Similarity=0.270 Sum_probs=208.1
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
...++.+.||.|.-|+||++++.+.+...|+|++.+..- +...+...|-++|+.++||.++.+++.+..+...||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 344566889999999999999999889999999987433 34456778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC--
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP-- 665 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~-- 665 (796)
|||+||+|..++++.+.+.+++..+..++.+++-||+|||-. |||.|||||+||||.++|.+.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999999999999999999999999999999998 999999999999999999999999998864410
Q ss_pred -------------------------------CCc----------------------ceeeeeccCCCCCchhhhccCCCC
Q 003772 666 -------------------------------DQT----------------------RTFTLVRGTRGYMAPEWYKNTPIS 692 (796)
Q Consensus 666 -------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~t 692 (796)
... ......+||..|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 001124588999999999999999
Q ss_pred ccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC---CCHHHHHHHHHHHHHhccCCCC
Q 003772 693 VKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE---VDRNTLENMIKIGLWCVQDEPA 769 (796)
Q Consensus 693 ~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~ 769 (796)
.++|.|+|||+||||+.|+.||........ + ..++.... ..++....+.+||+..|.+||+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~T---l-------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKET---L-------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhh---H-------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 999999999999999999999986653321 1 11111111 1225557899999999999999
Q ss_pred CCCC----HHHHHH
Q 003772 770 LRPS----MKSVVL 779 (796)
Q Consensus 770 ~RPt----~~evl~ 779 (796)
+|-- +.||.+
T Consensus 378 kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKR 391 (459)
T ss_pred hhhccccchHHhhc
Confidence 9998 777764
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=311.68 Aligned_cols=259 Identities=23% Similarity=0.243 Sum_probs=195.0
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccC------Cce
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAED------SKR 583 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 583 (796)
.+.+.+.||+|+||.||++.....++.||||++.... ....+.+.+|+.+++.++|+||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 4556688999999999999988888899999987532 23346678899999999999999999987543 346
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
++||||+++ +|.+.+. ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 98 ~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 98 YLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred EEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 999999975 6766663 3588899999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH------HHhhhhh
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA------YKCFIDR 737 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~------~~~~~~~ 737 (796)
.... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||................ .......
T Consensus 170 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 170 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 4322 2223458999999999999999999999999999999999999996432111000000000 0000000
Q ss_pred hhhhhhc---------------C------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 738 ELNKLVR---------------G------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 738 ~~~~~~~---------------~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.+..... . ..........+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 0 00112234578899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.16 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=194.1
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
++.+.||+|+||.||++.....++.||||++.+.. ......+++|+.++..++|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 45678999999999999998888999999997532 233456888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc--
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT-- 668 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~-- 668 (796)
++|+|.+++.+ ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 84 ~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 84 PGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 99999999976 45789999999999999999999998 999999999999999999999999999875432110
Q ss_pred --------------------------------ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCC
Q 003772 669 --------------------------------RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEI 716 (796)
Q Consensus 669 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~ 716 (796)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001124589999999999999999999999999999999999999965
Q ss_pred CCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 003772 717 DPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPS---MKSVVLM 780 (796)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~~ 780 (796)
..... . ........ .....+. .......+.+++..++. +|.+|++ +.++++.
T Consensus 239 ~~~~~--~------~~~i~~~~-~~~~~p~--~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 239 ETPQE--T------YRKVMNWK-ETLVFPP--EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCHHH--H------HHHHHcCC-CceecCC--CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 43211 0 01000000 0000000 01123456667777664 9999985 5666543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=294.92 Aligned_cols=251 Identities=25% Similarity=0.433 Sum_probs=202.0
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc------chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV------TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~------~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
...+.||+|++|.||++....+++.||+|.+.... ....+.++.|+.++++++|+||+++++++.+.+..++|+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 34578999999999999988888899999986432 123467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC-ceEEeccCCccccCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW-TAKISDFGLAKLLMPD 666 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgl~~~~~~~ 666 (796)
||+++++|.+++.+ ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 83 EWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred eccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999975 35788999999999999999999998 999999999999998765 5999999999876543
Q ss_pred Ccc---eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 667 QTR---TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 667 ~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
... ......++..|+|||.+.+..++.++||||+|+++|||++|+.|+............ .. .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~------~~~~~ 227 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI----FK------IASAT 227 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH----HH------HhccC
Confidence 211 112234788999999998888999999999999999999999998644321111100 00 00111
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.....+......+.+++.+|++.+|.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 112334455678999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.57 Aligned_cols=247 Identities=25% Similarity=0.344 Sum_probs=193.5
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-----chhHHHHHHHHHHHhccCcCchhhhhhhhccC--CceeEE
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-----TEGEREFRAEMHVIGRTHHKNLVRLIGYCAED--SKRLLV 586 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 586 (796)
...+.||+|+||.||++.....++.||+|++.... .+..+.+.+|+.++++++|+||+++++++.+. ...+++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 45678999999999999998888899999886422 12345688999999999999999999987653 567899
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
+||+++++|.+++.. ...+++...+.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++.+...
T Consensus 85 ~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 85 MEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 999999999999975 34688999999999999999999988 9999999999999999999999999999865432
Q ss_pred Cc--ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 667 QT--RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 667 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
.. .......++..|+|||.+.+..++.++|||||||++|||++|+.||...... ... .. ......
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-~~~------~~------~~~~~~ 226 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-AAI------FK------IATQPT 226 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-HHH------HH------HhcCCC
Confidence 11 1112244788999999999988999999999999999999999998643211 000 00 000000
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....+....+.+..++ .||..+|++||+++||++
T Consensus 227 ~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1112233345556665 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=295.47 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=203.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.+.+.||+|+||.||++.+...++.+|+|++..... ...+++.+|++++++++|+||+++++.+..+...++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 3456889999999999999988888999999876533 445678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhc-cCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD-ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
+++|.+++.... ..++...+..++.|++.||.|||+ . +++|+||||+||++++++.++|+|||.+..........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 158 (265)
T cd06605 83 GGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT 158 (265)
T ss_pred CCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence 999999997642 678899999999999999999999 7 99999999999999999999999999987654322211
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
..++..|+|||.+.+..++.++||||||+++|||++|+.|+........... . ..+..... ........
T Consensus 159 ---~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~--~-~~~~~~~~-----~~~~~~~~ 227 (265)
T cd06605 159 ---FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF--E-LLQYIVNE-----PPPRLPSG 227 (265)
T ss_pred ---ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHH--H-HHHHHhcC-----CCCCCChh
Confidence 4578899999999999999999999999999999999999865432111110 0 00100000 00011111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.....+.+++..||..+|.+|||+.+++.
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 228 KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 25567899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=304.51 Aligned_cols=261 Identities=21% Similarity=0.260 Sum_probs=198.5
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+.+.++||+|+||.||+|.....++.||+|.+..... .....+.+|+.++++++|+||+++++++.++...++|+||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 34566889999999999999988888999999865332 23456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
+ ++|.+++... ...+++..+..++.||++||.|||+. +|+|+||||+||++++++.+||+|||++........ .
T Consensus 87 ~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 160 (301)
T cd07873 87 D-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 160 (301)
T ss_pred c-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence 7 5898888653 45688999999999999999999998 999999999999999999999999999976533221 1
Q ss_pred eeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC----
Q 003772 671 FTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG---- 745 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 745 (796)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||........ ......................
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhchhhhcccccc
Confidence 2223468899999998754 578999999999999999999999875432111 1000000000000000000000
Q ss_pred ----C--------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 746 ----Q--------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 746 ----~--------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
. .........+.+++.+|++.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 011233456889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=302.84 Aligned_cols=196 Identities=24% Similarity=0.354 Sum_probs=160.5
Q ss_pred hcccCcccceEEEEEEEcC--CcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhcc--CCceeEEEeecC
Q 003772 516 KEELGKGSFGAVYKGTLYK--GEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE--DSKRLLVYEYMS 591 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~--~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~ 591 (796)
.++||+|+||.||+|+..+ .++.+|+|.+... .....+.+|+.++++++||||+++++++.. +...++|+||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 3689999999999999753 4578999998653 223457889999999999999999998854 446789999986
Q ss_pred CCChhhhhhcC-------CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe----cCCCceEEeccCCc
Q 003772 592 NGSLADILFRG-------PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM----DEFWTAKISDFGLA 660 (796)
Q Consensus 592 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFgl~ 660 (796)
+ +|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 788877532 123588999999999999999999998 99999999999999 45678999999999
Q ss_pred cccCCCCc--ceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCC
Q 003772 661 KLLMPDQT--RTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEID 717 (796)
Q Consensus 661 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~ 717 (796)
+....... .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87643322 122335689999999999774 5899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=306.36 Aligned_cols=252 Identities=25% Similarity=0.342 Sum_probs=212.2
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchh---HHHHHHHHHHHhccC-cCchhhhhhhhccCCceeE
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG---EREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~---~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~l 585 (796)
...+.+.+.||+|.||.||+++.+.+++.+|+|.+.+..... ...+.+|+.+|+++. ||||+.+.+.+.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 455677799999999999999999989999999998754433 357899999999998 9999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC----CceEEeccCCcc
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF----WTAKISDFGLAK 661 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFgl~~ 661 (796)
|||++.+|.|.+.+.+. .+++.....++.|++.++.|||+. +|+||||||+|+|+... +.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999775 399999999999999999999998 99999999999999643 479999999999
Q ss_pred ccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 662 LLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 662 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
.... .......+||+.|+|||++....++..+||||+|+++|.|++|..||.......... .+.....
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------~i~~~~~-- 255 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------AILRGDF-- 255 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------HHHcCCC--
Confidence 8776 455667789999999999999999999999999999999999999997654322111 1111111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 742 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.-....-+...+.+.+++..|+..||.+|+|+.++++.
T Consensus 256 -~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 00112223446778899999999999999999999984
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=295.70 Aligned_cols=246 Identities=33% Similarity=0.450 Sum_probs=197.5
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.+.||+|+||.||++.. .++.||+|++.... ....+.+|+.++.+++|+|++++++++..+ ..++||||++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 456778999999999999975 45679999986532 345789999999999999999999988654 5799999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+++|.+++.......+++..++.++.|+++||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999999875556789999999999999999999998 99999999999999999999999999987643221
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .. ....... .. .....
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~------~~~~~~~-----~~-~~~~~ 220 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EV------KECVEKG-----YR-MEPPE 220 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HH------HHHHhCC-----CC-CCCCC
Confidence 11224568999999998899999999999999999998 88887543211 10 0000000 00 11123
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
..+..+.+++.+||+.+|++||++++|++.|++
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 445778899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=315.49 Aligned_cols=260 Identities=22% Similarity=0.261 Sum_probs=198.8
Q ss_pred HHHHHhhhcccCcccceEEEEEEEcC--CcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 509 KKATNRFKEELGKGSFGAVYKGTLYK--GEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 509 ~~~~~~~~~~LG~G~fg~Vy~g~~~~--~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
....+.+.+.||+|+||.||++...+ .++.||+|.+... +...+|+.++++++|+||+++++++......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 34457778999999999999997643 3468999987642 2456899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
||++. ++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||+++.....
T Consensus 165 ~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 165 MPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred ehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 99986 688888843 46799999999999999999999998 9999999999999999999999999999866543
Q ss_pred Cc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhh---------
Q 003772 667 QT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFID--------- 736 (796)
Q Consensus 667 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 736 (796)
.. .......||+.|+|||++....++.++|||||||++|||++|+.||...........+... ......
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i-~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSI-IRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHH-HHHhccCccccCCcc
Confidence 32 2222356899999999999999999999999999999999999999754332211111110 000000
Q ss_pred -----hhhhhhh---cCCC-C-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 737 -----RELNKLV---RGQE-V-----DRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 737 -----~~~~~~~---~~~~-~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
....+.. .... . .......+.+++..||+.||++|||+.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 0000 0 01223567889999999999999999999865
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=296.69 Aligned_cols=247 Identities=23% Similarity=0.365 Sum_probs=211.7
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch--hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE--GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
..|.+.+.||+|.|++|-++++.-.++.||||++++..-. ....+..|+..++.++|||||+++.+.......|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3456778899999999999999888999999999874433 33568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec-CCCceEEeccCCccccCCCC
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFgl~~~~~~~~ 667 (796)
.-++|+|.++|.+. ...+++....+++.||+.|+.|+|+. .+|||||||+||.+- .-|-+||.|||++..+.+++
T Consensus 98 LGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred ecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999999999875 56799999999999999999999998 999999999999875 56889999999999887765
Q ss_pred cceeeeeccCCCCCchhhhccCCCC-ccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPIS-VKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
.. +..+|+..|-|||++.+..|. ++.||||||||||.|++|+.||......+. +-.+++.+
T Consensus 174 kL--~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----------------LTmImDCK 235 (864)
T KOG4717|consen 174 KL--TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----------------LTMIMDCK 235 (864)
T ss_pred hh--hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh----------------hhhhhccc
Confidence 43 345799999999999999884 678999999999999999999986543322 22223322
Q ss_pred -CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 747 -EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 747 -~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..+.....++.+|+..||+.||.+|.|.+||+.
T Consensus 236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 346677788999999999999999999999974
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=298.50 Aligned_cols=256 Identities=27% Similarity=0.367 Sum_probs=201.0
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccC--CceeEEEeec
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAED--SKRLLVYEYM 590 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~ 590 (796)
.+.++||.|++|.||++.+...++.+|+|.+..... .....+.+|++++++++|+||+++++++.+. +..++||||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 345789999999999999988889999999875433 3456789999999999999999999988653 4689999999
Q ss_pred CCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 591 SNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 591 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
++++|.+++... ....+++..+..++.||++||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 999999987542 245688999999999999999999998 999999999999999999999999999876543221
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCc-hhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKP-EEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .......+.... ....+.....
T Consensus 161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 233 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPELKDEPG 233 (287)
T ss_pred ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----CchhhccCCC
Confidence 12346889999999999899999999999999999999999997553211 111111111110 0011111111
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......+.+.+++.+||+.+|++|||+.||++
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11234567899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.29 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=198.4
Q ss_pred hhcccCcccceEEEEEEEcCCcEEEEEEEeecccc----------hhHHHHHHHHHHHhccCcCchhhhhhhhccCCcee
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT----------EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~----------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 584 (796)
..+.||+|+||.||+|.....++.||+|.++.... ...+.+.+|+.++.+++|+|++++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 45789999999999999887788999998853211 11346788999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+|+||+++++|.+++.+. ..+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred EEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999763 5789999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCcc-eeeeeccCCCCCchhhhccCC--CCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 665 PDQTR-TFTLVRGTRGYMAPEWYKNTP--ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 665 ~~~~~-~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
..... ......++..|+|||.+.... ++.++||||||+++||+++|+.|+........ . .. ..... ..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~----~~-~~~~~-~~ 230 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA---M----FK-LGNKR-SA 230 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH---H----HH-hhccc-cC
Confidence 32211 122345788999999987754 89999999999999999999999853321100 0 00 00000 00
Q ss_pred hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 742 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
..............+.+++..||+.+|++|||+.+|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000111122345788999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=301.44 Aligned_cols=260 Identities=23% Similarity=0.300 Sum_probs=199.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|+||.||++.....++.||+|++.... ....+.+.+|+.++.+++|+||+++++++.+....++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 455678999999999999998888899999986532 223456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|..++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........ .
T Consensus 83 ~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 83 DHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred CccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 99988887754 34689999999999999999999998 999999999999999999999999999987654332 1
Q ss_pred eeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh---------h
Q 003772 671 FTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL---------N 740 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 740 (796)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............ ............ .
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI-RKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHhCCCChHHhhhcccccccc
Confidence 122346789999999876 46789999999999999999999998744322111110 000000000000 0
Q ss_pred h--hhcCCC-C-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 741 K--LVRGQE-V-----DRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 741 ~--~~~~~~-~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
. ...... . .......+.+++.+||+.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 000000 0 0123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.90 Aligned_cols=259 Identities=23% Similarity=0.333 Sum_probs=202.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|+||.||+|....+++.||+|++.... ....+.+.+|+.++++++|+||+++++++.++...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 456788999999999999998888899999987643 334567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
+++|.+++... ...+++..++.++.||++||.|||+. +++|+||||+||+++.++.++|+|||++..........
T Consensus 82 -~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 82 -PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred -CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 99999998654 36799999999999999999999998 99999999999999999999999999998775543333
Q ss_pred eeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhh------------
Q 003772 671 FTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDR------------ 737 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------ 737 (796)
.....++..|+|||.+.+. .++.++||||+|+++|||++|+.++...... ... ..........
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQL---AIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHH---HHHHHHcCCCChHHHhhccCcc
Confidence 3344588999999998654 4689999999999999999997766533211 110 0011100000
Q ss_pred hhhhhhcCC-------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 738 ELNKLVRGQ-------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 738 ~~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
......... ....+....+.+++.+|++.+|++|||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0012335789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=333.38 Aligned_cols=260 Identities=19% Similarity=0.284 Sum_probs=200.7
Q ss_pred HHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhcc--CCcee
Q 003772 509 KKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE--DSKRL 584 (796)
Q Consensus 509 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~ 584 (796)
....+.+.+.||+|+||.||++.+...+..+|+|.+... .......|..|+.++.+++||||+++++++.+ ....+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 334567788999999999999999988899999998643 23345678999999999999999999998754 35689
Q ss_pred EEEeecCCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCC----CCeeeeccCccceEecC----------
Q 003772 585 LVYEYMSNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECE----APIIHCDIKPQNILMDE---------- 648 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~----~~ivH~Dlkp~NIll~~---------- 648 (796)
|||||+++|+|.++|... ....+++..++.|+.||+.||.|||+... .+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999999998652 23579999999999999999999998521 25999999999999964
Q ss_pred -------CCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhcc--CCCCccccchhhHHHHHHHhhcccCCCCCCC
Q 003772 649 -------FWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN--TPISVKADVFSYGVVLLEIVCCRRNMEIDPS 719 (796)
Q Consensus 649 -------~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvil~elltg~~p~~~~~~ 719 (796)
...+||+|||++..+..... .....||+.|+|||++.. ..++.++|||||||+||||++|+.||.....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 23489999999986643221 223458999999999864 4589999999999999999999999964332
Q ss_pred CchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH--HHHhcC
Q 003772 720 KPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVV--LMLEGI 784 (796)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl--~~L~~~ 784 (796)
... . .... ... +..........+.+|+..||+.+|.+||++.+++ ..+..+
T Consensus 249 ~~q--l-----i~~l-----k~~--p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 249 FSQ--L-----ISEL-----KRG--PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHH--H-----HHHH-----hcC--CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 110 0 0000 000 0111122346789999999999999999999998 445433
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=298.62 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=198.5
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhcc------CCce
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAE------DSKR 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~------~~~~ 583 (796)
..+.+.+.||+|+||.||+|.....++.+|+|.+.... ....++..|+.++.++ +|+||+++++++.. ....
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 34556689999999999999998888899999986543 3345688899999998 69999999998853 4567
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
+++|||+++|+|.+++.......+++..+..++.||+.||.|||+. +|+|+||||+||++++++.++|+|||++...
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 9999999999999999765556788899999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCcceeeeeccCCCCCchhhhc-----cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhh
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYK-----NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE 738 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
..... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||...... .... .
T Consensus 172 ~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-~~~~------------~ 237 (282)
T cd06636 172 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-RALF------------L 237 (282)
T ss_pred hcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-hhhh------------h
Confidence 32211 122345888999999986 346788999999999999999999998643211 0000 0
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 739 LNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
+................+.+++..||+.||.+|||+.||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 01111111122234567999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=294.57 Aligned_cols=247 Identities=24% Similarity=0.314 Sum_probs=195.8
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-----chhHHHHHHHHHHHhccCcCchhhhhhhhccC--CceeEE
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-----TEGEREFRAEMHVIGRTHHKNLVRLIGYCAED--SKRLLV 586 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 586 (796)
.+.+.||+|+||.||+|...+.++.||||.+.... ....+.+.+|+.++++++|+||+++++++.+. ...++|
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 45688999999999999998888999999885321 12345788999999999999999999988664 457899
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
+||+++++|.+++.. ...+++...+.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 85 MEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 999999999999875 34588899999999999999999998 9999999999999999999999999999865432
Q ss_pred Cc--ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 667 QT--RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 667 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
.. .......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .... . . .....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~----~-~-----~~~~~ 226 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM---AAIF----K-I-----ATQPT 226 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH---HHHH----H-H-----hcCCC
Confidence 11 1222345888999999999888999999999999999999999998643111 0000 0 0 00001
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....+......+.+++..|+. +|.+||+++||++
T Consensus 227 ~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 112344555678888888985 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.19 Aligned_cols=261 Identities=23% Similarity=0.307 Sum_probs=197.8
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+..+.||+|++|.||+|+....++.||||++.... ......+.+|++++++++|+||+++++++.+++..++||||+.
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 44578999999999999998888899999986432 2233578899999999999999999999999999999999996
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
++|.+++.......+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++........ ..
T Consensus 83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (284)
T cd07860 83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY 157 (284)
T ss_pred -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-cc
Confidence 6899998766567799999999999999999999998 999999999999999999999999999876543221 12
Q ss_pred eeeccCCCCCchhhhccCC-CCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH-------HHhhh--hh---h
Q 003772 672 TLVRGTRGYMAPEWYKNTP-ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA-------YKCFI--DR---E 738 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~--~~---~ 738 (796)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.||................ +.... .. .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 2234678999999887654 6889999999999999999999986543211111000000 00000 00 0
Q ss_pred hhhhhcCC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 739 LNKLVRGQ--EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 739 ~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
........ ...+.....+.+++..||+.||.+|||+++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000 001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=301.48 Aligned_cols=261 Identities=23% Similarity=0.293 Sum_probs=202.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+++.+.||+|+||.||+|...++++.||||+++... ....+.+.+|++++++++|+||+++++++.+++..++|+||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 456788999999999999998888899999986532 233467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
+++.|..++.+ ...+++..+..++.||++||.|||+. +++|+||+|+||++++++.+||+|||++..........
T Consensus 83 ~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 83 ERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 98777666544 35589999999999999999999998 99999999999999999999999999998775544323
Q ss_pred eeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh---------
Q 003772 671 FTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN--------- 740 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 740 (796)
.....++..|+|||++... .++.++||||||+++|||++|+.|+....... ..................
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 3344578899999999888 88999999999999999999999886432211 111000000000000000
Q ss_pred --hhhcC-------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 741 --KLVRG-------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 741 --~~~~~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..... ...+......+.+++..||+.+|++|||+++|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0011223678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=292.90 Aligned_cols=247 Identities=26% Similarity=0.293 Sum_probs=203.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||.|+||.||++.....++.+|+|.+.+.. ....+.+.+|++++++++||||+++++++.++...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 346688999999999999998888899999997532 23467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 82 LLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 9999999999763 5789999999999999999999998 99999999999999999999999999998765432
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
......++..|+|||.+.+...+.++|+||||+++|+|++|+.|+........... ... ... .....+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~-----~~~--~~~~~~ 222 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI-----RAK-----QET--ADVLYP 222 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH-----HHH-----hcc--ccccCc
Confidence 12234578899999999988899999999999999999999999876543211111 000 000 112223
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCH--HHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSM--KSVV 778 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~--~evl 778 (796)
...+..+.+++.+||+.+|.+||++ +|++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 3445789999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=304.64 Aligned_cols=258 Identities=22% Similarity=0.274 Sum_probs=193.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccC------Cce
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAED------SKR 583 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 583 (796)
.+.+.+.||+|+||.||++.....++.||||++..... ...+.+.+|+.++++++|+||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 45566889999999999999988888999999875322 2345678899999999999999999988643 346
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
++++|++ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 96 ~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 96 YLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred EEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceec
Confidence 8899987 6789887753 4699999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH-------HHhhh
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA-------YKCFI 735 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~ 735 (796)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||................ .....
T Consensus 169 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred CCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 432 123358999999999977 468999999999999999999999986432111000000000 00000
Q ss_pred hhhhhhhhcC-CCCC--------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 736 DRELNKLVRG-QEVD--------RNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 736 ~~~~~~~~~~-~~~~--------~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.......... ...+ ....+.+.+++..|++.||.+|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 0000 0123457899999999999999999999954
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.43 Aligned_cols=252 Identities=23% Similarity=0.279 Sum_probs=196.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhc-----cCCceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCA-----EDSKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~l 585 (796)
++.+.+.||+|+||.||++.....++.+|+|++... ......+.+|+.++.++ +|+||+++++++. .+...++
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 345568899999999999999888889999998653 23346788999999999 6999999999874 3456899
Q ss_pred EEeecCCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 586 VYEYMSNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
||||+++++|.+++... ....+++..+..++.|+++||.|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 99999999999987632 345688999999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCcceeeeeccCCCCCchhhhcc-----CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhh
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKN-----TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE 738 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
..... ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+....... ... ......
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~---~~~-----~~~~~~ 245 (286)
T cd06638 175 TSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR---ALF-----KIPRNP 245 (286)
T ss_pred ccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH---HHh-----hccccC
Confidence 43222 1223358999999999853 357899999999999999999999986432110 000 000000
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 739 LNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.... ..+......+.+++.+||+.+|++|||+.||++.
T Consensus 246 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 PPTL----HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCcc----cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000 0111234568899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.90 Aligned_cols=254 Identities=22% Similarity=0.269 Sum_probs=201.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||++.....++.|++|.+.... ....+.+.+|+.++..++|+||+++++.+..++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 345688999999999999998888899999987643 23345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc-
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT- 668 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~- 668 (796)
+++++|.+++.. ...+++..+..++.|+++||.|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 83 VEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999999966 35689999999999999999999998 999999999999999999999999999874211100
Q ss_pred -------------ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh
Q 003772 669 -------------RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI 735 (796)
Q Consensus 669 -------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.......++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--~~~------~~~~~ 229 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--EEL------FGQVI 229 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHH------HHHHH
Confidence 011123478899999999888899999999999999999999999864321 110 01111
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 736 DRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
... ..........+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 230 ~~~----~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 SDD----IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred hcc----cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000 00001112345678999999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=294.91 Aligned_cols=255 Identities=26% Similarity=0.385 Sum_probs=204.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.+.+.||.|+||.||+|....++..+|+|++.... ....+.+.+|++.++.++|+||+++++.+.++...++|+|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 456788999999999999988888899999986532 3356789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCC-CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc-
Q 003772 592 NGSLADILFRGPE-RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR- 669 (796)
Q Consensus 592 ~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~- 669 (796)
+++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..+......
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 9999999976432 5789999999999999999999998 9999999999999999999999999999876543322
Q ss_pred --eeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 670 --TFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 670 --~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
......++..|+|||++... ..+.++||||||+++|||++|+.|+....... ..... .... .......
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~-----~~~~-~~~~~~~ 230 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLT-----LQND-PPSLETG 230 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHH-----hcCC-CCCcCCc
Confidence 12234578999999999877 78999999999999999999999986443211 00000 0000 0000000
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.........+.+++..||+.||++|||+++|++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 011244577899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=292.01 Aligned_cols=248 Identities=24% Similarity=0.389 Sum_probs=201.5
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.||+|+||.||++....++..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+.+.+..++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 45688999999999999999888899999986532 2345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC-ceEEeccCCccccCCCCcce
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW-TAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgl~~~~~~~~~~~ 670 (796)
+++|.+++.+.....+++..+..++.|+++||.|||+. +++|+||||+||++++++ .+||+|||.+........ .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~ 158 (257)
T cd08225 83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-L 158 (257)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-c
Confidence 99999999775555689999999999999999999998 999999999999999875 469999999987653322 1
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
.....|++.|+|||++.+..++.++||||||+++|||++|+.|+...... .. ... ...... ....+
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~-----~~~-~~~~~~------~~~~~ 224 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH--QL-----VLK-ICQGYF------APISP 224 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HH-----HHH-HhcccC------CCCCC
Confidence 22235888999999999888999999999999999999999998643211 10 000 000000 11122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.....+.+++.+|++.+|++|||+.||+.
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 34467999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.18 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=197.3
Q ss_pred hhhcccCcccceEEEEEEEcC---CcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCC------c
Q 003772 514 RFKEELGKGSFGAVYKGTLYK---GEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS------K 582 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~---~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~ 582 (796)
.+.+.||+|+||.||+|.+.. .++.||||++.... ....+++.+|+.++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 356789999999999998753 35789999986532 334567899999999999999999999876432 2
Q ss_pred eeEEEeecCCCChhhhhhcC----CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccC
Q 003772 583 RLLVYEYMSNGSLADILFRG----PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFG 658 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 658 (796)
.++++||+++|+|.+++... ....+++...+.++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence 47899999999999887532 123578899999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhh
Q 003772 659 LAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFID 736 (796)
Q Consensus 659 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
+++........ ......+++.|++||.+.+..++.++||||||+++|||++ |+.|+..... .. .... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~--~~~~----~~~ 230 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SE--IYNY----LIK 230 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HH--HHHH----HHc
Confidence 99876433211 1122335678999999999899999999999999999999 7777753321 11 1000 000
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 737 RELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
.. ....+......+.+++.+|++.+|++|||+.+|++.|+++
T Consensus 231 ~~------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GN------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0011233456899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=296.26 Aligned_cols=245 Identities=22% Similarity=0.305 Sum_probs=200.3
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
-+.||+|++|.||++.....++.+++|++........+.+.+|+.++++++|+||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 36899999999999998878889999998765555566789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeec
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR 675 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~ 675 (796)
.+++.. ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........ ......
T Consensus 104 ~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 176 (285)
T cd06648 104 TDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLV 176 (285)
T ss_pred HHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccccc
Confidence 999865 4688999999999999999999998 999999999999999999999999998876543222 112234
Q ss_pred cCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 003772 676 GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLEN 755 (796)
Q Consensus 676 gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (796)
|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... .. ........ . ............
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~------~~~~~~~~-~---~~~~~~~~~~~~ 244 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QA------MKRIRDNL-P---PKLKNLHKVSPR 244 (285)
T ss_pred CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HH------HHHHHhcC-C---CCCcccccCCHH
Confidence 789999999998888999999999999999999999998643211 00 00000000 0 000011224567
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHH
Q 003772 756 MIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 756 l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
+.+++.+||+.+|++|||+.++++
T Consensus 245 l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 245 LRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHcccChhhCcCHHHHcc
Confidence 999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=295.39 Aligned_cols=243 Identities=24% Similarity=0.291 Sum_probs=191.0
Q ss_pred ccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHh---ccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIG---RTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 518 ~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~---~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.||+|+||.||++.....++.+|+|.+.+... .....+.+|..++. ..+|+||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999988888999999865321 22333445544443 3479999999999998899999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 152 (279)
T cd05633 81 GGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (279)
T ss_pred CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence 9999998865 45699999999999999999999998 999999999999999999999999999876533221
Q ss_pred eeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 672 TLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... .... ........+.
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~-----------~~~~~~~~~~ 220 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRM-----------TLTVNVELPD 220 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHH-----------hhcCCcCCcc
Confidence 22358999999999864 568999999999999999999999997543221111 0000 0001112233
Q ss_pred HHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRP-----SMKSVVLM 780 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 780 (796)
.....+.+++..||+.||.+|| |++++++.
T Consensus 221 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 221 SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 4567789999999999999999 69999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=295.18 Aligned_cols=248 Identities=24% Similarity=0.362 Sum_probs=197.5
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc------chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV------TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~------~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
...+.||+|+||.||+|... .++.+|||.+.... .+..+.+.+|++++++++|+||+++++++.+.+..++|+
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred cccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 35678999999999999875 45689999886432 122356889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++++|.+++.+ ...+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 82 EFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999965 35688999999999999999999998 99999999999999999999999999987653211
Q ss_pred -----cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 668 -----TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 668 -----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
........++..|+|||.+.+..++.++||||||+++|||++|+.||....... ... . .... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~~--~-----~~~~--~~- 225 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AMF--Y-----IGAH--RG- 225 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HHH--H-----hhhc--cC-
Confidence 111223457889999999999889999999999999999999999996432111 000 0 0000 00
Q ss_pred hcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 743 VRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 743 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.....+......+.+++.+||+.+|++||++.++++
T Consensus 226 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 -LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001123345567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=303.09 Aligned_cols=195 Identities=26% Similarity=0.359 Sum_probs=159.8
Q ss_pred cccCcccceEEEEEEEcC--CcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhcc--CCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYK--GEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE--DSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~--~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~ 592 (796)
.+||+|+||.||+|+..+ .+..||+|.+.... ....+.+|+.++++++|+||+++++++.. +...++|+||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 579999999999999754 34689999986532 23467889999999999999999998853 4567899999875
Q ss_pred CChhhhhhcC-------CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe----cCCCceEEeccCCcc
Q 003772 593 GSLADILFRG-------PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM----DEFWTAKISDFGLAK 661 (796)
Q Consensus 593 gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFgl~~ 661 (796)
+|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+||++ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777776421 123588899999999999999999998 99999999999999 566789999999998
Q ss_pred ccCCCCc--ceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCC
Q 003772 662 LLMPDQT--RTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEID 717 (796)
Q Consensus 662 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~ 717 (796)
....... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 7654322 122334589999999998764 5799999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=295.07 Aligned_cols=252 Identities=24% Similarity=0.329 Sum_probs=199.3
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhccCC------ce
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDS------KR 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~------~~ 583 (796)
..+.+.+.||+|++|.||+|.....++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++.+.. ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 345667899999999999999988888999999876433 456799999999999 6999999999987544 48
Q ss_pred eEEEeecCCCChhhhhhcCC--CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcc
Q 003772 584 LLVYEYMSNGSLADILFRGP--ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~ 661 (796)
++||||+++++|.+++.... ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccce
Confidence 99999999999999986533 46789999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCcceeeeeccCCCCCchhhhcc-----CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhh
Q 003772 662 LLMPDQTRTFTLVRGTRGYMAPEWYKN-----TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFID 736 (796)
Q Consensus 662 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
....... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...... . .. .....
T Consensus 162 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~-~~-----~~~~~ 232 (275)
T cd06608 162 QLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--R-AL-----FKIPR 232 (275)
T ss_pred ecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--H-HH-----HHhhc
Confidence 6543222 1223447889999998853 35788999999999999999999998633211 0 00 00000
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 737 RELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
. .......+......+.+++.+||+.||++|||+.+|++
T Consensus 233 ~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 N----PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred c----CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 00001112234568899999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=306.56 Aligned_cols=197 Identities=29% Similarity=0.418 Sum_probs=172.0
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-c-----CchhhhhhhhccCCceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-H-----KNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~~l 585 (796)
+|.+.+.||+|.||.|-++.+...++.||||+++.. ..-.++-..|+.+|..++ | -|+|++++++...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 567789999999999999999999999999999763 233455567999999986 3 489999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC--CceEEeccCCcccc
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF--WTAKISDFGLAKLL 663 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFgl~~~~ 663 (796)
|+|.+.. +|.++|+.+.-..++...++.++.||+.||.+||+. +|||+||||+||||.+. ..+||+|||.+...
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9998864 899999988778899999999999999999999998 99999999999999753 47999999999875
Q ss_pred CCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCC
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEID 717 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~ 717 (796)
...- .....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|..+
T Consensus 342 ~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 342 SQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred CCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 4322 2344688999999999999999999999999999999997776544
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=298.49 Aligned_cols=261 Identities=22% Similarity=0.287 Sum_probs=196.0
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.+.+.||+|++|.||+|.....++.||||.+...... ....+.+|++++++++|+||+++++++.+++..++||||+.
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 45668899999999999999878889999998653322 23457789999999999999999999999999999999998
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+ +|.+++.+. ...+++.....++.|+++||.|||+. +|+|+||||+||++++++.+||+|||+++...... ...
T Consensus 87 ~-~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (291)
T cd07844 87 T-DLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTY 160 (291)
T ss_pred C-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-ccc
Confidence 5 999988754 34788999999999999999999998 99999999999999999999999999987543211 111
Q ss_pred eeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc------
Q 003772 672 TLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR------ 744 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 744 (796)
....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.....................+........
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 22236789999999875 45899999999999999999999998644321111111100000000000000000
Q ss_pred -------CC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 745 -------GQ-----EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 745 -------~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.. .........+.+++..|++.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 001111266789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=297.37 Aligned_cols=251 Identities=21% Similarity=0.317 Sum_probs=203.8
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.++.+.+.||+|+||.||++....+++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 34566788999999999999987777899999987655555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|.+++.+ ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~- 171 (293)
T cd06647 99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 171 (293)
T ss_pred CCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-
Confidence 99999999864 3578999999999999999999998 9999999999999999999999999998765443321
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
.....+++.|+|||.+....++.++||||||+++||+++|+.||............ . ..+ ........
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-----~--~~~-----~~~~~~~~ 239 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-----A--TNG-----TPELQNPE 239 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-----h--cCC-----CCCCCCcc
Confidence 12234788999999998888999999999999999999999999654321110000 0 000 00001122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.....+.+++..||+.+|++||++.+++..
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 334568899999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=296.97 Aligned_cols=261 Identities=25% Similarity=0.308 Sum_probs=198.5
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.||.|++|.||+|....+++.||+|++.... ....+.+.+|++++++++|+|++++++++.+++..++||||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 35678999999999999998888899999986533 2234578899999999999999999999999999999999995
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
++|.+++.......+++..++.++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~ 156 (283)
T cd07835 82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TY 156 (283)
T ss_pred -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-cc
Confidence 6899998765445799999999999999999999998 999999999999999999999999999976543221 11
Q ss_pred eeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH-------H--Hhhhhhhhhh
Q 003772 672 TLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA-------Y--KCFIDRELNK 741 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~-------~--~~~~~~~~~~ 741 (796)
....++..|+|||++.+. .++.++||||||+++|||++|+.||................ + .....+....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 223468899999988664 57899999999999999999999986442211111100000 0 0000000000
Q ss_pred hhcC-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 742 LVRG-----QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 742 ~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.... ..........+.+++.+|++.+|++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 0011233467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=293.81 Aligned_cols=248 Identities=27% Similarity=0.404 Sum_probs=201.8
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+.+.+.||+|+||.||+|.....++.||||.+.... ....+.+.+|+.++.+++|+||+++++++.++...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3556688999999999999988788899999986432 234467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++..+..... .
T Consensus 85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06641 85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence 99999999854 4689999999999999999999998 999999999999999999999999999876543221 1
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
.....++..|+|||.+.+..++.++|||||||++|||++|..|+...... .. ....... .......
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~----~~~~~~~------~~~~~~~ 223 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM----KV----LFLIPKN------NPPTLEG 223 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH----HH----HHHHhcC------CCCCCCc
Confidence 12234788999999999888999999999999999999999998642211 00 0000000 0111223
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.....+.+++.+||+.+|.+||+++++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 445678899999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=290.33 Aligned_cols=244 Identities=25% Similarity=0.347 Sum_probs=198.8
Q ss_pred cCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 519 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
||+|+||.||+++....++.+++|.+..... ...+.+.+|+.++++++|+||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999988788999999865433 3456789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc-------
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT------- 668 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~------- 668 (796)
.+++.+. ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 9999763 4789999999999999999999998 999999999999999999999999999876543211
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
.......++..|+|||.......+.++||||||+++|||++|+.|+...... .. . .....+. ...
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~-~-----~~~~~~~-------~~~ 220 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--EI-F-----QNILNGK-------IEW 220 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HH-H-----HHHhcCC-------cCC
Confidence 1222345788999999999888999999999999999999999998644311 10 0 0000000 011
Q ss_pred CHH--HHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 749 DRN--TLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 749 ~~~--~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
+.. ....+.+++..||+.+|.+|||+.++.+.|+
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 111 2577899999999999999999977776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=290.53 Aligned_cols=243 Identities=25% Similarity=0.282 Sum_probs=198.5
Q ss_pred cCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 519 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
||.|+||.||+++....++.+|+|++.+... ...+.+.+|+.++++++|+||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999988788999999875322 3456799999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeec
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR 675 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~ 675 (796)
.+++.+ ...+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 999976 34689999999999999999999998 99999999999999999999999999998765432 122235
Q ss_pred cCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 003772 676 GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLEN 755 (796)
Q Consensus 676 gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (796)
++..|+|||.+.+..++.++|+||||+++|||++|..|+........... ... .........+......
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~-----~~~~~~~~~~~~~~~~ 222 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY------NDI-----LKGNGKLEFPNYIDKA 222 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH------HHH-----hccCCCCCCCcccCHH
Confidence 78899999999888899999999999999999999999976543211111 000 0000111222333678
Q ss_pred HHHHHHHhccCCCCCCCC-----HHHHHH
Q 003772 756 MIKIGLWCVQDEPALRPS-----MKSVVL 779 (796)
Q Consensus 756 l~~l~~~cl~~dP~~RPt-----~~evl~ 779 (796)
+.+++..||+.+|++||+ ++|+++
T Consensus 223 ~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 223 AKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 999999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=298.24 Aligned_cols=246 Identities=29% Similarity=0.359 Sum_probs=196.7
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+.+.+.||+|+||.||+|.....++.||+|++.... .+..+++.+|+++++.++|+||+++++++.+++..++|+|
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 3556688999999999999998888899999986432 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+. |+|.+++... ...+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++.......
T Consensus 96 ~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~- 169 (307)
T cd06607 96 YCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN- 169 (307)
T ss_pred hhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCCC-
Confidence 997 5777776543 35689999999999999999999998 99999999999999999999999999997654322
Q ss_pred ceeeeeccCCCCCchhhhc---cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 669 RTFTLVRGTRGYMAPEWYK---NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
...++..|+|||.+. ...++.++||||||+++|||++|+.|+...... . .. .. .... ...
T Consensus 170 ----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~--~-~~----~~-~~~~-----~~~ 232 (307)
T cd06607 170 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--S-AL----YH-IAQN-----DSP 232 (307)
T ss_pred ----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH--H-HH----HH-HhcC-----CCC
Confidence 234788999999874 456889999999999999999999998643211 0 00 00 0000 001
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
..........+.+++.+||+.+|++||++.+|+..
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11123345678999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=294.81 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=199.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccC---cCchhhhhhhhccCCceeEEEe
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTH---HKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e 588 (796)
+.+.+.||+|+||.||+|.+...++.+|+|.+.... .....++.+|+.++++++ |+|++++++++.++...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 445678999999999999998888899999986542 334567889999999986 9999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++++|.+++.. ..+++...+.++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 83 YAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred cCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 9999999999864 3689999999999999999999998 999999999999999999999999999987654432
Q ss_pred ceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
. .....|+..|+|||.+.+. .++.++||||||+++|||++|+.|+....... .. ... ........
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~-------~~~-----~~~~~~~~ 222 (277)
T cd06917 157 K-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-AM-------MLI-----PKSKPPRL 222 (277)
T ss_pred c-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-hh-------hcc-----ccCCCCCC
Confidence 2 2233588899999998754 57899999999999999999999986432110 00 000 00000001
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
........+.+++.+||+.||++||++.+++.
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11124567889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=291.85 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=201.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhcc--CCceeEEEe
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE--DSKRLLVYE 588 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e 588 (796)
+.+.+.||.|+||.||++.....++.+|+|++... .....+.+.+|+.++++++|+||+++++++.. +...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 34567899999999999999888889999998643 23345678899999999999999999997754 446789999
Q ss_pred ecCCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccC--CCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 589 YMSNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDEC--EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 589 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
|+++++|.+++... ....+++..++.++.||++||.|||..+ ..+++|+||||+||++++++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999998653 2467899999999999999999999221 2399999999999999999999999999998765
Q ss_pred CCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
..... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.|+..... .. .. +......
T Consensus 162 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~--~~----~~~~~~~------ 226 (265)
T cd08217 162 HDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQ--LA----SKIKEGK------ 226 (265)
T ss_pred CCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HH--HH----HHHhcCC------
Confidence 43321 1223578999999999998899999999999999999999999875431 11 10 0000000
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
....+......+.+++.+|++.+|++||++.+|++.
T Consensus 227 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112233456789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=291.04 Aligned_cols=250 Identities=28% Similarity=0.364 Sum_probs=206.3
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
++.+.||+|++|.||+++....++.|+||++..... ...+.+.+|+..+.+++|+||+++++++......++|+||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 456889999999999999998889999999876543 4567899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhc-cCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHD-ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
++|.+++... ..+++..++.++.|+++||.|||+ . +++|+||+|+||+++.++.++|+|||++..........
T Consensus 84 ~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~- 157 (264)
T cd06623 84 GSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC- 157 (264)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-
Confidence 9999999763 678999999999999999999999 8 99999999999999999999999999998765433222
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
....++..|+|||.+.+...+.++||||||+++|||++|+.|+........ .... .... .... ...+..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~----~~~~-----~~~~-~~~~~~ 226 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF-FELM----QAIC-----DGPP-PSLPAE 226 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH-HHHH----HHHh-----cCCC-CCCCcc
Confidence 234478899999999999999999999999999999999999865532111 1110 0000 0000 112223
Q ss_pred -HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 752 -TLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 752 -~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
....+.+++..||+.+|++|||+.++++.
T Consensus 227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 56789999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=275.64 Aligned_cols=243 Identities=28% Similarity=0.392 Sum_probs=199.3
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc----h----hHHHHHHHHHHHhcc-CcCchhhhhhhhccCCcee
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT----E----GEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~----~----~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 584 (796)
.-++.||+|..++|.+..++.++.+.|+|++..... + -.+.-+.|+.+|+++ .||+|+.+.+++......+
T Consensus 20 ~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~F 99 (411)
T KOG0599|consen 20 EPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVF 99 (411)
T ss_pred ChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhh
Confidence 345789999999999999999999999999864221 1 123456799999998 5999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+|+|.|+.|.|.|+|.. .-.+++....+|+.|+.+|+.|||.. .||||||||+|||+|++.++||+|||++..+.
T Consensus 100 lVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999999966 56799999999999999999999998 99999999999999999999999999999887
Q ss_pred CCCcceeeeeccCCCCCchhhhcc------CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhh
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKN------TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE 738 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
++.. ....+|||+|+|||.+.- ..|+...|+|+.||++|-|+.|..||-... ... .
T Consensus 175 ~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk----Qml------------M 236 (411)
T KOG0599|consen 175 PGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK----QML------------M 236 (411)
T ss_pred Cchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH----HHH------------H
Confidence 6653 335679999999998853 257889999999999999999999984211 000 0
Q ss_pred hhhhhcCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 739 LNKLVRGQ-----EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 739 ~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
+..++++. +.=.+......+|+.+||+.||.+|.|.+|.+.
T Consensus 237 LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 237 LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11111111 111244567889999999999999999999874
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=296.77 Aligned_cols=242 Identities=25% Similarity=0.284 Sum_probs=200.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||++.....++.+|+|++.+.. .+..+.+.+|++++++++|+||+++++++.++...++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 356688999999999999998888999999986532 23346688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++++|.+++.. ...++...+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 83 VPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999999976 36789999999999999999999998 9999999999999999999999999999876443
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.|+..... .. ..+..... ....+
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~------~~~~~~~~-------~~~~~ 218 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQ------IYEKILEG-------KVRFP 218 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HH------HHHHHhcC-------CccCC
Confidence 2233578999999999888899999999999999999999999864431 00 00111000 01122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCC-----CHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRP-----SMKSVV 778 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl 778 (796)
......+.+++..||+.+|.+|| +.+|++
T Consensus 219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 23357788999999999999999 777776
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=295.96 Aligned_cols=250 Identities=25% Similarity=0.313 Sum_probs=195.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhccC-----CceeEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAED-----SKRLLV 586 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~-----~~~~lV 586 (796)
+.+.+.||+|+||.||++....+++.+|+|.+.... .....+.+|+.++.++ +|+|++++++++... ...++|
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 345678999999999999998888899999986532 2345678899999998 799999999988653 357999
Q ss_pred EeecCCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 587 YEYMSNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+||+++|+|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+|||++....
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 9999999999988642 346789999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCcceeeeeccCCCCCchhhhccC-----CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNT-----PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
...... ....++..|+|||.+... .++.++|||||||++|||++|+.|+...... . .+.. ......
T Consensus 180 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~-~~~~-----~~~~~~ 250 (291)
T cd06639 180 STRLRR-NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--K-TLFK-----IPRNPP 250 (291)
T ss_pred cccccc-cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--H-HHHH-----HhcCCC
Confidence 322211 223478899999998654 3689999999999999999999998643211 0 1100 000000
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 740 NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
... ..+......+.+++..||+.+|++||++.|+++
T Consensus 251 ~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 251 PTL----LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCC----CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 112233456899999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=300.43 Aligned_cols=241 Identities=27% Similarity=0.358 Sum_probs=197.8
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeec---ccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEK---MVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~---~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
+.||.|.||.||-+.+..+.+.||||++.- .+.+....+..|+..|.+++|||++.+.|++..+...+||||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG- 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG- 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence 679999999999999999999999999863 3344566789999999999999999999999999999999999974
Q ss_pred ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeee
Q 003772 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL 673 (796)
Q Consensus 594 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~ 673 (796)
|-.|+|.-. .+++-+..+..|+.+.+.||+|||+. +.||||||..||||++.+.+||+|||.+.+..+.. .
T Consensus 111 SAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn-----s 181 (948)
T KOG0577|consen 111 SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN-----S 181 (948)
T ss_pred cHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh-----c
Confidence 556665322 56788899999999999999999998 99999999999999999999999999998875543 3
Q ss_pred eccCCCCCchhhhc---cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 674 VRGTRGYMAPEWYK---NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 674 ~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
..|||.|||||++. .+.|+-|+|||||||+..||.-.++|..+...-... ++ +-. --.+.....
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL-------YH-IAQ-----NesPtLqs~ 248 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------YH-IAQ-----NESPTLQSN 248 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH-------HH-HHh-----cCCCCCCCc
Confidence 45999999999874 568999999999999999999999887654311110 10 000 001112244
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
+-...+..++..||++-|.+|||.++++..
T Consensus 249 eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 249 EWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred hhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 556789999999999999999999998754
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=317.36 Aligned_cols=258 Identities=19% Similarity=0.298 Sum_probs=188.6
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCc------CchhhhhhhhccC-Cce
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHH------KNLVRLIGYCAED-SKR 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h------~niv~l~g~~~~~-~~~ 583 (796)
..+.+.++||+|+||.||++.+...++.||||+++... ...+++..|+.++..++| .+++++++++..+ .+.
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 34566789999999999999998888999999996532 233455667777766654 4578888887654 467
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC-------------
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW------------- 650 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~------------- 650 (796)
++|||++ +++|.+++.+ ...+++..+..++.||+.||.|||++ .+|+||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred EEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 8888887 6788888865 35799999999999999999999973 2899999999999998765
Q ss_pred ---ceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHH
Q 003772 651 ---TAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLI 727 (796)
Q Consensus 651 ---~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~ 727 (796)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....
T Consensus 283 ~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i 357 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH-LHLM 357 (467)
T ss_pred CCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH
Confidence 499999998864321 22345689999999999999999999999999999999999999975432111 1110
Q ss_pred H---------HHHHh-------hh-----------hhhhhhhhcCCC-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 728 N---------WAYKC-------FI-----------DRELNKLVRGQE-VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 728 ~---------~~~~~-------~~-----------~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
. |.... +. ...+........ ........+.+|+..||+.||.+|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0 00000 00 000000000000 00112356789999999999999999999986
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=292.92 Aligned_cols=245 Identities=27% Similarity=0.349 Sum_probs=197.0
Q ss_pred cCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 519 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
||+|+||+||++.....++.+|+|.+.... ....+.+.+|++++++++|+||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999988888899999986532 22344577899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeec
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR 675 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~ 675 (796)
.+++.......+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 9999775445799999999999999999999998 99999999999999999999999999987654321 112234
Q ss_pred cCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 003772 676 GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLEN 755 (796)
Q Consensus 676 gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (796)
++..|+|||.+.+..++.++||||||+++|||++|+.||...........+ .. .... .....+....+.
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~----~~~~---~~~~~~~~~~~~ 224 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL----KR----RTLE---MAVEYPDKFSPE 224 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH----Hh----cccc---ccccCCccCCHH
Confidence 788999999998888999999999999999999999998654321111110 00 0000 011122334567
Q ss_pred HHHHHHHhccCCCCCCC-----CHHHHHH
Q 003772 756 MIKIGLWCVQDEPALRP-----SMKSVVL 779 (796)
Q Consensus 756 l~~l~~~cl~~dP~~RP-----t~~evl~ 779 (796)
+.+++..||+.+|.+|| +..+++.
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 89999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=296.59 Aligned_cols=250 Identities=27% Similarity=0.335 Sum_probs=198.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+...+.||+|+||.||+++...++..||+|++.... .+..+.+.+|+.++++++|+|++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 455678999999999999998888899999986432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+. |+|.+.+... ...+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 97 5787777543 45689999999999999999999998 9999999999999999999999999998754322
Q ss_pred eeeeeccCCCCCchhhhc---cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 670 TFTLVRGTRGYMAPEWYK---NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
....++..|+|||++. ...++.++|||||||++|||++|+.|+....... .. ...... ....
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~-----~~~~~~-----~~~~ 243 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---AL-----YHIAQN-----ESPT 243 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HH-----HHHHhc-----cCCC
Confidence 1234788999999974 4568999999999999999999999986432110 00 000000 0011
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
.........+.+++.+||+.+|.+||++.+|++.+--..
T Consensus 244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 112234567899999999999999999999998654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=286.41 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=204.0
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
...+.||+|++|.||++....+++.+++|++........+.+.+|+.++++++|+|++++++++......++++||++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 34578999999999999998778899999998765556778999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeee
Q 003772 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL 673 (796)
Q Consensus 594 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~ 673 (796)
+|.+++.... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.+........ ...
T Consensus 83 ~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 156 (253)
T cd05122 83 SLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNT 156 (253)
T ss_pred cHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccc
Confidence 9999987642 5789999999999999999999998 999999999999999999999999999987655432 223
Q ss_pred eccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 003772 674 VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTL 753 (796)
Q Consensus 674 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (796)
..++..|+|||.+.....+.++||||||+++|||++|+.|+....... ... .......... .......
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~------~~~~~~~~~~----~~~~~~~ 224 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--ALF------KIATNGPPGL----RNPEKWS 224 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH--HHH------HHHhcCCCCc----CcccccC
Confidence 457889999999998889999999999999999999999986432111 000 0000000000 0111125
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 754 ENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 754 ~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..+.+++..||+.||++|||+.++++
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 67899999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=295.70 Aligned_cols=260 Identities=23% Similarity=0.275 Sum_probs=199.5
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccC--CceeEEEee
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAED--SKRLLVYEY 589 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~ 589 (796)
.+.+.||+|+||.||+|+....++.+|+|++.... ....+.+.+|+.++++++|+|++++++++.+. +..++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 35678999999999999998888999999998653 33346788999999999999999999999887 789999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++ +|.+++... ...+++..++.++.||++||.|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 82 ~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 82 MDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred ccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 985 898888653 25789999999999999999999998 9999999999999999999999999999877554432
Q ss_pred eeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh---h----
Q 003772 670 TFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN---K---- 741 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~---- 741 (796)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.............. ........... .
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE-LCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCchhhccccccchhh
Confidence 2333446788999998765 4679999999999999999999999865432110000000 00000000000 0
Q ss_pred -hhcC-C--------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 742 -LVRG-Q--------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 742 -~~~~-~--------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.... . .....+...+.+++..||+.+|.+||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000 0 001112567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=293.89 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=193.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHH-HhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHV-IGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|+||.||++.....++.||||+++... .+....+..|+.. ++.++|+||+++++++.+++..++|+||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 345678999999999999998888999999987643 2334455566664 56678999999999999999999999999
Q ss_pred CCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 591 SNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 591 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
+ |+|.+++... ....+++..++.++.||+.||.|||++ .+++||||||+||+++.++.+||+|||++........
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 7 6888887542 235789999999999999999999974 3899999999999999999999999999986543221
Q ss_pred ceeeeeccCCCCCchhhhcc----CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 669 RTFTLVRGTRGYMAPEWYKN----TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
.....++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+........... ..... ..
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-------~~~~~-----~~ 225 (283)
T cd06617 160 --KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK-------QVVEE-----PS 225 (283)
T ss_pred --cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH-------HHHhc-----CC
Confidence 122347889999998865 4568999999999999999999999864322111100 00000 00
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...........+.+++..||+.+|.+||++.+|++
T Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111234567899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=293.45 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=202.7
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.+.+.||+|++|.||++.+...+..+++|++..... ..+.+.+|++++.+++|+|++++++.+...+..++|+||+++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence 4556789999999999999987788999999976444 567789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 100 ~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 174 (286)
T cd06614 100 GSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRN 174 (286)
T ss_pred CcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhc
Confidence 99999997642 4799999999999999999999998 999999999999999999999999999876543322 112
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...++..|+|||++.+..++.++||||||+++|||++|+.|+...... . .... ..... ..........
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~-~~~~-----~~~~~----~~~~~~~~~~ 242 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--R-ALFL-----ITTKG----IPPLKNPEKW 242 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--H-HHHH-----HHhcC----CCCCcchhhC
Confidence 234778999999999888999999999999999999999998643211 1 0000 00000 0001112224
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 753 LENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...+.+++.+|++.+|.+|||+.+|++
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 567899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=292.47 Aligned_cols=244 Identities=23% Similarity=0.331 Sum_probs=198.9
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCChh
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLA 596 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 596 (796)
.+||+|+||.||++.....++.||||++..........+.+|+.++++++|+|++++++.+..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 67999999999999998888999999987655555677999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeecc
Q 003772 597 DILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRG 676 (796)
Q Consensus 597 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~g 676 (796)
+++.. ..+++.....++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........ ......+
T Consensus 106 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 178 (292)
T cd06657 106 DIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG 178 (292)
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccccc
Confidence 98754 4588999999999999999999998 999999999999999999999999999876543221 2223457
Q ss_pred CCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHH
Q 003772 677 TRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENM 756 (796)
Q Consensus 677 t~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 756 (796)
+..|+|||.+.+..++.++||||||+++|||++|+.|+...... . .. ... .......+ .........+
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~-~~-~~~-~~~~~~~~-------~~~~~~~~~l 246 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--K-AM-KMI-RDNLPPKL-------KNLHKVSPSL 246 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H-HH-HHH-HhhCCccc-------CCcccCCHHH
Confidence 89999999998888999999999999999999999998643211 0 00 000 00000000 0112234568
Q ss_pred HHHHHHhccCCCCCCCCHHHHHH
Q 003772 757 IKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 757 ~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.+++.+||+.+|.+||++.+|++
T Consensus 247 ~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 247 KGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHhCCcccCcCHHHHhc
Confidence 88999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=294.90 Aligned_cols=260 Identities=22% Similarity=0.272 Sum_probs=194.3
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.+.+.||+|+||.||+|.....++.||+|++...... ....+.+|+.+++.++|+||+++.+++.++...++|+||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 45568899999999999999888889999998654332 23467889999999999999999999999999999999996
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
++|.+.+... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++....... ..
T Consensus 87 -~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 160 (291)
T cd07870 87 -TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TY 160 (291)
T ss_pred -CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-CC
Confidence 6777776543 34578888999999999999999998 999999999999999999999999999976432221 11
Q ss_pred eeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh-hhh---hh------
Q 003772 672 TLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI-DRE---LN------ 740 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~---~~------ 740 (796)
....+++.|+|||++.+. .++.++||||||+++|||++|+.||....... +.....+...... +.. +.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 223468899999998764 57899999999999999999999987443211 1111111000000 000 00
Q ss_pred -hhh---cCCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 741 -KLV---RGQE-----VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 741 -~~~---~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
... .... ........+.+++.+|++.||.+|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 0000 00112456788999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=294.15 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=195.2
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccC-cCchhhhhhhhccCCceeEEEeecC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.||+|+||.||++.....++.+|+|++.... ......+.+|+.++.++. |+||+++++++.++...++++||+.
T Consensus 7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 34578999999999999998888999999987533 234567889999999996 9999999999998889999999986
Q ss_pred CCChhhh---hhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 592 NGSLADI---LFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 592 ~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
. +|.++ +.......+++..+..++.|+++||+|||+. .+++||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 I-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred C-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 4 55443 3333346799999999999999999999974 3899999999999999999999999999976543221
Q ss_pred ceeeeeccCCCCCchhhhccC---CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNT---PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
. ....++..|+|||.+.+. .++.++|||||||++|||++|+.||...... .. ............+ .
T Consensus 164 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~----~~~~~~~~~~~~~--~ 232 (288)
T cd06616 164 K--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV---FD----QLTQVVKGDPPIL--S 232 (288)
T ss_pred c--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH---HH----HHhhhcCCCCCcC--C
Confidence 1 223478899999999876 6899999999999999999999998643210 00 0000000000000 0
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
..........+.+++.+||+.+|++|||+.+|+..
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11123356779999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=294.98 Aligned_cols=259 Identities=18% Similarity=0.196 Sum_probs=186.5
Q ss_pred HHHhhhcccCcccceEEEEEEEcCC---cEEEEEEEeecccchh-----------HHHHHHHHHHHhccCcCchhhhhhh
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKG---EKLVAVKKLEKMVTEG-----------EREFRAEMHVIGRTHHKNLVRLIGY 576 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~~~~-----------~~~f~~E~~~l~~l~h~niv~l~g~ 576 (796)
..+.+.++||+|+||.||+|...++ ...+|+|+........ ......+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4566788999999999999998766 5567777643221111 0112233445667789999999987
Q ss_pred hccCC----ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCce
Q 003772 577 CAEDS----KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTA 652 (796)
Q Consensus 577 ~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 652 (796)
+.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||.|||+. +|+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence 65443 34667776543 56666543 23457788899999999999999998 99999999999999999999
Q ss_pred EEeccCCccccCCCCc------ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHH
Q 003772 653 KISDFGLAKLLMPDQT------RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVL 726 (796)
Q Consensus 653 kl~DFgl~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~ 726 (796)
+|+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 9999999987643221 1112245899999999999999999999999999999999999999765332221111
Q ss_pred HHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 727 INWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
.. . +.+..+..........+..+.+++..|++.+|++||++.++++.|+
T Consensus 246 ~~---~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 246 AK---C----DFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hH---H----HHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11 0 0111111111112234577999999999999999999999999874
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.58 Aligned_cols=262 Identities=21% Similarity=0.272 Sum_probs=196.5
Q ss_pred HhhhcccCcccceEEEEEEEcC--CcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccC--CceeE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYK--GEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAED--SKRLL 585 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~--~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 585 (796)
+.+.+.||+|+||.||+|.... .++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 3456789999999999999987 67899999997633 33346678899999999999999999999887 78999
Q ss_pred EEeecCCCChhhhhhcC---CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC----CCceEEeccC
Q 003772 586 VYEYMSNGSLADILFRG---PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE----FWTAKISDFG 658 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DFg 658 (796)
||||+++ +|.+++... ....++...++.++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999985 677766432 123688999999999999999999998 9999999999999999 9999999999
Q ss_pred CccccCCCCc--ceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchh------HHHHHH
Q 003772 659 LAKLLMPDQT--RTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEE------IVLINW 729 (796)
Q Consensus 659 l~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~------~~~~~~ 729 (796)
++........ .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+......... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987643322 122234578899999988764 5799999999999999999999999754332200 000000
Q ss_pred HHHhhh---h---------hhhhh---hhcCCCCC---------H--HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 730 AYKCFI---D---------RELNK---LVRGQEVD---------R--NTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 730 ~~~~~~---~---------~~~~~---~~~~~~~~---------~--~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..... . ..... .......+ . .....+.+++.+|++.||.+|||+.|+++
T Consensus 238 -~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 -FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred -HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 0 00000 00000001 0 23457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=287.89 Aligned_cols=261 Identities=24% Similarity=0.337 Sum_probs=198.2
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccC-cCchhhhhhhhccCCceeEEEeecC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.||+|++|.||+|+..+.++.|+||++..... .......+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 456889999999999999988888999999876433 22334567999999999 999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+|+|.+++.......+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 155 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--Y 155 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--c
Confidence 88999998765446789999999999999999999998 999999999999999999999999999986643222 1
Q ss_pred eeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHH---------HHHHhhhhhhhhh
Q 003772 672 TLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLIN---------WAYKCFIDRELNK 741 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 741 (796)
....++..|+|||++.. ..++.++|+||||++++||++|+.|+.............. |............
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 22347889999998854 4679999999999999999999988864432111000000 0000000000000
Q ss_pred hhcCCC------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 742 LVRGQE------VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 742 ~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
...... ........+.+++..||+.+|++|||++|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 001124679999999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=298.00 Aligned_cols=269 Identities=21% Similarity=0.287 Sum_probs=201.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccC-----CceeE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAED-----SKRLL 585 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 585 (796)
+.+.+.||+|+||.||++.....++.||||.+... .......+.+|+.++..++|+||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 44567899999999999999888899999998653 223345678899999999999999999988654 34799
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 87 VYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 999996 689888865 35799999999999999999999998 999999999999999999999999999987643
Q ss_pred CCcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHH--------Hhhhh
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAY--------KCFID 736 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 736 (796)
.. .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...... .......... .....
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 KG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred Cc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCChHHhhhcCc
Confidence 32 11223347889999998875 46899999999999999999999998643211 1110000000 00000
Q ss_pred hhhhhhh----cCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HhcCcCCCC
Q 003772 737 RELNKLV----RGQ-----EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM--LEGITDISI 789 (796)
Q Consensus 737 ~~~~~~~----~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~~~~ 789 (796)
......+ ... ...+.....+.+++.+||+.+|++|||++++++. ++.+.+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~ 302 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD 302 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence 0000000 000 0112345778999999999999999999999876 665544433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=292.55 Aligned_cols=264 Identities=22% Similarity=0.291 Sum_probs=198.0
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCC------
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS------ 581 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------ 581 (796)
...+.+.+.||+|+||.||+|.....++.||||+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 3455677899999999999999988888999999875332 23356788999999999999999999887654
Q ss_pred ----ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEecc
Q 003772 582 ----KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDF 657 (796)
Q Consensus 582 ----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 657 (796)
..++|+||+++ +|.+.+... ...+++..++.++.||+.||.|||+. +|+|+||||+||++++++.+||+||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999986 677777543 45789999999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhh
Q 003772 658 GLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFID 736 (796)
Q Consensus 658 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
|++...............++..|+|||.+.+. ..+.++|||||||++|||++|+.|+...... ...............
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCh
Confidence 99987654433222333467889999988654 5789999999999999999999988643211 111100000000000
Q ss_pred hhhhhhhc--------CC--------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 737 RELNKLVR--------GQ--------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 737 ~~~~~~~~--------~~--------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
........ .. ......+..+.+++..||+.+|.+|||+++|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000 00 001123567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=287.15 Aligned_cols=245 Identities=24% Similarity=0.306 Sum_probs=191.8
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHH-HhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHV-IGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+|+||.||+|.....++.||+|.+.+... .....+..|..+ ....+|+|++++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 568999999999999988888999999865322 222334455444 4455899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
++|.+++.. ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||+++.... ..
T Consensus 82 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 999999975 35689999999999999999999998 999999999999999999999999999875432 12
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...++..|+|||.+.+..++.++||||||+++|||++|..|+..... .. .. ........ ..........
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~-~~-----~~~~~~~~---~~~~~~~~~~ 220 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--DA-VF-----DNILSRRI---NWPEEVKEFC 220 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--HH-HH-----HHHHhccc---CCCCcccccC
Confidence 23478899999999888889999999999999999999999864321 11 11 00000000 0011112234
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 753 LENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
...+.+++..||+.+|++||++.++.+.|+
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 577999999999999999998876666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.04 Aligned_cols=261 Identities=21% Similarity=0.272 Sum_probs=197.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccC--CceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAED--SKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 587 (796)
.+.+.+.||+|+||.||+|.....++.+|+|.++.... .....+.+|+.++.+++|+||+++++++... ...++|+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 45667899999999999999988888999999875332 2234577899999999999999999998877 7899999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+. ++|.+++... ...+++..++.++.|+++||.|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 86 e~~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 86 EYVE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred hhcC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9998 4899988653 24689999999999999999999998 99999999999999999999999999998765432
Q ss_pred cceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH-------HHHhh--hh-
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW-------AYKCF--ID- 736 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~--~~- 736 (796)
. ......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||...........+... .+..+ ..
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 1 12223468899999998765 4689999999999999999999998644321100000000 00000 00
Q ss_pred ---hhhhh----hhcCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 737 ---RELNK----LVRGQEVDRN-TLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 737 ---~~~~~----~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..... .+. ...+.. ..+.+.+++..||+.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLR-KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhh-ccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000 000 001111 3567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=289.78 Aligned_cols=259 Identities=21% Similarity=0.312 Sum_probs=201.0
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch--hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE--GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.||+|++|.||++....+++.+++|++...... ....+..|+.++++++|+||+++++++.+++..++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 3457899999999999999888899999998754332 45678889999999999999999999999999999999997
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+ +|.+++... ...+++..++.++.|+++||.|||+. +|+|+||||+||++++++.++|+|||.+....... ...
T Consensus 82 ~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 82 T-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred C-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 5 888888653 35789999999999999999999998 99999999999999999999999999998775543 122
Q ss_pred eeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh--------
Q 003772 672 TLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL-------- 742 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 742 (796)
....++..|+|||.+.+. ..+.++||||||+++|+|++|+.||...... .....................
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 233477889999999877 7899999999999999999999888643321 111000000000000000000
Q ss_pred ---hcC-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 743 ---VRG-----QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 743 ---~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
... ....++....+.+++..||+.||.+||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 0112345678999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=293.27 Aligned_cols=258 Identities=19% Similarity=0.220 Sum_probs=192.7
Q ss_pred hhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.+.+|.|+++.||++. ..++.||||++... ..+..+.+..|+.++++++|+||+++++++.+.+..+++|||+++
T Consensus 6 i~~~~~~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 6 IGKCFEDLMIVHLAKHK--PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhHhhcCCceEEEEEec--CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 34455555555555554 46789999998754 344557899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc----
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT---- 668 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~---- 668 (796)
|+|.+++.......+++..+..++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999999865456789999999999999999999998 999999999999999999999999998875532211
Q ss_pred --ceeeeeccCCCCCchhhhccC--CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH--HHhhh-----h-
Q 003772 669 --RTFTLVRGTRGYMAPEWYKNT--PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA--YKCFI-----D- 736 (796)
Q Consensus 669 --~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~-----~- 736 (796)
.......++..|+|||++... .++.++|||||||++|||++|+.||........ ...... ..... .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhh
Confidence 111223467789999999763 588999999999999999999999975432111 000000 00000 0
Q ss_pred --hhhhh-----------hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 737 --RELNK-----------LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 737 --~~~~~-----------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..... ..............+.+++..||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 00000112334567889999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=289.79 Aligned_cols=255 Identities=22% Similarity=0.279 Sum_probs=200.8
Q ss_pred hhhcccCcccceEEEEEEEc---CCcEEEEEEEeeccc----chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeE
Q 003772 514 RFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMV----TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 585 (796)
.+.+.||+|++|.||++... ..++.||||.+.+.. ....+.+.+|+.++.++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 45688999999999999864 345789999987532 22345688999999999 59999999999998899999
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
||||+++|+|.+++.. ...+++..+..++.|+++||.|||+. +++|+||||+||+++.++.++|+|||+++.+..
T Consensus 83 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 83 ILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 9999999999999865 35688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcceeeeeccCCCCCchhhhccCC--CCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYKNTP--ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
..........++..|+|||.+.+.. .+.++||||||+++|||++|+.|+............. +. ...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----~~-----~~~-- 226 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS----RR-----ILK-- 226 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHH----HH-----HHc--
Confidence 4332223345789999999987765 7899999999999999999999986433221111110 00 000
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
.....+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 227 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 227 SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00112223446688999999999999999999998877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=297.28 Aligned_cols=260 Identities=18% Similarity=0.229 Sum_probs=193.9
Q ss_pred cccCcc--cceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKG--SFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G--~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.||+| +||+||++++...++.||||++.... .+..+.+++|+.+++.++|+||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 89999999998888999999986432 23346789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce--
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT-- 670 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~-- 670 (796)
|+|.+++.+.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999999775455689999999999999999999998 99999999999999999999999998654332211100
Q ss_pred ----eeeeccCCCCCchhhhccC--CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH-------------HH
Q 003772 671 ----FTLVRGTRGYMAPEWYKNT--PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW-------------AY 731 (796)
Q Consensus 671 ----~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-------------~~ 731 (796)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||............... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 0011245679999999764 5789999999999999999999998643211100000000 00
Q ss_pred Hhh------hh-----hhhh-----hhhc---CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 732 KCF------ID-----RELN-----KLVR---GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 732 ~~~------~~-----~~~~-----~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
... .+ .... .... ...........+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 00 0000 0000 00112345678999999999999999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=278.48 Aligned_cols=248 Identities=26% Similarity=0.347 Sum_probs=205.9
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
...+.++||+|.||.||++.++..+..+|||++.- ..+.+++..|+.++++.+.+++|+++|.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 34566899999999999999999999999999853 4567889999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
-|++.+++..+ ++.|.+..+..++..-++||+|||.. .-+|||||..||||+.+|.+||+|||.+..+.......
T Consensus 112 AGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR- 186 (502)
T KOG0574|consen 112 AGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR- 186 (502)
T ss_pred CCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh-
Confidence 99999999754 68899999999999999999999998 88999999999999999999999999998764332222
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC-CCCH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ-EVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 750 (796)
..+.||+.|||||+++.-.|..++||||||+...||.-|++|+..--.- ...+ . +..-..+. ..+.
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM--RAIF------M-----IPT~PPPTF~KPE 253 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM--RAIF------M-----IPTKPPPTFKKPE 253 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc--ceeE------e-----ccCCCCCCCCChH
Confidence 2355999999999999999999999999999999999999998532100 0000 0 00000000 1233
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
+-..++-++++.||-++|++|.|+-++++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 44577889999999999999999988875
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=284.64 Aligned_cols=249 Identities=29% Similarity=0.386 Sum_probs=205.0
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccC--CceeEEEee
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAED--SKRLLVYEY 589 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~ 589 (796)
...+.||+|++|.||+|.....++.|++|++..... ...+.+.+|+..+++++|+||+++++.+.+. ...++|+||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 345789999999999999988888999999876442 4567899999999999999999999999888 889999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++++|.+++... ..+++..++.++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 83 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 83 VSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999999999763 3899999999999999999999998 9999999999999999999999999999877554321
Q ss_pred -eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 670 -TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 670 -~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
......++..|+|||.+.....+.++||||||+++|+|++|+.|+....... ... .. +.........
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~-----~~------~~~~~~~~~~ 225 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-AAL-----YK------IGSSGEPPEI 225 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-HHH-----Hh------ccccCCCcCC
Confidence 1223457889999999998889999999999999999999999987544111 000 00 0000011122
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
+......+.+++.+|++.+|++||++.+++.
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 3344678999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=287.82 Aligned_cols=243 Identities=24% Similarity=0.285 Sum_probs=190.5
Q ss_pred ccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHH---HHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMH---VIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 518 ~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~---~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.||+|+||.||++.....++.||+|.+.+... .....+..|.. .+...+|+||+++++++.+.+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999988888999999865321 22233444544 3444579999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+|+|.+++.. ...+++..+..++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++..+.....
T Consensus 81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--- 152 (278)
T cd05606 81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (278)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence 9999998865 45799999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 672 TLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||............ .. . .......+.
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-----~~------~-~~~~~~~~~ 220 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----RM------T-LTMAVELPD 220 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-----HH------h-hccCCCCCC
Confidence 223589999999999754 6899999999999999999999999754322111000 00 0 000111222
Q ss_pred HHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRP-----SMKSVVLM 780 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~ 780 (796)
.....+.+++..|++.+|.+|| ++.++++.
T Consensus 221 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 221 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 3456789999999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=299.19 Aligned_cols=267 Identities=23% Similarity=0.300 Sum_probs=198.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccC-----CceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAED-----SKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 585 (796)
.+.+.+.||+|+||.||+|.....++.||||++.... ......+..|+.++++++|+||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 3556789999999999999998888899999986432 23445688899999999999999999987643 35799
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
|+||+.+ +|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 86 VQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred Eehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 9999974 78777743 5689999999999999999999998 999999999999999999999999999987643
Q ss_pred CCcc--eeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh-
Q 003772 666 DQTR--TFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK- 741 (796)
Q Consensus 666 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 741 (796)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ...................
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHh
Confidence 2221 1123457899999998755 468999999999999999999999986432110 0000000000000000000
Q ss_pred -----------hhcCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HhcCcC
Q 003772 742 -----------LVRGQEV-----DRNTLENMIKIGLWCVQDEPALRPSMKSVVLM--LEGITD 786 (796)
Q Consensus 742 -----------~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~ 786 (796)
....... .+.....+.+++..||+.+|++|||+.++++. ++...+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000000 11234678899999999999999999999986 665544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=292.75 Aligned_cols=248 Identities=26% Similarity=0.335 Sum_probs=197.0
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc---cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
.++...+.||+|+||.||+|+....++.+|+|.+... .....+.+.+|+.+++.++|+|++++++++.+....++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3455567899999999999999888889999998642 2233456888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+. |+|.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9997 6888877543 35688999999999999999999998 9999999999999999999999999998765432
Q ss_pred cceeeeeccCCCCCchhhhc---cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 668 TRTFTLVRGTRGYMAPEWYK---NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
....++..|+|||.+. ....+.++|||||||++|||++|+.|+....... . . .... ....
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~-~-----~~~~-----~~~~ 231 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A-L-----YHIA-----QNES 231 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--H-H-----HHHh-----hcCC
Confidence 1234788999999985 3468899999999999999999999985432110 0 0 0000 0000
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLML 781 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 781 (796)
...........+.+++.+||+.+|.+||++.+|+..-
T Consensus 232 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1111234556788999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=283.28 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=203.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.++||+|+||.||+++....++.+++|.+.... .....++..|++++++++|+||+++++++.++...++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 345688999999999999988888899999987532 233456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 591 SNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 591 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
++++|.+++.+. ....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 158 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA 158 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCCc
Confidence 999999998652 235689999999999999999999998 999999999999999999999999999987654421
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
....++..|+|||.+.+..++.++|+||||+++|||++|+.|+..... .... . ..... .....
T Consensus 159 ---~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~--~----~~~~~------~~~~~ 221 (256)
T cd08530 159 ---KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--QDLR--Y----KVQRG------KYPPI 221 (256)
T ss_pred ---ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH--H----HHhcC------CCCCC
Confidence 223478899999999999999999999999999999999999864321 1100 0 00000 00112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
+......+.+++..|++.+|++|||+.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 23556779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.23 Aligned_cols=261 Identities=23% Similarity=0.289 Sum_probs=196.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|++|.||+|.....++.||+|++..... ...+.+.+|+.++++++|+||+++++++.++...++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 4556889999999999999988888999999865322 23467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-CCceEEeccCCccccCCCCcc
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE-FWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+ ++|.+++.......+++..+..++.||+.||.|||+. +++|+||+|+||+++. ++.+||+|||++....... .
T Consensus 84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~ 158 (294)
T PLN00009 84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-R 158 (294)
T ss_pred c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-c
Confidence 6 5888887654445578888899999999999999998 9999999999999985 5679999999997654321 1
Q ss_pred eeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh------hh-
Q 003772 670 TFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL------NK- 741 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~- 741 (796)
......+++.|+|||++.+. .++.++||||||+++|||++|+.||....... ................. ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChhhccccccchhh
Confidence 12233468899999998764 57899999999999999999999987543211 11100000000000000 00
Q ss_pred --hhc---CC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 742 --LVR---GQ---EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 742 --~~~---~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
... .. ...+...+.+.+++.+|++.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00 011233466889999999999999999999986
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=287.99 Aligned_cols=254 Identities=24% Similarity=0.283 Sum_probs=193.2
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccC-cCchhhhhhhhccC--CceeEEEee
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTH-HKNLVRLIGYCAED--SKRLLVYEY 589 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~e~ 589 (796)
++.++||+|+||.||+|.....++.||+|++.+... ........|+..+.++. |+|++++++++.+. +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 456789999999999999988888999999876432 22334557888888885 99999999999887 889999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
++ |+|.+.+... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++. +.+||+|||++.........
T Consensus 82 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 82 MD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred CC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 97 5888887653 35789999999999999999999998 9999999999999999 99999999999876433221
Q ss_pred eeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh--hhhhhhhhhc--
Q 003772 670 TFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF--IDRELNKLVR-- 744 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-- 744 (796)
....++..|+|||.+.. ..++.++|||||||++|||++|..||....... .. ....... ....+.....
T Consensus 156 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 156 --TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QI---AKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred --CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HH---HHHHHHcCCCCHHHHHhhccc
Confidence 22347889999997754 567899999999999999999999986432111 00 0000000 0000000000
Q ss_pred -------CCC-------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 745 -------GQE-------VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 745 -------~~~-------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
... ........+.+++..||+.+|++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000 01234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=316.14 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=204.8
Q ss_pred hhhcccCcccceEEEEEEEcC-------CcEEEEEEEeecccc-hhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCcee
Q 003772 514 RFKEELGKGSFGAVYKGTLYK-------GEKLVAVKKLEKMVT-EGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~-------~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 584 (796)
.+.+.||+|.||.|++|.... ....||||.++.... ...+.+..|+++++.+ +|+||+.++|+|...+..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 466799999999999998541 145799999986444 3557899999999998 5999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCC------------C--CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC
Q 003772 585 LVYEYMSNGSLADILFRGP------------E--RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW 650 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 650 (796)
+|.||+++|+|.++|.+.+ . ..+...+.+.++.|||.||+||++. ++|||||..+|||+.++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence 9999999999999998653 0 2388899999999999999999999 999999999999999999
Q ss_pred ceEEeccCCccccCCCCcceeeeec--cCCCCCchhhhccCCCCccccchhhHHHHHHHhhccc-CCCCCCCCchhHHHH
Q 003772 651 TAKISDFGLAKLLMPDQTRTFTLVR--GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRR-NMEIDPSKPEEIVLI 727 (796)
Q Consensus 651 ~~kl~DFgl~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~-p~~~~~~~~~~~~~~ 727 (796)
.+||+|||+++.............. -...|||||.+....++.|+|||||||+||||+|... |+.. .....+.
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-~~~~~~l--- 531 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-IPPTEEL--- 531 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC-CCcHHHH---
Confidence 9999999999976554433322222 3456999999999999999999999999999999554 4432 1111111
Q ss_pred HHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 728 NWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
.+...++. ....+..+..+++++++.||+.+|++||++.++++.++..
T Consensus 532 ---~~~l~~G~------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 532 ---LEFLKEGN------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ---HHHHhcCC------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11111111 1134566788999999999999999999999999999874
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=291.30 Aligned_cols=261 Identities=23% Similarity=0.267 Sum_probs=193.7
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccC-cCchhhhhhhhccCCc-----ee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSK-----RL 584 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~-----~~ 584 (796)
+.+.+.||+|+||.||+|....+++.||||++..... .....+.+|+.++.+++ |+||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 3456789999999999999988889999998865332 23457888999999995 6999999998876655 79
Q ss_pred EEEeecCCCChhhhhhcCC---CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-CCceEEeccCCc
Q 003772 585 LVYEYMSNGSLADILFRGP---ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE-FWTAKISDFGLA 660 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgl~ 660 (796)
+||||+++ +|.+++.... ...+++..++.++.||++||.|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 7888876432 34689999999999999999999998 9999999999999998 899999999999
Q ss_pred cccCCCCcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh
Q 003772 661 KLLMPDQTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739 (796)
Q Consensus 661 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
........ ......+++.|+|||++.+ ..++.++||||||+++|||++|..||............... .........
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL-LGTPTEQVW 236 (295)
T ss_pred eecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH-hCCCChhhC
Confidence 86533211 1122246788999998865 45799999999999999999999998643221111100000 000000000
Q ss_pred h---hh------hcC-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 740 N---KL------VRG-----QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 740 ~---~~------~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
. .. ... ....+.....+.+++..||+.+|.+||+++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00 000 0001234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=299.15 Aligned_cols=260 Identities=22% Similarity=0.239 Sum_probs=196.2
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccC------Cc
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAED------SK 582 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~ 582 (796)
..+...+.||+|+||.||++.....++.||||++.+. .....+.+.+|+.++++++|+||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 3355568899999999999999888899999998643 223345677899999999999999999987543 35
Q ss_pred eeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 583 RLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
.++|+||+. ++|.+.+.. .++...+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred EEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 799999996 588888754 288899999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHH--------------
Q 003772 663 LMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLIN-------------- 728 (796)
Q Consensus 663 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~-------------- 728 (796)
...... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+..
T Consensus 168 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 168 AGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 643222 2223478899999999999999999999999999999999999864431110000000
Q ss_pred HHHHhhhh-------hhhhhhhcCC-------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 729 WAYKCFID-------RELNKLVRGQ-------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 729 ~~~~~~~~-------~~~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
........ ..+.+..... .........+.+++.+||+.||++|||+.|++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000000000 0012345678899999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=283.69 Aligned_cols=247 Identities=26% Similarity=0.380 Sum_probs=203.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|++|.||+++....++.+++|.+..... ...+.+.+|++++.+++|+|++++++++.+++..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 3456889999999999999988888999999976543 34567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 82 ENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 999999999763 6799999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
.....++..|+|||.......+.++|||++|+++|||++|+.|+...... .. .+... . ......+.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~~---~~~~~---~------~~~~~~~~ 221 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--AA---LFRIV---Q------DDHPPLPE 221 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--HH---HHHHh---c------cCCCCCCC
Confidence 22344788999999998888899999999999999999999998643211 00 00000 0 01111233
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.....+.+++.+||+.+|++|||+.+++.
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 44577889999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=283.09 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=204.6
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.||+|+||.||++....+++.+++|++..... ...+.+.+|+++++.++|+|++++++.+..+...++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 456789999999999999988888999999976433 456678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCC--CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 592 NGSLADILFRGP--ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 592 ~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|.+++.... ...+++..+..++.++++||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (258)
T cd08215 83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD- 158 (258)
T ss_pred CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcc-
Confidence 999999997643 47799999999999999999999998 999999999999999999999999999987654431
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
......+++.|+|||.+.....+.++||||+|+++++|++|+.|+..... ... ........ ....+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~------~~~~~~~~------~~~~~ 224 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--LEL------ALKILKGQ------YPPIP 224 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--HHH------HHHHhcCC------CCCCC
Confidence 22223578899999999998999999999999999999999999864321 111 01111111 11122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......+.+++.+||+.+|++|||+.++++
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 225 SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 244567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=293.81 Aligned_cols=262 Identities=24% Similarity=0.310 Sum_probs=197.7
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhcc-CcCchhhhhhhhccC--CceeE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAED--SKRLL 585 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~--~~~~l 585 (796)
..+.+.+.||+|+||.||+|.+..+++.+|+|++... .......+..|+.++.++ +|+||+++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 4566778999999999999999888889999988542 223345677899999999 999999999988653 36799
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
|+||++ ++|.+++.. ..+++..+..++.||+.||.|||+. +|+|+||||+||++++++.+||+|||++.....
T Consensus 87 v~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 87 VFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred Eecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 999997 599888865 2788999999999999999999998 999999999999999999999999999987644
Q ss_pred CCc----ceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHH--------
Q 003772 666 DQT----RTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYK-------- 732 (796)
Q Consensus 666 ~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 732 (796)
... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDIE 238 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHH
Confidence 332 12223457889999998765 4678999999999999999999999864322111 000000000
Q ss_pred ----hhhhhhhhhhhcCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 733 ----CFIDRELNKLVRGQ-----EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 733 ----~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
......+....... ...++....+.+++.+||+.+|++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000 0112245678999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=295.94 Aligned_cols=268 Identities=21% Similarity=0.309 Sum_probs=205.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCC-----ceeE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS-----KRLL 585 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l 585 (796)
+.+.+.||.|+||.||+++....++.||||++.... ....+.+.+|+.+++.++|+||+++++++.+.. ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 456788999999999999998878899999997644 334567899999999999999999999998775 7899
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
||||++ ++|.+++.. ...+++..++.++.|+++||.|||+. +|+|+||||+||++++++.++|+|||++.....
T Consensus 82 v~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 82 VTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred Eecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 999998 489888865 34899999999999999999999998 999999999999999999999999999987654
Q ss_pred CCc--ceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHh--------h
Q 003772 666 DQT--RTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKC--------F 734 (796)
Q Consensus 666 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------~ 734 (796)
... .......++..|+|||.+.+. ..+.++||||||+++|+|++|+.||.............. .... .
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 234 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVE-VLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH-hcCCCChhHhhhc
Confidence 431 122334578899999999888 889999999999999999999999864432110000000 0000 0
Q ss_pred hhhhhhhhhc----CC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HhcCcCC
Q 003772 735 IDRELNKLVR----GQ-----EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM--LEGITDI 787 (796)
Q Consensus 735 ~~~~~~~~~~----~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~~ 787 (796)
........+. .. ...+.....+.+++..||+.+|.+|||+.++++. ++++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0000000000 00 0112245678999999999999999999999974 6665554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=286.94 Aligned_cols=260 Identities=24% Similarity=0.330 Sum_probs=198.1
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
.+.++||.|++|.||+|+...+++.||||++...... ....+.+|+.++++++|+||+++++++.+.+..++||||+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK 82 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence 4568899999999999999888899999998764332 345678899999999999999999999999999999999985
Q ss_pred CChhhhhhcCC-CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 593 GSLADILFRGP-ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 593 gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++........ ..
T Consensus 83 -~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (284)
T cd07836 83 -DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TF 157 (284)
T ss_pred -cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-cc
Confidence 8888876532 35689999999999999999999998 999999999999999999999999999976533221 12
Q ss_pred eeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc-----C
Q 003772 672 TLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR-----G 745 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 745 (796)
....++..|++||.+.+. .++.++||||||+++|||++|+.|+............... ...........+.. .
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRI-MGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCCCChhhHHHHhcCchhcc
Confidence 223468899999998664 5789999999999999999999998654321111100000 00000000000000 0
Q ss_pred ----------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 746 ----------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 746 ----------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....+.....+.+++..|++.||.+||++++|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011233567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=288.53 Aligned_cols=251 Identities=26% Similarity=0.411 Sum_probs=193.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccC-cCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|+||.||+|.....++.||||++.+... ....++..|+.++.+.. |+||+++++++.++...++||||+
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 4567899999999999999988788999999975432 33455677777676665 999999999999999999999998
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
. ++|.+++... ...+++..+..++.|+++||.|||+. .+|+|+||+|+||++++++.+||+|||++..+......
T Consensus 97 ~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~- 171 (296)
T cd06618 97 S-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171 (296)
T ss_pred C-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc-
Confidence 5 4677766543 34789999999999999999999973 28999999999999999999999999999765432221
Q ss_pred eeeeccCCCCCchhhhccCC----CCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTP----ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
....++..|+|||.+.... ++.++||||||+++|||++|+.|+....... . .+ ...........
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~-~~-----~~~~~~~~~~~---- 239 (296)
T cd06618 172 -TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-E-VL-----TKILQEEPPSL---- 239 (296)
T ss_pred -cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-H-HH-----HHHhcCCCCCC----
Confidence 2234778999999987653 7899999999999999999999986432110 0 00 00011100000
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.........+.+++.+||+.+|.+||++.++++.
T Consensus 240 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111245678999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=294.31 Aligned_cols=261 Identities=21% Similarity=0.307 Sum_probs=197.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhcc----CCceeEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAE----DSKRLLV 586 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV 586 (796)
+.+.+.||+|+||.||++.....++.||+|++..... ...+.+.+|+.++.+++|+||+++++++.. ....++|
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 4556789999999999999988889999999875322 334667889999999999999999998763 3467999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
+||+. |+|.+++.. ...+++..+..++.||++||.|||+. +|+|+||||+||++++++.+||+|||++......
T Consensus 87 ~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 87 MDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred Eehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 99996 689998865 35699999999999999999999998 9999999999999999999999999999765433
Q ss_pred Ccc---eeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH-------HHHhhh
Q 003772 667 QTR---TFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW-------AYKCFI 735 (796)
Q Consensus 667 ~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~ 735 (796)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............... ......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 221 1123457889999999866 46899999999999999999999999643221100000000 000000
Q ss_pred hhhhhhhh----cCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 736 DRELNKLV----RGQEV-----DRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 736 ~~~~~~~~----~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.+.+.... ..... .+.....+.+++..||+.+|++|||+++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00111100 00011 1234678999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=314.41 Aligned_cols=266 Identities=18% Similarity=0.221 Sum_probs=187.1
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcE-EEEEE--------------Eeec---ccchhHHHHHHHHHHHhccCcCchh
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEK-LVAVK--------------KLEK---MVTEGEREFRAEMHVIGRTHHKNLV 571 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~-~vAvK--------------~l~~---~~~~~~~~f~~E~~~l~~l~h~niv 571 (796)
...+++.++||+|+||.||++.+..... ..++| ++.+ ........+.+|+.++.+++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3567788999999999999987643221 11111 0111 1122345688999999999999999
Q ss_pred hhhhhhccCCceeEEEeecCCCChhhhhhcCC---CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC
Q 003772 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGP---ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE 648 (796)
Q Consensus 572 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 648 (796)
++++++.+.+..++|+|++. ++|.+++.... ........+..++.||+.||.|||+. +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 99999999999999999985 57777765421 12234566778999999999999998 9999999999999999
Q ss_pred CCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHH
Q 003772 649 FWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLIN 728 (796)
Q Consensus 649 ~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~ 728 (796)
++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.++...........+..
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999987754433333345689999999999999999999999999999999998864432221111111111
Q ss_pred HHH------Hhhhh--hhhhhhhcCC-------CC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 729 WAY------KCFID--RELNKLVRGQ-------EV-----DRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 729 ~~~------~~~~~--~~~~~~~~~~-------~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
... ..+.+ ..+.+.+... .. .......+.+++.+||+.||.+|||+.|++.
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00000 0000010000 00 0112345677889999999999999999986
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=283.40 Aligned_cols=248 Identities=24% Similarity=0.311 Sum_probs=197.3
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc-----cchhHHHHHHHHHHHhccCcCchhhhhhhhccC--CceeE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM-----VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAED--SKRLL 585 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 585 (796)
+++.+.||+|+||.||++.....++.||+|.+... ..+..+.+++|+.++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 45678999999999999999888889999987432 123346788999999999999999999988654 45789
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
|+||+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 84 FVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 9999999999999865 34588999999999999999999998 999999999999999999999999999986543
Q ss_pred CCc--ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 666 DQT--RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 666 ~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
... .......++..|+|||.+.+...+.++|||||||++|||++|+.||...... . .. .+ .....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~-~~----~~------~~~~~ 225 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--A-AI----FK------IATQP 225 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--H-HH----HH------HHcCC
Confidence 111 1112345788999999999888999999999999999999999998643211 0 00 00 00000
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.....+....+.+.+++..|++ +|..||+..+++.
T Consensus 226 ~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1122344556789999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=291.60 Aligned_cols=262 Identities=22% Similarity=0.284 Sum_probs=193.2
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCC--------
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS-------- 581 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-------- 581 (796)
.+.+.++||+|+||.||++.....++.||||++..... .....+.+|+.++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 35567889999999999999988889999999864322 22345678999999999999999999886544
Q ss_pred ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcc
Q 003772 582 KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~ 661 (796)
..++||||+.+ +|.+.+... ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 34999999974 788877543 34689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCc---ceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhh
Q 003772 662 LLMPDQT---RTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDR 737 (796)
Q Consensus 662 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
....... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... ..............+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLISQLCGSITPE 246 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChh
Confidence 7643222 112233467889999998765 4789999999999999999999888644321 1111111100000000
Q ss_pred hhh---------hhhcCC---------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 738 ELN---------KLVRGQ---------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 738 ~~~---------~~~~~~---------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
... ...... .........+.+++..||+.||.+|||++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 000000 001112345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-33 Score=287.57 Aligned_cols=242 Identities=26% Similarity=0.320 Sum_probs=205.1
Q ss_pred hhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.-++||+||||.||-......++.+|.|++++.. .+++..-.+|-.+|.+++.+.||.+--.++..+.+++|+..|.
T Consensus 189 ~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMN 268 (591)
T KOG0986|consen 189 VYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMN 268 (591)
T ss_pred eeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeec
Confidence 3478999999999999999999999999997632 3456677899999999999999999989999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+|+|.-+|.......+++..++.++.+|+-||.+||.. .||.||+||+|||||+.|+++|+|+|+|..+..++...
T Consensus 269 GGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~- 344 (591)
T KOG0986|consen 269 GGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR- 344 (591)
T ss_pred CCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCccc-
Confidence 99999999987777899999999999999999999998 99999999999999999999999999999886655433
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc--CCCCC
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR--GQEVD 749 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 749 (796)
...||.+|||||++.+..|+...|.||+||+||||+-|+.||....... ...++.+.+. ..+.+
T Consensus 345 -~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-------------k~eEvdrr~~~~~~ey~ 410 (591)
T KOG0986|consen 345 -GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-------------KREEVDRRTLEDPEEYS 410 (591)
T ss_pred -cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-------------hHHHHHHHHhcchhhcc
Confidence 3369999999999999999999999999999999999999997543221 1112222221 12345
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSM 774 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~ 774 (796)
....++...+....|+.||.+|---
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccC
Confidence 5556778888888999999998643
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=285.41 Aligned_cols=247 Identities=25% Similarity=0.375 Sum_probs=202.1
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc---cchhHHHHHHHHHHHhccC-cCchhhhhhhhccCCceeEEEe
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e 588 (796)
+.+.+.||+|+||.||++....+++.||+|++.+. .....+.+..|+.++++++ |+||+++++++.+++..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 34567899999999999999888889999998652 2234567889999999998 9999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++++|.+++.+ ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 83 YAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999999999976 34799999999999999999999998 999999999999999999999999999987643321
Q ss_pred -------------------ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH
Q 003772 669 -------------------RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW 729 (796)
Q Consensus 669 -------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 729 (796)
.......++..|+|||.+.....+.++||||||++++|+++|+.|+..... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~---- 230 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLT---- 230 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHH----
Confidence 112223478899999999988899999999999999999999999874431 000
Q ss_pred HHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCH----HHHHH
Q 003772 730 AYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSM----KSVVL 779 (796)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~evl~ 779 (796)
.+... . .....+....+.+.+++..||+.+|.+|||+ +++++
T Consensus 231 -~~~~~-----~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 -FQKIL-----K--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -HHHHH-----h--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00000 0 0112233446779999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=292.52 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=200.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
.++...||.|+||.||++..+......|.|.+...+.+..+.|.-|+++|...+||+||++++.+..++.++++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 45667899999999999998877666788888887888889999999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|-++.++..- +..|.+.++.-+++|++.||.|||++ .|||||||..|||++-+|.++|+|||.+........ ...
T Consensus 114 GAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q-kRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ-KRD 188 (1187)
T ss_pred chHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHh-hhc
Confidence 9999988764 57799999999999999999999999 999999999999999999999999999865432211 112
Q ss_pred eeccCCCCCchhhhc-----cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 673 LVRGTRGYMAPEWYK-----NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
...|||.|||||+.. ..+|+.++||||||++|.||.-+.+|...-. +-.+ +.. ..+-.+ ..++
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--pMRV-llK--iaKSeP---PTLl---- 256 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRV-LLK--IAKSEP---PTLL---- 256 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--hHHH-HHH--HhhcCC---Cccc----
Confidence 345999999999864 5589999999999999999999887764211 0000 000 000000 0011
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.+..-...+.+++..||..||..||+.+++++
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 12233456888899999999999999999975
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=286.77 Aligned_cols=248 Identities=23% Similarity=0.351 Sum_probs=195.0
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeec--ccchhHHHHHHHHHHHhccC-cCchhhhhhhhccCCceeEEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 587 (796)
..+.+.++||+||.+.||++...+. ..+|+|++.. ...+...-|++|+..|.+++ |.+|+++++|-..++..|+||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3456678999999999999987544 5677776532 34445677999999999995 999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||=+ .+|..+|.+.......| .++.+..|++.|+.+.|++ +|||.||||.|+|+-. |.+||+|||+|.-+..+.
T Consensus 440 E~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred eccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 9754 58999998764444445 8889999999999999998 9999999999998865 689999999999888776
Q ss_pred cceee-eeccCCCCCchhhhccC-----------CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh
Q 003772 668 TRTFT-LVRGTRGYMAPEWYKNT-----------PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI 735 (796)
Q Consensus 668 ~~~~~-~~~gt~~y~aPE~~~~~-----------~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
..-.. ...||+.||+||.+... +++.++||||+|||||+|+.|+.||..-.. .|
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--------~~------ 579 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--------QI------ 579 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--------HH------
Confidence 65443 35699999999998432 467899999999999999999999963210 11
Q ss_pred hhhhhhhhcCC---CC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 736 DRELNKLVRGQ---EV-DRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 736 ~~~~~~~~~~~---~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
..+..+.++. ++ ......+++++++.||+.||.+|||..+|++.
T Consensus 580 -aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 -AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1122223321 11 11122339999999999999999999999863
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=297.86 Aligned_cols=200 Identities=32% Similarity=0.480 Sum_probs=174.7
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCC------ceeEEEe
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS------KRLLVYE 588 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lV~e 588 (796)
.+.||+|+||.||+|+.+..++.||||.+.+... ...+....|++++++++|+|||+++++-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 4789999999999999999999999999977443 33456789999999999999999999876544 5689999
Q ss_pred ecCCCChhhhhhcC-CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec--C--CCceEEeccCCcccc
Q 003772 589 YMSNGSLADILFRG-PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD--E--FWTAKISDFGLAKLL 663 (796)
Q Consensus 589 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~--~~~~kl~DFgl~~~~ 663 (796)
||.+|||+..|.+. +...|++...+.+..+++.||.|||++ +|+||||||.||++- . ....||+|||.|+-+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999764 346799999999999999999999998 999999999999994 2 335799999999987
Q ss_pred CCCCcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCC
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSK 720 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~ 720 (796)
..+. ......||..|.+||.++. ..++..+|.|||||++||.+||..||......
T Consensus 175 ~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 175 DDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 6544 6667889999999999994 88999999999999999999999999865443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=279.71 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=195.7
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc-----cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM-----VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
+.+.++||+|+||.||+++....+..+++|.++.. .......+..|+.++.+++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 45678999999999999998766555666666432 1223345778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhc--CCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 588 EYMSNGSLADILFR--GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 588 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
||+++++|.+++.. .....+++..++.++.|+++||.|||+. +++|+||+|+||++++ +.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998864 2346799999999999999999999998 9999999999999986 5699999999987643
Q ss_pred CCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.|+..... ... ....... ..
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~------~~~~~~~------~~ 222 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--LSV------VLRIVEG------PT 222 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHH------HHHHHcC------CC
Confidence 322 11223478899999999888899999999999999999999999853221 000 0000000 01
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...+......+.+++.+||+.+|++||++.++++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1123455678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=285.84 Aligned_cols=250 Identities=24% Similarity=0.289 Sum_probs=196.7
Q ss_pred hhhcccCcccceEEEEEEEc---CCcEEEEEEEeecccc----hhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeE
Q 003772 514 RFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMVT----EGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~~----~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 585 (796)
.+.+.||+|+||.||++... ..++.||+|++..... ...+.+.+|+.++.++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 45688999999999999874 3567899999875322 2346688899999999 59999999999998889999
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
|+||+++++|.+++.. ...+++..+..++.|+++||.|||+. +++||||+|+||++++++.+||+|||++.....
T Consensus 83 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 83 ILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 9999999999999976 35688899999999999999999998 999999999999999999999999999987654
Q ss_pred CCcceeeeeccCCCCCchhhhccC--CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYKNT--PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
..........|+..|+|||.+... ..+.++||||||+++|||++|+.|+.............. . +..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~------~~~-- 226 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR---R------ILK-- 226 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH---H------hhc--
Confidence 333333344588999999998753 468899999999999999999999864322111111100 0 000
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRP-----SMKSVVL 779 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 779 (796)
.....+......+.+++..||+.+|.+|| +..+++.
T Consensus 227 ~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01122334456788999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=285.92 Aligned_cols=256 Identities=25% Similarity=0.316 Sum_probs=194.8
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhcc---CcCchhhhhhhhccCCc-----e
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRT---HHKNLVRLIGYCAEDSK-----R 583 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l---~h~niv~l~g~~~~~~~-----~ 583 (796)
++.+.||+|+||.||+|+....++.+|+|++..... .....+.+|+.++.++ +|+|++++++++.+.+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 356789999999999999987788999999964322 2234566787777665 59999999999987776 8
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
+++|||+.+ +|.+++.......+++..++.++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++...
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 999999974 899988765445699999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhh-hhh---
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFID-REL--- 739 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~--- 739 (796)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ..... ...... ...
T Consensus 158 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~ 231 (287)
T cd07838 158 SFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKI-FDVIGLPSEEEWP 231 (287)
T ss_pred cCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHH-HHHcCCCChHhcC
Confidence 43322 122346889999999999999999999999999999999988876432111 11000 000000 000
Q ss_pred ------hhhhcC------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 740 ------NKLVRG------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 740 ------~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...... ....++....+.+++.+||+.||.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000 0111234577889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=291.19 Aligned_cols=264 Identities=21% Similarity=0.274 Sum_probs=195.4
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCC------ceeE
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS------KRLL 585 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~~l 585 (796)
.+.+.||+|+||.||+|.....++.||||++.+.. ......+.+|+.++.+++|+||+++++++.... ..++
T Consensus 18 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 97 (342)
T cd07879 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL 97 (342)
T ss_pred EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEE
Confidence 34578999999999999988788899999986532 223456889999999999999999999886543 4589
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
|+||+.. +|.+++ ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 98 v~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 98 VMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred Eeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 9999874 676665 34688999999999999999999998 999999999999999999999999999976532
Q ss_pred CCcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh-----
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL----- 739 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 739 (796)
.. ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .......... ......+
T Consensus 170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~ 243 (342)
T cd07879 170 EM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVT-GVPGPEFVQKLE 243 (342)
T ss_pred CC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc-CCCCHHHHHHhc
Confidence 21 22346889999999876 46899999999999999999999999743211 1110000000 0000000
Q ss_pred ----hhhhcC-CCC--------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HhcCcCCCCCC
Q 003772 740 ----NKLVRG-QEV--------DRNTLENMIKIGLWCVQDEPALRPSMKSVVLM--LEGITDISIPP 791 (796)
Q Consensus 740 ----~~~~~~-~~~--------~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~~~~p~ 791 (796)
...... ... .+.....+.+++..||+.||.+||++++++.. ++...+.+..+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~ 310 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET 310 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC
Confidence 000000 000 01234568899999999999999999999944 77766654333
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=268.80 Aligned_cols=279 Identities=22% Similarity=0.290 Sum_probs=203.8
Q ss_pred HHhhhcccCcccceEEEEEEEcCCc----EEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhcc-CCcee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGE----KLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAE-DSKRL 584 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~----~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~ 584 (796)
.++....||+|.||.||++.-.+++ +.+|||+++.... .....-.+|+.+++.++|+||+.+..++.+ +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 3455678999999999999765443 3789999975322 223456789999999999999999999987 67889
Q ss_pred EEEeecCCCChhhhhhcC---CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC----CceEEecc
Q 003772 585 LVYEYMSNGSLADILFRG---PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF----WTAKISDF 657 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DF 657 (796)
+++||.++ +|.++++.. ..+.++...+.+|+.||+.|+.|||++ .|+||||||.|||+..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999997 788888643 236789999999999999999999999 99999999999999877 99999999
Q ss_pred CCccccCCCCcc--eeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCC-----chhHHHHHH
Q 003772 658 GLAKLLMPDQTR--TFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSK-----PEEIVLINW 729 (796)
Q Consensus 658 gl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~-----~~~~~~~~~ 729 (796)
|+++++...-.. ....++-|.-|+|||.+.+. .+|++.|||+.|||+.||++.++.|...... +-.......
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999998654322 22345578999999999876 6899999999999999999988877633211 111111110
Q ss_pred HHHhh-------------hh---hhhhhhhcCCCCC----------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 730 AYKCF-------------ID---RELNKLVRGQEVD----------RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 730 ~~~~~-------------~~---~~~~~~~~~~~~~----------~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
..... .+ ..+.+.....-.+ ..-.+..++|+..+|+.||.+|.|.++.++-. -
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~-y 339 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP-Y 339 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc-c
Confidence 00000 00 0000000000000 00112367888899999999999999988754 4
Q ss_pred CcCCCCCCCCCC
Q 003772 784 ITDISIPPCPTS 795 (796)
Q Consensus 784 ~~~~~~p~~p~~ 795 (796)
..+.+.||.|++
T Consensus 340 F~~d~lpp~pt~ 351 (438)
T KOG0666|consen 340 FTEDPLPPLPTS 351 (438)
T ss_pred cccCCCCCCccc
Confidence 566777887764
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=287.29 Aligned_cols=242 Identities=28% Similarity=0.372 Sum_probs=192.6
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
.++||+|+||.||+|+....++.|++|++..... ...+.+.+|++++++++|+|++++++++.++...++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 4679999999999999988889999999864322 233568889999999999999999999999999999999996
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++... ...+++..++.++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++...... .
T Consensus 105 ~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-----~ 175 (313)
T cd06633 105 GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-----N 175 (313)
T ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-----C
Confidence 5787777543 35689999999999999999999998 9999999999999999999999999998643221 2
Q ss_pred eeccCCCCCchhhhc---cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 673 LVRGTRGYMAPEWYK---NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
...++..|+|||++. ...++.++||||||+++|||++|+.|+......... .. ..... ......
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-------~~-~~~~~-----~~~~~~ 242 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------YH-IAQND-----SPTLQS 242 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-------HH-HHhcC-----CCCCCc
Confidence 335788999999984 456889999999999999999999998644211100 00 00000 011112
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
......+.+++.+||+.+|.+||++.+++..
T Consensus 243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2234568899999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=281.28 Aligned_cols=240 Identities=22% Similarity=0.271 Sum_probs=187.9
Q ss_pred hhhcc--cCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeec
Q 003772 514 RFKEE--LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 514 ~~~~~--LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+.+. ||+|+||.||++.....++.+|+|.+........ |+.....+ +|+||+++++.+...+..++||||+
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~ 91 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI 91 (267)
T ss_pred ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence 34444 5999999999999988888999999865322111 22222222 7999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC-ceEEeccCCccccCCCCcc
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW-TAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgl~~~~~~~~~~ 669 (796)
++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||||+||+++.++ .++|+|||++.......
T Consensus 92 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-- 164 (267)
T PHA03390 92 KDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-- 164 (267)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc--
Confidence 999999999763 4899999999999999999999998 999999999999999988 99999999987654322
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
...++..|+|||++.+..++.++||||||+++|||++|+.|+....... .....+.... . ......
T Consensus 165 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~------~---~~~~~~ 230 (267)
T PHA03390 165 ---CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ------Q---KKLPFI 230 (267)
T ss_pred ---cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh------c---ccCCcc
Confidence 2247899999999999899999999999999999999999997433221 1111111110 0 011122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPS-MKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~ 779 (796)
......+.+++..||+.+|.+||+ ++++++
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 245577899999999999999996 688874
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=283.35 Aligned_cols=258 Identities=27% Similarity=0.325 Sum_probs=198.6
Q ss_pred hhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.+.||+|++|.||+|+....++.+|+|++.... ....+.+..|+.++++++|+|++++++++.+.+..++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 4578999999999999998888999999997653 3334678899999999999999999999999999999999998
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
++|.+++.+.. ..+++..+..++.|+++||.|||+. +|+|+||+|+||++++++.++|+|||++........ ...
T Consensus 82 ~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (282)
T cd07829 82 MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYT 156 (282)
T ss_pred cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccC
Confidence 58999997642 4699999999999999999999998 999999999999999999999999999987643322 122
Q ss_pred eeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh---hhh------
Q 003772 673 LVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL---NKL------ 742 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~------ 742 (796)
...++..|+|||.+.+. .++.++||||||+++|||++|+.|+.............. ......+... ..+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ-ILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH-HhCCCcHHHHHhhccccccccc
Confidence 23357789999998776 789999999999999999999988865432111000000 0000000000 000
Q ss_pred hcC---C---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 743 VRG---Q---EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 743 ~~~---~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
... . ...+.....+.+++..||+.+|++||++++|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000 0 001122567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=289.23 Aligned_cols=263 Identities=22% Similarity=0.258 Sum_probs=194.9
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch--hHHHHHHHHHHHhccCcCchhhhhhhhccC--CceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE--GEREFRAEMHVIGRTHHKNLVRLIGYCAED--SKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 587 (796)
.+++.+.||+|+||.||+|.....++.||+|++...... ....+.+|+.++++++|+||+++++++.+. +..++|+
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 345668899999999999999888899999998643222 233567899999999999999999988654 4689999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+.+ +|.+++... ...+++..++.++.||++||.|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 88 e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 88 EYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred ecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99974 888888653 36789999999999999999999998 99999999999999999999999999998765432
Q ss_pred cceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH-------HHhhhhhhh
Q 003772 668 TRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA-------YKCFIDREL 739 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 739 (796)
. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||................ +..+.....
T Consensus 163 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 163 K-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred C-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 1 1222335788999999875 467999999999999999999999986432211100000000 000000000
Q ss_pred hhhh--cCCC-C-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 740 NKLV--RGQE-V-----DRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 740 ~~~~--~~~~-~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.... .... . .....+.+.+++..|++.||++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 0000 0 01134667889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=265.23 Aligned_cols=248 Identities=23% Similarity=0.384 Sum_probs=194.8
Q ss_pred hhcccCcccceEEEEEEEcCCcEEEEEEEeecc-cchhHHHHHHHHHHHhccC-cCchhhhhhhhccCCceeEEEeecCC
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM-VTEGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+...||.|..|.|++......+..+|||.+.+. ..+..+++...+.++.+-+ +|.||+.+|++..+....+.||.|.-
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 346799999999999999999999999998764 3445677888888877765 89999999999999999999998853
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
.++.+|.+ -.+.+++..+=++...+.+||.||.++ ++|+|||+||+|||+|+.|++||+|||++..+.... ..+
T Consensus 176 -C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Aht 249 (391)
T KOG0983|consen 176 -CAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHT 249 (391)
T ss_pred -HHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccc--ccc
Confidence 24444433 356788888889999999999999987 799999999999999999999999999998775433 233
Q ss_pred eeccCCCCCchhhhcc---CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 673 LVRGTRGYMAPEWYKN---TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
...|-+.|||||.+.- ..|..++||||||+.|+||.||+.|+.....+-+... ++.+.+- ..+. ..
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt-------kvln~eP-P~L~---~~ 318 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT-------KVLNEEP-PLLP---GH 318 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH-------HHHhcCC-CCCC---cc
Confidence 3458899999999864 4789999999999999999999999986543321111 1111000 1111 11
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......+.+++..||+.|+.+||...++++
T Consensus 319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 224577899999999999999999988874
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=293.35 Aligned_cols=258 Identities=21% Similarity=0.236 Sum_probs=194.8
Q ss_pred hhcccCcccceEEEEEEEcCCcEEEEEEEeecccchh--------------HHHHHHHHHHHhccCcCchhhhhhhhccC
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG--------------EREFRAEMHVIGRTHHKNLVRLIGYCAED 580 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~--------------~~~f~~E~~~l~~l~h~niv~l~g~~~~~ 580 (796)
+.+.||+|+||.||++.....++.||||++....... ...+.+|++++.+++|+||+++++++..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 4567999999999999998888899999986532211 12577899999999999999999999999
Q ss_pred CceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCc
Q 003772 581 SKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA 660 (796)
Q Consensus 581 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~ 660 (796)
+..++||||+. |+|.+++.. ...+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccce
Confidence 99999999997 689998865 45689999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCC-------------cceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHH
Q 003772 661 KLLMPDQ-------------TRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVL 726 (796)
Q Consensus 661 ~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~ 726 (796)
....... ........++..|+|||.+.+. .++.++|||||||++|||++|+.|+...........+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i 246 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 8664110 1111223367889999998764 4789999999999999999999998754321111000
Q ss_pred HHHHHHhhhhhhhhhh--------hcCC------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 727 INWAYKCFIDRELNKL--------VRGQ------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 727 ~~~~~~~~~~~~~~~~--------~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
... ............ .... .........+.+++..||+.+|++|||++|++.
T Consensus 247 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 247 FEL-LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHH-hCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 000 000000000000 0000 001123467889999999999999999999986
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=287.80 Aligned_cols=262 Identities=24% Similarity=0.273 Sum_probs=192.8
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch--hHHHHHHHHHHHhccCcCchhhhhhhhccCC--------
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE--GEREFRAEMHVIGRTHHKNLVRLIGYCAEDS-------- 581 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-------- 581 (796)
.+.+.++||+|+||.||+|.....++.+|||++...... ....+.+|++++++++|+||+++++++.+..
T Consensus 9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 455678899999999999999888889999998653322 2346788999999999999999999875433
Q ss_pred ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcc
Q 003772 582 KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~ 661 (796)
..++|+||+.. +|...+... ...+++..+..++.|+++||.|||+. +|+|+||||+||++++++.++|+|||+++
T Consensus 89 ~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 89 SVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred eEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccch
Confidence 45899999875 677766542 45799999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcc----------eeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH
Q 003772 662 LLMPDQTR----------TFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA 730 (796)
Q Consensus 662 ~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 730 (796)
........ ..+...+++.|+|||.+.+. .++.++||||||+++|||++|+.||........ .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~~~~~ 242 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHLIFKL 242 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH
Confidence 65432211 11223467889999988654 589999999999999999999999864322111 1100000
Q ss_pred HHhhhhhh------hhhhh----cCCC-C-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 731 YKCFIDRE------LNKLV----RGQE-V-----DRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 731 ~~~~~~~~------~~~~~----~~~~-~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.....+.. +.... .... . .....+.+.+++.+|++.+|.+|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000 00000 0000 0 0122357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=274.85 Aligned_cols=237 Identities=27% Similarity=0.328 Sum_probs=195.0
Q ss_pred cCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 519 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
||+|+||.||++.....++.+|+|.+.+... .....+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999987788999999876432 2455789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeec
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR 675 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~ 675 (796)
.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 9999763 4689999999999999999999998 99999999999999999999999999998764432 1222345
Q ss_pred cCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 003772 676 GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLEN 755 (796)
Q Consensus 676 gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (796)
++..|+|||...+...+.++|+||||+++|||++|+.|+..... ... ...... .....+......
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~-----~~~~~~-------~~~~~~~~~~~~ 219 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEI-----YEKILK-------DPLRFPEFLSPE 219 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH-----HHHHhc-------CCCCCCCCCCHH
Confidence 78899999999988899999999999999999999999864431 100 000000 111122333567
Q ss_pred HHHHHHHhccCCCCCCCCHHH
Q 003772 756 MIKIGLWCVQDEPALRPSMKS 776 (796)
Q Consensus 756 l~~l~~~cl~~dP~~RPt~~e 776 (796)
+.+++..||+.||++||++.+
T Consensus 220 l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 220 ARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHhcCCHhhCCCccc
Confidence 889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=291.33 Aligned_cols=261 Identities=20% Similarity=0.272 Sum_probs=194.2
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccC-----------
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAED----------- 580 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~----------- 580 (796)
++.+.+.||.|+||.||+|.....++.||+|++........+.+.+|++++++++|+||+++++++...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 455668899999999999999888899999998766556667889999999999999999999877654
Q ss_pred ---CceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec-CCCceEEec
Q 003772 581 ---SKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISD 656 (796)
Q Consensus 581 ---~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~D 656 (796)
...++|+||++ ++|.+++.. ..+++..++.++.||++||.|||+. +|+||||||+||+++ ++..+||+|
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECC
Confidence 34689999997 589888853 4688999999999999999999998 999999999999998 456789999
Q ss_pred cCCccccCCCCcce--eeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHH-H---
Q 003772 657 FGLAKLLMPDQTRT--FTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLIN-W--- 729 (796)
Q Consensus 657 Fgl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~-~--- 729 (796)
||+++.+....... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||.............. .
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99998664322111 122346889999998754 4678999999999999999999999964422111000000 0
Q ss_pred ---HHHhhhh---hhhhhhhcCCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 730 ---AYKCFID---RELNKLVRGQE-----VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 730 ---~~~~~~~---~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....... ........... ..+.....+.+++..||+.||.+|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000 00000000000 01123467889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=307.92 Aligned_cols=246 Identities=28% Similarity=0.404 Sum_probs=186.3
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecc-cchhHHHHHHHHHHHhccCcCchhhhhhhhcc----------------
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKM-VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE---------------- 579 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~---------------- 579 (796)
+.||+||||.|||++.+-+++.+|||++.-. .......+.+|+++|++|+|||||+++..+.+
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 5799999999999999999999999998653 33445678899999999999999998654420
Q ss_pred -------------------------------------------------C------------------------------
Q 003772 580 -------------------------------------------------D------------------------------ 580 (796)
Q Consensus 580 -------------------------------------------------~------------------------------ 580 (796)
+
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence 0
Q ss_pred ------------------------CceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeee
Q 003772 581 ------------------------SKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIH 636 (796)
Q Consensus 581 ------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH 636 (796)
.-.||=||||+.-+|.+++.++.-.. .....++++.+|++||+|+|++ +|||
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~---giIH 720 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQ---GIIH 720 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhC---ceee
Confidence 01266788998888888876531111 4678899999999999999999 9999
Q ss_pred eccCccceEecCCCceEEeccCCccccC----------------C-CCcceeeeeccCCCCCchhhhccC---CCCcccc
Q 003772 637 CDIKPQNILMDEFWTAKISDFGLAKLLM----------------P-DQTRTFTLVRGTRGYMAPEWYKNT---PISVKAD 696 (796)
Q Consensus 637 ~Dlkp~NIll~~~~~~kl~DFgl~~~~~----------------~-~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksD 696 (796)
|||||.||+||++..+||+|||++.... . ......+...||.-|+|||++.+. +++.|+|
T Consensus 721 RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiD 800 (1351)
T KOG1035|consen 721 RDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKID 800 (1351)
T ss_pred ccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhh
Confidence 9999999999999999999999999731 0 011133456799999999999776 4999999
Q ss_pred chhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 003772 697 VFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKS 776 (796)
Q Consensus 697 V~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 776 (796)
+||+||||+||+. ||....+. +. ....+..+.+... ..+..+..+.-.+++.|+++.||++|||+.|
T Consensus 801 mYSLGIVlFEM~y---PF~TsMER---a~----iL~~LR~g~iP~~---~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 801 MYSLGIVLFEMLY---PFGTSMER---AS----ILTNLRKGSIPEP---ADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred hHHHHHHHHHHhc---cCCchHHH---HH----HHHhcccCCCCCC---cccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 9999999999983 55543321 11 1222222222211 1223445566789999999999999999999
Q ss_pred HHH
Q 003772 777 VVL 779 (796)
Q Consensus 777 vl~ 779 (796)
++.
T Consensus 868 LL~ 870 (1351)
T KOG1035|consen 868 LLN 870 (1351)
T ss_pred Hhh
Confidence 975
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=288.27 Aligned_cols=264 Identities=22% Similarity=0.270 Sum_probs=196.7
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCC------cee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS------KRL 584 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~~ 584 (796)
+.+.+.||+|+||.||++.....++.||||++.... ....+.+.+|+.++++++|+||+++++++.... ..+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence 445678999999999999988888999999986432 223456889999999999999999999887543 358
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+||||+ +++|.+++.. ..+++..++.++.|+++||.|||+. +|+||||||+||++++++.++|+|||++....
T Consensus 97 lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 97 LVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 999998 6789888753 4689999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH-------HHhhhh
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA-------YKCFID 736 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~ 736 (796)
... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||................ ......
T Consensus 170 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 170 SEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred cCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 321 22346889999999876 458899999999999999999999987443211100000000 000000
Q ss_pred hhhhhhhc----CC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH--HHHhcCcCC
Q 003772 737 RELNKLVR----GQ-----EVDRNTLENMIKIGLWCVQDEPALRPSMKSVV--LMLEGITDI 787 (796)
Q Consensus 737 ~~~~~~~~----~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl--~~L~~~~~~ 787 (796)
........ .. .........+.+++.+|++.||++|||+.+++ ..++...+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 00000000 00 01123345688999999999999999999998 455554443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-33 Score=317.02 Aligned_cols=245 Identities=28% Similarity=0.374 Sum_probs=199.9
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeec--ccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGS 594 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 594 (796)
..||.|.||.||.+...+.++..|+|-+.- ......+.+.+|+.++..++|||+|+++|+-.+.+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 579999999999999999999999997643 224455678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc---cee
Q 003772 595 LADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT---RTF 671 (796)
Q Consensus 595 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~---~~~ 671 (796)
|.+.+.. +...++....-+-.|++.|+.|||++ +||||||||.||+|+.+|.+|++|||.|..+..+.. ...
T Consensus 1321 La~ll~~--gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1321 LASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred HHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 9999976 45677777788899999999999999 999999999999999999999999999998866531 122
Q ss_pred eeeccCCCCCchhhhccC---CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh-hhhhhhhhhcCCC
Q 003772 672 TLVRGTRGYMAPEWYKNT---PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF-IDRELNKLVRGQE 747 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 747 (796)
....||+-|||||++.+. ...-+.||||+|||+.||+||++|+...+. +|+.... -.+.. ..
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--------e~aIMy~V~~gh~------Pq 1461 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--------EWAIMYHVAAGHK------PQ 1461 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--------hhHHHhHHhccCC------CC
Confidence 345699999999999764 346679999999999999999999975432 1221111 11111 12
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.+.....+-.+++..||+.||.+|-++.|+++.
T Consensus 1462 ~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 333456677889999999999999988887764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=286.25 Aligned_cols=256 Identities=23% Similarity=0.277 Sum_probs=194.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCc------ee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSK------RL 584 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~------~~ 584 (796)
+.+.+.||+|++|.||+|....+++.||||++... .....+.+.+|+.++++++|+||+++++++...+. .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 44568899999999999999888889999998653 22334567889999999999999999998876554 89
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+|+||||+||++++++.++|+|||++....
T Consensus 97 lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 97 LVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred EEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 999998 5699998864 4689999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH-------HHHhhhh
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW-------AYKCFID 736 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~ 736 (796)
.. .....++..|+|||.+.+. ..+.++||||||+++|||++|+.||...........+... .......
T Consensus 170 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 170 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred cc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 32 2233478899999998653 6789999999999999999999998643221100000000 0000000
Q ss_pred hhhhhhhc----CCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 737 RELNKLVR----GQE-----VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 737 ~~~~~~~~----~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......+. ... ........+.+++.+||+.+|.+|||+.+|++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000 000 00123567899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=283.58 Aligned_cols=260 Identities=22% Similarity=0.246 Sum_probs=191.4
Q ss_pred HhhhcccCcccceEEEEEEEcCC--cEEEEEEEeeccc--chhHHHHHHHHHHHhcc-CcCchhhhhhhhccC----Cce
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKG--EKLVAVKKLEKMV--TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAED----SKR 583 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~--~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~----~~~ 583 (796)
+.+.+.||+|+||.||++..... +..||||++.... ....+.+.+|+.+++++ +|+||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 34568899999999999998876 7889999986532 22346688899999999 599999999875432 346
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
++++||+. ++|.+.+.. ...+++..++.++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 82 ~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 82 YLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 78888876 689988865 46789999999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCcc---eeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH--------H
Q 003772 664 MPDQTR---TFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA--------Y 731 (796)
Q Consensus 664 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~--------~ 731 (796)
...... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ........ .
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 432211 1123458899999998765 468999999999999999999999986533110 00000000 0
Q ss_pred Hhhhhhhhh----hhhcCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 732 KCFIDRELN----KLVRGQ-----EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 732 ~~~~~~~~~----~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......... ...... ...+.....+.+++.+|++.||.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 000000 001123467899999999999999999999873
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=287.45 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=203.6
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchh--HHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG--EREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~--~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
..+.+.+.||+|.|+.|.++++...+..||||.+++..... .+.+.+|++++..++|||||+++.+.......|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 44567789999999999999999999999999998744332 2448899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+.+|.+.++|.+ ..++.......++.|+.+|++|||++ .|+|||||++||||+.+.++||+|||++..+....
T Consensus 136 ya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~- 209 (596)
T KOG0586|consen 136 YASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL- 209 (596)
T ss_pred eccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccc-
Confidence 9999999999987 45666688899999999999999999 99999999999999999999999999999876332
Q ss_pred ceeeeeccCCCCCchhhhccCCC-CccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
.....+|++.|.|||++.+..+ .+++|+||+|++||-|+.|..||+......- .+..+.. .-.
T Consensus 210 -~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L------------r~rvl~g---k~r 273 (596)
T KOG0586|consen 210 -MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL------------RPRVLRG---KYR 273 (596)
T ss_pred -cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc------------cchheee---eec
Confidence 3334569999999999998876 7899999999999999999999985432110 0000000 001
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
++.-...++-++++.+|-.+|.+|+++.++..
T Consensus 274 Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 274 IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 22223355778889999999999999999863
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=286.88 Aligned_cols=257 Identities=22% Similarity=0.280 Sum_probs=193.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhcc-CCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAE-DSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~ 589 (796)
+.+.+.||.|+||.||++.....++.||||++.+.. ....+.+..|+.++.+++||||+++++++.. ....++|+||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 445688999999999999998888999999886422 2345678899999999999999999998865 5678999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+ +++|.+++.. ..+++.....++.|+++||.|||+. +|+|+||+|+||++++++.++|+|||++.......
T Consensus 92 ~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-- 162 (328)
T cd07856 92 L-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-- 162 (328)
T ss_pred h-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCCc--
Confidence 8 4689888854 4578888899999999999999998 99999999999999999999999999997543221
Q ss_pred eeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH-------HHhhhhhhhhh
Q 003772 670 TFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA-------YKCFIDRELNK 741 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 741 (796)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ..........+
T Consensus 163 --~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 163 --TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred --CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 22346889999998866 568999999999999999999999986432111100000000 00000000000
Q ss_pred h---h-cCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 742 L---V-RGQEVD-----RNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 742 ~---~-~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
. . .....+ +.....+.+++..||+.+|++|||+.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0 000011 1234789999999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=268.55 Aligned_cols=253 Identities=24% Similarity=0.329 Sum_probs=201.1
Q ss_pred hhhcccCcccceEEEEEEEcCCc-----EEEEEEEeecc-cchhHHHHHHHHHHHhccCcCchhhhhhhhccC-CceeEE
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGE-----KLVAVKKLEKM-VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAED-SKRLLV 586 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~-----~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV 586 (796)
+.+..+-+|.||.||.|.+.+.+ +.|-+|.++.. +.-....+..|..++..+.|||+..+.+++.++ ...+++
T Consensus 287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~ 366 (563)
T KOG1024|consen 287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVL 366 (563)
T ss_pred echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEE
Confidence 34567999999999999876443 34666766543 333456788999999999999999999998764 578999
Q ss_pred EeecCCCChhhhhh-----cC-CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCc
Q 003772 587 YEYMSNGSLADILF-----RG-PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA 660 (796)
Q Consensus 587 ~e~~~~gsL~~~l~-----~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~ 660 (796)
|.++.-|+|..+|. +. ....+...+...++.|++.|++|||.. +|||.||..+|.+||+..++||+|=.++
T Consensus 367 y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 367 YPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred EeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhc
Confidence 99999999999997 21 235677888899999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcceeee-eccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhh
Q 003772 661 KLLMPDQTRTFTL-VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRE 738 (796)
Q Consensus 661 ~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
+.+.+.+.+.... ...+..||+||.+.+..++..+|||||||+||||+| |+.|+..-+ +.+. ...+.++.
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID--PfEm------~~ylkdGy 515 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID--PFEM------EHYLKDGY 515 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC--HHHH------HHHHhccc
Confidence 9988877655433 234678999999999999999999999999999998 555553221 1111 11111110
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 739 LNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
- -..+.+++++++.++.-||...|++||++++++.-|.+
T Consensus 516 R------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 516 R------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred e------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 0 01356889999999999999999999999999998865
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=259.77 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=202.7
Q ss_pred CHHHHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-cCchhhhhhhhccCCc
Q 003772 504 SYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSK 582 (796)
Q Consensus 504 ~~~~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~ 582 (796)
++.++-+-| .+.||+|+|+.|-..+....+.++|||++++.......++.+|++++.+.+ |+||+.++.+++++..
T Consensus 74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 355554444 367999999999999888888999999999987777888999999999985 9999999999999999
Q ss_pred eeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC---ceEEeccCC
Q 003772 583 RLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW---TAKISDFGL 659 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFgl 659 (796)
.|||||.|.+|+|..+|.+ .+.+++..+.++..+|+.||.|||.+ +|.|||+||+|||-.+-. -+||+||.+
T Consensus 151 FYLVfEKm~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEEecccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccc
Confidence 9999999999999999987 57899999999999999999999999 999999999999997543 489999988
Q ss_pred ccccCCCC------cceeeeeccCCCCCchhhhcc-----CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHH--H
Q 003772 660 AKLLMPDQ------TRTFTLVRGTRGYMAPEWYKN-----TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIV--L 726 (796)
Q Consensus 660 ~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~--~ 726 (796)
..-..-.. +......+|+..|||||+..- ..|+.++|.||||||||-|++|-.||...-...-... -
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 76543211 122223457788999998742 2678999999999999999999999974322110000 0
Q ss_pred HHHHHHhhhhhhhhhhhcCC-CCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 727 INWAYKCFIDRELNKLVRGQ-EVDR----NTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.-..-+. .....+.++. +++. ....+..+++...+..++.+|-++.++++
T Consensus 306 ~Cr~CQ~---~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 306 VCRVCQN---KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccHHHHH---HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0000011 1111222221 2222 33456677777888899999999999886
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=284.67 Aligned_cols=256 Identities=21% Similarity=0.257 Sum_probs=190.4
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccC------CceeE
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAED------SKRLL 585 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 585 (796)
.+.+.||+|+||.||++.....++.||+|++.+.. ....+.+.+|+.++.+++|+||+++++++... ...++
T Consensus 20 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 99 (345)
T cd07877 20 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 99 (345)
T ss_pred EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEE
Confidence 34578999999999999988888899999997532 22345688899999999999999999987543 34677
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
+++++ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 100 v~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 100 VTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred Eehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 77776 7899888754 4689999999999999999999998 999999999999999999999999999876532
Q ss_pred CCcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH-------HHHhhhhh
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW-------AYKCFIDR 737 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~ 737 (796)
. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............... ........
T Consensus 173 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T cd07877 173 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248 (345)
T ss_pred c----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence 2 123357889999999876 46889999999999999999999998643221100000000 00000000
Q ss_pred hhhhh---hcCC-C--C---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 738 ELNKL---VRGQ-E--V---DRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 738 ~~~~~---~~~~-~--~---~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
..... +... . . .......+.+++..|++.+|.+||++.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 0000 0 0 00124568899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=297.99 Aligned_cols=267 Identities=22% Similarity=0.279 Sum_probs=215.9
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc---cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
...+.+.+.||+|+||.|...+++..++.+|.|++.+. .......|+.|-.+|..-+.+=|+.++-.|.++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 45567789999999999999999999999999999872 233456789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
||||+||+|-.+|.+. .++++..+..++..|+-||.-||+. |+|||||||+|||||..|.+||+|||.+-.+..+
T Consensus 154 MdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999999774 3899999999999999999999998 9999999999999999999999999999999877
Q ss_pred CcceeeeeccCCCCCchhhhcc-----CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhh-hhh
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKN-----TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDR-ELN 740 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 740 (796)
..-.....+|||.|++||++.. +.|.+.+|.||+||++|||+.|..||..+.. .-.+.++... ...
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl--------veTY~KIm~hk~~l 300 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL--------VETYGKIMNHKESL 300 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH--------HHHHHHHhchhhhc
Confidence 7766666779999999999953 4789999999999999999999999975431 1122222221 111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH--H-----hcCcCCCCCCCCC
Q 003772 741 KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPS---MKSVVLM--L-----EGITDISIPPCPT 794 (796)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~~--L-----~~~~~~~~p~~p~ 794 (796)
.+.+ ..+..+...+||+..+. +|+.|-. ++++... + ++|.+..+|-.|.
T Consensus 301 ~FP~----~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPe 359 (1317)
T KOG0612|consen 301 SFPD----ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPE 359 (1317)
T ss_pred CCCc----ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCc
Confidence 1111 12355677788887775 7888887 7777532 1 4455555565553
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=270.31 Aligned_cols=221 Identities=20% Similarity=0.173 Sum_probs=179.4
Q ss_pred ccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCChhhhhhc
Q 003772 522 GSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFR 601 (796)
Q Consensus 522 G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 601 (796)
|.+|.||++....+++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999999999999999986532 234455555566799999999999999999999999999999999876
Q ss_pred CCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeeccCCCCC
Q 003772 602 GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYM 681 (796)
Q Consensus 602 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~ 681 (796)
...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.++++|||.+..+.... ....++..|+
T Consensus 79 --~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~ 149 (237)
T cd05576 79 --FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYC 149 (237)
T ss_pred --hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcccc
Confidence 34689999999999999999999998 99999999999999999999999999876554321 2233567899
Q ss_pred chhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHH
Q 003772 682 APEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGL 761 (796)
Q Consensus 682 aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 761 (796)
|||.+....++.++||||+|+++|||++|+.|+...+..... . .....+......+.+++.
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~------------------~-~~~~~~~~~~~~~~~li~ 210 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT------------------H-TTLNIPEWVSEEARSLLQ 210 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc------------------c-cccCCcccCCHHHHHHHH
Confidence 999998888999999999999999999999876533211000 0 000112234467889999
Q ss_pred HhccCCCCCCCCHH
Q 003772 762 WCVQDEPALRPSMK 775 (796)
Q Consensus 762 ~cl~~dP~~RPt~~ 775 (796)
+|++.||++||++.
T Consensus 211 ~~l~~dp~~R~~~~ 224 (237)
T cd05576 211 QLLQFNPTERLGAG 224 (237)
T ss_pred HHccCCHHHhcCCC
Confidence 99999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=261.99 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=200.5
Q ss_pred CCcccCHHHHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhcc-CcCchhhhhhh
Q 003772 499 NLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRT-HHKNLVRLIGY 576 (796)
Q Consensus 499 ~~~~~~~~~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~ 576 (796)
.+..|+-.+|+.. ..||.|+||+|+|-.++..++.+|||++..... ..+++++.|.+...+- +.||||+++|.
T Consensus 57 ~~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 57 HLHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 3455555555432 579999999999999999999999999976444 5567788888876665 69999999999
Q ss_pred hccCCceeEEEeecCCCChhhhh---hcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceE
Q 003772 577 CAEDSKRLLVYEYMSNGSLADIL---FRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAK 653 (796)
Q Consensus 577 ~~~~~~~~lV~e~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 653 (796)
+..++..++.||.|.- ||+.+- +.-.+..+++.-+-.|....+.||.||... ..|||||+||+|||++..|.+|
T Consensus 132 ~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 132 LFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEe
Confidence 9999999999999863 554443 333456788888889999999999999986 6999999999999999999999
Q ss_pred EeccCCccccCCCCcceeeeeccCCCCCchhhhccC--CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHH
Q 003772 654 ISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT--PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAY 731 (796)
Q Consensus 654 l~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 731 (796)
|+|||++..+... ...+...|-..|||||.+... .+..+|||||||++|||+.||+-|+......
T Consensus 209 LCDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv----------- 275 (361)
T KOG1006|consen 209 LCDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV----------- 275 (361)
T ss_pred eecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----------
Confidence 9999999876432 223334578899999999654 4899999999999999999999998644321
Q ss_pred HhhhhhhhhhhhcCCC-------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 732 KCFIDRELNKLVRGQE-------VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 732 ~~~~~~~~~~~~~~~~-------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
-+++...+.++. ...+....|..++..|+.+|.++||...++..
T Consensus 276 ----feql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 276 ----FEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ----HHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111222222221 12345677999999999999999999998864
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=261.10 Aligned_cols=239 Identities=27% Similarity=0.319 Sum_probs=198.3
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch---hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE---GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
..|.++||+|.||.|-+.+.+..++.+|||++++..-- ....-..|-.+|+..+||.+..+.-.+...++.|+||||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 35678999999999999999999999999999874332 233456788999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
..+|.|.-+|.+ ...+++.....+-..|+.||.|||+. +||.||||.+|.|+|.+|.+||+|||+++.--. ...
T Consensus 250 anGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~g~ 323 (516)
T KOG0690|consen 250 ANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-YGD 323 (516)
T ss_pred ccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc-ccc
Confidence 999999999976 57788888899999999999999998 999999999999999999999999999985432 234
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.+...+|||.|+|||++....+....|.|.+||++|||++||.||...... ..+ ..+ +...-.++
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLF-----eLI-------l~ed~kFP 388 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLF-----ELI-------LMEDLKFP 388 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHH-----HHH-------HhhhccCC
Confidence 455678999999999999999999999999999999999999999754322 111 000 01111234
Q ss_pred HHHHHHHHHHHHHhccCCCCCCC
Q 003772 750 RNTLENMIKIGLWCVQDEPALRP 772 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RP 772 (796)
....++...|+.-.|..||.+|.
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhc
Confidence 45556677788889999999995
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=279.10 Aligned_cols=244 Identities=25% Similarity=0.387 Sum_probs=198.2
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeec--ccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
.+.||+|-||+||-|++...++.||||++++ .....+..+++|+.+|++++||.||.+--.|+..+..++|||.+.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 3689999999999999999999999999986 4456678899999999999999999999999999999999999865
Q ss_pred ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC---CCceEEeccCCccccCCCCcce
Q 003772 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE---FWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 594 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
+..+.+.....++|++.....++.||+.||.|||.+ +|+|+||||+|||+.+ -..+||+|||.+++.....-
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 555555455578899999999999999999999999 9999999999999964 35799999999998864332
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
...+.||+.|+|||++.++.|...-|+||.|||+|--++|.-||..+.+..+.+..+.+.++ . ..=.
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyP---p----------~PW~ 789 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYP---P----------NPWS 789 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccC---C----------Cchh
Confidence 23456999999999999999999999999999999999999999765433222222111111 1 1112
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVV 778 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl 778 (796)
+.....++++...||..=.+|-|...-+
T Consensus 790 eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 790 EISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred hcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 3345677888888888888888876543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=304.09 Aligned_cols=144 Identities=30% Similarity=0.420 Sum_probs=129.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.++||+|+||.||+|.+...++.||||++.... ......+..|+.++..++|+||+++++.+......++||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 456688999999999999998888899999986532 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~ 661 (796)
+.+++|.+++.. .+.+++..++.++.||+.||.|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999965 35688899999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=284.79 Aligned_cols=239 Identities=24% Similarity=0.325 Sum_probs=195.4
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
..+.+...+|.|.|+.|-.+.....++..++|++.+.. .+-.+|+.++.+. +|+||+++.+.+.++.+.++|||.
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 34556678999999999999999999999999997642 2234566555555 699999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe-cCCCceEEeccCCccccCCCCc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM-DEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
+.++-|.+.+... .... ..+..|+.+|+.|+.|||++ +||||||||+|||+ ++.++++|+|||.++...+.
T Consensus 398 l~g~ell~ri~~~--~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSK--PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred ccccHHHHHHHhc--chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999887777552 2222 67778999999999999998 99999999999999 58999999999999987655
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
....+-|..|.|||++....+++++|+||||++||+|++|+.|+...+.. . ++...+....+
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~-------------ei~~~i~~~~~ 531 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---I-------------EIHTRIQMPKF 531 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---H-------------HHHHhhcCCcc
Confidence 22224588999999999999999999999999999999999999877644 1 11222222223
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.....+...+|+.+||+.||.+||+|.++..
T Consensus 532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 3455677899999999999999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=262.54 Aligned_cols=239 Identities=30% Similarity=0.390 Sum_probs=194.8
Q ss_pred cceEEEEEEEcCCcEEEEEEEeecccchh-HHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCChhhhhhc
Q 003772 523 SFGAVYKGTLYKGEKLVAVKKLEKMVTEG-EREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFR 601 (796)
Q Consensus 523 ~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 601 (796)
+||.||+|+....++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999998878899999997654444 67899999999999999999999999999999999999999999999876
Q ss_pred CCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeeccCCCCC
Q 003772 602 GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYM 681 (796)
Q Consensus 602 ~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~ 681 (796)
. ..+++..++.++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus 81 ~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 R--GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred c--cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 3 2388999999999999999999998 99999999999999999999999999998765432 223344788999
Q ss_pred chhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHH
Q 003772 682 APEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGL 761 (796)
Q Consensus 682 aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 761 (796)
+||.+....++.++|||+||++++||++|+.|+....... ... ....... .............+.+++.
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~-----~~~~~~~----~~~~~~~~~~~~~~~~~i~ 222 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELF-----KKIGKPK----PPFPPPEWKISPEAKDLIR 222 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHH-----HHHhccC----CCCccccccCCHHHHHHHH
Confidence 9999998889999999999999999999999986532111 000 0000000 0000000014577999999
Q ss_pred HhccCCCCCCCCHHHHHH
Q 003772 762 WCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 762 ~cl~~dP~~RPt~~evl~ 779 (796)
+|+..+|++||++.++++
T Consensus 223 ~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 223 KLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHccCCchhccCHHHHhh
Confidence 999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=265.75 Aligned_cols=244 Identities=25% Similarity=0.332 Sum_probs=198.1
Q ss_pred HHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch---hHHHHHHHHHHHhcc-CcCchhhhhhhhccCCc
Q 003772 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE---GEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSK 582 (796)
Q Consensus 507 ~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~---~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~ 582 (796)
-++....+|..+||+|.||.|.++..+...+.+|||++++..-- +.+--+.|-++|... +-|.++.++.++..-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 34445578899999999999999999988899999999874322 223345677777766 57899999999999999
Q ss_pred eeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 583 RLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
+|+||||+.+|+|--++.+ -+.+.+..+..+|.+||-||-+||++ +|+.||||.+||+||.+|.+||+|||+++.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccc
Confidence 9999999999999999976 46788889999999999999999999 999999999999999999999999999985
Q ss_pred cCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 663 LMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 663 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
-.-+ .......+||+.|+|||++...+|...+|.|||||+||||+.|+.||+..+..+ .+ ..+
T Consensus 500 ni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---lF-------------~aI 562 (683)
T KOG0696|consen 500 NIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LF-------------QAI 562 (683)
T ss_pred cccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---HH-------------HHH
Confidence 3222 233445679999999999999999999999999999999999999998654221 11 111
Q ss_pred hcCC-CCCHHHHHHHHHHHHHhccCCCCCCC
Q 003772 743 VRGQ-EVDRNTLENMIKIGLWCVQDEPALRP 772 (796)
Q Consensus 743 ~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RP 772 (796)
.+.. ..+.....+...+....+.++|.+|.
T Consensus 563 ~ehnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 563 MEHNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1111 23444556677788888999999884
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=263.71 Aligned_cols=268 Identities=19% Similarity=0.255 Sum_probs=209.5
Q ss_pred ccCHHHHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-c-C----chhhhhh
Q 003772 502 SFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-H-K----NLVRLIG 575 (796)
Q Consensus 502 ~~~~~~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-h-~----niv~l~g 575 (796)
.+...+....++.+...+|+|.||.|-+..+...+..||||+++.. ..-.+.-+-|+++|+++. + | -++.+.+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 4455566677788889999999999999998888889999998753 333445677999999993 2 2 3677888
Q ss_pred hhccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-------
Q 003772 576 YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE------- 648 (796)
Q Consensus 576 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~------- 648 (796)
++...++.|||+|.+ +-|+.++|.+++...++...+..++.|+++++++||+. .++|-||||+|||+.+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEe
Confidence 899999999999987 34899999998888999999999999999999999998 9999999999999832
Q ss_pred -------------CCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCC
Q 003772 649 -------------FWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNME 715 (796)
Q Consensus 649 -------------~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~ 715 (796)
+..+||+|||.|..-.... ..++.|..|.|||++.+-.++.++||||+||||.|+.+|...|.
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 3358999999998654333 34567999999999999999999999999999999999999998
Q ss_pred CCCCCchhHHHHHHHHHhhhhhhhhhh-------------------------hcC-------CCCCHHHHHHHHHHHHHh
Q 003772 716 IDPSKPEEIVLINWAYKCFIDRELNKL-------------------------VRG-------QEVDRNTLENMIKIGLWC 763 (796)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~-------~~~~~~~~~~l~~l~~~c 763 (796)
...+.+.- ..++.....+....+... .+. ......+..++.+|+..|
T Consensus 311 tHen~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 311 THENLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred cCCcHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 76533322 122221111111111111 000 012456778899999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 003772 764 VQDEPALRPSMKSVVL 779 (796)
Q Consensus 764 l~~dP~~RPt~~evl~ 779 (796)
|..||.+|+|+.|+++
T Consensus 390 L~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 390 LEFDPARRITLREALS 405 (415)
T ss_pred HccCccccccHHHHhc
Confidence 9999999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=286.08 Aligned_cols=257 Identities=21% Similarity=0.201 Sum_probs=168.2
Q ss_pred HHhhhcccCcccceEEEEEEEcCC----cEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhh------hccCC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKG----EKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGY------CAEDS 581 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~----~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~------~~~~~ 581 (796)
.+.+.+.||+|+||.||+|++..+ +..||||++..... .+.+..| .+....+.++..++.. +.++.
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 345668999999999999999887 78999999864221 1111111 1222223333333332 23456
Q ss_pred ceeEEEeecCCCChhhhhhcCCC------------------CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccc
Q 003772 582 KRLLVYEYMSNGSLADILFRGPE------------------RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQN 643 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~~~------------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~N 643 (796)
..++|+||+.+++|.+++..... .......+..++.||+.||.|||+. +|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence 78999999999999999865321 0112234567999999999999998 99999999999
Q ss_pred eEecC-CCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccC----------------------CCCccccchhh
Q 003772 644 ILMDE-FWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT----------------------PISVKADVFSY 700 (796)
Q Consensus 644 Ill~~-~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksDV~S~ 700 (796)
||+++ ++.+||+|||+++.+............+++.|||||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 57999999999987654443333445689999999976432 23456799999
Q ss_pred HHHHHHHhhcccCCCCCCCCchhHHHHHHHHHh-hhhhhhhhhhcCCC---------CCHHHHHHHHHHHHHhccCCCCC
Q 003772 701 GVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKC-FIDRELNKLVRGQE---------VDRNTLENMIKIGLWCVQDEPAL 770 (796)
Q Consensus 701 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---------~~~~~~~~l~~l~~~cl~~dP~~ 770 (796)
||+||||+++..+.+.. ...+....... .....+........ ..........+|+..||+.||.+
T Consensus 366 GviL~el~~~~~~~~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSN-----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHHhCcCCCchH-----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 99999999866543211 01100000000 00000111111100 00011224558999999999999
Q ss_pred CCCHHHHHHH
Q 003772 771 RPSMKSVVLM 780 (796)
Q Consensus 771 RPt~~evl~~ 780 (796)
|||+.++++.
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999863
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=252.70 Aligned_cols=241 Identities=23% Similarity=0.275 Sum_probs=192.3
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhccC----CceeEEEeecC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAED----SKRLLVYEYMS 591 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~----~~~~lV~e~~~ 591 (796)
++||-|-.|.|.....+..++.+|+|++... ..-++|+++--+. .|+|||.+++++.+. ..+++|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 6899999999999999999999999998542 2245677665554 599999999998752 34678999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec---CCCceEEeccCCccccCCCCc
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD---EFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFgl~~~~~~~~~ 668 (796)
||.|...+.......+++.++-.|+.||+.|+.|||+. +|.||||||+|+|.. .+-.+||+|||+++......
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~- 218 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG- 218 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCCc-
Confidence 99999999988788899999999999999999999998 999999999999996 45679999999998754322
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC-C
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ-E 747 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 747 (796)
....-+-|+.|.|||++...+++..+|+||+||++|-|++|-+||.......-. ++.-.++..+. .
T Consensus 219 -~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais------------pgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 219 -DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKRRIRTGQYE 285 (400)
T ss_pred -cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC------------hhHHhHhhccCcc
Confidence 223345789999999999999999999999999999999999999754322111 11111111111 1
Q ss_pred CC----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 748 VD----RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 748 ~~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
++ ....+...++++.+|..+|++|-|+.+++.
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 11 133567788999999999999999999975
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=277.11 Aligned_cols=258 Identities=19% Similarity=0.232 Sum_probs=177.4
Q ss_pred HHhhhcccCcccceEEEEEEEc----------------CCcEEEEEEEeecccchhHHH--------------HHHHHHH
Q 003772 512 TNRFKEELGKGSFGAVYKGTLY----------------KGEKLVAVKKLEKMVTEGERE--------------FRAEMHV 561 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~----------------~~~~~vAvK~l~~~~~~~~~~--------------f~~E~~~ 561 (796)
.+.+.++||+|+||.||+|.+. ..++.||||++........++ +..|+.+
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 4556789999999999999752 233579999986533322223 3446777
Q ss_pred HhccCcCch-----hhhhhhhcc--------CCceeEEEeecCCCChhhhhhcCC----------------------CCC
Q 003772 562 IGRTHHKNL-----VRLIGYCAE--------DSKRLLVYEYMSNGSLADILFRGP----------------------ERS 606 (796)
Q Consensus 562 l~~l~h~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~----------------------~~~ 606 (796)
+.+++|.++ ++++++|.. .+..+|||||+++|+|.++|+... ...
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 777776654 677888753 356899999999999999986421 123
Q ss_pred CchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeeccCCCCCchhhh
Q 003772 607 LGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686 (796)
Q Consensus 607 l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~ 686 (796)
+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++..+............+++.|+|||.+
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 56778899999999999999998 999999999999999999999999999976544322222222357899999988
Q ss_pred ccCC----------------------CCccccchhhHHHHHHHhhccc-CCCCCCCCchhH-----HHHHHHHHhhhhhh
Q 003772 687 KNTP----------------------ISVKADVFSYGVVLLEIVCCRR-NMEIDPSKPEEI-----VLINWAYKCFIDRE 738 (796)
Q Consensus 687 ~~~~----------------------~t~ksDV~S~Gvil~elltg~~-p~~~~~~~~~~~-----~~~~~~~~~~~~~~ 738 (796)
.... ...+.||||+||++|||+++.. |+........+. ....| .......
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~~~~~~ 460 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RMYKGQK 460 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--HhhcccC
Confidence 5432 1234799999999999999875 543211110000 00011 0000000
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHhccCCC---CCCCCHHHHHH
Q 003772 739 LNKLVRGQEVDRNTLENMIKIGLWCVQDEP---ALRPSMKSVVL 779 (796)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPt~~evl~ 779 (796)
. + -.......+...+++..+|..+| .+|+|++|+++
T Consensus 461 ~----~-~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 Y----D-FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred C----C-cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 0 00112334678888899998766 68999999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=262.54 Aligned_cols=263 Identities=25% Similarity=0.335 Sum_probs=201.9
Q ss_pred cCHHHHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEee--cccchh-----HHHHHHHHHHHhccCcCchhhhhh
Q 003772 503 FSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLE--KMVTEG-----EREFRAEMHVIGRTHHKNLVRLIG 575 (796)
Q Consensus 503 ~~~~~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~--~~~~~~-----~~~f~~E~~~l~~l~h~niv~l~g 575 (796)
|.-+.....+|-+.+.||+|||+.||++.+...++.||+|+-. +.-.+. .+.-.+|..+-+.|+||.||++++
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 3333344455667788999999999999998888999999853 222221 234567999999999999999999
Q ss_pred hhc-cCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec---CCCc
Q 003772 576 YCA-EDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD---EFWT 651 (796)
Q Consensus 576 ~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~ 651 (796)
++. +.+..|-|+|||++.+|+-+|+. .+.+++..+..|+.||+.||.||.+. +++|||-||||.||||- ..|.
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGe 611 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGE 611 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccce
Confidence 986 45667899999999999999987 57899999999999999999999986 78999999999999995 4578
Q ss_pred eEEeccCCccccCCCCcc------eeeeeccCCCCCchhhhccC----CCCccccchhhHHHHHHHhhcccCCCCCCCCc
Q 003772 652 AKISDFGLAKLLMPDQTR------TFTLVRGTRGYMAPEWYKNT----PISVKADVFSYGVVLLEIVCCRRNMEIDPSKP 721 (796)
Q Consensus 652 ~kl~DFgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~ 721 (796)
+||.|||+++++..+... ......||..|++||.+.-. +++.|.||||.|||+|+.+.|++||..+....
T Consensus 612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ 691 (775)
T KOG1151|consen 612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ 691 (775)
T ss_pred eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence 999999999998754432 22335699999999987533 68999999999999999999999998664321
Q ss_pred hhHHHHHHHHHhhhhhhhhhhhcCCC-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 003772 722 EEIVLINWAYKCFIDRELNKLVRGQE-VDRNTLENMIKIGLWCVQDEPALRPSMKSVV 778 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 778 (796)
. +. ....+....+-.. .-+....+...++++||+.--++|....++.
T Consensus 692 d-IL---------qeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 D-IL---------QENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred H-HH---------hhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 11 0111111111111 1233446678899999999999998776664
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=226.38 Aligned_cols=258 Identities=21% Similarity=0.270 Sum_probs=195.0
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
.++||+|.||+||+|+..+..+.||+|+..-. .......-.+|+-+++.++|.|||++++..+.+...-+|+|||..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 47899999999999999999999999987542 222345678899999999999999999999999999999999974
Q ss_pred ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeee
Q 003772 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL 673 (796)
Q Consensus 594 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~ 673 (796)
+|..+... -++.++.+....++.|+++||.+.|++ ++.|||+||+|.||+.+|.+|++|||+++-+.-. ..+...
T Consensus 86 dlkkyfds-lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip-vrcysa 160 (292)
T KOG0662|consen 86 DLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-VRCYSA 160 (292)
T ss_pred HHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc-eEeeec
Confidence 66666543 357789999999999999999999998 9999999999999999999999999999876532 234445
Q ss_pred eccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh---hhhcCCC--
Q 003772 674 VRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN---KLVRGQE-- 747 (796)
Q Consensus 674 ~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-- 747 (796)
..-|.-|.+|.++.+. .+++..|+||-||++.|+....+|......-.....-+.+......++... ++.+...
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 5578999999999876 579999999999999999987766654433222222222222222222211 1212111
Q ss_pred ----------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 748 ----------VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 748 ----------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.-+.....=.++....+.-+|..|.++++.++
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11222334456666677779999999988765
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=279.35 Aligned_cols=239 Identities=28% Similarity=0.367 Sum_probs=184.8
Q ss_pred cccCcccceE-EEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeecCCCC
Q 003772 517 EELGKGSFGA-VYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYMSNGS 594 (796)
Q Consensus 517 ~~LG~G~fg~-Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gs 594 (796)
+.+|.|..|+ ||+|... +++||||++-. +......+|+..|+.- +||||||+++.-.+.+..||..|.|.. +
T Consensus 515 eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s 588 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE--GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S 588 (903)
T ss_pred HHcccCCCCcEEEEEeeC--CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence 5689999885 8999984 57999999842 3344567899999887 599999999998999999999999874 8
Q ss_pred hhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-----CCceEEeccCCccccCCCC
Q 003772 595 LADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE-----FWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 595 L~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFgl~~~~~~~~ 667 (796)
|.+++... ......-...+.+..|+++||+|||+. +||||||||+||||+. ..+++|+|||+++.+..+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 99999763 111122245578899999999999997 9999999999999975 3579999999999987665
Q ss_pred cce--eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhc-ccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 668 TRT--FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCC-RRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 668 ~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
..- .....||.+|+|||++....-+.++||||+||++|+.++| ..||.........+... ...+..+
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~--------~~~L~~L-- 735 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG--------NYTLVHL-- 735 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC--------ccceeee--
Confidence 432 3345699999999999999888899999999999999997 78887543322221110 0001111
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVV 778 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 778 (796)
....++ +..+|+..|++++|..||++.+|+
T Consensus 736 --~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 736 --EPLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred --ccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 011122 678899999999999999999996
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=241.87 Aligned_cols=259 Identities=21% Similarity=0.307 Sum_probs=191.2
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeec--ccchhHHHHHHHHHHHhccCcCchhhhhhhhccC--------CceeE
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAED--------SKRLL 585 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--------~~~~l 585 (796)
..+||+|.||.||+++..++++.||+|+.-- ....-...-.+|+++|..++|+|++.++..|... ...++
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 3679999999999999999999999887521 1111123457899999999999999999999642 34799
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
|+.+|++ +|..+|.. ...+++...+.+++.++..||.|+|.. .|+|||+||.|+||+.++.+||+|||+++.+..
T Consensus 102 Vf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred eHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 9999987 78777754 346789999999999999999999998 999999999999999999999999999987643
Q ss_pred CC---cceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH--------HHh
Q 003772 666 DQ---TRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA--------YKC 733 (796)
Q Consensus 666 ~~---~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~~ 733 (796)
.. ....+..+-|..|++||.+.+. .++++.|||.-|||+.||+++.+-+..+.... ...++... ++.
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqq-ql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ-QLHLISQLCGSITKEVWPN 255 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHH-HHHHHHHHhccCCcccCCC
Confidence 22 2234445568999999998765 79999999999999999999988776543322 11111111 000
Q ss_pred hhhhhhhhhhcCCC-------CCHHH------HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 734 FIDRELNKLVRGQE-------VDRNT------LENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 734 ~~~~~~~~~~~~~~-------~~~~~------~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
...-.+-+.++... .-.+. .+..++|+..++..||.+|+...+++..
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 00001111110000 01111 2367788888999999999999888743
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=273.41 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=203.1
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhcc-----CCceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAE-----DSKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~-----~~~~~l 585 (796)
+..|.+.||.|.+|.||+++..+.++.+|||++.-. ....+++..|..+|+.. +|||++.++|++.. ++.++|
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 345678999999999999999999999999998753 44567788899999888 69999999998863 568999
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
|||||.+||..|+++...+.++.|..+..|++.++.||.|||.. .++|||||=.|||++.++.+||.|||.+..+..
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 99999999999999877788999999999999999999999998 999999999999999999999999999987754
Q ss_pred CCcceeeeeccCCCCCchhhhccC-----CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYKNT-----PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
.-....+ ..||+.|||||++.-. .++.++|+||||++..||.-|.+|+...-. -. +.-.+ .
T Consensus 176 T~grRnT-~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--mr------aLF~I-----p 241 (953)
T KOG0587|consen 176 TVGRRNT-FIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--MR------ALFLI-----P 241 (953)
T ss_pred ccccccC-cCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch--hh------hhccC-----C
Confidence 4333333 3499999999998533 578899999999999999999988753211 00 00000 0
Q ss_pred hhhcCCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 741 KLVRGQEV-DRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 741 ~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.-..+... +..=..++.+++..||.+|-..||++.++++
T Consensus 242 RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 242 RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 00011111 3344578999999999999999999999875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=243.79 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=196.1
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccC-----CceeEEEee
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAED-----SKRLLVYEY 589 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e~ 589 (796)
+-||.|+||.||..++..+++.||.|++...-. ...+.+.+|+++|..++|.|++..+++..-. .+.|+|+|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 679999999999999999999999999865322 2346788999999999999999999877543 256788888
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
|.. +|..++.. -..++...+.-+.+||++||+|||+. +|.||||||.|.|++.+..+||+|||+++.-..++..
T Consensus 139 mQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 139 MQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 753 67776654 46788888899999999999999998 9999999999999999999999999999998888888
Q ss_pred eeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH-------HHHhhhhhhhhh
Q 003772 670 TFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW-------AYKCFIDRELNK 741 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 741 (796)
.++...-|..|.|||++.+. .++...||||.|||+.||+..|..|.....-.....+.+. +++.--++.-..
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 88887889999999999886 6899999999999999999888777643321111010000 111101111111
Q ss_pred hhcCCC------------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 003772 742 LVRGQE------------VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLML 781 (796)
Q Consensus 742 ~~~~~~------------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 781 (796)
++.+.. .+.....+...+...++..||++|.+..+.+..+
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111110 1112233456677788999999999988877544
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=262.00 Aligned_cols=237 Identities=24% Similarity=0.264 Sum_probs=198.6
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeec---ccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEK---MVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~---~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
..||-||||.|=+..........|+|++++ .....++.+..|-.+|...+.+.||+++-.+.++...|+.||-|-+|
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 459999999999998876655588888865 33445667889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeee
Q 003772 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL 673 (796)
Q Consensus 594 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~ 673 (796)
.|...|.. ++.++......++..+++|++|||.+ +||.|||||+|.+||.+|-+||.|||+++.+..+. ....
T Consensus 506 ElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--KTwT 578 (732)
T KOG0614|consen 506 ELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--KTWT 578 (732)
T ss_pred hhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC--ceee
Confidence 99999976 57899999999999999999999999 99999999999999999999999999999876443 3345
Q ss_pred eccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 003772 674 VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTL 753 (796)
Q Consensus 674 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (796)
.+||+.|.|||++.+...+..+|.||||+++|||++|++||.....-. .+. .+.+-++.-..+....
T Consensus 579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk--------tYn-----~ILkGid~i~~Pr~I~ 645 (732)
T KOG0614|consen 579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK--------TYN-----LILKGIDKIEFPRRIT 645 (732)
T ss_pred ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH--------HHH-----HHHhhhhhhhcccccc
Confidence 679999999999999999999999999999999999999997543211 111 1222223333455566
Q ss_pred HHHHHHHHHhccCCCCCCCC
Q 003772 754 ENMIKIGLWCVQDEPALRPS 773 (796)
Q Consensus 754 ~~l~~l~~~cl~~dP~~RPt 773 (796)
....++++.....+|.+|--
T Consensus 646 k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 646 KTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhHHHHHHHHHhcCcHhhhc
Confidence 67778888888899999976
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=245.03 Aligned_cols=246 Identities=22% Similarity=0.357 Sum_probs=198.7
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEee
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
++.++||+|.|+.|.+++++...+.+|+|++++..- +.....+.|-.+..+. +||.+|.+..++..++..++|.||
T Consensus 253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey 332 (593)
T KOG0695|consen 253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY 332 (593)
T ss_pred eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence 456789999999999999999999999999977332 3334566677776665 699999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
.++|+|--++.+ ...++++.+..+..+|.-||.|||+. +|+.||||..|+|+|..+.+||.|+|+.+.--.+. .
T Consensus 333 v~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~g-d 406 (593)
T KOG0695|consen 333 VNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-D 406 (593)
T ss_pred ecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCC-c
Confidence 999999877765 57799999999999999999999998 99999999999999999999999999998643332 2
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....+||+.|+|||++.+..+....|.|++||+++||+.|+.||+.......+..-..+..+.+.+..+ .++
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-------rip 479 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-------RIP 479 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-------ccc
Confidence 3345679999999999999999999999999999999999999998644332222222233333222221 123
Q ss_pred HHHHHHHHHHHHHhccCCCCCCC
Q 003772 750 RNTLENMIKIGLWCVQDEPALRP 772 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RP 772 (796)
.....+...+++.-|++||.+|.
T Consensus 480 rslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 480 RSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ceeehhhHHHHHHhhcCCcHHhc
Confidence 44456677888889999999984
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-29 Score=232.25 Aligned_cols=199 Identities=29% Similarity=0.441 Sum_probs=168.0
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
.+.||+|++|.|-+-++...+...|+|++.... .+..+...+|+.+..+- .+|.+|+++|...++...++.||.|.-
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t- 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT- 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence 468999999999999999999999999997533 44556778888877665 699999999999999999999999864
Q ss_pred Chhhhhhc--CCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 594 SLADILFR--GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 594 sL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
||..+-.+ ..++.+++..+=+|+..+.+||.|||++ ..++|||+||+|||++.+|++|++|||++..+...-...
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt- 206 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT- 206 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH-
Confidence 67665433 2367899999999999999999999997 699999999999999999999999999998775433222
Q ss_pred eeeccCCCCCchhhhcc----CCCCccccchhhHHHHHHHhhcccCCCCCCC
Q 003772 672 TLVRGTRGYMAPEWYKN----TPISVKADVFSYGVVLLEIVCCRRNMEIDPS 719 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~----~~~t~ksDV~S~Gvil~elltg~~p~~~~~~ 719 (796)
...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++....
T Consensus 207 -~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 207 -MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred -HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 2337789999999854 3789999999999999999999999986653
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-29 Score=222.97 Aligned_cols=103 Identities=37% Similarity=0.576 Sum_probs=76.4
Q ss_pred CCeEEEEeeCCCCCCCC--CcEEEEecCCceEEEcCCCceeEee-cCCCC--CceeEEEecCcCEEEeecCCCccccccC
Q 003772 76 DITIVWTAYRDDPPVSS--NAALTLTKDGKLILRTEEGHDKVVA-AGKSE--PASSASMLDSGNFVLYNNRSDIIWSSFK 150 (796)
Q Consensus 76 ~~t~VWvANr~~p~~~~--~~~l~l~~~G~Lvl~~~~g~~~w~t-~~~~~--~~~~a~Lld~GNlVl~~~~~~~lWQSFD 150 (796)
++||||+|||++|+.++ ..+|.|+.||+|+|+|.+|+.+|++ .+... .+..|+|+|+|||||+|..++++|||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 47999999999998653 4899999999999999998999999 55544 3788999999999999999999999999
Q ss_pred CCCccccCCCCCCCC------CeeeeccCCCCCC
Q 003772 151 IPTDTILGNQSLLAG------NELFSRISETSSS 178 (796)
Q Consensus 151 ~PtDtlLp~~~l~~~------~~L~S~~s~~dps 178 (796)
|||||+||+|+++.+ ..|+||++.+|||
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999863 3599999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=257.88 Aligned_cols=244 Identities=25% Similarity=0.376 Sum_probs=192.9
Q ss_pred CHHHHHHHHHh---hh--cccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhh
Q 003772 504 SYNELKKATNR---FK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIG 575 (796)
Q Consensus 504 ~~~~l~~~~~~---~~--~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g 575 (796)
.|..|++++-. |. +.||-|+||.|.++.-.+....+|.|.+.+.. .......++|-+||..-+.+=||+++-
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 45566665532 32 45999999999999887888889999997632 233456889999999999999999999
Q ss_pred hhccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEe
Q 003772 576 YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKIS 655 (796)
Q Consensus 576 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 655 (796)
.|.+.+.+|+||+|+++|++-.+|.+ .+.+.+..+..++.++..|+++.|.. ++|||||||+|||||.+|.+||.
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeee
Confidence 99999999999999999999999987 57899999999999999999999997 99999999999999999999999
Q ss_pred ccCCccccC---------CCC----------------cc----------------eeeeeccCCCCCchhhhccCCCCcc
Q 003772 656 DFGLAKLLM---------PDQ----------------TR----------------TFTLVRGTRGYMAPEWYKNTPISVK 694 (796)
Q Consensus 656 DFgl~~~~~---------~~~----------------~~----------------~~~~~~gt~~y~aPE~~~~~~~t~k 694 (796)
||||+.-+. .+. .. .....+||+.|+|||++....++.-
T Consensus 772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~ 851 (1034)
T KOG0608|consen 772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL 851 (1034)
T ss_pred eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence 999987441 000 00 0112459999999999999999999
Q ss_pred ccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHH
Q 003772 695 ADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKI 759 (796)
Q Consensus 695 sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 759 (796)
+|.||.|||||||+.|+.||-.+...+....+.+|.. ..++.-......++...+.+|
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~-------~l~~~~~~~ls~e~~~li~kL 909 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN-------FLHIPYQGNLSKEALDLIQKL 909 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh-------ccccccccccCHHHHHHHHHH
Confidence 9999999999999999999986655444333333322 222222234456666655555
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=233.26 Aligned_cols=211 Identities=37% Similarity=0.569 Sum_probs=184.7
Q ss_pred cCcccceEEEEEEEcCCcEEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCChhh
Q 003772 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLAD 597 (796)
Q Consensus 519 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 597 (796)
||+|.+|.||++.....++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999877889999999764332 34679999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-CCceEEeccCCccccCCCCcceeeeecc
Q 003772 598 ILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE-FWTAKISDFGLAKLLMPDQTRTFTLVRG 676 (796)
Q Consensus 598 ~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgl~~~~~~~~~~~~~~~~g 676 (796)
++.... ..+++..+..++.+++++|.+||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 986532 4689999999999999999999998 9999999999999999 89999999999987654321 1222347
Q ss_pred CCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHH
Q 003772 677 TRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLEN 755 (796)
Q Consensus 677 t~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (796)
...|++||.+... ..+.+.|+|++|+++++| ..
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------~~ 189 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------PE 189 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------HH
Confidence 7899999999887 889999999999999998 34
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 756 MIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 756 l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
+.+++..|++.+|++||++.++++.
T Consensus 190 ~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHhhCCcccCcCHHHHhhC
Confidence 7788999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=221.87 Aligned_cols=256 Identities=17% Similarity=0.330 Sum_probs=199.0
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-cCchhhhhhhhccCC--ceeEEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDS--KRLLVY 587 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~lV~ 587 (796)
..+++.+++|+|.++.||.|....+++.++||+++.. ..+.+++|+++|..+. |+||++++++..+.. ...||+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 4567778999999999999998888889999999753 4567899999999997 999999999998754 568999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC-CceEEeccCCccccCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF-WTAKISDFGLAKLLMPD 666 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFgl~~~~~~~ 666 (796)
||+.+-+...+. ..++...+..++.++++||.|+|+. ||.|||+||.|++||.. -.++|+|+|+|....++
T Consensus 115 E~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 115 EYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 999998876655 4577788999999999999999998 99999999999999964 56999999999988765
Q ss_pred CcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH------------HHHh
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW------------AYKC 733 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~------------~~~~ 733 (796)
... .....+.-|-.||.+... .+...-|+|||||+|.+|+..+.||....+.........- .++.
T Consensus 187 ~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 187 KEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred cee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 532 223457778999998765 5788889999999999999999999866554332221110 1122
Q ss_pred hhhhhhhhhhcCCC-------C---CH-HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 734 FIDRELNKLVRGQE-------V---DR-NTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 734 ~~~~~~~~~~~~~~-------~---~~-~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..++....++.... . +. -..++.++++...|..|-.+|||++|.+.
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 23333333332211 0 11 12367888899999999999999999763
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=239.00 Aligned_cols=145 Identities=23% Similarity=0.384 Sum_probs=121.8
Q ss_pred CCCcccCHHHHHH-HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-----c---C
Q 003772 498 SNLRSFSYNELKK-ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-----H---K 568 (796)
Q Consensus 498 ~~~~~~~~~~l~~-~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-----h---~ 568 (796)
.+.+.....+... ++|-+.++||=|.|++||++.+....+.||+|+.+.. ..-.+.-..|+++|++++ | .
T Consensus 64 GGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~ 142 (590)
T KOG1290|consen 64 GGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKK 142 (590)
T ss_pred CCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence 3445555666666 7788889999999999999999999999999998642 233445678999999883 2 3
Q ss_pred chhhhhhhhc----cCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccce
Q 003772 569 NLVRLIGYCA----EDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNI 644 (796)
Q Consensus 569 niv~l~g~~~----~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NI 644 (796)
.||+++++|. .+.+.|+|+|++- -+|..+|.....+.++...+.+|+.||+.||.|||.+| +|||-||||+||
T Consensus 143 ~VV~LlD~FkhsGpNG~HVCMVfEvLG-dnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENv 219 (590)
T KOG1290|consen 143 CVVQLLDHFKHSGPNGQHVCMVFEVLG-DNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENV 219 (590)
T ss_pred eeeeeeccceecCCCCcEEEEEehhhh-hHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCccee
Confidence 6999999986 4568999999984 47888888877889999999999999999999999986 999999999999
Q ss_pred Ee
Q 003772 645 LM 646 (796)
Q Consensus 645 ll 646 (796)
|+
T Consensus 220 Ll 221 (590)
T KOG1290|consen 220 LL 221 (590)
T ss_pred ee
Confidence 98
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=248.34 Aligned_cols=192 Identities=25% Similarity=0.341 Sum_probs=167.1
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccc--------hhHHHHHHHHHHHhccC---cCchhhhhhhhccCCcee
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--------EGEREFRAEMHVIGRTH---HKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~ 584 (796)
.+.+|+|+||.|+++.++....+|+||.+.+..- ...-.+-.|+.+|..++ |+||+++++++++++..|
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 4679999999999999999999999999866221 11223567999999997 999999999999999999
Q ss_pred EEEeec-CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 585 LVYEYM-SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 585 lV~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
|+||.. ++.+|.+++.. ...+++....-|+.|++.|+++||++ +|||||||-+|+.++.+|-+||+|||.+...
T Consensus 646 l~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred EEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhh
Confidence 999986 46699999965 57899999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCcceeeeeccCCCCCchhhhccCCC-CccccchhhHHHHHHHhhcccCCC
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVCCRRNME 715 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvil~elltg~~p~~ 715 (796)
..+.- ...+||.+|.|||++.+.+| ...-|||++|++||-++....|+.
T Consensus 721 ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 721 KSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 65443 34569999999999999887 555799999999999998777764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-26 Score=230.03 Aligned_cols=199 Identities=33% Similarity=0.486 Sum_probs=173.5
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
.+.+.||.|++|.||++...+.++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||+++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 3567899999999999999887789999999865544 567899999999999999999999999998999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
++|.+++..... .+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+............
T Consensus 82 ~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 82 GDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999976321 288999999999999999999998 9999999999999999999999999999887554311222
Q ss_pred eeccCCCCCchhhh-ccCCCCccccchhhHHHHHHHhhcccCCCC
Q 003772 673 LVRGTRGYMAPEWY-KNTPISVKADVFSYGVVLLEIVCCRRNMEI 716 (796)
Q Consensus 673 ~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvil~elltg~~p~~~ 716 (796)
...++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34477899999999 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=237.22 Aligned_cols=272 Identities=19% Similarity=0.215 Sum_probs=207.0
Q ss_pred CcccCHHHHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC------cCchhhh
Q 003772 500 LRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH------HKNLVRL 573 (796)
Q Consensus 500 ~~~~~~~~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~------h~niv~l 573 (796)
..++.+.|+....|.+.-..|+|-|++|..|.+..-+..||||++.... --.+.=+.|+++|.+|+ ..|.+++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 4456677888888888888999999999999998888899999997532 12234467999999994 4589999
Q ss_pred hhhhccCCceeEEEeecCCCChhhhhhcC-CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC-Cc
Q 003772 574 IGYCAEDSKRLLVYEYMSNGSLADILFRG-PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF-WT 651 (796)
Q Consensus 574 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~ 651 (796)
+..|...+++|||+|.+. -+|.++|++. .+..|....+..++.|+.-||..|... +|+|+||||.|||+++. ..
T Consensus 500 ~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 999999999999999764 4899999864 345688899999999999999999987 99999999999999965 56
Q ss_pred eEEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH--
Q 003772 652 AKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW-- 729 (796)
Q Consensus 652 ~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-- 729 (796)
+||+|||.|.....+.. +...-+..|.|||++.+.+|+...|+||.||+||||.||+..|.......-....+..
T Consensus 576 LKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred eeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 89999999987654332 2233466899999999999999999999999999999999988744322111110000
Q ss_pred ------------HHHhh--------------------------hh-hhhhhhhcC-CC---CCHHHHHHHHHHHHHhccC
Q 003772 730 ------------AYKCF--------------------------ID-RELNKLVRG-QE---VDRNTLENMIKIGLWCVQD 766 (796)
Q Consensus 730 ------------~~~~~--------------------------~~-~~~~~~~~~-~~---~~~~~~~~l~~l~~~cl~~ 766 (796)
.-+++ .+ ..+...+.. +. ..+....++..|+..|+-.
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 00000 00 111111111 11 1345567888999999999
Q ss_pred CCCCCCCHHHHHH
Q 003772 767 EPALRPSMKSVVL 779 (796)
Q Consensus 767 dP~~RPt~~evl~ 779 (796)
||++|.|..+.+.
T Consensus 733 dP~KRit~nqAL~ 745 (752)
T KOG0670|consen 733 DPEKRITVNQALK 745 (752)
T ss_pred ChhhcCCHHHHhc
Confidence 9999999998774
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=200.60 Aligned_cols=111 Identities=32% Similarity=0.481 Sum_probs=97.9
Q ss_pred ccccCCCCCccccCCCeeeeeeeecCCC--eEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEEcCCCcee
Q 003772 37 SLSPTKQPGSWNSSLGAFQFGFYKQDAG--FKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDK 114 (796)
Q Consensus 37 ~l~~~~~~~~~~S~~g~F~lgFf~~~~~--~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~~~~g~~~ 114 (796)
.|..++. |+|++|.|++|||++... .+.+|||.+++ +++||+|||+.| ....+.|.|+.||+|+|+|.+|.++
T Consensus 3 ~l~~~~~---l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~v 77 (116)
T cd00028 3 PLSSGQT---LVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVV 77 (116)
T ss_pred CcCCCCE---EEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEE
Confidence 4555543 469999999999987644 89999999887 899999999998 6677899999999999999999999
Q ss_pred EeecCCC-CCceeEEEecCcCEEEeecCCCccccccCCC
Q 003772 115 VVAAGKS-EPASSASMLDSGNFVLYNNRSDIIWSSFKIP 152 (796)
Q Consensus 115 w~t~~~~-~~~~~a~Lld~GNlVl~~~~~~~lWQSFD~P 152 (796)
|+|++.. ....+|+|+|+|||||++.++.++|||||||
T Consensus 78 W~S~~~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 78 WSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred EEecccCCCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 9998775 5667899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=223.99 Aligned_cols=253 Identities=23% Similarity=0.250 Sum_probs=188.5
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhcc------CCceeEEEe
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE------DSKRLLVYE 588 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~~~~lV~e 588 (796)
+.+|.|.- .|-.+.+.-.+++||||++... .....+.-.+|..++..++|+|+++++.++.- ..+.|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 34677776 6666766666789999998542 23345667789999999999999999998863 346799999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
+|. .+|.+.+. ..++-..+..+..|++.|+.|||+. +|+||||||+||++..+..+||.|||+++....+
T Consensus 102 ~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-- 171 (369)
T KOG0665|consen 102 LMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-- 171 (369)
T ss_pred hhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc--
Confidence 997 47888775 3577788899999999999999998 9999999999999999999999999999865443
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCch-------------hH-H-H----HHH
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPE-------------EI-V-L----INW 729 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~-------------~~-~-~----~~~ 729 (796)
..++....|.-|.|||++.+..+.+.+||||.||++.||++|+..|......+. .. . + +.+
T Consensus 172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y 251 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY 251 (369)
T ss_pred cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence 456667789999999999988899999999999999999999988763211100 00 0 0 000
Q ss_pred HH--HhhhhhhhhhhhcCC------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 730 AY--KCFIDRELNKLVRGQ------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 730 ~~--~~~~~~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.. ++...-...+..... +.++-.......++.+||-.+|++|-+..++++.
T Consensus 252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 000000011111100 1123345678899999999999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=223.39 Aligned_cols=256 Identities=21% Similarity=0.318 Sum_probs=194.1
Q ss_pred hhhcccCcccceEEEEEEEcC---CcEEEEEEEeecccchhHHHHHHHHHHHhccC-cCchhhhhhhhccCCceeEEEee
Q 003772 514 RFKEELGKGSFGAVYKGTLYK---GEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~---~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
...++||+|.|++||++++.. .++.||+|.+.. .+....+.+|+++|..+. +.||+++.+++..++...+|+||
T Consensus 39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~--ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR--TSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhccccccchhhhhhhhHhhhccccceEeeeeccc--ccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 445789999999999999876 678999999865 334567899999999995 99999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-CCceEEeccCCccccCCC--
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE-FWTAKISDFGLAKLLMPD-- 666 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgl~~~~~~~-- 666 (796)
+++-...+++.. ++...+..++..+.+||.++|.+ +||||||||+|+|.+. -++-.|.|||++......
T Consensus 117 ~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 117 FEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred cCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 999999998854 67889999999999999999999 9999999999999984 567899999999822100
Q ss_pred -----------C------------------------------cceeeeeccCCCCCchhhhccC-CCCccccchhhHHHH
Q 003772 667 -----------Q------------------------------TRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVL 704 (796)
Q Consensus 667 -----------~------------------------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil 704 (796)
. ........||+||.|||++... .-|+++||||-|||+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 0011123499999999999876 569999999999999
Q ss_pred HHHhhcccCCCCCCCCchhHHH-HHH----HHHh--hhhhh---------------------h--hhhhcCC-------C
Q 003772 705 LEIVCCRRNMEIDPSKPEEIVL-INW----AYKC--FIDRE---------------------L--NKLVRGQ-------E 747 (796)
Q Consensus 705 ~elltg~~p~~~~~~~~~~~~~-~~~----~~~~--~~~~~---------------------~--~~~~~~~-------~ 747 (796)
+-+++++.||.....+-....- +.. ...+ ...+. + ......+ .
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 9999999999866544322111 000 0000 00000 0 0000000 0
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.....+..+++++.+|+..||.+|-|++|.+.
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 11222347889999999999999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=238.46 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=197.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.+..++|.|.||.|||++++..++..|+|+++-......+-+..|+-+++..+|+||+.++|-+...+..+++||||.+
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg 96 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG 96 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence 44568899999999999999999999999999876677777788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+.-+- ...+++.++...+...++||+|||+. +-+|||||=.||++++.+.+|++|||.+-.+...-. ...
T Consensus 97 gslQdiy~~--TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-Krk 170 (829)
T KOG0576|consen 97 GSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-KRK 170 (829)
T ss_pred Ccccceeee--cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhh-hhh
Confidence 999998765 67899999999999999999999998 889999999999999999999999999876543222 222
Q ss_pred eeccCCCCCchhhhc---cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 673 LVRGTRGYMAPEWYK---NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
...||+.|||||+.. .+.+..++|||+.|+...|+--...|...-- ......+. ....+.+..+. -.
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-pmr~l~Lm--TkS~~qpp~lk-------Dk 240 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-PMRALFLM--TKSGFQPPTLK-------DK 240 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-hHHHHHHh--hccCCCCCccc-------CC
Confidence 345999999999873 4578999999999999999876665543110 00000000 00000000011 01
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..-.+.+-++++.|+..+|.+|||.+.+++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 122456778888999999999999977653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=205.91 Aligned_cols=247 Identities=16% Similarity=0.287 Sum_probs=180.6
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhh-hccCCceeEEEe
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGY-CAEDSKRLLVYE 588 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~-~~~~~~~~lV~e 588 (796)
..+++.+.||+|.||.+-++++...+..+++|.+.+. ....++|.+|..---.| .|.||+.-++. +...+...+++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 3467788999999999999999999999999998763 33467898888765555 59999987765 455667789999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec--CCCceEEeccCCccccCCC
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD--EFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFgl~~~~~~~ 666 (796)
|++.|+|..-+.. ..+-+.....++.|++.||.|||++ .+||||||.+||||- +..++||+|||+.+..+..
T Consensus 103 ~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred cCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999988744 4577788889999999999999999 999999999999994 4568999999999764321
Q ss_pred CcceeeeeccCCCCCchhhhccC-----CCCccccchhhHHHHHHHhhcccCCCCCCCCchh-HHHHHHHHHhhhhhhhh
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNT-----PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEE-IVLINWAYKCFIDRELN 740 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 740 (796)
- .....+..|.+||..... ...+.+|||.||+++|.++||+.|+..+...... .....| .......+.
T Consensus 177 V----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w--~~rk~~~~P 250 (378)
T KOG1345|consen 177 V----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW--LKRKNPALP 250 (378)
T ss_pred e----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH--hcccCccCc
Confidence 1 122246689999976532 4578899999999999999999999854332222 222222 111111111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 003772 741 KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKS 776 (796)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 776 (796)
+.. ....+++.++-+.-+..+|++|=-..+
T Consensus 251 ~~F------~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 251 KKF------NPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred hhh------cccCHHHHHHHHHhcCCcccccchhHH
Confidence 111 112345666667778888888833333
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=190.76 Aligned_cols=110 Identities=28% Similarity=0.470 Sum_probs=95.7
Q ss_pred ccccCCCCCccccCCCeeeeeeeecCCC-eEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEEcCCCceeE
Q 003772 37 SLSPTKQPGSWNSSLGAFQFGFYKQDAG-FKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKV 115 (796)
Q Consensus 37 ~l~~~~~~~~~~S~~g~F~lgFf~~~~~-~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~~~~g~~~w 115 (796)
.|..++ .|+|++|.|++|||.+... .+.+|||++.+ +++||+|||+.|..+ ++.|.|+.||+|+|+|.+|.++|
T Consensus 3 ~l~~~~---~l~s~~~~f~~G~~~~~~q~dgnlV~~~~~~-~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW 77 (114)
T smart00108 3 TLSSGQ---TLVSGNSLFELGFFTLIMQNDYNLILYKSSS-RTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVW 77 (114)
T ss_pred ccCCCC---EEecCCCcEeeeccccCCCCCEEEEEEECCC-CcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEE
Confidence 344444 3579999999999987654 89999999887 899999999998644 48999999999999999999999
Q ss_pred eecCC-CCCceeEEEecCcCEEEeecCCCccccccCC
Q 003772 116 VAAGK-SEPASSASMLDSGNFVLYNNRSDIIWSSFKI 151 (796)
Q Consensus 116 ~t~~~-~~~~~~a~Lld~GNlVl~~~~~~~lWQSFD~ 151 (796)
+|++. ..+..+|+|+|+|||||++..++++||||||
T Consensus 78 ~S~t~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 78 SSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred EecccCCCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 99886 5566789999999999999999999999997
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=259.77 Aligned_cols=195 Identities=19% Similarity=0.241 Sum_probs=138.4
Q ss_pred ccCc-Cchhhhhhhhc-------cCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCee
Q 003772 564 RTHH-KNLVRLIGYCA-------EDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPII 635 (796)
Q Consensus 564 ~l~h-~niv~l~g~~~-------~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iv 635 (796)
.++| +||.++++.+. +....++++|++ +++|.++|... ...+++..++.++.||++||.|||++ +|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 3455 68888888772 233556778876 56999999653 45699999999999999999999998 999
Q ss_pred eeccCccceEecC-------------------CCceEEeccCCccccCCCCc---------------ceeeeeccCCCCC
Q 003772 636 HCDIKPQNILMDE-------------------FWTAKISDFGLAKLLMPDQT---------------RTFTLVRGTRGYM 681 (796)
Q Consensus 636 H~Dlkp~NIll~~-------------------~~~~kl~DFgl~~~~~~~~~---------------~~~~~~~gt~~y~ 681 (796)
||||||+||||+. ++.+||+|||+++....... .......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566677776654211000 0011134788899
Q ss_pred chhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHH
Q 003772 682 APEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGL 761 (796)
Q Consensus 682 aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 761 (796)
|||++.+..++.++|||||||+||||+++..|+.... ......... ...+ ...........++.
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~---------~~~~--~~~~~~~~~~~~~~ 246 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR---------VLPP--QILLNWPKEASFCL 246 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh---------hcCh--hhhhcCHHHHHHHH
Confidence 9999999999999999999999999999877653211 000000000 0000 00112344568888
Q ss_pred HhccCCCCCCCCHHHHHH
Q 003772 762 WCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 762 ~cl~~dP~~RPt~~evl~ 779 (796)
+||+++|.+||+|.||++
T Consensus 247 ~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 247 WLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HhCCCChhhCcChHHHhh
Confidence 999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=205.55 Aligned_cols=167 Identities=21% Similarity=0.194 Sum_probs=126.1
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++... +..+++..++.++.||++||.|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence 7899999753 45699999999999999999999997 4 999999999999999 99998754322
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
..||+.|||||++.+..++.++|||||||++|||++|+.|+........... ... .................
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~--~~~-----~~~~~~~~~~~~~~~~~ 135 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILE--ILL-----NGMPADDPRDRSNLESV 135 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHH--HHH-----HHhccCCccccccHHHH
Confidence 2488999999999999999999999999999999999999864332111111 100 00000000000111222
Q ss_pred HH--HHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 753 LE--NMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 753 ~~--~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
.. .+.+++.+||+.+|.+||++.++++.+..+
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 22 699999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.8e-24 Score=204.97 Aligned_cols=250 Identities=22% Similarity=0.379 Sum_probs=194.2
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEee--cccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLE--KMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~--~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
..++..+|.+...|..|+|++++++ +++|++. .......+.|..|.-.|+.+.||||+.++|.|....+..+|..|
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 3456678999999999999997653 5566663 34445567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEe--ccCCccccCCCC
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKIS--DFGLAKLLMPDQ 667 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--DFgl~~~~~~~~ 667 (796)
|+.|+|...|++...-.++..+..+++.++|+|++|||+. ++-|----|.+..+++|++.+++|+ |--++-
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf------ 341 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------ 341 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee------
Confidence 9999999999988777889999999999999999999997 3334444588999999999988875 211111
Q ss_pred cceeeeeccCCCCCchhhhccCCC---CccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPI---SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~---t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
......-.+.||+||.++..+- -..+|+|||+++||||.|...||.....-+....+ + ++. +.
T Consensus 342 --qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---a--------leg-lr 407 (448)
T KOG0195|consen 342 --QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---A--------LEG-LR 407 (448)
T ss_pred --eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---h--------hcc-cc
Confidence 0111124688999999987754 35689999999999999999999754332211111 0 111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
..+++.....+.+++.-|++.||.+||.+..|+..||++.
T Consensus 408 -v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 408 -VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1245666778999999999999999999999999999864
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-23 Score=182.33 Aligned_cols=109 Identities=27% Similarity=0.498 Sum_probs=90.2
Q ss_pred ccccccccceeEEEeecCc-eEEEEcCCcceeeeeecCCCCCccceeEEEEeecccEEEEEeccCCCCCcceeEEeeccC
Q 003772 208 WASDSQRERQLHLYLSNTG-NLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSHYPVPKGAYNTSVDWNVPD 286 (796)
Q Consensus 208 w~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~rl~L~~~G~l~~~~~~~~~~~~~~w~~~w~~p~ 286 (796)
||+|+|+|..+..+++... .++.+.......+.++++...+.+.++|++|+.+|++|++.|.+ ..++|.+.|.+|.
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~---~~~~W~~~~~~p~ 77 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNE---STQSWSVFWSAPK 77 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEec---CCCcEEEEEEecc
Confidence 8999999998887776542 23333333444455677777788999999999999999999975 5679999999999
Q ss_pred CCCcccCCCCCCCCcccCCCCCcccCCCCCCcCC
Q 003772 287 DLCEVKTFCGLNSYCTLYDDQPMCRCLPGTDFLD 320 (796)
Q Consensus 287 d~Cd~~~~CG~~g~C~~~~~~~~C~Cl~GF~p~~ 320 (796)
|+||+|+.||+||+|+. +..|.|+||+||+|++
T Consensus 78 d~Cd~y~~CG~~g~C~~-~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 78 DQCDVYGFCGPNGICNS-NNSPKCSCLPGFEPKN 110 (110)
T ss_pred cCCCCccccCCccEeCC-CCCCceECCCCcCCCc
Confidence 99999999999999986 6689999999999985
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-22 Score=214.34 Aligned_cols=164 Identities=19% Similarity=0.122 Sum_probs=127.4
Q ss_pred HHHhhhcccCcccceEEEEEEEcC-CcEEEEEEEeecc-----cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCcee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYK-GEKLVAVKKLEKM-----VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~-~~~~vAvK~l~~~-----~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 584 (796)
..+.+.+.||+|+||+||+|.+.. +++.||||++... .....+.|.+|++++.+++|+|++..+.. .+..+
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~ 94 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG 94 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence 346677899999999999998765 5677899987532 12234568999999999999999853322 24679
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeecc-CccceEecCCCceEEeccCCcccc
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDI-KPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
+||||+++++|... .. .. ...++.|+++||.|||+. +|+|||| ||+|||++.++.+||+|||+++.+
T Consensus 95 LVmE~~~G~~L~~~-~~--~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 95 LVRGWTEGVPLHLA-RP--HG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred EEEEccCCCCHHHh-Cc--cc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 99999999999632 11 11 146789999999999998 9999999 999999999999999999999977
Q ss_pred CCCCcce-------eeeeccCCCCCchhhhccC
Q 003772 664 MPDQTRT-------FTLVRGTRGYMAPEWYKNT 689 (796)
Q Consensus 664 ~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 689 (796)
....... .....+++.|+|||++...
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 5433111 1345678899999998644
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=199.99 Aligned_cols=261 Identities=22% Similarity=0.253 Sum_probs=192.9
Q ss_pred HHhhhcccCcccceEEEEEEEcCCc-EEEEEEEeecccchhHHHHHHHHHHHhccCc----Cchhhhhhhh-ccCCceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGE-KLVAVKKLEKMVTEGEREFRAEMHVIGRTHH----KNLVRLIGYC-AEDSKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~-~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~l 585 (796)
.+.+.++||+|+||.||++...... +.+|+|............+..|..++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 4567789999999999999987653 5788887765433333378889888888863 5788888877 47778899
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC-----CceEEeccCCc
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF-----WTAKISDFGLA 660 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DFgl~ 660 (796)
||+.. +-+|.++......+.++....+.++.|++.+|.+||+. +++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99865 56899988665568899999999999999999999998 99999999999999854 46999999999
Q ss_pred c--ccCCCCc------ce-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHH
Q 003772 661 K--LLMPDQT------RT-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAY 731 (796)
Q Consensus 661 ~--~~~~~~~------~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 731 (796)
+ ....... .. ....+||..|.+++...+...+.+.|+||++.++.|++.|..|+...........+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 9 3221111 11 2235599999999999999999999999999999999999999865433222111111101
Q ss_pred HhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 732 KCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
...... .....+..+.++...+-..+..++|....+...|+....
T Consensus 255 --------~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 255 --------KLLTDR--FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred --------hhcccc--ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 101110 111223445555555556899999999999988766543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-21 Score=222.67 Aligned_cols=253 Identities=20% Similarity=0.236 Sum_probs=193.6
Q ss_pred hhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhH----HHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGE----REFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~----~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
..+.+|.|++|.|+........+..+.|..... ....+ ..+..|+.+-..++|+|++..+..+.+......+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 346799999998888776655554555543210 11111 225668888888999999999998888877777799
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|++. +|..++.. ...+....+..++.|++.|+.|||+. +|.|||+|++|++++.++.+||+|||.+..+.....
T Consensus 402 ~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 99999976 35788899999999999999999998 999999999999999999999999999998765443
Q ss_pred ---ceeeeeccCCCCCchhhhccCCCCcc-ccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 669 ---RTFTLVRGTRGYMAPEWYKNTPISVK-ADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 669 ---~~~~~~~gt~~y~aPE~~~~~~~t~k-sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
.......|+..|+|||.+....+.+. .||||.|+++..|++|+.||........... .............
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~------~~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK------TNNYSDQRNIFEG 549 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh------hhccccccccccC
Confidence 45556779999999999999988765 7999999999999999999986644332210 0000001111111
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
........+.+...++.++|+.+|.+|.|+++|++
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 11223456678899999999999999999999985
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.3e-19 Score=191.19 Aligned_cols=259 Identities=30% Similarity=0.393 Sum_probs=195.0
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch---hHHHHHHHHHHHhccCcC-chhhhhhhhccCCceeEEEee
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE---GEREFRAEMHVIGRTHHK-NLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~---~~~~f~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV~e~ 589 (796)
.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++..++......++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred eeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 44578999999999999986 67899998764443 367799999999999988 799999999777778999999
Q ss_pred cCCCChhhhhhcCCC-CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC-ceEEeccCCccccCCCC
Q 003772 590 MSNGSLADILFRGPE-RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW-TAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgl~~~~~~~~ 667 (796)
+.+++|.+++..... ..+.......++.|++.++.|+|+. +++|||+||+||+++... .+++.|||.++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977755322 2788999999999999999999998 899999999999999988 79999999998665433
Q ss_pred cc-----eeeeeccCCCCCchhhhcc---CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh
Q 003772 668 TR-----TFTLVRGTRGYMAPEWYKN---TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739 (796)
Q Consensus 668 ~~-----~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
.. ......|+..|+|||.+.. ...+...|+|++|+++++++++..|+...................... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 22 2345669999999999987 578999999999999999999999965443210000100000000000 00
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 740 NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
...... .........+.+++..|+..+|..|.++.+....
T Consensus 236 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSP-SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCc-cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000 0001223568888899999999999999887753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.2e-20 Score=200.17 Aligned_cols=217 Identities=26% Similarity=0.435 Sum_probs=167.0
Q ss_pred HhccCcCchhhhhhhhccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCe-eeeccC
Q 003772 562 IGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI-IHCDIK 640 (796)
Q Consensus 562 l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i-vH~Dlk 640 (796)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.|.+... ...+++.....++.+|++||.|||.. +| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 35688999999999999999999999999999999999873 57899999999999999999999997 44 999999
Q ss_pred ccceEecCCCceEEeccCCccccCCC-CcceeeeeccCCCCCchhhhccC-------CCCccccchhhHHHHHHHhhccc
Q 003772 641 PQNILMDEFWTAKISDFGLAKLLMPD-QTRTFTLVRGTRGYMAPEWYKNT-------PISVKADVFSYGVVLLEIVCCRR 712 (796)
Q Consensus 641 p~NIll~~~~~~kl~DFgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~S~Gvil~elltg~~ 712 (796)
++|.++|....+||+|||+..+.... .........-...|.|||.+... ..+.++||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999999877431 11111122245679999999764 25788999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 713 NMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR-NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 713 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
||...........++..... .......+..... +..+.+..++..||..+|.+||+++.|-..++.+...
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99875443332111111111 0111111111111 4445799999999999999999999999988876543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=3e-19 Score=176.43 Aligned_cols=139 Identities=17% Similarity=0.143 Sum_probs=108.4
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccch--h-------HHH-----------------HHHHHHHHhccCcCc
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE--G-------ERE-----------------FRAEMHVIGRTHHKN 569 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--~-------~~~-----------------f~~E~~~l~~l~h~n 569 (796)
...||+|+||.||+|... ++++||||+++..... . ... ...|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 367999999999999987 6789999999753211 1 112 234999999998887
Q ss_pred hhhhhhhhccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHh-hccCCCCeeeeccCccceEecC
Q 003772 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL-HDECEAPIIHCDIKPQNILMDE 648 (796)
Q Consensus 570 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~ivH~Dlkp~NIll~~ 648 (796)
+.....+ .....++||||+++++|...+.. ...++......++.|++.+|.+| |+. +|+||||||+||+++
T Consensus 81 v~~p~~~--~~~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPI--LLKSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEE--EecCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 6443332 22334899999999877655433 35688899999999999999999 676 999999999999998
Q ss_pred CCceEEeccCCcccc
Q 003772 649 FWTAKISDFGLAKLL 663 (796)
Q Consensus 649 ~~~~kl~DFgl~~~~ 663 (796)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-19 Score=178.95 Aligned_cols=173 Identities=13% Similarity=0.116 Sum_probs=132.0
Q ss_pred HHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHH---------HHHHHHHHhccCcCchhhhhhhh
Q 003772 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE---------FRAEMHVIGRTHHKNLVRLIGYC 577 (796)
Q Consensus 507 ~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~---------f~~E~~~l~~l~h~niv~l~g~~ 577 (796)
++....++..+.||.|+||.||+... ++..+|||.+........+. +.+|+..+.+++|++|..+..++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 34455667778999999999999655 34579999997543333322 67899999999999999998875
Q ss_pred ccC--------CceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC
Q 003772 578 AED--------SKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF 649 (796)
Q Consensus 578 ~~~--------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 649 (796)
... ...+|||||+++.+|.++.. ++. ....+++.+|..+|+. +++|||+||+||+++.+
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 532 35789999999999988742 222 3456999999999998 99999999999999998
Q ss_pred CceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHh
Q 003772 650 WTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIV 708 (796)
Q Consensus 650 ~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ell 708 (796)
+ ++|+|||........... ..+.....+..++|+|+||+.+..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999998754221110 11334445667999999999988664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-18 Score=170.57 Aligned_cols=141 Identities=18% Similarity=0.124 Sum_probs=110.8
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccch--------------------------hHHHHHHHHHHHhccCcCc
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE--------------------------GEREFRAEMHVIGRTHHKN 569 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--------------------------~~~~f~~E~~~l~~l~h~n 569 (796)
...||+|+||.||+|.+. +++.||||++...... ....+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 367999999999999987 6789999998754211 0112457889999999988
Q ss_pred hhhhhhhhccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhc-cCCCCeeeeccCccceEecC
Q 003772 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD-ECEAPIIHCDIKPQNILMDE 648 (796)
Q Consensus 570 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~ 648 (796)
+.....+... ..+|||||++++++...... ...++......++.|++.++.+||+ . +|+||||||+||+++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 7544433222 35899999998865444222 3457788899999999999999999 7 999999999999999
Q ss_pred CCceEEeccCCccccCC
Q 003772 649 FWTAKISDFGLAKLLMP 665 (796)
Q Consensus 649 ~~~~kl~DFgl~~~~~~ 665 (796)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.3e-19 Score=200.90 Aligned_cols=247 Identities=26% Similarity=0.333 Sum_probs=179.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHH--HhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHV--IGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
..+.+.||.+.|=.|.++++..| .|+||++-+.. .-..+.|+++++- ...++|||.+.+.-....+...|||-+|
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 34567899999999999998765 49999986533 3345556555444 4455899999998887777788888888
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc--CCCC
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL--MPDQ 667 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~--~~~~ 667 (796)
..+ +|.|.|.. +.-+...+..=|+.|++.||.-+|.. +|.|+|||.+||||+.-.=+.|+||..-+.. ..+.
T Consensus 103 vkh-nLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 876 68887754 33456666777899999999999998 9999999999999999888999999876643 2222
Q ss_pred cceeeee----ccCCCCCchhhhccC----------C-CCccccchhhHHHHHHHhhc-ccCCCCCCCCchhHHHHHHHH
Q 003772 668 TRTFTLV----RGTRGYMAPEWYKNT----------P-ISVKADVFSYGVVLLEIVCC-RRNMEIDPSKPEEIVLINWAY 731 (796)
Q Consensus 668 ~~~~~~~----~gt~~y~aPE~~~~~----------~-~t~ksDV~S~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~ 731 (796)
....+-. +.-.+|+|||.+... . ++++.||||+||++.||++- +++|.... +. ++
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-------L~--aY 247 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-------LL--AY 247 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-------HH--hH
Confidence 2222221 223479999987541 2 78999999999999999985 55554221 11 12
Q ss_pred Hhh---hhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 732 KCF---IDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 732 ~~~---~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
+.. ..+.+.+.++. ..+.+++..|++.||..|-++++.++...|+
T Consensus 248 r~~~~~~~e~~Le~Ied--------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEKIED--------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred hccCccCHHHHHHhCcC--------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 211 11122222221 2588999999999999999999999987665
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.3e-18 Score=174.36 Aligned_cols=229 Identities=18% Similarity=0.240 Sum_probs=149.0
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeec---ccchhHHHHHHHHHHHhccCc----------Cchhhhhhhhc----
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEK---MVTEGEREFRAEMHVIGRTHH----------KNLVRLIGYCA---- 578 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~---~~~~~~~~f~~E~~~l~~l~h----------~niv~l~g~~~---- 578 (796)
.+.||.|+++.||.+++...++++|+|++.- ......+.+++|...+..+.+ -.++..++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 4679999999999999999999999998743 233345677888766666432 11222222111
Q ss_pred -----cCC--------ceeEEEeecCCCChhhhhh---cCCC--CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccC
Q 003772 579 -----EDS--------KRLLVYEYMSNGSLADILF---RGPE--RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIK 640 (796)
Q Consensus 579 -----~~~--------~~~lV~e~~~~gsL~~~l~---~~~~--~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlk 640 (796)
... ..+++|+-+ .++|.+++. .... ..+....++.+..|+++.+++||+. +++|+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 111 124566655 468877753 2211 2355556677889999999999999 99999999
Q ss_pred ccceEecCCCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhcc--------CCCCccccchhhHHHHHHHhhccc
Q 003772 641 PQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN--------TPISVKADVFSYGVVLLEIVCCRR 712 (796)
Q Consensus 641 p~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~S~Gvil~elltg~~ 712 (796)
|+|++++.+|.+.|+||+.....+.... . ...+..|.+||.... -.+|.+.|.|++|+++|.|++++.
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYR---C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEE---G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceee---c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999999999999988765432111 1 234578999997744 257899999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 003772 713 NMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALR 771 (796)
Q Consensus 713 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 771 (796)
|+........... +=.... +.++.+..|+..+|+.||.+|
T Consensus 249 Pf~~~~~~~~~~~------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9985532111100 011234 677889999999999999988
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=158.70 Aligned_cols=201 Identities=25% Similarity=0.272 Sum_probs=166.7
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCc-CchhhhhhhhccCCceeEEEe
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHH-KNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e 588 (796)
...+++.++||.|.||.+|.|.....+++||||.-+... ....+.-|..+...++| ..|.++..+..+...-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 456778899999999999999998889999999875432 23456778888888864 678888888899999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec---CCCceEEeccCCccccCC
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD---EFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFgl~~~~~~ 665 (796)
.. +-||++++.- -...++....+-++-|++.-++|+|.. +++||||||+|+|+. ....+.++|||+++.+..
T Consensus 92 LL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 86 4588887642 246788899999999999999999998 999999999999996 456799999999998754
Q ss_pred CCc------ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCC
Q 003772 666 DQT------RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEID 717 (796)
Q Consensus 666 ~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~ 717 (796)
..+ .......||.+|.+-....+..-+.+.|+=|+|.+|.++.-|+.||..-
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 332 1223345899999998888888899999999999999999999999754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=161.23 Aligned_cols=185 Identities=19% Similarity=0.124 Sum_probs=139.3
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccch----hHHHHHHHHHHHhccC-cCchhhhhhhhccCCceeEEEeec
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE----GEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~----~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|.+++ |+++++++++ +..+++|||+
T Consensus 7 ~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 46799999999997665 4567887777653321 1225889999999995 5788888875 4579999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeecc-CccceEecCCCceEEeccCCccccCCCCcc
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDI-KPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
++.+|.+.+.. ....++.|++++|.++|+. +|+|||| ||+|||++.++.++|+|||++....+....
T Consensus 81 ~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 81 AGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred cCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99998754421 1135788999999999998 9999999 799999999999999999999865543310
Q ss_pred ----e--------eeeeccCCCCCchhhhccC-CCC-ccccchhhHHHHHHHhhcccCCCCCC
Q 003772 670 ----T--------FTLVRGTRGYMAPEWYKNT-PIS-VKADVFSYGVVLLEIVCCRRNMEIDP 718 (796)
Q Consensus 670 ----~--------~~~~~gt~~y~aPE~~~~~-~~t-~ksDV~S~Gvil~elltg~~p~~~~~ 718 (796)
. ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-.+.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0012257888888865432 223 56799999999999999998775543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.5e-17 Score=164.08 Aligned_cols=199 Identities=23% Similarity=0.303 Sum_probs=166.1
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeec
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+++.++||+|.||.++.|+..-.+++||||.-.. ....-+++.|....+.| ..++|...+-|-.++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 35678999999999999999888889999998543 22334567787777777 4789999888888888999999987
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec-----CCCceEEeccCCccccCC
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD-----EFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~DFgl~~~~~~ 665 (796)
+-||+|+.. .-+.+++...+.-+|.|++.-++|+|++ .+|.|||||+|+||. +...+.|+|||+++....
T Consensus 107 -GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 447877653 2367899999999999999999999999 999999999999996 345689999999998865
Q ss_pred CCcc------eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCC
Q 003772 666 DQTR------TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEID 717 (796)
Q Consensus 666 ~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~ 717 (796)
..+. ......||.+||+-.-..+..-+.+.|.=|+|-++++.+-|..||..-
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 5432 233455999999999999999999999999999999999999999744
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.8e-17 Score=161.08 Aligned_cols=134 Identities=20% Similarity=0.264 Sum_probs=105.6
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-----CcCchhhhhhhhccCC---cee-EEE
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-----HHKNLVRLIGYCAEDS---KRL-LVY 587 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-----~h~niv~l~g~~~~~~---~~~-lV~ 587 (796)
+.||+|+||.||. ++..... +||++........+.+.+|+.++..+ +||||++++|++.++. ..+ +|+
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred ceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 6799999999996 5544444 68988664444567899999999999 5799999999998763 333 789
Q ss_pred ee--cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHH-HHhhccCCCCeeeeccCccceEecC----CCceEEeccCCc
Q 003772 588 EY--MSNGSLADILFRGPERSLGWDERVRIASDVAKGI-LYLHDECEAPIIHCDIKPQNILMDE----FWTAKISDFGLA 660 (796)
Q Consensus 588 e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DFgl~ 660 (796)
|| +.+|+|.+++.+. .+++. ..++.|++.++ .|||++ +|+||||||+|||++. +..++|+||+.+
T Consensus 85 e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 99 5689999999652 35544 35677888777 899998 9999999999999973 347999995444
Q ss_pred c
Q 003772 661 K 661 (796)
Q Consensus 661 ~ 661 (796)
.
T Consensus 157 ~ 157 (210)
T PRK10345 157 S 157 (210)
T ss_pred c
Confidence 3
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.2e-17 Score=187.15 Aligned_cols=200 Identities=23% Similarity=0.272 Sum_probs=159.1
Q ss_pred CHHHHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC---cCchhhhhhhhccC
Q 003772 504 SYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH---HKNLVRLIGYCAED 580 (796)
Q Consensus 504 ~~~~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~ 580 (796)
+.-++...++.+.+.||+|+||+||+|...+ ++.||+|+-+....= +|.-=.+++.||+ -+-|+.+...+.-.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 3444555566678899999999999999877 789999987652211 0111112222332 24566677777778
Q ss_pred CceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec-------CCCceE
Q 003772 581 SKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD-------EFWTAK 653 (796)
Q Consensus 581 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~~k 653 (796)
+..+||+||.+.|||.+++. ..+.++|...+.++.|+++.+++||.. +|||+||||+|+||. +...++
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred CcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence 88999999999999999997 468899999999999999999999998 999999999999994 345699
Q ss_pred EeccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhccc
Q 003772 654 ISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRR 712 (796)
Q Consensus 654 l~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~ 712 (796)
|+|||.+..+..-.. .......+|-.+--+|...+.+.+.+.|-|.++.+++-||.|+.
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999999987643222 34556678999999999999999999999999999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.4e-17 Score=181.46 Aligned_cols=225 Identities=24% Similarity=0.281 Sum_probs=174.3
Q ss_pred ccCcccceEEEEEEE---cCCcEEEEEEEeecccch--hHHHHHHHHHHHhccC-cCchhhhhhhhccCCceeEEEeecC
Q 003772 518 ELGKGSFGAVYKGTL---YKGEKLVAVKKLEKMVTE--GEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 518 ~LG~G~fg~Vy~g~~---~~~~~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+|+|.||.|++..- .+.+..+|.|.+.+.... .....+.|..++...+ |+.++++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999986532 334556788877653221 1124567888888887 9999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+|.|...+.+ ...........+...++-+++++|+. +|+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 81 GGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 9999888866 45677777788888999999999998 9999999999999999999999999999976544333
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc-CCCCCH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR-GQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 750 (796)
+||.-|||||++. .....+|.||||++++||++|-.||..+ + ...++. ....+.
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~------~--------------~~~Il~~~~~~p~ 208 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD------T--------------MKRILKAELEMPR 208 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH------H--------------HHHHhhhccCCch
Confidence 6899999999999 4678899999999999999999999651 0 111111 112344
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSM 774 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~ 774 (796)
+......+++..++..+|..|--.
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 455556666666777777777554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.2e-16 Score=160.21 Aligned_cols=142 Identities=19% Similarity=0.195 Sum_probs=109.4
Q ss_pred HhhhcccCcccceEEEEEE-EcCCcEEEEEEEeecccch------------------------hHHHHHHHHHHHhccCc
Q 003772 513 NRFKEELGKGSFGAVYKGT-LYKGEKLVAVKKLEKMVTE------------------------GEREFRAEMHVIGRTHH 567 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~-~~~~~~~vAvK~l~~~~~~------------------------~~~~f~~E~~~l~~l~h 567 (796)
+.+.+.||+|+||.||+|. ....++.||||++...... ....+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4566889999999999998 5556789999998643210 11235679999999975
Q ss_pred Cc--hhhhhhhhccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCC-eeeeccCccce
Q 003772 568 KN--LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP-IIHCDIKPQNI 644 (796)
Q Consensus 568 ~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~-ivH~Dlkp~NI 644 (796)
.+ +.++++. ...++||||+++++|...+.. ...+.......++.|++.+|.+||+. + |+||||||+||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NI 180 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNI 180 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhE
Confidence 33 3333332 345899999999888776533 23455566789999999999999998 8 99999999999
Q ss_pred EecCCCceEEeccCCccccC
Q 003772 645 LMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 645 ll~~~~~~kl~DFgl~~~~~ 664 (796)
+++ ++.++|+|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.8e-16 Score=159.95 Aligned_cols=195 Identities=19% Similarity=0.236 Sum_probs=137.3
Q ss_pred CcCchhhhhhhhcc---------------------------CCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHH
Q 003772 566 HHKNLVRLIGYCAE---------------------------DSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASD 618 (796)
Q Consensus 566 ~h~niv~l~g~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 618 (796)
+|||||++++++.+ ....|+||.-.+. +|+++|.. ...+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~---~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT---RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc---CCCchHHHHHHHHH
Confidence 68999998887753 2235788876654 89999865 44566677788899
Q ss_pred HHHHHHHhhccCCCCeeeeccCccceEec--CCC--ceEEeccCCccccCC-----CCcceeeeeccCCCCCchhhhccC
Q 003772 619 VAKGILYLHDECEAPIIHCDIKPQNILMD--EFW--TAKISDFGLAKLLMP-----DQTRTFTLVRGTRGYMAPEWYKNT 689 (796)
Q Consensus 619 ia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DFgl~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~ 689 (796)
+++|+.|||.+ +|.|||+|++|||+. +|. .+.|+|||++---.. +..+-.....|.-.-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999998 999999999999993 443 478999998743221 111222234577889999998643
Q ss_pred C------CCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHh
Q 003772 690 P------ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWC 763 (796)
Q Consensus 690 ~------~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 763 (796)
+ --.|+|.|+.|.+.||+++.+.||..... ..+.... +.+.++. ..+..++..+.+++...
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe----m~L~~r~---Yqe~qLP------alp~~vpp~~rqlV~~l 493 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE----MLLDTRT---YQESQLP------ALPSRVPPVARQLVFDL 493 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccch----heechhh---hhhhhCC------CCcccCChHHHHHHHHH
Confidence 1 24689999999999999999999975321 1111101 1111111 12345667789999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 003772 764 VQDEPALRPSMKSVVLM 780 (796)
Q Consensus 764 l~~dP~~RPt~~evl~~ 780 (796)
|+.||++||+..-....
T Consensus 494 L~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 494 LKRDPSKRVSPNIAANV 510 (598)
T ss_pred hcCCccccCCccHHHhH
Confidence 99999999997544433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=8e-16 Score=155.63 Aligned_cols=134 Identities=19% Similarity=0.311 Sum_probs=112.4
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccch--------hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE--------GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
+.||+|++|.||+|.. .+..|++|+....... ....+.+|+.++..++|+++.....++.+....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999987 3456888876532211 12457889999999999999888777777788899999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
|+++++|.+++.... . .+..++.+++.+|.+||+. +++|+|++|.||+++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999985421 1 7889999999999999998 999999999999999 78899999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.8e-17 Score=172.32 Aligned_cols=173 Identities=24% Similarity=0.276 Sum_probs=129.5
Q ss_pred ceeEEEeecCCCChhhhhhcC-CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCc
Q 003772 582 KRLLVYEYMSNGSLADILFRG-PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA 660 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~ 660 (796)
..++.|+++...+|.++|.+. .....++...+.++.|++.|+.| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999743 45678889999999999999999 5 8999999999999999999999999999
Q ss_pred cccCCCC-----cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhh
Q 003772 661 KLLMPDQ-----TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCF 734 (796)
Q Consensus 661 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 734 (796)
....... ....+...||..||+||.+.+..++.|+||||||++|+|++. -...++.. .+...+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-----------~t~~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-----------ATLTDI 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------Hhhhhh
Confidence 8765544 234455679999999999999999999999999999999996 22222100 011111
Q ss_pred hhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 003772 735 IDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777 (796)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 777 (796)
.++.+... ....-+.-+.++.+++.+.|.+||+..++
T Consensus 473 r~g~ip~~------~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 473 RDGIIPPE------FLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hcCCCChH------HhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 11111100 00111334577889999999999944443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.7e-15 Score=151.73 Aligned_cols=130 Identities=21% Similarity=0.342 Sum_probs=106.8
Q ss_pred ccCcccceEEEEEEEcCCcEEEEEEEeecccc--------hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--------EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 518 ~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
.||+|+||.||+|... +..|++|+...... ...+.+.+|++++..++|+++.....++.+....++||||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 4899999999999853 46788998643211 1135678899999999998876666666667778999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
+++++|.+.+.... . .++.+++++|.+||+. +++|+|++|+||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999875421 0 7899999999999998 999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.7e-15 Score=172.82 Aligned_cols=133 Identities=22% Similarity=0.315 Sum_probs=109.1
Q ss_pred hhcccCcccceEEEEEEEcCCcEEEEEEEe-ecc-cc------hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKL-EKM-VT------EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l-~~~-~~------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
..+.||+|+||.||+|.+.... +++|+. .+. .. ...+.+.+|++++.+++|++++....++.+....++|
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 4578999999999999886543 333332 211 11 1235688999999999999998887777777788999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
|||+++++|.+++. ....++.+++++|.+||+. +++||||||+||++ +++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999884 3567999999999999998 99999999999999 6789999999999753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=4e-15 Score=148.82 Aligned_cols=136 Identities=18% Similarity=0.166 Sum_probs=106.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc----------------------hhHHHHHHHHHHHhccCcCc-
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT----------------------EGEREFRAEMHVIGRTHHKN- 569 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~----------------------~~~~~f~~E~~~l~~l~h~n- 569 (796)
+.+.+.||+|+||.||++... +++.||||++..... .....+..|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 566788999999999999885 567899998754220 01123567888888888774
Q ss_pred -hhhhhhhhccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC
Q 003772 570 -LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE 648 (796)
Q Consensus 570 -iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 648 (796)
++..++ ....++||||+++++|.+.... .....++.++++++.++|+. +|+|+||||+||++++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDD 160 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcC
Confidence 333333 3456899999999998775421 34567899999999999998 9999999999999999
Q ss_pred CCceEEeccCCccccC
Q 003772 649 FWTAKISDFGLAKLLM 664 (796)
Q Consensus 649 ~~~~kl~DFgl~~~~~ 664 (796)
++.++|+|||++....
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 9999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.9e-15 Score=170.97 Aligned_cols=206 Identities=23% Similarity=0.282 Sum_probs=141.1
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
.+.|..|+||.||..+++...+++|+|+=++.. -.++ ++.....|. .| |+-
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn---ilt~a~npf---------------vv------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN---ILTFAGNPF---------------VV------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcccccch-----hhhc---cccccCCcc---------------ee------chh
Confidence 467899999999999998777888884322210 0011 111222222 22 444
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC--------C
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD--------Q 667 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~--------~ 667 (796)
...++. -+.++... +.+++|||+. +|+|||+||+|.+|+.-|.+|+.|||+++..... .
T Consensus 139 ~tllk~--~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 139 ATLLKN--IGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred hhhccc--CCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence 444433 12333322 7899999999 9999999999999999999999999999864211 1
Q ss_pred ----c--ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 668 ----T--RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 668 ----~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
. .....++||+-|+|||++....|...+|.|++|+|+||.+-|..||..+..++ .+ ..-+.+
T Consensus 206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lf---------g~visd 273 (1205)
T KOG0606|consen 206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LF---------GQVISD 273 (1205)
T ss_pred hHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HH---------hhhhhh
Confidence 1 11233579999999999999999999999999999999999999998664221 11 111112
Q ss_pred hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 003772 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMK 775 (796)
Q Consensus 742 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 775 (796)
.+.-.+.......+...++...|+.+|.+|--..
T Consensus 274 ~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 274 DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 2222223444556788888899999999995443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=3e-14 Score=141.10 Aligned_cols=137 Identities=19% Similarity=0.209 Sum_probs=94.6
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccchhH--HHH----------------------HHHHHHHhccCcCc--
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE--REF----------------------RAEMHVIGRTHHKN-- 569 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~--~~f----------------------~~E~~~l~~l~h~n-- 569 (796)
.+.||+|+||.||++... +++.||||++........ ..+ ..|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 567899999865322111 111 23344444433222
Q ss_pred hhhhhhhhccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhc-cCCCCeeeeccCccceEecC
Q 003772 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD-ECEAPIIHCDIKPQNILMDE 648 (796)
Q Consensus 570 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~ 648 (796)
+.+.+++ ...++||||++++++......... .. .....++.+++.++.++|. . +|+|+||||+||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 2222221 246899999999654322111100 11 6678899999999999998 6 999999999999999
Q ss_pred CCceEEeccCCccccC
Q 003772 649 FWTAKISDFGLAKLLM 664 (796)
Q Consensus 649 ~~~~kl~DFgl~~~~~ 664 (796)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=5.1e-14 Score=141.46 Aligned_cols=208 Identities=22% Similarity=0.331 Sum_probs=144.8
Q ss_pred HHHHHHHHhccCcCchhhhhhhhccC-----CceeEEEeecCCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhh
Q 003772 555 FRAEMHVIGRTHHKNLVRLIGYCAED-----SKRLLVYEYMSNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLH 627 (796)
Q Consensus 555 f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH 627 (796)
.+.-...|-++.|.|||+++.|+.+. .+..++.|||+.|+|..+|++. ..+.+......+|+-||+.||.|||
T Consensus 114 ~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 114 RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh
Confidence 33445566677899999999998753 3578999999999999999864 3466888888899999999999999
Q ss_pred ccCCCCeeeeccCccceEecCCCceEEeccCCcccc---CCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHH
Q 003772 628 DECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL---MPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVL 704 (796)
Q Consensus 628 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil 704 (796)
+. .++|+|+++..+.|++..++-+||.----.... ............+-++|.|||+-.....+..+|||+||.+.
T Consensus 194 s~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 194 SC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred cc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 84 789999999999999999998888632111110 00011111223367899999998888899999999999999
Q ss_pred HHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 705 LEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 705 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
+||.-+..-......... . +..+...+...+ ...=..++..|++..|..||+|.+++..
T Consensus 273 lemailEiq~tnseS~~~----~--------ee~ia~~i~~le-----n~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 273 LEMAILEIQSTNSESKVE----V--------EENIANVIIGLE-----NGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHHHheeccCCCcceee----h--------hhhhhhheeecc-----CccccCcCcccccCCCCCCcchhhhhcC
Confidence 999877653222111100 0 000011110000 0111234556999999999999998643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=9.2e-14 Score=131.94 Aligned_cols=134 Identities=19% Similarity=0.192 Sum_probs=114.0
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCc--CchhhhhhhhccCCceeEEEeecCCC
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHH--KNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++++++++....+..++++||++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred ceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 3679999999999999854 5799999865433 5678899999999987 58889988888888899999999987
Q ss_pred ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 594 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
.+..+ +......++.+++++|.+||.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76543 4567778899999999999986445799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.8e-13 Score=138.93 Aligned_cols=134 Identities=17% Similarity=0.164 Sum_probs=104.0
Q ss_pred cccC-cccceEEEEEEEcCCcEEEEEEEeeccc-------------chhHHHHHHHHHHHhccCcCch--hhhhhhhccC
Q 003772 517 EELG-KGSFGAVYKGTLYKGEKLVAVKKLEKMV-------------TEGEREFRAEMHVIGRTHHKNL--VRLIGYCAED 580 (796)
Q Consensus 517 ~~LG-~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-------------~~~~~~f~~E~~~l~~l~h~ni--v~l~g~~~~~ 580 (796)
..|| .||.|+||..... +..++||++.... ......+.+|+.++.+++|+++ ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4687 8899999998874 4578999885311 1223457889999999998885 6677664432
Q ss_pred C----ceeEEEeecCC-CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEe
Q 003772 581 S----KRLLVYEYMSN-GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKIS 655 (796)
Q Consensus 581 ~----~~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 655 (796)
. ..++|+|++++ .+|.+++.. ..++.. .+.+|+++|.+||+. +|+|+||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 699988854 234433 367899999999998 99999999999999998899999
Q ss_pred ccCCccc
Q 003772 656 DFGLAKL 662 (796)
Q Consensus 656 DFgl~~~ 662 (796)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.4e-15 Score=168.48 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=187.3
Q ss_pred HhhhcccCcccceEEEEEEEcCC-cEEEEEEEeeccc--chhHHHHHHHHHHHhccC-cCchhhhhhhhccCCceeEEEe
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKG-EKLVAVKKLEKMV--TEGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~-~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e 588 (796)
+++.+.||+|.|+.|-......+ ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++.+
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 45556799999999988776433 3466777665433 222344555777777776 9999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhh-ccCCCCeeeeccCccceEecCCC-ceEEeccCCccccCC-
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLH-DECEAPIIHCDIKPQNILMDEFW-TAKISDFGLAKLLMP- 665 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgl~~~~~~- 665 (796)
|..++++.+.+........+....-.++.|+..++.|+| .. ++.|+||||+|.+++..+ ..+++|||++..+..
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999884322336677788889999999999999 76 999999999999999999 999999999998876
Q ss_pred -CCcceeeeecc-CCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 666 -DQTRTFTLVRG-TRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 666 -~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
+.........| ++.|+|||...+. -..+..|+||.|+++.-+++|..|+........... .|...+ ....
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~--~~~~~~---~~~~-- 251 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS--SWKSNK---GRFT-- 251 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce--eecccc---cccc--
Confidence 33344445668 9999999999884 457789999999999999999999876543332111 111100 0000
Q ss_pred hcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 003772 743 VRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVV 778 (796)
Q Consensus 743 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 778 (796)
...-........++...++..+|..|.+.+++.
T Consensus 252 ---~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 252 ---QLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ---cCccccCChhhhhcccccccCCchhcccccccc
Confidence 001112234466777778889999999988874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.31 E-value=5.8e-12 Score=140.41 Aligned_cols=141 Identities=24% Similarity=0.276 Sum_probs=97.0
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchh----------------------------------------HHHHH
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG----------------------------------------EREFR 556 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~----------------------------------------~~~f~ 556 (796)
+.||.|++|.||+|++.+ ++.||||+......+. +-.|.
T Consensus 123 ~plasaSigQVh~A~l~~-G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVD-GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEecC-CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 359999999999999975 4789999985432111 01244
Q ss_pred HHHHHHhccC----cCchhhhhhhh-ccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHH-HHHHhhccC
Q 003772 557 AEMHVIGRTH----HKNLVRLIGYC-AEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAK-GILYLHDEC 630 (796)
Q Consensus 557 ~E~~~l~~l~----h~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-aL~~LH~~~ 630 (796)
+|+..+.+++ |.+-+.+-..+ ......+|||||+++++|.++...... .. .+..++.++++ .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC-
Confidence 4555444442 22222222222 223457899999999999987643211 11 34556777666 46778887
Q ss_pred CCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 631 ~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
+++|+|+||.||++++++.++++|||++..+..
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.1e-11 Score=132.63 Aligned_cols=136 Identities=21% Similarity=0.205 Sum_probs=89.0
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchh----------------------------------HHHHHHHHHHH
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG----------------------------------EREFRAEMHVI 562 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~----------------------------------~~~f~~E~~~l 562 (796)
+.||+|++|.||+|+++++++.||||++.+...+. .+.+.+|++..
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 36999999999999998867899999997532110 11122233332
Q ss_pred hccCcCchhhhhhhhcc-------------CCceeEEEeecCCCChhhhh--hcCC--CCCCchhHHHHHHHHHHHHHHH
Q 003772 563 GRTHHKNLVRLIGYCAE-------------DSKRLLVYEYMSNGSLADIL--FRGP--ERSLGWDERVRIASDVAKGILY 625 (796)
Q Consensus 563 ~~l~h~niv~l~g~~~~-------------~~~~~lV~e~~~~gsL~~~l--~~~~--~~~l~~~~~~~i~~~ia~aL~~ 625 (796)
... +|+.++...+.+ ....+|||||++|+.|.++- .+.. .+.+.......++.|+.
T Consensus 205 ~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif----- 277 (537)
T PRK04750 205 REA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF----- 277 (537)
T ss_pred HHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-----
Confidence 222 344444443332 23457999999999998753 2210 01233333334444443
Q ss_pred hhccCCCCeeeeccCccceEecCCC----ceEEeccCCccccC
Q 003772 626 LHDECEAPIIHCDIKPQNILMDEFW----TAKISDFGLAKLLM 664 (796)
Q Consensus 626 LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFgl~~~~~ 664 (796)
.. +++|+|+||.||+++.++ ++++.|||+...+.
T Consensus 278 --~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 --RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred --hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 23 999999999999999888 99999999997654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=8.5e-12 Score=136.75 Aligned_cols=255 Identities=20% Similarity=0.216 Sum_probs=185.5
Q ss_pred CHHHHHHHHHhhhcccCc--ccceEEEEEEE--cCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccC-cCchhhhhhh
Q 003772 504 SYNELKKATNRFKEELGK--GSFGAVYKGTL--YKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTH-HKNLVRLIGY 576 (796)
Q Consensus 504 ~~~~l~~~~~~~~~~LG~--G~fg~Vy~g~~--~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~-h~niv~l~g~ 576 (796)
...+.+.....+.+.+|. |.+|.||.+.. ......+|+|+-+.... .....=.+|+..-.+++ |+|.++....
T Consensus 107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred CccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 344555666677888999 99999999998 77778899998654333 22222345666666664 9999998888
Q ss_pred hccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHH----HHHHhhccCCCCeeeeccCccceEecCC-Cc
Q 003772 577 CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAK----GILYLHDECEAPIIHCDIKPQNILMDEF-WT 651 (796)
Q Consensus 577 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~ 651 (796)
+...+..++-+|++. .+|.++.+.. ...++....+....+..+ ||.++|+. .++|-|+||.||++..+ ..
T Consensus 187 ~e~~~~lfiqtE~~~-~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 187 WEGSGILFIQTELCG-ESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred cccCCcceeeecccc-chhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccce
Confidence 888899999999876 6777777542 345777788888888888 99999998 99999999999999999 89
Q ss_pred eEEeccCCccccCCCCcc----eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHH
Q 003772 652 AKISDFGLAKLLMPDQTR----TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLI 727 (796)
Q Consensus 652 ~kl~DFgl~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~ 727 (796)
.++.|||+...+...... ......|...|++||...+. ++..+|+|++|.++.|..++..+.......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------- 333 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNS------- 333 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCC-------
Confidence 999999999988765422 12223577889999988764 788999999999999999988766543211
Q ss_pred HHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 003772 728 NWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVV 778 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 778 (796)
.|. . +.......++-......+..++..+++.+|..|++...+.
T Consensus 334 ~W~--~-----~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 334 SWS--Q-----LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred Ccc--c-----cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 110 0 0111111111111123344578889999999999887765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.1e-10 Score=125.59 Aligned_cols=171 Identities=16% Similarity=0.204 Sum_probs=129.8
Q ss_pred EEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCChhhhhhcCCCCCCc
Q 003772 529 KGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLG 608 (796)
Q Consensus 529 ~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~ 608 (796)
.|..+..+.+|.|...+..........++-++.|+.++||||++++.....++..|||+|-+. .|..++.+ +.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~ 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LG 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hH
Confidence 466666778899998877555445567888999999999999999999999999999999875 46666654 22
Q ss_pred hhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhcc
Q 003772 609 WDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN 688 (796)
Q Consensus 609 ~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 688 (796)
.....--+.||+.||.|||+.| +++|++|..+.|+++..|..||++|.+......... ......--..|..|+.+..
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence 4455567889999999999764 999999999999999999999999988865432211 0000111234666665543
Q ss_pred CCCCccccchhhHHHHHHHhhcc
Q 003772 689 TPISVKADVFSYGVVLLEIVCCR 711 (796)
Q Consensus 689 ~~~t~ksDV~S~Gvil~elltg~ 711 (796)
.. -..|.|-||++++|++.|.
T Consensus 180 s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCcc
Confidence 32 3469999999999999983
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.6e-11 Score=98.11 Aligned_cols=60 Identities=22% Similarity=0.422 Sum_probs=50.8
Q ss_pred ccceeeecccCCCccce--eeccCCHHHHHHHhccCCcceeeecccccCCCCCceeccccCCcc
Q 003772 345 EYNMTSMEKMTWDDYYY--FKASITKEECKESCLEDCECDVALYEESVDDKPSYCTKQKLPLKS 406 (796)
Q Consensus 345 ~~~~~~~~~~~~~~~~~--~~~~~s~~~C~~~Cl~nCsC~a~~y~~~~~~~~~~c~~~~~~l~~ 406 (796)
.++|+++++|++|++.. +..++++++|++.||+||||+||+|.+.. ++++|..|.+.|.+
T Consensus 4 ~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~--~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 4 GDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS--GGGGCLLWYGDLVD 65 (66)
T ss_pred CCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC--CCCEEEEEcCEeec
Confidence 35899999999999855 44779999999999999999999996421 56899999998865
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.3e-10 Score=112.90 Aligned_cols=130 Identities=17% Similarity=0.117 Sum_probs=96.4
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchh-hhhhhhccCCceeEEEeecCCCCh
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLV-RLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
+.|+.|.++.||+++.. ++.+++|....... ....+..|+..+..+.+.+++ +++.+ .....++||||+++.++
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence 46889999999999874 56799999754322 233567899999988765554 34433 33456899999999887
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccC--CCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDEC--EAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
.+.- .....++.+++++|..||... ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6431 112345789999999999873 22369999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.4e-09 Score=106.50 Aligned_cols=138 Identities=15% Similarity=0.171 Sum_probs=97.8
Q ss_pred cccCcccceEEEEEEEcC------CcEEEEEEEeecccc----------------------hhHHHHH----HHHHHHhc
Q 003772 517 EELGKGSFGAVYKGTLYK------GEKLVAVKKLEKMVT----------------------EGEREFR----AEMHVIGR 564 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~------~~~~vAvK~l~~~~~----------------------~~~~~f~----~E~~~l~~ 564 (796)
..||.|.-+.||.|...+ .+..+|||+...... ...+.++ .|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998654 246899998742110 1122333 78888888
Q ss_pred cCc--CchhhhhhhhccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHh-hccCCCCeeeeccCc
Q 003772 565 THH--KNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL-HDECEAPIIHCDIKP 641 (796)
Q Consensus 565 l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~ivH~Dlkp 641 (796)
+.. -++.+++++ ...+|||||+.+..+.....+ ...++......+..+++.+|..| |.. +++|+||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 854 344555543 567899999987544322111 12344456677889999999999 776 999999999
Q ss_pred cceEecCCCceEEeccCCccccC
Q 003772 642 QNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 642 ~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
.||++++ +.+.|+|||.+....
T Consensus 154 ~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEEC-CcEEEEECCCceeCC
Confidence 9999974 679999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.2e-09 Score=112.91 Aligned_cols=217 Identities=16% Similarity=0.176 Sum_probs=155.0
Q ss_pred cceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhc----cCCceeEEEeecCC-CChhh
Q 003772 523 SFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCA----EDSKRLLVYEYMSN-GSLAD 597 (796)
Q Consensus 523 ~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lV~e~~~~-gsL~~ 597 (796)
...+.||+....++..+.+|+++....+.......-+++++++.|.|+|++..++. .+...++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34678999988888899999996544433333445678899999999999999886 34568999999985 68888
Q ss_pred hhhcC-------------CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 598 ILFRG-------------PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 598 ~l~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+-+.. .....++..+|.++.|+..||.++|+. |..-+-|.+.+|+++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 76542 124577899999999999999999999 99999999999999999999999999988776
Q ss_pred CCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
.+..... |. -.+-|.=.||.+++.|.||........... +.. .
T Consensus 445 ~d~~~~l------------e~------~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~-~s~--------------~---- 487 (655)
T KOG3741|consen 445 EDPTEPL------------ES------QQQNDLRDLGLLLLALATGTENSNRTDSTQ-SSH--------------L---- 487 (655)
T ss_pred CCCCcch------------hH------HhhhhHHHHHHHHHHHhhcccccccccchH-HHH--------------H----
Confidence 5541111 11 134688899999999999975432111100 000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLML 781 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 781 (796)
+.+......++.+++.-....++++ -++.+++.++
T Consensus 488 -~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 488 -TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred -HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 0111233445666666666666666 6666666554
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=98.96 E-value=8.7e-10 Score=93.47 Aligned_cols=72 Identities=19% Similarity=0.378 Sum_probs=57.8
Q ss_pred cceeeecccCCCccceeeccCCHHHHHHHhccCCcceeeecccccCCCCCceeccccCCcccccccCCCCCccceeee
Q 003772 346 YNMTSMEKMTWDDYYYFKASITKEECKESCLEDCECDVALYEESVDDKPSYCTKQKLPLKSAKRDLKNSSSSIAYFKT 423 (796)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~y~~~~~~~~~~c~~~~~~l~~~~~~~~~~~~~~~~l~~ 423 (796)
+.|+.+.++++|+..+...++++++|++.|++||+|.||+|.+ +.++|+.|..++.+....... +..+|+|+
T Consensus 12 ~~f~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~----~~~~C~~~~~~~~~~~~~~~~--~~~~yiKv 83 (84)
T cd01098 12 DGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNN----GSGGCLLWNGLLNNLRSLSSG--GGTLYLRL 83 (84)
T ss_pred CEEEEeCCeeCCCchhhhccCCHHHHHHHHhcCCCcceeeecC----CCCeEEEEeceecceEeecCC--CcEEEEEe
Confidence 5788999999998765337889999999999999999999974 367899999988776653322 46788876
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.4e-10 Score=123.42 Aligned_cols=244 Identities=20% Similarity=0.218 Sum_probs=173.4
Q ss_pred hhhcccCcccceEEEEEEEc-CCcEEEEEEEeecccchhHHHH--HHHHHHHhcc-CcCchhhhhhhhccCCceeEEEee
Q 003772 514 RFKEELGKGSFGAVYKGTLY-KGEKLVAVKKLEKMVTEGEREF--RAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~-~~~~~vAvK~l~~~~~~~~~~f--~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
++...||.|.|+.|++.... .++..+++|.+.+.......++ ..|+.+...+ .|.++++....+......++=-||
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 34467999999999987654 5667889998866444333322 3455555555 588899988888888888899999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC-CceEEeccCCccccCCCCc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF-WTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFgl~~~~~~~~~ 668 (796)
++++++...+.- ...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||....+.-
T Consensus 348 ~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~--- 419 (524)
T KOG0601|consen 348 CEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF--- 419 (524)
T ss_pred hcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccce---
Confidence 999988776622 35677888899999999999999987 99999999999999886 8889999999864211
Q ss_pred ceeeeeccCCCC-CchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC-
Q 003772 669 RTFTLVRGTRGY-MAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ- 746 (796)
Q Consensus 669 ~~~~~~~gt~~y-~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 746 (796)
........+..| .+|+......+-.+.|++|||.-+.|.+++......... ...+....
T Consensus 420 ~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------------------~~~i~~~~~ 480 (524)
T KOG0601|consen 420 SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------------------SLTIRSGDT 480 (524)
T ss_pred ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------------------ceeeecccc
Confidence 111111123334 466777788899999999999999999988754332110 00011110
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
........++..++..++..++..||...++..+.+-+
T Consensus 481 p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 481 PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 01111225566677779999999999998887665443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.92 E-value=5.2e-09 Score=106.46 Aligned_cols=142 Identities=20% Similarity=0.279 Sum_probs=109.5
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcC--chhhhhhhhccCC---ceeEEEeec
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHK--NLVRLIGYCAEDS---KRLLVYEYM 590 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~--niv~l~g~~~~~~---~~~lV~e~~ 590 (796)
+.|+.|..+.||+++..+ ++.+++|+...... .....+..|+++++.+++. ++.+++.+..+.. ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 468999999999998754 36789998754322 1345788999999999764 4567777766543 568999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccC----------------------------------------
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC---------------------------------------- 630 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~---------------------------------------- 630 (796)
++.++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99988776532 34677778888889999998888531
Q ss_pred -------------CCCeeeeccCccceEecC--CCceEEeccCCccc
Q 003772 631 -------------EAPIIHCDIKPQNILMDE--FWTAKISDFGLAKL 662 (796)
Q Consensus 631 -------------~~~ivH~Dlkp~NIll~~--~~~~kl~DFgl~~~ 662 (796)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=8.4e-09 Score=96.73 Aligned_cols=142 Identities=19% Similarity=0.270 Sum_probs=106.6
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEE-Eeecccch-------hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVK-KLEKMVTE-------GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK-~l~~~~~~-------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
...+-+|+-+.|+++... ++...|| ++.+.... ..++.++|++.|.+++--.|.-..-++.+.....|+|
T Consensus 12 l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred ceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 356889999999999884 3444455 44442221 2356788999999887666655555666777888999
Q ss_pred eecCC-CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC---ceEEeccCCccc
Q 003772 588 EYMSN-GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW---TAKISDFGLAKL 662 (796)
Q Consensus 588 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFgl~~~ 662 (796)
||+++ .++.+++...............++.+|-+.+.-||.. .|+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99986 4888888765444444444478999999999999999 999999999999996543 458999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.2e-08 Score=96.47 Aligned_cols=131 Identities=22% Similarity=0.335 Sum_probs=102.1
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEE-eecccch-------hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKK-LEKMVTE-------GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~-l~~~~~~-------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
..+++|+-+.+|.+.+.+. .+.+|. +.+.... ..+.-++|+.++.+++--.|.-..-+..+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~--~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL--PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeeccCc--ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 3578999999999977433 345553 3332221 12346789999999877677666667778888999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
|+++-.|.+.+... ...++..+-..+.-||.. +|+|+||.++||++..+. +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999998653 366788888889999998 999999999999998775 99999999974
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.5e-09 Score=87.32 Aligned_cols=66 Identities=11% Similarity=0.206 Sum_probs=53.4
Q ss_pred ceeeecccCCCccceeeccCCHHHHHHHhcc---CCcceeeecccccCCCCCceeccccCC-cccccccCCCCCccceee
Q 003772 347 NMTSMEKMTWDDYYYFKASITKEECKESCLE---DCECDVALYEESVDDKPSYCTKQKLPL-KSAKRDLKNSSSSIAYFK 422 (796)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~y~~~~~~~~~~c~~~~~~l-~~~~~~~~~~~~~~~~l~ 422 (796)
.|+++.+|++|+... .+++||+++|++ ||||+||+|.+ .+.+|..|.+.+ .+.+..... +.++|+|
T Consensus 10 ~fl~~~~~klpd~~~----~s~~eC~~~Cl~~~~nCsC~Aya~~~----~~~gC~~W~~~l~~d~~~~~~~--g~~Ly~r 79 (80)
T cd00129 10 TTLIKIALKIKTTKA----NTADECANRCEKNGLPFSCKAFVFAK----ARKQCLWFPFNSMSGVRKEFSH--GFDLYEN 79 (80)
T ss_pred eEEEeecccCCcccc----cCHHHHHHHHhcCCCCCCceeeeccC----CCCCeEEecCcchhhHHhccCC--CceeEeE
Confidence 588888899887654 789999999999 99999999964 235899999999 887766443 5677775
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.5e-09 Score=123.33 Aligned_cols=242 Identities=20% Similarity=0.196 Sum_probs=162.3
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecc---cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
+-+-+|.++.++.+.-...+...++|..... .....+..+.+-.++-..+||-+++..--+.-.....|+++|..++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 3567778888876654433323333332211 1111222333333333344566665554445567789999999999
Q ss_pred ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC---------
Q 003772 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM--------- 664 (796)
Q Consensus 594 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~--------- 664 (796)
+|...|+.. ...+.+-....+..+.+++.|||.. .+.|+|++|.|++...++..+++||+......
T Consensus 890 ~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~s 964 (1205)
T KOG0606|consen 890 DLPSKLHNS--GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLS 964 (1205)
T ss_pred CchhhhhcC--CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCcc
Confidence 999999763 4566666777888899999999997 79999999999999999999999998433221
Q ss_pred ------------C----CC-----cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchh
Q 003772 665 ------------P----DQ-----TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEE 723 (796)
Q Consensus 665 ------------~----~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~ 723 (796)
. .. ........+|+.|.+||...+......+|.|+.|++++|.++|..||.......
T Consensus 965 g~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~-- 1042 (1205)
T KOG0606|consen 965 GPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ-- 1042 (1205)
T ss_pred cccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh--
Confidence 0 00 011233558999999999999999999999999999999999999997543211
Q ss_pred HHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 003772 724 IVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMK 775 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 775 (796)
..+..+...+....-+.+..+.+..++...+..+|..|-.|.
T Consensus 1043 ----------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 ----------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ----------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 111111111111222445556777888888889999998776
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.7e-08 Score=99.07 Aligned_cols=132 Identities=15% Similarity=0.046 Sum_probs=97.2
Q ss_pred EEEEEEEcCCcEEEEEEEeecccch-hHH----------HHHHHHHHHhccCcCchh--hhhhhhcc-----CCceeEEE
Q 003772 526 AVYKGTLYKGEKLVAVKKLEKMVTE-GER----------EFRAEMHVIGRTHHKNLV--RLIGYCAE-----DSKRLLVY 587 (796)
Q Consensus 526 ~Vy~g~~~~~~~~vAvK~l~~~~~~-~~~----------~f~~E~~~l~~l~h~niv--~l~g~~~~-----~~~~~lV~ 587 (796)
.|.+..+ +++.+.||+....... ..+ .+.+|...+.++...+|. .++++... ....+||+
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 4667665 4568999977442211 111 377899999888655543 44555533 23578999
Q ss_pred eecCCC-ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-------CCceEEeccCC
Q 003772 588 EYMSNG-SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE-------FWTAKISDFGL 659 (796)
Q Consensus 588 e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~~kl~DFgl 659 (796)
|++++- +|.+++........+......++.++++.+.-||.. +|+|+|++++|||++. +..+.|+||+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 999986 899998543234455667789999999999999999 9999999999999985 56899999999
Q ss_pred ccc
Q 003772 660 AKL 662 (796)
Q Consensus 660 ~~~ 662 (796)
+..
T Consensus 192 ~~~ 194 (268)
T PRK15123 192 AQI 194 (268)
T ss_pred ccc
Confidence 864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.6e-07 Score=91.84 Aligned_cols=126 Identities=25% Similarity=0.285 Sum_probs=82.4
Q ss_pred EEEEEEEcCCcEEEEEEEeecccc--------------------------hhHHHHHHHHHHHhccCcC--chhhhhhhh
Q 003772 526 AVYKGTLYKGEKLVAVKKLEKMVT--------------------------EGEREFRAEMHVIGRTHHK--NLVRLIGYC 577 (796)
Q Consensus 526 ~Vy~g~~~~~~~~vAvK~l~~~~~--------------------------~~~~~f~~E~~~l~~l~h~--niv~l~g~~ 577 (796)
.||.|...++ ..+|||+...... ......++|...|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~~~-~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDPDG-EEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEECTT-EEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECCCC-CEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 3899987654 6899998732100 0123457799999999766 45555543
Q ss_pred ccCCceeEEEeecC--CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHh-hccCCCCeeeeccCccceEecCCCceEE
Q 003772 578 AEDSKRLLVYEYMS--NGSLADILFRGPERSLGWDERVRIASDVAKGILYL-HDECEAPIIHCDIKPQNILMDEFWTAKI 654 (796)
Q Consensus 578 ~~~~~~~lV~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~ivH~Dlkp~NIll~~~~~~kl 654 (796)
....|||||++ +..+..+... .++......++.+++..+..+ |.. +|+|+||.+.||+++++ .+.|
T Consensus 79 ---~~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 ---NRNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---ETTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---eCCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 35689999998 5555443321 222455677888888866664 666 99999999999999988 9999
Q ss_pred eccCCccccC
Q 003772 655 SDFGLAKLLM 664 (796)
Q Consensus 655 ~DFgl~~~~~ 664 (796)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999997643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.65 E-value=9.4e-08 Score=86.00 Aligned_cols=85 Identities=31% Similarity=0.549 Sum_probs=63.8
Q ss_pred EEEecCCceEEEcCC-CceeEeecCCCC--CceeEEEecCcCEEEeecCCCccccccCCCCccccCCCCCCCCCeeeecc
Q 003772 96 LTLTKDGKLILRTEE-GHDKVVAAGKSE--PASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRI 172 (796)
Q Consensus 96 l~l~~~G~Lvl~~~~-g~~~w~t~~~~~--~~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtlLp~~~l~~~~~L~S~~ 172 (796)
+.+..||+||+++.. +.++|++++... ....+.|.++|||||++.++.++|+|
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S------------------------ 79 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSS------------------------ 79 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEe------------------------
Confidence 445689999999865 478999886532 33678999999999999989999998
Q ss_pred CCCCCCCccEEEEEecCCcEEEeeecCCCccccccccc
Q 003772 173 SETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWAS 210 (796)
Q Consensus 173 s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~ 210 (796)
... ...|.|.+.|+.+|++++|.... ...|.+
T Consensus 80 ~t~-~~~~~~~~~L~ddGnlvl~~~~~-----~~~W~S 111 (114)
T smart00108 80 NTT-GANGNYVLVLLDDGNLVIYDSDG-----NFLWQS 111 (114)
T ss_pred ccc-CCCCceEEEEeCCCCEEEECCCC-----CEEeCC
Confidence 111 24577899999999999984322 356764
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.63 E-value=8.5e-08 Score=86.55 Aligned_cols=85 Identities=29% Similarity=0.504 Sum_probs=64.3
Q ss_pred EEec-CCceEEEcCC-CceeEeecCCC--CCceeEEEecCcCEEEeecCCCccccccCCCCccccCCCCCCCCCeeeecc
Q 003772 97 TLTK-DGKLILRTEE-GHDKVVAAGKS--EPASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRI 172 (796)
Q Consensus 97 ~l~~-~G~Lvl~~~~-g~~~w~t~~~~--~~~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtlLp~~~l~~~~~L~S~~ 172 (796)
.+.. ||+||+++.. +..+|++++.. .....+.|.++|||||++.++.++|||
T Consensus 25 ~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S------------------------ 80 (116)
T cd00028 25 IMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSS------------------------ 80 (116)
T ss_pred CCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEe------------------------
Confidence 3455 8999999764 47899998754 345678999999999999999999998
Q ss_pred CCCCCCCccEEEEEecCCcEEEeeecCCCcccccccccc
Q 003772 173 SETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASD 211 (796)
Q Consensus 173 s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~ 211 (796)
.... +.+.+.+.|+.+|++++|... ....|.+.
T Consensus 81 ~~~~-~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf 113 (116)
T cd00028 81 NTTR-VNGNYVLVLLDDGNLVLYDSD-----GNFLWQSF 113 (116)
T ss_pred cccC-CCCceEEEEeCCCCEEEECCC-----CCEEEcCC
Confidence 1111 357889999999999998543 24567653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.4e-06 Score=89.80 Aligned_cols=260 Identities=15% Similarity=0.141 Sum_probs=152.8
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhh----hhhhhc--cCCc-eeEEE
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVR----LIGYCA--EDSK-RLLVY 587 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~----l~g~~~--~~~~-~~lV~ 587 (796)
+..||+|+-+.+|..-.-.+ -+.|+..+..........+| |... .||-+.. ...... +++. .-+.|
T Consensus 16 gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CccccCCccceeeecchhhc---hhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 46799999999996433222 23466665433333322222 2222 4554332 111111 2222 34566
Q ss_pred eecCCC-Chhhhhhc----CCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 588 EYMSNG-SLADILFR----GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 588 e~~~~g-sL~~~l~~----~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
..+++. ....++.. ..-...+|...++.+..+|.+.+.||.. +.+-+|++++|+|+.++..+.|.|-..-.+
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 665543 23333321 1224588999999999999999999998 999999999999999999999998544333
Q ss_pred cCCCCcceeeeeccCCCCCchhhhc-----cCCCCccccchhhHHHHHHHhhc-ccCCCCCCC-----CchhHHHHHHHH
Q 003772 663 LMPDQTRTFTLVRGTRGYMAPEWYK-----NTPISVKADVFSYGVVLLEIVCC-RRNMEIDPS-----KPEEIVLINWAY 731 (796)
Q Consensus 663 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvil~elltg-~~p~~~~~~-----~~~~~~~~~~~~ 731 (796)
... .....-..|...|.+||.-. +..-+..+|-|.+|+++++++.| +.|+..-.. .+.+..+....+
T Consensus 167 ~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 167 NAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred ccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 211 11122234788999999764 33557889999999999999998 888864321 122212111100
Q ss_pred HhhhhhhhhhhhcCCCCCHHH-HHHHHHHHHHhccCC--CCCCCCHHHHHHHHhcCcC
Q 003772 732 KCFIDRELNKLVRGQEVDRNT-LENMIKIGLWCVQDE--PALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~d--P~~RPt~~evl~~L~~~~~ 786 (796)
-.-.+........+...+.+. +..+.-+-..|+... +.-|||.+--+..|..+.+
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 000001111111112222222 345556666777653 5689999988887766543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=6.9e-07 Score=100.35 Aligned_cols=141 Identities=23% Similarity=0.288 Sum_probs=87.6
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchh----------------------------------------HHHHH
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG----------------------------------------EREFR 556 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~----------------------------------------~~~f~ 556 (796)
+-|+.+.-|.||+|++++ ++.||||+......+. +-.+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 458999999999999986 5789999985433211 11123
Q ss_pred HHHHHHhccC-----cCchhhhhhhhccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHH-HhhccC
Q 003772 557 AEMHVIGRTH-----HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGIL-YLHDEC 630 (796)
Q Consensus 557 ~E~~~l~~l~-----h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~-~LH~~~ 630 (796)
.|+..+.+++ .+++.-.--+..-.+...|+|||++|-.+.+...... ..++. ..++..++++.. .+-.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~---k~ia~~~~~~f~~q~~~-- 283 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDR---KELAELLVRAFLRQLLR-- 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCH---HHHHHHHHHHHHHHHHh--
Confidence 3333333331 1111111111222456789999999999988853221 23332 222332222211 1111
Q ss_pred CCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 631 ~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
.+++|+|.+|.||+++.++++.+.|||+...+.+
T Consensus 284 -dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 -DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2899999999999999999999999999987754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.8e-06 Score=84.95 Aligned_cols=139 Identities=17% Similarity=0.125 Sum_probs=105.7
Q ss_pred cCcccceEEEEEEEcCCcEEEEEEEeeccc------chhHHHHHHHHHHHhccCcCc--hhhhhhhhcc-----CCceeE
Q 003772 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMV------TEGEREFRAEMHVIGRTHHKN--LVRLIGYCAE-----DSKRLL 585 (796)
Q Consensus 519 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~------~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~~~-----~~~~~l 585 (796)
-|+||-+.|+.-.+.+. .+-+|+-+... .-+...|.+|...|.++...+ +.+++ ++.. .-..+|
T Consensus 26 ~~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 36688899999777433 57888875211 335678999999999996443 44444 3321 123689
Q ss_pred EEeecCC-CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc--eEEeccCCccc
Q 003772 586 VYEYMSN-GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT--AKISDFGLAKL 662 (796)
Q Consensus 586 V~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFgl~~~ 662 (796)
|+|-+.+ -+|.+++.+......+...+..++.++++.+.-||+. ++.|+|+.+.||+++.++. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9997764 4899998665445677888899999999999999998 9999999999999986666 99999988764
Q ss_pred c
Q 003772 663 L 663 (796)
Q Consensus 663 ~ 663 (796)
.
T Consensus 180 ~ 180 (216)
T PRK09902 180 R 180 (216)
T ss_pred h
Confidence 3
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=8.3e-08 Score=107.09 Aligned_cols=152 Identities=18% Similarity=0.259 Sum_probs=104.6
Q ss_pred HHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce--------eeeeccCCCCCchhhh
Q 003772 615 IASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT--------FTLVRGTRGYMAPEWY 686 (796)
Q Consensus 615 i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~--------~~~~~gt~~y~aPE~~ 686 (796)
-+.+++.||.|+|.. ..+||++|.|++|.++..+..||+.|+.+.......... ..-......|.|||++
T Consensus 104 nl~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 345566999999987 699999999999999999999999999887554321110 0012244679999999
Q ss_pred ccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccC
Q 003772 687 KNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQD 766 (796)
Q Consensus 687 ~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 766 (796)
.....++++|+||+|+++|-+..++.+............+.. ........ -...+.+.++.+=+..++..
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~------~~~~~~~~----~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR------NLLNAGAF----GYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh------cccccccc----cccccCcHHHHHHHHHHhcC
Confidence 998899999999999999999965555433322221111100 00001110 12245566677777889999
Q ss_pred CCCCCCCHHHHH
Q 003772 767 EPALRPSMKSVV 778 (796)
Q Consensus 767 dP~~RPt~~evl 778 (796)
++.-||++.++.
T Consensus 252 ~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 252 DSAVRPTLDLLL 263 (700)
T ss_pred CcccCcchhhhh
Confidence 999999877764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.8e-06 Score=86.64 Aligned_cols=136 Identities=21% Similarity=0.210 Sum_probs=94.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch----------------------hHHHHHHHHHHHhccCcC--
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE----------------------GEREFRAEMHVIGRTHHK-- 568 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~----------------------~~~~f~~E~~~l~~l~h~-- 568 (796)
+.+++.||.|.-+.||.|..+.+ .++|||.=...... ....-++|.+.|.++.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g-~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKG-RKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECCCC-CEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45778999999999999998755 57999964211000 012245688888888544
Q ss_pred chhhhhhhhccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC
Q 003772 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE 648 (796)
Q Consensus 569 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 648 (796)
.+.+.++ .+.+.+||||+++-.|...- ++....-.++..|++-+..+-.. +|||+|+++-||++++
T Consensus 172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIA----WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCccc----cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 4555554 46789999999986554321 12334444555555555555554 9999999999999999
Q ss_pred CCceEEeccCCcccc
Q 003772 649 FWTAKISDFGLAKLL 663 (796)
Q Consensus 649 ~~~~kl~DFgl~~~~ 663 (796)
++.+.++||-.+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999887643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.7e-06 Score=85.32 Aligned_cols=107 Identities=22% Similarity=0.286 Sum_probs=84.7
Q ss_pred HHHHHHHHHHHhccCcCc--hhhhhhhhccCC----ceeEEEeecCCC-ChhhhhhcCCCCCCchhHHHHHHHHHHHHHH
Q 003772 552 EREFRAEMHVIGRTHHKN--LVRLIGYCAEDS----KRLLVYEYMSNG-SLADILFRGPERSLGWDERVRIASDVAKGIL 624 (796)
Q Consensus 552 ~~~f~~E~~~l~~l~h~n--iv~l~g~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~ 624 (796)
.....+|...+.++...+ ..+.+++..... ..+||+|++++- +|.+++.... ..+......++.++++.+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence 345778888888885444 445566655422 458999999974 8999987532 2666778899999999999
Q ss_pred HhhccCCCCeeeeccCccceEecCCC---ceEEeccCCcccc
Q 003772 625 YLHDECEAPIIHCDIKPQNILMDEFW---TAKISDFGLAKLL 663 (796)
Q Consensus 625 ~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFgl~~~~ 663 (796)
-||+. +|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=6.8e-06 Score=92.04 Aligned_cols=144 Identities=22% Similarity=0.233 Sum_probs=90.5
Q ss_pred hh-cccCcccceEEEEEEEcCCcEEEEEEEeecccchh-------------------------------------HHHHH
Q 003772 515 FK-EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG-------------------------------------EREFR 556 (796)
Q Consensus 515 ~~-~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~-------------------------------------~~~f~ 556 (796)
|. +.||....|.||+|++++ ++.||||+-+...... +-.|.
T Consensus 164 f~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~ 242 (538)
T KOG1235|consen 164 FDEEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFT 242 (538)
T ss_pred cCcchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchH
Confidence 44 459999999999999987 5789999976533211 11244
Q ss_pred HHHHHHhcc----CcCch---hhhhhhh-ccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhc
Q 003772 557 AEMHVIGRT----HHKNL---VRLIGYC-AEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628 (796)
Q Consensus 557 ~E~~~l~~l----~h~ni---v~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~ 628 (796)
.|++...+. .|-++ |++=.++ .-...+.|+||||+|..+.|.-.-. +..++...+..-+.+...-+.+-
T Consensus 243 ~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~~~~qIf~-- 319 (538)
T KOG1235|consen 243 KEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID-KRGISPHDILNKLVEAYLEQIFK-- 319 (538)
T ss_pred HHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH-HcCCCHHHHHHHHHHHHHHHHHh--
Confidence 444433333 23331 1111111 2234679999999999887764322 23344444443333332222222
Q ss_pred cCCCCeeeeccCccceEecC----CCceEEeccCCccccCC
Q 003772 629 ECEAPIIHCDIKPQNILMDE----FWTAKISDFGLAKLLMP 665 (796)
Q Consensus 629 ~~~~~ivH~Dlkp~NIll~~----~~~~kl~DFgl~~~~~~ 665 (796)
.|++|+|-+|.||+++. ++.+.+.|||+...+..
T Consensus 320 ---~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 ---TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 28999999999999983 67899999999876543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.97 E-value=4.1e-05 Score=77.85 Aligned_cols=139 Identities=12% Similarity=0.178 Sum_probs=83.7
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCch--hhhhhhhccCCceeEEEeecCCCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNL--VRLIGYCAEDSKRLLVYEYMSNGS 594 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~ni--v~l~g~~~~~~~~~lV~e~~~~gs 594 (796)
..||+|..+.||+.. + ...++|...... ......+|.+.+..+..-++ .+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~---~-~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---T-GKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEec---C-CCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 568999999999832 3 346778876432 23456889999988865444 667777777777789999999863
Q ss_pred -hhhhh---------------------hcCCCCCCchhHHH-HHHH----------HHHH-HHHHhhcc-CCCCeeeecc
Q 003772 595 -LADIL---------------------FRGPERSLGWDERV-RIAS----------DVAK-GILYLHDE-CEAPIIHCDI 639 (796)
Q Consensus 595 -L~~~l---------------------~~~~~~~l~~~~~~-~i~~----------~ia~-aL~~LH~~-~~~~ivH~Dl 639 (796)
+...+ +.-.-......... .+.. .+.+ ...+|... ....++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 22111 11000011101000 0000 0011 11122111 1345789999
Q ss_pred CccceEecCCCceEEeccCCccc
Q 003772 640 KPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 640 kp~NIll~~~~~~kl~DFgl~~~ 662 (796)
+|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.93 E-value=5.1e-05 Score=75.01 Aligned_cols=132 Identities=18% Similarity=0.175 Sum_probs=81.1
Q ss_pred hhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHH---------HHHHHHhccCcCchh---hhhhhhc----
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFR---------AEMHVIGRTHHKNLV---RLIGYCA---- 578 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~---------~E~~~l~~l~h~niv---~l~g~~~---- 578 (796)
..+.+-......|.+-.. +++...+|.........++.|. +++..+.+++..++. .++....
T Consensus 35 ~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~ 112 (229)
T PF06176_consen 35 IIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIF 112 (229)
T ss_pred EEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeec
Confidence 334455555555665555 3456778876543333333322 334444444322222 2222111
Q ss_pred -cCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEecc
Q 003772 579 -EDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDF 657 (796)
Q Consensus 579 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 657 (796)
.....+++|||++|..|.+... ++. .++..+++++.-||.. |++|+|.+|+|+++++++ +++.||
T Consensus 113 ~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 113 RYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred cceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEEC
Confidence 1234568999999988766542 111 3556788889999998 999999999999999654 999999
Q ss_pred CCccc
Q 003772 658 GLAKL 662 (796)
Q Consensus 658 gl~~~ 662 (796)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 87753
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.93 E-value=2.5e-05 Score=76.71 Aligned_cols=104 Identities=22% Similarity=0.309 Sum_probs=84.0
Q ss_pred HHHHHHHhccCc-CchhhhhhhhccCCceeEEEeecCCCChhhhhhc-CCCCCCchhHHHHHHHHHHHHHHHhhccCCCC
Q 003772 556 RAEMHVIGRTHH-KNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFR-GPERSLGWDERVRIASDVAKGILYLHDECEAP 633 (796)
Q Consensus 556 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ 633 (796)
.+|..+++.+++ +++++++|+|- .++|.||...+++...-.. ..--..+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888876 69999999993 4789999998766432100 00134689999999999999999999976667
Q ss_pred eeeeccCccceEecCCCceEEeccCCcccc
Q 003772 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 634 ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
+.-+|++++|+-+++++++|+.|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999877544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.0001 Score=73.58 Aligned_cols=136 Identities=24% Similarity=0.254 Sum_probs=85.6
Q ss_pred ccCcccceEEEEEEEcCCcEEEEEEEeecccchhH---------HH---------------HHHHHHHHhccC--cCchh
Q 003772 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE---------RE---------------FRAEMHVIGRTH--HKNLV 571 (796)
Q Consensus 518 ~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~---------~~---------------f~~E~~~l~~l~--h~niv 571 (796)
.|..|.-+.||+|.-. ++..+|||++........ .. -..|...|.++. +-.+.
T Consensus 55 ~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 5888899999999863 457899999864322111 11 123344333332 11122
Q ss_pred hhhhhhccCCceeEEEeecCCCChhh-hhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC
Q 003772 572 RLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW 650 (796)
Q Consensus 572 ~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 650 (796)
+.+++ .+-.|||||+....+.. .|. .-.+.......+..++++.+.-|-.. .++||+||+.-|||+. ++
T Consensus 134 ~Pi~~----~~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 134 EPIAF----RNNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred Cceee----cCCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CC
Confidence 22222 23479999986532111 111 12222335667777888888887763 3999999999999999 88
Q ss_pred ceEEeccCCccccC
Q 003772 651 TAKISDFGLAKLLM 664 (796)
Q Consensus 651 ~~kl~DFgl~~~~~ 664 (796)
.+.|+||+.+....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999997654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=8.1e-06 Score=90.37 Aligned_cols=184 Identities=20% Similarity=0.147 Sum_probs=131.8
Q ss_pred hhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCc-hhhhhhhhccCCceeEEEeecCCC
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKN-LVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
+-+.+++++++.++|.+-... +....+.+.. .....-++++|.+++||| .++.++-+..++..+++++++..+
T Consensus 246 ~fh~fvK~altknpKkRptae-klL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAE-KLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHHHHHhcCCCccCCChh-hheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 335678899999998765433 2222443322 255677899999999999 777777777788889999999877
Q ss_pred -ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 594 -SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 594 -sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
+-..... .....+...+...+...-++++++||+. .-+|+| ||+..+ ...+..||+....+.+.. ...
T Consensus 320 rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 320 RSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred ccccccCC-hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 2222111 1123344455556677778899999986 568988 776665 678999999988765543 222
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCC
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNME 715 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~ 715 (796)
...+++.++|||......+..+.|+|+.|+---++.-|-.|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3448999999999999999999999999997777776655543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00015 Score=75.00 Aligned_cols=139 Identities=17% Similarity=0.123 Sum_probs=83.4
Q ss_pred cCcccc-eEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-cCchhhhhhhhccCCceeEEEeecCCCChh
Q 003772 519 LGKGSF-GAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLLVYEYMSNGSLA 596 (796)
Q Consensus 519 LG~G~f-g~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 596 (796)
|-.|.. ..||+....+ ..+.||+..... ...+..|++++..+. +--+.+++++...++..++|||++++.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~~--~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGKN--PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCCC--CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 444555 7899987642 467888875432 345677888888874 334556777766666789999999988776
Q ss_pred hhhh-------------------cCCCC--CCch--hHHHHHHH--------------------HHHHHHHHhhcc----
Q 003772 597 DILF-------------------RGPER--SLGW--DERVRIAS--------------------DVAKGILYLHDE---- 629 (796)
Q Consensus 597 ~~l~-------------------~~~~~--~l~~--~~~~~i~~--------------------~ia~aL~~LH~~---- 629 (796)
+... ..... .... ...+.... .+...+..|-..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4421 10000 1100 00000000 011112222111
Q ss_pred CCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 630 ~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
..+.++|+|+.|.||+++++....|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 134689999999999999987789999998854
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00018 Score=73.40 Aligned_cols=142 Identities=21% Similarity=0.232 Sum_probs=83.5
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCc--hhhhhhhhcc---CCceeEEEeecC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKN--LVRLIGYCAE---DSKRLLVYEYMS 591 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~~~---~~~~~lV~e~~~ 591 (796)
+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+.... +.+++.+... ....+++|++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 468889999999999865 37889997553 45567888988888885443 4566654432 234689999999
Q ss_pred CCChhh----------------hh---hcC--CCCCCchhH---------HHHH------------HHHHHH-HHHHhhc
Q 003772 592 NGSLAD----------------IL---FRG--PERSLGWDE---------RVRI------------ASDVAK-GILYLHD 628 (796)
Q Consensus 592 ~gsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-aL~~LH~ 628 (796)
+..+.. .+ +.. ......... .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 111 111111100 0000 111222 2333332
Q ss_pred ----cCCCCeeeeccCccceEec-CCCceEEeccCCccc
Q 003772 629 ----ECEAPIIHCDIKPQNILMD-EFWTAKISDFGLAKL 662 (796)
Q Consensus 629 ----~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFgl~~~ 662 (796)
.....++|+|+.|+||+++ +++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1235799999999999999 666668999998854
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00034 Score=62.68 Aligned_cols=95 Identities=21% Similarity=0.283 Sum_probs=63.5
Q ss_pred cCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeC-CCCCCCCCcEEEEecCCceEEEcCCCceeEeecCCCCCceeE
Q 003772 49 SSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYR-DDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSA 127 (796)
Q Consensus 49 S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr-~~p~~~~~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~~~~~~a 127 (796)
+.+|.+.|-|...+ .|-|. . ...+++|..+. ... ......+.|.+||||||+|..+..+|++.. ..+.+..
T Consensus 16 ~~s~~~~L~l~~dG---nLvl~-~--~~~~~iWss~~t~~~-~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~-~ptdt~L 87 (114)
T PF01453_consen 16 SSSGNYTLILQSDG---NLVLY-D--SNGSVIWSSNNTSGR-GNSGCYLVLQDDGNLVLYDSSGNVLWQSFD-YPTDTLL 87 (114)
T ss_dssp ECETTEEEEEETTS---EEEEE-E--TTTEEEEE--S-TTS-S-SSEEEEEETTSEEEEEETTSEEEEESTT-SSS-EEE
T ss_pred cccccccceECCCC---eEEEE-c--CCCCEEEEecccCCc-cccCeEEEEeCCCCEEEEeecceEEEeecC-CCccEEE
Confidence 43478888887655 34432 2 23677999943 322 115788999999999999999999999843 3344556
Q ss_pred EEec--CcCEEEeecCCCccccccCCC
Q 003772 128 SMLD--SGNFVLYNNRSDIIWSSFKIP 152 (796)
Q Consensus 128 ~Lld--~GNlVl~~~~~~~lWQSFD~P 152 (796)
..++ .||++ +.....+.|.|=+-|
T Consensus 88 ~~q~l~~~~~~-~~~~~~~sw~s~~dp 113 (114)
T PF01453_consen 88 PGQKLGDGNVT-GKNDSLTSWSSNTDP 113 (114)
T ss_dssp EEET--TSEEE-EESTSSEEEESS---
T ss_pred eccCcccCCCc-cccceEEeECCCCCC
Confidence 6677 89998 777778899985555
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.69 E-value=8.2e-05 Score=61.60 Aligned_cols=58 Identities=19% Similarity=0.412 Sum_probs=45.4
Q ss_pred ceeeecccCCCccce-eeccCCHHHHHHHhcc-CCcceeeecccccCCCCCceeccc-cCCcccc
Q 003772 347 NMTSMEKMTWDDYYY-FKASITKEECKESCLE-DCECDVALYEESVDDKPSYCTKQK-LPLKSAK 408 (796)
Q Consensus 347 ~~~~~~~~~~~~~~~-~~~~~s~~~C~~~Cl~-nCsC~a~~y~~~~~~~~~~c~~~~-~~l~~~~ 408 (796)
.|+.++++.+++... .....++++|++.|++ +|+|.||.|.. ..+.|..|. ..+.+..
T Consensus 5 ~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~----~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 5 CFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNN----GTKGCLLWSESSLGDAR 65 (78)
T ss_pred eeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcC----CCCEEEEeeCCccccce
Confidence 577888888875544 3457799999999999 99999999963 567899998 6555544
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0005 Score=83.67 Aligned_cols=148 Identities=18% Similarity=0.265 Sum_probs=91.3
Q ss_pred cccCcccceEEEEEEEcCCc--EEEEEEEeeccc-chhHHHHHHHHHHHhccC-cCch--hhhhhhhccC---CceeEEE
Q 003772 517 EELGKGSFGAVYKGTLYKGE--KLVAVKKLEKMV-TEGEREFRAEMHVIGRTH-HKNL--VRLIGYCAED---SKRLLVY 587 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~--~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lV~ 587 (796)
+.++.|.+..+|+.....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 56889999999998775443 356777754322 123356889999999995 6665 7778887764 4678999
Q ss_pred eecCCCChhhh-----------------------hhcCCC---------CCCch--hHHHHHH---------------HH
Q 003772 588 EYMSNGSLADI-----------------------LFRGPE---------RSLGW--DERVRIA---------------SD 618 (796)
Q Consensus 588 e~~~~gsL~~~-----------------------l~~~~~---------~~l~~--~~~~~i~---------------~~ 618 (796)
||+++..+.+. |+.-.. ....+ .++..+. ..
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 99987654321 111000 00011 0111111 12
Q ss_pred HHHHHHHhhccCC--------CCeeeeccCccceEecC-CCc-eEEeccCCccccC
Q 003772 619 VAKGILYLHDECE--------APIIHCDIKPQNILMDE-FWT-AKISDFGLAKLLM 664 (796)
Q Consensus 619 ia~aL~~LH~~~~--------~~ivH~Dlkp~NIll~~-~~~-~kl~DFgl~~~~~ 664 (796)
+.+.+.+|..+.. ..++|+|+++.||+++. +.. .-|.||.++..-.
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2334556644321 35999999999999985 333 5799999887643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00079 Score=69.11 Aligned_cols=73 Identities=14% Similarity=0.161 Sum_probs=44.7
Q ss_pred cccCcccce-EEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcC---chhhhhhhhccC---CceeEEEee
Q 003772 517 EELGKGSFG-AVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHK---NLVRLIGYCAED---SKRLLVYEY 589 (796)
Q Consensus 517 ~~LG~G~fg-~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~---niv~l~g~~~~~---~~~~lV~e~ 589 (796)
+.|+.|+.. .||+.. ..+.+|.... ......+..|.+.+..+... -+.++++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 456767666 588741 2356676543 22345788899999887532 234444443332 234889999
Q ss_pred cCCCChh
Q 003772 590 MSNGSLA 596 (796)
Q Consensus 590 ~~~gsL~ 596 (796)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0014 Score=69.68 Aligned_cols=75 Identities=11% Similarity=0.061 Sum_probs=54.8
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCc---Cchhhhhhhhcc---CCceeEEEeec
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHH---KNLVRLIGYCAE---DSKRLLVYEYM 590 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h---~niv~l~g~~~~---~~~~~lV~e~~ 590 (796)
+.||.|..+.||+....++ .+.+|..+. ......+..|...|+.+.- -.+.+++++|.. .+..+||||++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~--~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 20 ECISEQPYAALWALYDSQG--NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eecCCccceeEEEEEcCCC--CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 4699999999999876443 456666432 1133578999999988853 357788887754 35689999999
Q ss_pred CCCCh
Q 003772 591 SNGSL 595 (796)
Q Consensus 591 ~~gsL 595 (796)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0018 Score=64.00 Aligned_cols=131 Identities=21% Similarity=0.256 Sum_probs=89.7
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc----------------chhHHHHHHHHHHHhccC------cCchhhhh
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV----------------TEGEREFRAEMHVIGRTH------HKNLVRLI 574 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~----------------~~~~~~f~~E~~~l~~l~------h~niv~l~ 574 (796)
..||+|+.-.||.= +.+ ....||+..... ....+++.+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H--P~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--CCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 56999999999963 333 346788876544 123456667766665555 88999999
Q ss_pred hhhccCCceeEEEeecCC--C----ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC
Q 003772 575 GYCAEDSKRLLVYEYMSN--G----SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE 648 (796)
Q Consensus 575 g~~~~~~~~~lV~e~~~~--g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 648 (796)
|+...+...-+|+|.+.+ | +|.+++.+ +.++. ...+.+. +-..||-+. .|+.+|++|+||++..
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccEEEEe
Confidence 999998888999998632 3 67888854 33444 3333333 334566665 8999999999999963
Q ss_pred C---C-ceEEec-cCCc
Q 003772 649 F---W-TAKISD-FGLA 660 (796)
Q Consensus 649 ~---~-~~kl~D-Fgl~ 660 (796)
. . .+.|+| ||-.
T Consensus 154 ~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGEK 170 (199)
T ss_pred cCCCceEEEEEeCCCCc
Confidence 2 2 577777 4544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0014 Score=61.99 Aligned_cols=129 Identities=21% Similarity=0.272 Sum_probs=85.1
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhh-hhhhhccCCceeEEEeecCC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVR-LIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~-l~g~~~~~~~~~lV~e~~~~ 592 (796)
+..+.|++|.+|.||+|.+.. .++|+|+-... .....+..|+++|..+.-.++-. ++.+ +.-.+.|||+.+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~--~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRG--GEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeeccC--ceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcC
Confidence 345789999999999999854 47889886543 33566888999988886555433 2222 223455999998
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccC-ccceEecCCCceEEeccCCccc
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIK-PQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~DFgl~~~ 662 (796)
-.|.+.-... +... ...+++.-.-|-.. +|-|+.|+ |..++|..+..+.|+||..|+.
T Consensus 97 ~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIGG-----DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhcc-----cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7877655321 1222 23344442333333 88888887 5555555556999999999974
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0022 Score=65.79 Aligned_cols=141 Identities=16% Similarity=0.166 Sum_probs=79.4
Q ss_pred cccCcccceEEEEEEEcC-CcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchh-hhhhhhccCCceeEEEeecCCCC
Q 003772 517 EELGKGSFGAVYKGTLYK-GEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLV-RLIGYCAEDSKRLLVYEYMSNGS 594 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~-~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~gs 594 (796)
+.|..|-...+|+....+ .++.+++|+...... ..-....|+.++..+...+++ ++++... ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 456778888999987653 235688887654222 112334688888888544443 3333222 248999999877
Q ss_pred hhhh-------h----------hcCC-C--------CCCc-hhHHHHHHH----------------------HHHHHHHH
Q 003772 595 LADI-------L----------FRGP-E--------RSLG-WDERVRIAS----------------------DVAKGILY 625 (796)
Q Consensus 595 L~~~-------l----------~~~~-~--------~~l~-~~~~~~i~~----------------------~ia~aL~~ 625 (796)
+... + +... . .... +..+..+.. .+.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 1 1110 0 0111 112112111 11111111
Q ss_pred h----hcc-CCCCeeeeccCccceEecC-CCceEEeccCCccc
Q 003772 626 L----HDE-CEAPIIHCDIKPQNILMDE-FWTAKISDFGLAKL 662 (796)
Q Consensus 626 L----H~~-~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgl~~~ 662 (796)
| ... ....++|+|+++.||++++ +..+.|+||..+..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1 111 2346899999999999998 57899999998854
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0017 Score=67.64 Aligned_cols=137 Identities=12% Similarity=0.094 Sum_probs=77.2
Q ss_pred cCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCch-hhhhhhhccCCceeEEEeecCCCChhh
Q 003772 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNL-VRLIGYCAEDSKRLLVYEYMSNGSLAD 597 (796)
Q Consensus 519 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~ 597 (796)
+..|-...+|+... +++.+++|..........-...+|..+++.+...++ .+++... ...+|+||+++..+..
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 45677788998873 445788887644222211235778888888864444 3334332 2368999999876542
Q ss_pred h-----------------hhcCC--CCCCchhHH-HHHHHHH---------HHHHHHhhcc-----CCCCeeeeccCccc
Q 003772 598 I-----------------LFRGP--ERSLGWDER-VRIASDV---------AKGILYLHDE-----CEAPIIHCDIKPQN 643 (796)
Q Consensus 598 ~-----------------l~~~~--~~~l~~~~~-~~i~~~i---------a~aL~~LH~~-----~~~~ivH~Dlkp~N 643 (796)
. |+... ...++.... ..+..++ .+.+..+... ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 111221111 1111111 1112222111 12368999999999
Q ss_pred eEecCCCceEEeccCCccc
Q 003772 644 ILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 644 Ill~~~~~~kl~DFgl~~~ 662 (796)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0097 Score=65.31 Aligned_cols=76 Identities=21% Similarity=0.267 Sum_probs=53.2
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc-------chhHHHHHHHHHHHhccC---cCchhhhhhhhccCCceeEE
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-------TEGEREFRAEMHVIGRTH---HKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-------~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV 586 (796)
+.||.|.+..||+....++.+.|.||.-.... .-..+.+..|.+.|..+. ..++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 57999999999999987665689999853211 123456677888887763 2346666665 44567899
Q ss_pred EeecCCCC
Q 003772 587 YEYMSNGS 594 (796)
Q Consensus 587 ~e~~~~gs 594 (796)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0045 Score=60.71 Aligned_cols=125 Identities=26% Similarity=0.397 Sum_probs=87.9
Q ss_pred HHHhhhcccCcccc-eEEEEEEEcCCcEEEEEEEeecc-----------cc----------hhHHHHHHHHHHHhccC--
Q 003772 511 ATNRFKEELGKGSF-GAVYKGTLYKGEKLVAVKKLEKM-----------VT----------EGEREFRAEMHVIGRTH-- 566 (796)
Q Consensus 511 ~~~~~~~~LG~G~f-g~Vy~g~~~~~~~~vAvK~l~~~-----------~~----------~~~~~f~~E~~~l~~l~-- 566 (796)
+...|.+.||.|.- |.||+.++. ++.+|+|.+... .. .....|..|+....+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 45567789999999 999999994 568999994220 00 11235888999988885
Q ss_pred -cCch--hhhhhhhccC------------------CceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHH
Q 003772 567 -HKNL--VRLIGYCAED------------------SKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILY 625 (796)
Q Consensus 567 -h~ni--v~l~g~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~ 625 (796)
+.++ ++.+|+..-. ....||.||.+... ....+-+.+|.+-|..
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQIRDIPQMLRDLKI 179 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccchhHHHHHHHHHHH
Confidence 4455 7887776311 12356777765432 1223445677788889
Q ss_pred hhccCCCCeeeeccCccceEecCCCceEEeccCCc
Q 003772 626 LHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA 660 (796)
Q Consensus 626 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~ 660 (796)
+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 9988 9999999999986 5689999865
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.004 Score=66.32 Aligned_cols=141 Identities=18% Similarity=0.182 Sum_probs=84.3
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCc--hhhhhhhh------ccCCceeEEEe
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKN--LVRLIGYC------AEDSKRLLVYE 588 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lV~e 588 (796)
+.|..|....+|+....+ ..+++|+... .....+..|+.++..+.+.+ +.+++... ..++..++|++
T Consensus 20 ~~i~~G~~n~~y~v~~~~--~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 20 EGISAGIENTNYFVTTDS--GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred ecccCccccceEEEEeCC--CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 457778778999987543 3588888754 23345667888888775443 44444421 12345689999
Q ss_pred ecCCCChhh----hh----------hcCC-C--------CCCchhHHH----------HHHHHHHHHHHHhhc----cCC
Q 003772 589 YMSNGSLAD----IL----------FRGP-E--------RSLGWDERV----------RIASDVAKGILYLHD----ECE 631 (796)
Q Consensus 589 ~~~~gsL~~----~l----------~~~~-~--------~~l~~~~~~----------~i~~~ia~aL~~LH~----~~~ 631 (796)
|++|..+.. .+ +... . ....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 11 1000 0 011121111 011123334444443 123
Q ss_pred CCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 632 ~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
..++|+|++|.||+++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999987789999998853
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0025 Score=76.06 Aligned_cols=196 Identities=18% Similarity=0.161 Sum_probs=134.2
Q ss_pred HHHHHHHHhccCcCchhhhhhhhccCCce----eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccC
Q 003772 555 FRAEMHVIGRTHHKNLVRLIGYCAEDSKR----LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630 (796)
Q Consensus 555 f~~E~~~l~~l~h~niv~l~g~~~~~~~~----~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~ 630 (796)
..-|...+.++.|+|+++++++-.+.... .+..|++..-++...+.. -..++....+.+..++.+||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHHHHh-
Confidence 34577888899999999998887654322 344567777788888765 46788899999999999999999997
Q ss_pred CCCeeeeccCcc---ceEecCCCceEEe--ccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCc--cccchhhHHH
Q 003772 631 EAPIIHCDIKPQ---NILMDEFWTAKIS--DFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV--KADVFSYGVV 703 (796)
Q Consensus 631 ~~~ivH~Dlkp~---NIll~~~~~~kl~--DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--ksDV~S~Gvi 703 (796)
...|.-+..+ +--.+.++...++ ||+.+..+........ ...+..+.+||......... ..|+|.+|..
T Consensus 306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred --ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHH
Confidence 5555444444 4445566677777 8888876643322111 12355678888877665544 4799999999
Q ss_pred HHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 003772 704 LLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLML 781 (796)
Q Consensus 704 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L 781 (796)
+..+..|..+....... ..++.. .....+......|+..++++|++..+++...
T Consensus 382 ~~~~~~~~~i~~~~~~~-------------------~~~l~~-----~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAVP-------------------VSLLDV-----LSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HhhhhhcCcccccccch-------------------hhhhcc-----ccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 99999877654322110 011110 0011356667789999999999999998764
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.0071 Score=64.62 Aligned_cols=140 Identities=22% Similarity=0.233 Sum_probs=81.0
Q ss_pred ccCcccceEEEEEEEcCC------cEEEEEEEeecccchhHHHHHHHHHHHhccCcCch-hhhhhhhccCCceeEEEeec
Q 003772 518 ELGKGSFGAVYKGTLYKG------EKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNL-VRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 518 ~LG~G~fg~Vy~g~~~~~------~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~ 590 (796)
.|..|--..+|+.....+ ++.+++|+..... .......+|.+++..+...++ .++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 455566678998876542 4678889875532 223345778888877754333 344444432 3589999
Q ss_pred CCCChhhhh-----------------hcCCCC-------CCc--hhHHHH--------------------------HHHH
Q 003772 591 SNGSLADIL-----------------FRGPER-------SLG--WDERVR--------------------------IASD 618 (796)
Q Consensus 591 ~~gsL~~~l-----------------~~~~~~-------~l~--~~~~~~--------------------------i~~~ 618 (796)
+|.++.... ++.... ..+ +..+.. +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 887764311 111000 000 111100 1112
Q ss_pred HHHHHHHhhc------cCCCCeeeeccCccceEecCC----CceEEeccCCccc
Q 003772 619 VAKGILYLHD------ECEAPIIHCDIKPQNILMDEF----WTAKISDFGLAKL 662 (796)
Q Consensus 619 ia~aL~~LH~------~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFgl~~~ 662 (796)
+.+.+..|.. .....++|+|+.+.||+++++ +.+.++||..+..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2223333432 234578999999999999985 8899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0028 Score=51.73 Aligned_cols=35 Identities=23% Similarity=0.488 Sum_probs=30.1
Q ss_pred cCCHHHHHHHhccCCcceeeecccccCCCCCceeccccC
Q 003772 365 SITKEECKESCLEDCECDVALYEESVDDKPSYCTKQKLP 403 (796)
Q Consensus 365 ~~s~~~C~~~Cl~nCsC~a~~y~~~~~~~~~~c~~~~~~ 403 (796)
..+.++|++.|+.||+|.||.|.. ..+.|+.+...
T Consensus 24 ~~s~~~Cq~~C~~~~~C~afT~~~----~~~~C~lk~~~ 58 (73)
T cd01100 24 ASSAEQCQAACTADPGCLAFTYNT----KSKKCFLKSSE 58 (73)
T ss_pred cCCHHHHHHHcCCCCCceEEEEEC----CCCeEEcccCC
Confidence 568999999999999999999963 56889987763
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.028 Score=60.52 Aligned_cols=141 Identities=14% Similarity=0.211 Sum_probs=76.3
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCc--hhhhhhh------hccCCceeEEEe
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKN--LVRLIGY------CAEDSKRLLVYE 588 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lV~e 588 (796)
+.|+.|....+|+....++ .+++|+++.. ..+....|+.++..+...+ +.+++.. ....+..++++|
T Consensus 28 ~~l~~G~~n~~y~v~t~~g--~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG--EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeCCC--cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 3466777789999876543 5788887521 2233344555555553222 3333321 122445789999
Q ss_pred ecCCCChhh-----------hh---hcCCC---------CCCch-hHHHH------------HH-HHHHHHHHHhhcc--
Q 003772 589 YMSNGSLAD-----------IL---FRGPE---------RSLGW-DERVR------------IA-SDVAKGILYLHDE-- 629 (796)
Q Consensus 589 ~~~~gsL~~-----------~l---~~~~~---------~~l~~-~~~~~------------i~-~~ia~aL~~LH~~-- 629 (796)
|++|..+.. .| +.... ..+.| ..... .. ..+...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 998875421 11 11000 01111 11111 11 1111122233211
Q ss_pred --CCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 630 --CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 630 --~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
...+++|+|++|.||+++++...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 245899999999999999776668999999853
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.023 Score=59.72 Aligned_cols=72 Identities=18% Similarity=0.279 Sum_probs=46.8
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC---cCchhhhhhhhccCCceeEEEeecCCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH---HKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
+.++.|....+|+.. .+++.+.||+-. ......|..|.+-|+.|. --.+.+++++...++..+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 458889999999977 455688899875 334457888988888873 445778888877777789999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.05 Score=58.28 Aligned_cols=142 Identities=17% Similarity=0.206 Sum_probs=81.0
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCc--hhhhhhhh------ccCCceeEEEe
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKN--LVRLIGYC------AEDSKRLLVYE 588 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lV~e 588 (796)
+.++.|....+|+.... ++ .+.+|+..... ...+...|..++..+...+ +.+++... ..++..++++|
T Consensus 28 ~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTD-VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred cccCCccccceEEEEeC-CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34677777899987753 33 46678765421 2334556677777764332 34444422 12345789999
Q ss_pred ecCCCChhh-----------h---hhcCCC-------C---CCchhHHH------------HHHHHHHHHHHHhhc----
Q 003772 589 YMSNGSLAD-----------I---LFRGPE-------R---SLGWDERV------------RIASDVAKGILYLHD---- 628 (796)
Q Consensus 589 ~~~~gsL~~-----------~---l~~~~~-------~---~l~~~~~~------------~i~~~ia~aL~~LH~---- 628 (796)
|++|..+.. . ++.... . .-.|.... .....+.+.+.++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998865421 1 111000 0 01111110 011123344555542
Q ss_pred cCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 629 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
....+++|+|+++.||++++++...|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2245899999999999999887778999999853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.06 Score=57.07 Aligned_cols=131 Identities=19% Similarity=0.243 Sum_probs=77.0
Q ss_pred EEEEEEEcCCcEEEEEEEee-cccchhHHHHHHHHHHHhccCc--CchhhhhhhhccCC--ceeEEEeecCCCChhhhhh
Q 003772 526 AVYKGTLYKGEKLVAVKKLE-KMVTEGEREFRAEMHVIGRTHH--KNLVRLIGYCAEDS--KRLLVYEYMSNGSLADILF 600 (796)
Q Consensus 526 ~Vy~g~~~~~~~~vAvK~l~-~~~~~~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l~ 600 (796)
.+|..... +++.++++-. ...........+|..+++.+.- --+.+.+++|.++. ..+.||+|.++..+.+.+.
T Consensus 40 ~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 40 DTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred ceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 34444332 4566666211 1122233445667777777632 33456788888776 6799999998843333221
Q ss_pred cCCCCCCchhHHHHHH-HHHHHHHH--------------------------------------------------Hhhcc
Q 003772 601 RGPERSLGWDERVRIA-SDVAKGIL--------------------------------------------------YLHDE 629 (796)
Q Consensus 601 ~~~~~~l~~~~~~~i~-~~ia~aL~--------------------------------------------------~LH~~ 629 (796)
..... .+++ ..+++.|. +|+..
T Consensus 118 ~~~~~-------~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~ 190 (321)
T COG3173 118 PESLG-------RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN 190 (321)
T ss_pred cccch-------HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence 11000 0111 13333333 33332
Q ss_pred C-----CCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 630 C-----EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 630 ~-----~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
. .+.++|+|+++.||+++.+..+-|.||+++.+..+
T Consensus 191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 1 35789999999999999988899999999986543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.041 Score=59.81 Aligned_cols=140 Identities=19% Similarity=0.192 Sum_probs=79.4
Q ss_pred ccCcccceEEEEEEEcC----CcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchh-hhhhhhccCCceeEEEeecCC
Q 003772 518 ELGKGSFGAVYKGTLYK----GEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLV-RLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 518 ~LG~G~fg~Vy~g~~~~----~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~ 592 (796)
.|-.|---.+|+..... .++.+.+|+........ -.-.+|..++..+...++- ++++++..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 34446667888877543 23578889876543221 1236788888887654443 455554332 58999987
Q ss_pred CChhhh-----------------hhcCC--C-C-CCchhHHHHHHHHH-----------------HHHHHHh----hc-c
Q 003772 593 GSLADI-----------------LFRGP--E-R-SLGWDERVRIASDV-----------------AKGILYL----HD-E 629 (796)
Q Consensus 593 gsL~~~-----------------l~~~~--~-~-~l~~~~~~~i~~~i-----------------a~aL~~L----H~-~ 629 (796)
.+|... +|+.. . . ...+..+..+..++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 676421 11110 0 1 11122222332111 1112222 21 1
Q ss_pred CCCCeeeeccCccceEecC-CCceEEeccCCccc
Q 003772 630 CEAPIIHCDIKPQNILMDE-FWTAKISDFGLAKL 662 (796)
Q Consensus 630 ~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgl~~~ 662 (796)
....++|+|+++.||++++ ++.+.|+||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2346899999999999986 46899999998864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.067 Score=56.18 Aligned_cols=32 Identities=31% Similarity=0.449 Sum_probs=26.5
Q ss_pred CCeeeeccCccceEecCCCc-eEEeccCCcccc
Q 003772 632 APIIHCDIKPQNILMDEFWT-AKISDFGLAKLL 663 (796)
Q Consensus 632 ~~ivH~Dlkp~NIll~~~~~-~kl~DFgl~~~~ 663 (796)
..++|+|++|.||+++++++ .-|.||+.+...
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 35899999999999997555 569999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.0031 Score=76.86 Aligned_cols=159 Identities=14% Similarity=0.055 Sum_probs=110.9
Q ss_pred HHHHHHHHhccCcCchhhhhhhhc--cCCceeEEEeecCCCChhhhhhcCCCCC--CchhHHHHHHHHHHHHHHHhhccC
Q 003772 555 FRAEMHVIGRTHHKNLVRLIGYCA--EDSKRLLVYEYMSNGSLADILFRGPERS--LGWDERVRIASDVAKGILYLHDEC 630 (796)
Q Consensus 555 f~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~e~~~~gsL~~~l~~~~~~~--l~~~~~~~i~~~ia~aL~~LH~~~ 630 (796)
...|...++...|+++.+...=.. +..+.+.+++|+..|.+.+.|.++.++. ++.......-.+...+..-.|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555555667887766544333 2346788999999999999997754332 333333333333344555545442
Q ss_pred --CCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHh
Q 003772 631 --EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIV 708 (796)
Q Consensus 631 --~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ell 708 (796)
..-.+|+++|+-|.+|..+.++|++++|+.++..+.. .......+++-|++|++...-.++.++|+|..|+-+|+..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 2346899999999999999999999999999543322 2223344678899999999889999999999999999987
Q ss_pred hcccCC
Q 003772 709 CCRRNM 714 (796)
Q Consensus 709 tg~~p~ 714 (796)
-|..++
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 666544
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.12 Score=54.73 Aligned_cols=140 Identities=19% Similarity=0.230 Sum_probs=90.6
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccc---------hhH-------------H----HHHHHHHHHhccCcCc
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---------EGE-------------R----EFRAEMHVIGRTHHKN 569 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---------~~~-------------~----~f~~E~~~l~~l~h~n 569 (796)
.-.|..|.-+-||.+.-.++ ..+|||+.+...- .++ + .-..|+..|.+++...
T Consensus 149 nGCiSTGKEANVYHat~~dG-~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDG-SEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred ccccccCccceeEeeecCCC-ceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 34688999999999988766 4599998753110 011 1 1123555555554433
Q ss_pred hhhhhhhhccCCceeEEEeecCCCChhh-hhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC
Q 003772 570 LVRLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE 648 (796)
Q Consensus 570 iv~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 648 (796)
|.-.--+. -....|||+|+....-.. .| ....++...+..+-.|++.-|.-|.+.| .+||.||.--|+|+-+
T Consensus 228 IP~PePIl--Lk~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 228 IPCPEPIL--LKNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCCcee--eecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence 22111110 124579999986322111 12 1345667778888899999999998885 8999999999998764
Q ss_pred CCceEEeccCCccccC
Q 003772 649 FWTAKISDFGLAKLLM 664 (796)
Q Consensus 649 ~~~~kl~DFgl~~~~~ 664 (796)
|.+.|+|-+.+....
T Consensus 301 -G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 301 -GKLYIIDVSQSVEHD 315 (520)
T ss_pred -CEEEEEEccccccCC
Confidence 578899988886543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.038 Score=57.53 Aligned_cols=134 Identities=15% Similarity=0.127 Sum_probs=83.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEee--cccc------------------hhHH--HHHHHHHHHhccCc--C
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLE--KMVT------------------EGER--EFRAEMHVIGRTHH--K 568 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~--~~~~------------------~~~~--~f~~E~~~l~~l~h--~ 568 (796)
+.+++.||-|.-+.||.+....+ .+.++|.-. ..+- .... .-..|...|+.+.. -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G-~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEG-NPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecCCC-CchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 35678999999999999998755 466666421 1000 0001 12345555555532 1
Q ss_pred chhhhhhhhccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC
Q 003772 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE 648 (796)
Q Consensus 569 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 648 (796)
-+.+.+ +.+.+++|||++.+-.|.+.-+- .+.. .+...+..-+.-|..+ ++||+|.+--||++++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v-----~d~~---~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHV-----EDPP---TLYDDLMGLIVRLANH---GLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeec-----CChH---HHHHHHHHHHHHHHHc---CceecccchheeEEec
Confidence 223333 34578999999988877664422 1222 2233333334445555 9999999999999999
Q ss_pred CCceEEeccCCccc
Q 003772 649 FWTAKISDFGLAKL 662 (796)
Q Consensus 649 ~~~~kl~DFgl~~~ 662 (796)
+..++++||-....
T Consensus 238 d~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVS 251 (465)
T ss_pred CCCEEEeechHhhc
Confidence 99999999965543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.21 Score=53.51 Aligned_cols=135 Identities=20% Similarity=0.254 Sum_probs=81.0
Q ss_pred cceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCch------hhhhh----hhccCCceeEEEeecCC
Q 003772 523 SFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNL------VRLIG----YCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 523 ~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~ni------v~l~g----~~~~~~~~~lV~e~~~~ 592 (796)
.-..+|+....++. .++|+.... ....++..|...+..+.-.++ ..+=| ........+-+++|++|
T Consensus 37 ~eN~~f~~~~~~g~--~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G 112 (331)
T COG2334 37 EENSNFRVQTEDGR--YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPG 112 (331)
T ss_pred ccCceEEEEecCCC--eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCC
Confidence 45678888876554 378887664 445566777777777632222 22211 11112377889999999
Q ss_pred CChhh-h----h----------hc--------C--CCCCCchhH-------------HHHHHHHHHHHHHHhhccC----
Q 003772 593 GSLAD-I----L----------FR--------G--PERSLGWDE-------------RVRIASDVAKGILYLHDEC---- 630 (796)
Q Consensus 593 gsL~~-~----l----------~~--------~--~~~~l~~~~-------------~~~i~~~ia~aL~~LH~~~---- 630 (796)
..+.. . + +. . ......|.. -.....++...+..+.+.-
T Consensus 113 ~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~l 192 (331)
T COG2334 113 RPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHL 192 (331)
T ss_pred cCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhC
Confidence 88873 1 1 10 0 011233431 0123344455555555432
Q ss_pred CCC---eeeeccCccceEecCCCc-eEEeccCCcc
Q 003772 631 EAP---IIHCDIKPQNILMDEFWT-AKISDFGLAK 661 (796)
Q Consensus 631 ~~~---ivH~Dlkp~NIll~~~~~-~kl~DFgl~~ 661 (796)
... +||+|+.|.||+++.+.. ..+.||+-+.
T Consensus 193 p~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 193 PALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred CcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 223 999999999999999885 8999999885
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.89 E-value=0.047 Score=54.86 Aligned_cols=30 Identities=33% Similarity=0.476 Sum_probs=21.4
Q ss_pred CeeeeccCccceEe-cCCCceEEeccCCccc
Q 003772 633 PIIHCDIKPQNILM-DEFWTAKISDFGLAKL 662 (796)
Q Consensus 633 ~ivH~Dlkp~NIll-~~~~~~kl~DFgl~~~ 662 (796)
.+.|+|+.|.||++ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 57799999999999 8899999999999864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.034 Score=61.24 Aligned_cols=164 Identities=21% Similarity=0.276 Sum_probs=89.5
Q ss_pred HHHHHHHHHHHhccCcCchhhhhhhhccCC-ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccC
Q 003772 552 EREFRAEMHVIGRTHHKNLVRLIGYCAEDS-KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630 (796)
Q Consensus 552 ~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~ 630 (796)
...+.-...+++.++|+|+..++.+..... ...+|+|++. -||++.+..+... ... .. -|
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~l~---~~s------~~------~~--- 86 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGNLK---DES------LL------AH--- 86 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcccc---hhh------hc------cc---
Confidence 344566778888999999999998876543 4677888875 5899988764211 110 00 11
Q ss_pred CCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhc
Q 003772 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCC 710 (796)
Q Consensus 631 ~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg 710 (796)
++.| .|| .+++| -++. .. ..+..+|+|||++|.++.|+.-|
T Consensus 87 --~~~~-----~~~-------~~~td-~~~t----------------~~--------~~~~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 87 --GVLH-----LNI-------IYITD-HFLT----------------KY--------PSPIGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred --ccce-----ehh-------hhccc-cccc----------------cC--------CCCCCcchhhhhHHHHHHHHHHh
Confidence 2222 122 22233 0000 00 01122599999999999999988
Q ss_pred ccCCCCCCCCchhHHHHHHHHHhh-hhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 003772 711 RRNMEIDPSKPEEIVLINWAYKCF-IDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777 (796)
Q Consensus 711 ~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 777 (796)
...+..-.. ..........+ .++....+...+....++....+++...|+-..|..||...+.
T Consensus 128 ~~l~~~~~~----s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 128 ISLEAELTE----SEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred hHHHHHHHH----HHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 754431110 00001011111 1111111111123344566778888999999999988865443
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.085 Score=56.65 Aligned_cols=59 Identities=20% Similarity=0.219 Sum_probs=42.6
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD 647 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 647 (796)
.|+=+|+++.++..++.. +..++....+++.-.++|+.-|--- .+.+|.|++|.||++.
T Consensus 321 vl~E~~~~Gl~v~~~v~~---~~~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKW---KSQPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIR 379 (565)
T ss_pred eeeeeccccccHHhhhhc---ccChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEE
Confidence 566668888899988865 3344456667776666776554433 2899999999999995
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 796 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-55 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-41 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-37 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-31 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-31 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-21 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-20 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-20 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-19 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-19 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-18 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-18 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-18 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-18 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 386 bits (993), Expect = e-128
Identities = 124/294 (42%), Positives = 177/294 (60%), Gaps = 10/294 (3%)
Query: 499 NLRSFSYNELKKATNRFKEE--LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG-EREF 555
L+ FS EL+ A++ F + LG+G FG VYKG L G LVAVK+L++ T+G E +F
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-TLVAVKRLKEERTQGGELQF 74
Query: 556 RAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERS--LGWDERV 613
+ E+ +I H+NL+RL G+C ++RLLVY YM+NGS+A L PE L W +R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 614 RIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL 673
RIA A+G+ YLHD C+ IIH D+K NIL+DE + A + DFGLAKL+ T T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194
Query: 674 VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEID-PSKPEEIVLINWAYK 732
VRGT G++APE+ S K DVF YGV+LLE++ +R ++ + ++++L++W
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 733 CFIDRELNKLV---RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783
+++L LV +E +I++ L C Q P RP M VV MLEG
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 363 bits (934), Expect = e-120
Identities = 113/316 (35%), Positives = 169/316 (53%), Gaps = 27/316 (8%)
Query: 488 ENGSLGLAYESNLRSFSYNELKKATNRFKEE--------LGKGSFGAVYKGTLYKGEKLV 539
EN SL ++ ++ SFS+ ELK TN F E +G+G FG VYKG + V
Sbjct: 1 ENKSLEVS-DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTV 57
Query: 540 AVKKLEKMVT----EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595
AVKKL MV E +++F E+ V+ + H+NLV L+G+ ++ LVY YM NGSL
Sbjct: 58 AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 596 ADILFRGPERS-LGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKI 654
D L L W R +IA A GI +LH+ IH DIK NIL+DE +TAKI
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKI 174
Query: 655 SDFGLAKLL-MPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRN 713
SDFGLA+ QT + + GT YMAPE I+ K+D++S+GVVLLEI+
Sbjct: 175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPA 233
Query: 714 MEIDPSKPEEIVLINWAYKCFID-RELNKLV--RGQEVDRNTLENMIKIGLWCVQDEPAL 770
+D + + +L++ + + + + + + + D ++E M + C+ ++
Sbjct: 234 --VDEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNK 290
Query: 771 RPSMKSVVLMLEGITD 786
RP +K V +L+ +T
Sbjct: 291 RPDIKKVQQLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 356 bits (917), Expect = e-117
Identities = 106/307 (34%), Positives = 163/307 (53%), Gaps = 17/307 (5%)
Query: 491 SLGLAYESNLRSFSYNELKKATNRFKEE--LGKGSFGAVYKGTLYKGEKLVAVKKLEKMV 548
S +L++ATN F + +G G FG VYKG L G K VA+K+
Sbjct: 17 SSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK-VALKRRTPES 75
Query: 549 TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFR--GPERS 606
++G EF E+ + H +LV LIG+C E ++ +L+Y+YM NG+L L+ P S
Sbjct: 76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 607 LGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL-LMP 665
+ W++R+ I A+G+ YLH IIH D+K NIL+DE + KI+DFG++K
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 666 DQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKP-EEI 724
DQT T+V+GT GY+ PE++ ++ K+DV+S+GVVL E++C R I S P E +
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA--IVQSLPREMV 250
Query: 725 VLINWAYKCFIDRELNKLV----RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780
L WA + + +L ++V + + +L + C+ RPSM V+
Sbjct: 251 NLAEWAVESHNNGQLEQIVDPNLADK-IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309
Query: 781 LEGITDI 787
LE +
Sbjct: 310 LEYALRL 316
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 9e-79
Identities = 68/315 (21%), Positives = 123/315 (39%), Gaps = 35/315 (11%)
Query: 498 SNLRSFSYNELKKATNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREF 555
S+ L + + E +G FG V+K E VAVK + + +
Sbjct: 9 SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEY-VAVKIF-PIQDKQSWQN 65
Query: 556 RAEMHVIGRTHHKNLVRLIGYCAEDSK----RLLVYEYMSNGSLADILFRGPERSLGWDE 611
E++ + H+N+++ IG + L+ + GSL+D L + W+E
Sbjct: 66 EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNE 122
Query: 612 RVRIASDVAKGILYLHDECEA-------PIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664
IA +A+G+ YLH++ I H DIK +N+L+ TA I+DFGLA
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 665 PDQTRTFTLVR-GTRGYMAPE-----WYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDP 718
++ T + GTR YMAPE ++ D+++ G+VL E+ + P
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD-GP 241
Query: 719 SKPEEIVLINWAYKCFIDRELNKLVRGQEVD---------RNTLENMIKIGLWCVQDEPA 769
+ + ++ ++V ++ + + + C +
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 770 LRPSMKSVVLMLEGI 784
R S V + +
Sbjct: 302 ARLSAGCVGERITQM 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 4e-72
Identities = 92/293 (31%), Positives = 148/293 (50%), Gaps = 31/293 (10%)
Query: 505 YNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKL--EKMVTEGEREFRAEMHVI 562
+ +L KE++G GSFG V++ + G VAVK L + E EF E+ ++
Sbjct: 36 WCDLN-----IKEKIGAGSFGTVHRAE-WHGSD-VAVKILMEQDFHAERVNEFLREVAIM 88
Query: 563 GRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFR-GPERSLGWDERVRIASDVAK 621
R H N+V +G + +V EY+S GSL +L + G L R+ +A DVAK
Sbjct: 89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 622 GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYM 681
G+ YLH PI+H ++K N+L+D+ +T K+ DFGL++ L + GT +M
Sbjct: 149 GMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWM 206
Query: 682 APEWYKNTPISVKADVFSYGVVLLEIVCCR---RNMEIDPSKPEEIVLINWAYKCFIDRE 738
APE ++ P + K+DV+S+GV+L E+ + N+ P ++V A F +
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN-----PAQVV----AAVGFKCKR 257
Query: 739 LNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPP 791
L E+ RN + I C +EP RPS +++ +L + ++PP
Sbjct: 258 L-------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-69
Identities = 79/283 (27%), Positives = 133/283 (46%), Gaps = 31/283 (10%)
Query: 505 YNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGR 564
Y E++ +E +G+G+FG V K ++ + VA+K++E + F E+ + R
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAK-WRAKD-VAIKQIES--ESERKAFIVELRQLSR 57
Query: 565 THHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILF-RGPERSLGWDERVRIASDVAKGI 623
+H N+V+L G C LV EY GSL ++L P + ++G+
Sbjct: 58 VNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 624 LYLHDECEAPIIHCDIKPQNILMDEFWT-AKISDFGLAKLLMPDQTRTFTLVRGTRGYMA 682
YLH +IH D+KP N+L+ T KI DFG A D T +G+ +MA
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMA 171
Query: 683 PEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKP-EEIVLINWAYKCFIDRELNK 741
PE ++ + S K DVFS+G++L E++ R KP +EI + +
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRR--------KPFDEIGGPAFRIMWAVHNGT-- 221
Query: 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
R + +N + + + C +P+ RPSM+ +V ++ +
Sbjct: 222 --R-PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 2e-67
Identities = 69/322 (21%), Positives = 119/322 (36%), Gaps = 48/322 (14%)
Query: 503 FSYNELKKATNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMH 560
+ +E + K E +G+G +GAVYKG+ VAVK + F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGS-LDERP-VAVKVFS---FANRQNFINEKN 57
Query: 561 V--IGRTHHKNLVRLIGYCAEDS-----KRLLVYEYMSNGSLADILFRGPERSLGWDERV 613
+ + H N+ R I + + LLV EY NGSL L + W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSC 114
Query: 614 RIASDVAKGILYLHDE------CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD- 666
R+A V +G+ YLH E + I H D+ +N+L+ T ISDFGL+ L +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 667 ------QTRTFTLVRGTRGYMAPEWYKNT-------PISVKADVFSYGVVLLEIVC-CRR 712
+ GT YMAPE + + D+++ G++ EI C
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 713 NMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ----------EVDRNTLENMIKIGLW 762
+ ++ ++ LV + + + + ++ +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 763 CVQDEPALRPSMKSVVLMLEGI 784
C + R + + + +
Sbjct: 295 CWDQDAEARLTAQXAEERMAEL 316
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 5e-67
Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 48/297 (16%)
Query: 505 YNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKL----EKMVTEGEREFRAEMH 560
+ EL +E +G G FG VY+ + G++ VAVK ++ +++ R E
Sbjct: 6 FAELT-----LEEIIGIGGFGKVYRAF-WIGDE-VAVKAARHDPDEDISQTIENVRQEAK 58
Query: 561 VIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVA 620
+ H N++ L G C ++ LV E+ G L +L + + D V A +A
Sbjct: 59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIA 115
Query: 621 KGILYLHDECEAPIIHCDIKPQNILMDEF--------WTAKISDFGLAKLLMPDQTRTFT 672
+G+ YLHDE PIIH D+K NIL+ + KI+DFGLA+ +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCR---RNMEIDPSKPEEIVLINW 729
G +MAPE + + S +DV+SYGV+L E++ R ++ +
Sbjct: 176 ---GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-----GLAVA---- 223
Query: 730 AYKCFIDRELNKLVRGQ--EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ + E K+ C +P RPS +++ L I
Sbjct: 224 ---------YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 5e-67
Identities = 81/310 (26%), Positives = 131/310 (42%), Gaps = 39/310 (12%)
Query: 501 RSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMH 560
R F ++L E LGKG FG K T + +++ +K+L + E +R F E+
Sbjct: 5 RIFRPSDLI-----HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVK 59
Query: 561 VIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVA 620
V+ H N+++ IG +D + + EY+ G+L I+ + + W +RV A D+A
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIA 118
Query: 621 KGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT------------ 668
G+ YLH IIH D+ N L+ E ++DFGLA+L++ ++T
Sbjct: 119 SGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 669 -RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNME-IDPSKPEEIVL 726
+ V G +MAPE K DVFS+G+VL EI+ P + +
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235
Query: 727 INWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI-- 784
+ + N + I + C +P RPS + LE +
Sbjct: 236 VRGFLD-------------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282
Query: 785 -TDISIPPCP 793
+P P
Sbjct: 283 HLAGHLPLGP 292
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 3e-66
Identities = 73/305 (23%), Positives = 135/305 (44%), Gaps = 44/305 (14%)
Query: 497 ESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKL-------EKMVT 549
+S L + + NE++ +++++GKG FG V+KG L K + +VA+K L E +
Sbjct: 10 KSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 550 EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGW 609
E +EF+ E+ ++ +H N+V+L G +V E++ G L L + W
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRL-LDKAHPIKW 121
Query: 610 DERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW-----TAKISDFGLAKLLM 664
++R+ D+A GI Y+ + PI+H D++ NI + AK++DFGL++
Sbjct: 122 SVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--- 177
Query: 665 PDQTRTFTLVRGTRGYMAPE--WYKNTPISVKADVFSYGVVLLEIVCCR---RNMEIDPS 719
+ + + G +MAPE + + KAD +S+ ++L I+
Sbjct: 178 -QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY----- 231
Query: 720 KPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779
+I IN + +R + + + + C +P RP +V
Sbjct: 232 SYGKIKFINMI--------REEGLRP-TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282
Query: 780 MLEGI 784
L +
Sbjct: 283 ELSEL 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-65
Identities = 67/298 (22%), Positives = 124/298 (41%), Gaps = 47/298 (15%)
Query: 505 YNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKL--EKMVTEGEREFRAEMHVI 562
+ +L+ E +GKG FG VY G + GE VA++ + E+ + + F+ E+
Sbjct: 32 FEQLE-----IGELIGKGRFGQVYHGR-WHGE--VAIRLIDIERDNEDQLKAFKREVMAY 83
Query: 563 GRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKG 622
+T H+N+V +G C ++ +L ++ R + L ++ +IA ++ KG
Sbjct: 84 RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKG 142
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL----LMPDQTRTFTLVRGTR 678
+ YLH + I+H D+K +N+ D I+DFGL + + + G
Sbjct: 143 MGYLHAK---GILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 679 GYMAPEWYKNT---------PISVKADVFSYGVVLLEIVCCR---RNMEIDPSKPEEIVL 726
++APE + P S +DVF+ G + E+ + E I+
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-----AEAII- 252
Query: 727 INWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
W + ++ + + I L+C E RP+ ++ MLE +
Sbjct: 253 --WQ--------MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 6e-64
Identities = 69/304 (22%), Positives = 123/304 (40%), Gaps = 64/304 (21%)
Query: 505 YNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKL--EKMVTEGEREFRAEMHVI 562
+ +L F +L + G ++KG ++G + VK L T R+F E +
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGR-WQGND-IVVKVLKVRDWSTRKSRDFNEECPRL 61
Query: 563 GRTHHKNLVRLIGYCAE--DSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVA 620
H N++ ++G C L+ +M GSL ++L G + + V+ A D+A
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 621 KGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGY 680
+G+ +LH E I + +++++DE TA+IS + + +
Sbjct: 122 RGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAW 174
Query: 681 MAPEWYKNTPISV---KADVFSYGVVLLEIVCCRR------NMEID---------PSKPE 722
+APE + P AD++S+ V+L E+V NMEI P+ P
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234
Query: 723 EIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
I ++KL++ C+ ++PA RP +V +LE
Sbjct: 235 G-----------ISPHVSKLMK-----------------ICMNEDPAKRPKFDMIVPILE 266
Query: 783 GITD 786
+ D
Sbjct: 267 KMQD 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-63
Identities = 75/280 (26%), Positives = 130/280 (46%), Gaps = 29/280 (10%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKL--EKMVTEGEREFRAEMHVIGRTHHKNLV 571
+ +G GSFG VYKG + G+ VAVK L + + F+ E+ V+ +T H N++
Sbjct: 27 TVGQRIGSGSFGTVYKGK-WHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
+GY + +V ++ SL L E + + IA A+G+ YLH +
Sbjct: 84 LFMGYSTAP-QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHAK-- 139
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLL-MPDQTRTFTLVRGTRGYMAPEWYKN-- 688
IIH D+K NI + E T KI DFGLA + F + G+ +MAPE +
Sbjct: 140 -SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 689 -TPISVKADVFSYGVVLLEIVCCR---RNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744
P S ++DV+++G+VL E++ + N+ + ++ + R +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNI-----NNRDQII--EM----VGRG-SLSPD 246
Query: 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+V N + M ++ C++ + RPS ++ +E +
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 8e-60
Identities = 72/297 (24%), Positives = 126/297 (42%), Gaps = 31/297 (10%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
+++GKG +G V+ G ++GEK VAVK E E++ H+N++ I
Sbjct: 41 MVKQIGKGRYGEVWMGK-WRGEK-VAVKVF-FTTEEASWFRETEIYQTVLMRHENILGFI 97
Query: 575 GYCAEDSKR----LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE- 629
+ + L+ +Y NGSL D L +L +++A G+ +LH E
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 630 ----CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF---TLVRGTRGYMA 682
+ I H D+K +NIL+ + T I+D GLA + D GT+ YM
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 683 PE------WYKNTPISVKADVFSYGVVLLEIV-CCRRNMEIDPSKP--EEIVLINWAYKC 733
PE + + AD++S+G++L E+ C ++ + ++V + +Y+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 734 FIDRELNKLVR----GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786
+ K +R + L M K+ C PA R + V L +++
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 2e-59
Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 35/297 (11%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAE--MHVIGRTHHKNLVR 572
E +GKG +G V++G+ ++GE VAVK + E+ + E ++ H+N++
Sbjct: 12 LLECVGKGRYGEVWRGS-WQGEN-VAVKIFS---SRDEKSWFRETELYNTVMLRHENILG 66
Query: 573 LIGYCAEDSKR----LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
I L+ Y GSL D L +L +RI +A G+ +LH
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHI 123
Query: 629 ECEA-----PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR---TFTLVRGTRGY 680
E I H D+K +NIL+ + I+D GLA + + GT+ Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 681 MAPEWYKNTPISV------KADVFSYGVVLLEIV-CCRRNMEIDPSKP--EEIVLINWAY 731
MAPE T + D++++G+VL E+ N ++ KP ++V + ++
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 732 KCFIDRELNKLVR----GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ R + TL ++ K+ C P+ R + + L I
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-57
Identities = 74/297 (24%), Positives = 124/297 (41%), Gaps = 35/297 (11%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHV--IGRTHHKNLVR 572
+E +GKG FG V++G ++GE+ VAVK + ER + E + H+N++
Sbjct: 46 LQESIGKGRFGEVWRGK-WRGEE-VAVKIFS---SREERSWFREAEIYQTVMLRHENILG 100
Query: 573 LIGYCAEDSKR----LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
I +D+ LV +Y +GSL D L R ++ + +++A A G+ +LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHM 157
Query: 629 ECEA-----PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF---TLVRGTRGY 680
E I H D+K +NIL+ + T I+D GLA GT+ Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 681 MAPE------WYKNTPISVKADVFSYGVVLLEIV-CCRRNMEIDPSKP--EEIVLINWAY 731
MAPE K+ +AD+++ G+V EI C + + ++V + +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 732 KCFIDRELNKLVR----GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ + +R + L M KI C A R + + L +
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-45
Identities = 71/287 (24%), Positives = 118/287 (41%), Gaps = 31/287 (10%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKL-EKMVTEGEREFRAEMHVIGRT 565
L E++G+G+FG V+ G L LVAVK E + + + +F E ++ +
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169
Query: 566 HHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILY 625
H N+VRLIG C + +V E + G L R L +++ D A G+ Y
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 626 LHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGY----M 681
L IH D+ +N L+ E KISDFG+++ + G R
Sbjct: 229 LE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGLRQVPVKWT 282
Query: 682 APEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-LN 740
APE S ++DV+S+G++L E + P Y +++
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETF-------SLGASP---------YPNLSNQQTRE 326
Query: 741 KLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785
+ +G + + + ++ C EP RPS ++ L+ I
Sbjct: 327 FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-44
Identities = 73/281 (25%), Positives = 124/281 (44%), Gaps = 23/281 (8%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+++ K +LG G +G VY+G K VAVK L K T EF E V+
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIK 274
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H NLV+L+G C + ++ E+M+ G+L D L + + + +A+ ++ + YL
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
+ IH ++ +N L+ E K++DFGL++L+ D + + APE
Sbjct: 335 EKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391
Query: 687 KNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-LNKLVRG 745
S+K+DV+++GV+L EI P Y + L +
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGM-------SP---------YPGIDLSQVYELLEKD 435
Query: 746 QEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
++R E + ++ C Q P+ RPS + E +
Sbjct: 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-42
Identities = 80/281 (28%), Positives = 136/281 (48%), Gaps = 25/281 (8%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+ + + R + +LG+G FG V+ GT + G VA+K L K T F E V+ +
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 237
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H+ LV+L +E+ +V EYMS GSL D L + L + V +A+ +A G+ Y+
Sbjct: 238 HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
+H D++ NIL+ E K++DFGLA+L+ ++ + + APE
Sbjct: 297 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 353
Query: 687 KNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-LNKLVRG 745
++K+DV+S+G++L E+ R P Y ++RE L+++ RG
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGR-------VP---------YPGMVNREVLDQVERG 397
Query: 746 QEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ E++ + C + EP RP+ + + LE
Sbjct: 398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 73/291 (25%), Positives = 132/291 (45%), Gaps = 21/291 (7%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLY----KGEKLVAVKKLEKMVTEGEREFRAEMHVI 562
++ ++ +LGKG+FG+V LVAVK+L+ + +R+F+ E+ ++
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 563 GRTHHKNLVRLIGYCAEDSKR--LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVA 620
H +V+ G ++ LV EY+ +G L D L + L + +S +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQIC 137
Query: 621 KGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG- 679
KG+ YL +H D+ +NIL++ KI+DFGLAKLL D+ + + +
Sbjct: 138 KGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD-YYVVREPGQSP 193
Query: 680 --YMAPEWYKNTPISVKADVFSYGVVLLEIV-CCRRNMEIDPSKPEEIVLINWAYKCFID 736
+ APE + S ++DV+S+GVVL E+ C ++ E + ++
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC---SPSAEFLRMMGCERDVPAL 250
Query: 737 RELNKLV-RGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
L +L+ GQ + + ++ C P RPS ++ L+ +
Sbjct: 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-42
Identities = 73/286 (25%), Positives = 133/286 (46%), Gaps = 31/286 (10%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+ F +ELG G FG V G ++G+ VA+K + K + E EF E V+
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLS 77
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H+ LV+L G C + ++ EYM+NG L + L R + + + DV + + YL
Sbjct: 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAP 683
+ +H D+ +N L+++ K+SDFGL++ ++ D+ +T G++ + P
Sbjct: 137 ESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPP 190
Query: 684 EWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-LNKL 742
E + S K+D++++GV++ EI + P Y+ F + E +
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGK-------MP---------YERFTNSETAEHI 234
Query: 743 VRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786
+G + R E + I C ++ RP+ K ++ + + D
Sbjct: 235 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-42
Identities = 76/286 (26%), Positives = 137/286 (47%), Gaps = 31/286 (10%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
ELK+ +ELG G FG V G +KG+ VAVK +++ E EF E + +
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLS 61
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H LV+ G C+++ +V EY+SNG L + L R + L + + + DV +G+ +L
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAP 683
IH D+ +N L+D K+SDFG+ + ++ DQ + GT+ + AP
Sbjct: 121 ESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAP 174
Query: 684 EWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-LNKL 742
E + S K+DV+++G+++ E+ + P Y + + E + K+
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGK-------MP---------YDLYTNSEVVLKV 218
Query: 743 VRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786
+G + R + + +I C + P RP+ + ++ +E + +
Sbjct: 219 SQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-41
Identities = 80/281 (28%), Positives = 136/281 (48%), Gaps = 25/281 (8%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+ + + R + +LG+G FG V+ GT + G VA+K L K T F E V+ +
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 320
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H+ LV+L +E+ +V EYMS GSL D L + L + V +A+ +A G+ Y+
Sbjct: 321 HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
+H D++ NIL+ E K++DFGLA+L+ ++ + + APE
Sbjct: 380 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 436
Query: 687 KNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-LNKLVRG 745
++K+DV+S+G++L E+ R P Y ++RE L+++ RG
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGR-------VP---------YPGMVNREVLDQVERG 480
Query: 746 QEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ E++ + C + EP RP+ + + LE
Sbjct: 481 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 63/293 (21%), Positives = 127/293 (43%), Gaps = 22/293 (7%)
Query: 506 NELKKATNRFKEELGKGSFGAVYKGTL----YKGEKLVAVKKLEKMVTEGER-EFRAEMH 560
+K + +LG+G FG V + VAVK L+ + + E+
Sbjct: 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75
Query: 561 VIGRTHHKNLVRLIGYCAEDSKR--LLVYEYMSNGSLADILFRGPERSLGWDERVRIASD 618
++ +H+N+V+ G C ED L+ E++ +GSL + L + + ++++ A
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQ 134
Query: 619 VAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR 678
+ KG+ YL +H D+ +N+L++ KI DFGL K + +T+
Sbjct: 135 ICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRD 190
Query: 679 ---GYMAPEWYKNTPISVKADVFSYGVVLLEIV-CCRRNMEIDPSKPEEIVLINWAYKCF 734
+ APE + + +DV+S+GV L E++ C + + +I +
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS---SPMALFLKMIGPTHGQM 247
Query: 735 IDRELNKLV-RGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
L + G+ + N + + ++ C + +P+ R S ++++ E +
Sbjct: 248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 81/293 (27%), Positives = 134/293 (45%), Gaps = 20/293 (6%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEK-----LVAVKKLEKMVTEGEREFRAEMHV 561
+ ++ +F ++LGKG+FG+V Y + +VAVKKL+ E R+F E+ +
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 64
Query: 562 IGRTHHKNLVRLIGYCAEDSKR--LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDV 619
+ H N+V+ G C +R L+ EY+ GSL D L + + + + ++ S +
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQI 123
Query: 620 AKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG 679
KG+ YL + IH D+ +NIL++ KI DFGL K+L P F +
Sbjct: 124 CKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFKVKEPGES 179
Query: 680 ---YMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFID 736
+ APE + SV +DV+S+GVVL E+ P ++ N I
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELF-TYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 737 RELNKLV-RGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786
L +L+ + R + + I C + RPS + + L ++ I D
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 79/291 (27%), Positives = 133/291 (45%), Gaps = 20/291 (6%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEK-----LVAVKKLEKMVTEGEREFRAEMHV 561
+ ++ +F ++LGKG+FG+V Y + +VAVKKL+ E R+F E+ +
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCR-YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 95
Query: 562 IGRTHHKNLVRLIGYCAEDSKR--LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDV 619
+ H N+V+ G C +R L+ EY+ GSL D L + + + + ++ S +
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQI 154
Query: 620 AKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG 679
KG+ YL + IH D+ +NIL++ KI DFGL K+L P + +
Sbjct: 155 CKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEYYKVKEPGES 210
Query: 680 ---YMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFID 736
+ APE + SV +DV+S+GVVL E+ P ++ N I
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELF-TYIEKSKSPPAEFMRMIGNDKQGQMIV 269
Query: 737 RELNKLV-RGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
L +L+ + R + + I C + RPS + + L ++ I
Sbjct: 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-41
Identities = 74/284 (26%), Positives = 134/284 (47%), Gaps = 31/284 (10%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
+ + F +E+G G FG V+ G + + VA+K + + E +F E V+ +
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLS 61
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H LV+L G C E + LV E+M +G L+D L R + + + DV +G+ YL
Sbjct: 62 HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAP 683
+ C +IH D+ +N L+ E K+SDFG+ + ++ DQ +T GT+ + +P
Sbjct: 121 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASP 174
Query: 684 EWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-LNKL 742
E + + S K+DV+S+GV++ E+ + P Y+ + E + +
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGK-------IP---------YENRSNSEVVEDI 218
Query: 743 VRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
G + + ++ +I C ++ P RP+ ++ L I
Sbjct: 219 STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-41
Identities = 74/284 (26%), Positives = 134/284 (47%), Gaps = 31/284 (10%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+ + + + +++LG G FG V+ T Y VAVK + K + F AE +V+
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQ 241
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H LV+L ++ ++ E+M+ GSL D L + + ++ +A+G+ ++
Sbjct: 242 HDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG---YMAP 683
IH D++ NIL+ KI+DFGLA+++ ++ +T G + + AP
Sbjct: 301 EQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAP 354
Query: 684 EWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-LNKL 742
E ++K+DV+S+G++L+EIV R P Y + E + L
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGR-------IP---------YPGMSNPEVIRAL 398
Query: 743 VRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
RG + R N E + I + C ++ P RP+ + + +L+
Sbjct: 399 ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-40
Identities = 67/205 (32%), Positives = 112/205 (54%), Gaps = 12/205 (5%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+ + T + E LG G FG V+ G Y G VAVK L K + F AE +++ +
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQ 66
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H+ LVRL ++ ++ EYM NGSL D L L ++ + +A+ +A+G+ ++
Sbjct: 67 HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAP 683
+ IH D++ NIL+ + + KI+DFGLA+L+ ++ +T G + + AP
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAP 179
Query: 684 EWYKNTPISVKADVFSYGVVLLEIV 708
E ++K+DV+S+G++L EIV
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIV 204
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 78/292 (26%), Positives = 137/292 (46%), Gaps = 38/292 (13%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTL----YKGEKLVAVKKLEKMVTEGER-EFRAEMHV 561
E+ + ++ +G G FG VYKG L K E VA+K L+ TE +R +F E +
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99
Query: 562 IGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAK 621
+G+ H N++RL G ++ +++ EYM NG+L L R + + V + +A
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAA 158
Query: 622 GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG-- 679
G+ YL + +H D+ +NIL++ K+SDFGL+++L D T+T T G
Sbjct: 159 GMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT----TSGGK 211
Query: 680 ----YMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI 735
+ APE + +DV+S+G+V+ E++ +P Y
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE-------RP---------YWELS 255
Query: 736 DRE-LNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ E + + G + + + ++ + C Q E A RP +V +L+ +
Sbjct: 256 NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 76/284 (26%), Positives = 129/284 (45%), Gaps = 29/284 (10%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+++ K +LG G +G VY+G K VAVK L++ E E EF E V+
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H NLV+L+G C + ++ E+M+ G+L D L + + + +A+ ++ + YL
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAP 683
+ IH D+ +N L+ E K++DFGL++L+ D +T G + + AP
Sbjct: 128 EKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAP 181
Query: 684 EWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-LNKL 742
E S+K+DV+++GV+L EI P Y + L
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGM-------SP---------YPGIDLSQVYELL 225
Query: 743 VRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ ++R E + ++ C Q P+ RPS + E +
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 7e-40
Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 16/211 (7%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTL---YKGEKLVAVKKLEKMVTEGER-EFRAEMHVI 562
E++ + ++ +G G G V G L + + VA+K L+ TE +R +F +E ++
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 563 GRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKG 622
G+ H N++RL G ++V EYM NGSL L R + + V + V G
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAG 163
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG--- 679
+ YL D +H D+ +N+L+D K+SDFGL+++L D +T T G
Sbjct: 164 MRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT---TTGGKIP 217
Query: 680 --YMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+ APE S +DV+S+GVV+ E++
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVK--KLEKMVTEGEREFRAEMHVIGRTHHKNLV 571
+F E+G+GSF VYKG + VA + K+ + F+ E ++ H N+V
Sbjct: 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88
Query: 572 RLIGYC---AEDSKRLLVY-EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLH 627
R + K +++ E M++G+L L R + + + KG+ +LH
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH 146
Query: 628 DECEAPIIHCDIKPQNILMD-EFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
PIIH D+K NI + + KI D GLA L + V GT +MAPE Y
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMY 202
Query: 687 KNTPISVKADVFSYGVVLLEIV 708
+ DV+++G+ +LE+
Sbjct: 203 EE-KYDESVDVYAFGMCMLEMA 223
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 59/297 (19%), Positives = 117/297 (39%), Gaps = 42/297 (14%)
Query: 505 YNELKKATNRFKEELGKGSFGAVYKGTL-------YKGEKLVAVKKLEKMVTEGEREFRA 557
+++++ F E LG+G+F ++KG E V +K L+K F
Sbjct: 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 558 EMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIAS 617
++ + HK+LV G C + +LV E++ GSL L + + + ++ +A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAK 120
Query: 618 DVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT--------AKISDFGLAKLLMPDQTR 669
+A + +L + +IH ++ +NIL+ K+SD G++ ++P
Sbjct: 121 QLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
Query: 670 TFTLVRGTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLIN 728
+ ++ PE +N ++ D +S+G L EI KP
Sbjct: 178 QER-IP----WVPPECIENPKNLNLATDKWSFGTTLWEICSGGD-------KP------- 218
Query: 729 WAYKCFIDRE-LNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ L ++ + + C+ EP RPS ++++ L +
Sbjct: 219 --LSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 75/292 (25%), Positives = 135/292 (46%), Gaps = 24/292 (8%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEK-----LVAVKKLEKMVTEGER-EFRAEMH 560
K + +LG+G FG V Y +VAVK L+ R ++ E+
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYC-YDPTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85
Query: 561 VIGRTHHKNLVRLIGYCAEDSKR--LLVYEYMSNGSLADILFRGPERSLGWDERVRIASD 618
++ +H+++++ G C + LV EY+ GSL D L P S+G + + A
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQ 142
Query: 619 VAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR 678
+ +G+ YLH + IH D+ +N+L+D KI DFGLAK + P+ + +
Sbjct: 143 ICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGD 198
Query: 679 ---GYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI 735
+ APE K +DV+S+GV L E++ + + P+K E++ I
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA--QGQMT 256
Query: 736 DRELNKLV-RGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
L +L+ RG+ + R + + C + E + RP+ ++++ +L+ +
Sbjct: 257 VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 56/305 (18%)
Query: 514 RFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHH 567
K ELG+G+FG V+ Y K + LVAVK L K T R +F+ E ++ H
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQH 76
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL--------------FRGPERSLGWDERV 613
+++V+ G C + ++V+EYM +G L L R + LG + +
Sbjct: 77 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 614 RIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM-PDQTRTFT 672
IAS +A G++YL + +H D+ +N L+ KI DFG+++ + D R
Sbjct: 137 HIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR--- 190
Query: 673 LVRGTRG-----YMAPEWYKNTPISVKADVFSYGVVLLEIV-CCRRNMEIDPSKPEEIVL 726
G +M PE + ++DV+S+GV+L EI ++ P
Sbjct: 191 --VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ-----P-------- 235
Query: 727 INWAYKCFIDRE-LNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783
+ + E + + +G+ ++R + + + L C Q EP R ++K + +L
Sbjct: 236 ----WFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHA 291
Query: 784 ITDIS 788
+ +
Sbjct: 292 LGKAT 296
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 55/272 (20%), Positives = 109/272 (40%), Gaps = 32/272 (11%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKK--LEKMVTEGEREF-RAEMHVIGRTHHKNLVRL 573
+++G+G F VY+ VA+KK + ++ R E+ ++ + +H N+++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGILYLHDECE 631
ED++ +V E G L+ ++ ++ ER + + + ++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR- 156
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
++H DIKP N+ + K+ D GL + T +LV GT YM+PE
Sbjct: 157 --VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY 213
Query: 692 SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ----- 746
+ K+D++S G +L E+ + D + K+ +
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC--------------KKIEQCDYPPLP 259
Query: 747 -EVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777
+ L ++ C+ +P RP + V
Sbjct: 260 SDHYSEELRQLVN---MCINPDPEKRPDVTYV 288
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-39
Identities = 77/286 (26%), Positives = 129/286 (45%), Gaps = 31/286 (10%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMVTEGER-EFRAEMHVI 562
EL + +G G FG V G L K E VA+K L+ TE +R +F E ++
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 563 GRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKG 622
G+ H N++RL G + ++V EYM NGSL L R + + V + +A G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASG 159
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---G 679
+ YL D +H D+ +NIL++ K+SDFGL ++L D RG +
Sbjct: 160 MKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAYTTRGGKIPIR 215
Query: 680 YMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE- 738
+ +PE + +DV+SYG+VL E++ +P Y +++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE-------RP---------YWEMSNQDV 259
Query: 739 LNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
+ + G + + + ++ L C Q + RP + +V +L+
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-39
Identities = 83/282 (29%), Positives = 129/282 (45%), Gaps = 31/282 (10%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
L + + +GKG FG V G Y+G K VAVK ++ T + F AE V+ +
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGD-YRGNK-VAVKCIKNDATA--QAFLAEASVMTQLR 244
Query: 567 HKNLVRLIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILY 625
H NLV+L+G E+ L +V EYM+ GSL D L LG D ++ + DV + + Y
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 626 LHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEW 685
L +H D+ +N+L+ E AK+SDFGL K Q V+ + APE
Sbjct: 305 LEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEA 357
Query: 686 YKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-LNKLVR 744
+ S K+DV+S+G++L EI R P Y ++ + ++ +
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSFGR-------VP---------YPRIPLKDVVPRVEK 401
Query: 745 GQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
G ++D + + C + A RP+ + LE I
Sbjct: 402 GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 514 RFKEELGKGSFGAVYKGTLY----KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHK 568
+ + LG G+FG VYKG K + VA+K+L + + E E +V+ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
++ RL+G C + L+ + M G L D + R + ++G + +AKG+ YL D
Sbjct: 78 HVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAPEW 685
++H D+ +N+L+ KI+DFGLAKLL ++ G + +MA E
Sbjct: 136 RR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALES 190
Query: 686 YKNTPISVKADVFSYGVVLLEIV 708
+ + ++DV+SYGV + E++
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELM 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 67/285 (23%), Positives = 131/285 (45%), Gaps = 37/285 (12%)
Query: 514 RFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHKN 569
+GKG FG VY G + A+K L ++ + F E ++ +H N
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 570 LVRLIGYC-AEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
++ LIG + ++ YM +G L + R P+R+ + + VA+G+ YL +
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYLAE 142
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG------YMA 682
+ +H D+ +N ++DE +T K++DFGLA+ + R + V+ R + A
Sbjct: 143 QK---FVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWTA 196
Query: 683 PEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-LNK 741
E + + K+DV+S+GV+L E++ P Y+ + +
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGA-------PP---------YRHIDPFDLTHF 240
Query: 742 LVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
L +G+ + + +++ ++ C + +PA+RP+ + +V +E I
Sbjct: 241 LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 73/302 (24%), Positives = 131/302 (43%), Gaps = 59/302 (19%)
Query: 514 RFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHH 567
ELG+GSFG VY+G + E VA+K + + + ER EF E V+ +
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL--------FRGPERSLGWDERVRIASDV 619
++VRL+G ++ L++ E M+ G L L + +++A ++
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 620 AKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM-PDQTRTFTLVRGTR 678
A G+ YL+ +H D+ +N ++ E +T KI DFG+ + + D R +G +
Sbjct: 148 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGGK 199
Query: 679 GY-----MAPEWYKNTPISVKADVFSYGVVLLEIV-------CCRRNMEIDPSKPEEIVL 726
G M+PE K+ + +DV+S+GVVL EI N ++
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---------- 249
Query: 727 INWAYKCFIDRELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
L ++ G +D+ N + + ++ C Q P +RPS ++ ++
Sbjct: 250 ------------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
Query: 785 TD 786
+
Sbjct: 298 ME 299
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 77/302 (25%), Positives = 130/302 (43%), Gaps = 49/302 (16%)
Query: 514 RFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGR-TH 566
+F + LG G+FG V + T + VAVK L+ E+ +E+ ++
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL------------FRGPERSLGWDERVR 614
H+N+V L+G C L++ EY G L + L F + + +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 615 IASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLV 674
+S VA+G+ +L + IH D+ +N+L+ AKI DFGLA+ +M D +
Sbjct: 169 FSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS----NYI 221
Query: 675 RGTRG-----YMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW 729
+MAPE + +V++DV+SYG++L EI N P +L+N
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN-------PYPGILVN- 273
Query: 730 AYKCFIDRELNKLVR-GQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786
+ KLV+ G ++ + +N+ I C EP RP+ + + L+
Sbjct: 274 -------SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326
Query: 787 IS 788
Sbjct: 327 ED 328
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 73/318 (22%), Positives = 133/318 (41%), Gaps = 50/318 (15%)
Query: 487 LENGSLGLAYESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEK---LVAVKK 543
++ +L ++ F E +G+G FG VY GTL + AVK
Sbjct: 2 IDLSALNPELVQAVQHV-VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 60
Query: 544 LEKMVTEGER-EFRAEMHVIGRTHHKNLVRLIGYCAE-DSKRLLVYEYMSNGSLADILFR 601
L ++ GE +F E ++ H N++ L+G C + L+V YM +G L + + R
Sbjct: 61 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-R 119
Query: 602 GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661
+ + + VAKG+ YL +H D+ +N ++DE +T K++DFGLA+
Sbjct: 120 NETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
Query: 662 LLMPDQTRTFTLVRGTRG------YMAPEWYKNTPISVKADVFSYGVVLLEIV------- 708
+ + + V G +MA E + + K+DV+S+GV+L E++
Sbjct: 177 DM---YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233
Query: 709 CCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR--NTLENMIKIGLWCVQD 766
+I L++G+ + + + + ++ L C
Sbjct: 234 PDVNTFDI----------------------TVYLLQGRRLLQPEYCPDPLYEVMLKCWHP 271
Query: 767 EPALRPSMKSVVLMLEGI 784
+ +RPS +V + I
Sbjct: 272 KAEMRPSFSELVSRISAI 289
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-38
Identities = 77/302 (25%), Positives = 121/302 (40%), Gaps = 59/302 (19%)
Query: 514 RFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHH 567
LG G+FG VY+G + VAVK L ++ +E + +F E +I + +H
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL-----FRGPERSLGWDERVRIASDVAKG 622
+N+VR IG + R ++ E M+ G L L SL + + +A D+A G
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFW---TAKISDFGLAKLLM-PDQTRTFTLVRGTR 678
YL + IH DI +N L+ AKI DFG+A+ + R +G
Sbjct: 153 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR-----KGGC 204
Query: 679 GY-----MAPEWYKNTPISVKADVFSYGVVLLEIV-------CCRRNMEIDPSKPEEIVL 726
M PE + + K D +S+GV+L EI + N E+
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---------- 254
Query: 727 INWAYKCFIDRELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
L + G +D N + +I C Q +P RP+ ++ +E
Sbjct: 255 ------------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302
Query: 785 TD 786
T
Sbjct: 303 TQ 304
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-38
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLY----KGEKLVAVKKL-EKMVTEGEREFRAEMHV 561
K+ R + LG G FG V+KG + V +K + +K + + M
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 562 IGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAK 621
IG H ++VRL+G C S LV +Y+ GSL D + R +LG + +AK
Sbjct: 69 IGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAK 126
Query: 622 GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR--- 678
G+ YL + ++H ++ +N+L+ +++DFG+A LL PD + +
Sbjct: 127 GMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPI 181
Query: 679 GYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+MA E + ++DV+SYGV + E++
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELM 211
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-38
Identities = 79/303 (26%), Positives = 130/303 (42%), Gaps = 53/303 (17%)
Query: 514 RFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHK 568
K ELG+G+FG V+ + + + LVAVK L++ ++F+ E ++ H+
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103
Query: 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLADIL-------------FRGPERSLGWDERVRI 615
++VR G C E L+V+EYM +G L L LG + + +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 616 ASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM-PDQTRTFTLV 674
AS VA G++YL +H D+ +N L+ + KI DFG+++ + D R
Sbjct: 164 ASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR----- 215
Query: 675 RGTRG-----YMAPEWYKNTPISVKADVFSYGVVLLEIV-CCRRNMEIDPSKPEEIVLIN 728
G R +M PE + ++DV+S+GVVL EI ++ P
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ-----P---------- 260
Query: 729 WAYKCFIDRELNKLVR-GQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785
+ + E + G+E++R + I C Q EP R S+K V L+ +
Sbjct: 261 --WYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318
Query: 786 DIS 788
Sbjct: 319 QAP 321
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 65/225 (28%), Positives = 98/225 (43%), Gaps = 16/225 (7%)
Query: 493 GLAYESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTL---YKGEKLVAVK--KLEKM 547
G A E L+S + + + R E+LG GSFG V +G VAVK K + +
Sbjct: 1 GSAGEGPLQSLTC-LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL 59
Query: 548 VTEGER-EFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERS 606
+F E++ + H+NL+RL G +V E GSL D L R +
Sbjct: 60 SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRL-RKHQGH 117
Query: 607 LGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666
R A VA+G+ YL + IH D+ +N+L+ KI DFGL + L +
Sbjct: 118 FLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174
Query: 667 QTRTFTLVRGTR---GYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
+ + + + APE K S +D + +GV L E+
Sbjct: 175 DD-HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 9e-38
Identities = 72/291 (24%), Positives = 127/291 (43%), Gaps = 49/291 (16%)
Query: 514 RFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHKN 569
F E +G+G FG VY GTL + AVK L ++ GE +F E ++ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 570 LVRLIGYCAE-DSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
++ L+G C + L+V YM +G L + + R + + + VAKG+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLA- 209
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG------YMA 682
+H D+ +N ++DE +T K++DFGLA+ + + F V G +MA
Sbjct: 210 --SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDSVHNKTGAKLPVKWMA 264
Query: 683 PEWYKNTPISVKADVFSYGVVLLEIV-------CCRRNMEIDPSKPEEIVLINWAYKCFI 735
E + + K+DV+S+GV+L E++ +I
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------------------- 305
Query: 736 DRELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
L++G+ + + + + ++ L C + +RPS +V + I
Sbjct: 306 ---TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 74/298 (24%), Positives = 128/298 (42%), Gaps = 53/298 (17%)
Query: 514 RFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHH 567
RF EELG+ FG VYKG L+ + + VA+K L+ R EFR E + R H
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL--------------FRGPERSLGWDERV 613
N+V L+G +D +++ Y S+G L + L R + +L + V
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 614 RIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL 673
+ + +A G+ YL ++H D+ +N+L+ + KISD GL + +
Sbjct: 132 HLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK--- 185
Query: 674 VRGTRG-----YMAPEWYKNTPISVKADVFSYGVVLLEIV-CCRRNMEIDPSKPEEIVLI 727
+MAPE S+ +D++SYGVVL E+ + P
Sbjct: 186 -LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ-----P--------- 230
Query: 728 NWAYKCFIDRELNKLVR-GQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
Y + ++++ +++R Q + + + + + C + P+ RP K + L
Sbjct: 231 ---YCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 59/290 (20%), Positives = 119/290 (41%), Gaps = 38/290 (13%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTL---YKGEKLVAVKKLEKMVTEGER-EFRAEMHVI 562
E+++ +G+G FG V++G VA+K + ++ R +F E +
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 563 GRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKG 622
+ H ++V+LIG E + ++ E + G L L + + SL + A ++
Sbjct: 71 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTA 128
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG--- 679
+ YL + +H DI +N+L+ K+ DFGL++ + + ++G
Sbjct: 129 LAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-----YKASKGKLP 180
Query: 680 --YMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDR 737
+MAPE + +DV+ +GV + EI+ KP ++ +
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV-------KP---------FQGVKNN 224
Query: 738 E-LNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ + ++ G+ + N + + C +P+ RP + L I
Sbjct: 225 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 60/290 (20%), Positives = 119/290 (41%), Gaps = 36/290 (12%)
Query: 497 ESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKK--LEKMVTEGERE 554
+ + + ++K +++G+GSFG + + +K+ + +M + ERE
Sbjct: 12 DLGTENLYFQSMEKYV--RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKERE 68
Query: 555 F-RAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERV 613
R E+ V+ H N+V+ E+ +V +Y G L + D+ +
Sbjct: 69 ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128
Query: 614 RIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL 673
+ + ++HD I+H DIK QNI + + T ++ DFG+A++L
Sbjct: 129 DWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC 185
Query: 674 VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKC 733
+ GT Y++PE +N P + K+D+++ G VL E+ + A++
Sbjct: 186 I-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH-----------------AFEA 227
Query: 734 FIDRELNKLVRGQEVDR------NTLENMIKIGLWCVQDEPALRPSMKSV 777
+ L + L +++ + P RPS+ S+
Sbjct: 228 GSMKNLVLKIISGSFPPVSLHYSYDLRSLVS---QLFKRNPRDRPSVNSI 274
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 58/302 (19%), Positives = 111/302 (36%), Gaps = 46/302 (15%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
F ++LG+G F V A+K++ + E + E + +H N++RL
Sbjct: 32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRL 91
Query: 574 IGYCAEDSKR----LLVYEYMSNGSLADILFRGPERSLGWDER--VRIASDVAKGILYLH 627
+ YC + L+ + G+L + + R ++ E + + + +G+ +H
Sbjct: 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 628 DECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM--PDQTRTFTLV------RGTRG 679
+ H D+KP NIL+ + + D G + +R + R T
Sbjct: 152 AK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 680 YMAPE---WYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLI-----NWAY 731
Y APE + I + DV+S G VL ++ ++ K + + L +
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQ 268
Query: 732 KCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPP 791
L +L+ + +P RP + ++ LE + PP
Sbjct: 269 SPRHSSALWQLLN-----------------SMMTVDPHQRPHIPLLLSQLEALQ----PP 307
Query: 792 CP 793
P
Sbjct: 308 AP 309
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 76/311 (24%), Positives = 117/311 (37%), Gaps = 63/311 (20%)
Query: 514 RFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGER-EFRAEMHV---IGR 564
F + LG G+FG V + T Y VAVK L+ ER +E+ V +G
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 565 THHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL----------------FRGPERSLG 608
H N+V L+G C L++ EY G L + L E +L
Sbjct: 86 --HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 609 WDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668
++ + + VAKG+ +L IH D+ +NIL+ KI DFGLA+ + D
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 669 RTFTLVRGTRG-----YMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDP----S 719
+MAPE N + ++DV+SYG+ L E+ + P
Sbjct: 201 YV----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS----PYPGMP 252
Query: 720 KPEEIVLINWAYKCFIDRELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSV 777
+ + G + + M I C +P RP+ K +
Sbjct: 253 VDSKF--------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298
Query: 778 VLMLEGITDIS 788
V ++E S
Sbjct: 299 VQLIEKQISES 309
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 83/285 (29%), Positives = 132/285 (46%), Gaps = 37/285 (12%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
L + + +GKG FG V G Y+G K VAVK ++ T + F AE V+ +
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGD-YRGNK-VAVKCIKNDATA--QAFLAEASVMTQLR 72
Query: 567 HKNLVRLIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILY 625
H NLV+L+G E+ L +V EYM+ GSL D L LG D ++ + DV + + Y
Sbjct: 73 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 626 LHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMA 682
L +H D+ +N+L+ E AK+SDFGL K + + T + + A
Sbjct: 133 LEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQD---TGKLPVKWTA 182
Query: 683 PEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-LNK 741
PE + S K+DV+S+G++L EI R P Y ++ + +
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGR-------VP---------YPRIPLKDVVPR 226
Query: 742 LVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ +G ++D + ++ C + A+RPS + LE I
Sbjct: 227 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 516 KEELGKGSFGAVYKGTL--YKGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHKNLVR 572
ELG G+FG+V +G K + VA+K L++ + + E E ++ + + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
LIG C ++ +LV E G L L G + + V+ G+ YL ++
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKN-- 130
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAPEWYKNT 689
+H D+ +N+L+ AKISDFGL+K L D + +T + + APE
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFR 188
Query: 690 PISVKADVFSYGVVLLEIV 708
S ++DV+SYGV + E +
Sbjct: 189 KFSSRSDVWSYGVTMWEAL 207
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-37
Identities = 77/302 (25%), Positives = 121/302 (40%), Gaps = 59/302 (19%)
Query: 514 RFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHH 567
LG G+FG VY+G + VAVK L ++ +E + +F E +I + +H
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL-----FRGPERSLGWDERVRIASDVAKG 622
+N+VR IG + R ++ E M+ G L L SL + + +A D+A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFW---TAKISDFGLAKLLM-PDQTRTFTLVRGTR 678
YL + IH DI +N L+ AKI DFG+A+ + R +G
Sbjct: 194 CQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-----KGGC 245
Query: 679 GY-----MAPEWYKNTPISVKADVFSYGVVLLEIVCC-------RRNMEIDPSKPEEIVL 726
M PE + + K D +S+GV+L EI + N E+
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---------- 295
Query: 727 INWAYKCFIDRELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
L + G +D N + +I C Q +P RP+ ++ +E
Sbjct: 296 ------------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343
Query: 785 TD 786
T
Sbjct: 344 TQ 345
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 60/193 (31%), Positives = 96/193 (49%), Gaps = 10/193 (5%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCA 578
LGKG++G VY G + +A+K++ + + + E+ + HKN+V+ +G +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 579 EDSKRLLVYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGILYLHDECEAPIIH 636
E+ + E + GSL+ +L R L +E+ + +G+ YLHD I+H
Sbjct: 90 ENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 637 CDIKPQNILMDEFW-TAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI--SV 693
DIK N+L++ + KISDFG +K L T T GT YMAPE P
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPRGYGK 204
Query: 694 KADVFSYGVVLLE 706
AD++S G ++E
Sbjct: 205 AADIWSLGCTIIE 217
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 9/204 (4%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKK--LEKMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
+G GS+G K K++ K+ M ++ +E++++ H N+VR
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 575 G-YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGILYLHDEC 630
+ L +V EY G LA ++ +G + DE R+ + + + H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 631 EAP--IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN 688
+ ++H D+KP N+ +D K+ DFGLA++L D + T V GT YM+PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190
Query: 689 TPISVKADVFSYGVVLLEIVCCRR 712
+ K+D++S G +L E+
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMP 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-37
Identities = 76/315 (24%), Positives = 127/315 (40%), Gaps = 66/315 (20%)
Query: 514 RFKEELGKGSFGAVYKGTLY-------KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGR- 564
+ LG+G+FG V K VAVK L+ TE + + +EM ++
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 565 THHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL--------------FRGPERSLGWD 610
HKN++ L+G C +D ++ EY S G+L + L R PE + +
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 611 ERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670
+ V +A+G+ YL IH D+ +N+L+ E KI+DFGLA+ +
Sbjct: 158 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 671 FTLVRGTRG-----YMAPEWYKNTPISVKADVFSYGVVLLEIV-------CCRRNMEIDP 718
+ T G +MAPE + + ++DV+S+GV++ EI E+
Sbjct: 215 ----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 268
Query: 719 SKPEEIVLINWAYKCFIDRELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKS 776
L G +D+ N + + C P+ RP+ K
Sbjct: 269 --------------------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQ 308
Query: 777 VVLMLEGITDISIPP 791
+V L+ I ++
Sbjct: 309 LVEDLDRILTLTTNE 323
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 62/288 (21%), Positives = 116/288 (40%), Gaps = 34/288 (11%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKL---VAVKKLEKMVTEGER-EFRAEMHVI 562
+ + LG+G FG VY+G + VAVK +K T + +F +E ++
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 563 GRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKG 622
H ++V+LIG E+ ++ E G L L + SL V + + K
Sbjct: 68 KNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKA 125
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---G 679
+ YL +H DI +NIL+ K+ DFGL++ + + + TR
Sbjct: 126 MAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIK 179
Query: 680 YMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE- 738
+M+PE + +DV+ + V + EI+ + +P + +++
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGK-------QP---------FFWLENKDV 223
Query: 739 LNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ L +G + + + + C +P+ RP +V L +
Sbjct: 224 IGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 514 RFKEELGKGSFGAVYKGTLY----KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHHK 568
+ + LG G+FG VYKG K + VA+K+L + + E E +V+ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
++ RL+G C + L+ + M G L D + R + ++G + +AKG+ YL D
Sbjct: 78 HVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAPEW 685
++H D+ +N+L+ KI+DFGLAKLL ++ G + +MA E
Sbjct: 136 RR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALES 190
Query: 686 YKNTPISVKADVFSYGVVLLEIV 708
+ + ++DV+SYGV + E++
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELM 213
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 79/313 (25%), Positives = 135/313 (43%), Gaps = 71/313 (22%)
Query: 514 RFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHH 567
+ LG+G FG V K T + G VAVK L++ + E + +E +V+ + +H
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL----------------------FRGPER 605
++++L G C++D LL+ EY GSL L ER
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 606 SLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665
+L + + A +++G+ YL + ++H D+ +NIL+ E KISDFGL++ +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 666 DQTRTFTLVRGTRG-----YMAPEWYKNTPISVKADVFSYGVVLLEIV-------CCRRN 713
+ + V+ ++G +MA E + + ++DV+S+GV+L EIV
Sbjct: 203 ED----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
Query: 714 MEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALR 771
+ N L G ++R N E M ++ L C + EP R
Sbjct: 259 ERL----------------------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296
Query: 772 PSMKSVVLMLEGI 784
P + LE +
Sbjct: 297 PVFADISKDLEKM 309
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 76/308 (24%), Positives = 125/308 (40%), Gaps = 66/308 (21%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEK-------LVAVKKLEKMVTEGER-EFRAEMHVIGR- 564
+ LG+G FG V +K VAVK L+ TE + + +EM ++
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 565 THHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL--------------FRGPERSLGWD 610
HKN++ L+G C +D ++ EY S G+L + L R PE + +
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 611 ERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670
+ V +A+G+ YL IH D+ +N+L+ E KI+DFGLA+ +
Sbjct: 204 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID--- 257
Query: 671 FTLVRGTRG-----YMAPEWYKNTPISVKADVFSYGVVLLEIV-------CCRRNMEIDP 718
+ T G +MAPE + + ++DV+S+GV++ EI E+
Sbjct: 258 -YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 314
Query: 719 SKPEEIVLINWAYKCFIDRELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKS 776
L G +D+ N + + C P+ RP+ K
Sbjct: 315 --------------------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQ 354
Query: 777 VVLMLEGI 784
+V L+ I
Sbjct: 355 LVEDLDRI 362
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 75/303 (24%), Positives = 136/303 (44%), Gaps = 64/303 (21%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEK--LVAVKKLEKMVTEGER-EFRAEMHVIGR-THHKN 569
+F++ +G+G+FG V K + K A+K++++ ++ + +F E+ V+ + HH N
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADIL--------------FRGPERSLGWDERVRI 615
++ L+G C L EY +G+L D L +L + +
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 616 ASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR 675
A+DVA+G+ YL + IH D+ +NIL+ E + AKI+DFGL++ + +
Sbjct: 148 AADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYV-----K 197
Query: 676 GTRG-----YMAPEWYKNTPISVKADVFSYGVVLLEIV-------CCRRNMEIDPSKPEE 723
T G +MA E + + +DV+SYGV+L EIV C E+
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------- 250
Query: 724 IVLINWAYKCFIDRELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLML 781
KL +G +++ N + + + C +++P RPS +++ L
Sbjct: 251 ---------------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295
Query: 782 EGI 784
+
Sbjct: 296 NRM 298
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 58/304 (19%)
Query: 514 RFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGR-TH 566
+ + LG+G+FG V + + + VAVK L++ T E +E+ ++ H
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 567 HKNLVRLIGYC-AEDSKRLLVYEYMSNGSLADIL--------------FRGPERSLGWDE 611
H N+V L+G C +++ E+ G+L+ L + L +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 612 RVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671
+ + VAKG+ +L IH D+ +NIL+ E KI DFGLA+ + D
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV- 205
Query: 672 TLVRGTRG-----YMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDP----SKPE 722
R +MAPE + ++++DV+S+GV+L EI + P E
Sbjct: 206 ---RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS----PYPGVKIDE 258
Query: 723 EIVLINWAYKCFIDRELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLM 780
E +L G + T M + L C EP+ RP+ +V
Sbjct: 259 EF--------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304
Query: 781 LEGI 784
L +
Sbjct: 305 LGNL 308
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 85/304 (27%), Positives = 133/304 (43%), Gaps = 58/304 (19%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEK-------LVAVKKLEKMVTEGER-EFRAEMHV---I 562
+ LG+G+FG V +K VAVK L+ TE + + +EM + I
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 563 GRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL--------------FRGPERSLG 608
G+ HKN++ L+G C +D ++ EY S G+L + L PE L
Sbjct: 132 GK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189
Query: 609 WDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668
+ V A VA+G+ YL IH D+ +N+L+ E KI+DFGLA+ +
Sbjct: 190 SKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246
Query: 669 RTFTLVRGTRG-----YMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEE 723
+ T G +MAPE + + ++DV+S+GV+L EI + P
Sbjct: 247 YK----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----P----- 293
Query: 724 IVLINWAYKCFIDRELNKLVR-GQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLM 780
Y EL KL++ G +D+ N + + C P+ RP+ K +V
Sbjct: 294 -------YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346
Query: 781 LEGI 784
L+ I
Sbjct: 347 LDRI 350
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 68/302 (22%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 514 RFKEELGKGSFGAVYKGTLY---KGEKLVAVK--KLEKMVTEGEREFRAEMHVIGRTHHK 568
+ LG+G FG+V +G L VAVK KL+ EF +E + H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 569 NLVRLIGYCAED-----SKRLLVYEYMSNGSLADIL----FRGPERSLGWDERVRIASDV 619
N++RL+G C E K +++ +M G L L + + ++ D+
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 620 AKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP-DQTRTFTLVRGTR 678
A G+ YL + +H D+ +N ++ + T ++DFGL+K + D R +G
Sbjct: 157 ALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR-----QGRI 208
Query: 679 G-----YMAPEWYKNTPISVKADVFSYGVVLLEIV-------CCRRNMEIDPSKPEEIVL 726
++A E + + K+DV+++GV + EI +N E+
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---------- 258
Query: 727 INWAYKCFIDRELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ L+ G + + + L+ + +I C + +P RP+ + L LE +
Sbjct: 259 ------------YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
Query: 785 TD 786
+
Sbjct: 307 LE 308
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 18/197 (9%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRA---EMHVIGRTHHKNLVRL 573
ELG G+ G V+K + ++A K + + E+ V+ + +V
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNSPYIVGF 96
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRG---PERSLGWDERVRIASDVAKGILYLHDEC 630
G D + + E+M GSL +L + PE+ LG +++ V KG+ YL ++
Sbjct: 97 YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREKH 151
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
+ I+H D+KP NIL++ K+ DFG++ L+ +F GTR YM+PE + T
Sbjct: 152 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTH 206
Query: 691 ISVKADVFSYGVVLLEI 707
SV++D++S G+ L+E+
Sbjct: 207 YSVQSDIWSMGLSLVEM 223
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 55/279 (19%), Positives = 101/279 (36%), Gaps = 48/279 (17%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGY 576
E +G G FG V+K K +K+++ + E+ + + H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 577 CAEDSKRL----------------LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVA 620
+ E+ G+L + + L + + +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 621 KGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGY 680
KG+ Y+H + +I+ D+KP NI + + KI DFGL L D RT GT Y
Sbjct: 133 KGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT-RSK-GTLRY 187
Query: 681 MAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740
M+PE + + D+++ G++L E++ E +
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHV-------CDTAFE-----------TSKFFT 229
Query: 741 KLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSV 777
L G D + +++ + +P RP+ +
Sbjct: 230 DLRDGIISDIFDKKEKTLLQ---KLLSKKPEDRPNTSEI 265
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 23/213 (10%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTHHKNLVR 572
+ LG+G+ V++G K L A+K + + E V+ + +HKN+V+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 573 LIGYCAEDSKRL--LVYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGILYLHD 628
L E + R L+ E+ GSL +L P + G E + DV G+ +L +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 629 ECEAPIIHCDIKPQNILM----DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
I+H +IKP NI+ D K++DFG A+ L D+ +L GT Y+ P+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV-SLY-GTEEYLHPD 185
Query: 685 --------WYKNTPISVKADVFSYGVVLLEIVC 709
D++S GV
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 6e-36
Identities = 77/277 (27%), Positives = 117/277 (42%), Gaps = 33/277 (11%)
Query: 518 ELGKGSFGAVYKGTL--YKGEKLVAVK--KLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
ELG G+FG V KG K K VAVK K E + E AE +V+ + + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
IG C +S +LV E G L L + R + + + V+ G+ YL +
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN--- 137
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTR---GYMAPEWYKNTP 690
+H D+ +N+L+ AKISDFGL+K L D+ + + + APE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGKWPVKWYAPECINYYK 196
Query: 691 ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE-LNKLVRGQEVD 749
S K+DV+S+GV++ E + KP Y+ E L +G+ +
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQ-------KP---------YRGMKGSEVTAMLEKGERMG 240
Query: 750 R--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
M + C + RP +V L L
Sbjct: 241 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 144 bits (363), Expect = 6e-36
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 514 RFKEELGKGSFGAVYKGT-LYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTHHKNLV 571
KE LG G FG V + GE+ VA+K+ + ++ RE + E+ ++ + +H N+V
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQ-VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 572 RLI------GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGI 623
A + LL EY G L L + E G E + SD++ +
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSAL 134
Query: 624 LYLHDECEAPIIHCDIKPQNILMD---EFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGY 680
YLH+ IIH D+KP+NI++ + KI D G AK L + T V GT Y
Sbjct: 135 RYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT-EFV-GTLQY 189
Query: 681 MAPEWYKNTPISVKADVFSYGVVLLEIVC 709
+APE + +V D +S+G + E +
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 62/306 (20%), Positives = 108/306 (35%), Gaps = 57/306 (18%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTHHKNLVRLIG 575
+ LG+G FG V++ + A+K++ E RE E+ + + H +VR
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 576 YCAED---------SKRLLVY---EYMSNGSLADIL-FRGPERSLGWDERVRIASDVAKG 622
E S ++ +Y + +L D + R + I +A+
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR------- 675
+ +LH + ++H D+KP NI K+ DFGL + D+ L
Sbjct: 131 VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 676 ----GTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWA 730
GT+ YM+PE S K D+FS G++L E++ ME
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQME--------------- 232
Query: 731 YKCFIDRELNKLVRGQ-----EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785
R L + + M++ + P RP + ++
Sbjct: 233 ----RVRTLTDVRNLKFPPLFTQKYPCEYVMVQ---DMLSPSPMERPEAIN-IIENAVFE 284
Query: 786 DISIPP 791
D+ P
Sbjct: 285 DLDFPG 290
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-36
Identities = 70/315 (22%), Positives = 125/315 (39%), Gaps = 71/315 (22%)
Query: 514 RFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHH 567
+ ++G+G+FG V++ + +VAVK L++ + + +F+ E ++ +
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADIL----------------------FRGPER 605
N+V+L+G CA L++EYM+ G L + L
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 606 SLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665
L E++ IA VA G+ YL E +H D+ +N L+ E KI+DFGL++ +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 666 D-----QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIV-------CCRRN 713
+R +M PE + ++DV++YGVVL EI +
Sbjct: 227 ADYYKADGNDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
Query: 714 MEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALR 771
E+ + + G + N + + C PA R
Sbjct: 283 EEV----------------------IYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 320
Query: 772 PSMKSVVLMLEGITD 786
PS S+ +L+ + +
Sbjct: 321 PSFCSIHRILQRMCE 335
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 80/359 (22%), Positives = 131/359 (36%), Gaps = 77/359 (21%)
Query: 476 FKY-QVLKYEWLLENGSLGLAYESNLRSFSYNELKKATN--------RFKEELGKGSFGA 526
KY + +YE L+ + + ++ + E + F + LG G+FG
Sbjct: 1 HKYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGK 60
Query: 527 VYKGTLY-----KGEKLVAVKKLEKMVTEGER-EFRAEMHV---IGRTHHKNLVRLIGYC 577
V T Y VAVK L++ ER +E+ + +G H+N+V L+G C
Sbjct: 61 VMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--HENIVNLLGAC 118
Query: 578 AEDSKRLLVYEYMSNGSLADIL---------------------FRGPERSLGWDERVRIA 616
L++EY G L + L L +++ + A
Sbjct: 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 178
Query: 617 SDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRG 676
VAKG+ +L +H D+ +N+L+ KI DFGLA+ +M D
Sbjct: 179 YQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV----VR 231
Query: 677 TRG-----YMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDP----SKPEEIVLI 727
+MAPE ++K+DV+SYG++L EI N P
Sbjct: 232 GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN----PYPGIPVDANF--- 284
Query: 728 NWAYKCFIDRELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ G ++D+ E + I C + RPS ++ L
Sbjct: 285 -----------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-35
Identities = 59/290 (20%), Positives = 119/290 (41%), Gaps = 38/290 (13%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTL---YKGEKLVAVKKLEKMVTEGER-EFRAEMHVI 562
E+++ +G+G FG V++G VA+K + ++ R +F E +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 563 GRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKG 622
+ H ++V+LIG E+ ++ E + G L L + + SL + A ++
Sbjct: 446 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTA 503
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG--- 679
+ YL + +H DI +N+L+ K+ DFGL++ + + ++G
Sbjct: 504 LAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-----YKASKGKLP 555
Query: 680 --YMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDR 737
+MAPE + +DV+ +GV + EI+ KP ++ +
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV-------KP---------FQGVKNN 599
Query: 738 E-LNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ + ++ G+ + N + + C +P+ RP + L I
Sbjct: 600 DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-35
Identities = 52/201 (25%), Positives = 80/201 (39%), Gaps = 21/201 (10%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
+ +G+GSFG V++ + AVKK+ + E E+ +V L
Sbjct: 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRVE---ELVACAGLSSPRIVPL 115
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFR-GPERSLGWDERV--RIASDVAKGILYLHDEC 630
G E + E + GSL ++ + G E +G+ YLH
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCL-----PEDRALYYLGQALEGLEYLHTRR 170
Query: 631 EAPIIHCDIKPQNILMDEF-WTAKISDFGLAKLLMPDQTRTFTL----VRGTRGYMAPEW 685
I+H D+K N+L+ A + DFG A L PD L + GT +MAPE
Sbjct: 171 ---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 686 YKNTPISVKADVFSYGVVLLE 706
P K D++S ++L
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLH 248
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-35
Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK-MVTEGEREFRAEMHVIGRTHHKNLVRL 573
K+ LG G+ G + ++ + VAVK++ + +RE + H N++R
Sbjct: 28 PKDVLGHGAEGTIVYRGMFDN-RDVAVKRILPECFSFADREVQLLRES---DEHPNVIRY 83
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
+ + + E + +L + + + + + E + + G+ +LH
Sbjct: 84 FCTEKDRQFQYIAIELCA-ATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 634 IIHCDIKPQNILMDE-----FWTAKISDFGLAKLLMPDQ---TRTFTLVRGTRGYMAPEW 685
I+H D+KP NIL+ A ISDFGL K L + +R + GT G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWIAPEM 197
Query: 686 YK---NTPISVKADVFSYGVVLLEIVC 709
+ D+FS G V ++
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 53/197 (26%), Positives = 73/197 (37%), Gaps = 13/197 (6%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVK--KLEKMVTEGEREFRAEMHVIGR-THHKNLVRL 573
LG GS+G V+K + +L AVK + AE+ + H VRL
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
E L E SL L + D + +LH +
Sbjct: 123 EQAWEEGGILYLQTEL-CGPSLQQHCEAWGAS-LPEAQVWGYLRDTLLALAHLHSQ---G 177
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLL-MPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
++H D+KP NI + K+ DFGL L G YMAPE +
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPELLQG-SYG 233
Query: 693 VKADVFSYGVVLLEIVC 709
ADVFS G+ +LE+ C
Sbjct: 234 TAADVFSLGLTILEVAC 250
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 50/220 (22%), Positives = 83/220 (37%), Gaps = 33/220 (15%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKK--LEKMVTEGEREFRAEMHVIGR-THHKNLVRL 573
E++G G FG+V+K + A+K+ + E+ E++ H ++VR
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGILYLHDECE 631
AED L+ EY + GSLAD + + E + V +G+ Y+H
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-- 134
Query: 632 APIIHCDIKPQNILMDE-------------------FWTAKISDFGLAKLLMPDQTRTFT 672
++H DIKP NI + KI D G + Q
Sbjct: 135 -SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV---- 189
Query: 673 LVRGTRGYMAPE-WYKNTPISVKADVFSYGVVLLEIVCCR 711
G ++A E +N KAD+F+ + ++
Sbjct: 190 -EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 68/328 (20%), Positives = 122/328 (37%), Gaps = 61/328 (18%)
Query: 486 LLENGSLGLAYESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLY---KGEKLVAVK 542
+L++ + + L + + LGKG FG+V + L VAVK
Sbjct: 1 MLDSLGISDELKEKLEDV---LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVK 57
Query: 543 KL-EKMVTEGERE-FRAEMHVIGRTHHKNLVRLIGYCAED------SKRLLVYEYMSNGS 594
L ++ + E F E + H ++ +L+G +++ +M +G
Sbjct: 58 MLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGD 117
Query: 595 LADIL----FRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW 650
L L +L VR D+A G+ YL IH D+ +N ++ E
Sbjct: 118 LHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM 174
Query: 651 TAKISDFGLAKLLMPDQTRTFTLVRGTRG-----YMAPEWYKNTPISVKADVFSYGVVLL 705
T ++DFGL++ + +G ++A E + +V +DV+++GV +
Sbjct: 175 TVCVADFGLSRKIYSGDYYR----QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMW 230
Query: 706 EIV-------CCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR--NTLENM 756
EI+ N EI N L+ G + + +E +
Sbjct: 231 EIMTRGQTPYAGIENAEI----------------------YNYLIGGNRLKQPPECMEEV 268
Query: 757 IKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ C +P RPS + + LE I
Sbjct: 269 YDLMYQCWSADPKQRPSFTCLRMELENI 296
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-35
Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 23/213 (10%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTHHKNLVR 572
+ LG+G+ V++G K L A+K + + E V+ + +HKN+V+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 573 LIGYCAEDSKRL--LVYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGILYLHD 628
L E + R L+ E+ GSL +L P + G E + DV G+ +L +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 629 ECEAPIIHCDIKPQNILM----DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
I+H +IKP NI+ D K++DFG A+ L D+ +L GT Y+ P+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV-SLY-GTEEYLHPD 185
Query: 685 WYKNTPI--------SVKADVFSYGVVLLEIVC 709
Y+ + D++S GV
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-35
Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 12/220 (5%)
Query: 495 AYESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTL--YKGEKLVAVKKLEKMVTEGE 552
+ L+ + ELG G+FG+V +G K + VA+K L++ + +
Sbjct: 320 SDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD 379
Query: 553 R-EFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDE 611
E E ++ + + +VRLIG C ++ +LV E G L L G +
Sbjct: 380 TEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFL-VGKREEIPVSN 437
Query: 612 RVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671
+ V+ G+ YL ++ +H ++ +N+L+ AKISDFGL+K L D + +
Sbjct: 438 VAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YY 493
Query: 672 TLVRGTR---GYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
T + + APE S ++DV+SYGV + E +
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 26/212 (12%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVK--KLEKMVTEGEREFRAEMHVIGRTHHKNL--VR 572
+++G G V++ K + + A+K LE+ + +R E+ + + + +R
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
L Y D +V E N L L + ++S+ ER ++ + + +H
Sbjct: 93 LYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHG-- 147
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF--TLVRGTRGYMAPE------ 684
I+H D+KP N L+ + K+ DFG+A + PD T + V GT YM PE
Sbjct: 148 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMS 204
Query: 685 -----WYKNTPISVKADVFSYGVVLLEIVCCR 711
+ IS K+DV+S G +L + +
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVK--KLEKMVTEGEREFRAEMHVIG--RTHHKNLVR 572
+++G G V++ K + + A+K LE+ + +R E+ + + H ++R
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
L Y D +V E N L L + ++S+ ER ++ + + +H
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHG-- 128
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF-TLVRGTRGYMAPE------- 684
I+H D+KP N L+ + K+ DFG+A + PD T GT YM PE
Sbjct: 129 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 685 ----WYKNTPISVKADVFSYGVVLLEIVCCR 711
+ IS K+DV+S G +L + +
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 49/192 (25%), Positives = 93/192 (48%), Gaps = 7/192 (3%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGY 576
++G+GS G V + VAVK ++ + E+ ++ H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 577 CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIH 636
+ ++ E++ G+L DI+ + L ++ + V + + YLH + +IH
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQ---GVIH 164
Query: 637 CDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKAD 696
DIK +IL+ K+SDFG + D + +LV GT +MAPE + + + D
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVD 223
Query: 697 VFSYGVVLLEIV 708
++S G++++E+V
Sbjct: 224 IWSLGIMVIEMV 235
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 48/192 (25%), Positives = 94/192 (48%), Gaps = 7/192 (3%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGY 576
E++G+G+ G VY + VA++++ + E+ V+ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 577 CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIH 636
+ +V EY++ GSL D++ + + + + + + +LH +IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 637 CDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKAD 696
DIK NIL+ + K++DFG + P+Q++ T+V GT +MAPE K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 697 VFSYGVVLLEIV 708
++S G++ +E++
Sbjct: 199 IWSLGIMAIEMI 210
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-34
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVK--KLEKMVTEGEREFRAEMHVIGRTHHKNL--VR 572
+++G G V++ K + + A+K LE+ + +R E+ + + + +R
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
L Y D +V E N L L + ++S+ ER ++ + + +H
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHG-- 175
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF--TLVRGTRGYMAPE------ 684
I+H D+KP N L+ + K+ DFG+A + PD T + V G YM PE
Sbjct: 176 -IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKDMS 232
Query: 685 -----WYKNTPISVKADVFSYGVVLLEIVCCR 711
+ IS K+DV+S G +L + +
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 52/200 (26%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRT-HHKNLVRLI 574
ELG+G++G V K +++AVK++ V E++ ++ + RT V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERV--RIASDVAKGILYLHDECEA 632
G + + E M + SL + ++ E + +IA + K + +LH +
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS- 130
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPE----WYK 687
+IH D+KP N+L++ K+ DFG++ L+ D + G + YMAPE
Sbjct: 131 -VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPERINPELN 186
Query: 688 NTPISVKADVFSYGVVLLEI 707
SVK+D++S G+ ++E+
Sbjct: 187 QKGYSVKSDIWSLGITMIEL 206
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 40/215 (18%), Positives = 76/215 (35%), Gaps = 23/215 (10%)
Query: 515 FKEELGKGSFGAVYKGT-----LYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKN 569
LG+G+F VY+ T K ++ +K + M + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADIL---FRGPERSLGWDERVRIASDVAKGILYL 626
++ + +LV E S G+L + + PE+ + + A + I +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTA-----------KISDFGLAK-LLMPDQTRTFTLV 674
H + IIH DIKP N ++ + + D G + + + + FT
Sbjct: 189 H---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 675 RGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC 709
T G+ E N P + + D F + ++
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRT-HHKNLVRLI 574
E+G+G++G+V K +++AVK++ V E E++ ++ V+ R+ +V+
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGW-DERV--RIASDVAKGILYLHDECE 631
G + + E M + S E + +I K + +L + +
Sbjct: 88 GALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE----WYK 687
IIH DIKP NIL+D K+ DFG++ L+ +T G R YMAPE
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERIDPSAS 202
Query: 688 NTPISVKADVFSYGVVLLEI 707
V++DV+S G+ L E+
Sbjct: 203 RQGYDVRSDVWSLGITLYEL 222
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-32
Identities = 57/225 (25%), Positives = 85/225 (37%), Gaps = 37/225 (16%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK-MVTEGEREFRAEMHVIGRTHHKNLVR 572
++ LG GS G V ++G VAVK++ E + H N++R
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLIDFCDIALMEIKLLTESD---DHPNVIR 73
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADIL-----FRGPERSLGWDERVRIASDVAKGILYLH 627
D + E N +L D++ + + + +A G+ +LH
Sbjct: 74 YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 628 DECEAPIIHCDIKPQNILMD-------------EFWTAKISDFGLAKLLMPDQTRTFTLV 674
IIH D+KPQNIL+ E ISDFGL K L Q+ T +
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 675 R---GTRGYMAPE-------WYKNTPISVKADVFSYGVVLLEIVC 709
GT G+ APE ++ D+FS G V I+
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 65/310 (20%), Positives = 115/310 (37%), Gaps = 53/310 (17%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGR-THHKNLVR 572
R + L +G F VY+ + A+K+L E R E+ + + + H N+V+
Sbjct: 31 RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90
Query: 573 LIGYCAEDSKR-------LLVYEYMSNGSLADILFRGPER-SLGWDERVRIASDVAKGIL 624
+ + L+ + G L + L + R L D ++I + +
Sbjct: 91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL----------- 673
++H + PIIH D+K +N+L+ T K+ DFG A + +++
Sbjct: 151 HMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 674 VRGTRGYMAPE---WYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA 730
T Y PE Y N PI K D+++ G +L + + P
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ-----HP------------ 252
Query: 731 YKCFIDRELNKLVRGQ----EVDR--NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
F D ++V G+ D ++I+ +Q P R S+ VV L+ I
Sbjct: 253 ---FEDGAKLRIVNGKYSIPPHDTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQLQEI 306
Query: 785 TDISIPPCPT 794
+
Sbjct: 307 AAARNVNPKS 316
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTHHKNLVRL 573
LG+G+FG V K + A+KK+ TE + +E+ ++ +H+ +VR
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 574 IG-------------YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVA 620
+ S + EY NG+L D++ + DE R+ +
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQIL 126
Query: 621 KGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR----- 675
+ + Y+H + IIH D+KP NI +DE KI DFGLAK + +
Sbjct: 127 EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 676 --------GTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVC 709
GT Y+A E T + K D++S G++ E++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 17/197 (8%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
F E LG G+F V+ KL A+K ++K + E+ V+ + H+N+V L
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 574 IGYCAEDSKRLLVYEYMSNGSLAD-ILFRG--PERSLGWDERVRIASDVAKGILYLHDEC 630
+ LV + +S G L D IL RG E+ + + V + YLH+
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEK-----DASLVIQQVLSAVKYLHENG 126
Query: 631 EAPIIHCDIKPQNIL---MDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYK 687
I+H D+KP+N+L +E I+DFGL+K+ T GT GY+APE
Sbjct: 127 ---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC---GTPGYVAPEVLA 180
Query: 688 NTPISVKADVFSYGVVL 704
P S D +S GV+
Sbjct: 181 QKPYSKAVDCWSIGVIT 197
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 9/194 (4%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGERE-FRAEMHVIGRTHHKNLVRLIG 575
LGKG F ++ + +++ A K + K ++ +RE E+ + H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 576 YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPII 635
+ ++ +V E SL ++ R ++L E + G YLH +I
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNR---VI 137
Query: 636 HCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKA 695
H D+K N+ ++E KI DFGLA + D R L GT Y+APE S +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSFEV 196
Query: 696 DVFSYGVVLLEIVC 709
DV+S G ++ ++
Sbjct: 197 DVWSIGCIMYTLLV 210
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-32
Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 9/194 (4%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGERE-FRAEMHVIGRTHHKNLVRLIG 575
LGKG F ++ + +++ A K + K ++ +RE E+ + H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 576 YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPII 635
+ ++ +V E SL ++ R ++L E + G YLH +I
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRNR---VI 163
Query: 636 HCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKA 695
H D+K N+ ++E KI DFGLA + D R L GT Y+APE S +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSFEV 222
Query: 696 DVFSYGVVLLEIVC 709
DV+S G ++ ++
Sbjct: 223 DVWSIGCIMYTLLV 236
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTH-HKNLVRLI 574
E+G G+ G V+K K ++AVK++ + + E + ++ V+ ++H +V+
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRG---PERSLGWDERVRIASDVAKGILYLHDECE 631
G ++ + E M + PER LG ++ + K + YL ++
Sbjct: 91 GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLKEKHG 145
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE-----WY 686
+IH D+KP NIL+DE K+ DFG++ L+ D+ + G YMAPE
Sbjct: 146 --VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD-RSA-GCAAYMAPERIDPPDP 201
Query: 687 KNTPISVKADVFSYGVVLLEI 707
++ADV+S G+ L+E+
Sbjct: 202 TKPDYDIRADVWSLGISLVEL 222
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 52/198 (26%), Positives = 81/198 (40%), Gaps = 19/198 (9%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
KE++G GS+ + AVK ++K + E + H N++ L
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQ---HPNIITL 81
Query: 574 IGYCAEDSKRLLVYEYMSNGSLAD-ILFRGP--ERSLGWDERVRIASDVAKGILYLHDEC 630
+ +V E M G L D IL + ER E + + K + YLH +
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER-----EASAVLFTITKTVEYLHAQG 136
Query: 631 EAPIIHCDIKPQNILM----DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
++H D+KP NIL + +I DFG AK L + T T ++APE
Sbjct: 137 ---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVL 192
Query: 687 KNTPISVKADVFSYGVVL 704
+ D++S GV+L
Sbjct: 193 ERQGYDAACDIWSLGVLL 210
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 61/190 (32%), Positives = 104/190 (54%), Gaps = 7/190 (3%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGY 576
E+LG+GS+G+VYK + ++VA+K++ V +E E+ ++ + ++V+ G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 577 CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIH 636
+++ +V EY GS++DI+ R ++L DE I KG+ YLH IH
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDII-RLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIH 148
Query: 637 CDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKAD 696
DIK NIL++ AK++DFG+A L + T++ GT +MAPE + + AD
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVAD 207
Query: 697 VFSYGVVLLE 706
++S G+ +E
Sbjct: 208 IWSLGITAIE 217
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 71/196 (36%), Positives = 109/196 (55%), Gaps = 16/196 (8%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVK--KLEKMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
E++GKGSFG V+KG + +K+VA+K LE+ E E + + E+ V+ + + +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYY 86
Query: 575 GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIAS---DVAKGILYLHDECE 631
G +D+K ++ EY+ GS D+L GP DE IA+ ++ KG+ YLH E
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQ-IATILREILKGLDYLHSE-- 138
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
IH DIK N+L+ E K++DFG+A L Q + T V GT +MAPE K +
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 196
Query: 692 SVKADVFSYGVVLLEI 707
KAD++S G+ +E+
Sbjct: 197 DSKADIWSLGITAIEL 212
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGERE-FRAEMHVIGRTHHKNLVRLIG 575
LGKGSF VY+ VA+K ++K M G + + E+ + + H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPI 634
Y EDS + LV E NG + L + + +E + G+LYLH I
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITGMLYLHSHG---I 133
Query: 635 IHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVK 694
+H D+ N+L+ KI+DFGLA L + +TL GT Y++PE + ++
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAHGLE 192
Query: 695 ADVFSYGVVLLEIVC 709
+DV+S G + ++
Sbjct: 193 SDVWSLGCMFYTLLI 207
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 56/203 (27%), Positives = 83/203 (40%), Gaps = 20/203 (9%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVK-----KLEKMVTEGEREFRAEMHVIGRTHHKN 569
E +GKG F V + + + AVK K + + E + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRGPERSLGWDERVRIASDVAKGIL---- 624
+V L+ + D +V+E+M L I+ R + + E V AS + IL
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV-YSEAV--ASHYMRQILEALR 144
Query: 625 YLHDECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYM 681
Y HD IIH D+KP +L+ + K+ FG+A L V GT +M
Sbjct: 145 YCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFM 200
Query: 682 APEWYKNTPISVKADVFSYGVVL 704
APE K P DV+ GV+L
Sbjct: 201 APEVVKREPYGKPVDVWGCGVIL 223
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 56/194 (28%), Positives = 92/194 (47%), Gaps = 11/194 (5%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEG-EREFRAEMHVIGRTHHKNLVRLIG 575
LGKG FG VY + + ++A+K L K + G E + R E+ + H N++RL G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 576 YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPII 635
Y + ++ L+ EY G++ L + +++A + Y H + +I
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKR---VI 131
Query: 636 HCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKA 695
H DIKP+N+L+ KI+DFG + +R L GT Y+ PE + K
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTDLC-GTLDYLPPEMIEGRMHDEKV 188
Query: 696 DVFSYGVVLLEIVC 709
D++S GV+ E +
Sbjct: 189 DLWSLGVLCYEFLV 202
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 10/195 (5%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGY 576
ELG G+FG VYK + L A K +E E ++ E+ ++ H +V+L+G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 577 CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIH 636
D K ++ E+ G++ I+ +R L + + + + + +LH + IIH
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIM-LELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 637 CDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE-----WYKNTPI 691
D+K N+LM +++DFG++ + + + + GT +MAPE K+TP
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPY 199
Query: 692 SVKADVFSYGVVLLE 706
KAD++S G+ L+E
Sbjct: 200 DYKADIWSLGITLIE 214
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 18/199 (9%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHKNLV 571
KEELGKG+F V + A K + + ++ E + + H N+V
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRG--PERSLGWDERVRIASDVAKGILYLHD 628
RL E+S LV++ ++ G L + I+ R E + + + I Y H
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA-----DASHCIQQILESIAYCHS 123
Query: 629 ECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEW 685
I+H ++KP+N+L+ + K++DFGLA + + GT GY++PE
Sbjct: 124 NG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFA-GTPGYLSPEV 178
Query: 686 YKNTPISVKADVFSYGVVL 704
K P S D+++ GV+L
Sbjct: 179 LKKDPYSKPVDIWACGVIL 197
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 14/195 (7%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
EELG G+FG V++ ++ K + + + E+ ++ + HH L+ L
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 575 GYCAEDSKRLLVYEYMSNGSLAD-ILFRGPERSLGWDER--VRIASDVAKGILYLHDECE 631
+ + +L+ E++S G L D I + S E + +G+ ++H+
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS----EAEVINYMRQACEGLKHMHEH-- 168
Query: 632 APIIHCDIKPQNILM--DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT 689
I+H DIKP+NI+ + + KI DFGLA L PD+ + T + APE
Sbjct: 169 -SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDRE 225
Query: 690 PISVKADVFSYGVVL 704
P+ D+++ GV+
Sbjct: 226 PVGFYTDMWAIGVLG 240
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 11/194 (5%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEG-EREFRAEMHVIGRTHHKNLVRLIG 575
LGKG FG VY + + ++A+K L K + EG E + R E+ + H N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 576 YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPII 635
Y + + L+ E+ G L L + ++A + Y H+ +I
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHERK---VI 136
Query: 636 HCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKA 695
H DIKP+N+LM KI+DFG + R T+ GT Y+ PE + K
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSV--HAPSLRRRTMC-GTLDYLPPEMIEGKTHDEKV 193
Query: 696 DVFSYGVVLLEIVC 709
D++ GV+ E +
Sbjct: 194 DLWCAGVLCYEFLV 207
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-31
Identities = 63/197 (31%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIG 575
LG+G FG V+ + KL A KKL K +G + E ++ + H + +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDE-RVRI-ASDVAKGILYLHDECEA 632
Y E L LV M+ G + ++ E + G+ E R + + G+ +LH
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN-- 309
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
II+ D+KP+N+L+D+ +ISD GLA L QT+T GT G+MAPE
Sbjct: 310 -IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYD 367
Query: 693 VKADVFSYGVVLLEIVC 709
D F+ GV L E++
Sbjct: 368 FSVDYFALGVTLYEMIA 384
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 48/195 (24%), Positives = 90/195 (46%), Gaps = 15/195 (7%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
E+LG+G FG V++ +K K ++ + + E+ ++ H+N++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLH 67
Query: 575 GYCAEDSKRLLVYEYMSNGSLAD-ILFRGPERSLGWDER--VRIASDVAKGILYLHDECE 631
+ ++++E++S + + I E + ER V V + + +LH
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELN----EREIVSYVHQVCEALQFLHSH-- 121
Query: 632 APIIHCDIKPQNILM--DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT 689
I H DI+P+NI+ T KI +FG A+ L P F L+ Y APE +++
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHD 178
Query: 690 PISVKADVFSYGVVL 704
+S D++S G ++
Sbjct: 179 VVSTATDMWSLGTLV 193
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 16/195 (8%)
Query: 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIG 575
E LG G FG V+K +A K ++ + + E + E+ V+ + H NL++L
Sbjct: 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 576 YCAEDSKRL-LVYEYMSNGSLAD-ILFRGPERSLGWDER--VRIASDVAKGILYLHDECE 631
E + LV EY+ G L D I+ + E + + +GI ++H
Sbjct: 154 AF-ESKNDIVLVMEYVDGGELFDRIIDESYNLT----ELDTILFMKQICEGIRHMHQM-- 206
Query: 632 APIIHCDIKPQNILMDEFWTA--KISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT 689
I+H D+KP+NIL KI DFGLA+ P + + GT ++APE
Sbjct: 207 -YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVNFGTPEFLAPEVVNYD 263
Query: 690 PISVKADVFSYGVVL 704
+S D++S GV+
Sbjct: 264 FVSFPTDMWSVGVIA 278
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-30
Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK-MVTEGERE-FRAEMHVIGRTHHKNLV 571
+ EELGKG+F V + + A + ++ + + E + H N+V
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRGPERSLGWDERVRIASDVAKGIL----YL 626
RL +E+ L+++ ++ G L + I+ R + E AS + IL +
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREY-----YSEAD--ASHCIQQILEAVLHC 126
Query: 627 HDECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAP 683
H ++H ++KP+N+L+ + K++DFGLA + +Q F GT GY++P
Sbjct: 127 HQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSP 182
Query: 684 EWYKNTPISVKADVFSYGVVL 704
E + P D+++ GV+L
Sbjct: 183 EVLRKDPYGKPVDLWACGVIL 203
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGR-THHKNLVR 572
+ELG+G F V + + A K L+K + E E+ V+ ++
Sbjct: 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLAD-ILFRGPERSLGWDER--VRIASDVAKGILYLHDE 629
L S+ +L+ EY + G + L E E +R+ + +G+ YLH
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEM---VSENDVIRLIKQILEGVYYLHQN 150
Query: 630 CEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
I+H D+KPQNIL+ KI DFG+++ + + GT Y+APE
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEIL 205
Query: 687 KNTPISVKADVFSYGVVL 704
PI+ D+++ G++
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 68/203 (33%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 513 NRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE---REFRAEMHVIGRTHH 567
R+K ++LG G VY VA+K + E E + F E+H + H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADILF-RGPERSLGWDERVRIASDVAKGILYL 626
+N+V +I ED LV EY+ +L++ + GP L D + + + GI +
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHA 127
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT-LVRGTRGYMAPEW 685
H + I+H DIKPQNIL+D T KI DFG+AK L + + T T V GT Y +PE
Sbjct: 128 H---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQ 183
Query: 686 YKNTPISVKADVFSYGVVLLEIV 708
K D++S G+VL E++
Sbjct: 184 AKGEATDECTDIYSIGIVLYEML 206
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 23/203 (11%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVK-----KLEKMVTEGERE-FRAEMHVIGRTHHK 568
EELG G F V K A K + RE E+ ++ + H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRG--PERSLGWDERVRIASDVAKGILY 625
N++ L + +L+ E +S G L D + + E E + G+ Y
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-----EATSFIKQILDGVNY 130
Query: 626 LHDECEAPIIHCDIKPQNILM----DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYM 681
LH + I H D+KP+NI++ K+ DFGLA + F + GT ++
Sbjct: 131 LHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFV 185
Query: 682 APEWYKNTPISVKADVFSYGVVL 704
APE P+ ++AD++S GV+
Sbjct: 186 APEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 23/203 (11%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGER------EFRAEMHVIGRTHHK 568
EELG G F V K K A K ++K R E E++++ H
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRG--PERSLGWDERVRIASDVAKGILY 625
N++ L + +L+ E +S G L D + + E E + + G+ Y
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-----EATQFLKQILDGVHY 123
Query: 626 LHDECEAPIIHCDIKPQNILM----DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYM 681
LH + I H D+KP+NI++ K+ DFG+A + F + GT ++
Sbjct: 124 LHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEFV 178
Query: 682 APEWYKNTPISVKADVFSYGVVL 704
APE P+ ++AD++S GV+
Sbjct: 179 APEIVNYEPLGLEADMWSIGVIT 201
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIG 575
E +G G++G VYKG K +L A+K + + + E E + E++++ + HH+N+ G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 576 ------YCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
D + LV E+ GS+ D++ +L + I ++ +G+ +LH
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE----- 684
+IH DIK QN+L+ E K+ DFG++ L R T + GT +MAPE
Sbjct: 149 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 204
Query: 685 WYKNTPISVKADVFSYGVVLLEI 707
+ K+D++S G+ +E+
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEM 227
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 18/197 (9%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
+ ELG+G+ VY+ +K A+K L+K T ++ R E+ V+ R H N+++L
Sbjct: 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 574 IGYCAEDSKRLLVYEYMSNGSLAD-ILFRG--PERSLGWDERVRIASDVAKGILYLHDEC 630
++ LV E ++ G L D I+ +G ER + + + + YLH+
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSER-----DAADAVKQILEAVAYLHENG 168
Query: 631 EAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYK 687
I+H D+KP+N+L KI+DFGL+K++ V GT GY APE +
Sbjct: 169 ---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILR 223
Query: 688 NTPISVKADVFSYGVVL 704
+ D++S G++
Sbjct: 224 GCAYGPEVDMWSVGIIT 240
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK---------MVTEGEREFRAEMHVIGR 564
KE LG+G V + K AVK ++ V E E+ ++ +
Sbjct: 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 565 -THHKNLVRLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRG--PERSLGWDERVRIASDVA 620
+ H N+++L ++ LV++ M G L D + + E+ E +I +
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK-----ETRKIMRALL 134
Query: 621 KGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGY 680
+ I LH I+H D+KP+NIL+D+ K++DFG + L P + + + GT Y
Sbjct: 135 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVC-GTPSY 189
Query: 681 MAPE------WYKNTPISVKADVFSYGVVL 704
+APE + + D++S GV++
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 23/203 (11%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGER------EFRAEMHVIGRTHHK 568
EELG G F V K A K ++K + R E E+ ++ + H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRG--PERSLGWDERVRIASDVAKGILY 625
N++ L + +L+ E +S G L D + + E E + G+ Y
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-----EATSFIKQILDGVNY 130
Query: 626 LHDECEAPIIHCDIKPQNILM----DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYM 681
LH I H D+KP+NI++ K+ DFGLA + F + GT ++
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFV 185
Query: 682 APEWYKNTPISVKADVFSYGVVL 704
APE P+ ++AD++S GV+
Sbjct: 186 APEIVNYEPLGLEADMWSIGVIT 208
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVK--KLEKMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
E +G G+ V ++ VA+K LEK T + E E+ + + HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHPNIVSYY 79
Query: 575 GYCAEDSKRLLVYEYMSNGSLADIL----FRGPERSLGWDERVRIAS---DVAKGILYLH 627
+ LV + +S GS+ DI+ +G +S DE IA+ +V +G+ YLH
Sbjct: 80 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST-IATILREVLEGLEYLH 138
Query: 628 DECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR----GTRGYMAP 683
IH D+K NIL+ E + +I+DFG++ L T VR GT +MAP
Sbjct: 139 KN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 684 E-WYKNTPISVKADVFSYGVVLLEI 707
E + KAD++S+G+ +E+
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIEL 220
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHKNLV 571
+ ++LG G++G V A+K + K + T + E+ V+ H N++
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 572 RLIGYCAEDSKRL-LVYEYMSNGSLAD-ILFRG--PERSLGWDERVRIASDVAKGILYLH 627
+L + ED + LV E G L D I+ R E + I V G+ YLH
Sbjct: 100 KLYDFF-EDKRNYYLVMECYKGGELFDEIIHRMKFNEV-----DAAVIIKQVLSGVTYLH 153
Query: 628 DECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
I+H D+KP+N+L+ ++ KI DFGL+ + + GT Y+APE
Sbjct: 154 KHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPE 208
Query: 685 WYKNTPISVKADVFSYGVVLLEIVC 709
+ K DV+S GV+L ++
Sbjct: 209 VLRK-KYDEKCDVWSIGVILFILLA 232
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 60/242 (24%), Positives = 97/242 (40%), Gaps = 38/242 (15%)
Query: 498 SNLRSFSYNELKKAT--NRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGER 553
SNL + +K N ++ L +G F + K K A+KK EK + E +R
Sbjct: 14 SNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKR 71
Query: 554 EF-----------------RAEMHVIGRTHHKNLVRLIGYCAEDSKRL-LVYEYMSNGSL 595
+F + E+ +I ++ + G + + ++YEYM N S+
Sbjct: 72 DFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII-TNYDEVYIIYEYMENDSI 130
Query: 596 ADILFR------GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF 649
+ I V Y+H+E I H D+KP NILMD+
Sbjct: 131 LKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKN 188
Query: 650 WTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI--SVKADVFSYGVVLLEI 707
K+SDFG ++ M D+ GT +M PE++ N K D++S G+ L +
Sbjct: 189 GRVKLSDFGESE-YMVDKKIK-GSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245
Query: 708 VC 709
Sbjct: 246 FY 247
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 55/196 (28%), Positives = 83/196 (42%), Gaps = 19/196 (9%)
Query: 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEK-MVTEGEREFRAEMHVIGRTHHKNLVRLI 574
+ LG+GSF K K + AVK + K M ++E A H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLC---EGHPNIVKLH 72
Query: 575 GYCAEDSKRLLVYEYMSNGSLAD-ILFRGP--ERSLGWDERVRIASDVAKGILYLHDECE 631
+ LV E ++ G L + I + E E I + + ++HD
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHFSET-----EASYIMRKLVSAVSHMHDVG- 126
Query: 632 APIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN 688
++H D+KP+N+L ++ KI DFG A+L PD T T Y APE
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQ 183
Query: 689 TPISVKADVFSYGVVL 704
D++S GV+L
Sbjct: 184 NGYDESCDLWSLGVIL 199
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 18/199 (9%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHKNLV 571
KEELGKG+F V + A K + + ++ E + + H N+V
Sbjct: 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRG--PERSLGWDERVRIASDVAKGILYLHD 628
RL E+S LV++ ++ G L + I+ R E + + + I Y H
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA-----DASHCIQQILESIAYCHS 146
Query: 629 ECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEW 685
I+H ++KP+N+L+ + K++DFGLA + + GT GY++PE
Sbjct: 147 NG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFA-GTPGYLSPEV 201
Query: 686 YKNTPISVKADVFSYGVVL 704
K P S D+++ GV+L
Sbjct: 202 LKKDPYSKPVDIWACGVIL 220
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 42/206 (20%), Positives = 76/206 (36%), Gaps = 21/206 (10%)
Query: 514 RFKEELGKGSFGAVYKGT-LYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTHHKNLV 571
K + G G +Y + V +K L + AE + H ++V
Sbjct: 83 EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 572 RLIGYCAEDSKRL-----LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
++ + + +V EY+ SL L E + ++ + YL
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-GQK---LPVAEAIAYLLEILPALSYL 198
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
H +++ D+KP+NI++ E K+ D G + L GT G+ APE
Sbjct: 199 H---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSFGYLY-GTPGFQAPEIV 249
Query: 687 KNTPISVKADVFSYGVVLLEIVCCRR 712
+ P +V D+++ G L +
Sbjct: 250 RTGP-TVATDIYTVGRTLAALTLDLP 274
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 49/197 (24%), Positives = 83/197 (42%), Gaps = 17/197 (8%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
+ +G+GS+G V A KK+ K E F+ E+ ++ H N++RL
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 574 IGYCAEDSKRLLVYEYMSNGSLAD-ILFRG--PERSLGWDERVRIASDVAKGILYLHDEC 630
+++ LV E + G L + ++ + E + RI DV + Y H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRES-----DAARIMKDVLSAVAYCHKL- 125
Query: 631 EAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYK 687
+ H D+KP+N L K+ DFGLA P + GT Y++P+ +
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLE 181
Query: 688 NTPISVKADVFSYGVVL 704
+ D +S GV++
Sbjct: 182 G-LYGPECDEWSAGVMM 197
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--------MVTEGEREFRAEMHVIGR- 564
K+ +G+G V + AVK +E + E R E H++ +
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 565 THHKNLVRLIGYCAEDSKRL-LVYEYMSNGSLAD-ILFRG--PERSLGWDERVRIASDVA 620
H +++ LI E S + LV++ M G L D + + E+ E I +
Sbjct: 157 AGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEK-----ETRSIMRSLL 210
Query: 621 KGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGY 680
+ + +LH I+H D+KP+NIL+D+ ++SDFG + L P + + L GT GY
Sbjct: 211 EAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-KLRELC-GTPGY 265
Query: 681 MAPE------WYKNTPISVKADVFSYGVVL 704
+APE + + D+++ GV+L
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKL-EKMVTEGE--REFRAEMHVIGRTHHKNL 570
R + +G+G G VY+ E++VA+K + E + ++ + E GR ++
Sbjct: 37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFR-GPERSLGWDERVRIASDVAKGILYLHDE 629
V + + D + + ++ LA +L R GP L V I + + H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAH-- 151
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT-LVRGTRGYMAPEWYKN 688
A H D+KP+NIL+ A + DFG+A D+ T GT YMAPE +
Sbjct: 152 -AAGATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 689 TPISVKADVFSYGVVLLEIV 708
+ + +AD+++ VL E +
Sbjct: 210 SHATYRADIYALTCVLYECL 229
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-29
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGERE-FRAEMHVIGRTHHKNL 570
+ + LGKGSFG V + AVK + K + + ++E E+ ++ + H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 571 VRLIGYCAEDSKRL-LVYEYMSNGSLAD-ILFRG--PERSLGWDERVRIASDVAKGILYL 626
++L + ED LV E + G L D I+ R E + RI V GI Y+
Sbjct: 89 MKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----DAARIIRQVLSGITYM 142
Query: 627 HDECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAP 683
H I+H D+KP+N+L+ + +I DFGL+ + GT Y+AP
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAP 197
Query: 684 EWYKNTPISVKADVFSYGVVLLEIVC 709
E K DV+S GV+L ++
Sbjct: 198 EVLHG-TYDEKCDVWSTGVILYILLS 222
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 53/203 (26%), Positives = 83/203 (40%), Gaps = 23/203 (11%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVK-----KLEKMVTEGERE-FRAEMHVIGRTHHK 568
EELG G F V K A K + + RE E+ ++ H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRG--PERSLGWDERVRIASDVAKGILY 625
N++ L + +L+ E ++ G L D + + E E + G+ Y
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-----EATEFLKQILNGVYY 129
Query: 626 LHDECEAPIIHCDIKPQNILM----DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYM 681
LH I H D+KP+NI++ KI DFGLA + F + GT ++
Sbjct: 130 LHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFV 184
Query: 682 APEWYKNTPISVKADVFSYGVVL 704
APE P+ ++AD++S GV+
Sbjct: 185 APEIVNYEPLGLEADMWSIGVIT 207
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 60/199 (30%), Positives = 89/199 (44%), Gaps = 19/199 (9%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHKNLV 571
LGKGSFG V K ++ AVK + K + E+ ++ + H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRG--PERSLGWDERVRIASDVAKGILYLHD 628
+L + S +V E + G L D I+ R E + RI V GI Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH-----DAARIIKQVFSGITYMHK 139
Query: 629 ECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEW 685
I+H D+KP+NIL+ ++ KI DFGL+ + GT Y+APE
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEV 194
Query: 686 YKNTPISVKADVFSYGVVL 704
+ K DV+S GV+L
Sbjct: 195 LRG-TYDEKCDVWSAGVIL 212
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 8e-29
Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 14/195 (7%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
EELG G+FG V++ T A K + + R E+ + H LV L
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 575 GYCAEDSKRLLVYEYMSNGSLAD-ILFRGPERSLGWDER--VRIASDVAKGILYLHDECE 631
+D++ +++YE+MS G L + + + S E V V KG+ ++H+
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS----EDEAVEYMRQVCKGLCHMHEN-- 274
Query: 632 APIIHCDIKPQNILMDEFWTA--KISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT 689
+H D+KP+NI+ + K+ DFGL L P Q + + GT + APE +
Sbjct: 275 -NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGK 331
Query: 690 PISVKADVFSYGVVL 704
P+ D++S GV+
Sbjct: 332 PVGYYTDMWSVGVLS 346
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-29
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHKNLV 571
LGKGSFG V K ++ AVK + K + E+ ++ + H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 572 RLIGYCAEDSKRL-LVYEYMSNGSLAD-ILFRG--PERSLGWDERVRIASDVAKGIL--- 624
+L EDS +V E + G L D I+ R E A+ + K +
Sbjct: 85 KLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEHD---------AARIIKQVFSGI 134
Query: 625 -YLHDECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGY 680
Y+H I+H D+KP+NIL+ ++ KI DFGL+ + GT Y
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYY 189
Query: 681 MAPEWYKNTPISVKADVFSYGVVLLEIVC 709
+APE + K DV+S GV+L ++
Sbjct: 190 IAPEVLRG-TYDEKCDVWSAGVILYILLS 217
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 24/231 (10%), Positives = 51/231 (22%), Gaps = 42/231 (18%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE---FRAEMHVIGRTHHKNL 570
+ E L G V+ + + A+K E R ++
Sbjct: 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESP 124
Query: 571 VRLIGYC----AEDSKRL----------------------LVYEYM--SNGSLADILFRG 602
D+ + L+ L L
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV 184
Query: 603 PER--SLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA 660
G + + + + L + ++H P N+ + + D
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 661 KLLMPDQTRTFTLVRGTRGYMAPEWY--KNTPISVKADVFSYGVVLLEIVC 709
TR Y E+ + + + G+ + + C
Sbjct: 242 W---KVGTRGPASS-VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 24/206 (11%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGERE------FRAEMHVIGRT 565
+ LG G+ G V K K VA++ + K RE E+ ++ +
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 566 HHKNLVRLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRGPERSLGWDERVRIASDVAKGIL 624
+H ++++ + + +V E M G L D ++ L + +
Sbjct: 198 NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQ 253
Query: 625 YLHDECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYM 681
YLH+ IIH D+KP+N+L+ +E KI+DFG +K ++ + + TL GT Y+
Sbjct: 254 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTLC-GTPTYL 308
Query: 682 APE---WYKNTPISVKADVFSYGVVL 704
APE + D +S GV+L
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 24/206 (11%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGERE------FRAEMHVIGRT 565
+ LG G+ G V K K VA+K + K RE E+ ++ +
Sbjct: 13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 566 HHKNLVRLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRGPERSLGWDERVRIASDVAKGIL 624
+H ++++ + + +V E M G L D ++ L + +
Sbjct: 73 NHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQ 128
Query: 625 YLHDECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYM 681
YLH+ IIH D+KP+N+L+ +E KI+DFG +K ++ + + TL GT Y+
Sbjct: 129 YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTLC-GTPTYL 183
Query: 682 APE---WYKNTPISVKADVFSYGVVL 704
APE + D +S GV+L
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 53/245 (21%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVK-----KLEKMVTEGEREFRAEMHVIGRTHHKN 569
K +G+GS+G V + + A+K K+ ++ + + E+ ++ + HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRGPERSLGWDERV--------------- 613
+ RL ++ LV E G L D + + + V
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 614 ------------------RIASDVAKGIL----YLHDECEAPIIHCDIKPQNILM--DEF 649
++ S++ + I YLH++ I H DIKP+N L ++
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKS 206
Query: 650 WTAKISDFGLAKLLMPDQTRTFTLVR---GTRGYMAPE--WYKNTPISVKADVFSYGVVL 704
+ K+ DFGL+K + + GT ++APE N K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 705 LEIVC 709
++
Sbjct: 267 HLLLM 271
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 14/198 (7%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTHHKNLVR 572
FK +LG G+FG V+ +K + K ++ E AE+ V+ H N+++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 573 LIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDER--VRIASDVAKGILYLHDE 629
+ ED + +V E G L + + R E + + + Y H +
Sbjct: 85 IFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 630 CEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
++H D+KP+NIL KI DFGLA+L D+ T GT YMAPE +
Sbjct: 144 ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVF 198
Query: 687 KNTPISVKADVFSYGVVL 704
K ++ K D++S GVV+
Sbjct: 199 KR-DVTFKCDIWSAGVVM 215
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-28
Identities = 41/209 (19%), Positives = 77/209 (36%), Gaps = 21/209 (10%)
Query: 514 RFKEELGKG--SFGAVYKGTLYKGEKLVAVKK--LEKMVTEGEREFRAEMHVIGRTHHKN 569
+GKG V + V V++ LE E + E+HV +H N
Sbjct: 28 ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPN 87
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIAS---DVAKGILYL 626
+V D++ +V +M+ GS D++ + +E IA V K + Y+
Sbjct: 88 IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM--NELA-IAYILQGVLKALDYI 144
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR------GTRGY 680
H +H +K +IL+ +S ++ R + +
Sbjct: 145 HHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 681 MAPEWYKNTPI--SVKADVFSYGVVLLEI 707
++PE + K+D++S G+ E+
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACEL 230
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-28
Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 40/220 (18%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK-------------MVTEGEREFRAEMH 560
+LG G++G V G A+K ++K + + E E+
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 561 VIGRTHHKNLVRLIGYCAEDSKRL-LVYEYMSNGSLAD-ILFRG--PERSLGWDERVRIA 616
++ H N+++L ED K LV E+ G L + I+ R E A
Sbjct: 99 LLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRHKFDECD---------A 148
Query: 617 SDVAKGIL----YLHDECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTR 669
+++ K IL YLH I+H DIKP+NIL+ + KI DFGL+ D
Sbjct: 149 ANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-- 203
Query: 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC 709
GT Y+APE K + K DV+S GV++ ++C
Sbjct: 204 KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLC 242
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-28
Identities = 62/197 (31%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIG 575
LGKG FG V + K+ A KKLEK +GE E ++ + + + +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEAP 633
Y E L LV M+ G L ++ + + R A+++ G+ LH E
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYAAEICCGLEDLHRER--- 306
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ-TRTFTLVRGTRGYMAPEWYKNTPIS 692
I++ D+KP+NIL+D+ +ISD GLA + Q + GT GYMAPE KN +
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAPEVVKNERYT 363
Query: 693 VKADVFSYGVVLLEIVC 709
D ++ G +L E++
Sbjct: 364 FSPDWWALGCLLYEMIA 380
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGR-THHKNLVRLI 574
++ LG+G+ V + AVK +EK E+ ++ + H+N++ LI
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 575 GYCAEDSKRLLVYEYMSNGSLAD-ILFRGP--ERSLGWDERVRIASDVAKGILYLHDECE 631
+ E+ + LV+E M GS+ I R E E + DVA + +LH++
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-----EASVVVQDVASALDFLHNKG- 131
Query: 632 APIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRT-------FTLVRGTRGYM 681
I H D+KP+NIL ++ KI DF L + + + T G+ YM
Sbjct: 132 --IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYM 188
Query: 682 APE-----WYKNTPISVKADVFSYGVVL 704
APE + + + D++S GV+L
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 36/241 (14%), Positives = 82/241 (34%), Gaps = 53/241 (21%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVK---KLEKMVTEGEREFRAEMHVIGR------ 564
LG+ A + T + + V E+ + ++ + E+ +
Sbjct: 76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 565 -------------------THHKNLVRLIGYCAEDS--KRLLVYEYM--SNGSLADILFR 601
K ++R+ + R +Y M + + ++L
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 602 GPE--RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGL 659
+SL R+++ V + + LH ++H ++P +I++D+ ++ F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEH 252
Query: 660 AKLLMPDQTRTFTLVRGTRGYMAPEW-----------YKNTPISVKADVFSYGVVLLEIV 708
D R + +RG+ PE + T ++ D ++ G+V+ I
Sbjct: 253 LV---RDGAR--VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 709 C 709
C
Sbjct: 308 C 308
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREF---RAEMHVIGRTHHKNLVRL 573
E+G GSFGAVY + ++VA+KK+ + ++ E+ + + H N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
G + LV EY GS +D+L ++ L E + +G+ YLH
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLL-EVHKKPLQEVEIAAVTHGALQGLAYLHSH---N 174
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE---WYKNTP 690
+IH D+K NIL+ E K+ DFG A ++ + V GT +MAPE
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMAPEVILAMDEGQ 229
Query: 691 ISVKADVFSYGVVLLEI 707
K DV+S G+ +E+
Sbjct: 230 YDGKVDVWSLGITCIEL 246
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 51/200 (25%), Positives = 83/200 (41%), Gaps = 25/200 (12%)
Query: 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIG 575
K+ LG G G V + + + A+K L + +E G ++V ++
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYD-SPKARQEVDHHWQASG---GPHIVCILD 89
Query: 576 YCAEDSKR-----LLVYEYMSNGSLAD-ILFRGPERSLGWDER--VRIASDVAKGILYLH 627
E+ L++ E M G L I RG + + ER I D+ I +LH
Sbjct: 90 VY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQA---FTEREAAEIMRDIGTAIQFLH 145
Query: 628 DECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
I H D+KP+N+L ++ K++DFG AK + +T T Y+APE
Sbjct: 146 SHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC---YTPYYVAPE 199
Query: 685 WYKNTPISVKADVFSYGVVL 704
D++S GV++
Sbjct: 200 VLGPEKYDKSCDMWSLGVIM 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 513 NRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE---REFRAEMHVIGRTHH 567
+R++ E LG G V+ + + VAVK L + FR E +H
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 568 KNLVRLIGYCAEDSKRL----LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGI 623
+V + ++ +V EY+ +L DI+ E + + + +D + +
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQAL 129
Query: 624 LYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ---TRTFTLVRGTRGY 680
+ H + IIH D+KP NI++ K+ DFG+A+ + T+T ++ GT Y
Sbjct: 130 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQY 185
Query: 681 MAPEWYKNTPISVKADVFSYGVVLLEIV 708
++PE + + ++DV+S G VL E++
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVL 213
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 51/201 (25%), Positives = 81/201 (40%), Gaps = 24/201 (11%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
+ LG G G V + + ++ A+K L+ + RE ++VR++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQ---CPHIVRIV 121
Query: 575 GYCAEDSKR-----LLVYEYMSNGSLAD-ILFRGPERSLGWDER--VRIASDVAKGILYL 626
E+ L+V E + G L I RG + + ER I + + I YL
Sbjct: 122 DVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYL 177
Query: 627 HDECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAP 683
H I H D+KP+N+L K++DFG AK + T T Y+AP
Sbjct: 178 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAP 232
Query: 684 EWYKNTPISVKADVFSYGVVL 704
E D++S GV++
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIM 253
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK---MVTEGEREFRAEMHVIGRTHHKN---LVR 572
+G+G FG VY K+ A+K L+K + +GE E ++ + +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 573 LIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDEC 630
+ Y +L + + M+ G L L + + +R A+++ G+ ++H+
Sbjct: 257 MS-YAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFS-EADMRFYAAEIILGLEHMHNRF 312
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE-WYKNT 689
+++ D+KP NIL+DE +ISD GLA + GT GYMAPE K
Sbjct: 313 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGV 366
Query: 690 PISVKADVFSYGVVLLEIVC 709
AD FS G +L +++
Sbjct: 367 AYDSSADWFSLGCMLFKLLR 386
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREF-RAEMHVIGRTHHKNLV 571
F + LG+GSF V + A+K LEK ++ E + + E V+ R H V
Sbjct: 34 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 572 RLIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDE 629
+L + +D ++L Y NG L + + S + R +++ + YLH +
Sbjct: 94 KLY-FTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFD-ETCTRFYTAEIVSALEYLHGK 149
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP--DQTRTFTLVRGTRGYMAPEWYK 687
IIH D+KP+NIL++E +I+DFG AK+L P Q R + V GT Y++PE
Sbjct: 150 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPELLT 205
Query: 688 NTPISVKADVFSYGVVLLEIVC 709
+D+++ G ++ ++V
Sbjct: 206 EKSACKSSDLWALGCIIYQLVA 227
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 60/227 (26%), Positives = 90/227 (39%), Gaps = 38/227 (16%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK-------------------MVTEGERE 554
K+E+GKGS+G V A+K L K G +
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 555 FRAEMHVIGR-------THHKNLVRL--IGYCAEDSKRLLVYEYMSNGSLADILFRGPER 605
R + + + H N+V+L + + +V+E ++ G + ++ P
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-- 133
Query: 606 SLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665
L D+ D+ KGI YLH + IIH DIKP N+L+ E KI+DFG++
Sbjct: 134 -LSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 666 DQTRTFTLVRGTRGYMAPEWYKNTPISV---KADVFSYGVVLLEIVC 709
V GT +MAPE T DV++ GV L V
Sbjct: 190 SDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 26/235 (11%), Positives = 71/235 (30%), Gaps = 42/235 (17%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVK---KLEKMVTEGEREFRAEMHVIGRT----- 565
LG+ A + T + + V E+ + ++ + E+ +
Sbjct: 81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 140
Query: 566 -----------------HHKNLVRLIGYCAEDSKRLLVYEY-------MSNGSLADILFR 601
++I ++ ++ + + + ++L
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200
Query: 602 GP--ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGL 659
+SL R+++ V + + LH ++H ++P +I++D+ ++ F
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 660 AKLLMPDQTRTFTLVRGTRGYMAPEW-----YKNTPISVKADVFSYGVVLLEIVC 709
A + T ++ D ++ G+ + I C
Sbjct: 258 LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 58/346 (16%), Positives = 102/346 (29%), Gaps = 107/346 (30%)
Query: 514 RFKEE------LGKGSFGAVYKGTLYKGEKLVAVKK---------LEKMVTE-------- 550
R+ + +G+G FG V++ + A+K+ EK++ E
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 551 --------------------------------------GEREFRAEMHVIGRTHHKNLVR 572
A I R +
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 573 LIGYCAEDSKRLLVY---EYMSNGSLADILFRGPERSLGWDERV-RIASDVAKGILYLHD 628
+G S ++ +Y + +L D + R I +A+ + +LH
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR-----------GT 677
+ ++H D+KP NI K+ DFGL + D+ L GT
Sbjct: 183 KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 678 RGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFID 736
+ YM+PE S K D+FS G++L E++ ME
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------------------RV 280
Query: 737 RELNKLVRGQ-----EVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777
R + + + M++ + P RP +
Sbjct: 281 RIITDVRNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPEATDI 323
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 514 RFKEELGKGSFGAVYKGT-LYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHKNL 570
R + +GKG+F V + G + VA+K ++K + ++ E+ ++ +H N+
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGRE-VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
V+L + L+ EY S G + D ++ G + E + + Y H +
Sbjct: 77 VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQK 133
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKN 688
I+H D+K +N+L+D KI+DFG + F G Y APE ++
Sbjct: 134 R---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPELFQG 187
Query: 689 TP-ISVKADVFSYGVVLLEIVC 709
+ DV+S GV+L +V
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVS 209
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-24
Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 26/206 (12%)
Query: 519 LGKGSFGAVY----KGTLYKGEKLVAVKKLEK--MVTEGERE-FRAEMHVIGRTHHKNLV 571
+G+G+FG V K +K+ A+K L K M+ E FR E V+ K +
Sbjct: 82 IGRGAFGEVAVVKLKNA----DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 572 RLIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDE 629
L Y +D L LV +Y G L +L + +R +E R +++ I +H
Sbjct: 138 TLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP--EEMARFYLAEMVIAIDSVHQL 194
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKN 688
+H DIKP NILMD +++DFG LM D T ++ V GT Y++PE +
Sbjct: 195 H---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQA 250
Query: 689 TPISVK-----ADVFSYGVVLLEIVC 709
D +S GV + E++
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 514 RFKEELGKGSFGAVYKGT-LYKGEKLVAVKKLEK-------MVTEGEREFRAEMHVIGRT 565
+ LG G FG+VY G + VA+K +EK + G R E+ ++ +
Sbjct: 46 QVGPLLGSGGFGSVYSGIRVSDNLP-VAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 103
Query: 566 HHK--NLVRLIGYCAEDSKRLLVYEYMSN-GSLAD-ILFRGPERSLGWDERVRIASDVAK 621
++RL+ + +L+ E L D I RG L + V +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLE 160
Query: 622 GILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGY 680
+ + H+ ++H DIK +NIL+D K+ DFG LL F GTR Y
Sbjct: 161 AVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVY 214
Query: 681 MAPEWYKNTP-ISVKADVFSYGVVLLEIVC 709
PEW + A V+S G++L ++VC
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 28/208 (13%)
Query: 519 LGKGSFGAVY----KGTLYKGEKLVAVKKLEK--MVTEGERE-FRAEMHVIGRTHHKNLV 571
+G+G+F V K T ++ A+K + K M+ GE FR E V+ + +
Sbjct: 69 IGRGAFSEVAVVKMKQT----GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 572 RLIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDE 629
+L + +D L LV EY G L +L + + E R +++ I +H
Sbjct: 125 QLH-FAFQDENYLYLVMEYYVGGDLLTLLSK-FGERIP-AEMARFYLAEIVMAIDSVHRL 181
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD-QTRTFTLVRGTRGYMAPE---- 684
+H DIKP NIL+D +++DFG L D R+ V GT Y++PE
Sbjct: 182 G---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQA 237
Query: 685 ---WYKNTPISVKADVFSYGVVLLEIVC 709
+ D ++ GV E+
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 62/198 (31%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREF---RAEMHVIGRTHHKNLVRLIG 575
LGKG+FG V + A+K L+K V + E E V+ + H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEAP 633
Y + RL V EY + G L L R ER ++R R +++ + YLH E
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSR--ERVFS-EDRARFYGAEIVSALDYLHSEKN-- 269
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV 693
+++ D+K +N+++D+ KI+DFGL K + D T GT Y+APE ++
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGR 328
Query: 694 KADVFSYGVVLLEIVCCR 711
D + GVV+ E++C R
Sbjct: 329 AVDWWGLGVVMYEMMCGR 346
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 58/200 (29%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 519 LGKGSFGAVY---KGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHKNLVRL 573
LG+GSFG V+ K + +L A+K L+K + + E ++ +H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 574 IGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECE 631
Y + +L L+ +++ G L L + E +E V+ +++A + +LH
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSK--EVMFT-EEDVKFYLAELALALDHLH---S 144
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
II+ D+KP+NIL+DE K++DFGL+K + + + ++ GT YMAPE
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRGH 203
Query: 692 SVKADVFSYGVVLLEIVCCR 711
+ AD +S+GV++ E++
Sbjct: 204 TQSADWWSFGVLMFEMLTGT 223
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 61/212 (28%), Positives = 90/212 (42%), Gaps = 27/212 (12%)
Query: 514 RFKEELGKGSFGAVYKGT-LYKGEKLVAVKKLEK-------MVTEGEREFRAEMH----V 561
R LGKG FG V+ G L + VA+K + + +++ E+ V
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQ-VAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKV 91
Query: 562 IGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGS-LAD-ILFRGPERSLGWDERVRIASDV 619
H ++RL+ + +LV E L D I +GP LG V
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQV 148
Query: 620 AKGILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISDFGLAKLLMPDQTRTFTLVRGTR 678
I + H ++H DIK +NIL+D AK+ DFG LL + F GTR
Sbjct: 149 VAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTR 202
Query: 679 GYMAPEWYKNTP-ISVKADVFSYGVVLLEIVC 709
Y PEW ++ A V+S G++L ++VC
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVC 234
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 519 LGKGSFGAVY----KGTLYKGEKLVAVKKLEK--MVTEGERE-FRAEMHVIGRTHHKNLV 571
+G+G+FG V K T K+ A+K L K M+ + F E ++ + +V
Sbjct: 77 IGRGAFGEVQLVRHKST----RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 572 RLIGYCAEDSKRL-LVYEYMSNGSLADILFRG--PERSLGWDERVRI-ASDVAKGILYLH 627
+L Y +D + L +V EYM G L +++ PE + R ++V + +H
Sbjct: 133 QLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE------KWARFYTAEVVLALDAIH 185
Query: 628 DECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK-LLMPDQTRTFTLVRGTRGYMAPEWY 686
IH D+KP N+L+D+ K++DFG + R T V GT Y++PE
Sbjct: 186 SMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVL 241
Query: 687 KNTPISVK----ADVFSYGVVLLEIVC 709
K+ D +S GV L E++
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLV 268
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFR---AEMHVIGRTHHKNLVRLIG 575
+GKGSFG V +K+ A+K + K E R E+ ++ H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRG---PERSLGWDERVRI-ASDVAKGILYLHDEC 630
Y +D + + +V + + G L L + E E V++ ++ + YL ++
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE------ETVKLFICELVMALDYLQNQ- 134
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
IIH D+KP NIL+DE I+DF +A ++P +T+ T+ GT+ YMAPE + +
Sbjct: 135 --RIIHRDMKPDNILLDEHGHVHITDFNIAA-MLPRETQITTMA-GTKPYMAPEMFSSRK 190
Query: 691 I---SVKADVFSYGVVLLEIVCCRR 712
S D +S GV E++ RR
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-23
Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREF---RAEMHVIGRTHHKNLVRLIG 575
LGKG+FG V + A+K L K V + E E V+ T H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDE-RVRI-ASDVAKGILYLHDECEA 632
Y + RL V EY + G L F R + E R R +++ + YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVSALEYLH---SR 124
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
+++ DIK +N+++D+ KI+DFGL K + D T GT Y+APE ++
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYG 183
Query: 693 VKADVFSYGVVLLEIVCCR 711
D + GVV+ E++C R
Sbjct: 184 RAVDWWGLGVVMYEMMCGR 202
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 25/202 (12%)
Query: 519 LGKGSFGAVYKGT-LYKGEKLVAVKKLEK-------MVTEGEREFRAEMHVIGRTHHKNL 570
LG G+FG V G G K VAVK L + +V + +RE + + + H ++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHK-VAVKILNRQKIRSLDVVGKIKREIQN-LKLF---RHPHI 73
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
++L + + +V EY+S G L D I G + E R+ + + Y H
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCHRH 130
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKN 688
++H D+KP+N+L+D AKI+DFGL+ ++ + RT G+ Y APE
Sbjct: 131 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISG 184
Query: 689 TP-ISVKADVFSYGVVLLEIVC 709
+ D++S GV+L ++C
Sbjct: 185 RLYAGPEVDIWSCGVILYALLC 206
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 3e-22
Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 27/207 (13%)
Query: 519 LGKGSFGAVY---KGTLYKGEKLVAVKKLEK-MVTEGEREF---RAEMHVIGRTHHKNLV 571
LGKG +G V+ K T K+ A+K L+K M+ ++ +AE +++ H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 572 RLIGYCAEDSKRL-LVYEYMSNGSL-----ADILFRGPERSLGWDERVRI-ASDVAKGIL 624
LI Y + +L L+ EY+S G L + +F E + ++++ +
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIF--ME------DTACFYLAEISMALG 135
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
+LH + II+ D+KP+NI+++ K++DFGL K + D T T T GT YMAPE
Sbjct: 136 HLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPE 191
Query: 685 WYKNTPISVKADVFSYGVVLLEIVCCR 711
+ + D +S G ++ +++
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 57/205 (27%), Positives = 87/205 (42%), Gaps = 21/205 (10%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKL--EKMVTEGEREFRA------EMHVIGRTHHK 568
LG G+FG V+ + K V VK + EK++ + E E+ ++ R H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 569 NLVRLIGYCAEDSKRLLVYEYMSNGS-LAD-ILFRGPERSLGWDERVRIASDVAKGILYL 626
N+++++ LV E +G L I L I + + YL
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYL 146
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEW 685
+ IIH DIK +NI++ E +T K+ DFG A L + TF GT Y APE
Sbjct: 147 RLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEV 200
Query: 686 YKNTP-ISVKADVFSYGVVLLEIVC 709
P + +++S GV L +V
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 28/234 (11%)
Query: 493 GLAYESNLRSFSYNELKKATNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE 550
G N + + +K +RF+ G+G+FG V G VA+KK+ +
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62
Query: 551 GEREFRAEMHVIGRTHHKNLVRLIGY-------CAEDSKRLLVYEYMSNGSLADIL--FR 601
RE + M + HH N+V+L Y D +V EY+ + +L +
Sbjct: 63 RNRELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYY 120
Query: 602 GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF-WTAKISDFGLA 660
+ + + + I LH + H DIKP N+L++E T K+ DFG A
Sbjct: 121 RRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179
Query: 661 KLLMPDQTRTFTLVRGTRGYMAPE------WYKNTPISVKADVFSYGVVLLEIV 708
K L P + + +R Y APE Y T + D++S G + E++
Sbjct: 180 KKLSPSEPNVAYIC--SRYYRAPELIFGNQHY-TTAV----DIWSVGCIFAEMM 226
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 6e-22
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 36/208 (17%)
Query: 519 LGKGSFGAVYKGT-LYKGEKLVAVK-----KLEKMVTEGEREFRAEMHVIGRTHHKNLVR 572
LG+G++G V E VAVK + ++E ++ +H+N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKML---NHENVVK 69
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAK--------GIL 624
G+ E + + L EY S G L D + + + + A+ G++
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRI----------EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF--TLVRGTRGYMA 682
YLH I H DIKP+N+L+DE KISDFGLA + + + GT Y+A
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVA 175
Query: 683 PEWYKNTP-ISVKADVFSYGVVLLEIVC 709
PE K + DV+S G+VL ++
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLA 203
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 9e-22
Identities = 25/198 (12%), Positives = 57/198 (28%), Gaps = 38/198 (19%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKL--EKMVTEGERE-FRAEMHVIGRTHHKNL 570
R G ++ ++ VA+ + + ++ + + + + R +
Sbjct: 34 RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
R++ + L+V E++ GSL ++ P +R +A H
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPS----PVGAIRAMQSLAAAADAAH--- 146
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
A + P + +S G L M
Sbjct: 147 RAGVALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPDA------ 179
Query: 691 ISVKADVFSYGVVLLEIV 708
+ + D+ G L ++
Sbjct: 180 -NPQDDIRGIGASLYALL 196
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 16/196 (8%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREF---RAEMHVIGRTHHKNLVRLIG 575
LG GSFG V + A+K L+K ++ E ++ + LV+L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEAP 633
+ +D+ L +V EY++ G + L R + R A+ + YLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFS-EPHARFYAAQIVLTFEYLHSLD--- 161
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV 693
+I+ D+KP+N+L+D+ +++DFG AK + RT+TL GT +APE + +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLC-GTPEALAPEIILSKGYNK 217
Query: 694 KADVFSYGVVLLEIVC 709
D ++ GV++ E+
Sbjct: 218 AVDWWALGVLIYEMAA 233
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 23/205 (11%)
Query: 519 LGKGSFGAVYKGT-LYKGEKLVAVKKLEK----MVTEGEREFRAEMHVIGRTHHKNLVRL 573
LG+GS+G V + + AVK L+K + GE + E+ ++ R HKN+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCR-RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 574 --IGYCAEDSKRLLVYEYMSNGS--LADILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
+ Y E K +V EY G + D + + + G+ YLH +
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR---FPVCQAHGYFCQLIDGLEYLHSQ 128
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR---GTRGYMAPEWY 686
I+H DIKP N+L+ T KIS G+A+ R G+ + PE
Sbjct: 129 G---IVHKDIKPGNLLLTTGGTLKISALGVAEA--LHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 687 KNTPI--SVKADVFSYGVVLLEIVC 709
K D++S GV L I
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-21
Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 519 LGKGSFGAVYKGT-LYKGEKLVAVKKLEK--MVTEG--EREFRAEMHVIGRTHHKNLVRL 573
LG G+FG V G G K VAVK L + + + + R E+ + H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHK-VAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKL 81
Query: 574 IGYCAEDSKRLLVYEYMSNGSLAD-ILFRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
+ S +V EY+S G L D I G L E R+ + G+ Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHRHM-- 136
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTP- 690
++H D+KP+N+L+D AKI+DFGL+ ++ + RT G+ Y APE
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLY 192
Query: 691 ISVKADVFSYGVVLLEIVC 709
+ D++S GV+L ++C
Sbjct: 193 AGPEVDIWSSGVILYALLC 211
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 36/208 (17%)
Query: 519 LGKGSFGAVYKGT-LYKGEKLVAVK-----KLEKMVTEGEREFRAEMHVIGRTHHKNLVR 572
LG+G++G V E VAVK + ++E ++ +H+N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICI-NKML---NHENVVK 69
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAK--------GIL 624
G+ E + + L EY S G L D + + + + A+ G++
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRI----------EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF--TLVRGTRGYMA 682
YLH I H DIKP+N+L+DE KISDFGLA + + + GT Y+A
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVA 175
Query: 683 PEWYKNTP-ISVKADVFSYGVVLLEIVC 709
PE K + DV+S G+VL ++
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLA 203
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-21
Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREF-RAEMHVIGR-THHKNLVRLI 574
+GKGSFG V E AVK L+K ++ + E + +E +V+ + H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 575 GYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEA 632
+ + + +L V +Y++ G L L R ER + R R A+++A + YLH
Sbjct: 106 -FSFQTADKLYFVLDYINGGELFYHLQR--ERCFL-EPRARFYAAEIASALGYLH---SL 158
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
I++ D+KP+NIL+D ++DFGL K + + T T GT Y+APE P
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPEVLHKQPYD 217
Query: 693 VKADVFSYGVVLLEIVCCR 711
D + G VL E++
Sbjct: 218 RTVDWWCLGAVLYEMLYGL 236
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 31/211 (14%)
Query: 513 NRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-------REFRAEMHVIG 563
+++ ++G+GS+G V+K ++VA+KK + RE R +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQL-- 59
Query: 564 RTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGI 623
H NLV L+ + LV+EY + ++ L R R + I + +
Sbjct: 60 --KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ-RGVPEHLVKSITWQTLQAV 115
Query: 624 LYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAP 683
+ H IH D+KP+NIL+ + K+ DFG A+LL + + TR Y +P
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSP 171
Query: 684 E------WYKNTPISVKADVFSYGVVLLEIV 708
E Y P+ DV++ G V E++
Sbjct: 172 ELLVGDTQY-GPPV----DVWAIGCVFAELL 197
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 8e-21
Identities = 64/248 (25%), Positives = 119/248 (47%), Gaps = 21/248 (8%)
Query: 477 KYQVLKYEWLLENGSLGLAYESNLRSFSYNELKKATNRFKEE-------LGKGSFGAVYK 529
Y + E L G++G E + + E KA++ + +G+GS+ V
Sbjct: 11 DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLL 70
Query: 530 GTLYKGEKLVAVKKLEKMVTEGEREF---RAEMHVIGR-THHKNLVRLIGYCAEDSKRL- 584
L K +++ A++ ++K + + + + E HV + ++H LV L C + RL
Sbjct: 71 VRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLF 129
Query: 585 LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEAPIIHCDIKPQN 643
V EY++ G L + R +R L +E R +++++ + YLH+ II+ D+K N
Sbjct: 130 FVIEYVNGGDLMFHMQR--QRKLP-EEHARFYSAEISLALNYLHER---GIIYRDLKLDN 183
Query: 644 ILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVV 703
+L+D K++D+G+ K + T T GT Y+APE + D ++ GV+
Sbjct: 184 VLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDYGFSVDWWALGVL 242
Query: 704 LLEIVCCR 711
+ E++ R
Sbjct: 243 MFEMMAGR 250
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 47/174 (27%), Positives = 87/174 (50%), Gaps = 15/174 (8%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE------FRAEMHVIGRTHHKNL 570
E++G+G++G VYK ++VA+KK+ ++ + E E R E+ ++ +H N+
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKI-RL--DTETEGVPSTAIR-EISLLKELNHPNI 64
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
V+L+ ++K LV+E++ L + + + +G+ + H
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
++H D+KPQN+L++ K++DFGLA+ RT+T T Y APE
Sbjct: 124 ---VLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPE 173
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 9e-21
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 519 LGKGSFGAVY---KGTLYKGEKLVAVKKLEKMVTEGEREF----RAEMHVIGRT-HHKNL 570
LG G++G V+ K + + KL A+K L+K + + R E V+ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 571 VRLIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHD 628
V L Y + +L L+ +Y++ G L L + + V+I ++ + +LH
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGELFTHLSQ--RERFT-EHEVQIYVGEIVLALEHLH- 176
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ-TRTFTLVRGTRGYMAPE--W 685
+ II+ DIK +NIL+D ++DFGL+K + D+ R + GT YMAP+
Sbjct: 177 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVR 233
Query: 686 YKNTPISVKADVFSYGVVLLEIVCCR 711
++ D +S GV++ E++
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 56/207 (27%), Positives = 80/207 (38%), Gaps = 33/207 (15%)
Query: 519 LGKGSFGAVYKGT-LYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYC 577
+G G+FG E VAVK +E+ E R E+ H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKEL-VAVKYIERGAAIDENVQR-EIINHRSLRHPNIVRFKEVI 85
Query: 578 AEDSKRLLVYEYMSNGSLAD-ILFRGPERSLGWDERVRIASDVAK--------GILYLHD 628
+ ++ EY S G L + I G R + D A+ G+ Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAG-----------RFSEDEARFFFQQLLSGVSYCHS 134
Query: 629 ECEAPIIHCDIKPQNILMDEFWTA--KISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEW 685
I H D+K +N L+D KI DFG +K + ++ GT Y+APE
Sbjct: 135 MQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEV 188
Query: 686 YKNTP-ISVKADVFSYGVVLLEIVCCR 711
ADV+S GV L ++
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 54/196 (27%), Positives = 100/196 (51%), Gaps = 16/196 (8%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREF---RAEMHVIGRTHHKNLVRLIG 575
LG GSFG V+ + A+K L+K + ++ E ++ H ++R+
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW- 72
Query: 576 YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEAP 633
+D++++ ++ +Y+ G L +L + + + + A++V + YLH +
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFP-NPVAKFYAAEVCLALEYLHSK---D 126
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV 693
II+ D+KP+NIL+D+ KI+DFG AK T+TL GT Y+APE P +
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKY---VPDVTYTLC-GTPDYIAPEVVSTKPYNK 182
Query: 694 KADVFSYGVVLLEIVC 709
D +S+G+++ E++
Sbjct: 183 SIDWWSFGILIYEMLA 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-------REFRAEMHVIGRTHHKN 569
+G+GS+G V K ++VA+KK + + RE + + H+N
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQL----RHEN 85
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
LV L+ C + + LV+E++ + ++ D L P L + + + GI + H
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE----- 684
IIH DIKP+NIL+ + K+ DFG A+ L + TR Y APE
Sbjct: 144 N---IIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYRAPELLVGD 199
Query: 685 -WYKNTPISVKADVFSYGVVLLEIV 708
Y + DV++ G ++ E+
Sbjct: 200 VKY-GKAV----DVWAIGCLVTEMF 219
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 56/199 (28%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREF---RAEMHVIGR-THHKNLVRLI 574
+G+GS+ V L K +++ A+K ++K + + + + E HV + ++H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 575 GYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHDECEA 632
C + RL V EY++ G L + R +R L +E R +++++ + YLH+
Sbjct: 77 -SCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLP-EEHARFYSAEISLALNYLHER--- 129
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
II+ D+K N+L+D K++D+G+ K + T T GT Y+APE +
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDYG 188
Query: 693 VKADVFSYGVVLLEIVCCR 711
D ++ GV++ E++ R
Sbjct: 189 FSVDWWALGVLMFEMMAGR 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 519 LGKGSFGAV----YKGTLYKGEKLVAVKKLEKMVTEGEREF---RAEMHVIGR-THHKNL 570
LGKGSFG V +K T + A+K L+K V + + E V+ H L
Sbjct: 25 LGKGSFGKVFLAEFKKT----NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 571 VRLIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHD 628
+ + + L V EY++ G L + R A+++ G+ +LH
Sbjct: 81 THMF-CTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFD-LSRATFYAAEIILGLQFLHS 136
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN 688
+ I++ D+K NIL+D+ KI+DFG+ K M +T T GT Y+APE
Sbjct: 137 K---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLG 192
Query: 689 TPISVKADVFSYGVVLLEIVCCR 711
+ D +S+GV+L E++ +
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 26/202 (12%)
Query: 519 LGKGSFGAVYKGT-LYKGEKLVAVKKLEK-------MVTEGEREFRAEMHVIGRTHHKNL 570
LG+GSFG V T +K VA+K + + M ERE + ++ H ++
Sbjct: 17 LGEGSFGKVKLATHYKTQQK-VALKFISRQLLKKSDMHMRVEREISY-LKLL---RHPHI 71
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLAD-ILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
++L + ++V EY + G L D I+ + + DE R + I Y H
Sbjct: 72 IKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCHRH 127
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKN 688
I+H D+KP+N+L+D+ KI+DFGL+ ++ +T G+ Y APE
Sbjct: 128 K---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVING 181
Query: 689 TP-ISVKADVFSYGVVLLEIVC 709
+ DV+S G+VL ++
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLV 203
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 51/232 (21%)
Query: 501 RSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMH 560
R +Y K +G GSFG V++ L + ++ VA+KK ++ + + R E+
Sbjct: 38 REIAYTNCKV--------IGNGSFGVVFQAKLVESDE-VAIKK---VLQDKRFKNR-ELQ 84
Query: 561 VIGRTHHKNLVRLIGYCAEDSKRL------LVYEYMSNGSLADILFRGPERSLGWDERVR 614
++ H N+V L + + + LV EY+ ++ R +
Sbjct: 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS-----RHY-AKLKQT 137
Query: 615 IASDVAK--------GILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISDFGLAKLLMP 665
+ + K + Y+H I H DIKPQN+L+D K+ DFG AK+L+
Sbjct: 138 MPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194
Query: 666 DQTRTFTLVRGTRGYMAPE------WYKNTPISVKADVFSYGVVLLEIVCCR 711
+ + +R Y APE Y T I D++S G V+ E++ +
Sbjct: 195 GEPNVSYIC--SRYYRAPELIFGATNY-TTNI----DIWSTGCVMAELMQGQ 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 42/216 (19%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGY 576
+ +G GSFG VY+ L +LVA+KK ++ + + R E+ ++ + H N+VRL +
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKK---VLQDKRFKNR-ELQIMRKLDHCNIVRLRYF 115
Query: 577 CAEDSKRL------LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAK--------G 622
++ LV +Y+ ++ + R R+ + + K
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVA-RHYSRA-----KQTLPVIYVKLYMYQLFRS 168
Query: 623 ILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYM 681
+ Y+H I H DIKPQN+L+D + K+ DFG AK L+ + + +R Y
Sbjct: 169 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYR 223
Query: 682 APE------WYKNTPISVKADVFSYGVVLLEIVCCR 711
APE Y + I DV+S G VL E++ +
Sbjct: 224 APELIFGATDY-TSSI----DVWSAGCVLAELLLGQ 254
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 3e-20
Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 34/219 (15%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE------FRAEMHVIGRTHHKNL 570
E++G+G++G V+K + ++VA+K++ ++ + + E R E+ ++ HKN+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV-RL--DDDDEGVPSSALR-EICLLKELKHKNI 63
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
VRL D K LV+E+ L L + + KG+ + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL-MPDQTRTFTLVRGTRGYMAPE----- 684
++H D+KPQN+L++ K+++FGLA+ +P + + +V T Y P+
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGA 176
Query: 685 -WYKNTPISVKADVFSYGVVLLEIVCCRR-----NMEID 717
Y +T I D++S G + E+ R N D
Sbjct: 177 KLY-STSI----DMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 519 LGKGSFGAVY----KGTLYKGEKLVAVKKLEK--MVTEGEREF-RAEMHVIGR-THHKNL 570
LGKGSFG V K T L AVK L+K ++ + + E E ++ +H L
Sbjct: 31 LGKGSFGKVMLARVKET----GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 571 VRLIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRI-ASDVAKGILYLHD 628
+L C + RL V E+++ G L + + R + R R A+++ +++LHD
Sbjct: 87 TQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFD-EARARFYAAEIISALMFLHD 142
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN 688
+ II+ D+K N+L+D K++DFG+ K + + T T GT Y+APE +
Sbjct: 143 K---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQE 198
Query: 689 TPISVKADVFSYGVVLLEIVCCR 711
D ++ GV+L E++C
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-20
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 519 LGKGSFGAV----YKGTLYKGEKLVAVKKLEK--MVTEGEREF-RAEMHVIGR-THHKNL 570
LGKGSFG V KGT ++L AVK L+K ++ + + E E V+ L
Sbjct: 28 LGKGSFGKVMLSERKGT----DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 571 VRLIGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDE-RVRI-ASDVAKGILYLH 627
+L C + RL V EY++ G L ++ + E A+++A G+ +L
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGD----LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 628 DECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYK 687
+ II+ D+K N+++D KI+DFG+ K + D T T GT Y+APE
Sbjct: 139 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIA 194
Query: 688 NTPISVKADVFSYGVVLLEIVCCR 711
P D +++GV+L E++ +
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 47/201 (23%), Positives = 75/201 (37%), Gaps = 45/201 (22%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
+ LG G G V + + ++ A+K L+ + RE ++VR++
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQ---CPHIVRIV 77
Query: 575 GYCAEDSKR-----LLVYEYMSNGSLAD-ILFRGPERSLGWDER--VRIASDVAKGILYL 626
E+ L+V E + G L I RG + + ER I + + I YL
Sbjct: 78 DVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYL 133
Query: 627 HDECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAP 683
H I H D+KP+N+L K++DFG AK G Y
Sbjct: 134 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----------ETTG-EKY--- 175
Query: 684 EWYKNTPISVKADVFSYGVVL 704
D++S GV++
Sbjct: 176 --------DKSCDMWSLGVIM 188
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 1e-19
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 519 LGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREF-RAEMHVIGR-THHKNLVRLI 574
LGKGSFG V ++L AVK L+K ++ + + E E V+ L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 575 GYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDE-RVRI-ASDVAKGILYLHDECE 631
C + RL V EY++ G L ++ + E A+++A G+ +L +
Sbjct: 409 -SCFQTMDRLYFVMEYVNGGD----LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK-- 461
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
II+ D+K N+++D KI+DFG+ K + D T T GT Y+APE P
Sbjct: 462 -GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAYQPY 519
Query: 692 SVKADVFSYGVVLLEIVCCR 711
D +++GV+L E++ +
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQ 539
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 23/183 (12%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE----------REFRAEMHVIGRTH 566
E+G G++G VYK VA+K + ++ G RE + +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVAL-LRRLEAFE 72
Query: 567 HKNLVRLI-----GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAK 621
H N+VRL+ + K LV+E++ L L + P L + + +
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 622 GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYM 681
G+ +LH C I+H D+KP+NIL+ T K++DFGLA++ T +V T Y
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWYR 186
Query: 682 APE 684
APE
Sbjct: 187 APE 189
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 16/176 (9%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREF-----RAEMHVIGRTHHKNLV 571
E+LG G++ VYKG VA+K++ K+ + E R E+ ++ H+N+V
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEV-KL--DSEEGTPSTAIR-EISLMKELKHENIV 66
Query: 572 RLIGYCAEDSKRLLVYEYMSN---GSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
RL ++K LV+E+M N + R L + + +G+ + H+
Sbjct: 67 RLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
I+H D+KPQN+L+++ K+ DFGLA+ TF+ T Y AP+
Sbjct: 127 NK---ILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIPVNTFSSEVVTLWYRAPD 178
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 31/210 (14%)
Query: 517 EELGKGSFGAVYKGTLYK-GEKLVAVKKLEKMVTEGE-------REFRAEMHVIGRTHHK 568
E+G+G++G V+K K G + VA+K++ ++ T E RE + + H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAV-LRHLETFEHP 74
Query: 569 NLVRLI-----GYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGI 623
N+VRL ++K LV+E++ L L + PE + + + + +G+
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 624 LYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAP 683
+LH ++H D+KPQNIL+ K++DFGLA++ T +V T Y AP
Sbjct: 134 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAP 188
Query: 684 EW-----YKNTPISVKADVFSYGVVLLEIV 708
E Y TP+ D++S G + E+
Sbjct: 189 EVLLQSSY-ATPV----DLWSVGCIFAEMF 213
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 56/189 (29%), Positives = 89/189 (47%), Gaps = 21/189 (11%)
Query: 507 ELKKATNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-------FRA 557
++K R++ + LG+G F VYK ++VA+KK+ K+ E + R
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALR- 61
Query: 558 EMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIAS 617
E+ ++ H N++ L+ S LV+++M L I+ + L
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII-KDNSLVLTPSHIKAYML 119
Query: 618 DVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT--LVR 675
+G+ YLH I+H D+KP N+L+DE K++DFGLAK R +T +V
Sbjct: 120 MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVV- 174
Query: 676 GTRGYMAPE 684
TR Y APE
Sbjct: 175 -TRWYRAPE 182
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 30/205 (14%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE------FRAEMHVIGRTHHKNL 570
E++G+G++G VYK +G +VA+K++ ++ + E E R E+ ++ HH N+
Sbjct: 27 EKVGEGTYGVVYKAKDSQGR-IVALKRI-RL--DAEDEGIPSTAIR-EISLLKELHHPNI 81
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
V LI + LV+E+M L +L L + + +G+ + H
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQHR 139
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL-MPDQTRTFTLVRGTRGYMAPE----- 684
I+H D+KPQN+L++ K++DFGLA+ +P ++ T +V T Y AP+
Sbjct: 140 ---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGS 194
Query: 685 -WYKNTPISVKADVFSYGVVLLEIV 708
Y +T + D++S G + E++
Sbjct: 195 KKY-STSV----DIWSIGCIFAEMI 214
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 19/175 (10%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-------REFRAEMHVIGRTHHKN 569
E++G+G++G VYK GE A+KK+ ++ E E RE + ++ H N
Sbjct: 8 EKIGEGTYGVVYKAQNNYGE-TFALKKI-RLEKEDEGIPSTTIRE----ISILKELKHSN 61
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
+V+L + +LV+E++ L +L L + GI Y HD
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDR 119
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
++H D+KPQN+L++ KI+DFGLA+ R +T T Y AP+
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIVTLWYRAPD 170
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 46/180 (25%), Positives = 79/180 (43%), Gaps = 24/180 (13%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-------REFRAEMHVIGRTHHKN 569
+LG+G++G VYK + VA+K++ ++ E E RE + ++ H+N
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIRE----VSLLKELQHRN 94
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
++ L + + L++EY N L + + P+ + + G+ + H
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSR 151
Query: 630 CEAPIIHCDIKPQNILMDEFWTA-----KISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
+H D+KPQN+L+ + KI DFGLA+ R FT T Y PE
Sbjct: 152 R---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQFTHEIITLWYRPPE 207
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 84.2 bits (207), Expect = 2e-18
Identities = 32/238 (13%), Positives = 70/238 (29%), Gaps = 48/238 (20%)
Query: 69 IWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSAS 128
I + + T + S+ T+ D L+L + + A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLF-DSDVRVWASNTAGATGCRAV 61
Query: 129 MLDSGNFVLYNNRSDIIWSS-------------------------------------FKI 151
+ G V+ ++ I WSS
Sbjct: 62 LQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVA 121
Query: 152 PTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASD 211
+ + N + + S +RL+M+ D NLVL+ D + W+++
Sbjct: 122 NNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLF------DRDDRVWSTN 175
Query: 212 SQ-RERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSH 268
+ + L G + +L + + + S ++ S+ + + L ++
Sbjct: 176 TAGKGTGCRAVLQPNGRMDVLTNQNIAV---WTSGNSRSAGRYVFVLQPDRNLAIYGG 230
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 56.9 bits (136), Expect = 5e-09
Identities = 24/132 (18%), Positives = 42/132 (31%), Gaps = 37/132 (28%)
Query: 81 WTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAG--KSEPASSASMLDSGNFVLY 138
T + S L++ D L+L + D+V + A + +G +
Sbjct: 139 QTLHATQSLQLSPYRLSMETDCNLVLF--DRDDRVWSTNTAGKGTGCRAVLQPNGRMDVL 196
Query: 139 NNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPIN 198
N++ +W+S S S GR+ +Q D NL +
Sbjct: 197 TNQNIAVWTS-------------------------GNSRSAGRYVFVLQPDRNLAI---- 227
Query: 199 TIDDYTEAYWAS 210
Y A W +
Sbjct: 228 ----YGGALWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 56.5 bits (135), Expect = 5e-09
Identities = 34/167 (20%), Positives = 54/167 (32%), Gaps = 23/167 (13%)
Query: 144 IIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDY 203
I++ + Q+L A L FR MQ D NLVL+ D
Sbjct: 3 ILFG----LSHEGSHPQTLHAAQSL---------ELSSFRFTMQSDCNLVLF------DS 43
Query: 204 TEAYWASDSQRERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGIL 263
WAS++ L + G LV+L I + S + S L + + +
Sbjct: 44 DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIR---WSSGTKGSIGNYVLVLQPDRTV 100
Query: 264 RLF-SHYPVPKGAYNTSVDWNVPDDLCEVKTFCGLNSYCTLYDDQPM 309
++ + SV + T N TL+ Q +
Sbjct: 101 TIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSL 147
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 50/187 (26%), Positives = 82/187 (43%), Gaps = 30/187 (16%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE------FRAEMHVIGRTHHKNL 570
++G+G+FG V+K K + VA+KK+ M E E+E R E+ ++ H+N+
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV-LM--ENEKEGFPITALR-EIKILQLLKHENV 78
Query: 571 VRLIGYCAEDSKRL--------LVYEYMSNGSLADI--LFRGPERSLGWDERVRIASDVA 620
V LI C + LV+++ + D+ L E R+ +
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 621 KGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL---MPDQTRTFTLVRGT 677
G+ Y+H I+H D+K N+L+ K++DFGLA+ Q +T T
Sbjct: 135 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 678 RGYMAPE 684
Y PE
Sbjct: 192 LWYRPPE 198
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 512 TNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTH 566
R++ + +G G+ G V E+ VA+KKL + T +R +R E+ ++ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 82
Query: 567 HKNLVRLIG-YCAEDSKRL-----LVYEYMSNGSLADILFRGPERSLGWDERVR-IASDV 619
HKN++ L+ + + S +V E M +L ++ + ER+ + +
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI-----QMELDHERMSYLLYQM 136
Query: 620 AKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG 679
GI +LH A IIH D+KP NI++ T KI DFGLA+ T TR
Sbjct: 137 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRY 191
Query: 680 YMAPEWYKNTPISVKADVFSYGVVLLEIV 708
Y APE D++S G ++ E++
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMI 220
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 26/203 (12%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE-----REFRAEMHVIGRTHHKNLV 571
++LG+G++ VYKG + LVA+K++ EG RE + ++ H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANIV 63
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
L + LV+EY+ L L + + +G+ Y H +
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYCHRQK- 120
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE------W 685
++H D+KPQN+L++E K++DFGLA+ T+T+ T Y P+
Sbjct: 121 --VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 686 YKNTPISVKADVFSYGVVLLEIV 708
Y +T I D++ G + E+
Sbjct: 178 Y-STQI----DMWGVGCIFYEMA 195
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 35/217 (16%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE------------REFRAEMHV 561
+ + GS+GAV G +G VA+K++ V++G R R E+ +
Sbjct: 25 TVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVLR-EIRL 82
Query: 562 IGRTHHKNLVRL----IGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVR-I 615
+ HH N++ L + + +L LV E M LA ++ + + ++
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI-HDQRIVIS-PQHIQYF 139
Query: 616 ASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVR 675
+ G+ LH+ A ++H D+ P NIL+ + I DF LA+ D +T +
Sbjct: 140 MYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT- 195
Query: 676 GTRGYMAPE----WYKNTPISVKADVFSYGVVLLEIV 708
R Y APE + T D++S G V+ E+
Sbjct: 196 -HRWYRAPELVMQFKGFTK---LVDMWSAGCVMAEMF 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 48/212 (22%), Positives = 89/212 (41%), Gaps = 27/212 (12%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVK---KLEKMVTEGEREFR-------AEMHVIGRTH 566
+LG G F V+ VA+K + E E + A+
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 567 HKNLVRLIG---YCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKG 622
++++L+ + + + +V+E + +L ++ + R + +I+ + G
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDE------FWTAKISDFGLAKLLMPDQTRTFTLVRG 676
+ Y+H C IIH DIKP+N+LM+ KI+D G A D+ T ++
Sbjct: 144 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSIQ-- 197
Query: 677 TRGYMAPEWYKNTPISVKADVFSYGVVLLEIV 708
TR Y +PE P AD++S ++ E++
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELI 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 512 TNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTH 566
R++ + +G G+ G V ++ VA+KKL + T +R +R E+ ++ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 119
Query: 567 HKNLVRLI-----GYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVR-IASDV 619
HKN++ L+ E+ + + LV E M + +L ++ + ER+ + +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQM 173
Query: 620 AKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG 679
GI +LH A IIH D+KP NI++ T KI DFGLA+ T +V TR
Sbjct: 174 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 228
Query: 680 YMAPEWYKNTPISVKADVFSYGVVLLEIV 708
Y APE D++S G ++ E+V
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMV 257
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 31/212 (14%)
Query: 512 TNRFK--EELGKGSFGAVYKGTLYKGEKLVAVK---KLEKMVTEGEREFR--AEMHVIGR 564
R++ + +GKGSFG V K +K + VA+K ++ + E R + +
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDK 155
Query: 565 THHKNLVRLIGY-------CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIAS 617
+ N++ ++ C + +E +S +L +++ + + + A
Sbjct: 156 DNTMNVIHMLENFTFRNHIC-------MTFELLSM-NLYELIKKNKFQGFSLPLVRKFAH 207
Query: 618 DVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTA--KISDFGLAKLLMPDQTRTFTLVR 675
+ + + LH IIHCD+KP+NIL+ + + K+ DFG + Q +
Sbjct: 208 SILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQ- 261
Query: 676 GTRGYMAPEWYKNTPISVKADVFSYGVVLLEI 707
+R Y APE + D++S G +L E+
Sbjct: 262 -SRFYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 48/233 (20%), Positives = 85/233 (36%), Gaps = 50/233 (21%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGY 576
+ LG GSFG V + + K A+KK+ + + + R E+ ++ H N+++L+ Y
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQ---DPRYKNR-ELDIMKVLDHVNIIKLVDY 68
Query: 577 CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDV----------------- 619
+ + V + +
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 620 ----------------------AKGILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISD 656
+ + ++H I H DIKPQN+L++ + T K+ D
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 657 FGLAKLLMPDQTRTFTLVRGTRGYMAPE-WYKNTPISVKADVFSYGVVLLEIV 708
FG AK L+P + + +R Y APE T + D++S G V E++
Sbjct: 186 FGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 33/213 (15%)
Query: 512 TNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTH 566
+ +G G++G+V + + VA+KKL + +R +R E+ ++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQ 81
Query: 567 HKNLVRLI-----GYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVR-IASDV 619
H+N++ L+ + LV +M L I+ +E+++ + +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM-----GLKFSEEKIQYLVYQM 135
Query: 620 AKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG 679
KG+ Y+H A ++H D+KP N+ ++E KI DFGLA+ + T TR
Sbjct: 136 LKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRW 188
Query: 680 YMAPE----WYKNTPISVKADVFSYGVVLLEIV 708
Y APE W D++S G ++ E++
Sbjct: 189 YRAPEVILSWMHYNQ---TVDIWSVGCIMAEML 218
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 50/192 (26%), Positives = 82/192 (42%), Gaps = 29/192 (15%)
Query: 513 NRFKEELGKGSFGAVYKGT--LYKGEKLVAVKKLEKMVTEGEREFRA--EMHVIGRTHHK 568
++G+G++G VYK K +K A+K++E G A E+ ++ H
Sbjct: 23 EYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TG-ISMSACREIALLRELKHP 78
Query: 569 NLVRLIGYCAEDSKRL--LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAK----- 621
N++ L + R L+++Y + L I+ + S + V++ + K
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEH-DLWHII-KFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 622 ---GILYLHDECEAPIIHCDIKPQNILMDEFWTA----KISDFGLAKLL-MPDQTRT-FT 672
GI YLH ++H D+KP NIL+ KI+D G A+L P +
Sbjct: 137 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193
Query: 673 LVRGTRGYMAPE 684
V T Y APE
Sbjct: 194 PVVVTFWYRAPE 205
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 38/164 (23%), Positives = 77/164 (46%), Gaps = 33/164 (20%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNL 570
+ +G GS+G V + +++VA+KK+ ++ + + +R R E+ ++ R +H ++
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHV 114
Query: 571 VRL----IGYCAEDSKRL-LVYEYM---------SNGSLADILFRGPERSLGWDERVRIA 616
V++ I E L +V E + L ++ + +
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK------------TLL 162
Query: 617 SDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA 660
++ G+ Y+H A I+H D+KP N L+++ + K+ DFGLA
Sbjct: 163 YNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 53/251 (21%), Positives = 94/251 (37%), Gaps = 44/251 (17%)
Query: 553 REFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDER 612
R+ + + I + L + + S + + +S+ + + L +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195
Query: 613 VRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672
+ + VAKG+ +L IH D+ +NIL+ E KI DFGLA+ + D
Sbjct: 196 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----D 248
Query: 673 LVRGTRG-----YMAPEWYKNTPISVKADVFSYGVVLLEIVC--------CRRNMEIDPS 719
VR +MAPE + ++++DV+S+GV+L EI + + E
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--- 305
Query: 720 KPEEIVLINWAYKCFIDRELNKLVRGQEVDR--NTLENMIKIGLWCVQDEPALRPSMKSV 777
+L G + T M + L C EP+ RP+ +
Sbjct: 306 -------------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 346
Query: 778 VLMLEGITDIS 788
V L + +
Sbjct: 347 VEHLGNLLQAN 357
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 38/160 (23%), Positives = 65/160 (40%), Gaps = 17/160 (10%)
Query: 514 RFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGER-EFRAEMHV-IGRTH 566
+ + LG+G+FG V + + + VAVK L++ T E +E+ + I H
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 567 HKNLVRLIGYCAEDSKRLLV-YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILY 625
H N+V L+G C + L+V E+ G+L+ L +R KG +
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARF 135
Query: 626 LHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665
+ I D+K + + ++ S F K L
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNL 570
R + +G G++GAV + VA+KKL + +R +R E+ ++ H+N+
Sbjct: 28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENV 86
Query: 571 VRLI-----GYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGIL 624
+ L+ +D LV +M L ++ LG D + + KG+
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK---LGEDRIQFLVYQMLKGLR 142
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
Y+H A IIH D+KP N+ ++E KI DFGLA+ + T TR Y APE
Sbjct: 143 YIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV----TRWYRAPE 195
Query: 685 ----WYKNTPISVKADVFSYGVVLLEIV 708
W + T D++S G ++ E++
Sbjct: 196 VILNWMRYTQ---TVDIWSVGCIMAEMI 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 8e-15
Identities = 49/201 (24%), Positives = 87/201 (43%), Gaps = 38/201 (18%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNL 570
K +G+GS+G VY EK VA+KK+ +M + + +R R E+ ++ R +
Sbjct: 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYI 87
Query: 571 VRLIG-YCAEDSKRL----LVYEYMSNGSLADILFRGPERSLGWDERVR-IASDVAKGIL 624
+RL +D + +V E + L + + +E ++ I ++ G
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLT---EEHIKTILYNLLLGEN 143
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRG-------- 676
++H E+ IIH D+KP N L+++ + K+ DFGLA+ + ++
Sbjct: 144 FIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 677 -------------TRGYMAPE 684
TR Y APE
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPE 221
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 44/229 (19%)
Query: 496 YESNLRSFS----YNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG 551
YES++ + Y ++K LG+G + V++ + V VK L K V +
Sbjct: 25 YESHVVEWGNQDDYQLVRK--------LGRGKYSEVFEAINITNNEKVVVKIL-KPVKKK 75
Query: 552 E--REFRAEMHVIGRTHHKNLVRLIG-YCAEDSKRL-LVYEYMSNGSLADILFRGPERSL 607
+ RE + ++ G N++ L S+ LV+E+++N + ++L
Sbjct: 76 KIKREIKILENLRG---GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTL 127
Query: 608 GWDERVR-IASDVAKGILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISDFGLAKLLMP 665
D +R ++ K + Y H I+H D+KP N+++D E ++ D+GLA+ P
Sbjct: 128 T-DYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183
Query: 666 DQTRTFTLVRGTRGYMAPE------WYKNTPISVKADVFSYGVVLLEIV 708
Q + +R + PE Y + + D++S G +L ++
Sbjct: 184 GQEYNVRVA--SRYFKGPELLVDYQMY-DYSL----DMWSLGCMLASMI 225
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 21/179 (11%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLI 574
+G+G++G V + VA+KK+ T +R R E+ ++ R H+N++ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 91
Query: 575 GYCAEDSKRL-----LVYEYMSNGSLADILFRGPERSLGWDERVR-IASDVAKGILYLHD 628
+ +V + M L +L L ++ + + +G+ Y+H
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH---LS-NDHICYFLYQILRGLKYIHS 146
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL---VRGTRGYMAPE 684
A ++H D+KP N+L++ KI DFGLA++ PD T L V TR Y APE
Sbjct: 147 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV-ATRWYRAPE 201
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 32/213 (15%)
Query: 512 TNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTH 566
R++ +G G++G+V K VAVKKL + + +R +R E+ ++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK 86
Query: 567 HKNLVRLI-----GYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVR-IASDV 619
H+N++ L+ E+ + LV M L +I+ L D+ V+ + +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK---LT-DDHVQFLIYQI 141
Query: 620 AKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG 679
+G+ Y+H A IIH D+KP N+ ++E KI DFGLA+ + T TR
Sbjct: 142 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA----TRW 194
Query: 680 YMAPE----WYKNTPISVKADVFSYGVVLLEIV 708
Y APE W D++S G ++ E++
Sbjct: 195 YRAPEIMLNWMHYNQ---TVDIWSVGCIMAELL 224
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 39/226 (17%)
Query: 512 TNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLE-KMVTEGEREFRAEMHVIGRTHHK 568
+R+ + LG G G V+ +K VA+KK+ + R E+ +I R H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHD 68
Query: 569 NLVRLI-------------GYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVR 614
N+V++ + + +V EYM LA++L +GP L +E R
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGP---LL-EEHAR 123
Query: 615 -IASDVAKGILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISDFGLAKLLMPDQTRTFT 672
+ +G+ Y+H A ++H D+KP N+ ++ E KI DFGLA+++ P +
Sbjct: 124 LFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 673 L---VRGTRGYMAPE----WYKNTPISVKADVFSYGVVLLEIVCCR 711
L + T+ Y +P T D+++ G + E++ +
Sbjct: 181 LSEGL-VTKWYRSPRLLLSPNNYTK---AIDMWAAGCIFAEMLTGK 222
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-14
Identities = 21/132 (15%), Positives = 39/132 (29%), Gaps = 34/132 (25%)
Query: 84 YRDDPPVSSNAALTLTKDGKLILRTEEGHD-KVVAAGKSEPASSASMLDSGNFVLYNNRS 142
Y + +D L+L + A + GNFV+Y+
Sbjct: 11 YAGQSLDVEPYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEG 70
Query: 143 DIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDD 202
+W+S + G + L +Q DGN+V+
Sbjct: 71 RSLWAS-------------------------HSVRGNGNYVLVLQEDGNVVI-------- 97
Query: 203 YTEAYWASDSQR 214
Y W++ + +
Sbjct: 98 YGSDIWSTGTYK 109
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 8e-13
Identities = 26/117 (22%), Positives = 47/117 (40%), Gaps = 20/117 (17%)
Query: 154 DTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDS- 212
+ + + L AG L + MQ D NLVLY D++ + WAS++
Sbjct: 2 NLLTNGEGLYAGQSLDV---------EPYHFIMQEDCNLVLY------DHSTSVWASNTG 46
Query: 213 -QRERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSH 268
++ L + GN V+ D + L+ S S + L + +G + ++
Sbjct: 47 ILGKKGCKAVLQSDGNFVVYDAEG---RSLWASHSVRGNGNYVLVLQEDGNVVIYGS 100
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 6e-07
Identities = 25/111 (22%), Positives = 37/111 (33%), Gaps = 31/111 (27%)
Query: 126 SASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLN 185
M + N VLY++ S +W+S +
Sbjct: 22 HFIMQEDCNLVLYDH-STSVWASN------------------------TGILGKKGCKAV 56
Query: 186 MQRDGNLVLYPINTIDDYTEAYWASDSQRER-QLHLYLSNTGNLVLLDDSM 235
+Q DGN V+Y D + WAS S R L L GN+V+ +
Sbjct: 57 LQSDGNFVVY-----DAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSDI 102
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.8 bits (177), Expect = 3e-14
Identities = 42/247 (17%), Positives = 76/247 (30%), Gaps = 24/247 (9%)
Query: 32 IGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAG------FKVGIWLLTFPDITIVWTAYR 85
+ +LS S F+ Q G +W+ R
Sbjct: 17 LPAYQTLSA---GQYLLSPNQRFKLLL--QGDGNLVIQDNGATVWVANEQQPFSSTIPLR 71
Query: 86 DDP-PVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLYNNRSDI 144
+ P++ D R + + + + D GN VL ++ +
Sbjct: 72 NKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSLALW 131
Query: 145 IWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYT 204
+ + + L G+EL + G +L Q DGNLV Y
Sbjct: 132 NGTPAIPLVPGAIDSLLLAPGSELVQGVV---YGAGASKLVFQGDGNLVAY-----GPNG 183
Query: 205 EAYWASDSQRERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILR 264
A W + +Q + + GNLV+ ++ + S + + L + NG +
Sbjct: 184 AATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVL---WHSHTGGHA-SAVLRLQANGSIA 239
Query: 265 LFSHYPV 271
+ PV
Sbjct: 240 ILDEKPV 246
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 52.0 bits (123), Expect = 2e-07
Identities = 21/174 (12%), Positives = 44/174 (25%), Gaps = 33/174 (18%)
Query: 54 FQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHD 113
+ + + + + + + L DG L+ G
Sbjct: 126 DSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDGNLVAYGPNGAA 185
Query: 114 KVVAAGKSEPASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRIS 173
A + + A A GN V+Y + ++W S
Sbjct: 186 TWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSH------------------------ 221
Query: 174 ETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQRERQLHLYLSNTGN 227
+ L +Q +G++ + + WA + H+ N
Sbjct: 222 --TGGHASAVLRLQANGSIAILDEKPV-------WARFGFQPTYRHIRKINPDQ 266
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.4 bits (119), Expect = 7e-07
Identities = 31/168 (18%), Positives = 52/168 (30%), Gaps = 13/168 (7%)
Query: 146 WSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTI---DD 202
+ T + Q+L AG L S RF+L +Q DGNLV+ +
Sbjct: 7 IPFNGVGTSVLPAYQTLSAGQYL-------LSPNQRFKLLLQGDGNLVIQDNGATVWVAN 59
Query: 203 YTEAYWASDSQRERQLHLYLSNTGNLVLLDDSMGIIKDLYES--PSNNSSIIRRLTIGHN 260
+ + ++ R ++ L L D S + S SN+ L + +
Sbjct: 60 EQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDD 119
Query: 261 GILRLFSHYPVPKGAYNTSVDWNVPDDLCEVKTFCGLNSYCTLYDDQP 308
G + L + G + D L + L
Sbjct: 120 GNIVLVDSLALWNGTPAIPLVPGAIDSLL-LAPGSELVQGVVYGAGAS 166
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 43/188 (22%), Positives = 79/188 (42%), Gaps = 26/188 (13%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLV 571
+ K LG+G++G V T ++VA+KK+E R R E+ ++ H+N++
Sbjct: 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENII 72
Query: 572 RLIG-YCAEDSKRL----LVYEYMSNGSLADILFRGPERSLGWDERVR-IASDVAKGILY 625
+ + + ++ E M L ++ S D+ ++ + +
Sbjct: 73 TIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-STQMLS---DDHIQYFIYQTLRAVKV 127
Query: 626 LHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRG--------- 676
LH + +IH D+KP N+L++ K+ DFGLA+++
Sbjct: 128 LHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 677 TRGYMAPE 684
TR Y APE
Sbjct: 185 TRWYRAPE 192
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 6e-14
Identities = 26/116 (22%), Positives = 46/116 (39%), Gaps = 19/116 (16%)
Query: 154 DTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDS- 212
+ +L Q+L A + L + G + L +Q NLV Y WAS++
Sbjct: 3 NVLLSGQTLHADHSLQA---------GAYTLTIQNKCNLVKY------QNGRQIWASNTD 47
Query: 213 QRERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSH 268
+R L L + GNLV+ D + + + S + L + +G ++
Sbjct: 48 RRGSGCRLTLLSDGNLVIYDHNNNDV---WGSACWGDNGKYALVLQKDGRFVIYGP 100
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 2e-10
Identities = 20/135 (14%), Positives = 41/135 (30%), Gaps = 33/135 (24%)
Query: 84 YRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLYNNRSD 143
+ D + LT+ L+ + ++L GN V+Y++ ++
Sbjct: 12 HADHSLQAGAYTLTIQNKCNLVKYQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNN 71
Query: 144 IIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDY 203
+W S G++ L +Q+DG V+ Y
Sbjct: 72 DVWG-------------------------SACWGDNGKYALVLQKDGRFVI--------Y 98
Query: 204 TEAYWASDSQRERQL 218
W+ R++
Sbjct: 99 GPVLWSLGPNGCRRV 113
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 23/110 (20%), Positives = 32/110 (29%), Gaps = 32/110 (29%)
Query: 126 SASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLN 185
+ ++ + N V Y N IW+S T RL
Sbjct: 23 TLTIQNKCNLVKYQNGR-QIWASN-------------------------TDRRGSGCRLT 56
Query: 186 MQRDGNLVLYPINTIDDYTEAYWASDSQRERQ-LHLYLSNTGNLVLLDDS 234
+ DGNLV+Y D W S + L L G V+
Sbjct: 57 LLSDGNLVIY-----DHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV 101
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 7e-14
Identities = 27/116 (23%), Positives = 41/116 (35%), Gaps = 20/116 (17%)
Query: 153 TDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDS 212
+D + L G L G + +Q D NLVLY N A WAS +
Sbjct: 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDNNR------AVWASGT 45
Query: 213 -QRERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFS 267
+ L + N GNLV+ S I + N L + + + ++
Sbjct: 46 NGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNY----YLILQRDRNVVIYD 97
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 8e-09
Identities = 25/131 (19%), Positives = 39/131 (29%), Gaps = 31/131 (23%)
Query: 84 YRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLYNNRSD 143
+ D L+L M + GN V+Y+ S
Sbjct: 11 DTGGSLAEGGYLFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-SR 69
Query: 144 IIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDY 203
IW+S T+ G + L +QRD N+V+Y D+
Sbjct: 70 AIWASN-------------------------TNRQNGNYYLILQRDRNVVIY-----DNS 99
Query: 204 TEAYWASDSQR 214
A WA+ +
Sbjct: 100 NNAIWATHTNV 110
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 7e-07
Identities = 16/82 (19%), Positives = 31/82 (37%), Gaps = 7/82 (8%)
Query: 78 TIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSASMLDSGNFVL 137
VW + +S L + DG L++ + + + N V+
Sbjct: 38 RAVWASGT--NGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVI 95
Query: 138 YNNRSDIIWSSFKIPTDTILGN 159
Y+N ++ IW++ T +GN
Sbjct: 96 YDNSNNAIWAT-----HTNVGN 112
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-13
Identities = 24/111 (21%), Positives = 39/111 (35%), Gaps = 11/111 (9%)
Query: 159 NQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASD-SQRERQ 217
N LL G+ + ++ S MQ D NLVLY + S+ R
Sbjct: 2 NNVLLTGDVI---HTDNQLSYESAAFVMQGDCNLVLYNEAGG-------FQSNTHGRGVD 51
Query: 218 LHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSH 268
L L+N G L + + +Y N T+G + + ++
Sbjct: 52 CTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYGP 102
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-06
Identities = 14/133 (10%), Positives = 37/133 (27%), Gaps = 37/133 (27%)
Query: 84 YRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASS--ASMLDSGNFVLYNNR 141
+ D+ +AA + D L+L + + + G +++
Sbjct: 12 HTDNQLSYESAAFVMQGDCNLVL---YNEAGGFQSNTHGRGVDCTLRLNNRGQLEIHSAN 68
Query: 142 SD-IIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTI 200
S+ +W ++ G + + D ++ +
Sbjct: 69 SNTPVWVY-----------------------PRSVNTVRGNYAATLGPDQHVTI------ 99
Query: 201 DDYTEAYWASDSQ 213
Y A W++ +
Sbjct: 100 --YGPAIWSTPAA 110
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 39/216 (18%)
Query: 512 TNRFK--EELGKGSFGAVYKGTLYKGEKLVAVK---KLEKMVTEGEREFR--AEMHVIGR 564
+R++ +GKGSFG V K ++ VA+K + + + + E R M+
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 565 THHKNLVRLIGY-------CAEDSKRLLVYEYMSNGSLADIL----FRGPERSLGWDERV 613
+V L + C LV+E +S +L D+L FRG +L
Sbjct: 113 EMKYYIVHLKRHFMFRNHLC-------LVFEMLSY-NLYDLLRNTNFRGVSLNL-----T 159
Query: 614 R-IASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTA--KISDFGLAKLLMPDQTRT 670
R A + +L+L E IIHCD+KP+NIL+ + KI DFG + L Q
Sbjct: 160 RKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 216
Query: 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLE 706
+ +R Y +PE P + D++S G +L+E
Sbjct: 217 QYIQ--SRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 2e-13
Identities = 28/127 (22%), Positives = 47/127 (37%), Gaps = 19/127 (14%)
Query: 142 SDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTID 201
++II+S Q L A L E T +R MQ D NLVLY N
Sbjct: 1 NNIIFSKQPDDN----HPQILHATESL-----EILFGTHVYRFIMQTDCNLVLYDNNN-- 49
Query: 202 DYTEAYWASDSQ-RERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHN 260
WA+++ L G LV++ + + ++SP + L + +
Sbjct: 50 ----PIWATNTGGLGNGCRAVLQPDGVLVVITNENVTV---WQSPVAGKAGHYVLVLQPD 102
Query: 261 GILRLFS 267
+ ++
Sbjct: 103 RNVVIYG 109
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 1e-12
Identities = 21/124 (16%), Positives = 36/124 (29%), Gaps = 33/124 (26%)
Query: 91 SSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLYNNRSDIIWSSFK 150
+ + D L+L G A + G V+ N + +W
Sbjct: 29 THVYRFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQ--- 85
Query: 151 IPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWAS 210
S + G + L +Q D N+V+ Y +A WA+
Sbjct: 86 ----------------------SPVAGKAGHYVLVLQPDRNVVI--------YGDALWAT 115
Query: 211 DSQR 214
+ R
Sbjct: 116 QTVR 119
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 5e-07
Identities = 25/132 (18%), Positives = 43/132 (32%), Gaps = 38/132 (28%)
Query: 111 GHDKVVAAGKSEPASSAS------MLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLA 164
H +++ A +S + M N VLY+N ++ IW++
Sbjct: 12 NHPQILHATESLEILFGTHVYRFIMQTDCNLVLYDN-NNPIWATN--------------- 55
Query: 165 GNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQ-RERQLHLYLS 223
T R +Q DG LV+ + W S + L L
Sbjct: 56 ----------TGGLGNGCRAVLQPDGVLVVI-----TNENVTVWQSPVAGKAGHYVLVLQ 100
Query: 224 NTGNLVLLDDSM 235
N+V+ D++
Sbjct: 101 PDRNVVIYGDAL 112
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-13
Identities = 21/124 (16%), Positives = 41/124 (33%), Gaps = 33/124 (26%)
Query: 89 PVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLYNNRSDIIWSS 148
V + L + D +L G ++ ++GN V+Y+ + +IW
Sbjct: 17 EVGPSYRLIMQGDCNFVLYDSGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQ- 75
Query: 149 FKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYW 208
++T+ + L +Q+D N+V+ Y W
Sbjct: 76 ------------------------TKTNGKEDHYVLVLQQDRNVVI--------YGPVVW 103
Query: 209 ASDS 212
A+ S
Sbjct: 104 ATGS 107
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 9e-13
Identities = 29/115 (25%), Positives = 48/115 (41%), Gaps = 18/115 (15%)
Query: 154 DTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDS- 212
+++ SL G+ L +RL MQ D N VLY D + WAS++
Sbjct: 2 NSLSSPNSLFTGHSL--------EVGPSYRLIMQGDCNFVLY------DSGKPVWASNTG 47
Query: 213 QRERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFS 267
L L N GNLV+ D S +I +++ +N L + + + ++
Sbjct: 48 GLGSGCRLTLHNNGNLVIYDQSNRVI---WQTKTNGKEDHYVLVLQQDRNVVIYG 99
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-13
Identities = 25/118 (21%), Positives = 42/118 (35%), Gaps = 20/118 (16%)
Query: 152 PTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASD 211
+ + Q L L + +L MQ D NLVLY W S+
Sbjct: 5 TNNLLFSGQVLYGDGRLTA---------KNHQLVMQGDCNLVLYGGKYG-------WQSN 48
Query: 212 SQ-RERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSH 268
+ L L++ G L++ DD I + S S++ L + +G ++
Sbjct: 49 THGNGEHCFLRLNHKGELIIKDDDFKTI---WSSRSSSKQGEYVLILQDDGFGVIYGP 103
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 9e-12
Identities = 25/129 (19%), Positives = 41/129 (31%), Gaps = 34/129 (26%)
Query: 84 YRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLYNNRSD 143
Y D + N L + D L+L + + G E + G ++ ++
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLYGGKYGWQSNTHGNGEHCF-LRLNHKGELIIKDDDFK 74
Query: 144 IIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDY 203
IWSS +SS G + L +Q DG V+ Y
Sbjct: 75 TIWSS-------------------------RSSSKQGEYVLILQDDGFGVI--------Y 101
Query: 204 TEAYWASDS 212
A + + S
Sbjct: 102 GPAIFETSS 110
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 40/200 (20%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGR-THHKN 569
++LGKG++G V+K + ++VAVKK+ T+ +R FR E+ ++ + H+N
Sbjct: 12 ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHEN 70
Query: 570 LVRLIG-YCAEDSKRL-LVYEYMSNGSLADI--LFRGPERSLGWDERVR-IASDVAKGIL 624
+V L+ A++ + + LV++YM D+ + R + + + K I
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYME----TDLHAVIRANILE---PVHKQYVVYQLIKVIK 123
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRG-------- 676
YLH ++H D+KP NIL++ K++DFGL++ + + T +
Sbjct: 124 YLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 677 ------------TRGYMAPE 684
TR Y APE
Sbjct: 181 DDDQPILTDYVATRWYRAPE 200
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 4e-13
Identities = 30/113 (26%), Positives = 46/113 (40%), Gaps = 16/113 (14%)
Query: 157 LGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQ-RE 215
LG LL+G L + E G F L MQ D NLVLY W S++
Sbjct: 1 LGTNYLLSGQTLDT---EGHLKNGDFDLVMQDDCNLVLY---------NGNWQSNTANNG 48
Query: 216 RQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSH 268
R L L++ G LV+ + + ++S + + + +G L +F
Sbjct: 49 RDCKLTLTDYGELVIKNGDGSTV---WKSGAQSVKGNYAAVVHPDGRLVVFGP 98
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-08
Identities = 18/123 (14%), Positives = 33/123 (26%), Gaps = 36/123 (29%)
Query: 90 VSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLYNNRSDIIWSSF 149
+ + L + D L+L G+ ++ D G V+ N +W
Sbjct: 19 KNGDFDLVMQDDCNLVLYNGNWQSNTANNGRD---CKLTLTDYGELVIKNGDGSTVWK-- 73
Query: 150 KIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWA 209
S S G + + DG LV+ + + +
Sbjct: 74 -----------------------SGAQSVKGNYAAVVHPDGRLVV--------FGPSVFK 102
Query: 210 SDS 212
D
Sbjct: 103 IDP 105
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 45/207 (21%), Positives = 82/207 (39%), Gaps = 23/207 (11%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG---EREFRAEMHVIGRTHHKNL 570
+ +G+GSFG +++GT + VA+K E ++ E+R + G T +
Sbjct: 13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTG---I 68
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
+ + E +LV + + SL D L R A + + +H++
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGP-SLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 631 EAPIIHCDIKPQNILMDEFWTAK-----ISDFGLAKLLMPDQT------RTFTLVRGTRG 679
+++ DIKP N L+ + + DFG+ K T R + GT
Sbjct: 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 680 YMAPEWYKNTPISVKADVFSYGVVLLE 706
YM+ + S + D+ + G V +
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMY 210
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 27/211 (12%)
Query: 513 NRFK--EELGKGSFGAVYKGT-LYKGEKLVAVKKLEKMVTEG---EREFRAEMHVIGRTH 566
F+ +++G G+FG + G LY E VA+K LE M + E+R +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEY-VAIK-LEPMKSRAPQLHLEYRFYKQLGSGDG 66
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
+ ++ + +V E + SL D LF +R+ + IA + + Y+
Sbjct: 67 ---IPQVYYFGPCGKYNAMVLELLGP-SLED-LFDLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAK-----ISDFGLAKLLMPDQT------RTFTLVR 675
H + +I+ D+KP+N L+ I DF LAK + +T R +
Sbjct: 122 HSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178
Query: 676 GTRGYMAPEWYKNTPISVKADVFSYGVVLLE 706
GT YM+ + S + D+ + G + +
Sbjct: 179 GTARYMSINTHLGKEQSRRDDLEALGHMFMY 209
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-12
Identities = 21/118 (17%), Positives = 44/118 (37%), Gaps = 17/118 (14%)
Query: 152 PTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASD 211
+ + +Q + +L + + L M+ D NLVL + + W S
Sbjct: 5 VRNVLFSSQVMYDNAQLAT---------RDYSLVMRDDCNLVLTKGSKTN----IVWESG 51
Query: 212 SQ-RERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSH 268
+ R + + L ++G L + DD + + + S + L + NG ++
Sbjct: 52 TSGRGQHCFMRLGHSGELDITDDRLNTV---FVSNTVGQEGDYVLILQINGQAVVYGP 106
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 2e-11
Identities = 20/131 (15%), Positives = 42/131 (32%), Gaps = 35/131 (26%)
Query: 84 YRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAG--KSEPASSASMLDSGNFVLYNNR 141
Y + + + +L + D L+L + V +G + SG + ++R
Sbjct: 16 YDNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR 75
Query: 142 SDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTID 201
+ ++ S T G + L +Q +G V+
Sbjct: 76 LNTVFV-------------------------SNTVGQEGDYVLILQINGQAVV------- 103
Query: 202 DYTEAYWASDS 212
Y A W++ +
Sbjct: 104 -YGPAVWSTAA 113
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 7e-12
Identities = 24/115 (20%), Positives = 48/115 (41%), Gaps = 19/115 (16%)
Query: 154 DTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDS- 212
+ + ++L G L + GR+ MQ D NLVLY ++ WA+++
Sbjct: 2 NILYSGETLSPGEFL---------NNGRYVFIMQEDCNLVLYDVDK------PIWATNTG 46
Query: 213 QRERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFS 267
+R+ HL + + GNLV+ I + S + + + + + ++
Sbjct: 47 GLDRRCHLSMQSDGNLVVYSPRNNPI---WASNTGGENGNYVCVLQKDRNVVIYG 98
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 1e-11
Identities = 24/129 (18%), Positives = 43/129 (33%), Gaps = 33/129 (25%)
Query: 84 YRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLYNNRSD 143
+ + + +D L+L + G + SM GN V+Y+ R++
Sbjct: 11 SPGEFLNNGRYVFIMQEDCNLVLYDVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNN 70
Query: 144 IIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDY 203
IW+ S T G + +Q+D N+V+ Y
Sbjct: 71 PIWA-------------------------SNTGGENGNYVCVLQKDRNVVI--------Y 97
Query: 204 TEAYWASDS 212
A WA+ +
Sbjct: 98 GTARWATGT 106
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-06
Identities = 25/110 (22%), Positives = 36/110 (32%), Gaps = 32/110 (29%)
Query: 126 SASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLN 185
M + N VLY+ IW++ T R L+
Sbjct: 22 VFIMQEDCNLVLYDV-DKPIWATN-------------------------TGGLDRRCHLS 55
Query: 186 MQRDGNLVLYPINTIDDYTEAYWASDSQRER-QLHLYLSNTGNLVLLDDS 234
MQ DGNLV+Y WAS++ E L N+V+ +
Sbjct: 56 MQSDGNLVVY-----SPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA 100
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 513 NRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG---EREFRAEMHVIGRTHH 567
NR++ ++G GSFG +Y GT + VA+K E + T+ E + + G
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVG- 66
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLH 627
+ + AE ++V E + SL D LF R + +A + I Y+H
Sbjct: 67 --IPTIRWCGAEGDYNVMVMELLGP-SLED-LFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 628 DECEAPIIHCDIKPQNILMDEFWTAK---ISDFGLAKLLMPDQT------RTFTLVRGTR 678
+ IH D+KP N LM I DFGLAK +T R + GT
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 679 GYMAPEWYKNTPISVKADVFSYGVVLLE 706
Y + + S + D+ S G VL+
Sbjct: 180 RYASINTHLGIEQSRRDDLESLGYVLMY 207
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 45/229 (19%), Positives = 81/229 (35%), Gaps = 49/229 (21%)
Query: 512 TNRFK--EELGKGSFGAVYKGT-LYKGEKLVAVK---KLEKMVTEGEREFR--AEMHVIG 563
R++ LG+G+FG V + +G+ VA+K + K E ++
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKD 77
Query: 564 RTHHKNLVRLIGY-------CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIA 616
+ + V + + C + +E + + + L + +A
Sbjct: 78 KENKFLCVLMSDWFNFHGHMC-------IAFELLGK-NTFEFLKENNFQPYPLPHVRHMA 129
Query: 617 SDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTA-------------------KISDF 657
+ + +LH+ + H D+KP+NIL +++DF
Sbjct: 130 YQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 658 GLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLE 706
G A D T+V TR Y PE + DV+S G +L E
Sbjct: 187 GSA---TFDHEHHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 513 NRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG---EREFRAEMHVIGRTHH 567
N+F+ ++G GSFG +Y GT + + VA+K E + T+ E + + G T
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTG- 64
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLH 627
+ + + E +LV + + SL D LF R L + +A + + ++H
Sbjct: 65 --IPNVRWFGVEGDYNVLVMDLLGP-SLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 628 DECEAPIIHCDIKPQNILMDEFWTAK---ISDFGLAKLLMPDQT------RTFTLVRGTR 678
+ +H DIKP N LM A I DFGLAK T R + GT
Sbjct: 121 SKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 679 GYMAPEWYKNTPISVKADVFSYGVVLLE 706
Y + + S + D+ S G VL+
Sbjct: 178 RYASVNTHLGIEQSRRDDLESLGYVLMY 205
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 53/245 (21%), Positives = 90/245 (36%), Gaps = 77/245 (31%)
Query: 512 TNRFK--EELGKGSFGAVYKGTLYKGEKLVAVK---KLEKMVTEGEREFRAEMHVIGRT- 565
N F ++G G+FG V +K AVK ++K + E + I
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADI-LKKIQNDD 92
Query: 566 -HHKNLVRLIGY-------CAEDSKRLLVYEYMSNGSLADIL----FRGPERSLGWDERV 613
++ N+V+ G C L++E + SL +I+ + G +
Sbjct: 93 INNNNIVKYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRNNYNGFHIED-----I 139
Query: 614 R-IASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTA-------------------- 652
+ ++ K + YL + H D+KP+NIL+D+ +
Sbjct: 140 KLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 653 -----KISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE------WYKNTPISVKADVFSYG 701
K+ DFG A +++ TR Y APE W + D++S+G
Sbjct: 197 KSTGIKLIDFGCA---TFKSDYHGSIIN-TRQYRAPEVILNLGW--DVSS----DMWSFG 246
Query: 702 VVLLE 706
VL E
Sbjct: 247 CVLAE 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 56/240 (23%), Positives = 93/240 (38%), Gaps = 71/240 (29%)
Query: 512 TNRFK--EELGKGSFGAVYKGTLYK-GEKLVAVK---KLEKMVTEGEREFR--AEMHVIG 563
+ R++ + LG+G+FG V + +K G + VAVK +++ E + ++
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTD 72
Query: 564 RTHHKNLVRLIGY-------CAEDSKRLLVYEYMSNGSLADIL----FRGPERSLGWDER 612
V+++ + C +V+E + S D + F
Sbjct: 73 PNSTFRCVQMLEWFEHHGHIC-------IVFELLGL-STYDFIKENGFLPFRLDH----- 119
Query: 613 VR-IASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTA------------------- 652
+R +A + K + +LH + H D+KP+NIL +
Sbjct: 120 IRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 653 KISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE------WYKNTPISVKADVFSYGVVLLE 706
K+ DFG A D TLV TR Y APE W + P DV+S G +L+E
Sbjct: 177 KVVDFGSA---TYDDEHHSTLVS-TRHYRAPEVILALGW--SQPC----DVWSIGCILIE 226
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 54/266 (20%), Positives = 87/266 (32%), Gaps = 83/266 (31%)
Query: 512 TNRFK--EELGKGSFGAVYKGTLYKGEKLVAVK---KLEKMVTEGEREFRAEMHV--IGR 564
R+ +LG G F V+ +G+K VA+K E E R V
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDP 95
Query: 565 TH--HKNLVRLIGY-----------CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDE 611
+ +V+L+ C +V+E + + L + + + L
Sbjct: 96 NDPNREMVVQLLDDFKISGVNGTHIC-------MVFEVLGH-HLLKWIIKSNYQGLPLPC 147
Query: 612 RVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM------------------------- 646
+I V +G+ YLH +C IIH DIKP+NIL+
Sbjct: 148 VKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205
Query: 647 ------------------------DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMA 682
E KI+D G A + T + TR Y +
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQ--TRQYRS 261
Query: 683 PEWYKNTPISVKADVFSYGVVLLEIV 708
E + + AD++S + E+
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELA 287
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.4 bits (140), Expect = 4e-09
Identities = 30/220 (13%), Positives = 60/220 (27%), Gaps = 59/220 (26%)
Query: 491 SLGLAYESNLRSFSYNELKKATNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKL---- 544
S+G + FS+ T + + E++G+G FG V++ VA+K +
Sbjct: 1 SMGECSQKGPVPFSHC---LPTEKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEG 55
Query: 545 --------EKMVTEGEREFR-----AEMHVIGRTHHKNLVRLIGYC-------------- 577
+K E E + + + + L
Sbjct: 56 PDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAW 115
Query: 578 ----------------AEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAK 621
+D + +V E+ G L + + I +
Sbjct: 116 DHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTA 172
Query: 622 GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661
+ H D+ N+L+ + K+ K
Sbjct: 173 SLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 27/180 (15%), Positives = 66/180 (36%), Gaps = 29/180 (16%)
Query: 513 NRFK--EELGKGSFGAVYKGT--------LYKGEKLVAVKKLEKMVTEGEREFR------ 556
++K + + G +Y+ ++ ++K L+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 557 --AEMHVIGRTHHKNLV---RLIGY-CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWD 610
+++ + + L+ +G+ +D R LV + SL L P+ L
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSER 159
Query: 611 ERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKI--SDFGLAKLLMPDQT 668
+++A + + +LH+ +H ++ +NI +D +++ + +G A P
Sbjct: 160 SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 5e-08
Identities = 59/492 (11%), Positives = 131/492 (26%), Gaps = 157/492 (31%)
Query: 329 ERKFV-DERCKGINISAEYNMTSMEKMTWDDYYYFKASITKEECKESCLEDCECDVALYE 387
E FV + CK + D K+ ++KEE +
Sbjct: 26 EDAFVDNFDCKDV----------------QDM--PKSILSKEEIDH-----------IIM 56
Query: 388 ESVDDKPSY------CTKQKLPLKSAKRDLKNSSSSIAYFKTGIRNITTSSNNTNSAMPQ 441
+ +KQ+ ++ ++ + + + I+ + +
Sbjct: 57 SKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK--FLMSPIKTEQRQPSMMTRMYIE 114
Query: 442 DRNRSKKAIILILVITIGLVTCSCAFLTFSGVFIF-KYQVLKYEWLLENGSLGLAYESNL 500
R+R ++ +F KY V + +
Sbjct: 115 QRDR-----------------------LYNDNQVFAKYNVSRLQ---------------- 135
Query: 501 RSFSYNELKKATNRFKEEL-----GKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREF 555
Y +L++A + G G K + A+ + + +F
Sbjct: 136 ---PYLKLRQALLELRPAKNVLIDGVLGSG---KTWV-------ALDVCLSYKVQCKMDF 182
Query: 556 RAEMHVIGRTHHKNLVRLIGYCAEDSKRL-----LVYEYMSNG-SLADILFRGPERSLGW 609
++ + + C L L+Y+ N S +D R
Sbjct: 183 --KIFWLN----------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 610 DERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISD-FGL-AKLLMPDQ 667
+R +L ++ + AK + F L K+L+
Sbjct: 231 QAELRR-------LLKSKPYENCLLV----------LLNVQNAKAWNAFNLSCKILL--T 271
Query: 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSK-PEEIVL 726
TR + +++ + + + + + + + ++ P P E++
Sbjct: 272 TRFKQVTD----FLSAATTTHISLDHHSMTLTPD-EVKSL--LLKYLDCRPQDLPREVLT 324
Query: 727 IN-------WAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779
N I L + V+ + L +I+ L V + R + +
Sbjct: 325 TNPRRLSIIAE---SIRDGLATWDNWKHVNCDKLTTIIESSL-NVLEPAEYRKMFDRLSV 380
Query: 780 MLEGITDISIPP 791
IP
Sbjct: 381 FPP---SAHIPT 389
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 4e-04
Identities = 94/697 (13%), Positives = 188/697 (26%), Gaps = 247/697 (35%)
Query: 65 FKVGIWLLTFPDITIVWT-AYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEP 123
F+ G + DI V+ A+ D+ + K IL EE D ++ + +
Sbjct: 9 FETGEHQYQYKDILSVFEDAFVDN--FDCKDVQDMPKS---ILSKEE-IDHIIMSKDAVS 62
Query: 124 ASSA---SMLDSGN-----FV--LYNNRSDIIWSSF----KIPT-DTILGNQS---LLAG 165
+ ++L FV + + S + P+ T + + L
Sbjct: 63 GTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122
Query: 166 NELFSRISETSSSTGRFR---------LNMQRDGNLVLY----------PINTIDDYT-- 204
N++F++ + + R + L ++ N+++ ++ Y
Sbjct: 123 NQVFAKYNVS-----RLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQ 177
Query: 205 -----EAYWASDSQRERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGH 259
+ +W + L L+ I + ++S+I R+
Sbjct: 178 CKMDFKIFWLNLKNCNSP-ETVLEMLQKLLYQ-----IDPNWTSRSDHSSNIKLRIHSIQ 231
Query: 260 NGILRLFSHYPVPKGAYNTSVDWNVPDDLCEVKTFCGLNSYC-TLYDDQPMCRCLPGTDF 318
+ RL P Y + V ++ K + N C L R TDF
Sbjct: 232 AELRRLLKSKP-----YENCLL--VLLNVQNAKAWNAFNLSCKILL----TTRFKQVTDF 280
Query: 319 LDPNQTSSGCERKFVDERCKGINISAEYNMTSMEKMTWDDYYYFKASITKEECKE---SC 375
L T+ +D + T +E K
Sbjct: 281 LSAATTT----HISLDHHSMTL--------------------------TPDEVKSLLLKY 310
Query: 376 LEDCECDVALYEESVDDKPSYCTKQKLPLKSAKRDLKNSSSSIAYFKTGIRNITTSSNNT 435
L+ C Q LP + L + ++ IR+ + +N
Sbjct: 311 LD-------------------CRPQDLP----REVLTTNPRRLSIIAESIRDGLATWDNW 347
Query: 436 NSAMPQDRNRSKKAIILILVITIGLVTCSCAFLT-------FSGVFIF------KYQVLK 482
+ N K I+ S L F + +F +L
Sbjct: 348 -----KHVNCDKLTTIIES---------SLNVLEPAEYRKMFDRLSVFPPSAHIPTILLS 393
Query: 483 YEW--LLENGSLGLAYESNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVA 540
W ++++ + + + + S ++K + ++Y L
Sbjct: 394 LIWFDVIKSDVMVVVNKLHKYSL----VEKQPKESTISI--------P--SIY----LEL 435
Query: 541 VKKLEKMVTEGEREFRAEMHVIGRTHHKNLVR----LIGYCAED-SKRLL---VYEY--- 589
KLE H+++V + ++D L Y +
Sbjct: 436 KVKLENE----------------YALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH 479
Query: 590 -MSNGSLAD--ILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM 646
+ N + LFR +++L D +
Sbjct: 480 HLKNIEHPERMTLFR---------------------MVFL-----------DFR------ 501
Query: 647 DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAP 683
F KI A T ++ + Y+
Sbjct: 502 --FLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICD 536
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 32/179 (17%), Positives = 62/179 (34%), Gaps = 30/179 (16%)
Query: 513 NRFK--EELGKGSFGAVYKGTLYKGEKLVAVK--KLEKMVTEG-EREFRAEMHVIGRTHH 567
N++ +++G G FG +Y + A K+E E + V +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 568 KNLV-----------RLIGYCAEDSK----RLLVYEYMSNGSLADILFRGPERSLGWDER 612
K + G + K R +V E + L I +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKK---ST 152
Query: 613 V-RIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKI--SDFGLAKLLMPDQT 668
V ++ + + Y+H+ +H DIK N+L+ ++ +D+GL+ P+
Sbjct: 153 VLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 32/229 (13%), Positives = 76/229 (33%), Gaps = 39/229 (17%)
Query: 513 NRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE---FRAEMHVIGRTHH 567
+K +G+G FG +Y + E + +V + E+ R
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVG--SDAPCVVKVEPSDNGPLFTELKFYQRAAK 92
Query: 568 KNLV---------------RLIGYCAEDSK----RLLVYEYMSNGSLADILFRGPERSLG 608
+ + G D R ++ + + L ++ +
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQK-IYEANAKRFS 150
Query: 609 WDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKI--SDFGLAKLLMPD 666
++++ + + Y+H+ +H DIK N+L++ ++ D+GLA P+
Sbjct: 151 RKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 667 QT------RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC 709
GT + + + + S + D+ G +++ +
Sbjct: 208 GVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT 256
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 796 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.81 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.8 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.78 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.77 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.7 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.61 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.6 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.6 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.56 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.51 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.5 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.4 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.36 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.35 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.26 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.25 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.24 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.18 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.12 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.06 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.85 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.8 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.69 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.26 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.14 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.11 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.02 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.89 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.89 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.76 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.46 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.31 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.06 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.03 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.72 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.64 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.59 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.56 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.39 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.07 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.89 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.68 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.53 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.4 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.93 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 89.24 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.63 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 87.17 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 84.53 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=441.82 Aligned_cols=265 Identities=26% Similarity=0.426 Sum_probs=215.9
Q ss_pred HHHHHHHHhhhcccCcccceEEEEEEEc-----CCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhcc
Q 003772 506 NELKKATNRFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAE 579 (796)
Q Consensus 506 ~~l~~~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~ 579 (796)
.|+..++.+|.++||+|+||+||+|++. ..++.||||+++.... ...++|++|+.++++++|||||+++|+|.+
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 3444456678899999999999999974 2457899999975433 345789999999999999999999999999
Q ss_pred CCceeEEEeecCCCChhhhhhcCC--------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceE
Q 003772 580 DSKRLLVYEYMSNGSLADILFRGP--------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNIL 645 (796)
Q Consensus 580 ~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIl 645 (796)
++..+||||||++|+|.++|.... ...++|..++.++.|||+||.|||++ +||||||||+|||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL 177 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence 999999999999999999996532 24689999999999999999999998 9999999999999
Q ss_pred ecCCCceEEeccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchh
Q 003772 646 MDEFWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEE 723 (796)
Q Consensus 646 l~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~ 723 (796)
|++++.+||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||.... ..+
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--~~~ 255 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--NQD 255 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--HHH
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--HHH
Confidence 99999999999999987654332 23334569999999999999999999999999999999999 788986432 111
Q ss_pred HHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 724 IVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
+. ..+..+. ....+.+++..+.+|+.+||+.||++||||+||++.|+....+
T Consensus 256 --~~----~~i~~~~------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl 307 (308)
T 4gt4_A 256 --VV----EMIRNRQ------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL 307 (308)
T ss_dssp --HH----HHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred --HH----HHHHcCC------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence 11 1111111 1123456678899999999999999999999999999976544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=440.27 Aligned_cols=257 Identities=30% Similarity=0.451 Sum_probs=208.2
Q ss_pred hhhcccCcccceEEEEEEEcC-----CcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 514 RFKEELGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+.++||+|+||.||+|++.. +++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 456889999999999998753 467899999987766777889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCC-------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEe
Q 003772 589 YMSNGSLADILFRGP-------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKIS 655 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 655 (796)
|+++|+|.++|+... ...++|..++.|+.|||+||.|||+. +||||||||+||||++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence 999999999997532 24699999999999999999999998 99999999999999999999999
Q ss_pred ccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHh
Q 003772 656 DFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKC 733 (796)
Q Consensus 656 DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 733 (796)
|||+++.+..... .......||+.|||||++.+..++.++|||||||+||||+| |+.||..... .+ + ...
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--~~--~----~~~ 272 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TE--A----IDC 272 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--HH--H----HHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--HH--H----HHH
Confidence 9999997654432 23344669999999999999999999999999999999999 8999864321 11 1 111
Q ss_pred hhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 734 FIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
+..+ .....+..+++.+.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 273 i~~g------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 273 ITQG------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHT------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHcC------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111 01123445667899999999999999999999999999998765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=436.60 Aligned_cols=258 Identities=27% Similarity=0.472 Sum_probs=214.4
Q ss_pred HhhhcccCcccceEEEEEEEcC-----CcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
..+.++||+|+||.||+|++.. ++..||||+++....+..++|.+|++++++++|||||+++|+|.+++..+|||
T Consensus 15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 94 (299)
T 4asz_A 15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 94 (299)
T ss_dssp EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 4567899999999999998753 45789999998777777788999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcC-----------CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEec
Q 003772 588 EYMSNGSLADILFRG-----------PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISD 656 (796)
Q Consensus 588 e~~~~gsL~~~l~~~-----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 656 (796)
||+++|+|.++|++. ....++|..++.++.|||+||.|||++ +|+||||||+||||++++.+||+|
T Consensus 95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECC
Confidence 999999999999753 235799999999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCcce-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhh
Q 003772 657 FGLAKLLMPDQTRT-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCF 734 (796)
Q Consensus 657 Fgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 734 (796)
||+++......... .....||+.|||||++.+..++.++|||||||+||||+| |+.||.... ..++ ....
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--~~~~------~~~i 243 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--NNEV------IECI 243 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHH------HHHH
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHH------HHHH
Confidence 99998765443322 223568999999999999999999999999999999999 899986432 1111 1111
Q ss_pred hhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 735 IDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
..+. ....+..+++.+.+|+.+||+.||++||||++|++.|+.+.+.
T Consensus 244 ~~~~------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 244 TQGR------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCC------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111 1123445667899999999999999999999999999987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=426.88 Aligned_cols=256 Identities=29% Similarity=0.434 Sum_probs=202.4
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.++||+|+||+||+|++.. .||||+++.. ..+..+.|.+|+.++++++|||||+++|+|.+ +..+||||||+
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred EEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 467899999999999998753 5999998643 33455789999999999999999999998865 56899999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC-cce
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ-TRT 670 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~-~~~ 670 (796)
+|+|.++|+.. ...+++..++.|+.|||+||.|||++ +||||||||+||||++++.+||+|||+|+...... ...
T Consensus 115 gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 115 GSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp SCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred CCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 99999999763 45799999999999999999999998 99999999999999999999999999998765433 233
Q ss_pred eeeeccCCCCCchhhhcc---CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 671 FTLVRGTRGYMAPEWYKN---TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
.....||+.|||||++.. .+++.++|||||||+||||+||+.||...... . .+.......... .....
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~-~~~~~~~~~~~~------p~~~~ 261 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--D-QIIFMVGRGYAS------PDLSK 261 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--H-HHHHHHHTTCCC------CCSTT
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--H-HHHHHHhcCCCC------CCccc
Confidence 345679999999999964 46899999999999999999999999643321 1 111101111000 01112
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.+.++++.+.+|+.+||+.||++||||.||++.|+.+..
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 344567789999999999999999999999999987653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=419.64 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=209.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.+.++||+|+||.||+|++...++.||||+++.......+.+.+|+.+|++++|||||++++++.+++..||||||+++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 45568899999999999999988999999999876666667799999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++.+ ..+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.+..... ...
T Consensus 156 g~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~ 228 (346)
T 4fih_A 156 GALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 228 (346)
T ss_dssp EEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBC
T ss_pred CcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-ccc
Confidence 999999975 4699999999999999999999998 999999999999999999999999999997754433 233
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
..+||+.|||||++.+..++.++|||||||++|||++|+.||.... ... . ...+... ...........
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~--~----~~~i~~~----~~~~~~~~~~~ 296 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLK--A----MKMIRDN----LPPRLKNLHKV 296 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHH--H----HHHHHHS----SCCCCSCGGGS
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHH--H----HHHHHcC----CCCCCCccccC
Confidence 4579999999999999999999999999999999999999996432 111 1 1111110 00001112344
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 753 LENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.+.+.+|+..||+.||++|||++|+++
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 567899999999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=422.65 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=204.0
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
.|.+.++||+|+||.||+++....++.||||++.+.. ....+.+++|+.++++++|||||++++++.+++..||||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 3567789999999999999999889999999997532 33456799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.++|.......+++..++.++.||+.||.|||++ +|+||||||+||||++++.+||+|||+++.+.... .
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-E 180 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-H
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-c
Confidence 9999999999876566789999999999999999999998 99999999999999999999999999998764322 1
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
......||+.|||||++.+..++.++|||||||+||||++|+.||.... .... ......... ...+
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--~~~~------~~~i~~~~~------~~~~ 246 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--MKNL------VLKIISGSF------PPVS 246 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHH------HHHHHHTCC------CCCC
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHH------HHHHHcCCC------CCCC
Confidence 2234569999999999999999999999999999999999999996432 1111 111111111 1223
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 345567899999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=409.78 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=198.9
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhcc----CCceeEEE
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAE----DSKRLLVY 587 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~ 587 (796)
+|.++||+|+||.||+|.+...++.||||++.... ....+.|.+|+.++++++|||||++++++.+ +...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 46678999999999999999889999999997532 3345679999999999999999999998864 34579999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-CCceEEeccCCccccCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE-FWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgl~~~~~~~ 666 (796)
||+++|+|.++|.+ ...+++..+..++.||+.||.|||++ .++|+||||||+||||+. ++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 99999999999976 46799999999999999999999997 123999999999999984 789999999999865432
Q ss_pred CcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
......||+.|||||++.+ .++.++|||||||+||||+||+.||...... . .+ ......+ ..+.
T Consensus 186 ---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~-~~----~~~i~~~-----~~~~ 249 (290)
T 3fpq_A 186 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--A-QI----YRRVTSG-----VKPA 249 (290)
T ss_dssp ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--H-HH----HHHHTTT-----CCCG
T ss_pred ---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--H-HH----HHHHHcC-----CCCC
Confidence 2334579999999999875 6999999999999999999999999643211 1 11 1111111 1111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..+....+++.+++..||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112223456889999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=417.68 Aligned_cols=266 Identities=27% Similarity=0.307 Sum_probs=200.2
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCC----ceeEEEee
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS----KRLLVYEY 589 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~e~ 589 (796)
.+.++||+|+||+||+|++. ++.||||+++... .....+..|+..+.+++|||||+++|+|.+++ ..+|||||
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEECSSSEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 45688999999999999984 5789999996532 22233445777778899999999999998654 57999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccC-----CCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC-----EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+++|+|.++|+. ..++|..+++++.|+++||+|||+++ .++|+||||||+||||++++.+||+|||+++...
T Consensus 83 ~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 83 HEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 999999999976 46999999999999999999999862 4589999999999999999999999999998765
Q ss_pred CCCcc---eeeeeccCCCCCchhhhccC------CCCccccchhhHHHHHHHhhcccCCCCCCCCchh--------HHHH
Q 003772 665 PDQTR---TFTLVRGTRGYMAPEWYKNT------PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEE--------IVLI 727 (796)
Q Consensus 665 ~~~~~---~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~--------~~~~ 727 (796)
..... ......||+.|||||++.+. .++.++|||||||+||||+||+.|+......... ...
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~- 238 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV- 238 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH-
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH-
Confidence 43322 22235699999999999764 4688999999999999999999887543221100 000
Q ss_pred HHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 728 NWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.........+.+...+.....+.+.+..+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus 239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 00011111111100001111234667889999999999999999999999999988754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=424.88 Aligned_cols=264 Identities=26% Similarity=0.376 Sum_probs=214.3
Q ss_pred HHHHHhhhcccCcccceEEEEEEEcCC-----cEEEEEEEeecccch-hHHHHHHHHHHHhccCc-CchhhhhhhhccC-
Q 003772 509 KKATNRFKEELGKGSFGAVYKGTLYKG-----EKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHH-KNLVRLIGYCAED- 580 (796)
Q Consensus 509 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~-----~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~- 580 (796)
....+.+.++||+|+||.||+|.+... .+.||||++...... ..+.|.+|+.++.+++| ||||+++|+|.+.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 344566788999999999999997643 368999999764433 45679999999999965 8999999998764
Q ss_pred CceeEEEeecCCCChhhhhhcCC--------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe
Q 003772 581 SKRLLVYEYMSNGSLADILFRGP--------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM 646 (796)
Q Consensus 581 ~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 646 (796)
+..+||||||++|+|.++|+... ...+++..++.++.|||+||.|||++ +||||||||+|||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceee
Confidence 56899999999999999997532 24589999999999999999999998 99999999999999
Q ss_pred cCCCceEEeccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhH
Q 003772 647 DEFWTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEI 724 (796)
Q Consensus 647 ~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~ 724 (796)
++++.+||+|||+|+.+..+... ......||+.|||||++.+..++.++|||||||+||||+| |+.||....... .+
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-~~ 297 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF 297 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HH
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 99999999999999977554433 3334679999999999999999999999999999999998 899997543221 11
Q ss_pred HHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCC
Q 003772 725 VLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDIS 788 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 788 (796)
......+. ....+..+++++.+++..||+.||++|||++||++.|+.+++..
T Consensus 298 ------~~~i~~g~------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 298 ------CRRLKEGT------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp ------HHHHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ------HHHHHcCC------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 01111110 11223445678999999999999999999999999999876543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=416.78 Aligned_cols=249 Identities=23% Similarity=0.247 Sum_probs=204.1
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.+.++||+|+||.||+|++...++.||||+++... ...+|+.++++++|||||++++++.+++..+|||||+++
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 345678999999999999999889999999997532 235799999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC-ceEEeccCCccccCCCCcc--
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW-TAKISDFGLAKLLMPDQTR-- 669 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgl~~~~~~~~~~-- 669 (796)
|+|.++|.+ .+.+++..+..++.||+.||.|||++ +|+||||||+||||+.++ .+||+|||+++.+......
T Consensus 135 g~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 135 GSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp CBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 999999976 46799999999999999999999998 999999999999999887 6999999999987544321
Q ss_pred --eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 670 --TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 670 --~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
.....+||+.|||||++.+..++.++|||||||+||||++|+.||...........+ .... .....
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i--------~~~~----~~~~~ 277 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI--------ASEP----PPIRE 277 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH--------HHSC----CGGGG
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH--------HcCC----CCchh
Confidence 122356999999999999999999999999999999999999999754322211110 0000 00012
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
.++...+.+.+++.+||+.||.+|||+.||++.|+.
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 334556778999999999999999999999887654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=420.50 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=209.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.+.++||+|+||.||+|++...++.||||++........+.+.+|+.+|++++|||||++++++.+++..|||||||++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 55668899999999999999998999999999876666667899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++.. ..+++..+..++.||+.||.|||++ +||||||||+||||+.++.+||+|||+++.+..... ...
T Consensus 233 G~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~ 305 (423)
T 4fie_A 233 GALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 305 (423)
T ss_dssp EEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBC
T ss_pred CcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-ccc
Confidence 999999965 4699999999999999999999998 999999999999999999999999999997754433 233
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
..+||+.|||||++.+..++.++|||||||++|||++|+.||.... .. .. ...+... ...........
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~--~~----~~~i~~~----~~~~~~~~~~~ 373 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PL--KA----MKMIRDN----LPPRLKNLHKV 373 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HH--HH----HHHHHHS----CCCCCSCTTSS
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HH--HH----HHHHHcC----CCCCCcccccC
Confidence 4569999999999999999999999999999999999999996432 11 11 1111110 00001112234
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 753 LENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.+.+.+|+.+||+.||++|||+.|+++
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 567889999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=407.33 Aligned_cols=246 Identities=24% Similarity=0.323 Sum_probs=208.5
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+.+.+.||+|+||+||+++....++.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..|||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 3677899999999999999999999999999997632 2345679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++|+|.++|.+ .+.+++..+..++.||+.||.|||++ +|+||||||+||||++++.+||+|||+|+.+.....
T Consensus 113 y~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 113 YAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred cCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999976 46799999999999999999999998 999999999999999999999999999998765433
Q ss_pred -ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 669 -RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 669 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
......+||+.|||||++.+..++.++||||+||+||||++|+.||.... .... ...+.... -.
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~------~~~i~~~~-------~~ 252 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EGLI------FAKIIKLE-------YD 252 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHH------HHHHHHTC-------CC
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHH------HHHHHcCC-------CC
Confidence 23345679999999999999999999999999999999999999996432 1111 11111111 11
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSV 777 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 777 (796)
.+....+++.+|+..||+.||++|||++|+
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence 223345678899999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=393.66 Aligned_cols=245 Identities=23% Similarity=0.379 Sum_probs=192.7
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+++.+.||+|+||+||+++....++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4677899999999999999998888999999997532 2234679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+ +|+|.+++.+ .+.+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 94 y~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 94 YA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp CC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred CC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 99 6899999976 46799999999999999999999998 99999999999999999999999999998764332
Q ss_pred ceeeeeccCCCCCchhhhccCCC-CccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
......||+.|||||++.+..+ +.++||||+||++|||++|+.||.... . ... .+...... ..
T Consensus 167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--~-~~~-----~~~i~~~~-------~~ 230 (275)
T 3hyh_A 167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--I-PVL-----FKNISNGV-------YT 230 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--H-HHH-----HHHHHHTC-------CC
T ss_pred -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--H-HHH-----HHHHHcCC-------CC
Confidence 2234569999999999998876 589999999999999999999996432 1 111 11111110 11
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.+....+.+.+++.+||+.||++|||++|+++
T Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22334567889999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=399.17 Aligned_cols=247 Identities=23% Similarity=0.300 Sum_probs=196.5
Q ss_pred HHhhhcccCcccceEEEEEEEc---CCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
.+++.+.||+|+||+||+++.. ..++.||||++++.. ......+.+|+.++++++|||||++++++.+++..++|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4677899999999999999873 346789999997532 22344688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|||+++|+|.++|.+ .+.+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 105 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp ECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 999999999999976 46799999999999999999999998 9999999999999999999999999999865433
Q ss_pred CcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
.. ......||+.|||||++.+..++.++|||||||+||||++|+.||.... ..+. ....... ..
T Consensus 180 ~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--~~~~------~~~i~~~-------~~ 243 (304)
T 3ubd_A 180 EK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--RKET------MTMILKA-------KL 243 (304)
T ss_dssp -C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHH------HHHHHHC-------CC
T ss_pred Cc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--HHHH------HHHHHcC-------CC
Confidence 32 2234569999999999999999999999999999999999999996432 1111 1111111 11
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPS-----MKSVVL 779 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 779 (796)
..+....+.+.+++.+||+.||++||| ++|+++
T Consensus 244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 123344567899999999999999998 567764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=388.30 Aligned_cols=248 Identities=21% Similarity=0.291 Sum_probs=187.0
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhccCC----------
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAEDS---------- 581 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~---------- 581 (796)
+++.+.||+|+||+||+|+...+++.||||+++....+ ..+.+.+|+.++++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 56678999999999999999988899999999764433 3467899999999999999999999886543
Q ss_pred --ceeEEEeecCCCChhhhhhcCCC-CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccC
Q 003772 582 --KRLLVYEYMSNGSLADILFRGPE-RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFG 658 (796)
Q Consensus 582 --~~~lV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 658 (796)
..++||||+++|+|.+++..... ...++..++.++.||++||.|||++ +|+||||||+||||+.++.+||+|||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCc
Confidence 36899999999999999976422 3355667889999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCcc-----------eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHH
Q 003772 659 LAKLLMPDQTR-----------TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLI 727 (796)
Q Consensus 659 l~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~ 727 (796)
+++.+...... ..+...||+.|||||++.+..++.++|||||||++|||++ ||.... .....
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---~~~~~- 236 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---ERVRT- 236 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---HHHHH-
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---HHHHH-
Confidence 99987543321 1223569999999999999999999999999999999996 654210 00000
Q ss_pred HHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 728 NWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......... ........+.+.+++.+||+.||.+|||+.|+++
T Consensus 237 ---~~~~~~~~~------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 ---LTDVRNLKF------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ---HHHHHTTCC------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHhcCCC------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000000000 0011223355678999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=381.97 Aligned_cols=266 Identities=21% Similarity=0.291 Sum_probs=202.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhcc------CCce
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAE------DSKR 583 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 583 (796)
.+.+.+.||+|+||+||+|.+...++.||||++.+.. ....+.+.+|+.+|++++|||||++++++.. .+..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 3567789999999999999999889999999996532 2344678899999999999999999998653 4678
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
||||||++ |+|.+++.+ .+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+
T Consensus 135 ~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 99999996 789999976 56899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCC---cceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhh---
Q 003772 664 MPDQ---TRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFID--- 736 (796)
Q Consensus 664 ~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 736 (796)
.... ........||+.|||||++.+. .++.++||||+||++|||++|+.||....... ..............
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCGGGT
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCChHHh
Confidence 4322 2233446799999999998875 56999999999999999999999996432111 00000000000000
Q ss_pred ---------hhhhhhhcCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhcC
Q 003772 737 ---------RELNKLVRGQEVD-----RNTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEGI 784 (796)
Q Consensus 737 ---------~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~ 784 (796)
..+..+......+ +...+.+.+|+..||+.||.+|||+.|+++ .+.+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 0000000001111 122457889999999999999999999986 34443
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=365.00 Aligned_cols=230 Identities=19% Similarity=0.211 Sum_probs=188.0
Q ss_pred CCCCcccCCCCccccCCCCCccccCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCC----CcEEEEecC
Q 003772 26 HPQPKSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSS----NAALTLTKD 101 (796)
Q Consensus 26 ~~~~~~~~~g~~l~~~~~~~~~~S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~----~~~l~l~~~ 101 (796)
.++.++|++|++|+++++ |+||+|+|+||||.++ ++|| |+ |.+ +|||||||+|+.++ +++|+|+.|
T Consensus 11 ~~~~~~l~~g~~l~~~~~---l~S~~g~F~lgf~~~~-~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~ 80 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAGQY---LLSPNQRFKLLLQGDG-NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFY 80 (276)
T ss_dssp CTTSSEECTTEEBCTTCE---EECTTSSEEEEECTTS-CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEE
T ss_pred cccCCEecCCCEecCCCE---EEcCCCcEEEEEECCC-CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCC
Confidence 456799999999999874 6999999999999543 6777 87 778 99999999999875 789999999
Q ss_pred CceEE--EcCCCceeEeecCCC------CCceeEEEecCcCEEEeecCCCccccccCCCCccccCCCC----CCCCCeee
Q 003772 102 GKLIL--RTEEGHDKVVAAGKS------EPASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQS----LLAGNELF 169 (796)
Q Consensus 102 G~Lvl--~~~~g~~~w~t~~~~------~~~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtlLp~~~----l~~~~~L~ 169 (796)
|+||| .|++|+++|+|+++. .+++.|+|+|+|||||+| +.+|||| |||||+||||+ +..|++|
T Consensus 81 G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~~L- 155 (276)
T 3m7h_A 81 VQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGSEL- 155 (276)
T ss_dssp ESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSEEE-
T ss_pred CcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCccc-
Confidence 99999 888899999998754 345789999999999998 7899999 99999999999 7788888
Q ss_pred eccCCCCCCCccEEEEEecCCcEEEeeecCCCccccccccccccccceeEEEeecCceEEEEcCCcceeeeeecCCCCCc
Q 003772 170 SRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQRERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNS 249 (796)
Q Consensus 170 S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (796)
++..||++|.|++++|++|++++|. .. ...||++++++.....+.++..|++++++.++...... ... .
T Consensus 156 --~S~~dps~G~fsl~l~~dGnlvLy~-~~----~~~yW~Sgt~~~~~~~l~l~~dGnLvl~d~~~~~vWsS--~t~--~ 224 (276)
T 3m7h_A 156 --VQGVVYGAGASKLVFQGDGNLVAYG-PN----GAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHS--HTG--G 224 (276)
T ss_dssp --CTTCEEEETTEEEEECTTSCEEEEC-TT----SSEEEECCCTTTTCCEEEECTTSCEEEECTTSCEEEEC--SCT--T
T ss_pred --ccCCCCCCceEEEeecCCceEEEEe-CC----CeEEEECCCCCCccEEEEEcCCCeEEEEeCCCcEEEEe--cCC--C
Confidence 5688999999999999999887752 11 37899999887655667888899999988765433222 221 2
Q ss_pred cceeEEEEeecccEEEEEeccCCCCCcceeEEeeccCC
Q 003772 250 SIIRRLTIGHNGILRLFSHYPVPKGAYNTSVDWNVPDD 287 (796)
Q Consensus 250 s~~~rl~L~~~G~l~~~~~~~~~~~~~~w~~~w~~p~d 287 (796)
...+|++|+.||+|++|.|. ..|..+|.+|+.
T Consensus 225 ~~~~rl~Ld~dGnLvly~~~------~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 225 HASAVLRLQANGSIAILDEK------PVWARFGFQPTY 256 (276)
T ss_dssp CTTCEEEECTTSCEEEEEEE------EEEESSSCCTTS
T ss_pred CCCEEEEEcCCccEEEEcCC------CeEEccCccCCc
Confidence 23589999999999999882 357766666543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=374.52 Aligned_cols=197 Identities=24% Similarity=0.365 Sum_probs=168.7
Q ss_pred HHhhhcccCcccceEEEEEEEc---CCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 587 (796)
.+++.++||+|+||+||+|+.+ ..++.||||++.+. .....+.+|++++..+ +||||+++++++.+.++.++||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 3567789999999999999874 34678999998653 3345688999999988 6999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC-CceEEeccCCccccCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF-WTAKISDFGLAKLLMPD 666 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFgl~~~~~~~ 666 (796)
||+++|+|.+++. .+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 100 E~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 100 PYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp ECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred eCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 9999999999983 489999999999999999999998 99999999999999876 79999999999865432
Q ss_pred Cc---------------------------ceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCC
Q 003772 667 QT---------------------------RTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDP 718 (796)
Q Consensus 667 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~ 718 (796)
.. .......||+.|||||++.+. .++.++||||+||++|||++|+.||....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 11 112334699999999999876 58999999999999999999999997544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=394.50 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=209.1
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.|.+.+.||+|+||.||++.....++.||||++........+.+++|+.+|+.++||||+++++++.+.+..+|||||++
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 35678899999999999999999999999999987666667789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC--CceEEeccCCccccCCCCcc
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF--WTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFgl~~~~~~~~~~ 669 (796)
+|+|.++|... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 238 gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-- 311 (573)
T 3uto_A 238 GGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 311 (573)
T ss_dssp CCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--
T ss_pred CCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--
Confidence 99999999653 46799999999999999999999998 99999999999999854 899999999999875443
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
......||+.|||||++.+..++.++||||+||++|||++|+.||..... .. .+ ..+...... ......
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--~~-~~-----~~i~~~~~~---~~~~~~ 380 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DE-TL-----RNVKSCDWN---MDDSAF 380 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HH-HH-----HHHHTTCCC---CCSGGG
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HH-HH-----HHHHhCCCC---CCcccc
Confidence 33445799999999999999999999999999999999999999964321 11 11 111100000 000111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....+.+.+|+..||+.||.+|||+.|+++
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 233467889999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=389.87 Aligned_cols=247 Identities=22% Similarity=0.278 Sum_probs=200.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHH---HHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFR---AEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~---~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
+.+.+.||+|+||.||+++....++.||||++.+.. .+....+. .++.++..++|||||++++++.+.+..|||
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 567789999999999999999999999999997532 12223333 346777788999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|||+++|+|.++|.+ .+.+++..+..++.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+.+...
T Consensus 271 mEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp ECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 999999999999976 46799999999999999999999998 9999999999999999999999999999877543
Q ss_pred CcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
.. ...+||+.|||||++.. ..++.++|+|||||+||||++|+.||......... .+ ...... ..
T Consensus 346 ~~---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-~i----~~~i~~-------~~ 410 (689)
T 3v5w_A 346 KP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EI----DRMTLT-------MA 410 (689)
T ss_dssp CC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-HH----HHHHHH-------CC
T ss_pred CC---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HH----HHhhcC-------CC
Confidence 32 23569999999999975 57999999999999999999999999754322211 11 000000 11
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPS-----MKSVVL 779 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 779 (796)
...+....+.+.+|+..||+.||.+|++ ++||++
T Consensus 411 ~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1223344567899999999999999998 677763
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=364.60 Aligned_cols=288 Identities=43% Similarity=0.736 Sum_probs=231.9
Q ss_pred CCCcccCHHHHHHHHHhh--hcccCcccceEEEEEEEcCCcEEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhh
Q 003772 498 SNLRSFSYNELKKATNRF--KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLI 574 (796)
Q Consensus 498 ~~~~~~~~~~l~~~~~~~--~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~ 574 (796)
...+.+++.++.....++ .+.||+|+||.||+|... +++.||||++...... ....+.+|+.++.+++|+||++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 345778888888777655 578999999999999865 4678999999764322 334689999999999999999999
Q ss_pred hhhccCCceeEEEeecCCCChhhhhhcCC--CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCce
Q 003772 575 GYCAEDSKRLLVYEYMSNGSLADILFRGP--ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTA 652 (796)
Q Consensus 575 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 652 (796)
+++.+.+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+..+|+||||||+|||+++++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999998653 3459999999999999999999999866799999999999999999999
Q ss_pred EEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCC-CchhHHHHHHHH
Q 003772 653 KISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPS-KPEEIVLINWAY 731 (796)
Q Consensus 653 kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~-~~~~~~~~~~~~ 731 (796)
||+|||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||..... .........|..
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 9999999998765555555556699999999999999999999999999999999999999962210 111112223332
Q ss_pred HhhhhhhhhhhhcC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 732 KCFIDRELNKLVRG---QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 732 ~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.......+....+. .....+....+.+++.+||+.||.+|||+.||+++|++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 22222222322222 23467888999999999999999999999999999987543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=367.09 Aligned_cols=260 Identities=30% Similarity=0.445 Sum_probs=213.8
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.+.||+|+||.||++.+..+++.||+|++........+.+.+|+.++.+++||||+++++++.+++..++||||++
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 34567899999999999999988889999999977666777889999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce-
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT- 670 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~- 670 (796)
+|+|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 91 ~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 91 GGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99999999764 46799999999999999999999998 99999999999999999999999999998765433211
Q ss_pred ------------eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhh
Q 003772 671 ------------FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE 738 (796)
Q Consensus 671 ------------~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (796)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+............. ....
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-------~~~~ 239 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-------VRGF 239 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-------HHHH
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-------hhcc
Confidence 113468999999999999999999999999999999999999886543221111000 0000
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 739 LNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 739 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
... ..+...++.+.+++..||+.||++|||+.+|++.|+.+...
T Consensus 240 ~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 240 LDR-----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HHH-----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccc-----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000 11223345688999999999999999999999999887543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=360.18 Aligned_cols=265 Identities=32% Similarity=0.485 Sum_probs=202.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
.+++.+.||+|+||.||+++. .++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred HceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 455678999999999999987 45789999986543 33446789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCC-CCCchhHHHHHHHHHHHHHHHhhccCCCC--eeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 590 MSNGSLADILFRGPE-RSLGWDERVRIASDVAKGILYLHDECEAP--IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
+++|+|.+++..... ..+++..++.++.|+++||.|||+. + |+||||||+||+++.++.+||+|||+++.....
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 999999999976421 3489999999999999999999998 7 999999999999999999999999999865432
Q ss_pred CcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .... . .+.......
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--~~~~--~---------~~~~~~~~~ 258 (309)
T 3p86_A 193 F-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--AQVV--A---------AVGFKCKRL 258 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--HHHH--H---------HHHHSCCCC
T ss_pred c-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH--H---------HHHhcCCCC
Confidence 2 122335689999999999999999999999999999999999999964321 1110 0 000011112
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCCCCCCCC
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPPCPTS 795 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p~~ 795 (796)
..+......+.+++..||+.||.+|||+.+|++.|+.+.+...||++.+
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~~ 307 (309)
T 3p86_A 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307 (309)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---------
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCcc
Confidence 2334556779999999999999999999999999999988877776543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=360.91 Aligned_cols=271 Identities=34% Similarity=0.611 Sum_probs=223.1
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.+.+.||+|+||.||+|.+. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 119 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTT
T ss_pred cCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCC
Confidence 345678999999999999975 4578999999876666778899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCC--CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC-cc
Q 003772 593 GSLADILFRGP--ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ-TR 669 (796)
Q Consensus 593 gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~-~~ 669 (796)
|+|.+++.... ...+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 120 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 196 (321)
T 2qkw_B 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196 (321)
T ss_dssp CBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred CcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 99999997543 24589999999999999999999998 99999999999999999999999999998754322 22
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC---C
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG---Q 746 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 746 (796)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......|.......+.+...++. .
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (321)
T 2qkw_B 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNLAEWAVESHNNGQLEQIVDPNLAD 275 (321)
T ss_dssp CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-CCCHHHHTHHHHTTTCCCSSSSSSCTT
T ss_pred cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH-HHHHHHHhhhccccccHHHhcChhhcc
Confidence 2233458999999999999999999999999999999999999997543322 12222333333333333333332 2
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCC
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDIS 788 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 788 (796)
....+.+..+.+++.+||+.||++|||+.||++.|+.+.+..
T Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 276 KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 346788899999999999999999999999999999876554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=352.17 Aligned_cols=249 Identities=21% Similarity=0.311 Sum_probs=208.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.+.||+|+||.||++.....++.||||++........+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 34566889999999999999988889999999987666667789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+|+|.+++.+ ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......... .
T Consensus 101 ~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~ 173 (297)
T 3fxz_A 101 GGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 173 (297)
T ss_dssp TCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-B
T ss_pred CCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-c
Confidence 9999999976 3689999999999999999999998 9999999999999999999999999999876544332 2
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .. ..... .........+..
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~-~~~~~---------~~~~~~~~~~~~ 241 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RA-LYLIA---------TNGTPELQNPEK 241 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HH-HHHHH---------HHCSCCCSCGGG
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HH-HHHHH---------hCCCCCCCCccc
Confidence 3346899999999999999999999999999999999999999643211 11 00000 000001112334
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 752 TLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 752 ~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....+.+++..||+.||.+|||++|+++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 5567899999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=353.13 Aligned_cols=260 Identities=20% Similarity=0.269 Sum_probs=214.7
Q ss_pred cccCHHHHHHHHHh------------hhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcC
Q 003772 501 RSFSYNELKKATNR------------FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHK 568 (796)
Q Consensus 501 ~~~~~~~l~~~~~~------------~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~ 568 (796)
..+++++++.++.. +.+.||+|+||.||+|+....++.||||++........+.+.+|+.++.+++|+
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 55788888887754 235799999999999999888889999999876666677899999999999999
Q ss_pred chhhhhhhhccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC
Q 003772 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE 648 (796)
Q Consensus 569 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 648 (796)
||+++++++...+..++||||+++|+|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||+++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence 999999999999999999999999999999864 4699999999999999999999998 9999999999999999
Q ss_pred CCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHH
Q 003772 649 FWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLIN 728 (796)
Q Consensus 649 ~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~ 728 (796)
++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... . ..
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~--~~-- 249 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--V--QA-- 249 (321)
T ss_dssp TCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--H--HH--
T ss_pred CCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H--HH--
Confidence 999999999999876543322 2345689999999999999999999999999999999999999964321 1 11
Q ss_pred HHHHhhhhhhhhhhhcCC-CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 729 WAYKCFIDRELNKLVRGQ-EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.... ....... .........+.+++..||+.||++|||+.|+++.
T Consensus 250 --~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 --MKRL-----RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --HHHH-----HHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHH-----hcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0100 1111111 1122345678899999999999999999999863
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=359.04 Aligned_cols=265 Identities=26% Similarity=0.373 Sum_probs=211.0
Q ss_pred HHHhhhcccCcccceEEEEEEEcCC---cEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKG---EKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
..+.+.+.||+|+||.||+|.+... +..||||++.... ....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 3455678899999999999998643 3569999997643 33456799999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 129 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 129 TEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred eeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 9999999999999653 45799999999999999999999998 9999999999999999999999999999987544
Q ss_pred Ccc--eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 667 QTR--TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 667 ~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ... ... ...
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~------~~~-----~~~- 270 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVI------SSV-----EEG- 270 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHH------HHH-----HTT-
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHH------HHH-----HcC-
Confidence 322 2222346778999999999999999999999999999999 99998643211 100 000 000
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPPCP 793 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p 793 (796)
.....+...+..+.+++..||+.||.+|||+.+|+++|+.+...+....+
T Consensus 271 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~ 320 (325)
T 3kul_A 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRA 320 (325)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC----
T ss_pred CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccccc
Confidence 01122345567899999999999999999999999999998766554433
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=347.58 Aligned_cols=280 Identities=37% Similarity=0.602 Sum_probs=225.2
Q ss_pred CCcccCHHHHHHHHHhhh--------cccCcccceEEEEEEEcCCcEEEEEEEeeccc----chhHHHHHHHHHHHhccC
Q 003772 499 NLRSFSYNELKKATNRFK--------EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV----TEGEREFRAEMHVIGRTH 566 (796)
Q Consensus 499 ~~~~~~~~~l~~~~~~~~--------~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~ 566 (796)
....|++.++..++.+|. +.||+|+||.||+|.. .++.||||++.... .+..+.+.+|+.++.+++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 457899999999999886 4599999999999987 45689999986532 234567999999999999
Q ss_pred cCchhhhhhhhccCCceeEEEeecCCCChhhhhhcC-CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceE
Q 003772 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRG-PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNIL 645 (796)
Q Consensus 567 h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIl 645 (796)
||||+++++++.+.+..++||||+++|+|.+++... ....+++..++.++.|+++||.|||+. +|+||||||+||+
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 999999999999999999999999999999999743 235699999999999999999999998 9999999999999
Q ss_pred ecCCCceEEeccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhH
Q 003772 646 MDEFWTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEI 724 (796)
Q Consensus 646 l~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~ 724 (796)
+++++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||..........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 999999999999999876543322 2233468999999998875 48899999999999999999999997554322111
Q ss_pred HHHHHHHHhhhhhhhhhhhcC--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 725 VLINWAYKCFIDRELNKLVRG--QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
...... . .....+...+.. ..........+.+++..||+.||.+|||+.+|++.|+++..
T Consensus 245 ~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DIKEEI-E-DEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHH-H-TTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHh-h-hhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 111100 0 011112222222 12456778899999999999999999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=379.19 Aligned_cols=259 Identities=27% Similarity=0.380 Sum_probs=216.7
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+.+.+.||+|+||.||+|.+...+..||||+++... ...++|.+|+.++++++||||++++++|.+....++||||+
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 34567789999999999999998878999999997643 34678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|+|.+++.......+++..++.++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 999999999876567799999999999999999999998 99999999999999999999999999999775443333
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....++..|+|||++....++.++|||||||+||||++ |+.|+...... ... . . +.... ....+
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~--~----~-----~~~~~-~~~~~ 441 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY--E----L-----LEKDY-RMERP 441 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHH--H----H-----HHTTC-CCCCC
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHH--H----H-----HHcCC-CCCCC
Confidence 333446788999999999999999999999999999999 88888643311 110 0 0 00000 11223
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
..++..+.+++.+||+.||.+|||+.+|++.|+.+.+.
T Consensus 442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 45567899999999999999999999999999998654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=359.84 Aligned_cols=260 Identities=28% Similarity=0.405 Sum_probs=211.2
Q ss_pred HHHhhhcccCcccceEEEEEEEc-------CCcEEEEEEEeecccc-hhHHHHHHHHHHHhcc-CcCchhhhhhhhccCC
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLY-------KGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDS 581 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~-------~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~ 581 (796)
..+.+.+.||+|+||.||+|++. ..+..||||++..... ...+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 34566789999999999999864 2446799999976433 3456799999999999 8999999999999999
Q ss_pred ceeEEEeecCCCChhhhhhcCC--------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec
Q 003772 582 KRLLVYEYMSNGSLADILFRGP--------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD 647 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 647 (796)
..++||||+++|+|.+++.... ...+++..++.++.||++||.|||+. +|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence 9999999999999999997642 24589999999999999999999998 999999999999999
Q ss_pred CCCceEEeccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHH
Q 003772 648 EFWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIV 725 (796)
Q Consensus 648 ~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~ 725 (796)
.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~~~ 315 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--ELF 315 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH
Confidence 999999999999987654332 22223446789999999999999999999999999999999 88888643211 111
Q ss_pred HHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 726 LINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
...... .....+..+...+.+++..||+.||.+|||+.||++.|+.+..+
T Consensus 316 ------~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 316 ------KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp ------HHHHTT------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HHHhcC------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 000000 01122345567899999999999999999999999999987643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=350.02 Aligned_cols=266 Identities=26% Similarity=0.354 Sum_probs=210.6
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+.+.+.||+|+||.||++.....++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 3566789999999999999998888999999985432 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 92 ~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 92 YIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp CCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred CCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 9999999999976 35799999999999999999999998 999999999999999999999999999987755443
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ...... ...... ...
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--~~~-----~~~~~~-~~~~~~--~~~ 236 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV--SIA-----IKHIQD-SVPNVT--TDV 236 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH--HHH-----HHHHSS-CCCCHH--HHS
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHH-----HHHhhc-cCCCcc--hhc
Confidence 3444456999999999999999999999999999999999999999654211 110 010000 000000 011
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHhcCcCCCCCCC
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRP-SMKSVVLMLEGITDISIPPC 792 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~~~~~~p~~ 792 (796)
....+..+.+++.+||+.||.+|| ++.++.+.|+.+........
T Consensus 237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 233457799999999999999998 99999999999876654443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=355.08 Aligned_cols=267 Identities=28% Similarity=0.433 Sum_probs=207.2
Q ss_pred HHHhhhcccCcccceEEEEEE----EcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhcc--CCcee
Q 003772 511 ATNRFKEELGKGSFGAVYKGT----LYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE--DSKRL 584 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~----~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~ 584 (796)
..+++.+.||+|+||.||+++ ....++.||||++........+.+.+|+.++.+++||||+++++++.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 445677899999999999998 455678999999987666667889999999999999999999998854 35689
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+||||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 999999999999999764 34699999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCc--ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHH----hhhhhh
Q 003772 665 PDQT--RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYK----CFIDRE 738 (796)
Q Consensus 665 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~ 738 (796)
.... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ....... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccchhHHH
Confidence 4332 1222234677899999999999999999999999999999999887532110 0000000 000000
Q ss_pred hhhhh-c--CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 739 LNKLV-R--GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 739 ~~~~~-~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
+...+ . ....+...++.+.+++..||+.||++|||+.||++.|+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 11111 1 112344566789999999999999999999999999988643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.64 Aligned_cols=258 Identities=22% Similarity=0.363 Sum_probs=206.9
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCc-------EEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCce
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGE-------KLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~-------~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 583 (796)
..+.+.+.||+|+||.||+|.....+ ..||+|++........+.+.+|+.++.+++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 34567789999999999999887544 57999999876667778899999999999999999999999999999
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc--------eEEe
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT--------AKIS 655 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~ 655 (796)
++||||+++|+|.+++... ...+++..++.++.||++||.|||+. +|+||||||+|||++.++. +||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence 9999999999999999763 34589999999999999999999998 9999999999999998887 9999
Q ss_pred ccCCccccCCCCcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh
Q 003772 656 DFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF 734 (796)
Q Consensus 656 DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 734 (796)
|||++...... ....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+...........
T Consensus 164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~--------- 229 (289)
T 4fvq_A 164 DPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ--------- 229 (289)
T ss_dssp CCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH---------
T ss_pred cCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH---------
Confidence 99999765322 22347899999999987 6799999999999999999997665543321111000
Q ss_pred hhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 003772 735 IDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPPC 792 (796)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~ 792 (796)
........+......+.+++..||+.||.+|||+.++++.|+.+.....++.
T Consensus 230 ------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 230 ------FYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp ------HHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred ------HhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 0001111122234568899999999999999999999999999987665554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=361.96 Aligned_cols=257 Identities=28% Similarity=0.440 Sum_probs=197.9
Q ss_pred HHhhhcccCcccceEEEEEEEc---CCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
.+.+.+.||+|+||.||+|++. ..+..||||+++... ....+.|.+|+.++.+++||||+++++++.+.+..++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 4456789999999999999886 445689999997643 334567999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++|+|.+++... ...+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 126 e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 126 EYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp ECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred eCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 999999999999753 45799999999999999999999998 99999999999999999999999999998765433
Q ss_pred ccee--eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 668 TRTF--TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 668 ~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
.... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ... . ... .....
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--~~~--~----~~i-----~~~~~ 268 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDV--I----KAV-----DEGYR 268 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--HHH--H----HHH-----HTTEE
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHH--H----HHH-----HcCCC
Confidence 2221 12235778999999999999999999999999999998 9999864321 111 0 000 00000
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
...+..++..+.+++..||+.||.+||++.+|+++|+.+..
T Consensus 269 -~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 269 -LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp -CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 11233456789999999999999999999999999988754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=351.04 Aligned_cols=247 Identities=21% Similarity=0.326 Sum_probs=205.2
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
.+.+.+.||+|+||.||+|.+...++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 3566789999999999999998888999999997642 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 96 ~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 169 (328)
T 3fe3_A 96 ASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK- 169 (328)
T ss_dssp CTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG-
T ss_pred CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc-
Confidence 999999999976 35699999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeeeccCCCCCchhhhccCCCC-ccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPIS-VKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
.....||+.|+|||++.+..+. .++|||||||++|||++|+.||..... .. + ......+ ....
T Consensus 170 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~--~----~~~i~~~-------~~~~ 233 (328)
T 3fe3_A 170 -LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--KE--L----RERVLRG-------KYRI 233 (328)
T ss_dssp -GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--HH--H----HHHHHHC-------CCCC
T ss_pred -cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--HH--H----HHHHHhC-------CCCC
Confidence 2335699999999999988764 899999999999999999999964321 11 0 0000000 1112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
+......+.+++..||+.||.+|||++|+++.
T Consensus 234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 23345678899999999999999999999863
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=343.98 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=211.3
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+.+.+.||+|+||.||++.... +..||||++.... ...+++.+|+.++.+++||||+++++++.++...++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 345677899999999999998864 5679999997643 23567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 86 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp TTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 999999999763 34699999999999999999999998 99999999999999999999999999998776554444
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ...... .....+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~------~~~~~~------~~~~~~ 227 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--EVV------LKVSQG------HRLYRP 227 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHH------HHHHTT------CCCCCC
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--HHH------HHHHcC------CCCCCC
Confidence 444456778999999999899999999999999999999 89898643211 110 000000 001112
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
....+.+.+++..||+.||.+|||+.++++.|+.+.+.
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 23346789999999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=343.36 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=210.6
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.+.||+|+||.||++.... ++.||||++.... ...+.+.+|+.++.+++||||+++++++.+++..++||||++
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 35567899999999999999875 5679999997643 335679999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+|+|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 89 ~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 99999999653 45689999999999999999999998 999999999999999999999999999987655433333
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ....... .....+.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--~~~------~~~~~~~------~~~~~~~ 230 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEV------VEDISTG------FRLYKPR 230 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHH------HHHHHTT------CCCCCCT
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--HHH------HHHHhcC------ccCCCCC
Confidence 34456788999999999999999999999999999999 8888864321 110 0000000 0111223
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
.....+.+++..||+.||.+|||++++++.|+++.+.
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 3456789999999999999999999999999987643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=346.61 Aligned_cols=258 Identities=28% Similarity=0.394 Sum_probs=217.4
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
...+.+.+.||+|+||.||+|.+...+..||||++... ....+.+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 34456678999999999999999988899999999753 34567799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++++|.+++.......+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++.........
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 9999999999876667799999999999999999999999 9999999999999999999999999999987655544
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...... ... .. +... .....
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~--~~---------~~~~-~~~~~ 233 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVY--EL---------LEKD-YRMER 233 (288)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHH--HH---------HHTT-CCCCC
T ss_pred cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH--HH---------Hhcc-CCCCC
Confidence 4445567889999999999999999999999999999999 88888643311 110 00 0000 01122
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
+...++.+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 3345577999999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=362.90 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=208.9
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+.+.+.||+|+||.||+|.+..+++.||||++..... ...+.|.+|+.++++++||||+++++++.+++..++||||+
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 194 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 194 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence 44567899999999999999987888999999976433 33457899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|+|.+++... ...+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 195 QGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp TTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 999999999753 34689999999999999999999998 99999999999999999999999999998654332111
Q ss_pred e-eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 671 F-TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 671 ~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
. ....+++.|+|||.+....++.++|||||||++|||++ |+.|+..... .. ... .. ... .....
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~~--~~~----~~-----~~~-~~~~~ 336 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--QQ--TRE----FV-----EKG-GRLPC 336 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--HH--HHH----HH-----HTT-CCCCC
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HH--HHH----HH-----HcC-CCCCC
Confidence 1 11235778999999999999999999999999999998 8888864321 11 000 00 000 01122
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
+..++..+.+++..||+.||++|||+++|++.|+.+.
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 3345677899999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.06 Aligned_cols=260 Identities=27% Similarity=0.371 Sum_probs=208.7
Q ss_pred HHHhhhcccCcccceEEEEEEE-----cCCcEEEEEEEeecccc-hhHHHHHHHHHHHhcc-CcCchhhhhhhhccCC-c
Q 003772 511 ATNRFKEELGKGSFGAVYKGTL-----YKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDS-K 582 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~-----~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~-~ 582 (796)
..+.+.+.||+|+||.||+|.+ ...++.||||++..... ...+.+.+|++++.++ +||||+++++++.+.+ .
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 4456678999999999999984 44568999999976433 3456799999999999 7999999999988755 4
Q ss_pred eeEEEeecCCCChhhhhhcCCC----------------------------------------------------------
Q 003772 583 RLLVYEYMSNGSLADILFRGPE---------------------------------------------------------- 604 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 604 (796)
.++||||+++|+|.+++.....
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 8999999999999999976432
Q ss_pred ------CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc-ceeeeeccC
Q 003772 605 ------RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT-RTFTLVRGT 677 (796)
Q Consensus 605 ------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt 677 (796)
..+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++....... .......||
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 1288999999999999999999998 999999999999999999999999999987644332 233345688
Q ss_pred CCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHH
Q 003772 678 RGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENM 756 (796)
Q Consensus 678 ~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 756 (796)
+.|+|||++.+..++.++||||||+++|||++ |+.||........... ..... .....+....+.+
T Consensus 259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------~~~~~------~~~~~~~~~~~~l 325 (359)
T 3vhe_A 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-------RLKEG------TRMRAPDYTTPEM 325 (359)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH-------HHHHT------CCCCCCTTCCHHH
T ss_pred ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH-------HHHcC------CCCCCCCCCCHHH
Confidence 99999999999999999999999999999998 9999865432211100 00000 0111233345678
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 757 IKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 757 ~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.+++..||+.||.+|||++||++.|+.+.+
T Consensus 326 ~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 326 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 999999999999999999999999988653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=368.99 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=211.4
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+.+.+.||+|+||.||+|.+.. +..||||+++... ...+.|.+|+.++++++||||+++++++. .+..++||||+
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 345667899999999999999864 5689999997643 34678999999999999999999999986 56789999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|+|.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 999999999764345688999999999999999999998 99999999999999999999999999998765433222
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....++..|+|||++....++.++|||||||++|||++ |+.||..... .+.. ... .... ....+
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--~~~~------~~i-----~~~~-~~~~~ 407 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVI------RAL-----ERGY-RMPRP 407 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHH------HHH-----HHTC-CCCCC
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--HHHH------HHH-----HcCC-CCCCC
Confidence 233346788999999999999999999999999999999 9999864321 1110 000 0000 11123
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCC
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISI 789 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 789 (796)
..+++.+.+++..||+.||++|||+++|+++|+.+.....
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 4556789999999999999999999999999999876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=352.37 Aligned_cols=268 Identities=24% Similarity=0.315 Sum_probs=205.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCC----ceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS----KRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~ 587 (796)
.+.+.+.||+|+||.||+|+.. ++.||||++.... .....+..|+.++.+++||||+++++++.+.. ..++||
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 3456789999999999999875 5799999996532 33445667999999999999999999998754 369999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccC-------CCCeeeeccCccceEecCCCceEEeccCCc
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC-------EAPIIHCDIKPQNILMDEFWTAKISDFGLA 660 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~ 660 (796)
||+++|+|.+++.. ..+++..++.++.|+++||.|||+.+ ..+|+||||||+|||++.++.+||+|||++
T Consensus 102 e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 102 AFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp ECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 99999999999976 35999999999999999999999852 238999999999999999999999999999
Q ss_pred cccCCCCcc-eeeeeccCCCCCchhhhccC-----CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh
Q 003772 661 KLLMPDQTR-TFTLVRGTRGYMAPEWYKNT-----PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF 734 (796)
Q Consensus 661 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 734 (796)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||............ .......
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-~~~~~~~ 257 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE-EEIGQHP 257 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH-HHHCSSC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh-hhhccCC
Confidence 876544322 22335689999999999863 5677899999999999999999999754332111000 0000000
Q ss_pred hhhhhhhhhc-----C----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 735 IDRELNKLVR-----G----QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 735 ~~~~~~~~~~-----~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
....+..... + ..........+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0001111110 0 01133566789999999999999999999999999988653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=366.50 Aligned_cols=260 Identities=27% Similarity=0.396 Sum_probs=206.4
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+.+.++||+|+||.||+|.+..+ ..||||+++... ...+.|.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 3455678999999999999998754 679999997643 345679999999999999999999999876 6789999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|+|.+++.......+++..++.++.||++||.|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999999754345689999999999999999999998 99999999999999999999999999998765443333
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....++..|+|||.+....++.++||||||+++|||++ |+.|+..... .+. ......+ .....+
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~------~~~i~~~------~~~~~~ 403 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REV------LDQVERG------YRMPCP 403 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHH------HHHHHTT------CCCCCC
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--HHH------HHHHHcC------CCCCCC
Confidence 333457789999999999999999999999999999999 8888864321 111 0000000 011223
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCCC
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIP 790 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p 790 (796)
..+++.+.+++..||+.||++|||+++|++.|+.+.....|
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 45667899999999999999999999999999998765544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=343.68 Aligned_cols=268 Identities=21% Similarity=0.279 Sum_probs=212.7
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCC--ceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS--KRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+|.....++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 556789999999999999999888999999997543 234567889999999999999999999987655 67999999
Q ss_pred cCCCChhhhhhcCC-CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe----cCCCceEEeccCCccccC
Q 003772 590 MSNGSLADILFRGP-ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM----DEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 590 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFgl~~~~~ 664 (796)
+++|+|.+++.... ...+++..++.++.||++||.|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 99999999997642 23499999999999999999999998 99999999999999 788889999999998765
Q ss_pred CCCcceeeeeccCCCCCchhhhc--------cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhh
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYK--------NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFID 736 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.... .....||+.|+|||++. +..++.++|||||||++|||++|+.||......................
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~ 245 (319)
T 4euu_A 168 DDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (319)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred CCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence 4432 22345899999999986 4678999999999999999999999997544332222221111111111
Q ss_pred hhhh--------------hhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 737 RELN--------------KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 737 ~~~~--------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
..+. ...............+.+++..||+.||++|||+.|+++......
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1000 011111345678889999999999999999999999999886543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=345.54 Aligned_cols=246 Identities=26% Similarity=0.329 Sum_probs=205.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+++....++.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence 456789999999999999999888999999997632 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.+ ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 160 (337)
T 1o6l_A 87 ANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp CTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-
Confidence 999999999976 45789999999999999999999998 999999999999999999999999999986433222
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. . ...... .....+
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~-~-----~~~i~~-------~~~~~p 225 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ER-L-----FELILM-------EEIRFP 225 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HH-H-----HHHHHH-------CCCCCC
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HH-H-----HHHHHc-------CCCCCC
Confidence 22345699999999999999999999999999999999999999964321 11 0 011111 111123
Q ss_pred HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRP-----SMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 779 (796)
......+.+++..||+.||.+|| +++||++
T Consensus 226 ~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 34456789999999999999999 8999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.92 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=201.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEE----EEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKL----VAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~----vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
.+.+.+.||+|+||.||+|++...++. ||+|.+.... ....+++.+|+.++.+++||||+++++++.++ ..++|
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v 94 (327)
T 3poz_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 94 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEE
T ss_pred HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEE
Confidence 456678999999999999998666543 5888775432 34567899999999999999999999999875 47899
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
+||+++|+|.+++... ...+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 95 TQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 9999999999999764 45799999999999999999999998 9999999999999999999999999999877544
Q ss_pred Ccc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 667 QTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 667 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... .. .. +.. ..
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~--~~---------~~~-~~ 236 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS--SI---------LEK-GE 236 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HH--HH---------HHT-TC
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HH--HH---------HHc-CC
Confidence 332 2223446889999999999999999999999999999999 999986543211 10 00 000 01
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
....+..+...+.+++..||+.||.+|||+.+|++.|+.+..
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 112234456679999999999999999999999999987653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.87 Aligned_cols=259 Identities=25% Similarity=0.326 Sum_probs=198.0
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhc--cCcCchhhhhhhhcc----CCceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGR--THHKNLVRLIGYCAE----DSKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~h~niv~l~g~~~~----~~~~~l 585 (796)
.+.+.+.||+|+||.||+|+. .++.||||++... ..+.+..|.+++.. ++||||+++++++.+ ....++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 456678999999999999988 4678999998652 34555666666665 799999999998654 345789
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhh--------ccCCCCeeeeccCccceEecCCCceEEecc
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLH--------DECEAPIIHCDIKPQNILMDEFWTAKISDF 657 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 657 (796)
||||+++|+|.+++.. ..+++..++.++.|++.||.||| +. +|+||||||+|||++.++.+||+||
T Consensus 84 v~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCC
T ss_pred ehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeC
Confidence 9999999999999954 57999999999999999999999 66 9999999999999999999999999
Q ss_pred CCccccCCCCcce---eeeeccCCCCCchhhhccC------CCCccccchhhHHHHHHHhhc----------ccCCCCCC
Q 003772 658 GLAKLLMPDQTRT---FTLVRGTRGYMAPEWYKNT------PISVKADVFSYGVVLLEIVCC----------RRNMEIDP 718 (796)
Q Consensus 658 gl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvil~elltg----------~~p~~~~~ 718 (796)
|+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9998764433221 2234689999999999876 456799999999999999999 67765433
Q ss_pred CCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 719 SKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
.......... ........................+.+++..||+.||.+|||+.+|++.|+++
T Consensus 238 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPSFEDMR---KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCCHHHHH---HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcchhhhh---HHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2221111100 00000000000000112345778899999999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=346.24 Aligned_cols=251 Identities=26% Similarity=0.360 Sum_probs=205.5
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch------hHHHHHHHHHHHhccCcCchhhhhhhhccCCcee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE------GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 584 (796)
..+.+.+.||+|+||.||++.....++.||||++...... ..+.+.+|+.++.+++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4567789999999999999999888899999999764322 3567999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC----ceEEeccCCc
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW----TAKISDFGLA 660 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFgl~ 660 (796)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 99999999999999965 46799999999999999999999998 999999999999999877 8999999999
Q ss_pred cccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh
Q 003772 661 KLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740 (796)
Q Consensus 661 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .+........ ...
T Consensus 166 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~-~~~~~~~~~~---~~~ 237 (326)
T 2y0a_A 166 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QE-TLANVSAVNY---EFE 237 (326)
T ss_dssp EECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HH-HHHHHHHTCC---CCC
T ss_pred eECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--HH-HHHHHHhcCC---CcC
Confidence 87654322 2334589999999999999999999999999999999999999964321 11 1100000000 000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 741 KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
. .........+.+++..||+.||.+|||+.|+++
T Consensus 238 ~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 238 D-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp H-----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred c-----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 000123466889999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=349.99 Aligned_cols=259 Identities=27% Similarity=0.409 Sum_probs=210.4
Q ss_pred HHhhhcccCcccceEEEEEEEcC-----CcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
.+.+.+.||+|+||.||+++... .++.||||++..... ...+.+.+|+.++.+++||||+++++++.+++..++
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 127 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence 34567889999999999999863 347899999976433 345679999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCC----------------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccc
Q 003772 586 VYEYMSNGSLADILFRGP----------------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQN 643 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~N 643 (796)
||||+++|+|.+++.... ...+++..++.++.||++||.|||+. +|+||||||+|
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~N 204 (343)
T 1luf_A 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 204 (343)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcce
Confidence 999999999999997632 15689999999999999999999998 99999999999
Q ss_pred eEecCCCceEEeccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCc
Q 003772 644 ILMDEFWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKP 721 (796)
Q Consensus 644 Ill~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~ 721 (796)
|+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-- 282 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-- 282 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh--
Confidence 9999999999999999987643322 22233457889999999999999999999999999999999 8888864321
Q ss_pred hhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 722 EEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
... ......... ...+...+..+.+++..||+.||++|||+.+|++.|+.+.+-
T Consensus 283 ~~~------~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 283 EEV------IYYVRDGNI------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHH------HHHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred HHH------HHHHhCCCc------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 111 011111110 112334557799999999999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=345.39 Aligned_cols=257 Identities=17% Similarity=0.185 Sum_probs=207.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.+.+.||+|+||.||+|+....++.||||++.... ..+.+.+|+.++.++ +|+||+++++++.+++..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~- 87 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence 456789999999999999998888999999987532 234688999999999 9999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc-----eEEeccCCccccCCC
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT-----AKISDFGLAKLLMPD 666 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DFgl~~~~~~~ 666 (796)
+++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 88 ~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 88 GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 99999999764 46799999999999999999999998 9999999999999998887 999999999876443
Q ss_pred Ccc------eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh
Q 003772 667 QTR------TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740 (796)
Q Consensus 667 ~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................... .....
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~~ 242 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR-ATPIE 242 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH-HSCHH
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc-cCCHH
Confidence 321 12345699999999999999999999999999999999999999986543322111111100000 00000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 741 KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
.. ....+ .+.+++..||+.||.+||++.+|++.|+.+
T Consensus 243 ~~------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 243 VL------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HH------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HH------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 00 01123 799999999999999999999999999765
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=338.19 Aligned_cols=253 Identities=26% Similarity=0.455 Sum_probs=204.4
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchh-------HHHHHHHHHHHhccCcCchhhhhhhhccCCce
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG-------EREFRAEMHVIGRTHHKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~-------~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 583 (796)
..+.+.+.||+|+||.||+|.+..+++.||||++....... .+.+.+|+.++.+++|+||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 34566789999999999999998888999999986533221 167899999999999999999999986654
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCC--eeeeccCccceEecCCCc-----eEEec
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP--IIHCDIKPQNILMDEFWT-----AKISD 656 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~kl~D 656 (796)
++||||+++|+|.+++.+. ...+++..++.++.|++.||.|||+. + |+||||||+||+++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999999988764 45799999999999999999999998 7 999999999999987776 99999
Q ss_pred cCCccccCCCCcceeeeeccCCCCCchhhhc--cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh
Q 003772 657 FGLAKLLMPDQTRTFTLVRGTRGYMAPEWYK--NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF 734 (796)
Q Consensus 657 Fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 734 (796)
||+++.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||......... ......
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~--- 243 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMIR--- 243 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--HHHHHH---
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH--HHHHHh---
Confidence 999975432 233456899999999984 456789999999999999999999999755433211 111000
Q ss_pred hhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 735 IDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
........+...++.+.+++..||+.||.+|||+++|++.|+++
T Consensus 244 ------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 ------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 00011123345567899999999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.35 Aligned_cols=261 Identities=18% Similarity=0.204 Sum_probs=211.2
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeec
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+.+.+.||+|+||.||+|.....++.||||++... ...+.+.+|+.++.++ +|+|++++++++.++...++||||+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 355678999999999999999888899999998653 3345688999999999 7999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc-----eEEeccCCccccCC
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT-----AKISDFGLAKLLMP 665 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DFgl~~~~~~ 665 (796)
+++|.+++... ...+++..++.++.||++||.|||+. +|+||||||+||+++.++. +||+|||+++....
T Consensus 89 -~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 89 -GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp -CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred -CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 99999999764 35699999999999999999999998 9999999999999987776 99999999987754
Q ss_pred CCcc------eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh
Q 003772 666 DQTR------TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739 (796)
Q Consensus 666 ~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||................ ........
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~ 242 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG-EKKQSTPL 242 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH-HHHHHSCH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH-hhccCccH
Confidence 3321 2234568999999999999999999999999999999999999998654332221111111 10000111
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 740 NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
... ....++.+.+++..||+.||++|||+++|++.|+.+..
T Consensus 243 ~~~------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 243 REL------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHH------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHH------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 111 11335679999999999999999999999999988654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=361.81 Aligned_cols=250 Identities=30% Similarity=0.404 Sum_probs=205.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCC-ceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS-KRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~e~~~ 591 (796)
+.+.+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+.++++++||||+++++++.+.. ..++||||++
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred eEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 445688999999999999985 5689999997643 5678999999999999999999999987665 7899999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+|+|.+++.......+++..++.++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 271 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 343 (450)
T 1k9a_A 271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 343 (450)
T ss_dssp TCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc----
Confidence 99999999875455689999999999999999999998 99999999999999999999999999998643221
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
....++..|+|||.+.+..++.++|||||||++|||++ |+.|+....... .. .....+ . ....+.
T Consensus 344 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~------~~i~~~-----~-~~~~p~ 409 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VV------PRVEKG-----Y-KMDAPD 409 (450)
T ss_dssp ---CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HH------HHHHTT-----C-CCCCCT
T ss_pred cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH------HHHHcC-----C-CCCCCC
Confidence 12247889999999999999999999999999999998 999987543221 10 000000 0 112334
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
.++..+.+++..||+.||.+|||+.+|++.|+.+...
T Consensus 410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 5667899999999999999999999999999887543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=350.20 Aligned_cols=246 Identities=26% Similarity=0.351 Sum_probs=204.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch------hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE------GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
.+.+.+.||+|+||.||++.....++.||||++.+.... ..+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 356778999999999999999988899999999764332 24679999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC----ceEEeccCCcc
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW----TAKISDFGLAK 661 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFgl~~ 661 (796)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++ .+||+|||++.
T Consensus 93 v~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 93 ILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 9999999999999965 46799999999999999999999998 999999999999998776 79999999998
Q ss_pred ccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 662 LLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 662 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .+ ..+....
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--~~-~~-----~~i~~~~--- 234 (361)
T 2yab_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QE-TL-----ANITAVS--- 234 (361)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HH-HH-----HHHHTTC---
T ss_pred EcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HH-HH-----HHHHhcC---
Confidence 765432 22345699999999999999999999999999999999999999964321 11 11 0000000
Q ss_pred hhcCCCCC----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 742 LVRGQEVD----RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 742 ~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...+ ......+.+++..||+.||.+|||+.|+++
T Consensus 235 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 ----YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0011 123456889999999999999999999984
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=346.94 Aligned_cols=251 Identities=26% Similarity=0.359 Sum_probs=203.0
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.+.+.||+|+||.||++.....++.||||++..... ...+.+.+|+.+++.++|+||+++++++.+++..++||||++
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 4567899999999999999998889999999865332 334678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc-ce
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT-RT 670 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~-~~ 670 (796)
+|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 89 GGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp TEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 9999999965 45699999999999999999999998 999999999999999999999999999986643222 22
Q ss_pred eeeeccCCCCCchhhhccCCC-CccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....||+.|+|||++.+..+ +.++|||||||++|||++|+.||........... .+... .......
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--~~~~~----------~~~~~~~ 231 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--DWKEK----------KTYLNPW 231 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH--HHHTT----------CTTSTTG
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH--HHhcc----------cccCCcc
Confidence 234568999999999988765 7899999999999999999999975543322111 11000 0000111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
......+.+++..||+.||.+|||+.|+++.
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 2345678899999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=341.49 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=207.1
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+.+.+.||+|+||.||++... ++..||||++.... ...+++.+|++++.+++|+||+++++++.+.+..++||||+
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 34566789999999999999886 45789999997643 23567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 102 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp TTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 999999999753 35699999999999999999999998 99999999999999999999999999998765443333
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... . . .... .... ....+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~--~----~~~~-----~~~~-~~~~~ 243 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--E--T----AEHI-----AQGL-RLYRP 243 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--H--H----HHHH-----HTTC-CCCCC
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--H--H----HHHH-----hccc-CCCCC
Confidence 333446788999999999999999999999999999998 99998643211 1 0 0000 0000 11122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
....+.+.+++.+||+.+|.+|||+.++++.|+.+.+
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 3335678999999999999999999999999987653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=350.41 Aligned_cols=266 Identities=15% Similarity=0.165 Sum_probs=205.0
Q ss_pred HHhhhcccCcccceEEEEEEEcCC-----cEEEEEEEeecccchh-----------HHHHHHHHHHHhccCcCchhhhhh
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKG-----EKLVAVKKLEKMVTEG-----------EREFRAEMHVIGRTHHKNLVRLIG 575 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~-----~~~vAvK~l~~~~~~~-----------~~~f~~E~~~l~~l~h~niv~l~g 575 (796)
.+.+.+.||+|+||.||+|.+..+ ++.||||++....... ...+..|+..+..++|+||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 456778999999999999998764 4689999987543221 122445666778889999999999
Q ss_pred hhccC----CceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec--CC
Q 003772 576 YCAED----SKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD--EF 649 (796)
Q Consensus 576 ~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~ 649 (796)
++.+. ...++||||+ +++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++ .+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCT
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCC
Confidence 98764 4579999999 99999999763 46799999999999999999999998 999999999999999 88
Q ss_pred CceEEeccCCccccCCCCcc------eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchh
Q 003772 650 WTAKISDFGLAKLLMPDQTR------TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEE 723 (796)
Q Consensus 650 ~~~kl~DFgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~ 723 (796)
+.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 99999999999876543221 112345999999999999999999999999999999999999999854333222
Q ss_pred HHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 724 IVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.......... .+..+++........+..+.+++..||+.+|.+||++.+|++.|+.+..
T Consensus 271 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 271 VRDSKIRYRE----NIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp HHHHHHHHHH----CHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhhh----hHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 2111111111 1222221111112335678999999999999999999999999987643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=367.07 Aligned_cols=253 Identities=23% Similarity=0.282 Sum_probs=204.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.++||+|+||.||++++..+++.||||++.+... ...+.+++|+.++..++||||+++++++.+.+..++||||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence 3455789999999999999999899999999976322 2233489999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.+. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 156 ~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 156 YVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp CTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 9999999999763 46799999999999999999999998 9999999999999999999999999999877655554
Q ss_pred eeeeeccCCCCCchhhhc-----cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 670 TFTLVRGTRGYMAPEWYK-----NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+. ...+..... . ..
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--~~~------~~~i~~~~~-~-~~ 301 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--VET------YGKIMNHKE-R-FQ 301 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHH------HHHHHTHHH-H-CC
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh--hHH------HHhhhhccc-c-cc
Confidence 445567999999999997 45789999999999999999999999974321 111 111111000 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPAL--RPSMKSVVL 779 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~ 779 (796)
-........+.+.+++..||+.+|++ ||+++|+++
T Consensus 302 ~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 302 FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 00111224567889999999888888 999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=339.73 Aligned_cols=256 Identities=20% Similarity=0.312 Sum_probs=196.7
Q ss_pred HHHhhhcccCcccceEEEEEEEcCC---cEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKG---EKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
..+.+.+.||+|+||.||+|..... +..||||++.... ....+.+.+|+.++.+++||||+++++++. ++..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 4556778999999999999998543 3579999987533 334567899999999999999999999874 5678999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|||+++|+|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 94 MELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 9999999999999763 45699999999999999999999998 9999999999999999999999999999877544
Q ss_pred CcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
.........+++.|+|||.+....++.++||||||+++|||++ |+.||...... ... . ..... ..
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~--~----~i~~~------~~ 235 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVI--G----RIENG------ER 235 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHH--H----HHHTT------CC
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHH--H----HHHcC------CC
Confidence 3333334457789999999999999999999999999999997 88888644321 110 0 00000 01
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
...+...+..+.+++..||+.||++|||+.+|++.|+.+.
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1223455678999999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=353.63 Aligned_cols=262 Identities=29% Similarity=0.410 Sum_probs=212.7
Q ss_pred HHHHhhhcccCcccceEEEEEEEcC-------CcEEEEEEEeecccc-hhHHHHHHHHHHHhcc-CcCchhhhhhhhccC
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYK-------GEKLVAVKKLEKMVT-EGEREFRAEMHVIGRT-HHKNLVRLIGYCAED 580 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~-------~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~ 580 (796)
...+.+.+.||+|+||.||+|+... ....||||++..... ...+.+.+|++++.++ +||||+++++++.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 3456677899999999999998642 336899999976433 3447789999999999 899999999999999
Q ss_pred CceeEEEeecCCCChhhhhhcCC--------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe
Q 003772 581 SKRLLVYEYMSNGSLADILFRGP--------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM 646 (796)
Q Consensus 581 ~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 646 (796)
+..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 99999999999999999997643 24599999999999999999999998 99999999999999
Q ss_pred cCCCceEEeccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhH
Q 003772 647 DEFWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEI 724 (796)
Q Consensus 647 ~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~ 724 (796)
++++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.|+..... ..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--~~- 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EE- 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH-
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HH-
Confidence 9999999999999987654332 22233457889999999999999999999999999999999 8888864321 11
Q ss_pred HHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCC
Q 003772 725 VLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDIS 788 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 788 (796)
. ....... .....+......+.+++..||+.||++|||+.||++.|+.+....
T Consensus 302 -~----~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 302 -L----FKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp -H----HHHHHTT------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred -H----HHHHHcC------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 0 0100000 011123345577999999999999999999999999999876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.15 Aligned_cols=252 Identities=21% Similarity=0.296 Sum_probs=205.4
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
...+.+.+.||+|+||.||++.....++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 355677899999999999999998888999999997532 234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC---ceEEeccCCccccC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW---TAKISDFGLAKLLM 664 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFgl~~~~~ 664 (796)
||+++|+|.+.+.. ...+++..+..++.||++||.|||+. +|+||||||+|||++.++ .+||+|||++....
T Consensus 108 e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 99999999999975 46789999999999999999999998 999999999999998654 59999999998765
Q ss_pred CCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .. ......... .
T Consensus 183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~-~~-----~~i~~~~~~---~ 249 (362)
T 2bdw_A 183 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HR-LY-----AQIKAGAYD---Y 249 (362)
T ss_dssp TCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH-HH-----HHHHHTCCC---C
T ss_pred CCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HH-HH-----HHHHhCCCC---C
Confidence 332 22335699999999999999999999999999999999999999964321 11 10 111110000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...........+.+++..||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00111234567899999999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=354.92 Aligned_cols=252 Identities=18% Similarity=0.277 Sum_probs=204.8
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
..+.+.+.||+|+||.||++.....++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 45677899999999999999999889999999997533 2345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec---CCCceEEeccCCccccCC
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD---EFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFgl~~~~~~ 665 (796)
|+++|+|.+.+.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ +++.+||+|||++.....
T Consensus 91 ~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 91 LVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred eCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 9999999999976 46799999999999999999999998 999999999999998 467899999999987654
Q ss_pred CCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .. .....+... ..
T Consensus 166 ~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~-~~-----~~i~~~~~~---~~ 233 (444)
T 3soa_A 166 EQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HR-LY-----QQIKAGAYD---FP 233 (444)
T ss_dssp TCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH-HH-----HHHHHTCCC---CC
T ss_pred CCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HH-HH-----HHHHhCCCC---CC
Confidence 332 22345699999999999999999999999999999999999999964321 11 11 111111000 00
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
........+.+.+++..||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0111234567889999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=355.13 Aligned_cols=260 Identities=28% Similarity=0.404 Sum_probs=207.5
Q ss_pred HHHHhhhcccCcccceEEEEEEEc-----CCcEEEEEEEeecc-cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCce
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKM-VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 583 (796)
...+.+.+.||+|+||.||+|++. ..++.||||++... .......+.+|+.++.+++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 345567789999999999999953 45678999999654 334456789999999999999999999999999999
Q ss_pred eEEEeecCCCChhhhhhcCC-----CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC---ceEEe
Q 003772 584 LLVYEYMSNGSLADILFRGP-----ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW---TAKIS 655 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 655 (796)
++||||+++|+|.+++.... ...+++..++.++.||++||.|||+. +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997532 24689999999999999999999998 999999999999999554 59999
Q ss_pred ccCCccccCCCC-cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHh
Q 003772 656 DFGLAKLLMPDQ-TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKC 733 (796)
Q Consensus 656 DFgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 733 (796)
|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... .. .. ..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~--~~----~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QE--VL----EF 298 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH--HH----HH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HH--HH----HH
Confidence 999998653221 122223457899999999999999999999999999999998 8888864321 11 10 00
Q ss_pred hhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 734 FIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.... .....+...+..+.+++..||+.||.+|||+.+|++.|+.+.+
T Consensus 299 i~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 299 VTSG------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcC------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 0000 0112233455678999999999999999999999999987643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=344.78 Aligned_cols=250 Identities=20% Similarity=0.316 Sum_probs=205.0
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.+.||+|+||.||++....+++.+|+|.+... ......+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 355678999999999999999988999999998753 3445678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC--CCceEEeccCCccccCCCCcc
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE--FWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+|+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 85 g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-- 158 (321)
T 1tki_A 85 GLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--
Confidence 99999999653 35699999999999999999999998 9999999999999997 7899999999998875433
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .. ......... ......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~-~~-----~~i~~~~~~---~~~~~~ 227 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQ-II-----ENIMNAEYT---FDEEAF 227 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HH-HH-----HHHHHTCCC---CCHHHH
T ss_pred ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--HH-HH-----HHHHcCCCC---CChhhh
Confidence 23345689999999999998899999999999999999999999964321 11 11 000000000 000000
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......+.+++..||+.||.+|||+.|+++
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 228 KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 123467899999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=342.72 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=212.4
Q ss_pred HHHhhhcccCcccceEEEEEEE-----cCCcEEEEEEEeecccc-hhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCce
Q 003772 511 ATNRFKEELGKGSFGAVYKGTL-----YKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~-----~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 583 (796)
..+.+.+.||+|+||.||+|.+ ...++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+++..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 4456778999999999999985 34567999999976433 3456799999999999 999999999999999999
Q ss_pred eEEEeecCCCChhhhhhcCCC----------------CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec
Q 003772 584 LLVYEYMSNGSLADILFRGPE----------------RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD 647 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 647 (796)
++||||+++|+|.+++..... ..+++..++.++.||++||.|||+. +|+||||||+||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEc
Confidence 999999999999999976432 2589999999999999999999998 999999999999999
Q ss_pred CCCceEEeccCCccccCCCCcce-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHH
Q 003772 648 EFWTAKISDFGLAKLLMPDQTRT-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIV 725 (796)
Q Consensus 648 ~~~~~kl~DFgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~ 725 (796)
.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 259 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence 99999999999998775543322 223457889999999999999999999999999999999 8988875443211110
Q ss_pred HHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 726 LINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
. +.... ....+...+..+.+++..||+.||.+|||+.||++.|+++.+
T Consensus 260 ~------------~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 260 M------------IKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp H------------HHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H------------hccCC-CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 0 00000 111223445778999999999999999999999999988654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=343.47 Aligned_cols=259 Identities=29% Similarity=0.439 Sum_probs=210.9
Q ss_pred HHHhhhcccCcccceEEEEEEEc-----CCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCcee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 584 (796)
..+.+.+.||+|+||.||++... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 34556789999999999999873 345789999997643 334567899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCC----------------------CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCcc
Q 003772 585 LVYEYMSNGSLADILFRGPE----------------------RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQ 642 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~ 642 (796)
+||||+++|+|.+++..... ..+++..++.++.||++||.|||+. +|+||||||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~ 179 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAAR 179 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchh
Confidence 99999999999999976422 3489999999999999999999998 9999999999
Q ss_pred ceEecCCCceEEeccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCC
Q 003772 643 NILMDEFWTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSK 720 (796)
Q Consensus 643 NIll~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~ 720 (796)
||++++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876543322 2223447788999999999999999999999999999999 99998644321
Q ss_pred chhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 721 PEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
... ...... .....+....+.+.+++..||+.||++|||+.+|++.|+++..
T Consensus 260 --~~~------~~~~~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 260 --RLF------NLLKTG------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp --GHH------HHHHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHH------HHhhcC------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 110 000000 0112233456779999999999999999999999999988653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.75 Aligned_cols=252 Identities=29% Similarity=0.483 Sum_probs=197.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.+.+.||+|+||.||+++.. ++.||||++.. ....+.|.+|+.++++++||||+++++++.+ ..++||||+++
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEET--TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred eeeeeEeecCCCceEEEEEEC--CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 456788999999999999984 57899999964 3445779999999999999999999998874 58999999999
Q ss_pred CChhhhhhcCCC-CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc-eEEeccCCccccCCCCcce
Q 003772 593 GSLADILFRGPE-RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT-AKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 593 gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DFgl~~~~~~~~~~~ 670 (796)
|+|.+++..... ..+++..++.++.|+++||.|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 999999976432 34788899999999999999999932238999999999999998876 799999999765432
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........... +.... . .......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~---~------~~~~~~~ 227 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHN---G------TRPPLIK 227 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH---HHHHT---T------CCCCCBT
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH---HHHhc---C------CCCCccc
Confidence 1233589999999999999999999999999999999999999975432211111 11110 0 0111223
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
..+..+.+++.+||+.||.+|||+++|++.|+.+.+
T Consensus 228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 345678999999999999999999999999988654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=334.79 Aligned_cols=252 Identities=29% Similarity=0.415 Sum_probs=193.8
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc----hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT----EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
.+.+.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred heeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 3456789999999999999974 57899999865332 23467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC--------CCceEEeccCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE--------FWTAKISDFGL 659 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~DFgl 659 (796)
||+++++|.+++.. ..+++..++.++.|+++||.|||++...+|+||||||+||+++. ++.+||+|||+
T Consensus 86 e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 86 EFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp ECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999999853 57999999999999999999999982223999999999999986 77899999999
Q ss_pred ccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh
Q 003772 660 AKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739 (796)
Q Consensus 660 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
+........ ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ... .. .
T Consensus 163 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~-----~~-~----- 226 (271)
T 3dtc_A 163 AREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--AVA-----YG-V----- 226 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--HHH-----HH-H-----
T ss_pred ccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH-----Hh-h-----
Confidence 986543322 2345899999999999999999999999999999999999999643211 100 00 0
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 740 NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
.........+...++.+.+++..||+.||.+|||+.|+++.|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 000001122344557799999999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.02 Aligned_cols=261 Identities=27% Similarity=0.365 Sum_probs=208.6
Q ss_pred HHHhhhcccCcccceEEEEEEEc-----CCcEEEEEEEeeccc-chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCce
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 583 (796)
..+.+.+.||+|+||.||+|.+. ..+..||||++.... ....+.+.+|+.++.++ +||||+++++++.+.+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 44567789999999999999973 345689999997532 33456799999999999 899999999999999999
Q ss_pred eEEEeecCCCChhhhhhcCCC---------------------CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCcc
Q 003772 584 LLVYEYMSNGSLADILFRGPE---------------------RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQ 642 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~ 642 (796)
++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+. +|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence 999999999999999976432 3489999999999999999999998 9999999999
Q ss_pred ceEecCCCceEEeccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCC
Q 003772 643 NILMDEFWTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSK 720 (796)
Q Consensus 643 NIll~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~ 720 (796)
||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 999999999999999999876543322 2233457889999999999999999999999999999998 99998755322
Q ss_pred chhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 721 PEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
.... ... .... ....+....+.+.+++..||+.||.+|||+.+|++.|+.+...
T Consensus 282 ~~~~---~~~---------~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 282 ANFY---KLI---------QNGF-KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp HHHH---HHH---------HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHH---HHH---------hcCC-CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1110 000 0000 1112334457799999999999999999999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=350.29 Aligned_cols=252 Identities=22% Similarity=0.331 Sum_probs=207.7
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.+.||+|+||.||+|....+++.||+|++..........+.+|+.++.+++||||+++++++.+....++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 45677899999999999999998889999999987655566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC--CCceEEeccCCccccCCCCcc
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE--FWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+|+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 132 gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~- 206 (387)
T 1kob_A 132 GGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 206 (387)
T ss_dssp CCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred CCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc-
Confidence 99999999653 35799999999999999999999998 9999999999999974 57799999999987754432
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .+ . ...... ........
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~-~~-~----~i~~~~---~~~~~~~~ 274 (387)
T 1kob_A 207 -VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LE-TL-Q----NVKRCD---WEFDEDAF 274 (387)
T ss_dssp -EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HH-HH-H----HHHHCC---CCCCSSTT
T ss_pred -eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HH-HH-H----HHHhCC---CCCCcccc
Confidence 2334689999999999999999999999999999999999999964321 11 11 0 000000 00001112
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
......+.+++..||+.||.+|||+.|+++.
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 2345678999999999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.54 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=196.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--------------------------hhHHHHHHHHHHHhcc
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--------------------------EGEREFRAEMHVIGRT 565 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--------------------------~~~~~f~~E~~~l~~l 565 (796)
.+.+.+.||+|+||.||+|.....++.||||++..... ...+.+.+|+.+++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 35667899999999999999988899999999865321 1134688999999999
Q ss_pred CcCchhhhhhhhcc--CCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccc
Q 003772 566 HHKNLVRLIGYCAE--DSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQN 643 (796)
Q Consensus 566 ~h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~N 643 (796)
+||||+++++++.+ +...++||||+++++|.+++. ...+++..++.++.||++||.|||+. +|+||||||+|
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 167 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSN 167 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHH
Confidence 99999999999886 567899999999999988763 35799999999999999999999998 99999999999
Q ss_pred eEecCCCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccCC---CCccccchhhHHHHHHHhhcccCCCCCCCC
Q 003772 644 ILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP---ISVKADVFSYGVVLLEIVCCRRNMEIDPSK 720 (796)
Q Consensus 644 Ill~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvil~elltg~~p~~~~~~~ 720 (796)
||++.++.+||+|||+++....... ......||+.|+|||.+.+.. .+.++|||||||++|||++|+.||.....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~- 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI- 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred EEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH-
Confidence 9999999999999999987654332 223456899999999998765 37889999999999999999999964321
Q ss_pred chhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 721 PEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
... ........ . .........+.+.+++.+||+.||++|||+.|+++
T Consensus 246 ---~~~----~~~~~~~~----~-~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 ---MCL----HSKIKSQA----L-EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ---HHH----HHHHHHCC----C-CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---HHH----HHHHhccc----C-CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 111 00000000 0 00112234567899999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=345.67 Aligned_cols=250 Identities=21% Similarity=0.271 Sum_probs=204.5
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-----hhHHHHHHHHHHHhccCcCchhhhhhhhccCCcee
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-----EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-----~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 584 (796)
...+.+.+.||+|+||.||++.....++.||||++..... ...+.+.+|+.++.+++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4567788999999999999999988889999999864221 13567999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc---eEEeccCC
Q 003772 585 LVYEYMSNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT---AKISDFGL 659 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFgl 659 (796)
+||||+++|+|.+.+.+. ....+++..+..++.||++||.|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999888643 234689999999999999999999998 9999999999999987655 99999999
Q ss_pred ccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh
Q 003772 660 AKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739 (796)
Q Consensus 660 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .... .......
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~-----~~i~~~~- 248 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLF-----EGIIKGK- 248 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHH-----HHHHHTC-
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHH-----HHHHcCC-
Confidence 987754332 2233468999999999999999999999999999999999999996431 1111 1010000
Q ss_pred hhhhcCCCCC----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 740 NKLVRGQEVD----RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 740 ~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.... ......+.+++..||+.||++|||+.|+++
T Consensus 249 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 ------YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp ------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------CCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0011 123467899999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.30 Aligned_cols=266 Identities=15% Similarity=0.164 Sum_probs=202.6
Q ss_pred HHHhhhcccCcccceEEEEEEEcC---CcEEEEEEEeecccch-----------hHHHHHHHHHHHhccCcCchhhhhhh
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYK---GEKLVAVKKLEKMVTE-----------GEREFRAEMHVIGRTHHKNLVRLIGY 576 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~---~~~~vAvK~l~~~~~~-----------~~~~f~~E~~~l~~l~h~niv~l~g~ 576 (796)
..+.+.+.||+|+||.||+|.... .+..+|||++...... ..+.+.+|+..+..++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 345677899999999999999976 6678999998764322 12346678899999999999999999
Q ss_pred hcc----CCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC--
Q 003772 577 CAE----DSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW-- 650 (796)
Q Consensus 577 ~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 650 (796)
+.+ ....++||||+ +++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence 887 67889999999 99999999763 4899999999999999999999998 999999999999999887
Q ss_pred ceEEeccCCccccCCCCcc------eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhH
Q 003772 651 TAKISDFGLAKLLMPDQTR------TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEI 724 (796)
Q Consensus 651 ~~kl~DFgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~ 724 (796)
.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 9999999999876433211 1133468999999999999999999999999999999999999996543332222
Q ss_pred HHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 725 VLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
..............+..... ....+..+.+++..||+.||++|||+.+|++.|+.+..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 271 QTAKTNLLDELPQSVLKWAP----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHTTTHHHHHHSC----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHhhcccccHHHHhhcc----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 21111111111111111111 11344679999999999999999999999999987643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=348.87 Aligned_cols=247 Identities=25% Similarity=0.314 Sum_probs=198.8
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
.+.||+|+||.||+|.....++.||||++........+.+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 35799999999999999888899999999876656677899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe--cCCCceEEeccCCccccCCCCcceeee
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM--DEFWTAKISDFGLAKLLMPDQTRTFTL 673 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DFgl~~~~~~~~~~~~~~ 673 (796)
.+++... ...+++..++.++.||++||.|||+. +|+||||||+|||+ ++++.+||+|||+++....... ...
T Consensus 174 ~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~ 247 (373)
T 2x4f_A 174 FDRIIDE-SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247 (373)
T ss_dssp HHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence 9998753 35689999999999999999999998 99999999999999 5678899999999987754332 223
Q ss_pred eccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHH
Q 003772 674 VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTL 753 (796)
Q Consensus 674 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (796)
..||+.|+|||++....++.++|||||||++|||++|+.||..... ...+... .. .... ..........
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i-~~----~~~~---~~~~~~~~~~ 316 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AETLNNI-LA----CRWD---LEDEEFQDIS 316 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHH-HH----TCCC---SCSGGGTTSC
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH-Hh----ccCC---CChhhhccCC
Confidence 4589999999999999999999999999999999999999964421 1111110 00 0000 0001112335
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 754 ENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 754 ~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
+.+.+++..||+.||.+|||+.|+++
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 67899999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.44 Aligned_cols=263 Identities=21% Similarity=0.272 Sum_probs=201.5
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch---hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE---GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~---~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+.+.+.||+|+||.||++.....++.||||++...... ..+.+.+|+.++.+++||||+++++++.+++..++|+|
T Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 356678999999999999999888899999999764322 24678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++++|.+++.. ...+++..++.++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 115 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 115 LINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp CCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred ecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 9999999999976 35689999999999999999999998 999999999999999999999999999987655443
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... . ... . ...... ......
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~-~~~----~-~~~~~~---~~~~~~ 257 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---S-VMG----A-HINQAI---PRPSTV 257 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---H-HHH----H-HHHSCC---CCGGGT
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---H-HHH----H-HhccCC---CCcccc
Confidence 333445689999999999999999999999999999999999999964321 1 100 0 000000 001112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHhcCcCCCCCC
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRP-SMKSVVLMLEGITDISIPP 791 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~~~~~~p~ 791 (796)
....+..+.+++..||+.||++|| |++++++.|+.......+.
T Consensus 258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 234456788999999999999999 9999999999887665544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=349.29 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=200.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 587 (796)
.+.+.+.||+|+||.||+++...+++.||||++++... ...+.+..|..++.++ +||||+++++++.+.+..++||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 35567899999999999999999999999999986432 2334578899999887 8999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++|+|.+++.+ ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 133 E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 133 EYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp ECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 99999999999976 46799999999999999999999998 99999999999999999999999999998643222
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchh-HHHHHHHHHhhhhhhhhhhhcCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEE-IVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........+.... ...
T Consensus 208 -~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-------~~~ 279 (396)
T 4dc2_A 208 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-------KQI 279 (396)
T ss_dssp -CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-------CCC
T ss_pred -CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-------ccc
Confidence 2233456999999999999999999999999999999999999999643221110 0000001111111 111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSM 774 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 774 (796)
..+......+.+++..||+.||.+||+.
T Consensus 280 ~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 2233455678999999999999999995
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.98 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=203.8
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccC--CceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAED--SKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 587 (796)
.+.+.+.||+|+||.||+|++. ++.||||++.... ....+.+.+|+.++.+++||||+++++++.+. ...++||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 3556789999999999999985 6789999987532 34456799999999999999999999999876 7789999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCC--eeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP--IIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
||+++|+|.+++.......+++..++.++.|+++||.|||+. + |+||||||+||+++.++.++|.|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999999876555799999999999999999999997 7 99999999999999999999999888754322
Q ss_pred CCcceeeeeccCCCCCchhhhccCCCC---ccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYKNTPIS---VKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~~~~~t---~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
....||+.|+|||.+.+...+ .++||||||+++|||++|+.||...... ... .. . ...
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~-----~~-~----~~~- 226 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM--EIG-----MK-V----ALE- 226 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH--HHH-----HH-H----HHS-
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH--HHH-----HH-H----Hhc-
Confidence 123479999999999876444 4899999999999999999999643211 100 00 0 000
Q ss_pred hcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 743 VRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 743 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
......+......+.+++..||+.||++|||++++++.|+.+.+
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 00112234456779999999999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=349.97 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=201.4
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeE
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 585 (796)
...+.+.+.||+|+||.||+++....++.||||++.+.. ....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 344567789999999999999999888999999997632 23445688899999988 69999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
||||+++|+|.+++.+ ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999976 46799999999999999999999998 999999999999999999999999999986433
Q ss_pred CCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. . ...+... .
T Consensus 177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~-~-----~~~i~~~-------~ 240 (353)
T 3txo_A 177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--DD-L-----FEAILND-------E 240 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH-H-----HHHHHHC-------C
T ss_pred CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--HH-H-----HHHHHcC-------C
Confidence 22 223345699999999999998999999999999999999999999964421 11 1 1111111 1
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHH
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSM------KSVVL 779 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~ 779 (796)
...+......+.+++..||+.||.+||++ .|+++
T Consensus 241 ~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11233345678899999999999999998 67764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=345.55 Aligned_cols=263 Identities=22% Similarity=0.320 Sum_probs=198.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCce----e
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKR----L 584 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~----~ 584 (796)
.+.+.+.||+|+||.||++++...++.||||++..... .....+.+|+.++.+++||||+++++++...... +
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 45677899999999999999988899999999976432 2345789999999999999999999998765543 9
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+||||+++|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 93 lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred EEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 99999999999999976 35799999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCc--ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 665 PDQT--RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 665 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .... ............
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--~~~~-----~~~~~~~~~~~~ 240 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVA-----YQHVREDPIPPS 240 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHH-----HHHHHCCCCCHH
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHH-----HHHhcCCCCCcc
Confidence 4322 222334589999999999999999999999999999999999999964321 1111 000000000000
Q ss_pred hcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH-HHHHhcCcCCCCC
Q 003772 743 VRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSV-VLMLEGITDISIP 790 (796)
Q Consensus 743 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev-l~~L~~~~~~~~p 790 (796)
.........+.+++..||+.||.+||+..++ ...+..+.....|
T Consensus 241 ----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~ 285 (311)
T 3ork_A 241 ----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP 285 (311)
T ss_dssp ----HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCC
T ss_pred ----cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCC
Confidence 0011235678899999999999999966554 4555554443333
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.55 Aligned_cols=261 Identities=21% Similarity=0.255 Sum_probs=201.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+++.++||+|+||.||+|.....++.||||++..... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 4567899999999999999998889999999975332 33467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++ +|.+.+... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 84 ~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 157 (292)
T 3o0g_A 84 DQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RC 157 (292)
T ss_dssp SE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SC
T ss_pred CC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-cc
Confidence 86 555555442 46799999999999999999999998 99999999999999999999999999998764332 22
Q ss_pred eeeeccCCCCCchhhhccCC-CCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh---hhhhcC-
Q 003772 671 FTLVRGTRGYMAPEWYKNTP-ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL---NKLVRG- 745 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~- 745 (796)
.....||+.|+|||++.+.. ++.++|||||||++|||++|+.|+......................... ......
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 23345899999999998765 7999999999999999999999875443221111110000000000000 000000
Q ss_pred -----------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 746 -----------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 746 -----------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....+.....+.+++..||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0112245567889999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=338.98 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=207.7
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+++.+.||+|+||.||+|... ++..||||++.... ...+.+.+|++++.+++|+||+++++++. .+..++||||++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred hhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 4566789999999999999976 45789999997543 34567999999999999999999999876 456899999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+++|.+++.......+++..++.++.|+++||.|||+. +|+||||||+||++++++.+||+|||++...........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 99999999653334799999999999999999999998 999999999999999999999999999987754433333
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ....... . ....+.
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~------~~~~~~~-----~-~~~~~~ 233 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEV------IQNLERG-----Y-RMVRPD 233 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHH------HHHHHTT-----C-CCCCCT
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--HHH------HHHHhcc-----c-CCCCcc
Confidence 33446789999999998899999999999999999999 8888864321 110 0000000 0 111233
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
.....+.+++..||+.||++|||+.+|++.|+.+...
T Consensus 234 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 4457799999999999999999999999999987544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=368.92 Aligned_cols=260 Identities=27% Similarity=0.397 Sum_probs=211.5
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+.+.++||+|+||.||+|.+..+ ..||||+++... ...+.|.+|+.++++++|+||+++++++.+ +..++||||+
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 3456778999999999999998754 679999997643 345679999999999999999999999876 6789999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|+|.++|.......+++..++.++.||++||.|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 999999999754345689999999999999999999998 99999999999999999999999999998765432222
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....++..|+|||.+....++.++|||||||+||||++ |+.||..... .+. ......+ . ....+
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--~~~------~~~i~~~-----~-~~~~~ 486 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REV------LDQVERG-----Y-RMPCP 486 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--HHH------HHHHHTT-----C-CCCCC
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHH------HHHHHcC-----C-CCCCC
Confidence 223346788999999999999999999999999999999 8888864321 111 0100000 0 11223
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCCC
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIP 790 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p 790 (796)
..+...+.+++..||+.||++|||+++|+++|+.+.....|
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 45567899999999999999999999999999998765444
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=349.32 Aligned_cols=260 Identities=27% Similarity=0.391 Sum_probs=209.0
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCc-----EEEEEEEeecccc-hhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCc
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGE-----KLVAVKKLEKMVT-EGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSK 582 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~-----~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~ 582 (796)
...+.+.+.||+|+||.||+|.....+ +.||+|++..... ...+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 344567789999999999999986544 3799999976433 3456789999999999 89999999999999999
Q ss_pred eeEEEeecCCCChhhhhhcCC------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC
Q 003772 583 RLLVYEYMSNGSLADILFRGP------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW 650 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 650 (796)
.++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 999999999999999996421 34689999999999999999999998 999999999999999999
Q ss_pred ceEEeccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHH
Q 003772 651 TAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLIN 728 (796)
Q Consensus 651 ~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~ 728 (796)
.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......... .
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~---~ 278 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY---K 278 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH---H
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH---H
Confidence 9999999999866433322 2223457889999999999999999999999999999999 888886543221111 0
Q ss_pred HHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 729 WAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
.... .. ....+...+..+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus 279 ~~~~---------~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 279 LVKD---------GY-QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHH---------TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhc---------CC-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 0000 00 01112234567899999999999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=334.46 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=209.2
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.+.||+|+||.||++.... ++.||+|++..... ..+.+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred heeeeeEecCCCceeEEEEEecC-CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 34567889999999999999864 57899999976433 34679999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+++|.+++... ...+++..++.++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++...........
T Consensus 87 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 99999999764 45689999999999999999999998 999999999999999999999999999987654332222
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ....... . ....+.
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~------~~~i~~~-----~-~~~~~~ 228 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEV------VEDISTG-----F-RLYKPR 228 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHH------HHHHHTT-----C-CCCCCT
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--HHH------HHHHhcC-----C-cCCCCc
Confidence 33446788999999999999999999999999999999 8888864321 110 0000000 0 011223
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.....+.+++.+||+.||++|||++++++.|+.+.+
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 345678999999999999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=350.75 Aligned_cols=270 Identities=18% Similarity=0.235 Sum_probs=207.1
Q ss_pred HHhhhcccCcc--cceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 512 TNRFKEELGKG--SFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G--~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
.+.+.+.||+| +||.||+++....++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 45677899999 99999999999888999999997643 334467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++|+|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999999999876567799999999999999999999998 99999999999999999999999999986543221
Q ss_pred c------ceeeeeccCCCCCchhhhcc--CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhh---
Q 003772 668 T------RTFTLVRGTRGYMAPEWYKN--TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFID--- 736 (796)
Q Consensus 668 ~------~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 736 (796)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....................+
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 1 11112358899999999987 578999999999999999999999997543322111100000000000
Q ss_pred ---h-------------hhhhhh------------cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HhcC
Q 003772 737 ---R-------------ELNKLV------------RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM--LEGI 784 (796)
Q Consensus 737 ---~-------------~~~~~~------------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~ 784 (796)
. .+.... ............+.+++.+||+.||.+|||++|+++. ++.+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 0 000000 0001122345679999999999999999999999854 4444
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=344.06 Aligned_cols=259 Identities=24% Similarity=0.380 Sum_probs=194.5
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcE---EEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCce--
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEK---LVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKR-- 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~---~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~-- 583 (796)
..+.+.+.||+|+||.||+|.+...+. .||||++... .....+.+.+|+.++++++||||+++++++.+....
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 456677899999999999999876654 7999999754 344567899999999999999999999999876655
Q ss_pred ----eEEEeecCCCChhhhhhcCC----CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEe
Q 003772 584 ----LLVYEYMSNGSLADILFRGP----ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKIS 655 (796)
Q Consensus 584 ----~lV~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 655 (796)
++|+||+++|+|.+++.... ...+++..++.++.|+++||.|||+. +|+||||||+|||+++++.+||+
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEe
Confidence 99999999999999986421 23689999999999999999999998 99999999999999999999999
Q ss_pred ccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHh
Q 003772 656 DFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKC 733 (796)
Q Consensus 656 DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 733 (796)
|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... ... ..
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~------~~ 251 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIY------NY 251 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHH------HH
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHH------HH
Confidence 9999987644332 22233446789999999999999999999999999999999 88888644321 110 00
Q ss_pred hhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 734 FIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.... .....+......+.+++..||+.||.+|||+.++++.|+++..
T Consensus 252 ~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 252 LIGG------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HHTT------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcC------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0000 0112234455779999999999999999999999999988643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=338.28 Aligned_cols=243 Identities=23% Similarity=0.321 Sum_probs=203.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+++....++.||+|++.+.. ....+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 456789999999999999998888999999997632 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 88 IEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp CCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred CCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 999999999976 46789999999999999999999998 9999999999999999999999999999875432
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. . ....... ....+
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~-~-----~~~i~~~-------~~~~p 223 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MK-T-----YEKILNA-------ELRFP 223 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HH-H-----HHHHHHC-------CCCCC
T ss_pred -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HH-H-----HHHHHhC-------CCCCC
Confidence 2234689999999999999999999999999999999999999964321 10 0 1111111 01123
Q ss_pred HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRP-----SMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 779 (796)
......+.+++..||+.||.+|| +++||++
T Consensus 224 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 33456789999999999999999 8899873
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=341.10 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=196.2
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCC--------
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS-------- 581 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~-------- 581 (796)
..+.+.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 345667899999999999999988889999999975333 34577999999999999999999999875543
Q ss_pred -------------------------------------------------ceeEEEeecCCCChhhhhhcCCC-CCCchhH
Q 003772 582 -------------------------------------------------KRLLVYEYMSNGSLADILFRGPE-RSLGWDE 611 (796)
Q Consensus 582 -------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~-~~l~~~~ 611 (796)
..++||||+++|+|.+++..... ...++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 27899999999999999986432 3456667
Q ss_pred HHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc-----------ceeeeeccCCCC
Q 003772 612 RVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT-----------RTFTLVRGTRGY 680 (796)
Q Consensus 612 ~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~-----------~~~~~~~gt~~y 680 (796)
++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 899999999999999998 999999999999999999999999999988755421 122334589999
Q ss_pred CchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHH
Q 003772 681 MAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIG 760 (796)
Q Consensus 681 ~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 760 (796)
+|||++.+..++.++|||||||++|||++|..|+.. .... ....... ..........+.+.+++
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~------~~~~----~~~~~~~------~~~~~~~~~~~~~~~li 306 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME------RVRI----ITDVRNL------KFPLLFTQKYPQEHMMV 306 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH------HHHH----HHHHHTT------CCCHHHHHHCHHHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH------HHHH----HHHhhcc------CCCcccccCChhHHHHH
Confidence 999999999999999999999999999997654310 0000 0000000 00011123446678999
Q ss_pred HHhccCCCCCCCCHHHHHH
Q 003772 761 LWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 761 ~~cl~~dP~~RPt~~evl~ 779 (796)
..||+.||.+|||+.|+++
T Consensus 307 ~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHH
T ss_pred HHHccCCCCcCCCHHHHhh
Confidence 9999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.27 Aligned_cols=267 Identities=22% Similarity=0.350 Sum_probs=208.1
Q ss_pred HHHHhhhcccCcccceEEEEEE----EcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccC--Cc
Q 003772 510 KATNRFKEELGKGSFGAVYKGT----LYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAED--SK 582 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~----~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~ 582 (796)
...+++.+.||+|+||.||+++ ....++.||||++.... ....+.+.+|+.++.+++|+||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 3446677899999999999999 45567899999997533 33457799999999999999999999999876 56
Q ss_pred eeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 583 RLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
.++||||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccc
Confidence 89999999999999999653 35699999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCcc--eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHH---hhhhh
Q 003772 663 LMPDQTR--TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYK---CFIDR 737 (796)
Q Consensus 663 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 737 (796)
....... ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+..... ........ .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA-----LFLKMIGPTHGQMTVT 250 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH-----HHHHHHCSCCGGGHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh-----HHhhccCCcccccCHH
Confidence 7654332 22234578889999999999999999999999999999999988642210 00000000 00000
Q ss_pred hhhhhh-c--CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 738 ELNKLV-R--GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 738 ~~~~~~-~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
.+...+ . ....+....+.+.+++..||+.||.+|||+.+|++.|+.++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 011111 1 11234455678999999999999999999999999998764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.37 Aligned_cols=251 Identities=21% Similarity=0.274 Sum_probs=204.3
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+++....++.||+|++.+.. ....+.+.+|+.++..++||||+++++++.+++..++||||
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 445688999999999999999888999999997632 22334588999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 151 ~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 151 MPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp CTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred CCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 999999999975 3589999999999999999999998 9999999999999999999999999999877655443
Q ss_pred eeeeeccCCCCCchhhhccCC----CCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTP----ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... . . ...+...... ..
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~-~-----~~~i~~~~~~-~~-- 293 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--G-T-----YSKIMNHKNS-LT-- 293 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--H-H-----HHHHHTHHHH-CC--
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--h-H-----HHHHHhcccc-cc--
Confidence 444567999999999998765 789999999999999999999999743211 1 1 1111111000 00
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPAL--RPSMKSVVLM 780 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~ 780 (796)
-.........+.+++..||+.+|.+ ||+++||++.
T Consensus 294 ~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 294 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0011234467889999999999988 9999999853
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.04 Aligned_cols=257 Identities=20% Similarity=0.277 Sum_probs=208.4
Q ss_pred HHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhcc-------
Q 003772 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE------- 579 (796)
Q Consensus 507 ~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------- 579 (796)
......+.+.+.||+|+||.||++....+++.||||++.... +.+.+|++++.+++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 344556677889999999999999998788899999997533 357789999999999999999998754
Q ss_pred ---------CCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC
Q 003772 580 ---------DSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW 650 (796)
Q Consensus 580 ---------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 650 (796)
....++||||+++|+|.+++.......+++..++.++.||+.||.|||+. +|+|+||||+||++++++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 34579999999999999999765556799999999999999999999998 999999999999999999
Q ss_pred ceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH
Q 003772 651 TAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA 730 (796)
Q Consensus 651 ~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 730 (796)
.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+... .. .
T Consensus 160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~~----~ 227 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------SK----F 227 (284)
T ss_dssp EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------HH----H
T ss_pred CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------HH----H
Confidence 999999999987654332 22345899999999999999999999999999999999998876311 00 0
Q ss_pred HHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCCCC
Q 003772 731 YKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPP 791 (796)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~ 791 (796)
.... . ....+......+.+++..||+.||.+|||+.|+++.|+.+.......
T Consensus 228 ~~~~-----~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 228 FTDL-----R----DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp HHHH-----H----TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred HHHh-----h----cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 0111 1 11122233456889999999999999999999999999887655443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=335.72 Aligned_cols=256 Identities=23% Similarity=0.379 Sum_probs=205.2
Q ss_pred hhcccCcccceEEEEEEEcCCc---EEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCce-eEEEee
Q 003772 515 FKEELGKGSFGAVYKGTLYKGE---KLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKR-LLVYEY 589 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~---~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lV~e~ 589 (796)
+.+.||+|+||.||+|.+.+.+ ..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|+||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 4578999999999999875443 3799999976433 3456789999999999999999999999876655 999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc-
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT- 668 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~- 668 (796)
+.+|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 105 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 105 MCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp CTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred ccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 9999999999763 46789999999999999999999998 999999999999999999999999999986644321
Q ss_pred --ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 669 --RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 669 --~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
.......+++.|+|||.+.+..++.++||||||+++|||++|+.|+........... .. .. ....
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~---~~---------~~-~~~~ 247 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH---FL---------AQ-GRRL 247 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH---HH---------HT-TCCC
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH---Hh---------hc-CCCC
Confidence 122234578899999999999999999999999999999997777654332211110 00 00 0011
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
..+......+.+++..||+.||.+|||+.++++.|+.+...
T Consensus 248 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 12334456799999999999999999999999999886443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.47 Aligned_cols=266 Identities=19% Similarity=0.318 Sum_probs=202.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc---cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+.+.+.||+|+||.||++....+++.||||++... .....+.+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 456778999999999999999888889999999752 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 589 YMSNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 589 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|+++|+|.+++... ....+++..++.++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 99999999998642 346689999999999999999999998 9999999999999999999999999999876433
Q ss_pred CcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........... . .. .......
T Consensus 190 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--~----~~-----~~~~~~~ 257 (310)
T 2wqm_A 190 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC--K----KI-----EQCDYPP 257 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH--H----HH-----HTTCSCC
T ss_pred Cc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH--H----Hh-----hcccCCC
Confidence 22 12234589999999999999999999999999999999999999865432211110 0 00 0000011
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPPC 792 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~ 792 (796)
.........+.+++..||+.||.+|||+.+|++.|+.+.....+|.
T Consensus 258 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 1123345679999999999999999999999999999876655553
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=329.36 Aligned_cols=245 Identities=23% Similarity=0.364 Sum_probs=206.0
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+.+.+.||+|+||.||+|.....+..||+|++........+.+.+|+.++.+++||||+++++++.+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 45667789999999999999999888899999998876667788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe---cCCCceEEeccCCccccCCCC
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFgl~~~~~~~~ 667 (796)
++++|.+++.. ...+++..++.++.|++.||.|||+. +|+|+||||+||++ +.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 89 TGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 99999999876 45689999999999999999999998 99999999999999 788999999999998765433
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC-
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ- 746 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 746 (796)
. .....||+.|+|||.+.+. ++.++||||||+++|||++|+.||..... .. ... ......
T Consensus 164 ~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~-~~~-------------~~~~~~~ 224 (277)
T 3f3z_A 164 M--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD--SE-VML-------------KIREGTF 224 (277)
T ss_dssp C--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HH-HHH-------------HHHHCCC
T ss_pred c--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--HH-HHH-------------HHHhCCC
Confidence 2 2234589999999998765 89999999999999999999999965321 11 100 000110
Q ss_pred CCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 747 EVDR----NTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 747 ~~~~----~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..+. ...+.+.+++..||+.||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 23467899999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.70 Aligned_cols=251 Identities=24% Similarity=0.273 Sum_probs=197.4
Q ss_pred HHHHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhcc-CcCchhhhhhhhccCC
Q 003772 505 YNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDS 581 (796)
Q Consensus 505 ~~~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~ 581 (796)
..++....+.+.++||+|+||+||+|.+..+++.||||++..... .....+..|+..+.++ +|+||+++++++.+++
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 345556677888999999999999999998889999999865322 2333455566555555 8999999999999999
Q ss_pred ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcc
Q 003772 582 KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~ 661 (796)
..++||||+ +++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV 205 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred EEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeee
Confidence 999999999 67999988764 45699999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 662 LLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 662 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
...... ......||+.|+|||++.+ .++.++|||||||++|||++|+.++.... . ..........
T Consensus 206 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~-------~~~~~~~~~~- 270 (311)
T 3p1a_A 206 ELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----G-------WQQLRQGYLP- 270 (311)
T ss_dssp ECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----H-------HHHHTTTCCC-
T ss_pred ecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----H-------HHHHhccCCC-
Confidence 764332 2233458999999999876 79999999999999999999987664211 0 0111111000
Q ss_pred hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 742 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
........+.+.+++..||+.||++|||++|+++
T Consensus 271 ----~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 ----PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0011123467999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=345.35 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=203.1
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEE----EEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKL----VAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~----vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
+++.+.||+|+||.||+|.+...++. ||+|.+.... ....+.+.+|+.++.+++|+||+++++++. ++..++|+
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 93 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT 93 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence 45668899999999999998766554 7788775432 233456788999999999999999999886 56789999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++|+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 94 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 94 QYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp ECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 999999999999763 45799999999999999999999998 99999999999999999999999999999875543
Q ss_pred cc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 668 TR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 668 ~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .. .. .... ..
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~--~~----~~~~------~~ 235 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VP--DL----LEKG------ER 235 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HH--HH----HHTT------CB
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HH--HH----HHcC------CC
Confidence 32 2334557889999999999999999999999999999999 999997543221 10 00 0000 00
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
...+......+.+++..||+.||.+|||+.+|++.|+.+..
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 236 LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11122334568889999999999999999999999988654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=346.95 Aligned_cols=269 Identities=26% Similarity=0.351 Sum_probs=211.0
Q ss_pred HHhhhcccCcccceEEEEEEE----cCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhc--cCCceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTL----YKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCA--EDSKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~----~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~--~~~~~~l 585 (796)
.+++.+.||+|+||.||++++ ...++.||||++........+.+.+|+.++.+++|+||+++++++. +....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 456678999999999999994 5567899999998766666778999999999999999999999886 4556889
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 99999999999999753 34699999999999999999999998 999999999999999999999999999987754
Q ss_pred CCcc--eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 666 DQTR--TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 666 ~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
.... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+....... ...............+...+
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF--LRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHCC----CCHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh--hhhcccccccccHHHHHHHh
Confidence 4322 2223457888999999999999999999999999999999999986321100 00000000000000111111
Q ss_pred c---CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 744 R---GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 744 ~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
. ....+....+.+.+++..||+.||.+|||+++|++.|+.+..
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 112344566789999999999999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=338.41 Aligned_cols=263 Identities=28% Similarity=0.449 Sum_probs=197.6
Q ss_pred HHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCcee
Q 003772 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 507 ~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 584 (796)
|+....+.+.++||+|+||.||+|+... .||||++.... ....+.+.+|+.++++++|+||+++++++ .....+
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 3334556778899999999999998743 49999986533 33456799999999999999999999965 456789
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 96 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 999999999999999653 46799999999999999999999998 99999999999999999999999999998654
Q ss_pred CCC-cceeeeeccCCCCCchhhhc---cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh
Q 003772 665 PDQ-TRTFTLVRGTRGYMAPEWYK---NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740 (796)
Q Consensus 665 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
... ........||+.|+|||.+. ...++.++||||||+++|||++|+.||........ ............
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~--- 245 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSP--- 245 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH---HHHHHHHTSCCC---
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH---HHHHhcccccCc---
Confidence 322 22333456899999999996 56789999999999999999999999975432211 111111100000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 741 KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
........++..+.+++..||+.+|.+|||+.+|+++|+.+.+
T Consensus 246 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 ---DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ---CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ---chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0111233456789999999999999999999999999998864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=345.88 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=205.6
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+.+.+.||+|+||.||++.....++.||+|++.+.. ....+.+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 4566789999999999999999889999999997532 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 169 (384)
T 4fr4_A 96 LLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET- 169 (384)
T ss_dssp CCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred cCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence 9999999999976 46799999999999999999999998 99999999999999999999999999998765432
Q ss_pred ceeeeeccCCCCCchhhhcc---CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 669 RTFTLVRGTRGYMAPEWYKN---TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||.............. ... ..
T Consensus 170 -~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-----~~~-------~~ 236 (384)
T 4fr4_A 170 -QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT-----FET-------TV 236 (384)
T ss_dssp -CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH-----HHH-------CC
T ss_pred -ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH-----Hhh-------cc
Confidence 2334569999999999974 4589999999999999999999999975433322111100 000 01
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPS-MKSVVL 779 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~ 779 (796)
...+......+.+++..||+.||.+||+ +++|.+
T Consensus 237 ~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1223344577899999999999999999 777764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.74 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=203.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCC---cEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKG---EKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
.+.+.+.||+|+||.||+|..... +..||||++.... ....+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEE
Confidence 345678999999999999986543 3569999997643 3345779999999999999999999998765 4578999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++++|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 92 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 92 ELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp ECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred ecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 999999999999753 35689999999999999999999998 99999999999999999999999999998765544
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .. .... .. ...
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~--~~~~----~~------~~~ 233 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VI--GVLE----KG------DRL 233 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HH--HHHH----HT------CCC
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HH--HHHh----cC------CCC
Confidence 333344457889999999999999999999999999999998 999986433211 10 0000 00 011
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
..+....+.+.+++..||+.||++|||+.||++.|+.+.+
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 234 PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 1223345679999999999999999999999999987643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=340.85 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=200.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEe
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 588 (796)
+.+.+.||+|+||.||+++....++.||||++.+.. ....+.+.+|..++.++ +||||+++++++.+.+..++|||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 456789999999999999999889999999997643 23345688999999987 89999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++|+|.+++.+ ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 91 ~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 91 YVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 9999999999976 35799999999999999999999998 999999999999999999999999999986433222
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhH-HHHHHHHHhhhhhhhhhhhcCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEI-VLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .......+..... ...
T Consensus 166 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-------~~~ 237 (345)
T 3a8x_A 166 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------QIR 237 (345)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-------CCC
T ss_pred -cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-------CCC
Confidence 2334569999999999999999999999999999999999999997532211100 0000011111110 112
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSM 774 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~ 774 (796)
.+......+.+++..||+.||.+||++
T Consensus 238 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 233455678999999999999999995
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=334.63 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=202.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCc---EEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhc-cCCceeEEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGE---KLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCA-EDSKRLLVY 587 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~---~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~ 587 (796)
+.+.+.||+|+||.||+|.+...+ ..||+|++..... ...+.+.+|+.++++++||||+++++++. +++..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 456689999999999999975433 3689999876433 34567999999999999999999999865 456789999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++|+|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 107 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 107 PYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp ECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred eCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 999999999999753 46689999999999999999999998 99999999999999999999999999998765433
Q ss_pred c---ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 668 T---RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 668 ~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
. .......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+............ . ... .
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~---~----~~~------~ 249 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---L----LQG------R 249 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH---H----HTT------C
T ss_pred hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---H----hcC------C
Confidence 2 1223345778999999999999999999999999999999965554333222111100 0 000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
....+...+..+.+++..||+.||.+|||++|+++.|+.+...
T Consensus 250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 250 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1112233456799999999999999999999999999987653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=336.87 Aligned_cols=270 Identities=22% Similarity=0.265 Sum_probs=198.2
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
+.||+|+||.||++.....++.||||++........+.+.+|+.++.++ +||||+++++++.+++..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 6799999999999998888899999999876656677899999999885 799999999999999999999999999999
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc---eEEeccCCccccCCCCc----
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT---AKISDFGLAKLLMPDQT---- 668 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFgl~~~~~~~~~---- 668 (796)
.+++.. ...+++..+..++.||++||.|||+. +|+||||||+|||++.++. +||+|||++........
T Consensus 99 ~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 173 (316)
T 2ac3_A 99 LSHIHK--RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173 (316)
T ss_dssp HHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------
T ss_pred HHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccc
Confidence 999976 35789999999999999999999998 9999999999999998766 99999999986543211
Q ss_pred --ceeeeeccCCCCCchhhhcc-----CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 669 --RTFTLVRGTRGYMAPEWYKN-----TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 669 --~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||.............. ............
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~ 252 (316)
T 2ac3_A 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE-ACPACQNMLFES 252 (316)
T ss_dssp --------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-----CCHHHHHHHHHH
T ss_pred cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc-cchhHHHHHHHH
Confidence 11223458999999999975 4578999999999999999999999975432211000000 000000000001
Q ss_pred hhcCC-CCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhcCcCCCCCCC
Q 003772 742 LVRGQ-EVDR----NTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEGITDISIPPC 792 (796)
Q Consensus 742 ~~~~~-~~~~----~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~~~~p~~ 792 (796)
..... ..+. .....+.+++.+||+.||.+|||+.|+++ .+++.......|.
T Consensus 253 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~ 310 (316)
T 2ac3_A 253 IQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPT 310 (316)
T ss_dssp HHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----------
T ss_pred HhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccCCC
Confidence 11111 1111 23467899999999999999999999997 4555544444443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.10 Aligned_cols=265 Identities=20% Similarity=0.290 Sum_probs=208.2
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhc----cCCceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCA----EDSKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lV~ 587 (796)
.+.+.+.||+|+||.||++.....++.||||++........+.+.+|+.++++++||||+++++++. .....++|+
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 3566789999999999999998888999999997766666778999999999999999999999987 344788999
Q ss_pred eecCCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 588 EYMSNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 588 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
||+++|+|.+++... ....+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 999999999998752 346799999999999999999999998 999999999999999999999999999876532
Q ss_pred CCcc--------eeeeeccCCCCCchhhhccCC---CCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh
Q 003772 666 DQTR--------TFTLVRGTRGYMAPEWYKNTP---ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF 734 (796)
Q Consensus 666 ~~~~--------~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 734 (796)
.... ......||+.|+|||++.... ++.++||||||+++|||++|+.||............ .
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---~---- 259 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL---A---- 259 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH---H----
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH---H----
Confidence 1110 011234799999999987653 689999999999999999999998532111101000 0
Q ss_pred hhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCCCC
Q 003772 735 IDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPP 791 (796)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~ 791 (796)
..... ...........+.+++..||+.||.+|||+.+|++.|+.+.....++
T Consensus 260 ----~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 260 ----VQNQL-SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp ----HHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred ----hhccC-CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 00000 01112334567999999999999999999999999999887554443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.06 Aligned_cols=259 Identities=23% Similarity=0.301 Sum_probs=185.6
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-cCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
+.||+|+||.||++.....++.||||++.+. ....+.+|+.++.+++ ||||+++++++.++...++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 6799999999999999988899999999653 4567788999999997 99999999999999999999999999999
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC---ceEEeccCCccccCCCCcceee
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW---TAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++....... ...
T Consensus 94 ~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 167 (325)
T 3kn6_A 94 FERIKK--KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLK 167 (325)
T ss_dssp HHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccc
Confidence 999987 46799999999999999999999998 999999999999998665 899999999987654322 223
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............. ........+... .........
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-~~~~~i~~~~~~---~~~~~~~~~ 243 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV-EIMKKIKKGDFS---FEGEAWKNV 243 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH-HHHHHHTTTCCC---CCSHHHHTS
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH-HHHHHHHcCCCC---CCcccccCC
Confidence 3458999999999999999999999999999999999999997543211100000 001111110000 000001234
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHH--HHhcCcCCC
Q 003772 753 LENMIKIGLWCVQDEPALRPSMKSVVL--MLEGITDIS 788 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~~~ 788 (796)
.+.+.+++..||+.||.+|||++|+++ .+++....+
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~ 281 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCC
T ss_pred CHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCC
Confidence 567899999999999999999999984 344444433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.37 Aligned_cols=246 Identities=24% Similarity=0.331 Sum_probs=203.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 587 (796)
.+.+.+.||+|+||.||+++....++.||||++++.. ....+.+..|..++..+ +||||+++++++.+.+..++||
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4556789999999999999999889999999997642 23456678899999877 8999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 98 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 98 EYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp ECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred eCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 99999999999976 35799999999999999999999998 99999999999999999999999999998653322
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. . ...... ....
T Consensus 173 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~-~-----~~~i~~-------~~~~ 236 (345)
T 1xjd_A 173 A-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EE-L-----FHSIRM-------DNPF 236 (345)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH-H-----HHHHHH-------CCCC
T ss_pred C-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HH-H-----HHHHHh-------CCCC
Confidence 2 22345699999999999999999999999999999999999999964321 11 1 011110 0111
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMK-SVV 778 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl 778 (796)
.+......+.+++..||+.||.+||++. +|+
T Consensus 237 ~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 237 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 2333456788999999999999999997 665
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=346.88 Aligned_cols=255 Identities=26% Similarity=0.432 Sum_probs=194.1
Q ss_pred hhhcccCcccceEEEEEEEcCC---cEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhcc-CCceeEEEe
Q 003772 514 RFKEELGKGSFGAVYKGTLYKG---EKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAE-DSKRLLVYE 588 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e 588 (796)
.+.+.||+|+||.||+|.+... ...||||.+..... ...+.|.+|+.++++++||||+++++++.+ ++..++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 4567899999999999987533 24689999875433 445789999999999999999999998754 567899999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++|+|.+++... ...+++..++.++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 172 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 172 YMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp CCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 99999999999753 45688999999999999999999998 999999999999999999999999999987643322
Q ss_pred c---eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 669 R---TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 669 ~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
. ......+|+.|+|||.+.+..++.++|||||||++|||++ |..|+....... ... .. ... .
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-~~~---~~----~~~------~ 313 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITV---YL----LQG------R 313 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-HHH---HH----HTT------C
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-HHH---HH----HcC------C
Confidence 1 2223457788999999999999999999999999999999 455554332211 110 00 000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
....+...+..+.+++..||+.||++|||++||++.|+.+..
T Consensus 314 ~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 314 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111233455679999999999999999999999999988654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.99 Aligned_cols=244 Identities=24% Similarity=0.372 Sum_probs=202.8
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+.+.+.||+|+||.||+|.+...++.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 3566789999999999999998888999999997532 2234578999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+ +|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 90 ~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 90 YA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp CC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred CC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 99 7899998876 35799999999999999999999999 999999999999999999999999999987654332
Q ss_pred ceeeeeccCCCCCchhhhccCCC-CccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC-C
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG-Q 746 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 746 (796)
.....||+.|+|||++.+..+ ++++|||||||++|||++|+.||........ ....... .
T Consensus 164 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~~~~ 225 (336)
T 3h4j_B 164 --LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNSCVY 225 (336)
T ss_dssp --TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCSSCC
T ss_pred --cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHcCCC
Confidence 233469999999999988775 7899999999999999999999975422110 0000000 1
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..+......+.+++..||+.||.+|||++|+++
T Consensus 226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 123334567889999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=342.65 Aligned_cols=255 Identities=21% Similarity=0.236 Sum_probs=198.9
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc-----cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM-----VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
..+.+.+.||+|+||.||++.....++.||||++.+. .....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 4567789999999999999999888899999998753 23445789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcC--------------------------------------CCCCCchhHHHHHHHHHHHHHHHhh
Q 003772 586 VYEYMSNGSLADILFRG--------------------------------------PERSLGWDERVRIASDVAKGILYLH 627 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~aL~~LH 627 (796)
||||+++|+|.+++... ....+++..++.++.||++||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998521 0123467788899999999999999
Q ss_pred ccCCCCeeeeccCccceEecCCC--ceEEeccCCccccCCCC---cceeeeeccCCCCCchhhhcc--CCCCccccchhh
Q 003772 628 DECEAPIIHCDIKPQNILMDEFW--TAKISDFGLAKLLMPDQ---TRTFTLVRGTRGYMAPEWYKN--TPISVKADVFSY 700 (796)
Q Consensus 628 ~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DFgl~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~ 700 (796)
+. +|+||||||+||+++.++ .+||+|||+++.+.... ........||+.|+|||.+.. ..++.++|||||
T Consensus 186 ~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 186 NQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 98 999999999999998776 89999999998654322 122334568999999999975 678999999999
Q ss_pred HHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 701 GVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 701 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
|+++|||++|+.||...... . .. ........ .............+.+++..||+.||.+|||+.++++
T Consensus 263 G~il~el~~g~~pf~~~~~~--~-~~-----~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDA--D-TI-----SQVLNKKL---CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHH--H-HH-----HHHHHCCC---CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHCCCCCCCCChH--H-HH-----HHHHhccc---ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999999999643211 1 10 00000000 0000111224567899999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=331.52 Aligned_cols=262 Identities=22% Similarity=0.248 Sum_probs=205.8
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhh-ccCCceeEEEee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYC-AEDSKRLLVYEY 589 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~e~ 589 (796)
..+.+.+.||+|+||.||+|+....++.||||++... ...+.+.+|+.++.+++|++++..+..+ .+++..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 4466778999999999999999888999999987543 2334688999999999998888877766 456678999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe---cCCCceEEeccCCccccCCC
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFgl~~~~~~~ 666 (796)
+ +++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 87 ~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 87 L-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp C-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred c-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 9 99999999753 45699999999999999999999998 99999999999999 78999999999999876543
Q ss_pred Cc------ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh
Q 003772 667 QT------RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740 (796)
Q Consensus 667 ~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
.. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||................... ......
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~ 240 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-MSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-HHSCHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc-ccchhh
Confidence 32 12234568999999999999999999999999999999999999997644332221111111110 000000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 741 KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.. ....+..+.+++..||+.||++|||+++|++.|+.+..
T Consensus 241 ~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 241 VL------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HH------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hh------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 00 11224678999999999999999999999999988643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=342.07 Aligned_cols=246 Identities=27% Similarity=0.354 Sum_probs=200.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+.+.+.||+|+||.||+|....+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 3556688999999999999998888999999997532 2234678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+. |+|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 135 ~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~- 208 (348)
T 1u5q_A 135 YCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN- 208 (348)
T ss_dssp CCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC-
T ss_pred cCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC-
Confidence 998 6888887542 46799999999999999999999998 99999999999999999999999999998764322
Q ss_pred ceeeeeccCCCCCchhhhc---cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 669 RTFTLVRGTRGYMAPEWYK---NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
...||+.|+|||++. ...++.++|||||||++|||++|+.||...... . .+ . ..... ...
T Consensus 209 ----~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~-~~----~-~~~~~-----~~~ 271 (348)
T 1u5q_A 209 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--S-AL----Y-HIAQN-----ESP 271 (348)
T ss_dssp ----CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--H-HH----H-HHHHS-----CCC
T ss_pred ----cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--H-HH----H-HHHhc-----CCC
Confidence 345899999999985 567899999999999999999999998643211 1 00 0 00000 011
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
........+.+.+++..||+.||++|||++++++.
T Consensus 272 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11223345678899999999999999999999853
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.01 Aligned_cols=262 Identities=16% Similarity=0.159 Sum_probs=204.3
Q ss_pred HHhhhcccCcccceEEEEEEEcC--------CcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhh--------
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYK--------GEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIG-------- 575 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~--------~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g-------- 575 (796)
.+.+.+.||+|+||.||+|+... .++.||||++... +.+.+|+.++.+++|+||+++++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 45677899999999999999876 3678999998753 46889999999999999999654
Q ss_pred -------hhcc-CCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec
Q 003772 576 -------YCAE-DSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD 647 (796)
Q Consensus 576 -------~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 647 (796)
++.. +...++||||+ +++|.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||++
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVD 193 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEc
Confidence 3333 56789999999 99999999875457899999999999999999999998 999999999999999
Q ss_pred CCC--ceEEeccCCccccCCCCcc------eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCC
Q 003772 648 EFW--TAKISDFGLAKLLMPDQTR------TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPS 719 (796)
Q Consensus 648 ~~~--~~kl~DFgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~ 719 (796)
.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 988 9999999999876543221 11234689999999999999999999999999999999999999976542
Q ss_pred CchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 720 KPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
........ ...+ ......+.............+.+++..||+.||.+|||+++|+++|+++.+
T Consensus 274 ~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 274 NTEDIMKQ---KQKF-VDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp CHHHHHHH---HHHH-HHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CHHHHHHH---HHhc-cCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 32221111 0100 011111111111111235779999999999999999999999999988653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=341.37 Aligned_cols=244 Identities=21% Similarity=0.234 Sum_probs=204.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+.+.+.||+|+||.||+++....++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 3556789999999999999998888999999997632 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++|+|.+++.+ ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 122 ~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~- 195 (350)
T 1rdq_E 122 YVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp CCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCCc-
Confidence 9999999999976 35689999999999999999999998 99999999999999999999999999998764322
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. . ...+..+ ....
T Consensus 196 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~-~-----~~~i~~~-------~~~~ 257 (350)
T 1rdq_E 196 ---WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQ-I-----YEKIVSG-------KVRF 257 (350)
T ss_dssp ---CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH-H-----HHHHHHC-------CCCC
T ss_pred ---ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--HH-H-----HHHHHcC-------CCCC
Confidence 234589999999999999999999999999999999999999964321 11 0 1111111 0112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPS-----MKSVVL 779 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 779 (796)
+......+.+++..||+.||.+||+ ++||++
T Consensus 258 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 3344567899999999999999998 888874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=344.05 Aligned_cols=252 Identities=24% Similarity=0.261 Sum_probs=194.5
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.+.||+|+||.||+++....++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 4667789999999999999999888999999997633 334678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc--eEEeccCCccccCCCCcc
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT--AKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFgl~~~~~~~~~~ 669 (796)
+|+|.+++.. .+.+++..++.++.|++.||.|||+. +|+||||||+|||++.++. +||+|||+++......
T Consensus 100 ~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-- 172 (361)
T 3uc3_A 100 GGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 172 (361)
T ss_dssp SCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--
Confidence 9999999976 45799999999999999999999998 9999999999999987765 9999999997543222
Q ss_pred eeeeeccCCCCCchhhhccCCCCcc-ccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVK-ADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~k-sDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
......||+.|+|||++.+..++.+ +|||||||++|||++|+.||............. ...... ......
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----~~~~~~-----~~~~~~ 243 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI----QRILSV-----KYSIPD 243 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH----HHHHTT-----CCCCCT
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH----HHHhcC-----CCCCCC
Confidence 2233458999999999988877665 899999999999999999997543322111110 000000 000011
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.......+.+++.+||+.||.+|||+.|+++.
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11234678899999999999999999999863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=354.45 Aligned_cols=246 Identities=24% Similarity=0.314 Sum_probs=195.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc---cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||++.....++.||||++.+. .......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence 55678999999999999999988899999999763 223345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhc-cCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD-ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
+++|+|.+++.. ...+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||+++......
T Consensus 230 ~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 303 (446)
T 4ejn_A 230 ANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 303 (446)
T ss_dssp CSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-
Confidence 999999999976 4579999999999999999999998 7 99999999999999999999999999998643322
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ..... .....
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~-----~~i~~-------~~~~~ 368 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLF-----ELILM-------EEIRF 368 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH-----HHHHH-------CCCCC
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHH-----HHHHh-------CCCCC
Confidence 223345699999999999999999999999999999999999999964321 1110 00000 11122
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRP-----SMKSVVL 779 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 779 (796)
+......+.+++..||+.||.+|| |++|+++
T Consensus 369 p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 334456789999999999999999 9999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=337.14 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=205.9
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch------hHHHHHHHHHHHhccCcCchhhhhhhhccCCce
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE------GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 583 (796)
...+.+.+.||+|+||.||++....+++.||||++...... ..+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34567889999999999999999888899999999764322 356799999999999999999999999999999
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC----ceEEeccCC
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW----TAKISDFGL 659 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFgl 659 (796)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 999999999999999976 46789999999999999999999998 999999999999999887 799999999
Q ss_pred ccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh
Q 003772 660 AKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739 (796)
Q Consensus 660 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
+........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .. .. ........
T Consensus 166 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~-~~-----~~i~~~~~ 235 (321)
T 2a2a_A 166 AHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QE-TL-----ANITSVSY 235 (321)
T ss_dssp CEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HH-HH-----HHHHTTCC
T ss_pred ceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--HH-HH-----HHHHhccc
Confidence 987654322 2334589999999999999999999999999999999999999964321 11 10 00000000
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 740 NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
. ............+.+++..||+.||.+|||+.|+++
T Consensus 236 ~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 D---FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C---CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c---cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 000000123467889999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=341.29 Aligned_cols=247 Identities=25% Similarity=0.339 Sum_probs=203.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 587 (796)
.+.+.+.||+|+||.||+++....++.||||++.+.. ....+.+..|..++..+ +||||+++++++.+.+..++||
T Consensus 21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 100 (353)
T 2i0e_A 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100 (353)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence 4566789999999999999998888999999997642 23456688999999988 8999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++|+|.+++.+ ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 101 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 101 EYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 99999999999976 35799999999999999999999998 99999999999999999999999999998643322
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .... ...+... ...
T Consensus 176 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--~~~~------~~~i~~~-------~~~ 239 (353)
T 2i0e_A 176 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--EDEL------FQSIMEH-------NVA 239 (353)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHH------HHHHHHC-------CCC
T ss_pred c-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--HHHH------HHHHHhC-------CCC
Confidence 2 2234569999999999999999999999999999999999999996432 1111 1111111 111
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPS-----MKSVVL 779 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 779 (796)
.+......+.+++..||+.||.+||+ +++|++
T Consensus 240 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 23345577899999999999999995 467763
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=340.99 Aligned_cols=242 Identities=24% Similarity=0.299 Sum_probs=203.2
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--------hhHHHHHHHHHHHhccCcCchhhhhhhhccCCc
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--------EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSK 582 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 582 (796)
..+.+.+.||+|+||.||++.....++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 445667889999999999999998999999999976421 133467889999999999999999999999999
Q ss_pred eeEEEeecCCC-ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcc
Q 003772 583 RLLVYEYMSNG-SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661 (796)
Q Consensus 583 ~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~ 661 (796)
.++||||+..| +|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 99999999777 99999976 45799999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeeeeccCCCCCchhhhccCCC-CccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh
Q 003772 662 LLMPDQTRTFTLVRGTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740 (796)
Q Consensus 662 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ...
T Consensus 179 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------~~~ 238 (335)
T 3dls_A 179 YLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------TVE 238 (335)
T ss_dssp ECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------------GTT
T ss_pred ECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------------HHh
Confidence 7654432 233558999999999988876 8899999999999999999999963210 001
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 741 KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
... ..+......+.+++..||+.||.+|||+.++++.
T Consensus 239 ~~~---~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 AAI---HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hcc---CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 1122234668899999999999999999999974
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=349.36 Aligned_cols=270 Identities=21% Similarity=0.274 Sum_probs=213.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCC--ceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS--KRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+|.+...++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 556789999999999999999888999999997643 234567889999999999999999999987655 67999999
Q ss_pred cCCCChhhhhhcCC-CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe----cCCCceEEeccCCccccC
Q 003772 590 MSNGSLADILFRGP-ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM----DEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 590 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFgl~~~~~ 664 (796)
+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 99999999997642 23499999999999999999999998 99999999999999 778889999999998765
Q ss_pred CCCcceeeeeccCCCCCchhhhcc--------CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhh
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKN--------TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFID 736 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
.... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||......................
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~ 245 (396)
T 4eut_A 168 DDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245 (396)
T ss_dssp CGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred CCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence 4332 223458999999999875 467889999999999999999999997543322222211111111111
Q ss_pred hhhh--------------hhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 737 RELN--------------KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 737 ~~~~--------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
..+. ...............+.+++..||+.||++|||+.++++.++.++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0000 00011123467888999999999999999999999999999887654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=336.34 Aligned_cols=260 Identities=22% Similarity=0.277 Sum_probs=198.9
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
.+.+.++||+|+||.||+++... ++.||||++..... ...+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 35567899999999999999865 67899999865322 2346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++ +|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 101 ~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 101 MEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp CSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 984 888888653 45699999999999999999999998 999999999999999999999999999987643322
Q ss_pred eeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh-----
Q 003772 670 TFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV----- 743 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 743 (796)
......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. ..............
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS-ILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH-HHCCCCTTTSGGGTTSHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HHCCCChHHhhhhhccchh
Confidence 2233458999999999976 5689999999999999999999999975543322111111 00000000000000
Q ss_pred --------cCC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 744 --------RGQ---EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 744 --------~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
... ...+....++.+++..||+.||.+|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 001123457889999999999999999999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=345.08 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=189.5
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.+.||+|+||.||+|+....++.||||++.... ..+.+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 3556789999999999999998888899999997632 35678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC---CCceEEeccCCccccCCCCc
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE---FWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFgl~~~~~~~~~ 668 (796)
+|+|.+++.. ...+++..++.++.||++||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 132 ~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 205 (349)
T 2w4o_A 132 GGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV- 205 (349)
T ss_dssp SCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence 9999999976 45689999999999999999999998 9999999999999975 8899999999998764322
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .......... .....
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~-----~~~i~~~~~~---~~~~~ 274 (349)
T 2w4o_A 206 -LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFM-----FRRILNCEYY---FISPW 274 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHH-----HHHHHTTCCC---CCTTT
T ss_pred -ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHH-----HHHHHhCCCc---cCCch
Confidence 223345899999999999999999999999999999999999999644321 111 1111111000 00111
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..+....+.+++..||+.||++|||+.|+++
T Consensus 275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2344567899999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=343.53 Aligned_cols=261 Identities=28% Similarity=0.406 Sum_probs=210.0
Q ss_pred HHHHhhhcccCcccceEEEEEEEc-------CCcEEEEEEEeecccc-hhHHHHHHHHHHHhcc-CcCchhhhhhhhccC
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLY-------KGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRT-HHKNLVRLIGYCAED 580 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~-------~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~ 580 (796)
...+.+.+.||+|+||.||+|... ..+..||||++..... ...+.+.+|+.++.++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 455677889999999999999975 2446899999976433 3456789999999999 899999999999999
Q ss_pred CceeEEEeecCCCChhhhhhcCC--------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe
Q 003772 581 SKRLLVYEYMSNGSLADILFRGP--------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM 646 (796)
Q Consensus 581 ~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 646 (796)
+..++||||+++|+|.+++.... ...+++..++.++.||++||.|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 99999999999999999997642 23489999999999999999999998 99999999999999
Q ss_pred cCCCceEEeccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhH
Q 003772 647 DEFWTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEI 724 (796)
Q Consensus 647 ~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~ 724 (796)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+..... ...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~ 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EEL 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--HHH
Confidence 99999999999999876543321 2223446789999999999899999999999999999999 8888864321 111
Q ss_pred HHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 725 VLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
. ...... .....+......+.+++..||+.||.+|||+.+|++.|+.+...
T Consensus 269 --~----~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 269 --F----KLLKEG------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp --H----HHHHHT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --H----HHHhcC------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0 000000 01122334557799999999999999999999999999987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=366.31 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=200.8
Q ss_pred ccCcccceEEEEEEEc--CCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCC
Q 003772 518 ELGKGSFGAVYKGTLY--KGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGS 594 (796)
Q Consensus 518 ~LG~G~fg~Vy~g~~~--~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 594 (796)
+||+|+||.||+|.+. ..+..||||+++... ....++|.+|+.++.+++||||+++++++.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 345689999997643 3356789999999999999999999999876 56899999999999
Q ss_pred hhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce--ee
Q 003772 595 LADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT--FT 672 (796)
Q Consensus 595 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~--~~ 672 (796)
|.+++... ...+++..++.++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++.+....... ..
T Consensus 422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 99999653 46799999999999999999999998 99999999999999999999999999998765433221 12
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
...+++.|+|||++.+..++.++|||||||+||||++ |+.||...... ++. ..+..+ .....+..
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~------~~i~~~------~~~~~p~~ 563 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM------AFIEQG------KRMECPPE 563 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHH------HHHHTT------CCCCCCTT
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHH------HHHHcC------CCCCCCCc
Confidence 2335689999999999999999999999999999998 99998754321 110 111010 01123445
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 752 TLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 752 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
++..+.+++..||+.+|++||++.+|++.|+.+
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 667899999999999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=337.21 Aligned_cols=260 Identities=27% Similarity=0.386 Sum_probs=208.9
Q ss_pred HHHhhhcccCcccceEEEEEEEc-----CCcEEEEEEEeecccc-hhHHHHHHHHHHHhcc-CcCchhhhhhhhccCC-c
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDS-K 582 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~-~ 582 (796)
..+.+.+.||+|+||.||++.+. ..++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+.+ .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 44567789999999999999853 4568999999976433 3446789999999999 7999999999987654 5
Q ss_pred eeEEEeecCCCChhhhhhcCCC--------------CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC
Q 003772 583 RLLVYEYMSNGSLADILFRGPE--------------RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE 648 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 648 (796)
.++||||+++|+|.+++..... ..+++..++.++.|+++||.|||+. +|+||||||+||+++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 183 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECC
Confidence 8999999999999999976432 2289999999999999999999998 9999999999999999
Q ss_pred CCceEEeccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHH
Q 003772 649 FWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVL 726 (796)
Q Consensus 649 ~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~ 726 (796)
++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..........
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~-- 261 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-- 261 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH--
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH--
Confidence 99999999999987654433 22233557899999999999999999999999999999998 999986543221110
Q ss_pred HHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 727 INWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
...... .....+......+.+++..||+.||.+|||+.+|++.|+.+.+
T Consensus 262 -----~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 262 -----RRLKEG------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp -----HHHHHT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHhccC------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000000 0011223345678999999999999999999999999988754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=357.99 Aligned_cols=251 Identities=27% Similarity=0.320 Sum_probs=208.3
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||++.....++.||||++.+.. ......+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 445688999999999999998888999999997632 23456688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~- 341 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 341 (576)
T ss_dssp CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCcc-
Confidence 9999999999876556699999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... +.. .....+
T Consensus 342 -~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~---------i~~--~~~~~p 409 (576)
T 2acx_A 342 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---------VKE--VPEEYS 409 (576)
T ss_dssp -EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH---------HHH--CCCCCC
T ss_pred -ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH---------hhc--ccccCC
Confidence 23346999999999999989999999999999999999999999765432211111110 000 011223
Q ss_pred HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRP-----SMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 779 (796)
......+.+++..||+.||.+|| +++||++
T Consensus 410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 34457789999999999999999 7888874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=338.52 Aligned_cols=273 Identities=24% Similarity=0.308 Sum_probs=202.3
Q ss_pred HHHHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhc--cCcCchhhhhhhhccC--
Q 003772 505 YNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGR--THHKNLVRLIGYCAED-- 580 (796)
Q Consensus 505 ~~~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~h~niv~l~g~~~~~-- 580 (796)
..+.....+.+.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++.. ++|+||+++++++.+.
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 33444566778899999999999999985 689999998642 23344455555554 4999999999998876
Q ss_pred --CceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccC-----CCCeeeeccCccceEecCCCceE
Q 003772 581 --SKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC-----EAPIIHCDIKPQNILMDEFWTAK 653 (796)
Q Consensus 581 --~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~k 653 (796)
...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 678999999999999999965 36999999999999999999999752 34899999999999999999999
Q ss_pred EeccCCccccCCCCcce---eeeeccCCCCCchhhhccCCCCcc------ccchhhHHHHHHHhhcc----------cCC
Q 003772 654 ISDFGLAKLLMPDQTRT---FTLVRGTRGYMAPEWYKNTPISVK------ADVFSYGVVLLEIVCCR----------RNM 714 (796)
Q Consensus 654 l~DFgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~k------sDV~S~Gvil~elltg~----------~p~ 714 (796)
|+|||+++......... .....||+.|+|||++.+...+.+ +|||||||++|||++|. .|+
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999998765433221 123458999999999988766655 99999999999999994 444
Q ss_pred CCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCC
Q 003772 715 EIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDIS 788 (796)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 788 (796)
............. ....................++...+.+++.+||+.||.+|||+.+|++.|+.+.+..
T Consensus 263 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 263 HDLVPSDPSYEDM---REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTSCSSCCHHHH---HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhhcCCCCchhhh---HHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 3322111111100 0000000000000001112377888999999999999999999999999999876543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.11 Aligned_cols=261 Identities=21% Similarity=0.240 Sum_probs=206.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhh-ccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYC-AEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~e~~~ 591 (796)
+.+.+.||+|+||.||+|+....++.||||++.... ..+.+.+|+.++.+++|++++..+..+ .++...++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 456789999999999999998888999999986533 334688999999999998877777666 4566779999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe---cCCCceEEeccCCccccCCCCc
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
+++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||++ ++++.+||+|||+++.......
T Consensus 88 ~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 88 GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 99999999743 45799999999999999999999998 99999999999999 4889999999999987654432
Q ss_pred c------eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 669 R------TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 669 ~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.................... .......
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 242 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPIEVL 242 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-HSCHHHH
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc-CCchHHH
Confidence 1 12345689999999999999999999999999999999999999986433222111111111100 0000000
Q ss_pred hcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 743 VRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 743 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
....++.+.+++..||+.||++|||+++|++.|+.+...
T Consensus 243 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 243 ------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp ------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 112346789999999999999999999999999886543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=339.75 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=199.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCc----EEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGE----KLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~----~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
+.+.+.||+|+||.||+|.....+ ..||||++..... .....+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 46 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 125 (333)
T 1mqb_A 46 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 125 (333)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEE
Confidence 345678999999999999876442 4699999976433 34557899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++|+|.+++... ...+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 126 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 126 EYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp ECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 999999999999763 46799999999999999999999998 99999999999999999999999999998765433
Q ss_pred cce--eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 668 TRT--FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 668 ~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ....... .
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~------~~~~~~~-----~- 267 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEV------MKAINDG-----F- 267 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHH------HHHHHTT-----C-
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--HHH------HHHHHCC-----C-
Confidence 221 122346788999999999999999999999999999999 9999864321 111 0111000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
....+......+.+++..||+.||.+||++.+|++.|+.+.
T Consensus 268 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01123345677999999999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=335.87 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=191.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+.+.+.||+|+||.||+|.....++.||||++..... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 45667899999999999999988889999999975433 23467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC----CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 591 SNGSLADILFRG----PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 591 ~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
+ |+|.+++... ....+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 8 6999988642 124689999999999999999999998 9999999999999999999999999999876432
Q ss_pred CcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh---hhh---hh
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF---IDR---EL 739 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~---~~ 739 (796)
.. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... . .+ ....... ... ..
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~-~~-~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--E-QL-KLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H-HH-HHHHHHHCSCCTTTCGGG
T ss_pred cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--H-HH-HHHHHHhCCCChhHhhhh
Confidence 22 22334589999999999764 6899999999999999999999999744321 1 11 1011100 000 00
Q ss_pred h------------------hhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 740 N------------------KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 740 ~------------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
. +.+.. .........+.+++..||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQP-HTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGG-GCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccchhHHHhhcc-cccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 00000 001123457899999999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.69 Aligned_cols=262 Identities=24% Similarity=0.306 Sum_probs=200.8
Q ss_pred HHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-----hhHHHHHHHHHHHhccC---cCchhhhhhhhcc
Q 003772 508 LKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-----EGEREFRAEMHVIGRTH---HKNLVRLIGYCAE 579 (796)
Q Consensus 508 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-----~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~ 579 (796)
+....+++.+.||+|+||.||++++...++.||||++..... .....+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 334566778999999999999999988889999999864321 12345677877777765 9999999999876
Q ss_pred CC-----ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEE
Q 003772 580 DS-----KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKI 654 (796)
Q Consensus 580 ~~-----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 654 (796)
.. ..++||||+. |+|.+++.......+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 54 4789999998 5999999876556699999999999999999999998 9999999999999999999999
Q ss_pred eccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh
Q 003772 655 SDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF 734 (796)
Q Consensus 655 ~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 734 (796)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .. .......
T Consensus 162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~-~~-~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--D-QL-GKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH--H-HH-HHHHHHH
T ss_pred eeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--H-HH-HHHHHHh
Confidence 9999998764332 223456899999999999999999999999999999999999999654311 1 11 1011100
Q ss_pred ---hhhhhhh-------hhcCC-C-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 735 ---IDRELNK-------LVRGQ-E-----VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 735 ---~~~~~~~-------~~~~~-~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....... ..... . ..++..+.+.+++..||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000000 00000 0 01234567899999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=340.17 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=199.9
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEE----EEEEEeecc-cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKL----VAVKKLEKM-VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~----vAvK~l~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
.+++.+.||+|+||.||+|.+...++. ||+|.+... .....+.+.+|+.++.+++||||+++++++.++. .++|
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v 94 (327)
T 3lzb_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEE
T ss_pred HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEE
Confidence 355678999999999999998766553 577776543 3345678999999999999999999999998654 7899
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
+||+++|+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp ECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 9999999999999764 45699999999999999999999998 9999999999999999999999999999876543
Q ss_pred Cc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 667 QT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 667 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
.. .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... .. .. +.. ..
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~--~~---------~~~-~~ 236 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS--SI---------LEK-GE 236 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HH--HH---------HHT-TC
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HH--HH---------HHc-CC
Confidence 32 22223446788999999999999999999999999999999 999986543211 10 00 000 00
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
....+......+.+++..||+.||.+|||+.||++.|+.+..
T Consensus 237 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 112233455678999999999999999999999999998764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=351.24 Aligned_cols=252 Identities=21% Similarity=0.254 Sum_probs=202.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+++....++.||||++.+.. ....+.+++|..++.+++|+||+++++++.+.+..++||||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 345678999999999999998888999999997632 22334588999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.+. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 143 ~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 143 YVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp CCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 9999999999753 34799999999999999999999998 9999999999999999999999999999887655443
Q ss_pred eeeeeccCCCCCchhhhc-------cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 670 TFTLVRGTRGYMAPEWYK-------NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~-------~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ... +..+.... ..
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~------~~~i~~~~--~~ 288 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--AET------YGKIVHYK--EH 288 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHH------HHHHHTHH--HH
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--HHH------HHHHHhcc--cC
Confidence 334457999999999997 35689999999999999999999999965321 111 11111100 00
Q ss_pred hcCCCCCHHHHHHHHHHHHHhccCCCCCC---CCHHHHHH
Q 003772 743 VRGQEVDRNTLENMIKIGLWCVQDEPALR---PSMKSVVL 779 (796)
Q Consensus 743 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~evl~ 779 (796)
.............+.+++..||+ +|.+| |+++||++
T Consensus 289 ~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 289 LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 00011122345678999999999 99998 69999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=367.80 Aligned_cols=248 Identities=29% Similarity=0.397 Sum_probs=200.0
Q ss_pred cccCcccceEEEEEEEc--CCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLY--KGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~--~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
++||+|+||.||+|.+. ..++.||||+++.... ...+++.+|+.++.+++|+||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 4567899999976433 33578999999999999999999999986 4568899999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc--ce
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT--RT 670 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~--~~ 670 (796)
|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 999999976 46799999999999999999999998 999999999999999999999999999987754432 22
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .. ....... .....+
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~------~~~i~~~------~~~~~p 594 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EV------TAMLEKG------ERMGCP 594 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH------HHHHHTT------CCCCCC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HH------HHHHHcC------CCCCCC
Confidence 233446789999999999999999999999999999998 99999654311 10 0000000 111234
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
..++..+.+++..||+.||++|||+.+|++.|+.+
T Consensus 595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 45667899999999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=339.03 Aligned_cols=271 Identities=26% Similarity=0.322 Sum_probs=209.3
Q ss_pred ccCHHHHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhc--cCcCchhhhhhhhcc
Q 003772 502 SFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGR--THHKNLVRLIGYCAE 579 (796)
Q Consensus 502 ~~~~~~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~--l~h~niv~l~g~~~~ 579 (796)
.+...+.....+.+.+.||+|+||.||+|+.. ++.||||++.. ...+.+..|++++.. ++||||+++++++.+
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 34445556677888899999999999999983 68999999964 334567788888877 789999999999987
Q ss_pred CC----ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhh--------ccCCCCeeeeccCccceEec
Q 003772 580 DS----KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLH--------DECEAPIIHCDIKPQNILMD 647 (796)
Q Consensus 580 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH--------~~~~~~ivH~Dlkp~NIll~ 647 (796)
.. ..++||||+++|+|.+++.+ ..+++..++.++.|++.||.||| +. +|+||||||+||+++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK 181 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence 65 78999999999999999975 46899999999999999999999 66 999999999999999
Q ss_pred CCCceEEeccCCccccCCCCcc---eeeeeccCCCCCchhhhccC------CCCccccchhhHHHHHHHhhc--------
Q 003772 648 EFWTAKISDFGLAKLLMPDQTR---TFTLVRGTRGYMAPEWYKNT------PISVKADVFSYGVVLLEIVCC-------- 710 (796)
Q Consensus 648 ~~~~~kl~DFgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvil~elltg-------- 710 (796)
.++.+||+|||++......... ......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999876544322 12334689999999999876 234789999999999999999
Q ss_pred --ccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 711 --RRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 711 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
+.||............ .............+.......+....+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 262 ~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEE---MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CCCCTTTTTSCSSCCHHH---HHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCccccCcCcccHHH---HHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 5666543222111111 001111111110000011234677899999999999999999999999999988753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=330.47 Aligned_cols=247 Identities=24% Similarity=0.358 Sum_probs=184.1
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+|+....++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 4566889999999999999988888999999975322 2246789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++++|.+++... ...+++..++.++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++.........
T Consensus 93 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 93 CHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp CTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred CCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 9999999999753 46789999999999999999999998 9999999999999999999999999999876533222
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .... ......+
T Consensus 169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------~~~~-------~~~~~~~ 232 (278)
T 3cok_A 169 -HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL--------NKVV-------LADYEMP 232 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CC-------SSCCCCC
T ss_pred -ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH--------HHHh-------hcccCCc
Confidence 22345899999999999989999999999999999999999999754322100 0000 0011122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......+.+++.+||+.||++|||+++|++
T Consensus 233 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 233 SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 334567889999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=330.06 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=198.4
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
..+.+.+.||+|+||.||++.....+..||+|++..... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 456778999999999999999988889999999976443 3457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe---cCCCceEEeccCCccccC
Q 003772 590 MSNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 590 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFgl~~~~~ 664 (796)
+++|+|.+++... ....+++..++.++.|+++||.|||+. +|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998642 246799999999999999999999998 99999999999999 456789999999998764
Q ss_pred CCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
.... .....||+.|+|||.+. ..++.++||||||+++|||++|+.||..... .... .... .. ...
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--~~~~--~~~~----~~----~~~ 243 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--EEVQ--QKAT----YK----EPN 243 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH--HHHH----HC----CCC
T ss_pred Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--HHHH--hhhc----cC----Ccc
Confidence 4322 23345899999999986 4689999999999999999999999964321 1110 0000 00 000
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.........+.+.+++..||+.||.+|||+.||++
T Consensus 244 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00001113467889999999999999999999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.30 Aligned_cols=250 Identities=21% Similarity=0.298 Sum_probs=203.7
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
.+.+.+.||+|+||.||++.....++.||+|++.... ....+.+.+|+.++.+++|+||+++++++.+++..++||||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 3456789999999999999998888999999997533 33446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc---eEEeccCCccccCCC
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT---AKISDFGLAKLLMPD 666 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFgl~~~~~~~ 666 (796)
+++++|.+.+.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++......
T Consensus 87 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 87 VTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 999999998876 36799999999999999999999998 9999999999999986655 999999999876543
Q ss_pred CcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .. .. ......... ...
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~-~~-----~~~~~~~~~---~~~ 228 (284)
T 3kk8_A 162 EA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HR-LY-----AQIKAGAYD---YPS 228 (284)
T ss_dssp CB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH-HH-----HHHHHTCCC---CCT
T ss_pred cc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--hH-HH-----HHHHhcccc---CCc
Confidence 32 2334589999999999999999999999999999999999999964321 11 11 000000000 001
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.......+.+.+++..||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111234567899999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=329.89 Aligned_cols=244 Identities=26% Similarity=0.398 Sum_probs=200.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||++....+++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 456789999999999999999888899999986532 22346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-- 163 (279)
T 3fdn_A 91 APLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 163 (279)
T ss_dssp CTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc--
Confidence 999999999976 35689999999999999999999998 99999999999999999999999999986543322
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . . .... .. .....+
T Consensus 164 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~-~-----~~~~-----~~--~~~~~~ 227 (279)
T 3fdn_A 164 -RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--E-T-----YKRI-----SR--VEFTFP 227 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--H-H-----HHHH-----HH--TCCCCC
T ss_pred -ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--H-H-----HHHH-----Hh--CCCCCC
Confidence 22345899999999999999999999999999999999999999643211 1 0 0000 00 001122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......+.+++..||+.||.+|||+.||++
T Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 228 DFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp TTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 334567889999999999999999999995
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=338.27 Aligned_cols=265 Identities=29% Similarity=0.432 Sum_probs=209.5
Q ss_pred HHhhhcccCcccceEEEEEEE----cCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCC--ceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTL----YKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS--KRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~----~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~--~~~l 585 (796)
.+.+.+.||+|+||.||+++. ...++.||||++........+.+.+|+.++.+++|+||+++++++...+ ..++
T Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 121 (326)
T 2w1i_A 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121 (326)
T ss_dssp GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence 456678999999999999984 4567899999998766666788999999999999999999999887654 6899
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
||||+++++|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 122 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 122 IMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 99999999999999764 35699999999999999999999998 999999999999999999999999999988754
Q ss_pred CCcce--eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHH----hhhhhhh
Q 003772 666 DQTRT--FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYK----CFIDREL 739 (796)
Q Consensus 666 ~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~ 739 (796)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... . ....... ......+
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~---~--~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---E--FMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH---H--HHHHHCTTCCTHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH---H--HHHhhccccchhhhHHHH
Confidence 43221 1223467789999999998899999999999999999999988753210 0 0000000 0000011
Q ss_pred hhhhc---CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 740 NKLVR---GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 740 ~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
.+.+. ....+...+..+.+++..||+.||++|||+.||++.|+.+.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 11223455678999999999999999999999999998764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=349.53 Aligned_cols=250 Identities=25% Similarity=0.397 Sum_probs=206.5
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+.+.+.||+|+||.||+|++...++.||||++.+... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35667899999999999999988889999999975322 234678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++|+|.+++.+ ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 97 ~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 97 YVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp CCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 9999999999975 46799999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceeeeeccCCCCCchhhhccCCC-CccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
.....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .. ......+. ..
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~------~~~i~~~~-------~~ 234 (476)
T 2y94_A 172 --LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TL------FKKICDGI-------FY 234 (476)
T ss_dssp --BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HH------HHHHHTTC-------CC
T ss_pred --ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HH------HHHHhcCC-------cC
Confidence 233469999999999998765 78999999999999999999999743211 10 11111110 01
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhc
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEG 783 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~ 783 (796)
.+......+.+++..||+.||.+|||+.|+++ .+..
T Consensus 235 ~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 235 TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 12233467889999999999999999999996 4544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=332.52 Aligned_cols=253 Identities=28% Similarity=0.385 Sum_probs=203.5
Q ss_pred Hhhhc-ccCcccceEEEEEEE--cCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 513 NRFKE-ELGKGSFGAVYKGTL--YKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 513 ~~~~~-~LG~G~fg~Vy~g~~--~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
+.+.+ .||+|+||.||+|.+ ...++.||||++.... ....+.+.+|+.++.+++||||+++++++ +.+..++||
T Consensus 18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 96 (291)
T 1xbb_A 18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM 96 (291)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence 34555 899999999999954 4556899999997543 22356799999999999999999999998 667789999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++++|.+++.. ...+++..++.++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 97 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 97 EMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp ECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 99999999999976 45699999999999999999999998 99999999999999999999999999998775543
Q ss_pred cce--eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 668 TRT--FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 668 ~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ... . ...... .
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~--~----~~~~~~------~ 237 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEV--T----AMLEKG------E 237 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHH--H----HHHHTT------C
T ss_pred CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHH--H----HHHHcC------C
Confidence 322 122346788999999999889999999999999999999 9999864321 110 0 000000 1
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
....+...+..+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus 238 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 238 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11223455678999999999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=337.70 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=208.3
Q ss_pred HHHhhhcccCcccceEEEEEEEc-----CCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCcee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 584 (796)
..+.+.+.||+|+||.||+|... ..++.||||++..... .....+.+|+.++++++|+||+++++++.+.+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 34567789999999999999876 2457899999975433 34457899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCC--------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEec
Q 003772 585 LVYEYMSNGSLADILFRGP--------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISD 656 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 656 (796)
+||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~D 181 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 181 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECc
Confidence 9999999999999986421 24578999999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhh
Q 003772 657 FGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCF 734 (796)
Q Consensus 657 Fgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 734 (796)
||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+..... .. . ....
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~--~----~~~~ 253 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQ--V----LRFV 253 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HH--H----HHHH
T ss_pred CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--HH--H----HHHH
Confidence 9999865433221 1122346889999999999999999999999999999999 7888754321 11 0 0111
Q ss_pred hhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 735 IDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.... ....+...+..+.+++..||+.||.+|||+.|+++.|+++..
T Consensus 254 ~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 MEGG------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCC------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1110 011233455778999999999999999999999999988654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=343.29 Aligned_cols=245 Identities=27% Similarity=0.347 Sum_probs=193.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHH-HhccCcCchhhhhhhhccCCceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHV-IGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
.+.+.+.||+|+||.||+++....++.||||++.+... ...+.+..|..+ ++.++||||+++++++.+.+..++||
T Consensus 39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~ 118 (373)
T 2r5t_A 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118 (373)
T ss_dssp GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence 45677899999999999999998889999999976432 233456677776 57789999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++|+|.+++.+ ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 119 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 119 DYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 99999999999976 45788999999999999999999998 99999999999999999999999999998643222
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. . ...+... ...
T Consensus 194 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~-~-----~~~i~~~-------~~~ 257 (373)
T 2r5t_A 194 S-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AE-M-----YDNILNK-------PLQ 257 (373)
T ss_dssp C-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--HH-H-----HHHHHHS-------CCC
T ss_pred C-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--HH-H-----HHHHHhc-------ccC
Confidence 1 23345699999999999999999999999999999999999999964321 11 1 1111111 111
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSV 777 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 777 (796)
.+......+.+++..||+.||.+||++.+.
T Consensus 258 ~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 258 LKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp CCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred CCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 233445678999999999999999998543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.98 Aligned_cols=199 Identities=25% Similarity=0.366 Sum_probs=176.2
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-----cCchhhhhhhhccCCcee
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-----HKNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-----h~niv~l~g~~~~~~~~~ 584 (796)
...+.+.++||+|+||.||+++....++.||||++.. .....+.+..|+.++..++ |+||+++++++...+..+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~ 112 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC 112 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence 3456677899999999999999988889999999975 2344566788999999986 999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC----------------
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE---------------- 648 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---------------- 648 (796)
+||||+ +++|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++.
T Consensus 113 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp EEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccccc
Confidence 999999 99999999876666799999999999999999999998 9999999999999975
Q ss_pred ---------CCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCC
Q 003772 649 ---------FWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEID 717 (796)
Q Consensus 649 ---------~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~ 717 (796)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 7899999999998654322 2345899999999999999999999999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.03 Aligned_cols=262 Identities=21% Similarity=0.332 Sum_probs=207.5
Q ss_pred cCHHHHHHHHHhhh-cccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccC-cCchhhhhhhhc
Q 003772 503 FSYNELKKATNRFK-EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTH-HKNLVRLIGYCA 578 (796)
Q Consensus 503 ~~~~~l~~~~~~~~-~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~-h~niv~l~g~~~ 578 (796)
|...+.....+.+. +.||+|+||.||++.....++.||||++..... .....+.+|+.++.+++ ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 44444455555555 789999999999999998889999999976432 33577899999999994 699999999999
Q ss_pred cCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC---CCceEEe
Q 003772 579 EDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE---FWTAKIS 655 (796)
Q Consensus 579 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 655 (796)
+.+..++||||+++|+|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||+++. ++.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEe
Confidence 999999999999999999999776567899999999999999999999998 9999999999999997 7899999
Q ss_pred ccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh
Q 003772 656 DFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI 735 (796)
Q Consensus 656 DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... .. ..
T Consensus 177 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~-~~-----i~ 246 (327)
T 3lm5_A 177 DFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ--ETY-LN-----IS 246 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH-HH-----HH
T ss_pred eCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHH-HH-----HH
Confidence 9999987643322 22345899999999999999999999999999999999999999643211 110 00 00
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 736 DRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.. ...............+.+++..||+.||.+|||++++++.
T Consensus 247 ~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 247 QV---NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HT---CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hc---ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00 0000111123445678999999999999999999999863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=343.65 Aligned_cols=271 Identities=25% Similarity=0.389 Sum_probs=208.8
Q ss_pred hhhcccCcccceEEEEEEE----cCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccC--CceeEE
Q 003772 514 RFKEELGKGSFGAVYKGTL----YKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAED--SKRLLV 586 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~----~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 586 (796)
++.+.||+|+||.||++.. ...++.||||++..... ...+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 6678999999999988764 34568899999976433 3456799999999999999999999999874 567899
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 114 ~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp ECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 999999999999975 3489999999999999999999998 9999999999999999999999999999887554
Q ss_pred Ccc--eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 667 QTR--TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 667 ~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
... ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+....... .....+.........+...+.
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF--LELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--HHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh--hhhhcccccchhHHHHHHHHh
Confidence 321 2223457888999999999999999999999999999999999986421100 000000000000011111111
Q ss_pred ---CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 003772 745 ---GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPPC 792 (796)
Q Consensus 745 ---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~ 792 (796)
....+......+.+++.+||+.||.+|||+.||++.|+.+.+.-.++.
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 112344566789999999999999999999999999998765544433
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=338.51 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=201.1
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
..+.+.+.||+|+||.||++.....++.||||++.+... ...+|++++.++ +||||+++++++.++...++||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 456677899999999999999998899999999976432 345688888887 799999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC----CceEEeccCCccccCC
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF----WTAKISDFGLAKLLMP 665 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFgl~~~~~~ 665 (796)
+++|+|.+++.+ ...+++..+..++.||+.||.|||+. +|+||||||+|||+.++ +.+||+|||+++....
T Consensus 98 ~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 98 MKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999976 46799999999999999999999998 99999999999998543 3599999999987654
Q ss_pred CCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.............. ...+.. ...
T Consensus 173 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~-----i~~~~~---~~~ 243 (342)
T 2qr7_A 173 ENGL-LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR-----IGSGKF---SLS 243 (342)
T ss_dssp TTCC-BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH-----HHHCCC---CCC
T ss_pred CCCc-eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH-----HccCCc---ccC
Confidence 3322 2234589999999999988899999999999999999999999975433222111111 111100 000
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..........+.+++..||+.||++|||+.++++
T Consensus 244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1112334567899999999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.80 Aligned_cols=246 Identities=27% Similarity=0.404 Sum_probs=198.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhcc----CCceeEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAE----DSKRLLV 586 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV 586 (796)
+.+.+.||+|+||.||+|.....+..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 356678999999999999999888999999987532 3345678999999999999999999998764 3558999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCC--eeeeccCccceEec-CCCceEEeccCCcccc
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP--IIHCDIKPQNILMD-EFWTAKISDFGLAKLL 663 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DFgl~~~~ 663 (796)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+. + |+|+||||+||+++ +++.+||+|||++...
T Consensus 108 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 108 TELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 999999999999976 36789999999999999999999998 7 99999999999998 7899999999999765
Q ss_pred CCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
..... ....||+.|+|||.+.+ .++.++||||||+++|||++|+.||........ . ...... ..
T Consensus 183 ~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~----~~~~~~-----~~ 246 (290)
T 1t4h_A 183 RASFA---KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---I----YRRVTS-----GV 246 (290)
T ss_dssp CTTSB---EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---H----HHHHTT-----TC
T ss_pred ccccc---ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH---H----HHHHhc-----cC
Confidence 43322 23458999999998875 589999999999999999999999965332111 0 011110 01
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.....+....+.+.+++..||+.||.+|||+.||++
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111112223357899999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.78 Aligned_cols=252 Identities=26% Similarity=0.364 Sum_probs=205.7
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
..+.+.+.||+|+||.||++.....++.||||++.... ....+.+.+|+.++++++|+||+++++++.+++..++|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45667789999999999999998888899999997533 33457789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc-
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT- 668 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~- 668 (796)
+++++|.+++.. ...+++..++.++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 87 CSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 999999999865 45799999999999999999999998 999999999999999999999999999986543221
Q ss_pred ceeeeeccCCCCCchhhhccCCC-CccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
.......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||.......... ..+... . ....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~-----~-----~~~~ 229 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SDWKEK-----K-----TYLN 229 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH--HHHHTT-----C-----TTST
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH--HHhhhc-----c-----cccC
Confidence 12233558999999999987765 789999999999999999999997644322111 111100 0 0001
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
........+.+++..||+.||.+|||++|+++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 11234567889999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.59 Aligned_cols=256 Identities=23% Similarity=0.298 Sum_probs=196.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|+||.||++.. ..++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred chhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 45678999999999999998 4567899999865332 23467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++ +|.+++... ...+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 83 ~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 83 DQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp SE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred CC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence 85 899988653 46789999999999999999999998 999999999999999999999999999987643222 2
Q ss_pred eeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh---hhh---hhhhh
Q 003772 671 FTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI---DRE---LNKLV 743 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~---~~~~~ 743 (796)
.....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...... . .+.. ...... ... .....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~-~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--D-QLMR-IFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H-HHHH-HHHHHCCCCTTTSTTGGGST
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--H-HHHH-HHHHHCCCChhhchhhhccc
Confidence 2334589999999999764 5899999999999999999999999643211 1 1110 111000 000 00000
Q ss_pred --cCC----------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 744 --RGQ----------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 744 --~~~----------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
+.. .......+.+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 011234567889999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=327.34 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=209.5
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+.+.+.||+|+||.||++....+++.||||++.... ....+.+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 4566789999999999999999888999999996532 2234678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++|+|.+++.. ...+++..++.++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 95 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 95 FAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169 (284)
T ss_dssp CCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred eCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence 9999999999976 35689999999999999999999998 999999999999999999999999999976543222
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .. ....... ....
T Consensus 170 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~------~~~~~~~-------~~~~ 231 (284)
T 2vgo_A 170 ---RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--ET------HRRIVNV-------DLKF 231 (284)
T ss_dssp ---CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HH------HHHHHTT-------CCCC
T ss_pred ---ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--HH------HHHHhcc-------ccCC
Confidence 2345899999999999999999999999999999999999999643211 10 0000000 0112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhcCcCCCCCC
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEGITDISIPP 791 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~~~~p~ 791 (796)
+......+.+++..||+.||.+|||+.++++ .++.......||
T Consensus 232 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~ 276 (284)
T 2vgo_A 232 PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPP 276 (284)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCC
T ss_pred CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCC
Confidence 2334567889999999999999999999985 555444433333
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.24 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=204.4
Q ss_pred cccCcccceEEEEEEEc--CCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 517 EELGKGSFGAVYKGTLY--KGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~--~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
+.||+|+||.||+|... ..+..||||++.... ....+.+.+|+.++.+++||||+++++++ +.+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 38999999999999863 456789999997643 33457799999999999999999999998 556789999999999
Q ss_pred ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce--e
Q 003772 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT--F 671 (796)
Q Consensus 594 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~--~ 671 (796)
+|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++.......... .
T Consensus 95 ~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 170 (287)
T 1u59_A 95 PLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170 (287)
T ss_dssp EHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred CHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecc
Confidence 999999653 45699999999999999999999998 99999999999999999999999999998775443321 1
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... . ..... .....+.
T Consensus 171 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~--~----~i~~~------~~~~~~~ 236 (287)
T 1u59_A 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM--A----FIEQG------KRMECPP 236 (287)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHH--H----HHHTT------CCCCCCT
T ss_pred ccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHH--H----HHhcC------CcCCCCC
Confidence 22346889999999998899999999999999999998 99998654321 110 0 00000 0112334
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
..+..+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 55678999999999999999999999999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.08 Aligned_cols=256 Identities=24% Similarity=0.348 Sum_probs=205.8
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+.+.+.||+|+||.||+++....++.||||++........+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 45667889999999999999998888999999998755555667899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe---cCCCceEEeccCCccccCCCC
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFgl~~~~~~~~ 667 (796)
++++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+||++ ++++.+||+|||++.......
T Consensus 89 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 89 SGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp CSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred CCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 99999999876 35689999999999999999999998 99999999999999 788999999999997654322
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .... ........ .....
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~-----~~i~~~~~---~~~~~ 229 (304)
T 2jam_A 164 ---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLF-----EKIKEGYY---EFESP 229 (304)
T ss_dssp ---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH-----HHHHHCCC---CCCTT
T ss_pred ---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHH-----HHHHcCCC---CCCcc
Confidence 2234589999999999999999999999999999999999999864321 1110 11111000 00011
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhcCc
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEGIT 785 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~ 785 (796)
........+.+++..||+.||++|||+.++++ .+++..
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 230 FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 12344577899999999999999999999986 455443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=340.99 Aligned_cols=255 Identities=23% Similarity=0.298 Sum_probs=190.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-cCchhhhhhhhc--------cCCc
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-HKNLVRLIGYCA--------EDSK 582 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~--------~~~~ 582 (796)
.+++.+.||+|+||.||+++....++.||||++........+.+.+|+.++.++. ||||+++++++. ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 4567789999999999999998888999999997766666778999999999996 999999999883 3445
Q ss_pred eeEEEeecCCCChhhhhhcC-CCCCCchhHHHHHHHHHHHHHHHhhccCCCC--eeeeccCccceEecCCCceEEeccCC
Q 003772 583 RLLVYEYMSNGSLADILFRG-PERSLGWDERVRIASDVAKGILYLHDECEAP--IIHCDIKPQNILMDEFWTAKISDFGL 659 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DFgl 659 (796)
.++|+||+. |+|.+++... ....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 789999996 7999988642 345799999999999999999999998 7 99999999999999999999999999
Q ss_pred ccccCCCCcce-----------eeeeccCCCCCchhhh---ccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHH
Q 003772 660 AKLLMPDQTRT-----------FTLVRGTRGYMAPEWY---KNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIV 725 (796)
Q Consensus 660 ~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~ 725 (796)
++......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 98765432211 1134489999999998 56678999999999999999999999986432110
Q ss_pred HHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 726 LINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
....... ..........+.+++..||+.||.+|||+.|+++.|+.+...
T Consensus 261 --------~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 261 --------IVNGKYS-----IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -------------CC-----CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------hhcCccc-----CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0000000 011112234578899999999999999999999999887543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=344.40 Aligned_cols=247 Identities=21% Similarity=0.243 Sum_probs=190.3
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhc-cCcCchhhhhhhhcc----CCceeEEEeecC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGR-THHKNLVRLIGYCAE----DSKRLLVYEYMS 591 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~-l~h~niv~l~g~~~~----~~~~~lV~e~~~ 591 (796)
+.||+|+||.||++.....++.||||+++. ...+.+|+.++.+ .+|+||+++++++.. ....++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 689999999999999998889999999964 2356778888744 589999999998865 567899999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC---CCceEEeccCCccccCCCCc
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE---FWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFgl~~~~~~~~~ 668 (796)
+|+|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~- 218 (400)
T 1nxk_A 143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN- 218 (400)
T ss_dssp SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC-
Confidence 99999999875556799999999999999999999998 9999999999999997 7899999999998764322
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.............. ....+.. ......
T Consensus 219 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~i~~~~~---~~~~~~ 290 (400)
T 1nxk_A 219 -SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQY---EFPNPE 290 (400)
T ss_dssp ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH----HHHHTCC---CCCTTT
T ss_pred -ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH----HHHcCcc---cCCCcc
Confidence 22345689999999999999999999999999999999999999975433211100000 0000000 000011
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.......+.+++..||+.||++|||+.||++.
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 12345678999999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.96 Aligned_cols=252 Identities=21% Similarity=0.266 Sum_probs=192.7
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--------hhHHHHHHHHHHHhccCcCchhhhhhhhccCC
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--------EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS 581 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~ 581 (796)
...+.+.+.||+|+||.||+|.....++.||||++.+... .....+.+|+.++++++||||+++++++. .+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 3456778899999999999999998889999999975321 12235889999999999999999999875 45
Q ss_pred ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC---CceEEeccC
Q 003772 582 KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF---WTAKISDFG 658 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFg 658 (796)
..++||||+++|+|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+|||++.+ ..+||+|||
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecc
Confidence 68999999999999999875 46799999999999999999999998 99999999999999754 459999999
Q ss_pred CccccCCCCcceeeeeccCCCCCchhhhcc---CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh
Q 003772 659 LAKLLMPDQTRTFTLVRGTRGYMAPEWYKN---TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI 735 (796)
Q Consensus 659 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ .....
T Consensus 288 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~---i~~~~- 361 (419)
T 3i6u_A 288 HSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ---ITSGK- 361 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH---HHTTC-
T ss_pred cceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH---HhcCC-
Confidence 99876432 22234568999999999853 57889999999999999999999999754322211110 00000
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 736 DRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...... ......+.+.+++..||+.||.+|||+.|+++
T Consensus 362 ~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 362 YNFIPE------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CCCCHH------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCch------hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000000 00123467899999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.38 Aligned_cols=260 Identities=22% Similarity=0.303 Sum_probs=198.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|+||.||++.....++.||||++..... ...+.+.+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 4567899999999999999988889999999865332 23466889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........ .
T Consensus 85 ~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 158 (311)
T 4agu_A 85 DHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-Y 158 (311)
T ss_dssp SEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-c
Confidence 99999998865 45699999999999999999999998 999999999999999999999999999987653322 2
Q ss_pred eeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhh--------hh-h
Q 003772 671 FTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDR--------EL-N 740 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~-~ 740 (796)
.....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ............+. .. .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhcccccccccccccccccc
Confidence 233458999999999976 5789999999999999999999999965432111 11111000000000 00 0
Q ss_pred h--hhcCCCC------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 741 K--LVRGQEV------DRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 741 ~--~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
. ....... .+.....+.+++..||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0000000 1234567899999999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.17 Aligned_cols=248 Identities=23% Similarity=0.292 Sum_probs=193.3
Q ss_pred HHHhhhcccCcccceEEEEEEEc---CCcEEEEEEEeeccc----chhHHHHHHHHHHHhccCcCchhhhhhhhccCCce
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMV----TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 583 (796)
..+.+.+.||+|+||.||+++.. ..++.||||++.+.. ......+.+|+.++++++||||+++++++.+++..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 34567789999999999999974 467899999997642 22345688999999999999999999999999999
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 97 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 97 YLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 999999999999999976 35689999999999999999999998 9999999999999999999999999999764
Q ss_pred CCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .. . .......
T Consensus 172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~-~-----~~~i~~~------ 236 (327)
T 3a62_A 172 IHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--KK-T-----IDKILKC------ 236 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH-H-----HHHHHHT------
T ss_pred ccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--HH-H-----HHHHHhC------
Confidence 33221 22234589999999999999999999999999999999999999964321 11 0 0111100
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRP-----SMKSVVL 779 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 779 (796)
....+......+.+++..||+.||.+|| ++.|+++
T Consensus 237 -~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 -KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1112334456789999999999999999 7778874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.12 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=202.4
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch------hHHHHHHHHHHHhccCcCchhhhhhhhccCCce
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE------GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~------~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~ 583 (796)
...+.+.+.||+|+||.||++.....++.||+|++...... ..+.+.+|+.++.+++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 34567789999999999999999888889999998753221 357799999999999999999999999999999
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC----ceEEeccCC
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW----TAKISDFGL 659 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFgl 659 (796)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+|+||||+||+++.++ .+||+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 999999999999999975 45789999999999999999999998 999999999999998877 899999999
Q ss_pred ccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh
Q 003772 660 AKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739 (796)
Q Consensus 660 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
+........ .....+++.|+|||.+.+..++.++||||||+++|||++|+.||..... .. .. ........
T Consensus 159 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~-~~-----~~~~~~~~ 228 (283)
T 3bhy_A 159 AHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--QE-TL-----TNISAVNY 228 (283)
T ss_dssp CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HH-HH-----HHHHTTCC
T ss_pred ceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--HH-HH-----HHhHhccc
Confidence 987644322 2334589999999999999999999999999999999999999864321 11 10 00000000
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 740 NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
. ............+.+++.+||+.||++|||+.++++
T Consensus 229 ~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 D---FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C---CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C---CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 000001123467899999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=328.19 Aligned_cols=254 Identities=26% Similarity=0.334 Sum_probs=203.1
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc----chhHHHHHHHHHHHhccCcCchhhhhhhhc--cCCceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV----TEGEREFRAEMHVIGRTHHKNLVRLIGYCA--EDSKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~h~niv~l~g~~~--~~~~~~l 585 (796)
.+.+.+.||+|+||.||++.....++.||||++.... ....+.+.+|+.++++++|+||+++++++. +....++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 3566789999999999999998888999999997532 234577999999999999999999999984 4567899
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
||||++++ |.+++.......+++..++.++.||++||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999977 87888766667899999999999999999999998 999999999999999999999999999987654
Q ss_pred CCc-ceeeeeccCCCCCchhhhccCC--CCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 666 DQT-RTFTLVRGTRGYMAPEWYKNTP--ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 666 ~~~-~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
... .......||+.|+|||++.+.. .+.++||||||+++|||++|+.||..... .. . .......
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~--~----~~~i~~~----- 228 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--YK--L----FENIGKG----- 228 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--HH--H----HHHHHHC-----
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HH--H----HHHHhcC-----
Confidence 322 2223455899999999998654 37899999999999999999999974321 10 0 0111000
Q ss_pred hcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhcC
Q 003772 743 VRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEGI 784 (796)
Q Consensus 743 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~ 784 (796)
....+......+.+++.+||+.||.+|||+.|+++ .+++.
T Consensus 229 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 229 --SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp --CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred --CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 01123344567889999999999999999999995 45544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.84 Aligned_cols=259 Identities=29% Similarity=0.456 Sum_probs=206.1
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEE--EEEEeeccc-chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLV--AVKKLEKMV-TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~v--AvK~l~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 586 (796)
..+.+.+.||+|+||.||++....++..+ |||++.... ....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 34567789999999999999988777654 999987533 33446789999999999 899999999999999999999
Q ss_pred EeecCCCChhhhhhcCC--------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCce
Q 003772 587 YEYMSNGSLADILFRGP--------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTA 652 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 652 (796)
|||+++|+|.+++.... ...+++..++.++.||++||.|||+. +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997642 24799999999999999999999998 99999999999999999999
Q ss_pred EEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHH
Q 003772 653 KISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAY 731 (796)
Q Consensus 653 kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 731 (796)
||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .. ..
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~------~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AE------LY 251 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HH------HH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--HH------HH
Confidence 99999999743221 11222346889999999999889999999999999999998 9999864321 10 01
Q ss_pred HhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCC
Q 003772 732 KCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDIS 788 (796)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 788 (796)
...... . ....+......+.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus 252 ~~~~~~-----~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 252 EKLPQG-----Y-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHGGGT-----C-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHhhcC-----C-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 111110 0 11223345577999999999999999999999999998865543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.97 Aligned_cols=268 Identities=27% Similarity=0.367 Sum_probs=195.8
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHH--HHHHhccCcCchhhhhhhhc-----cCCcee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAE--MHVIGRTHHKNLVRLIGYCA-----EDSKRL 584 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E--~~~l~~l~h~niv~l~g~~~-----~~~~~~ 584 (796)
.+.+.+.||+|+||.||+|+. .++.||||++.... ...+..| +..+..++|+||+++++.+. .....+
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 345678999999999999987 46899999997532 2334444 44455689999999997432 334678
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccC------CCCeeeeccCccceEecCCCceEEeccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC------EAPIIHCDIKPQNILMDEFWTAKISDFG 658 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~DFg 658 (796)
+||||+++|+|.+++.. ...++..++.++.||++||.|||+.. ..+|+||||||+|||++.++.+||+|||
T Consensus 89 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 99999999999999965 34588999999999999999999863 2389999999999999999999999999
Q ss_pred CccccCCCCc-------ceeeeeccCCCCCchhhhcc-------CCCCccccchhhHHHHHHHhhcccCCCCCCCCchh-
Q 003772 659 LAKLLMPDQT-------RTFTLVRGTRGYMAPEWYKN-------TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEE- 723 (796)
Q Consensus 659 l~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~- 723 (796)
+++.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 9987653321 12223458999999999986 45678999999999999999998887544322111
Q ss_pred HHHHHHHHHhhhhhhhhhhh----------cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 724 IVLINWAYKCFIDRELNKLV----------RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
.................... ..-.........+.+++..||+.||++|||++||++.|+.+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 00000000000000001100 00112345677899999999999999999999999999987644
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.10 Aligned_cols=259 Identities=24% Similarity=0.401 Sum_probs=196.7
Q ss_pred HHHhhhcccCcccceEEEEEEEcC---CcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCc---
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYK---GEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSK--- 582 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~---~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~--- 582 (796)
..+.+.+.||+|+||.||+|.... .+..||||++... .....+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 345567889999999999998764 3458999998753 23345679999999999999999999999987553
Q ss_pred --eeEEEeecCCCChhhhhhcC----CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEec
Q 003772 583 --RLLVYEYMSNGSLADILFRG----PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISD 656 (796)
Q Consensus 583 --~~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 656 (796)
.++||||+++|+|.+++... ....+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECS
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEee
Confidence 49999999999999998532 346799999999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhh
Q 003772 657 FGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCF 734 (796)
Q Consensus 657 Fgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 734 (796)
||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... ... .. .
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~--~~----~ 262 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMY--DY----L 262 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHH--HH----H
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHH--HH----H
Confidence 999987654332 22233457889999999999999999999999999999999 77887644321 110 00 0
Q ss_pred hhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 735 IDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
... .....+......+.+++..||+.||.+|||+++|++.|+.+.+
T Consensus 263 ~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 263 LHG------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HTT------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcC------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000 0111233455779999999999999999999999999988653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=341.54 Aligned_cols=254 Identities=23% Similarity=0.274 Sum_probs=204.8
Q ss_pred HHhhhcccCcccceEEEEEEEc---CCcEEEEEEEeeccc----chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCce
Q 003772 512 TNRFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMV----TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 583 (796)
.+.+.+.||+|+||.||+++.. ..++.||||++.+.. ....+.+.+|+.++.++ +|+||+++++++.+++..
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 134 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 134 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence 4566789999999999999984 466899999986532 23345678899999999 699999999999999999
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
++||||+++|+|.+++.. ...+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 135 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 999999999999999976 35789999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcceeeeeccCCCCCchhhhcc--CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKN--TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---------- 279 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL---------- 279 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH----------
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh----------
Confidence 5544444445569999999999986 3578999999999999999999999975543322211111000
Q ss_pred hhcCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHH
Q 003772 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRP-----SMKSVVLML 781 (796)
Q Consensus 742 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~L 781 (796)
......+.+....+.+++.+||+.||.+|| |+.|+++..
T Consensus 280 -~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 280 -KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 011123344556788999999999999999 999998643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=328.67 Aligned_cols=246 Identities=23% Similarity=0.330 Sum_probs=204.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||++.....++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 456789999999999999999888999999987542 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++++|.+++.. ...+++..++.++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 97 CRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp CTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 999999999875 35789999999999999999999998 999999999999999999999999999987653322
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .. ....... ....+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~------~~~~~~~-------~~~~~ 235 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ET------YLRIKKN-------EYSIP 235 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HH------HHHHHTT-------CCCCC
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH------HHHHhhc-------cCCCc
Confidence 222345899999999999989999999999999999999999999643211 10 0000000 01122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......+.+++..||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 236 KHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 334567889999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=337.40 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=193.3
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCc--CchhhhhhhhccCCceeEEEe
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHH--KNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e 588 (796)
+.+.+.||+|+||.||++.... ++.||||++.... .+..+.+.+|+.++.+++| +||+++++++.+++..++|||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 89 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 89 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTT-SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEecCCCeEEEEEEeCC-CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence 5567899999999999999854 6789999987532 3345678999999999976 999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
+.+|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.......
T Consensus 90 -~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 90 -CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp -CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred -CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 578899999987 46789999999999999999999998 999999999999997 57899999999987754433
Q ss_pred c-eeeeeccCCCCCchhhhcc-----------CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhh
Q 003772 669 R-TFTLVRGTRGYMAPEWYKN-----------TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFID 736 (796)
Q Consensus 669 ~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ......
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~~~~~ 235 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-------LHAIID 235 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-------HHHHHC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH-------HHHHhc
Confidence 2 2234569999999999975 67899999999999999999999999643221100 000000
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 737 RELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
. ......+......+.+++..||+.||.+|||+.|+++.
T Consensus 236 ~-----~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 236 P-----NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp T-----TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C-----CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 0 00111222334578899999999999999999999853
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=347.21 Aligned_cols=239 Identities=14% Similarity=0.127 Sum_probs=186.3
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc---cchhHHHHHHHH---HHHhccCcCchhhhhhhh-------cc
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM---VTEGEREFRAEM---HVIGRTHHKNLVRLIGYC-------AE 579 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~---~~l~~l~h~niv~l~g~~-------~~ 579 (796)
+.+.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+ ..+++++||||+++++.+ .+
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 34568899999999999998877889999999742 334557799999 555566899999999544 33
Q ss_pred CC-----------------ceeEEEeecCCCChhhhhhcC-----CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeee
Q 003772 580 DS-----------------KRLLVYEYMSNGSLADILFRG-----PERSLGWDERVRIASDVAKGILYLHDECEAPIIHC 637 (796)
Q Consensus 580 ~~-----------------~~~lV~e~~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~ 637 (796)
.+ ..++||||+ +|+|.+++... ....+++..++.++.||++||.|||+. +|+||
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHr 230 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT 230 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 22 278999999 68999999752 123355688899999999999999998 99999
Q ss_pred ccCccceEecCCCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccC-----------CCCccccchhhHHHHHH
Q 003772 638 DIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT-----------PISVKADVFSYGVVLLE 706 (796)
Q Consensus 638 Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~S~Gvil~e 706 (796)
||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999999999999999986432 2334457 999999999887 89999999999999999
Q ss_pred HhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 707 IVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 707 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
|++|+.||........ ....... .....+.+.+++..||+.||++|||+.++++
T Consensus 306 lltg~~Pf~~~~~~~~----------------~~~~~~~---~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 306 IWCADLPITKDAALGG----------------SEWIFRS---CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHSSCCC------CC----------------SGGGGSS---CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHCCCCCcccccccc----------------hhhhhhh---ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999964321110 0111110 1223467889999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=328.47 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=199.5
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCCChh
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLA 596 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 596 (796)
..||+|+||.||+|....+++.||||++........+.+.+|+.++.+++|+||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 47999999999999998888999999998766666778999999999999999999999999999999999999999999
Q ss_pred hhhhcCC-CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-CCceEEeccCCccccCCCCcceeeee
Q 003772 597 DILFRGP-ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE-FWTAKISDFGLAKLLMPDQTRTFTLV 674 (796)
Q Consensus 597 ~~l~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgl~~~~~~~~~~~~~~~ 674 (796)
+++.... ...+++..+..++.|+++||.|||+. +|+|+||||+||+++. ++.+||+|||++........ .....
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 183 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETF 183 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-ccccc
Confidence 9997642 24567888999999999999999998 9999999999999987 89999999999987643222 12234
Q ss_pred ccCCCCCchhhhccCC--CCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 675 RGTRGYMAPEWYKNTP--ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 675 ~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
.|++.|+|||++.+.. ++.++||||||+++|||++|+.||........ .... . .........+...
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~--~--------~~~~~~~~~~~~~ 251 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AMFK--V--------GMFKVHPEIPESM 251 (295)
T ss_dssp CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--HHHH--H--------HHHCCCCCCCTTS
T ss_pred CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--HHHh--h--------ccccccccccccC
Confidence 5899999999997653 89999999999999999999999864321111 0000 0 0001111223445
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 753 LENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...+.+++..||+.||++|||+.++++
T Consensus 252 ~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 252 SAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 577899999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=335.33 Aligned_cols=246 Identities=22% Similarity=0.315 Sum_probs=204.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||++.....++.||+|++.+.. ....+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 122 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEec
Confidence 456688999999999999999888999999987542 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++++|.+++.. ...+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 123 ~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 123 CRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp CTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 999999999876 35789999999999999999999998 999999999999999999999999999987653322
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .... ...... ....+
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~------~~~~~~-------~~~~~ 261 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--KETY------LRIKKN-------EYSIP 261 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHH------HHHHHT-------CCCCC
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--HHHH------HHHhcC-------CCCCC
Confidence 22334589999999999999999999999999999999999999964321 1110 000000 01122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......+.+++..||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 262 KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 334467889999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=350.99 Aligned_cols=251 Identities=25% Similarity=0.326 Sum_probs=205.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+++....++.||||++.+... ...+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 187 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 3445789999999999999988889999999976332 3346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCC--CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 590 MSNGSLADILFRGP--ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 590 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 99999999997643 45699999999999999999999998 99999999999999999999999999998765443
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ..... ....
T Consensus 344 ~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~----~~i~~-------~~~~ 411 (543)
T 3c4z_A 344 TK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK----QRVLE-------QAVT 411 (543)
T ss_dssp CC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH----HHHHH-------CCCC
T ss_pred cc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH----HHHhh-------cccC
Confidence 22 223469999999999999999999999999999999999999997653322111111 11100 0112
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSM-----KSVV 778 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl 778 (796)
.+......+.+++..||+.||.+||++ .+|+
T Consensus 412 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 234455778999999999999999976 5665
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=329.68 Aligned_cols=250 Identities=30% Similarity=0.418 Sum_probs=197.5
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccC-CceeEEEeec
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAED-SKRLLVYEYM 590 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~e~~ 590 (796)
.+.+.+.||+|+||.||+++.. ++.||||++... ...+.+.+|+.++.+++|+||+++++++.+. +..++||||+
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hceEEeEEecCCCceEEEEEEc--CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 4566789999999999999874 678999999753 3456799999999999999999999987654 4789999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|+|.+++.......+++..++.++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 171 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence 999999999764333488999999999999999999998 99999999999999999999999999998654322
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... ... ...... .....+
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~------~~~~~~------~~~~~~ 236 (278)
T 1byg_A 172 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVV------PRVEKG------YKMDAP 236 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHH------HHHTTT------CCCCCC
T ss_pred -cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHH------HHHhcC------CCCCCc
Confidence 12347889999999999999999999999999999998 99888654311 110 000000 011223
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
...+..+.+++..||+.||.+|||+.++++.|+.+..
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 4456779999999999999999999999999988753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=347.22 Aligned_cols=257 Identities=23% Similarity=0.245 Sum_probs=193.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccC------Ccee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAED------SKRL 584 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 584 (796)
+.+.+.||+|+||.||++.....++.||||++.+. .....+.+.+|+.+++.++||||+++++++... .+.+
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 143 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence 55678999999999999999988999999999764 233456788999999999999999999998654 3569
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+||||++++ |.+.+. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 144 lv~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 144 LVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred EEEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 999999864 666663 3489999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH-------HHhhhhh
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA-------YKCFIDR 737 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~ 737 (796)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... .... ..
T Consensus 216 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~-~~ 292 (464)
T 3ttj_A 216 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL-QP 292 (464)
T ss_dssp -C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS-CH
T ss_pred CC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc-ch
Confidence 32 22334568999999999999999999999999999999999999996432111000000000 0000 00
Q ss_pred hhhhhhcCC---------------------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 738 ELNKLVRGQ---------------------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 738 ~~~~~~~~~---------------------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.....+... .........+.+|+..||+.||++|||++|+++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 0011225679999999999999999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=341.63 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=193.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccC--cCchhhhhhhhccCCceeEEEe
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTH--HKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV~e 588 (796)
+.+.+.||+|+||.||++.... ++.||||++.... ....+.+.+|+.++.+++ |+||+++++++..++..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 5667899999999999999876 6789999986532 334577999999999996 5999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
+.+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.+.....
T Consensus 137 -~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 137 -CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp -CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred -cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 678899999987 35788999999999999999999998 999999999999995 57899999999987754432
Q ss_pred c-eeeeeccCCCCCchhhhcc-----------CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhh
Q 003772 669 R-TFTLVRGTRGYMAPEWYKN-----------TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFID 736 (796)
Q Consensus 669 ~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ . ......
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--~-----~~~~~~ 282 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--K-----LHAIID 282 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--H-----HHHHHC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH--H-----HHHHhC
Confidence 2 2234569999999999975 3689999999999999999999999964321110 0 011111
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 737 RELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.. .....+......+.+++..||+.||.+|||+.||++
T Consensus 283 ~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 283 PN-----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp TT-----SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cc-----ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 00 001112222457889999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=327.03 Aligned_cols=244 Identities=23% Similarity=0.313 Sum_probs=199.6
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 587 (796)
..+.+.+.||+|+||.||++.....++.||||++... .......+.+|+..+.++ +||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 4566778999999999999999888899999999753 233456788999999999 9999999999999999999999
Q ss_pred eecCCCChhhhhhcCC--CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-----------------
Q 003772 588 EYMSNGSLADILFRGP--ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE----------------- 648 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~----------------- 648 (796)
||+++|+|.+++.... ...+++..++.++.||++||.|||++ +|+||||||+||+++.
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 9999999999997532 25689999999999999999999998 9999999999999984
Q ss_pred --CCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHH
Q 003772 649 --FWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIV 725 (796)
Q Consensus 649 --~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~ 725 (796)
...+||+|||++........ ..||+.|+|||.+.+. .++.++||||||+++|||++|+.++.... .
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~-- 236 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----Q-- 236 (289)
T ss_dssp --CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----H--
T ss_pred CCceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----H--
Confidence 44799999999987654332 2389999999999876 67789999999999999999987654221 0
Q ss_pred HHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 726 LINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......... ...+......+.+++..||+.||++|||+.|+++
T Consensus 237 -----~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 -----WHEIRQGRL------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -----HHHHHTTCC------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHHHcCCC------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 011111111 1122344567899999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.78 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=190.9
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccC-cCchhhhhhhhccCC--ceeE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDS--KRLL 585 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~l 585 (796)
..+.+.+.||+|+||.||+|.+...++.||||++.+. .....+.+.+|+.++.++. |+||+++++++...+ ..++
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 3456778999999999999999888899999998653 2334567889999999997 999999999987543 6899
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
||||++ |+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 89 v~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 999998 689999875 4689999999999999999999998 999999999999999999999999999987532
Q ss_pred C--------------------CcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhH
Q 003772 666 D--------------------QTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEI 724 (796)
Q Consensus 666 ~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~ 724 (796)
. .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1 1112234569999999999986 578999999999999999999999996432111000
Q ss_pred HHHHHHHHhhhhhhhh------------hh---------------------hcCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 003772 725 VLINWAYKCFIDRELN------------KL---------------------VRGQEVDRNTLENMIKIGLWCVQDEPALR 771 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~~------------~~---------------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 771 (796)
.+.. .........+. .+ ...........+.+.+++..||+.||.+|
T Consensus 242 ~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 242 RIIG-VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHH-HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHH-hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 0000 00000000000 00 00000011234678999999999999999
Q ss_pred CCHHHHHHH
Q 003772 772 PSMKSVVLM 780 (796)
Q Consensus 772 Pt~~evl~~ 780 (796)
||++|+++.
T Consensus 321 ~t~~e~l~H 329 (388)
T 3oz6_A 321 ISANDALKH 329 (388)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhCC
Confidence 999999865
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=338.59 Aligned_cols=251 Identities=20% Similarity=0.198 Sum_probs=200.9
Q ss_pred HHHhhhcccCcccceEEEEEE-----EcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC---cCchhhhhhhhccCCc
Q 003772 511 ATNRFKEELGKGSFGAVYKGT-----LYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH---HKNLVRLIGYCAEDSK 582 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~-----~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~ 582 (796)
..+.+.+.||+|+||.||+|. ....++.||||++... ...++..|+.++.+++ |+||+++++++.+.+.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 345567889999999999994 4556678999999753 3456777777777776 9999999999999999
Q ss_pred eeEEEeecCCCChhhhhhcC---CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-----------
Q 003772 583 RLLVYEYMSNGSLADILFRG---PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE----------- 648 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~----------- 648 (796)
.++||||+++|+|.+++... ....+++..++.++.||++||.|||+. +|+||||||+|||++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccc
Confidence 99999999999999999742 346799999999999999999999998 9999999999999998
Q ss_pred CCceEEeccCCccccCCC-CcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHH
Q 003772 649 FWTAKISDFGLAKLLMPD-QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLI 727 (796)
Q Consensus 649 ~~~~kl~DFgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~ 727 (796)
++.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---- 294 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---- 294 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee----
Confidence 899999999999765422 223344566999999999999999999999999999999999999998643221100
Q ss_pred HHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCC-CCHHHHHHHHhcCcC
Q 003772 728 NWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALR-PSMKSVVLMLEGITD 786 (796)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Pt~~evl~~L~~~~~ 786 (796)
+..... .....+.+.+++..|++.+|.+| |++.++.+.|+.+.+
T Consensus 295 -----------~~~~~~----~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 295 -----------PEGLFR----RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp -----------ECSCCT----TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred -----------echhcc----ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 011111 11124567788889999999998 788888888877543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=336.47 Aligned_cols=266 Identities=21% Similarity=0.270 Sum_probs=196.7
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchh-HHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG-EREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~-~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.+.+.||+|+||.||+|.....++.||||++....... ...+.+|+.++++++|+||+++++++.+++..++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 456688999999999999998888999999986533222 2245679999999999999999999999999999999998
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
|+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 84 -~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~ 157 (324)
T 3mtl_A 84 -KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY 157 (324)
T ss_dssp -EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred -cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccc
Confidence 5899988764 45699999999999999999999998 99999999999999999999999999998654322 222
Q ss_pred eeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc------
Q 003772 672 TLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR------ 744 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 744 (796)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .....................
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHhchhhhcchhhcc
Confidence 33458999999999876 5689999999999999999999999975431110 000000000000000000000
Q ss_pred ---CC-------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhcCc
Q 003772 745 ---GQ-------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEGIT 785 (796)
Q Consensus 745 ---~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~ 785 (796)
.. ...+.....+.+++..||+.||.+|||++|+++ .+.++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 00 001233467889999999999999999999986 444443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=337.63 Aligned_cols=261 Identities=28% Similarity=0.403 Sum_probs=203.8
Q ss_pred HHHHHhhhcccCcccceEEEEEEE-----cCCcEEEEEEEeecc-cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCc
Q 003772 509 KKATNRFKEELGKGSFGAVYKGTL-----YKGEKLVAVKKLEKM-VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSK 582 (796)
Q Consensus 509 ~~~~~~~~~~LG~G~fg~Vy~g~~-----~~~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~ 582 (796)
....+.+.+.||+|+||.||+|++ ...++.||||++... .......+.+|+.++.+++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 344566788999999999999984 345568999999754 33455678999999999999999999999999999
Q ss_pred eeEEEeecCCCChhhhhhcCCC-----CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC---CCceEE
Q 003772 583 RLLVYEYMSNGSLADILFRGPE-----RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE---FWTAKI 654 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 654 (796)
.++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+. +|+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999976422 4589999999999999999999998 9999999999999994 456999
Q ss_pred eccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHH
Q 003772 655 SDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYK 732 (796)
Q Consensus 655 ~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 732 (796)
+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .. .. .
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~--~~----~ 256 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QE--VL----E 256 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH--HH----H
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HH--HH----H
Confidence 99999986533222 22223457889999999999999999999999999999998 8888864321 11 10 0
Q ss_pred hhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 733 CFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
..... .....+......+.+++..||+.||.+|||+.+|++.|+.+..
T Consensus 257 ~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 257 FVTSG------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHTT------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcC------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 00000 0111233455678999999999999999999999999987643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=341.10 Aligned_cols=269 Identities=22% Similarity=0.270 Sum_probs=208.7
Q ss_pred cCHHHHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC--------cCchhhhh
Q 003772 503 FSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH--------HKNLVRLI 574 (796)
Q Consensus 503 ~~~~~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~--------h~niv~l~ 574 (796)
+...++....+.+.++||+|+||.||+++...+++.||||++... ....+.+.+|+.++.+++ |+||++++
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 334444455677889999999999999999888999999999753 344567889999999986 78899999
Q ss_pred hhhc----cCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC
Q 003772 575 GYCA----EDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW 650 (796)
Q Consensus 575 g~~~----~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 650 (796)
+++. ++...++||||+ +++|.+.+.......+++..++.++.||+.||.|||+++ +|+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCH
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccc
Confidence 9887 566789999999 667777776655577999999999999999999999852 899999999999999775
Q ss_pred -------------------------------------------------ceEEeccCCccccCCCCcceeeeeccCCCCC
Q 003772 651 -------------------------------------------------TAKISDFGLAKLLMPDQTRTFTLVRGTRGYM 681 (796)
Q Consensus 651 -------------------------------------------------~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~ 681 (796)
.+||+|||+++..... .....||+.|+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~ 260 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGC
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCccc
Confidence 7999999999876432 22345899999
Q ss_pred chhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchh--HHHHHHHHHhhh--hhh-------------------
Q 003772 682 APEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEE--IVLINWAYKCFI--DRE------------------- 738 (796)
Q Consensus 682 aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~--~~~------------------- 738 (796)
|||++.+..++.++|||||||++|||++|+.||......... ............ +..
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 999999999999999999999999999999999755433211 111111100000 000
Q ss_pred ----------hhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 739 ----------LNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 739 ----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...+......+.+....+.+|+.+||+.||++|||++||++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00011111235677788999999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.92 Aligned_cols=261 Identities=25% Similarity=0.339 Sum_probs=203.0
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+.+.+.||+|+||.||++.....++.||+|++.... ....+.+.+|+.++.+++|+||+++++++.+++..++||||+
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 113 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence 4556688999999999999999888999999997643 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|+|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++...... .
T Consensus 114 ~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 186 (360)
T 3eqc_A 114 DGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 186 (360)
T ss_dssp TTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---c
Confidence 99999999976 35689999999999999999999983 17999999999999999999999999999755321 1
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHH----------------------H
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLI----------------------N 728 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~----------------------~ 728 (796)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||............. .
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence 223458999999999999999999999999999999999999997532111000000 0
Q ss_pred HHHHhh----hhhhhhhhhc---CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 729 WAYKCF----IDRELNKLVR---GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 729 ~~~~~~----~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
+..... ....+..... ...........+.+++..||+.||++|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000 0000011111 11112234567999999999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.86 Aligned_cols=259 Identities=26% Similarity=0.330 Sum_probs=197.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCC---cEEEEEEEeecc---cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKG---EKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
.+.+.+.||+|+||.||+|++... ...||||++... ..+..+.+.+|+.++.+++|+||+++++++.+.. .++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 456778999999999999986432 236999998753 2344577999999999999999999999987754 889
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
|+||+++|+|.+++... ...+++..++.++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++.....
T Consensus 98 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 99999999999999753 35689999999999999999999998 999999999999999999999999999987754
Q ss_pred CCcc--eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 666 DQTR--TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 666 ~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
.... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... ... . ... ...
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~-~-----~~~-----~~~ 240 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQI-L-----HKI-----DKE 240 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHH-H-----HHH-----HTS
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--HHH-H-----HHH-----Hcc
Confidence 4322 1223457788999999999889999999999999999999 9999864421 110 0 000 000
Q ss_pred hcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCC
Q 003772 743 VRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDIS 788 (796)
Q Consensus 743 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 788 (796)
......+...+..+.+++..||+.||.+|||+.+|++.|+++....
T Consensus 241 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 241 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 0011123345677999999999999999999999999999876543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.48 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=203.1
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhc--cCCceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCA--EDSKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~ 587 (796)
.+.+.+.||+|+||.||++....+++.||+|++.... ....+.+.+|+.++++++||||+++++++. .....++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 3456789999999999999998888999999997532 334567899999999999999999999874 456789999
Q ss_pred eecCCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccCCCC-----eeeeccCccceEecCCCceEEeccCCc
Q 003772 588 EYMSNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDECEAP-----IIHCDIKPQNILMDEFWTAKISDFGLA 660 (796)
Q Consensus 588 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DFgl~ 660 (796)
||+++|+|.+++... ....+++..++.++.|++.||.|||+. + |+|+||||+||+++.++.+||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999753 234599999999999999999999998 6 999999999999999999999999999
Q ss_pred cccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh
Q 003772 661 KLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740 (796)
Q Consensus 661 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
+....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .. .. ........
T Consensus 164 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~--~~----~~i~~~~~- 233 (279)
T 2w5a_A 164 RILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KE--LA----GKIREGKF- 233 (279)
T ss_dssp HHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HH--HH----HHHHHTCC-
T ss_pred eeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HH--HH----HHHhhccc-
Confidence 87654322 11234589999999999999999999999999999999999999864421 11 10 11111110
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 741 KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
...+......+.+++..||+.||.+|||+.||++.+..
T Consensus 234 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 -----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 12233455779999999999999999999999987643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=343.44 Aligned_cols=259 Identities=20% Similarity=0.239 Sum_probs=205.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcC-chhhhhhhhccCCceeEEEeec
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHK-NLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+.+.++||+|+||.||+|++...++.||||++.... ....+..|++++..++|. ++..+..++.+.+..++||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 3566789999999999999998888999999886533 234688999999999874 5555555666778889999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe---cCCCceEEeccCCccccCCCC
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFgl~~~~~~~~ 667 (796)
+++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||| +.++.+||+|||+++.+....
T Consensus 86 -g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 86 -GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp -CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred -CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 99999999753 45799999999999999999999998 99999999999999 688999999999998765433
Q ss_pred cc------eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 668 TR------TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 668 ~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
.. ......||+.|+|||.+.+..++.++|||||||+||||++|+.||...........+... ........+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i-~~~~~~~~~~~ 239 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI-SEKKVATSIEA 239 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH-HHHHHHSCHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH-hhccccccHHH
Confidence 21 122456999999999999999999999999999999999999999865443222221111 11111111111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 742 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
+. ...+..+.+++..||+.+|++||++.+|+++|+.+
T Consensus 240 l~------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 240 LC------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HH------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred Hh------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11 12346789999999999999999999999999876
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=329.80 Aligned_cols=253 Identities=21% Similarity=0.264 Sum_probs=197.9
Q ss_pred HHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--------hhHHHHHHHHHHHhccCcCchhhhhhhhccC
Q 003772 509 KKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--------EGEREFRAEMHVIGRTHHKNLVRLIGYCAED 580 (796)
Q Consensus 509 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~ 580 (796)
....+.+.+.||+|+||.||++.....++.||||++..... .....+.+|+.++.+++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 34567788999999999999999998889999999865321 2234588999999999999999999998665
Q ss_pred CceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc---eEEecc
Q 003772 581 SKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT---AKISDF 657 (796)
Q Consensus 581 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DF 657 (796)
. .++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++. +||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 4 8999999999999999865 46799999999999999999999998 9999999999999987654 999999
Q ss_pred CCccccCCCCcceeeeeccCCCCCchhhhc---cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh
Q 003772 658 GLAKLLMPDQTRTFTLVRGTRGYMAPEWYK---NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF 734 (796)
Q Consensus 658 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 734 (796)
|+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||............ .....
T Consensus 162 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~ 236 (322)
T 2ycf_A 162 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ---ITSGK 236 (322)
T ss_dssp TTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH---HHHTC
T ss_pred ccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH---HHhCc
Confidence 9998764332 122345899999999974 457899999999999999999999999754332211110 00000
Q ss_pred hhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 735 IDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
. ...... .......+.+++..||+.||++|||+.++++
T Consensus 237 ~-~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 237 Y-NFIPEV------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp C-CCCHHH------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c-ccCchh------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0 000000 0123467899999999999999999999873
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=333.29 Aligned_cols=257 Identities=21% Similarity=0.279 Sum_probs=192.7
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch--hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE--GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
.+.+.++||+|+||.||++.....++.||||++...... ..+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 456678999999999999999988999999999653322 245678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec-----CCCceEEeccCCccccC
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD-----EFWTAKISDFGLAKLLM 664 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~DFgl~~~~~ 664 (796)
++ |+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++ +++.+||+|||+++...
T Consensus 115 ~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 115 AE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp CS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred CC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 98 599999976 35699999999999999999999998 999999999999994 55569999999998764
Q ss_pred CCCcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh--hh-hhhh
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF--ID-RELN 740 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~-~~~~ 740 (796)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... . .+.. ..... .. ....
T Consensus 189 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~-~~~~-~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 189 IPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--D-QLFK-IFEVLGLPDDTTWP 263 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--H-HHHH-HHHHHCCCCTTTST
T ss_pred Cccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--H-HHHH-HHHHhCCCchhhhh
Confidence 3322 22334579999999999875 5899999999999999999999999654211 1 1101 00000 00 0000
Q ss_pred hhhc----------CCC------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 741 KLVR----------GQE------VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 741 ~~~~----------~~~------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.... ... ........+.+++..||+.||.+|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 000 01113467889999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=327.54 Aligned_cols=247 Identities=28% Similarity=0.417 Sum_probs=204.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.+.+.||+|+||.||+|.....++.||||++.... ....+.+.+|+.++.+++|+||+++++++.+....++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 455688999999999999998888999999997543 3345789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+++|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++........ ..
T Consensus 104 ~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 176 (303)
T 3a7i_A 104 GGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR 176 (303)
T ss_dssp TEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CB
T ss_pred CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-cc
Confidence 9999999854 5689999999999999999999998 999999999999999999999999999987654322 22
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
....|++.|+|||.+.+..++.++||||||+++|||++|+.|+..... .... .. . .. .........
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~--~~-~--------~~-~~~~~~~~~ 242 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--MKVL--FL-I--------PK-NNPPTLEGN 242 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH--HH-H--------HH-SCCCCCCSS
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--HHHH--HH-h--------hc-CCCCCCccc
Confidence 334589999999999999999999999999999999999999864321 1110 00 0 00 011122234
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 752 TLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 752 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
....+.+++..||+.||.+|||+.+|++.
T Consensus 243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 243 YSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 45678999999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=328.07 Aligned_cols=252 Identities=18% Similarity=0.305 Sum_probs=200.2
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-cCchhhhhhhhcc--CCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-HKNLVRLIGYCAE--DSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lV~e 588 (796)
.+.+.+.||+|+||.||++.....++.||||++.. ...+.+.+|+.++.+++ |+||+++++++.+ ....++|||
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 45667899999999999999988889999999864 33567899999999997 9999999999987 567899999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC-ceEEeccCCccccCCCC
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW-TAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgl~~~~~~~~ 667 (796)
|+++++|.+++. .+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++......
T Consensus 114 ~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 114 HVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp CCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred ccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 999999999984 388899999999999999999998 999999999999999766 89999999998765433
Q ss_pred cceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh-------
Q 003772 668 TRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL------- 739 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 739 (796)
. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............ . ........+
T Consensus 186 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~--~-~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR--I-AKVLGTEDLYDYIDKY 260 (330)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH--H-HHHHCHHHHHHHHHHT
T ss_pred c--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHH--H-HHhcCCchhhhHHHHh
Confidence 2 223458999999999987 67899999999999999999999999654332211111 0 000000000
Q ss_pred --------hhhhcC-----------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 740 --------NKLVRG-----------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 740 --------~~~~~~-----------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...... ..........+.+++..||+.||.+|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0111224678999999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.72 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=198.6
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.+.||+|+||.||+|.....++.||+|++........+.+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 35667889999999999999988888999999987666667889999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+++|.+++... ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++....... ...
T Consensus 100 ~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 174 (302)
T 2j7t_A 100 GGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKR 174 (302)
T ss_dssp TEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC-
T ss_pred CCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-ccc
Confidence 99999998653 35699999999999999999999998 99999999999999999999999999875432111 111
Q ss_pred eeeccCCCCCchhhhc-----cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 672 TLVRGTRGYMAPEWYK-----NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
....||+.|+|||++. ...++.++||||||+++|||++|+.|+..... .. .... .... .....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~-~~~~-----~~~~----~~~~~ 242 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MR-VLLK-----IAKS----DPPTL 242 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--HH-HHHH-----HHHS----CCCCC
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--HH-HHHH-----Hhcc----CCccc
Confidence 2345899999999984 56789999999999999999999999864321 11 0000 0000 00001
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..+......+.+++..||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 123344567899999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=331.54 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=201.1
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--------hhHHHHHHHHHHHhcc-CcCchhhhhhhhccCC
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--------EGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDS 581 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~ 581 (796)
..+.+.+.||+|+||.||++.+..+++.||||++..... ...+.+.+|+.++.++ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 345566899999999999999987788999999865331 1245678999999999 7999999999999999
Q ss_pred ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcc
Q 003772 582 KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~ 661 (796)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++.
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 99999999999999999975 35799999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeeeeccCCCCCchhhhccC------CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh
Q 003772 662 LLMPDQTRTFTLVRGTRGYMAPEWYKNT------PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI 735 (796)
Q Consensus 662 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..... ...
T Consensus 249 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~~~~~----~i~ 318 (365)
T 2y7j_A 249 HLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ----ILMLR----MIM 318 (365)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH----HHH
T ss_pred ccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH----HHHHH----HHH
Confidence 7654332 2335689999999998643 578999999999999999999999964321 11100 000
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 736 DRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...... ...........+.+++..||+.||.+|||+.++++
T Consensus 319 ~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 EGQYQF---SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HTCCCC---CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCCCCC---CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000000 00000122456889999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=345.54 Aligned_cols=193 Identities=23% Similarity=0.354 Sum_probs=154.2
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhcc-----CCcee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAE-----DSKRL 584 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~ 584 (796)
.+.+.+.||+|+||.||+|.+...++.||||++.+.. ....+.+.+|+.++.+++|+||+++++++.. ....+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 4567789999999999999998888999999996532 2345678999999999999999999999843 35689
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+||||+. |+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 134 lv~e~~~-~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 134 VVLEIAD-SDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEECCCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEeccc-cchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 9999875 789999876 46799999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCc--------------------------ceeeeeccCCCCCchhhh-ccCCCCccccchhhHHHHHHHhhc
Q 003772 665 PDQT--------------------------RTFTLVRGTRGYMAPEWY-KNTPISVKADVFSYGVVLLEIVCC 710 (796)
Q Consensus 665 ~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvil~elltg 710 (796)
.... ...+...||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 3221 123345689999999986 456799999999999999999994
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.35 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=203.8
Q ss_pred HHHhhhcccCcccceEEEEEEE-cCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCc------hhhhhhhhccCCce
Q 003772 511 ATNRFKEELGKGSFGAVYKGTL-YKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKN------LVRLIGYCAEDSKR 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~-~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~n------iv~l~g~~~~~~~~ 583 (796)
..+.+.+.||+|+||.||++.. ..+++.||||++... ....+.+.+|+.++..++|++ ++++++++.+.+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 3566778999999999999998 557789999999753 344567889999999987765 89999999999999
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC---------------
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE--------------- 648 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--------------- 648 (796)
++||||+ +++|.+++.......+++..+..++.||++||.|||+. +|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 89999999876556789999999999999999999998 9999999999999987
Q ss_pred ----CCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhH
Q 003772 649 ----FWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEI 724 (796)
Q Consensus 649 ----~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~ 724 (796)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~ 243 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH-L 243 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH-H
T ss_pred ccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH-H
Confidence 6689999999998654322 234589999999999999999999999999999999999999975432111 1
Q ss_pred HHHHHHHHhhhhhhh------------------------------hhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 003772 725 VLINWAYKCFIDREL------------------------------NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSM 774 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 774 (796)
..............+ ..+...........+.+.+++..||+.||.+|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 110000000000000 00000112234567889999999999999999999
Q ss_pred HHHHH
Q 003772 775 KSVVL 779 (796)
Q Consensus 775 ~evl~ 779 (796)
.||++
T Consensus 324 ~ell~ 328 (339)
T 1z57_A 324 REALK 328 (339)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.88 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=198.7
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
.+.+.+.||+|+||.||++.....++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 35566899999999999999998889999999865332 2345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 106 ~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 179 (331)
T 4aaa_A 106 VDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 179 (331)
T ss_dssp CSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred CCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence 999999988765 35699999999999999999999998 999999999999999999999999999986643322
Q ss_pred eeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH-------HHhhhhhh-hh
Q 003772 670 TFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA-------YKCFIDRE-LN 740 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~-~~ 740 (796)
......||+.|+|||.+.+. .++.++|||||||++|||++|+.||................ ...+.... ..
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 22234589999999999875 78999999999999999999999997543211111100000 00000000 00
Q ss_pred hhhcCC---C-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 741 KLVRGQ---E-----VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 741 ~~~~~~---~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....+. . ..+...+.+.+++..||+.||.+|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 0 01234577999999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.66 Aligned_cols=197 Identities=23% Similarity=0.318 Sum_probs=172.7
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc------CcCchhhhhhhhccCCceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT------HHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l------~h~niv~l~g~~~~~~~~~l 585 (796)
.+.+.+.||+|+||.||+|.....++.||||++... ....+.+.+|+.++..+ +|+||+++++++......++
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 356678999999999999999988899999999753 33445677888888777 57799999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc--eEEeccCCcccc
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT--AKISDFGLAKLL 663 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFgl~~~~ 663 (796)
||||+. ++|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+|||+++..
T Consensus 177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 999996 6999999876666799999999999999999999998 9999999999999999887 999999999765
Q ss_pred CCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCC
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEID 717 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~ 717 (796)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 253 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 253 HQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 432 22345899999999999999999999999999999999999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=346.34 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=203.5
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
...+.+.+.||+|+||.||++.....++.||||++.+.. ......+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 456778899999999999999998888999999996532 334577899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec---CCCceEEeccCCccccC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD---EFWTAKISDFGLAKLLM 664 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFgl~~~~~ 664 (796)
||+++|+|.+.+.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 99999999999876 35799999999999999999999998 999999999999995 45679999999998765
Q ss_pred CCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ... + ......... .
T Consensus 176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~-~-----~~i~~~~~~---~ 241 (486)
T 3mwu_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDI-L-----KRVETGKYA---F 241 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH-H-----HHHHHTCCC---S
T ss_pred CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHH-H-----HHHHhCCCC---C
Confidence 432 2234468999999999976 599999999999999999999999964321 111 1 001000000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
...........+.+++..||+.||.+|||+.++++.
T Consensus 242 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001112345678999999999999999999999873
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=321.03 Aligned_cols=247 Identities=23% Similarity=0.368 Sum_probs=195.8
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+.+.+.||+|+||.||+|.....++.||||++.... ....+.+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 3556789999999999999998888899999997532 2234678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++++|.+++.. ...+++..++.++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 92 YVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp CCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred ccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 9999999999976 35689999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceeeeeccCCCCCchhhhccCCC-CccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
.....+++.|+|||.+.+... +.++||||||+++|||++|+.||..... .. . ....... ...
T Consensus 167 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~-~-----~~~~~~~-------~~~ 229 (276)
T 2h6d_A 167 --LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PT-L-----FKKIRGG-------VFY 229 (276)
T ss_dssp ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HH-H-----HHHHHHC-------CCC
T ss_pred --eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HH-H-----HHHhhcC-------ccc
Confidence 223458999999999988765 6899999999999999999999864321 11 0 0111000 011
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.+......+.+++..||+.||++|||++||++.
T Consensus 230 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 222344678899999999999999999999973
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=346.83 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=198.9
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
...+.+.+.||+|+||.||++.....+..||||++.+.. ......+.+|+.++++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 345677899999999999999998888999999997643 334567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC---CceEEeccCCccccC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF---WTAKISDFGLAKLLM 664 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFgl~~~~~ 664 (796)
||+++|+|.+.+.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.. +.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999998876 35789999999999999999999998 99999999999999764 459999999998765
Q ss_pred CCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
... ......||+.|+|||++. ..++.++|||||||++|||++|+.||..... ... + ......... .
T Consensus 191 ~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~-~-----~~i~~~~~~---~ 256 (494)
T 3lij_A 191 NQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--QEI-L-----RKVEKGKYT---F 256 (494)
T ss_dssp TTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH-H-----HHHHHTCCC---C
T ss_pred CCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHH-H-----HHHHhCCCC---C
Confidence 432 223456999999999986 4699999999999999999999999964321 111 1 000000000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...........+.+++..||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00001133467889999999999999999999884
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.39 Aligned_cols=250 Identities=25% Similarity=0.332 Sum_probs=200.4
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
...+.+.+.||+|+||.||+|.....++.||||++... ...+.+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 34456678999999999999999888899999999753 3456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++++|.+++... ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 106 ~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 106 CGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 9999999998632 46789999999999999999999998 999999999999999999999999999987643322
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC-CCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG-QEV 748 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 748 (796)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... .... . ... ..... ...
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~--~-~~~--------~~~~~~~~~ 247 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP--MRAI--F-MIP--------TNPPPTFRK 247 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH--H-HHH--------HSCCCCCSS
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--HHHH--H-HHh--------cCCCcccCC
Confidence 22234589999999999999999999999999999999999999864321 1100 0 000 00000 011
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
+......+.+++..||+.||.+|||+.++++
T Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 2233567899999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=331.14 Aligned_cols=260 Identities=24% Similarity=0.356 Sum_probs=184.8
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+.+.+.||+|+||.||++.....++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++||||+
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 95 (303)
T 2vwi_A 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 95 (303)
T ss_dssp CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence 3456789999999999999988778899999986532 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhc------CCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 591 SNGSLADILFR------GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 591 ~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
++++|.+++.. .....+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 99999999864 1245699999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCc----ceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh
Q 003772 665 PDQT----RTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739 (796)
Q Consensus 665 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
.... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||....... ... ....... ...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~--~~~~~~~-~~~ 247 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--VLM--LTLQNDP-PSL 247 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHH--HHHTSSC-CCT
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--HHH--HHhccCC-Ccc
Confidence 4321 11223458999999999976 568999999999999999999999997543211 110 0011000 000
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 740 NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
................+.+++..||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1000111112234467889999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=348.12 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=205.4
Q ss_pred HHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
...+.+.+.||+|+||.||++.....++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 456778899999999999999999888999999996532 33467799999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe---cCCCceEEeccCCcccc
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLL 663 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFgl~~~~ 663 (796)
+||+.+|+|.+.+.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999999976 46799999999999999999999998 99999999999999 46789999999999876
Q ss_pred CCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
..... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ... + .........
T Consensus 180 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~-~-----~~i~~~~~~--- 245 (484)
T 3nyv_A 180 EASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDI-L-----KKVEKGKYT--- 245 (484)
T ss_dssp CCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH-H-----HHHHHCCCC---
T ss_pred ccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHH-H-----HHHHcCCCC---
Confidence 54332 233458999999999976 699999999999999999999999964321 111 1 011000000
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..........+.+.+++..||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 000111234567899999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=329.37 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=195.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhcc------CCceeE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAE------DSKRLL 585 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~------~~~~~l 585 (796)
+.+.+.||+|+||.||+|.....++.||||++... ....+.+.+|+.++.++ +|+||+++++++.. .+..++
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 45678999999999999999888889999999753 33457789999999999 79999999999876 457899
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
||||+++|+|.+++.......+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp EEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred EEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 99999999999999875556799999999999999999999998 999999999999999999999999999987643
Q ss_pred CCcceeeeeccCCCCCchhhhc-----cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYK-----NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
... ......||+.|+|||++. +..++.++|||||||++|||++|+.||..... ... . . . +.
T Consensus 182 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~-~-~----~-----~~ 247 (326)
T 2x7f_A 182 TVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--MRA-L-F----L-----IP 247 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH--HHH-H-H----H-----HH
T ss_pred Ccc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHH-H-H----H-----hh
Confidence 221 122345899999999997 56789999999999999999999999864321 110 0 0 0 00
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 741 KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...............+.+++..||+.||.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 001111122334567899999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.59 Aligned_cols=260 Identities=23% Similarity=0.298 Sum_probs=198.4
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch-----hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE-----GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-----~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
..+.+.+.||+|+||.||++.....++.||||++...... ..+.+.+|+.++.+++|+||+++++++.+.+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 4466778999999999999999888889999998653221 13468899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
||||+++ +|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 9999986 888888653 45789999999999999999999998 999999999999999999999999999987643
Q ss_pred CCcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh---hhhhhh
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI---DRELNK 741 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 741 (796)
... ......+|+.|+|||++.+. .++.++|||||||++|||++|..|+...... . .+.. ...... ......
T Consensus 165 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~-~~~~-i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 165 PNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--D-QLTR-IFETLGTPTEEQWPD 239 (346)
T ss_dssp CCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--H-HHHH-HHHHHCCCCTTTSSS
T ss_pred Ccc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--H-HHHH-HHHHcCCCChhhhhh
Confidence 322 22334589999999999764 5899999999999999999999888644211 1 1111 111000 000000
Q ss_pred h---hc---CC---CC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 742 L---VR---GQ---EV-----DRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 742 ~---~~---~~---~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
. .+ .. .. .......+.+++..||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00 00 00 12334679999999999999999999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=326.11 Aligned_cols=251 Identities=22% Similarity=0.331 Sum_probs=187.7
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
.+++.+.||+|+||.||++.....++.||||++..... ...+.+.++...++.++||||+++++++.+++..++||||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 87 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence 45667899999999999999988899999999975422 2233455566668889999999999999999999999999
Q ss_pred cCCCChhhhhhc--CCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 590 MSNGSLADILFR--GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 590 ~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
++ |+|.+++.. .....+++..++.++.|++.||.|||++ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 164 (290)
T 3fme_A 88 MD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164 (290)
T ss_dssp CS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred hc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence 98 588887754 2356799999999999999999999984 389999999999999999999999999998764432
Q ss_pred cceeeeeccCCCCCchhhh----ccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 668 TRTFTLVRGTRGYMAPEWY----KNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
.. ....||+.|+|||++ .+..++.++||||||+++|||++|+.||........... ... ...
T Consensus 165 ~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~-----~~~ 230 (290)
T 3fme_A 165 AK--DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK-------QVV-----EEP 230 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH-------HHH-----HSC
T ss_pred cc--cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH-------HHh-----ccC
Confidence 22 223589999999996 456789999999999999999999999964322111110 000 001
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
............+.+++..||+.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111122344567899999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=357.69 Aligned_cols=247 Identities=25% Similarity=0.342 Sum_probs=205.0
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 587 (796)
.+.+.+.||+|+||.||+++....++.||||++.+.. ....+.+..|..++..+ +|+||+++++++.+.+..++||
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 3556788999999999999999888999999997632 23456688899999987 7999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 422 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred eCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 99999999999976 35799999999999999999999998 99999999999999999999999999998643332
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
. ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... .+. ...+... ...
T Consensus 497 ~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~~~------~~~i~~~-------~~~ 560 (674)
T 3pfq_A 497 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DEL------FQSIMEH-------NVA 560 (674)
T ss_dssp C-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH------HHHHHSS-------CCC
T ss_pred c-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--HHH------HHHHHhC-------CCC
Confidence 2 23345699999999999999999999999999999999999999975321 111 1111111 112
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSM-----KSVVL 779 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~ 779 (796)
.+......+.+|+..||+.||.+||++ +||++
T Consensus 561 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 561 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 334456779999999999999999998 67763
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.62 Aligned_cols=265 Identities=23% Similarity=0.283 Sum_probs=196.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCC------cee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS------KRL 584 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~~ 584 (796)
+.+.+.||+|+||.||+|.....++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..+
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 556788999999999999998888999999996532 233567889999999999999999999987653 459
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+||||+ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 107 lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp EEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 999999 7899999975 4689999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH-------HHHhhhh
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW-------AYKCFID 736 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~ 736 (796)
.. .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||........-..+... .......
T Consensus 180 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 180 SE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp SS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 32 233458999999999987 67999999999999999999999999744211100000000 0000000
Q ss_pred hhh----hhhhcCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhcCcCCC
Q 003772 737 REL----NKLVRGQ-----EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEGITDIS 788 (796)
Q Consensus 737 ~~~----~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~~~ 788 (796)
... ..+.... .........+.+++.+||+.||.+|||+.|+++ .++.+.+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 318 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCc
Confidence 000 0000000 112234567899999999999999999999997 455554433
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.93 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=202.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---------chhHHHHHHHHHHHhccC-cCchhhhhhhhccCC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---------TEGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDS 581 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---------~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~ 581 (796)
.+.+.+.||+|+||.||++.....++.||||++.... ....+.+.+|+.++.++. ||||+++++++.+..
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 3456688999999999999999888999999996532 122456889999999996 999999999999999
Q ss_pred ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcc
Q 003772 582 KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~ 661 (796)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++.
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchh
Confidence 99999999999999999976 35789999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcceeeeeccCCCCCchhhhc------cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh
Q 003772 662 LLMPDQTRTFTLVRGTRGYMAPEWYK------NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI 735 (796)
Q Consensus 662 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
....... .....+++.|+|||++. ...++.++||||||+++|||++|+.|+..... .... ....
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~-----~~~~ 242 (298)
T 1phk_A 173 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLML-----RMIM 242 (298)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH-----HHHH
T ss_pred hcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HHHH-----HHHh
Confidence 7654332 22345899999999985 44688999999999999999999999864321 1110 1111
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 736 DRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..... ............+.+++..||+.||.+|||+.|+++
T Consensus 243 ~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 SGNYQ---FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HTCCC---CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCcc---cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 10000 000111344577999999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=339.21 Aligned_cols=249 Identities=10% Similarity=0.014 Sum_probs=180.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhcc--CcCchhhhhhhh-------ccC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRT--HHKNLVRLIGYC-------AED 580 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l--~h~niv~l~g~~-------~~~ 580 (796)
+.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+++|+.++..+ +||||++++..+ ...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 4566889999999999999988889999999987432 3345678885544444 699988855332 211
Q ss_pred -----------------CceeEEEeecCCCChhhhhhcCCCCCCchhHH------HHHHHHHHHHHHHhhccCCCCeeee
Q 003772 581 -----------------SKRLLVYEYMSNGSLADILFRGPERSLGWDER------VRIASDVAKGILYLHDECEAPIIHC 637 (796)
Q Consensus 581 -----------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~aL~~LH~~~~~~ivH~ 637 (796)
...++||||++ |+|.+++... ...+.+..+ +.++.||++||.|||++ +|+||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHr 218 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG 218 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccC
Confidence 34799999999 8999999763 234466666 78889999999999998 99999
Q ss_pred ccCccceEecCCCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhcc--CCCCccccchhhHHHHHHHhhcccCCC
Q 003772 638 DIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN--TPISVKADVFSYGVVLLEIVCCRRNME 715 (796)
Q Consensus 638 Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvil~elltg~~p~~ 715 (796)
||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998764221 13447799999999987 679999999999999999999999997
Q ss_pred CCCCCchhHHHHHHHHHhhhhhhhhhhhcCC---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 716 IDPSKPEEIVLINWAYKCFIDRELNKLVRGQ---EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......... +............ .......+.+.+++..||+.||++|||+.++++
T Consensus 295 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 295 LVTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp BCCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CcCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 653221100 0000000000000 011244678999999999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=338.97 Aligned_cols=198 Identities=26% Similarity=0.380 Sum_probs=167.1
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccC-----Ccee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAED-----SKRL 584 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 584 (796)
.+.+.+.||+|+||.||+|.....++.||||++.+.. ....+.+.+|+.++++++|+||+++++++... ...+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 4567789999999999999999999999999997532 23456789999999999999999999998766 5689
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+||||++ |+|.+++.. ...+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 107 lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 9999987 599999976 46799999999999999999999998 99999999999999999999999999999765
Q ss_pred CCCc---------------------ceeeeeccCCCCCchhhh-ccCCCCccccchhhHHHHHHHhhcccCCC
Q 003772 665 PDQT---------------------RTFTLVRGTRGYMAPEWY-KNTPISVKADVFSYGVVLLEIVCCRRNME 715 (796)
Q Consensus 665 ~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvil~elltg~~p~~ 715 (796)
.... .......||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 4321 123456689999999986 55679999999999999999998655443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=330.68 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=202.7
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchh-----------------HHHHHHHHHHHhccCcCchhhhh
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG-----------------EREFRAEMHVIGRTHHKNLVRLI 574 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~-----------------~~~f~~E~~~l~~l~h~niv~l~ 574 (796)
.+.+.+.||+|+||.||++.. .++.||||++....... .+.+.+|+.++.+++||||++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred ceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 456778999999999999998 67899999997532221 17899999999999999999999
Q ss_pred hhhccCCceeEEEeecCCCChhhh------hhcCCCCCCchhHHHHHHHHHHHHHHHhhc-cCCCCeeeeccCccceEec
Q 003772 575 GYCAEDSKRLLVYEYMSNGSLADI------LFRGPERSLGWDERVRIASDVAKGILYLHD-ECEAPIIHCDIKPQNILMD 647 (796)
Q Consensus 575 g~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dlkp~NIll~ 647 (796)
+++.+.+..++||||+++|+|.++ +.......+++..++.++.|++.||.|||+ . +|+|+||||+||+++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMD 186 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEEC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEc
Confidence 999999999999999999999999 655446789999999999999999999998 7 999999999999999
Q ss_pred CCCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccC-CCCc-cccchhhHHHHHHHhhcccCCCCCCCCchhHH
Q 003772 648 EFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT-PISV-KADVFSYGVVLLEIVCCRRNMEIDPSKPEEIV 725 (796)
Q Consensus 648 ~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~ 725 (796)
.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||..........
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~- 262 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF- 262 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH-
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH-
Confidence 9999999999999876433 23345589999999999887 6666 9999999999999999999997554321110
Q ss_pred HHHHHHHhhhhhhhhhhhc------C------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 726 LINWAYKCFIDRELNKLVR------G------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~------~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
............. . ..........+.+++..||+.||.+|||+.|+++
T Consensus 263 ------~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 263 ------NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ------HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ------HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111110000000 0 0001344578899999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=330.08 Aligned_cols=254 Identities=22% Similarity=0.235 Sum_probs=190.6
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCC------ce
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS------KR 583 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 583 (796)
.+.+.+.||+|+||.||++.....++.||||++.... ....+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 3556788999999999999998888999999997532 234567889999999999999999999987654 67
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 106 YIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred EEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 999999984 7888884 3588999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh---------
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF--------- 734 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 734 (796)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. .......
T Consensus 178 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~-~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 178 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QW-NKVIEQLGTPCPEFMK 251 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH-HHHHC-CCCCCHHHHT
T ss_pred cccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HH-HHHHHHhCCCCHHHHH
Confidence 4322 2233568999999999999999999999999999999999999996532110 00 0000000
Q ss_pred -hhhhhhhhhc-------------------CC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 735 -IDRELNKLVR-------------------GQ--EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 735 -~~~~~~~~~~-------------------~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....+..... +. .........+.+++.+||+.||.+|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000000000 00 001233678999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=330.84 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=200.8
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccC-----CceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAED-----SKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 585 (796)
.+.+.+.||+|+||.||++.....++.||||++..... ...+.+.+|+.++.+++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 45667899999999999999988899999999975333 3346789999999999999999999988654 36799
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
|+||++ |+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 108 v~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 999998 599999865 4699999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcce--eeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH-------HHhhh
Q 003772 666 DQTRT--FTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA-------YKCFI 735 (796)
Q Consensus 666 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~ 735 (796)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||................ .....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 33221 233468999999998764 458999999999999999999999996543222111110000 00000
Q ss_pred hh----hhhhhhcCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 736 DR----ELNKLVRGQEV-----DRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 736 ~~----~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.. ........... .......+.+++..||+.||.+|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 00000011111 1233467899999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=328.34 Aligned_cols=262 Identities=21% Similarity=0.295 Sum_probs=198.5
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhcc--------CC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAE--------DS 581 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--------~~ 581 (796)
.+.+.+.||+|+||.||+++....++.||||++..... .....+.+|+.++.+++|+||+++++++.+ .+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 45677899999999999999988889999999865332 234578899999999999999999999876 34
Q ss_pred ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcc
Q 003772 582 KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~ 661 (796)
..++||||+++ +|.+.+... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 68999999985 777777653 35699999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCC---cceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhh
Q 003772 662 LLMPDQ---TRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDR 737 (796)
Q Consensus 662 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
.+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..............
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSITPE 251 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChh
Confidence 765322 222234568999999999876 4589999999999999999999999875431111 11100000000000
Q ss_pred hhhhh--------h---cCCCCC-HH------HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 738 ELNKL--------V---RGQEVD-RN------TLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 738 ~~~~~--------~---~~~~~~-~~------~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..... . ...... .+ ..+.+.+++..||+.||.+|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00000 0 000000 00 1345889999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=357.33 Aligned_cols=256 Identities=21% Similarity=0.312 Sum_probs=204.2
Q ss_pred HHHhhhcccCcccceEEEEEEEcCC---cEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKG---EKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
..+.+.+.||+|+||.||+|.+... ...||||++..... ...+.+.+|+.++.+++||||+++++++. ++..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence 4556778999999999999998543 46799999875433 33467999999999999999999999985 4568999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|||+++|+|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 469 ~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 469 MELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 9999999999999753 45689999999999999999999998 9999999999999999999999999999877554
Q ss_pred CcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
.........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ... . ...... ..
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--~~~--~----~~i~~~------~~ 610 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDV--I----GRIENG------ER 610 (656)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHH--H----HHHHHT------CC
T ss_pred cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--HHH--H----HHHHcC------CC
Confidence 4333334457889999999999999999999999999999997 8888864321 111 0 000000 01
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
...+...+..+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus 611 ~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1233455678999999999999999999999999998764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=344.45 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=198.9
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-------------hhHHHHHHHHHHHhccCcCchhhhhhhhc
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-------------EGEREFRAEMHVIGRTHHKNLVRLIGYCA 578 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-------------~~~~~f~~E~~~l~~l~h~niv~l~g~~~ 578 (796)
.+.+.++||+|+||.||++....+++.||||++.+... ...+.+.+|+.++++++||||+++++++.
T Consensus 37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 116 (504)
T 3q5i_A 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116 (504)
T ss_dssp TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 45667899999999999999998889999999975321 23567899999999999999999999999
Q ss_pred cCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC---ceEEe
Q 003772 579 EDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW---TAKIS 655 (796)
Q Consensus 579 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 655 (796)
+....++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+
T Consensus 117 ~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 117 DKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred cCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEE
Confidence 99999999999999999999876 36799999999999999999999998 999999999999998775 69999
Q ss_pred ccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh
Q 003772 656 DFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI 735 (796)
Q Consensus 656 DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
|||++........ .....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ... + ....
T Consensus 192 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~-~-----~~i~ 260 (504)
T 3q5i_A 192 DFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND--QDI-I-----KKVE 260 (504)
T ss_dssp CCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH-H-----HHHH
T ss_pred ECCCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHH-H-----HHHH
Confidence 9999987654332 233459999999999874 689999999999999999999999974321 111 0 0000
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 736 DRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..... ............+.+++..||+.||.+|||++|+++
T Consensus 261 ~~~~~---~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 261 KGKYY---FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HCCCC---CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCCC---CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 000000123467899999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=329.29 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=197.1
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|+||.||+|.... .+|+|++.... ....+.+.+|+.++.+++|+||+++++++.+.+..++|+||+
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred eEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence 4567899999999999999854 49999986532 233456888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC---
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ--- 667 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~--- 667 (796)
++++|.+++... ...+++..++.++.||++||.|||+. +|+||||||+||+++ ++.+||+|||+++......
T Consensus 112 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 112 KGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp CSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred cCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 999999999653 35799999999999999999999998 999999999999998 6799999999987653211
Q ss_pred -cceeeeeccCCCCCchhhhcc---------CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhh
Q 003772 668 -TRTFTLVRGTRGYMAPEWYKN---------TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDR 737 (796)
Q Consensus 668 -~~~~~~~~gt~~y~aPE~~~~---------~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
........|++.|+|||.+.. ..++.++||||||+++|||++|+.||..... .... ...
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~------~~~--- 255 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--EAII------WQM--- 255 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH--HHHH------HHH---
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH------HHh---
Confidence 112223458999999999874 3579999999999999999999999965421 1110 000
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCC
Q 003772 738 ELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDIS 788 (796)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~ 788 (796)
................+.+++..||+.||.+|||+.+|+++|+.+....
T Consensus 256 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 256 --GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp --HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred --ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 0001111112233456889999999999999999999999999987654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=319.57 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=193.3
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhcc-----------
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE----------- 579 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----------- 579 (796)
..+.+.+.||+|+||.||+|+...+++.||||++... ....+.+.+|+.++.+++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 3456678999999999999999888899999999653 3445778999999999999999999998754
Q ss_pred --CCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEecc
Q 003772 580 --DSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDF 657 (796)
Q Consensus 580 --~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 657 (796)
....++||||+++|+|.+++... ...+++..++.++.|+++||.|||++ +|+|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeC
Confidence 45679999999999999999763 45678899999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCC-------------cceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchh
Q 003772 658 GLAKLLMPDQ-------------TRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEE 723 (796)
Q Consensus 658 gl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~ 723 (796)
|++....... ........||+.|+|||.+.+. .++.++||||||+++|||++ |+.... ..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---~~ 234 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---ER 234 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---HH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---hH
Confidence 9998764321 1122334589999999999865 78999999999999999998 443110 00
Q ss_pred HHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 724 IVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
... ....... ....+..........+.+++..||+.||.+|||+.++++
T Consensus 235 ~~~----~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNI----LKKLRSV---SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHH----HHHHHST---TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH----HHhcccc---ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 000 0110000 000112234455677899999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=329.27 Aligned_cols=268 Identities=21% Similarity=0.287 Sum_probs=205.6
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-----------cCchhhhhhhhcc
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-----------HKNLVRLIGYCAE 579 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-----------h~niv~l~g~~~~ 579 (796)
..+.+.+.||+|+||.||+++....++.||||++... ....+.+.+|+.++.+++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 4567789999999999999999888899999999753 234567888999999886 8899999999876
Q ss_pred CC----ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec------CC
Q 003772 580 DS----KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD------EF 649 (796)
Q Consensus 580 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~------~~ 649 (796)
.+ ..++||||+ +++|.+++.......+++..++.++.||+.||.|||++ .+|+||||||+|||++ ..
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcCc
Confidence 44 689999999 89999999876667799999999999999999999984 2899999999999995 44
Q ss_pred CceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCch---hHHH
Q 003772 650 WTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPE---EIVL 726 (796)
Q Consensus 650 ~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~---~~~~ 726 (796)
+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 58999999999876432 2234589999999999999999999999999999999999999975432211 0011
Q ss_pred HHHHHHhhh--hhh----------------------------hhh-hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 003772 727 INWAYKCFI--DRE----------------------------LNK-LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMK 775 (796)
Q Consensus 727 ~~~~~~~~~--~~~----------------------------~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 775 (796)
.. ...... +.. +.. .......+......+.+++..||+.||++|||++
T Consensus 251 ~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 251 AQ-IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HH-HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HH-HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 00 000000 000 000 0111124567788999999999999999999999
Q ss_pred HHHH--HHhcCcCC
Q 003772 776 SVVL--MLEGITDI 787 (796)
Q Consensus 776 evl~--~L~~~~~~ 787 (796)
||++ .+.+....
T Consensus 330 ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 330 GLVNHPWLKDTLGM 343 (373)
T ss_dssp HHHTCGGGTTCTTC
T ss_pred HHhhChhhhcccCc
Confidence 9997 45554433
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.28 Aligned_cols=257 Identities=23% Similarity=0.286 Sum_probs=194.0
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhcc------------
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE------------ 579 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------------ 579 (796)
.+.+.+.||+|+||.||++.+...++.||||++..... ...+|+.+++.++|+||+++++++..
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 45667899999999999999988889999999865322 23479999999999999999998843
Q ss_pred --------------------------CCceeEEEeecCCCChhhhhhc--CCCCCCchhHHHHHHHHHHHHHHHhhccCC
Q 003772 580 --------------------------DSKRLLVYEYMSNGSLADILFR--GPERSLGWDERVRIASDVAKGILYLHDECE 631 (796)
Q Consensus 580 --------------------------~~~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~ 631 (796)
....++||||++ |+|.+.+.. .....+++..+..++.||++||.|||+.
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 160 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-- 160 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 234789999999 588887753 2356799999999999999999999998
Q ss_pred CCeeeeccCccceEec-CCCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhh
Q 003772 632 APIIHCDIKPQNILMD-EFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVC 709 (796)
Q Consensus 632 ~~ivH~Dlkp~NIll~-~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~ellt 709 (796)
+|+||||||+|||++ +++.+||+|||+++.+...... ....+|+.|+|||.+.+. .++.++||||+||++|||++
T Consensus 161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC--CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC--cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 999999999999998 6889999999999876543322 234579999999998875 48999999999999999999
Q ss_pred cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh-------c----CC----CCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 003772 710 CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV-------R----GQ----EVDRNTLENMIKIGLWCVQDEPALRPSM 774 (796)
Q Consensus 710 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~----~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 774 (796)
|+.||............... ........+...- - .. ..+......+.+++..||+.||.+|||+
T Consensus 238 g~~pf~~~~~~~~~~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQI-MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHH-HCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred CCCCCCCCChHHHHHHHHHH-hCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 99999754321111110000 0000000000000 0 00 0122345678999999999999999999
Q ss_pred HHHHH
Q 003772 775 KSVVL 779 (796)
Q Consensus 775 ~evl~ 779 (796)
.|+++
T Consensus 317 ~e~l~ 321 (383)
T 3eb0_A 317 YEAMA 321 (383)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99983
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=325.50 Aligned_cols=259 Identities=19% Similarity=0.263 Sum_probs=201.3
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCc-EEEEEEEeecccchhHHHHHHHHHHHhccCcCc------hhhhhhhhccCCce
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGE-KLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKN------LVRLIGYCAEDSKR 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~-~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~n------iv~l~g~~~~~~~~ 583 (796)
..+.+.+.||+|+||.||++.....+ +.||||++... ....+.+.+|+.++.+++|++ ++.+.+++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 45667789999999999999987655 78999999753 344567889999999998776 88888888889999
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe-----------------
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM----------------- 646 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll----------------- 646 (796)
++||||+ +++|.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 67788888765556799999999999999999999998 99999999999999
Q ss_pred --cCCCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhH
Q 003772 647 --DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEI 724 (796)
Q Consensus 647 --~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~ 724 (796)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~ 248 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH-L 248 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H
T ss_pred cccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-H
Confidence 668899999999998654322 234589999999999999999999999999999999999999975432111 1
Q ss_pred HHHHHHHHhhhhhhh------------------------------hhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 003772 725 VLINWAYKCFIDREL------------------------------NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSM 774 (796)
Q Consensus 725 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 774 (796)
..............+ ............+...+.+++..||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 110000000000000 00000011233456789999999999999999999
Q ss_pred HHHHH
Q 003772 775 KSVVL 779 (796)
Q Consensus 775 ~evl~ 779 (796)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99984
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=320.53 Aligned_cols=257 Identities=20% Similarity=0.280 Sum_probs=193.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhc-------------
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCA------------- 578 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~------------- 578 (796)
.+.+.+.||+|+||.||+|.....++.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 3456688999999999999999888999999998766666778999999999999999999988763
Q ss_pred -cCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec-CCCceEEec
Q 003772 579 -EDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISD 656 (796)
Q Consensus 579 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~D 656 (796)
+....++||||++ |+|.+++.. ..+++..++.++.|+++||.|||+. +|+||||||+||+++ +++.+||+|
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEcc
Confidence 4467899999998 699999854 5689999999999999999999998 999999999999997 567999999
Q ss_pred cCCccccCCCCc--ceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHh
Q 003772 657 FGLAKLLMPDQT--RTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKC 733 (796)
Q Consensus 657 Fgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 733 (796)
||+++....... .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||...... . .. ......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~-~~-~~~~~~ 240 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL--E-QM-QLILES 240 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--H-HH-HHHHHH
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH--H-HH-HHHHHh
Confidence 999987653322 12223457899999998875 67899999999999999999999999754311 1 00 000000
Q ss_pred h---hhhh-----------hhhhhcCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 734 F---IDRE-----------LNKLVRGQEV-----DRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 734 ~---~~~~-----------~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
. .... +......... .......+.+++..||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0 0000 0000000000 1234577999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=315.77 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=203.1
Q ss_pred HHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 508 LKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 508 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
.....+.+.+.||+|+||.||+++....++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 334566778999999999999999988888999999975432 345778999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC---CceEEeccCCccc
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF---WTAKISDFGLAKL 662 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFgl~~~ 662 (796)
|+||+++++|.+.+.. ...+++..++.++.||+.||.|||+. +|+|+||||+||+++.+ +.+||+|||++..
T Consensus 99 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 99 VGELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999998875 35789999999999999999999998 99999999999999754 4699999999987
Q ss_pred cCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 663 LMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 663 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...... .....+++.|+|||.+.+. ++.++||||||+++|||++|+.||..... .. .. .....+...
T Consensus 174 ~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~--~~----~~~~~~~~~-- 240 (287)
T 2wei_A 174 FQQNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE--YD--IL----KRVETGKYA-- 240 (287)
T ss_dssp BCCCSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH--HH----HHHHHCCCC--
T ss_pred ecCCCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCH--HH--HH----HHHHcCCCC--
Confidence 654322 2233488999999998764 89999999999999999999999864321 11 10 001000000
Q ss_pred hcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 743 VRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 743 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
............+.+++..||+.||++|||+.++++
T Consensus 241 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 -FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000001233467899999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=327.36 Aligned_cols=258 Identities=21% Similarity=0.268 Sum_probs=182.1
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccC------Cce
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAED------SKR 583 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 583 (796)
.+.+.+.||+|+||.||+|.....++.||||++.... ....+.+.+|+.+++.++|+||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 3456788999999999999998889999999996532 23456788999999999999999999988653 567
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
++|+|++ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp EEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred EEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 9999998 6899998864 5699999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH-------HHHhhh
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW-------AYKCFI 735 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~ 735 (796)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+... ......
T Consensus 183 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 183 ADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred ccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 432 233468999999999987 67899999999999999999999999643211100000000 000000
Q ss_pred hhhhhhhh----cCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 736 DRELNKLV----RGQEVD-----RNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 736 ~~~~~~~~----~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.......+ ...... ......+.+|+..||+.||.+|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000 000011 1234678899999999999999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.40 Aligned_cols=257 Identities=20% Similarity=0.257 Sum_probs=195.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCce------
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKR------ 583 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~------ 583 (796)
.+.+.+.||+|+||.||+|.....++.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 3456688999999999999999889999999997633 23356788999999999999999999999877654
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
++||||+. ++|.+++ ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 123 ~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp EEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred EEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999998 6888887 34599999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH-------HHhhh
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA-------YKCFI 735 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~ 735 (796)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||................ .....
T Consensus 195 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 195 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred ccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 432 223458999999999987 688999999999999999999999997432111000000000 00000
Q ss_pred hh----hhhhhhcCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 736 DR----ELNKLVRGQEV-----DRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 736 ~~----~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.. ........... .......+.+++..||+.||.+|||+.|+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 00000000000 12335779999999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=326.20 Aligned_cols=200 Identities=27% Similarity=0.349 Sum_probs=171.0
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-cC-----chhhhhhhhccCCcee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-HK-----NLVRLIGYCAEDSKRL 584 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~~ 584 (796)
..+.+.+.||+|+||.||+|.....++.||||++... ....+++..|+.++..++ |+ +|+++++++...+..+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 3456678999999999999999988899999999753 334566788888888875 44 4888899999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec--CCCceEEeccCCccc
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD--EFWTAKISDFGLAKL 662 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFgl~~~ 662 (796)
+||||++ |+|.+++.......+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+++.
T Consensus 133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 9999996 5999999876556799999999999999999999953 23899999999999995 478899999999987
Q ss_pred cCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCC
Q 003772 663 LMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEID 717 (796)
Q Consensus 663 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~ 717 (796)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 211 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 211 LGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 6432 22345899999999999999999999999999999999999999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=320.82 Aligned_cols=258 Identities=25% Similarity=0.352 Sum_probs=199.7
Q ss_pred HHhhhcccCcccceEEEEEEEc-CCcEEEEEEEeecccch--hHHHHHHHHHHHhcc---CcCchhhhhhhhc-----cC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLY-KGEKLVAVKKLEKMVTE--GEREFRAEMHVIGRT---HHKNLVRLIGYCA-----ED 580 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~-~~~~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l---~h~niv~l~g~~~-----~~ 580 (796)
.+.+.+.||+|+||.||++... .+++.||||++...... ....+.+|+.+++.+ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 3556789999999999999984 66789999998753322 233567787777766 8999999999987 55
Q ss_pred CceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCc
Q 003772 581 SKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA 660 (796)
Q Consensus 581 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~ 660 (796)
...++||||++ |+|.+++.......+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCccc
Confidence 67899999998 6999999876566799999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh---hh
Q 003772 661 KLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI---DR 737 (796)
Q Consensus 661 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 737 (796)
+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... . .+ ........ ..
T Consensus 168 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~-~~-~~i~~~~~~~~~~ 241 (326)
T 1blx_A 168 RIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--D-QL-GKILDVIGLPGEE 241 (326)
T ss_dssp CCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H-HH-HHHHHHHCCCCGG
T ss_pred ccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH--H-HH-HHHHHHcCCCCcc
Confidence 8764322 223345899999999999999999999999999999999999999754311 1 11 11111000 00
Q ss_pred hhhh-------hhcC------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 738 ELNK-------LVRG------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 738 ~~~~-------~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.... .... ..........+.+++..||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 0000 0112334567889999999999999999999994
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=332.60 Aligned_cols=258 Identities=21% Similarity=0.292 Sum_probs=179.8
Q ss_pred hcccCcccceEEEEEEEc--CCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhc--cCCceeEEEeecC
Q 003772 516 KEELGKGSFGAVYKGTLY--KGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCA--EDSKRLLVYEYMS 591 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~--~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lV~e~~~ 591 (796)
.++||+|+||.||+|+.. ..++.||||++... .....+.+|+.++.+++||||+++++++. .....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 467999999999999976 34678999999753 23456889999999999999999999994 4678899999997
Q ss_pred CCChhhhhhcC-------CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe----cCCCceEEeccCCc
Q 003772 592 NGSLADILFRG-------PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM----DEFWTAKISDFGLA 660 (796)
Q Consensus 592 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFgl~ 660 (796)
|+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 4788877521 123599999999999999999999998 99999999999999 67889999999999
Q ss_pred cccCCCCc--ceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCch-----hHHHHHHHHH
Q 003772 661 KLLMPDQT--RTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPE-----EIVLINWAYK 732 (796)
Q Consensus 661 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~-----~~~~~~~~~~ 732 (796)
+....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ..........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 87654322 222345689999999999874 589999999999999999999999965432110 0000000000
Q ss_pred hh---hhhhhhhh------------hcCCC------------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 733 CF---IDRELNKL------------VRGQE------------VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 733 ~~---~~~~~~~~------------~~~~~------------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.. ........ ..... ........+.+|+..||+.||.+|||++|+++
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 00000000 00000 00011356789999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=327.63 Aligned_cols=267 Identities=22% Similarity=0.296 Sum_probs=200.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccC-----CceeEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAED-----SKRLLV 586 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV 586 (796)
+.+.+.||+|+||.||+|.....++.||||++..... .....+.+|+.++++++|+||+++++++... ...++|
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 4567899999999999999988889999999975332 3346788999999999999999999987654 678999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
+||+. |+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 93 ~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 93 QELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp ECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 99998 689999875 4689999999999999999999998 9999999999999999999999999999876533
Q ss_pred Ccc---------eeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHH----
Q 003772 667 QTR---------TFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYK---- 732 (796)
Q Consensus 667 ~~~---------~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---- 732 (796)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..................
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 211 1223458999999998765 67899999999999999999999999754311100000000000
Q ss_pred ----hhhhhhhhhhhc----CCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhcCcC
Q 003772 733 ----CFIDRELNKLVR----GQE-----VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEGITD 786 (796)
Q Consensus 733 ----~~~~~~~~~~~~----~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~ 786 (796)
........+... ... ........+.+++.+||+.||++|||++|+++ .++....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 000000000000 000 01234567889999999999999999999987 4555443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=325.42 Aligned_cols=256 Identities=19% Similarity=0.222 Sum_probs=176.0
Q ss_pred Hhh-hcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhcc----CCceeEEE
Q 003772 513 NRF-KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE----DSKRLLVY 587 (796)
Q Consensus 513 ~~~-~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~ 587 (796)
+.+ .+.||+|+||.||++.....++.||||++.... +...+....+..++|+||+++++++.. +...++||
T Consensus 30 y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 30 YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 344 356999999999999999888999999996521 122223344566799999999999875 44579999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC---CCceEEeccCCccccC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE---FWTAKISDFGLAKLLM 664 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFgl~~~~~ 664 (796)
||+++|+|.+++.......+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 106 e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 106 ECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp ECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 999999999999876566899999999999999999999998 9999999999999986 4559999999998654
Q ss_pred CCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
... .....+|+.|+|||++....++.++||||||+++|||++|+.||............ ...... .....
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~~~---~~~~~ 252 (336)
T 3fhr_A 183 QNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM----KRRIRL---GQYGF 252 (336)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CC
T ss_pred ccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH----HHhhhc---ccccc
Confidence 322 22345899999999998888999999999999999999999999654322110000 000000 00000
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhcCc
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEGIT 785 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~ 785 (796)
...........+.+++..||+.||.+|||+.|+++ .++...
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 01111244567899999999999999999999997 555433
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.34 Aligned_cols=240 Identities=26% Similarity=0.399 Sum_probs=199.6
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch------hHHHHHHHHHHHhccC--cCchhhhhhhhccCCc
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE------GEREFRAEMHVIGRTH--HKNLVRLIGYCAEDSK 582 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~------~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~~ 582 (796)
..+.+.+.||+|+||.||+|....+++.||||++...... ..+.+.+|+.++.+++ |+||+++++++.+.+.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 3456778999999999999999888999999999764322 2356778999999996 5999999999999999
Q ss_pred eeEEEeecCC-CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec-CCCceEEeccCCc
Q 003772 583 RLLVYEYMSN-GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISDFGLA 660 (796)
Q Consensus 583 ~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFgl~ 660 (796)
.++|+|++.+ ++|.+++.. ...+++..++.++.||++||.|||+. +|+||||||+|||++ +++.+||+|||++
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 9999999986 899999976 46789999999999999999999998 999999999999999 7899999999999
Q ss_pred cccCCCCcceeeeeccCCCCCchhhhccCCC-CccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh
Q 003772 661 KLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739 (796)
Q Consensus 661 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
+...... .....||+.|+|||++.+... +.++||||||+++|||++|+.||.... .. ..
T Consensus 198 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~~----------~~--- 257 (320)
T 3a99_A 198 ALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EI----------IR--- 257 (320)
T ss_dssp EECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HH----------HH---
T ss_pred ccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----hh----------hc---
Confidence 8765432 223458999999999987765 788999999999999999999985321 00 00
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 740 NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
............+.+++.+||+.||++|||++||++
T Consensus 258 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 258 ----GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ----CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001112234467889999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=335.10 Aligned_cols=259 Identities=24% Similarity=0.305 Sum_probs=194.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccC------CceeEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAED------SKRLLV 586 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV 586 (796)
+.+.+.||+|+||.||+|++...++.||||++.... +.+.+|++++++++|+||+++++++... ...++|
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 456688999999999999998888999999986532 2345799999999999999999988532 236789
Q ss_pred EeecCCCChhhhhhc--CCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC-CceEEeccCCcccc
Q 003772 587 YEYMSNGSLADILFR--GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF-WTAKISDFGLAKLL 663 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFgl~~~~ 663 (796)
|||+++ +|.+.+.. .....+++..++.++.||++||.|||+. +|+||||||+|||++.+ +.+||+|||+++.+
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999986 56666542 2356799999999999999999999998 99999999999999955 67899999999876
Q ss_pred CCCCcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh---hhhhh
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF---IDREL 739 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~ 739 (796)
...... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+... .... ....+
T Consensus 208 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~i-~~~lg~p~~~~~ 281 (420)
T 1j1b_A 208 VRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEI-IKVLGTPTREQI 281 (420)
T ss_dssp CTTCCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH-HHHHCSCCHHHH
T ss_pred ccCCCc--eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH-HHHhCCCCHHHH
Confidence 543322 234589999999999765 78999999999999999999999997543111 11111 1100 00011
Q ss_pred hhhh-------cCC--------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhcCc
Q 003772 740 NKLV-------RGQ--------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEGIT 785 (796)
Q Consensus 740 ~~~~-------~~~--------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~ 785 (796)
.... .+. .........+.+|+.+||+.||.+|||+.|+++ .++++.
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 1100 000 012234577999999999999999999999985 344443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=324.22 Aligned_cols=244 Identities=28% Similarity=0.441 Sum_probs=193.8
Q ss_pred HHHHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch------hHHHHHHHHHHHhcc----CcCchhhhhhh
Q 003772 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE------GEREFRAEMHVIGRT----HHKNLVRLIGY 576 (796)
Q Consensus 507 ~l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~------~~~~f~~E~~~l~~l----~h~niv~l~g~ 576 (796)
+.....+.+.+.||+|+||.||+|....+++.||||++...... ....+.+|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 33445677889999999999999999888899999999653321 233466789999888 89999999999
Q ss_pred hccCCceeEEEee-cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec-CCCceEE
Q 003772 577 CAEDSKRLLVYEY-MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD-EFWTAKI 654 (796)
Q Consensus 577 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl 654 (796)
+.+.+..++|+|| +.+++|.+++.. ...+++..++.++.||++||.|||+. +|+||||||+||+++ +++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999 789999999976 35699999999999999999999998 999999999999999 8899999
Q ss_pred eccCCccccCCCCcceeeeeccCCCCCchhhhccCCC-CccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHh
Q 003772 655 SDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKC 733 (796)
Q Consensus 655 ~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 733 (796)
+|||+++...... .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||.... ..
T Consensus 182 ~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~--------- 245 (312)
T 2iwi_A 182 IDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----EI--------- 245 (312)
T ss_dssp CCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HH---------
T ss_pred EEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----HH---------
Confidence 9999998765432 233458999999999987766 458999999999999999999985321 00
Q ss_pred hhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 734 FIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.. .....+......+.+++..||+.||++|||++|+++
T Consensus 246 -~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 -LE-------AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -HH-------TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -hh-------hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 001122344567899999999999999999999997
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.62 Aligned_cols=255 Identities=20% Similarity=0.256 Sum_probs=194.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCc------ee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSK------RL 584 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~------~~ 584 (796)
+.+.+.||+|+||.||+|.....++.||||++.... ....+.+.+|+.++.+++||||+++++++...+. .+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 456688999999999999998889999999996532 2234678899999999999999999999887654 49
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+||||+. |+|.+++. ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 106 lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp EEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 9999998 68888873 3599999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHH-------HHHhhhh
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW-------AYKCFID 736 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~ 736 (796)
.. .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||............... .......
T Consensus 178 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 178 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 32 223458999999999987 67899999999999999999999999754311100000000 0000000
Q ss_pred hh----hhhhhcC-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 737 RE----LNKLVRG-----QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 737 ~~----~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.. +..+... ..........+.+++..||+.||++|||++++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 0000000 0112345678999999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=323.73 Aligned_cols=265 Identities=22% Similarity=0.203 Sum_probs=187.7
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCc-------e
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSK-------R 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~-------~ 583 (796)
..+.+.+.||+|+||.||+|+....++.||||++.... .....+.+|+..+..++||||+++++++..... .
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 34556789999999999999998888999999986532 233456778888899999999999999865333 7
Q ss_pred eEEEeecCCCChhhhhhc--CCCCCCchhHHHHHHHHHHHHHHHhh--ccCCCCeeeeccCccceEecC-CCceEEeccC
Q 003772 584 LLVYEYMSNGSLADILFR--GPERSLGWDERVRIASDVAKGILYLH--DECEAPIIHCDIKPQNILMDE-FWTAKISDFG 658 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFg 658 (796)
++||||+++ +|.+.+.. .....+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+||+|||
T Consensus 102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 899999996 45444432 23567899999999999999999999 76 9999999999999996 8999999999
Q ss_pred CccccCCCCcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHH-hhhh
Q 003772 659 LAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYK-CFID 736 (796)
Q Consensus 659 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~ 736 (796)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+...... ....
T Consensus 178 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 178 SAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEIVRVLGCPS 252 (360)
T ss_dssp TCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCC
T ss_pred CceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHHHHHcCCCC
Confidence 9987654332 2234589999999998765 48999999999999999999999997543211 11111000 0000
Q ss_pred hhhhhhhcC----------C---------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HhcCc
Q 003772 737 RELNKLVRG----------Q---------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM--LEGIT 785 (796)
Q Consensus 737 ~~~~~~~~~----------~---------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~ 785 (796)
......... . .........+.+++..||+.||.+|||+.|+++. ++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 000000000 0 1122346789999999999999999999999863 44443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=326.46 Aligned_cols=259 Identities=21% Similarity=0.230 Sum_probs=189.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch-----------hHHHHHHHHHHHhccCcCchhhhhhhhcc--
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE-----------GEREFRAEMHVIGRTHHKNLVRLIGYCAE-- 579 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-----------~~~~f~~E~~~l~~l~h~niv~l~g~~~~-- 579 (796)
+.+.+.||+|+||.||+|.... ++.||||++...... ..+.+.+|+.++.+++||||+++++++..
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 102 (362)
T 3pg1_A 24 YTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE 102 (362)
T ss_dssp CEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC
T ss_pred eEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc
Confidence 4456899999999999999866 678999998653221 13678999999999999999999999843
Q ss_pred ---CCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEec
Q 003772 580 ---DSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISD 656 (796)
Q Consensus 580 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 656 (796)
....++||||++ |+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 103 EPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp TTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEe
Confidence 345799999998 6888888753 45799999999999999999999998 999999999999999999999999
Q ss_pred cCCccccCCCCcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHH----
Q 003772 657 FGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAY---- 731 (796)
Q Consensus 657 Fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~---- 731 (796)
||+++...... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.................
T Consensus 178 fg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 178 FNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp TTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 99997543322 2233458999999999987 6789999999999999999999999975431110000000000
Q ss_pred ---HhhhhhhhhhhhcCC----C------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 732 ---KCFIDRELNKLVRGQ----E------VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 732 ---~~~~~~~~~~~~~~~----~------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
............... . ......+.+.+++..||+.||.+|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 000000000110000 0 11233467899999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=320.53 Aligned_cols=249 Identities=21% Similarity=0.306 Sum_probs=178.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch--hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE--GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|+||.||++.....++.||||++...... ..+.+.++..+++.++||||+++++++.+.+..++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (318)
T 2dyl_A 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM 106 (318)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence 45568899999999999999888889999999764332 2234555666788889999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhc-cCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD-ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
++.+..+... ....+++..++.++.|+++||.|||+ . +|+|+||||+||+++.++.+||+|||++........
T Consensus 107 -~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (318)
T 2dyl_A 107 -GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA- 180 (318)
T ss_dssp -SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred -CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc-
Confidence 4444444432 34679999999999999999999998 5 899999999999999999999999999976644322
Q ss_pred eeeeeccCCCCCchhhhc-----cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 670 TFTLVRGTRGYMAPEWYK-----NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
.....+|+.|+|||++. ...++.++||||||+++|||++|+.||....... ... ....... ..
T Consensus 181 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~----~~~~~~~----~~ 248 (318)
T 2dyl_A 181 -KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF---EVL----TKVLQEE----PP 248 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHH----HHHHHSC----CC
T ss_pred -ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH---HHH----HHHhccC----CC
Confidence 22345899999999994 4578999999999999999999999997533211 110 0000000 00
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...........+.+++..||+.||.+|||+.+|++
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00111234567889999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.34 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=192.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccC--cCchhhhhhhhccCCceeEEE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTH--HKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV~ 587 (796)
.+.+.+.||+|+||.||++.... ++.||||++.... ....+.+.+|+.++.+++ |+||+++++++.+++..++||
T Consensus 29 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 29 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 35667899999999999999865 6789999986532 334577899999999997 599999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
| +.+++|.+++.. ...+++..++.++.|+++||.|||+. +|+||||||+||++++ +.+||+|||+++......
T Consensus 108 e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 108 E-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp C-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred e-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 9 678899999986 45789999999999999999999998 9999999999999965 899999999998765433
Q ss_pred cc-eeeeeccCCCCCchhhhcc-----------CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh
Q 003772 668 TR-TFTLVRGTRGYMAPEWYKN-----------TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI 735 (796)
Q Consensus 668 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 735 (796)
.. ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......... .....
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-------~~~~~ 253 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-------LHAII 253 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-------HHHHH
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-------HHHHH
Confidence 22 2223458999999999875 47889999999999999999999999644321110 00000
Q ss_pred hhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 736 DRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
... .....+......+.+++..||+.||.+|||+.|+++
T Consensus 254 ~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 254 DPN-----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp CTT-----SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcc-----cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 000 001122233467889999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=326.66 Aligned_cols=264 Identities=20% Similarity=0.271 Sum_probs=194.0
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCC------ceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS------KRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~~l 585 (796)
.+.+.+.||+|+||.||++++..+++ ||+|++..... ...+|+.+++.++|+||+++++++.... ..++
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 35667899999999999999977654 89998854322 2346999999999999999999985433 3789
Q ss_pred EEeecCCCChhhhhh-cCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec-CCCceEEeccCCcccc
Q 003772 586 VYEYMSNGSLADILF-RGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISDFGLAKLL 663 (796)
Q Consensus 586 V~e~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFgl~~~~ 663 (796)
||||++++.+..... ......+++..+..++.||++||.|||+. +|+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999999764444332 12246799999999999999999999998 999999999999999 7999999999999876
Q ss_pred CCCCcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh-
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK- 741 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 741 (796)
...... ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...........+... ........+..
T Consensus 193 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~-~g~p~~~~~~~~ 269 (394)
T 4e7w_A 193 IAGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV-LGTPSREQIKTM 269 (394)
T ss_dssp CTTCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH-HCCCCHHHHHHH
T ss_pred cCCCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCCHHHHHhh
Confidence 543322 234579999999999765 5899999999999999999999999754321111111000 00000000000
Q ss_pred ---hhcC-----C------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HhcCcC
Q 003772 742 ---LVRG-----Q------EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM--LEGITD 786 (796)
Q Consensus 742 ---~~~~-----~------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~ 786 (796)
.... . .........+.+++..||+.||.+|||+.|+++. ++++..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 0000 0 0122345689999999999999999999999863 555543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=317.00 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=177.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHH-HHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMH-VIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|+||.||++.....++.||||++..... ....++..|+. +++.++||||+++++++.+.+..++||||+
T Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~ 103 (327)
T 3aln_A 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM 103 (327)
T ss_dssp EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence 3456889999999999999988889999999976432 33445556655 778889999999999999999999999999
Q ss_pred CCCChhhhhhc---CCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 591 SNGSLADILFR---GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 591 ~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
++ +|.+++.. .....+++..+..++.|+++||.|||+. .+|+||||||+||+++.++.+||+|||+++......
T Consensus 104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 180 (327)
T 3aln_A 104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180 (327)
T ss_dssp SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence 85 78777652 2356799999999999999999999984 389999999999999999999999999998764332
Q ss_pred cceeeeeccCCCCCchhhh----ccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 668 TRTFTLVRGTRGYMAPEWY----KNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
. .....||+.|+|||++ .+..++.++||||||+++|||++|+.||......... ...........+
T Consensus 181 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~~~~- 250 (327)
T 3aln_A 181 A--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-------LTQVVKGDPPQL- 250 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCCCCC-
T ss_pred c--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-------HHHHhcCCCCCC-
Confidence 2 2233589999999998 4567899999999999999999999999743211000 000000000000
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...........+.+++..||+.||.+|||+.+|++
T Consensus 251 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 251 -SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00111234567999999999999999999999964
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=327.55 Aligned_cols=246 Identities=25% Similarity=0.292 Sum_probs=183.5
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeecCCCC
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYMSNGS 594 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gs 594 (796)
.+.||+|+||+||.+.. ..++.||||++... ..+.+.+|+.++.++ +||||+++++++.+++..++||||+. |+
T Consensus 20 ~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs 94 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN 94 (434)
T ss_dssp EEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred cCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence 47799999999976544 34679999998653 345678899999876 89999999999999999999999996 69
Q ss_pred hhhhhhcCCCC-----CCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC-------------CceEEec
Q 003772 595 LADILFRGPER-----SLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF-------------WTAKISD 656 (796)
Q Consensus 595 L~~~l~~~~~~-----~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~kl~D 656 (796)
|.+++...... ...+..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 99999764221 124446678999999999999998 99999999999999754 4899999
Q ss_pred cCCccccCCCCcc---eeeeeccCCCCCchhhhcc-------CCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHH
Q 003772 657 FGLAKLLMPDQTR---TFTLVRGTRGYMAPEWYKN-------TPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIV 725 (796)
Q Consensus 657 Fgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~ 725 (796)
||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||....... ..
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~ 249 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SN 249 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HH
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HH
Confidence 9999987654322 1233569999999999976 578999999999999999999 888986432111 00
Q ss_pred HHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 726 LINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
. ...... ... ............+.+++.+||+.||.+|||+.+|++
T Consensus 250 i---~~~~~~---~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 250 I---IRGIFS---LDE--MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H---HHTCCC---CCC--CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H---hcCCCC---ccc--ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 000000 000 011224566788999999999999999999999985
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=292.57 Aligned_cols=211 Identities=15% Similarity=0.206 Sum_probs=161.3
Q ss_pred CCCcccCCCCccccCCCCCccccCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEE
Q 003772 27 PQPKSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLIL 106 (796)
Q Consensus 27 ~~~~~~~~g~~l~~~~~~~~~~S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl 106 (796)
++.++|++|++|.+++++ ++|.|+|||+.+++. .+ |.. +|+||+|||+.| +.+.|+|+.||||||
T Consensus 6 ~~~~~i~~g~~L~~g~~l-----~~g~f~l~f~~~gnl---~l-y~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl 70 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL-----ELSSFRFTMQSDCNL---VL-FDS---DVRVWASNTAGA---TGCRAVLQSDGLLVI 70 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE-----CSTTEEEEECTTSCE---EE-EES---SSEEECCCCCSC---SCCBCCBCSSSCBCC
T ss_pred eccceeCCCCEECCCCEE-----EcCCEEEEECCCCcE---EE-EEC---CEEEEECCCCCC---CCeEEEEcCCCcEEE
Confidence 356899999999998853 499999999876543 33 433 799999999988 678999999999999
Q ss_pred EcCCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccccCCCCccc----------cCCCCCCCC-CeeeeccCC
Q 003772 107 RTEEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTI----------LGNQSLLAG-NELFSRISE 174 (796)
Q Consensus 107 ~~~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtl----------Lp~~~l~~~-~~L~S~~s~ 174 (796)
+|++|+++|+|++... ....|+|+|+|||||++. ++||||||||||+ +|||+++.+ ++|+ +.
T Consensus 71 ~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~---s~ 144 (236)
T 1dlp_A 71 LTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLH---AT 144 (236)
T ss_dssp BCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEEC---SS
T ss_pred EcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEE---cC
Confidence 9999999999987543 345799999999999954 8999999998665 666666543 4777 47
Q ss_pred CCCCCccEEEEEecCCcEEEeeecCCCccccccccccccccc-eeEEEeecCceEEEEcCCcceeeeeecCCCCCcccee
Q 003772 175 TSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQRER-QLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIR 253 (796)
Q Consensus 175 ~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 253 (796)
.||++|.|++.++++|+++++ ... ..||+++++++. .....+..+|++++++.++.....++ ...+ ...+
T Consensus 145 ~d~s~G~~~l~l~~dG~LvL~--~~~----~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~~~~vw~s~--~~~~-~~~~ 215 (236)
T 1dlp_A 145 QSLQLSPYRLSMETDCNLVLF--DRD----DRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSG--NSRS-AGRY 215 (236)
T ss_dssp CCCBCSSCEEEEETTTEEEEE--BTT----BCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEECC--CCCS-SSCC
T ss_pred cEeecCcEEEEECCCCcEEEE--cCC----EeEEeCCCcCCCCceEEEECCCCcEEEEeCCCcEEEEeC--CCCC-CCCE
Confidence 899999999999999977665 222 579999988642 23455667888888876554433332 2222 2468
Q ss_pred EEEEeecccEEEEE
Q 003772 254 RLTIGHNGILRLFS 267 (796)
Q Consensus 254 rl~L~~~G~l~~~~ 267 (796)
|++|+.||++++|.
T Consensus 216 rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 216 VFVLQPDRNLAIYG 229 (236)
T ss_dssp EEEECSSSCEEEEC
T ss_pred EEEEcCCCcEEEeC
Confidence 99999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=308.85 Aligned_cols=233 Identities=12% Similarity=0.099 Sum_probs=184.1
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
..+.+.+.||+|+||.||+|.+...++.||||++..... +..+.+.+|+..+.+++|+||+++++++.+++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 346677899999999999999988889999999976432 23467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++++|.+++.+. .....+..++.|++.||.|||+. +|+||||||+|||+++++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999542 34557889999999999999998 99999999999999999999997443
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
|++| ++.++|||||||++|||++|+.||............ .. ...... .....
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~----~~-~~~~~~---~~~~~ 227 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----ER-DTAGQP---IEPAD 227 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----CB-CTTSCB---CCHHH
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----HH-HhccCC---CChhh
Confidence 3333 789999999999999999999999754322100000 00 000000 00000
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
.....+..+.+++.+||+.||++| |+.|+++.|+.+...
T Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 228 IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 112345678999999999999999 999999999886554
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=323.68 Aligned_cols=246 Identities=22% Similarity=0.268 Sum_probs=182.3
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.+.+.||+|+||+|+.... ..++.||||++.... ...+.+|+.+++++ +||||+++++++.+....++||||+.
T Consensus 26 y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 34557899999998654333 345789999986532 23457899999999 79999999999999999999999997
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-----CCceEEeccCCccccCCC
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE-----FWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFgl~~~~~~~ 666 (796)
|+|.+++... ...+....++.++.||++||.|||+. +|+||||||+|||++. ...+||+|||+++.....
T Consensus 102 -g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 102 -ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp -EEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred -CCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 6999999764 23455567789999999999999998 9999999999999953 346889999999877543
Q ss_pred Cc--ceeeeeccCCCCCchhhhc---cCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhh
Q 003772 667 QT--RTFTLVRGTRGYMAPEWYK---NTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740 (796)
Q Consensus 667 ~~--~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
.. .......||+.|+|||++. ...++.++|||||||++|||++ |+.||....... .. ......
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--~~-------~~~~~~-- 245 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--AN-------ILLGAC-- 245 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--HH-------HHTTCC--
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--HH-------HHhccC--
Confidence 22 2233456999999999997 4577889999999999999999 888885432110 00 000000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 741 KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..............+.+++..||+.||.+|||+.+|++
T Consensus 246 -~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 -SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00011122345566889999999999999999999983
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=335.46 Aligned_cols=271 Identities=23% Similarity=0.257 Sum_probs=203.5
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc-cchhHHHHHHHHHHHhccCcCchhhhhhhhcc------CCce
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM-VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE------DSKR 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 583 (796)
..+.+.+.||+|+||.||+|.+...++.||||++... .....+.+.+|+.++.+++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 4577889999999999999999888899999998764 33445679999999999999999999998765 6778
Q ss_pred eEEEeecCCCChhhhhhcCC-CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCc---eEEeccCC
Q 003772 584 LLVYEYMSNGSLADILFRGP-ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWT---AKISDFGL 659 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFgl 659 (796)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999998642 34699999999999999999999998 9999999999999997664 99999999
Q ss_pred ccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhH--HHHHHHHHhhhhh
Q 003772 660 AKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEI--VLINWAYKCFIDR 737 (796)
Q Consensus 660 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~ 737 (796)
+........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........-. .............
T Consensus 171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 987654332 233468999999999999999999999999999999999999996432100000 0000000000000
Q ss_pred hhhh-------hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH-----HHHHHhcCcC
Q 003772 738 ELNK-------LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKS-----VVLMLEGITD 786 (796)
Q Consensus 738 ~~~~-------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e-----vl~~L~~~~~ 786 (796)
.... ...+..........+.+++..||+.||.+|||+.+ ..+.++.+..
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000 00111234567889999999999999999999977 3444544433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=340.62 Aligned_cols=238 Identities=20% Similarity=0.288 Sum_probs=191.4
Q ss_pred HHhhhcccCcccceEEEEEEEcC-CcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCc-----ee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYK-GEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSK-----RL 584 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~-~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~ 584 (796)
.+.+.+.||+|+||.||++.+.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+. .+
T Consensus 81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~ 160 (681)
T 2pzi_A 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY 160 (681)
T ss_dssp TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence 46677899999999999999875 67899999986533 3445678999999999999999999999987665 69
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+||||+++++|.+++.. .+++..++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||+++...
T Consensus 161 lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 161 IVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 99999999999988743 799999999999999999999998 99999999999999986 89999999998765
Q ss_pred CCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
.. ....||+.|+|||++.+.. +.++|||||||++|||++|..|+........ .
T Consensus 233 ~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------------~ 285 (681)
T 2pzi_A 233 SF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------------P 285 (681)
T ss_dssp CC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------------C
T ss_pred cC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc---------------------c
Confidence 43 3345899999999998764 8999999999999999999887753211000 0
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHHHhcC
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPS-MKSVVLMLEGI 784 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~L~~~ 784 (796)
...........+.+++.+||+.||.+||+ ++++.+.|.++
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00001122356889999999999999995 66666666554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=317.48 Aligned_cols=236 Identities=15% Similarity=0.107 Sum_probs=179.0
Q ss_pred hhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCc-Cchhhhhhh--------------
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHH-KNLVRLIGY-------------- 576 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h-~niv~l~g~-------------- 576 (796)
+.+.||+|+||.||+|.+...++.||||++..... ...+.+++|+.++..++| +|...+..+
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 45789999999999999988889999999874222 235779999999999987 444443333
Q ss_pred -------hcc-----CCceeEEEeecCCCChhhhhh-----cCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeecc
Q 003772 577 -------CAE-----DSKRLLVYEYMSNGSLADILF-----RGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDI 639 (796)
Q Consensus 577 -------~~~-----~~~~~lV~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dl 639 (796)
... ....+++|++ .+++|.+++. ......+++..++.++.||++||.|||+. +|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence 111 1124555554 5689999884 23345688999999999999999999998 9999999
Q ss_pred CccceEecCCCceEEeccCCccccCCCCcceeeeeccCCCCCchhhh----------ccCCCCccccchhhHHHHHHHhh
Q 003772 640 KPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY----------KNTPISVKADVFSYGVVLLEIVC 709 (796)
Q Consensus 640 kp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~ksDV~S~Gvil~ellt 709 (796)
||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999999865432 333457 999999999 55568899999999999999999
Q ss_pred cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 003772 710 CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVV 778 (796)
Q Consensus 710 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 778 (796)
|+.||....... ......... ...++.+.+++..||+.||.+|||+.+++
T Consensus 313 g~~Pf~~~~~~~----------------~~~~~~~~~---~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 313 ADLPNTDDAALG----------------GSEWIFRSC---KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp SSCCCCTTGGGS----------------CSGGGGSSC---CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCCCCCcchhh----------------hHHHHHhhc---ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999996432110 011111110 12346789999999999999999976664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=298.33 Aligned_cols=229 Identities=21% Similarity=0.294 Sum_probs=181.3
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHH-hccCcCchhhhhhhhcc----CCceeEEEeecC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVI-GRTHHKNLVRLIGYCAE----DSKRLLVYEYMS 591 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l-~~l~h~niv~l~g~~~~----~~~~~lV~e~~~ 591 (796)
+.||+|+||.||++.....++.||||+++. ...+.+|+.++ +..+||||+++++++.+ ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 679999999999999988889999999964 24567788887 55689999999999876 667899999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC---CCceEEeccCCccccCCCCc
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE---FWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFgl~~~~~~~~~ 668 (796)
+|+|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---- 171 (299)
T 3m2w_A 99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---- 171 (299)
T ss_dssp SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence 99999999886566899999999999999999999998 9999999999999998 7889999999997542
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC-C
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ-E 747 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 747 (796)
+..++.++|||||||++|||++|+.||......... ........... .
T Consensus 172 -------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~~~~~~~~~~~~~ 220 (299)
T 3m2w_A 172 -------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKTRIRMGQYE 220 (299)
T ss_dssp -------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSCCSSCTTCCS
T ss_pred -------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------HHHHHHHhhcccc
Confidence 134678999999999999999999999643211100 00000000000 1
Q ss_pred CC----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhcCcCCC
Q 003772 748 VD----RNTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEGITDIS 788 (796)
Q Consensus 748 ~~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~~~ 788 (796)
.+ ......+.+++..||+.||.+|||+.|+++ .+......+
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence 11 223567999999999999999999999997 444444333
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=303.02 Aligned_cols=239 Identities=13% Similarity=0.124 Sum_probs=187.2
Q ss_pred HHHHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--------chhHHHHHHHHHHHhccC--------------
Q 003772 509 KKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--------TEGEREFRAEMHVIGRTH-------------- 566 (796)
Q Consensus 509 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--------~~~~~~f~~E~~~l~~l~-------------- 566 (796)
....+.+.+.||+|+||.||+|+. .++.||||++.... ....+.+.+|+.+++.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 356678889999999999999998 45899999997642 122367889999998887
Q ss_pred ------------cCchhhhhhhhcc-------------CCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHH
Q 003772 567 ------------HKNLVRLIGYCAE-------------DSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAK 621 (796)
Q Consensus 567 ------------h~niv~l~g~~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~ 621 (796)
||||+++++++.+ .+..++||||+++|++.+.+.+ ..+++..++.++.||+.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA 172 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence 8999999998886 7889999999999987777643 56899999999999999
Q ss_pred HHHHhh-ccCCCCeeeeccCccceEecCCC--------------------ceEEeccCCccccCCCCcceeeeeccCCCC
Q 003772 622 GILYLH-DECEAPIIHCDIKPQNILMDEFW--------------------TAKISDFGLAKLLMPDQTRTFTLVRGTRGY 680 (796)
Q Consensus 622 aL~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y 680 (796)
||.||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 88 999999999999999887 8999999999876432 23589999
Q ss_pred CchhhhccCCCCccccchhhHHH-HHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC----CCCCHHHHHH
Q 003772 681 MAPEWYKNTPISVKADVFSYGVV-LLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG----QEVDRNTLEN 755 (796)
Q Consensus 681 ~aPE~~~~~~~t~ksDV~S~Gvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 755 (796)
+|||++.+.. +.++||||++++ .+++++|..||... .|. ....+......... ........+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV----------LWL-HYLTDKMLKQMTFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH----------HHH-HHHHHHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch----------hhh-hHHHHhhhhhhccCcccchhhhhhcCHH
Confidence 9999998776 899999998777 78888888877310 000 00000111010000 1113456788
Q ss_pred HHHHHHHhccCCCCCCCCHHHHH
Q 003772 756 MIKIGLWCVQDEPALRPSMKSVV 778 (796)
Q Consensus 756 l~~l~~~cl~~dP~~RPt~~evl 778 (796)
+.+++.+||+.| |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999966 999887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-28 Score=279.46 Aligned_cols=186 Identities=16% Similarity=0.109 Sum_probs=131.1
Q ss_pred ccCcccceEEEEEEEcCCcEEEEEEEeeccc----------chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEE
Q 003772 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV----------TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 518 ~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~----------~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 586 (796)
.+..|++|.+..+....-++.+|+|.+.+.. ....++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4566777766665544445679999986531 22346799999999999 799999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|||++|++|.++|.+ .+.++.. +|+.||+.||.|||++ +||||||||+||||++++.+||+|||+++.....
T Consensus 321 MEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 999999999999976 3455543 5889999999999999 9999999999999999999999999999876544
Q ss_pred CcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccC
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRN 713 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p 713 (796)
... .....||+.|||||++.+. ...++|+||+|++++++.++..+
T Consensus 393 ~~~-~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSW-PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Ccc-ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 332 2345699999999999764 67789999999999998766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.4e-25 Score=250.56 Aligned_cols=182 Identities=18% Similarity=0.198 Sum_probs=145.0
Q ss_pred hcccCcccceEEEEEEEcCCcEEEEEEEeecccc--------hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--------EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 516 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
.+.||+|+||.||++... ++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 468999999999999553 45788887643211 11345899999999999999997777777888889999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+++|+|.+++.. +..++.|+++||.|||++ +|+||||||+|||+++ .+||+|||+++......
T Consensus 419 E~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 419 SYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp ECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred ECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 99999999999954 568999999999999998 9999999999999999 99999999999876543
Q ss_pred cce------eeeeccCCCCCchhhhcc--CCCCccccchhhHHHHHHHhhcccCC
Q 003772 668 TRT------FTLVRGTRGYMAPEWYKN--TPISVKADVFSYGVVLLEIVCCRRNM 714 (796)
Q Consensus 668 ~~~------~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvil~elltg~~p~ 714 (796)
... .....||+.|||||++.. ..++.++|+|+..+-..+-+-++.++
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 221 124569999999999987 56788899999999998888776654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=8.9e-22 Score=206.71 Aligned_cols=142 Identities=15% Similarity=0.085 Sum_probs=117.6
Q ss_pred hhcccCcccceEEEEEEEcCCcEEEEEEEeecccc------------------hhHHHHHHHHHHHhccCcCchhhhhhh
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT------------------EGEREFRAEMHVIGRTHHKNLVRLIGY 576 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~------------------~~~~~f~~E~~~l~~l~h~niv~l~g~ 576 (796)
+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++.+++ | +++.++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 448899999999999999 6678999999864221 13456899999999998 5 677775
Q ss_pred hccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEec
Q 003772 577 CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISD 656 (796)
Q Consensus 577 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 656 (796)
+ +.+..++||||+++|+|.+ +.. .....++.|+++||.|||+. +|+||||||+|||++ ++.+||+|
T Consensus 170 ~-~~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 170 Y-AWEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp E-EEETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECC
T ss_pred E-eccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEE
Confidence 4 4466799999999999998 421 23457999999999999998 999999999999999 99999999
Q ss_pred cCCccccCCCCcceeeeeccCCCCCchhhhcc
Q 003772 657 FGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN 688 (796)
Q Consensus 657 Fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 688 (796)
||+++ .+..++|||++..
T Consensus 236 FG~a~--------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 236 FPQSV--------------EVGEEGWREILER 253 (282)
T ss_dssp CTTCE--------------ETTSTTHHHHHHH
T ss_pred CCCCe--------------ECCCCCHHHHHHH
Confidence 99996 3557899999864
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=162.89 Aligned_cols=106 Identities=14% Similarity=0.190 Sum_probs=90.9
Q ss_pred CCcccCCCCccccCCCCCccc--cCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceE
Q 003772 28 QPKSIGLGSSLSPTKQPGSWN--SSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLI 105 (796)
Q Consensus 28 ~~~~~~~g~~l~~~~~~~~~~--S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lv 105 (796)
..++|.+|++|.++++ |+ |++|.|+|+|+.+++- +||++ +++||+|||+.| +.++.|+|.+|||||
T Consensus 7 ~~~~l~~g~~L~~g~~---l~~~S~~g~~~L~~~~dgnl----vly~~---~~~vW~sn~~~~--~~~~~l~l~~dGNLV 74 (119)
T 1b2p_A 7 KQPDDNHPQILHATES---LEILFGTHVYRFIMQTDCNL----VLYDN---NNPIWATNTGGL--GNGCRAVLQPDGVLV 74 (119)
T ss_dssp SCSSSCCCCEEETTCE---EEEEETTEEEEEEECTTSCE----EEEET---TEEEEECCCTTS--CSSCEEEECTTSCEE
T ss_pred cCcccCCCCEEcCCCE---EEEeCCCCCEEEEEecCCCE----EEEEC---CEEEEeCCCccC--CCceEEEEccCCEEE
Confidence 4678999999999985 57 9999999999987752 58875 799999999876 456899999999999
Q ss_pred EEcCCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccc
Q 003772 106 LRTEEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSS 148 (796)
Q Consensus 106 l~~~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQS 148 (796)
|+|++|.++|+|.+... +...++|+|+|||||++ .++|||
T Consensus 75 l~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~S 115 (119)
T 1b2p_A 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWAT 115 (119)
T ss_dssp EECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred EEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence 99999999999986543 35679999999999998 389998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-19 Score=159.13 Aligned_cols=109 Identities=15% Similarity=0.188 Sum_probs=91.6
Q ss_pred CcccCCCCccccCCCCCccccCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEEc
Q 003772 29 PKSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRT 108 (796)
Q Consensus 29 ~~~~~~g~~l~~~~~~~~~~S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~~ 108 (796)
.|+|.+|+.|.+++++ + ++|.|+|+|+.+++- +||+ .+++||+||++.| +..+.++|.+||||||+|
T Consensus 1 ~d~l~~g~~L~~g~~l---~-~~~~~~l~~~~dGnl----vl~~---~~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~~ 67 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSL---E-VGPSYRLIMQGDCNF----VLYD---SGKPVWASNTGGL--GSGCRLTLHNNGNLVIYD 67 (110)
T ss_dssp CCEEETTCEECTTCEE---E-ETTTEEEEECTTSCE----EEEE---TTEEEEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CCEeCCCCEECCCCEE---E-ECCCEEEEEcCCCcE----EEEE---CCEEEEECCCCCC--CCcEEEEEeCCCCEEEEC
Confidence 3688999999999864 6 899999999887653 6776 3799999999876 346789999999999999
Q ss_pred CCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccccCCCC
Q 003772 109 EEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSSFKIPT 153 (796)
Q Consensus 109 ~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQSFD~Pt 153 (796)
.+|..+|+|.+... +...++|+|+|||||++. .+||||+||.
T Consensus 68 ~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 68 QSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred CCCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 99999999987644 345799999999999875 7999999983
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.78 E-value=6.7e-19 Score=154.10 Aligned_cols=104 Identities=15% Similarity=0.283 Sum_probs=85.9
Q ss_pred CcccCCCCccccCCCCCccccCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEEc
Q 003772 29 PKSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRT 108 (796)
Q Consensus 29 ~~~~~~g~~l~~~~~~~~~~S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~~ 108 (796)
+++|.+|+.|.+++++ .| |.|.|.|...+ .|.++. ..++||+|||+.|. ...+.|+|+.||||||+|
T Consensus 1 kn~L~~g~~L~~g~~L---~s--g~y~l~~q~Dg---NLvly~----~~~~vW~ant~~~~-~~~~~L~l~~dGnLvL~d 67 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSL---DV--EPYHFIMQDDC---NLVLYD----HSTSTWASNTEIGG-KSGCSAVLQSDGNFVVYD 67 (105)
T ss_dssp CCEECTTEEECTTCEE---EE--TTEEEEECTTS---CEEEEE----TTEEEEECCCCCTT-CCSCEEEECTTSCEEEEC
T ss_pred CCCcCCCCEEcCCCEE---EE--CCEEEEECCCC---eEEEEE----CCEEEEEecCCCCC-CccEEEEEeCCccEEEEC
Confidence 4678899999998864 45 88999998766 456644 36999999999994 446789999999999999
Q ss_pred CCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccc
Q 003772 109 EEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSS 148 (796)
Q Consensus 109 ~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQS 148 (796)
++|+.+|+|++... ....|+|+|+|||||++. .+|||
T Consensus 68 ~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 68 SSGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp TTCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred CCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 99999999987643 456799999999999964 69998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=9.1e-19 Score=156.58 Aligned_cols=109 Identities=19% Similarity=0.281 Sum_probs=90.7
Q ss_pred CcccCCCCccccCCCCCccccCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEEc
Q 003772 29 PKSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRT 108 (796)
Q Consensus 29 ~~~~~~g~~l~~~~~~~~~~S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~~ 108 (796)
.|+|.+||+|.+++++ + +|.|+|+|+.+++- . +|+ ..++||+|||+.| ..++.|+|.+||||||+|
T Consensus 2 ~dtl~~gq~L~~g~~L---~--~g~~~L~~~~dgnl-v---ly~---~~~~vW~sn~~~~--~~~~~l~l~~~GnLvl~d 67 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSL---Q--AGAYTLTIQNKCNL-V---KYQ---NGRQIWASNTDRR--GSGCRLTLLSDGNLVIYD 67 (115)
T ss_dssp CCEEETTCEEETTEEE---E--ETTEEEEECTTSCE-E---EEE---TTEEEEECSCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CCEeCCCCEECCCCEE---E--CCCEEEEEcCCCcE-E---EEe---CCEEEEeCCCCCC--CCceEEEECCCCcEEEEC
Confidence 5789999999998865 4 89999999876643 2 365 3899999999987 356899999999999999
Q ss_pred CCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccccCCCCc
Q 003772 109 EEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSSFKIPTD 154 (796)
Q Consensus 109 ~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtD 154 (796)
.++..+|+|.+... +...++|+|+|||||++. ++||||.++..
T Consensus 68 ~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 68 HNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred CCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 98999999887533 446799999999999964 89999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.5e-18 Score=154.43 Aligned_cols=109 Identities=16% Similarity=0.277 Sum_probs=91.2
Q ss_pred CcccCCCCccccCCCCCccccCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEEc
Q 003772 29 PKSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRT 108 (796)
Q Consensus 29 ~~~~~~g~~l~~~~~~~~~~S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~~ 108 (796)
+|+|.+||+|.+++++ ++|.|+|+|+.+++- +||++ +++||+||++.+ +.++.|+|.+||||||+|
T Consensus 1 tdtl~~gq~L~~g~~L-----~~~~~~L~~~~dgnl----vl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d 66 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL-----AEGGYLFIIQNDCNL----VLYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS 66 (112)
T ss_dssp CCEEETTEEECTTCEE-----EETTEEEEECTTSCE----EEEET---TEEEEECCCTTS--CSSEEEEECTTSCEEEEE
T ss_pred CCCCCCCCEECCCCEE-----eCCCEEEEEcCCCcE----EEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc
Confidence 4789999999999864 489999999988753 35765 699999999753 456899999999999999
Q ss_pred CCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccccCCC
Q 003772 109 EEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSSFKIP 152 (796)
Q Consensus 109 ~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQSFD~P 152 (796)
++..+|+|.+... +...++|+++|||||++..+.++||||+|.
T Consensus 67 -~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 -GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp -TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred -CCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 8889999876543 345799999999999987788999999985
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=7.5e-18 Score=174.53 Aligned_cols=135 Identities=19% Similarity=0.190 Sum_probs=105.2
Q ss_pred hhcccCcccceEEEEEEEcCCcEE--EEEEEeecccch------------------------hHHHHHHHHHHHhccCcC
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEKL--VAVKKLEKMVTE------------------------GEREFRAEMHVIGRTHHK 568 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~~--vAvK~l~~~~~~------------------------~~~~f~~E~~~l~~l~h~ 568 (796)
+.+.||+|+||.||+|....+++. ||||++...... ....+.+|+.++.+++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 557899999999999998556678 999987532111 123678899999999988
Q ss_pred ch--hhhhhhhccCCceeEEEeecC-CC----ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhh-ccCCCCeeeeccC
Q 003772 569 NL--VRLIGYCAEDSKRLLVYEYMS-NG----SLADILFRGPERSLGWDERVRIASDVAKGILYLH-DECEAPIIHCDIK 640 (796)
Q Consensus 569 ni--v~l~g~~~~~~~~~lV~e~~~-~g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH-~~~~~~ivH~Dlk 640 (796)
++ +.++. ....+|||||+. +| +|.+.... .++..+..++.|++.||.||| +. +|+|||||
T Consensus 131 ~i~~p~~~~----~~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlk 198 (258)
T 1zth_A 131 GVSVPQPYT----YMKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHADLS 198 (258)
T ss_dssp TCCCCCEEE----EETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCS
T ss_pred CCCCCeEEE----cCCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCC
Confidence 64 23332 246789999994 24 66665432 335677899999999999999 87 99999999
Q ss_pred ccceEecCCCceEEeccCCcccc
Q 003772 641 PQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 641 p~NIll~~~~~~kl~DFgl~~~~ 663 (796)
|+|||+++ .++|+|||++...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999754
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.5e-17 Score=144.66 Aligned_cols=102 Identities=16% Similarity=0.260 Sum_probs=84.6
Q ss_pred cccCCCCccccCCCCCccccCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEEcC
Q 003772 30 KSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTE 109 (796)
Q Consensus 30 ~~~~~g~~l~~~~~~~~~~S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~~~ 109 (796)
.+|.+||+|.+++.+ + +|.|+|+|+.+++- .| |.. .++||+||++.+ +..+.|+|.+||||||.|.
T Consensus 2 ntL~~gq~L~~g~~L----~-~g~~~L~~q~dGnL-vl---y~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~ 67 (109)
T 3dzw_A 2 NILYSGETLSPGEFL----N-NGRYVFIMQEDCNL-VL---YDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSP 67 (109)
T ss_dssp CEEETTEEECTTCEE----E-ETTEEEEECTTSCE-EE---EET---TEEEEECCCTTS--SSSCEEEECTTSCEEEECT
T ss_pred CCcCCCCEeCCCCEE----E-CCCEEEEEcCCCcE-EE---EeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEECC
Confidence 578999999998875 3 79999999887652 33 654 699999999875 4567999999999999999
Q ss_pred CCceeEeecCCCCC-ceeEEEecCcCEEEeecCCCccccc
Q 003772 110 EGHDKVVAAGKSEP-ASSASMLDSGNFVLYNNRSDIIWSS 148 (796)
Q Consensus 110 ~g~~~w~t~~~~~~-~~~a~Lld~GNlVl~~~~~~~lWQS 148 (796)
++..+|++++.... ..+|+|+|+|||||++. .+|||
T Consensus 68 ~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s 104 (109)
T 3dzw_A 68 RNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWAT 104 (109)
T ss_dssp TSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCC
T ss_pred CCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeC
Confidence 88999998876443 36799999999999984 89998
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-15 Score=135.39 Aligned_cols=97 Identities=24% Similarity=0.446 Sum_probs=79.1
Q ss_pred CCCCCCCcEEEEecCCceEEEcCCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccccCCCCccccCCCCCCCC
Q 003772 87 DPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAG 165 (796)
Q Consensus 87 ~p~~~~~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtlLp~~~l~~~ 165 (796)
.|+.+...+|.|..||||+|++. ++++|++++... ....|+|+|+|||||+| ++.++||||+
T Consensus 14 ~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~--------------- 76 (112)
T 1xd5_A 14 GSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNT--------------- 76 (112)
T ss_dssp CEEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCC---------------
T ss_pred CEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCc---------------
Confidence 34445678999999999999987 789999987643 34689999999999999 7789999994
Q ss_pred CeeeeccCCCCCCCccEEEEEecCCcEEEeeecCCCcccccccccccccc
Q 003772 166 NELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQRE 215 (796)
Q Consensus 166 ~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~ 215 (796)
++++|.|++.++++|++++|.. . ...||+++++++
T Consensus 77 ----------~~~~g~~~l~l~~dGnlvl~~~-~----~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ----------NRQNGNYYLILQRDRNVVIYDN-S----NNAIWATHTNVG 111 (112)
T ss_dssp ----------CCSCCCCEEEECTTSCEEEECT-T----SCEEEECCCCCC
T ss_pred ----------cCCCCCEEEEEeCCCcEEEECC-C----CceEEECCCccC
Confidence 4567899999999999888741 1 267999988864
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.5e-15 Score=134.07 Aligned_cols=103 Identities=15% Similarity=0.167 Sum_probs=81.9
Q ss_pred CCcccCCCCccccCCCCCccccCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEE
Q 003772 28 QPKSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILR 107 (796)
Q Consensus 28 ~~~~~~~g~~l~~~~~~~~~~S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~ 107 (796)
+.|+|.+||+|.+++.+ +| |.|.|-|...+ + |.+ |.. ++||++|++.. +..+.|+|.+||||||+
T Consensus 5 ~~dtL~~gq~L~~g~~L---~s--g~~~L~~q~dG-n--Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGNLvl~ 69 (110)
T 3r0e_B 5 TNNLLFSGQVLYGDGRL---TA--KNHQLVMQGDC-N--LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGELIIK 69 (110)
T ss_dssp BTTEEETTCEEETTEEE---EC--SSCEEEECTTS-C--EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred ccCEECCCCEecCCCEE---Ee--CCEEEEEcCCC-e--EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence 57899999999999865 45 56999665444 3 444 543 48999999762 44579999999999999
Q ss_pred cCCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccc
Q 003772 108 TEEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSS 148 (796)
Q Consensus 108 ~~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQS 148 (796)
|.+|..+|++++... ...+|+|+|+|||||++ ..+|+|
T Consensus 70 d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 70 DDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred eCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 999999999987543 33679999999999998 489987
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.3e-15 Score=134.60 Aligned_cols=89 Identities=22% Similarity=0.458 Sum_probs=74.6
Q ss_pred CCCcEEEEecCCceEEEcCCCceeEeecCCCCC-ceeEEEecCcCEEEeecCCCccccccCCCCccccCCCCCCCCCeee
Q 003772 91 SSNAALTLTKDGKLILRTEEGHDKVVAAGKSEP-ASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELF 169 (796)
Q Consensus 91 ~~~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~~~-~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtlLp~~~l~~~~~L~ 169 (796)
+...+|.|+.||||||++ .++++|++++.... ...++|+|+|||||++.++.++||||
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~-------------------- 77 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTK-------------------- 77 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECC--------------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecC--------------------
Confidence 456889999999999999 57899999875433 46799999999999998889999998
Q ss_pred eccCCCCCCCccEEEEEecCCcEEEeeecCCCcccccccccccc
Q 003772 170 SRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQ 213 (796)
Q Consensus 170 S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~ 213 (796)
+++++|.|++.++++|++++|. ..||++++.
T Consensus 78 -----t~~~~g~~~l~l~~dGnlvl~~--------~~~W~S~~~ 108 (110)
T 3a0c_A 78 -----TNGKEDHYVLVLQQDRNVVIYG--------PVVWATGSG 108 (110)
T ss_dssp -----CCCSSSCCEEEECTTSCEEEEC--------SEEEECSCC
T ss_pred -----CCCCCCCEEEEEeCCccEEEEC--------CCEecCCCc
Confidence 3567899999999999988863 168988764
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.59 E-value=4.4e-15 Score=131.84 Aligned_cols=106 Identities=12% Similarity=0.166 Sum_probs=86.1
Q ss_pred CCcccCCCCccccCCCCCccccCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEE
Q 003772 28 QPKSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILR 107 (796)
Q Consensus 28 ~~~~~~~g~~l~~~~~~~~~~S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~ 107 (796)
..++|.+||.|.+++.+ + +|.|.|-|...+ .|.++.. ...++||.+|+..+ +....|+|.+||||||+
T Consensus 5 ~~~tL~~gq~L~~g~~L----~-~g~~~L~~q~dG---NLvL~~~--~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~ 72 (113)
T 3mez_B 5 VRNVLFSSQVMYDNAQL----A-TRDYSLVMRDDC---NLVLTKG--SKTNIVWESGTSGR--GQHCFMRLGHSGELDIT 72 (113)
T ss_dssp CSSEEETTCEEETTCEE----E-ETTEEEEECTTS---CEEEEET--TTTEEEEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred cCCEeCCCCEECCCCEe----E-cCCEEEEEcCCC---EEEEEEC--CCCEEEEECCcccC--CcCEEEEEeCCCcEEEE
Confidence 57899999999998865 3 588999997665 3555432 14799999999865 34678999999999999
Q ss_pred cCCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccc
Q 003772 108 TEEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSS 148 (796)
Q Consensus 108 ~~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQS 148 (796)
|.++..+|++++... +..+|+|+|+|||||++ ..+|+|
T Consensus 73 d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 73 DDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp CTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred CCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 999999999987543 34679999999999997 689998
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.6e-15 Score=161.54 Aligned_cols=139 Identities=16% Similarity=0.073 Sum_probs=102.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--------------hhHHHHHHHHHHHhccCcCchhhhhhhhc
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--------------EGEREFRAEMHVIGRTHHKNLVRLIGYCA 578 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--------------~~~~~f~~E~~~l~~l~h~niv~l~g~~~ 578 (796)
+.+.+.||+|+||.||+|.... ++.||||+++.... ......+.++++.....|+||.+++....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~-G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEK-GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTT-CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECCC-CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3466789999999999999865 57899998753211 01122344455555556788877765543
Q ss_pred cC------CceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC--
Q 003772 579 ED------SKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW-- 650 (796)
Q Consensus 579 ~~------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 650 (796)
.- ...+|||||+++++|.++.. ......++.|++.+|.+||+. +||||||||.|||+++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECS
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCc
Confidence 22 23479999999988876542 123467889999999999998 999999999999998876
Q ss_pred --------ceEEeccCCcccc
Q 003772 651 --------TAKISDFGLAKLL 663 (796)
Q Consensus 651 --------~~kl~DFgl~~~~ 663 (796)
.+.|+||+.+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 3899999988654
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.56 E-value=1.1e-14 Score=130.45 Aligned_cols=87 Identities=22% Similarity=0.384 Sum_probs=73.3
Q ss_pred CcEEEEecCCceEEEcCCCceeEeecCCCCC-ceeEEEecCcCEEEeecCCCccccccCCCCccccCCCCCCCCCeeeec
Q 003772 93 NAALTLTKDGKLILRTEEGHDKVVAAGKSEP-ASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSR 171 (796)
Q Consensus 93 ~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~~~-~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtlLp~~~l~~~~~L~S~ 171 (796)
..+|.|..||||+|++. ++++|++++.... ...|+|+|+|||||+|.++.++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~---------------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP---------------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS----------------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCC----------------------
Confidence 45688899999999986 7899999875433 46799999999999998899999998
Q ss_pred cCCCCCCCccEEEEEecCCcEEEeeecCCCcccccccccccc
Q 003772 172 ISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQ 213 (796)
Q Consensus 172 ~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~ 213 (796)
++|++|.|++.++++|+++++. ..||++++.
T Consensus 88 ---~~~~~g~~~l~l~~~Gnlvl~~--------~~~W~Sg~~ 118 (119)
T 1b2p_A 88 ---VAGKAGHYVLVLQPDRNVVIYG--------DALWATQTV 118 (119)
T ss_dssp ---CCCCSSCEEEEECTTSCEEEEE--------SEEEECCCC
T ss_pred ---CCCCCCCEEEEEECCCcEEEEC--------ccEeCCCCC
Confidence 3567899999999999988763 268998763
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=4.6e-14 Score=125.93 Aligned_cols=90 Identities=21% Similarity=0.477 Sum_probs=75.3
Q ss_pred CCcEEEEecCCceEEEcCCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccccCCCCccccCCCCCCCCCeeee
Q 003772 92 SNAALTLTKDGKLILRTEEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFS 170 (796)
Q Consensus 92 ~~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtlLp~~~l~~~~~L~S 170 (796)
....|.|..||||+|++ .++++|++++... ....++|+++|||||+|.++.++|||||+
T Consensus 20 g~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~------------------- 79 (115)
T 2dpf_A 20 GAYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACW------------------- 79 (115)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCC-------------------
T ss_pred CCEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCC-------------------
Confidence 45789999999999998 5788999986543 34679999999999999888999999997
Q ss_pred ccCCCCCCCccEEEEEecCCcEEEeeecCCCcccccccccccccc
Q 003772 171 RISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQRE 215 (796)
Q Consensus 171 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~~ 215 (796)
+++|.|++.++++|++++|. ..||++++|..
T Consensus 80 ------~~~g~~~l~l~~dGnlvl~~--------~~~W~S~~~~~ 110 (115)
T 2dpf_A 80 ------GDNGKYALVLQKDGRFVIYG--------PVLWSLGPNGC 110 (115)
T ss_dssp ------CSSSCCEEEECTTSCEEEEC--------SEEECSSTTCB
T ss_pred ------CCCCCEEEEEeCCCeEEEEC--------CCEEECCCCCC
Confidence 35688999999999988872 16999998864
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.50 E-value=3.6e-14 Score=124.97 Aligned_cols=101 Identities=16% Similarity=0.255 Sum_probs=81.3
Q ss_pred CCcccCCCCccccCCCCCccccCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEE
Q 003772 28 QPKSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILR 107 (796)
Q Consensus 28 ~~~~~~~g~~l~~~~~~~~~~S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~ 107 (796)
+.++|.|||.|.+++.+ .+|.|.|.|...++- -+ |.. +|.+|+..+ +....|+|.+||||||.
T Consensus 2 ~~dtL~~gq~L~~g~~L-----~~g~~~L~~q~dGNL---vl-~~~------~Wssnt~~~--~~~~~l~l~~dGnLvl~ 64 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEGHL-----KNGDFDLVMQDDCNL---VL-YNG------NWQSNTANN--GRDCKLTLTDYGELVIK 64 (109)
T ss_dssp CCSEEETTCEECTTCEE-----EETTEEEEECTTSCE---EE-ETT------TEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred ccCCcCCCCCcCCCCEe-----ECCCEEEEEecCCeE---EE-EeC------eEEcCCCCC--CCcEEEEEcCCCeEEEE
Confidence 46899999999998864 479999999776643 11 321 699998764 44689999999999999
Q ss_pred cCCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccc
Q 003772 108 TEEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSS 148 (796)
Q Consensus 108 ~~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQS 148 (796)
|.++..+|++++... ...+|+|+|+|||||++ ..+|+|
T Consensus 65 d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s 103 (109)
T 3r0e_A 65 NGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI 103 (109)
T ss_dssp CTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE
T ss_pred eCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC
Confidence 999999999886543 34579999999999997 689998
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.40 E-value=6.4e-13 Score=117.87 Aligned_cols=95 Identities=17% Similarity=0.299 Sum_probs=75.7
Q ss_pred CCCCCCCCCcEEEEecCCceEEEcC-CCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccccCCCCccccCCCCC
Q 003772 85 RDDPPVSSNAALTLTKDGKLILRTE-EGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSL 162 (796)
Q Consensus 85 r~~p~~~~~~~l~l~~~G~Lvl~~~-~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtlLp~~~l 162 (796)
.+.|+.+...+|.|+.||||||++. .+..+|++++... ....++|+|+|||||+|.++.++|||-.
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t------------ 84 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNT------------ 84 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSC------------
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCC------------
Confidence 4566667788999999999999998 4889999987643 3468999999999999988899999811
Q ss_pred CCCCeeeeccCCCCCCCccEEEEEecCCcEEEeeecCCCccccccccccc
Q 003772 163 LAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDS 212 (796)
Q Consensus 163 ~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~ 212 (796)
. ...|.|.+.++.+|++++|. .+.|++++
T Consensus 85 ------------~-~~~~~~~~~L~~dGnlvly~--------~~~W~s~~ 113 (113)
T 3mez_B 85 ------------V-GQEGDYVLILQINGQAVVYG--------PAVWSTAA 113 (113)
T ss_dssp ------------C-CSSSCCEEEECTTSCEEEEC--------SEEEESCC
T ss_pred ------------c-CCCCCEEEEEcCCceEEEec--------CCEecCCC
Confidence 0 11356899999999999983 45787753
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.36 E-value=1.2e-12 Score=115.61 Aligned_cols=102 Identities=14% Similarity=0.167 Sum_probs=79.7
Q ss_pred CcccCCCCccccCCCCCccccCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEEc
Q 003772 29 PKSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRT 108 (796)
Q Consensus 29 ~~~~~~g~~l~~~~~~~~~~S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~~ 108 (796)
+++|.+||.|.+++.+ .+|.|.|-|...++- -+ |.. .. ||.+|+..+ .....|+|.+||||||+|
T Consensus 2 ~~~l~~gq~L~~g~~L-----~~g~~~L~~q~dGnL---vl-~~~---~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~ 66 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL-----SYESAAFVMQGDCNL---VL-YNE---AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHS 66 (111)
T ss_dssp TTEEETTCEECTTCEE-----EETTEEEEECTTSCE---EE-ECS---SC-CEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred cCEeCCCCEeCCCCEE-----ecCCEEEEEccCCeE---EE-ECC---CC-EEECCcccC--CcCEEEEEcCCCcEEEEe
Confidence 4689999999998864 378999999765532 22 432 23 999999775 345789999999999999
Q ss_pred CCCce-eEeecCCC---CCceeEEEecCcCEEEeecCCCccccc
Q 003772 109 EEGHD-KVVAAGKS---EPASSASMLDSGNFVLYNNRSDIIWSS 148 (796)
Q Consensus 109 ~~g~~-~w~t~~~~---~~~~~a~Lld~GNlVl~~~~~~~lWQS 148 (796)
.++.. +|++++.. .....++|+|+|||||++ ..+|+|
T Consensus 67 ~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 67 ANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp SSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred CCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 88764 99988532 234679999999999997 689998
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.35 E-value=2.2e-12 Score=113.94 Aligned_cols=94 Identities=17% Similarity=0.364 Sum_probs=73.2
Q ss_pred CCCCCCCCcEEEEecCCceEEEcCCCceeEeecCCCCC-ceeEEEecCcCEEEeecCCC-ccccccCCCCccccCCCCCC
Q 003772 86 DDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEP-ASSASMLDSGNFVLYNNRSD-IIWSSFKIPTDTILGNQSLL 163 (796)
Q Consensus 86 ~~p~~~~~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~~~-~~~a~Lld~GNlVl~~~~~~-~lWQSFD~PtDtlLp~~~l~ 163 (796)
+.++.+....|.|..||||||++.++ +|++++.... ...++|+|+|||||++.+++ ++|||.-+
T Consensus 14 g~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~------------ 79 (111)
T 3mez_A 14 DNQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS------------ 79 (111)
T ss_dssp TCEEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS------------
T ss_pred CCEEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc------------
Confidence 34444556889999999999999876 9999876433 36899999999999998766 59999521
Q ss_pred CCCeeeeccCCCCCCCccEEEEEecCCcEEEeeecCCCccccccccccc
Q 003772 164 AGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDS 212 (796)
Q Consensus 164 ~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~ 212 (796)
.....|.|.+.++.||++++|. .++|++++
T Consensus 80 -----------~~~~~~~~~l~Lq~dGNlvly~--------~~~W~s~t 109 (111)
T 3mez_A 80 -----------VNTVRGNYAATLGPDQHVTIYG--------PAIWSTPA 109 (111)
T ss_dssp -----------CCCCSSCCEEEECTTSCEEEEC--------SEEEECCC
T ss_pred -----------cCCCCcCEEEEECCCCeEEEec--------cCEEccCC
Confidence 1124578999999999999984 56898765
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.2e-11 Score=108.94 Aligned_cols=88 Identities=22% Similarity=0.306 Sum_probs=69.3
Q ss_pred CCCCCcEEEEecCCceEEEcCCCceeEeecCCCCC-ceeEEEecCcCEEEeecCCCccccccCCCCccccCCCCCCCCCe
Q 003772 89 PVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEP-ASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNE 167 (796)
Q Consensus 89 ~~~~~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~~~-~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtlLp~~~l~~~~~ 167 (796)
+++....|.|..||||||++. +.+|++++.... ...++|+|+|||||+|.++.++|||-.+
T Consensus 21 L~sg~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~---------------- 82 (110)
T 3r0e_B 21 LTAKNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSS---------------- 82 (110)
T ss_dssp EECSSCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCC----------------
T ss_pred EEeCCEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCc----------------
Confidence 344568899999999999976 589999876433 3579999999999999888999999321
Q ss_pred eeeccCCCCCCCccEEEEEecCCcEEEeeecCCCcccccccccc
Q 003772 168 LFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASD 211 (796)
Q Consensus 168 L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~ 211 (796)
...|.|.+.++.+|++++|. .+.|+++
T Consensus 83 ---------~~~~~~~~~L~~dGNlvly~--------~~~W~t~ 109 (110)
T 3r0e_B 83 ---------SKQGEYVLILQDDGFGVIYG--------PAIFETS 109 (110)
T ss_dssp ---------CSSSCCEEEECTTSCEEEEC--------SEEEESC
T ss_pred ---------CCCCCEEEEEcCCccEEEec--------CCEecCC
Confidence 12356899999999999984 3568765
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=2.2e-11 Score=107.29 Aligned_cols=87 Identities=25% Similarity=0.427 Sum_probs=69.9
Q ss_pred CCcEEEEecCCceEEEcCCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccccCCCCccccCCCCCCCCCeeee
Q 003772 92 SNAALTLTKDGKLILRTEEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFS 170 (796)
Q Consensus 92 ~~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtlLp~~~l~~~~~L~S 170 (796)
....|.|..||||||++. +.++|++++... ....++|+|+|||||+|.++.++|||...
T Consensus 19 g~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~------------------- 78 (109)
T 3dzw_A 19 GRYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTG------------------- 78 (109)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCC-------------------
T ss_pred CCEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCC-------------------
Confidence 457899999999999987 688999987543 34679999999999999888999998321
Q ss_pred ccCCCCCCCccEEEEEecCCcEEEeeecCCCccccccccccc
Q 003772 171 RISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDS 212 (796)
Q Consensus 171 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~ 212 (796)
...+.|.+.++.+|++++|. .+.|.+++
T Consensus 79 ------~~~~~~~~~L~ddGNlvly~--------~~~W~s~t 106 (109)
T 3dzw_A 79 ------GENGNYVCVLQKDRNVVIYG--------TARWATGT 106 (109)
T ss_dssp ------CSSSCEEEEECTTSCEEEEE--------SCCCCCCC
T ss_pred ------CCCCCEEEEEeCCCEEEEEC--------CCEEeCCC
Confidence 12357899999999999984 25788765
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=2.4e-11 Score=125.49 Aligned_cols=112 Identities=13% Similarity=0.191 Sum_probs=85.8
Q ss_pred CCCcccCCCCc----cccCCCCCccccCCCeeeeeeeecC---CCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEe
Q 003772 27 PQPKSIGLGSS----LSPTKQPGSWNSSLGAFQFGFYKQD---AGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLT 99 (796)
Q Consensus 27 ~~~~~~~~g~~----l~~~~~~~~~~S~~g~F~lgFf~~~---~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~ 99 (796)
.++||+.||+. |..++++ .| +..++.|+|... .+ .+-+ |++ ..+++|.+++..+ +. ..|.+.
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L---~S-~~dps~G~fsl~l~~dG-nlvL-y~~--~~~~yW~Sgt~~~--~~-~~l~l~ 202 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSEL---VQ-GVVYGAGASKLVFQGDG-NLVA-YGP--NGAATWNAGTQGK--GA-VRAVFQ 202 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEE---CT-TCEEEETTEEEEECTTS-CEEE-ECT--TSSEEEECCCTTT--TC-CEEEEC
T ss_pred ccccccccccccccccccCccc---cc-CCCCCCceEEEeecCCc-eEEE-EeC--CCeEEEECCCCCC--cc-EEEEEc
Confidence 67899999999 7777654 33 456666666431 22 2333 332 2689999999876 22 789999
Q ss_pred cCCceEEEcCCCceeEeecCCCCCceeEEEecCcCEEEeecCCCccccccCC
Q 003772 100 KDGKLILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLYNNRSDIIWSSFKI 151 (796)
Q Consensus 100 ~~G~Lvl~~~~g~~~w~t~~~~~~~~~a~Lld~GNlVl~~~~~~~lWQSFD~ 151 (796)
.+|+|+++|.++..+|.+.+......+|+|+++|||||++. +.+||||||
T Consensus 203 ~dGnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 203 GDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp TTSCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred CCCeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 99999999988889999887655567899999999999986 689999997
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.18 E-value=5.1e-11 Score=104.76 Aligned_cols=91 Identities=19% Similarity=0.337 Sum_probs=71.2
Q ss_pred CCCCCCCCcEEEEecCCceEEEcCCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccccCCCCccccCCCCCCC
Q 003772 86 DDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLA 164 (796)
Q Consensus 86 ~~p~~~~~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtlLp~~~l~~ 164 (796)
+.|+.+....|.|..||||||+++ +|++++... ....++|+++|||||+|.++.++|+|- |
T Consensus 15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~-----t--------- 76 (109)
T 3r0e_A 15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSG-----A--------- 76 (109)
T ss_dssp TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECC-----C---------
T ss_pred CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCC-----C---------
Confidence 444555678899999999999984 699887643 346799999999999998889999771 1
Q ss_pred CCeeeeccCCCCCCCccEEEEEecCCcEEEeeecCCCcccccccccccc
Q 003772 165 GNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQ 213 (796)
Q Consensus 165 ~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~ 213 (796)
....+.|.+.++++|++++|. .+.|+++++
T Consensus 77 -----------~~~~~~~~~~L~~dGNlvly~--------~~~W~s~t~ 106 (109)
T 3r0e_A 77 -----------QSVKGNYAAVVHPDGRLVVFG--------PSVFKIDPW 106 (109)
T ss_dssp -----------CCSSSCCEEEEETTTEEEEEC--------SEEEEECTT
T ss_pred -----------cCCCcCEEEEEcCCCeEEEEe--------cCEECCCCc
Confidence 112467899999999999983 467988775
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.12 E-value=3.4e-10 Score=114.73 Aligned_cols=137 Identities=20% Similarity=0.329 Sum_probs=94.3
Q ss_pred CcEEEEecCCceEEEcCCCceeEeecCCCCCceeEEEecCcCEEEeecCCCccccccCCCCccccCCCCCCCCCeeeecc
Q 003772 93 NAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRI 172 (796)
Q Consensus 93 ~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~~~~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtlLp~~~l~~~~~L~S~~ 172 (796)
.-+|.|..||+|+|++. ++++|.+++.......++|+++|||||+|.++.++|+|+++
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~--------------------- 84 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTK--------------------- 84 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCC---------------------
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCcc---------------------
Confidence 45677778899999885 68899988755556679999999999999999999999864
Q ss_pred CCCCCCCccEEEEEecCCcEEEeeecCCCccccccccccccc----------------------------------ccee
Q 003772 173 SETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQR----------------------------------ERQL 218 (796)
Q Consensus 173 s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~----------------------------------~~~~ 218 (796)
.+.|.|.+.++.+|+++++. ..+|.+.... ...+
T Consensus 85 ----~~~~~~~~~l~d~Gnlvl~~--------~~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s~~d~s~G~~ 152 (236)
T 1dlp_A 85 ----GSIGNYVLVLQPDRTVTIYG--------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPY 152 (236)
T ss_dssp ----CCSSCCEEEECSSSCEEEEC--------SEEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECSSCCCBCSSC
T ss_pred ----ccCCcEEEEEeCCCCEEEec--------CCEEECCCCCCcccccCCccceEEecCCcCCCccceEEcCcEeecCcE
Confidence 12456788999999998872 1455543221 0224
Q ss_pred EEEeecCceEEEEcCCcceeeeeecCCCCCccceeEEEEeecccEEEEE
Q 003772 219 HLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFS 267 (796)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~rl~L~~~G~l~~~~ 267 (796)
.+.++..+++++++... .++.....+.....++.|+.+|++.+|.
T Consensus 153 ~l~l~~dG~LvL~~~~~----~~W~s~~~~~~~~~~~~L~~~Gnl~ly~ 197 (236)
T 1dlp_A 153 RLSMETDCNLVLFDRDD----RVWSTNTAGKGTGCRAVLQPNGRMDVLT 197 (236)
T ss_dssp EEEEETTTEEEEEBTTB----CCSCCCCCSSCSSCEEEEETTTEEEEEE
T ss_pred EEEECCCCcEEEEcCCE----eEEeCCCcCCCCceEEEECCCCcEEEEe
Confidence 45566667777665431 2233322222334678899999988875
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.06 E-value=6.2e-10 Score=96.99 Aligned_cols=77 Identities=25% Similarity=0.531 Sum_probs=63.2
Q ss_pred CcEEEEecCCceEEEcCCCceeEeecCCC--CCceeEEEecCcCEEEeecCCCccccccCCCCccccCCCCCCCCCeeee
Q 003772 93 NAALTLTKDGKLILRTEEGHDKVVAAGKS--EPASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFS 170 (796)
Q Consensus 93 ~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~--~~~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtlLp~~~l~~~~~L~S 170 (796)
.-+|.+..||||||++. ++++|.+++.. ..+..++|+++|||||+|.+++++|+|-
T Consensus 20 ~y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~--------------------- 77 (105)
T 4h3o_A 20 PYHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASH--------------------- 77 (105)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECC---------------------
T ss_pred CEEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEec---------------------
Confidence 46789999999999984 57899998653 3456799999999999999999999871
Q ss_pred ccCCCCCCCccEEEEEecCCcEEEe
Q 003772 171 RISETSSSTGRFRLNMQRDGNLVLY 195 (796)
Q Consensus 171 ~~s~~dps~G~~~~~~~~~g~~~~~ 195 (796)
+....+.|.+.++.+|++++|
T Consensus 78 ----t~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 78 ----STRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp ----CCCCSSCEEEEECTTSCEEEE
T ss_pred ----CCCCCCCEEEEEeCCCeEEEE
Confidence 122356789999999999998
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=2e-10 Score=118.85 Aligned_cols=140 Identities=14% Similarity=0.056 Sum_probs=109.2
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-cCchhhhhhhhccCCceeEEEeecCC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
.+...++.|+.+.||+.... +..+++|+...........+.+|+.+++.+. |..+.++++++.+.+..++||||++|
T Consensus 17 ~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 17 RCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp EEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred eeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 34566788888999998754 4679999986533233456899999999884 67788899988888889999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccC------------------------------------------
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC------------------------------------------ 630 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------------------------------------------ 630 (796)
.+|.+.+. +......++.+++++|..||+..
T Consensus 95 ~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 95 VLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp EEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred eehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 99987642 12234578899999999999821
Q ss_pred --------------CCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 631 --------------EAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 631 --------------~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13589999999999998766677999998853
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.85 E-value=3.1e-09 Score=109.41 Aligned_cols=131 Identities=16% Similarity=0.102 Sum_probs=97.2
Q ss_pred ccC-cccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCc--hhhhhhhhccCCceeEEEeecCCCC
Q 003772 518 ELG-KGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKN--LVRLIGYCAEDSKRLLVYEYMSNGS 594 (796)
Q Consensus 518 ~LG-~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~e~~~~gs 594 (796)
.++ .|..+.||+.... +++.+++|+.... ....+..|+.+++.+.+.+ +.+++++..+++..++||||+++.+
T Consensus 26 ~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~ 101 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 101 (264)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred ecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence 344 5556999999764 3457899987543 2346788999999886544 4568888777778899999999988
Q ss_pred hhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccC--------------------------------------------
Q 003772 595 LADILFRGPERSLGWDERVRIASDVAKGILYLHDEC-------------------------------------------- 630 (796)
Q Consensus 595 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-------------------------------------------- 630 (796)
|. ... .....++.++++.|..||+..
T Consensus 102 l~--~~~--------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 102 LL--SSH--------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp TT--TSC--------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cC--cCc--------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 84 211 112367788888888888742
Q ss_pred -----------CCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 631 -----------EAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 631 -----------~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999999854
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.80 E-value=8.5e-09 Score=111.76 Aligned_cols=141 Identities=16% Similarity=0.239 Sum_probs=105.4
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEee--ccc-chhHHHHHHHHHHHhccC--cCchhhhhhhhccC---CceeEEEe
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLE--KMV-TEGEREFRAEMHVIGRTH--HKNLVRLIGYCAED---SKRLLVYE 588 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~--~~~-~~~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~---~~~~lV~e 588 (796)
+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..++|||
T Consensus 44 ~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EECCC-CCSCEEEEECSS--CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEcCCcccceEEEEEECC--ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 568999999999988753 467888765 321 123456888999999887 45578888888766 45899999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccC--------------------------------------
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC-------------------------------------- 630 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-------------------------------------- 630 (796)
|+++..+.+.. -..++...+..++.++++.|..||...
T Consensus 122 ~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 122 FVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred ecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99998875432 234677888899999999999999731
Q ss_pred -----------------CCCeeeeccCccceEecCCCc--eEEeccCCcccc
Q 003772 631 -----------------EAPIIHCDIKPQNILMDEFWT--AKISDFGLAKLL 663 (796)
Q Consensus 631 -----------------~~~ivH~Dlkp~NIll~~~~~--~kl~DFgl~~~~ 663 (796)
...++|+|+++.||+++.++. +.|+||+.+...
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246999999999999997653 689999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.69 E-value=6.8e-09 Score=109.76 Aligned_cols=185 Identities=18% Similarity=0.196 Sum_probs=122.0
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-cCc--hhhhhhhhccCC---ceeEEEeec
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-HKN--LVRLIGYCAEDS---KRLLVYEYM 590 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-h~n--iv~l~g~~~~~~---~~~lV~e~~ 590 (796)
+.++.|....||+.. ..+++|+.... .....+.+|+.++..+. +.. +.+++......+ ..++|||++
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 458899999999863 24788886432 34567889999998873 333 344444443333 358899999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccC----------------------------------------
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC---------------------------------------- 630 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~---------------------------------------- 630 (796)
++.+|.+... ..++...+..++.++++.|..||...
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988876443 24667777888888888888888611
Q ss_pred ---------------CCCeeeeccCccceEecC--CCceEEeccCCccccCCCCcceeee-------------eccCCCC
Q 003772 631 ---------------EAPIIHCDIKPQNILMDE--FWTAKISDFGLAKLLMPDQTRTFTL-------------VRGTRGY 680 (796)
Q Consensus 631 ---------------~~~ivH~Dlkp~NIll~~--~~~~kl~DFgl~~~~~~~~~~~~~~-------------~~gt~~y 680 (796)
...++|+|++|.||++++ ...+.|+||+.+....+........ .....+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 135899999999999998 5668899999987643321110000 0001112
Q ss_pred Cc-hhhhccCCCCccccchhhHHHHHHHhhcccCC
Q 003772 681 MA-PEWYKNTPISVKADVFSYGVVLLEIVCCRRNM 714 (796)
Q Consensus 681 ~a-PE~~~~~~~t~ksDV~S~Gvil~elltg~~p~ 714 (796)
.. |+..... ....+.|+++.++|++.+|+.++
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 22 3322211 22368999999999999988755
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=7.3e-06 Score=84.59 Aligned_cols=136 Identities=15% Similarity=0.105 Sum_probs=99.0
Q ss_pred ccCcccce-EEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-cCchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 518 ELGKGSFG-AVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 518 ~LG~G~fg-~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
.+..|..+ .||+.....++..+.+|+-.. .....+.+|...|..+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445554 699988776677788898643 23456788999888774 33467788888888899999999999888
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccC---------------------------------------------
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHDEC--------------------------------------------- 630 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~--------------------------------------------- 630 (796)
.+..... ......++.++++.|..||...
T Consensus 108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 7765321 2233456667777777777431
Q ss_pred ----------CCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 631 ----------EAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 631 ----------~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
...++|+|+++.||++++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12378999999999999887778999999864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=1.1e-05 Score=84.88 Aligned_cols=136 Identities=20% Similarity=0.190 Sum_probs=93.7
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcC---chhhhhhhhc-cCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHK---NLVRLIGYCA-EDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lV~e~~~~ 592 (796)
+.++.|....||+. + ..+++|+-.. ......+..|+.+|..+.+. .+.+++.++. ..+..++||||+++
T Consensus 25 ~~l~~G~~n~v~~v----g-~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----N-GDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE----T-TTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE----C-CEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 45788888899987 2 3577887432 23456789999999998653 2455566553 34567899999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhcc-------------------------------------------
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE------------------------------------------- 629 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~------------------------------------------- 629 (796)
.+|.+.... .++......++.++++.|..||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888764321 234455555666666666666543
Q ss_pred --------------CCCCeeeeccCccceEecC---CCc-eEEeccCCcccc
Q 003772 630 --------------CEAPIIHCDIKPQNILMDE---FWT-AKISDFGLAKLL 663 (796)
Q Consensus 630 --------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DFgl~~~~ 663 (796)
....++|+|++|.||+++. ++. ..|+||+.+...
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235699999999999997 455 489999988653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=2.2e-05 Score=84.55 Aligned_cols=81 Identities=9% Similarity=0.018 Sum_probs=54.7
Q ss_pred ccc-CcccceEEEEEEEc---C---CcEEEEEEEeeccc---chhHHHHHHHHHHHhccCc---CchhhhhhhhccC---
Q 003772 517 EEL-GKGSFGAVYKGTLY---K---GEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHH---KNLVRLIGYCAED--- 580 (796)
Q Consensus 517 ~~L-G~G~fg~Vy~g~~~---~---~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h---~niv~l~g~~~~~--- 580 (796)
+.| +.|....+|+.... + +++.+++|+..... ......+..|+.+++.+.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 88889999988764 1 14578888764422 1012457888888888853 3466777776655
Q ss_pred CceeEEEeecCCCChhh
Q 003772 581 SKRLLVYEYMSNGSLAD 597 (796)
Q Consensus 581 ~~~~lV~e~~~~gsL~~ 597 (796)
+..++||||+++.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=5.8e-05 Score=82.55 Aligned_cols=75 Identities=16% Similarity=0.169 Sum_probs=48.0
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccc-------hhHHHHHHHHHHHhccCc--Cc-hhhhhhhhccCCceeEE
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-------EGEREFRAEMHVIGRTHH--KN-LVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-------~~~~~f~~E~~~l~~l~h--~n-iv~l~g~~~~~~~~~lV 586 (796)
+.||.|..+.||++....+++.++||....... .....+..|.+++..+.. +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 568999999999997765556899997643211 123456778888887742 33 3344433 34567899
Q ss_pred EeecCCC
Q 003772 587 YEYMSNG 593 (796)
Q Consensus 587 ~e~~~~g 593 (796)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00026 Score=75.37 Aligned_cols=139 Identities=14% Similarity=0.170 Sum_probs=79.4
Q ss_pred ccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcC--chhhhhhh------hccCCceeEEEee
Q 003772 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHK--NLVRLIGY------CAEDSKRLLVYEY 589 (796)
Q Consensus 518 ~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~--niv~l~g~------~~~~~~~~lV~e~ 589 (796)
.|+.|..+.||+....+ ..+++|+.... ...+..|..++..+... .+.+++.. ....+..++|+||
T Consensus 39 ~l~gG~~n~~~~v~~~~--~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDS--GAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp ECC----CEEEEEEETT--EEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eccccccCcEEEEEeCC--CCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 46667788999987643 35889988652 23344555555555321 23344431 1235567899999
Q ss_pred cCCCChh-----------h---hhhcC------CC------CCCchhHH-------------------------------
Q 003772 590 MSNGSLA-----------D---ILFRG------PE------RSLGWDER------------------------------- 612 (796)
Q Consensus 590 ~~~gsL~-----------~---~l~~~------~~------~~l~~~~~------------------------------- 612 (796)
+++.++. + .++.. .. ..-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 1 11110 00 00122111
Q ss_pred HHHHHHHHHHHHHhhc----------cCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 613 VRIASDVAKGILYLHD----------ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 613 ~~i~~~ia~aL~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
..+..++.+++.+|+. .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111234446666763 1245899999999999998888999999998854
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0006 Score=71.56 Aligned_cols=136 Identities=17% Similarity=0.160 Sum_probs=89.3
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC---cCchhhhhhhhccCCceeEEEeecCCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH---HKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
+.|+.|....+|+... ++..+++|+.... ....+..|+..|+.+. ...+++++.++...+..++||||+++.
T Consensus 42 ~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 4689999999999875 3457888887542 3566888998888884 256778888887778899999999987
Q ss_pred Chhh-----------hhhcCCC-C-------------------CCchhHHH---HHH----------------HHHHHHH
Q 003772 594 SLAD-----------ILFRGPE-R-------------------SLGWDERV---RIA----------------SDVAKGI 623 (796)
Q Consensus 594 sL~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~----------------~~ia~aL 623 (796)
.+.. .|+.... . .-+|.... ++. .++++.+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 1222111 0 11333221 111 1111111
Q ss_pred -HHhhc-cCCCCeeeeccCccceEecCCCceEEeccC
Q 003772 624 -LYLHD-ECEAPIIHCDIKPQNILMDEFWTAKISDFG 658 (796)
Q Consensus 624 -~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 658 (796)
..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 2356899999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0013 Score=72.35 Aligned_cols=80 Identities=10% Similarity=-0.018 Sum_probs=49.7
Q ss_pred CCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeeeeccCCCCCchhhhccC---CCCccccchhhHHHHHHH
Q 003772 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT---PISVKADVFSYGVVLLEI 707 (796)
Q Consensus 631 ~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvil~el 707 (796)
...++|+|++|.||+++.++ ++|+||+.+....+..........-...|.+|+..... .-....++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 34899999999999999876 99999999875432211110000011345666655321 112345666888888888
Q ss_pred hhcc
Q 003772 708 VCCR 711 (796)
Q Consensus 708 ltg~ 711 (796)
+.++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0014 Score=68.04 Aligned_cols=74 Identities=22% Similarity=0.260 Sum_probs=51.8
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcC---chhhhhhhhccCCceeEEEeecCCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHK---NLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~---niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
+.+|.|..+.||+.++.++ +.+.+|+-..........|..|+..|+.+.-. -+.++++. +..++||||++.+
T Consensus 21 ~~~g~G~~~~vyrv~l~DG-~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~ 95 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADG-TPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDER 95 (288)
T ss_dssp EEEEEETTEEEEEEEETTS-CEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCC
T ss_pred EecCCCCCeEEEEEEECCC-CEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeeccc
Confidence 4689999999999998765 67899986544333445688899988887422 23344433 2457899999876
Q ss_pred Ch
Q 003772 594 SL 595 (796)
Q Consensus 594 sL 595 (796)
..
T Consensus 96 ~~ 97 (288)
T 3f7w_A 96 PP 97 (288)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0023 Score=70.42 Aligned_cols=73 Identities=18% Similarity=0.200 Sum_probs=48.4
Q ss_pred cccCcccceEEEEEEEcC-------CcEEEEEEEeecccchhHHHHHHHHHHHhccCcCch-hhhhhhhccCCceeEEEe
Q 003772 517 EELGKGSFGAVYKGTLYK-------GEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNL-VRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~-------~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e 588 (796)
+.|+.|....+|+....+ .++.+.+|+.... .....+..|..++..+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 457888889999998753 2357888887431 111455679888888854444 456665443 28999
Q ss_pred ecCCCCh
Q 003772 589 YMSNGSL 595 (796)
Q Consensus 589 ~~~~gsL 595 (796)
|+++-+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986444
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0031 Score=65.80 Aligned_cols=70 Identities=11% Similarity=0.110 Sum_probs=42.6
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCch-hhhhhhhccCCceeEEEeec-CCCC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNL-VRLIGYCAEDSKRLLVYEYM-SNGS 594 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~-~~gs 594 (796)
+.|+.|....+|+. +.+++|+....... .....+|+.+++.+...++ .+++++ +.+..++|+||+ ++-+
T Consensus 24 ~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 24 LERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp EEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 56888999999998 24778887542211 1123567777777653333 344543 334467899999 5544
Q ss_pred h
Q 003772 595 L 595 (796)
Q Consensus 595 L 595 (796)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0056 Score=67.72 Aligned_cols=74 Identities=12% Similarity=0.068 Sum_probs=46.9
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCch-hhhhhhhccCCceeEEEeecCCCCh
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNL-VRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
+.|+.|-...+|+....+.+..+++|+....... .-....|..++..+...++ .++++++.. .+|+||+++-+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 4678888899999987653467888887442211 1112578888888865554 456666532 259999987554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0035 Score=65.99 Aligned_cols=142 Identities=14% Similarity=0.127 Sum_probs=79.0
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCc--hhhhhhhh------ccCCceeEEEe
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKN--LVRLIGYC------AEDSKRLLVYE 588 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lV~e 588 (796)
+.|+.|....+|+....++ .+++|+.... .....+..|+.++..+...+ +.+++... ...+..+++++
T Consensus 28 ~~i~~G~~n~~~~v~~~~g--~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD--PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEECC---EEEEEEEESSC--CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eccCCCcccceEEEEeCCc--cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 3467788889999887543 5788887652 12234566777777764323 23333221 12345689999
Q ss_pred ecCCCChhh--------------hhhcC----CCC-----C-CchhHHHH------------HHHHHHHHHHHhhcc---
Q 003772 589 YMSNGSLAD--------------ILFRG----PER-----S-LGWDERVR------------IASDVAKGILYLHDE--- 629 (796)
Q Consensus 589 ~~~~gsL~~--------------~l~~~----~~~-----~-l~~~~~~~------------i~~~ia~aL~~LH~~--- 629 (796)
|+++..+.. .++.. ... . ..|...+. +...+.+.+..++..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 998865421 01110 000 0 11222110 011234445555432
Q ss_pred -CCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 630 -CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 630 -~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
....++|+|+++.||+++++..+.|+||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 134789999999999999876668999998853
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0057 Score=65.88 Aligned_cols=141 Identities=15% Similarity=0.176 Sum_probs=81.4
Q ss_pred cccCcccceEEEEEEEcC-------CcEEEEEEEeecccchhHHHHHHHHHHHhccCcCch-hhhhhhhccCCceeEEEe
Q 003772 517 EELGKGSFGAVYKGTLYK-------GEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNL-VRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~-------~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e 588 (796)
+.|..|-...+|+....+ +++.+.+|+.... ......+.+|..+++.+.-.++ .++++++.++ +|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 356667778889988642 2357888886432 2234456689888888753333 4566665442 9999
Q ss_pred ecCCCChhhh-----------------hhcCC---CCCC--chhHHHHHHHHHHH-------------------HHHHhh
Q 003772 589 YMSNGSLADI-----------------LFRGP---ERSL--GWDERVRIASDVAK-------------------GILYLH 627 (796)
Q Consensus 589 ~~~~gsL~~~-----------------l~~~~---~~~l--~~~~~~~i~~~ia~-------------------aL~~LH 627 (796)
|+++.+|..- |+... .+.. -+.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665321 11110 1112 23444455444322 223332
Q ss_pred ----cc-CCCCeeeeccCccceEecCC----CceEEeccCCccc
Q 003772 628 ----DE-CEAPIIHCDIKPQNILMDEF----WTAKISDFGLAKL 662 (796)
Q Consensus 628 ----~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~DFgl~~~ 662 (796)
.. ....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 11 23468999999999999876 7899999999864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.07 E-value=0.04 Score=53.50 Aligned_cols=102 Identities=11% Similarity=0.020 Sum_probs=67.4
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
-||.++|... +.+++++++|.++.|.+++|.-+-.... . ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 4788988653 6789999999999999999887722100 1 1223457999999999988864 1111
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhccc
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRR 712 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~ 712 (796)
.....+.|||... ...+.+.=|||+|+++|.-+--..
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0123466888764 345788899999999999885443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.89 E-value=0.014 Score=62.81 Aligned_cols=74 Identities=14% Similarity=0.125 Sum_probs=43.0
Q ss_pred cccCcccceEEEEEEEcCC--------cEEEEEEEeecccchhHHHHHHHHHHHhccCcCch-hhhhhhhccCCceeEEE
Q 003772 517 EELGKGSFGAVYKGTLYKG--------EKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNL-VRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~--------~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~ 587 (796)
+.|+.|....+|+....++ ++.+++|+...... .......|..++..+...++ .++++.. .-.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 4577788889999886531 25788888754221 11134678888887754443 3555433 236899
Q ss_pred eecCCCCh
Q 003772 588 EYMSNGSL 595 (796)
Q Consensus 588 e~~~~gsL 595 (796)
||+++.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.68 E-value=0.029 Score=59.18 Aligned_cols=33 Identities=30% Similarity=0.274 Sum_probs=28.4
Q ss_pred CCCeeeeccCccceEecCC----CceEEeccCCcccc
Q 003772 631 EAPIIHCDIKPQNILMDEF----WTAKISDFGLAKLL 663 (796)
Q Consensus 631 ~~~ivH~Dlkp~NIll~~~----~~~kl~DFgl~~~~ 663 (796)
...++|+|+++.||+++.+ ..+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3479999999999999874 68999999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.53 E-value=0.041 Score=57.83 Aligned_cols=140 Identities=12% Similarity=0.077 Sum_probs=77.7
Q ss_pred ccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCc--hhhhhhh-----hccCCceeEEEeec
Q 003772 518 ELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKN--LVRLIGY-----CAEDSKRLLVYEYM 590 (796)
Q Consensus 518 ~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~n--iv~l~g~-----~~~~~~~~lV~e~~ 590 (796)
.++ |....||+....++ +.+++|+..... .....+..|..++..+.... +++++.. ...++..++++|++
T Consensus 33 ~l~-g~~n~~y~v~~~~g-~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDR-RRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEC-CSSSEEEEECCTTC-CCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred eec-CcccceEEEEcCCC-CEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 355 77789998776443 468899886321 12445677888877774322 3444443 11234557899999
Q ss_pred CCCChhh-----------h---hhc----CC---CCCCchhHH----HH---------------HHHHHHHHHHHhhcc-
Q 003772 591 SNGSLAD-----------I---LFR----GP---ERSLGWDER----VR---------------IASDVAKGILYLHDE- 629 (796)
Q Consensus 591 ~~gsL~~-----------~---l~~----~~---~~~l~~~~~----~~---------------i~~~ia~aL~~LH~~- 629 (796)
++.++.. . ++. .. ....++... .. +...+.+.+..+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8755421 1 111 00 011221110 00 011111222222211
Q ss_pred ---CCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 630 ---CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 630 ---~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.40 E-value=0.11 Score=55.06 Aligned_cols=32 Identities=25% Similarity=0.270 Sum_probs=28.4
Q ss_pred CCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 632 ~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
..++|+|+.+.||++++++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47999999999999998888999999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=89.24 E-value=0.73 Score=50.05 Aligned_cols=140 Identities=12% Similarity=0.179 Sum_probs=80.9
Q ss_pred cccCcccceEEEEEEEcCC-------cEEEEEEEeecccchhHHHHHHHHHHHhccCcCch-hhhhhhhccCCceeEEEe
Q 003772 517 EELGKGSFGAVYKGTLYKG-------EKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNL-VRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~-------~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e 588 (796)
+.+..|-...+|+.....+ ++.+++|+..... ...-...+|..+++.+...++ .++++.+ .-.+|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEE
Confidence 3567788889999887531 3568888864422 111223568887777753333 3444432 2378999
Q ss_pred ecCCCChhhh--------------h---hc----C---C---C-CCCchhHHHHHHHHH-------------------HH
Q 003772 589 YMSNGSLADI--------------L---FR----G---P---E-RSLGWDERVRIASDV-------------------AK 621 (796)
Q Consensus 589 ~~~~gsL~~~--------------l---~~----~---~---~-~~l~~~~~~~i~~~i-------------------a~ 621 (796)
|+++.+|..- | +. . . . ...-|.++..+..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 9998664210 0 10 0 0 1 111234433333222 12
Q ss_pred HHHHhhc---------------------cCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 622 GILYLHD---------------------ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 622 aL~~LH~---------------------~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
.+..|.. .....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2233321 11246889999999999 8888999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.63 E-value=0.6 Score=50.47 Aligned_cols=29 Identities=28% Similarity=0.358 Sum_probs=24.9
Q ss_pred eeeeccCccceEe------cCCCceEEeccCCccc
Q 003772 634 IIHCDIKPQNILM------DEFWTAKISDFGLAKL 662 (796)
Q Consensus 634 ivH~Dlkp~NIll------~~~~~~kl~DFgl~~~ 662 (796)
++|+|+.+.||++ +++..++++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5699999999999 4567799999999864
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=87.17 E-value=22 Score=35.62 Aligned_cols=73 Identities=16% Similarity=0.150 Sum_probs=46.7
Q ss_pred eEEEEEeecCCCCeEEEEeeCCCC--C----CCCCcEEEEecCCceEEEcCCCceeEeecCCC-CCceeEEEecCcCEEE
Q 003772 65 FKVGIWLLTFPDITIVWTAYRDDP--P----VSSNAALTLTKDGKLILRTEEGHDKVVAAGKS-EPASSASMLDSGNFVL 137 (796)
Q Consensus 65 ~~lgiw~~~~~~~t~VWvANr~~p--~----~~~~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~-~~~~~a~Lld~GNlVl 137 (796)
-.+.||= ....+++|...++.+ + ...++.+-++.++.+...|++|+.+|.-.... .....++.+.+||+++
T Consensus 15 ~~v~~~d--~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv 92 (276)
T 3no2_A 15 NKIAIIN--KDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALV 92 (276)
T ss_dssp SEEEEEE--TTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEE
T ss_pred CEEEEEE--CCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEE
Confidence 3566763 336789999987642 1 12344455566666777888899999876432 2334567788888877
Q ss_pred ee
Q 003772 138 YN 139 (796)
Q Consensus 138 ~~ 139 (796)
-+
T Consensus 93 ~~ 94 (276)
T 3no2_A 93 AW 94 (276)
T ss_dssp EE
T ss_pred Ee
Confidence 64
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=84.53 E-value=0.6 Score=37.45 Aligned_cols=35 Identities=23% Similarity=0.528 Sum_probs=30.1
Q ss_pred ccCCHHHHHHHhccCCcceeeecccccCCCCCceecccc
Q 003772 364 ASITKEECKESCLEDCECDVALYEESVDDKPSYCTKQKL 402 (796)
Q Consensus 364 ~~~s~~~C~~~Cl~nCsC~a~~y~~~~~~~~~~c~~~~~ 402 (796)
..+++++|++.|+.+=.|.+|.|+. ....|+.+.+
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN~----~s~~CflKs~ 62 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYNV----KSGLCYPKRG 62 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEET----TTTEEEEEES
T ss_pred cCCCHHHHHHHhhccCCCCeEEecc----CCCceEcccC
Confidence 4578999999999999999999974 6678998865
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 796 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-70 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-66 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-17 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-16 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 6e-17 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 3e-11 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 3e-15 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 2e-09 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 4e-13 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 5e-07 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 3e-04 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 4e-11 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-10 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 7e-10 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-05 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 1e-10 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 3e-08 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 4e-70
Identities = 74/271 (27%), Positives = 127/271 (46%), Gaps = 19/271 (7%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
+ E LG G FG V+ G G VAVK L++ + F AE +++ + H+ LVRL
Sbjct: 16 KLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
++ EYM NGSL D L L ++ + +A+ +A+G+ ++ +
Sbjct: 74 YAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV 693
IH D++ NIL+ + + KI+DFGLA+L+ ++ + + APE ++
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 694 KADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTL 753
K+DV+S+G++L EIV R + PE I + Y+ N
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-------------MVRPDNCP 236
Query: 754 ENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
E + ++ C ++ P RP+ + +LE
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 8e-68
Identities = 73/277 (26%), Positives = 128/277 (46%), Gaps = 23/277 (8%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKL--EKMVTEGEREFRAEMHVIGRTHHKNLV 571
+ +G GSFG VYKG + VAVK L + + F+ E+ V+ +T H N++
Sbjct: 11 TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
+GY + +V ++ SL L E + + IA A+G+ YLH +
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAK-- 123
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ-TRTFTLVRGTRGYMAPEWYK--- 687
IIH D+K NI + E T KI DFGLA + + F + G+ +MAPE +
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 688 NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747
P S ++DV+++G+VL E++ + + + ++I+ + D +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLS--------K 233
Query: 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
V N + M ++ C++ + RP ++ +E +
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 4e-66
Identities = 71/271 (26%), Positives = 129/271 (47%), Gaps = 19/271 (7%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
F +E+G G FG V+ G +K VA+K + + E +F E V+ + H LV+L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
G C E + LV+E+M +G L+D R + + + DV +G + EA
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEG---MAYLEEAC 121
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV 693
+IH D+ +N L+ E K+SDFG+ + ++ DQ + T + + +PE + + S
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 694 KADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTL 753
K+DV+S+GV++ E+ + + S E + I+ ++ + R +
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS------------- 228
Query: 754 ENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
++ +I C ++ P RP+ ++ L I
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 2e-65
Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 25/272 (9%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
+ + +GKG FG V G Y+G K VAVK ++ + F AE V+ + H NLV+L
Sbjct: 10 KLLQTIGKGEFGDVMLGD-YRGNK-VAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 65
Query: 574 IGYCAEDSKRL-LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
+G E+ L +V EYM+ GSL D L LG D ++ + DV + + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 122
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPIS 692
+H D+ +N+L+ E AK+SDFGL K Q + + APE + S
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFS 178
Query: 693 VKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752
K+DV+S+G++L EI R + + + YK +
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------------MDAPDGC 225
Query: 753 LENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ ++ C + A+RPS + LE I
Sbjct: 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 217 bits (553), Expect = 4e-65
Identities = 75/301 (24%), Positives = 133/301 (44%), Gaps = 36/301 (11%)
Query: 503 FSYNELKKATNRFKEE-----------LGKGSFGAVYKGTLY---KGEKLVAVKKLEKMV 548
F++ + +A F +E +G G FG V G L K E VA+K L+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 549 TEGE-REFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSL 607
TE + R+F +E ++G+ H N++ L G + + +++ E+M NGSL D R +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125
Query: 608 GWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667
+ V + +A G+ YL D +H D+ +NIL++ K+SDFGL++ L D
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 668 T----RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEE 723
+ + + + APE + + +DV+SYG+V+ E++ D + +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242
Query: 724 IVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783
I I Y+ + + ++ L C Q + RP +V L+
Sbjct: 243 INAIEQDYRLPPPMDCP-------------SALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
Query: 784 I 784
+
Sbjct: 290 M 290
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (549), Expect = 9e-65
Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 17/278 (6%)
Query: 507 ELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH 566
E+++ K +LG G +G VY+G K VAVK L++ E E EF E V+
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 71
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
H NLV+L+G C + ++ E+M+ G+L D L + + + +A+ ++ + YL
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
+ IH D+ +N L+ E K++DFGL++L+ D + + APE
Sbjct: 132 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 687 KNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746
S+K+DV+++GV+L EI + + L+ Y+
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------------M 235
Query: 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
E E + ++ C Q P+ RPS + E +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 2e-64
Identities = 74/278 (26%), Positives = 125/278 (44%), Gaps = 19/278 (6%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
R + +LG+G FG V+ GT G VA+K L+ T F E V+ + H+ LV+L
Sbjct: 20 RLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
+E+ +V EYMS GSL D L + L + V +A+ +A G+ Y+
Sbjct: 78 YAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV 693
+H D++ NIL+ E K++DFGLA+L+ ++ + + APE ++
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 694 KADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTL 753
K+DV+S+G++L E+ R E + + Y+
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-------------MPCPPECP 240
Query: 754 ENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPP 791
E++ + C + EP RP+ + + LE + P
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 2e-64
Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 19/271 (7%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
F +ELG G FG V G +G+ VA+K +++ + E EF E V+ H+ LV+L
Sbjct: 7 TFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
G C + ++ EYM+NG L + L R + + + DV + + YL +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ--- 120
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISV 693
+H D+ +N L+++ K+SDFGL++ ++ D+ + + + PE + S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 694 KADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTL 753
K+D++++GV++ EI + + E I + + +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS------------- 227
Query: 754 ENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
E + I C ++ RP+ K ++ + +
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 5e-62
Identities = 65/274 (23%), Positives = 121/274 (44%), Gaps = 15/274 (5%)
Query: 508 LKKATNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGR 564
++ + F+ ELG G+ G V+K + ++A K + + R E+ V+
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 565 THHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGIL 624
+ +V G D + + E+M GSL +L + + +++ V KG+
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLT 118
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
YL ++ I+H D+KP NIL++ K+ DFG++ L+ +F GTR YM+PE
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPE 173
Query: 685 WYKNTPISVKADVFSYGVVLLEIVCCRR-----NMEIDPSKPEEIVLINWAYKCFIDREL 739
+ T SV++D++S G+ L+E+ R + + V + A R
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 740 NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPS 773
+ + +D + ++ + V + P PS
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 1e-61
Identities = 74/297 (24%), Positives = 122/297 (41%), Gaps = 31/297 (10%)
Query: 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLI 574
+E +GKG FG V++G +GE+ VAVK E AE++ H+N++ I
Sbjct: 7 LQESIGKGRFGEVWRGKW-RGEE-VAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFI 63
Query: 575 GYCAED----SKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
+D ++ LV +Y +GSL D L R + + +++A A G+ +LH E
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEI 120
Query: 631 -----EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL---VRGTRGYMA 682
+ I H D+K +NIL+ + T I+D GLA GT+ YMA
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 683 PEWY------KNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKP---EEIVLINWAYKC 733
PE K+ +AD+++ G+V EI I ++V + + +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 734 FIDRELNKLVR----GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786
+ +R + L M KI C A R + + L ++
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 3e-61
Identities = 67/286 (23%), Positives = 114/286 (39%), Gaps = 26/286 (9%)
Query: 507 ELKKATNRFK---EELGKGSFGAVYKGTLY--KGEKLVAVKKLEKMVTEGERE-FRAEMH 560
+L + ELG G+FG+V +G K + VA+K L++ + + E E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 561 VIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVA 620
++ + + +VRLIG C + +LV E G L L G + + V+
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVS 119
Query: 621 KGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT--RTFTLVRGTR 678
G+ YL ++ +H D+ +N+L+ AKISDFGL+K L D + + +
Sbjct: 120 MGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 679 GYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE 738
+ APE S ++DV+SYGV + E + + PE + I +
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------ 230
Query: 739 LNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
E + + C + RP +V +
Sbjct: 231 -------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 4e-61
Identities = 68/279 (24%), Positives = 120/279 (43%), Gaps = 25/279 (8%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEK---LVAVKKLEKMVTEGE-REFRAEMHVIGRTHHKN 569
F E +G+G FG VY GTL + AVK L ++ GE +F E ++ H N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 570 LVRLIGYCAE-DSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
++ L+G C + L+V YM +G L + R + + + VAKG +
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKG---MKF 145
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ---TRTFTLVRGTRGYMAPEW 685
+H D+ +N ++DE +T K++DFGLA+ + + T + +MA E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 686 YKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745
+ + K+DV+S+GV+L E++ D + + V + +
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP----- 260
Query: 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ + ++ L C + +RPS +V + I
Sbjct: 261 --------DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 6e-61
Identities = 70/272 (25%), Positives = 115/272 (42%), Gaps = 26/272 (9%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKL--EKMVTEGEREFRAEMHVIGRTHHKNLV 571
+F E+G+GSF VYKG + VA +L K+ + F+ E ++ H N+V
Sbjct: 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71
Query: 572 RLIGYCAEDSKR----LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLH 627
R K +LV E M++G+L L R + + + KG+ +LH
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH 129
Query: 628 DECEAPIIHCDIKPQNILM-DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
PIIH D+K NI + + KI D GLA L + V GT +MAPE Y
Sbjct: 130 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMY 185
Query: 687 KNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746
+ DV+++G+ +LE+ + + I R + V+
Sbjct: 186 EE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------------IYRRVTSGVKPA 232
Query: 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVV 778
D+ + + +I C++ R S+K ++
Sbjct: 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 2e-60
Identities = 79/299 (26%), Positives = 120/299 (40%), Gaps = 39/299 (13%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEK-----LVAVKKLEKMVTEGERE-FRAEMHVIGR-TH 566
F + LG G+FG V + T Y K VAVK L+ ERE +E+ V+ +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFR----------------GPERSLGWD 610
H N+V L+G C L++ EY G L + L R E +L +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 611 ERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670
+ + + VAKG+ +L IH D+ +NIL+ KI DFGLA+ + D
Sbjct: 146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 671 F-TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW 729
R +MAPE N + ++DV+SYG+ L E+ + + +
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM-- 260
Query: 730 AYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDIS 788
I L + M I C +P RP+ K +V ++E S
Sbjct: 261 -----IKEGFRML-----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-59
Identities = 74/281 (26%), Positives = 131/281 (46%), Gaps = 26/281 (9%)
Query: 513 NRFKEE--LGKGSFGAVYKGTL----YKGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRT 565
+ + +G G FG VYKG L K E VA+K L+ TE +R +F E ++G+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 566 HHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILY 625
H N++RL G ++ +++ EYM NG+L R + + V + +A G+ Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 626 LHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLV--RGTRGYMAP 683
L + +H D+ +NIL++ K+SDFGL+++L D T+T + + AP
Sbjct: 126 LANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 684 EWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743
E + +DV+S+G+V+ E++ + S E + IN ++
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR----------- 231
Query: 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ + ++ + C Q E A RP +V +L+ +
Sbjct: 232 --LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 3e-59
Identities = 71/271 (26%), Positives = 111/271 (40%), Gaps = 25/271 (9%)
Query: 518 ELGKGSFGAVYKGTLYKGE--KLVAVKKLEKMVTEGE--REFRAEMHVIGRTHHKNLVRL 573
ELG G+FG V KG + K VAVK L+ + E AE +V+ + + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
IG C E +LV E G L L + R + + + V+ G+ YL +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN--- 127
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT--RTFTLVRGTRGYMAPEWYKNTPI 691
+H D+ +N+L+ AKISDFGL+K L D+ + T + + APE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 692 SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751
S K+DV+S+GV++ E + E ++ +
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-------------MGCPAG 234
Query: 752 TLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
M + C + RP +V L L
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 4e-59
Identities = 77/316 (24%), Positives = 125/316 (39%), Gaps = 47/316 (14%)
Query: 499 NLRSFSYN---ELKKATNRFKEELGKGSFGAVYKGTLYKGEKL-----VAVKKLEKMVTE 550
+ R + Y+ E + F + LG G+FG V T Y K VAVK L++
Sbjct: 22 DFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS 81
Query: 551 GERE-FRAEMHVIGR-THHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPER--- 605
ERE +E+ ++ + H+N+V L+G C L++EY G L + L E+
Sbjct: 82 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 141
Query: 606 ------------------SLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD 647
L +++ + A VAKG+ +L +H D+ +N+L+
Sbjct: 142 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVT 198
Query: 648 EFWTAKISDFGLAKLLMPDQTRTF-TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLE 706
KI DFGLA+ +M D R +MAPE ++K+DV+SYG++L E
Sbjct: 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258
Query: 707 IVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQD 766
I N + + + + E + I C
Sbjct: 259 IFSLGVNPYPGIPVDANFYKL-----------IQNGFKM-DQPFYATEEIYIIMQSCWAF 306
Query: 767 EPALRPSMKSVVLMLE 782
+ RPS ++ L
Sbjct: 307 DSRKRPSFPNLTSFLG 322
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (506), Expect = 1e-58
Identities = 74/314 (23%), Positives = 129/314 (41%), Gaps = 51/314 (16%)
Query: 504 SYNELKKATNRFK--EELGKGSFGAVYKGTL-----YKGEKLVAVKKLEKMVTEGER-EF 555
L+ N + ++G+G+FG V++ Y+ +VAVK L++ + + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 556 RAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERS--------- 606
+ E ++ + N+V+L+G CA L++EYM+ G L + L +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 607 -------------LGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAK 653
L E++ IA VA G+ YL E +H D+ +N L+ E K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 180
Query: 654 ISDFGLAKLLMP-DQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRR 712
I+DFGL++ + D + +M PE + ++DV++YGVVL EI
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 713 NMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ--EVDRNTLENMIKIGLWCVQDEPAL 770
+ EE+ + + G N + + C PA
Sbjct: 241 QPYYGMA-HEEV--------------IYYVRDGNILACPENCPLELYNLMRLCWSKLPAD 285
Query: 771 RPSMKSVVLMLEGI 784
RPS S+ +L+ +
Sbjct: 286 RPSFCSIHRILQRM 299
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-58
Identities = 76/305 (24%), Positives = 137/305 (44%), Gaps = 41/305 (13%)
Query: 498 SNLRSFSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKL--VAVKKLEKMVT-EGERE 554
+ +N++K F++ +G+G+FG V K + K A+K++++ + + R+
Sbjct: 2 TIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 555 FRAEMHVIGR-THHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFR------------ 601
F E+ V+ + HH N++ L+G C L EY +G+L D L +
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 602 --GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGL 659
+L + + A+DVA+G+ YL + IH D+ +NIL+ E + AKI+DFGL
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL 173
Query: 660 AKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPS 719
++ +T R +MA E + + +DV+SYGV+L EIV +
Sbjct: 174 SRGQEVYVKKTM--GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231
Query: 720 KPEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779
E + Y+ E N + + + C +++P RPS +++
Sbjct: 232 CAELYEKLPQGYR-------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 278
Query: 780 MLEGI 784
L +
Sbjct: 279 SLNRM 283
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 1e-57
Identities = 58/275 (21%), Positives = 115/275 (41%), Gaps = 27/275 (9%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHKNLV 571
+G GS+G K K++ K+L+ M ++ +E++++ H N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 572 RLIGYCAEDSKRLL--VYEYMSNGSLADILFRGPER--SLGWDERVRIASDVAKGILYLH 627
R + + L V EY G LA ++ +G + L + +R+ + + + H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 628 D--ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEW 685
+ ++H D+KP N+ +D K+ DFGLA++L D + GT YM+PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQ 185
Query: 686 YKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745
+ K+D++S G +L E+ +E+ K+ G
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--QKEL--------------AGKIREG 229
Query: 746 Q--EVDRNTLENMIKIGLWCVQDEPALRPSMKSVV 778
+ + + + +I + + RPS++ ++
Sbjct: 230 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-57
Identities = 56/275 (20%), Positives = 104/275 (37%), Gaps = 22/275 (8%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEK---LVAVKKLEKMVTEGERE-FRAEMHVIGRTHHKN 569
+G+G FG V++G E VA+K + ++ RE F E + + H +
Sbjct: 10 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
+V+LIG ++ ++ E + G L L + SL + A ++ + YL
Sbjct: 70 IVKLIGVI-TENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLE-- 125
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT 689
+H DI +N+L+ K+ DFGL++ + + + +MAPE
Sbjct: 126 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 690 PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749
+ +DV+ +GV + EI+ + I I + +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP--------- 235
Query: 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
+ + C +P+ RP + L I
Sbjct: 236 ----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-57
Identities = 63/270 (23%), Positives = 112/270 (41%), Gaps = 30/270 (11%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG---EREFRAEMHVIGRTHHKNL 570
LGKG FG VY + + ++A+K L K E E + R E+ + H N+
Sbjct: 9 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
+RL GY + ++ L+ EY G++ L + +++A + Y H
Sbjct: 69 LRLYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCH--- 123
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
+IH DIKP+N+L+ KI+DFG + + T GT Y+ PE +
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMIEGRM 180
Query: 691 ISVKADVFSYGVVLLEIVCCRRNMEIDPSKP--EEIVLINWAYKCFIDRELNKLVRGQEV 748
K D++S GV+ E + + E + + + I + + + F+ L+
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS---- 236
Query: 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVV 778
++ P+ RP ++ V+
Sbjct: 237 -------------RLLKHNPSQRPMLREVL 253
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-56
Identities = 64/283 (22%), Positives = 115/283 (40%), Gaps = 27/283 (9%)
Query: 505 YNELKKATN-----RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEM 559
Y + + N ELG G+FG VYK + L A K ++ E ++ E+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 560 HVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDV 619
++ H N+V+L+ ++ ++ E+ + G++ ++ ER L + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQT 119
Query: 620 AKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRG 679
+ YLH + IIH D+K NIL K++DFG++ R + + GT
Sbjct: 120 LDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPY 175
Query: 680 YMAPEW-----YKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF 734
+MAPE K+ P KADV+S G+ L+E+ P + +
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP-----PHHELNPMRV---LLKI 227
Query: 735 IDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777
E L + N ++ +K C++ R + +
Sbjct: 228 AKSEPPTLAQPSRWSSN-FKDFLK---KCLEKNVDARWTTSQL 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (491), Expect = 3e-56
Identities = 59/268 (22%), Positives = 103/268 (38%), Gaps = 29/268 (10%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE---REFRAEMHVIGRTHHKNLVRL 573
E+G GSFGAVY + ++VA+KK+ + ++ E+ + + H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
G + LV EY + + ++ L E + +G+ YLH
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 634 IIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY---KNTP 690
+IH D+K NIL+ E K+ DFG A ++ P + GT +MAPE
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAMDEGQ 190
Query: 691 ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750
K DV+S G+ +E+ + + + + +
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS---------- 240
Query: 751 NTLENMIKIGLWCVQDEPALRPSMKSVV 778
E C+Q P RP+ + ++
Sbjct: 241 ---EYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 6e-55
Identities = 66/267 (24%), Positives = 115/267 (43%), Gaps = 20/267 (7%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK-MVTEGEREFRAEMHVIGRTHHKNLVR 572
+ LG+G++G V E+ VAVK ++ + + E+ + +H+N+V+
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
G+ E + + L EY S G L D + + + + R + G++YLH
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD-QTRTFTLVRGTRGYMAPEWYKNTPI 691
I H DIKP+N+L+DE KISDFGLA + + + R + GT Y+APE K
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 692 -SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750
+ DV+S G+VL ++ D +W K K+
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTYLNPWKKI-------D 233
Query: 751 NTLENMIKIGLWCVQDEPALRPSMKSV 777
+ ++ + + P+ R ++ +
Sbjct: 234 SAPLALLH---KILVENPSARITIPDI 257
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 6e-55
Identities = 72/277 (25%), Positives = 116/277 (41%), Gaps = 25/277 (9%)
Query: 514 RFKEELGKGSFGAVYKGTLYKG---EKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHH 567
R E+LG GSFG V +G VAVK L+ V E +F E++ + H
Sbjct: 11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 70
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLH 627
+NL+RL G +V E GSL D L + + R A VA+G+ YL
Sbjct: 71 RNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 628 DECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF--TLVRGTRGYMAPEW 685
+ IH D+ +N+L+ KI DFGL + L + + + APE
Sbjct: 129 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 686 YKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745
K S +D + +GV L E+ + I + + + ID+E +L R
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK--------IDKEGERLPRP 237
Query: 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
++ +++ + + C +P RP+ ++ L
Sbjct: 238 EDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-54
Identities = 56/269 (20%), Positives = 117/269 (43%), Gaps = 23/269 (8%)
Query: 512 TNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKN 569
++ E++G+G+ G VY + VA++++ + E+ V+ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
+V + + +V EY++ GSL D++ + + + + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLH-- 133
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT 689
+IH DIK NIL+ + K++DFG + P+Q++ T+V GT +MAPE
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191
Query: 690 PISVKADVFSYGVVLLEIVCCRR-NMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748
K D++S G++ +E++ + +P + ++ N + +L+ + R
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR---- 247
Query: 749 DRNTLENMIKIGLWCVQDEPALRPSMKSV 777
+ + C+ + R S K +
Sbjct: 248 ------DFLN---RCLDMDVEKRGSAKEL 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-52
Identities = 68/288 (23%), Positives = 123/288 (42%), Gaps = 31/288 (10%)
Query: 514 RFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVTEGER-EFRAEMHVIGRTHH 567
ELG+GSFG VY+G + E VA+K + + + ER EF E V+ +
Sbjct: 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADILF--------RGPERSLGWDERVRIASDV 619
++VRL+G ++ L++ E M+ G L L + +++A ++
Sbjct: 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142
Query: 620 AKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP-DQTRTFTLVRGTR 678
A G+ YL+ +H D+ +N ++ E +T KI DFG+ + + D R
Sbjct: 143 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 679 GYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE 738
+M+PE K+ + +DV+S+GVVL EI S + + +
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL------ 253
Query: 739 LNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786
+ N + + ++ C Q P +RPS ++ ++ +
Sbjct: 254 -------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 4e-52
Identities = 65/277 (23%), Positives = 121/277 (43%), Gaps = 24/277 (8%)
Query: 514 RFKEELGKGSFGAVYKGT-LYKGEKL---VAVKKLEKMVT-EGEREFRAEMHVIGRTHHK 568
+ + LG G+FG VYKG + +GEK+ VA+K+L + + + +E E +V+ +
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71
Query: 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
++ RL+G C S L+ + M G L D + + G + +AKG+ YL D
Sbjct: 72 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLED 129
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYK 687
++H D+ +N+L+ KI+DFGLAKLL ++ + +MA E
Sbjct: 130 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 688 NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747
+ + ++DV+SYGV + E++ E ++ +
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT------- 239
Query: 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
++ I + C + RP + +++ +
Sbjct: 240 ------IDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 4e-52
Identities = 77/299 (25%), Positives = 126/299 (42%), Gaps = 40/299 (13%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEK-------LVAVKKLEKMVTEGE-REFRAEMHVIGR- 564
+ LG+G+FG V +K VAVK L+ TE + + +EM ++
Sbjct: 16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 75
Query: 565 THHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILF--------------RGPERSLGWD 610
HKN++ L+G C +D ++ EY S G+L + L PE L
Sbjct: 76 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135
Query: 611 ERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670
+ V A VA+G+ YL IH D+ +N+L+ E KI+DFGLA+ +
Sbjct: 136 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 671 FTLV-RGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINW 729
T R +MAPE + + ++DV+S+GV+L EI + E L+
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252
Query: 730 AYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDIS 788
++ + N + + C P+ RP+ K +V L+ I ++
Sbjct: 253 GHR-------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-52
Identities = 77/294 (26%), Positives = 127/294 (43%), Gaps = 38/294 (12%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGE-----KLVAVKKLEKMVTEGE-REFRAEMHVIGRT-H 566
+ + LG+G+FG V + + + + VAVK L++ T E R +E+ ++ H
Sbjct: 16 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 75
Query: 567 HKNLVRLIGYCAEDSKRL-LVYEYMSNGSLADILFR--------------GPERSLGWDE 611
H N+V L+G C + L ++ E+ G+L+ L + L +
Sbjct: 76 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 612 RVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671
+ + VAKG+ +L IH D+ +NIL+ E KI DFGLA+ + D
Sbjct: 136 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 672 -TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA 730
R +MAPE + ++++DV+S+GV+L EI + EE
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC----- 247
Query: 731 YKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784
R L + R + D T M + L C EP+ RP+ +V L +
Sbjct: 248 ------RRLKEGTRMRAPD-YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (448), Expect = 9e-50
Identities = 61/266 (22%), Positives = 109/266 (40%), Gaps = 19/266 (7%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
EELG G+FG V++ T A K + + R E+ + H LV L
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
+D++ +++YE+MS G L + + + + DE V V KG+ ++H+
Sbjct: 89 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN--- 144
Query: 634 IIHCDIKPQNILM--DEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
+H D+KP+NI+ K+ DFGL L P Q+ T GT + APE + P+
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPV 202
Query: 692 SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751
D++S GV+ ++ + E + + D + +
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMDDSAFSGI-------SE 254
Query: 752 TLENMIKIGLWCVQDEPALRPSMKSV 777
++ I+ + +P R ++
Sbjct: 255 DGKDFIR---KLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 3e-49
Identities = 62/275 (22%), Positives = 106/275 (38%), Gaps = 30/275 (10%)
Query: 509 KKATNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE---REFRAEMHVIG 563
KK FK + LG+GSF V + A+K LEK E E V+
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 564 RTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGI 623
R H V+L +D K Y NG L + + S +++ +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSAL 121
Query: 624 LYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF-TLVRGTRGYMA 682
YLH + IIH D+KP+NIL++E +I+DFG AK+L P+ + GT Y++
Sbjct: 122 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 683 PEWYKNTPISVKADVFSYGVVLLEIVCCRR--NMEIDPSKPEEIVLINWAYKCFIDRELN 740
PE +D+++ G ++ ++V + ++I+ + + + +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 238
Query: 741 KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMK 775
LV + + R +
Sbjct: 239 DLVE-----------------KLLVLDATKRLGCE 256
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (438), Expect = 2e-48
Identities = 59/266 (22%), Positives = 110/266 (41%), Gaps = 19/266 (7%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
EELG G+FG V++ ++ K + + + E+ ++ + HH L+ L
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 91
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
+ + +L+ E++S G L D + + + E + +G+ ++H E
Sbjct: 92 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMH---EHS 147
Query: 634 IIHCDIKPQNILMDEF--WTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
I+H DIKP+NI+ + + KI DFGLA L PD+ T T + APE P+
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPV 205
Query: 692 SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751
D+++ GV+ ++ E + + F + + +
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKRCDWEFDEDAFSSV-------SP 257
Query: 752 TLENMIKIGLWCVQDEPALRPSMKSV 777
++ IK +Q EP R ++
Sbjct: 258 EAKDFIK---NLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 1e-46
Identities = 61/276 (22%), Positives = 108/276 (39%), Gaps = 18/276 (6%)
Query: 505 YNELKKATNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHV 561
+ + + + + + LG G+F V + +KLVA+K + K EG+ E+ V
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 562 IGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAK 621
+ + H N+V L L+ + +S G L D + + + R+ V
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLD 118
Query: 622 GILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYM 681
+ YLHD +DE ISDFGL+K+ P + GT GY+
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--ACGTPGYV 176
Query: 682 APEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741
APE P S D +S GV+ ++C D + + I A F +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKLFEQILKAEYEFDSPYWDD 235
Query: 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777
+ ++ ++ I+ ++ +P R + +
Sbjct: 236 I-------SDSAKDFIR---HLMEKDPEKRFTCEQA 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-46
Identities = 63/272 (23%), Positives = 107/272 (39%), Gaps = 29/272 (10%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE---FRAEMHVIGRT-HHKN 569
+ LGKGSFG V+ K + A+K L+K V + + E V+ H
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 570 LVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDE 629
L + V EY++ G L + A+++ G+ +LH +
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK 122
Query: 630 CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNT 689
I++ D+K NIL+D+ KI+DFG+ K M +T T GT Y+APE
Sbjct: 123 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178
Query: 690 PISVKADVFSYGVVLLEIVCCRRNMEIDPSKP--EEIVLINWAYKCFIDRELNKLVRGQE 747
+ D +S+GV+L E++ + + I + N Y ++++E L+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK-- 236
Query: 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779
EP R ++ +
Sbjct: 237 ---------------LFVREPEKRLGVRGDIR 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (411), Expect = 1e-45
Identities = 55/273 (20%), Positives = 105/273 (38%), Gaps = 27/273 (9%)
Query: 512 TNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGE---REFRAEMHVIGRTH 566
++R++ E LG G V+ + + VAVK L + FR E +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 567 HKNLVRLIGYCAEDSKRL----LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKG 622
H +V + ++ +V EY+ +L DI+ E + + + +D +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQA 123
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR--TFTLVRGTRGY 680
+ + + IIH D+KP NI++ K+ DFG+A+ + V GT Y
Sbjct: 124 LNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 681 MAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740
++PE + + ++DV+S G VL E++ D P + + +
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--PVSVAYQHVREDPIPPSARH 238
Query: 741 KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPS 773
+ + L+ ++ + P R
Sbjct: 239 EGLSAD------LDAVVL---KALAKNPENRYQ 262
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-45
Identities = 52/266 (19%), Positives = 106/266 (39%), Gaps = 20/266 (7%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
E+LG+G FG V++ +K K ++ T+ + + E+ ++ H+N++ L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHL 66
Query: 574 IGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAP 633
+ ++++E++S + + + L E V V + + +LH
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLH---SHN 122
Query: 634 IIHCDIKPQNILMD--EFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPI 691
I H DI+P+NI+ T KI +FG A+ L F L+ Y APE +++ +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 692 SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751
S D++S G ++ ++ + + I I A F + ++
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFL-AETNQQIIENIMNAEYTFDEEAFKEI-------SI 232
Query: 752 TLENMIKIGLWCVQDEPALRPSMKSV 777
+ + + E R +
Sbjct: 233 EAMDFVD---RLLVKERKSRMTASEA 255
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 161 bits (409), Expect = 2e-44
Identities = 58/269 (21%), Positives = 103/269 (38%), Gaps = 29/269 (10%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK---MVTEGEREFRAE---MHVIGRTHH 567
+G+G FG VY K+ A+K L+K + +GE E + ++
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLH 627
+V + K + + M+ G L L + S + A+++ G+ ++H
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAEIILGLEHMH 124
Query: 628 DECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY- 686
+ +++ D+KP NIL+DE +ISD GLA + GT GYMAPE
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQ 178
Query: 687 KNTPISVKADVFSYGVVLLEIVCCRRNME-IDPSKPEEIVLINWAYKCFIDRELNKLVRG 745
K AD FS G +L +++ EI + + + +R
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR- 237
Query: 746 QEVDRNTLENMIKIGLWCVQDEPALRPSM 774
++++ +Q + R
Sbjct: 238 ---------SLLE---GLLQRDVNRRLGC 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (402), Expect = 2e-44
Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 34/280 (12%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEK---------MVTEGEREFRAEMHVIGR 564
KE LG+G V + K AVK ++ V E E+ ++ +
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 565 TH-HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGI 623
H N+++L ++ LV++ M G L D L + +L E +I + + I
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVI 123
Query: 624 LYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAP 683
LH + I+H D+KP+NIL+D+ K++DFG + L P + V GT Y+AP
Sbjct: 124 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPSYLAP 178
Query: 684 EWY------KNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDR 737
E + + D++S GV++ ++ + + +I F
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSGNYQFGSP 237
Query: 738 ELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777
E + +T+++++ + +P R + +
Sbjct: 238 EWDDY-------SDTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-44
Identities = 57/275 (20%), Positives = 104/275 (37%), Gaps = 35/275 (12%)
Query: 516 KEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIG 575
+ LG G G V + + ++ A+K L+ + RE ++VR++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRAS---QCPHIVRIVD 72
Query: 576 YC----AEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
A L+V E + G L + +++ E I + + I YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN- 131
Query: 632 APIIHCDIKPQNILMDEFW---TAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN 688
I H D+KP+N+L K++DFG AK + T T Y+APE
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGP 187
Query: 689 TPISVKADVFSYGVVLLEIVCCRR------NMEIDPSKPEEIVLINWAYKCFIDRELNKL 742
D++S GV++ ++C + I P I + + + E+++
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247
Query: 743 VRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777
V+ +I+ ++ EP R ++
Sbjct: 248 VK----------MLIR---NLLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 8e-44
Identities = 65/287 (22%), Positives = 109/287 (37%), Gaps = 39/287 (13%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE------FRAEMHVIGR--T 565
+ LG G FG+VY G VA+K +EK E E+ ++ + +
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 566 HHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILY 625
++RL+ + +L+ E +L + V + + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRH 125
Query: 626 LHDECEAPIIHCDIKPQNILMD-EFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE 684
++H DIK +NIL+D K+ DFG LL F GTR Y PE
Sbjct: 126 C---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPE 179
Query: 685 WYKNTP-ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743
W + A V+S G++L ++VC E D EEI+ ++ + E L+
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EEIIRGQVFFRQRVSSECQHLI 235
Query: 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIP 790
R WC+ P+ RP+ + + + D+ +P
Sbjct: 236 R-----------------WCLALRPSDRPTFEE-IQNHPWMQDVLLP 264
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (394), Expect = 5e-43
Identities = 54/281 (19%), Positives = 93/281 (33%), Gaps = 24/281 (8%)
Query: 513 NRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNL 570
NR++ ++G GSFG +Y GT + VA+K + E +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
+ I +C + ++ + SL D LF R + +A + I Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIH--- 120
Query: 631 EAPIIHCDIKPQNILM---DEFWTAKISDFGLAKLLMPDQTRTF------TLVRGTRGYM 681
IH D+KP N LM + I DFGLAK +T + GT Y
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 682 APEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741
+ + S + D+ S G VL+ + + + + K
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI--- 237
Query: 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
+ + + +C +P + +
Sbjct: 238 ----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 9e-43
Identities = 60/280 (21%), Positives = 104/280 (37%), Gaps = 25/280 (8%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEK-----MVTEGEREFRAEMHVIGRTHHKNLV 571
+ LG+G F VYK ++VA+KK++ R E+ ++ H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
L+ S LV+++M I L +G+ YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN-TP 690
I+H D+KP N+L+DE K++DFGLAK +T TR Y APE
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARM 177
Query: 691 ISVKADVFSYGVVLLEIVC-------------CRRNMEIDPSKPEEIVLINWAYKCFIDR 737
V D+++ G +L E++ R E + EE + ++
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 738 ELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777
+ + + ++++ + P R +
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-42
Identities = 58/292 (19%), Positives = 111/292 (38%), Gaps = 32/292 (10%)
Query: 512 TNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE-FRAEMHVIGRTHHK 568
R+ +G+G++G V + VA+KK+ + + E+ ++ R H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 569 NLVRLIGYCAEDS----KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGIL 624
N++ + + K + + ++ L +L L D + +G+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLK 123
Query: 625 YLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR--TFTLVRGTRGYMA 682
Y+H A ++H D+KP N+L++ KI DFGLA++ PD T TR Y A
Sbjct: 124 YIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 683 PE-WYKNTPISVKADVFSYGVVLLEIVCCR-------------RNMEIDPSKPEEI---V 725
PE + + D++S G +L E++ R + I S +E +
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 726 LINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777
+ A + V + N + + + P R ++
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 5e-42
Identities = 61/274 (22%), Positives = 109/274 (39%), Gaps = 28/274 (10%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGER------EFRAEMHVIGRTHH 567
EELG G F V K A K ++K T+ R + E+ ++ H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 568 KNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLH 627
N++ L + +L+ E ++ G L D L SL +E + G ++
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNG---VY 127
Query: 628 DECEAPIIHCDIKPQNILMDEFWTA----KISDFGLAKLLMPDQTRTFTLVRGTRGYMAP 683
I H D+KP+NI++ + KI DFGLA + D F + GT ++AP
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAP 185
Query: 684 EWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743
E P+ ++AD++S GV+ ++ +K E + ++ F D +
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNYEFEDEYFSNT- 243
Query: 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777
++ I+ + +P R +++
Sbjct: 244 ------SALAKDFIR---RLLVKDPKKRMTIQDS 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (387), Expect = 6e-42
Identities = 54/237 (22%), Positives = 101/237 (42%), Gaps = 14/237 (5%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNL 570
+ LG GSFG V+ + A+K L+K + + E ++ H +
Sbjct: 7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
+R+ G + + ++ +Y+ G L +L + A++V L L
Sbjct: 67 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP--NPVAKFYAAEVC---LALEYLH 121
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
II+ D+KP+NIL+D+ KI+DFG AK + + GT Y+APE P
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGTPDYIAPEVVSTKP 177
Query: 691 ISVKADVFSYGVVLLEIVCCRRNMEIDPSKP--EEIVLINWAYKCFIDRELNKLVRG 745
+ D +S+G+++ E++ + E+I+ + F + ++ L+
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 234
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-40
Identities = 65/293 (22%), Positives = 118/293 (40%), Gaps = 31/293 (10%)
Query: 510 KATNRFK--EELGKGSFGAVYKGTLYK-GEKLVAVKKLEKMVTEGEREFR-----AEMHV 561
+A +++ E+G+G++G V+K K G + VA+K++ E A +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 562 IGRTHHKNLVRLIGYCAEDSKRLLVYEYM----SNGSLADILFRGPERSLGWDERVRIAS 617
+ H N+VRL C + + L L + PE + + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 618 DVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGT 677
+ +G+ +LH ++H D+KPQNIL+ K++DFGLA++ T V T
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVT 178
Query: 678 RGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLI---------- 727
Y APE + + D++S G + E+ + S +++ I
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR-GSSDVDQLGKILDVIGLPGEE 237
Query: 728 NWAYKCFIDRELNKLVRGQEVDR---NTLENMIKIGLWCVQDEPALRPSMKSV 777
+W + R+ Q +++ + E + L C+ PA R S S
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 148 bits (374), Expect = 2e-40
Identities = 46/281 (16%), Positives = 90/281 (32%), Gaps = 26/281 (9%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGR-THHKNLVR 572
+ +G+GSFG +++GT + VA+K + + R E +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPN 65
Query: 573 LIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEA 632
+ + E +LV + + G + L R A + + +H E
Sbjct: 66 VYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EK 120
Query: 633 PIIHCDIKPQNILMDEFWT-----AKISDFGLAKLLMPDQTRTF------TLVRGTRGYM 681
+++ DIKP N L+ + + DFG+ K T+ + GT YM
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 682 APEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741
+ + S + D+ + G V + + + + K E +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-------TNKQKYERIGEKKQ 233
Query: 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782
+E+ E K + P + +
Sbjct: 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 4e-40
Identities = 60/281 (21%), Positives = 112/281 (39%), Gaps = 22/281 (7%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKL--EKMVTEGEREFRAEMHVIGRTHHKNLV 571
+ E++G+G++G VYK ++VA+KK+ + E+ ++ +H N+V
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 572 RLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECE 631
+L+ ++K LV+E++ + L + + + +G+ + H
Sbjct: 65 KLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 632 APIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP- 690
++H D+KPQN+L++ K++DFGLA+ V T Y APE
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGCKY 179
Query: 691 ISVKADVFSYGVVLLEIVCCR------------RNMEIDPSKPEEIVLINWAYKCFIDRE 738
S D++S G + E+V R + P+E+V
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 739 LNKLVRG--QEVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777
K R +V E+ + + +P R S K+
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 145 bits (367), Expect = 2e-39
Identities = 56/283 (19%), Positives = 108/283 (38%), Gaps = 24/283 (8%)
Query: 513 NRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKL--EKMVTEGEREFRAEMHVIGRTHHK 568
++ E++G+G++G VYK GE A+KK+ EK E+ ++ H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
N+V+L + +LV+E++ + E L + GI Y H
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCH- 117
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN 688
+ ++H D+KPQN+L++ KI+DFGLA+ + + +
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 689 TPISVKADVFSYGVVLLEIVCCR-------------RNMEIDPSKPEEIVL-INWAYKCF 734
S D++S G + E+V R I + + + K
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 735 IDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777
+ + + + + + E+ I + ++ +P R + K
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-39
Identities = 63/297 (21%), Positives = 110/297 (37%), Gaps = 38/297 (12%)
Query: 503 FSYNELKKATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVI 562
SY + K +G GSFG VY+ L +LVA+KK+ + +R E+ ++
Sbjct: 20 VSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIM 67
Query: 563 GRTHHKNLVRLIGYCAEDSKR------LLVYEYMSNGSLADILFRG-PERSLGWDERVRI 615
+ H N+VRL + ++ LV +Y+ +++L
Sbjct: 68 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 616 ASDVAKGILYLHDECEAPIIHCDIKPQNI-LMDEFWTAKISDFGLAKLLMPDQTRTFTLV 674
+ + + Y+H I H DIKPQN+ L + K+ DFG AK L+ + + +
Sbjct: 128 MYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYI 183
Query: 675 RGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEID--------------PSK 720
+ T + DV+S G VL E++ + D
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 721 PEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777
E+I +N Y F ++ + T I + ++ P R +
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-38
Identities = 54/202 (26%), Positives = 84/202 (41%), Gaps = 9/202 (4%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGERE---FRAEMHVIGRTHHKNL 570
+ + LGKG+FG V + A+K L K V + E E V+ T H L
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 571 VRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
L + V EY + G L L R + +++ L
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSA---LEYLH 122
Query: 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTP 690
+++ DIK +N+++D+ KI+DFGL K + D T GT Y+APE ++
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDND 181
Query: 691 ISVKADVFSYGVVLLEIVCCRR 712
D + GVV+ E++C R
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (344), Expect = 2e-36
Identities = 50/284 (17%), Positives = 103/284 (36%), Gaps = 24/284 (8%)
Query: 513 NRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKL--EKMVTEGEREFRAEMHVIGRTHHK 568
+++ E++G+G++G V+K + ++VA+K++ + E+ ++ HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 569 NLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHD 628
N+VRL D K LV+E+ F L + + KG+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKY--FDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 629 ECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKN 688
++H D+KPQN+L++ K+++FGLA+ V +
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 689 TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG--- 745
S D++S G + E+ R + +++ I + + + +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 746 ------------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSV 777
V + ++ P R S +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-36
Identities = 57/298 (19%), Positives = 106/298 (35%), Gaps = 38/298 (12%)
Query: 513 NRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKL--EKMVTEGEREFRAEMHVIGRTHHK 568
++++ ++G+G+FG V+K K + VA+KK+ E E+ ++ H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 569 NLVRLIGYCAEDSKR--------LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVA 620
N+V LI C + LV+++ + + E R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLL 127
Query: 621 KGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT---RTFTLVRGT 677
G L+ I+H D+K N+L+ K++DFGLA+ + +T T
Sbjct: 128 NG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 678 RGYMAPEWYKN-TPISVKADVFSYGVVLLEIVC-------------CRRNMEIDPSKPEE 723
Y PE D++ G ++ E+ ++ S E
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 724 IVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGL----WCVQDEPALRPSMKSV 777
+ Y+ + EL K + + DR L + +PA R
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (335), Expect = 1e-34
Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 15/224 (6%)
Query: 495 AYESNLRSFSYNELKKAT-NRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEG 551
A E L+ + A ++F + LG GSFG V + A+K L+K
Sbjct: 22 AKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK 81
Query: 552 ERE---FRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLG 608
++ E ++ + LV+L ++S +V EY++ G + L R
Sbjct: 82 LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFS 139
Query: 609 WDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668
A+ + YLH +I+ D+KP+N+L+D+ +++DFG AK +
Sbjct: 140 EPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRR 712
+ GT +APE + + D ++ GV++ E+
Sbjct: 197 T----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 2e-34
Identities = 65/306 (21%), Positives = 117/306 (38%), Gaps = 42/306 (13%)
Query: 503 FSYNELKKAT----NRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGERE 554
F E+ K ++ + +G G++GAV + VA+KKL + +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 555 FRAEMHVIGRTHHKNLVRLIGYCAEDSKR------LLVYEYMSNGSLADILFRGPERSLG 608
E+ ++ H+N++ L+ D LV +M G+ L + LG
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMK--HEKLG 119
Query: 609 WDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668
D + + KG+ Y+H IIH D+KP N+ ++E KI DFGLA+ + T
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176
Query: 669 RTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCR-------------RNM 714
TR Y APE N + D++S G ++ E++ + M
Sbjct: 177 GY----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232
Query: 715 EIDPSKPEEIV-LINWAYKCFIDRELNKLVRG--QEVDRNTLENMIKIGLWCVQDEPALR 771
++ + P E V + + L +L + + N + + + + R
Sbjct: 233 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292
Query: 772 PSMKSV 777
+
Sbjct: 293 VTAGEA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (330), Expect = 4e-34
Identities = 43/219 (19%), Positives = 93/219 (42%), Gaps = 18/219 (8%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGR-THHKNLVR 572
+ +LG+G + V++ + V VK L+ +++ + E+ ++ N++
Sbjct: 38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIIT 94
Query: 573 LIGYCAEDSKRL--LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC 630
L + R LV+E+++N + ++L + ++ K + Y H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 631 EAPIIHCDIKPQNILMD-EFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPE-WYKN 688
I+H D+KP N+++D E ++ D+GLA+ P Q + +R + PE
Sbjct: 150 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDY 204
Query: 689 TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLI 727
D++S G +L ++ + +++V I
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 7e-32
Identities = 61/273 (22%), Positives = 111/273 (40%), Gaps = 30/273 (10%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGE---KLVAVKKLEKMV----TEGEREFRAEMHVIGR-T 565
+ LG G++G V+ G KL A+K L+K + R E V+
Sbjct: 27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86
Query: 566 HHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILY 625
LV L ++K L+ +Y++ G L L + + + V + +L
Sbjct: 87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEIVLA 141
Query: 626 LHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEW 685
L + II+ DIK +NIL+D ++DFGL+K + D+T GT YMAP+
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 686 Y--KNTPISVKADVFSYGVVLLEIVCCRR--NMEIDPSKPEEIVLINWAYKCFIDRELNK 741
++ D +S GV++ E++ ++ + + EI + +E++
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261
Query: 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSM 774
L + ++I+ + +P R
Sbjct: 262 LAK----------DLIQ---RLLMKDPKKRLGC 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-31
Identities = 53/209 (25%), Positives = 84/209 (40%), Gaps = 20/209 (9%)
Query: 513 NRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGEREFRAEMHVIGRTHHK 568
R++ + +G G+ G V ++ VA+KKL + + E+ ++ +HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 569 NLVRLIGYCA------EDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKG 622
N++ L+ E LV E M I + + + G
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCG 131
Query: 623 ILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMA 682
I +LH IIH D+KP NI++ T KI DFGLA+ T TR Y A
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP--YVVTRYYRA 186
Query: 683 PEWYKNTPISVKADVFSYGVVLLEIVCCR 711
PE D++S G ++ E+V +
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-30
Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 502 SFSYNELKKA----TNRFK--EELGKGSFGAVYKGTLYKGEKLVAVKKLEK--MVTEGER 553
+F EL K R++ +G G++G+V K VAVKKL + +
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 554 EFRAEMHVIGRTHHKNLVRLIGYCAE-----DSKRLLVYEYMSNGSLADILFRGPERSLG 608
E+ ++ H+N++ L+ + + + ++ L +I+ L
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LT 119
Query: 609 WDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668
D + + +G+ Y+H IIH D+KP N+ ++E KI DFGLA+ + T
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
Query: 669 RTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCR 711
TR Y APE N + D++S G ++ E++ R
Sbjct: 177 GYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (277), Expect = 5e-27
Identities = 48/244 (19%), Positives = 85/244 (34%), Gaps = 19/244 (7%)
Query: 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRL 573
+LG G F V+ VA+K + E E+ ++ R + + +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKE 74
Query: 574 IGYCAEDSKRLLVYEYMSNGSLA--------------DILFRGPERSLGWDERVRIASDV 619
A +LL + + ++ + R + +I+ +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 620 AKGILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISDFGLAKLLMPDQT-RTFTLVRGT 677
G+ Y+H C IIH DIKP+N+LM+ + +A L +T T
Sbjct: 135 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 678 RGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDR 737
R Y +PE P AD++S ++ E++ E D + A +
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 738 ELNK 741
EL
Sbjct: 253 ELPS 256
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.4 bits (226), Expect = 1e-21
Identities = 34/200 (17%), Positives = 67/200 (33%), Gaps = 24/200 (12%)
Query: 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE----------GEREFRAEMHVIGRTH 566
+ +G+G AV+ K + VK + T G+ F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 567 HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYL 626
+ L +L G VY + N L +++ + + + + + +
Sbjct: 65 FRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 627 HDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWY 686
+ I+H D+ N+L+ E I DF + + + R L R R ++
Sbjct: 120 YHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREI-LERDVRN--IITYF 172
Query: 687 KNTPISVKADVFSYGVVLLE 706
+ D+ S +L+
Sbjct: 173 SR-TYRTEKDINSAIDRILQ 191
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 76.5 bits (188), Expect = 2e-17
Identities = 24/143 (16%), Positives = 50/143 (34%), Gaps = 29/143 (20%)
Query: 126 SASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLN 185
S + ++GN +LY+ T+ QSL +RL+
Sbjct: 2 SVVVANNGNSILYST------QGNDNHPQTLHATQSL---------------QLSPYRLS 40
Query: 186 MQRDGNLVLYPINTIDDYTEAYWASDSQRERQLHLYLSNTGNLVLLDDSMGIIKDLYESP 245
M+ D NLVL+ D + + + + L G + +L + + + S
Sbjct: 41 METDCNLVLF-----DRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAV---WTSG 92
Query: 246 SNNSSIIRRLTIGHNGILRLFSH 268
++ S+ + + L ++
Sbjct: 93 NSRSAGRYVFVLQPDRNLAIYGG 115
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 74.6 bits (183), Expect = 1e-16
Identities = 24/142 (16%), Positives = 41/142 (28%), Gaps = 33/142 (23%)
Query: 69 IWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSAS 128
I T + T + S L++ D L+L + A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAV 71
Query: 129 MLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQR 188
+ +G + N++ +W+S S S GR+ +Q
Sbjct: 72 LQPNGRMDVLTNQNIAVWTSG-------------------------NSRSAGRYVFVLQP 106
Query: 189 DGNLVLYPINTIDDYTEAYWAS 210
D NL +Y A W +
Sbjct: 107 DRNLAIYG--------GALWTT 120
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 75.0 bits (184), Expect = 6e-17
Identities = 23/147 (15%), Positives = 41/147 (27%), Gaps = 34/147 (23%)
Query: 69 IWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSAS 128
I + + T + S+ T+ D L+L + + A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVL-FDSDVRVWASNTAGATGCRAV 61
Query: 129 MLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQR 188
+ G V+ ++ I WSS T S G + L +Q
Sbjct: 62 LQSDGLLVILTAQNTIRWSSG-------------------------TKGSIGNYVLVLQP 96
Query: 189 DGNLVLYPINTIDDYTEAYWASDSQRE 215
D + + Y W S + +
Sbjct: 97 DRTVTI--------YGPGLWDSGTSNK 115
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 59.2 bits (143), Expect = 3e-11
Identities = 27/113 (23%), Positives = 39/113 (34%), Gaps = 19/113 (16%)
Query: 166 NELFSRISETSS----------STGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQRE 215
N LF E S FR MQ D NLVL+ D WAS++
Sbjct: 2 NILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLF------DSDVRVWASNTAGA 55
Query: 216 RQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSH 268
L + G LV+L I + S + S L + + + ++
Sbjct: 56 TGCRAVLQSDGLLVILTAQNTIR---WSSGTKGSIGNYVLVLQPDRTVTIYGP 105
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 70.4 bits (172), Expect = 3e-15
Identities = 21/123 (17%), Positives = 39/123 (31%), Gaps = 19/123 (15%)
Query: 146 WSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTE 205
+ +SL E T +R MQ D NLVLY D+
Sbjct: 7 KQPDDNHPQILHATESL-----------EILFGTHVYRFIMQTDCNLVLY-----DNNNP 50
Query: 206 AYWASDSQRERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRL 265
+ + L G LV++ + + ++SP + L + + + +
Sbjct: 51 IWATNTGGLGNGCRAVLQPDGVLVVITNENVTV---WQSPVAGKAGHYVLVLQPDRNVVI 107
Query: 266 FSH 268
+
Sbjct: 108 YGD 110
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 53.9 bits (129), Expect = 2e-09
Identities = 21/124 (16%), Positives = 36/124 (29%), Gaps = 33/124 (26%)
Query: 91 SSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLYNNRSDIIWSSFK 150
+ + D L+L G A + G V+ N + +W S
Sbjct: 29 THVYRFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP- 87
Query: 151 IPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWAS 210
+ G + L +Q D N+V+ Y +A WA+
Sbjct: 88 ------------------------VAGKAGHYVLVLQPDRNVVI--------YGDALWAT 115
Query: 211 DSQR 214
+ R
Sbjct: 116 QTVR 119
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 64.3 bits (156), Expect = 4e-13
Identities = 23/115 (20%), Positives = 40/115 (34%), Gaps = 17/115 (14%)
Query: 154 DTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQ 213
+ + ++L G L G F MQ D NLVLY D + +
Sbjct: 2 NILYSGETLSTGEFLNY---------GSFVFIMQEDCNLVLY-----DVDKPIWATNTGG 47
Query: 214 RERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSH 268
R L + GNLV+ + S I + S + + + + + ++
Sbjct: 48 LSRSCFLSMQTDGNLVVYNPSNKPI---WASNTGGQNGNYVCILQKDRNVVIYGT 99
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 46.5 bits (110), Expect = 5e-07
Identities = 19/94 (20%), Positives = 32/94 (34%), Gaps = 16/94 (17%)
Query: 126 SASMLDSGNFVLYNNRSDIIWSSFKIPTD-------TILGNQSLLAGNELFSRISETSSS 178
M + N VLY+ IW++ GN + + S T
Sbjct: 22 VFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQ 80
Query: 179 TGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDS 212
G + +Q+D N+V+Y WA+ +
Sbjct: 81 NGNYVCILQKDRNVVIYG--------TDRWATGT 106
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 38.8 bits (90), Expect = 3e-04
Identities = 11/73 (15%), Positives = 21/73 (28%), Gaps = 6/73 (8%)
Query: 78 TIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGH-DKVVAAGKSEPASSASMLDSGNFV 136
+W S + L++ DG L++ G + N V
Sbjct: 38 KPIWATNTGGL--SRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVV 95
Query: 137 LYNNRSDIIWSSF 149
+Y W++
Sbjct: 96 IY---GTDRWATG 105
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 58.4 bits (141), Expect = 4e-11
Identities = 25/117 (21%), Positives = 43/117 (36%), Gaps = 20/117 (17%)
Query: 154 DTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWAS--D 211
+ + + L AG L + MQ D NLVLY +T + WAS
Sbjct: 2 NLLTNGEGLYAGQSL---------DVEPYHFIMQEDCNLVLYDHST------SVWASNTG 46
Query: 212 SQRERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSH 268
++ L + GN V+ D + + S S + L + +G + ++
Sbjct: 47 ILGKKGCKAVLQSDGNFVVYDAEGRSL---WASHSVRGNGNYVLVLQEDGNVVIYGS 100
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 56.1 bits (135), Expect = 3e-10
Identities = 23/129 (17%), Positives = 41/129 (31%), Gaps = 40/129 (31%)
Query: 90 VSSNAALTLTKDGKLILRTEEGHDKVVAA----GKSEPASSASMLDSGNFVLYNNRSDII 145
+ +D L+L H V A + A + GNFV+Y+ +
Sbjct: 17 DVEPYHFIMQEDCNLVLY---DHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSL 73
Query: 146 WSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTE 205
W+S + G + L +Q DGN+V+ Y
Sbjct: 74 WASH-------------------------SVRGNGNYVLVLQEDGNVVI--------YGS 100
Query: 206 AYWASDSQR 214
W++ + +
Sbjct: 101 DIWSTGTYK 109
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 55.0 bits (132), Expect = 7e-10
Identities = 17/109 (15%), Positives = 33/109 (30%), Gaps = 11/109 (10%)
Query: 44 PGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGK 103
G + + Y + L+ + T VW + L DG
Sbjct: 6 NGEGLYAGQSLDVEPYH--FIMQEDCNLVLYDHSTSVWASNTGIL-GKKGCKAVLQSDGN 62
Query: 104 LILRTEEGHDKVVAA---GKSEPASSASMLDSGNFVLYNNRSDIIWSSF 149
++ + + A + + + GN V+Y + IWS+
Sbjct: 63 FVVYD--AEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---IWSTG 106
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 42.6 bits (100), Expect = 1e-05
Identities = 25/111 (22%), Positives = 39/111 (35%), Gaps = 31/111 (27%)
Query: 126 SASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLN 185
M + N VLY++ + +W+S T + +
Sbjct: 22 HFIMQEDCNLVLYDHST-SVWASN---TGILGKKGC---------------------KAV 56
Query: 186 MQRDGNLVLYPINTIDDYTEAYWASDSQRERQ-LHLYLSNTGNLVLLDDSM 235
+Q DGN V+Y D + WAS S R L L GN+V+ +
Sbjct: 57 LQSDGNFVVY-----DAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSDI 102
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 57.5 bits (138), Expect = 1e-10
Identities = 31/132 (23%), Positives = 48/132 (36%), Gaps = 21/132 (15%)
Query: 153 TDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWAS-D 211
+D + L G L G + +Q D NLVLY D A WAS
Sbjct: 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLY------DNNRAVWASGT 45
Query: 212 SQRERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSHYPV 271
+ + L + N GNLV+ S I + N L + + + ++ +
Sbjct: 46 NGKASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGN----YYLILQRDRNVVIYDNSNN 101
Query: 272 PKGAYNTSVDWN 283
A +T+V N
Sbjct: 102 AIWATHTNV-GN 112
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 50.2 bits (119), Expect = 3e-08
Identities = 17/103 (16%), Positives = 37/103 (35%), Gaps = 9/103 (8%)
Query: 52 GAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEG 111
G + F Q+ V + + VW + + +S L + DG L++ +
Sbjct: 19 GGYLFII--QNDCNLV-----LYDNNRAVWASGTNGK--ASGCVLKMQNDGNLVIYSGSR 69
Query: 112 HDKVVAAGKSEPASSASMLDSGNFVLYNNRSDIIWSSFKIPTD 154
+ + N V+Y+N ++ IW++ +
Sbjct: 70 AIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 796 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.8 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.76 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.76 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.76 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.67 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.49 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.16 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.16 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.06 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.06 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.06 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.95 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.98 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.36 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.81 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.5 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.75 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.18 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 85.37 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 84.3 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-49 Score=415.88 Aligned_cols=259 Identities=27% Similarity=0.398 Sum_probs=219.7
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
..+.+.++||+|+||+||+|.+...++.||||+++... ...++|.+|+.++++++|||||++++++.+++..++||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 34566789999999999999999888999999997643 34567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|+|.+++.+.....+++..++.++.|||+||.|||++ +|+||||||+||||++++.+||+|||+++.........
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 999999999876678899999999999999999999998 99999999999999999999999999999876655555
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
.....|++.|||||++.+..++.++|||||||++|||++|+.|+....... . + .... ..-. ....+.
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~--~----~~~i-----~~~~-~~~~~~ 239 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-Q--V----YELL-----EKDY-RMERPE 239 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-H--H----HHHH-----HTTC-CCCCCT
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-H--H----HHHH-----hcCC-CCCCCc
Confidence 555668999999999999999999999999999999999888775433211 1 1 0000 0000 112234
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
..++.+.+|+..||+.||++||||+||++.|+.+.+
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 556789999999999999999999999999998754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=408.06 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=199.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.+.+.||+|+||.||+|.+.+ ++.||||++... ....++|.+|++++++++||||++++|+|.+++..++||||+++
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred cEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 3567899999999999999875 468999999763 34457899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++... ...+++..++.++.|||+||.|||+. +|+||||||+|||+++++.+||+|||+++...........
T Consensus 85 g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 85 GCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp CBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 9999998753 46789999999999999999999998 9999999999999999999999999999887655444444
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...||+.|+|||++.+..++.++|||||||++|||+|++.|+...... ... . .....+ .....+..+
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~--~----~~i~~~------~~~~~p~~~ 227 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEV--V----EDISTG------FRLYKPRLA 227 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHH--H----HHHHHT------CCCCCCTTS
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHH--H----HHHHhc------CCCCCcccc
Confidence 566899999999999999999999999999999999976655433211 111 0 111000 011223344
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 753 LENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
++++.+++..||+.||++||||+||++.|+++++
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 5778999999999999999999999999998753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9e-49 Score=413.61 Aligned_cols=268 Identities=25% Similarity=0.423 Sum_probs=206.7
Q ss_pred cccCHHHHHHHHHhhh-----------cccCcccceEEEEEEEcCCcE---EEEEEEeeccc-chhHHHHHHHHHHHhcc
Q 003772 501 RSFSYNELKKATNRFK-----------EELGKGSFGAVYKGTLYKGEK---LVAVKKLEKMV-TEGEREFRAEMHVIGRT 565 (796)
Q Consensus 501 ~~~~~~~l~~~~~~~~-----------~~LG~G~fg~Vy~g~~~~~~~---~vAvK~l~~~~-~~~~~~f~~E~~~l~~l 565 (796)
..++|+++..++.+|. +.||+|+||+||+|.+...++ .||||++.... ....++|.+|+.+++++
T Consensus 5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 84 (299)
T d1jpaa_ 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84 (299)
T ss_dssp CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence 4466777777776653 579999999999999865443 68999986543 34456799999999999
Q ss_pred CcCchhhhhhhhccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceE
Q 003772 566 HHKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNIL 645 (796)
Q Consensus 566 ~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIl 645 (796)
+|||||+++|++.+++..++||||+++|+|.+++... ...+++..++.++.|||+||.|||++ +|+||||||+|||
T Consensus 85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNIL 160 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEE
Confidence 9999999999999999999999999999999988763 45799999999999999999999998 9999999999999
Q ss_pred ecCCCceEEeccCCccccCCCCcce----eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCC
Q 003772 646 MDEFWTAKISDFGLAKLLMPDQTRT----FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSK 720 (796)
Q Consensus 646 l~~~~~~kl~DFgl~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~ 720 (796)
|++++.+||+|||+++.+....... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~- 239 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN- 239 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-
Confidence 9999999999999999775443221 122457899999999999999999999999999999998 7888864321
Q ss_pred chhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 721 PEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.. +. .....+ .....+.+++..+.+++.+||+.||++||||.||++.|+.+++
T Consensus 240 -~~--~~----~~i~~~------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 240 -QD--VI----NAIEQD------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp -HH--HH----HHHHTT------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HH--HH----HHHHcC------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11 10 001000 0112344566789999999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=409.41 Aligned_cols=254 Identities=29% Similarity=0.450 Sum_probs=209.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+++.++||+|+||.||+|.+. +++.||||+++... ...+.|.+|++++.+++|||||+++|++.+ +..++||||++
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 4566789999999999999986 45789999997643 345679999999999999999999998765 56799999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+|+|.+++.......+++..++.++.||++||.|||+. +|+||||||+||||++++.+||+|||+++.+........
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 99999988765445799999999999999999999998 999999999999999999999999999998765554444
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
....||+.|||||++.+..++.++|||||||++|||+||+.|+....... .. ......+ .....+..
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~------~~~i~~~------~~~~~p~~ 234 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EV------IQNLERG------YRMVRPDN 234 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HH------HHHHHTT------CCCCCCTT
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HH------HHHHHhc------CCCCCccc
Confidence 55668999999999999999999999999999999999877665432211 11 0111100 01122344
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 752 TLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 752 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
.++.+.+|+.+||+.||++||||++|+++|+.+
T Consensus 235 ~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 567799999999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=407.25 Aligned_cols=257 Identities=28% Similarity=0.444 Sum_probs=202.5
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|+||+||+|++.. .||||+++.. ..+..+.|++|+.++++++||||+++++++.+ +..++||||+
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~ 85 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC 85 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence 4567899999999999998742 5999998643 34456789999999999999999999998754 5689999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc-c
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT-R 669 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~-~ 669 (796)
++|+|.+++... ...+++..++.++.|||+||.|||++ +|+||||||+||||++++.+||+|||+++....... .
T Consensus 86 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 86 EGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 999999999753 45699999999999999999999998 999999999999999999999999999987654332 3
Q ss_pred eeeeeccCCCCCchhhhccC---CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNT---PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
......||+.|||||++.+. .++.++|||||||+||||+||+.||....... .+............+ .
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~~~~~~~~~~p~~------~ 232 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIFMVGRGYLSPDL------S 232 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHHTSCCCCG------G
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHHHHHhcCCCCCcc------h
Confidence 33456799999999999643 58999999999999999999999997543211 111111111111111 1
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
..+.++++.+.+++.+||+.||++||||+||++.|+.+.+
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2234556789999999999999999999999999998764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=404.78 Aligned_cols=263 Identities=27% Similarity=0.394 Sum_probs=209.9
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+++.+.||+|+||.||+|++.++ +.||||+++.. ....+.|.+|+.++++++|+|||+++|++.+ +..++||||++
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 467789999999999999998765 57999999754 3456789999999999999999999999854 56789999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+|+|.+++.......++|..++.++.||++||.|||+. +|+||||||+||||++++.+||+|||+++..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 99999998765556799999999999999999999998 999999999999999999999999999988765554445
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRN 751 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (796)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+.......... . .. .... ....+.+
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~---~----~i-----~~~~-~~~~~~~ 238 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---D----QV-----ERGY-RMPCPPE 238 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---H----HH-----HTTC-CCCCCTT
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH---H----HH-----HhcC-CCCCCcc
Confidence 55668999999999999999999999999999999999887776543221111 1 00 0000 1123445
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 003772 752 TLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDISIPPCP 793 (796)
Q Consensus 752 ~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p 793 (796)
.++++.+++.+||+.||++||||++|+++|+.......|+.+
T Consensus 239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~ 280 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCC
Confidence 567899999999999999999999999999997766555443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=398.75 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=204.2
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc-chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
+.+.+.||+|+||+||+|++..+++.||||++.... .+..+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 456789999999999999998888999999997543 2345679999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc-ce
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT-RT 670 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~-~~ 670 (796)
+|+|.++|.. ...+++..+..++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++.+..... ..
T Consensus 87 gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 87 GGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp TEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 9999999965 46799999999999999999999998 999999999999999999999999999997754332 23
Q ss_pred eeeeccCCCCCchhhhccCCC-CccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....||+.|||||++.+..+ +.++|||||||++|||++|+.||............ . ... .......
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~--~-----~~~-----~~~~~~~ 229 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD--W-----KEK-----KTYLNPW 229 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH--H-----HTT-----CTTSTTG
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH--H-----hcC-----CCCCCcc
Confidence 344679999999999988876 67899999999999999999999755433221110 0 000 0000111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....+.+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 233467889999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=398.14 Aligned_cols=248 Identities=21% Similarity=0.302 Sum_probs=208.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+.+.++||+|+||+||+|.....++.||||++........+.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 56678999999999999999888899999999876555667899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++.+ +.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..... ...
T Consensus 102 g~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~ 174 (293)
T d1yhwa1 102 GSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 174 (293)
T ss_dssp CBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred CcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-ccc
Confidence 999998865 4699999999999999999999998 999999999999999999999999999997754332 223
Q ss_pred eeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 673 LVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
...||+.|||||++.+..++.++|||||||++|||++|+.||..... .. .+.. ... ........+...
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~-~~~~-~~~--------~~~~~~~~~~~~ 242 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LR-ALYL-IAT--------NGTPELQNPEKL 242 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HH-HHHH-HHH--------HCSCCCSSGGGS
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH--HH-HHHH-HHh--------CCCCCCCCcccC
Confidence 45699999999999999999999999999999999999999964321 11 1100 000 000011123344
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 753 LENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.+.+.+++.+||+.||.+|||+.|+++
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 577899999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=393.89 Aligned_cols=244 Identities=26% Similarity=0.392 Sum_probs=206.4
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+|+...+++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 567789999999999999999888999999997532 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.+ ...+++..+..++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 88 APLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred cCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence 999999999976 46799999999999999999999998 99999999999999999999999999998664332
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....||+.|||||++.+..++.++|||||||+||||++|+.||.... .... ....... ....+
T Consensus 161 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~------~~~i~~~-------~~~~p 224 (263)
T d2j4za1 161 -RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--YQET------YKRISRV-------EFTFP 224 (263)
T ss_dssp -CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHH------HHHHHTT-------CCCCC
T ss_pred -ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--HHHH------HHHHHcC-------CCCCC
Confidence 234569999999999999999999999999999999999999996432 1111 1111110 01123
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....+.+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 344567899999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=390.77 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=211.2
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCCC
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSNG 593 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 593 (796)
.+.++||+|+||+||+|+++ +++.||||++++.. ...++|++|+.++++++||||++++|+|.+++..++||||+++|
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred EEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 46789999999999999985 56789999998643 34578999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceeee
Q 003772 594 SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFTL 673 (796)
Q Consensus 594 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~~ 673 (796)
+|.+++... ...+++..+++++.|+|+||.|||+. +|+||||||+||++++++.+||+|||+++............
T Consensus 85 ~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 85 CLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp EHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred cHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 999997653 46789999999999999999999998 99999999999999999999999999998776655545555
Q ss_pred eccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCHHH
Q 003772 674 VRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDRNT 752 (796)
Q Consensus 674 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (796)
..||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..++. .....+ .....+...
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--~~~~~------~~i~~~------~~~~~p~~~ 226 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NSETA------EHIAQG------LRLYRPHLA 226 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--HHHHH------HHHHTT------CCCCCCTTC
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--HHHHH------HHHHhC------CCCCCcccc
Confidence 668999999999999999999999999999999998 788886442 11111 111111 011223345
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 753 LENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 753 ~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
++.+.+++..||+.||++|||+++|++.|..|
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 57799999999999999999999999998654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=402.07 Aligned_cols=257 Identities=27% Similarity=0.429 Sum_probs=203.2
Q ss_pred hhhcccCcccceEEEEEEEcCCc----EEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGE----KLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~----~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+.+.||+|+||.||+|.+...+ ..||||++.....+ ...+|.+|+.++.+++|||||+++|++.+.+..++|||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 45678999999999999986543 47999999764333 34579999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+.+|+|.+++... ...+++..++.++.||++||.|||+. +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 90 ~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 90 YMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp CCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred ecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 99999999988763 46799999999999999999999998 999999999999999999999999999988754432
Q ss_pred c--eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 669 R--TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 669 ~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
. ......||+.|||||++.+..++.++|||||||++|||++++.|+...... ..+ ......+ . ..
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~------~~~i~~~-----~-~~ 232 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEV------MKAINDG-----F-RL 232 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHH------HHHHHTT-----C-CC
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHH------HHHHhcc-----C-CC
Confidence 2 223345899999999999999999999999999999999987776543321 111 0111110 0 11
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
..+.+++..+.+|+.+||+.||++||||.||+++|+.+.+.
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 23445667899999999999999999999999999987654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-47 Score=394.63 Aligned_cols=247 Identities=28% Similarity=0.381 Sum_probs=200.6
Q ss_pred cccCcccceEEEEEEEcC--CcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 517 EELGKGSFGAVYKGTLYK--GEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~--~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
++||+|+||.||+|.+.. .++.||||+++... ....++|.+|++++++++||||++++|+|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998753 34789999996532 2335679999999999999999999999854 567899999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce--
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT-- 670 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~-- 670 (796)
|+|.+++.+ ...+++..++.++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999999976 46799999999999999999999998 99999999999999999999999999999876544322
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....||+.|||||.+.+..++.++|||||||++|||+| |+.||.... ..++ ...+..+ .....+
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--~~~~------~~~i~~~------~~~~~p 232 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEV------TAMLEKG------ERMGCP 232 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHH------HHHHHTT------CCCCCC
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--HHHH------HHHHHcC------CCCCCC
Confidence 233568999999999999999999999999999999998 899986432 1111 0111111 111234
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
..+++.+.+|+.+||+.||++|||+++|+++|+.
T Consensus 233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 4556789999999999999999999999998875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=391.99 Aligned_cols=247 Identities=27% Similarity=0.417 Sum_probs=198.3
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhcc----CCceeEEE
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAE----DSKRLLVY 587 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~ 587 (796)
+|.++||+|+||+||+|++..+++.||+|++.... ....+.|.+|++++++++||||+++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999999888899999987532 3345679999999999999999999999864 34578999
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec-CCCceEEeccCCccccCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD-EFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFgl~~~~~~~ 666 (796)
||+++|+|.+++.+ ...+++..++.++.||++||.|||++ ..+|+||||||+|||++ +++.+||+|||+++.....
T Consensus 92 E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999999976 46799999999999999999999997 12399999999999997 5789999999999865433
Q ss_pred CcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCC
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQ 746 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (796)
. .....||+.|||||++.+ .++.++|||||||++|||++|+.||...... .. + ......+ ..+.
T Consensus 169 ~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-~~--~----~~~i~~~-----~~~~ 232 (270)
T d1t4ha_ 169 F---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQ--I----YRRVTSG-----VKPA 232 (270)
T ss_dssp S---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HH--H----HHHHTTT-----CCCG
T ss_pred c---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-HH--H----HHHHHcC-----CCCc
Confidence 2 234569999999999876 5999999999999999999999999643211 11 1 1111111 1111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 747 EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 747 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..+....+++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 112233456889999999999999999999976
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=398.07 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=206.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
+++.+.||+|+||.||+|+....++.||||+++.......+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 46678899999999999999988899999999876667778899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcceee
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTFT 672 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~~ 672 (796)
|+|.+++.+. .+.+++..+..++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 94 g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~ 168 (288)
T d2jfla1 94 GAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 168 (288)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHT
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cccc
Confidence 9999998653 45799999999999999999999998 99999999999999999999999999997653221 1222
Q ss_pred eeccCCCCCchhhhc-----cCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 673 LVRGTRGYMAPEWYK-----NTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 673 ~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
...||+.|||||++. +..++.++|||||||++|||++|+.||..... .+... . ..... .....
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--~~~~~-~-----i~~~~----~~~~~ 236 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MRVLL-K-----IAKSE----PPTLA 236 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--GGHHH-H-----HHHSC----CCCCS
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--HHHHH-H-----HHcCC----CCCCC
Confidence 356999999999984 45689999999999999999999999964321 11110 0 00000 00111
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.+....+.+.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22345577899999999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=393.28 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=204.7
Q ss_pred hhc-ccCcccceEEEEEEEc--CCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 515 FKE-ELGKGSFGAVYKGTLY--KGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 515 ~~~-~LG~G~fg~Vy~g~~~--~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+ +||+|+||.||+|.+. +.+..||||+++.... ...++|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 345 4999999999999875 3345899999976443 345789999999999999999999999864 5689999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
++|+|.+++... ...+++..++.++.|||+||.|||++ +|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 91 ~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 91 GGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp TTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred CCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 999999998653 46799999999999999999999998 99999999999999999999999999999876543322
Q ss_pred --eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 671 --FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 671 --~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
.....||+.|||||++.+..++.++|||||||++|||+| |+.||..... .++. ..+..+ ....
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~------~~i~~~------~~~~ 232 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVM------AFIEQG------KRME 232 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHH------HHHHTT------CCCC
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHH------HHHHcC------CCCC
Confidence 223458899999999999999999999999999999998 8999874431 1111 111111 0112
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
.+..+++.+.+|+.+||+.||++||||.+|++.|+.+
T Consensus 233 ~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 3445667899999999999999999999999998753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=396.02 Aligned_cols=246 Identities=24% Similarity=0.320 Sum_probs=203.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||+||+|+...+++.||||++.+.. ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 567899999999999999998888999999997532 23446789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc-
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT- 668 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~- 668 (796)
+++|+|.+++.. .+.+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 90 ~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 90 AKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 999999999876 46799999999999999999999998 999999999999999999999999999998754432
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
.......||+.|||||++.+..++.++|||||||++|||++|+.||.... .... ........ ...
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~~~~------~~~i~~~~-------~~~ 229 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EYLI------FQKIIKLE-------YDF 229 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHH------HHHHHTTC-------CCC
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--HHHH------HHHHHcCC-------CCC
Confidence 23334569999999999999999999999999999999999999997432 1111 11111110 112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMKSVV 778 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 778 (796)
+....+.+.+++..||+.||++|||++|++
T Consensus 230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 230 PEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 334456789999999999999999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=392.58 Aligned_cols=252 Identities=21% Similarity=0.338 Sum_probs=194.1
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhcc--CCceeEEEe
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAE--DSKRLLVYE 588 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e 588 (796)
+.+.+.||+|+||.||+|+...+++.||||++.... ....+.+.+|++++++++||||+++++++.+ ++..++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 566789999999999999999888999999987543 2344678999999999999999999998865 456789999
Q ss_pred ecCCCChhhhhhcC--CCCCCchhHHHHHHHHHHHHHHHhhccC--CCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 589 YMSNGSLADILFRG--PERSLGWDERVRIASDVAKGILYLHDEC--EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 589 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
|+++|+|.+++.+. ....+++..++.++.||+.||.|||++. ..+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 99999999998642 2467999999999999999999999862 1249999999999999999999999999999875
Q ss_pred CCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhc
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVR 744 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (796)
..... .....||+.|||||++.+..++.++|||||||++|||++|+.||.... ..+. .........
T Consensus 166 ~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--~~~~------~~~i~~~~~----- 231 (269)
T d2java1 166 HDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--QKEL------AGKIREGKF----- 231 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHH------HHHHHHTCC-----
T ss_pred cCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--HHHH------HHHHHcCCC-----
Confidence 43322 234569999999999999999999999999999999999999996432 1111 111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 745 GQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 745 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...+....+.+.+++.+||+.||.+|||+.|+++
T Consensus 232 -~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 -RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1223345567999999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=402.50 Aligned_cols=256 Identities=27% Similarity=0.391 Sum_probs=206.4
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCc-----EEEEEEEeeccc-chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCce
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGE-----KLVAVKKLEKMV-TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~-----~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 583 (796)
..+.+.++||+|+||+||+|++...+ ..||||++.... ......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 34567789999999999999986443 479999986533 33456789999999998 899999999999999999
Q ss_pred eEEEeecCCCChhhhhhcCCC---------------------CCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCcc
Q 003772 584 LLVYEYMSNGSLADILFRGPE---------------------RSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQ 642 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~ 642 (796)
++||||+++|+|.++|..... ..+++..++.++.||++||.|||++ +|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 999999999999999975421 3589999999999999999999998 9999999999
Q ss_pred ceEecCCCceEEeccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCC
Q 003772 643 NILMDEFWTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSK 720 (796)
Q Consensus 643 NIll~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~ 720 (796)
|||++.++.+||+|||+++........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876544332 2334568999999999999999999999999999999998 88898654322
Q ss_pred chhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHh
Q 003772 721 PEEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLE 782 (796)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~ 782 (796)
.. +.... ..-. ....+...++.+.+|+.+||+.||++|||++||+++|.
T Consensus 274 ~~---~~~~~---------~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 AN---FYKLI---------QNGF-KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HH---HHHHH---------HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH---HHHHH---------hcCC-CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11 11100 0000 11223455678999999999999999999999999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=404.45 Aligned_cols=262 Identities=24% Similarity=0.320 Sum_probs=205.5
Q ss_pred HHHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
..+.+.++||+|+||+||+|+....++.||||+++.... ...+.+.+|+.++++++|||||++++++.++++.++||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 345667899999999999999998899999999976433 3356789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.+ .+.+++..+..++.|+++||.|||++ .+|+||||||+|||+++++.+||+|||+|+......
T Consensus 86 ~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 159 (322)
T d1s9ja_ 86 MDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 159 (322)
T ss_dssp CTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred CCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence 999999999976 45799999999999999999999973 189999999999999999999999999998764322
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHH-----------------
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYK----------------- 732 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~----------------- 732 (796)
.....||+.|||||++.+..++.++||||+||++|||++|+.||..................
T Consensus 160 -~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 160 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp -C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred -cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 22356999999999999999999999999999999999999999754432211110000000
Q ss_pred -----hh----hhhhhhhhhcC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 733 -----CF----IDRELNKLVRG---QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 733 -----~~----~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
.. ....+...... .........++.+++.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00 00000000000 0111122457889999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.3e-46 Score=391.49 Aligned_cols=245 Identities=25% Similarity=0.316 Sum_probs=202.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+...++||+|+||.||+|+...+++.||||++..... ...+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 45667889999999999999998899999999976432 234568999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++|+|..++.. .+.+++..++.++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp CCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 9999999877655 46799999999999999999999998 9999999999999999999999999999875432
Q ss_pred ceeeeeccCCCCCchhhhcc---CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 669 RTFTLVRGTRGYMAPEWYKN---TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
....||+.|||||++.+ ..++.++|||||||++|||++|+.||..... ... + ...... ...
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--~~~-~-----~~i~~~-----~~~ 232 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSA-L-----YHIAQN-----ESP 232 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHH-H-----HHHHHS-----CCC
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--HHH-H-----HHHHhC-----CCC
Confidence 23459999999999864 4689999999999999999999999964321 110 0 000000 011
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
...+....+.+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1123344567999999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-45 Score=391.01 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=191.4
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+.+.+.||+|+||+||+|+....++.||||++.+... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 36678899999999999999988889999999976432 33456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec---CCCceEEeccCCccccCCCC
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD---EFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFgl~~~~~~~~ 667 (796)
++|+|.++|.+ .+.+++..+..++.||+.||.|||+. +|+||||||+|||+. +++.+||+|||+++......
T Consensus 90 ~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 90 SGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred CCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 99999999976 56799999999999999999999998 999999999999995 57899999999998764332
Q ss_pred cceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCC
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQE 747 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (796)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||..... .. . ......... .....
T Consensus 165 ~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~--~----~~~i~~~~~---~~~~~ 231 (307)
T d1a06a_ 165 V--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--AK--L----FEQILKAEY---EFDSP 231 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH--H----HHHHHTTCC---CCCTT
T ss_pred e--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--HH--H----HHHHhccCC---CCCCc
Confidence 2 2345699999999999999999999999999999999999999964321 11 1 011111000 00111
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 748 VDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 748 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
......+.+.+++..||+.||++|||++|+++
T Consensus 232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 22345577899999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.4e-45 Score=393.79 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=209.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+.+.+.||+|+||.||+|+....++.||||++........+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 46778999999999999999998899999999987666667789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC--CCceEEeccCCccccCCCCcc
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE--FWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+|+|.+++.+. ...+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++.+.....
T Consensus 107 gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~- 181 (350)
T d1koaa2 107 GGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS- 181 (350)
T ss_dssp SCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC-
T ss_pred CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccc-
Confidence 99999999653 45799999999999999999999998 9999999999999964 67899999999987754332
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.... ..+ .+ ........ .......
T Consensus 182 -~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~-~~-----~~i~~~~~---~~~~~~~ 249 (350)
T d1koaa2 182 -VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--DDE-TL-----RNVKSCDW---NMDDSAF 249 (350)
T ss_dssp -EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHH-HH-----HHHHHTCC---CSCCGGG
T ss_pred -cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--HHH-HH-----HHHHhCCC---CCCcccc
Confidence 334569999999999999999999999999999999999999996432 111 11 11100000 0001111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
....+.+.+++.+||+.||++|||++|+++.
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2345678999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-45 Score=389.66 Aligned_cols=258 Identities=27% Similarity=0.411 Sum_probs=209.1
Q ss_pred HHhhhcccCcccceEEEEEEEcC-----CcEEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
.+.+.+.||+|+||+||+|+... +++.||||+++..... ..++|.+|++++++++||||++++++|.+.+..++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 34567899999999999999753 4578999999764433 45679999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCC----------------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccc
Q 003772 586 VYEYMSNGSLADILFRGP----------------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQN 643 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~N 643 (796)
||||+++|+|.++++... ...+++..++.++.|+++||+|||+. +|+||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccc
Confidence 999999999999996421 23488999999999999999999998 99999999999
Q ss_pred eEecCCCceEEeccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccC-CCCCCCCc
Q 003772 644 ILMDEFWTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRN-MEIDPSKP 721 (796)
Q Consensus 644 Ill~~~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p-~~~~~~~~ 721 (796)
||++.++.+||+|||+++.+...... ......|++.|+|||.+.+..++.++|||||||++|||++|..| +.... .
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~-~- 248 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-H- 248 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-H-
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC-H-
Confidence 99999999999999999876544332 23345688999999999999999999999999999999999754 44321 1
Q ss_pred hhHHHHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 722 EEIVLINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
.+.. .....+.. ...+...+.++.+|+.+||+.+|++||||.||+++|+++.+
T Consensus 249 ~e~~------~~v~~~~~------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 249 EEVI------YYVRDGNI------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HHHH------HHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHH------HHHHcCCC------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111 11111111 12234556789999999999999999999999999998864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4e-45 Score=393.56 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=211.2
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
.+++.+.||+|+||.||+|.....++.||||+++.......+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 36778999999999999999988889999999987665666788999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec--CCCceEEeccCCccccCCCCcc
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD--EFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+|+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+||||+ .++.+||+|||+++.+.....
T Consensus 110 gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~- 184 (352)
T d1koba_ 110 GGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 184 (352)
T ss_dssp CCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred CChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCc-
Confidence 99999987653 45699999999999999999999998 999999999999998 678999999999998765432
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....||+.|||||++.+..++.++|||||||++|||++|+.||..... .. .+ ........ .......
T Consensus 185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~-~~-----~~i~~~~~---~~~~~~~ 252 (352)
T d1koba_ 185 -VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LE-TL-----QNVKRCDW---EFDEDAF 252 (352)
T ss_dssp -EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HH-HH-----HHHHHCCC---CCCSSTT
T ss_pred -eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HH-HH-----HHHHhCCC---CCCcccc
Confidence 3345689999999999999999999999999999999999999964321 11 10 11110000 0011122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--Hhc
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPSMKSVVLM--LEG 783 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~ 783 (796)
......+.+|+.+||+.||.+|||+.|+++. +++
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 3455678999999999999999999999873 544
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=387.67 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=206.8
Q ss_pred hhhcccCcccceEEEEEEEcCCc---EEEEEEEeecc-cchhHHHHHHHHHHHhccCcCchhhhhhhhcc-CCceeEEEe
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGE---KLVAVKKLEKM-VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE-DSKRLLVYE 588 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~---~~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e 588 (796)
+|.++||+|+||+||+|++...+ ..||||++++. .....++|.+|++++++++||||++++|++.+ +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 45678999999999999986543 36999999753 33445789999999999999999999999875 457899999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++|+|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+||||++++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999998753 55688899999999999999999998 999999999999999999999999999998754432
Q ss_pred c---eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 669 R---TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 669 ~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
. ......||+.|+|||.+....++.++||||||+++|||++|+.|+.......... . ....+. .
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~---~----~i~~g~------~ 252 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---V----YLLQGR------R 252 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CH---H----HHHTTC------C
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHH---H----HHHcCC------C
Confidence 2 2223568999999999999999999999999999999999998886543221111 0 001110 1
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
...+...++.+.+++.+||+.||++||||.||++.|+.+...
T Consensus 253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 112334456799999999999999999999999999987654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=386.44 Aligned_cols=256 Identities=20% Similarity=0.315 Sum_probs=197.8
Q ss_pred HHHhhhcccCcccceEEEEEEEcCC---cEEEEEEEeecccch-hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYKG---EKLVAVKKLEKMVTE-GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
..+.+.+.||+|+||.||+|++... ...||||+++..... ..+.|.+|+.++++++||||+++++++. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 3456778999999999999987543 357999998754433 3467999999999999999999999986 4678999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|||+++|+|.+++... ...+++..++.++.||++||.|||+. +|+||||||+||++++++.+||+|||+++.+...
T Consensus 86 ~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 9999999999988653 46799999999999999999999998 9999999999999999999999999999987655
Q ss_pred CcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
.........||+.|+|||.+.+..++.++|||||||++|||++ |+.|+...... +.. .....+ ..
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~------~~i~~~------~~ 227 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVI------GRIENG------ER 227 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHH------HHHHTT------CC
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHH------HHHHcC------CC
Confidence 5444555668999999999999999999999999999999998 77777644321 111 111111 01
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
...+...++.+.+++..||+.||++|||++||++.|+.++
T Consensus 228 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1234456678999999999999999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-46 Score=382.19 Aligned_cols=248 Identities=30% Similarity=0.418 Sum_probs=196.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccC-CceeEEEeecC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAED-SKRLLVYEYMS 591 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~e~~~ 591 (796)
.++.+.||+|+||.||+|.++ ++.||||++++. ...+.|.+|++++++++||||++++|+|.+. +..++||||++
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred eEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 356788999999999999984 468999999753 3457799999999999999999999998654 56799999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
+|+|.++|.......+++..+++++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---- 157 (262)
T d1byga_ 85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 157 (262)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC----
Confidence 99999999764445689999999999999999999998 99999999999999999999999999998654322
Q ss_pred eeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 672 TLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
....+|..|+|||++.+..+++++|||||||++|||+| |+.|+.... ...+. . .+..+ ...+.+.
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--~~~~~--~----~i~~~------~~~~~~~ 223 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVV--P----RVEKG------YKMDAPD 223 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGGHH--H----HHTTT------CCCCCCT
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC--HHHHH--H----HHHcC------CCCCCCc
Confidence 22347899999999999999999999999999999998 566654332 11111 1 01110 1112344
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
..++.+.+++.+||+.||.+||||.+|+++|+.++
T Consensus 224 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 55678999999999999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=383.25 Aligned_cols=250 Identities=25% Similarity=0.337 Sum_probs=204.9
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc------hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT------EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~------~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
.+++.+.||+|+||+||+|+...+++.||||++++... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46778999999999999999988889999999975322 235679999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC----ceEEeccCCcc
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW----TAKISDFGLAK 661 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFgl~~ 661 (796)
||||+++|+|.+++.+ .+.+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 91 v~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 91 ILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhh
Confidence 9999999999999976 45799999999999999999999998 999999999999998776 59999999998
Q ss_pred ccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 662 LLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 662 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+ .. .........
T Consensus 166 ~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~-~~-----~~i~~~~~~- 234 (293)
T d1jksa_ 166 KIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QE-TL-----ANVSAVNYE- 234 (293)
T ss_dssp ECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH-HH-----HHHHTTCCC-
T ss_pred hcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--HH-HH-----HHHHhcCCC-
Confidence 7754332 2334589999999999999999999999999999999999999974321 11 10 000000000
Q ss_pred hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 742 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
............+.+++.+||+.||++|||++|+++
T Consensus 235 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 --FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001123467889999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-45 Score=386.80 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=201.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCcE----EEEEEEeecc-cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEK----LVAVKKLEKM-VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVY 587 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~----~vAvK~l~~~-~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 587 (796)
+++.+.||+|+||+||+|.+...++ +||||+++.. ..+..++|.+|+.++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 5667899999999999999876554 6899988653 344567899999999999999999999999864 567889
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
||+.+|+|.+++... ...+++..+++++.|||+||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 90 e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 90 QLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp ECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 999999999988764 56799999999999999999999998 99999999999999999999999999999876544
Q ss_pred cce-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 668 TRT-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 668 ~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
... .....||+.|||||++.+..++.++|||||||++|||+| |+.|+...... .+. .... .+ ..
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~--~~i~----~~------~~ 231 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EIS--SILE----KG------ER 231 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHH--HHHH----HT------CC
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHH--HHHH----cC------CC
Confidence 332 233568999999999999999999999999999999999 67777543211 111 0000 00 01
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
...+..+++.+.+++.+||+.||.+|||+.||++.|+.+
T Consensus 232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 123345567899999999999999999999999988765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=386.47 Aligned_cols=260 Identities=27% Similarity=0.391 Sum_probs=197.8
Q ss_pred HHHhhhcccCcccceEEEEEEEcC-----CcEEEEEEEeeccc-chhHHHHHHHHHHHhcc-CcCchhhhhhhhccC-Cc
Q 003772 511 ATNRFKEELGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMV-TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAED-SK 582 (796)
Q Consensus 511 ~~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~-~~ 582 (796)
..+.+.++||+|+||.||+|.+.. .++.||||+++... ....+.+..|...+.++ +|+||+.+++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 345677899999999999999754 34689999997543 33456788888888777 689999999987664 46
Q ss_pred eeEEEeecCCCChhhhhhcCC--------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC
Q 003772 583 RLLVYEYMSNGSLADILFRGP--------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE 648 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 648 (796)
.++||||+++|+|.++|.... ...+++..++.++.||++||.|||++ +|+||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 899999999999999997532 24589999999999999999999998 9999999999999999
Q ss_pred CCceEEeccCCccccCCCCcc-eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhccc-CCCCCCCCchhHHH
Q 003772 649 FWTAKISDFGLAKLLMPDQTR-TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRR-NMEIDPSKPEEIVL 726 (796)
Q Consensus 649 ~~~~kl~DFgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~-p~~~~~~~~~~~~~ 726 (796)
++.+||+|||+++........ ......||+.|||||++.+..++.++|||||||++|||+++.. ||...... ....
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~~~~- 247 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFC- 247 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HHHH-
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-HHHH-
Confidence 999999999999876544332 2334569999999999999999999999999999999999765 55433222 1111
Q ss_pred HHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcC
Q 003772 727 INWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITD 786 (796)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~ 786 (796)
. ....+ . ....+...++++.+++.+||+.||++|||++||++.|+.+++
T Consensus 248 -~----~~~~~-----~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 248 -R----RLKEG-----T-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp -H----HHHHT-----C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -H----HHhcC-----C-CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0 00010 0 112233455678999999999999999999999999998754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=385.57 Aligned_cols=257 Identities=29% Similarity=0.464 Sum_probs=205.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcE--EEEEEEeeccc-chhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCceeEEEe
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEK--LVAVKKLEKMV-TEGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~--~vAvK~l~~~~-~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 588 (796)
+++.++||+|+||.||+|++.+++. .||||++.... .+..+.|.+|++++.++ +||||++++|+|.+++..++|||
T Consensus 12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 3567899999999999999987665 57888886533 33456799999999998 79999999999999999999999
Q ss_pred ecCCCChhhhhhcC--------------CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEE
Q 003772 589 YMSNGSLADILFRG--------------PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKI 654 (796)
Q Consensus 589 ~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 654 (796)
|+++|+|.++|+.. ....+++..++.++.|||+||.|||+. +|+||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEE
Confidence 99999999999753 246799999999999999999999998 9999999999999999999999
Q ss_pred eccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh
Q 003772 655 SDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF 734 (796)
Q Consensus 655 ~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 734 (796)
+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|..|+...... ... ....
T Consensus 169 ~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-~~~------~~~i 239 (309)
T d1fvra_ 169 ADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AEL------YEKL 239 (309)
T ss_dssp CCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHH------HHHG
T ss_pred cccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-HHH------HHHH
Confidence 99999986543222 22345899999999999999999999999999999999987654322211 111 1111
Q ss_pred hhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 735 IDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
..+ .....+...++++.+|+.+||+.||++||||+||++.|+++.+.
T Consensus 240 ~~~------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 240 PQG------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GGT------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred Hhc------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 111 01123345567899999999999999999999999999887654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=376.10 Aligned_cols=253 Identities=26% Similarity=0.332 Sum_probs=195.5
Q ss_pred HhhhcccCcccceEEEEEEEcCC---cEEEEEEEeecc---cchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKG---EKLVAVKKLEKM---VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~---~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
+++.+.||+|+||.||+|++... ...||||++++. ..+..++|.+|+.++++++||||++++|++.+ ...++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 46678999999999999986432 247999998753 23345689999999999999999999999965 467899
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|||+++|+|.+.+... ...+++..++.++.|||+||.|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 9999999999988653 45699999999999999999999998 9999999999999999999999999999987554
Q ss_pred Ccce--eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 667 QTRT--FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 667 ~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
.... .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+. ...... . -
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~--~~~~--~~~i~~---~------~ 231 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--GSQI--LHKIDK---E------G 231 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHH--HHHHHT---S------C
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC--HHHH--HHHHHh---C------C
Confidence 4322 223457889999999999999999999999999999998 888886332 1111 010000 0 0
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhc
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEG 783 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~ 783 (796)
...+.+...+..+.+++..||+.||++||||+||++.|++
T Consensus 232 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 0112234455779999999999999999999999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-44 Score=380.58 Aligned_cols=246 Identities=26% Similarity=0.331 Sum_probs=206.7
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+.+.+.||+|+||.||+++....++.||||++.+.. ....+.+.+|+.+|++++||||+++++++.+++..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 566789999999999999999889999999997632 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|.+++.+ ...+++..++.++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 87 ~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~- 160 (337)
T d1o6la_ 87 ANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp CTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred cCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc-
Confidence 999999999976 46789999999999999999999999 999999999999999999999999999987654332
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
......||+.|||||++.+..++.++||||+||++|||++|+.||..... ... .+..... ....+
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~~~------~~~i~~~-------~~~~p 225 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERL------FELILME-------EIRFP 225 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHH------HHHHHHC-------CCCCC
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--HHH------HHHHhcC-------CCCCC
Confidence 23345699999999999999999999999999999999999999975421 111 1111111 11223
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRPS-----MKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 779 (796)
....+.+.+|+..||+.||.+||+ +.|+++
T Consensus 226 ~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 344567889999999999999995 778875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=381.43 Aligned_cols=266 Identities=27% Similarity=0.306 Sum_probs=198.2
Q ss_pred hhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCC----ceeEEEee
Q 003772 514 RFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS----KRLLVYEY 589 (796)
Q Consensus 514 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~e~ 589 (796)
-+.++||+|+||.||+|++ .++.||||+++... .....+..|+..+.+++||||++++++|.+.+ ..++||||
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 3567899999999999997 45789999996432 22222345666667889999999999998654 57899999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccC-----CCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDEC-----EAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+++|+|.++|.+ ..++|..++.++.|+|.||.|||+.. ..+|+||||||+||||++++.+||+|||+++...
T Consensus 83 ~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 83 HEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred ccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 999999999976 46999999999999999999999731 2499999999999999999999999999999875
Q ss_pred CCCcc---eeeeeccCCCCCchhhhccCC------CCccccchhhHHHHHHHhhcccCCCCCCCCchhHH-------HHH
Q 003772 665 PDQTR---TFTLVRGTRGYMAPEWYKNTP------ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIV-------LIN 728 (796)
Q Consensus 665 ~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~-------~~~ 728 (796)
..... ......||+.|||||++.+.. ++.++|||||||+||||+||..|+........... ...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence 44322 223456999999999987652 67899999999999999999988754332211000 000
Q ss_pred HHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 729 WAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
........+....-+.......+.+..+.+++.+||+.||++||||.||++.|+.+.
T Consensus 240 ~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 001111111110000001113456678999999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=382.80 Aligned_cols=261 Identities=28% Similarity=0.401 Sum_probs=211.7
Q ss_pred HHHHhhhcccCcccceEEEEEEEc-----CCcEEEEEEEeecccc-hhHHHHHHHHHHHhcc-CcCchhhhhhhhccCCc
Q 003772 510 KATNRFKEELGKGSFGAVYKGTLY-----KGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSK 582 (796)
Q Consensus 510 ~~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~ 582 (796)
...+.+.+.||+|+||.||+|++. ..++.||||+++.... ....+|.+|+.++.++ +||||++++++|.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 345667899999999999999863 3457899999976443 3445799999999999 69999999999999999
Q ss_pred eeEEEeecCCCChhhhhhcCC----------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEe
Q 003772 583 RLLVYEYMSNGSLADILFRGP----------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILM 646 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 646 (796)
.++||||+++|+|.++++... ...+++..++.++.||++||.|||++ +|+||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999997532 23689999999999999999999998 99999999999999
Q ss_pred cCCCceEEeccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHH
Q 003772 647 DEFWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIV 725 (796)
Q Consensus 647 ~~~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~ 725 (796)
+.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+|++.|+...........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999997765433 333346789999999999999999999999999999999996666543332222211
Q ss_pred HHHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCc
Q 003772 726 LINWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGIT 785 (796)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~ 785 (796)
...... . ....+...+..+.+|+.+||+.||.+||||++|+++|++++
T Consensus 259 --~~i~~~---------~-~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 259 --KMIKEG---------F-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp --HHHHHT---------C-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHhcC---------C-CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 000000 0 11223344577999999999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.9e-44 Score=375.70 Aligned_cols=257 Identities=22% Similarity=0.332 Sum_probs=201.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---hhHHHHHHHHHHHhccCcCchhhhhhhhccCC----cee
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS----KRL 584 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~ 584 (796)
++.+.+.||+|+||.||+|++...++.||||++++... +..+.|.+|+.++++++||||+++++++...+ ..+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 35677899999999999999988899999999975432 23457899999999999999999999987644 378
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+||||+++|+|.+++.. .+.+++..++.++.||++||.|||+. +|+||||||+|||++.++..+|+|||.+....
T Consensus 88 lvmE~~~g~~L~~~~~~--~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEECCCCCEehhhhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhc
Confidence 99999999999999876 46799999999999999999999998 99999999999999999999999999987664
Q ss_pred CCCc--ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 665 PDQT--RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 665 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
.... .......||+.|||||++.+..+++++|||||||++|||++|+.||.... ..+.. .........
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~-----~~~~~~~~~--- 232 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--PVSVA-----YQHVREDPI--- 232 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHH-----HHHHHCCCC---
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC--HHHHH-----HHHHhcCCC---
Confidence 3322 23334569999999999999999999999999999999999999996432 11111 111100000
Q ss_pred hcCCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHhcC
Q 003772 743 VRGQEVDRNTLENMIKIGLWCVQDEPALRP-SMKSVVLMLEGI 784 (796)
Q Consensus 743 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~~ 784 (796)
.........++.+.+++.+||+.||.+|| |++++++.|.++
T Consensus 233 -~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 -PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 00111233456789999999999999999 899999888764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=380.92 Aligned_cols=260 Identities=25% Similarity=0.383 Sum_probs=209.2
Q ss_pred HHhhhcccCcccceEEEEEEEcC-----CcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeE
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYK-----GEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLL 585 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 585 (796)
...+.++||+|+||.||+|.+.. .+..||||++++... +....|.+|++++++++||||++++|+|..++..++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence 44567899999999999998742 246899999976433 344568999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcC--------CCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEecc
Q 003772 586 VYEYMSNGSLADILFRG--------PERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDF 657 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 657 (796)
||||+++|+|.+++... ....+++..+..++.|+|+||.|||++ +|+||||||+|||+++++.+||+||
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeec
Confidence 99999999999998642 124578999999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCcce-eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhh
Q 003772 658 GLAKLLMPDQTRT-FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFID 736 (796)
Q Consensus 658 gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
|+++.+....... .....||+.|+|||.+.+..++.++||||||+++|||+||+.|+....... .. ......
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-~~------~~~i~~ 250 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QV------LRFVME 250 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-HH------HHHHHT
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH-HH------HHHHHh
Confidence 9998765433322 223458999999999999999999999999999999999975443222111 11 111111
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 737 RELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
+. ....+...+..+.+++.+||+.+|++||||++|+++|++.++.
T Consensus 251 ~~------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 251 GG------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp TC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CC------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 11 1112344567899999999999999999999999999987653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.5e-44 Score=377.51 Aligned_cols=243 Identities=23% Similarity=0.319 Sum_probs=205.1
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEY 589 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 589 (796)
+++.+.||+|+||+||+++...+++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 567789999999999999998888999999997532 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcc
Q 003772 590 MSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTR 669 (796)
Q Consensus 590 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~ 669 (796)
+++|+|..++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 86 IEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp CCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred cCCccccccccc--cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 999999999876 56788899999999999999999998 9999999999999999999999999999876432
Q ss_pred eeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCC
Q 003772 670 TFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVD 749 (796)
Q Consensus 670 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (796)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.... .... ....... ....+
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~------~~~i~~~-------~~~~p 221 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--TMKT------YEKILNA-------ELRFP 221 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHH------HHHHHHC-------CCCCC
T ss_pred -cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--HHHH------HHHHHcC-------CCCCC
Confidence 234569999999999999999999999999999999999999996432 1111 1111111 11223
Q ss_pred HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003772 750 RNTLENMIKIGLWCVQDEPALRP-----SMKSVVL 779 (796)
Q Consensus 750 ~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~ 779 (796)
....+.+.+++.+||+.||.+|| |++++++
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 34456788999999999999996 8999985
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=377.81 Aligned_cols=259 Identities=30% Similarity=0.412 Sum_probs=205.2
Q ss_pred HHhhhcccCcccceEEEEEEEcCCc-------EEEEEEEeecccch-hHHHHHHHHHHHhcc-CcCchhhhhhhhccCCc
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGE-------KLVAVKKLEKMVTE-GEREFRAEMHVIGRT-HHKNLVRLIGYCAEDSK 582 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~-------~~vAvK~l~~~~~~-~~~~f~~E~~~l~~l-~h~niv~l~g~~~~~~~ 582 (796)
.+.+.+.||+|+||.||+|+....+ ..||||++++...+ ...++.+|...+.++ +||||++++++|.+++.
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 4567789999999999999875443 47999999775543 457789999999888 79999999999999999
Q ss_pred eeEEEeecCCCChhhhhhcCC--------------CCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC
Q 003772 583 RLLVYEYMSNGSLADILFRGP--------------ERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE 648 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 648 (796)
.++||||+++|+|.++|.... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence 999999999999999997542 35689999999999999999999999 9999999999999999
Q ss_pred CCceEEeccCCccccCCCCc-ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhh-cccCCCCCCCCchhHHH
Q 003772 649 FWTAKISDFGLAKLLMPDQT-RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVC-CRRNMEIDPSKPEEIVL 726 (796)
Q Consensus 649 ~~~~kl~DFgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ellt-g~~p~~~~~~~~~~~~~ 726 (796)
++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..|+.... ....
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~--~~~~-- 246 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VEEL-- 246 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHH--
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC--HHHH--
Confidence 99999999999987754332 22334568999999999999999999999999999999998 566664322 1111
Q ss_pred HHHHHHhhhhhhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcCcCC
Q 003772 727 INWAYKCFIDRELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGITDI 787 (796)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~~~~ 787 (796)
......+ .....+...++.+.+|+.+||+.||++|||+.||+++|+++..+
T Consensus 247 ----~~~i~~~------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 247 ----FKLLKEG------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp ----HHHHHTT------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHcC------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 1111111 01122334556799999999999999999999999999987643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-43 Score=367.94 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=204.1
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc---------hhHHHHHHHHHHHhccC-cCchhhhhhhhccCCc
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT---------EGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSK 582 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---------~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~ 582 (796)
+.+.+.||+|+||+||+++...+++.||||++.+... ...+.+.+|+.++++++ ||||+++++++.+++.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 4567899999999999999988899999999975321 12345889999999997 9999999999999999
Q ss_pred eeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 583 RLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 583 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
.++||||+++|+|.++|.. ...+++..++.++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence 9999999999999999976 46799999999999999999999998 999999999999999999999999999998
Q ss_pred cCCCCcceeeeeccCCCCCchhhhcc------CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhh
Q 003772 663 LMPDQTRTFTLVRGTRGYMAPEWYKN------TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFID 736 (796)
Q Consensus 663 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 736 (796)
...... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .. . ......
T Consensus 160 ~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--~~-~-----~~~i~~ 229 (277)
T d1phka_ 160 LDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--ML-M-----LRMIMS 229 (277)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH-H-----HHHHHH
T ss_pred ccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--HH-H-----HHHHHh
Confidence 755332 234569999999999863 3568899999999999999999999974421 11 1 111111
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 737 RELNKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
+... ..........+++.+++.+||+.||++|||+.||++
T Consensus 230 ~~~~---~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 230 GNYQ---FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TCCC---CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCC---CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1100 011122345578999999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-43 Score=380.74 Aligned_cols=247 Identities=23% Similarity=0.280 Sum_probs=200.0
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHH---HHHHHhccCcCchhhhhhhhccCCceeEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRA---EMHVIGRTHHKNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~---E~~~l~~l~h~niv~l~g~~~~~~~~~lV 586 (796)
+.+.+.||+|+||.||+|+....++.||||++.+.. ......+.+ |+.+++.++||||+++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 456789999999999999999888999999996532 122233444 47777888999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCC
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPD 666 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~ 666 (796)
|||+++|+|.++|.+ ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 86 mE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp ECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 999999999999976 46788999999999999999999998 9999999999999999999999999999876543
Q ss_pred CcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcC
Q 003772 667 QTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRG 745 (796)
Q Consensus 667 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (796)
.. ....||+.|||||++.. ..++.++|||||||+||||++|+.||........... .... ....
T Consensus 161 ~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-----~~~~-------~~~~ 225 (364)
T d1omwa3 161 KP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-----DRMT-------LTMA 225 (364)
T ss_dssp CC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-----HHHS-------SSCC
T ss_pred cc---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhc-------ccCC
Confidence 32 33469999999999975 5689999999999999999999999975433221110 0000 0011
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 003772 746 QEVDRNTLENMIKIGLWCVQDEPALRPS-----MKSVVL 779 (796)
Q Consensus 746 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 779 (796)
...+....+.+.+++..||+.||.+||| ++|+++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1223345567899999999999999999 588864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-43 Score=370.11 Aligned_cols=257 Identities=23% Similarity=0.286 Sum_probs=197.6
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeecccch-----hHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecC
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE-----GEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMS 591 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-----~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 591 (796)
++||+|+||+||+|++...++.||||+++..... ..+.+.+|+.++++++||||+++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 6799999999999999888899999998653322 13468899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCccee
Q 003772 592 NGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRTF 671 (796)
Q Consensus 592 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~~ 671 (796)
++++..++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 84 ~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~ 157 (299)
T d1ua2a_ 84 TDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-Y 157 (299)
T ss_dssp EEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-C
T ss_pred chHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc-c
Confidence 9877766643 56799999999999999999999998 9999999999999999999999999999876543322 2
Q ss_pred eeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhh---hhhhhhhhcC--
Q 003772 672 TLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFI---DRELNKLVRG-- 745 (796)
Q Consensus 672 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-- 745 (796)
....||+.|+|||++... .++.++|||||||++|||++|+.||...... + .+ ....+... ..........
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~-~l-~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--D-QL-TRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--H-HH-HHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH--H-HH-HHHHHhcCCCChhhccchhccch
Confidence 234589999999998755 6799999999999999999999998643211 1 11 10111000 0000000000
Q ss_pred -------CCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhc
Q 003772 746 -------QEV-----DRNTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEG 783 (796)
Q Consensus 746 -------~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~ 783 (796)
... .....+.+.+|+.+||+.||++|||++|+++ .++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 000 1123467899999999999999999999987 4644
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=375.07 Aligned_cols=246 Identities=24% Similarity=0.324 Sum_probs=202.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHh-ccCcCchhhhhhhhccCCceeEEEe
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIG-RTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
+.+.+.||+|+||+||+|+....++.||||++++.. ....+.+..|..++. .++||||+++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 457789999999999999999999999999997532 233455667777665 6899999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 84 y~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 84 YLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred ecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 9999999999976 46789999999999999999999998 999999999999999999999999999986654332
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ... . ...... .....
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--~~~-~-----~~~i~~-------~~~~~ 222 (320)
T d1xjda_ 159 -KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--EEE-L-----FHSIRM-------DNPFY 222 (320)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHH-H-----HHHHHH-------CCCCC
T ss_pred -cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--HHH-H-----HHHHHc-------CCCCC
Confidence 2334569999999999999999999999999999999999999996432 111 1 111111 11122
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALRPSMK-SVVL 779 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~ 779 (796)
+......+.+|+.+||+.||++|||+. +|++
T Consensus 223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 334456789999999999999999995 6753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-43 Score=371.02 Aligned_cols=249 Identities=20% Similarity=0.309 Sum_probs=203.8
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeecCC
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYMSN 592 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 592 (796)
|.+.+.||+|+||+||+|....+++.||||+++... .....+.+|+++|++++||||+++++++.+++..++||||+++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 567789999999999999999889999999997643 3445688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCC--CceEEeccCCccccCCCCcce
Q 003772 593 GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEF--WTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 593 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFgl~~~~~~~~~~~ 670 (796)
|+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.+ ..+||+|||+++...... .
T Consensus 86 g~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--~ 159 (321)
T d1tkia_ 86 LDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N 159 (321)
T ss_dssp CBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--E
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC--c
Confidence 9999999653 34699999999999999999999998 99999999999999854 589999999998765433 2
Q ss_pred eeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCCCH
Q 003772 671 FTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEVDR 750 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (796)
.....+|+.|+|||.+.+..++.++||||+||++|||++|+.||..... .. . ...+...... -......
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--~~-~-----~~~i~~~~~~---~~~~~~~ 228 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQ-I-----IENIMNAEYT---FDEEAFK 228 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HH-H-----HHHHHHTCCC---CCHHHHT
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--HH-H-----HHHHHhCCCC---CChhhcc
Confidence 3345689999999999999999999999999999999999999975421 11 1 0111100000 0000001
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 751 NTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 751 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....++.+++..||+.||.+|||+.|+++
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 23456889999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-43 Score=376.29 Aligned_cols=244 Identities=21% Similarity=0.248 Sum_probs=205.1
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc---chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV---TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 588 (796)
.+++.+.||+|+||.||++++..+++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 4566789999999999999998888999999997532 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCc
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQT 668 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~ 668 (796)
|+.+|+|.+++.+ .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 122 ~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~- 195 (350)
T d1rdqe_ 122 YVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp CCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred cccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence 9999999999976 35799999999999999999999998 99999999999999999999999999999765322
Q ss_pred ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhhcCCCC
Q 003772 669 RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLVRGQEV 748 (796)
Q Consensus 669 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (796)
....||+.|||||++.+..++.++|||||||++|||++|+.||.... ... . ....... ....
T Consensus 196 ---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~-~-----~~~i~~~-------~~~~ 257 (350)
T d1rdqe_ 196 ---WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQ-I-----YEKIVSG-------KVRF 257 (350)
T ss_dssp ---CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHH-H-----HHHHHHC-------CCCC
T ss_pred ---ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHH-H-----HHHHhcC-------CCCC
Confidence 23469999999999999999999999999999999999999996432 111 1 1111111 0112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCC-----CCHHHHHH
Q 003772 749 DRNTLENMIKIGLWCVQDEPALR-----PSMKSVVL 779 (796)
Q Consensus 749 ~~~~~~~l~~l~~~cl~~dP~~R-----Pt~~evl~ 779 (796)
+....+.+.+++..||+.||.+| ||++|+++
T Consensus 258 p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 33445678999999999999999 48999985
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-43 Score=375.44 Aligned_cols=250 Identities=21% Similarity=0.242 Sum_probs=197.8
Q ss_pred Hhhh-cccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhcc-CcCchhhhhhhhcc----CCceeEE
Q 003772 513 NRFK-EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRT-HHKNLVRLIGYCAE----DSKRLLV 586 (796)
Q Consensus 513 ~~~~-~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lV 586 (796)
+.+. +.||+|+||.||+|++..+++.||||++++ .+.+.+|+.++.++ +||||+++++++.+ +...++|
T Consensus 13 y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 3444 569999999999999988889999999864 34577899887655 89999999998865 4568999
Q ss_pred EeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC---CCceEEeccCCcccc
Q 003772 587 YEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE---FWTAKISDFGLAKLL 663 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFgl~~~~ 663 (796)
|||+++|+|.++|.+.....+++..+..++.||+.||.|||+. +|+||||||+|||+++ ++.+||+|||+++..
T Consensus 88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeec
Confidence 9999999999999875556899999999999999999999998 9999999999999985 567999999999876
Q ss_pred CCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
..... .....||+.|||||++.+..++.++|||||||+||||++|+.||...........+ ........ ..
T Consensus 165 ~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~----~~~i~~~~---~~ 235 (335)
T d2ozaa1 165 TSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQ---YE 235 (335)
T ss_dssp CCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCS---SS
T ss_pred cCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH----HHHHhcCC---CC
Confidence 54432 23456999999999999999999999999999999999999999754322110000 00000000 00
Q ss_pred cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 744 RGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 744 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
-+........+.+.+|+..||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000011234567999999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=364.78 Aligned_cols=239 Identities=26% Similarity=0.394 Sum_probs=197.2
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccch------hHHHHHHHHHHHhccC--cCchhhhhhhhccCCce
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTE------GEREFRAEMHVIGRTH--HKNLVRLIGYCAEDSKR 583 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~------~~~~f~~E~~~l~~l~--h~niv~l~g~~~~~~~~ 583 (796)
++.+.+.||+|+||.||+|+...+++.||||++.+.... ....+.+|+.++++++ ||||+++++++.+.+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 456778999999999999999888899999998753211 2244778999999986 89999999999999999
Q ss_pred eEEEeecCC-CChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-CCceEEeccCCcc
Q 003772 584 LLVYEYMSN-GSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE-FWTAKISDFGLAK 661 (796)
Q Consensus 584 ~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgl~~ 661 (796)
++||||+.+ +++.+++.+ ...+++..++.++.||++||.|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccce
Confidence 999999976 678888765 46799999999999999999999998 9999999999999985 5799999999998
Q ss_pred ccCCCCcceeeeeccCCCCCchhhhccCCC-CccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhh
Q 003772 662 LLMPDQTRTFTLVRGTRGYMAPEWYKNTPI-SVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELN 740 (796)
Q Consensus 662 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (796)
...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+ ...
T Consensus 160 ~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~i----------~~~--- 219 (273)
T d1xwsa_ 160 LLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EI----------IRG--- 219 (273)
T ss_dssp ECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HH----------HHC---
T ss_pred eccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----HH----------hhc---
Confidence 754332 234569999999999988765 677899999999999999999996321 00 000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 741 KLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 741 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
....+....+++.+++.+||+.||++|||++|+++
T Consensus 220 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 ----QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01122234467899999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-42 Score=363.26 Aligned_cols=263 Identities=22% Similarity=0.307 Sum_probs=202.3
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc--hhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT--EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+.+.+.||+|+||+||+|++...++.||||+++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 4556889999999999999988888999999965332 23567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
.+ ++.+++.......+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 84 ~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-~ 158 (298)
T d1gz8a_ 84 HQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-T 158 (298)
T ss_dssp SE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-C
T ss_pred CC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc-c
Confidence 75 455555555567899999999999999999999998 999999999999999999999999999987654332 2
Q ss_pred eeeeccCCCCCchhhhccCC-CCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh--hhh----hhhhhh
Q 003772 671 FTLVRGTRGYMAPEWYKNTP-ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF--IDR----ELNKLV 743 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~----~~~~~~ 743 (796)
.....||+.|+|||.+.... .+.++|||||||++|||++|+.||..... ... +.. ..... ... ......
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~--~~~-~~~-i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQ-LFR-IFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHH-HHH-HHHHHCCCCTTTSTTGGGST
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH--HHH-HHH-HHHhcCCCchhhcccccccc
Confidence 23346899999999987765 58999999999999999999999964321 111 100 01100 000 000000
Q ss_pred cCC-------CC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HhcC
Q 003772 744 RGQ-------EV-----DRNTLENMIKIGLWCVQDEPALRPSMKSVVLM--LEGI 784 (796)
Q Consensus 744 ~~~-------~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~ 784 (796)
... .. .......+.+++.+||+.||++|||+.|+++. ++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000 00 11233678899999999999999999999984 6555
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.8e-41 Score=351.85 Aligned_cols=258 Identities=22% Similarity=0.254 Sum_probs=196.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+++.++||+|+||+||+|++. .++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++++||+
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 455688999999999999986 45789999996533 233578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
.++.+..+... .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||.+.........
T Consensus 83 ~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~- 156 (286)
T d1ob3a_ 83 DQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK- 156 (286)
T ss_dssp SEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred hhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc-
Confidence 98777766644 57899999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHH-Hhhhhhhh---hhhhcC
Q 003772 671 FTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAY-KCFIDREL---NKLVRG 745 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~ 745 (796)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.... ........... ........ ......
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC--HHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 2233589999999998765 57999999999999999999999996432 11111000000 00000000 000000
Q ss_pred ------------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 746 ------------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 746 ------------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
..........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0012233467889999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-41 Score=356.06 Aligned_cols=263 Identities=24% Similarity=0.325 Sum_probs=196.9
Q ss_pred HHhhhcccCcccceEEEEEEEc-CCcEEEEEEEeecccch--hHHHHHHHHHHHhcc---CcCchhhhhhhhcc-----C
Q 003772 512 TNRFKEELGKGSFGAVYKGTLY-KGEKLVAVKKLEKMVTE--GEREFRAEMHVIGRT---HHKNLVRLIGYCAE-----D 580 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~-~~~~~vAvK~l~~~~~~--~~~~f~~E~~~l~~l---~h~niv~l~g~~~~-----~ 580 (796)
.+++.++||+|+||+||+|++. .+++.||||++...... ....+.+|+.+++.+ +||||+++++++.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 4566789999999999999985 44678999998653322 233566777777665 79999999998853 3
Q ss_pred CceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCc
Q 003772 581 SKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLA 660 (796)
Q Consensus 581 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~ 660 (796)
...++++||++++.+...... ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhh
Confidence 467999999998876554433 357799999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh---hhh
Q 003772 661 KLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF---IDR 737 (796)
Q Consensus 661 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 737 (796)
+..... .......||+.|||||++.+..++.++||||+||++|||++|+.||..... .. .+.. ..... ...
T Consensus 164 ~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~--~~-~~~~-i~~~~~~~~~~ 237 (305)
T d1blxa_ 164 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VD-QLGK-ILDVIGLPGEE 237 (305)
T ss_dssp CCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH-HHHH-HHHHHCCCCGG
T ss_pred hhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH--HH-HHHH-HHHhhCCCchh
Confidence 865432 233445699999999999999999999999999999999999999964321 11 1111 00000 000
Q ss_pred hhhh-------hh-cCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HhcC
Q 003772 738 ELNK-------LV-RGQ-----EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM--LEGI 784 (796)
Q Consensus 738 ~~~~-------~~-~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~ 784 (796)
.... .. ... .......+.+.+|+.+||+.||++|||++|+++. ++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 0000 00 000 0122334678899999999999999999999863 5444
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-40 Score=348.28 Aligned_cols=259 Identities=22% Similarity=0.236 Sum_probs=198.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhh-hccCCceeEEEeec
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGY-CAEDSKRLLVYEYM 590 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~-~~~~~~~~lV~e~~ 590 (796)
++.+.+.||+|+||.||+|++..+++.||||++... ...+++..|++++++++|+|++..+.. ..+++..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC--TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh--ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 366789999999999999999888899999998653 234568899999999988776665544 46677888999998
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEec---CCCceEEeccCCccccCCCC
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMD---EFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFgl~~~~~~~~ 667 (796)
. ++|.+.+... ...+++..+..++.|+++||+|||++ +|+||||||+|||++ .+..+||+|||+++.+....
T Consensus 86 ~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 86 G-PSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp C-CBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred C-Cchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 5 5666665442 56799999999999999999999998 999999999999986 45679999999999875433
Q ss_pred c------ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhh
Q 003772 668 T------RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNK 741 (796)
Q Consensus 668 ~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (796)
. .......||+.|||||.+.+..++.++|||||||++|||++|+.||................... .......
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 239 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-MSTPIEV 239 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH-HHSCHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc-CCCChhH
Confidence 2 12234569999999999999999999999999999999999999997554332211111111110 0000111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 742 LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 742 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
. ....++.+.+++..||+.+|++||+++++.+.|+.+
T Consensus 240 ~------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 240 L------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp H------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred h------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1 123346788999999999999999999999888764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.7e-40 Score=346.03 Aligned_cols=259 Identities=19% Similarity=0.210 Sum_probs=205.8
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCc-CchhhhhhhhccCCceeEEEeec
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHH-KNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
.+.+.++||+|+||.||+|++...++.||||++... .....+++|++.+..++| +|++.+++++.++...++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 356788999999999999999988999999998653 234467889999999975 89999999999999999999998
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecC-----CCceEEeccCCccccCC
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDE-----FWTAKISDFGLAKLLMP 665 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFgl~~~~~~ 665 (796)
+++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.+..
T Consensus 84 -~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 84 -GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp -CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred -CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 68999988653 45799999999999999999999998 9999999999999974 57899999999997654
Q ss_pred CCc------ceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhh
Q 003772 666 DQT------RTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDREL 739 (796)
Q Consensus 666 ~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (796)
... .......||+.|||||.+.+..++.++|||||||++|||++|+.||................... .....
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~ 237 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QSTPL 237 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-HHSCH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-CCCCh
Confidence 322 12234569999999999999999999999999999999999999997554333221111110000 00011
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHhcC
Q 003772 740 NKLVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLMLEGI 784 (796)
Q Consensus 740 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~~ 784 (796)
.++ ....++++.+++..|++.+|++||+++.+.+.|+.+
T Consensus 238 ~~l------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 238 REL------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHH------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHh------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111 112346688899999999999999999998888764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=355.64 Aligned_cols=267 Identities=22% Similarity=0.273 Sum_probs=198.3
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccc-hhHHHHHHHHHHHhccCcCchhhhhhhhccCC----ceeEEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT-EGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS----KRLLVY 587 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~ 587 (796)
+++.++||+|+||+||+|....+++.||||++.+... ...+.+++|+.+|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 5567899999999999999988889999999976433 34567899999999999999999999987543 345666
Q ss_pred eecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCC
Q 003772 588 EYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 588 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~ 667 (796)
+|+.+|+|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 90 ~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 90 THLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 77889999999965 4699999999999999999999998 99999999999999999999999999998765433
Q ss_pred cc--eeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhh--------
Q 003772 668 TR--TFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFID-------- 736 (796)
Q Consensus 668 ~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 736 (796)
.. ......||+.|+|||.+.. ..++.++||||+||++|||++|+.||........ .............
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHTCCC
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhhccCCChhhhhhhhh
Confidence 22 2234568999999999854 4678999999999999999999999965421110 0000000000000
Q ss_pred ----hhhhhhhcCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HhcCcC
Q 003772 737 ----RELNKLVRGQEVD-----RNTLENMIKIGLWCVQDEPALRPSMKSVVLM--LEGITD 786 (796)
Q Consensus 737 ----~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~ 786 (796)
............+ .....++.+++..||+.||.+|||+.|+++. |+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 0000000000011 1223568899999999999999999999974 554433
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-40 Score=345.66 Aligned_cols=261 Identities=20% Similarity=0.232 Sum_probs=204.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCCceeEEEeec
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDSKRLLVYEYM 590 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 590 (796)
+++.++||+|+||+||+|++..+++.||||+++... ....+.+.+|+.++++++|+||+++++++.+....++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 456689999999999999999888999999986533 234578899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCCCCcce
Q 003772 591 SNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMPDQTRT 670 (796)
Q Consensus 591 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~~~~~~ 670 (796)
.+++|..++.. .+.+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||.++........
T Consensus 84 ~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~- 157 (292)
T d1unla_ 84 DQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC- 157 (292)
T ss_dssp SEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-
T ss_pred ccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc-
Confidence 99999888765 56789999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeeeccCCCCCchhhhccCC-CCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhh---hhhhhcC-
Q 003772 671 FTLVRGTRGYMAPEWYKNTP-ISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRE---LNKLVRG- 745 (796)
Q Consensus 671 ~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~- 745 (796)
.....+++.|+|||.+.... ++.++|||||||++|||++|+.||........................ .......
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 22334778899999987765 699999999999999999999998644322211111110000000000 0000000
Q ss_pred -----------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 746 -----------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 746 -----------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
........+.+.+|+.+||+.||.+|||++||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112334467889999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=347.85 Aligned_cols=263 Identities=20% Similarity=0.254 Sum_probs=194.2
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecc--cchhHHHHHHHHHHHhccCcCchhhhhhhhcc--------CC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKM--VTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE--------DS 581 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~--------~~ 581 (796)
++++.++||+|+||+||+|++...++.||||++... .....+.+.+|+.+|++++|+||+++++++.. +.
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 456678999999999999999888899999998543 23345678999999999999999999998754 34
Q ss_pred ceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcc
Q 003772 582 KRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661 (796)
Q Consensus 582 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~ 661 (796)
..++||||+.++.+...... ...++...+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceee
Confidence 67899999998876655433 56788999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcc---eeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhh
Q 003772 662 LLMPDQTR---TFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDR 737 (796)
Q Consensus 662 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 737 (796)
........ ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ ..............
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~ 244 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSITPE 244 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH-HHHHHHhcCCCChh
Confidence 76543321 22234589999999998765 689999999999999999999999964321111 10000000000000
Q ss_pred hhhhh--------hc---CCCCC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 738 ELNKL--------VR---GQEVD-------RNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 738 ~~~~~--------~~---~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
..... .. ..... ....+.+.+|+.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000 00 00000 0113456789999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-40 Score=350.63 Aligned_cols=251 Identities=23% Similarity=0.271 Sum_probs=203.2
Q ss_pred HhhhcccCcccceEEEEEEEc---CCcEEEEEEEeeccc----chhHHHHHHHHHHHhccCc-CchhhhhhhhccCCcee
Q 003772 513 NRFKEELGKGSFGAVYKGTLY---KGEKLVAVKKLEKMV----TEGEREFRAEMHVIGRTHH-KNLVRLIGYCAEDSKRL 584 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~----~~~~~~f~~E~~~l~~l~h-~niv~l~g~~~~~~~~~ 584 (796)
+++.+.||+|+||.||+|+.. ..++.||||++++.. ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 677899999999999999863 356899999986532 2335678899999999976 89999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+|+||+.+|+|.+++.. ...++...+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 106 ~v~e~~~~~~L~~~i~~--~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeecccccHHHHHHHh--cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 99999999999999976 45678889999999999999999998 99999999999999999999999999998776
Q ss_pred CCCcceeeeeccCCCCCchhhhccC--CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhh
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNT--PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKL 742 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (796)
...........|++.|+|||.+... .++.++|||||||+||||++|+.||...........+.....
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~----------- 249 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL----------- 249 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-----------
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-----------
Confidence 5544444456699999999999754 478899999999999999999999976543322211111000
Q ss_pred hcCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 003772 743 VRGQEVDRNTLENMIKIGLWCVQDEPALRPS-----MKSVVL 779 (796)
Q Consensus 743 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~ 779 (796)
......+.+..+++.+++..||+.||++||| ++|+++
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0111223445678999999999999999994 788875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-40 Score=353.17 Aligned_cols=267 Identities=22% Similarity=0.267 Sum_probs=194.9
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhccCC------ce
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAEDS------KR 583 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 583 (796)
++.+.++||+|+||+||+|.+...++.||||++.+.. ....+.+.+|+++|++++||||+++++++...+ +.
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 3556688999999999999998888999999997532 233567889999999999999999999987654 46
Q ss_pred eEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCcccc
Q 003772 584 LLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLL 663 (796)
Q Consensus 584 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~ 663 (796)
++||||+ +.+|..++.. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 99 ~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp EEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceecc
Confidence 9999999 4577777654 5699999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHH--------Hhh
Q 003772 664 MPDQTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAY--------KCF 734 (796)
Q Consensus 664 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~ 734 (796)
.... +...||+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ........ ...
T Consensus 172 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 172 DSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHTC
T ss_pred CCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HHHHHhccCCCcHHHHhhh
Confidence 4332 334589999999998764 579999999999999999999999965421110 00000000 000
Q ss_pred hhh----hhhhhhcCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HhcCcCCCCC
Q 003772 735 IDR----ELNKLVRGQ-----EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM--LEGITDISIP 790 (796)
Q Consensus 735 ~~~----~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~~~~~~~p 790 (796)
... ......... .......+.+.+|+.+||+.||.+|||+.|+++. ++.+.+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~ 313 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE 313 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-----
T ss_pred cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcccc
Confidence 000 000000000 0112334568899999999999999999999974 7776554433
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-40 Score=353.18 Aligned_cols=263 Identities=24% Similarity=0.269 Sum_probs=194.9
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhhhhhhhcc------CCceeEE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVRLIGYCAE------DSKRLLV 586 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~~~~lV 586 (796)
|+..++||+|+||+||+|++...++.||||++.+... .+.+|+.++++++|+||+++++++.. ....++|
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 4456789999999999999998889999999975432 23579999999999999999998853 2346899
Q ss_pred EeecCCCChhhhhhc-CCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC-ceEEeccCCccccC
Q 003772 587 YEYMSNGSLADILFR-GPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW-TAKISDFGLAKLLM 664 (796)
Q Consensus 587 ~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgl~~~~~ 664 (796)
|||++++.+..+... .....+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++...
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999987654444321 2356799999999999999999999998 999999999999999765 89999999998775
Q ss_pred CCCcceeeeeccCCCCCchhhhcc-CCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhhhhhhhhhhh
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKN-TPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCFIDRELNKLV 743 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (796)
..... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........ ...............+....
T Consensus 175 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 175 RGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp TTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHC
T ss_pred CCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCChHHhhhhhc
Confidence 44322 23458999999998875 4789999999999999999999999965431110 00000000000000000000
Q ss_pred ----cC-----------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhcCc
Q 003772 744 ----RG-----------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEGIT 785 (796)
Q Consensus 744 ----~~-----------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~ 785 (796)
.. ........+++.+|+.+||+.||++|||+.|+++ .++.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00 0112234567889999999999999999999995 355543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.4e-39 Score=343.63 Aligned_cols=255 Identities=18% Similarity=0.317 Sum_probs=197.3
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-cCchhhhhhhhcc--CCceeEEEe
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-HKNLVRLIGYCAE--DSKRLLVYE 588 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lV~e 588 (796)
.+++.++||+|+||+||+|+...+++.||||+++.. ..+.+.+|+.+|.+++ ||||+++++++.. ....++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 466778999999999999999888999999999653 3467889999999995 9999999999874 456899999
Q ss_pred ecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC-ceEEeccCCccccCCCC
Q 003772 589 YMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW-TAKISDFGLAKLLMPDQ 667 (796)
Q Consensus 589 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgl~~~~~~~~ 667 (796)
|+++++|..+. +.+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++......
T Consensus 113 ~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 113 HVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp CCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred ecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 99999998764 4589999999999999999999998 999999999999998654 69999999998765443
Q ss_pred cceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHH-----hh-------
Q 003772 668 TRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYK-----CF------- 734 (796)
Q Consensus 668 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~------- 734 (796)
. .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.................. ..
T Consensus 185 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 185 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred c--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 2 2334589999999998775 4799999999999999999999999755432111111000000 00
Q ss_pred hhhhhhhhhcC-----------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003772 735 IDRELNKLVRG-----------QEVDRNTLENMIKIGLWCVQDEPALRPSMKSVVL 779 (796)
Q Consensus 735 ~~~~~~~~~~~-----------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~ 779 (796)
........... ........+++.+|+.+||+.||.+|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000111000 0011233467889999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-38 Score=340.53 Aligned_cols=266 Identities=20% Similarity=0.235 Sum_probs=197.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhcc-----CCceeE
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAE-----DSKRLL 585 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~l 585 (796)
|++.++||+|+||+||+|++...++.||||++.+.. ....+.+.+|+.+|++++|+|++++++++.. ....++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 566789999999999999998889999999997543 2344678899999999999999999998863 334577
Q ss_pred EEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccCC
Q 003772 586 VYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLMP 665 (796)
Q Consensus 586 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~~ 665 (796)
+++|+.+|+|.+++.. +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++.....
T Consensus 100 i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp EEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc
Confidence 8888999999999954 4699999999999999999999998 999999999999999999999999999976532
Q ss_pred CCcceeeeeccCCCCCchhhhccC-CCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHH-------HHhhhhh
Q 003772 666 DQTRTFTLVRGTRGYMAPEWYKNT-PISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWA-------YKCFIDR 737 (796)
Q Consensus 666 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~ 737 (796)
......|++.|+|||.+.+. .++.++|||||||++|||++|+.||................ .......
T Consensus 174 ----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 174 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp ----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred ----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 22334588999999987765 46899999999999999999999996432111000000000 0000000
Q ss_pred hhhhh----hcCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHhcCcCCC
Q 003772 738 ELNKL----VRGQEV-----DRNTLENMIKIGLWCVQDEPALRPSMKSVVL--MLEGITDIS 788 (796)
Q Consensus 738 ~~~~~----~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~~~~~~ 788 (796)
..... ...... .....+.+.+|+.+||+.||.+|||++|+++ .+++..+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~ 311 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCc
Confidence 00000 000000 1123456889999999999999999999997 566654433
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=336.00 Aligned_cols=255 Identities=22% Similarity=0.213 Sum_probs=187.6
Q ss_pred HhhhcccCcccceEEEEEEEcCCcEEEEEEEeeccc--chhHHHHHHHHHHHhccCcCchhhhhhhhcc------CCcee
Q 003772 513 NRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV--TEGEREFRAEMHVIGRTHHKNLVRLIGYCAE------DSKRL 584 (796)
Q Consensus 513 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~~l~~l~h~niv~l~g~~~~------~~~~~ 584 (796)
+++.++||+|+||+||+|.+...++.||||++.+.. ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 456689999999999999999889999999997533 2344578899999999999999999999863 36789
Q ss_pred EEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEeccCCccccC
Q 003772 585 LVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISDFGLAKLLM 664 (796)
Q Consensus 585 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~~~ 664 (796)
+||||+.++.+ +.+. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+|++|||+++...
T Consensus 99 iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 99 LVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccc
Confidence 99999976544 4442 4589999999999999999999998 99999999999999999999999999988664
Q ss_pred CCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchhHHHHHHHHHhh---------h
Q 003772 665 PDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEEIVLINWAYKCF---------I 735 (796)
Q Consensus 665 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------~ 735 (796)
... ......+|+.|+|||++.+..+++++||||+||++|||++|+.||...... ........... .
T Consensus 171 ~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~---~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 171 TSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHTTS
T ss_pred ccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH---HHHHHHHHhccCCCHHHHHHh
Confidence 432 223445899999999999999999999999999999999999999643211 00000000000 0
Q ss_pred hhhhhhhhcC-------------------C--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003772 736 DRELNKLVRG-------------------Q--EVDRNTLENMIKIGLWCVQDEPALRPSMKSVVLM 780 (796)
Q Consensus 736 ~~~~~~~~~~-------------------~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~ 780 (796)
.......... . .........+.+|+.+||+.||++|||++||++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000 0 0123456788999999999999999999999843
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-34 Score=315.35 Aligned_cols=276 Identities=21% Similarity=0.258 Sum_probs=197.5
Q ss_pred HHhhhcccCcccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCc-----------CchhhhhhhhccC
Q 003772 512 TNRFKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHH-----------KNLVRLIGYCAED 580 (796)
Q Consensus 512 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h-----------~niv~l~g~~~~~ 580 (796)
+|.+.++||+|+||+||+|+...+++.||||++++.. ...+.+.+|+.+++.++| +||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 3678899999999999999998888999999997642 234567889988888764 6777788777543
Q ss_pred --CceeEEEeecCCC-ChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCC------c
Q 003772 581 --SKRLLVYEYMSNG-SLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFW------T 651 (796)
Q Consensus 581 --~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~------~ 651 (796)
...+++++++..+ .............+++..+..++.||++||.|||+. .+|+||||||+|||++.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccce
Confidence 4556677766554 334444444567889999999999999999999983 2899999999999998655 3
Q ss_pred eEEeccCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHHHHhhcccCCCCCCCCchh---HHHHH
Q 003772 652 AKISDFGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLLEIVCCRRNMEIDPSKPEE---IVLIN 728 (796)
Q Consensus 652 ~kl~DFgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~elltg~~p~~~~~~~~~~---~~~~~ 728 (796)
++++|||.+....... ....||+.|+|||++....++.++||||+||+++||++|+.||......... ..+..
T Consensus 171 ~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 9999999998654322 2345899999999999999999999999999999999999999754322111 01100
Q ss_pred H--HHHhhhhhhh---------------------------hh-hhcCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 003772 729 W--AYKCFIDREL---------------------------NK-LVRGQEVDRNTLENMIKIGLWCVQDEPALRPSMKSVV 778 (796)
Q Consensus 729 ~--~~~~~~~~~~---------------------------~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl 778 (796)
. .......... .. ..............+.+|+.+||+.||.+|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0 0000000000 00 0001123456778899999999999999999999998
Q ss_pred HH--Hh---cCcCCCCCCCCC
Q 003772 779 LM--LE---GITDISIPPCPT 794 (796)
Q Consensus 779 ~~--L~---~~~~~~~p~~p~ 794 (796)
+. ++ ...+...|+.|.
T Consensus 327 ~Hp~f~~~~~~~~~~~p~~~~ 347 (362)
T d1q8ya_ 327 NHPWLKDTLGMEEIRVPDREL 347 (362)
T ss_dssp TCGGGTTCTTCTTCCCTTSCT
T ss_pred cCcccCCCCCcccCCCCCccc
Confidence 73 44 334555565554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=4.8e-21 Score=186.81 Aligned_cols=169 Identities=15% Similarity=0.120 Sum_probs=118.4
Q ss_pred hhcccCcccceEEEEEEEcCCcEEEEEEEeecccc------------------hhHHHHHHHHHHHhccCcCchhhhhhh
Q 003772 515 FKEELGKGSFGAVYKGTLYKGEKLVAVKKLEKMVT------------------EGEREFRAEMHVIGRTHHKNLVRLIGY 576 (796)
Q Consensus 515 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~------------------~~~~~f~~E~~~l~~l~h~niv~l~g~ 576 (796)
+.++||+|+||.||+|+..+ ++.||||+++.... ........|...+.++.|.+++..+++
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~-g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEECSSEEEEEEEETT-TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hCCEeeeCcceEEEEEECCC-CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 56899999999999999864 57899998743111 112234567888889999988877654
Q ss_pred hccCCceeEEEeecCCCChhhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhccCCCCeeeeccCccceEecCCCceEEec
Q 003772 577 CAEDSKRLLVYEYMSNGSLADILFRGPERSLGWDERVRIASDVAKGILYLHDECEAPIIHCDIKPQNILMDEFWTAKISD 656 (796)
Q Consensus 577 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 656 (796)
. ..+++|||+++..+.+ ++......++.|++++|.|||+. +|+||||||+|||++++ .++|+|
T Consensus 83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 2 3479999999865433 34455678999999999999998 99999999999999965 589999
Q ss_pred cCCccccCCCCcceeeeeccCCCCCchhhhccCCCCccccchhhHHHHH
Q 003772 657 FGLAKLLMPDQTRTFTLVRGTRGYMAPEWYKNTPISVKADVFSYGVVLL 705 (796)
Q Consensus 657 Fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvil~ 705 (796)
||++.............. ... --.|.+ ...++.++|+||..--+.
T Consensus 146 FG~a~~~~~~~~~~~l~r--d~~-~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGWREILER--DVR-NIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTHHHHHHH--HHH-HHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCCcccCCCCCcHHHHHH--HHH-HHHHHH-cCCCCCcccHHHHHHHHh
Confidence 999976543221110000 000 001122 345788899999865443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.80 E-value=7.4e-20 Score=160.62 Aligned_cols=111 Identities=15% Similarity=0.298 Sum_probs=92.1
Q ss_pred CcccCCCCccccCCCCCccccCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEEc
Q 003772 29 PKSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRT 108 (796)
Q Consensus 29 ~~~~~~g~~l~~~~~~~~~~S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~~ 108 (796)
+|+|.|||.|.+++.+ + +|.|+|.|+.+++ |.|++ ..++||.||++.| .+...|.|+.||+|+|+|
T Consensus 1 tDtL~~gq~L~~g~~l---~--~g~~~l~~q~DGN---Lvly~----~~~~vW~s~~~~~--~~~~~l~l~~dGnLvl~~ 66 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSL---A--EGGYLFIIQNDCN---LVLYD----NNRAVWASGTNGK--ASGCVLKMQNDGNLVIYS 66 (112)
T ss_dssp CCEEETTEEECTTCEE---E--ETTEEEEECTTSC---EEEEE----TTEEEEECCCTTS--CSSEEEEECTTSCEEEEE
T ss_pred CCEecCCCEecCCCEE---E--ECCEEEEEcCCCC---EEEEc----CCcEEEEccCccC--CCCcEEEEeccccEEEEe
Confidence 4789999999999875 3 5999999998774 55554 3689999999886 345789999999999999
Q ss_pred CCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccccCCCCc
Q 003772 109 EEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSSFKIPTD 154 (796)
Q Consensus 109 ~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtD 154 (796)
+ +..+|++++... +..+|+|+|+|||||++.++.++|||+.+|+|
T Consensus 67 ~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 67 G-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp T-TEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred c-CCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 6 567788775544 45679999999999999999999999999986
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.76 E-value=1.2e-18 Score=151.19 Aligned_cols=107 Identities=17% Similarity=0.273 Sum_probs=87.3
Q ss_pred CcccCCCCccccCCCCCccccCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEEc
Q 003772 29 PKSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRT 108 (796)
Q Consensus 29 ~~~~~~g~~l~~~~~~~~~~S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~~ 108 (796)
+++|.+|+.|.+++++ .+|.|.|+|+..++ |-++. ..++||+||++.|. ...+.|.|+.||+|||.|
T Consensus 1 ~~~L~~g~~L~~g~~l-----~~g~~~l~~q~dgn---Lvl~~----~~~~vW~ant~~~~-~~~~~l~l~~dGnLvl~~ 67 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSL-----DVEPYHFIMQEDCN---LVLYD----HSTSVWASNTGILG-KKGCKAVLQSDGNFVVYD 67 (109)
T ss_dssp CCEEETTCEEETTCEE-----EETTEEEEECTTSC---EEEEE----TTEEEEECCCCCTT-CCCCEEEECTTSCEEEEC
T ss_pred CCCccCCCEEeCCCEE-----EeCCEEEEecCCCe---EEEEe----CCEEEEEeCCCCCC-ceeEEEEEcCCceEEEEe
Confidence 3678899999988864 36899999987664 44443 36899999999984 456789999999999999
Q ss_pred CCCceeEeecCCC-CCceeEEEecCcCEEEeecCCCccccccCC
Q 003772 109 EEGHDKVVAAGKS-EPASSASMLDSGNFVLYNNRSDIIWSSFKI 151 (796)
Q Consensus 109 ~~g~~~w~t~~~~-~~~~~a~Lld~GNlVl~~~~~~~lWQSFD~ 151 (796)
++|.++|+|+++. .+...|+|+|+|||||+++ .+|||+-|
T Consensus 68 ~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 68 AEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp SSSCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred CCCcEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 9999999998764 4556799999999999963 59999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.76 E-value=7.4e-19 Score=155.11 Aligned_cols=102 Identities=22% Similarity=0.247 Sum_probs=88.9
Q ss_pred EEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEEcCCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccc
Q 003772 68 GIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIW 146 (796)
Q Consensus 68 giw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lW 146 (796)
-|||.++++++.+|++|++.|+.....+|.|+.||||+|.+. +..+|++++... ..+.|+|+|+|||||+|.+++++|
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 389999999999999999999988888999999999999985 678899887654 346799999999999999999999
Q ss_pred cccCCCCccccCCCCCCCCCeeeeccCCCCCCCccEEEEEecCCcEEEe
Q 003772 147 SSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLY 195 (796)
Q Consensus 147 QSFD~PtDtlLp~~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~ 195 (796)
|||. +.++|.|.+.||+||++++|
T Consensus 90 ~S~t-------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 90 TSGN-------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp ECCC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EeCC-------------------------CCCCCcEEEEECCCCcEEEe
Confidence 9963 45678899999999999998
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.76 E-value=1.1e-18 Score=151.39 Aligned_cols=105 Identities=15% Similarity=0.227 Sum_probs=87.2
Q ss_pred cccCCCCccccCCCCCccccCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEEcC
Q 003772 30 KSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTE 109 (796)
Q Consensus 30 ~~~~~g~~l~~~~~~~~~~S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~~~ 109 (796)
++|.+|++|.+++.+ .+|.|.|.|+.+++ |.||. ..++||.||++.| ++.+.|.|+.+|+|+|.|+
T Consensus 2 ~~L~~g~~L~~G~~l-----~ng~~~l~~q~DGN---Lvly~----~~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~ 67 (108)
T d1jpca_ 2 NILYSGETLSTGEFL-----NYGSFVFIMQEDCN---LVLYD----VDKPIWATNTGGL--SRSCFLSMQTDGNLVVYNP 67 (108)
T ss_dssp CEEETTEEECTTCEE-----EETTEEEEECTTSC---EEEEE----TTEEEEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred CCccCCCEecCCCEE-----EcCCEEEEECCCCe---EEEEe----CCceeeEeCCCCC--CCccEEEEeccceEEEECC
Confidence 678889999888854 36999999998874 66665 3589999999887 4567899999999999999
Q ss_pred CCceeEeecCCCCC-ceeEEEecCcCEEEeecCCCccccccCC
Q 003772 110 EGHDKVVAAGKSEP-ASSASMLDSGNFVLYNNRSDIIWSSFKI 151 (796)
Q Consensus 110 ~g~~~w~t~~~~~~-~~~a~Lld~GNlVl~~~~~~~lWQSFD~ 151 (796)
+|.++|++++.... ..+|+|+|+|||||++. .+||||+|
T Consensus 68 ~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 68 SNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp TCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred CccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 99999999865443 34689999999999964 59999987
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.67 E-value=1e-17 Score=145.99 Aligned_cols=111 Identities=20% Similarity=0.240 Sum_probs=97.4
Q ss_pred EEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEEcCCCceeEeecCCCCCceeEEEecCcCEEEeecCCCccccc
Q 003772 69 IWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSEPASSASMLDSGNFVLYNNRSDIIWSS 148 (796)
Q Consensus 69 iw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~~~~~~a~Lld~GNlVl~~~~~~~lWQS 148 (796)
|||.-.++.+..|..+.+.++.+...+|.|..||||||++ .+..+|++++....+..|.|+|+|||||++.++.++|||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEc
Confidence 7888778888899999999998888999999999999998 467899998877777889999999999999999999998
Q ss_pred cCCCCccccCCCCCCCCCeeeeccCCCCCCCccEEEEEecCCcEEEeeecCCCcccccccccccc
Q 003772 149 FKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQ 213 (796)
Q Consensus 149 FD~PtDtlLp~~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~ 213 (796)
+. +.+.|.|.+.|++||++++|. .++|.+++.
T Consensus 82 ~t-------------------------~~~~g~y~l~Lq~DGNlvlY~--------~~~Wssgt~ 113 (115)
T d1dlpa1 82 GT-------------------------KGSIGNYVLVLQPDRTVTIYG--------PGLWDSGTS 113 (115)
T ss_dssp CC-------------------------CCCSSCCEEEECSSSCEEEEC--------SEEEECSCC
T ss_pred CC-------------------------CCCCCCEEEEECCCCcEEEeC--------CCeecCCCC
Confidence 52 456899999999999999872 568988764
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.49 E-value=5.4e-14 Score=123.09 Aligned_cols=106 Identities=15% Similarity=0.223 Sum_probs=82.7
Q ss_pred CCCCcccCCCCccccCCCCCccccCCCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceE
Q 003772 26 HPQPKSIGLGSSLSPTKQPGSWNSSLGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLI 105 (796)
Q Consensus 26 ~~~~~~~~~g~~l~~~~~~~~~~S~~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lv 105 (796)
...+.+|.+||+|. ..+..|.|.|.|..+++ |-+ |+ ..++||.||+..| .....|.|..||+|+
T Consensus 11 ~~~~~~l~~~q~l~-------~~~~~~~y~l~mQ~DGN---LVL-y~---~~~~vWssnt~~~--~~~~~l~l~~dGnLv 74 (119)
T d1b2pa_ 11 DNHPQILHATESLE-------ILFGTHVYRFIMQTDCN---LVL-YD---NNNPIWATNTGGL--GNGCRAVLQPDGVLV 74 (119)
T ss_dssp SCCCCEEETTCEEE-------EEETTEEEEEEECTTSC---EEE-EE---TTEEEEECCCTTS--CSSCEEEECTTSCEE
T ss_pred CCCCCEEeCCCeEE-------EecCCceEEEEECCCCc---EEE-EE---CCeEEEEecCCCC--CcceEEEEEeCCCEE
Confidence 33446777777764 25778999999998875 333 33 3689999999775 345789999999999
Q ss_pred EEcCCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccccC
Q 003772 106 LRTEEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSSFK 150 (796)
Q Consensus 106 l~~~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQSFD 150 (796)
|.|++|..+|++.+... ...+++|+|+|||||++ ..+|||-.
T Consensus 75 L~d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp EECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred EECCCCcEEEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 99999999999887654 34568999999999995 47999954
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.16 E-value=6.4e-11 Score=103.19 Aligned_cols=84 Identities=23% Similarity=0.423 Sum_probs=68.2
Q ss_pred EEEEecCCceEEEcCCCceeEeecCCCC-CceeEEEecCcCEEEeecCCCccccccCCCCccccCCCCCCCCCeeeeccC
Q 003772 95 ALTLTKDGKLILRTEEGHDKVVAAGKSE-PASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSRIS 173 (796)
Q Consensus 95 ~l~l~~~G~Lvl~~~~g~~~w~t~~~~~-~~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtlLp~~~l~~~~~L~S~~s 173 (796)
.|.|..||||||.++ +..+|++++.+. ..+.++|.++|||||+|.++.++|+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~------------------------ 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP------------------------ 87 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS------------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECC------------------------
Confidence 577889999999985 568899987654 357899999999999999999999871
Q ss_pred CCCCCCccEEEEEecCCcEEEeeecCCCccccccccccc
Q 003772 174 ETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDS 212 (796)
Q Consensus 174 ~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~ 212 (796)
+.-+.|.|.+.|++||++++|. .+.|.+++
T Consensus 88 -t~~~~~~~~l~Lq~DGNlvlYg--------~~~W~S~T 117 (119)
T d1b2pa_ 88 -VAGKAGHYVLVLQPDRNVVIYG--------DALWATQT 117 (119)
T ss_dssp -CCCCSSCEEEEECTTSCEEEEE--------SEEEECCC
T ss_pred -CcCCCCceEEEEcCCCCEEEEC--------CCEeccCC
Confidence 1234578999999999999983 45788765
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.16 E-value=1.9e-11 Score=105.77 Aligned_cols=86 Identities=16% Similarity=0.275 Sum_probs=68.4
Q ss_pred CCeeeeeeeecCCCeEEEEEeecCCCCeEEEEeeCCCCCCCCCcEEEEecCCceEEEcCCCceeEeecCCCC-CceeEEE
Q 003772 51 LGAFQFGFYKQDAGFKVGIWLLTFPDITIVWTAYRDDPPVSSNAALTLTKDGKLILRTEEGHDKVVAAGKSE-PASSASM 129 (796)
Q Consensus 51 ~g~F~lgFf~~~~~~~lgiw~~~~~~~t~VWvANr~~p~~~~~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~~-~~~~a~L 129 (796)
+|.|.|.|..+++ |.|+. ..++||.+|... .....+.|.+||||||.|.++..+|++.+... +...++|
T Consensus 25 ~g~~~l~~q~DGN---LvL~~----~~~~vW~s~t~~---~~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~~g~y~l~L 94 (115)
T d1dlpa1 25 LSSFRFTMQSDCN---LVLFD----SDVRVWASNTAG---ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVL 94 (115)
T ss_dssp STTEEEEECTTSC---EEEEE----SSSEEECCCCCS---CSCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCEEEE
T ss_pred cCCEEEEECCCCe---EEEEc----CCeeEEEcccCC---CCceEEEEeccCCEEEEccCCCEEEEcCCCCCCCCEEEEE
Confidence 4779999988774 55643 257899998754 34678999999999999999999999887643 4456999
Q ss_pred ecCcCEEEeecCCCcccccc
Q 003772 130 LDSGNFVLYNNRSDIIWSSF 149 (796)
Q Consensus 130 ld~GNlVl~~~~~~~lWQSF 149 (796)
+++|||||++ ..+|+|-
T Consensus 95 q~DGNlvlY~---~~~Wssg 111 (115)
T d1dlpa1 95 QPDRTVTIYG---PGLWDSG 111 (115)
T ss_dssp CSSSCEEEEC---SEEEECS
T ss_pred CCCCcEEEeC---CCeecCC
Confidence 9999999994 4799984
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.06 E-value=2.3e-10 Score=99.87 Aligned_cols=111 Identities=22% Similarity=0.334 Sum_probs=76.8
Q ss_pred cCEEEeecCCCccc--cccCCCCccccCCCCCCCCCeeeeccCCCCCCCccEEEEEecCCcEEEeeecCCCccccccccc
Q 003772 133 GNFVLYNNRSDIIW--SSFKIPTDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWAS 210 (796)
Q Consensus 133 GNlVl~~~~~~~lW--QSFD~PtDtlLp~~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~ 210 (796)
||+|++++.+.++| +|+|.|+++|.++|.+ ..|.|+|.|+.||++++|.. ...+|.+
T Consensus 1 g~~v~~~~~n~il~~~~~~~~~~~~l~~~q~l---------------~~g~y~L~~q~DGNLvL~~~------~~~vW~s 59 (120)
T d1dlpa2 1 GSVVVANNGNSILYSTQGNDNHPQTLHATQSL---------------QLSPYRLSMETDCNLVLFDR------DDRVWST 59 (120)
T ss_dssp SCCCCSSCCCEECCCC--CCCCCCEECSSCCC---------------BCSSCEEEEETTTEEEEEBT------TBCCSCC
T ss_pred CcEEEEeCCCeEEEcCCCCCCcccEEcCCCee---------------EcCCEEEEEcCCCcEEEecC------CcEEEEE
Confidence 34444444444444 5679999999999998 35789999999999998842 2567877
Q ss_pred cccc-cceeEEEeecCceEEEEcCCcceeeeeecCCCCCccceeEEEEeecccEEEEE
Q 003772 211 DSQR-ERQLHLYLSNTGNLVLLDDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFS 267 (796)
Q Consensus 211 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~rl~L~~~G~l~~~~ 267 (796)
.... +......+..+|++++++.++...-. ..........|++|+.||+|++|.
T Consensus 60 ~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~---S~t~~~~~~~~l~Lq~DGnlvlY~ 114 (120)
T d1dlpa2 60 NTAGKGTGCRAVLQPNGRMDVLTNQNIAVWT---SGNSRSAGRYVFVLQPDRNLAIYG 114 (120)
T ss_dssp CCCSSCSSCEEEEETTTEEEEEETTTEEEEE---CCCCCSSSCCEEEECSSSCEEEEC
T ss_pred ccccCCCcEEEEEeCCeeEEEEcCCCCEEEE---eCCCCCCCcEEEEECCCCcEEEeC
Confidence 6543 33456778889999998887655433 222222334589999999999983
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.06 E-value=3e-10 Score=97.50 Aligned_cols=86 Identities=23% Similarity=0.506 Sum_probs=68.5
Q ss_pred CcEEEEecCCceEEEcCCCceeEeecCCC--CCceeEEEecCcCEEEeecCCCccccccCCCCccccCCCCCCCCCeeee
Q 003772 93 NAALTLTKDGKLILRTEEGHDKVVAAGKS--EPASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFS 170 (796)
Q Consensus 93 ~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~--~~~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtlLp~~~l~~~~~L~S 170 (796)
.-.|.|..||||||.+ .+..+|++++.. ..+..+.|.++|||||++.++.++|+|
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s---------------------- 76 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWAS---------------------- 76 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEEC----------------------
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEE----------------------
Confidence 4678889999999997 567899988653 345679999999999999999999988
Q ss_pred ccCCCCCCCccEEEEEecCCcEEEeeecCCCccccccccccc
Q 003772 171 RISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDS 212 (796)
Q Consensus 171 ~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~ 212 (796)
.+..+.|.|.+.|+++|++++|. .+.|.+++
T Consensus 77 ---~t~~~~~~~~l~L~ddGNlvly~--------~~~W~S~t 107 (109)
T d1kj1a_ 77 ---HSVRGNGNYVLVLQEDGNVVIYG--------SDIWSTGT 107 (109)
T ss_dssp ---CCCCCSSCCEEEECTTSCEEEEC--------CEEEECCC
T ss_pred ---eeECCCCCEEEEEeCCCcEEEEC--------CCEecCCC
Confidence 11223578899999999999982 34787654
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.06 E-value=3.9e-10 Score=96.73 Aligned_cols=86 Identities=26% Similarity=0.449 Sum_probs=69.0
Q ss_pred CcEEEEecCCceEEEcCCCceeEeecCCCCC-ceeEEEecCcCEEEeecCCCccccccCCCCccccCCCCCCCCCeeeec
Q 003772 93 NAALTLTKDGKLILRTEEGHDKVVAAGKSEP-ASSASMLDSGNFVLYNNRSDIIWSSFKIPTDTILGNQSLLAGNELFSR 171 (796)
Q Consensus 93 ~~~l~l~~~G~Lvl~~~~g~~~w~t~~~~~~-~~~a~Lld~GNlVl~~~~~~~lWQSFD~PtDtlLp~~~l~~~~~L~S~ 171 (796)
.-+|.+..||||||++ .+.++|++++.... ...++|+++|||||++.++.++|+|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS----------------------- 75 (108)
T d1jpca_ 20 SFVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS----------------------- 75 (108)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC-----------------------
T ss_pred CEEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc-----------------------
Confidence 4578899999999998 45789998876543 4579999999999999999999987
Q ss_pred cCCCCCCCccEEEEEecCCcEEEeeecCCCccccccccccc
Q 003772 172 ISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDS 212 (796)
Q Consensus 172 ~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~ 212 (796)
.+..+.+.|.+.|+.+|++++|. .+.|.++.
T Consensus 76 --~t~~~~~~~~l~L~ddGNlVly~--------~~~W~S~t 106 (108)
T d1jpca_ 76 --NTGGQNGNYVCILQKDRNVVIYG--------TDRWATGT 106 (108)
T ss_dssp --CCCCSCSCEEEEECTTSCEEEEE--------CCCCCCCC
T ss_pred --cccCCCCcEEEEEcCCCCEEEeC--------CCcccCCC
Confidence 12234678899999999999983 34687654
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.95 E-value=2e-09 Score=93.06 Aligned_cols=110 Identities=25% Similarity=0.403 Sum_probs=80.9
Q ss_pred CccccCCCCCCCCCeeeeccCCCCCCCccEEEEEecCCcEEEeeecCCCccccccccccccc-cceeEEEeecCceEEEE
Q 003772 153 TDTILGNQSLLAGNELFSRISETSSSTGRFRLNMQRDGNLVLYPINTIDDYTEAYWASDSQR-ERQLHLYLSNTGNLVLL 231 (796)
Q Consensus 153 tDtlLp~~~l~~~~~L~S~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~yw~~~~~~-~~~~~~~~~~~~~~~~~ 231 (796)
||||+|||.|..|+.|++ |.|+|.|+.||++++|.. ..++|.++... +......+..+|+++++
T Consensus 1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~~------~~~vW~s~~~~~~~~~~l~l~~dGnLvl~ 65 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDN------NRAVWASGTNGKASGCVLKMQNDGNLVIY 65 (112)
T ss_dssp CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEET------TEEEEECCCTTSCSSEEEEECTTSCEEEE
T ss_pred CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEcC------CcEEEEccCccCCCCcEEEEeccccEEEE
Confidence 799999999999999964 999999999999999842 25688876543 34456788899999988
Q ss_pred cCCcceeeeeecCCCCCccceeEEEEeecccEEEEEeccCCCCCcceeEEeeccCCCC
Q 003772 232 DDSMGIIKDLYESPSNNSSIIRRLTIGHNGILRLFSHYPVPKGAYNTSVDWNVPDDLC 289 (796)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~s~~~rl~L~~~G~l~~~~~~~~~~~~~~w~~~w~~p~d~C 289 (796)
+.... .+...........+++|+.||+|++|.- .....|+...+.|
T Consensus 66 ~~~~~----~w~s~t~~~~~~~~l~L~ddGNlvly~~--------~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 66 SGSRA----IWASNTNRQNGNYYLILQRDRNVVIYDN--------SNNAIWATHTNVG 111 (112)
T ss_dssp ETTEE----EEECCCCCSCCCCEEEECTTSCEEEECT--------TSCEEEECCCCCC
T ss_pred ecCCe----EEEEeeccCCCceEEEEcCCCCEEEECC--------CCcEEecCCCccC
Confidence 75432 2233333334457899999999999832 1245688776655
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.98 E-value=7.3e-06 Score=81.62 Aligned_cols=132 Identities=14% Similarity=0.056 Sum_probs=92.6
Q ss_pred ccceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccC-cCchhhhhhhhccCCceeEEEeecCCCChhhhhh
Q 003772 522 GSFGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTH-HKNLVRLIGYCAEDSKRLLVYEYMSNGSLADILF 600 (796)
Q Consensus 522 G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~ 600 (796)
+..+.||+... ++..+.+|+...........+.+|...+..+. +--+.+++.+..+++..++||+++++.++.+...
T Consensus 25 ~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~ 102 (263)
T d1j7la_ 25 MSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp CSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred CCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc
Confidence 33468998764 34467888887655444556788888887764 3335677777777888999999999988866542
Q ss_pred cCCCCCCchhHHHHHHHHHHHHHHHhhccC--------------------------------------------------
Q 003772 601 RGPERSLGWDERVRIASDVAKGILYLHDEC-------------------------------------------------- 630 (796)
Q Consensus 601 ~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-------------------------------------------------- 630 (796)
. ......++.++++.+..||+..
T Consensus 103 ~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 103 D-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp T-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred c-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 2 1123345566666666666421
Q ss_pred ------CCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 631 ------EAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 631 ------~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
...++|+|+.|.||+++++...-|+||+.+..
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999877778999999864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.36 E-value=0.00032 Score=73.78 Aligned_cols=77 Identities=17% Similarity=0.188 Sum_probs=47.3
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEEeeccc-------chhHHHHHHHHHHHhccC-c--CchhhhhhhhccCCceeEE
Q 003772 517 EELGKGSFGAVYKGTLYKGEKLVAVKKLEKMV-------TEGEREFRAEMHVIGRTH-H--KNLVRLIGYCAEDSKRLLV 586 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-------~~~~~~f~~E~~~l~~l~-h--~niv~l~g~~~~~~~~~lV 586 (796)
+.||.|....||+....++++.++||.-.... .....+...|.+.|..+. + ..+++++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 56899999999999987777889999753211 111233456777776652 2 234444443 45567899
Q ss_pred EeecCCCCh
Q 003772 587 YEYMSNGSL 595 (796)
Q Consensus 587 ~e~~~~gsL 595 (796)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.32 E-value=0.00026 Score=69.48 Aligned_cols=130 Identities=16% Similarity=0.118 Sum_probs=82.7
Q ss_pred cCccc-ceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCc--CchhhhhhhhccCCceeEEEeecCCCCh
Q 003772 519 LGKGS-FGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHH--KNLVRLIGYCAEDSKRLLVYEYMSNGSL 595 (796)
Q Consensus 519 LG~G~-fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL 595 (796)
+..|. .+.||+..... +..+.+|..... ....+..|+..++.+.. -.+.+++.+..+++..++||+++++-++
T Consensus 18 ~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQG-RPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTT-SCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCC-CCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 44444 36799988754 445777875432 23356778887777643 3356677777788889999999988665
Q ss_pred hhhhhcCCCCCCchhHHHHHHHHHHHHHHHhhc-----------------------------------------------
Q 003772 596 ADILFRGPERSLGWDERVRIASDVAKGILYLHD----------------------------------------------- 628 (796)
Q Consensus 596 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~~LH~----------------------------------------------- 628 (796)
.+.. .. ....+.++++.|.-||+
T Consensus 94 ~~~~-------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cccc-------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 4311 00 11122233333333332
Q ss_pred ----c----CCCCeeeeccCccceEecCCCceEEeccCCccc
Q 003772 629 ----E----CEAPIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 629 ----~----~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
. ....++|+|+.|.||+++++..+-|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 112479999999999999887778999999854
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.81 E-value=0.0074 Score=61.15 Aligned_cols=135 Identities=11% Similarity=0.055 Sum_probs=74.9
Q ss_pred ceEEEEEEEcCCcEEEEEEEeecccchhHHHHHHHHHHHhccCcCchhh--hhh-----hhccCCceeEEEeecCCCChh
Q 003772 524 FGAVYKGTLYKGEKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNLVR--LIG-----YCAEDSKRLLVYEYMSNGSLA 596 (796)
Q Consensus 524 fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~niv~--l~g-----~~~~~~~~~lV~e~~~~gsL~ 596 (796)
--.||+...+++ ..+++|+..... ...+++..|...+..|...++.- .+. ....++..+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg-~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDEDR-RRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCTTC-CCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcCCC-CEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 358999998655 568889875432 23566788888888775433321 111 112344578899998764332
Q ss_pred h----hh----------hc----C---CCCCCc-------------------hhHHHHHHHHHHHHHHHhh----ccCCC
Q 003772 597 D----IL----------FR----G---PERSLG-------------------WDERVRIASDVAKGILYLH----DECEA 632 (796)
Q Consensus 597 ~----~l----------~~----~---~~~~l~-------------------~~~~~~i~~~ia~aL~~LH----~~~~~ 632 (796)
. .+ +. . ....++ ...+..+...+.+.+..+. +....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 11 00 0 001111 1111122222222233332 22245
Q ss_pred CeeeeccCccceEecCCCceEEeccCCccc
Q 003772 633 PIIHCDIKPQNILMDEFWTAKISDFGLAKL 662 (796)
Q Consensus 633 ~ivH~Dlkp~NIll~~~~~~kl~DFgl~~~ 662 (796)
+++|+|+++.|||++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 78999999999999754 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.50 E-value=0.013 Score=61.04 Aligned_cols=73 Identities=18% Similarity=0.188 Sum_probs=48.4
Q ss_pred cccCcccceEEEEEEEcCC-------cEEEEEEEeecccchhHHHHHHHHHHHhccCcCch-hhhhhhhccCCceeEEEe
Q 003772 517 EELGKGSFGAVYKGTLYKG-------EKLVAVKKLEKMVTEGEREFRAEMHVIGRTHHKNL-VRLIGYCAEDSKRLLVYE 588 (796)
Q Consensus 517 ~~LG~G~fg~Vy~g~~~~~-------~~~vAvK~l~~~~~~~~~~f~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e 588 (796)
+.|+.|---.+|+...... .+.|.+++.... ...-...+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4678888889999987543 345777776532 223345678888888753444 466776643 68899
Q ss_pred ecCCCCh
Q 003772 589 YMSNGSL 595 (796)
Q Consensus 589 ~~~~gsL 595 (796)
|+++-+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.75 E-value=0.0053 Score=37.99 Aligned_cols=33 Identities=30% Similarity=0.490 Sum_probs=26.5
Q ss_pred CCCCcccCCCCCCCCcccCCCCCcccCCCCCCcC
Q 003772 286 DDLCEVKTFCGLNSYCTLYDDQPMCRCLPGTDFL 319 (796)
Q Consensus 286 ~d~Cd~~~~CG~~g~C~~~~~~~~C~Cl~GF~p~ 319 (796)
.|.|.+-..|| +|.|+.-...-.|.|-+||+|.
T Consensus 1 tdECsignpCG-nGTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 1 TDECSVGNPCG-NGTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CCGGGTTCSSS-SSCEEECSSSEEECCSSSSCCC
T ss_pred CCccccCCccC-CceeeecccceEEeecCCcCCC
Confidence 37899999999 7899753344569999999985
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.18 E-value=0.19 Score=49.82 Aligned_cols=31 Identities=26% Similarity=0.267 Sum_probs=28.0
Q ss_pred CCCeeeeccCccceEecCCCceEEeccCCcc
Q 003772 631 EAPIIHCDIKPQNILMDEFWTAKISDFGLAK 661 (796)
Q Consensus 631 ~~~ivH~Dlkp~NIll~~~~~~kl~DFgl~~ 661 (796)
..++||+|+.++||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4579999999999999998878999999985
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.37 E-value=0.11 Score=34.33 Aligned_cols=31 Identities=26% Similarity=0.517 Sum_probs=24.7
Q ss_pred CCCcc-cCCCCCCCCcccCCCCCcccCCCCCC
Q 003772 287 DLCEV-KTFCGLNSYCTLYDDQPMCRCLPGTD 317 (796)
Q Consensus 287 d~Cd~-~~~CG~~g~C~~~~~~~~C~Cl~GF~ 317 (796)
|.|.. ...|..+|.|.....+-.|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 66875 46899999997544566899999996
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.30 E-value=0.22 Score=32.24 Aligned_cols=30 Identities=30% Similarity=0.596 Sum_probs=23.6
Q ss_pred CCCcccCCCCCCCCcccCCCCCcccCCCCCC
Q 003772 287 DLCEVKTFCGLNSYCTLYDDQPMCRCLPGTD 317 (796)
Q Consensus 287 d~Cd~~~~CG~~g~C~~~~~~~~C~Cl~GF~ 317 (796)
|.|. ...|...|.|.....+-.|.|++||+
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFE 30 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEE
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCC
Confidence 4565 47899999997645577899999986
|